Citrus Sinensis ID: 044428

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------
Protein Sequence
MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAKTN
Secondary Structure (PSIPRED)
ccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEccccccccccHHHHHHHHHcccccccccEEEEcccccccEEEEccccccccHHHcccccccccHHHHHHHHHHHHHHHHHHccccccccEEEccccccccccccccEEEEccccccccccccccccEEEEccccccccccccccccccccccHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccccccEEEEcccccccccccHHHcccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccEccHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHcHHHHHccccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccHHHEEEcccccEEEccccccEEcccccccEEEEEEEcccccccccHcccccccHHHHHHHHHHHHccccccccccccHHHHHHHHHHHccHHHHccHHHccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
mtigglkdLATLSLAAnkfhgpipksfgslislesldlssnnlsgeipKSLEALLYLKQLNVSQnrlegeipvegpfrnfstesfswnyalcgpsrfqvppckeennkrSKKVALLVLNYILPPIISIMLLLIAIIVYVRcqnrstkksdeedllplvtwRRISYLDIQRAtnefdecnllgigsfgsvykgtlsdgtNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEfmpngslekwLYSHNYFLDILERLNIMIDVGLALEYLhyghalapiihcdlkpsnilldenmvahvsdfgiskllgegddsliqtktmatigymapegivstkcdvYSYGILLLETFsrkkptndlgemslkhwvnqslphklaevvdsnlvrrehsFSAKMDCLLRIMNLALdccmespderiHTTNAAAKLRKIKVQFLDDVAKTN
Flexible Loop (DISEMBL)
MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCqnrstkksdeedllplvTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAKTN
Low Complexity Region (SEG)
MTIGGLKDLATLSLAANKFHGPIPKSFGslislesldlssnnlsGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYilppiisimllliaiiVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAKTN
Disordered region (IsUnstruct)
********LATLSLAANKFHGPIPKSFGSLISLE************IPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVP**********KKVALLVLNYILPPIISIMLLLIAIIVYVRCQNR*******EDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL*******
Disordered Region (DISOPRED)
MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPS**********************LNYILPPIISIMLLLIAIIVYV*********************RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD***I*TKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD*****
Disordered Region (DISEMBL)
MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAKTN
Disordered Region (DISPRO)
*TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENN***KKVALLVLNYILPPIISIMLLLIAIIVYVRCQNR*********LLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI**Q*********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAKTN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	457	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.978	0.442	0.385	3e-85
C0LGT6	1031	LRR receptor-like serine/	no	no	0.956	0.423	0.381	2e-75
Q9SD62	1025	Putative receptor-like pr	no	no	0.978	0.436	0.383	3e-68
Q9FL28	1173	LRR receptor-like serine/	no	no	0.954	0.371	0.352	4e-65
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.940	0.438	0.342	1e-63
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.943	0.427	0.333	2e-54
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.949	0.362	0.321	6e-54
C0LGF4	591	LRR receptor-like serine/	no	no	0.905	0.700	0.353	8e-54
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.949	0.425	0.326	9e-54
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.967	0.379	0.327	2e-53

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  316 bits (809), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 194/503 (38%), Positives = 284/503 (56%), Gaps = 56/503 (11%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESL-----------------------DLS 39
            IG L++L TLSL  NK  G +P++ G+ +++ESL                       DLS
Sbjct: 501  IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLS 560

Query: 40   SNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGP-SRFQ 98
            +N+LSG IP+   +   L+ LN+S N LEG++PV+G F N +T S   N  LCG    FQ
Sbjct: 561  NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQ 620

Query: 99   VPPCKEENNKRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPL- 157
            + PC  +     KK +  +   ++   + I LLL+  +  V       +K ++E   P  
Sbjct: 621  LKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTP 680

Query: 158  ----VTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERT 212
                V   +ISY D++ ATN F   N++G GSFG+VYK   L++   VA+K+ N+Q    
Sbjct: 681  STLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGA 740

Query: 213  FVSFNSECEVLRNVRHRNLIKILSGCSNLD-----FKALVLEFMPNGSLEKWLYSH---- 263
              SF +ECE L+++RHRNL+K+L+ CS++D     F+AL+ EFMPNGSL+ WL+      
Sbjct: 741  MKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEE 800

Query: 264  ----NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG 319
                +  L +LERLNI IDV   L+YLH  H   PI HCDLKPSN+LLD+++ AHVSDFG
Sbjct: 801  IHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNVLLDDDLTAHVSDFG 859

Query: 320  ISKLLGEGDD-----SLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKK 370
            +++LL + D+      L       TIGY APE    G  S   DVYS+GILLLE F+ K+
Sbjct: 860  LARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKR 919

Query: 371  PTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS-AKMDCLLRIMNLALDCCME 427
            PTN+L  G  +L  +   +LP ++ ++VD +++          ++CL  +  + L CC E
Sbjct: 920  PTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEE 979

Query: 428  SPDERIHTTNAAAKLRKIKVQFL 450
            SP  R+ T+    +L  I+ +F 
Sbjct: 980  SPMNRLATSIVVKELISIRERFF 1002

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  283 bits (724), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 184/482 (38%), Positives = 263/482 (54%), Gaps = 45/482 (9%)

Query: 2    TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
             IGG   +  L +  N F G IP     L+SL+++D S+NNLSG IP+ L +L  L+ LN
Sbjct: 532  AIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLN 590

Query: 62   VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSR-FQVPPCKEENNKRSKKVALLVLNY 120
            +S N+ EG +P  G FRN +  S   N  +CG  R  Q+ PC  + + R +K   +    
Sbjct: 591  LSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKV 650

Query: 121  ILPPIISIMLLLIAIIVYVRCQ-NRSTKKSDEEDLLPL------VTWRRISYLDIQRATN 173
            +    I I  LL+ IIV   C   +  KK++  D  P       +   ++SY ++  AT+
Sbjct: 651  VSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATS 710

Query: 174  EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
             F   NL+G G+FG+V+KG L  +   VA+K+ NL       SF +ECE  + +RHRNL+
Sbjct: 711  RFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLV 770

Query: 233  KILSGCSNL-----DFKALVLEFMPNGSLEKWLY--------SHNYFLDILERLNIMIDV 279
            K+++ CS+L     DF+ALV EFMP GSL+ WL          H+  L   E+LNI IDV
Sbjct: 771  KLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDV 830

Query: 280  GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD-----DSLIQT 334
              ALEYLH  H   P+ HCD+KPSNILLD+++ AHVSDFG+++LL + D     +     
Sbjct: 831  ASALEYLHV-HCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSA 889

Query: 335  KTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTND--LGEMSLKHWVNQSL 388
                TIGY APE    G  S + DVYS+GILLLE FS KKPT++   G+ +L H   +S+
Sbjct: 890  GVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNL-HSYTKSI 948

Query: 389  PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ 448
                     SN +          + L  ++ + + C  E P +R+ T  A  +L  I+ +
Sbjct: 949  LSGCTSSGGSNAID---------EGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSK 999

Query: 449  FL 450
            F 
Sbjct: 1000 FF 1001

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  259 bits (662), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 187/487 (38%), Positives = 271/487 (55%), Gaps = 40/487 (8%)

Query: 2    TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            T+     L  L L  N F GPIP   G L  L  LDLS NNLSG IP+ +     L+ LN
Sbjct: 540  TLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLN 598

Query: 62   VSQNRLEGEIPVEGPFRNFSTESFSWNYALCG--PSRFQVPPCKEENNKRS---KKVALL 116
            +S N  +G +P EG FRN S  S   N  LCG  PS  Q+ PC  E  +R    +K+  +
Sbjct: 599  LSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS-LQLQPCSVELPRRHSSVRKIITI 657

Query: 117  VLNYILPPIISIMLLLIAIIVY-VRCQN-RSTKKSDEEDLLPLVT-WRRISYLDIQRATN 173
             ++ ++  ++ + L ++ +  Y +R ++ R+    ++    P+ + + +ISY ++ + T 
Sbjct: 658  CVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTG 717

Query: 174  EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
             F   NL+G G+FG+V+KG L S    VAIK+ NL       SF +ECE L  +RHRNL+
Sbjct: 718  GFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLV 777

Query: 233  KILSGCSNL-----DFKALVLEFMPNGSLEKWLY--------SHNYFLDILERLNIMIDV 279
            K+++ CS+      DF+ALV EFMPNG+L+ WL+        + +  L +  RLNI IDV
Sbjct: 778  KLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDV 837

Query: 280  GLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK--- 335
              AL YLH Y H   PI HCD+KPSNILLD+++ AHVSDFG+++LL + D      +   
Sbjct: 838  ASALVYLHTYCH--NPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSS 895

Query: 336  --TMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDL--GEMSLKHWVNQS 387
                 TIGY APE    G  S   DVYS+GI+LLE F+ K+PTN L    ++L  +   +
Sbjct: 896  AGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSA 955

Query: 388  LPHKLA-EVVDSNLVRREHSFSAKM-DCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
            L  + A ++ D  ++R  ++    M +CL  +  + + C  ESP  RI    A +KL  I
Sbjct: 956  LQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSI 1015

Query: 446  KVQFLDD 452
            +  F  D
Sbjct: 1016 RESFFRD 1022

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  249 bits (635), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 165/468 (35%), Positives = 274/468 (58%), Gaps = 32/468 (6%)

Query: 5    GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            G+  + +L+L+ N F G IP+SFG++  L SLDLSSNNL+GEIP+SL  L  LK L ++ 
Sbjct: 696  GMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLAS 755

Query: 65   NRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPC--KEENNKRSKKVALLVLNYIL 122
            N L+G +P  G F+N +      N  LCG S+  + PC  K++++  SK+  ++++  IL
Sbjct: 756  NNLKGHVPESGVFKNINASDLMGNTDLCG-SKKPLKPCTIKQKSSHFSKRTRVILI--IL 812

Query: 123  PPIISIMLLLIAIIVYVRCQN-----RSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDE 177
                +++L+L+ +++   C+       ++ +S   DL   +  +R    ++++AT+ F+ 
Sbjct: 813  GSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNS 872

Query: 178  CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVS---FNSECEVLRNVRHRNLIKI 234
             N++G  S  +VYKG L DGT +A+K+ NL+ E +  S   F +E + L  ++HRNL+KI
Sbjct: 873  ANIIGSSSLSTVYKGQLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLKHRNLVKI 931

Query: 235  LS-GCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            L     +   KALVL FM NG+LE  ++ S      +LE++++ + +   ++YLH G+  
Sbjct: 932  LGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGF 991

Query: 293  APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA---TIGYMAPEGI- 348
             PI+HCDLKP+NILLD + VAHVSDFG +++LG  +D      T A   TIGY+APE   
Sbjct: 992  -PIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAY 1050

Query: 349  ---VSTKCDVYSYGILLLETFSRKKPTN----DLGEMSLKHWVNQSLPH---KLAEVVDS 398
               V+TK DV+S+GI+++E  ++++PT+    D  +M+L+  V +S+ +    +  V+D 
Sbjct: 1051 MRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDM 1110

Query: 399  NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             L     S   + + +   + L L C    P++R         L K++
Sbjct: 1111 ELGDSIVSLKQE-EAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  244 bits (622), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 169/493 (34%), Positives = 254/493 (51%), Gaps = 63/493 (12%)

Query: 11  TLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE 70
           ++ L++N+  G IP   GS I+LE L+LS N  S  +P SL  L YLK+L+VS NRL G 
Sbjct: 471 SVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGA 530

Query: 71  IPV------------------------EGPFRNFSTESFSWNYALCGPSRFQVPPCKEEN 106
           IP                         +G F   + ESF  +  LCG  +  +  CK+++
Sbjct: 531 IPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKH 589

Query: 107 N-------KRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVT 159
                        +A  VL     P++        + VY + +    +K ++ D      
Sbjct: 590 KYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQND----PK 645

Query: 160 WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV-SFNS 218
           + RISY  +  AT  F+  +L+G G FG VYKG L + T VA+K+ + +    F  SF  
Sbjct: 646 YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR 705

Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---LDILERLNI 275
           EC++L+  RHRNLI+I++ CS   F ALVL  MPNGSLE+ LY   Y    LD+++ +NI
Sbjct: 706 ECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNI 765

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG------EGDD 329
             DV   + YLH+ ++   ++HCDLKPSNILLD+ M A V+DFGIS+L+         DD
Sbjct: 766 CSDVAEGIAYLHH-YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDD 824

Query: 330 SLIQTKT----MATIGYMAPE-GI---VSTKCDVYSYGILLLETFSRKKPTNDLGE--MS 379
           S+    T      ++GY+APE G+    ST  DVYS+G+LLLE  S ++PT+ L     S
Sbjct: 825 SVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSS 884

Query: 380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAK------MDCLLRIMNLALDCCMESPDERI 433
           L  ++    P  L  +++  L R +     +       + +L ++ L L C   +P  R 
Sbjct: 885 LHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRP 944

Query: 434 HTTNAAAKLRKIK 446
              + A ++ ++K
Sbjct: 945 DMLDVAHEMGRLK 957

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  213 bits (543), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 162/486 (33%), Positives = 241/486 (49%), Gaps = 55/486 (11%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
             G LK L    L  N   G IP S   + SLE+LDLS+N LSG IP SL+ L +L + +V
Sbjct: 543  FGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSV 602

Query: 63   SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENN----KRSKKVALLVL 118
            + N L G IP  G F+ F   SF  N+ LCG  RF   PC E       KRS++     +
Sbjct: 603  AYNNLSGVIPSGGQFQTFPNSSFESNH-LCGEHRF---PCSEGTESALIKRSRRSRGGDI 658

Query: 119  NYILP-PIISIMLLLIAIIVYVRCQNRSTKKSDEED------------------LLPLVT 159
               +     S+ LL +  ++ +R + RS +   E +                  +L    
Sbjct: 659  GMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELGEIGSKLVVLFQSN 718

Query: 160  WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSE 219
             + +SY D+  +TN FD+ N++G G FG VYK TL DG  VAIK  +    +    F +E
Sbjct: 719  DKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAE 778

Query: 220  CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIM 276
             E L   +H NL+ +   C   + + L+  +M NGSL+ WL+  N     L    RL I 
Sbjct: 779  VETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIA 838

Query: 277  IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
                  L YLH G     I+H D+K SNILLDEN  +H++DFG+++L+    ++ + T  
Sbjct: 839  QGAAKGLLYLHEG-CDPHILHRDIKSSNILLDENFNSHLADFGLARLMSP-YETHVSTDL 896

Query: 337  MATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTN---DLGEMSLKHWVNQSLP 389
            + T+GY+ PE     + + K DVYS+G++LLE  + K+P +     G   L  WV + + 
Sbjct: 897  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVK-MK 955

Query: 390  H--KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV 447
            H  + +EV D  +  +E+        + R++ +A  C  E+P +R  T           V
Sbjct: 956  HESRASEVFDPLIYSKENDKE-----MFRVLEIACLCLSENPKQRPTTQQL--------V 1002

Query: 448  QFLDDV 453
             +LDDV
Sbjct: 1003 SWLDDV 1008

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  212 bits (539), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 160/498 (32%), Positives = 240/498 (48%), Gaps = 64/498 (12%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            IG +  L  L+L  N   G IP   G L  L  LDLSSN L G IP+++ AL  L ++++
Sbjct: 674  IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 733

Query: 63   SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEEN------NKRS--KKVA 114
            S N L G IP  G F  F    F  N  LCG   + +P C   N      ++RS  ++ A
Sbjct: 734  SNNNLSGPIPEMGQFETFPPAKFLNNPGLCG---YPLPRCDPSNADGYAHHQRSHGRRPA 790

Query: 115  LLVLNYILPPIISIMLLLIAIIV-----------------YVRCQNRSTKKSDEEDLLPL 157
             L  +  +  + S + +   I+V                 Y      S  ++       L
Sbjct: 791  SLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKL 850

Query: 158  V---------------TWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAI 202
                              R++++ D+ +ATN F   +L+G G FG VYK  L DG+ VAI
Sbjct: 851  TGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAI 910

Query: 203  KIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKW 259
            K     + Q +R F++   E E +  ++HRNL+ +L  C   D + LV EFM  GSLE  
Sbjct: 911  KKLIHVSGQGDREFMA---EMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDV 967

Query: 260  LYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAP-IIHCDLKPSNILLDENMVAHV 315
            L+        L+   R  I I     L +LH  H  +P IIH D+K SN+LLDEN+ A V
Sbjct: 968  LHDPKKAGVKLNWSTRRKIAIGSARGLAFLH--HNCSPHIIHRDMKSSNVLLDENLEARV 1025

Query: 316  SDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKC----DVYSYGILLLETFSRKKP 371
            SDFG+++L+   D  L  +    T GY+ PE   S +C    DVYSYG++LLE  + K+P
Sbjct: 1026 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1085

Query: 372  TN--DLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESP 429
            T+  D G+ +L  WV Q    ++++V D  L++ + +   +   LL+ + +A+ C  +  
Sbjct: 1086 TDSPDFGDNNLVGWVKQHAKLRISDVFDPELMKEDPALEIE---LLQHLKVAVACLDDRA 1142

Query: 430  DERIHTTNAAAKLRKIKV 447
              R       A  ++I+ 
Sbjct: 1143 WRRPTMVQVMAMFKEIQA 1160

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  211 bits (538), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 164/464 (35%), Positives = 237/464 (51%), Gaps = 50/464 (10%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +G    L  + L +N F GPIP   G L  L+ LD+SSN LSG IP SL  L  L   N
Sbjct: 117 ALGNCTALEEIHLQSNYFTGPIPAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFN 176

Query: 62  VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQV-------PPCKEENNKRSKKVA 114
           VS N L G+IP +G    FS  SF  N  LCG     V       P    ++ +  KK +
Sbjct: 177 VSNNFLVGQIPSDGVLSGFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNS 236

Query: 115 LLVLNYILPPIISIMLLLIAIIVYVRC-----QNRSTKKSDEEDL---LPLVTWRR---I 163
             +L  I        LLL+A++ +  C       +   KS  +D+     +V +      
Sbjct: 237 GKLL--ISASATVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPY 294

Query: 164 SYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSF-NSECEV 222
           S  DI +     +E +++G G FG+VYK  + DG   A+K   L+L   F  F   E E+
Sbjct: 295 SSKDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRI-LKLNEGFDRFFERELEI 353

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           L +++HR L+ +   C++   K L+ +++P GSL++ L+     LD   R+NI+I     
Sbjct: 354 LGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKG 413

Query: 283 LEYLHYGHALAP-IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           L YLH  H  +P IIH D+K SNILLD N+ A VSDFG++KLL E ++S I T    T G
Sbjct: 414 LSYLH--HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFG 470

Query: 342 YMAPE----GIVSTKCDVYSYGILLLETFSRKKPT---------NDLGEMSLKHWVNQSL 388
           Y+APE    G  + K DVYS+G+L+LE  S K+PT         N +G   LK  +++  
Sbjct: 471 YLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGW--LKFLISEKR 528

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           P    ++VD N          +M+ L  ++++A  C   SP+ER
Sbjct: 529 PR---DIVDPNCE------GMQMESLDALLSIATQCVSPSPEER 563

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  211 bits (537), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 156/478 (32%), Positives = 241/478 (50%), Gaps = 44/478 (9%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
             G L+ L  L+L  N   G IP +   + SLE LDLS NNLSG IP SL  L +L   +V
Sbjct: 553  FGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIPPSLVKLSFLSTFSV 612

Query: 63   SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENN-------KRSKKVAL 115
            + N+L G IP    F+ F   SF  N  LCG       PC   +        K  K +  
Sbjct: 613  AYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGE---HASPCHITDQSPHGSAVKSKKNIRK 669

Query: 116  LVLNYILPPIISIMLLLIAIIVYVRCQNRST----KKSDEEDL----LPLVTWR------ 161
            +V   +   + ++ LL + +++ +R  +R      KK+D +++      +V +       
Sbjct: 670  IVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKADADEIELGSRSVVLFHNKDSNN 729

Query: 162  RISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECE 221
             +S  DI ++T+ F++ N++G G FG VYK TL DGT VAIK  +    +    F +E E
Sbjct: 730  ELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLSGDTGQMDREFQAEVE 789

Query: 222  VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMID 278
             L   +H NL+ +L  C+  + K L+  +M NGSL+ WL+        LD   RL I   
Sbjct: 790  TLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVDGPPSLDWKTRLRIARG 849

Query: 279  VGLALEYLHYGHALAP-IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
                L YLH   +  P I+H D+K SNILL +  VAH++DFG+++L+    D+ + T  +
Sbjct: 850  AAEGLAYLH--QSCEPHILHRDIKSSNILLSDTFVAHLADFGLARLILP-YDTHVTTDLV 906

Query: 338  ATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTN---DLGEMSLKHWVNQSLPH 390
             T+GY+ PE     + + K DVYS+G++LLE  + ++P +     G   L  WV Q    
Sbjct: 907  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMDVCKPRGSRDLISWVLQMKTE 966

Query: 391  KL-AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV 447
            K  +E+ D  +  ++H+     + +L ++ +A  C  E+P  R  T    + L  I V
Sbjct: 967  KRESEIFDPFIYDKDHA-----EEMLLVLEIACRCLGENPKTRPTTQQLVSWLENIDV 1019

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  210 bits (535), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 161/492 (32%), Positives = 237/492 (48%), Gaps = 50/492 (10%)

Query: 4    GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
            G +  L  L+L  N+  G IP SFG L ++  LDLS NNL G +P SL +L +L  L+VS
Sbjct: 660  GNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVS 719

Query: 64   QNRLEGEIPVEGPFRNFSTESFSWNYALCG-PSR--FQVP--PCKEENNKRSKKVALLVL 118
             N L G IP  G    F    ++ N  LCG P R     P  P     + + + VA  V+
Sbjct: 720  NNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVI 779

Query: 119  NYILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPL---VTW--------------- 160
              I    +  ++L++A+    + Q +  K+    + LP     +W               
Sbjct: 780  AGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVAT 839

Query: 161  -----RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVS 215
                 R++++  +  ATN F    ++G G FG VYK  L DG+ VAIK       +    
Sbjct: 840  FEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDRE 899

Query: 216  FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN-----YFLDIL 270
            F +E E +  ++HRNL+ +L  C   + + LV E+M  GSLE  L+  +      +L+  
Sbjct: 900  FMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWA 959

Query: 271  ERLNIMIDVGLALEYLHYGHALAP-IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
             R  I I     L +LH  H+  P IIH D+K SN+LLDE+  A VSDFG+++L+   D 
Sbjct: 960  ARKKIAIGAARGLAFLH--HSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDT 1017

Query: 330  SLIQTKTMATIGYMAPEGIVSTKC----DVYSYGILLLETFSRKKPTNDLGEM----SLK 381
             L  +    T GY+ PE   S +C    DVYSYG++LLE  S KKP  D GE     +L 
Sbjct: 1018 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPI-DPGEFGEDNNLV 1076

Query: 382  HWVNQSLPHKL-AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA 440
             W  Q    K  AE++D  LV  +   S  ++ L   + +A  C  + P +R       A
Sbjct: 1077 GWAKQLYREKRGAEILDPELVTDK---SGDVE-LFHYLKIASQCLDDRPFKRPTMIQLMA 1132

Query: 441  KLRKIKVQFLDD 452
              +++K    +D
Sbjct: 1133 MFKEMKADTEED 1144

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	457
224116832	1061	predicted protein [Populus trichocarpa]	0.984	0.424	0.606	1e-153
224139658	1019	predicted protein [Populus trichocarpa]	0.986	0.442	0.590	1e-150
255572272	1089	serine-threonine protein kinase, plant-t	0.991	0.415	0.574	1e-145
359483198	1087	PREDICTED: probable LRR receptor-like se	0.969	0.407	0.582	1e-144
255585401	843	serine-threonine protein kinase, plant-t	0.982	0.532	0.565	1e-140
255578886	1043	serine-threonine protein kinase, plant-t	0.980	0.429	0.556	1e-140
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.971	0.361	0.560	1e-138
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.971	0.389	0.560	1e-138
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.962	0.302	0.548	1e-137
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.960	0.353	0.547	1e-137

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 280/462 (60%), Positives = 350/462 (75%), Gaps = 12/462 (2%)

Query: 2    TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +I  L++LA  SL+ N+  GPIP SFG L+SLE LDLS N+LSG IPKSLE L++LK  N
Sbjct: 598  SIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFN 657

Query: 62   VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKE-ENNKRSKKVALLVLNY 120
            VS NRL+GEI   GPF NFS  SF  N ALCGP R QVPPCK    +++SK+    V+ Y
Sbjct: 658  VSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRY 717

Query: 121  ILPPIISIMLLL-IAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECN 179
            I+P I  I+L+L +A+I++ R   R  K S +ED LP  TWR+ISY ++ RAT  F+E N
Sbjct: 718  IVPAIAFIILVLALAVIIFRRSHKR--KLSTQEDPLPPATWRKISYHELYRATEGFNETN 775

Query: 180  LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
            LLG GS GSVYKGTLSDG  +A+K+F+LQLE   + F+SECEVLR +RHRNL+KI+S C 
Sbjct: 776  LLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCC 835

Query: 240  NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
            NLDFKAL+LEF+P+GSLEKWLYSHNY+LDIL+RLNIMIDV  ALEYLH+G    P++HCD
Sbjct: 836  NLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHG-CTRPVVHCD 894

Query: 300  LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP----EGIVSTKCDV 355
            LKPSN+L++E+MVAHVSDFGIS+LLGEG D++ QT T+ATIGYMAP    EGIVS K DV
Sbjct: 895  LKPSNVLINEDMVAHVSDFGISRLLGEG-DAVTQTLTLATIGYMAPEYGLEGIVSVKGDV 953

Query: 356  YSYGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDC 413
            YSYGI L+ETF+RKKPT+D+  GEMSLK+WV QSLP  + EV+D+NL+  E  F AK DC
Sbjct: 954  YSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFVAKKDC 1013

Query: 414  LLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAK 455
            +  I+NLAL+C  + P ERI   +    L KIK+++  DV +
Sbjct: 1014 ITSILNLALECSADLPGERICMRDVLPALEKIKLKYKKDVER 1055

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  538 bits (1385), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 272/461 (59%), Positives = 343/461 (74%), Gaps = 10/461 (2%)

Query: 2    TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            TIG L++L   SL+ N F G IP++FG L+SLE LDLS NNLSGEIPKSLEAL YL+  +
Sbjct: 559  TIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFS 618

Query: 62   VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYI 121
            VS N L+GEIP  GPF NF+  SF  N  LCGPSR QVPPC  E+ K SK  + L L + 
Sbjct: 619  VSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRL-LRFS 677

Query: 122  LPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLL 181
            LP + SI+L++  I + + C+ R  K    E L      RRISYL++  ATNEF E NLL
Sbjct: 678  LPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLL 737

Query: 182  GIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL 241
            GIGSFGSVY+G L DG NVA+KIFNLQL+R F SF++ECE++RN+RHRNL+KI+  CSNL
Sbjct: 738  GIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNL 797

Query: 242  DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLK 301
            DFKALVLE+MP GSLEKWLYSHNY LDI++R+NIMIDV  ALEYLH+G+  +P++HCDLK
Sbjct: 798  DFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYP-SPVVHCDLK 856

Query: 302  PSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYS 357
            PSN+LLDE+MVAHV DFGI+KLLGE ++S  QT+T+ATIGYMAPE    G+VSTK DVYS
Sbjct: 857  PSNVLLDEDMVAHVCDFGIAKLLGE-NESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYS 915

Query: 358  YGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD-CL 414
            +GI+L+E  +RK+PT+++  GEMSLK  V +SLP  + ++VDSN++ R   +S K + C+
Sbjct: 916  FGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCV 975

Query: 415  LRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAK 455
              IM LAL C  ESP ER+      A+L+ IK +FL D  +
Sbjct: 976  TSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRDSER 1016

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  521 bits (1343), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 266/463 (57%), Positives = 347/463 (74%), Gaps = 10/463 (2%)

Query: 1    MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
            ++IGGL+DLA L L+ NK  GPIP+S G + SLE LDLSSNNLSG IPKSL+ LLYLK  
Sbjct: 627  ISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYF 686

Query: 61   NVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKV-ALLVLN 119
            NVS N L+GEIP  G F NFS +SF  N ALCG +R QV PCK++N++ ++   + +VL 
Sbjct: 687  NVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLR 746

Query: 120  YILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECN 179
            Y+LP I+  + +L  +I+  R   R  K S E+D L L T RRISY ++Q ATN F E N
Sbjct: 747  YVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESN 806

Query: 180  LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
             LG+GSFGSVYKGTLSDGT +A K+FNLQLER F SF++ECEVLRN+RHRNL+KI++ CS
Sbjct: 807  FLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCS 866

Query: 240  NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
              +FKALVLEFMPN SLEKWLYS +YFL+ L+RLNIM+DV   LEYLH+G+ + P+ HCD
Sbjct: 867  GPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTI-PMAHCD 925

Query: 300  LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP----EGIVSTKCDV 355
            +KPSN+LL+E+MVA ++DFGISKLLGE + S++QT T+ATIGYMAP    EGIVS + DV
Sbjct: 926  IKPSNVLLNEDMVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAPEYGSEGIVSVRGDV 984

Query: 356  YSYGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVR-REHSFSAKMD 412
            YSYG+LL+ETF++KKPT+ +   ++SLK WV QSL  ++ +V+D+NL+   E   +AK D
Sbjct: 985  YSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKD 1044

Query: 413  CLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAK 455
            C++ I+ LAL C  + P +RI   +    L+KIK +FL D+ +
Sbjct: 1045 CIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDIRQ 1087

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  516 bits (1329), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 265/455 (58%), Positives = 336/455 (73%), Gaps = 12/455 (2%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            IGGL+DL +LSLA N+F GPI  SF +L SLE +DLS N L GEIPKSLE L+YLK L+V
Sbjct: 633  IGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDV 692

Query: 63   SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYIL 122
            S N L GEIP EGPF NFS ESF  N ALCG  R ++PPC+    + S  ++ L+L YIL
Sbjct: 693  SFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRT-GTRWSTTISWLLLKYIL 751

Query: 123  PPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLG 182
            P I+S +L L  I V+ RC+ R+     + + L   TWRRISY +I +ATN F   NLLG
Sbjct: 752  PAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLG 811

Query: 183  IGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN-- 240
             GS GSVY+GTLSDG N AIK+FNLQ E  F SF++ECEV+ ++RHRNLIKI+S CSN  
Sbjct: 812  RGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSY 871

Query: 241  LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
            +DFKALVLE++PNGSLE+WLYSHNY LDIL+RLNIMIDV LA+EYLH+G +  P++HCDL
Sbjct: 872  IDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCS-TPVVHCDL 930

Query: 301  KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVY 356
            KPSNILLDE+   HV DFGI+KLL E ++S+ +T+T+ATIGYMAP+    GIV+T  DVY
Sbjct: 931  KPSNILLDEDFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAPKYVSNGIVTTSGDVY 989

Query: 357  SYGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRRE-HSFSAKMDC 413
            SYGI+L+ETF+R++PT+++   EMS+K+WV   L   + EVVD+NL+R E   F AK  C
Sbjct: 990  SYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQC 1049

Query: 414  LLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ 448
            +  I+ LA+DC  +SP+ERI   +    L+KIK  
Sbjct: 1050 ISLILGLAMDCVADSPEERIKMKDVVTTLKKIKTH 1084

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  504 bits (1299), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 262/463 (56%), Positives = 336/463 (72%), Gaps = 14/463 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            IG L++L +LSL  N+F GPIP+ FG LISLESLDLSSNNLSG+IPKSLE L YLK LN
Sbjct: 385 AIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDLSSNNLSGKIPKSLEQLKYLKYLN 444

Query: 62  VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYI 121
           VS N L+GE+P +G F NFS  SF  N ALCG     + PCK   +  SK    L+L Y+
Sbjct: 445 VSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLPLMPCKNNTHGGSKTSTKLLLIYV 504

Query: 122 LPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLL 181
           LP  I   L +  I+V++RCQ    +  +  D++ + TWRRIS+ ++++AT+ F   NLL
Sbjct: 505 LPASI---LTIAFILVFLRCQKVKLELENVMDIITVGTWRRISFQELEQATDGFCASNLL 561

Query: 182 GIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL 241
           G G +GSVYKG L DGTNVAIK+FNL +E  F  F++ECEV+ ++RHRNL+KI+S CSN 
Sbjct: 562 GAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSSIRHRNLVKIISCCSNQ 621

Query: 242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLK 301
           DFKA+VLE+MPNGSLEKWLYSHNY L+I +RL +MIDV  ALEYLH+G + API+HCDLK
Sbjct: 622 DFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVASALEYLHHGFS-APIVHCDLK 680

Query: 302 PSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYS 357
           PSN+LLD++MV HV+DFG++KLLGEG D + QTKT+ATIGYMAPE    GIVS   DVYS
Sbjct: 681 PSNVLLDQDMVGHVADFGMAKLLGEG-DLITQTKTLATIGYMAPEYGSKGIVSISGDVYS 739

Query: 358 YGILLLETFSRKKPTNDL-GE--MSLKHWVNQSLPHK-LAEVVDSNLVRREHSFSAKMDC 413
           +GILL+ETF+R KPT+D+ GE  +SLK ++  +L H  ++E+ D+N +  E + S K DC
Sbjct: 740 FGILLMETFTRMKPTDDMFGERVLSLKQYIEDALLHNAVSEIADANFLIDEKNLSTK-DC 798

Query: 414 LLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVAKT 456
           +  I+ LALDC +E P  RI  +   A LR IK Q L   A+T
Sbjct: 799 VSSILGLALDCSVELPHGRIDMSQVLAALRSIKAQLLASSART 841

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  503 bits (1295), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 257/462 (55%), Positives = 342/462 (74%), Gaps = 14/462 (3%)

Query: 2    TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +IGGLK L  LSLA N+  G IP+ FG  ISL+ LDLS+NNLSGEIPKSLE L YL   N
Sbjct: 585  SIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFN 644

Query: 62   VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNY- 120
            VS N L+GEIP    F N S +SF  N  LCG ++ QV PC+   ++ SK  + L L Y 
Sbjct: 645  VSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTHQGSKAASKLALRYG 704

Query: 121  ILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNL 180
            ++   ++I+ +    I+++R + R+ + +  E LLPL T +RISY ++++AT++F+E NL
Sbjct: 705  LMATGLTILAVAAVAIIFIRSRKRNMRIT--EGLLPLATLKRISYRELEQATDKFNEMNL 762

Query: 181  LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS- 239
            LG GSFGSVYKGT SDG++VA+K+FNLQ+E  F SF+ ECEVLR +RHRNL+KI++ CS 
Sbjct: 763  LGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSD 822

Query: 240  -NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
             N+DFKALVLEFMPN SLEKWL S  +FL++LERLNIM+DV  A+EYLH+G+A+ PI+HC
Sbjct: 823  INIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAM-PIVHC 881

Query: 299  DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP----EGIVSTKCD 354
            DLKPSNILLDENMVAHV+DFGI+KLLG+ + S IQT T+AT+GYMAP    EG+VST  D
Sbjct: 882  DLKPSNILLDENMVAHVTDFGIAKLLGD-EHSFIQTITLATVGYMAPEYGSEGVVSTGGD 940

Query: 355  VYSYGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVR-REHSFSAKM 411
            +YS+GILL+ETF+RKKPT+D+   E+S+K WV +S+P  + ++ D +L+R  E  FSAK 
Sbjct: 941  IYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAKK 1000

Query: 412  DCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDV 453
            DC+L +M +AL C  + P+ER +  +    L   KV+FL D+
Sbjct: 1001 DCILSVMQVALQCSADLPEERPNIRDVLNTLNHTKVKFLKDI 1042

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  498 bits (1281), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 255/455 (56%), Positives = 341/455 (74%), Gaps = 11/455 (2%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            +G  ++LA LSL+ NK  GPIP  FG L+SLESLDLS NNLSG IPKSLEAL+YLK LNV
Sbjct: 778  MGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNV 837

Query: 63   SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYIL 122
            S N+L+GEIP  GPF NF+ ESF +N ALCG   FQV  C + N  +S K    +L YIL
Sbjct: 838  SLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYIL 897

Query: 123  PPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLG 182
             P+ SI+ L++ I++++R ++     +  +  LP  T  +IS+  +  ATN+F E NL+G
Sbjct: 898  LPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP-GTHEKISHQQLLYATNDFGEDNLIG 956

Query: 183  IGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD 242
             GS G VYKG LS+G  VAIK+FNL+ +    SF+SECEV++ +RHRNL++I++ CSNLD
Sbjct: 957  KGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLD 1016

Query: 243  FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP 302
            FKALVLE+MPNGSLEKWLYSHNYFLD+++RLNIMIDV  ALEYLH+  + + ++HCDLKP
Sbjct: 1017 FKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCS-SLVVHCDLKP 1075

Query: 303  SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSY 358
            +N+LLD++MVAHV+DFGI+KLL +  +S+ QTKT+ TIGYMAPE    GIVSTK DVYSY
Sbjct: 1076 NNVLLDDDMVAHVADFGITKLLTK-TESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSY 1134

Query: 359  GILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRRE-HSFSAKMDCLL 415
            GILL+E FSRKKP +++  G+++LK WV +SL + + +VVD+NL+RRE    + K+ CL 
Sbjct: 1135 GILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLS 1193

Query: 416  RIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL 450
             IM LAL C  +SP+ER++  +A  +L+K +++ L
Sbjct: 1194 SIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  497 bits (1280), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 255/455 (56%), Positives = 339/455 (74%), Gaps = 11/455 (2%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            +G L+ L TLSL+ N+  GPIP  FG L+SLESLDLS NNLSG IPKSLEAL+YLK LNV
Sbjct: 689  MGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNV 748

Query: 63   SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYIL 122
            S N+L+GEIP  GPF NF+ ESF +N ALCG   FQV  C + N  +S K    +L YIL
Sbjct: 749  SLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYIL 808

Query: 123  PPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLG 182
             P+ SI+ L++ I++++R ++     +  +  LP  T  +IS+  +  ATN+F E NL+G
Sbjct: 809  LPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP-GTHEKISHQQLLYATNDFGEDNLIG 867

Query: 183  IGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD 242
             GS G VYKG LS+G  VAIK+FNL+ +    SF+SECEV++ +RHRNL++I++ CSNLD
Sbjct: 868  KGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLD 927

Query: 243  FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP 302
            FKALVLE+MPNGSLEKWLYSHNYFLD+++RLNIMIDV  ALEYLH+  + + ++HCDLKP
Sbjct: 928  FKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCS-SLVVHCDLKP 986

Query: 303  SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSY 358
            +N+LLD++MVAHV+DFGI+KLL +  +S+ QTKT+ TIGYMAPE    GIVSTK DVYSY
Sbjct: 987  NNVLLDDDMVAHVADFGITKLLTK-TESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSY 1045

Query: 359  GILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRRE-HSFSAKMDCLL 415
            GILL+E FSRKKP +++  G ++LK WV +SL + + +VVD+NL+RRE    + K+ CL 
Sbjct: 1046 GILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLS 1104

Query: 416  RIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL 450
             IM LAL C   SP++R++  +A  +L+K K++ L
Sbjct: 1105 SIMALALACTTNSPEKRLNMKDAVVELKKSKMKLL 1139

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  495 bits (1274), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 253/461 (54%), Positives = 338/461 (73%), Gaps = 21/461 (4%)

Query: 2    TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            T+G L++L  LSL+ N+  GPIP  FG L+SL+ LDLS NNLSG IPKSL+AL YLK LN
Sbjct: 1002 TLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLN 1061

Query: 62   VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYI 121
            VS N+L+GEIP  GPF NF+ ESF +N ALCG   FQV  C +    RS +  L +L YI
Sbjct: 1062 VSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYI 1121

Query: 122  LPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTW-----RRISYLDIQRATNEFD 176
            LPP+ISI+ L++ +++++R      ++ + E   P+ +W      +IS+  +  ATN F 
Sbjct: 1122 LPPVISIITLVVFLVLWIR------RRKNLEVPTPIDSWLPGSHEKISHQQLLYATNYFG 1175

Query: 177  ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
            E NL+G GS   VYKG LS+G  VA+K+FNL+ +  F SF+SECEV++++RHRNL+KI++
Sbjct: 1176 EDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIIT 1235

Query: 237  GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
             CSNLDFKALVLE+MP GSL+KWLYSHNYFLD+++RLNIMIDV  ALEYLH+    + ++
Sbjct: 1236 CCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHH-DCPSLVV 1294

Query: 297  HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTK 352
            HCDLKP+NILLD++MVAHV DFGI++LL E  +S+ QTKT+ TIGYMAPE    GIVSTK
Sbjct: 1295 HCDLKPNNILLDDDMVAHVGDFGIARLLTE-TESMQQTKTLGTIGYMAPEYGSDGIVSTK 1353

Query: 353  CDVYSYGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRRE-HSFSA 409
             DV+SYGI+L+E F+RKKP +++  G+++LK WV +SL   + EVVD+NL+RRE   F+ 
Sbjct: 1354 GDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFAT 1412

Query: 410  KMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL 450
            K+ CL  IM LAL C  +SP+ERI   +    L+KIK++ L
Sbjct: 1413 KLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  493 bits (1270), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 252/460 (54%), Positives = 339/460 (73%), Gaps = 21/460 (4%)

Query: 3    IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            +G  ++LA LSL+ N+  GPIP  FG L+SLESLDLS NNLSG IPKSLEAL+YLK LNV
Sbjct: 790  MGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNV 849

Query: 63   SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYIL 122
            S N+L+GEIP  GPF NF+ ESF +N ALCG   FQV  C + N  +S K    +L YIL
Sbjct: 850  SSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYIL 909

Query: 123  PPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTW-----RRISYLDIQRATNEFDE 177
             P+ S + L++ I++++R      ++ + E   P+ +W      +IS+  +  ATN+F E
Sbjct: 910  LPVGSTITLVVFIVLWIR------RRDNMEIXTPIDSWLPGTHEKISHQQLLYATNDFGE 963

Query: 178  CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
             NL+G GS G VYKG LS+G  VAIK+FNL+ +    SF+SECEV++ +RHRNL++I++ 
Sbjct: 964  DNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITC 1023

Query: 238  CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
            CSNLDFKALVL++MPNGSLEKWLYSHNYFLD+++RLNIMIDV  ALEYLH+  + + ++H
Sbjct: 1024 CSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCS-SLVVH 1082

Query: 298  CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKC 353
            CDLKPSN+LLD+BMVAHV+DFGI+KLL +  +S+ QTKT+ TIGYMAPE    GIVSTK 
Sbjct: 1083 CDLKPSNVLLDDBMVAHVTDFGIAKLLTK-TESMQQTKTLGTIGYMAPEHGSDGIVSTKS 1141

Query: 354  DVYSYGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRRE-HSFSAK 410
            DVYSYGILL+E F+RKKP +++  G+++LK WV +SL + + +VVD NL+RRE    + K
Sbjct: 1142 DVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATK 1200

Query: 411  MDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL 450
            + CL  IM LAL C  +SP+ER+   +A  +L+K +++ L
Sbjct: 1201 LSCLSSIMALALACTNDSPEERLDMKDAVVELKKSRMKLL 1240

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	457
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.770	0.348	0.391	5.5e-70
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.625	0.283	0.431	1e-66
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.772	0.349	0.374	1.5e-66
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.735	0.327	0.377	3.8e-65
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.671	0.299	0.405	2.6e-60
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.606	0.268	0.412	6e-57
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.800	0.312	0.347	5.2e-56
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.822	0.749	0.359	8.8e-55
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.800	0.373	0.368	2.1e-52
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.557	0.430	0.370	5.7e-49

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 630 (226.8 bits), Expect = 5.5e-70, Sum P(2) = 5.5e-70
 Identities = 150/383 (39%), Positives = 217/383 (56%)

Query:    94 PSRFQVPPCKEENNKRSKKVALLVLNYXXXXXXXXXXXXXXXXVYVRCQNRSTKKSDEED 153
             P   Q P   ++++ R KKV + V                   +  R +N+ T       
Sbjct:   623 PCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPST 682

Query:   154 LLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERT 212
             L   V   +ISY D++ ATN F   N++G GSFG+VYK  L ++   VA+K+ N+Q    
Sbjct:   683 LE--VLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGA 740

Query:   213 FVSFNSECEVLRNVRHRNLIKILSGCSNLDF-----KALVLEFMPNGSLEKWLYS----- 262
               SF +ECE L+++RHRNL+K+L+ CS++DF     +AL+ EFMPNGSL+ WL+      
Sbjct:   741 MKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEE 800

Query:   263 -H--NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG 319
              H  +  L +LERLNI IDV   L+YLH  H   PI HCDLKPSN+LLD+++ AHVSDFG
Sbjct:   801 IHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNVLLDDDLTAHVSDFG 859

Query:   320 ISKLLGEGDDS-----LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKK 370
             +++LL + D+      L       TIGY APE    G  S   DVYS+GILLLE F+ K+
Sbjct:   860 LARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKR 919

Query:   371 PTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVR--REHSFSAKMDCLLRIMNLALDCCM 426
             PTN+L  G  +L  +   +LP ++ ++VD +++       F   ++CL  +  + L CC 
Sbjct:   920 PTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPV-VECLTMVFEVGLRCCE 978

Query:   427 ESPDERIHTTNAAAKLRKIKVQF 449
             ESP  R+ T+    +L  I+ +F
Sbjct:   979 ESPMNRLATSIVVKELISIRERF 1001

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 615 (221.5 bits), Expect = 1.0e-66, Sum P(2) = 1.0e-66
 Identities = 136/315 (43%), Positives = 202/315 (64%)

Query:   162 RISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSEC 220
             ++SY D++ AT+ F   N++G GSFG+V+K  L ++   VA+K+ N+Q      SF +EC
Sbjct:   688 KLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAEC 747

Query:   221 EVLRNVRHRNLIKILSGCSNLDF-----KALVLEFMPNGSLEKWLYS------H--NYFL 267
             E L+++RHRNL+K+L+ C+++DF     +AL+ EFMPNGSL+KWL+       H  +  L
Sbjct:   748 ESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTL 807

Query:   268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
              +LERLNI IDV   L+YLH  H   PI HCDLKPSNILLD+++ AHVSDFG+++LL + 
Sbjct:   808 TLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKF 866

Query:   328 D-DSLIQTKTMA----TIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDL--G 376
             D +S     + A    TIGY APE    G  S   DVYS+G+L+LE F+ K+PTN+L  G
Sbjct:   867 DQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGG 926

Query:   377 EMSLKHWVNQSLPHKLAEVVDSNLVRR--EHSFSAKMDCLLRIMNLALDCCMESPDERIH 434
               +L  +   +LP ++ ++ D +++       F   ++CL  I+++ L CC ESP  R+ 
Sbjct:   927 NFTLNSYTKAALPERVLDIADKSILHSGLRVGFPV-LECLKGILDVGLRCCEESPLNRLA 985

Query:   435 TTNAAAKLRKIKVQF 449
             T+ AA +L  I+ +F
Sbjct:   986 TSEAAKELISIRERF 1000

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 604 (217.7 bits), Expect = 1.5e-66, Sum P(2) = 1.5e-66
 Identities = 143/382 (37%), Positives = 217/382 (56%)

Query:    94 PSRFQVPPCKEENNKRSKKVALLVLNYXXXXXXXXXXXXXXXXVYVRCQNRSTKKSDEED 153
             P   Q PP + +++   KKVA+LV                      R +N+ T       
Sbjct:   624 PCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSK 683

Query:   154 LLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERT 212
             L   +   +ISY D++ ATN F   N++G GSFG+V+K  L ++   VA+K+ N+Q    
Sbjct:   684 LE--IFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGA 741

Query:   213 FVSFNSECEVLRNVRHRNLIKILSGCSNLDF-----KALVLEFMPNGSLEKWLYSHNY-- 265
               SF +ECE L++ RHRNL+K+L+ C++ DF     +AL+ E++PNGS++ WL+      
Sbjct:   742 MKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEE 801

Query:   266 ------FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG 319
                    L +LERLNI+IDV   L+YLH  H   PI HCDLKPSN+LL++++ AHVSDFG
Sbjct:   802 IRRPPRTLTLLERLNIVIDVASVLDYLHV-HCHEPIAHCDLKPSNVLLEDDLTAHVSDFG 860

Query:   320 ISKLLGEGD-DSLIQTKTMA----TIGYMAPE----GIVSTKCDVYSYGILLLETFSRKK 370
             +++LL + D +S +   + A    TIGY APE    G  S   DVYS+G+LLLE F+ K+
Sbjct:   861 LARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKR 920

Query:   371 PTNDL--GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM-DCLLRIMNLALDCCME 427
             PT++L  G ++L  +   +LP K+ E+ D  ++        +  +CL  ++ + L CC E
Sbjct:   921 PTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAECLTLVLEVGLRCCEE 980

Query:   428 SPDERIHTTNAAAKLRKIKVQF 449
              P  R+ T+  A +L  I+ +F
Sbjct:   981 YPTNRLATSEVAKELISIRERF 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 547 (197.6 bits), Expect = 3.8e-65, Sum P(2) = 3.8e-65
 Identities = 137/363 (37%), Positives = 189/363 (52%)

Query:     2 TIGGLKDLATLSLAANKFHGPIPKSFGXXXXXXXXXXXXXXXXGEIPKSLEALLYLKQLN 61
             T+G  + L  L L  N   G IP + G                G+IP SL  +  L  LN
Sbjct:   540 TLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLN 599

Query:    62 VSQNRLEGEIPVEGPFRNFSTESFSWNYALCG--PSRFQVPPCKEENNKRSKKVALLVLN 119
             +S N   GE+P  G F   S  S   N  LCG  P    +P C      R K   +L ++
Sbjct:   600 LSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPD-LHLPRCCPLLENR-KHFPVLPIS 657

Query:   120 YXXXXXXXXXXXXXXXXVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECN 179
                               + +   +           PLV     SY  + +AT+ F   N
Sbjct:   658 VSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLV-----SYSQLVKATDGFAPTN 712

Query:   180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
             LLG GSFGSVYKG L+   +VA+K+  L+  +   SF +ECE LRN+RHRNL+KI++ CS
Sbjct:   713 LLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICS 772

Query:   240 NLD-----FKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLHY 288
             ++D     FKA+V +FMPNGSLE W++      +    L++  R+ I++DV  AL+YLH 
Sbjct:   773 SIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR 832

Query:   289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-----MATIGYM 343
              H   P++HCD+K SN+LLD +MVAHV DFG++++L +G  SLIQ  T     + TIGY 
Sbjct:   833 -HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGT-SLIQQSTSSMGFIGTIGYA 890

Query:   344 APE 346
             APE
Sbjct:   891 APE 893

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 547 (197.6 bits), Expect = 2.6e-60, Sum P(2) = 2.6e-60
 Identities = 137/338 (40%), Positives = 197/338 (58%)

Query:   144 RSTKKSDEEDLLPLVT-WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVA 201
             R+    ++    P+ + + +ISY ++ + T  F   NL+G G+FG+V+KG L S    VA
Sbjct:   687 RANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVA 746

Query:   202 IKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF-----KALVLEFMPNGSL 256
             IK+ NL       SF +ECE L  +RHRNL+K+++ CS+ DF     +ALV EFMPNG+L
Sbjct:   747 IKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNL 806

Query:   257 EKWLY--------SHNYFLDILERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILL 307
             + WL+        + +  L +  RLNI IDV  AL YLH Y H   PI HCD+KPSNILL
Sbjct:   807 DMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHN--PIAHCDIKPSNILL 864

Query:   308 DENMVAHVSDFGISKLLGEGD-DSL-IQTKTMA---TIGYMAPE----GIVSTKCDVYSY 358
             D+++ AHVSDFG+++LL + D D+  IQ  +     TIGY APE    G  S   DVYS+
Sbjct:   865 DKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSF 924

Query:   359 GILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLA-EVVDSNLVRREHSFSAKM-DCL 414
             GI+LLE F+ K+PTN L    ++L  +   +L  + A ++ D  ++R  ++    M +CL
Sbjct:   925 GIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECL 984

Query:   415 LRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD 452
               +  + + C  ESP  RI    A +KL  I+  F  D
Sbjct:   985 TLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 526 (190.2 bits), Expect = 6.0e-57, Sum P(2) = 6.0e-57
 Identities = 129/313 (41%), Positives = 184/313 (58%)

Query:   162 RISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSEC 220
             ++SY ++  AT+ F   NL+G G+FG+V+KG L  +   VA+K+ NL       SF +EC
Sbjct:   699 KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAEC 758

Query:   221 EVLRNVRHRNLIKILSGCSNLD-----FKALVLEFMPNGSLEKWLY--------SHNYFL 267
             E  + +RHRNL+K+++ CS+LD     F+ALV EFMP GSL+ WL          H+  L
Sbjct:   759 ETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSL 818

Query:   268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
                E+LNI IDV  ALEYLH  H   P+ HCD+KPSNILLD+++ AHVSDFG+++LL + 
Sbjct:   819 TPAEKLNIAIDVASALEYLHV-HCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKY 877

Query:   328 D-DSLIQTKTMA----TIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTND--LG 376
             D +S +   + A    TIGY APE    G  S + DVYS+GILLLE FS KKPT++   G
Sbjct:   878 DRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAG 937

Query:   377 EMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTT 436
             + +L H   +S+         SN +          + L  ++ + + C  E P +R+ T 
Sbjct:   938 DYNL-HSYTKSILSGCTSSGGSNAID---------EGLRLVLQVGIKCSEEYPRDRMRTD 987

Query:   437 NAAAKLRKIKVQF 449
              A  +L  I+ +F
Sbjct:   988 EAVRELISIRSKF 1000

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 5.2e-56, P = 5.2e-56
 Identities = 134/386 (34%), Positives = 217/386 (56%)

Query:     5 GLKDLATLSLAANKFHGPIPKSFGXXXXXXXXXXXXXXXXGEIPKSLEALLYLKQLNVSQ 64
             G+  + +L+L+ N F G IP+SFG                GEIP+SL  L  LK L ++ 
Sbjct:   696 GMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLAS 755

Query:    65 NRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPC--KEENNKRSKKVALLVLNYXX 122
             N L+G +P  G F+N +      N  LCG S+  + PC  K++++  SK+  ++++    
Sbjct:   756 NNLKGHVPESGVFKNINASDLMGNTDLCG-SKKPLKPCTIKQKSSHFSKRTRVILIILGS 814

Query:   123 XXXXXXXXXXXXXXVYVRCQNRSTKKSDEEDLLPL---VTWRRISYLDIQRATNEFDECN 179
                              + + +  + S E  L  L   +  +R    ++++AT+ F+  N
Sbjct:   815 AAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSAN 874

Query:   180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVS---FNSECEVLRNVRHRNLIKILS 236
             ++G  S  +VYKG L DGT +A+K+ NL+ E +  S   F +E + L  ++HRNL+KIL 
Sbjct:   875 IIGSSSLSTVYKGQLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLKHRNLVKILG 933

Query:   237 -GCSNLDFKALVLEFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGLALEYLHYGHALAP 294
                 +   KALVL FM NG+LE  ++     +  +LE++++ + +   ++YLH G+   P
Sbjct:   934 FAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGF-P 992

Query:   295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA---TIGYMAPEGI--- 348
             I+HCDLKP+NILLD + VAHVSDFG +++LG  +D      T A   TIGY+APE     
Sbjct:   993 IVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMR 1052

Query:   349 -VSTKCDVYSYGILLLETFSRKKPTN 373
              V+TK DV+S+GI+++E  ++++PT+
Sbjct:  1053 KVTTKADVFSFGIIMMELMTKQRPTS 1078

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 532 (192.3 bits), Expect = 8.8e-55, Sum P(2) = 8.8e-55
 Identities = 158/440 (35%), Positives = 223/440 (50%)

Query:    45 GEIPKSLEALLYLKQLNVSQN--------RLEGEIPVEGPFRNFSTESFSWNYALCGPS- 95
             G I  S+  L +L+ LN+  N          EG +P +G F+N +T S   N  LCG   
Sbjct:    87 GSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQNGTTVSVFGNENLCGGVI 146

Query:    96 RFQVPPCKEENNKRSKKVALLVLNYXXXXXXXXXXXXXXXXVYVRCQNRSTKKSDEEDLL 155
               Q+ PC E  + R KK   L                    + V   +   KK+D     
Sbjct:   147 EMQLKPCIE--SPRQKKPFSL----GEKVAVGVGVALLFLFIIVASLSWFKKKND----- 195

Query:   156 PLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFV 214
                   +ISY ++  AT+ F   NL+G G+F  V+KG L  +   VA+K+ NL       
Sbjct:   196 ------KISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATK 249

Query:   215 SFNSECEVLRNVRHRNLIKILSGCSNLD-----FKALVLEFMPNGSLEKWLY-------- 261
             SF +ECE  + +RHRNL K+++ CS+LD     F+ALV EFMP GSL+ WL         
Sbjct:   250 SFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESAN 309

Query:   262 SHNYFLDILERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGI 320
             +H+  L   E++NI IDV  ALEYLH Y H   P+ HCD+KPSN+LLD+++ AHVSDFG+
Sbjct:   310 NHSRSLTFAEKVNIAIDVASALEYLHVYCHD--PVAHCDIKPSNVLLDDDLTAHVSDFGL 367

Query:   321 SKLLGEGDDSLIQTK-----TMATIGYMAPE-GI---VSTKCDVYSYGILLLETFSRKKP 371
             ++LL   D+     +        TIGY APE G+    S + DVYS+G+LLLE F+ KKP
Sbjct:   368 ARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKP 427

Query:   372 T-NDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR-IMNLALDCCMESP 429
             T N  G     H   +S       V+  +  R   +    +D  LR ++ + + C  E P
Sbjct:   428 TDNSFGGGYNLHGYTKS-------VLSCSTSRGGRTM---VDEWLRLVLEVGIKCSEEYP 477

Query:   430 DERIHTTNAAAKLRKIKVQF 449
              +R+    A  +L  IK +F
Sbjct:   478 RDRMGMAEAVRELVSIKSKF 497

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 551 (199.0 bits), Expect = 2.1e-52, P = 2.1e-52
 Identities = 147/399 (36%), Positives = 210/399 (52%)

Query:     3 IGGLKDLATLSLAANKFHGPIPKSFGXXXXXXXXXXXXXXXXGEIPKSLEALLYLKQLNV 62
             +G    L  L+L+ N F   +P S G                G IP S +    LK LN 
Sbjct:   487 LGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNF 546

Query:    63 SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALL------ 116
             S N L G +  +G F   + ESF  +  LCG  +  +  CK+++   S  + +L      
Sbjct:   547 SFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLSLIAT 605

Query:   117 -VLNYXXXXXXXXXXXXXXXXVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEF 175
              VL                  VY + +    +K ++ D  P   + RISY  +  AT  F
Sbjct:   606 PVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQND--P--KYPRISYQQLIAATGGF 661

Query:   176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKI 234
             +  +L+G G FG VYKG L + T VA+K+ + +    F  SF  EC++L+  RHRNLI+I
Sbjct:   662 NASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRI 721

Query:   235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVGLALEYLHYGHA 291
             ++ CS   F ALVL  MPNGSLE+ LY   Y    LD+++ +NI  DV   + YLH+ ++
Sbjct:   722 ITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YS 780

Query:   292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-------DDSLIQTKT----MATI 340
                ++HCDLKPSNILLD+ M A V+DFGIS+L+ +G       DDS+    T      ++
Sbjct:   781 PVKVVHCDLKPSNILLDDEMTALVTDFGISRLV-QGVEETVSTDDSVSFGSTDGLLCGSV 839

Query:   341 GYMAPE-GI---VSTKCDVYSYGILLLETFSRKKPTNDL 375
             GY+APE G+    ST  DVYS+G+LLLE  S ++PT+ L
Sbjct:   840 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVL 878

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 395 (144.1 bits), Expect = 5.7e-49, Sum P(2) = 5.7e-49
 Identities = 103/278 (37%), Positives = 158/278 (56%)

Query:   167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSF-NSECEVLRN 225
             DI +     +E +++G G FG+VYK  + DG   A+K   L+L   F  F   E E+L +
Sbjct:   298 DIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRI-LKLNEGFDRFFERELEILGS 356

Query:   226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGLALE 284
             ++HR L+ +   C++   K L+ +++P GSL++ L+      LD   R+NI+I     L 
Sbjct:   357 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAKGLS 416

Query:   285 YLHYGHALAP-IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
             YLH  H  +P IIH D+K SNILLD N+ A VSDFG++KLL E ++S I T    T GY+
Sbjct:   417 YLH--HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYL 473

Query:   344 APE----GIVSTKCDVYSYGILLLETFSRKKPTN----DLGEMSLKHWVNQSLPHKLA-E 394
             APE    G  + K DVYS+G+L+LE  S K+PT+    + G +++  W+   +  K   +
Sbjct:   474 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG-LNVVGWLKFLISEKRPRD 532

Query:   395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
             +VD N          +M+ L  ++++A  C   SP+ER
Sbjct:   533 IVDPNCE------GMQMESLDALLSIATQCVSPSPEER 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00110705 hypothetical protein (1061 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	457
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-32
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-26
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.001
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (400), Expect = 8e-46
 Identities = 70/192 (36%), Positives = 97/192 (50%), Gaps = 14/192 (7%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKILSGC 238
           LG G FG+VY       G  VAIKI   +   + +     E E+L+ + H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
            + +   LV+E+   GSL+  L  +   L   E L I++ +   LEYLH       IIH 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS----NGIIHR 116

Query: 299 DLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE-----GIVSTK 352
           DLKP NILLD  N    ++DFG+SKLL      L     + T  YMAPE     G  S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 353 CDVYSYGILLLE 364
            D++S G++L E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  152 bits (387), Expect = 3e-43
 Identities = 72/200 (36%), Positives = 100/200 (50%), Gaps = 17/200 (8%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLER--TFVSFNSECEVLRNVRHRNLIKILSG 237
           LG GSFG+VYK      G  VA+KI   + E+     +   E  +LR + H N+++++  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
             + D   LV+E+   G L  +L          E   I + +   LEYLH       IIH
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH----SNGIIH 121

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGI-----VST 351
            DLKP NILLDEN V  ++DFG++K L +   SL    T   T  YMAPE +        
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVLLGGNGYGP 178

Query: 352 KCDVYSYGILLLETFSRKKP 371
           K DV+S G++L E  + K P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  151 bits (384), Expect = 8e-43
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 30/262 (11%)

Query: 181 LGIGSFGSVYKGTL-----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG VYKGTL        T VA+K       E     F  E  +++ + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
           L  C+  +   +V E+MP G L  +L  H   L + + L + + +   +EYL   +    
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN---- 122

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVS 350
            +H DL   N L+ EN+V  +SDFG+S+ + E D    +      I +MAPE    G  +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 351 TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK 410
           +K DV+S+G+LL E F+       LGE       N+       EV+   L+   +     
Sbjct: 183 SKSDVWSFGVLLWEIFT-------LGEQPYPGMSNE-------EVL--ELLEDGYRLPRP 226

Query: 411 MDCLLRIMNLALDCCMESPDER 432
            +C   +  L L C    P++R
Sbjct: 227 ENCPDELYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  148 bits (377), Expect = 8e-42
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 179 NLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKILS 236
             LG GSFG VY       G  VAIK+   +  +        E ++L+ ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
              + D   LV+E+   G L   L          E    +  +  ALEYLH       I+
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKG----IV 119

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGI----VST 351
           H DLKP NILLDE+    ++DFG+++ L  G+    +  T   T  YMAPE +       
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE----KLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 352 KCDVYSYGILLLETFSRKKP 371
             D++S G++L E  + K P
Sbjct: 176 AVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  144 bits (367), Expect = 2e-40
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 35/264 (13%)

Query: 181 LGIGSFGSVYKGTLSD-----GTNVAIKIFNLQLERTFV---SFNSECEVLRNVRHRNLI 232
           LG G+FG VYKG L          VA+K   L+ + +      F  E  ++R + H N++
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKT--LKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           K+L  C+  +   +V+E+M  G L  +L  +   L + + L+  + +   +EYL      
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE----S 120

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GI 348
              IH DL   N L+ EN+V  +SDFG+S+ L + DD   +      I +MAPE    G 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 349 VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            ++K DV+S+G+LL E F+       LGE       N+ +   L  + +   + +  +  
Sbjct: 180 FTSKSDVWSFGVLLWEIFT-------LGEQPYPGMSNEEV---LEYLKNGYRLPQPPN-- 227

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
               C   + +L L C  E P++R
Sbjct: 228 ----CPPELYDLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  141 bits (359), Expect = 3e-39
 Identities = 80/263 (30%), Positives = 124/263 (47%), Gaps = 32/263 (12%)

Query: 181 LGIGSFGSVYKGTLSDG-----TNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG VYKGTL          VA+K       E+    F  E  ++R + H N++K+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C+  +   +V+E+MP G L  +L  +    L + + L+  + +   +EYL       
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SK 122

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIV 349
             IH DL   N L+ EN+V  +SDFG+S+ L + DD          I +MAPE    G  
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           ++K DV+S+G+LL E F+       LGE       N        EV+    +++ +    
Sbjct: 182 TSKSDVWSFGVLLWEIFT-------LGEEPYPGMSNA-------EVL--EYLKKGYRLPK 225

Query: 410 KMDCLLRIMNLALDCCMESPDER 432
             +C   +  L L C  E P++R
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  132 bits (335), Expect = 9e-36
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 47/276 (17%)

Query: 179 NLLGIGSFGSVYKGTLSDGTN----VAIK----IFNLQLERTFVSFNSECEVLRNVRHRN 230
             LG G+FG VYKG L         VA+K      + +  + F+    E  V++ + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57

Query: 231 LIKILSGCSNLDFK-ALVLEFMPNGSLEKWLYSH--------NYFLDILERLNIMIDVGL 281
           ++++L G    +    LVLE+M  G L  +L              L + + L+  I +  
Sbjct: 58  VVRLL-GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            +EYL         +H DL   N L+ E++V  +SDFG+S+ + + D    +T     I 
Sbjct: 117 GMEYLAS----KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 342 YMAPE----GIVSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
           +MAPE    GI ++K DV+S+G+LL E F+    P      +S     N+ +   L +  
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLS-----NEEVLEYLRK-- 222

Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
              L + E+       C   +  L L C    P++R
Sbjct: 223 GYRLPKPEY-------CPDELYELMLSCWQLDPEDR 251

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  123 bits (311), Expect = 2e-32
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 32/217 (14%)

Query: 179 NLLGIGSFGSVYKGTLSD-GTNVAIK--IFNLQLERTFVSFNSECEVLRNVRHRNLIKIL 235
            LLG GSFGSVY     D G  +A+K    +   E    +   E  +L +++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 236 SGCSNLDFKAL--VLEFMPNGSLEKWLYS---------HNYFLDILERLNIMIDVGLALE 284
               + +   L   LE++  GSL   L             Y   ILE           L 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLA 115

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YLH       I+H D+K +NIL+D + V  ++DFG +K LG+ +          T  +MA
Sbjct: 116 YLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 345 PE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGE 377
           PE           D++S G  ++E  + K P ++LG 
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  123 bits (309), Expect = 6e-30
 Identities = 120/458 (26%), Positives = 201/458 (43%), Gaps = 54/458 (11%)

Query: 7   KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNR 66
           K L +L L+ N+  G IP SF  +  L  LDLS N LSGEIPK+L  +  L Q+N+S N 
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582

Query: 67  LEGEIPVEGPFRNFSTESFSWNYALCGPSRFQ-VPPCKEENNKRSKKVALLVLNYILPPI 125
           L G +P  G F   +  + + N  LCG      +PPC     KR +K       YI   +
Sbjct: 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC-----KRVRKTPSWWF-YITCTL 636

Query: 126 ISIMLLLIA--IIVYVRCQNRS-TKKSDEEDLLPLVTW----------RRISYLDIQRAT 172
            + ++L +     V++R +N    K+ + ED     TW          + I+  DI  + 
Sbjct: 637 GAFLVLALVAFGFVFIRGRNNLELKRVENED----GTWELQFFDSKVSKSITINDILSSL 692

Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
            E    N++  G  G+ YKG ++ +G    +K  N  +     S  ++   +  ++H N+
Sbjct: 693 KEE---NVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNI 745

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           +K++  C +     L+ E++   +L + L +    L    R  I I +  AL +LH    
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHC-RC 800

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--- 348
              ++  +L P  I++D     H+    +  LL         TK   +  Y+APE     
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPETRETK 853

Query: 349 -VSTKCDVYSYGILLLETFSRKKPTNDLGEM--SLKHWVNQSLPH-KLAEVVDSNLVRRE 404
            ++ K D+Y +G++L+E  + K P +    +  S+  W         L   +D ++    
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG-- 911

Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL 442
              S   + ++ +MNLAL C    P  R    +    L
Sbjct: 912 -DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  115 bits (291), Expect = 1e-29
 Identities = 77/269 (28%), Positives = 121/269 (44%), Gaps = 27/269 (10%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           +R   EF     LG G FG V++G   +   VAIKI           F  E + L+ +RH
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGLALEYLH 287
           ++LI + + CS  +   ++ E M  GSL  +L S     L +   +++   V   + YL 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE- 346
             +     IH DL   NIL+ E++V  V+DFG+++L+   +D  + +       + APE 
Sbjct: 122 EQN----SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEA 175

Query: 347 ---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR 403
              G  STK DV+S+GILL E F+        G++      N        EV D   +  
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTY-------GQVPYPGMNNH-------EVYD--QITA 219

Query: 404 EHSFSAKMDCLLRIMNLALDCCMESPDER 432
            +       C   I  + L+C    P++R
Sbjct: 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (285), Expect = 8e-29
 Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G G FG VYK      G  VAIK+  L+ +       +E ++L+  +H N++K     S
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY--GS 65

Query: 240 NL--DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
            L  D   +V+EF   GSL+  L S N  L   +   +  ++   LEYLH       IIH
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG----IIH 121

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGIV----STK 352
            D+K +NILL  +    + DFG+S  L           TM  T  +MAPE I       K
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 353 CDVYSYGILLLETFSRKKPTNDLGEM 378
            D++S GI  +E    K P ++L  M
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPM 203

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 3e-26
 Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 20/211 (9%)

Query: 179 NLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKIL 235
           +L+G G+FG VYKG  L  G  VAIK  +L+   E    S   E ++L+N++H N++K +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGLALEYLH-YGHAL 292
                 D   ++LE+  NGSL + +     F    E L    +  V   L YLH  G   
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFP---ESLVAVYVYQVLQGLAYLHEQG--- 119

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---- 348
             +IH D+K +NIL  ++ V  ++DFG++  L   D S      + T  +MAPE I    
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 349 VSTKCDVYSYGILLLETFSRKKPTNDLGEMS 379
            ST  D++S G  ++E  +   P  DL  M+
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  108 bits (269), Expect = 6e-26
 Identities = 77/278 (27%), Positives = 115/278 (41%), Gaps = 29/278 (10%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVRH-R 229
            +     LG GSFG VY     D   VA+K+   +LE        F  E ++L ++ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGLALEYLH 287
           N++K+     +     LV+E++  GSLE  L        + E     I+  +  ALEYLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 288 YGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSLIQTKTMA----TIGY 342
                  IIH D+KP NILLD +  V  + DFG++KLL +   +       +    T GY
Sbjct: 119 SKG----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 343 MAPE-------GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV 395
           MAPE          S+  D++S GI L E  +   P         K+    S   K+   
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF-----EGEKNSSATSQTLKIILE 229

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
           + +  +    S S          +L      + P  R+
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267

Length = 384

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (264), Expect = 9e-26
 Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 51/286 (17%)

Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VYKG L         T+VAIK      E +    F  E E++ +++H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMID 278
           +L  C+      ++ E++ +G L ++L  ++                 LD  + L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           +   +EYL   H     +H DL   N L+ E +   +SDFG+S+ +   D   +Q+K++ 
Sbjct: 133 IAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
            + +M PE I+    +T+ D++S+G++L E FS        G      + NQ       E
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS-------YGLQPYYGFSNQ-------E 234

Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER-----IHT 435
           V+   ++R         DC  R+  L ++C  E P  R     IHT
Sbjct: 235 VI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (264), Expect = 9e-26
 Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 24/212 (11%)

Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKILSGC 238
           LG GS G VYK      G   A+K  ++  +  F      E + LR+     ++K    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 239 SNLDFK----ALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYGHALA 293
               +K    ++VLE+M  GSL   L       + +L  +   I  GL   YLH      
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD--YLHTKRH-- 120

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPEGIV--- 349
            IIH D+KPSN+L++      ++DFGISK+L   +++L Q  T + T+ YM+PE I    
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
            S   D++S G+ LLE    K P    G+ S 
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 1e-25
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 18/194 (9%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKILSGC 238
            +G G FG V  G    G  VA+K   L+ + T   +F +E  V+  +RH NL+++L   
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
              +   +V E+M  GSL  +L S     + + ++L   +DV   +EYL   +     +H
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN----FVH 125

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKC 353
            DL   N+L+ E++VA VSDFG++K     + S  Q      + + APE       STK 
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 354 DVYSYGILLLETFS 367
           DV+S+GILL E +S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (263), Expect = 1e-25
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 34/212 (16%)

Query: 179 NLLGIGSFGSVYKGT-LSDGTNVAIKIFNL----QLERTFVSFNSECEVLRNVRHRNLIK 233
             +G GSFG VY     SDG    +K  +L    + ER      +E ++L+ + H N+IK
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA--LNEVKILKKLNHPNIIK 63

Query: 234 -----ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGLALEY 285
                   G   +     V+E+   G L + +             + L+  + + LAL+Y
Sbjct: 64  YYESFEEKGKLCI-----VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMA 344
           LH       I+H D+KP NI L  N +  + DFGISK+L     ++   KT+  T  Y++
Sbjct: 119 LHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLS 171

Query: 345 PEGIV-----STKCDVYSYGILLLETFSRKKP 371
           PE +      + K D++S G +L E  + K P
Sbjct: 172 PE-LCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 82/263 (31%), Positives = 120/263 (45%), Gaps = 31/263 (11%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNL----QLERTFVSFNSECEVLRNVRHRNLIKIL 235
            +G G+FG VYKG L   T VA+K         L+R F+    E E+L+   H N++K++
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ---EAEILKQYDHPNIVKLI 58

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
             C       +V+E +P GSL  +L      L + + L + +D    +EYL   +     
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---- 114

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVST 351
           IH DL   N L+ EN V  +SDFG+S+    G  ++        I + APE    G  ++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM 411
           + DV+SYGILL ETFS       LG+       NQ    +  E ++S      +   A  
Sbjct: 175 ESDVWSYGILLWETFS-------LGDTPYPGMSNQ----QTRERIESG-----YRMPAPQ 218

Query: 412 DCLLRIMNLALDCCMESPDERIH 434
            C   I  L L C    P+ R  
Sbjct: 219 LCPEEIYRLMLQCWAYDPENRPS 241

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (257), Expect = 4e-25
 Identities = 68/195 (34%), Positives = 101/195 (51%), Gaps = 14/195 (7%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF-VSFNSECEVLRNVRHRNLIKILSGC 238
           LLG G+FG V+KGTL D T VA+K     L +   + F SE  +L+   H N++K++  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           +      +V+E +P G    +L      L   + +   +D    + YL   +     IH 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IHR 117

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPE----GIVSTK 352
           DL   N L+ EN V  +SDFG+S+   + DD +  +  +    I + APE    G  S++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 353 CDVYSYGILLLETFS 367
            DV+SYGILL ETFS
Sbjct: 175 SDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 75/289 (25%), Positives = 123/289 (42%), Gaps = 46/289 (15%)

Query: 181 LGIGSFGSVYKGTLS------DGTNVAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG V+ G         D   VA+K             F  E E+L N +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL-------------ERLNIMIDVG 280
               C+  D   +V E+M +G L K+L SH      L             + L I + + 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             + YL    A    +H DL   N L+  ++V  + DFG+S+ +   D   +   TM  I
Sbjct: 133 SGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEV 395
            +M PE I+    +T+ DV+S+G++L E F+  K+P           W   S   ++ E 
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-----------WYGLS-NEEVIEC 236

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK 444
           +    + +         C   + ++ L C    P +RI+  +   +L+K
Sbjct: 237 ITQGRLLQR-----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 64/192 (33%), Positives = 106/192 (55%), Gaps = 18/192 (9%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG+V +G  + G  VA+K  N++ + T  +F  E  V+  + H+NL+++L G   
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLL-GVIL 69

Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
            +   +V+E M  G+L  +L +    L  +++ L   +DV   +EYL        ++H D
Sbjct: 70  HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES----KKLVHRD 125

Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDV 355
           L   NIL+ E+ VA VSDFG++++   G D+     +   + + APE +     S+K DV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEALKHKKFSSKSDV 180

Query: 356 YSYGILLLETFS 367
           +SYG+LL E FS
Sbjct: 181 WSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 8e-23
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 59/273 (21%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+ GT +  T VA+K      +  E    +F  E ++++ +RH  L+++ + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE-------RLNIMIDV------GLA-L 283
           CS  +   +V E+M  GSL          LD L+       RL  ++D+      G+A L
Sbjct: 70  CSEEEPIYIVTEYMSKGSL----------LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           E  +Y       IH DL   NIL+ EN+V  ++DFG+++L+ E D+   +      I + 
Sbjct: 120 ESRNY-------IHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWT 171

Query: 344 APEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN 399
           APE       + K DV+S+GILL E  +        G +      N        EV++  
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVT-------YGRVPYPGMTN-------REVLEQ- 216

Query: 400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            V R +      +C   + +L L C  + P+ER
Sbjct: 217 -VERGYRMPRPPNCPEELYDLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 7e-22
 Identities = 65/201 (32%), Positives = 92/201 (45%), Gaps = 33/201 (16%)

Query: 181 LGIGSFGSVY----KGTLSDGTNVAIKIFN-------LQLERTFVSFNSECEVLRNVRHR 229
           LG GSFG V     K T   G   A+K+          ++E T     +E  +L  + H 
Sbjct: 1   LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTL----TERNILSRINHP 53

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH-Y 288
            ++K+       +   LVLE+ P G L   L     F +   R     ++ LALEYLH  
Sbjct: 54  FIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHSL 112

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEG 347
           G     II+ DLKP NILLD +    ++DFG++K L        +T T   T  Y+APE 
Sbjct: 113 G-----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEV 164

Query: 348 IVSTK----CDVYSYGILLLE 364
           ++        D +S G+LL E
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYE 185

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.4 bits (235), Expect = 9e-22
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 179 NLLGIGSFGSVYKGT---LSDGTN--VAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLI 232
             LG G FG V       L D T   VA+K  N   E    S F  E E+LR + H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 233 KILSGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           K   G           L++E++P+GSL  +L  H   +++   L     +   ++YL   
Sbjct: 70  K-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGI 348
                 IH DL   NIL++   +  +SDFG++K+L E  D   ++    + I + APE +
Sbjct: 129 R----YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 349 ----VSTKCDVYSYGILLLETFSRKKPT 372
                S+  DV+S+G+ L E F+   P+
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 69/231 (29%), Positives = 99/231 (42%), Gaps = 42/231 (18%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFN---LQLERTFVSFNSECEVL-RNVR 227
           ++F    ++G GSF +V            AIKI +   L  E+       E EVL R   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 228 HRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  +IK L        NL F   VLE+ PNG L +++      LD         ++ LAL
Sbjct: 61  HPGIIK-LYYTFQDEENLYF---VLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLAL 115

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG-- 341
           EYLH       IIH DLKP NILLD++M   ++DFG +K+L   + S    K  AT    
Sbjct: 116 EYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP-NSSPESNKGDATNIDS 170

Query: 342 -----------------YMAPE----GIVSTKCDVYSYGILLLETFSRKKP 371
                            Y++PE           D+++ G ++ +  + K P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 35/278 (12%)

Query: 179 NLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIK 233
            ++G G FG V +G L        +VAIK       ++  + F +E  ++    H N+I+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGH 290
           +    +      ++ E+M NGSL+K+L  ++    + + + ++  +   ++YL   +Y  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-- 348
                +H DL   NIL++ N+V  VSDFG+S+ L + + +         I + APE I  
Sbjct: 128 -----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 349 --VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS 406
              ++  DV+S+GI++ E  S        GE       NQ       +V+ +  V   + 
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS-------YGERPYWDMSNQ-------DVIKA--VEDGYR 226

Query: 407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK 444
               MDC   +  L LDC  +  +ER   +   + L K
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 63/275 (22%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V++G  ++ T VA+K      +  +     F +E ++++ +RH  LI++ + 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK----DFLAEAQIMKKLRHPKLIQLYAV 69

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER-------LNIMIDV------GLA-L 283
           C+  +   +V E M  GSL          L+ L+        L  +ID+      G+A L
Sbjct: 70  CTLEEPIYIVTELMKYGSL----------LEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           E  +Y       IH DL   N+L+ EN +  V+DFG+++++ E D    +      I + 
Sbjct: 120 EAQNY-------IHRDLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWT 171

Query: 344 APEGIV----STKCDVYSYGILLLE--TFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD 397
           APE  +    S K DV+S+GILL E  T+         G M      N       AEV+ 
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTY---------GRMPYPGMTN-------AEVLQ 215

Query: 398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
              V + +       C   + ++ LDC  E PD+R
Sbjct: 216 Q--VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 78/263 (29%), Positives = 126/263 (47%), Gaps = 40/263 (15%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+ GT +  T VAIK      +  E    +F  E +V++ +RH  L+++ + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQLYAV 69

Query: 238 CSNLDFKALVLEFMPNGSLEKWL---YSHNYFLDILERLNIMIDVGLA-LEYLHYGHALA 293
            S      +V E+M  GSL  +L         L  L  +   I  G+A +E ++Y     
Sbjct: 70  VSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----- 123

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIV 349
             +H DL+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  
Sbjct: 124 --VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           + K DV+S+GILL E  ++       G +     VN+       EV+D   V R +    
Sbjct: 181 TIKSDVWSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPC 224

Query: 410 KMDCLLRIMNLALDCCMESPDER 432
             +C   + +L   C  + P+ER
Sbjct: 225 PPECPESLHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.3 bits (229), Expect = 4e-21
 Identities = 71/264 (26%), Positives = 117/264 (44%), Gaps = 32/264 (12%)

Query: 180 LLGIGSFGSVYKGTL--SDGTNVAIKIFNLQ---LERTFVSFNSECEVLRNVRHRNLIKI 234
           ++G G FG V++G L       VA+ I  L+    E+    F SE  ++    H N+I++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               +      ++ E+M NG+L+K+L  H+      + + ++  +   ++YL    +   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMN 127

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG--YMAPEGIVSTK 352
            +H DL   NIL++ N+   VSDFG+S++L E D     T +   I   + APE I   K
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 353 ----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
                DV+S+GI++ E  S        GE       N        EV+ +  +       
Sbjct: 187 FTSASDVWSFGIVMWEVMS-------FGERPYWDMSNH-------EVMKA--INDGFRLP 230

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
           A MDC   +  L L C  +    R
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 179 NLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLER--TFVSFNSECEVLRNVRHRNLIKIL 235
           N +G G+FG VY    L  G  +A+K   +Q     T      E +VL  ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 236 SGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGLALEYLHYGHAL 292
            G      K  + +E+   G+LE+ L  H   LD  ++    + +  GLA  YLH     
Sbjct: 66  -GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLA--YLHSHG-- 119

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL--IQTKTMATIGYMAPEGIVS 350
             I+H D+KP+NI LD N V  + DFG +  L     ++         T  YMAPE I  
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 351 TK-------CDVYSYGILLLETFSRKKP 371
            K        D++S G ++LE  + K+P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 181 LGIGSFGSVYKGTLS------DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K      E     F  E E+L  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------------LNIMIDVG 280
              C+      +V E+M +G L ++L SH     IL                L I   + 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             + YL   H     +H DL   N L+ + +V  + DFG+S+ +   D   +  +TM  I
Sbjct: 133 SGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSRKK 370
            +M PE I+    +T+ D++S+G++L E F+  K
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 68/225 (30%), Positives = 97/225 (43%), Gaps = 41/225 (18%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
             FD    LG GS+GSVYK      G  VAIK+  +  E        E  +L+      +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYI 60

Query: 232 IKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVG 280
           +K   G    +    +V+E+   GS            DI++  N          I+    
Sbjct: 61  VKYY-GSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTL 109

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             LEYLH        IH D+K  NILL+E   A ++DFG+S  L    D++ +  T+  I
Sbjct: 110 KGLEYLHSNK----KIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAKRNTV--I 160

Query: 341 G---YMAPEGIVST----KCDVYSYGILLLETFSRKKPTNDLGEM 378
           G   +MAPE I       K D++S GI  +E    K P +D+  M
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 91.2 bits (226), Expect = 8e-21
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 16/197 (8%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVS---FNSECEVLRNVRHRNLIKILSG 237
           +G G FG V+ G   +   VAIK     +    +S   F  E +V+  + H  L+++   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
           C+      LV EFM +G L  +L +          L + +DV   + YL      + +IH
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES----SNVIH 123

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKC 353
            DL   N L+ EN V  VSDFG+++ + + D     T T   + + +PE       S+K 
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 354 DVYSYGILLLETFSRKK 370
           DV+S+G+L+ E FS  K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 18/195 (9%)

Query: 179 NLLGIGSFGSVYKGTLSD-GTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           + LG G +G VY+G        VA+K      +++E     F  E  V++ ++H NL+++
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQL 67

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +   
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV---- 349
             IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 182

Query: 350 STKCDVYSYGILLLE 364
           S K DV+++G+LL E
Sbjct: 183 SIKSDVWAFGVLLWE 197

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 68/194 (35%), Positives = 99/194 (51%), Gaps = 20/194 (10%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLL-GVIV 69

Query: 241 LDFKAL--VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
            +   L  V E+M  GSL  +L S     L     L   +DV  A+EYL   +     +H
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----FVH 125

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKC 353
            DL   N+L+ E+ VA VSDFG++K     + S  Q      + + APE +     STK 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 354 DVYSYGILLLETFS 367
           DV+S+GILL E +S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 26/215 (12%)

Query: 180 LLGIGSFGSVYKG-TLSDGTNVAIKIFNL---------QLERTFV-SFNSECEVLRNVRH 228
           L+G G++G VY    ++ G  +A+K   L           ++  V +  SE E L+++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 229 RNLIKILSGCSN-LDFKALVLEFMPNGSLEKWLYSHNYFLDILER-LNIMIDVGLALEYL 286
            N+++ L G     ++ ++ LE++P GS+   L ++  F + L R     +  GLA  YL
Sbjct: 68  LNIVQYL-GFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA--YL 124

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           H       I+H DLK  N+L+D + +  +SDFGISK   +  D+        ++ +MAPE
Sbjct: 125 HSKG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 347 GI------VSTKCDVYSYGILLLETFSRKKPTNDL 375
            I       S K D++S G ++LE F+ ++P +D 
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTN----VAIKIFNLQLER-TFVSFNSECEVLRNVR 227
           E ++  +LG G+FG+VYKG  + +G      VAIK+   +           E  V+ +V 
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H +++++L  C +     L+ + MP G L  ++ +H   +     LN  + +   + YL 
Sbjct: 68  HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE- 346
                  ++H DL   N+L+       ++DFG++KLL   +           I +MA E 
Sbjct: 127 EKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 347 ---GIVSTKCDVYSYGILLLE--TFSRK 369
               I + K DV+SYG+ + E  TF  K
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 32/264 (12%)

Query: 180 LLGIGSFGSVYKGTLS----DGTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKI 234
           ++G G FG V  G L         VAIK       E+    F SE  ++    H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               +      +V E+M NGSL+ +L  H+    +++ + ++  +   ++YL    +   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL----SDMG 126

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG--YMAPEGIV--- 349
            +H DL   NIL++ N+V  VSDFG+S++L E D     T     I   + APE I    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            ++  DV+SYGI++ E  S        GE       NQ       +V+ +  +   +   
Sbjct: 186 FTSASDVWSYGIVMWEVMS-------YGERPYWEMSNQ-------DVIKA--IEEGYRLP 229

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
           A MDC   +  L LDC  +  +ER
Sbjct: 230 APMDCPAALHQLMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 50/291 (17%)

Query: 181 LGIGSFGSVYKGTL-----SDGTNVAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG  +FG +YKG L          VAIK   ++   + +  F  E  ++  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHN----------------YFLDILERLNIMID 278
           L   +      ++ E++  G L ++L   +                  LD  + L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 279 VGLALEYL--HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
           +   +EYL  H+       +H DL   NIL+ E +   +SD G+S+ +   D   +Q K+
Sbjct: 133 IAAGMEYLSSHF------FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
           +  I +M PE I+    S+  D++S+G++L E FS        G      + NQ      
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS-------FGLQPYYGFSNQ------ 233

Query: 393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
            EV++  +VR+        DC  R+ +L  +C  E P  R    +   +LR
Sbjct: 234 -EVIE--MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 6e-20
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 181 LGIGSFGSVYKGT--LSDGT--NVAIKIF----NLQLERTFVSFNSECEVLRNVRHRNLI 232
           LG G+FGSV KG   +  G    VA+K          ++ F+    E  V+  + H  ++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIV 59

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           +++  C       LV+E  P G L K+L          +   +   V + + YL   H  
Sbjct: 60  RLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLESKH-- 115

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPE---- 346
              +H DL   N+LL     A +SDFG+S+ LG G D   +  T     + + APE    
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-RATTAGRWPLKWYAPECINY 172

Query: 347 GIVSTKCDVYSYGILLLETFSR-KKPTNDLGEMS 379
           G  S+K DV+SYG+ L E FS   KP    GEM 
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP---YGEMK 203

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.8 bits (220), Expect = 6e-20
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 26/256 (10%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+  + H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                +V E+M NG L  +L  H       + L +  DV   + YL         IH DL
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ----FIHRDL 126

Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVY 356
              N L+D+     VSDFG+S+ + + D+      +   + +  PE ++    S+K DV+
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++G+L+ E +S       LG+M  + + N     K+++      + R H  S K      
Sbjct: 186 AFGVLMWEVYS-------LGKMPYERFNNSETVEKVSQ---GLRLYRPHLASEK------ 229

Query: 417 IMNLALDCCMESPDER 432
           +  +   C  E  +ER
Sbjct: 230 VYAIMYSCWHEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 88.6 bits (220), Expect = 6e-20
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 27/211 (12%)

Query: 180 LLGIGSFGSVYKG-TLSDGTNVAIKIFNL----QLERTFVS-FNSECEVLRNVRHRNLIK 233
           LLG GSFGSVY+G  L DG   A+K  +L    Q  +  V     E  +L  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGLALEYLHYGH 290
            L      D   + LE +P GSL K L  +  F + + RL    I+    L LEYLH  +
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIV 349
                +H D+K +NIL+D N V  ++DFG++K + E        K+   +  +MAPE I 
Sbjct: 123 ----TVHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKSFKGSPYWMAPEVIA 174

Query: 350 ST-----KCDVYSYGILLLETFSRKKPTNDL 375
                    D++S G  +LE  + K P + L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 6e-20
 Identities = 73/224 (32%), Positives = 113/224 (50%), Gaps = 37/224 (16%)

Query: 180 LLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS-------------ECEVLRN 225
           L+G GSFGSVY G   S G  +A+K    Q+E   VS +S             E  +L+ 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVK----QVELPSVSASSKDRKRSMLDALAREIALLKE 62

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           ++H N+++ L    + D   + LE++P GS+   L ++  F + L R N +  +   L Y
Sbjct: 63  LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNY 121

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-------MA 338
           LH       IIH D+K +NIL+D      +SDFGISK L   + + + TKT         
Sbjct: 122 LH----NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQG 174

Query: 339 TIGYMAPEGIVST----KCDVYSYGILLLETFSRKKPTNDLGEM 378
           ++ +MAPE +  T    K D++S G L++E  + K P  D  ++
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.8 bits (220), Expect = 7e-20
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 32/257 (12%)

Query: 180 LLGIGSFGSVYKGTLS----DGTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKI 234
           ++G G FG V +G L         VAIK       E+    F SE  ++    H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               +      ++ EFM NG+L+ +L  ++    +++ + ++  +   ++YL    +   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----SEMN 126

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA---TIGYMAPEGIVST 351
            +H DL   NIL++ N+V  VSDFG+S+ L +       T ++     I + APE I   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 352 K----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
           K     DV+SYGI++ E  S        GE       NQ       +V+  N + +++  
Sbjct: 187 KFTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQ-------DVI--NAIEQDYRL 230

Query: 408 SAKMDCLLRIMNLALDC 424
              MDC   +  L LDC
Sbjct: 231 PPPMDCPTALHQLMLDC 247

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 45/280 (16%)

Query: 179 NLLGIGSFGSVYKGTLSD----GTN---VAIKIFNL-QLERTFVSFNSECEVLRNVRHRN 230
           N LG G+FG VY+GT +D    G+    VA+K       ++    F  E  ++ N  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFLDILERLNIMIDVGLALE 284
           ++K+L  C   + + +++E M  G L  +L            L + E L+I +DV     
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 285 YLHYGHALAPIIHCDLKPSNILLDE-----NMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           YL   H     IH DL   N L+ E     + V  + DFG+++ + + D    + + +  
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 340 IGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP-HKLAE 394
           + +MAPE    G  +T+ DV+S+G+L+ E  +       LG         Q  P     E
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT-------LG--------QQPYPALNNQE 221

Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH 434
           V+    V          +C  +I  L  +C  + P ER  
Sbjct: 222 VL--QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 18/192 (9%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G G+ G VYK T  + G  VAIK   L+ +   +  N E  ++++ +H N++      S
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYD--S 83

Query: 240 NLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
            L    L  V+E+M  GSL   +  +   ++  +   +  +V   LEYLH  +    +IH
Sbjct: 84  YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN----VIH 139

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIV----STK 352
            D+K  NILL ++    ++DFG +  L +      +  ++  T  +MAPE I       K
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPK 196

Query: 353 CDVYSYGILLLE 364
            D++S GI+ +E
Sbjct: 197 VDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 10/193 (5%)

Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTF-VSFNSECEVLRNVRHRNLIKILSGC 238
           +G G+FG V+ G L +D T VA+K     L       F  E  +L+   H N+++++  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           +      +V+E +  G    +L +    L + E + ++ +    +EYL   H     IH 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----IHR 118

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCD 354
           DL   N L+ E  V  +SDFG+S+   +G  +         + + APE    G  S++ D
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 355 VYSYGILLLETFS 367
           V+S+GILL E FS
Sbjct: 179 VWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 30/258 (11%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFN--LQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G FG V+ G      +VAIK+       E  F+    E +V+  + H NL+++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           +      +V E+M NG L  +L      L     L++  DV  A+EYL         IH 
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES----NGFIHR 124

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCD 354
           DL   N L+ E+ V  VSDFG+++ + + D       T   + +  PE       S+K D
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 355 VYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCL 414
           V+S+G+L+ E FS        G+M  + + N       +EVV+S  V   +         
Sbjct: 184 VWSFGVLMWEVFS-------EGKMPYERFSN-------SEVVES--VSAGYRLYRPKLAP 227

Query: 415 LRIMNLALDCCMESPDER 432
             +  +   C  E P++R
Sbjct: 228 TEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 34/222 (15%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSF-NSECEVLRNVRHRN 230
             F     +G GSFG VYK         VAIK+ +L+     +     E + L   R   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 231 LIKILSGCSNLDFK-ALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGL 281
           + K   G      K  +++E+   GS           LD+L+  +L+      I+ +V L
Sbjct: 61  ITKYY-GSFLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREVLL 109

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TI 340
            LEYLH        IH D+K +NILL E     ++DFG+S   G+   ++ +  T   T 
Sbjct: 110 GLEYLHEEGK----IHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFVGTP 162

Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEM 378
            +MAPE I       K D++S GI  +E    + P +DL  M
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL----QLERTFVSFNSECEVLRNVRH 228
           +++    +G GSFG+V K    SDG  +  K  +     + E+  +   SE  +LR ++H
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV--SEVNILRELKH 58

Query: 229 RNLIKILSGCSNLDFKAL--VLEFMPNGSLEKWL---YSHNYFLDILERLNIMIDVGLAL 283
            N+++      +   + L  V+E+   G L + +        +++      I+  + LAL
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 284 EYLHYGHALAP-IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIG 341
              H        ++H DLKP+NI LD N    + DFG++K+LG         KT   T  
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF---AKTYVGTPY 175

Query: 342 YMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
           YM+PE +       K D++S G L+ E  +   P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 65/264 (24%), Positives = 101/264 (38%), Gaps = 31/264 (11%)

Query: 180 LLGIGSFGSVYKGT----LSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIKI 234
            LG GSFG V +G           VA+K   + +L      F  E  ++ ++ H NLI+ 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR- 60

Query: 235 LSGCSNLDFKALVLEFMPNGSL-EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L G        +V E  P GSL ++          I    +  + +   + YL       
Sbjct: 61  LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT-IGYMAPEGI---- 348
             IH DL   NILL  +    + DFG+ + L + +D  +  + +     + APE +    
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 349 VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            S   DV+ +G+ L E F+        GE          +  K    +D    R E    
Sbjct: 177 FSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKK----IDKEGERLERP-- 223

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
               C   I N+ L C   +P +R
Sbjct: 224 --EACPQDIYNVMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 8e-19
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 32/208 (15%)

Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNL 231
           LG GSFG VY+G           T VAIK  N      ER    F +E  V++     ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEFNCHHV 71

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNIM-----IDVG 280
           +++L   S      +V+E M  G L+ +L S       N  L        +     I  G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           +A  YL         +H DL   N ++ E++   + DFG+++ + E D      K +  +
Sbjct: 132 MA--YLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 341 GYMAPE----GIVSTKCDVYSYGILLLE 364
            +MAPE    G+ +TK DV+S+G++L E
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)

Query: 180 LLGIGSFGSVYKGTLS--DGT--NVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIK 233
           +LG G FGSV +G LS  DG+   VA+K   L +        F SE   +++  H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 234 ILSGCSNLDFKA------LVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGLA 282
           ++  C             ++L FM +G L  +L           L +   L  M+D+ L 
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           +EYL   +     IH DL   N +L E+M   V+DFG+SK +  GD           + +
Sbjct: 126 MEYLSNRN----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 343 MAPEG----IVSTKCDVYSYGILLLETFSR 368
           +A E     + ++K DV+++G+ + E  +R
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 27/209 (12%)

Query: 184 GSFGSVYKG-TLSDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIKI---LS 236
           G++G V+     S G   AIK+     +  +       +E ++L   +   ++K+     
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH-YGHALAPI 295
           G  NL    LV+E++P G L   L +     + + R   + ++ LALEYLH  G     I
Sbjct: 64  GKKNL---YLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG-----I 114

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKL------LGEGDDSLIQTKTMATIGYMAPEGIV 349
           IH DLKP NIL+D N    ++DFG+SK+      +   DD     + + T  Y+APE I+
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 350 ----STKCDVYSYGILLLETFSRKKPTND 374
               S   D +S G +L E      P + 
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 70/255 (27%), Positives = 110/255 (43%), Gaps = 52/255 (20%)

Query: 180 LLGIGSFGSVYKGTLSD-GTNVAIKIFNL-----QLERTFVSFNSECEVLRNVRHRNLIK 233
           LLG G+FG VY     D G  +A+K         + ++   +   E ++L+N++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 234 ILSGCSNLDFK-ALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGLAL 283
              GC   D   ++ +E+MP GS++  L ++          Y   ILE           +
Sbjct: 69  YY-GCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GV 117

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL------GEGDDSLIQTKTM 337
           EYLH       I+H D+K +NIL D      + DFG SK L      G G  S+  T   
Sbjct: 118 EYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY- 172

Query: 338 ATIGYMAPEGIVST----KCDVYSYGILLLETFSRKKPTNDLGEMSL-----KHWVNQSL 388
               +M+PE I       K DV+S G  ++E  + K P  +   M+          N  L
Sbjct: 173 ----WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL 228

Query: 389 PHKLAEVVDSNLVRR 403
           P  ++     N +RR
Sbjct: 229 PSHVSPDA-RNFLRR 242

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 74/263 (28%), Positives = 125/263 (47%), Gaps = 40/263 (15%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+ GT +  T VA+K      +  E    SF  E ++++ +RH  L+++ + 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQLYAV 69

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLA-LEYLHYGHALA 293
            S      +V E+M  GSL  +L         L  L  +   +  G+A +E ++Y     
Sbjct: 70  VSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY----- 123

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIV 349
             IH DL+ +NIL+ + +V  ++DFG+++L+ + + +  Q      I + APE    G  
Sbjct: 124 --IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRF 180

Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           + K DV+S+GILL E  ++       G +      N+       EV++   V R +    
Sbjct: 181 TIKSDVWSFGILLTELVTK-------GRVPYPGMNNR-------EVLEQ--VERGYRMPC 224

Query: 410 KMDCLLRIMNLALDCCMESPDER 432
             DC + +  L L C  + P+ER
Sbjct: 225 PQDCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 30/232 (12%)

Query: 181 LGIGSFGSVYKGT------LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K            F  E E+L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDV 279
              C + D   +V E+M +G L K+L +H                  L + + L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
              + YL   H     +H DL   N L+  N++  + DFG+S+ +   D   +   TM  
Sbjct: 133 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 340 IGYMAPEGIV----STKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQ 386
           I +M PE I+    +T+ DV+S+G++L E F+  K+P   L    +   + Q
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 34/274 (12%)

Query: 181 LGIGSFGSVYKGTL---SDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKILS 236
           LG G+FG V KG         +VAIK+   + E++       E E++  + +  +++++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            C       LV+E    G L K+L      + +   + +M  V + ++YL   +     +
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN----FV 117

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI----VS 350
           H DL   N+LL     A +SDFG+SK LG  DDS  + ++     + + APE I     S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 351 TKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           ++ DV+SYGI + E FS  +KP   +               K  EV+  + + +      
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKM---------------KGPEVM--SFIEQGKRLDC 219

Query: 410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
             +C   +  L  DC +   ++R +      ++R
Sbjct: 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 179 NLLGIGSFGSVYKGT-LSDGTNVAIK-IFNLQLERTFVSFN----SECEVLRNVRHRNLI 232
             LG G++  VYK      G  VAIK I   + +      N     E ++L+ ++H N+I
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            +L    +     LV EFM    LEK +   +  L   +  + M+     LEYLH     
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---G-- 347
             I+H DLKP+N+L+  + V  ++DFG+++    G  +   T  + T  Y APE   G  
Sbjct: 123 --ILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLFGAR 178

Query: 348 IVSTKCDVYSYGILLLETFSRK 369
                 D++S G +  E   R 
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 50/216 (23%)

Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNL-------QLERTFVSFNSECE 221
           ++F+    LG GSFG V    +KG+   G   A+KI +        Q+E       +E  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHV----LNEKR 53

Query: 222 VLRNVRHRNLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMI-- 277
           +L+++RH  L+ +    S  D   L  V+E++P G L    +SH   L    R    +  
Sbjct: 54  ILQSIRHPFLVNLYG--SFQDDSNLYLVMEYVPGGEL----FSH---LRKSGRFPEPVAR 104

Query: 278 ----DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ 333
                V LALEYLH       I++ DLKP N+LLD +    ++DFG +K +         
Sbjct: 105 FYAAQVVLALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154

Query: 334 TKTM-ATIGYMAPEGIVSTKC----DVYSYGILLLE 364
           T T+  T  Y+APE I+S       D ++ GIL+ E
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.2 bits (205), Expect = 7e-18
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 47/282 (16%)

Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K      +     F+ E E+L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGLA 282
              C   D   +V E+M +G L K+L +H               L   + L+I   +   
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           + YL   H     +H DL   N L+ EN++  + DFG+S+ +   D   +   TM  I +
Sbjct: 133 MVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 343 MAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
           M PE I+    +T+ DV+S G++L E F+  K          + W   S    +  +   
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------QPWYQLSNNEVIECITQG 238

Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDER-----IHT 435
            +++R  +      C   + +L L C    P  R     IH+
Sbjct: 239 RVLQRPRT------CPKEVYDLMLGCWQREPHMRLNIKEIHS 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 8e-18
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 18/200 (9%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIK---I 234
           +G G++G VYK      G  VA+K   ++ E+      +  E ++L+ +RH N+++   I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
           ++         +V E+M +  L   L S        +    M  +   L+YLH       
Sbjct: 67  VTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---- 120

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----- 349
           I+H D+K SNIL++ + V  ++DFG+++      +S   T  + T+ Y  PE ++     
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLGATRY 179

Query: 350 STKCDVYSYGILLLETFSRK 369
             + D++S G +L E F  K
Sbjct: 180 GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 40/274 (14%)

Query: 179 NLLGIGSFGSVYKGTLS--DGTN----VAIK-IFNLQLERTFVSFNSECEVLRNVRHRNL 231
             LG G+FG VY+G     DG      VA+K +     E+    F  E  ++    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEY 285
           ++++        + ++LE M  G L+ +L            L + + L    DV    +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 286 LHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           L   H     IH D+   N LL       VA ++DFG+++ +          + M  I +
Sbjct: 132 LEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 343 MAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
           M PE    GI ++K DV+S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS-------LGYMPYPGRTNQ-------EVME- 232

Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
             V           C   +  +  DC   +P++R
Sbjct: 233 -FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDR 265

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 174 EFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           +++    +G G++G VYK   ++ G  VAIK+  L+    F     E  +L+  RH N++
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI---DVGLALEYLHYG 289
                    D   +V+E+   GSL+  +Y        L  L I     +    L YLH  
Sbjct: 64  AYFGSYLRRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT----IG---Y 342
                 IH D+K +NILL E+    ++DFG+S  L         T T+A     IG   +
Sbjct: 121 G----KIHRDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRKSFIGTPYW 167

Query: 343 MAPEGIV-------STKCDVYSYGILLLETFSRKKPTNDLGEM 378
           MAPE            KCD+++ GI  +E    + P  DL  M
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 75/263 (28%), Positives = 128/263 (48%), Gaps = 40/263 (15%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+ GT +  T VAIK      +  E    +F  E ++++ +RH  L+ + + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVPLYAV 69

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDV--GLA-LEYLHYGHALA 293
            S      +V EFM  GSL  +L   +  +L + + +++   +  G+A +E ++Y     
Sbjct: 70  VSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY----- 123

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIV 349
             IH DL+ +NIL+ +N+V  ++DFG+++L+ E ++   +      I + APE    G  
Sbjct: 124 --IHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           + K DV+S+GILL E  ++       G +     VN+       EV++   V R +    
Sbjct: 181 TIKSDVWSFGILLTELVTK-------GRVPYPGMVNR-------EVLEQ--VERGYRMPC 224

Query: 410 KMDCLLRIMNLALDCCMESPDER 432
              C   +  L   C  + PDER
Sbjct: 225 PQGCPESLHELMKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 30/218 (13%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK-IFNLQLERTFVSFNSECEVLRNV 226
            ++ +E +  N +G G+ G+VYK      G   A+K I+    +        E E+LR+V
Sbjct: 70  AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV 129

Query: 227 RHRNLIKILSGCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
            H N++K    C ++        ++LEFM  GSLE    +   FL  + R    I  G+A
Sbjct: 130 NHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIA 182

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
             YLH  H    I+H D+KPSN+L++      ++DFG+S++L +  D      ++ TI Y
Sbjct: 183 --YLHRRH----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC--NSSVGTIAY 234

Query: 343 MAPEGIVST---------KCDVYSYGILLLETFSRKKP 371
           M+PE I +            D++S G+ +LE +  + P
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 54/302 (17%)

Query: 181 LGIGSFGSVYKGT------LSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHRNLIK 233
           LG G FG V K T       +  T VA+K+       +      SE  +L+ V H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWL-----------------YSHNYFLDILERLNIM 276
           +   CS      L++E+   GSL  +L                  S          L + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 277 IDVGLA------LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
             +  A      ++YL    A   ++H DL   N+L+ E     +SDFG+S+ + E D  
Sbjct: 128 DLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 331 LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ 386
           + ++K    + +MA E     I +T+ DV+S+G+LL E  +       LG         +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGNPYPGIAPE 236

Query: 387 SLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
            L          NL++  +      +C   + NL L C  + PD+R    + + +L K+ 
Sbjct: 237 RL---------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287

Query: 447 VQ 448
           V+
Sbjct: 288 VK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 31/286 (10%)

Query: 180 LLGIGSFGSVYK---GTLSDGTN--VAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
            LG G+FGSV       L D T   VA+K            F  E E+L++++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 235 LSGC-----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
              C      NL    LV+E++P GSL  +L  H   LD  + L     +   +EYL   
Sbjct: 71  KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--- 124

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD-SLIQTKTMATIGYMAPEGI 348
                 +H DL   NIL++      + DFG++K+L +  +   ++    + I + APE +
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 349 VSTK----CDVYSYGILLLETFS----RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
             +K     DV+S+G++L E F+       P  +   M       Q + + L E++ +N 
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN- 242

Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
                   A   C   I  +  +C    P +R   +  A ++  I+
Sbjct: 243 ----GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 15/197 (7%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKILSG 237
           +G G++G VYK      G  VAIK   L+ E   +   +  E ++L+ + H N+IK+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
             +     LV EFM +  L K +      L      + +  +   L + H       I+H
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS----HGILH 121

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-----STK 352
            DLKP N+L++   V  ++DFG+++  G        T  + T  Y APE ++     ST 
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 353 CDVYSYGILLLETFSRK 369
            D++S G +  E  SR+
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 79.7 bits (197), Expect = 8e-17
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 28/207 (13%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQ--LERTFV-SFNSECEVLRNVRHRNLIKI 234
            ++G G+FG V      D   + A+K  N Q  +E+  V +  +E  +L+ + H  L+ +
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN------IMIDVGLALEYLHY 288
                + +   LV++ +  G L        Y L    + +       + ++ LALEYLH 
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLHS 118

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 IIH D+KP NILLDE    H++DF I+  +    D+L  + T  T GYMAPE +
Sbjct: 119 KG----IIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTS-TSGTPGYMAPEVL 171

Query: 349 VSTK----CDVYSYGILLLETFSRKKP 371
                    D +S G+   E    K+P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 79.7 bits (197), Expect = 9e-17
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 25/204 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFN---SECEVLRNVRHR 229
           ++ +    LG G+ G V K  L   T   + +  ++LE           E ++L      
Sbjct: 1   DDLEYLGELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGLALEYLH 287
            ++       N    ++ +E+M  GSL+K L          IL +  I + V   L YLH
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH 117

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMA 344
             H    IIH D+KPSNIL++      + DFG+S         L+ +     +G   YMA
Sbjct: 118 EKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG-------QLVNSLAKTFVGTSSYMA 167

Query: 345 PEGIVST----KCDVYSYGILLLE 364
           PE I       K D++S G+ L+E
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIE 191

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 179 NLLGIGSFGSVYKGT-LSDGTNVAIK-IFN-----LQLERTFVSFNSECEVLRNVRHRNL 231
             +G G++G V        G  VAIK I N     +  +R       E ++LR++RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENI 61

Query: 232 IKILS---GCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           I +L      S  DF  +  V E M    L K + S     D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ-TKTMATIGYMAP 345
           H  +    +IH DLKPSNIL++ N    + DFG+++ +   +D     T+ + T  Y AP
Sbjct: 120 HSAN----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Query: 346 EGIVSTK-----CDVYSYGILLLETFSRK 369
           E ++S+       D++S G +  E  +RK
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 62/199 (31%), Positives = 87/199 (43%), Gaps = 30/199 (15%)

Query: 181 LGIGSFGSVYKGTL-SDGTNVAIK------IFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG+G FG V    + S     A+K      I     +    S   E E+L    H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGLALEYLHYGHA 291
           +     +  +  +++E+   G L   L     F +   R  I  ++   LA EYLH    
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIVS 350
              II+ DLKP N+LLD N    + DFG +K L  G     +T T   T  Y+APE I+ 
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPE-IIL 165

Query: 351 TK-----CDVYSYGILLLE 364
            K      D +S GILL E
Sbjct: 166 NKGYDFSVDYWSLGILLYE 184

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 39/227 (17%)

Query: 174 EFDECN---LLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR 229
           E+DE     +LG G++G VY    LS    +AIK    +  R     + E  +   ++HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLE-----KW--LYSHN-----YFLDILERLNIMI 277
           N+++ L   S   F  + +E +P GSL      KW  L  +      Y   ILE      
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE------ 119

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSLIQTKT 336
                L+YLH       I+H D+K  N+L++  + V  +SDFG SK L  G +   +T T
Sbjct: 120 ----GLKYLHDNQ----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFT 170

Query: 337 MATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGE 377
             T+ YMAPE I           D++S G  ++E  + K P  +LGE
Sbjct: 171 -GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS-ECEVLRNVRHRNLIKILSGC 238
           +G+G+   VY    L +   VAIK  +L+  +T V     E + +    H N++K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66

Query: 239 SNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGLALEYLH-YGHAL 292
           S +    L  V+ ++  GSL   +   +Y    L+   I   + +V   LEYLH  G   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGE-GDDSLIQTKTMA-TIGYMAPEGIVS 350
              IH D+K  NILL E+    ++DFG+S  L + GD +    KT   T  +MAPE +  
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 351 T-----KCDVYSYGILLLE 364
                 K D++S+GI  +E
Sbjct: 181 VHGYDFKADIWSFGITAIE 199

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 21/216 (9%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ------LERTFVSFNSECEVLRNVRHRNLI 232
            +LG G++G+VY G  + G  +A+K   L        E+ +     E ++L++++H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI-LERLNIMIDVGLALEYLHYGHA 291
           + L  C + +  ++ +EF+P GS+   L       +    +    I  G+A  YLH    
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YLHNNC- 122

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG----EGDDSLIQTKTMATIGYMAPEG 347
              ++H D+K +N++L  N +  + DFG ++ L      G  S +      T  +MAPE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 348 IVST----KCDVYSYGILLLETFSRKKPTNDLGEMS 379
           I  +    K D++S G  + E  + K P   +  ++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 74/225 (32%), Positives = 100/225 (44%), Gaps = 42/225 (18%)

Query: 180 LLGIGSFGSVYK-GTLSDGTNVAIKIFNL----QLERTFVSFNSECEVLRNVRHRNLIK- 233
            LG GS+GSVYK   LSD    A+K  +L    Q ER   + N E  +L +V H N+I  
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVN-EIRILASVNHPNIISY 64

Query: 234 ---ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER---LNIMIDVGLALEYLH 287
               L G        +V+E+ P G L K +        ++       I I +   L+ LH
Sbjct: 65  KEAFLDGNK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIG---Y 342
                  I+H DLK +NILL  N +  + D GISK+L          K MA   IG   Y
Sbjct: 121 EQK----ILHRDLKSANILLVANDLVKIGDLGISKVL---------KKNMAKTQIGTPHY 167

Query: 343 MAPE----GIVSTKCDVYSYGILLLETFSRKKPTN--DLGEMSLK 381
           MAPE       S K D++S G LL E  +   P     + ++  K
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 18/214 (8%)

Query: 168 IQRATNEFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQLERTFVS-FNSECEV 222
           IQR       C  +G G FG VY+G      ++   VA+K        +    F  E  +
Sbjct: 3   IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           +R   H +++K++   +  +   +V+E  P G L  +L  + Y LD+   +     +  A
Sbjct: 61  MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           L YL         +H D+   N+L+       + DFG+S+ L E +     +K    I +
Sbjct: 120 LAYLESKR----FVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKW 174

Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
           MAPE I     ++  DV+ +G+ + E      KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 26/211 (12%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRN 230
           ++++  ++G G+FG V+     +D   V IK   ++   +   ++  +EC+VL+ + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 231 LIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLH 287
           +I+     + L+ KAL  V+E+ P G+L +++    N  LD    L+  + + LAL ++H
Sbjct: 61  IIEYYE--NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 288 YGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YM 343
                  I+H DLK  NILLD++ MV  + DFGISK+L        ++K    +G   Y+
Sbjct: 119 TKL----ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS------KSKAYTVVGTPCYI 168

Query: 344 APEGIVS----TKCDVYSYGILLLETFSRKK 370
           +PE         K D+++ G +L E  S K+
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 37/269 (13%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK      G   A KI  ++ E     F  E ++L   +H N++ +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
             +   +++EF   G+L+  +      L   +   +   +  AL +LH       +IH D
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK----VIHRD 128

Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGD---DSLIQTKTMATIGYMAPEGIV------- 349
           LK  NILL  +    ++DFG+S          D+ I T       +MAPE +        
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY-----WMAPEVVACETFKDN 183

Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
               K D++S GI L+E    + P ++L  M +   + +S P  L          +   +
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD---------QPSKW 234

Query: 408 SAKMDCLLRIMNLALDCCMESPDERIHTT 436
           S+  +  L+       C ++ PD+R    
Sbjct: 235 SSSFNDFLKS------CLVKDPDDRPTAA 257

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 38/262 (14%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VAIK    Q   +  +F +E  +++ ++H  L++ L     
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVR-LYAVVT 71

Query: 241 LDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLA-LEYLHYGHALAPII 296
            +   ++ E+M NGSL  +L +       ++ L  +   I  G+A +E  +Y       I
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY-------I 124

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTK 352
           H DL+ +NIL+ E +   ++DFG+++L+ E ++   +      I + APE    G  + K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 353 CDVYSYGILLLE--TFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK 410
            DV+S+GILL E  T+ R                    P      V  NL  R +     
Sbjct: 184 SDVWSFGILLTEIVTYGRI-----------------PYPGMTNPEVIQNL-ERGYRMPRP 225

Query: 411 MDCLLRIMNLALDCCMESPDER 432
            +C   +  L   C  E P+ER
Sbjct: 226 DNCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 77.1 bits (191), Expect = 8e-16
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 12/186 (6%)

Query: 178 CNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKI 234
              LG G++G VYK      G  VA+K   L  E   +   +  E  +L+ ++H N++K+
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
           L          LV E+     L+K+L      L      +IM  +   L Y H       
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---- 118

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCD 354
           I+H DLKP NIL++ + V  ++DFG+++  G    +   T  + T+ Y APE ++     
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLG--SK 174

Query: 355 VYSYGI 360
            YS  +
Sbjct: 175 HYSTAV 180

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 73/277 (26%), Positives = 113/277 (40%), Gaps = 45/277 (16%)

Query: 181 LGIGSFGSV----YKGTLSDGTN--VAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIK 233
           LG G FG V    Y    +DGT   VA+K    +  +   S +  E  +L+ + H N++K
Sbjct: 12  LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 234 ILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
               CS    K   L++E++P GSL  +L  H   L  L      I  G+A  YLH  H 
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA--YLHSQH- 127

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGIVS 350
               IH DL   N+LLD + +  + DFG++K + EG +   ++    + + + A E +  
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 351 TK----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD--------- 397
            K     DV+S+G+ L E  +                  QS P K  E++          
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSK-------------QSPPKKFEEMIGPKQGQMTVV 231

Query: 398 --SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
               L+ R        +C   +  L  +C       R
Sbjct: 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFR 268

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTN----VAIK-IFNLQLERTFVSFNSECEVLRN 225
             E  +  LLG G FG+V+KG  + +G +    VAIK I +    +TF         + +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           + H  ++++L  C     + LV +  P GSL   +  H   LD    LN  + +   + Y
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
           L   H +    H +L   NILL  + +  ++DFG++ LL   D     ++    I +MA 
Sbjct: 125 LEE-HRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 346 EGIV----STKCDVYSYGILLLETFS 367
           E I+    + + DV+SYG+ + E  S
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 35/215 (16%)

Query: 179 NLLGIGSFGSVYKGTLS-DGT--NVAIKIFN-LQLERTFVSFNSECEVLRNV-RHRNLIK 233
           +++G G+FG V +  +  DG   N AIK+      E     F  E EVL  +  H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 278
           +L  C N  +  + +E+ P G+L  +L                     L   + L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           V   ++YL    +    IH DL   N+L+ EN+ + ++DFG+S+    G++  ++ KTM 
Sbjct: 128 VATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMG 178

Query: 339 --TIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
              + +MA E     + +TK DV+S+G+LL E  S
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 38/94 (40%), Positives = 57/94 (60%), Gaps = 2/94 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            I  L+ L +++L+ N   G IP S GS+ SLE LDLS N+ +G IP+SL  L  L+ LN
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496

Query: 62  VSQNRLEGEIP--VEGPFRNFSTESFSWNYALCG 93
           ++ N L G +P  + G   + ++ +F+ N  LCG
Sbjct: 497 LNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530

Length = 623

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 43/283 (15%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRH---RNLIKI 234
           L+G G++G+VY+G  +  G  VA+KI NL      VS    E  +L  +R     N+ K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 235 LSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGLALEYLHYGH 290
             G   L    L  ++E+   GS+   + +      I E+    I+ +V +AL+Y+H   
Sbjct: 68  Y-GSY-LKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVALKYIHK-- 119

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV- 349
               +IH D+K +NIL+       + DFG++ LL +   S  ++  + T  +MAPE I  
Sbjct: 120 --VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPEVITE 175

Query: 350 ----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
                TK D++S GI + E  +   P +D+        + +S P +L           ++
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRL----------EDN 225

Query: 406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ 448
            +S  +            C  E P ER+ +     K + IK  
Sbjct: 226 GYSKLLR------EFVAACLDEEPKERL-SAEELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 69/287 (24%), Positives = 115/287 (40%), Gaps = 58/287 (20%)

Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIF----NLQLERTFVSFNSECEVLRNVRHRN 230
           +G G+FG V++            T VA+K+     +  ++     F  E  ++    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDHPN 69

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL--------------------YSHNYF-LDI 269
           ++K+L  C+      L+ E+M  G L ++L                       N   L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 270 LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
            E+L I   V   + YL         +H DL   N L+ ENMV  ++DFG+S+ +   D 
Sbjct: 130 TEQLCIAKQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 330 SLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN 385
                     I +M PE I     +T+ DV++YG++L E FS            ++ +  
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS----------YGMQPYYG 235

Query: 386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            +    +  V D N++      S   +C L + NL   C  + P +R
Sbjct: 236 MAHEEVIYYVRDGNVL------SCPDNCPLELYNLMRLCWSKLPSDR 276

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 55/198 (27%), Positives = 104/198 (52%), Gaps = 17/198 (8%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  ++ T VA+K        +  +F  E  +++ ++H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGLA-LEYLHYGHALAPII 296
            +   ++ E+M  GSL  +L S      +L +L   +  I  G+A +E  +Y       I
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY-------I 125

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTK 352
           H DL+ +N+L+ E+++  ++DFG+++++ E ++   +      I + APE I     + K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 353 CDVYSYGILLLETFSRKK 370
            DV+S+GILL E  +  K
Sbjct: 185 SDVWSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 47/238 (19%)

Query: 156 PLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDG--TNVAIK-IFNLQLER 211
           P++ W  I + D+            +G G+FG V K  +  DG   + AIK +     + 
Sbjct: 2   PVLEWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 49

Query: 212 TFVSFNSECEVL-RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---- 266
               F  E EVL +   H N+I +L  C +  +  L +E+ P+G+L  +L          
Sbjct: 50  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 109

Query: 267 -----------LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV 315
                      L   + L+   DV   ++YL    +    IH DL   NIL+ EN VA +
Sbjct: 110 AFAIANSTASTLSSQQLLHFAADVARGMDYL----SQKQFIHRDLAARNILVGENYVAKI 165

Query: 316 SDFGISKLLGEGDDSLIQTKTMA--TIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
           +DFG+S+    G +  ++ KTM    + +MA E     + +T  DV+SYG+LL E  S
Sbjct: 166 ADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 16/205 (7%)

Query: 179 NLLGIGSFGSVYKGTLSDG----TNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIK 233
            ++G G FG VY GTL D      + A+K  N   +   V  F  E  ++++  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 234 ILSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           +L  C   +   LV L +M +G L  ++ S  +   + + +   + V   +EYL    A 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL----AS 116

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI-- 348
              +H DL   N +LDE+    V+DFG+++ + + +   +   T A   + +MA E +  
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 349 --VSTKCDVYSYGILLLETFSRKKP 371
              +TK DV+S+G+LL E  +R  P
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 65/283 (22%), Positives = 118/283 (41%), Gaps = 53/283 (18%)

Query: 180 LLGIGSFGSVYKGTLSD------GTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRNL 231
            LG G+FG V K            + VA+K+      E+      SE E+++ + +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-------NYFLDILERLNIMI------- 277
           I +L  C+      +V+E+  +G+L  +L +        +          +         
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 278 -DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T  
Sbjct: 139 YQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 337 MATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH-- 390
              + +MAPE     + + + DV+S+G+LL E F+       LG            P+  
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-------LG----------GSPYPG 237

Query: 391 -KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
             + E+    L++  +      +C   + +L  DC  E P +R
Sbjct: 238 IPVEELFK--LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 58/249 (23%), Positives = 102/249 (40%), Gaps = 49/249 (19%)

Query: 215 SFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN 274
            F  E ++L  +   N+ ++L  C+      +++E+M NG L ++L  H           
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH----------- 113

Query: 275 IMIDVGLALEY--------LHYGHALAP---------IIHCDLKPSNILLDENMVAHVSD 317
           +    GLA           L+    +A           +H DL   N L+ +N    ++D
Sbjct: 114 VAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIAD 173

Query: 318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLE--TFSRKKP 371
           FG+S+ L   D   +Q +    I +MA E ++    +TK DV+++G+ L E  T  R++P
Sbjct: 174 FGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233

Query: 372 TNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE 431
              L +      V ++  H   +  D    R+ +       C   I  L L+C     ++
Sbjct: 234 YEHLTD----QQVIENAGHFFRD--DG---RQIYLPRPPN-CPKDIYELMLECWRRDEED 283

Query: 432 R-----IHT 435
           R     IH 
Sbjct: 284 RPTFREIHL 292

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 71/239 (29%), Positives = 97/239 (40%), Gaps = 49/239 (20%)

Query: 171 ATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNV-RH 228
            T  F+   ++G G++G VYK      G  VAIKI ++  +        E  +LR    H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNH 62

Query: 229 RNLIK-----ILSGCSNLDFKA-LVLEFMPNGS---LEKWLYSHNYFLDILERLN----- 274
            N+       I       D +  LV+E    GS   L K L          +RL      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIA 116

Query: 275 -IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS--DFGISKLLGEGDDSL 331
            I+ +    L YLH       +IH D+K  NILL +N  A V   DFG+S  L    DS 
Sbjct: 117 YILRETLRGLAYLHENK----VIHRDIKGQNILLTKN--AEVKLVDFGVSAQL----DST 166

Query: 332 IQTKTMATIG---YMAPEGIVS---------TKCDVYSYGILLLETFSRKKPTNDLGEM 378
           +  +    IG   +MAPE I            + DV+S GI  +E    K P  D+  M
Sbjct: 167 LG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 35/215 (16%)

Query: 179 NLLGIGSFGSVYKGTLS-DG--TNVAIKIFN-LQLERTFVSFNSECEVLRNV-RHRNLIK 233
           +++G G+FG V K  +  DG   + AIK       +     F  E EVL  +  H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 278
           +L  C +  +  L +E+ P+G+L  +L                     L   + L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           V   ++YL    +    IH DL   NIL+ EN VA ++DFG+S+    G +  ++ KTM 
Sbjct: 121 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMG 171

Query: 339 --TIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
              + +MA E     + +T  DV+SYG+LL E  S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 69/245 (28%), Positives = 117/245 (47%), Gaps = 26/245 (10%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTNV----AIKIFNLQL-ERTFVSFNSECEVLRNVR 227
           E     +LG G+FG+VYKG  + +G  V    AIKI N     +  V F  E  ++ ++ 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H +L+++L  C +   + LV + MP+G L  +++ H   +     LN  + +   + YL 
Sbjct: 68  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPE 346
                  ++H DL   N+L+       ++DFG+++LL EGD+           I +MA E
Sbjct: 127 ERR----LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALE 181

Query: 347 GI----VSTKCDVYSYGILLLE--TFSRKK----PTNDLGEMSLKHWVNQSLPHKLAEVV 396
            I     + + DV+SYG+ + E  TF  K     PT ++ ++  K    + LP      +
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK---GERLPQPPICTI 238

Query: 397 DSNLV 401
           D  +V
Sbjct: 239 DVYMV 243

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNVR 227
           EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL 
Sbjct: 68  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
                  ++H DL   N+L+       ++DFG++KLLG  +           I +MA E 
Sbjct: 127 ERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 348 IV----STKCDVYSYGILLLE--TFSRK 369
           I+    + + DV+SYG+ + E  TF  K
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 51/219 (23%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNL--------QLERTFVSFNSECEVL 223
            +  E + LG G+ GSV K  L + G   A+K            Q+ R       E E+ 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53

Query: 224 RNVRHRNLIKILSGC-----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER------ 272
           ++ +   ++K          S++    + +E+   GSL+  +Y       + +R      
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSI---GIAMEYCEGGSLDS-IYK-----KVKKRGGRIGE 104

Query: 273 ---LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
                I   V   L YLH       IIH D+KPSNILL       + DFG+S   GE  +
Sbjct: 105 KVLGKIAESVLKGLSYLHS----RKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVN 157

Query: 330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLE 364
           SL  T T  T  YMAPE I     S   DV+S G+ LLE
Sbjct: 158 SLAGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 40/285 (14%)

Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G FGSV +G L+   +   VA+K   + +        F SE   ++   H N+++++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 236 SGC----SNLDFKA--LVLEFMPNGSLEKWL-YSH----NYFLDILERLNIMIDVGLALE 284
             C     +  + +  ++L FM +G L  +L YS       +L     +  M D+   +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL    +    IH DL   N +L+ENM   V+DFG+SK +  GD           + ++A
Sbjct: 127 YL----SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 345 PEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
            E     + +TK DV+S+G+ + E  +R +      E S              E+ D   
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------------EIYD--Y 226

Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
           +R+ +      DCL  + +L   C + +P +R        +L K 
Sbjct: 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 44/221 (19%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKI---FNLQL--ERTFVSFNSECEVLRNVR 227
            +   + +G G++G V   T    G  VAIK    F  Q   +RT      E ++LR  +
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFK 61

Query: 228 HRNLIKILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHN-------YFL-DILERLN 274
           H N+I IL       F++     +V E M    L K + + +       YFL  IL    
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR--- 117

Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQ 333
                   L+Y+H     A ++H DLKPSN+LL+ N    + DFG++++   E D +   
Sbjct: 118 -------GLKYIHS----ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 334 TKTMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSRK 369
           T+ +AT  Y APE ++++K      D++S G +L E  S +
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 34/224 (15%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS--ECEVLRN 225
           +R  ++FD    +G G++G VYK    D G  VA+K   L  E+      +  E ++LR 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 226 VRHRNLIKILSGCSN----LDFKA------LVLEFMPN---GSLEKWL--YSHNYFLDIL 270
           + HRN++ +    ++    LDFK       LV E+M +   G LE  L  +S ++    +
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
           ++L   ++    L Y H  + L    H D+K SNILL+      ++DFG+++L    ++S
Sbjct: 123 KQL---LE---GLNYCHKKNFL----HRDIKCSNILLNNKGQIKLADFGLARLY-NSEES 171

Query: 331 LIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
              T  + T+ Y  PE ++         DV+S G +L E F++K
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 20/209 (9%)

Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV 226
           +I R + + ++   LG G FG V+  T +  T VA+K        +  +F +E  V++ +
Sbjct: 2   EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTL 58

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGLA- 282
           +H  L+K L      +   ++ EFM  GSL  +L S       L +L   +  I  G+A 
Sbjct: 59  QHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           +E  +Y       IH DL+ +NIL+  ++V  ++DFG+++++ E ++   +      I +
Sbjct: 118 IEQRNY-------IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKW 169

Query: 343 MAPEGI----VSTKCDVYSYGILLLETFS 367
            APE I     + K DV+S+GILL+E  +
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 50/232 (21%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFN--LQLERTFVS-FNSECEVLRNVRH 228
           ++F+   ++G G+FG V+     D   V A+K+      ++R  ++   +E ++L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGLALEYL 286
             ++K+     + +   LV+E+MP G L   L   + F +   R  I  ++   LAL+ +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSV 117

Query: 287 H-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDS------------- 330
           H  G      IH D+KP NIL+D +   H+  +DFG+ K + +  D              
Sbjct: 118 HKLGF-----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 331 ---------LIQTKTMA--TIG---YMAPEGIVST----KCDVYSYGILLLE 364
                      Q +  A  T+G   Y+APE +  T    +CD +S G++L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 19/211 (9%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS--ECEVLRNV 226
           R+  EF++ N +G G++G VY+   +  G  VA+K   +  ER  +  +S  E  +L N+
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63

Query: 227 RHRN---LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           RH N   L +++ G  +LD   LV+E+     L   L +        +   +M+ +   L
Sbjct: 64  RHPNIVELKEVVVG-KHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGL 121

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           +YLH       IIH DLK SN+LL +     ++DFG+++  G     +  T  + T+ Y 
Sbjct: 122 QYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYR 175

Query: 344 APEGIV-----STKCDVYSYGILLLETFSRK 369
           APE ++     +T  D+++ G +L E  + K
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 26/227 (11%)

Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK    + G   A K+   + E     +  E E+L    H  ++K+L    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDI-LERLNIMIDVGLALEYLHYGHALAPIIHC 298
                 +++EF P G+++  +      LD  L    I +     LE L Y H++  IIH 
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMK-IIHR 134

Query: 299 DLKPSNILLDENMVAHVSDFGIS----KLLGEGDDSLIQTKTMATIGYMAPEGIVST--- 351
           DLK  N+LL  +    ++DFG+S    K L +  DS I T       +MAPE ++     
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPY-----WMAPEVVMCETMK 188

Query: 352 ------KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
                 K D++S GI L+E    + P ++L  M +   + +S P  L
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 235

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 42/272 (15%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ------LERTFVSFNSECEVLRNVRHRNLI 232
            LG G+F S Y+   +  GT +A+K            E    +   E  ++  + H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYGHA 291
           ++L          L +E+M  GS+   L  +  F + ++      +  GL+  YLH    
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS--YLHENQ- 123

Query: 292 LAPIIHCDLKPSNILLDEN-MVAHVSDFGI-----SKLLGEGDDSLIQTKTMATIGYMAP 345
              IIH D+K +N+L+D       ++DFG      +K  G G     Q + + TI +MAP
Sbjct: 124 ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFMAP 177

Query: 346 EGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV 401
           E +        CDV+S G +++E  + K P N     + KH  + +L  K+A    +  +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-----AEKHSNHLALIFKIASATTAPSI 232

Query: 402 RREHSFSAKMDCLLRIMNLALDCCMES-PDER 432
             EH      D  LR        C+E  P++R
Sbjct: 233 -PEHLSPGLRDVTLR--------CLELQPEDR 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 14/196 (7%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G       VAIK  N +   +   F  E +V+  + H  L+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFL--DILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                +V EFM NG L  +L      L  D+L  L++  DV   +EYL         IH 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS----FIHR 124

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCD 354
           DL   N L+    V  VSDFG+++ + + D+    +     + +  PE       S+K D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 355 VYSYGILLLETFSRKK 370
           V+S+G+L+ E F+  K
Sbjct: 184 VWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 21/207 (10%)

Query: 178 CNLLGIGSFGSVYKGTLSDGTN-VAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKIL 235
           C   G+  F              VA+K+    + +T  + F  E +++  +++ N+I++L
Sbjct: 24  CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWL--------YSHNYFLDILERLNIM---IDVGLALE 284
             C + D   ++ E+M NG L ++L        ++H   +  +   N++   + +   ++
Sbjct: 84  GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK 143

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL    A    +H DL   N L+  +    ++DFG+S+ L  GD   IQ + +  I +MA
Sbjct: 144 YL----ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199

Query: 345 PEGIV----STKCDVYSYGILLLETFS 367
            E I+    +T  DV+++G+ L E F+
Sbjct: 200 WESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQ----LERTFVSFNSECEVLRNVRH 228
           +F+  N +G GSFG V+K    +D    A+K  +L      ER       E  VL  +  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE--EAIDEARVLAKLDS 58

Query: 229 RNLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLAL 283
             +I+     S LD   L  V+E+  NG L K L          D + R  I I +GLA 
Sbjct: 59  SYIIRYYE--SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA- 115

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
            +LH       I+H D+K  N+ LD      + D G++KLL   D++      + T  Y+
Sbjct: 116 -HLHSKK----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYL 168

Query: 344 APE----GIVSTKCDVYSYGILLLETFSRKKP 371
           +PE       + K DV++ G++L E  + K P
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 69/224 (30%), Positives = 100/224 (44%), Gaps = 24/224 (10%)

Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN---SECEVLRNVRHRNLIKILS 236
           +G GSFG+VY          VAIK  +   +++   +     E   L+ +RH N I+   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81

Query: 237 GCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
           GC   +  A LV+E+   GS    L  H   L  +E   I       L YLH  H     
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH-SHER--- 136

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVST---- 351
           IH D+K  NILL E     ++DFG + L+    +S + T       +MAPE I++     
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NSFVGTPY-----WMAPEVILAMDEGQ 190

Query: 352 ---KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
              K DV+S GI  +E   RK P  ++  MS  + + Q+    L
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 234

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 178 CNLLGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRN 230
              LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     +
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMI----DVGL 281
           ++++L   S      +++E M  G L+ +L S      N  +     L  MI    ++  
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            + YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + 
Sbjct: 131 GMAYLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 342 YMAPE----GIVSTKCDVYSYGILLLE 364
           +M+PE    G+ +T  DV+S+G++L E
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 39/184 (21%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNL---------QLERTFVSFNSECEVLRNVRHRN 230
           +G G+ G V+K      G  VA+K   L         Q  R       E + L+  +H  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-------EIKALQACQHPY 60

Query: 231 LIKIL------SGCSNLDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGLA 282
           ++K+L      SG        LV+E+MP   L + L           ++    M+     
Sbjct: 61  VVKLLDVFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML----- 108

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           L+ + Y HA   I+H DLKP+N+L+  + V  ++DFG+++L  E +  L  +  +AT  Y
Sbjct: 109 LKGVAYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQVATRWY 166

Query: 343 MAPE 346
            APE
Sbjct: 167 RAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 22/212 (10%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL-----SDGT-NVAIKIFNLQLERTFV-SFNSECE 221
           EF   NL     LG G+FG V + T      SD    VA+K+       +   +  SE +
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDV 279
           ++ ++  H N++ +L  C+      ++ E+   G L  +L      FL + + L+    V
Sbjct: 91  IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
              + +L    A    IH DL   N+LL    +  + DFG+++ +    + +++      
Sbjct: 151 AKGMAFL----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206

Query: 340 IGYMAPEGIV----STKCDVYSYGILLLETFS 367
           + +MAPE I     + + DV+SYGILL E FS
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 30/232 (12%)

Query: 197 GTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKIL-SGCSNLDFKALVLEFMP 252
           G  VAIK+      + E     F  E  +   + H N++ +L SG +       V E++P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DE 309
             +L + L +    L   E   +M+ V   L+ L   H    I+H DLKP NI++     
Sbjct: 63  GRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHN-QGIVHRDLKPQNIMVSQTGV 117

Query: 310 NMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IG---YMAPEGI----VSTKCDVYSYGI 360
              A V DFGI  LL    D+ + T T  T  +G   Y APE +    V+   D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 361 LLLETFSRKKPTN--DLGEMSLKHW--VNQSLP-----HKLAEVVDSNLVRR 403
           + LE  + ++      + E+  +    V+ SLP     H L +V+   L + 
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKD 229

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 30/215 (13%)

Query: 174 EFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNL-------QLERTFVSFNSECEVLR 224
           + +    +G G+FG V+  +  +S     A+K+  +       Q +      ++E  VL+
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHV----HNEKRVLK 56

Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            V H  +I++     +  F  +++E++P G L  +L +   F +         ++  ALE
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALE 115

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYM 343
           YLH       I++ DLKP NILLD+     ++DFG +K L +      +T T+  T  Y+
Sbjct: 116 YLH-SKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYL 165

Query: 344 APEGIVST----KCDVYSYGILLLETFSRKKPTND 374
           APE I S       D ++ GIL+ E      P  D
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 60/279 (21%), Positives = 115/279 (41%), Gaps = 47/279 (16%)

Query: 177 ECNLLGIGSFGSVY----KGTLSDGTN--VAIKIFNLQLERTFVS-FNSECEVLRNVRHR 229
           E   LG G FG V+    KG   +G    V +K      +    S F  E ++ R + H+
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------ERLNIMIDVGL 281
           N++++L  C   +   ++LE+   G L+++L +     + L        +++ +   + L
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            +++L         +H DL   N L+       VS   +SK +    +       +  + 
Sbjct: 129 GMDHLSNAR----FVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALIPLR 183

Query: 342 YMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD 397
           ++APE +     STK DV+S+G+L+ E F++ +                 LP     + D
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-----------------LPFY--GLSD 224

Query: 398 SNLVRREHSFSAKM----DCLLRIMNLALDCCMESPDER 432
             ++ R  +   ++     C  R+  L   C   +P +R
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDR 263

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 46/289 (15%)

Query: 181 LGIGSFGSVYKGTLSDGT------NVAIKIFNLQLERTF-VSFNSECEVLRNVRHRNLIK 233
           LG   FG VYKG L           VAIK    + E      F  E  +   ++H N++ 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI------------LER---LNIMID 278
           +L   +     +++  +  +  L ++L   +   D+            LE    ++I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           +   +E+L   H    ++H DL   N+L+ + +   +SD G+ + +   D   +   ++ 
Sbjct: 133 IAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 339 TIGYMAPEGIVSTKC----DVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
            I +M+PE I+  K     D++SYG++L E FS        G      + NQ       +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS-------YGLQPYCGYSNQ-------D 234

Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
           V++  ++R         DC   +  L L+C  E P  R    +  ++LR
Sbjct: 235 VIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS---ECEVLRNVRH 228
           N+++   ++G G++G V K      G  VAIK F  + E       +   E +VLR +RH
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++ +           LV E++    LE  L +    L      + +  +  A+ Y H 
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH- 117

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
            H    IIH D+KP NIL+ E+ V  + DFG ++ L     S + T  +AT  Y APE +
Sbjct: 118 SHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELL 173

Query: 349 VSTK-----CDVYSYGILLLE 364
           V         DV++ G ++ E
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAE 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 17/214 (7%)

Query: 174 EFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           +F+    +G G++G VYK   ++ G   AIK+  L+    F     E  ++++ +H N++
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
                    D   + +EF   GSL+  +Y   +    L    I       L+ L+Y H+ 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQD-IY---HVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPE----- 346
             + H D+K +NILL +N    ++DFG+S  +     ++ + K+ + T  +MAPE     
Sbjct: 126 GKM-HRDIKGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVE 181

Query: 347 --GIVSTKCDVYSYGILLLETFSRKKPTNDLGEM 378
             G  +  CD+++ GI  +E    + P  DL  M
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 64/246 (26%), Positives = 111/246 (45%), Gaps = 32/246 (13%)

Query: 180 LLGIGSFGSVYK--GTLSDGTNVAIKIFNL----------QLERTFVSFNSECEVLR-NV 226
            LG G+FG VYK     +    +A+K  N+          + +++     SE  +++  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS----HNYFLDILERL-NIMIDVGL 281
           RH N+++        D   +V++ +    L +   S       F +  ER+ NI + + L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YLH       I+H DL P+NI+L E+    ++DFG++K           T  + TI 
Sbjct: 125 ALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTIL 178

Query: 342 YMAPEGIVST-----KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
           Y  PE IV       K DV+++G +L +  + + P      +SL   + +++   L E +
Sbjct: 179 YSCPE-IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 397 DSNLVR 402
            S  V 
Sbjct: 238 YSEDVT 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 33/216 (15%)

Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHN------YFLDILERLNI 275
           +I +L  C+      +++E+   G+L ++L         Y +N        L   + ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 146 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 15/203 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHR 229
            +++   L+G GS+G V K    + G  VAIK F    +   V   +  E  +L+ +RH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           NL+ ++          LV EF+ +  L+  L  +   LD       +  +   +E+ H  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV 349
           +    IIH D+KP NIL+ ++ V  + DFG ++ L    +  + T  +AT  Y APE +V
Sbjct: 120 N----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLV 173

Query: 350 -STK----CDVYSYGILLLETFS 367
             TK     D+++ G L+ E  +
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 73/253 (28%), Positives = 118/253 (46%), Gaps = 49/253 (19%)

Query: 181 LGIGSFGSVYKG--TLSDGTNVAIK----IF-NLQL-ERTFVSFNSECEVLRNVRHRNLI 232
           +G G++G V     T S G  VAIK     F    L +RT      E ++LR+ +H N+I
Sbjct: 13  IGSGAYGVVCSAIDTRS-GKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNII 67

Query: 233 KILS--GCSNLDFKA--LVLEFMPNGSLEKWLYSH--------NYFLDILERLNIMIDVG 280
            I         DFK   +V++ M +  L   ++S          YFL  L R        
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR-------- 118

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG--DDSLIQTKTMA 338
             L+Y+H     A +IH DLKPSN+L++E+    + DFG+++ L     +     T+ +A
Sbjct: 119 -GLKYIHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 339 TIGYMAPEGIVS-----TKCDVYSYGILLLETFSRKK--PTND-LGEMSLKHWVNQSLPH 390
           T  Y APE ++S     T  D++S G +  E   R++  P  + + ++ L   V  S   
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233

Query: 391 KLAEVVDSNLVRR 403
           ++   + S+ VR+
Sbjct: 234 EVLNRIGSDRVRK 246

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 40/277 (14%)

Query: 181 LGIGSFGSVYKG---TLSDGTNVAIKIFNLQLERTFV--SFNSECEVLRNVRHRNLIKIL 235
           LG G+FG+V KG          VA+KI         +      E  V++ + +  +++++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGLALEYLHYGHALA 293
             C    +  LV+E    G L K+L  + +  +  I E ++    V + ++YL   +   
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVH---QVSMGMKYLEETN--- 115

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N+LL     A +SDFG+SK LG  D++  + KT     + + APE +   
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 349 -VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS 406
             S+K DV+S+G+L+ E FS  +KP   +               K  EV    ++     
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGM---------------KGNEVT--QMIESGER 216

Query: 407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                 C   + +L   C     DER        +LR
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 29/210 (13%)

Query: 181 LGIGSFGSVY----KGTLSDGTNVAIKIFN----LQLERTFVSFNSECEVLRNVRHRNLI 232
           LG G++G V+     G    G   A+K+      +Q  +T     +E +VL  VR    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 233 KILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGLALEYLHYGH 290
             L      D K  L+L+++  G L   LY   +F      + + I ++ LAL++LH   
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF--TESEVRVYIAEIVLALDHLHQ-- 123

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL--GEGDDSLIQTKTMATIGYMAPEGI 348
               II+ D+K  NILLD      ++DFG+SK     E + +        TI YMAPE +
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA---YSFCGTIEYMAPE-V 177

Query: 349 VSTK-------CDVYSYGILLLETFSRKKP 371
           +           D +S G+L  E  +   P
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR---- 227
           N+ +    +G G+ G VYK      G  +A+K    Q+ RT     ++  +L ++     
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVK----QMRRTGNKEENK-RILMDLDVVLK 69

Query: 228 -HR--NLIKILSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFL--DILERLNIMIDVGL 281
            H    ++K   G    D    + +E M    L+K L      +  DIL ++ + I    
Sbjct: 70  SHDCPYIVKCY-GYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVK-- 125

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL   H    +IH D+KPSNILLD +    + DFGIS   G   DS  +T++     
Sbjct: 126 ALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCAA 179

Query: 342 YMAPEGI--------VSTKCDVYSYGILLLE 364
           YMAPE I           + DV+S GI L+E
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVE 210

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 36/198 (18%)

Query: 184 GSFGSVYKG-TLSDGTNVAIKIF------------NLQLERTFVSFNSECEVLRNVRHRN 230
           G+FGSVY     S G   AIK+             N++ ER  +    E           
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP--------Y 58

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           + K+     + D+  LV+E++  G     + +     +   +   + +V L +E LH   
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLHQRG 117

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---G 347
               IIH D+KP N+L+D+     ++DFG+S+        L   K + T  Y+APE   G
Sbjct: 118 ----IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILG 167

Query: 348 IVSTK-CDVYSYGILLLE 364
           +   K  D +S G ++ E
Sbjct: 168 VGDDKMSDWWSLGCVIFE 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 27/211 (12%)

Query: 180 LLGIGSFGSVYKGTL--SDGT--NVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIK 233
           +LG G FGSV +  L   DG+   VA+K+    +        F  E   ++   H N+IK
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 234 ILSGCS-------NLDFKALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGL 281
           ++ G S        L    ++L FM +G L  +L         + L +   +  MID+  
Sbjct: 66  LI-GVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            +EYL   +     IH DL   N +L+ENM   V+DFG+SK +  GD       +   + 
Sbjct: 125 GMEYLSSKN----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 342 YMAPEGIV----STKCDVYSYGILLLETFSR 368
           ++A E +     +T  DV+++G+ + E  +R
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)

Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDIL----------ERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 143 TYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 44/221 (19%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVR---H 228
           ++E   +G G++G+VYK   L+ G  VA+K   + L    +  ++  E  +L+ +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 229 RNLIKILSGCSNLDFK-----ALVLEFM-----------PNGSLEKWLYSHNYFLDILER 272
            N++++L  C            LV E +           P   L                
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI----------- 109

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
            ++M  +   +++LH  H    I+H DLKP NIL+  +    ++DFG++++    + +L 
Sbjct: 110 KDLMRQLLRGVDFLH-SHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMAL- 163

Query: 333 QTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
            T  + T+ Y APE ++    +T  D++S G +  E F R+
Sbjct: 164 -TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 40/200 (20%)

Query: 181 LGIGSFGSVYKGTLSD---GTNVAIK-IF----NLQ-LERTF--VSFNSECEVLRNVRHR 229
           LG G++G V+K    D      VA+K IF    N    +RTF  + F  E   L +  H 
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE---LGD--HP 67

Query: 230 NLIKILS---GCSNLDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLAL 283
           N++K+L+     ++ D   LV E+M     E  L++    N   D+ +R  IM  +  AL
Sbjct: 68  NIVKLLNVIKAENDKDI-YLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKAL 120

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL---IQTKTMATI 340
           +Y+H G+    +IH DLKPSNILL+ +    ++DFG+++ L E +++    + T  +AT 
Sbjct: 121 KYIHSGN----VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 341 GYMAPEGIVSTKCDVYSYGI 360
            Y APE ++ +    Y+ G+
Sbjct: 177 WYRAPEILLGSTR--YTKGV 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 23/198 (11%)

Query: 200 VAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK 258
           VA+KI      +   + F  E ++L  ++  N+I++L  C + D   ++ E+M NG L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 259 WLYSHNYFLDILERLNIMIDV---GLALEYLHYGHALAPI------------IHCDLKPS 303
           +L S ++  D  E  N  +       A+ Y    H    I            +H DL   
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 304 NILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYG 359
           N L+ EN+   ++DFG+S+ L  GD   IQ + +  I +MA E I+    +T  DV+++G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 360 ILLLETFS--RKKPTNDL 375
           + L E     +++P  +L
Sbjct: 228 VTLWEILMLCKEQPYGEL 245

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 23/205 (11%)

Query: 180 LLGIGSFGSVY---KGTLSD-GTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLI 232
           +LG GSFG V+   K T  D G   A+K+     L++ R  V    E ++L  V H  ++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIV 61

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-MIDVGLALEYLHYGHA 291
           K+           L+L+F+  G L   L     F +  E +   + ++ LAL++LH   +
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH---S 116

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIV- 349
           L  II+ DLKP NILLDE     ++DFG+SK   E  D   +  +   T+ YMAPE +  
Sbjct: 117 LG-IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 350 ---STKCDVYSYGILLLETFSRKKP 371
              +   D +S+G+L+ E  +   P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)

Query: 175 FDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH---- 287
           +K+L      +   LV EF+ +  L+K       F+D      I   + L   YL     
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGI--PLPLIKSYLFQLLQ 111

Query: 288 ---YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
              + H+   ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y A
Sbjct: 112 GLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRA 168

Query: 345 PEGIV-----STKCDVYSYGILLLETFSRK 369
           PE ++     ST  D++S G +  E  +R+
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 180 LLGIGSFGSVYKGTLSD-GTNVAIK--IFNLQLERTFVSFNS-ECEV--LRNVRHRNLIK 233
           LLG G+FG VY    +D G  +A+K   F+   + T    N+ ECE+  L+N+RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 234 ILSGCSNLDFKALVL--EFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYGH 290
                 + + K L +  E+MP GS++  L ++    + +  R    I  G++  YLH   
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS--YLHSNM 126

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG--------- 341
               I+H D+K +NIL D      + DFG SK         IQT  M+  G         
Sbjct: 127 ----IVHRDIKGANILRDSAGNVKLGDFGASK--------RIQTICMSGTGIKSVTGTPY 174

Query: 342 YMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS 379
           +M+PE I       K DV+S    ++E  + K P  +   M+
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 69/220 (31%), Positives = 100/220 (45%), Gaps = 26/220 (11%)

Query: 181 LGIGSFGSVYKGTLSDGTN--VAIKIFNL---QLERTFVSFNSECEVLRNVRHRNLIKIL 235
           +G GSFG+VY  T S  TN  VA+K  +    Q    +     E + L+ ++H N I+  
Sbjct: 29  IGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-Y 86

Query: 236 SGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
            GC   +  A LV+E+   GS    L  H   L  +E   I       L YLH  H +  
Sbjct: 87  KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNM-- 142

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVST--- 351
            IH D+K  NILL E     ++DFG +      +        + T  +MAPE I++    
Sbjct: 143 -IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPYWMAPEVILAMDEG 195

Query: 352 ----KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
               K DV+S GI  +E   RK P  ++  MS  + + Q+
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 235

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 39/90 (43%), Positives = 48/90 (53%), Gaps = 13/90 (14%)

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL        IIH D+KPSNILLD N    + DFGIS   G+  DS+ +T+      
Sbjct: 119 ALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRP 172

Query: 342 YMAPEGIVST-------KCDVYSYGILLLE 364
           YMAPE I  +       + DV+S GI L E
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYE 202

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 37/66 (56%), Positives = 45/66 (68%), Gaps = 1/66 (1%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
           L  LSLA NKF G +P SFGS   LE+LDLS N  SG +P+ L +L  L QL +S+N+L 
Sbjct: 454 LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512

Query: 69  GEIPVE 74
           GEIP E
Sbjct: 513 GEIPDE 518

Length = 968

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 28/230 (12%)

Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK    + G   A K+ + + E     +  E ++L +  H N++K+L    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL----NIMIDVGLALEYLHYGHALAPI 295
             +   +++EF   G+++  +         LER      I +     LE L+Y H    I
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLE-------LERPLTEPQIRVVCKQTLEALNYLHE-NKI 124

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT--MATIGYMAPEGIVST-- 351
           IH DLK  NIL   +    ++DFG+S      +   IQ +   + T  +MAPE ++    
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 352 -------KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
                  K DV+S GI L+E    + P ++L  M +   + +S P  LA+
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ 230

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 40/272 (14%)

Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMI----DVGLALE 284
           +L   S      +V+E M +G L+ +L S      N        L  MI    ++   + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 134 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 345 PE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
           PE    G+ +T  D++S+G++L E  S       L E   +   N+ +   L  V+D   
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQV---LKFVMDGGY 239

Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + +        +C  R+ +L   C   +P  R
Sbjct: 240 LDQPD------NCPERVTDLMRMCWQFNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 24/220 (10%)

Query: 174 EFDECNLLGIGSFGSVY---KGTLSD-GTNVAIKIFN----LQLERTFVSFNSECEVLRN 225
            F+   +LG G++G V+   K T  D G   A+K+      +Q  +T     +E  VL +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 226 VRHRNLIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           VR    +  L      + K  L+L+++  G +   LY  + F +   R     ++ LALE
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALE 119

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK-LLGEGDDSLIQTKTM-ATIGY 342
           +LH       I++ D+K  NILLD      ++DFG+SK  L E  +   +T +   TI Y
Sbjct: 120 HLHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE---RTYSFCGTIEY 172

Query: 343 MAPEGIVSTK-----CDVYSYGILLLETFSRKKPTNDLGE 377
           MAPE I          D +S GIL+ E  +   P    GE
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 47/130 (36%), Positives = 68/130 (52%), Gaps = 22/130 (16%)

Query: 248 LEFMPNGSLEKW---LYSHNYFL--DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP 302
           +E M + SL+K+   +Y     +  DIL +  I + +  ALEYLH   +   +IH D+KP
Sbjct: 79  MEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLH---SKLSVIHRDVKP 132

Query: 303 SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--------VSTKCD 354
           SN+L++ N    + DFGIS   G   DS+ +T       YMAPE I           K D
Sbjct: 133 SNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSD 189

Query: 355 VYSYGILLLE 364
           V+S GI ++E
Sbjct: 190 VWSLGITMIE 199

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 24/230 (10%)

Query: 150 DEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ 208
           DEE L  L T   +S  D ++    F++   +G G+ G+VY    ++ G  VAIK  NLQ
Sbjct: 1   DEEILEKLRTI--VSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQ 55

Query: 209 LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD 268
            +       +E  V+R  +H N++  L      D   +V+E++  GSL   +      +D
Sbjct: 56  QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MD 113

Query: 269 ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
             +   +  +   ALE+LH       +IH D+K  NILL  +    ++DFG    +    
Sbjct: 114 EGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---- 165

Query: 329 DSLIQTKTMATIG---YMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
            +  Q+K    +G   +MAPE +       K D++S GI+ +E    + P
Sbjct: 166 -TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 26/203 (12%)

Query: 174 EFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ--LERTFVS-FNSECEVLRNV 226
           +F+    LG GSFG V    +KGT   G   AIK    +  L+   V     E  +L  +
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H  ++ ++    + +    +LEF+  G L   L     F + + +     ++ LA EYL
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYL 134

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAP 345
           H       II+ DLKP N+LLD      V+DFG +K + +      +T T+  T  Y+AP
Sbjct: 135 HS----KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAP 184

Query: 346 EGIVS----TKCDVYSYGILLLE 364
           E I S       D ++ G+LL E
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYE 207

Length = 329

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 20/178 (11%)

Query: 216 FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY---------- 265
           F  E +++  ++  N+I++L+ C   D   ++ E+M NG L ++L  H            
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
            +     + +   +   ++YL    +    +H DL   N L+ +N    ++DFG+S+ L 
Sbjct: 126 TISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 326 EGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS--RKKPTNDLGE 377
            GD   IQ + +  I +M+ E I+    +T  DV+++G+ L E  +  +++P + L +
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 36/72 (50%), Positives = 46/72 (63%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           ++G LK+L  L L  NK  GPIP S  SL  L SLDLS N+LSGEIP+ +  L  L+ L+
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314

Query: 62  VSQNRLEGEIPV 73
           +  N   G+IPV
Sbjct: 315 LFSNNFTGKIPV 326

Length = 968

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)

Query: 175 FDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQ-LERTFVSFNSECEVLRNVRHRNLI 232
           F +   +G GSFG VYKG  +    V AIKI +L+  E        E  VL       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 233 KILSGCSNLDFKALVLEFMPNGS----LEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
           +            +++E++  GS    L+       Y   IL       ++   L+YLH 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLHS 119

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPEG 347
                  IH D+K +N+LL E     ++DFG++   G+  D+ I+  T + T  +MAPE 
Sbjct: 120 ERK----IHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 348 IVST----KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
           I  +    K D++S GI  +E    + P +DL  M +   + ++ P  L
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL 221

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 30/219 (13%)

Query: 180 LLGIGSFGSVYKGTLSD-GTNVAIKI--FNLQLERTFVSFNS-ECEV--LRNVRHRNLIK 233
           LLG G+FG VY    +D G  +A+K   F+ +   T    N+ ECE+  L+N+ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 234 ILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYGH 290
                 +   + L   +E MP GS++  L S+    + +  +    I     LE + Y H
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL------GEGDDSLIQTKTMATIGYMA 344
           +   I+H D+K +NIL D      + DFG SK L      G G  S+  T       +M+
Sbjct: 124 S-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY-----WMS 177

Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS 379
           PE I       K D++S G  ++E  + K P  +   M+
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)

Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQ-LERTFVSFNSECEVLRNVRHRNL 231
           F +   +G GSFG V+KG + + T   VAIKI +L+  E        E  VL       +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
            K            +++E++  GS    L +  +  D  +   ++ ++   L+YLH    
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLHSEKK 122

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPEGI-- 348
               IH D+K +N+LL E     ++DFG++   G+  D+ I+  T + T  +MAPE I  
Sbjct: 123 ----IHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175

Query: 349 --VSTKCDVYSYGILLLETFSRKKPTNDLGEM 378
               +K D++S GI  +E    + P +D+  M
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.6 bits (153), Expect = 7e-11
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 20/213 (9%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNV 226
           R+ +E+++ N +  G++G VY+      G  VA+K   ++ E+      S  E  +L  +
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL 61

Query: 227 RHRNLIK---ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           +H N++    ++ G SNLD   +V+E++ +  L+  + +        E   +M+ +   +
Sbjct: 62  QHPNIVTVKEVVVG-SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
            +LH       I+H DLK SN+LL+   +  + DFG+++  G        T+ + T+ Y 
Sbjct: 120 AHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYR 173

Query: 344 APE-----GIVSTKCDVYSYGILLLETFSRKKP 371
           APE        ST  D++S G +  E    KKP
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAE-LLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)

Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V         K   +    VA+K+  +   ++      SE E+++ + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDIL----------ERLNI 275
           +I +L  C+      +++E+   G+L ++L +      +Y  D            + ++ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 140 AYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+LL E F+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 26/161 (16%)

Query: 246 LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSN 304
           + +EFM  GSL++         ++IL +  I + V   L YL+  H    I+H D+KPSN
Sbjct: 80  MCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR---IMHRDIKPSN 134

Query: 305 ILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGI 360
           IL++      + DFG+S   GE  +S+  T  + T  YM+PE I     + K DV+S GI
Sbjct: 135 ILVNSRGQIKLCDFGVS---GELINSIADT-FVGTSTYMSPERIQGGKYTVKSDVWSLGI 190

Query: 361 LLLE--------TFSRKKPTNDLGEMS----LKHWVNQSLP 389
            ++E         FS          M     L+  V +  P
Sbjct: 191 SIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 35/70 (50%), Positives = 42/70 (60%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           IGGL  L  L L  N   GPIP S G+L +L+ L L  N LSG IP S+ +L  L  L++
Sbjct: 232 IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291

Query: 63  SQNRLEGEIP 72
           S N L GEIP
Sbjct: 292 SDNSLSGEIP 301

Length = 968

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 31/157 (19%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-------HRNLI 232
           LG G+FGSVY       G  VAIK    ++++ F S+  EC  LR V+       H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSW-EECMNLREVKSLRKLNEHPNIV 61

Query: 233 KILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGLALEYLH- 287
           K+       +   L  V E+M  G+L + L          E +  +I+  +   L ++H 
Sbjct: 62  KLKE--VFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 288 --YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK 322
             +        H DLKP N+L+    V  ++DFG+++
Sbjct: 118 HGF-------FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 49/235 (20%)

Query: 158 VTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLE-----R 211
           + WRR                 LLG G+FG VY     D G  +A K      E     +
Sbjct: 2   INWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK 46

Query: 212 TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV--LEFMPNGSLEKWLYSHNYFLDI 269
              +   E ++L+N++H  +++      +   K L   +E+MP GS++  L ++    + 
Sbjct: 47  EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES 106

Query: 270 LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
           + R      +   + YLH       I+H D+K +NIL D      + DFG SK L     
Sbjct: 107 VTR-KYTRQILEGMSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRL----- 156

Query: 330 SLIQTKTMATIG---------YMAPEGI----VSTKCDVYSYGILLLETFSRKKP 371
              QT  M+  G         +M+PE I       K DV+S G  ++E  + K P
Sbjct: 157 ---QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 24/225 (10%)

Query: 175 FDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNL---QLERTFVSFNSECEVLRNVRHRN 230
           F +   +G GSFG+VY    + +   VAIK  +    Q    +     E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 231 LIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
            I+   GC   +  A LV+E+   GS    L  H   L  +E   +       L YLH  
Sbjct: 77  TIQ-YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV 349
           +    +IH D+K  NILL E  +  + DFG + ++   +        + T  +MAPE I+
Sbjct: 135 N----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVIL 184

Query: 350 ST-------KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
           +        K DV+S GI  +E   RK P  ++  MS  + + Q+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 33/247 (13%)

Query: 167 DIQRAT--NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVL 223
           DI R    ++++    +G G++G VYK   L  G   A+KI  L+    F     E  ++
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60

Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           +  +H N++       + +   + +E+   GSL+  +Y   +    L  L I       L
Sbjct: 61  KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IY---HVTGPLSELQIAYVCRETL 116

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT---- 339
           + L Y H+   + H D+K +NILL +N    ++DFG++  +         T T+A     
Sbjct: 117 QGLAYLHSKGKM-HRDIKGANILLTDNGDVKLADFGVAAKI---------TATIAKRKSF 166

Query: 340 IG---YMAPE-------GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS-- 387
           IG   +MAPE       G  +  CD+++ GI  +E    + P  DL  M     +++S  
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF 226

Query: 388 LPHKLAE 394
            P KL +
Sbjct: 227 QPPKLKD 233

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 50/223 (22%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFN------SECEVLRN 225
           + +   + +G G++G V     +  G  VAIK    +L R F S         E  +L++
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSAIHAKRTYRELRLLKH 70

Query: 226 VRHRNLIKILS----GCSNLDFKA--LVLEFMPNGSLEKWLYS------HNYFL--DILE 271
           + H N+I +L       S  DF+   LV   M    L   +        H  FL   IL 
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR 129

Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
                      L+Y+H     A IIH DLKPSNI ++E+    + DFG+++     DD +
Sbjct: 130 ----------GLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM 172

Query: 332 IQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
             T  +AT  Y APE ++     +   D++S G ++ E  + K
Sbjct: 173 --TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTN----VAIKIFNLQLERTFVSFNSE----CEVLR 224
           E  +  +LG G+FG+VYKG  + DG N    VAIK+     E T    N E      V+ 
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR---ENTSPKANKEILDEAYVMA 64

Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            V    + ++L  C     + LV + MP G L  ++  +   +   + LN  + +   + 
Sbjct: 65  GVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL        ++H DL   N+L+       ++DFG+++LL   +           I +MA
Sbjct: 124 YLEE----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 345 PEGIVSTK----CDVYSYGILLLE--TFSRK 369
            E I+  +     DV+SYG+ + E  TF  K
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 45/219 (20%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK-IFN-----LQLERTFVSFNSECEVLR 224
           TN + +   +G+G+FG V        G NVAIK I       +  +RT+     E ++L+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY----RELKLLK 64

Query: 225 NVRHRNLIKILS-GCSNLDFKALVLEFM--------PNGSLEKWLYSHNYFLDILERLNI 275
           ++RH N+I +     S L+    V E +         +  LEK      YFL  + R   
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR--- 119

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
                  L+Y+H     A ++H DLKPSNIL++EN    + DFG++++     D  + T 
Sbjct: 120 ------GLKYVHS----AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TG 164

Query: 336 TMATIGYMAPEGIVS-----TKCDVYSYGILLLETFSRK 369
            ++T  Y APE +++      + D++S G +  E    K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVA---IKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           +G G F  VYK   L DG  VA   ++IF +   +       E ++L+ + H N+IK L+
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 237 GCSNLDFKALVLEFMPNGSLEKWL-YSHNYFLDILERL--NIMIDVGLALEYLHYGHALA 293
                +   +VLE    G L + + +       I ER      + +  ALE++H      
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA------TIGYMAPEG 347
            I+H D+KP+N+ +    V  + D G+ +            KT A      T  YM+PE 
Sbjct: 127 -IMHRDIKPANVFITATGVVKLGDLGLGRFFSS--------KTTAAHSLVGTPYYMSPER 177

Query: 348 IVST----KCDVYSYGILLLETFSRKKP 371
           I       K D++S G LL E  + + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 13/154 (8%)

Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIM 276
           E E+LRN+ H N++K    C+        L++EF+P+GSL+++L  +   +++ ++L   
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
           + +   ++YL         +H DL   N+L++      + DFG++K + E D      K 
Sbjct: 116 VQICKGMDYL----GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKD 170

Query: 337 --MATIGYMAPEGIVSTK----CDVYSYGILLLE 364
              + + + APE ++ +K     DV+S+G+ L E
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 21/220 (9%)

Query: 175 FDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNSECEV--LRNVRHRN 230
           ++    +G GSFG +Y  K   SD  +  IK  +L          S+ EV  L  ++H N
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGLALEYLHYG 289
           ++   +         +V+E+   G L K +           + L+  + + L L+++H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD- 119

Query: 290 HALAPIIHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE- 346
                I+H D+K  NI L +N MVA + DFGI++ L   +DS+    T   T  Y++PE 
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEI 173

Query: 347 ---GIVSTKCDVYSYGILLLETFSRKKP--TNDLGEMSLK 381
                 + K D++S G +L E  + K P   N+L ++ LK
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 33/205 (16%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLI 232
            D    +G GS G V   T  S G  VA+K  +L + +R  + FN E  ++R+ +H N++
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIV 79

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGLALE 284
           ++ S     D   +V+EF+  G+L           DI+   R+N      + + V  AL 
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALS 129

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY-M 343
           +LH       +IH D+K  +ILL  +    +SDFG      +    + + K++    Y M
Sbjct: 130 FLHA----QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWM 182

Query: 344 APEGIV----STKCDVYSYGILLLE 364
           APE I      T+ D++S GI+++E
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 27/204 (13%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKILSG 237
           +G G++G VYKG     G  VA+K   L+ E   V   +  E  +L+ ++H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH-------YGH 290
                   L+ EF+ +  L+K       +LD L      +D  L   YL+       + H
Sbjct: 68  LMQESRLYLIFEFL-SMDLKK-------YLDSL-PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV- 349
           +   ++H DLKP N+L+D   V  ++DFG+++  G      + T  + T+ Y APE ++ 
Sbjct: 119 S-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVRVYTHEVVTLWYRAPEVLLG 175

Query: 350 ----STKCDVYSYGILLLETFSRK 369
               ST  D++S G +  E  ++K
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 24/225 (10%)

Query: 175 FDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNL---QLERTFVSFNSECEVLRNVRHRN 230
           F +   +G GSFG+VY    +     VAIK  +    Q    +     E + L+ ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 231 LIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
            I+   GC   +  A LV+E+   GS    L  H   L  +E   I       L YLH  
Sbjct: 87  SIE-YKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-S 143

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV 349
           H +   IH D+K  NILL E     ++DFG + +    +        + T  +MAPE I+
Sbjct: 144 HNM---IHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEVIL 194

Query: 350 ST-------KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
           +        K DV+S GI  +E   RK P  ++  MS  + + Q+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 239

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 32/70 (45%), Positives = 39/70 (55%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +G +K L  + L  N   G IP   G L SL  LDL  NNL+G IP SL  L  L+ L +
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267

Query: 63  SQNRLEGEIP 72
            QN+L G IP
Sbjct: 268 YQNKLSGPIP 277

Length = 968

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 23/230 (10%)

Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G FG V    +   G   A K  +   L+  +      +E ++L  V  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPI 295
                D   LV+  M  G L+  +Y+           +     +   LE+LH       I
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR----I 116

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVST 351
           ++ DLKP N+LLD++    +SD G++  L  G           T GYMAPE     +   
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQGEVYDF 173

Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ-------SLPHKLAE 394
             D ++ G  L E  + + P     E   K  + +         P K + 
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSP 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIK---IFNLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           +G G F  VY+ T L DG  VA+K   IF+L   +       E ++L+ + H N+IK  +
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGLALEYLHYGHALA 293
                +   +VLE    G L + +        ++    +    + +  ALE++H      
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--- 126

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----V 349
            ++H D+KP+N+ +    V  + D G+ +       +      + T  YM+PE I     
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGY 183

Query: 350 STKCDVYSYGILLLETFSRKKP 371
           + K D++S G LL E  + + P
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 36/230 (15%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQL-----ERTFVSFNSECEVLRNV 226
            +F     +G G +G V+     D G  VA+K     L     E   V   +E ++L   
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVL--TERDILTTT 58

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           +   L+K+L    + ++  L +E++P G     L ++   L        M ++  A++ L
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDAL 117

Query: 287 H-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---Y 342
           H  G      IH DLKP N L+D +    ++DFG+SK         I T   + +G   Y
Sbjct: 118 HELG-----YIHRDLKPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDY 164

Query: 343 MAPEGIVSTK----CDVYSYGILLLETFSRKKP-----TNDLGEMSLKHW 383
           MAPE +         D +S G +L E      P      N+  E +LK+W
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 10/92 (10%)

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           L+YLH       I+H D+KP N+L++ N V  + DFG+++ + E D+S   T+ + T  Y
Sbjct: 116 LKYLHSAG----ILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYY 170

Query: 343 MAPEGIV-----STKCDVYSYGILLLETFSRK 369
            APE ++     ++  D++S G +  E   R+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 30/76 (39%), Positives = 45/76 (59%), Gaps = 4/76 (5%)

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   NILL EN V  + DFG+++ + +  D + +      + +MAPE I     +T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 352 KCDVYSYGILLLETFS 367
           + DV+S+G+LL E FS
Sbjct: 255 QSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 61/241 (25%), Positives = 114/241 (47%), Gaps = 37/241 (15%)

Query: 164 SYLDIQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--EC 220
           SYL++++          LG GS+ +VYKG +  +G  VA+K+ +++ E   V F +  E 
Sbjct: 6   SYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREA 54

Query: 221 EVLRNVRHRNLI---KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            +L+ ++H N++    I+     L F   V E+M +  L +++  H   L        M 
Sbjct: 55  SLLKGLKHANIVLLHDIIHTKETLTF---VFEYM-HTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            +   L Y+H  H    I+H DLKP N+L+       ++DFG+++   +   S   +  +
Sbjct: 111 QLLRGLAYIHGQH----ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEV 164

Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKP----TNDLGEMSLKHWVNQSL 388
            T+ Y  P+ ++     S+  D++  G + +E   + +P     +D+ E   K W    +
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML-QGQPAFPGVSDVFEQLEKIWTVLGV 223

Query: 389 P 389
           P
Sbjct: 224 P 224

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.6 bits (141), Expect = 1e-09
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 16/225 (7%)

Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQ-LERTFVSFNSECEVLRNVRHRNL 231
           F +   +G GSFG V+KG + + T   VAIKI +L+  E        E  VL       +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
            K            +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKK 122

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--- 348
               IH D+K +N+LL E+    ++DFG++  L   D  + +   + T  +MAPE I   
Sbjct: 123 ----IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 349 -VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
              +K D++S GI  +E    + P ++L  M +   + ++ P  L
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL 221

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 38/223 (17%)

Query: 179 NLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--------------ECEVL 223
             LG G++G V K      G  VAIK   +      V+ +               E +++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
             ++H N++ ++      DF  LV++ M    L+K +      L   +   I++ +   L
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG--DDSLIQTKTMA--- 338
             LH  +     +H DL P+NI ++   +  ++DFG+++  G     D+L + +TM    
Sbjct: 133 NVLHKWY----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 339 -------TIGYMAPEGIV-STK----CDVYSYGILLLETFSRK 369
                  T+ Y APE ++ + K     D++S G +  E  + K
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 53/227 (23%), Positives = 101/227 (44%), Gaps = 30/227 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTNVA-IKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKILS 236
           +G G FG V  G ++ G   A + +  L++  +    + F  E +  R+++H NL++ L 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            C+ +    LV+EF P G L+ +L S         D      +  ++ L L +LH  +  
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---- 348
              IH DL   N LL  ++   + D+G+S    + D  +   +    + ++APE +    
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 349 -------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL 388
                   + + +V+S G+ + E F       +LG    +H  ++ +
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF-------ELGSQPYRHLSDEQV 218

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 29/195 (14%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNL----QLERTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G+ G+VYK   L     +A+K+  L    +L++  +S   E E+L       +I   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS---ELEILYKCDSPYIIGFY 65

Query: 236 SGCSNLDFKALVLEFMPNGSLEKW--LYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                 +  ++  EFM  GSL+ +  +  H     +L R+ + +  GL      Y  +L 
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVYRKIPEH-----VLGRIAVAVVKGLT-----YLWSLK 115

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV---- 349
            I+H D+KPSN+L++      + DFG+S  L       I    + T  YMAPE I     
Sbjct: 116 -ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQY 170

Query: 350 STKCDVYSYGILLLE 364
               DV+S GI  +E
Sbjct: 171 GIHSDVWSLGISFME 185

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 18/228 (7%)

Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL 207
           SDEE L  L +   +S  D ++    F++   +G G+ G+VY    ++ G  VAI+  NL
Sbjct: 1   SDEEILEKLRSI--VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL 55

Query: 208 QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 267
           Q +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +      +
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCM 113

Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
           D  +   +  +   ALE+LH       +IH D+K  NILL  +    ++DFG    +   
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 328 DDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                ++  + T  +MAPE +       K D++S GI+ +E    + P
Sbjct: 170 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 35/205 (17%)

Query: 181 LGIGSFGSVYKGTLSDGTNV--AIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G++GSVYK  L   T V  A+K   L+L E  F     E ++L       ++     
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFL-----DILERLNIMIDVGLALEYLHYGHAL 292
                   + +E+M  GSL+K LY+          D+L R+   +  GL  ++L   H  
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGL--KFLKEEHN- 123

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPEGI- 348
             IIH D+KP+N+L++ N    + DFG+S   G    SL +T     IG   YMAPE I 
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT----NIGCQSYMAPERIK 174

Query: 349 ---------VSTKCDVYSYGILLLE 364
                     + + DV+S G+ +LE
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 15/220 (6%)

Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T    G  VA+K  +L+ ++      +E  ++R+  H N++ + +   
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
             D   +V+EF+  G+L   + +H   ++  +   + + V  AL YLH       +IH D
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLHN----QGVIHRD 143

Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY-MAPEGI----VSTKCD 354
           +K  +ILL  +    +SDFG    + +    + + K++    Y MAPE I      T+ D
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSK---EVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 355 VYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
           ++S GI+++E    + P  +   +     +  +LP ++ +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 34/67 (50%), Positives = 43/67 (64%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
           L  L  L L +NKF G IPK+ G   +L  LDLS+NNL+GEIP+ L +   L +L +  N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390

Query: 66  RLEGEIP 72
            LEGEIP
Sbjct: 391 SLEGEIP 397

Length = 968

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 33/216 (15%)

Query: 181 LGIGSFGSVYKGTL--------SDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V +                VA+K+  +   ++      SE E+++ + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDILER----------LNI 275
           +I +L  C+      +++E+   G+L ++L +      +Y  DI +           ++ 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL         IH DL   N+L+ E+ V  ++DFG+++ + + D     + 
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+GIL+ E F+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 29/72 (40%), Positives = 41/72 (56%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           ++  L  L  L+LA+N+  G IP+  G + SL+ + L  NNLSGEIP  +  L  L  L+
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242

Query: 62  VSQNRLEGEIPV 73
           +  N L G IP 
Sbjct: 243 LVYNNLTGPIPS 254

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 33/77 (42%), Positives = 45/77 (58%), Gaps = 1/77 (1%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
           G + +L TL L+ N   G IP   GS  SL+ LDL  N L G+IP SL  L  L+ L ++
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196

Query: 64  QNRLEGEIPVE-GPFRN 79
            N+L G+IP E G  ++
Sbjct: 197 SNQLVGQIPRELGQMKS 213

Length = 968

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 46/164 (28%), Positives = 68/164 (41%), Gaps = 22/164 (13%)

Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLN- 274
            E ++L+ + HR +I ++        K+ V   MP        Y  + F  +D    L  
Sbjct: 135 REIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------YKCDLFTYVDRSGPLPL 184

Query: 275 ---IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
              I I   L LE L Y H    IIH D+K  NI LDE   A + DFG +  L    D+ 
Sbjct: 185 EQAITIQRRL-LEALAYLHGRG-IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 332 IQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                  T+   +PE +       K D++S G++L E   +   
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 24/205 (11%)

Query: 179 NLLGIGSFGSVYKGTLSDGTN-----VAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLI 232
           +LL  G+FG ++ G L D        V +K          V+    E  +L  + H+N++
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 233 KILSGCSNLDFKALVLE-FMPNGSLEKWLYSHNYF-------LDILERLNIMIDVGLALE 284
            IL  C        VL  +M  G+L+ +L             L   + +++ I +   + 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 285 YLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           YLH  G     +IH D+   N ++DE +   ++D  +S+ L   D   +       + +M
Sbjct: 132 YLHKRG-----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186

Query: 344 APEGIV----STKCDVYSYGILLLE 364
           A E +V    S+  DV+S+G+LL E
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWE 211

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 36/249 (14%)

Query: 175 FDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFN-------SECEVLRNV 226
           F +  +LG G FG V    + + G   A K    +LE+  +          +E ++L  V
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACK----RLEKKRIKKRKGESMALNEKQILEKV 57

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEY 285
             + ++ +       D   LVL  M  G L+  +Y+  N   +    L    ++   LE 
Sbjct: 58  NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
           LH  +     ++ DLKP NILLD+     +SD G++  + EG+   I+ + + T+GYMAP
Sbjct: 118 LHREN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGR-VGTVGYMAP 170

Query: 346 EGIVSTKC----DVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV 401
           E + + +     D +  G L+ E    + P     E   +            E VD  ++
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR------------EEVDRRVL 218

Query: 402 RREHSFSAK 410
             E  +SAK
Sbjct: 219 ETEEVYSAK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 25/220 (11%)

Query: 175 FDECNLLGIGSFGSVY---KGTLSD-GTNVAIKIFN----LQLERTFVSFNSECEVLRNV 226
           F+   +LG G++G V+   K +  D G   A+K+      +Q  +T     +E +VL ++
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 227 RHRNLIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGLALE 284
           R    +  L      D K  L+L+++  G L   L     F +  + + I   ++ LALE
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALE 119

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           +LH       II+ D+K  NILLD N    ++DFG+SK   E D+         TI YMA
Sbjct: 120 HLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMA 174

Query: 345 PEGIVS-------TKCDVYSYGILLLETFSRKKPTNDLGE 377
           P+ IV           D +S G+L+ E  +   P    GE
Sbjct: 175 PD-IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 24/205 (11%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEV-----LRNVRHRNLIKI 234
           +G+G++G+VYK      G  VA+K   +Q     +  ++  EV     L    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 235 LSGCSNLDFK-----ALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGLALEYLHY 288
           +  C+           LV E + +  L  +L          E + ++M      L++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 I+H DLKP NIL+       ++DFG++++       +  T  + T+ Y APE +
Sbjct: 126 ---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVL 179

Query: 349 V----STKCDVYSYGILLLETFSRK 369
           +    +T  D++S G +  E F RK
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 31/239 (12%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           F+   ++G G++G VYKG  +  G   AIK+ ++  E        E  +L+   H   I 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 234 ILSGC-------SNLDFKALVLEFMPNGS---LEKWLYSHNYFLDILERLNIMIDVGLAL 283
              G         + D   LV+EF   GS   L K    +    D +  +   I  GLA 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA- 135

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            +LH       +IH D+K  N+LL EN    + DFG+S  L   D ++ +  T + T  +
Sbjct: 136 -HLHAHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYW 187

Query: 343 MAPEGIV---------STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
           MAPE I            + D++S GI  +E      P  D+  M     + ++ P KL
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 32/67 (47%), Positives = 40/67 (59%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
           L++L  L L +N F G IP +  SL  L+ L L SN  SGEIPK+L     L  L++S N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Query: 66  RLEGEIP 72
            L GEIP
Sbjct: 367 NLTGEIP 373

Length = 968

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 30/76 (39%), Positives = 45/76 (59%), Gaps = 4/76 (5%)

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   NILL EN V  + DFG+++ + +  D + +      + +MAPE I     +T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 352 KCDVYSYGILLLETFS 367
           + DV+S+G+LL E FS
Sbjct: 256 QSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 27/208 (12%)

Query: 181 LGIGSFGSVYKGTLSDGTNVA-IKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKILS 236
           +G G FG V  G    G + A + +  L+   T    + F  E +  R + H N+++ L 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFL------DILERLNIMIDVGLALEYLHYGH 290
            C       LVLEF P G L+ +L S+   +      D+L+R+   +  GL   +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL--WLHQAD 120

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-- 348
                IH DL   N  L  ++   + D+G++      D  + +      + ++APE +  
Sbjct: 121 ----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 349 ---------VSTKCDVYSYGILLLETFS 367
                     + K +++S G+ + E F+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 41/215 (19%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQ-LERTFVSFN--------SECEVLRNVRHRN 230
           +LG G +G V++     G +   KIF ++ L++  +  N        +E  +L  V+H  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID---------VGL 281
           ++ ++          L+LE++  G L    + H      LER  I ++         + L
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGEL----FMH------LEREGIFMEDTACFYLSEISL 111

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATI 340
           ALE+LH       II+ DLKP NILLD      ++DFG+ K           T T   TI
Sbjct: 112 ALEHLHQ----QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTI 164

Query: 341 GYMAPEGIVST----KCDVYSYGILLLETFSRKKP 371
            YMAPE ++ +      D +S G L+ +  +   P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 20/201 (9%)

Query: 181 LGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G+FG   +Y+ T  D + V  K  NL    E+      +E  +L  ++H N+I   +
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 237 GCSNLDFKALV--LEFMPNGSL-EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
               +D   L+  +E+   G+L +K +       +    L  +  +  A+ Y+H     A
Sbjct: 67  --HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK----A 120

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GI-V 349
            I+H D+K  NI L +  +  + DFGISK+L  G +  +    + T  YM+PE   G+  
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 350 STKCDVYSYGILLLETFSRKK 370
           + K D+++ G +L E  + K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 45/214 (21%)

Query: 181 LGIGSFGSVYKGTLSD-GTNVAIK-IFN-----LQLERTFVSFNSECEVLRNVRHRNLIK 233
           +G G++G V     S+    VAIK I N     +  +RT      E ++LR++ H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68

Query: 234 ---ILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHN--------YFLDILERLNIMIDVG 280
              I+       F    +V E M +  L + + S          YFL  L R        
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------- 119

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             L+Y+H     A ++H DLKPSN+LL+ N    + DFG+++   E  D    T+ + T 
Sbjct: 120 -GLKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTR 172

Query: 341 GYMAPEGIVS-----TKCDVYSYGILLLETFSRK 369
            Y APE +++     T  DV+S G +  E   RK
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 52/232 (22%)

Query: 175 FDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQ--LERTFVS-FNSECEVLRNVR 227
           F +  LLG G  G V+    KGT   G   A+K+ + +  ++R  V    +E E+L  + 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGLALEY 285
           H  L  + +      +  LV+++ P G L + L         + + R     +V LALEY
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEY 118

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQ---------- 333
           LH    L  I++ DLKP NILL E+   H+  SDF +SK        + +          
Sbjct: 119 LH----LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 334 --------------TKTMATIG---YMAPEGIV----STKCDVYSYGILLLE 364
                          ++ + +G   Y+APE I      +  D ++ GILL E
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 25/222 (11%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIK---IFNLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           +G G F  VY+ T L D   VA+K   IF +   +       E ++L+ + H N+IK L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD----ILERL--NIMIDVGLALEYLHYGH 290
                +   +VLE    G L + +    YF      I ER      + +  A+E++H   
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMI---KYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-- 348
               ++H D+KP+N+ +    V  + D G+ +       +      + T  YM+PE I  
Sbjct: 127 ----VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHE 180

Query: 349 --VSTKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ 386
              + K D++S G LL E  + + P   + +   SL   + Q
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 26/223 (11%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHR 229
           T+ ++    +G G++G VYK T   DG+  A+KI +  +        +E  +L+++  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHP 79

Query: 230 NLIKILSGCSNLDFKA-----LVLEFMPNGS---LEKWLYSHNYFLDILERLNIMIDVGL 281
           N++K        D        LVLE    GS   L K L      LD      I+    L
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            L++LH       IIH D+K +NILL       + DFG+S  L      L +  ++ T  
Sbjct: 140 GLQHLHNNR----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPF 193

Query: 342 YMAPEGIV---------STKCDVYSYGILLLETFSRKKPTNDL 375
           +MAPE I            +CDV+S GI  +E      P  D+
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 180 LLGIGSFGSV-YKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILS 236
           +LG G+ G+V     +SDG   A+K+ +++   E       +E   L N    +++K   
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95

Query: 237 GC------------SNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGL 281
            C             N+   ALVL++   G L + + S    N      E   + I V L
Sbjct: 96  -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           A+ ++H  H    +IH D+K +NILL  N +  + DFG SK+        +      T  
Sbjct: 155 AVHHVHSKH----MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 342 YMAPE----GIVSTKCDVYSYGILLLETFSRKKP 371
           Y+APE       S K D++S G+LL E  + K+P
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 23/206 (11%)

Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKI 234
           +G GS+G V   +L    +DG    IK  NL+    R   +   E ++L  ++H N++  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 235 LSGCSNLD-FKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGHA 291
                  D    +V+ F   G L   L      L + E   +   + + +AL+YLH  H 
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVST 351
              I+H DLK  N+ L    +  V D GI+++L    D  + +  + T  YM+PE   + 
Sbjct: 123 ---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNK 177

Query: 352 ----KCDVYSYGILLLETFSRKKPTN 373
               K DV++ G  + E  + K   N
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.5 bits (133), Expect = 1e-08
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 21/200 (10%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G G+ G+V+    ++ G  VAIK  NLQ +       +E  V++ +++ N++  L    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
             D   +V+E++  GSL   +      +D  +   +  +   ALE+LH       +IH D
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ----VIHRD 140

Query: 300 LKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTMATIG---YMAPEGIV----ST 351
           +K  N+LL  +    ++DFG  +++  E      Q+K    +G   +MAPE +       
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 352 KCDVYSYGILLLETFSRKKP 371
           K D++S GI+ +E    + P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 33/88 (37%), Positives = 47/88 (53%), Gaps = 1/88 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           +I  L+ L +L L+ N   G IP+    L +LE L L SNN +G+IP +L +L  L+ L 
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338

Query: 62  VSQNRLEGEIPVE-GPFRNFSTESFSWN 88
           +  N+  GEIP   G   N +    S N
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 32/72 (44%), Positives = 39/72 (54%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           IG    L  L L  N   G IP S  +L SLE L L+SN L G+IP+ L  +  LK + +
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219

Query: 63  SQNRLEGEIPVE 74
             N L GEIP E
Sbjct: 220 GYNNLSGEIPYE 231

Length = 968

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 26/231 (11%)

Query: 150 DEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQ 208
           DEE L  L +   +S  D ++    F++   +G G+ G+VY    ++ G  VAIK  NLQ
Sbjct: 1   DEEILEKLRSI--VSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQ 55

Query: 209 LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD 268
            +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +      +D
Sbjct: 56  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMD 113

Query: 269 ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEG 327
             +   +  +   AL++LH       +IH D+K  NILL  +    ++DFG  +++  E 
Sbjct: 114 EGQIAAVCRECLQALDFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168

Query: 328 DDSLIQTKTMATIG---YMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                Q+K    +G   +MAPE +       K D++S GI+ +E    + P
Sbjct: 169 -----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 49/215 (22%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSDGT--NVAIKIF-------NLQLERTFVSFNSECEVLR 224
           +F+    LG GSFG V   T  +     VAIK F         Q++  F    SE ++L 
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKILN 86

Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG---- 280
            + H   + +     +  +  LVLEF+  G    +L  +  F +         DVG    
Sbjct: 87  YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---------DVGCFYA 137

Query: 281 ----LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
               L  EYL   +    I++ DLKP N+LLD++    ++DFG +K        ++ T+T
Sbjct: 138 AQIVLIFEYLQSLN----IVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRT 185

Query: 337 MATIG---YMAPEGIVST----KCDVYSYGILLLE 364
               G   Y+APE +++       D ++ GI + E
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220

Length = 340

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 69/244 (28%), Positives = 104/244 (42%), Gaps = 29/244 (11%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQ--LERTFVS-FNSECEVL-RNVRHRNLIKIL 235
           +G GSFG V      +DG   A+K+   +  L++       +E  VL +NV+H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
                 D    VL+++  G L   L     F +   R     ++  AL YLH  +    I
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSLN----I 117

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIVST--- 351
           I+ DLKP NILLD      ++DFG+ K   EG +    T T   T  Y+APE +      
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 352 -KCDVYSYGILLLETFSRKKP--TNDLGEM---------SLKHWVNQSLPHKLAEVVDSN 399
              D +  G +L E      P  + D  EM          LK  ++ S  H L  ++  +
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234

Query: 400 LVRR 403
             +R
Sbjct: 235 RTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 49/193 (25%)

Query: 197 GTNVAIKIFNLQLERTFVSFNS------ECEVLRNVRHRNLIKILSGCSNLDFKALVLEF 250
           G NVAIK    +L R F +         E  +++ V H+N+I +L    N+        F
Sbjct: 41  GQNVAIK----KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL----NV--------F 84

Query: 251 MPNGSLEKW--------LYSHNYF------LDILERLNIMIDVGL-ALEYLHYGHALAPI 295
            P  SLE++        L   N        LD  ER++ ++   L  +++LH     A I
Sbjct: 85  TPQKSLEEFQDVYLVMELMDANLCQVIQMDLD-HERMSYLLYQMLCGIKHLH----SAGI 139

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DLKPSNI++  +    + DFG+++  G    S + T  + T  Y APE I+      
Sbjct: 140 IHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKE 196

Query: 352 KCDVYSYGILLLE 364
             D++S G ++ E
Sbjct: 197 NVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 31/200 (15%)

Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIF-----NLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           +G GS+G V+K    + G  VAIK F     +  +++  +    E  +L+ ++H NL+ +
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKHPNLVNL 65

Query: 235 LSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           +       F+      LV E+  +  L + L  +   +       I+     A+ + H  
Sbjct: 66  IEV-----FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV 349
           +     IH D+KP NIL+ +     + DFG +++L    D    T  +AT  Y APE +V
Sbjct: 120 NC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLV 173

Query: 350 -----STKCDVYSYGILLLE 364
                    DV++ G +  E
Sbjct: 174 GDTQYGPPVDVWAIGCVFAE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 8/105 (7%)

Query: 267 LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
           LD  + L+    V   + +L    A    IH DL   NILL    +  + DFG+++ +  
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 327 GDDSLIQTKTMATIGYMAPEGI---VST-KCDVYSYGILLLETFS 367
             + +++      + +MAPE I   V T + DV+SYGILL E FS
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 8/105 (7%)

Query: 267 LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
           L  L+ L+    V   +E+L    A    +H DL   N+LL +  +  + DFG+++ +  
Sbjct: 234 LTTLDLLSFTYQVARGMEFL----ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH 289

Query: 327 GDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
             + + +  T   + +MAPE I     +T  DV+SYGILL E FS
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 4/76 (5%)

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   NILL EN V  + DFG+++ + +  D + +      + +MAPE I     + 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 352 KCDVYSYGILLLETFS 367
           + DV+S+G+LL E FS
Sbjct: 261 QSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 26/200 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTNVA---------IKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
           LG GSFG+VY   + D   VA         I +  L    T V  N E ++L  + H  +
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNET-VQANQEAQLLSKLDHPAI 64

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGLALEYLHY 288
           +K  +     D   ++ E+     L+  L    +    L    +    I + L + Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 I+H DLK  NI L  N++  + DFG+S+LL    D  + T    T  YM+PE +
Sbjct: 125 RR----ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177

Query: 349 ----VSTKCDVYSYGILLLE 364
                 +K D++S G +L E
Sbjct: 178 KHQGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTN-VAIKIFNLQLERTFVSFNS--ECEVLRNVRHR 229
           N+F+   ++G G++G V K    +    VAIK F    E   V   +  E ++LR ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 230 NLIKILSGCSNLDFKALVLEF-----------MPNGSLEKWLYSHNYFLDILERLNIMID 278
           N++++           LV E+           MPNG   + + S+ Y L           
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               ++ +H+ H    I+H D+KP N+L+  N V  + DFG ++ L EG ++   T+ +A
Sbjct: 110 ----IKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVA 163

Query: 339 TIGYMAPEGIVST----KCDVYSYGILLLE 364
           T  Y +PE ++        D++S G +L E
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 14/122 (11%)

Query: 248 LEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL 306
           +E M  GSL++ L        +IL +++I +  GL   YL   H    I+H D+KPSNIL
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLT--YLREKHK---IMHRDVKPSNIL 132

Query: 307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTK----CDVYSYGILL 362
           ++      + DFG+S   G+  DS+  +  + T  YM+PE +  T      D++S G+ L
Sbjct: 133 VNSRGEIKLCDFGVS---GQLIDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 363 LE 364
           +E
Sbjct: 189 VE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 38/266 (14%)

Query: 180 LLGIGSFGSVYKGTLSDGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI 234
           +LG G FG + +G L   +     VAI        ++    F +E   L    H N++++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               +  +   +V E+M NG+L+ +L  H   L   + + ++  +   ++YL    +   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL----SEMG 127

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM---ATIGYMAPEGI--- 348
            +H  L    +L++ ++V  +S F       + D S     TM   + + + APE I   
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 349 -VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS 406
             S+  DV+S+GI++ E  S  ++P  D+          Q       +V+ +  V     
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQ-------DVIKA--VEDGFR 226

Query: 407 FSAKMDCLLRIMNLALDCCMESPDER 432
             A  +C   +  L LDC  +   ER
Sbjct: 227 LPAPRNCPNLLHQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 36/208 (17%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIK---I 234
           +G G++G VYK      G  VA+K   L+ E   V   +  E  +L+ + H N+++   +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LD---ILERLNIMIDVGLALEYLHYGH 290
           +   + L    LV EF+ +  L+K++ S     LD   I   L  ++     + Y H  H
Sbjct: 67  VHSENKL---YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ---GIAYCH-SH 118

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT----MATIGYMAPE 346
               ++H DLKP N+L+D      ++DFG+++  G      +  +T    + T+ Y APE
Sbjct: 119 R---VLHRDLKPQNLLIDREGALKLADFGLARAFG------VPVRTYTHEVVTLWYRAPE 169

Query: 347 GIV-----STKCDVYSYGILLLETFSRK 369
            ++     ST  D++S G +  E  +R+
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 36/140 (25%), Positives = 55/140 (39%), Gaps = 12/140 (8%)

Query: 184 GSFGSVYKGTLSDGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL 241
                + K      T VA+K  NL    +        E    R ++H N++  ++     
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGLALEYLHYGHALAPIIHC 298
               +V   M  GS E  L +H  F + L  L    I+ DV  AL+Y+H        IH 
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG----FIHR 125

Query: 299 DLKPSNILLDENMVAHVSDF 318
            +K S+ILL  +    +S  
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 29/225 (12%)

Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GS G V   T+ S G  VA+K  +L + +R  + FN E  ++R+ +H N++++ +  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN------IMIDVGLALEYLHYGHAL 292
              D   +V+EF+  G+L   + +H        R+N      + + V  AL  LH     
Sbjct: 87  LVGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLKALSVLHA---- 134

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY-MAPEGI--- 348
             +IH D+K  +ILL  +    +SDFG      +    + + K++    Y MAPE I   
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRL 191

Query: 349 -VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
               + D++S GI+++E    + P  +   +     +  +LP KL
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL 236

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 49/199 (24%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRN 230
           + +++   LG GS+ +VYKG +  +G  VA+K+  LQ E  T  +   E  +L+ ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++ +       +   LV E++ +  L +++  H   L        +  +   L Y+H  +
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV- 349
               I+H DLKP N+L+ +     ++DFG+++   +   S   +  + T+ Y  P+ ++ 
Sbjct: 124 ----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 350 ----STKCDVYSYGILLLE 364
               ST  D++  G + +E
Sbjct: 178 STEYSTCLDMWGVGCIFVE 196

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 52/216 (24%)

Query: 181 LGIGSFGSV-YKGTLSDGTNVAIKIFNLQLERTFVS--FNS----ECEVLRNVRHRNLIK 233
           +G G++G+V        G  VAIK    +L R F S  F      E  +L++++H N+I 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIK----KLYRPFQSELFAKRAYRELRLLKHMKHENVI- 77

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI------------LERLN---IMID 278
                       L+  F P+ SL+++   H+++L +             E+L+   I   
Sbjct: 78  -----------GLLDVFTPDLSLDRF---HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           V   L+ L Y HA A IIH DLKP N+ ++E+    + DFG+++   + D  +  T  + 
Sbjct: 124 VYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGYVV 177

Query: 339 TIGYMAPEGIVS-----TKCDVYSYGILLLETFSRK 369
           T  Y APE I++        D++S G ++ E  + K
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 41/126 (32%), Positives = 70/126 (55%), Gaps = 16/126 (12%)

Query: 245 ALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPS 303
           ++ +E M  GSL++ L        +IL +++I +  GLA  YL   H    I+H D+KPS
Sbjct: 79  SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREKHQ---IMHRDVKPS 133

Query: 304 NILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSY 358
           NIL++      + DFG+S +L+    +S + T++     YM+PE +     S + D++S 
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERLQGTHYSVQSDIWSM 188

Query: 359 GILLLE 364
           G+ L+E
Sbjct: 189 GLSLVE 194

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 48/214 (22%), Positives = 100/214 (46%), Gaps = 23/214 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHR 229
           +++++   +G G+FG V+K         VA+K   ++ E+      +  E ++L+ ++H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 230 NLIKILSGCSNL-----DFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           N++ ++  C         +K    LV EF  +  L   L + N    + E   +M  +  
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN 130

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSLIQTKTMAT 339
            L Y+H       I+H D+K +NIL+ ++ +  ++DFG+++   L +       T  + T
Sbjct: 131 GLYYIH----RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 340 IGYMAPEGIVS-----TKCDVYSYGILLLETFSR 368
           + Y  PE ++         D++  G ++ E ++R
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 31/64 (48%), Positives = 43/64 (67%), Gaps = 2/64 (3%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
           L  L+L+ N F G IP+  GS+ +LE+LDLS+N LSGEIP  + +   LK L++  N L 
Sbjct: 120 LRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177

Query: 69  GEIP 72
           G+IP
Sbjct: 178 GKIP 181

Length = 968

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 50/201 (24%), Positives = 98/201 (48%), Gaps = 26/201 (12%)

Query: 181 LGIGSFGSVYKGTLSDGTN--VAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G++ +VYKG  +  T   VA+K  +L  E  T  +   E  +++ ++H N++++   
Sbjct: 8   LGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLNIMIDVGLALEYLHYGHALAPI 295
               +   LV E+M +  L+K++ +H     LD     +    +   + + H       +
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR----V 121

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA----TIGYMAPEGIV-- 349
           +H DLKP N+L+++     ++DFG+++  G      I   T +    T+ Y AP+ ++  
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFG------IPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 350 ---STKCDVYSYGILLLETFS 367
              ST  D++S G ++ E  +
Sbjct: 176 RTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 33/105 (31%), Positives = 55/105 (52%), Gaps = 8/105 (7%)

Query: 267 LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
           LD+ + L     V   +++L    A    IH D+   N+LL +  VA + DFG+++ +  
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL----ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 327 GDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
             + +++      + +MAPE I     + + DV+SYGILL E FS
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 180 LLGIGSFGSV-YKGTLSDGTNVAIKIFNLQ--LERTFVSFN-SECEVLRNVRHRNLIKIL 235
           LLG G+FG V      + G   A+KI   +  + +  V+   +E  VL+N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
                 D    V+E++  G L   L     F +   R     ++  AL+YLH G     I
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK----I 116

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGI----VS 350
           ++ DLK  N++LD++    ++DFG+ K   EG       KT   T  Y+APE +      
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 351 TKCDVYSYGILLLETFSRKKP 371
              D +  G+++ E    + P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 33/203 (16%)

Query: 181 LGIGSFGSVYKGTLSDGTNV-AIKIFNLQLERTFVSFNSECEVLRNVRHRNLI--KILSG 237
           +G G+FG VY+    D   + A+K+ + +         ++ EV   +  RN++   +L  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE------IVAKKEVAHTIGERNILVRTLLDE 54

Query: 238 CS---NLDFK-------ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
                 L F         LV ++M  G L   L     F +   +  I  ++ LALE+LH
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
                  I++ DLKP NILLD      + DFG+SK     + +   T T   T  Y+APE
Sbjct: 114 KYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPE 166

Query: 347 GIVSTK-----CDVYSYGILLLE 364
            ++  K      D +S G+L+ E
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 32/236 (13%)

Query: 181 LGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGC 238
           +G G++G V+K     +G+  A+KI +  +        +E  +L+ +  H N++K     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 239 SNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLN------IMIDVGLALEYLH 287
              D K      LVLE    GS+   +     FL   ER+       I+ +  + L++LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
                   IH D+K +NILL       + DFG+S  L      L +  ++ T  +MAPE 
Sbjct: 142 VNKT----IHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEV 195

Query: 348 IV---------STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
           I            +CDV+S GI  +E      P  DL  M     + ++ P  L +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 175 FDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFN-------SECEVLRNV 226
           F +  +LG G FG V    + + G   A K    +LE+  +          +E ++L  V
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACK----KLEKKRIKKRKGESMALNEKQILEKV 57

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM--IDVGLALE 284
             R ++ +       D   LVL  M  G L+  +Y H       E   +    ++   LE
Sbjct: 58  NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLE 116

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
            LH       I++ DLKP NILLD++    +SD G++  + EG    I+ + + T+GYMA
Sbjct: 117 DLHQER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGR-VGTVGYMA 169

Query: 345 PEGIVSTKC----DVYSYGILLLETFSRKKP 371
           PE + + +     D ++ G LL E  + + P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 24/223 (10%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECE-VLRNV-----RHRNLIK 233
           +LG GSFG V+   L  GTN    I  L+ +   +  + EC  V + V      H  L  
Sbjct: 2   MLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +       +    V+E++  G L   + S + F D+        ++   L++LH      
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLHS----K 115

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSLIQTKTM-ATIGYMAPEGIVS 350
            I++ DLK  NILLD +    ++DFG+ K  +LG+      +T T   T  Y+APE ++ 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-----KTCTFCGTPDYIAPEILLG 170

Query: 351 TK----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP 389
            K     D +S+G+LL E    + P +   E  L   +    P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G FG V    + + G   A K  N   L+  + +     E  +L  V  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                    LV+  M  G L   +Y+    N              +   LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT---MATIGYMAPEGIVS 350
            II+ DLKP N+LLD +    +SD G++  L +G     Q+KT     T G+MAPE +  
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTKGYAGTPGFMAPELLQG 171

Query: 351 TK----CDVYSYGILLLETFSRKKPTNDLGE 377
            +     D ++ G+ L E  + + P    GE
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 54/226 (23%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKIL-- 235
           LG G+FG VYK   +  G  VA+K   +  E+      +  E ++L+ ++H N++ ++  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 236 -------SGCSNLDFKALVLEFMP---NGSLE----KWLYSH--NYFLDILERLNIMIDV 279
                  S         +V  +M    +G LE    K   S    Y L +LE +N     
Sbjct: 76  AVERPDKSKRKRGSV-YMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN----- 129

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL-----------GEGD 328
                YLH  H    I+H D+K +NIL+D   +  ++DFG+++             G G 
Sbjct: 130 -----YLHENH----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
                T  + T  Y  PE ++     +T  D++  G +  E F+R+
Sbjct: 181 RKY--TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)

Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIM 276
           +E ++L  V  R ++ +       D   LVL  M  G L+  +Y+  N   D    +   
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            ++   LE LH       I++ DLKP NILLD+     +SD G++  + EG+   I+ + 
Sbjct: 109 AEITCGLEDLHRER----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGR- 161

Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKP 371
           + T+GYMAPE + + +     D +  G L+ E    K P
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 18/200 (9%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 122

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 123 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 174

Query: 349 ----VSTKCDVYSYGILLLE 364
                S + D++S G+ L+E
Sbjct: 175 QGTHYSVQSDIWSMGLSLVE 194

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 11/95 (11%)

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG--DDSLIQTKTMAT 339
            L+Y+H     A ++H DLKP N+L++ +    + DFG+++   E   +++   T+ +AT
Sbjct: 117 GLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 340 IGYMAPEGIVS----TKC-DVYSYGILLLETFSRK 369
             Y APE ++S    TK  DV+S G +L E   RK
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 53/218 (24%), Positives = 102/218 (46%), Gaps = 27/218 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHR 229
           + +++   +G G++G VYK    + G  VA+K   L+++   +   +  E  +L+ +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 230 NLIKILSGCSNLDFKA------LVLEFMPNGSLEKWLYSH----NYFLDILERLNIMIDV 279
             I  L    +++ K       LV E++ +  L+K++ S+       L      + M  +
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
              + + H  H    ++H DLKP N+L+D +  +  ++D G+ +       S   T  + 
Sbjct: 120 LKGVAHCH-KHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIV 173

Query: 339 TIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKP 371
           T+ Y APE ++     ST  D++S G +  E  SRK+P
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 39/223 (17%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFN---LQLERTFVSFNSECEVLRN 225
            +FD  +L+G G FG V     K T   G   A+K+     L  + T   F  E ++L  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
                + ++     + D   LV+E+ P G L          L +L R     D  +A  Y
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL----------LSLLNRYEDQFDEDMAQFY 107

Query: 286 L-------HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           L       H  H +   +H D+KP N+L+D      ++DFG +  L   +  +     + 
Sbjct: 108 LAELVLAIHSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVG 165

Query: 339 TIGYMAPE----------GIVSTKCDVYSYGILLLETFSRKKP 371
           T  Y+APE          G    +CD +S G++  E    + P
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 23/131 (17%)

Query: 246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIM--IDVGLALEYLH-YGHALAPIIHCDLKP 302
           +V+E+MP G L   +   NY  DI E+       +V LAL+ +H  G      IH D+KP
Sbjct: 120 MVMEYMPGGDLVNLM--SNY--DIPEKWARFYTAEVVLALDAIHSMGF-----IHRDVKP 170

Query: 303 SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPE--------GIVSTKC 353
            N+LLD++    ++DFG    +    + +++  T + T  Y++PE        G    +C
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDA--NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 354 DVYSYGILLLE 364
           D +S G+ L E
Sbjct: 229 DWWSVGVFLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 24/185 (12%)

Query: 197 GTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS 255
           G  VA+K+ +L + +R  + FN E  ++R+ +H+N++++       +   +++EF+  G+
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 256 LEKWLYSHNYFLDILE--RLN---IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN 310
           L           DI+   RLN   I       L+ L Y H+   +IH D+K  +ILL  +
Sbjct: 105 LT----------DIVSQTRLNEEQIATVCESVLQALCYLHSQG-VIHRDIKSDSILLTLD 153

Query: 311 MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETF 366
               +SDFG    + +  D   +   + T  +MAPE I      T+ D++S GI+++E  
Sbjct: 154 GRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Query: 367 SRKKP 371
             + P
Sbjct: 212 DGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 25/219 (11%)

Query: 168 IQRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI---FNLQLERTFVSFNSECEVL 223
           +Q    ++D   ++G G+FG V          V A+K+   F +        F  E +++
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGL 281
                  ++++     +  +  +V+E+MP G L   +   NY  D+ E+       +V L
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVL 153

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATI 340
           AL+ +H       +IH D+KP N+LLD++    ++DFG    + E    +++  T + T 
Sbjct: 154 ALDAIHS----MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE--TGMVRCDTAVGTP 207

Query: 341 GYMAPE--------GIVSTKCDVYSYGILLLETFSRKKP 371
            Y++PE        G    +CD +S G+ L E      P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 30/181 (16%)

Query: 180 LLGIGSFGSVYKGTL-SDGTNVAIKIF------------NLQLERTFVSFNSECEVLRNV 226
           ++G GSFG V      SDG+  A+K+             ++  ER  +        L+N+
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL--------LKNL 53

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           +H  L+ +       +    VL+++  G L   L     FL+   R     +V  A+ YL
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYL 112

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAP 345
           H  +    II+ DLKP NILLD      ++DFG+ K   EG +    T T   T  Y+AP
Sbjct: 113 HSLN----IIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAP 165

Query: 346 E 346
           E
Sbjct: 166 E 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 181 LGIGSFGSVYKG-TLSDGTN-VAIKIFNLQLERTFVSFNS--ECEVLRNVR---HRNLIK 233
           +G G++G V+K   L +G   VA+K   +Q     +  ++  E  VLR++    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 234 ILSGC--SNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGLALEYLH 287
           +   C  S  D +    LV E + +  L  +L          E + ++M  +   L++LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
             H    ++H DLKP NIL+  +    ++DFG++++       +  T  + T+ Y APE 
Sbjct: 128 -SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEV 180

Query: 348 IV----STKCDVYSYGILLLETFSRK 369
           ++    +T  D++S G +  E F RK
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)

Query: 246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI 305
            +L+ M  G L   L  H  F +   R     ++ L LE++H       +++ DLKP+NI
Sbjct: 74  FILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF----VVYRDLKPANI 128

Query: 306 LLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGI 360
           LLDE+    +SD G++    +         ++ T GYMAPE +       +  D +S G 
Sbjct: 129 LLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184

Query: 361 LLLETFS-----RKKPTNDLGEMS-LKHWVNQSLPHKLAEVVDS---NLVRREHSFSAKM 411
           +L +        R+  T D  E+  +   VN  LP   +  + S    L++R+   S ++
Sbjct: 185 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD--VSKRL 242

Query: 412 DCLLR 416
            CL R
Sbjct: 243 GCLGR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 44/210 (20%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSF------NSECEVLRNVRHRNLIKI 234
           +G G++GSV     +  T   +++   +L R F S         E  +L++++H N+I +
Sbjct: 25  VGSGAYGSVCA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81

Query: 235 LSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI--------LERLNIMIDVGLA 282
           L              F P  SLE+    +L +H    D+        L   ++   +   
Sbjct: 82  LD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 129

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     DD +  T  +AT  Y
Sbjct: 130 LRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWY 183

Query: 343 MAPEGIV-----STKCDVYSYGILLLETFS 367
            APE ++     +   D++S G ++ E  +
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 12/159 (7%)

Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIM 276
           +E  +L  V  R ++ +       D   LVL  M  G L+  +Y+  N   D    +   
Sbjct: 49  NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            ++   LE L        I++ DLKP NILLD+     +SD G++  + EG+   ++ + 
Sbjct: 109 AELCCGLEDLQRER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGR- 161

Query: 337 MATIGYMAPEGIVSTKC----DVYSYGILLLETFSRKKP 371
           + T+GYMAPE I + K     D +  G L+ E    + P
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.3 bits (121), Expect = 7e-07
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 37/206 (17%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFN-----SECEVLRNVR-HRNLIK 233
           +G G+F  V K  +   G   AIK     +++ F S        E + LR +  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 234 IL-------SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           ++       +G       ALV E M + +L + +      L      + M  +  +L+++
Sbjct: 63  LIEVLFDRKTGRL-----ALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           H  +    I H D+KP NIL+ ++++  ++DFG  + +         T+ ++T  Y APE
Sbjct: 117 H-RNG---IFHRDIKPENILIKDDIL-KLADFGSCRGI---YSKPPYTEYISTRWYRAPE 168

Query: 347 -----GIVSTKCDVYSYGILLLETFS 367
                G    K D+++ G +  E  S
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 31/225 (13%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           F+   L+G G++G VYKG  +  G   AIK+ ++  +        E  +L+   H   I 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 234 ILSGC------SNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILER---LNIMIDVGLAL 283
              G         +D +  LV+EF   GS+   +   N   + L+      I  ++   L
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            +LH       +IH D+K  N+LL EN    + DFG+S  L   D ++ +  T + T  +
Sbjct: 125 SHLHQ----HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYW 177

Query: 343 MAPEGIVST---------KCDVYSYGILLLETFSRKKPTNDLGEM 378
           MAPE I            K D++S GI  +E      P  D+  M
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 30/78 (38%), Positives = 47/78 (60%), Gaps = 5/78 (6%)

Query: 246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI 305
           LV+E++  G ++  L+ + YF + +    I  +V LAL+YLH  H    IIH DLKP N+
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHR-HG---IIHRDLKPDNM 135

Query: 306 LLDENMVAHVSDFGISKL 323
           L+       ++DFG+SK+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 35/208 (16%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS--FNS----ECEVLRNVRHRNLI 232
            +G G++GSV        G  VAIK    +L R F S  F      E  +L++++H N+I
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVI 77

Query: 233 KIL----SGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            +L    S  S  +F+   LV+ +M    L+K +  H    D ++ L     V   L  L
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQYL-----VYQMLCGL 130

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
            Y H+ A IIH DLKP N+ ++E+    + DFG+++     D  +  T  + T  Y APE
Sbjct: 131 KYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGYVVTRWYRAPE 184

Query: 347 GIVS-----TKCDVYSYGILLLETFSRK 369
            I++        D++S G ++ E  + K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 56/224 (25%)

Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSF------NSECEVLRNVRHRNL 231
           +G G++GSV   Y   L     VA+K    +L R F S         E  +L++++H N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL-----------ERL---NIMI 277
           I +L              F P  S+E   ++  Y +  L           ++L   ++  
Sbjct: 77  IGLLD------------VFTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++   + DD +  T  +
Sbjct: 123 LIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYV 176

Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKK--PTND 374
           AT  Y APE ++     +   D++S G ++ E    K   P ND
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 39/167 (23%)

Query: 180 LLGIGSFGSVY----KGTLSDGTNVAIKIFNLQLERTFVS----FNSECEV--------L 223
           L+G G FG VY                KI NL+ E T V     +N+  ++        +
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE-TIVMETLVYNNIYDIDKIALWKNI 77

Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---------N 274
            N+ H   I    GC +     +   F+    LEK + +     +I +R+         N
Sbjct: 78  HNIDHLG-IPKYYGCGSFKRCRMYYRFI---LLEKLVENTK---EIFKRIKCKNKKLIKN 130

Query: 275 IMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGI 320
           IM D+   LEY+H +G     I H D+KP NI++D N   ++ D+GI
Sbjct: 131 IMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 30/77 (38%), Positives = 44/77 (57%), Gaps = 4/77 (5%)

Query: 5   GLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
            L  + T++L+ N+  GPIP   F +  SL  L+LS+NN +G IP+     L    L++S
Sbjct: 91  RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLE--TLDLS 148

Query: 64  QNRLEGEIPVE-GPFRN 79
            N L GEIP + G F +
Sbjct: 149 NNMLSGEIPNDIGSFSS 165

Length = 968

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 20/211 (9%)

Query: 180 LLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVL-RNVRHRNLIKI 234
           ++G GSFG V       DG   A+K+   ++    +      +E  VL +NV+H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                  +    VL+F+  G L   L     F +   R     ++  AL YLH       
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS----IN 116

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGI----V 349
           I++ DLKP NILLD      ++DFG+ K   EG      T T   T  Y+APE I     
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 350 STKCDVYSYGILLLETFSRKKP--TNDLGEM 378
               D +  G +L E      P    D+ EM
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 48/134 (35%), Positives = 63/134 (47%), Gaps = 13/134 (9%)

Query: 246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI 305
           LVL F+  G L   L     F     R     ++  ALE LH  +    +I+ DLKP NI
Sbjct: 70  LVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKFN----VIYRDLKPENI 124

Query: 306 LLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE---GIVSTKC-DVYSYGI 360
           LLD      + DFG+ KL  + DD   +T T   T  Y+APE   G   TK  D ++ G+
Sbjct: 125 LLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGV 181

Query: 361 LLLETFSRKKPTND 374
           LL E  +   P  D
Sbjct: 182 LLYEMLTGLPPFYD 195

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 25/220 (11%)

Query: 167 DIQRATNEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV 222
           D++    +++   ++G G+FG V    +K T        +  F +        F  E ++
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVG 280
           +       ++++     +  +  +V+E+MP G L   +   NY  D+ E+       +V 
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEVV 152

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MAT 339
           LAL+ +H        IH D+KP N+LLD++    ++DFG    + +  + +++  T + T
Sbjct: 153 LALDAIHS----MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGT 206

Query: 340 IGYMAPE--------GIVSTKCDVYSYGILLLETFSRKKP 371
             Y++PE        G    +CD +S G+ L E      P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEVLRNVRHR 229
           +F+   ++G G+FG V    L +   V A+KI N    L+R   + F  E +VL N  ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD------ILERLNIMIDVGLAL 283
            +  +     + +   LV+++   G L   L      L        L  + I ID   ++
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID---SV 118

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
             LHY       +H D+KP NIL+D N    ++DFG    L E D ++  +  + T  Y+
Sbjct: 119 HQLHY-------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYI 170

Query: 344 APE---------GIVSTKCDVYSYGILLLETFSRKKP 371
           +PE         G    +CD +S G+ + E    + P
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 50/263 (19%)

Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI----- 234
           LG GS G V+    SD    VA+K   L   ++      E +++R + H N++K+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 235 ---------LSGCSNLDFKALVLEFMPNG---SLEKWLYSHNYFLDILERLNIMIDVGLA 282
                    +   + L+   +V E+M       LE+   S  +      RL  M  +   
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLG-EGDDSLIQTKTMATI 340
           L+Y+H     A ++H DLKP+N+ ++ E++V  + DFG+++++          ++ + T 
Sbjct: 127 LKYIHS----ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 341 GYMAPEGIVS----TKC-DVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV 395
            Y +P  ++S    TK  D+++ G +  E  + K       E+     + +S+P      
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP------ 236

Query: 396 VDSNLVRREHSFSAKMDCLLRIM 418
               +VR E       + LL ++
Sbjct: 237 ----VVREE-----DRNELLNVI 250

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)

Query: 180 LLGIGSFGSVY----KGTLSDGTNVAIKIFNLQ--LERTFVSFN-SECEVLRNVRHRNLI 232
           LLG G+FG V     K T   G   A+KI   +  + +  V+   +E  VL+N RH  L 
Sbjct: 2   LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            +       D    V+E+   G L   L     F +   R     ++  AL YLH     
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLHSCD-- 115

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
             +++ DLK  N++LD++    ++DFG+ K   EG       KT   T  Y+APE
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 37/210 (17%)

Query: 175 FDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLR------ 224
           F    +LG G FG V    YK T   G   AIK     L++  +    E E L       
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKA----LKKGDIIARDEVESLMCEKRIF 53

Query: 225 ----NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
               + RH  L+ + +     D    V+E+   G L   ++ H         +     V 
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVV 111

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKTM-A 338
           L L+YLH       I++ DLK  N+LLD      ++DFG+ K  +G GD    +T T   
Sbjct: 112 LGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFCG 163

Query: 339 TIGYMAPEGIVSTK----CDVYSYGILLLE 364
           T  ++APE +  T      D +  G+L+ E
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYE 193

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 22/223 (9%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECE-VLRNV-----RHRNLIK 233
           +LG GSFG V    L  GTN    I  L+ +      + EC  V R V      H  L  
Sbjct: 2   VLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +       +    V+E++  G L   + S   F +   R     ++   L++LH      
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG--- 116

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSLIQTKTMATIGYMAPEGIVST 351
            II+ DLK  N+LLD++    ++DFG+ K  + GEG  S        T  Y+APE +   
Sbjct: 117 -IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF----CGTPDYIAPEILKGQ 171

Query: 352 K----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH 390
           K     D +S+G+LL E    + P +   E  L   +    PH
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 55/214 (25%), Positives = 105/214 (49%), Gaps = 31/214 (14%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSFNS--ECEVLRNVRH 228
           +++++   +G G++G VYK      TN  +A+K   L+ E   V   +  E  +L+ ++H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVGLALEY 285
            N++++     +     LV E++ +  L+K + S   F     +++     I  G+A  +
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVA-HVSDFGISKLLGEGDDSLIQTKT----MATI 340
            H       ++H DLKP N+L+D    A  ++DFG+++  G      I  +T    + T+
Sbjct: 120 SHR------VLHRDLKPQNLLIDRRTNALKLADFGLARAFG------IPVRTFTHEVVTL 167

Query: 341 GYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
            Y APE ++     ST  D++S G +  E  ++K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 47/246 (19%)

Query: 165 YLDIQRATNEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQLERTFVSFNSEC 220
           Y D +   NE++    +G G FG V+    K T       AI    L+ ER       E 
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEV 63

Query: 221 EVLRNVRHRNLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYS-HNYFLDILERLNIMI 277
            V+R ++H+N+++ +    N   + L  ++EF   G L + +   +  F  I E   + I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 278 DVGLALEYLHYGHALAP------IIHCDLKPSNILLDENM-----------------VAH 314
              L L  L Y H L        ++H DLKP NI L   +                 +A 
Sbjct: 124 TRQL-LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 315 VSDFGISKLLGEGDDSLIQTKTMATIG---YMAPEGIV------STKCDVYSYGILLLET 365
           + DFG+SK +G      I++   + +G   Y +PE ++        K D+++ G ++ E 
Sbjct: 183 IGDFGLSKNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Query: 366 FSRKKP 371
            S K P
Sbjct: 237 CSGKTP 242

Length = 1021

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 14/132 (10%)

Query: 245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSN 304
           + +L+ M  G L   L  H  F +   R     ++ L LE++H       +++ DLKP+N
Sbjct: 73  SFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF----VVYRDLKPAN 127

Query: 305 ILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIV-STKCDVYSYG 359
           ILLDE+    +SD G++    +         ++ T GYMAPE    G+   +  D +S G
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLG 183

Query: 360 ILLLETFSRKKP 371
            +L +      P
Sbjct: 184 CMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 32/120 (26%), Positives = 58/120 (48%), Gaps = 8/120 (6%)

Query: 252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM 311
           P  +    L + +  L  ++ +     V   +E+L    A    +H DL   N+L+ E  
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL----ASKNCVHRDLAARNVLICEGK 276

Query: 312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           +  + DFG+++ +    + + +  T   + +MAPE I     +T  DV+S+GILL E F+
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 10/136 (7%)

Query: 246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI 305
           LV+  M  G L+  +Y+       +ER+ I     +    LH  H++  I++ D+KP N+
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERGLEMERV-IHYSAQITCGILHL-HSMD-IVYRDMKPENV 126

Query: 306 LLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGIL 361
           LLD+     +SD G++  L +G      T+   T GYMAPE       S   D ++ G  
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCS 183

Query: 362 LLETFSRKKPTNDLGE 377
           + E  + + P  D  E
Sbjct: 184 IYEMVAGRTPFKDHKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 31/217 (14%)

Query: 167 DIQRATNE-FDECNLLGIGSFGSVYKGTLSDGT-NVAIKIFNLQLERTFVSFNSECEVLR 224
           DI R+ N+ +   N++G GSFG VY+    D +  VAIK    ++ +     N E  +++
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMK 114

Query: 225 NVRHRNLIKI----LSGCSNLD----FKALVLEFMPNGSLEKWL--YS-HNYFLDILERL 273
           N+ H N+I +     + C   +    F  +V+EF+P  ++ K++  Y+ +N+ L +    
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173

Query: 274 NIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDDSLI 332
                +  AL Y+H       I H DLKP N+L+D N     + DFG +K L  G  S+ 
Sbjct: 174 LYSYQLCRALAYIHSKF----ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV- 228

Query: 333 QTKTMATIGYMAPEGIV-----STKCDVYSYGILLLE 364
               + +  Y APE ++     +T  D++S G ++ E
Sbjct: 229 --SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263

Length = 440

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEVLRNVRH 228
           ++F+   ++G G+FG V    +     + A+KI N    L+R   + F  E  VL N   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG---LALEY 285
           + +  +     + ++  LV+++   G L   L   + F D L        +    LA+  
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMA 344
           +H  H     +H D+KP N+LLD N    ++DFG    L    D  +Q+   + T  Y++
Sbjct: 118 IHQLH----YVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYIS 171

Query: 345 PE---------GIVSTKCDVYSYGILLLETFSRKKP 371
           PE         G    +CD +S G+ + E    + P
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 53/170 (31%)

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
           NL F   V++++P G +   L     F + L R  I  ++  A+E +H        IH D
Sbjct: 75  NLYF---VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHK----MGFIHRD 126

Query: 300 LKPSNILLDENMVAHVSDFGI---------SKLLGEGD----DSL--------------- 331
           +KP NIL+D +    ++DFG+         SK   +GD    DS+               
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 332 --------IQTKTMA-----TIGYMAPEGIVST----KCDVYSYGILLLE 364
                      + +A     T  Y+APE ++ T     CD +S G++L E
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 50/196 (25%)

Query: 182 GIGSFGSVYKG---TLSDGTNVAIKIFNLQLER-TFVSFNS--ECEVLRNVRHRNLIKIL 235
           G G++G VYK       DG   AIK F    E+ T +S ++  E  +LR ++H N++   
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS-- 66

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWL---YSHNYFLDIL----ERLNIMIDVGLA------ 282
                     LV  F+ +     +L   Y+ +    I+    +   + I   +       
Sbjct: 67  ----------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 283 -LEYLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGIS-------KLLGEGDDS 330
            L  +HY H+   ++H DLKP+NIL+     E  V  + D G++       K L + D  
Sbjct: 117 ILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-- 173

Query: 331 LIQTKTMATIGYMAPE 346
                 + TI Y APE
Sbjct: 174 ----PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 18/221 (8%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRN------VRHRNLIK 233
           +LG GSFG V    L  G      +  L+ +   +  + EC ++          +  L  
Sbjct: 2   VLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +       +    V+EF+  G L   +     F D+        ++   L++LH      
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLHSKG--- 116

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTK- 352
            II+ DLK  N++LD +    ++DFG+ K    GD+    +    T  Y+APE +   K 
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKY 173

Query: 353 ---CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH 390
               D +S+G+LL E    + P +   E  L   +    PH
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 5e-06
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 20/151 (13%)

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           + N IK+    + L    L+++++ +G L   L      L   E   I+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 288 YGHALAPIIHCDLKPSNILLDENMV-AHVSDFGISKLLGEGDDSLIQTKTM--ATIGYMA 344
             +    IIH D+K  N+L D      ++ D+G+ K++G        T +    T+ Y +
Sbjct: 127 KHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG--------TPSCYDGTLDYFS 174

Query: 345 PEGIVSTKCDV----YSYGILLLETFSRKKP 371
           PE I     DV    ++ G+L  E  + K P
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 19/202 (9%)

Query: 181 LGIGSFGSVYKGT---LSDG-----TNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           LG G+F  ++KG    + D      T V +K+ +        SF     ++  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
                C   D   +V E++  GSL+ +L  +   ++I  +L +   +  AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---- 118

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI-- 348
             + H ++   N+LL         +    KL   G    +  K +    I ++ PE I  
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178

Query: 349 ---VSTKCDVYSYGILLLETFS 367
              +S   D +S+G  L E FS
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 5/85 (5%)

Query: 246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI 305
           L++EF+P G L   L  ++ F + + R   M +  LA+E +H        IH D+KP NI
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVHK----LGFIHRDIKPDNI 132

Query: 306 LLDENMVAHVSDFGISKLLGEGDDS 330
           L+D      +SDFG+S    +  DS
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDS 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 23/102 (22%)

Query: 281 LALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL--------LGEGDDS- 330
           LALEYLH YG     I+H DLKP N+L+       ++DFG+SK+        L EG    
Sbjct: 112 LALEYLHNYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 331 ----LIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLE 364
                +  +   T  Y+APE I+        D ++ GI+L E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 41/215 (19%)

Query: 180 LLGIGSFGSV--YKGTLSDGTNVAIKIFNLQLERTFVSFN--SECEVLRNVRHRNLIKIL 235
           ++G GS+G V     T + G  VAIK  N   E    +     E ++LR +RH ++++I 
Sbjct: 7   VIGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 236 S---GCSNLDFKAL--VLEFM---------PNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
                 S  +FK +  V E M          N  L      H +FL  L R         
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP--EHHQFFLYQLLR--------- 114

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKTMATI 340
           AL+Y+H     A + H DLKP NIL + +    + DFG++++   +   ++  T  +AT 
Sbjct: 115 ALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 341 GYMAPE------GIVSTKCDVYSYGILLLETFSRK 369
            Y APE         +   D++S G +  E  + K
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 16/155 (10%)

Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP--NGSLEKWLYSHNYFLDILERLNIM 276
           E  +L+NV H ++I++      L   A+    +P  +  L  +L   +  L I + L I 
Sbjct: 107 EAMLLQNVNHPSVIRMKD---TLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             +   L YLH       IIH D+K  NI +++     + D G ++        L    T
Sbjct: 164 KQILEGLRYLH-AQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           + T    APE +     ++K D++S GI+L E  +
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.4 bits (112), Expect = 8e-06
 Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 43/193 (22%)

Query: 199 NVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP 252
           NVAIK    +L R F +         E  +++ V H+N+I +L+             F P
Sbjct: 44  NVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN------------VFTP 87

Query: 253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL------------APIIHCDL 300
             SLE+  +   Y +  L   N+   + + L++    + L            A IIH DL
Sbjct: 88  QKSLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145

Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVST----KCDVY 356
           KPSNI++  +    + DFG+++  G    S + T  + T  Y APE I+        D++
Sbjct: 146 KPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202

Query: 357 SYGILLLETFSRK 369
           S G ++ E    K
Sbjct: 203 SVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 22/195 (11%)

Query: 181 LGIGSFGSVYKGTLSDGTN-VAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G++ +V+KG      N VA+K   L+ E     +   E  +L+N++H N++ +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                  LV E++ +  L+++L   +   +++   N+ I +   L  L Y H    I+H 
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHR 127

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT----MATIGYMAPEGIV----- 349
           DLKP N+L++E     ++DFG+++         + TKT    + T+ Y  P+ ++     
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARA------KSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 350 STKCDVYSYGILLLE 364
           ST  D++  G +L E
Sbjct: 182 STPIDMWGVGCILYE 196

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 23/61 (37%), Positives = 33/61 (54%)

Query: 12  LSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEI 71
           L L      G IP     L  L+S++LS N++ G IP SL ++  L+ L++S N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 72  P 72
           P
Sbjct: 483 P 483

Length = 623

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 19/175 (10%)

Query: 180 LLGIGSFGSVY----KGTLSDGTNVAIKIFNLQ--LERTFVSFN-SECEVLRNVRHRNLI 232
           LLG G+FG V     K T   G   A+KI   +  + +  V+   +E  VL+N RH  L 
Sbjct: 2   LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            +       D    V+E+   G L   L     F +   R     ++  ALEYLH     
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLHSRD-- 115

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
             +++ D+K  N++LD++    ++DFG+ K   EG       KT   T  Y+APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 29/212 (13%)

Query: 175 FDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRN- 230
           +++   +G G++G+V+K         VA+K   L  +   V  ++  E  +L+ ++H+N 
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 231 --LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             L  +L     L    LV E+  +  L+K+  S N  +D     + M  +   L + H 
Sbjct: 62  VRLYDVLHSDKKL---TLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA----TIGYMA 344
            +    ++H DLKP N+L+++N    ++DFG+++  G      I  +  +    T+ Y  
Sbjct: 118 HN----VLHRDLKPQNLLINKNGELKLADFGLARAFG------IPVRCYSAEVVTLWYRP 167

Query: 345 PEGIV-----STKCDVYSYGILLLETFSRKKP 371
           P+ +      ST  D++S G +  E  +  +P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 57/250 (22%), Positives = 97/250 (38%), Gaps = 58/250 (23%)

Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRN 230
           F +   LGIG+FG V      D     A+K     ++ L        +E ++L    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++++     + D    V++++P G +   L     F + L R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHK-- 119

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGI---------SKLLGEGD----DSL------ 331
                IH D+KP NIL+D +    ++DFG+         SK    GD    DS+      
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 332 --------------------------IQTKTMATIGYMAPEGIVSTK----CDVYSYGIL 361
                                     +    + T  Y+APE ++ T     CD +S G++
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 362 LLETFSRKKP 371
           L E    + P
Sbjct: 238 LYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 24/196 (12%)

Query: 181 LGIGSFGSVYKG--TLSDGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G++ +VYKG   L+D   VA+K   L+ E     +   E  +L++++H N++ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
                   LV E++ +  L+++L       + +   N+ + +   L  L+Y H    ++H
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR-RKVLH 127

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT----MATIGYMAPEGIV---- 349
            DLKP N+L++E     ++DFG+++         I TKT    + T+ Y  P+ ++    
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARA------KSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 350 -STKCDVYSYGILLLE 364
            ST+ D++  G +  E
Sbjct: 182 YSTQIDMWGVGCIFYE 197

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 9/150 (6%)

Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ--LERTFVS-FNSECEVLRNVRHRN 230
           F +   LGIG+FG V      D     A+K    +  L R  V+   +E ++L    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++K+     + D    V++++P G +   L     F ++L R  I  ++ LA+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHK-- 119

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGI 320
                IH D+KP NIL+D +    ++DFG+
Sbjct: 120 --MGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 25/63 (39%), Positives = 34/63 (53%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
           L  L L +N   G IPKS G+  SL  + L  N+ SGE+P     L  +  L++S N L+
Sbjct: 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441

Query: 69  GEI 71
           G I
Sbjct: 442 GRI 444

Length = 968

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 46/226 (20%), Positives = 91/226 (40%), Gaps = 29/226 (12%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF-------NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           +G G FG V    +   T VA  +        + + +  F+    + +  R ++H N+++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQ---QGDPYRILQHPNILQ 59

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGLALEYLHYGH 290
            L  C       LV E+   G L+ +L    +      +L    +  ++   + ++H  +
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVS 350
            L    H DL   N  L  ++   V D+GI     + D    +      + ++APE +  
Sbjct: 120 FL----HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 351 ----------TK-CDVYSYGILLLETF-SRKKPTNDLGEMSLKHWV 384
                     TK  +V++ G+ L E F +  +P + L +  + + V
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 22/198 (11%)

Query: 181 LGIGSFGSVYKGTLSDGTN-VAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G++ +V+KG      N VA+K   L+ E     +   E  +L++++H N++ +    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                  LV E++ +  L++++       +I+   N+ I +   L  L Y H    ++H 
Sbjct: 74  HTDKSLTLVFEYL-DKDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR-RKVLHR 128

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT----MATIGYMAPEGIV----- 349
           DLKP N+L++E     ++DFG+++         + TKT    + T+ Y  P+ ++     
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA------KSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 350 STKCDVYSYGILLLETFS 367
           ST+ D++  G +  E  S
Sbjct: 183 STQIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 43/190 (22%)

Query: 197 GTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNLIKILSGCSNLDFKALVLEF 250
           G NVA+K    +L R F +         E  +L+ V H+N+I +L+             F
Sbjct: 46  GINVAVK----KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN------------VF 89

Query: 251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL------------APIIHC 298
            P  SLE+  +   Y +  L   N+   + + L++    + L            A IIH 
Sbjct: 90  TPQKSLEE--FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHR 147

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTK----CD 354
           DLKPSNI++  +    + DFG+++       + + T  + T  Y APE I+        D
Sbjct: 148 DLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVD 204

Query: 355 VYSYGILLLE 364
           ++S G ++ E
Sbjct: 205 IWSVGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 35/207 (16%)

Query: 188 SVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKI----LSGCSN 240
           S+YKG   +   V I+ F   +   +       +E + LR +   N++KI    +    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH------YGHALAP 294
           L   +L+LE+   G L + L      L    +L++ ID    L  L+      Y +    
Sbjct: 94  LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN---- 148

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----- 349
                L   + L+ EN    +   G+ K+L     S    K +  + Y + + +      
Sbjct: 149 -----LTSVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSE 198

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDL 375
            + K D+YS G++L E F+ K P  +L
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKIPFENL 225

Length = 283

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 51/229 (22%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFNS--ECEVLRNVRH 228
           E++ C + G G++G VYK    DG +    A+K    Q+E T +S ++  E  +LR ++H
Sbjct: 3   EYEGCKV-GRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKH 57

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWL---YSHNYFLDILE--------RLNIMI 277
            N+I            +L   F+ +   + WL   Y+ +    I++        +  + +
Sbjct: 58  PNVI------------SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 105

Query: 278 DVGLA-------LEYLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGE 326
             G+        L+ +HY HA   ++H DLKP+NIL+     E     ++D G ++L   
Sbjct: 106 PRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 327 GDDSLIQTK-TMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSRK 369
               L      + T  Y APE ++  +      D+++ G +  E  + +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 43/188 (22%)

Query: 199 NVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP 252
           NVAIK    +L R F +         E  +++ V H+N+I +L+             F P
Sbjct: 51  NVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN------------VFTP 94

Query: 253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL------------APIIHCDL 300
             SLE+  +   Y +  L   N+   + + L++    + L            A IIH DL
Sbjct: 95  QKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152

Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVST----KCDVY 356
           KPSNI++  +    + DFG+++  G    S + T  + T  Y APE I+        D++
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

Query: 357 SYGILLLE 364
           S G ++ E
Sbjct: 210 SVGCIMGE 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 180 LLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLI 232
           LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N RH  L 
Sbjct: 2   LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            +       D    V+E+   G L   L     F +   R     ++  AL+YLH   + 
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH---SE 114

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGI--- 348
             +++ DLK  N++LD++    ++DFG+ K   EG       KT   T  Y+APE +   
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDN 171

Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
                 D +  G+++ E    + P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 14/173 (8%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVL-RNVRHRNLIKI 234
           ++G GSFG V      ++    A+K+   +    ++      SE  VL +NV+H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                  D    VL+++  G L   L     FL+   R     ++  AL YLH  +    
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---- 116

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
           I++ DLKP NILLD      ++DFG+ K   E  +    T T   T  Y+APE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 12/99 (12%)

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           ++ L L++LH       II+ DLK  N+LLD      ++DFG+ K   EG    + T T 
Sbjct: 104 EIVLGLQFLHE----RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTF 156

Query: 338 -ATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKP 371
             T  Y+APE +         D ++ G+LL E  + + P
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEVLRNVRH 228
           ++F+   ++G G+FG V    + +   V A+KI N    L+R   + F  E +VL N   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER------LNIMIDVGLA 282
           R +  +     + +   LV+++   G L   L   + F D L        L  M+   LA
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMV---LA 114

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           ++ +H        +H D+KP N+LLD+N    ++DFG S L    D ++     + T  Y
Sbjct: 115 IDSVHQLG----YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDY 169

Query: 343 MAPE---------GIVSTKCDVYSYGILLLETFSRKKP 371
           ++PE         G    +CD +S G+ + E    + P
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 51/229 (22%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFNS--ECEVLRNVRH 228
           E++ C + G G++G VYK    DG +    A+K    Q+E T +S ++  E  +LR ++H
Sbjct: 3   EYEGCKV-GRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKH 57

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWL---YSHNYFLDI---------------L 270
            N+I            AL   F+ +   + WL   Y+ +    I               L
Sbjct: 58  PNVI------------ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL 105

Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGE 326
            R  +   +   L+ +HY HA   ++H DLKP+NIL+     E     ++D G ++L   
Sbjct: 106 PRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 327 GDDSLIQTK-TMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSRK 369
               L      + T  Y APE ++  +      D+++ G +  E  + +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 18/199 (9%)

Query: 181 LGIGSFG-SVYKGTLSDGTNVAIKIFNL----QLERTFVSFNSECEVLRNVRHRNLIKIL 235
           +G GSFG ++   +  DG    IK  N+      ER       E  VL N++H N+++  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE--ESRKEVAVLSNMKHPNIVQYQ 65

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER-LNIMIDVGLALEYLHYGHALAP 294
                     +V+++   G L K + +    L   ++ L+  + + LAL+++H       
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD----RK 121

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
           I+H D+K  NI L ++    + DFGI+++L    + L +T  + T  Y++PE       +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LART-CIGTPYYLSPEICENRPYN 179

Query: 351 TKCDVYSYGILLLETFSRK 369
            K D+++ G +L E  + K
Sbjct: 180 NKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 13/180 (7%)

Query: 200 VAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKW 259
           V  K   L  ER      SE   L    H  ++K      + D   L++E+   G L K 
Sbjct: 96  VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155

Query: 260 ----LYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV 315
               L  H  F +    L +   + LAL+ +H       ++H DLK +NI L    +  +
Sbjct: 156 IKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHS----RKMMHRDLKSANIFLMPTGIIKL 210

Query: 316 SDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKP 371
            DFG SK   +     + +    T  Y+APE       S K D++S G++L E  +  +P
Sbjct: 211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 37/220 (16%)

Query: 181 LGIGSFGSVYKGTL---SDGTN--------VAIKIFNLQLERTFVSFNSECEVLRNVRHR 229
           LG G+F ++YKG L   SD           V +K+      R  ++F     ++  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           +L+K L G    D   +V E++  G L+ +L+     + +  +L++   +  AL YL   
Sbjct: 62  HLVK-LYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120

Query: 290 HALAPIIHCDLKPSNILL-----DENMV--AHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
                ++H ++   NIL+     +E  V    +SD GI   +   ++ + +      I +
Sbjct: 121 K----LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPW 170

Query: 343 MAPEGI------VSTKCDVYSYGILLLETFSR-KKPTNDL 375
           +APE I      ++   D +S+G  LLE  S  ++P + L
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 19/70 (27%), Positives = 34/70 (48%), Gaps = 3/70 (4%)

Query: 12  LSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEI 71
           L ++ N   G I      + SL+ L L+ N   G +P S  +   L+ L++S+N+  G +
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491

Query: 72  PVEGPFRNFS 81
           P +    + S
Sbjct: 492 PRK--LGSLS 499

Length = 968

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 46/210 (21%)

Query: 181 LGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLI---K 233
           LG GS+ +VYKG  S  T   VA+K   L+ E     F +  E  +L++++H N++    
Sbjct: 13  LGEGSYATVYKGR-SKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL-------ALEYL 286
           I+     L    LV E++ +  L++++      L        M +V L        L Y 
Sbjct: 71  IIHTKKTL---TLVFEYL-DTDLKQYMDDCGGGLS-------MHNVRLFLFQLLRGLAYC 119

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT----MATIGY 342
           H       ++H DLKP N+L+ E     ++DFG+++         + +KT    + T+ Y
Sbjct: 120 HQRR----VLHRDLKPQNLLISERGELKLADFGLARA------KSVPSKTYSNEVVTLWY 169

Query: 343 MAPEGIV-----STKCDVYSYGILLLETFS 367
             P+ ++     ST  D++  G +  E  +
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 22/71 (30%), Positives = 38/71 (53%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           ++G  + L  + L  N F G +P  F  L  +  LD+S+NNL G I      +  L+ L+
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLS 458

Query: 62  VSQNRLEGEIP 72
           +++N+  G +P
Sbjct: 459 LARNKFFGGLP 469

Length = 968

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)

Query: 180 LLGIGSFGSVYKGTLSDGTNV-AIKIFNLQLERTFVSFNSECEVLRN------VRHRNLI 232
           +LG GSFG V    L     V AIK+  L+ +      + +C +          +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            +       D    V+E++  G L   +     F +   R     +V LAL +LH  H  
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHR-HG- 116

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIVST 351
             +I+ DLK  NILLD      ++DFG+ K   EG  + + T T   T  Y+APE +   
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQEL 171

Query: 352 K----CDVYSYGILLLETFSRKKP 371
           +     D ++ G+L+ E  + + P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 1e-04
 Identities = 21/59 (35%), Positives = 33/59 (55%)

Query: 9  LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
          L +L L+ N+       +F  L +L+ LDLS NNL+   P++   L  L+ L++S N L
Sbjct: 2  LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 1/65 (1%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLY-LKQLNVSQNRL 67
           + ++ L+     G I  +   L  +++++LS+N LSG IP  +      L+ LN+S N  
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130

Query: 68  EGEIP 72
            G IP
Sbjct: 131 TGSIP 135

Length = 968

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 15/144 (10%)

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKT 336
           ++ LAL YLH       II+ DLK  N+LLD      ++D+G+ K  L  GD +   +  
Sbjct: 104 EISLALNYLHE----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STF 156

Query: 337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
             T  Y+APE +         D ++ G+L+ E  + + P + +G        +Q+    L
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYL 213

Query: 393 AEVVDSNLVRREHSFSAKMDCLLR 416
            +V+    +R   S S K   +L+
Sbjct: 214 FQVILEKQIRIPRSLSVKAASVLK 237

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 46/232 (19%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEVLRNVRHR 229
           +F+   ++G G+FG V      D  +V A+KI      LE+  V    +E ++L      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
            ++K+     +     L++EF+P G +   L   +   +   +  I   V LA++ +H  
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ- 119

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG--------------DDSLIQT- 334
                 IH D+KP N+LLD      +SDFG+   L +                D   Q  
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 335 ------------------KTMATIGYMAPEGIVSTK----CDVYSYGILLLE 364
                              T+ T  Y+APE  + T     CD +S G+++ E
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 46/233 (19%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEVLRNVRH 228
           ++F+   ++G G+FG V      D  ++ A+KI      LE+  V+   +E ++L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             ++K+     +     L++EF+P G +   L   +   +   +  I   V LA++ +H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIHQ 119

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG--------------DDSLIQT 334
                  IH D+KP N+LLD      +SDFG+   L +                D   Q 
Sbjct: 120 ----LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 335 -------------------KTMATIGYMAPEGIVSTK----CDVYSYGILLLE 364
                               T+ T  Y+APE  + T     CD +S G+++ E
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 26/206 (12%)

Query: 180 LLGIGSFGSVYKGTL-SDGTNVAIKIFN----LQ---LERTFVSFNSECEVLRNVRHRNL 231
           +LG GSFG V    L   G   A+K+      LQ   +E T     +E  +L   R+   
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTM----TEKRILSLARNHPF 57

Query: 232 IKILSGC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           +  L  C    D    V+EF+  G L   +     F +   R     ++  AL +LH   
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHD-- 114

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAP---- 345
               II+ DLK  N+LLD      ++DFG+ K   EG  +   T T   T  Y+AP    
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 346 EGIVSTKCDVYSYGILLLETFSRKKP 371
           E +     D ++ G+LL E      P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 12/99 (12%)

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           ++ + L +LH       II+ DLK  N++LD      ++DFG+ K    G  +   T+T 
Sbjct: 109 EIAIGLFFLHS----KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTF 161

Query: 338 -ATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
             T  Y+APE I         D +++G+LL E  + + P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 11/80 (13%)

Query: 246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH---YGHALAPIIHCDLKP 302
           L++E++P G +   L   + F +   R  I   + LA++ +H   Y       IH D+KP
Sbjct: 78  LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAIDSIHKLGY-------IHRDIKP 129

Query: 303 SNILLDENMVAHVSDFGISK 322
            N+LLD      +SDFG+  
Sbjct: 130 DNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 35/124 (28%), Positives = 53/124 (42%), Gaps = 30/124 (24%)

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL-GEGDDSL 331
           L+I   +   +EY+H       ++H DLKP NILL       + D+G +     E +D L
Sbjct: 116 LSIFHKICATIEYVHS----KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171

Query: 332 ---------------IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLET------F 366
                          I  K + T  YMAPE +     S   D+Y+ G++L +       +
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Query: 367 SRKK 370
            RKK
Sbjct: 232 RRKK 235

Length = 932

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 37/242 (15%)

Query: 174 EFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQLERTFVSFNSECEVL--RNVR 227
           +F+   +LG GSFG V     KGT       AIKI  L+ +      + EC ++  R + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTMVEKRVLA 55

Query: 228 HRN----LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
            ++    L ++ S    +D    V+E++  G L   +     F +  + +    ++ + L
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGL 114

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK-LLGEGDDSLIQTKTM-ATIG 341
            +LH       II+ DLK  N++LD      ++DFG+ K  + +G    + T+T   T  
Sbjct: 115 FFLHR----RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPD 166

Query: 342 YMAPEGIV----STKCDVYSYGILLLETFSRKKP-----TNDLGEMSLKHWVNQSLPHKL 392
           Y+APE I         D ++YG+LL E  + + P      ++L +  ++H  N S P  L
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSL 224

Query: 393 AE 394
           ++
Sbjct: 225 SK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSD--GTN--VAIKIFNLQLERTFVSFNSECEVLRNVRHR 229
           +F+   +LG GSFG V    L++  GT+   AIKI  L+ +      + EC +   V  R
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVVIQDDDVECTM---VEKR 52

Query: 230 NL--------IKILSGC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
            L        +  L  C   +D    V+E++  G L   +     F +    +    ++ 
Sbjct: 53  VLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-HAVFYAAEIA 111

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-AT 339
           + L +LH       II+ DLK  N++LD      ++DFG+ K   E     + TKT   T
Sbjct: 112 IGLFFLHS----KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164

Query: 340 IGYMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
             Y+APE I         D +++G+LL E  + + P
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 17/145 (11%)

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKT 336
           ++ LAL +LH       II+ DLK  N+LLD      ++D+G+ K  +  GD     T T
Sbjct: 104 EISLALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTST 155

Query: 337 M-ATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
              T  Y+APE +         D ++ G+L+ E  + + P + +G        +Q+    
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP---DQNTEDY 212

Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           L +V+    +R   S S K   +L+
Sbjct: 213 LFQVILEKQIRIPRSLSVKASSVLK 237

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 12/99 (12%)

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKT 336
           ++ +AL +LH       II+ DLK  N+LLD +    ++D+G+ K  LG GD +   +  
Sbjct: 104 EICIALNFLHE----RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STF 156

Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKP 371
             T  Y+APE +   +     D ++ G+L+ E  + + P
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 19/155 (12%)

Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIM 276
           +E  +LR + H ++I++    +   F  L+L   P    + + Y +    + I + L I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V  A++YLH       IIH D+K  NI ++      + DFG +    +    +   K 
Sbjct: 189 RSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAACFPVD----INANKY 240

Query: 337 ---MATIGYMAPEGIV----STKCDVYSYGILLLE 364
                TI   APE +         D++S GI+L E
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFE 275

Length = 391

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 31/146 (21%), Positives = 59/146 (40%), Gaps = 14/146 (9%)

Query: 176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI--K 233
               LL  G    VY     D     +KI   + +        E  +L+ +  + L   K
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDED-YVLKINPSREKG--ADREREVAILQLLARKGLPVPK 57

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +L+   +  +  L++E++   +L++        +   E+ +I   +   L  LH    L 
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLL 108

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFG 319
            + H DL P NIL+D+  +  + D+ 
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	457
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.78
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
smart00090	237	RIO RIO-like kinase.	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PLN03150	623	hypothetical protein; Provisional	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.37
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.21
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
KOG3087	229	consensus Serine/threonine protein kinase [General	99.12
PLN03150	623	hypothetical protein; Provisional	99.12
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.12
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.08
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.95
COG4248	637	Uncharacterized protein with protein kinase and he	98.94
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.93
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.93
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.91
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.89
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.73
PRK09902	216	hypothetical protein; Provisional	98.69
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.64
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.58
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.57
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.55
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.47
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.36
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.29
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.29
PF01636	239	APH: Phosphotransferase enzyme family This family	98.28
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.24
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.23
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.23
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.22
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.22
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.18
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.17
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.13
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.12
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.1
PLN02876	822	acyl-CoA dehydrogenase	98.05
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.98
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.93
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	97.92
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.91
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.89
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.87
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.84
PRK10593	297	hypothetical protein; Provisional	97.83
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.82
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.81
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.74
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.73
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.7
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.63
PRK05231	319	homoserine kinase; Provisional	97.63
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.61
PLN03210	1153	Resistant to P. syringae 6; Provisional	97.59

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-59  Score=455.15  Aligned_cols=284  Identities=43%  Similarity=0.671  Sum_probs=245.4

Q ss_pred             cccccCHHHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeee
Q 044428          159 TWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC  238 (457)
Q Consensus       159 ~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  238 (457)
                      ..+.|++.++..||++|+..+.||+|+||.||+|.+++|+.||||++.........+|.+|++++++++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999988765433145699999999999999999999999


Q ss_pred             ecCC-eeEEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          239 SNLD-FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       239 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                      .+.+ +.+||||||++|+|.++|+.... .++|.+|++||.++|+||+|||+.+ .++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 59999999999999999998776 8999999999999999999999988 6789999999999999999999999


Q ss_pred             ccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCC---CCCcHHHHHHhhcC
Q 044428          317 DFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDL---GEMSLKHWVNQSLP  389 (457)
Q Consensus       317 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~---~~~~l~~~~~~~~~  389 (457)
                      |||+|+........ ..+...||.+|+|||    +..++|+|||||||+|+||+||+.|.+..   +...+.+|+...+.
T Consensus       220 DFGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999765431111 111118999999999    45889999999999999999999998863   45568999987777


Q ss_pred             ch-hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          390 HK-LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       390 ~~-~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      +. +.+++|+.+......   ..++...+.+++.+|++.+|++||+|.||+++|+.+..
T Consensus       299 ~~~~~eiiD~~l~~~~~~---~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYP---DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CcchhheeCCCccCCCCC---hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            74 899999998742221   11457779999999999999999999999999966543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-57  Score=503.04  Aligned_cols=421  Identities=27%  Similarity=0.433  Sum_probs=312.6

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      ++++|++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..+.++++|+.|++++|+++|.+|..+.+.++.
T Consensus       518 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~  597 (968)
T PLN00113        518 ELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAIN  597 (968)
T ss_pred             HHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccC
Confidence            46788999999999999999999999999999999999999999999999999999999999999999999988998999


Q ss_pred             ccccccccccCCCC-CcCCCCCccccccchhhhhhhhhhhhhhHHHHHHHHHHHHHHhhhhhcCCC--CCCCcccccc--
Q 044428           82 TESFSWNYALCGPS-RFQVPPCKEENNKRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCQNRST--KKSDEEDLLP--  156 (457)
Q Consensus        82 ~~~~~~n~~lcg~~-~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--  156 (457)
                      ...+.+|+.+||+. ....++|.....   ......++++++++ + +++++++++++++++++..  ++...+....  
T Consensus       598 ~~~~~~n~~lc~~~~~~~~~~c~~~~~---~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (968)
T PLN00113        598 ASAVAGNIDLCGGDTTSGLPPCKRVRK---TPSWWFYITCTLGA-F-LVLALVAFGFVFIRGRNNLELKRVENEDGTWEL  672 (968)
T ss_pred             hhhhcCCccccCCccccCCCCCccccc---cceeeeehhHHHHH-H-HHHHHHHHHHHHHHhhhcccccccccccccccc
Confidence            99999999999865 334567753211   11111111111111 1 1111222222222222111  1111110000  


Q ss_pred             ----cccccccCHHHHHHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcc
Q 044428          157 ----LVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL  231 (457)
Q Consensus       157 ----~~~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni  231 (457)
                          ....+.+++.+   ....|...+.||+|+||.||+|+. .+|..||||++......    ...|++.+++++||||
T Consensus       673 ~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnI  745 (968)
T PLN00113        673 QFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNI  745 (968)
T ss_pred             cccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCc
Confidence                00111233333   345677888999999999999987 57899999998643221    2356889999999999


Q ss_pred             ceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC
Q 044428          232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM  311 (457)
Q Consensus       232 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~  311 (457)
                      |+++|+|.+.+..++||||+++|+|.++++.    ++|.++.+++.|+|.|++|||+.+ .++|+||||||+||+++.++
T Consensus       746 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~  820 (968)
T PLN00113        746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKD  820 (968)
T ss_pred             ceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCC
Confidence            9999999999999999999999999999963    899999999999999999999776 67899999999999999999


Q ss_pred             cEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCC--CCCcHHHHHH
Q 044428          312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDL--GEMSLKHWVN  385 (457)
Q Consensus       312 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~--~~~~l~~~~~  385 (457)
                      .+++. ||.......      .....+++.|+|||..    ++.++|||||||++|||+||+.||+..  .......|+.
T Consensus       821 ~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  893 (968)
T PLN00113        821 EPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR  893 (968)
T ss_pred             ceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHH
Confidence            88876 665543321      1224678999999944    678999999999999999999999652  3345677776


Q ss_pred             hhcCch-hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          386 QSLPHK-LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       386 ~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ...... ..+.+|+.+.....   ...+++.++.+++.+||+.+|++||+|.||+++|+++.+..
T Consensus       894 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        894 YCYSDCHLDMWIDPSIRGDVS---VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HhcCccchhheeCccccCCCC---ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            655443 45556665533221   12244667899999999999999999999999999987644

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-50  Score=387.67  Aligned_cols=253  Identities=31%  Similarity=0.470  Sum_probs=208.5

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCC-eeEEEEeccCCC
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-FKALVLEFMPNG  254 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g  254 (457)
                      .+.+|+|+||+||+|.+.+...||||++.....  ....+|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            346999999999999997555599999986532  22568999999999999999999999999988 799999999999


Q ss_pred             CHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-eeeccCCCCCeeecCCC-cEEEeccccccccCCCCCcc
Q 044428          255 SLEKWLYS-HNYFLDILERLNIMIDVGLALEYLHYGHALAP-IIHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       255 ~L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~-ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +|.++++. .+..+++..+++++.|||+||.|||    ..+ ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH----~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH----SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            99999998 3677999999999999999999999    555 99999999999999998 99999999999764322  2


Q ss_pred             eeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          332 IQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      ..+...||+.|||||.+      ++.|+|||||||++|||+||+.||...........+-           .....    
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~-----------~~~~R----  264 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV-----------VGGLR----  264 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----------hcCCC----
Confidence            23447899999999933      6789999999999999999999998755322222211           11110    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                       ...+.+|+..+..++.+||..||..||++.+++..|+.+...+...
T Consensus       265 -p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  265 -PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             -CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence             0011125777999999999999999999999999999998876643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-50  Score=385.97  Aligned_cols=250  Identities=28%  Similarity=0.504  Sum_probs=212.5

Q ss_pred             CcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      ..++.||+|.||+||.|.++....||+|.++... ....+|.+|+++|.+++|+|||+++|+|..++.++||||||+.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            3456899999999999999888899999998653 345679999999999999999999999999999999999999999


Q ss_pred             HHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceec
Q 044428          256 LEKWLYS-HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT  334 (457)
Q Consensus       256 L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  334 (457)
                      |.++|.. .+..+...+.+.++.|||+||+||+    ++++|||||.++||||+++..+||+|||+|+...+ +......
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~  362 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASE  362 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEcccccccccCC-CceeecC
Confidence            9999997 4567899999999999999999999    77799999999999999999999999999995433 3333445


Q ss_pred             cccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          335 KTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       335 ~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ...-.+.|.|||    ..++.|||||||||+||||+| |+.||......+....+.                 ...+..+
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-----------------~GyRlp~  425 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-----------------RGYRLPR  425 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-----------------ccCcCCC
Confidence            566688999999    558999999999999999999 888886654333222222                 2234455


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      +..|+..+.++|..||..+|++|||+..+...|+++...
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            667899999999999999999999999998888887643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=353.51  Aligned_cols=248  Identities=25%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCC-eeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-FKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  250 (457)
                      +.+..+.||+|..|+|||++++ +++.+|+|.+....+ ...+++.+|+++++..+||+||.++|.|.... ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3345568999999999999986 788999999965543 34568999999999999999999999999888 59999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      |.+|+|.+++...+ .+++...-+|+.+|.+||.|||+   ..+||||||||+|||++..|++||||||.++.+...   
T Consensus       160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999999998764 48899999999999999999995   367999999999999999999999999999987543   


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......||..|||||.+    ++.++||||||++++|+.+|+.|+....+ +...         +.+.++.-..+....
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~---------~~~Ll~~Iv~~ppP~  301 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLD---------IFELLCAIVDEPPPR  301 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCC---------HHHHHHHHhcCCCCC
Confidence             33457899999999954    78899999999999999999999976411 1111         122222211111111


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .... .+..++..++..|+++||.+||++.|+++
T Consensus       302 lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 LPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111 35677999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.9e-48  Score=389.35  Aligned_cols=254  Identities=29%  Similarity=0.484  Sum_probs=216.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      +....+.||+|.||+||+|+..      +...||||.++...+. ...+|++|+++++.++|||||+++|.|.+++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3444568999999999999853      3567999999987655 67899999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcE
Q 044428          247 VLEFMPNGSLEKWLYSHN-------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                      |+|||..|||.++|....             ..++..+.+.||.|||.||+||-    +..+|||||..+|+||+++..+
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccceEE
Confidence            999999999999997532             23888999999999999999999    5669999999999999999999


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhc
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~  388 (457)
                      ||+|||+++.....+.........-.++|||||.    .+|++||||||||+|||++| |+.|+.........+.+..  
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~--  720 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA--  720 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc--
Confidence            9999999998776666655555667889999994    48999999999999999999 9999876554333222221  


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                               ..+      .+.+++||.++.+||..||+.+|++||+++||-..|+...+.
T Consensus       721 ---------g~l------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  721 ---------GQL------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ---------CCc------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                     111      445678999999999999999999999999999999987654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-48  Score=385.11  Aligned_cols=268  Identities=27%  Similarity=0.467  Sum_probs=227.0

Q ss_pred             cccCHHHHHHHhhcCC---------cCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc
Q 044428          161 RRISYLDIQRATNEFD---------ECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV  226 (457)
Q Consensus       161 ~~~~~~~l~~~~~~~~---------~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l  226 (457)
                      +.++|+|-.+|..+|.         +.++||.|.||+||+|+++    ....||||.++... +++..+|..|+.+|.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            4578888777776653         3478999999999999985    34579999998764 66778999999999999


Q ss_pred             CCCccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       227 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      .||||++|.|+.......++|+|||+||+|..+|..+...+.+.+...+..+||.||.||.    ..++|||||.++|||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhhee
Confidence            9999999999999999999999999999999999999888999999999999999999999    788999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSL  380 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l  380 (457)
                      ++.+..+|++|||+++.+.++.... ......-.++|.|||.+    ++.++|||||||||||.++ |.+||.+...++.
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence            9999999999999999885543221 22223346799999955    7889999999999999998 9999877554332


Q ss_pred             HHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          381 KHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       381 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ..-+                 ++..+...+++|+..|.+||+.||++|-.+||.+.||+..|.++..+.
T Consensus       844 IkaI-----------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  844 IKAI-----------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHH-----------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            2221                 223346678899999999999999999999999999999999976543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-46  Score=349.78  Aligned_cols=248  Identities=27%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchh-------hHHHHHHHHHHHhhcCCCccceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLER-------TFVSFNSECEVLRNVRHRNLIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  243 (457)
                      .+.|...+.||+|+||.|-+|.- ++|+.||||++++....       ......+|+++|.+++|||||++.+++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            35677788999999999999975 58999999999764211       12235799999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC---CcEEEecccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN---MVAHVSDFGI  320 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~  320 (457)
                      .|+|||||+||+|.+.+-.++. +.+..-.-++.|++.|+.|||    +.||+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999988764 666666789999999999999    8899999999999999766   7899999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HHHHHHhhcCchh
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LKHWVNQSLPHKL  392 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~~~~~~~~~~~~  392 (457)
                      |+..+.+   ......+||+.|.|||++       +..+.|+||+||+||-+++|.+||++..... +.+.+.+.     
T Consensus       326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-----  397 (475)
T KOG0615|consen  326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-----  397 (475)
T ss_pred             hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-----
Confidence            9997643   345568999999999966       2348899999999999999999998743322 33333221     


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                            +.   ......+....++..+++.+++..||++|||+.|+++.
T Consensus       398 ------~y---~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  398 ------RY---AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ------cc---cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                  11   11112344557778999999999999999999999863

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=344.72  Aligned_cols=206  Identities=31%  Similarity=0.510  Sum_probs=181.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  ..+..+....|+.+|+.++|||||.+++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888889999999999999985 6899999999876  4556677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC------CcEEEecccccc
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN------MVAHVSDFGISK  322 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~------~~~kl~Dfg~~~  322 (457)
                      |||.+|+|.++++..+ .+++.....++.|+|.||++||    .++||||||||.|||++.+      -.+||+|||+|+
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999999886 4899999999999999999999    7779999999999999764      568999999999


Q ss_pred             ccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHH
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN  385 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~  385 (457)
                      .+.++.   .....+|++.|||||+    .|+.|+|+||.|+++||+++|+.||+.....++..++.
T Consensus       164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~  227 (429)
T KOG0595|consen  164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK  227 (429)
T ss_pred             hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence            987543   2345889999999994    48899999999999999999999998755555554443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=361.00  Aligned_cols=243  Identities=23%  Similarity=0.314  Sum_probs=203.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQ---LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..|...+.||+|+|+.+|.++. .+|..||+|++.+.   ...+.....+||++.+.|+|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5788899999999999999997 89999999999864   2455667899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |+|++++|.+++.. ++.+++.+...+..||+.||.|||    +.+|+|||||..|+++++++++||+|||+|..+...+
T Consensus        98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            99999999999994 456999999999999999999999    7789999999999999999999999999999986432


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .  .....+|||.|+|||++    .+..+||||+|||||-|+.|++||+...-.+....+..      .+..-|      
T Consensus       173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~P------  238 (592)
T KOG0575|consen  173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSMP------  238 (592)
T ss_pred             c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCcccc------
Confidence            2  23458999999999966    56789999999999999999999986431111111110      011111      


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            .....+..+|+.++++.+|.+|||+.+|+.
T Consensus       239 ------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  239 ------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  122445789999999999999999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=362.70  Aligned_cols=262  Identities=25%  Similarity=0.422  Sum_probs=212.0

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF  243 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  243 (457)
                      .+.....+++.....||+|.||+||+|+|.  ..||||+++...  ....+.|..|+..+++-||.||+-+.|||.++..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            334444556667789999999999999984  469999998653  4467899999999999999999999999999888


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                       ++|+.+|+|-+|+.+++..+..++..+.+.||.|||.||.|||    .++|||||||+.||++.+++++||+|||++..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEecccceee
Confidence             9999999999999999988878999999999999999999999    78899999999999999999999999999986


Q ss_pred             cCCCCCcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ..............|...|||||++       +++.+||||||+|+|||+||..||......            .+.-.+
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d------------qIifmV  605 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD------------QIIFMV  605 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh------------heEEEe
Confidence            5433222233346689999999955       789999999999999999999999732110            010111


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      -..... ......-.+|++++.+|+..||..++++||.+.+|+.+|+++..
T Consensus       606 GrG~l~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  606 GRGYLM-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cccccC-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            111000 00011123678889999999999999999999999998888765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-45  Score=326.37  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=199.9

Q ss_pred             hcCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeee-eeecCC-eeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILS-GCSNLD-FKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~lv  247 (457)
                      .+|.+.++||+|.||+|||+. ..+|..||.|.++...  .+...+...|+.+|++++|||||++++ -+.+.. ..++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            456777899999999999997 4689999999987542  345667899999999999999999998 344444 48999


Q ss_pred             EeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          248 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      |||+..|+|.+.++.   ++..+++...++++.|+++||.++|+......|.||||||.||+++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999864   34678999999999999999999996432234999999999999999999999999999998


Q ss_pred             CCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ...  .......+|||.||+||.+    ++.|+||||+||++|||..-++||...   ++.+.-..     +...--+.+
T Consensus       179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~K-----I~qgd~~~~  248 (375)
T KOG0591|consen  179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKK-----IEQGDYPPL  248 (375)
T ss_pred             cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHH-----HHcCCCCCC
Confidence            542  2334558899999999955    789999999999999999999999764   22222111     111101111


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .        ..-....+.+++..|+.+||+.||+...+++.+.
T Consensus       249 p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  249 P--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             c--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            1        1223567899999999999999999655555443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-44  Score=374.70  Aligned_cols=258  Identities=28%  Similarity=0.456  Sum_probs=215.6

Q ss_pred             cCCcCCccCCCCceEEEEEEeC--CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS--DGT----NVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~--~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ..+..+.||+|.||.||.|...  +|.    .||||.+++.. .+...+|.+|..+|++++|||||+++|.|.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            3445578999999999999864  343    48999987654 5567789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          247 VLEFMPNGSLEKWLYSH------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      ++|||++|+|..+|.+.      ...+...+.+.++.|||+|+.||+    .+.+|||||.++|+||+....+||+|||+
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999987      567899999999999999999999    67799999999999999999999999999


Q ss_pred             ccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHh
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEV  395 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~  395 (457)
                      |+.+...+.........-...|||||    ++++.|+|||||||+|||++| |..||......+....+.          
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~----------  918 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL----------  918 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH----------
Confidence            99655444443333334457899999    679999999999999999999 889998765443332111          


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                           .+.  +...+..|+..+.+++..||+.+|++||++..+++++..+.+.....
T Consensus       919 -----~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  919 -----EGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             -----hCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence                 111  34456678999999999999999999999999999999988766543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=333.63  Aligned_cols=251  Identities=27%  Similarity=0.372  Sum_probs=199.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--eeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD--FKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  249 (457)
                      .+|...+.||+|+||+||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|.....+  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34666789999999999999875 49999999987664334667899999999999999999999855444  6899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEeccccccccCC-C
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGE-G  327 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~-~  327 (457)
                      |+++|+|.+++...+..+++.....+..||++||.|||    +++|+||||||+|||++. ++.+||+|||+++.... .
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999999999987656999999999999999999999    788999999999999999 79999999999987753 1


Q ss_pred             CCcceeccccccccccCCCCCC---CC--ccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGIV---ST--KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~~---~~--~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ..........||+.|||||.+.   ..  ++||||+||++.||+||+.||...  .....++.......    .-|.+  
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~----~~P~i--  244 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED----SLPEI--  244 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC----CCCCC--
Confidence            1112233478999999999664   23  899999999999999999998763  11122221111111    00111  


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                             +...+....+++.+|++.+|++||||.+++..-
T Consensus       245 -------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  245 -------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             -------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                   111245678999999999999999999998654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=341.91  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=215.3

Q ss_pred             CCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          175 FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      ....++||+|.||.|..+....+..||||.++...... ..+|.+|+++|.+++|||||+++|+|..++.+++|+|||++
T Consensus       540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn  619 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN  619 (807)
T ss_pred             eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence            34457999999999999999888999999999876444 47899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          254 GSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       254 g~L~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      |+|.+++..+..+ +....-.+|+.|||.||+||.    +..+|||||.++|+|+|.++++||+|||+++-+..++....
T Consensus       620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            9999999988633 356677889999999999999    67799999999999999999999999999998888877777


Q ss_pred             eccccccccccCCC----CCCCCccchhhhhHHHHHHhc--CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS--RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       333 ~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t--g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      .....-.++|||||    +.+++++|||+|||++||+++  +..||+........+-..        ++++..-...  -
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~--------~~~~~~~~~~--~  765 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG--------EFFRDQGRQV--V  765 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh--------hhcCCCCcce--e
Confidence            77777889999999    448999999999999999886  788987654433333222        2222211111  1


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ...+.-|+.++.+++.+||..+-++||+++++...|.+.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            223446788999999999999999999999999888653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=328.05  Aligned_cols=239  Identities=27%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|+..++||+|+||.||.++.. +++.+|+|++++..   ....+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999764 78999999998763   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      +||+.||.|+.+|++++. +++....-++.+|+.||.|||    +.+||||||||+|||||.+|+++|+|||+++.....
T Consensus       104 ld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            999999999999997764 677777778999999999999    788999999999999999999999999999964332


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      +  ..+...+||+.|||||.+    ++..+|.||+|+++|||++|.+||...+.   ..+.......+        +...
T Consensus       179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~~I~~~k--------~~~~  245 (357)
T KOG0598|consen  179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYDKILKGK--------LPLP  245 (357)
T ss_pred             C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHHHHhcCc--------CCCC
Confidence            2  223457999999999944    78899999999999999999999976442   22222222111        1111


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      ...      ...+..+++.+.+..||++|..
T Consensus       246 p~~------ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  246 PGY------LSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             Ccc------CCHHHHHHHHHHhccCHHHhcC
Confidence            110      1334688999999999999963

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.3e-43  Score=343.07  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=199.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC-C
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL-D  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  242 (457)
                      .++|...+.||+|+||.||+|..      .+++.||||++.... ......+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46788889999999999999974      245789999997543 23345789999999999 899999999988764 4


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  264 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  264 (457)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6889999999999999997532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecccccccc
Q 044428          265 ---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG  341 (457)
Q Consensus       265 ---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  341 (457)
                         ..+++....+++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++...............++..
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               23778888999999999999999    67899999999999999999999999999987643322222223456788


Q ss_pred             ccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHH
Q 044428          342 YMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR  416 (457)
Q Consensus       342 y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~  416 (457)
                      |+|||.+    ++.++|||||||++|||++ |..||.......  ....        .+.+......      +..++..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~--------~~~~~~~~~~------~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ--------RLKDGTRMRA------PENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH--------HHhcCCCCCC------CCCCCHH
Confidence            9999943    6889999999999999997 999997533211  1111        0111000000      1123456


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          417 IMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       417 l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      +.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=345.52  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=208.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC--CC--CE-EEEEEeccc---chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS--DG--TN-VAIKIFNLQ---LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~-vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      ++....++||+|+||.||+|++.  ++  .. ||||..+..   ......+|.+|+++|++++|||||+++|++......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            34444579999999999999874  23  23 899998852   355678899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++|||+|+||+|.++|...+..++..+++.++.+.|.||+|||    .++++||||-++|+|++.++.+||+|||+++.-
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999999998877999999999999999999999    778999999999999999999999999998864


Q ss_pred             CCCCCcceec-cccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHH-HhhcCchhHHhcc
Q 044428          325 GEGDDSLIQT-KTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWV-NQSLPHKLAEVVD  397 (457)
Q Consensus       325 ~~~~~~~~~~-~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~-~~~~~~~~~~~~d  397 (457)
                      .   ...... ...-...|+|||    .++++++|||||||++||+++ |..||..........++ ....+..      
T Consensus       313 ~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~------  383 (474)
T KOG0194|consen  313 S---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP------  383 (474)
T ss_pred             c---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC------
Confidence            2   111111 223568999999    558999999999999999999 88999776544444443 1111110      


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                                 .+...+..+..++.+||..+|++||+|.++.+.|+.+.+...
T Consensus       384 -----------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  384 -----------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -----------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                       111236678899999999999999999999999999877654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.9e-43  Score=313.97  Aligned_cols=261  Identities=22%  Similarity=0.269  Sum_probs=204.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-h-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-R-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +.|+...++|+|+||.||+++.+ +|+.||||++....+ . ..+-..+|+++|++++|+|+|.++.+|.....++||||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777889999999999999986 799999999976543 2 23457899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++..-| +-|.....-++.....+++.|++.|+.|+|    +++++||||||+|||++.++.+||||||+|+.+.... 
T Consensus        82 ~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-  155 (396)
T KOG0593|consen   82 YCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-  155 (396)
T ss_pred             ecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence            9976444 445554445888899999999999999999    6779999999999999999999999999999986322 


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch---hHHhccccc-
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK---LAEVVDSNL-  400 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~---~~~~~d~~l-  400 (457)
                       ...+....|..|+|||.+     ++..+||||.||++.||++|.+-|....+.+....+...+.+-   -..++...- 
T Consensus       156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence             234567889999999944     6788999999999999999999887766666555555443332   222322111 


Q ss_pred             -cc-----cccc---hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 -VR-----REHS---FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 -~~-----~~~~---~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       .+     ....   .........-+.+++..|++.||.+|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             00     0000   0011122345889999999999999999999873

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=325.99  Aligned_cols=256  Identities=24%  Similarity=0.324  Sum_probs=208.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+....||.|..++||+|+. ..+..||||++..... .....+.+|+..++.++||||++++..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            45788889999999999999985 5789999999987643 335789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||.+|++.+.+... ..-+++..+..|.+++++||.|||    .+|.||||||+.|||++++|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999764 244889999999999999999999    7889999999999999999999999999887765433


Q ss_pred             Cc-cee-ccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchh-HHhcccc
Q 044428          329 DS-LIQ-TKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL-AEVVDSN  399 (457)
Q Consensus       329 ~~-~~~-~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~-~~~~d~~  399 (457)
                      .. ... ....||++|||||++      |+.|+||||||++..||.+|..||.........-.--+..++.. ....   
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~---  257 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL---  257 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC---
Confidence            22 222 457899999999963      78899999999999999999999988665443322222222211 1111   


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            ..++.......+.+++..|++.||++|||++++++
T Consensus       258 ------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  258 ------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                  12222333557899999999999999999999874

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=327.96  Aligned_cols=270  Identities=24%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             CCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCccceeeeeeecCC----eeEEEE
Q 044428          175 FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRN--VRHRNLIKILSGCSNLD----FKALVL  248 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~  248 (457)
                      ....+.||+|+||.||||.+. ++.||||++...   +.+.|+.|-++.+.  ++|+||++++++-....    ++.||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            344568999999999999995 599999999854   45678888887765  48999999999765544    889999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH-----ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ||.++|+|.+||..+.  ++|....+|+..+++||+|||+..     ..++|+|||||++||||..|+++.|+|||+|..
T Consensus       288 ~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            9999999999999875  999999999999999999999643     257899999999999999999999999999999


Q ss_pred             cCCCCCcceeccccccccccCCCCC-----CC-----CccchhhhhHHHHHHhcCCCCCCC--CCCCc--HHHHHHhhcC
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI-----VS-----TKCDVYSYGILLLETFSRKKPTND--LGEMS--LKHWVNQSLP  389 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~-----~~~Dv~s~Gvvl~el~tg~~p~~~--~~~~~--l~~~~~~~~~  389 (457)
                      +..+.........+||.+|||||++     +.     .+.||||+|.|||||+++-.-++.  .++..  ...-+...-.
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            8765544444458899999999954     11     258999999999999997655432  11111  1111111000


Q ss_pred             -chhH-HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          390 -HKLA-EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       390 -~~~~-~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                       +++. -++.++..............+..+.+.+..||..||+.|.|+.=|.+++.++..-+.
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence             0111 112221111111111222346779999999999999999999999999998876554

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.4e-42  Score=327.41  Aligned_cols=256  Identities=23%  Similarity=0.298  Sum_probs=201.7

Q ss_pred             cccCHHHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCccceeeee
Q 044428          161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVRHRNLIKILSG  237 (457)
Q Consensus       161 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~  237 (457)
                      +.+++.++     +......||+|++|.||+|++ +|+.||||.++......   ...|.+|+.++.+++||||++++|+
T Consensus        13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~   86 (283)
T PHA02988         13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF   86 (283)
T ss_pred             eecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence            34455555     233335899999999999998 68899999997643222   4678899999999999999999999


Q ss_pred             eec----CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcE
Q 044428          238 CSN----LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       238 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                      +.+    ....++||||+++|+|.+++.... .+++....+++.+++.|+.|||..   .+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~~~~Hrdlkp~nill~~~~~~  162 (283)
T PHA02988         87 IIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY---TNKPYKNLTSVSFLVTENYKL  162 (283)
T ss_pred             EEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc---CCCCCCcCChhhEEECCCCcE
Confidence            876    357889999999999999998754 588999999999999999999942   367899999999999999999


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhh
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~  387 (457)
                      ||+|||+++.+....     ....++..|+|||..      ++.++|||||||++|||++|+.||.......+...+.. 
T Consensus       163 kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~-  236 (283)
T PHA02988        163 KIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN-  236 (283)
T ss_pred             EEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-
Confidence            999999998754321     234578999999943      57799999999999999999999976432222111110 


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                        ..      ...       ..+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       237 --~~------~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        237 --KN------NSL-------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             --cC------CCC-------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence              00      000       0011245678999999999999999999999999998764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.6e-42  Score=329.64  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=198.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcccee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD-----------------GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI  234 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  234 (457)
                      ++|...+.||+|+||.||++.+++                 +..||+|++.... ......|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            567788899999999999997532                 3479999987653 2335579999999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 044428          235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHN------------------YFLDILERLNIMIDVGLALEYLHYGHALAPII  296 (457)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~iv  296 (457)
                      ++++...+..++||||+++|+|.+++....                  ..+++...++++.|++.||.|||    ..+|+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~iv  160 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNFV  160 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCcc
Confidence            999999999999999999999999986532                  23678889999999999999999    67899


Q ss_pred             eccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc--CCC
Q 044428          297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS--RKK  370 (457)
Q Consensus       297 H~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t--g~~  370 (457)
                      ||||||+|||++.++.+||+|||+++.+.............++..|+|||.    .++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999987644332222233456789999994    36789999999999999987  566


Q ss_pred             CCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          371 PTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       371 p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      ||...........+.............          ..+..++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYL----------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccc----------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776543322222222211111000000          001123567899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=338.32  Aligned_cols=239  Identities=28%  Similarity=0.413  Sum_probs=198.0

Q ss_pred             CcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .+++-||.|+.|.||+|+++ ++.||||.++.-.       ..+|..|++|+||||+.+.|+|.....+++|||||+.|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            45568999999999999995 6789999876332       247899999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecc
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK  335 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  335 (457)
                      |.+.|...+. +.......+..+||.||.|||    ...|||||||+-|||+..+..+||+|||-++.....   .....
T Consensus       199 L~~VLka~~~-itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  199 LYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             HHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            9999998763 666677889999999999999    677999999999999999999999999999876433   22334


Q ss_pred             ccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHH
Q 044428          336 TMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM  411 (457)
Q Consensus       336 ~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  411 (457)
                      .+||..|||||++    +++|+||||||||||||+||..||.+.+...            +...+-...    .....+.
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------------IIwGVGsNs----L~LpvPs  334 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------------IIWGVGSNS----LHLPVPS  334 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------------eEEeccCCc----ccccCcc
Confidence            7899999999977    7889999999999999999999997643211            111111111    1123456


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          412 DCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       412 ~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      +|+..+.-|++.||+..|.+||++++++..|.-..
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            78999999999999999999999999999886543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-42  Score=329.10  Aligned_cols=264  Identities=25%  Similarity=0.302  Sum_probs=206.6

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKA  245 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  245 (457)
                      ..+.|+.+++||+|.||.||+|+. .+|..||+|.++...  +....-..+||.+|+++.||||+++.+...+.  ...|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            345677788999999999999985 689999999998664  34455678999999999999999999988776  6899


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||||||+ -+|..++....-.++..++..++.|++.||+|+|    ..+|+|||||.+|||+|.+|.+||+|||+|+++.
T Consensus       195 lVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  195 LVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999996 5899999887777999999999999999999999    7899999999999999999999999999999876


Q ss_pred             CCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hH---
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LA---  393 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~---  393 (457)
                      .... ...+..+-|..|.|||.+     |+.+.|+||.||||.||++|++.|....+....+.+.......    +.   
T Consensus       270 ~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            5433 335667889999999954     7889999999999999999999998755544333333222111    11   


Q ss_pred             ----HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          394 ----EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       394 ----~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ..+.+.-.....-.......+...++|+..++..||.+|.|+.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                11111000000000011122456789999999999999999999874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=329.59  Aligned_cols=262  Identities=25%  Similarity=0.310  Sum_probs=207.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchh-hHHHHHHHHHHHhhcC-CCccceeeeeeecCC-eeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLER-TFVSFNSECEVLRNVR-HRNLIKILSGCSNLD-FKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  247 (457)
                      -++|...++||.|.||+||+|+. .+|..||||.++.+... +.-.=.+|+..|+++. ||||+++..++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            35778888999999999999985 57999999999876432 2223478999999998 999999999998877 99999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||| ..+|++++..+++.+++..+..|+.||+.||+|+|    .+|+.|||+||+|||+.....+||+|||+||.....
T Consensus        89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999 57999999999999999999999999999999999    788999999999999999999999999999987543


Q ss_pred             CCcceeccccccccccCCC-----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----h------
Q 044428          328 DDSLIQTKTMATIGYMAPE-----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----L------  392 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE-----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~------  392 (457)
                         ...+....|..|+|||     ..++.+.||||+|||++|+.+-++.|.+..+.+-..-+-..+...    +      
T Consensus       164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence               2346678899999999     448899999999999999999999887755544333332222211    1      


Q ss_pred             HHhccccccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          393 AEVVDSNLVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       393 ~~~~d~~l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ...+.-.+......  ..-...+..+..+++.+|++.||.+|||+.|+++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111111100000  00111356778999999999999999999998763

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-42  Score=332.53  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ..|..-.+||+|..|.||.|+- .+++.||||++........+-+.+|+.+|+..+|+|||.++..|...++.+.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4567778999999999999974 578999999998877666677899999999999999999999998889999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++|+|.+.+....  +++.++..|+.+++.||+|||    ..+|+|||||++|||++.+|.+||+|||++..+.....  
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            9999999998765  899999999999999999999    78899999999999999999999999999998765432  


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      ..+...||+.|||||++    +++|.||||||++++||+.|.+||-...  .+.....      +...-.+.+..     
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrAlyL------Ia~ng~P~lk~-----  491 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYL------IATNGTPKLKN-----  491 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC--hHHHHHH------HhhcCCCCcCC-----
Confidence            34557899999999954    8999999999999999999999996533  2222111      11111122211     


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        ++-....+.++..+|++.||++||++.|+++
T Consensus       492 --~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 --PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              1122456899999999999999999999985

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.6e-41  Score=319.34  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|+..+.||+|+||.||+|++.    .+..||+|.++... ......|.+|+..+.+++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56788889999999999999763    46789999998653 23345789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++......+++.+++.++.|++.||+|||    ..+++||||||+||+++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999876666899999999999999999999    678999999999999999999999999987653221


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      . ........++..|+|||.+    ++.++|||||||++||+++ |+.||...........+....        .     
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~--------~-----  226 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------R-----  226 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------C-----
Confidence            1 1111123456789999943    6789999999999999875 999997654322222211110        0     


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                          ...+..++..+.+++.+||+.+|++||++.++.+.|.++
T Consensus       227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                001123466789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.5e-41  Score=334.18  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  243 (457)
                      .++|+..+.||+|+||.||+|+.      .++..||||+++... ......+.+|+.++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35688889999999999999974      246689999997543 23345688999999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-----------------------------------------------------------  264 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  264 (457)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          265 ---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       265 ---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                                     ..+++..+++++.||+.||.|||    ..+++||||||+|||++.++.+||+|||+++.......
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                           14788889999999999999999    67899999999999999999999999999987643322


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCC-CcHHHHHHhhcCchhHHhcccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGE-MSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~-~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ........++..|+|||..    ++.++|||||||++|||++ |..||..... .....++....            ...
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------~~~  337 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY------------RML  337 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc------------cCC
Confidence            2222224456789999943    6789999999999999998 8889865321 11112211110            000


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      .     +...+.++.+++.+|++.+|++||++.||++.|++.
T Consensus       338 ~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 S-----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             C-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0     011244688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-42  Score=323.12  Aligned_cols=244  Identities=34%  Similarity=0.523  Sum_probs=190.7

Q ss_pred             CCccCCCCceEEEEEEeC-----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          178 CNLLGIGSFGSVYKGTLS-----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+.||.|.||.||+|.+.     .+..|+||.++... ......|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            358999999999999876     36789999996543 334678999999999999999999999999888899999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++|+|.++|... ...+++..+.+|+.||+.||.|||    ..+++|+||+++||++++++.+||+|||+++........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccccc
Confidence            999999999987 556899999999999999999999    567999999999999999999999999999887433333


Q ss_pred             ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      ...........|+|||.    ..+.++||||||+++||+++ |+.||...........+..           .....   
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~-----------~~~~~---  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ-----------GQRLP---  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT-----------TEETT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------cccce---
Confidence            33334567889999993    37889999999999999999 7788866432222221111           10000   


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                         .+..++..+.+++..||+.+|++||++.++++.|
T Consensus       226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               1112355689999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=327.70  Aligned_cols=249  Identities=25%  Similarity=0.375  Sum_probs=201.6

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCe
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDF  243 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  243 (457)
                      .+..++|...+.||+|+|++|++|+. .+++.+|||++.+..   +....-...|-++|.+| .||.|++|+-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34456888889999999999999985 479999999997652   33344567899999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      +|+|+||+++|+|.++|.+.+ .+++....-++.+|..||+|||    ..|||||||||+|||||.||++||+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999999875 4888888889999999999999    88999999999999999999999999999999


Q ss_pred             cCCCCCc---------cee--ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc
Q 044428          324 LGEGDDS---------LIQ--TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       324 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~  388 (457)
                      +.+....         ...  ...+||..|.+||.+    .+..+|+|+||||+|+|+.|++||....+.-.-       
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-------  296 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-------  296 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-------
Confidence            8653222         111  347899999999944    788999999999999999999999764432111       


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ..+++-... ..      ...++.+.+|+.+.+..||.+|++..+|-+
T Consensus       297 ----qkI~~l~y~-fp------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  297 ----QKIQALDYE-FP------EGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ----HHHHHhccc-CC------CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                111111110 00      111345789999999999999999977754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=328.76  Aligned_cols=251  Identities=25%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEeccc----ch-hhHHHHHHHHHHHhhcC-CCccceeeeeeecCC
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQ----LE-RTFVSFNSECEVLRNVR-HRNLIKILSGCSNLD  242 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  242 (457)
                      ...+.|...+.||+|+||+|+.|+. .+|..||+|++...    .. .....+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456888999999999999999976 47899999987664    11 23445678999999999 999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEeccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGIS  321 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~  321 (457)
                      ..++||||+.+|+|.+++.. ..++.+.....++.|++.|++|+|    ..+|+||||||+|||++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999999 456888999999999999999999    7889999999999999999 99999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHh
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV  395 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~  395 (457)
                      .....  ........+||+.|+|||.+      -+.++||||+||+||-|++|+.||++.....+.   ......   ++
T Consensus       169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~---~ki~~~---~~  240 (370)
T KOG0583|consen  169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY---RKIRKG---EF  240 (370)
T ss_pred             cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH---HHHhcC---Cc
Confidence            98731  11234568899999999944      356899999999999999999999873322221   111100   00


Q ss_pred             ccccccccccchhHHHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          396 VDSNLVRREHSFSAKMDC-LLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~-~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      .-+.            .. ..++..++.+|+..+|.+|+++.+|+ .-.-++
T Consensus       241 ~~p~------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  241 KIPS------------YLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             cCCC------------CcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence            0010            11 34578999999999999999999998 433333

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.7e-41  Score=326.68  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=202.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT----NVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .+|+..+.||+|+||.||+|++. +|.    .||+|+++... ......+.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999863 343    38999987543 33456788999999999999999999998764 5679


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+||+++|+|.+++......+++...+.++.|++.||+|||    ..+|+||||||+||++++++.+||+|||+++.+..
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            99999999999999987666899999999999999999999    67899999999999999999999999999997754


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........++..|+|||.+    ++.++|||||||++|||++ |+.||.......+........          ...
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------~~~  231 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----------RLP  231 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC----------CCC
Confidence            3332222234456789999943    6789999999999999998 999987543222222111100          000


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                             .+..+...+.+++.+||+.+|.+||++.+++..+..+....
T Consensus       232 -------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         232 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                   01123456889999999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.2e-41  Score=297.60  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=204.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .+|...+++|+|.||.||+|+. .+|+.||||.++...  ++-.....+|+..|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3577778999999999999985 589999999998653  2234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      ||+ .+|+..+......++..+...++.++.+|++|+|    .+.|+||||||.|+|++++|.+||+|||+|+.+...+.
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            995 7999999999888999999999999999999999    66799999999999999999999999999999876544


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHH------
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAE------  394 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~------  394 (457)
                      .  .+...-|..|.|||.+     ++...||||.|||+.||+-|.+-|....+.+....+-..+..    .+.+      
T Consensus       157 ~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  157 I--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             c--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            3  2334789999999944     677899999999999999998877654433332222222111    1111      


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ...-..........--..+.....+++..++..||.+|++++|+++.
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11100000000000011234557999999999999999999998764

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=314.66  Aligned_cols=253  Identities=26%  Similarity=0.469  Sum_probs=204.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|+..+.||+|+||.||+|++.    +...||||.++... ......|.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357888899999999999999874    24579999987543 3345578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++++|.+++......+++..+.+++.|++.|++|||    ..+|+||||||+||++++++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999999876667899999999999999999999    67899999999999999999999999999998752


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........++..|+|||..    ++.++||||||+++||+++ |..||...........+......           
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-----------  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2222222234456789999943    6779999999999999998 99998654332222222111000           


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                            ..+.+++..+.+++.+|++.+|++||++.+|++.|.++
T Consensus       228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  00112355689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.2e-41  Score=332.05  Aligned_cols=255  Identities=24%  Similarity=0.381  Sum_probs=198.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  243 (457)
                      .++|+..+.||+|+||.||+|+..      ++..||||+++... ......+.+|+++++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357888899999999999998742      34579999997543 23345688999999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-----------------------------------------------------------  264 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  264 (457)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999986421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceec
Q 044428          265 ----------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT  334 (457)
Q Consensus       265 ----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  334 (457)
                                ..+++....+++.|++.||.|||    ..+|+||||||+||++++++.+||+|||+++............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                      23678889999999999999999    7789999999999999999999999999998754332222222


Q ss_pred             cccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          335 KTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       335 ~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ...++..|+|||.    .++.++|||||||++|||++ |+.||.........           .............    
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-----------~~~~~~~~~~~~~----  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-----------YKMVKRGYQMSRP----  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH-----------HHHHHcccCccCC----
Confidence            3345678999994    36889999999999999997 99999753321110           1111110000000    


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                       ...+..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus       338 -~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 -DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence             011346889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-40  Score=318.62  Aligned_cols=252  Identities=28%  Similarity=0.527  Sum_probs=202.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD------GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|+..+.||+|+||.||+|....      ...||+|.+.... ......|.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888899999999999998642      2579999987543 233457899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC
Q 044428          246 LVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN  310 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~  310 (457)
                      ++|||+++|+|.+++....               ..+++...+.++.|++.||.|||    ..+++||||||+||+++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcCC
Confidence            9999999999999997642               34788899999999999999999    6789999999999999999


Q ss_pred             CcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHH
Q 044428          311 MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVN  385 (457)
Q Consensus       311 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~  385 (457)
                      +.+||+|||+++...............+++.|+|||.    .++.++|||||||++|||++ |..||......+....+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999987644332222334556889999994    36789999999999999998 999987644322222221


Q ss_pred             hhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       386 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ..           ...      ..+..++.++.+++.+||+.+|.+||++.||.+.|+.+
T Consensus       241 ~~-----------~~~------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         241 SR-----------QLL------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             cC-----------CcC------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11           000      01123467799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-40  Score=312.56  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=199.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|+..+.||+|+||.||++.+.++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4677888999999999999999888899999886432 234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++......+++..+..++.+++.||.|||    ..+++||||||+||++++++.+||+|||.++....... ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS  157 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence            99999999876556899999999999999999999    67899999999999999999999999999886533221 11


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....++..|+|||..    ++.++||||||+++|||++ |+.||...........+......     ..+         
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----~~~---------  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----YRP---------  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----CCC---------
Confidence            1223456789999954    5678999999999999999 89999765433322222211100     000         


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                         ...+..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               01134589999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.5e-40  Score=316.20  Aligned_cols=255  Identities=28%  Similarity=0.468  Sum_probs=204.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|...+.||+|+||.||++..      .++..+|+|.+..........+.+|++++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            5678888999999999999974      2356699999886655556779999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEE
Q 044428          247 VLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH  314 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~k  314 (457)
                      ||||+++++|.+++....            ..+++..++.++.|++.||+|||    ..+++||||||+||++++++.+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEE
Confidence            999999999999997542            24899999999999999999999    67899999999999999999999


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcC
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      |+|||+++...............++..|+|||.+    ++.++|||||||+++||+| |+.||...........+...  
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~--  238 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG--  238 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--
Confidence            9999999866433222222234467889999943    6778999999999999998 89998654322221111110  


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                               ......      ..++..+.+++.+|++.+|.+|||+.++.+.|+++.+.
T Consensus       239 ---------~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 ---------RVLQRP------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             ---------CcCCCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                     000000      01234689999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.4e-40  Score=314.11  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=201.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT----NVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|+..+.||+|+||.||+|.+. +|+    .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788889999999999999864 444    47788775433 2334578888889999999999999998864 45778


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ++||+++|+|.+++......+++.....++.|++.||.|||    ..+++||||||+||++++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999877667899999999999999999999    67899999999999999999999999999987654


Q ss_pred             CCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........++..|+|||.    .++.++||||||+++||++| |+.||.........+.+.....          ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------~~  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER----------LA  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc----------CC
Confidence            333323334567789999994    36789999999999999998 9999976443333222221100          00


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                             .+..+...+.+++.+|+..+|++|||+.|+++.|..+....
T Consensus       232 -------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         232 -------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                   00112445788999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.2e-40  Score=316.05  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=194.4

Q ss_pred             CCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          175 FDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      |+..+.||+|+||.||++.. .+|+.||+|.+....   ......+.+|+.++.+++|+||+++.+++...+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999986 479999999987542   22234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||    ..+|+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998886543 45889999999999999999999    7889999999999999999999999999998753322 


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        ......||..|+|||.+    ++.++|||||||++|||++|+.||..........-+.......       .. ..  
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~-~~--  224 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-------QE-EY--  224 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-------cc-cC--
Confidence              12345689999999944    6789999999999999999999998644322211111111100       00 00  


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                          .......+.+++.+|++.||++||+     +.++.+
T Consensus       225 ----~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 ----SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ----CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                0012345789999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5e-40  Score=315.64  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=205.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|...+.||+|+||.||+|+..      ++..+++|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46777889999999999999742      356799999876655556778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC
Q 044428          247 VLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM  311 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~  311 (457)
                      ||||+++++|.+++....               ..+++..++.++.+++.|++|||    ..+++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCC
Confidence            999999999999997542               23789999999999999999999    67899999999999999999


Q ss_pred             cEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHh
Q 044428          312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQ  386 (457)
Q Consensus       312 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~  386 (457)
                      .++|+|||+++...............++..|+|||.+    ++.++||||||+++|||+| |+.||..............
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  240 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ  240 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence            9999999999865443222222335567889999943    5778999999999999999 9999866443222221111


Q ss_pred             hcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          387 SLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       387 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .           .....      ...++..+.+++.+|++.+|++||++.+|+++|.++.+.
T Consensus       241 ~-----------~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         241 G-----------RVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             C-----------CCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            1           00000      011245688999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.2e-40  Score=310.86  Aligned_cols=251  Identities=22%  Similarity=0.416  Sum_probs=202.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|+..++||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35788889999999999999998888899999986543 23567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++|+|.+++.... ..+++..+..++.+++.||+|||    ..+++||||||+||++++++.++|+|||+++....... 
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            9999999997643 55889999999999999999999    67899999999999999999999999999987643221 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      .......++..|+|||..    .+.++|||||||++|||+| |+.||...........+.....        .    .  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------~----~--  224 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR--------M----P--  224 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--------C----C--
Confidence            112223457789999943    5678999999999999998 9999975443332222221110        0    0  


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                         ....++..+.+++.+|+..+|++||++.++.+.|+++
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 ---RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               0011245688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.1e-40  Score=311.62  Aligned_cols=253  Identities=29%  Similarity=0.487  Sum_probs=206.9

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +...+|+..+.||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888899999999999999998899999999987655556678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |+++|+|.+++.... ..+++..+..++.+++.|+.|||    ..+++|+||+|+||++++++.+||+|||.+.......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999998643 45899999999999999999999    6789999999999999999999999999998764321


Q ss_pred             CcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                        .......++..|+|||.    .++.++||||||++++||++ |+.||...........+....            .. 
T Consensus       159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------~~-  223 (261)
T cd05148         159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY------------RM-  223 (261)
T ss_pred             --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC------------cC-
Confidence              11223446778999993    36779999999999999998 899996543222222211100            00 


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                          ..+..++..+.+++.+|++.+|++|||+.++.+.|+.+
T Consensus       224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                00112355689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.9e-40  Score=315.93  Aligned_cols=260  Identities=20%  Similarity=0.283  Sum_probs=197.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999875 789999999875432 2334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++ |+|.+++......+++.....++.|++.||+|||    +.+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            97 5999999876666889999999999999999999    77899999999999999999999999999986532221 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhc-----
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVV-----  396 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~-----  396 (457)
                       ......+++.|+|||.+     ++.++||||+||++|||+||+.||...........+.......    +.++.     
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             12335689999999944     5678999999999999999999997643322222222111111    11111     


Q ss_pred             ----cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 ----DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 ----d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .+....... ............+++.+|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~-~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCch-HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                110000000 0000012345789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.8e-40  Score=313.08  Aligned_cols=250  Identities=30%  Similarity=0.505  Sum_probs=200.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|...+.||+|+||.||+|+..      ++..||||.++..... ....+.+|++++.+++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            46777889999999999999864      3478999999765443 4568999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          246 LVLEFMPNGSLEKWLYSHN-------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      +||||+++++|.+++....             ..+++.....++.+++.|+.|||    ..+++||||||+||+++.++.
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCCe
Confidence            9999999999999997542             34788899999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||+++...............+++.|+|||.+    ++.++|||||||++|||++ |+.||...........+...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            999999999865433222222334567889999943    6789999999999999999 99998764433322222211


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .           ....      +..++..+.+++.+||+.+|++||++.||++.|+
T Consensus       241 ~-----------~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         241 R-----------LLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             C-----------cCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            0           0000      0122456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=309.90  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=201.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc--CCCccceeeeeeecC----CeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGCSNL----DFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~l  246 (457)
                      .+....+.||+|.||+||+|+++ |+.||||++....   ..++.+|.++.+..  ||+||+.+++.-..+    .+++|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            45666789999999999999995 7889999997543   45678888888765  999999999865433    26899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhc----CCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG----HALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      |++|.++|||+|+|.+..  ++....++++..+|.||+|||.+    ...+.|.|||||+.|||+..++...|+|+|+|.
T Consensus       287 vTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             eeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            999999999999999854  89999999999999999999942    126789999999999999999999999999998


Q ss_pred             ccCCCCCcc--eeccccccccccCCCCCC----------CCccchhhhhHHHHHHhcC----------CCCCCCCC--CC
Q 044428          323 LLGEGDDSL--IQTKTMATIGYMAPEGIV----------STKCDVYSYGILLLETFSR----------KKPTNDLG--EM  378 (457)
Q Consensus       323 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~----------~~~~Dv~s~Gvvl~el~tg----------~~p~~~~~--~~  378 (457)
                      .........  .....+||.+|||||++-          -..+||||||.|+||+.-+          +.||.+.-  +.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            765432221  234478999999999652          1258999999999999863          34554411  11


Q ss_pred             cHHHHHHhhcCchhHHh-ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          379 SLKHWVNQSLPHKLAEV-VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       379 ~l~~~~~~~~~~~~~~~-~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      +..+         ..++ ...++....+......+++..+.+++..||..+|.-|.|+-.+-+.|.++-+
T Consensus       445 s~ee---------MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  445 SFEE---------MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CHHH---------HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1111         1222 1223333333333445678899999999999999999999999999988875

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.4e-40  Score=314.77  Aligned_cols=264  Identities=26%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  245 (457)
                      ++|...+.||+|+||.||++..     .++..||+|.+..........+.+|++++++++||||+++.+++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677888999999999999974     2588999999987665666789999999999999999999998754  34688


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||    ..+++||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999999999876556899999999999999999999    6789999999999999999999999999998764


Q ss_pred             CCCCcce-eccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC-c----hhHHh
Q 044428          326 EGDDSLI-QTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP-H----KLAEV  395 (457)
Q Consensus       326 ~~~~~~~-~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~-~----~~~~~  395 (457)
                      ....... .....++..|+|||.    .++.++|||||||++|||++|..|+..... .....+..... .    .+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHH
Confidence            4322111 112234556999994    367789999999999999998877543211 11110010000 0    01111


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      +....     .......++..+.+++.+||+.+|++|||+.||++.|++++
T Consensus       239 ~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         239 LKNNG-----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HhcCC-----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            11110     00111223567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.9e-40  Score=328.91  Aligned_cols=254  Identities=23%  Similarity=0.391  Sum_probs=199.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  243 (457)
                      .++|...+.||+|+||.||+|+..      .+..||||++.... ......+.+|+++++++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            457888899999999999999852      23469999997543 233457899999999996 9999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-----------------------------------------------------------  264 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  264 (457)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999986531                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec
Q 044428          265 ------------------------------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD  308 (457)
Q Consensus       265 ------------------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~  308 (457)
                                                          ..+++..+..++.|++.||.|||    ..+++||||||+||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill~  271 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEEe
Confidence                                                13677888999999999999999    67899999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCC-cHHH
Q 044428          309 ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEM-SLKH  382 (457)
Q Consensus       309 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~-~l~~  382 (457)
                      +++.+||+|||+++...............++..|+|||.+    ++.++|||||||++|||++ |..||...... ....
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            9999999999999876433222222234567889999944    6789999999999999997 99998653211 1111


Q ss_pred             HHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       383 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      .+.            ....     ...+..++..+.+++.+||+.+|++||++.+|.+.|+++.
T Consensus       352 ~~~------------~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 KIK------------SGYR-----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHh------------cCCC-----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            100            0000     0011233567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.4e-40  Score=319.90  Aligned_cols=262  Identities=22%  Similarity=0.286  Sum_probs=200.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+..+.||+|+||.||+++.. +|..+|+|.+..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367888999999999999999875 688999999876532 334578999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++.... .+++..+..++.+++.||.|||+.   .+|+||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREK---HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhc---CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999998654 488899999999999999999942   359999999999999999999999999988653321 


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch--------------
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK--------------  391 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~--------------  391 (457)
                         .....|+..|+|||.+    ++.++|||||||++|||+||+.||.......+...+.......              
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence               2235689999999944    6789999999999999999999997543322222221110000              


Q ss_pred             -----------------hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          392 -----------------LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       392 -----------------~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                                       ..+..+........... .......+.+++.+|++.||++|||+.|+++.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                             00000000000000000 001245689999999999999999999998653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-40  Score=309.54  Aligned_cols=251  Identities=27%  Similarity=0.452  Sum_probs=201.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|...+.||+|++|.||+|...+++.||+|.++... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999998888899999987543 23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++++|.+++.... ..+++..+..++.+++.|+.|||    ..+++||||||+||++++++.+||+|||+++....... 
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence            9999999997654 45899999999999999999999    67899999999999999999999999999987653211 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      ........+..|+|||..    .+.++||||||+++|||+| |+.||...........+.....          +     
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------~-----  223 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR----------M-----  223 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------C-----
Confidence            111122334689999943    5779999999999999999 9999875432222211111000          0     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                        ..+..++..+.+++.+|++.+|++||++.++.+.|+++
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              00112345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-41  Score=324.80  Aligned_cols=249  Identities=26%  Similarity=0.433  Sum_probs=206.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      +....++||.|.||.||.|.|+ -...||||.++.+. ....+|.+|..+|..++|||+|+++|+|......|+|+|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            4455679999999999999986 45679999998664 346789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          253 NGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       253 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      .|+|.+||.+-. ..++..-.+.++.||+.||+||.    .+.+|||||.++|.|+.++..+|++|||+++++... ...
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYT  421 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYT  421 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-cee
Confidence            999999998754 34666778899999999999999    666999999999999999999999999999998543 222


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......-.+.|.|||.+    ++.|+|||+|||+||||.| |..||...+   +.+         ..+.+.     ...+
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---lSq---------VY~LLE-----kgyR  484 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQ---------VYGLLE-----KGYR  484 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---HHH---------HHHHHh-----cccc
Confidence            22334457889999955    6789999999999999999 888875433   211         122222     2233


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ...++.|+.++.+|+..||+.+|.+||++.|+.+.++.+
T Consensus       485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            445668899999999999999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-40  Score=327.38  Aligned_cols=243  Identities=25%  Similarity=0.340  Sum_probs=201.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +-|+..+.||.|+.|.|..|++ .+|+.+|||++.+..   ......+.+|+-+|+-+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4567778999999999999987 489999999998663   223456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|.|++++-.++. +++.+..+++.||..|+.|+|    ..+|+||||||+|+|||..+.+||+|||+|.+-.++.
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999988764 788888999999999999999    5669999999999999999999999999998754332


Q ss_pred             CcceeccccccccccCCCCCC-----CCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~~-----~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                         .....+|++.|.|||.+.     +.++||||+|||||-|+||+.||++..   +...+.......            
T Consensus       167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~------------  228 (786)
T KOG0588|consen  167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGV------------  228 (786)
T ss_pred             ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCc------------
Confidence               345578999999999663     558999999999999999999998543   333322221110            


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                         +..+...+.+..+|+.+|+.+||++|.|++||.+.
T Consensus       229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence               11122335568899999999999999999999863

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-41  Score=298.21  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=207.5

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--------hhhHHHHHHHHHHHhhc-CCCccceeeee
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--------ERTFVSFNSECEVLRNV-RHRNLIKILSG  237 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~  237 (457)
                      -+...+.|...+.+|+|..++|.++..+ +|..+|+|++....        ....++-.+|+.+|+++ .||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            3556678889999999999999998764 78899999986432        12234567899999999 69999999999


Q ss_pred             eecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEec
Q 044428          238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       238 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                      |..+...++|+|.|+.|.|+++|.+.- .+++....+|+.|+..|++|||    ...||||||||+|||+|++.++||+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceEEec
Confidence            999999999999999999999998764 4888899999999999999999    67799999999999999999999999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhh
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~  387 (457)
                      ||+++.+.++...   ...+||++|+|||.+          ++...|+||+||++|.|+.|.+||......-+...+.  
T Consensus       167 FGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im--  241 (411)
T KOG0599|consen  167 FGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM--  241 (411)
T ss_pred             cceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH--
Confidence            9999999876543   458899999999944          6778999999999999999999996432211111111  


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                ..  ...++..++.+......+|+.+|++.||.+|.|+.|+++
T Consensus       242 ----------eG--kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  242 ----------EG--KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----------hc--ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                      10  112233455666777899999999999999999999985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.6e-41  Score=322.18  Aligned_cols=242  Identities=26%  Similarity=0.397  Sum_probs=202.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|...+.||+|+||.||||+-+ +.+.||+|.+.+..  +++.+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777789999999999999865 78999999997653  4567789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+.| +|+.+|..... +++.....++.++..||.|||    +.+|.|||+||.|||++..+++|++|||+|+.+..  .
T Consensus        82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N  153 (808)
T ss_pred             hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence            9966 99999987754 899999999999999999999    78899999999999999999999999999998765  3


Q ss_pred             cceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      ....+...||+-|||||    ..++..+|.||+||++||+++|++||....   +.+.+.....+.       -  ..  
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I~~d~-------v--~~--  219 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSILKDP-------V--KP--  219 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHHhcCC-------C--CC--
Confidence            34556688999999999    447889999999999999999999996432   222222222111       0  00  


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          +.+....+..++...+.+||.+|.+..+++.
T Consensus       220 ----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  220 ----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                1123456889999999999999999998864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=316.20  Aligned_cols=241  Identities=24%  Similarity=0.329  Sum_probs=194.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|... +|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36788899999999999999875 78999999987542   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    ..+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            9999999999998654 4888899999999999999999    7789999999999999999999999999998763321


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                           ....|++.|+|||.+    .+.++|||||||++|||++|+.||...........+.           ..... ..
T Consensus       156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~-----------~~~~~-~~  218 (291)
T cd05612         156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-----------AGKLE-FP  218 (291)
T ss_pred             -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------hCCcC-CC
Confidence                 234689999999943    5778999999999999999999997643222111111           10000 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAAK  441 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~~  441 (457)
                      .      .....+.+++.+|++.||.+||+     +.|+++.
T Consensus       219 ~------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 R------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             c------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            0      11335789999999999999995     7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.6e-40  Score=311.66  Aligned_cols=256  Identities=23%  Similarity=0.403  Sum_probs=203.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGT----NVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      .++|+..+.||+|+||.||+|++ .+|.    .||+|++.... ......+.+|+.++..+.||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            35788889999999999999985 3454    48999987543 33456788999999999999999999998754 578


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +++||+++|+|.+++......+++...+.++.|++.||.|||    +.+++||||||+||++++++.+||+|||+++.+.
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999999876666899999999999999999999    7789999999999999999999999999998764


Q ss_pred             CCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ............++..|+|||..    ++.++||||||+++||+++ |..||.......+..++......          
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL----------  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC----------
Confidence            33222222223456789999944    6778999999999999998 89998765433333333221100          


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                             ..+..++..+.+++.+|++.+|++||++.+++..|+++...+
T Consensus       231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                   001123456889999999999999999999999998876544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-39  Score=307.54  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=199.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|...+.||+|+||.||+|+..++..+|+|.+.... .....+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4677788999999999999998877789999887543 234578999999999999999999999999889999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++......+++..++.++.|++.||.|||    ..+++|+||||+||++++++.+||+|||.++....... ..
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            99999999876556899999999999999999999    77899999999999999999999999999886543221 11


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....++..|+|||..    ++.++||||||+++|||++ |+.||...........+.....           ....   
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~---  223 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-----------LYRP---  223 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-----------CCCC---
Confidence            2223456789999944    5789999999999999999 9999875443222222111100           0000   


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                         ...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               011456899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-39  Score=305.66  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=193.3

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      +.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999874 78999999886543 23345789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccc
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT  336 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  336 (457)
                      .+++......+++..++.++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9999876556899999999999999999999    678999999999999999999999999998865432111111112


Q ss_pred             cccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHH
Q 044428          337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM  411 (457)
Q Consensus       337 ~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  411 (457)
                      ..+..|+|||.+    .+.++||||||+++||+++ |..||...........+..            .....     .+.
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~------------~~~~~-----~~~  219 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ------------GVRLP-----CPE  219 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc------------CCCCC-----Ccc
Confidence            335679999944    5778999999999999998 8888865332221111111            00000     011


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          412 DCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       412 ~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .++..+.+++.+|++.+|++||++.++.++|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            23456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.3e-40  Score=312.19  Aligned_cols=256  Identities=22%  Similarity=0.385  Sum_probs=206.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCC-----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSD-----GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSN-LDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  244 (457)
                      .++|...+.||+|+||.||+|...+     +..|++|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999998765     7889999987543 3345678899999999999999999998766 5678


Q ss_pred             EEEEeccCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEec
Q 044428          245 ALVLEFMPNGSLEKWLYSHN-------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                      ++++||+++|+|.+++....       ..+++..++.++.+++.||+|||    ..+++||||||+||++++++.+||+|
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEECC
Confidence            99999999999999997642       34889999999999999999999    67899999999999999999999999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchh
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKL  392 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~  392 (457)
                      ||+++.+.............++..|+|||..    ++.++||||||+++||+++ |+.||.......+..++.....   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---  237 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR---  237 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC---
Confidence            9999876543332222334567789999943    6789999999999999999 9999976544333333222110   


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                             +       .....++..+.+++.+|++.+|++|||+.++++.|.++.++
T Consensus       238 -------~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         238 -------L-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             -------C-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                   0       00112345689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-39  Score=311.28  Aligned_cols=251  Identities=27%  Similarity=0.474  Sum_probs=198.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .+|+..+.||+|+||.||+|..     .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4567778999999999999984     256789999987543 2334678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC
Q 044428          247 VLEFMPNGSLEKWLYSHN----------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN  310 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~  310 (457)
                      ||||+++++|.+++....                ..+++.+.+.++.+++.||.|||    ..+++||||||+||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcCC
Confidence            999999999999986321                24788889999999999999999    6789999999999999999


Q ss_pred             CcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHH
Q 044428          311 MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVN  385 (457)
Q Consensus       311 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~  385 (457)
                      +.+||+|||+++...............++..|+|||..    ++.++||||||+++|||++ |..||...........+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999999876443322222334467789999943    6789999999999999999 999986543222222221


Q ss_pred             hhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       386 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                      ...           ...      .+..++..+.+++.+|++.+|++||++.+|.+.|..
T Consensus       241 ~~~-----------~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 KRQ-----------LLP------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             cCC-----------cCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            110           000      011234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.1e-40  Score=318.92  Aligned_cols=237  Identities=22%  Similarity=0.280  Sum_probs=190.2

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      +.||+|+||.||+++.. +|+.||+|+++...   ......+.+|++++++++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999864 78999999997542   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceec
Q 044428          255 SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT  334 (457)
Q Consensus       255 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  334 (457)
                      +|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~  153 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence            9999998654 5889999999999999999999    6789999999999999999999999999987532211  1123


Q ss_pred             cccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHH
Q 044428          335 KTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK  410 (457)
Q Consensus       335 ~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  410 (457)
                      ...||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+..   .      +..+.         
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~---~------~~~~p---------  215 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---E------EIRFP---------  215 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---C------CCCCC---------
Confidence            35699999999954    67899999999999999999999975432211111110   0      00000         


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          411 MDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       411 ~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      ......+.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            01244578999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-39  Score=306.84  Aligned_cols=250  Identities=25%  Similarity=0.419  Sum_probs=199.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45777789999999999999865 58899999987542 33567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++++|.+++.... ..+++..++.++.|++.||+|||    ..+++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999997643 45899999999999999999999    678999999999999999999999999999876432211


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                       ......++..|+|||.+    .+.++|||||||++|||++ |..||................        ....     
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~-----  226 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------RMER-----  226 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------CCCC-----
Confidence             11123346789999943    6778999999999999998 899986533222111111100        0000     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                          +..++..+.+++.+|++.+|++||++.++.++|+.+
T Consensus       227 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 ----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                112355689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=290.28  Aligned_cols=243  Identities=23%  Similarity=0.310  Sum_probs=201.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|+..+.||+|.||.||.|+.+ ++-.||+|++.+..   .+...++.+|+++-++++||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367899999999999999999865 78899999997653   33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          248 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      +||.++|++...|.... ..++......++.|+|.|+.|+|    .+.++||||||+|+|++.++..||+|||-+..-..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            99999999999999654 45788888899999999999999    78899999999999999999999999998876432


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                          ......+||..|.+||+.    .+...|+|++||+.||++.|.+||...........+..      .++.++.   
T Consensus       177 ----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------~~~~~p~---  243 (281)
T KOG0580|consen  177 ----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------VDLKFPS---  243 (281)
T ss_pred             ----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------ccccCCc---
Confidence                223457899999999955    56789999999999999999999986543222222221      1222221   


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                               .......+++.+|+..+|.+|.+-.||+.
T Consensus       244 ---------~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  244 ---------TISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ---------ccChhHHHHHHHHhccCccccccHHHHhh
Confidence                     12445789999999999999999999875

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-39  Score=310.20  Aligned_cols=252  Identities=23%  Similarity=0.407  Sum_probs=198.5

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF  243 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  243 (457)
                      .+++|+..+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999753      35679999986432 2344568899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEE
Q 044428          244 KALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH  314 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~k  314 (457)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.||.|||    ..+++||||||+||++++++.++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEE
Confidence            999999999999999997532         23578889999999999999999    67899999999999999999999


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcC
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      |+|||+++...............+++.|+|||.    .++.++|||||||++|||++ |..||...........+..   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~---  236 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME---  236 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---
Confidence            999999886543322221222345788999994    36889999999999999999 7888865432222211111   


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                              ......      +..++..+.+++.+|++.+|++||++.|+++.|+
T Consensus       237 --------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 --------GGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --------CCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                    111000      0123456899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-40  Score=320.89  Aligned_cols=249  Identities=21%  Similarity=0.279  Sum_probs=198.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888899999999999999976 68999999997543   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999997654 4788899999999999999999    67899999999999999999999999999986533  


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                         ......||+.|+|||.+    ++.++|||||||++|||++|+.||...........+...     ...+........
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~  225 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-----KETLQRPVYDDP  225 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-----cccccCCCCCcc
Confidence               12345689999999944    678999999999999999999999764332221111110     000000000000


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                           .......+.+++.+|++.+|++||++.++++.
T Consensus       226 -----~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 -----RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -----ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                 01224568899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=305.95  Aligned_cols=247  Identities=28%  Similarity=0.382  Sum_probs=198.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      .+|+..+.||+|+||.||+|..+++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3577788999999999999998877889999986432 233568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +++|.+++......+++.....++.|++.|++|||    ..+++||||||+||++++++.+||+|||+++....... ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~  157 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS  157 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence            99999999876656899999999999999999999    67899999999999999999999999999986543211 11


Q ss_pred             eccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....++..|+|||.    .++.++||||||+++||+++ |+.||...........+...        .....       
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~-------  222 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG--------YRLYR-------  222 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC--------CcCCC-------
Confidence            122334568999994    36778999999999999999 89998754332222211111        00000       


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                        +..++..+.+++.+|+..+|++||++.|+++.|
T Consensus       223 --~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 --PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              011355789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=295.18  Aligned_cols=195  Identities=30%  Similarity=0.428  Sum_probs=174.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||.|+||.|..++.+ +|..+|+|++++..   .++.+...+|..+|+.+.||+++++++.|.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            57888899999999999999875 68899999998753   344556789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||++||.|+.++++.++ ++.....-+|.+|+.|++|||    +..|++|||||+|||+|.+|.+||+|||+|+..... 
T Consensus       124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999998754 788888889999999999999    778999999999999999999999999999987432 


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCC
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGE  377 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~  377 (457)
                          .-..+||+.|+|||.+    ++.++|.|||||++|||+.|.+||.....
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence                3358899999999966    56789999999999999999999987553

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-39  Score=317.62  Aligned_cols=254  Identities=25%  Similarity=0.410  Sum_probs=198.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeec-CCe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSN-LDF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~  243 (457)
                      ++|+..+.||+|+||.||+|...      +++.||+|+++... ......+.+|+.++.++ +|+||++++++|.. ...
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            57888899999999999999642      35789999987543 23345678899999999 89999999998865 456


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-----------------------------------------------------------  264 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  264 (457)
                      .++++||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999986421                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecccccccccc
Q 044428          265 -YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM  343 (457)
Q Consensus       265 -~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  343 (457)
                       ..+++..+.+++.||+.||.|||    ..+|+||||||+||++++++.+||+|||+++.+.............++..|+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             25789999999999999999999    6789999999999999999999999999998764433222223345677899


Q ss_pred             CCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCc-HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHH
Q 044428          344 APEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMS-LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRI  417 (457)
Q Consensus       344 aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~-l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l  417 (457)
                      |||.+    ++.++|||||||++|||++ |..||....... +.....            .......     +..+...+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~------------~~~~~~~-----~~~~~~~~  305 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK------------EGTRMRA-----PEYATPEI  305 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh------------ccCCCCC-----CccCCHHH
Confidence            99943    7889999999999999998 999986532111 111111            0000000     01224568


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          418 MNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       418 ~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      .+++.+|++.+|++||++.|+++.|+++.+
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-39  Score=307.40  Aligned_cols=253  Identities=27%  Similarity=0.505  Sum_probs=201.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DG---TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.+.... ......+..|++++++++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            357788899999999999999875 33   379999987553 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++++|.+++......+++.++..++.+++.|++|||    ..+++||||||+||++++++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999999876666899999999999999999999    67899999999999999999999999999987643


Q ss_pred             CCCcce-eccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          327 GDDSLI-QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       327 ~~~~~~-~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ...... ......+..|+|||.+    ++.++|||||||++||+++ |+.||...........+..            ..
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~------------~~  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND------------GF  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc------------CC
Confidence            222111 1122345679999943    5778999999999999998 9999965432221111111            00


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      .     .....+++..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 ~-----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 R-----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0     001112356689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.1e-40  Score=320.11  Aligned_cols=240  Identities=25%  Similarity=0.302  Sum_probs=193.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888899999999999999875 68999999987542   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            9999999999998754 4788888899999999999999    7789999999999999999999999999998764321


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                           ....||+.|+|||.+    .+.++|||||||++|||++|+.||...........+           ....+. ..
T Consensus       173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-----------~~~~~~-~p  235 (329)
T PTZ00263        173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-----------LAGRLK-FP  235 (329)
T ss_pred             -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH-----------hcCCcC-CC
Confidence                 235689999999944    577999999999999999999999654321111111           111110 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                      .      .....+.+++.+|++.||++||+     +.+++.
T Consensus       236 ~------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        236 N------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             C------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0      01335789999999999999997     566653

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-39  Score=321.21  Aligned_cols=244  Identities=26%  Similarity=0.348  Sum_probs=190.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34556679999999999999875 789999999865432 3345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++|+|.+..     ..++.....++.|++.||.|||    ..+|+||||||+|||+++++.+||+|||+++.+..... 
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            9999986532     2456778889999999999999    67899999999999999999999999999987643211 


Q ss_pred             ceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          331 LIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                       ......||..|+|||.+         .+.++|||||||++|||++|+.||......+.........        .....
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~  294 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--------MSQPP  294 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--------ccCCC
Confidence             12335789999999965         2348999999999999999999997433222222111110        00000


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .      ....+...+.+++.+||+.+|++||++.|+++.
T Consensus       295 ~------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 E------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0      011224568999999999999999999999864

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.1e-39  Score=309.94  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=200.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      +|...+.||+|+||.||+|+..      ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3667789999999999999853      235799998875432 334678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 044428          247 VLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPS  303 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~  303 (457)
                      |+||+++|+|.+++....                       ..+++...+.++.|++.||.|||    ..+++||||||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~  156 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAAR  156 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhh
Confidence            999999999999986421                       24788999999999999999999    678999999999


Q ss_pred             CeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCC
Q 044428          304 NILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEM  378 (457)
Q Consensus       304 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~  378 (457)
                      ||++++++.+||+|||+++...............++..|+|||..    ++.++||||||+++|||+| |..||......
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999999865433222222234457789999943    6788999999999999999 99998654433


Q ss_pred             cHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          379 SLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       379 ~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      .+..++....            ...     .+..++..+.+++.+|++.+|++||++.++++.|+++..
T Consensus       237 ~~~~~~~~~~------------~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 RLFNLLKTGY------------RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHHhCCC------------CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            3222222111            000     011224568899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-39  Score=311.58  Aligned_cols=262  Identities=22%  Similarity=0.257  Sum_probs=196.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....  ......+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888899999999999999985 68899999987542  2334567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++++.+..+.. ....+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            999877765543 3345889999999999999999999    67899999999999999999999999999987643221


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc---CchhHHhc--cccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL---PHKLAEVV--DSNL  400 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~---~~~~~~~~--d~~l  400 (457)
                      . ......|++.|+|||.    .++.++|||||||++|||++|+.||......+....+....   +.......  ++..
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 A-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             c-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            1 1223568999999993    36789999999999999999999997643222111111111   10000000  0000


Q ss_pred             c-----c--cccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 V-----R--REHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 ~-----~--~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .     .  ....  ..........+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0     0  0000  0001123456899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=317.90  Aligned_cols=244  Identities=29%  Similarity=0.377  Sum_probs=203.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ..|...+.||+|.||.||+|... .++.||+|++.... +....++++|+.++++++++||.+++|.+..+..+.++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35666789999999999999864 78999999998764 44567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      |.+|++.+.|..... +++....-|+.++..|+.|||    ..+.+|||||+.|||+..+|.+|++|||++..+..... 
T Consensus        93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-  166 (467)
T ss_pred             hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence            999999999987652 477777778999999999999    67799999999999999999999999999988754322 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......||+.|||||++    ++.|+||||+|++.+||++|.+|+.+...+.....+.+..+        |.+.+    
T Consensus       167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P--------P~L~~----  233 (467)
T KOG0201|consen  167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP--------PRLDG----  233 (467)
T ss_pred             -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC--------Ccccc----
Confidence             22558899999999966    77899999999999999999999987655332222222211        11211    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           .+...+.+++..|+..+|+.||++.++++
T Consensus       234 -----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  234 -----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                 23456899999999999999999999985

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.2e-39  Score=307.40  Aligned_cols=252  Identities=28%  Similarity=0.486  Sum_probs=201.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DG---TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|+..+.||+|+||.||+|... ++   ..||||.+.... ......|..|+.++++++||||+++.+++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35677789999999999999875 33   369999987542 34456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++......+++.++..++.|++.|+.|||    ..+++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999876666899999999999999999999    678999999999999999999999999998866432


Q ss_pred             CCcceecc-c--cccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          328 DDSLIQTK-T--MATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       328 ~~~~~~~~-~--~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ........ .  ..+..|+|||..    ++.++||||||+++||+++ |..||......+...++.....          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~----------  229 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR----------  229 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc----------
Confidence            22111111 1  124579999944    5778999999999999887 9999976543333333221100          


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                             ...+.+++..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 -------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   001123456688999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=311.06  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=196.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC---------------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD---------------GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILS  236 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  236 (457)
                      ++|+..+.||+|+||.||+++..+               ...||+|.++... ......|.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578888999999999999987532               2358999987643 233456899999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCe
Q 044428          237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-----------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI  305 (457)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NI  305 (457)
                      ++...+..++||||+++++|.+++....           ..+++..++.++.+++.|++|||    ..+++||||||+||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Ni  160 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRNC  160 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhhE
Confidence            9999999999999999999999996542           23688899999999999999999    67899999999999


Q ss_pred             eecCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc--CCCCCCCCCCCc
Q 044428          306 LLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS--RKKPTNDLGEMS  379 (457)
Q Consensus       306 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t--g~~p~~~~~~~~  379 (457)
                      ++++++.+||+|||++................++..|+|||.    .++.++|||||||+++||++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999986543322222223445778999994    36789999999999999998  667776543222


Q ss_pred             HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .............     .......     ...++..+.+++.+|++.+|++||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQG-----RQIYLSQ-----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhcc-----ccccCCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            2211111110000     0000000     0012456999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=290.55  Aligned_cols=257  Identities=22%  Similarity=0.251  Sum_probs=204.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Cee
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DFK  244 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  244 (457)
                      ..++|...+.+|+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++|||++++++++..+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34678889999999999999998 568899999999887777788899999999999999999999988544     358


Q ss_pred             EEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      |++++|...|+|.+.+...   +..+++.+.+.|+.+|++||++||..  .++++||||||.|||+.+.+.+++.|||.+
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~--~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK--EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc--CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            9999999999999988754   35689999999999999999999954  346999999999999999999999999998


Q ss_pred             cccCCCCCc-------ceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCC--CCcHHHHHH
Q 044428          322 KLLGEGDDS-------LIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLG--EMSLKHWVN  385 (457)
Q Consensus       322 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~--~~~l~~~~~  385 (457)
                      +...-.-..       .......+|..|+|||.+       .++++|||||||+||+|+.|..||+..-  +.++     
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-----  251 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-----  251 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-----
Confidence            865321110       011235589999999944       6889999999999999999999997521  1110     


Q ss_pred             hhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       386 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                            ..-+....+......     -.++.+.+++.+|+++||.+||++.+++..+..+
T Consensus       252 ------aLAv~n~q~s~P~~~-----~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  252 ------ALAVQNAQISIPNSS-----RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------EEeeeccccccCCCC-----CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                  011111111111100     1255789999999999999999999999998765

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=332.23  Aligned_cols=246  Identities=23%  Similarity=0.253  Sum_probs=196.7

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-C-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-D-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .|...+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3788889999999999999754 3 6789999876555555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          252 PNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       252 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ++|+|.+++...   ...+++.....++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988643   245788899999999999999999    6789999999999999999999999999998764432


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .........||++|+|||.+    ++.++|||||||++|||++|+.||......   .......        ....... 
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~--------~~~~~~~-  291 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVL--------YGKYDPF-  291 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH--------hCCCCCC-
Confidence            22223346699999999943    678999999999999999999999653321   1111111        0000000 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           +..+...+.+++.+|++.+|++||++.+++.
T Consensus       292 -----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 -----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                 0012345889999999999999999999874

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-39  Score=311.16  Aligned_cols=255  Identities=25%  Similarity=0.434  Sum_probs=202.1

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      ..++|+..+.||+|+||.||++...      +...+|+|.+.... ......+.+|++++.++ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3467888899999999999999864      23679999987542 33445688999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          243 FKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                      ..+++|||+++|+|.+++...               ...+++..+++++.|++.|+.|||    ..+|+||||||+||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil~  165 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEEE
Confidence            999999999999999999642               245889999999999999999999    6789999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHH
Q 044428          308 DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKH  382 (457)
Q Consensus       308 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~  382 (457)
                      ++++.+||+|||+++.+.............++..|+|||.    .++.++|||||||++||+++ |..||..........
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999999999987654332222223445678999994    36788999999999999998 999986543222211


Q ss_pred             HHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       383 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      ....            .....     .+..+...+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus       246 ~~~~------------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLKE------------GYRME-----KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHc------------CCcCC-----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1111            00000     01122456889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=315.30  Aligned_cols=232  Identities=25%  Similarity=0.264  Sum_probs=185.8

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999875 68899999987532   23345678899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccc
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT  336 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  336 (457)
                      .+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++......  ......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~  153 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF  153 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence            99998654 4889999999999999999999    7789999999999999999999999999998643221  122345


Q ss_pred             cccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHH
Q 044428          337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD  412 (457)
Q Consensus       337 ~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  412 (457)
                      .||+.|+|||.+    ++.++|||||||++|||++|+.||.....   ..........        ... .      +..
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~~~~~~~~--------~~~-~------~~~  215 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEMYRKILQE--------PLR-F------PDG  215 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHHHHHHHcC--------CCC-C------CCc
Confidence            689999999944    67899999999999999999999975332   2222211111        000 0      011


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHH
Q 044428          413 CLLRIMNLALDCCMESPDERIHTTN  437 (457)
Q Consensus       413 ~~~~l~~l~~~C~~~~P~~RPs~~e  437 (457)
                      ....+.+++.+|++.||++||++.+
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~  240 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNG  240 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCC
Confidence            2345789999999999999986433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-39  Score=304.44  Aligned_cols=250  Identities=28%  Similarity=0.492  Sum_probs=195.9

Q ss_pred             CCcCCccCCCCceEEEEEEeCC----CCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe-----
Q 044428          175 FDECNLLGIGSFGSVYKGTLSD----GTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF-----  243 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  243 (457)
                      |...+.||+|+||.||+|+...    +..||+|+++...  ......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    3679999987542  3345678999999999999999999998866544     


Q ss_pred             -eEEEEeccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEec
Q 044428          244 -KALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       244 -~~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                       .++|+||+++|+|.+++....     ..+++.....++.|++.||.|||    ..+++||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEECC
Confidence             789999999999999985432     35889999999999999999999    67899999999999999999999999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchh
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKL  392 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~  392 (457)
                      ||+++...............++..|+|||..    .+.++||||||+++|||++ |..||.........+++...     
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----  231 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-----  231 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----
Confidence            9999876443322222223456789999943    6789999999999999999 88898654432222222111     


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                            .....      +..++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       232 ------~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 ------NRLKQ------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------CCCCC------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  00000      112355789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.8e-39  Score=309.35  Aligned_cols=258  Identities=23%  Similarity=0.370  Sum_probs=201.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccce
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSD-----------------GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIK  233 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~  233 (457)
                      .++|+..+.||+|+||.||+++..+                 +..||+|.+.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578888999999999999997642                 2468999987654 334567899999999999999999


Q ss_pred             eeeeeecCCeeEEEEeccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 044428          234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHN----------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPS  303 (457)
Q Consensus       234 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~  303 (457)
                      +++++...+..++|+||+++++|.+++....          ..+++...+.++.|++.||.|||    ..+++||||||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATR  159 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchh
Confidence            9999999999999999999999999997654          25899999999999999999999    678999999999


Q ss_pred             CeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc--CCCCCCCCCC
Q 044428          304 NILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS--RKKPTNDLGE  377 (457)
Q Consensus       304 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t--g~~p~~~~~~  377 (457)
                      ||+++.++.++|+|||+++...............+++.|+|||.    .++.++||||||+++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999987644332222334556789999993    46789999999999999998  6778765433


Q ss_pred             CcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          378 MSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       378 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      ......+........     ......     .+..++.++.+++.+|++.+|++||++.||++.|.
T Consensus       240 ~~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRDDG-----RQIYLP-----RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhcccccc-----ccccCC-----CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            222222221111100     000000     01122456899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=333.73  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=203.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCC-CEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeee-eeec------CCe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDG-TNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILS-GCSN------LDF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~~  243 (457)
                      .++++.+.|.+|||+.||.|....+ ..+|+|++-...+.......+|+++|++|+ |+|||.+++ ....      ..+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3455667999999999999998765 999999998777777888999999999997 999999999 3221      247


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      .+|.||||++|.|-+++..+. ..+++.++++|+.++++|+++||.-  .++|||||||-+||||+.+++.||||||.+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            889999999999999998542 3499999999999999999999953  5789999999999999999999999999987


Q ss_pred             ccCCCCCcc-e------eccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc
Q 044428          323 LLGEGDDSL-I------QTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       323 ~~~~~~~~~-~------~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~  388 (457)
                      -........ .      .-....|+.|+|||++       +++|+||||+||+||-|+....||+..+...         
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------  265 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------  265 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence            532211110 0      0013479999999955       6899999999999999999999998754321         


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                            +++.     .+.+.........+.+||..|+++||.+||++-+|+..+.++...
T Consensus       266 ------Ilng-----~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  266 ------ILNG-----NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ------EEec-----cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                  1111     111111123466799999999999999999999999999887643

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.2e-39  Score=303.61  Aligned_cols=244  Identities=27%  Similarity=0.467  Sum_probs=193.1

Q ss_pred             ccCCCCceEEEEEEeC---CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          180 LLGIGSFGSVYKGTLS---DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .||+|+||.||+|.+.   ++..||+|++..... .....+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999764   456799999876543 234568999999999999999999998864 57899999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc-eec
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQT  334 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  334 (457)
                      |.+++......+++..+++++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++.......... ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999876667899999999999999999999    6789999999999999999999999999998654332211 112


Q ss_pred             cccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          335 KTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       335 ~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ...++..|+|||.    .++.++||||||+++||+++ |..||......+....+....+.            .     .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------~-----~  219 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL------------D-----C  219 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------------C-----C
Confidence            2334678999993    36779999999999999996 99999765433222222211100            0     0


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      +..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            112355688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-39  Score=310.40  Aligned_cols=250  Identities=23%  Similarity=0.404  Sum_probs=197.6

Q ss_pred             cCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      +|...+.||+|+||.||+|+..      ++..||+|+++..... ....+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4566678999999999999863      3578999999865433 34568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC
Q 044428          247 VLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM  311 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~  311 (457)
                      ++||+++++|.+++...               ...+++..+.+++.|++.||.|||    ..+++||||||+||++++++
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecCCC
Confidence            99999999999998532               134788889999999999999999    67899999999999999999


Q ss_pred             cEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHh
Q 044428          312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQ  386 (457)
Q Consensus       312 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~  386 (457)
                      .+||+|||+++...............+++.|+|||.    .++.++||||||+++|||++ |..||...........+..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999887644332222233456789999994    36779999999999999998 8888865432222221111


Q ss_pred             hcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          387 SLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       387 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                                 .....      .+.+++..+.+++.+|++.+|++||++.+|++.|+.
T Consensus       242 -----------~~~~~------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 -----------RQVLP------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------CCcCC------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                       11000      011345668999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-39  Score=318.07  Aligned_cols=262  Identities=23%  Similarity=0.285  Sum_probs=192.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----CeeE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DFKA  245 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  245 (457)
                      +|+..+.||+|+||.||+|+.. +|..||||++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4677789999999999999864 78999999987432  22345688999999999999999999987543     3579


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||++ ++|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 78999887654 4889999999999999999999    6789999999999999999999999999998653


Q ss_pred             CCCCc-ceeccccccccccCCCC------CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHH
Q 044428          326 EGDDS-LIQTKTMATIGYMAPEG------IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAE  394 (457)
Q Consensus       326 ~~~~~-~~~~~~~gt~~y~aPE~------~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~  394 (457)
                      ..... .......||+.|+|||.      .++.++|||||||++|||+||+.||...........+.......    ...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            22111 11234578999999993      35778999999999999999999997644322222221111110    000


Q ss_pred             hccc-------cccc-cccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          395 VVDS-------NLVR-REHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       395 ~~d~-------~l~~-~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      +...       .+.. ...... ........+.+++.+|++.+|++||++.|+++.
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000       0000 000000 000123457899999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.7e-39  Score=307.88  Aligned_cols=250  Identities=25%  Similarity=0.434  Sum_probs=199.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .+|...+.||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35666789999999999999642      466899999886665666789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          247 VLEFMPNGSLEKWLYSHN--------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      +|||+++|+|.+++....              ..+++..++.++.|++.|++|||    ..+++||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCCC
Confidence            999999999999997643              24789999999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||+++...............+++.|+|||.    .++.++|||||||++|||++ |+.||......+........
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG  240 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence            99999999986543222222223445788999993    36789999999999999998 89998654322221111110


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .           ...      .+..++..+.+++.+||+.+|++||++.||.+.|+
T Consensus       241 ~-----------~~~------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         241 R-----------ELE------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             c-----------cCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0           000      01123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-39  Score=309.35  Aligned_cols=260  Identities=24%  Similarity=0.347  Sum_probs=190.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC--CCCEEEEEEecccc--hhhHHHHHHHHHHHhhc---CCCccceeeeeee-----c
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS--DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV---RHRNLIKILSGCS-----N  240 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  240 (457)
                      ++|+..+.||+|+||.||+|+..  +|+.||+|+++...  ......+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999863  57889999987543  22234566777777766   6999999999885     3


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999996 69999997643 45889999999999999999999    6789999999999999999999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC----ch
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP----HK  391 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~----~~  391 (457)
                      +++.....   .......|++.|+|||.+    ++.++|||||||++|||++|+.||......+....+.....    ..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            99875432   122345689999999943    67899999999999999999999976543332222211110    00


Q ss_pred             hHHhc---cccccccc-cchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 LAEVV---DSNLVRRE-HSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ~~~~~---d~~l~~~~-~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +....   ...+.... .... ...+....+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            10000   00000000 0000 00122445789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.2e-39  Score=313.01  Aligned_cols=262  Identities=21%  Similarity=0.318  Sum_probs=195.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999975 789999999875432 223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++ ++|.+++......++...+..++.|++.||+|||    +.+|+||||||+||++++++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            995 7888888776666888999999999999999999    7789999999999999999999999999987543221 


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCch----hHH-----
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPHK----LAE-----  394 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~~----~~~-----  394 (457)
                       .......+++.|+|||.+     ++.++||||+||++|||++|+.||...... .....+.......    +..     
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             112335688999999943     466899999999999999999999764321 1111111100000    000     


Q ss_pred             hcccc-cccc-ccchh---HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VVDSN-LVRR-EHSFS---AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~d~~-l~~~-~~~~~---~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..++. .... .....   ........+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000 0000 00000   00011235779999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.5e-39  Score=304.43  Aligned_cols=252  Identities=28%  Similarity=0.486  Sum_probs=201.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+.||+|+||.||+|...    .+..+|+|.++... ......+.+|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56788899999999999999863    23479999987543 33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++......+++.+.+.++.|++.|+.|||    ..+++||||||+||+++.++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999999877666899999999999999999999    678999999999999999999999999999876443


Q ss_pred             CCcce-eccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          328 DDSLI-QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       328 ~~~~~-~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ..... .....++..|+|||.+    ++.++||||||+++||+++ |..||...........+.....          . 
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------~-  228 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----------L-  228 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----------C-
Confidence            22111 1123345689999943    6779999999999999887 9999876443322222221100          0 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                            .....++..+.+++.+|++.+|++||+|.++++.|.++
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  00112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-39  Score=314.42  Aligned_cols=237  Identities=22%  Similarity=0.281  Sum_probs=189.6

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      +.||+|+||.||+++.. +|..||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999864 78999999997542   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceec
Q 044428          255 SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT  334 (457)
Q Consensus       255 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  334 (457)
                      +|..++.... .+++.....++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  153 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence            9999987654 4889999999999999999999    6789999999999999999999999999987532211  1122


Q ss_pred             cccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHH
Q 044428          335 KTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK  410 (457)
Q Consensus       335 ~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  410 (457)
                      ...||+.|+|||.+    ++.++|||||||++|||++|+.||...........+.   ...      ..+.         
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~---~~~------~~~p---------  215 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL---MEE------IRFP---------  215 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCC------CCCC---------
Confidence            35689999999954    5789999999999999999999997543222111110   000      0000         


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          411 MDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       411 ~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      ......+.+++.+|++.+|++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            01234578999999999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-39  Score=310.79  Aligned_cols=256  Identities=23%  Similarity=0.407  Sum_probs=202.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  241 (457)
                      .++|...+.||+|+||.||+|+..        ++..||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467788899999999999999741        34579999987543 33456789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      ...++||||+++|+|.+++....               ..+++..+..++.|++.||.|||    ..+++||||||+||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nil  169 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARNVL  169 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccceEE
Confidence            99999999999999999997642               24788899999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLK  381 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~  381 (457)
                      +++++.+||+|||+++...............+++.|+|||..    ++.++||||||+++||+++ |..||.....   .
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~  246 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E  246 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---H
Confidence            999999999999999876443322222334567789999944    5778999999999999998 7888864332   2


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .+.......         ..     ...+..++..+.+++.+||+.+|++||++.|+++.|+++..-
T Consensus       247 ~~~~~~~~~---------~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 ELFKLLKEG---------HR-----MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHHHHcC---------Cc-----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            221111000         00     000112355688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.1e-39  Score=307.97  Aligned_cols=259  Identities=23%  Similarity=0.411  Sum_probs=198.3

Q ss_pred             CcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeEEE
Q 044428          176 DECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKALV  247 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  247 (457)
                      ...+.||+|+||.||++..     .++..||+|.+.... ......+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7778999999999988653     367899999987643 23456788999999999999999999988653  468899


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++....  +++.++..++.|++.|+.|||    ..+++||||||+||++++++.+||+|||+++.....
T Consensus        87 ~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999998754  899999999999999999999    678999999999999999999999999999876543


Q ss_pred             CCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC----chhHHhccc
Q 044428          328 DDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP----HKLAEVVDS  398 (457)
Q Consensus       328 ~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~----~~~~~~~d~  398 (457)
                      .... ......++..|+|||..    .+.++||||||+++|||+||..|+..... ...........    ....+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK-KFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc-hhhhhhcccccccchhhhhhhhhc
Confidence            2211 11223456779999943    67899999999999999999999865321 11111111100    011222222


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      .....     .+..++..+.+++.+|++.+|++||++.++++.|+++.
T Consensus       240 ~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GMRLP-----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCC-----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111     11233567999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-39  Score=318.01  Aligned_cols=241  Identities=23%  Similarity=0.289  Sum_probs=193.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCC--CCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSD--GTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|...+.||+|+||.||+|+..+  +..||+|++....   ......+.+|+.++..++||||+++++++...+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578888999999999999998642  3689999986542   2334568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+|||++.++++||+|||+++....
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999998764 4889999999999999999999    77899999999999999999999999999987533


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .     .....||+.|+|||.+    ++.++|||||||++|||++|+.||...........           +...... 
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-----------i~~~~~~-  246 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-----------ILEGIIY-  246 (340)
T ss_pred             C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-----------HhcCCCC-
Confidence            2     1235689999999944    67899999999999999999999975432211111           1111100 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      ...      .....+.+++.+|++.+|++|+     ++.++.+
T Consensus       247 ~p~------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        247 FPK------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCC------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            000      1133467999999999999995     7887764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.8e-40  Score=314.68  Aligned_cols=244  Identities=23%  Similarity=0.365  Sum_probs=193.6

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ..++|+.+..||+|+||.||.++- .+|..+|+|++++..   ..+......|-.+|....+|+||+++..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457899999999999999999975 479999999998764   3455668889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+|||++..+|...+ .|+......++.+.+.|++-+|    ..|+|||||||+|+|||..|++||+|||++.-+..
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999998876 4788888889999999999999    78899999999999999999999999999864321


Q ss_pred             C----------------------CCcc----ee-------------------ccccccccccCCCCC----CCCccchhh
Q 044428          327 G----------------------DDSL----IQ-------------------TKTMATIGYMAPEGI----VSTKCDVYS  357 (457)
Q Consensus       327 ~----------------------~~~~----~~-------------------~~~~gt~~y~aPE~~----~~~~~Dv~s  357 (457)
                      .                      +...    ..                   ...+|||-|+|||++    ++..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence            0                      0000    00                   024599999999966    677899999


Q ss_pred             hhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          358 YGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       358 ~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      +|||+|||+.|.+||.......  .|-         .++.-+..-   .+.....+..+..+++.+|+. ||++|..
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~--T~r---------kI~nwr~~l---~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQE--TYR---------KIVNWRETL---KFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHH--HHH---------HHHHHhhhc---cCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999998654322  111         111111000   011111224567899999998 9999987

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.6e-39  Score=308.37  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=199.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT--NVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|+..+.||+|+||.||+|... ++.  .+++|.++.. .......+.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46788889999999999999875 333  4788888743 233456789999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          248 LEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      +||+++|+|.+++....               ..+++.....++.|++.|++|||    ..+++||||||+||++++++.
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCe
Confidence            99999999999997532               24788999999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||++......   ........+..|+|||..    ++.++|||||||++|||++ |..||.............  
T Consensus       158 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~--  232 (297)
T cd05089         158 SKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP--  232 (297)
T ss_pred             EEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh--
Confidence            999999998643211   111112335679999943    5779999999999999998 999996543222111111  


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                                ......     .+..++..+.+++.+|++.+|.+||++.++++.|+++.+.+...
T Consensus       233 ----------~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~  282 (297)
T cd05089         233 ----------QGYRME-----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY  282 (297)
T ss_pred             ----------cCCCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence                      000000     01122456889999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-40  Score=323.77  Aligned_cols=240  Identities=24%  Similarity=0.294  Sum_probs=198.5

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCee
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  244 (457)
                      ...++|...++||+|.||+|+++..+ +++.+|||++++..   ..+.+....|.+++... +||.++.++..|...+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34568999999999999999999875 68899999998763   45566788888888877 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+.||++..+.+.  ..++.....-++..|+.||+|||    .++||+||||.+|||||.+|++||+|||+++..
T Consensus       445 ~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999995544443  34899999999999999999999    788999999999999999999999999999964


Q ss_pred             CCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      -..  ....+..+||+.|+|||.+    |+..+|.|||||+||||+.|..||...++.               +++|..+
T Consensus       519 m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------e~FdsI~  581 (694)
T KOG0694|consen  519 MGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------EVFDSIV  581 (694)
T ss_pred             CCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHh
Confidence            321  1234568999999999944    889999999999999999999999865542               3333333


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                      ..+..   .+..+..+...++.+.+..+|++|..+
T Consensus       582 ~d~~~---yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 NDEVR---YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cCCCC---CCCcccHHHHHHHHHHhccCcccccCC
Confidence            22211   122346678999999999999999987

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.5e-39  Score=303.83  Aligned_cols=247  Identities=23%  Similarity=0.372  Sum_probs=188.6

Q ss_pred             ccCCCCceEEEEEEeCC---CCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          180 LLGIGSFGSVYKGTLSD---GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            68999999999998643   45799998875432 234578899999999999999999999999999999999999999


Q ss_pred             HHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          256 LEKWLYSHN----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       256 L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      |.+++....    ...++..+..++.|++.|++|||    ..+++|+||||+||+++.++++||+|||.++.........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999997542    24567788899999999999999    6789999999999999999999999999997653322222


Q ss_pred             eeccccccccccCCCCC-----------CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          332 IQTKTMATIGYMAPEGI-----------VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~-----------~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ......++..|+|||.+           .+.++||||||+++|||++ |+.||..............   .......++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~  234 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR---EQQLKLPKPR  234 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---cccCCCCCCc
Confidence            22335578889999954           3678999999999999996 9999976433222111110   0001111111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      +..         .....+.+++..|+ .+|++|||+.||++.|+
T Consensus       235 ~~~---------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LKL---------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCC---------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            110         11334778999998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.1e-39  Score=314.54  Aligned_cols=238  Identities=22%  Similarity=0.294  Sum_probs=190.6

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      +.||+|+||.||+++.. +|+.||+|++....   ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999864 78999999997542   234457888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceec
Q 044428          255 SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT  334 (457)
Q Consensus       255 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  334 (457)
                      +|.+++.... .+++.+...++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  153 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK  153 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence            9999987654 4889999999999999999999    7789999999999999999999999999987542211  1123


Q ss_pred             cccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHH
Q 044428          335 KTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK  410 (457)
Q Consensus       335 ~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  410 (457)
                      ...||+.|+|||.+    ++.++|||||||++|||++|+.||.......   .........      ..+.         
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~~~~~------~~~p---------  215 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILMED------IKFP---------  215 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHhccCC------ccCC---------
Confidence            35689999999954    5789999999999999999999997543221   111111000      0010         


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 044428          411 MDCLLRIMNLALDCCMESPDERI-----HTTNAAAK  441 (457)
Q Consensus       411 ~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~~  441 (457)
                      ......+.+++.+|++.+|++||     ++.|+++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            01234578999999999999997     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.2e-39  Score=313.08  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=197.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+..+.||+|+||.||++... +|..+|+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368899999999999999999876 68899999887643 2334578999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++.... .+++.....++.+++.||.|||+   ..+++||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999998654 47888899999999999999994   236999999999999999999999999998765322  


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch--------------
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK--------------  391 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~--------------  391 (457)
                        ......|+..|+|||.+    ++.++|||||||++||+++|+.||.......+...........              
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence              12235689999999954    6778999999999999999999997543322222111000000              


Q ss_pred             ---------------hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 ---------------LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ---------------~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                     .....+........... ......++.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                           00000000000000000 0001345789999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.8e-39  Score=310.21  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=201.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  241 (457)
                      .++|...+.||+|+||.||+++..        ++..+|+|.+.... ......+.+|++++.++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357888899999999999999752        23579999997542 33455688899999999 799999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      +..++||||+++|+|.+++....               ..+++.++++++.|++.||+|||    ..+++||||||+||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil  172 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL  172 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheE
Confidence            99999999999999999997642               24789999999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLK  381 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~  381 (457)
                      +++++.+||+|||.++...............+++.|+|||..    ++.++|||||||++|||++ |+.||.....   .
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~  249 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E  249 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---H
Confidence            999999999999998865432221112223345789999933    6789999999999999998 8888864322   1


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      +....         +......     ..+..++..+.+++.+|+..+|++||++.+|++.|.++.+.-
T Consensus       250 ~~~~~---------~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         250 ELFKL---------LKEGHRM-----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHH---------HHcCCCC-----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            11111         1000000     001123456889999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-38  Score=303.10  Aligned_cols=249  Identities=27%  Similarity=0.478  Sum_probs=192.0

Q ss_pred             CcCCccCCCCceEEEEEEeCC-CC--EEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------Cee
Q 044428          176 DECNLLGIGSFGSVYKGTLSD-GT--NVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------DFK  244 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  244 (457)
                      ...+.||+|+||.||+|+..+ +.  .+|+|.++...  ......+.+|+++++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            445789999999999998754 33  58999887542  34456789999999999999999999987432      246


Q ss_pred             EEEEeccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          245 ALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                      ++++||+++|+|.+++...     ...+++.....++.|++.||+|||    ..+|+||||||+||++++++.+||+|||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEECCCC
Confidence            8999999999999987432     244789999999999999999999    6789999999999999999999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      +++...............+++.|+|||..    ++.++||||||+++||+++ |+.||...........+...       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-------  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-------  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-------
Confidence            99876443221112223467789999944    6789999999999999999 78898654322222211110       


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                          .....      ...++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       231 ----~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 ----NRLKQ------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ----CCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                00000      112345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-38  Score=300.16  Aligned_cols=244  Identities=25%  Similarity=0.330  Sum_probs=197.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|++|.||+|+.. +|+.|++|.+...  .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677789999999999999875 7899999998643  234456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++++|.+++... ...+++.....++.+++.||.|||    ..+++|+||+|+||+++.++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999999875 356889999999999999999999    67899999999999999999999999999987644321


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        ......+++.|+|||..    .+.++||||||++++||++|+.||...........+.....        +.+.    
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~----  222 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF--------PPVS----  222 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------CCCc----
Confidence              12234688899999943    57799999999999999999999976442221111111000        0000    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           ...+..+.+++.+|++.+|++||++.++++
T Consensus       223 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         223 -----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             -----cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                 022456899999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-38  Score=300.61  Aligned_cols=242  Identities=26%  Similarity=0.433  Sum_probs=191.9

Q ss_pred             ccCCCCceEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCC
Q 044428          180 LLGIGSFGSVYKGTL---SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      .||+|+||.||+|.+   .++..+|+|+++...  ......+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975   367899999987543  233567899999999999999999999885 45678999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc-ee
Q 044428          255 SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQ  333 (457)
Q Consensus       255 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~  333 (457)
                      +|.+++.... .+++.....++.|++.|+.|||    ..+++||||||+||++++++.+||+|||+++.+....... ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999997654 4889999999999999999999    6789999999999999999999999999998764432211 11


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchh
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS  408 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~  408 (457)
                      ....++..|+|||..    .+.++||||||+++|||++ |+.||...........+.....        ...        
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--------~~~--------  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--------MEC--------  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--------CCC--------
Confidence            223446789999943    5679999999999999998 9999976543332222221100        000        


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          409 AKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       409 ~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                       +..++..+.+++.+|++.+|++||++.+|++.|++
T Consensus       220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             11234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-38  Score=301.22  Aligned_cols=248  Identities=26%  Similarity=0.465  Sum_probs=198.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|+..+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46788889999999999999988888999999875432 3456899999999999999999999875 456789999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          253 NGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       253 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +++|.+++.... ..+++..+..++.+++.||.|||    ..+++||||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            999999997643 45899999999999999999999    677999999999999999999999999999876432211 


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......++..|+|||..    .+.++||||||+++||+++ |..||......+.........+            .    
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------~----  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR------------M----  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------C----
Confidence            11223456789999943    6779999999999999999 8899875433222222111100            0    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                       ..+.+.+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0011234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-38  Score=301.46  Aligned_cols=254  Identities=22%  Similarity=0.322  Sum_probs=201.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+....   ......+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47888899999999999999864 78999999876422   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||+++|+|.+++...   ...++......++.+++.||.|||    ..+++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999999988642   244788899999999999999999    6789999999999999999999999999988764


Q ss_pred             CCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ....  ......+++.|+|||..    .+.++||||||+++|||++|+.||..... +...+.....     ....+.. 
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~-----~~~~~~~-  228 (267)
T cd08228         158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIE-----QCDYPPL-  228 (267)
T ss_pred             chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHh-----cCCCCCC-
Confidence            3221  12235688899999943    56789999999999999999999864321 1122211110     0000100 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                             .....+..+.+++.+||+.+|++||++.+|++.++.++
T Consensus       229 -------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 -------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                   01123456899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-39  Score=322.66  Aligned_cols=250  Identities=20%  Similarity=0.306  Sum_probs=196.8

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ..++|+..+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4568899999999999999999875 68899999996532   2233457889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++....  ++......++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999997654  778888889999999999999    67899999999999999999999999999987643


Q ss_pred             CCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ... .......||+.|+|||.+        ++.++|||||||++|||++|+.||.........   .        .+.+.
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~--------~i~~~  262 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---S--------KIMDH  262 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH---H--------HHHcC
Confidence            221 112345799999999943        567899999999999999999999764321111   1        11110


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDE--RIHTTNAAAK  441 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPs~~ev~~~  441 (457)
                      .-.   ............+.+++.+|++.+|++  ||++.|+++.
T Consensus       263 ~~~---~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 KNS---LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCc---CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            000   000000112446789999999999988  9999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.2e-39  Score=307.61  Aligned_cols=257  Identities=24%  Similarity=0.383  Sum_probs=196.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-----------------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcccee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-----------------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI  234 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  234 (457)
                      ++|+..+.||+|+||.||++...                 ++..+|+|++.... ......+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888899999999999998532                 24469999987553 3345678999999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCC
Q 044428          235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHN----------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSN  304 (457)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~N  304 (457)
                      ++++...+..++||||+++|+|.+++....          ..+++.....++.|++.|++|||    ..+++||||||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~N  160 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhe
Confidence            999999999999999999999999997643          23677889999999999999999    6789999999999


Q ss_pred             eeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc--CCCCCCCCCCC
Q 044428          305 ILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS--RKKPTNDLGEM  378 (457)
Q Consensus       305 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t--g~~p~~~~~~~  378 (457)
                      |+++.++.++|+|||+++.+.............+++.|+|||    ..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999998664332221122234467899999    346889999999999999998  77888653322


Q ss_pred             cHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          379 SLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       379 ~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .......        +.+........  ...+..++..+.+++.+|++.+|++||++.+|++.|+
T Consensus       241 ~~~~~~~--------~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTG--------EFFRDQGRQVY--LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHH--------HHHhhcccccc--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2111111        11100000000  0001123567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.9e-39  Score=305.04  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=197.9

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF  243 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  243 (457)
                      .+++|...+.||+|++|.||+|.+.      .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567888999999999999999875      35679999886543 3334578999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC---cEE
Q 044428          244 KALVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM---VAH  314 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~---~~k  314 (457)
                      .++||||+++++|.+++....      ..+++..+++++.||+.|++|||    ..+++||||||+||+++.++   .+|
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceE
Confidence            999999999999999997653      25899999999999999999999    67899999999999998654   699


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcC
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      |+|||+++................+..|+|||.    .++.++|||||||++|||++ |+.||...........+...  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~--  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG--  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence            999999987633222111122334568999994    37889999999999999997 99998754332222211110  


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                                .....     +..++..+.+++.+|++.+|++||++.+|++.|.
T Consensus       238 ----------~~~~~-----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 ----------GRLDP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ----------CcCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                      00000     1122456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-38  Score=297.57  Aligned_cols=243  Identities=30%  Similarity=0.473  Sum_probs=194.6

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHH
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLE  257 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  257 (457)
                      ++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            37999999999999988899999999876542 23446889999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecccc
Q 044428          258 KWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM  337 (457)
Q Consensus       258 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  337 (457)
                      +++......+++..+..++.+++.||.|+|    ..+++||||||+||++++++.+||+|||++........ .......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~  155 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ  155 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence            999876666899999999999999999999    67899999999999999999999999999876432211 1111234


Q ss_pred             ccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHH
Q 044428          338 ATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD  412 (457)
Q Consensus       338 gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  412 (457)
                      ++..|+|||..    .+.++||||||+++||+++ |..||...........+....        ....         +..
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~---------~~~  218 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------RMSC---------PQK  218 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--------CCCC---------CCC
Confidence            46789999943    6778999999999999999 999986543222111111100        0000         012


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          413 CLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       413 ~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      ++..+.+++.+|++.+|++||++.|+.+.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2456899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=325.76  Aligned_cols=251  Identities=24%  Similarity=0.444  Sum_probs=212.5

Q ss_pred             CcCCccCCCCceEEEEEEe-CCC----CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          176 DECNLLGIGSFGSVYKGTL-SDG----TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~-~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ...++||+|+||+||+|.+ .+|    -+||+|++.... .+...++..|+-+|++++|||+++++|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4456899999999999975 444    468999987553 445678999999999999999999999998776 889999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |||.|+|.++++.++..+.....+.+..|||+||.|||    ..++|||||-++|||+..-..+||.|||+++.+...+.
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999998888999999999999999999999    67899999999999999999999999999999987666


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ........-.+.|||-|.+    ++.++|||||||++||++| |..|++...-.+            +.+.+     +..
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------I~dll-----e~g  916 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------IPDLL-----EKG  916 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------hhHHH-----hcc
Confidence            5555556667889999933    8899999999999999999 999987644222            22222     223


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .+.+++..|...+..++.+||..|+..||+++++...+.++...
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            34566778899999999999999999999999999999887544

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=317.14  Aligned_cols=251  Identities=26%  Similarity=0.437  Sum_probs=211.0

Q ss_pred             CCcCCccCCCCceEEEEEEeC---CC--CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          175 FDECNLLGIGSFGSVYKGTLS---DG--TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~---~g--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ....++||+|.||.||+|...   .|  -.||||..+.+. ....+.|..|..+|++++||||++++|.|.+. ..++||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            344578999999999999863   23  358999888753 34466799999999999999999999999865 578999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |.++-|.|..+|+.++..++......++.||+.||+|||    +..+|||||..+|||+....-+||+|||+++.+....
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999999999988999999999999999999999    7779999999999999999999999999999986544


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .... +...-.+.|||||.+    ++.++|||-|||.+||+++ |..||......               |++-.  .+.
T Consensus       546 yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DVI~~--iEn  607 (974)
T KOG4257|consen  546 YYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DVIGH--IEN  607 (974)
T ss_pred             hhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ceEEE--ecC
Confidence            3332 345567889999944    7999999999999999998 99999763321               22211  223


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      ..+...+..|+..+..++.+||..+|.+||++.++...|.++.++
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            344556778999999999999999999999999999999999874

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.2e-39  Score=318.89  Aligned_cols=256  Identities=21%  Similarity=0.345  Sum_probs=199.4

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLD  242 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  242 (457)
                      ..++|...+.||+|+||.||+|++.      .+..||||+++... ......+.+|++++.++. ||||++++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456778889999999999999863      34689999997543 223456889999999997 999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  264 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  264 (457)
                      ..++|+||+++|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999997532                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCe
Q 044428          265 ---------------------------------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI  305 (457)
Q Consensus       265 ---------------------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NI  305 (457)
                                                             ..+++....+++.|++.||.|||    ..+++||||||+||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp~Ni  270 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAARNV  270 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCcceE
Confidence                                                   13567788899999999999999    67899999999999


Q ss_pred             eecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcH
Q 044428          306 LLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSL  380 (457)
Q Consensus       306 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l  380 (457)
                      |+++++.+||+|||+++...............++..|+|||.+    ++.++|||||||++|||++ |..||........
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            9999999999999999865432221122234567889999944    5778999999999999998 8889865332111


Q ss_pred             HHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          381 KHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       381 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      .           .+.+.......     .+..+...+.+++.+||..+|++||++.||++.|+++.
T Consensus       351 ~-----------~~~~~~~~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 F-----------YNAIKRGYRMA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H-----------HHHHHcCCCCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0           11111110000     01122456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-39  Score=318.52  Aligned_cols=248  Identities=21%  Similarity=0.302  Sum_probs=196.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+++.. +|+.||+|+++...   ......+.+|+.+++.++||||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888899999999999999865 78999999997643   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++......+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999999887556899999999999999999999    7789999999999999999999999999998764332


Q ss_pred             CcceeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      .. ......||+.|+|||.+          ++.++|||||||++|||++|+.||.......   ........       .
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~~-------~  225 (330)
T cd05601         157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TYNNIMNF-------Q  225 (330)
T ss_pred             ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HHHHHHcC-------C
Confidence            21 22335689999999954          3578999999999999999999997543211   11111100       0


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ......    ........+.+++..|++ +|++||++.++++
T Consensus       226 ~~~~~~----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         226 RFLKFP----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CccCCC----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            000000    000123457889999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=303.51  Aligned_cols=255  Identities=24%  Similarity=0.438  Sum_probs=203.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC----EEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT----NVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .+|...+.||+|+||.||+|... +|.    .+|+|.+..... .....+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56778889999999999999864 333    589998875543 345678899999999999999999999987 78899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++......+++...+.++.|++.|++|||    ..+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999887666899999999999999999999    67899999999999999999999999999987654


Q ss_pred             CCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........++..|+|||.    .++.++||||||+++||+++ |+.||......++...+...           ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----------~~~  230 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-----------ERL  230 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-----------CCC
Confidence            333222222334678999994    36778999999999999999 99998764332222222110           000


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ..      +..+...+.+++.+||..+|.+||++.++++.|.++.+.+
T Consensus       231 ~~------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         231 PQ------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            00      1112345889999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-39  Score=307.06  Aligned_cols=264  Identities=25%  Similarity=0.409  Sum_probs=203.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-----CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeec--CCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-----DGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  244 (457)
                      .+|...+.||+|+||.||+|++.     ++..+|||++...... ....|.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35666789999999999999863     4688999999865443 46689999999999999999999999877  5678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||    ..+++|+||||+||+++.++.++|+|||.+...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            9999999999999999887666999999999999999999999    678999999999999999999999999999877


Q ss_pred             CCCCCcc-eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc----CchhHHh
Q 044428          325 GEGDDSL-IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL----PHKLAEV  395 (457)
Q Consensus       325 ~~~~~~~-~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~----~~~~~~~  395 (457)
                      ....... ......++..|+|||.    ..+.++||||||++++||+||+.|+....... ..++....    ...+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-LRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh-ccccccccccccHHHHHHH
Confidence            5322221 1112345667999993    36778999999999999999999986522111 00000000    0011111


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      +.....     ...+..++.++.+++.+|++.+|++||+|.||+++|++|+
T Consensus       239 ~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         239 LKEGER-----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHcCCc-----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            111111     1112234567999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.4e-39  Score=330.69  Aligned_cols=252  Identities=25%  Similarity=0.331  Sum_probs=198.2

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC---
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD---  242 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  242 (457)
                      ....++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+..+..++|+||+++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457899999999999999999985 479999999987542  334556889999999999999999887664332   


Q ss_pred             -----eeEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEE
Q 044428          243 -----FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH  314 (457)
Q Consensus       243 -----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~k  314 (457)
                           ..++||||+++|+|.+++....   ..+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCCCEE
Confidence                 3689999999999999997532   45888999999999999999999    78899999999999999999999


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH  390 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~  390 (457)
                      |+|||+++.+.............||+.|+|||.+    ++.++|||||||++|||++|+.||....   ....+......
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~~~~  260 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKTLAG  260 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHhcC
Confidence            9999999876433222223346799999999944    6789999999999999999999997532   22222211110


Q ss_pred             hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       391 ~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .    .++ +         +..++..+.+++.+|++.+|.+||++.++++.
T Consensus       261 ~----~~~-~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 R----YDP-L---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C----CCC-C---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            0    000 0         11224568899999999999999999999763

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-38  Score=300.59  Aligned_cols=250  Identities=26%  Similarity=0.445  Sum_probs=198.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|...++||+|+||.||+|+..++..||+|.+.... .....+.+|++++++++||||+++++++.. +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            35688889999999999999998777789999987532 234578999999999999999999998754 5679999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++|+|.+++.... ..+++..+..++.+++.||+|||    ..+++||||||+||++++++.+||+|||.++.+......
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999998643 45789999999999999999999    678999999999999999999999999999876433221


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                       ......++..|+|||..    ++.++||||||+++||++| |+.||............            .....    
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~------------~~~~~----  221 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYR----  221 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH------------hcCCC----
Confidence             12234467789999943    5779999999999999999 88888654321111110            00000    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                       .....+++..+.+++.+|++.+|++||++.++.+.|++.
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             000123456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.7e-39  Score=304.18  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            5788899999999999999986 478899999997654445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++.... .+++..+..++.|++.|+.|||    ..+|+||||+|+||+++.++.+||+|||+++.......  
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--  161 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence            9999999997654 4789999999999999999999    67899999999999999999999999999986632211  


Q ss_pred             eeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          332 IQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ......++..|+|||.+       .+.++|||||||++|||++|+.||.............   ..   ....+....  
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~---~~---~~~~~~~~~--  233 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS---KS---NFQPPKLKD--  233 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee---cC---CCCCCCCcc--
Confidence            11234688899999954       4568999999999999999999986432111000000   00   000000000  


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                           ....+..+.+++.+|++.+|++||++.++++.|
T Consensus       234 -----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 -----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                 011245688999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=298.76  Aligned_cols=244  Identities=30%  Similarity=0.511  Sum_probs=199.6

Q ss_pred             CccCCCCceEEEEEEeCC----CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLSD----GTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|...+    +..|++|.+...... ....+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            379999999999998753    888999999865433 366789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          254 GSLEKWLYSH--------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       254 g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ++|.+++...        ...+++..+..++.+++.|++|||    ..+++||||+|+||++++++.+||+|||.+....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999876        356899999999999999999999    7889999999999999999999999999998875


Q ss_pred             CCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ............++..|+|||.    ..+.++||||+|++++||++ |..||.......+...+..           ...
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----------~~~  225 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----------GYR  225 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------CCC
Confidence            5432222334567889999993    36789999999999999999 6999976533222222111           000


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .      ..+..++..+.+++.+|++.+|++||++.|+++.|+
T Consensus       226 ~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 L------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0      011122556899999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-38  Score=302.44  Aligned_cols=252  Identities=27%  Similarity=0.362  Sum_probs=199.2

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++.+++++.....||+|+||.||+|+.. ++..||+|.+..........+.+|+.++++++|+||+++++++...+..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3455667777789999999999999864 678899999876655566789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLYSHNYFL--DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~  323 (457)
                      |+||+++++|.+++......+  ++..+..++.|++.|+.|||    ..+|+||||||+||+++. ++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999998754334  78888999999999999999    678999999999999986 67999999999876


Q ss_pred             cCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      ......  ......++..|+|||.+      .+.++||||||+++|||++|+.||..........+.....     . ..
T Consensus       159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-----~-~~  230 (268)
T cd06624         159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-----K-IH  230 (268)
T ss_pred             cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-----c-cC
Confidence            543221  12234578999999943      5678999999999999999999986533211111111000     0 00


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +.+         +..+...+.+++.+|++.+|++||++.|+++
T Consensus       231 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 PEI---------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCC---------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            001         1122456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-38  Score=310.92  Aligned_cols=237  Identities=23%  Similarity=0.338  Sum_probs=188.0

Q ss_pred             CccCCCCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          179 NLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +.||+|+||.||+++.    .+++.||+|++....    ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    367899999987532    22334578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++|+|.+++.... .+.+.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            99999999997654 4778888889999999999999    67899999999999999999999999999875422211 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......||+.|+|||.+    .+.++|||||||++|||++|+.||......   .....        +......-    
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~--------~~~~~~~~----  219 (323)
T cd05584         156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDK--------ILKGKLNL----  219 (323)
T ss_pred             -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHH--------HHcCCCCC----
Confidence             12335689999999954    567899999999999999999999754321   11111        11111100    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                         +......+.+++.+|++.+|++||     ++.++.+
T Consensus       220 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 ---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               001234578999999999999999     7777755

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-38  Score=306.33  Aligned_cols=254  Identities=23%  Similarity=0.380  Sum_probs=199.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  243 (457)
                      .++|...+.||+|+||.||+++..      .+..||||.++... ......+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357888999999999999999741      35579999987543 23345789999999999 79999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      .++||||+++|+|.+++.... ..+++.++..++.+++.||.|||    ..+++|+||||+||+++.++.++++|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999998654 34899999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      ...............++..|+|||.+    .+.++|||||||++||+++ |+.||........           ....++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-----------~~~~~~  258 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-----------FYKLIK  258 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-----------HHHHHH
Confidence            66433222122234467889999944    5778999999999999998 9999865432110           011111


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      .......     +...+..+.+++.+|++.+|++||++.|+++.|.++
T Consensus       259 ~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 EGYRMAQ-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCcCCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1110000     001134688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=303.56  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=200.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .++|...+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888899999999999999864      24689999987543 23345788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEE
Q 044428          245 ALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV  315 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl  315 (457)
                      ++||||+++|+|.+++....         ..+++..++.++.|++.||.|||    ..+++||||||+||+++.++.+||
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEEE
Confidence            99999999999999997532         23688899999999999999999    678999999999999999999999


Q ss_pred             eccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCc
Q 044428          316 SDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPH  390 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~  390 (457)
                      +|||+++...............++..|+|||.    ..+.++|||||||++||++| |+.||..........+...    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----  236 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID----  236 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc----
Confidence            99999987644332222233456789999993    46789999999999999998 9999865443322222211    


Q ss_pred             hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       391 ~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                             ......      +..++..+.+++.+|++.+|++|||+.++++.|+
T Consensus       237 -------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 -------GGHLDL------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -------CCCCCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                   000000      1112456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-38  Score=304.75  Aligned_cols=254  Identities=24%  Similarity=0.410  Sum_probs=198.2

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF  243 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  243 (457)
                      ..++|+..+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578899999999999999999753      24589999886443 2234468889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEE
Q 044428          244 KALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH  314 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~k  314 (457)
                      .++||||+++|+|.+++....         ...++.....++.|++.||.|||    .++++||||||+||++++++.+|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcEE
Confidence            999999999999999997532         23466788899999999999999    77899999999999999999999


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcC
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      |+|||+++...............++..|+|||.    .++.++|||||||++|||++ |..||......+....+     
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~-----  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-----  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence            999999986543222221222345678999994    36789999999999999998 78888653322221111     


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                            .+......      +..++..+.+++.+|++.+|++||++.++++.|.+.
T Consensus       235 ------~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 ------MDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ------HcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                  11111100      012245689999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-40  Score=303.46  Aligned_cols=256  Identities=26%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----eeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-----FKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  246 (457)
                      -.|...+++|.|+||.||+|... ++..||||....+..    --.+|+++|+.++|||||+++-+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35667789999999999999875 579999998764432    1257999999999999999998875432     3458


Q ss_pred             EEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEecccccc
Q 044428          247 VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGISK  322 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~~  322 (457)
                      ||||||. +|.+.++.   .+..++...+.-+..|+.+||.|||    ..+|+||||||.|+|+|.+ |.+||||||.|+
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            9999974 88888874   2344777777889999999999999    6889999999999999966 899999999999


Q ss_pred             ccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-hHH--
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-LAE--  394 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-~~~--  394 (457)
                      .+..++..   .....|..|+|||.+     ++.+.||||.|||+.||+-|++-|...+..+....+-..+... -.+  
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            98766543   235678999999955     6789999999999999999999998755544443333332221 111  


Q ss_pred             --------hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 --------VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 --------~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              .-.+.+.......--......+..+++.++++.+|.+|.++.|+++
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                    1112222111100001123556899999999999999999999874

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-38  Score=303.77  Aligned_cols=262  Identities=22%  Similarity=0.395  Sum_probs=198.2

Q ss_pred             cCCcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeE
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKA  245 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  245 (457)
                      -|...+.||+|+||.||+++.     .++..||+|.++... ......+.+|+++++.++||||+++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            457778999999999999974     357889999987543 33346789999999999999999999988775  5688


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++++|.+++.+....+++..++.++.+++.||+|||    ..+++||||||+||+++.++.+||+|||+++.+.
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            999999999999999876556899999999999999999999    7889999999999999999999999999998764


Q ss_pred             CCCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHHhc
Q 044428          326 EGDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAEVV  396 (457)
Q Consensus       326 ~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~~~  396 (457)
                      ...... ......++..|+|||..    ++.++||||||+++||++|++.|...... ...........+    ...+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT-LFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc-hhhhhcccccccccHHHHHHHH
Confidence            432211 12234567789999943    67799999999999999998876532110 000000000000    000111


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      .....     ...+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       240 ~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKR-----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCcc-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            10000     001112356799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-39  Score=294.05  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=203.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhh--HHHHHHHHHHHhhcCCCccceeeeeeec--CCeeE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERT--FVSFNSECEVLRNVRHRNLIKILSGCSN--LDFKA  245 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  245 (457)
                      ..++|+..+.|++|.||.||+|+.+ +++.||+|+++...++.  --.-.+||.+|.+++|||||.+..+...  -+..|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            4567888899999999999999875 78999999998654322  2346799999999999999999887654  45799


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +|||||+ -+|..+++....++...+...+..|+++|++|||    ...|+|||||++|+|++..|.+||+|||+|+.++
T Consensus       154 ~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999995 5999999988877889999999999999999999    5669999999999999999999999999999986


Q ss_pred             CCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVV  396 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~  396 (457)
                      +.-  ...+..+-|..|.|||.+     +++..|+||+|||+.|++++++-|....+.+..+.+-+.+...    +..+.
T Consensus       229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            542  234567789999999944     7888999999999999999999998776665555443322211    11111


Q ss_pred             cc------ccccc-ccchhHHHH---HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DS------NLVRR-EHSFSAKMD---CLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~------~l~~~-~~~~~~~~~---~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..      .+... +......-.   ....-+++....+..||.+|.|+.|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            10      00000 000000000   1245688999999999999999999864

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.9e-39  Score=308.80  Aligned_cols=256  Identities=26%  Similarity=0.451  Sum_probs=201.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC----EEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT----NVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|+..+.||+|+||.||+|... +|.    .||+|.+..... .....+.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56778889999999999999863 444    478998875432 2334688999999999999999999998754 4679


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ++||+++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999999877666899999999999999999999    67899999999999999999999999999987643


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........++..|+|||.+    .+.++||||||+++||+++ |+.||..........++....          ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------~~~  231 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE----------RLP  231 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC----------CCC
Confidence            3222222234457789999944    5778999999999999998 899986543323333322110          000


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      .       +..++..+.+++.+||..+|++||++.++++.|+++.....
T Consensus       232 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         232 Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            0       01124568899999999999999999999999998865543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-38  Score=309.07  Aligned_cols=261  Identities=19%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888899999999999999875 68899999987543 22334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++ ++|.+++......+++.....++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            97 5898888776666889999999999999999999    67899999999999999999999999999976533221 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhc-----
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVV-----  396 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~-----  396 (457)
                       ......+++.|+|||.+     ++.++|||||||++|||+||+.||......+....+.......    +..+.     
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             12234678999999943     5678999999999999999999997644322222222111110    11100     


Q ss_pred             -ccccccccc--chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 -DSNLVRREH--SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 -d~~l~~~~~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       +........  ...........+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             000000000  00001122446789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-38  Score=299.23  Aligned_cols=249  Identities=24%  Similarity=0.422  Sum_probs=199.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|...++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35788889999999999999998899999999987543 23457889999999999999999999864 45689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++++|.+++.... ..+++.++..++.+++.||+|||    ..+++||||||+||++++++.++|+|||++........ 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            9999999987643 45899999999999999999999    67899999999999999999999999999987642221 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      .......++..|+|||..    .+.++||||||+++||+++ |+.||..................        ..     
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~-----  224 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------PR-----  224 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------CC-----
Confidence            112234467789999943    5779999999999999999 99999754432222221111000        00     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                          +..++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                01124568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-39  Score=302.28  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=202.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .+|+..+.||+|.||.|-+|.. ..|+.||||.+++..   +++...+.+|+++|+.++||||++++.+|.+.+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677778999999999999975 689999999998764   445567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||..+|.|++|+.+.+ .+++.+...++.||..|+.|+|    .++++|||||.+|||+|+++++||+|||++-++....
T Consensus       133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            9999999999999875 4889999999999999999999    7789999999999999999999999999999875432


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                         ..+..+|++-|.+||.+     -++..|-||+||+||-|+.|..||+..+...+...+..               +.
T Consensus       208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~---------------Ga  269 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR---------------GA  269 (668)
T ss_pred             ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc---------------cc
Confidence               34668999999999955     46789999999999999999999987654333322221               11


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      +.....    +....-|+.+|+.++|++|-|+.||...
T Consensus       270 YrEP~~----PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 YREPET----PSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ccCCCC----CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            111111    2335678999999999999999998754

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.6e-38  Score=307.18  Aligned_cols=262  Identities=23%  Similarity=0.405  Sum_probs=204.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  241 (457)
                      .++|...+.||+|+||.||+++..        ....+|+|.++... ......+.+|++++.++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888899999999999999742        34579999987543 33456788999999999 699999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      +..++||||+++|+|.+++....               ..+++.+..+++.|++.||.|||    ..+++||||||+||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil  166 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVL  166 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEE
Confidence            99999999999999999997532               34788999999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLK  381 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~  381 (457)
                      +++++.+||+|||+++...............++..|+|||.+    ++.++||||||+++||+++ |..||.........
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999999876432221111223345679999943    6779999999999999999 88888654322222


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhhhh
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVA  454 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~~~  454 (457)
                      ......           ....      .+..++..+.+++.+|++.+|++||++.|+++.|.++.....++.+
T Consensus       247 ~~~~~~-----------~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  302 (314)
T cd05099         247 KLLREG-----------HRMD------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL  302 (314)
T ss_pred             HHHHcC-----------CCCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCce
Confidence            211110           0000      0112345688999999999999999999999999999876655443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-38  Score=311.92  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=196.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC-C
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL-D  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  242 (457)
                      .++|+..+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788899999999999999973      357899999997543 23345688999999999 689999999988654 4


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  264 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  264 (457)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999987531                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccc
Q 044428          265 --------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT  336 (457)
Q Consensus       265 --------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  336 (457)
                              ..+++..+.+++.|++.||+|||    +.+|+||||||+||++++++++||+|||+++..............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    13678888999999999999999    778999999999999999999999999999875332221122223


Q ss_pred             cccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHH
Q 044428          337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM  411 (457)
Q Consensus       337 ~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  411 (457)
                      .++..|+|||..    ++.++||||||+++||+++ |..||.......  ..         ...+.........     .
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~---------~~~~~~~~~~~~~-----~  305 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF---------CRRLKEGTRMRAP-----D  305 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH---------HHHHhccCCCCCC-----C
Confidence            456789999943    6779999999999999997 899986532110  00         0111000000000     0


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          412 DCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       412 ~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      .....+.+++..||+.+|++||++.||++.|+.+.+
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            113458899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=303.60  Aligned_cols=235  Identities=22%  Similarity=0.306  Sum_probs=185.9

Q ss_pred             ccCCCCceEEEEEEeCC-------------------------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcccee
Q 044428          180 LLGIGSFGSVYKGTLSD-------------------------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI  234 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l  234 (457)
                      .||+|+||.||+|.+..                         ...||+|++..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13589999876544445678899999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC---
Q 044428          235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM---  311 (457)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~---  311 (457)
                      +++|......++||||+++|+|..++......+++..+..++.|++.||+|||    ..+|+||||||+||+++.++   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999876666899999999999999999999    67899999999999997644   


Q ss_pred             ----cEEEeccccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHh-cCCCCCCCCCCCcHH
Q 044428          312 ----VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETF-SRKKPTNDLGEMSLK  381 (457)
Q Consensus       312 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~-tg~~p~~~~~~~~l~  381 (457)
                          .+|++|||.+......      ....++..|+|||.+     ++.++||||||+++||++ +|+.||.........
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                4799999987653221      123577889999944     567899999999999984 799998754322221


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .+..            ........       ....+.+++.+||+.+|++||++.+|++.|+
T Consensus       232 ~~~~------------~~~~~~~~-------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RFYE------------KKHRLPEP-------SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHH------------hccCCCCC-------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1111            10000000       1235789999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-38  Score=311.02  Aligned_cols=235  Identities=22%  Similarity=0.293  Sum_probs=184.2

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHH---hhcCCCccceeeeeeecCCeeEEE
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVL---RNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      |...+.||+|+||.||+|... +|+.||||+++...   ......+.+|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556789999999999999865 68999999997542   22334566666654   566899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|..++...  .+++.....++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            9999999999988764  4899999999999999999999    778999999999999999999999999998753221


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .  .......|++.|+|||.+    ++.++|||||||++|||++|+.||.........   ..        +...... .
T Consensus       155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~---~~--------i~~~~~~-~  220 (324)
T cd05589         155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF---DS--------IVNDEVR-Y  220 (324)
T ss_pred             C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH---HH--------HHhCCCC-C
Confidence            1  112346689999999943    677899999999999999999999754322111   11        1110000 0


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                            +...+..+.+++.+|++.||.+||++
T Consensus       221 ------p~~~~~~~~~li~~~L~~dP~~R~~~  246 (324)
T cd05589         221 ------PRFLSREAISIMRRLLRRNPERRLGS  246 (324)
T ss_pred             ------CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence                  01124457899999999999999953

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=318.35  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=197.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888899999999999999875 78999999997542   234557889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++... ..+++.....++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999876 45889999999999999999999    6889999999999999999999999999998764432


Q ss_pred             C---------------------------cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCC
Q 044428          329 D---------------------------SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGE  377 (457)
Q Consensus       329 ~---------------------------~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~  377 (457)
                      .                           ........||+.|+|||.+    ++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            0                           0112235689999999943    67899999999999999999999976442


Q ss_pred             CcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 044428          378 MSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH-TTNAAAK  441 (457)
Q Consensus       378 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-~~ev~~~  441 (457)
                      .....-+...         ...+....     ....+..+.+++.+|+. +|.+||+ +.++++.
T Consensus       236 ~~~~~~i~~~---------~~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETYNKIINW---------KESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHhcc---------CCcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1111111000         00000000     00124568899999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.4e-38  Score=301.85  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=188.6

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ||+|+||.||+++.. +|+.+|+|.+....   ......+..|++++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999865 68999999986432   12233456799999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecc
Q 044428          257 EKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK  335 (457)
Q Consensus       257 ~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  335 (457)
                      .+++.... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            99886543 45889999999999999999999    7889999999999999999999999999988764322   1233


Q ss_pred             ccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCchhHHhccccccccccchhHH
Q 044428          336 TMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK  410 (457)
Q Consensus       336 ~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  410 (457)
                      ..|+..|+|||.+    ++.++||||+||++|||++|+.||...... .........        ....+....      
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~------  219 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT--------LEDEVKFEH------  219 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh--------hcccccccc------
Confidence            5689999999943    678999999999999999999999753221 111111111        111110000      


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          411 MDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       411 ~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                      .....++.+++.+|++.+|++||++.|+++.+
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            01244578999999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=297.18  Aligned_cols=245  Identities=28%  Similarity=0.456  Sum_probs=195.2

Q ss_pred             CccCCCCceEEEEEEeC--C--CCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS--D--GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+..  +  +..+|+|.+..... .....+.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999753  2  36899999876543 34567899999999999999999999876 4567999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce-
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI-  332 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-  332 (457)
                      |+|.+++.... .+++..+..++.|++.|+.|||    ..+++|+||||+||+++.++.+||+|||+++.......... 
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999998765 5899999999999999999999    67899999999999999999999999999987644332211 


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....++..|+|||..    ++.++||||||+++||+++ |+.||..........++......                 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  217 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-----------------  217 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-----------------
Confidence            1123345689999943    6779999999999999998 99999765543333333221100                 


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      ..+..++..+.+++.+|++.+|++||++.++++.|+++.
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            001123456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-38  Score=303.40  Aligned_cols=245  Identities=26%  Similarity=0.334  Sum_probs=196.1

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      |+..+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566678999999999999875 5788999998766555667789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      ++|..++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++.......  ...
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~  160 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR  160 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence            9999998765566899999999999999999999    6789999999999999999999999999987653221  112


Q ss_pred             ccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          334 TKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ....++..|+|||.+         ++.++|||||||++|||++|+.||..........-....        ..+.+.   
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~---  229 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------EPPTLA---  229 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc--------CCCCCC---
Confidence            235688999999954         346899999999999999999998754321111100000        000000   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .+..++..+.+++.+||+.+|.+||++.++++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                01112456889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-38  Score=304.53  Aligned_cols=251  Identities=27%  Similarity=0.454  Sum_probs=198.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .++|+..+.||+|+||.||+|...      ++..||+|++..... .....+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999863      467899999875432 3345788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 044428          245 ALVLEFMPNGSLEKWLYSHN---------------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPS  303 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~  303 (457)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.||+|||    ..+++||||||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~  159 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATR  159 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHh
Confidence            99999999999999997432                     24678889999999999999999    678999999999


Q ss_pred             CeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCC
Q 044428          304 NILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEM  378 (457)
Q Consensus       304 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~  378 (457)
                      ||++++++.++|+|||++..+..............+..|+|||    ..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999988654332222222334567899999    346789999999999999998 88888643321


Q ss_pred             cHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          379 SLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       379 ~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .....+           .+......      +..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus       240 ~~~~~~-----------~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 EVIYYV-----------RDGNVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHH-----------hcCCCCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            111111           11111100      1123556899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.6e-39  Score=312.36  Aligned_cols=238  Identities=22%  Similarity=0.285  Sum_probs=188.9

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      +.||+|+||.||+++.. +|+.||+|++....   ......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999864 78999999997542   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceec
Q 044428          255 SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT  334 (457)
Q Consensus       255 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  334 (457)
                      +|.+++.... .+++.....++.|++.||.|||.   ..+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS---EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9999987654 48899999999999999999993   15799999999999999999999999999875422111  122


Q ss_pred             cccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHH
Q 044428          335 KTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK  410 (457)
Q Consensus       335 ~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  410 (457)
                      ...||+.|+|||.+    ++.++|||||||++|||+||+.||...........+..   .      ...+..        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~---~------~~~~p~--------  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---E------EIRFPR--------  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc---C------CCCCCC--------
Confidence            35699999999943    67899999999999999999999965432211111110   0      000000        


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          411 MDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       411 ~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                       .....+.+++.+|++.||++|+     ++.++++
T Consensus       218 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         218 -TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence             1134578999999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=297.53  Aligned_cols=246  Identities=29%  Similarity=0.471  Sum_probs=200.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|+..+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357788889999999999999875 78999999976644 4567899999999999999999999999899999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||    ..+++|+||||+||++++++.+||+|||.++......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            9999999998654 35899999999999999999999    6789999999999999999999999999998763221  


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                         .....+..|+|||..    .+.++||||||+++||+++ |..||.......+...+.....        ...     
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~-----  220 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--------MEA-----  220 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------CCC-----
Confidence               123456789999943    5668999999999999997 9999875432222222111100        000     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                          +..++..+.+++.+|+..+|++||++.|++++|+.+
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                112245689999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-38  Score=306.00  Aligned_cols=253  Identities=29%  Similarity=0.452  Sum_probs=196.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC--EEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT--NVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|+..+.||+|+||.||+|... ++.  .+|+|.+.... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56778889999999999999874 454  45777776432 33455788999999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          248 LEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      |||+++|+|.+++....               ..+++.+++.++.|++.|++|||    ..+++||||||+|||+++++.
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCCc
Confidence            99999999999997542               24788999999999999999999    778999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||+++.....   .......++..|+|||.    ..+.++|||||||++|||+| |..||...........+...
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            999999998642111   11112234678999993    36789999999999999998 99998654322221111100


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                                  ....     .+..++..+.+++.+|++.+|++||++.++++.|.++.+.-
T Consensus       240 ------------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         240 ------------YRLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             ------------CcCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                        0000     00112345789999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-38  Score=312.16  Aligned_cols=247  Identities=25%  Similarity=0.316  Sum_probs=192.5

Q ss_pred             cCCcCCccCCCCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCee
Q 044428          174 EFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  244 (457)
                      +|+..+.||+|+||.||+++.    .+++.||+|++....    ......+.+|+.++.++ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477788999999999999975    368899999987532    22345678899999999 499999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999997654 4888999999999999999999    678999999999999999999999999999865


Q ss_pred             CCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ...... ......||+.|+|||.+     .+.++|||||||++|||+||+.||...........+......     .++.
T Consensus       156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~~  229 (332)
T cd05614         156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-----CDPP  229 (332)
T ss_pred             cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-----CCCC
Confidence            332221 12235689999999943     466899999999999999999999754322211111111000     0111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      +..         .....+.+++.+|++.||++||     ++.++++
T Consensus       230 ~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         230 FPS---------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCC---------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            110         1134578999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=304.11  Aligned_cols=246  Identities=24%  Similarity=0.323  Sum_probs=194.4

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677789999999999999864 78999999987542   1223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |+++|+|.+++.... ..+++.....++.|++.||.|||    ..+++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999999887543 45899999999999999999999    6789999999999999999999999999998753322


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .   .....|+..|+|||.+    .+.++|||||||++||+++|+.||...........+....        ....... 
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~-  224 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV--------KEDQEEY-  224 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh--------hhccccc-
Confidence            1   1235689999999944    5778999999999999999999997644322211111111        1000000 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                           +...+..+.+++.+|++.||++||     ++.++.+
T Consensus       225 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         225 -----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                 011244688999999999999999     7778755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=297.60  Aligned_cols=263  Identities=25%  Similarity=0.292  Sum_probs=203.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCccceeeeeeec-----CCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILSGCSN-----LDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  243 (457)
                      ...|...+.||+|+||.|+.+... +|..||||.+..  ......+...+|+.++++++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            445666789999999999999864 789999999873  344456678899999999999999999987754     457


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .|+|+|+| +.+|.+.++.++. ++.....-++.|+++||.|+|    +.+|+||||||+|++++.+...||+|||+|+.
T Consensus       101 vYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEeccccceee
Confidence            89999999 7899999987753 788888889999999999999    78899999999999999999999999999998


Q ss_pred             cCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHH
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAE  394 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~  394 (457)
                      ..........+....|..|.|||..     ++...||||.|||+.||++|++-|...+..+....+...++..    +..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            8654233345667889999999933     7889999999999999999999998755444444443333321    111


Q ss_pred             hc--------cccccccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VV--------DSNLVRREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~--------d~~l~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +-        ..........+. .-..+.....++..+|+..||.+|+|++|+++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11        000000111111 01123345789999999999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-39  Score=318.25  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ...++|+..+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.+++.++||||+++++++...+..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999875 68899999986532   223445788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++|+|.+++....  ++......++.|++.||+|||    ..+|+||||||+|||+++++.+||+|||+++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999999997653  788889999999999999999    6789999999999999999999999999998764


Q ss_pred             CCCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      .... .......||+.|+|||.+        ++.++||||+||++|||++|+.||.......   ...        .+.+
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~~~--------~i~~  261 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---TYS--------KIMD  261 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---HHH--------HHHh
Confidence            3221 112346799999999943        5679999999999999999999997543211   111        1111


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE--RIHTTNAAAK  441 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPs~~ev~~~  441 (457)
                      ....-   ......+....+.+++..|+..++.+  ||++.|+++.
T Consensus       262 ~~~~~---~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKNSL---NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCccc---CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            10000   00001112345678888888755543  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.4e-38  Score=297.90  Aligned_cols=247  Identities=26%  Similarity=0.446  Sum_probs=190.2

Q ss_pred             CccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeee-cCCeeEEEEeccC
Q 044428          179 NLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCS-NLDFKALVLEFMP  252 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  252 (457)
                      +.||+|+||.||+|...    ++..||+|.+.... ......+.+|+.+++.++||||+++++++. ..+..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999853    34579999986432 334567889999999999999999999775 4556889999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc-
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-  331 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-  331 (457)
                      +|+|.+++......+++.....++.+++.|+.|||    ..+++||||||+||++++++.+||+|||+++......... 
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999999876655788888999999999999999    6789999999999999999999999999998653321111 


Q ss_pred             -eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcC-CCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          332 -IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       332 -~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg-~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                       ......++..|+|||..    .+.++||||||+++|||++| ..||.......+...+....          ...    
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~----------~~~----  222 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR----------RLL----  222 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC----------CCC----
Confidence             11124467789999943    57789999999999999995 55665433222222211100          000    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                         .+..++..+.+++.+||+.+|++||++.||++.|+++.
T Consensus       223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence               00112456889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.6e-38  Score=299.26  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=201.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD----GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457777899999999999998643    3469999887654 3445678999999999999999999998875 457899


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++......+++..+..++.+++.||.|||    ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            9999999999999876656899999999999999999999    678999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .. ...+...++..|+|||.+    ++.++||||||+++||+++ |..||..........++....          .+. 
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----------~~~-  228 (270)
T cd05056         161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE----------RLP-  228 (270)
T ss_pred             cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------cCC-
Confidence            21 112223455689999943    6778999999999999986 999997654332222221110          000 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                            .+..++..+.+++.+|+..+|++|||+.++++.|.+++.+
T Consensus       229 ------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         229 ------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                  0112355689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-38  Score=299.02  Aligned_cols=244  Identities=26%  Similarity=0.406  Sum_probs=195.7

Q ss_pred             CccCCCCceEEEEEEeCC--C--CEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLSD--G--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... .....+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998743  3  3699999987654 556789999999999999999999999888 889999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc-
Q 044428          254 GSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-  331 (457)
Q Consensus       254 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-  331 (457)
                      |+|.+++.... ..+++.....++.|++.||+|||    ..+++|+||+|+||+++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999998765 56899999999999999999999    6789999999999999999999999999998775432221 


Q ss_pred             eeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......++..|+|||.    .++.++||||||+++|||++ |+.||...............         .....     
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---------~~~~~-----  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE---------GERLE-----  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------CCcCC-----
Confidence            1123457789999993    46778999999999999999 99998654322222211110         00000     


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                        .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 --RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              01123456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.2e-38  Score=296.73  Aligned_cols=254  Identities=23%  Similarity=0.336  Sum_probs=202.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...   ......+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999986 89999999886422   233567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||+++|+|.+++...   ...+++.++..++.+++.|+.|||    ..+++||||+|+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            999999999998642   345789999999999999999999    7789999999999999999999999999988654


Q ss_pred             CCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ....  ......++..|+|||..    ++.++|||||||++|||++|+.||.... .+...........     ..+.. 
T Consensus       158 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-----~~~~~-  228 (267)
T cd08224         158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEKC-----DYPPL-  228 (267)
T ss_pred             CCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-ccHHHHHhhhhcC-----CCCCC-
Confidence            3221  12234688899999944    5678999999999999999999986432 2222221111000     00000 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                             .....+..+.+++.+|+..+|++||++.+|+++|+++.
T Consensus       229 -------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 -------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                   01123456889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-38  Score=295.79  Aligned_cols=244  Identities=31%  Similarity=0.494  Sum_probs=196.1

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHH
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLE  257 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  257 (457)
                      ++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            379999999999999877999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecccc
Q 044428          258 KWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM  337 (457)
Q Consensus       258 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  337 (457)
                      +++......+++.....++.+++.|+.|||    ..+++||||+|+||+++.++.+||+|||++................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999776556889999999999999999999    6779999999999999999999999999998654222111111233


Q ss_pred             ccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHH
Q 044428          338 ATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD  412 (457)
Q Consensus       338 gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  412 (457)
                      .+..|+|||.    .++.++|||||||++||++| |..||...........+....          ..       ..+..
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----------~~-------~~~~~  219 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------RM-------PAPQL  219 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------CC-------CCCcc
Confidence            4667999993    36789999999999999999 888886544322222221110          00       00112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          413 CLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       413 ~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      ++..+.+++.+|++.+|++||++.|+++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3556899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-38  Score=297.65  Aligned_cols=248  Identities=26%  Similarity=0.429  Sum_probs=197.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|...+.||+|++|.||+|...++..+|+|.+.... .....+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4577788999999999999998877789999886543 23456889999999999999999998875 456889999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          253 NGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       253 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +|+|.+++.... ..+++..+..++.+++.||.|||    ..+++|+||||+||++++++.++|+|||+++........ 
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            999999997643 45789999999999999999999    678999999999999999999999999999876432211 


Q ss_pred             eeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......++..|+|||.    ..+.++||||||+++||++| |+.||..........+......        ..       
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~-------  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR--------MP-------  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CC-------
Confidence            1122346778999993    36779999999999999999 8999876433222222211110        00       


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                        .+.+.+..+.+++.+|+..+|++||++.+|.+.|++
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 --CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              011225568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-38  Score=309.85  Aligned_cols=233  Identities=24%  Similarity=0.281  Sum_probs=185.8

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 68899999987542   23345677888888877 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~  153 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT  153 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence            99999997654 4889999999999999999999    7789999999999999999999999999987542211  122


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+..           ......      
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-----------~~~~~~------  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----------DEVVYP------  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----------CCCCCC------
Confidence            345689999999943    57789999999999999999999976443222211111           000000      


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTT  436 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~  436 (457)
                       ......+.+++.+|++.||++||++.
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         217 -TWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence             01134578999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-39  Score=317.93  Aligned_cols=248  Identities=21%  Similarity=0.342  Sum_probs=193.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ......+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888899999999999999875 68999999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999998754 4889999999999999999999    6789999999999999999999999999987653211


Q ss_pred             Ccc------------------------------------eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcC
Q 044428          329 DSL------------------------------------IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSR  368 (457)
Q Consensus       329 ~~~------------------------------------~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg  368 (457)
                      ...                                    ......||+.|+|||.+    ++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            100                                    00124589999999943    67899999999999999999


Q ss_pred             CCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 044428          369 KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH---TTNAAA  440 (457)
Q Consensus       369 ~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs---~~ev~~  440 (457)
                      ..||...........+... .        ..+....     .......+.+++.+|+. +|.+|++   +.|+++
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~-~--------~~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQETYRKIINW-K--------ETLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcC-C--------CccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999764322111111100 0        0000000     00113456788888886 9999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.3e-38  Score=297.13  Aligned_cols=244  Identities=30%  Similarity=0.421  Sum_probs=195.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeee-cCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS-NLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  251 (457)
                      .+|...+.||+|+||.||++... |..||+|.++...  ....+.+|+.++++++|+|++++++++. ..+..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46788889999999999999874 7889999986443  3457889999999999999999999764 456789999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++++|.+++.... ..+++...+.++.+++.||+|||    ..+++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999998654 34789999999999999999999    6789999999999999999999999999988643221  


Q ss_pred             ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                         ....++..|+|||.    .++.++||||||+++|||++ |+.||...........+.....        +..     
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~-----  220 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDA-----  220 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------CCC-----
Confidence               12345678999993    36778999999999999998 9999865332222222211110        000     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                          ...++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 ----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                112355688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=304.11  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|+..+.||.|+||.||++... ++..+|+|++..........+.+|++++++++||||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356888889999999999999875 6899999999866555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++......+++.....++.|++.|+.|||    ..+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            9999999999876666899999999999999999999    67899999999999999999999999999876532211 


Q ss_pred             ceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          331 LIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                       ......+++.|+|||.+         .+.++||||||+++|||++|+.||..........-+...        ..+.+ 
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~-  228 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--------EPPTL-  228 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--------CCCCc-
Confidence             12235688999999953         456899999999999999999999764322111111000        00000 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                            ..+..+...+.+++.+|++.+|.+||++.++++.
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 ------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                  0111224468899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-38  Score=300.15  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=185.5

Q ss_pred             ccCCCCceEEEEEEeCC---CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          180 LLGIGSFGSVYKGTLSD---GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .||+|+||.||+|...+   ...+|+|.+.... ......+.+|++.++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            68999999999997543   4568888876443 2334568899999999999999999999999999999999999999


Q ss_pred             HHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          256 LEKWLYSHN----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       256 L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      |.+++....    ...++.....++.|++.|++|||    ..+|+||||||+||++++++.+||+|||++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999997653    22467778899999999999999    6789999999999999999999999999987543322211


Q ss_pred             eeccccccccccCCCCC-----------CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          332 IQTKTMATIGYMAPEGI-----------VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~-----------~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ......++..|+|||..           .+.++|||||||++|||++ |..||............   ......+..++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV---VREQDIKLPKPQ  234 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---hhccCccCCCCc
Confidence            12234467789999942           4678999999999999999 78888654322111111   111000111111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      +.         ..++..+.+++..|+ .+|++||++.+|++.|.
T Consensus       235 ~~---------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 LD---------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cc---------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            10         112445677888888 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.8e-38  Score=297.28  Aligned_cols=235  Identities=20%  Similarity=0.330  Sum_probs=186.5

Q ss_pred             CccCCCCceEEEEEEeCC-------------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          179 NLLGIGSFGSVYKGTLSD-------------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      +.||+|+||.||+|+..+             ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2358999887665555567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc-------EEEecc
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV-------AHVSDF  318 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~-------~kl~Df  318 (457)
                      +||||+++|+|..++......+++..+.+++.|++.||+|||    ..+|+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999999876666899999999999999999999    788999999999999987664       899999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHh-cCCCCCCCCCCCcHHHHHHhhcCchh
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETF-SRKKPTNDLGEMSLKHWVNQSLPHKL  392 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~-tg~~p~~~~~~~~l~~~~~~~~~~~~  392 (457)
                      |++......      ....++..|+|||.+     ++.++|||||||++|||+ +|+.|+.............       
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------  223 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-------  223 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-------
Confidence            998765321      224578899999944     566899999999999998 5888876432111111000       


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                           .......       .....+.+++.+||+.+|++||++.++++.+
T Consensus       224 -----~~~~~~~-------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 -----GQCMLVT-------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -----cCccCCC-------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                 0000000       0134578999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.5e-38  Score=301.17  Aligned_cols=240  Identities=23%  Similarity=0.312  Sum_probs=188.0

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ||+|+||+||++... +|+.||+|.+.....   .....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 789999999875422   2335678899999999999999999999999999999999999999


Q ss_pred             HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          257 EKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       257 ~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      .+++..   ....+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++..+.....  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~  154 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT  154 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence            988854   2245899999999999999999999    67899999999999999999999999999987643322  12


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||...+..........       .+......       .
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~-------~  220 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RILNDSVT-------Y  220 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------hhcccCCC-------C
Confidence            335689999999943    67789999999999999999999976432211111111       11111000       0


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      +...+..+.+++.+|++.+|++||     ++.++++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            112245688999999999999999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-38  Score=307.73  Aligned_cols=234  Identities=24%  Similarity=0.291  Sum_probs=183.6

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 68899999997542   22334456677777654 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            99999997654 4888899999999999999999    6789999999999999999999999999998643222  122


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||.......+..-+..   .      .+.+.        
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~------~~~~~--------  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN---D------RPHFP--------  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---C------CCCCC--------
Confidence            345789999999943    67899999999999999999999975432111111100   0      00000        


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTN  437 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~e  437 (457)
                       ..+...+.+++.+|++.+|++||++.+
T Consensus       217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         217 -RWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence             012345789999999999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.4e-38  Score=298.01  Aligned_cols=253  Identities=22%  Similarity=0.334  Sum_probs=200.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||++.. .+|+.+|||.+....   ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677788999999999999986 488999999876432   233457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||+++++|.+++...   ...+++.....++.+++.|+.|||    ..+++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            999999999998742   345899999999999999999999    6789999999999999999999999999988764


Q ss_pred             CCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ....  ......++..|+|||..    .+.++||||||+++|||++|..||..... +...+...     +.+...+...
T Consensus       158 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~-----~~~~~~~~~~  229 (267)
T cd08229         158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKK-----IEQCDYPPLP  229 (267)
T ss_pred             cCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhh-----hhcCCCCCCC
Confidence            3221  12235688999999944    56789999999999999999999864321 11111111     1111111110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                              .......+.+++.+|++.+|++||||.+|++.++++
T Consensus       230 --------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         230 --------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             --------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                    112345688999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-38  Score=316.78  Aligned_cols=248  Identities=22%  Similarity=0.323  Sum_probs=189.6

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .|..++.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778889999999999999864 78899999997542   2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+|||++.++++||+|||+++.+.....
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999998754 4788888889999999999999    67899999999999999999999999999764311000


Q ss_pred             c---------------------------------------------ceeccccccccccCCCCC----CCCccchhhhhH
Q 044428          330 S---------------------------------------------LIQTKTMATIGYMAPEGI----VSTKCDVYSYGI  360 (457)
Q Consensus       330 ~---------------------------------------------~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gv  360 (457)
                      .                                             .......||+.|+|||.+    ++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence            0                                             001124699999999943    678999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHh--ccCCCCCCCCCHHHH
Q 044428          361 LLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALD--CCMESPDERIHTTNA  438 (457)
Q Consensus       361 vl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~--C~~~~P~~RPs~~ev  438 (457)
                      ++|||+||+.||...........+.. .        ...+... .    ......++.+++.+  |...+|..||++.|+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~-~--------~~~~~~~-~----~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVIN-W--------ENTLHIP-P----QVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHc-c--------ccccCCC-C----CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            99999999999976432111111000 0        0000000 0    00112346677766  666777789999999


Q ss_pred             HH
Q 044428          439 AA  440 (457)
Q Consensus       439 ~~  440 (457)
                      ++
T Consensus       303 l~  304 (381)
T cd05626         303 KA  304 (381)
T ss_pred             hc
Confidence            76

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-38  Score=309.34  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=187.8

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCC-ccceeeeeeecCCeeEEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHR-NLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  248 (457)
                      +|+..+.||+|+||.||+|+.. +++.||||++....   ......+..|.+++..++|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4777889999999999999875 57899999997542   23445678899999999765 5888899999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            9999999999997654 4788999999999999999999    6789999999999999999999999999987532211


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .  ......||+.|+|||.+    ++.++|||||||++|||+||+.||...........+..           ... ...
T Consensus       156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-----------~~~-~~~  221 (324)
T cd05587         156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-----------HNV-SYP  221 (324)
T ss_pred             C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----------CCC-CCC
Confidence            1  12335689999999954    57789999999999999999999976432222211111           000 000


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                      .      .....+.+++.+|+..+|++||+.
T Consensus       222 ~------~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 K------SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             C------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            0      113457899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=305.25  Aligned_cols=251  Identities=27%  Similarity=0.373  Sum_probs=194.6

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--------------hhHHHHHHHHHHHhhcCCCcccee
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--------------RTFVSFNSECEVLRNVRHRNLIKI  234 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l  234 (457)
                      +..++|+....||+|.||.|-+|+.. +++.||||++.+...              ...+...+||.+|+++.|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            44578999999999999999999864 799999999975321              112467899999999999999999


Q ss_pred             eeeeecC--CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          235 LSGCSNL--DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       235 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      +.+..+.  +..|||+|||..|.+...-... .-++..+..+++.++..||+|||    ..+||||||||+|+|++++|+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEcCCCc
Confidence            9998764  6899999999988775433222 12888999999999999999999    788999999999999999999


Q ss_pred             EEEeccccccccCCCCCc---ceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHH
Q 044428          313 AHVSDFGISKLLGEGDDS---LIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK  381 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~  381 (457)
                      +||+|||.+.....+...   .......||+.|+|||..        .+.+.||||+||+||.|+.|+.||-......+.
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            999999999866332111   122347899999999943        356789999999999999999999653322221


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      +           .++...+.     +....+.-..+.+|+.+++++||++|.+..+|...
T Consensus       329 ~-----------KIvn~pL~-----fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  329 D-----------KIVNDPLE-----FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             H-----------HHhcCccc-----CCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            1           12222221     11111234568899999999999999999888643

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-38  Score=314.75  Aligned_cols=199  Identities=25%  Similarity=0.395  Sum_probs=170.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||+||+++.. +++.||+|++....   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888899999999999999865 68999999997542   223456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999999998754 5889999999999999999999    7889999999999999999999999999987653211


Q ss_pred             Cc---------------------------------ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCC
Q 044428          329 DS---------------------------------LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKP  371 (457)
Q Consensus       329 ~~---------------------------------~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p  371 (457)
                      ..                                 .......||+.|+|||.+    ++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 001234699999999944    67899999999999999999999


Q ss_pred             CCCCC
Q 044428          372 TNDLG  376 (457)
Q Consensus       372 ~~~~~  376 (457)
                      |....
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            97543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.9e-38  Score=304.24  Aligned_cols=246  Identities=22%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+|++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4788888999999999999986 478999999998665555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++...  .+++.++..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++........  
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--  171 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence            999999999764  3789999999999999999999    67899999999999999999999999999886543221  


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      ......+++.|+|||..    .+.++|||||||++|||++|+.||......  ..+.. .....     .+.+..     
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~-~~~~~-----~~~~~~-----  238 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL-IATNG-----TPELQN-----  238 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH-HhcCC-----CCCCCC-----
Confidence            12234688999999933    678999999999999999999999754321  11111 00000     000000     


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        +......+.+++.+|+..+|++||++.++++.
T Consensus       239 --~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         239 --PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             --ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence              11123458899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.1e-38  Score=308.75  Aligned_cols=237  Identities=23%  Similarity=0.270  Sum_probs=187.7

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999875 57899999997542   23345577888888876 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|..++.... .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~  153 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT  153 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence            99999987654 4888999999999999999999    67899999999999999999999999999875422211  12


Q ss_pred             ccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.    .++.++|||||||++|||++|+.||...........+..           .... ..     
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-----------~~~~-~p-----  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----------DDVL-YP-----  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------CCCC-CC-----
Confidence            34568999999994    367899999999999999999999976543222211111           0000 00     


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERI-------HTTNAAA  440 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RP-------s~~ev~~  440 (457)
                       ..+...+.+++.+|++.+|++||       ++.++.+
T Consensus       217 -~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 -VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             01134578999999999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.4e-38  Score=305.47  Aligned_cols=269  Identities=18%  Similarity=0.266  Sum_probs=201.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888899999999999999875 68899999987543 22334677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++ ++|.+++......+++.....++.|++.||.|||    ..+++|+||||+||++++++.+||+|||++........ 
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            96 6999999876666889999999999999999999    78899999999999999999999999999976533221 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhcccc--
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVVDSN--  399 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~d~~--  399 (457)
                       ......+++.|+|||..     .+.++|||||||++|||+||+.||...........+.......    +....+..  
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             12234578899999943     4668999999999999999999997644322222222221111    11111100  


Q ss_pred             ----ccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHhHHH
Q 044428          400 ----LVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA--KLRKIKVQ  448 (457)
Q Consensus       400 ----l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~--~L~~i~~~  448 (457)
                          .......  ..........+.+++.+|++.||.+|||+.|+++  -+..++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence                0000000  0001122445789999999999999999999986  34444433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.3e-39  Score=312.00  Aligned_cols=234  Identities=26%  Similarity=0.337  Sum_probs=187.0

Q ss_pred             CccCCCCceEEEEEEe----CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          179 NLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999975    3689999999975432  233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.......  .
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~  154 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K  154 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence            999999997654 4899999999999999999999    67899999999999999999999999999886533211  1


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchh
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS  408 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~  408 (457)
                      .....|++.|+|||.+    .+.++|||||||++|||++|+.||...........+.           .... ..     
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~-----------~~~~-~~-----  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL-----------KAKL-GM-----  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH-----------cCCC-CC-----
Confidence            2335689999999943    5779999999999999999999997543221111111           0000 00     


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 044428          409 AKMDCLLRIMNLALDCCMESPDERIHTTN  437 (457)
Q Consensus       409 ~~~~~~~~l~~l~~~C~~~~P~~RPs~~e  437 (457)
                       +......+.+++.+|++.||++||++.+
T Consensus       218 -p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 -PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             0012345789999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=297.23  Aligned_cols=250  Identities=27%  Similarity=0.460  Sum_probs=201.0

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|...+.||+|+||.||+|..++++.||||.+.... .....+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46788889999999999999998888899999987543 23467899999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++++|.+++.... ..+++..+..++.+++.|+.|||    ..+++|+||||+||++++++.+||+|||+++....... 
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            9999999998754 46899999999999999999999    67799999999999999999999999999987643211 


Q ss_pred             ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      ........+..|+|||.    ..+.++||||||++++|++| |+.||...........+.....          .     
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------~-----  223 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR----------M-----  223 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------C-----
Confidence            11122334678999993    36779999999999999999 9999965432222111111100          0     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                        ..+.+++..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              0011124568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.6e-38  Score=303.45  Aligned_cols=261  Identities=22%  Similarity=0.289  Sum_probs=199.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888899999999999999865 688899998875432 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++.... .+++.....++.|++.||.|||+.   .+++||||||+||+++.++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhh---CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999998663 478899999999999999999942   479999999999999999999999999987653221  


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch---------------
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK---------------  391 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~---------------  391 (457)
                        .....++..|+|||..    ++.++||||||+++|||++|+.||..........+........               
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence              2235688999999943    6778999999999999999999987543333322222111000               


Q ss_pred             ------hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          392 ------LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       392 ------~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                            ..+..+........... .......+.+++.+|++.+|++||++.+|++.-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                  00111100000000000 001244688999999999999999999998763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-38  Score=309.71  Aligned_cols=236  Identities=22%  Similarity=0.319  Sum_probs=184.4

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+++.. +++.||+|++....   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            37999999999999875 68899999997642   23345577888888877 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|..++.... .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~  153 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT  153 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence            99999887654 4889999999999999999999    67899999999999999999999999999875322111  12


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-----cHHHHHHhhcCchhHHhccccccccc
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-----SLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-----~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||...+..     ....++....       ..... .. 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-------~~~~~-~~-  224 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LEKQI-RI-  224 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-------hcCCC-CC-
Confidence            345789999999944    577999999999999999999999642211     1111221111       11110 00 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                           +......+.+++.+|++.||++||++
T Consensus       225 -----p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         225 -----PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                 01123457899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5e-38  Score=301.88  Aligned_cols=247  Identities=24%  Similarity=0.314  Sum_probs=198.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      +.|+..+.||+|+||.||+|+.. ++..+++|.+..........+.+|+.+++.++||||+++++.+......++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56788889999999999999875 58999999998766566678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|..++.+....+++..+..++.|++.|+.|||    ..+++||||||+||+++.++.+||+|||++.......  .
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~  165 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q  165 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence            999999988766566899999999999999999999    6789999999999999999999999999987543211  1


Q ss_pred             eeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          332 IQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ......++..|+|||.+         ++.++|||||||++|||++|+.||......   .........     ..+.+. 
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~-----~~~~~~-  236 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKS-----EPPTLS-  236 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHHhcC-----CCccCC-
Confidence            11234578899999954         356899999999999999999998653321   111111000     000000 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            .+..+...+.+++.+|++.+|++||++.++++
T Consensus       237 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 ------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  01122345889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.6e-38  Score=306.28  Aligned_cols=236  Identities=25%  Similarity=0.327  Sum_probs=186.1

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999875 57899999997642   23344566788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT  153 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence            99999997653 4888999999999999999999    67899999999999999999999999999875322211  12


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+..         ..+....       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~---------~~~~~~~-------  217 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM---------DNPCYPR-------  217 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCCCCCc-------
Confidence            335689999999943    67899999999999999999999976432222211111         0011100       


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTT-NAA  439 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~-ev~  439 (457)
                        .....+.+++.+|++.+|++||++. ++.
T Consensus       218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         218 --WLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence              1134578999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.3e-38  Score=295.52  Aligned_cols=247  Identities=27%  Similarity=0.422  Sum_probs=197.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ....|.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46777789999999999999987788999998875432 23568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +++|.+++......+++..+..++.+++.|++|||    ..+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  157 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS  157 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence            99999999876656889999999999999999999    67799999999999999999999999999886533211 11


Q ss_pred             eccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....++.+|+|||.    .++.++||||||+++||+++ |+.||.......+........     ....+.        
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~--------  224 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-----RLYKPR--------  224 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----CCCCCC--------
Confidence            122345678999994    36778999999999999998 999987544222222111100     000011        


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                          ..+..+.+++.+|++.+|++||++.++++.|
T Consensus       225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                0135689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-38  Score=315.54  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             HHHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 044428          165 YLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSN  240 (457)
Q Consensus       165 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  240 (457)
                      +.++....++|+..+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445556689999999999999999999875 68899999986432   2234457889999999999999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      .+..++||||+++|+|.+++....  ++......++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999999997654  788888899999999999999    78899999999999999999999999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchh
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL  392 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~  392 (457)
                      ++.+..... .......||+.|+|||.+        ++.++|||||||++|||++|+.||........   ........ 
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~-  263 (371)
T cd05622         189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKIMNHK-  263 (371)
T ss_pred             eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---HHHHHcCC-
Confidence            987643221 122346799999999943        56799999999999999999999975432111   11110000 


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE--RIHTTNAAAKL  442 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPs~~ev~~~L  442 (457)
                           ..+.     ..........+.+++..|+...+.+  ||++.|+.+..
T Consensus       264 -----~~~~-----~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 -----NSLT-----FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -----Cccc-----CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                 0000     0000112445788999999844433  77888887643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-38  Score=315.47  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=194.8

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----eeE
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-----FKA  245 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  245 (457)
                      +|+..+.||+|+||.||++.. .+|+.||+|++....  ......+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999986 478999999986532  233457889999999999999999999998776     789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +|+||+. ++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 68888876543 4899999999999999999999    6789999999999999999999999999998654


Q ss_pred             CCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-hHH-----
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-LAE-----  394 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-~~~-----  394 (457)
                      .... .......+++.|+|||.+     ++.++|||||||++|||++|+.||...........+....... ..+     
T Consensus       155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            3221 122335678999999943     5678999999999999999999997654332222222111110 000     


Q ss_pred             -----hccccccccccc---hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          395 -----VVDSNLVRREHS---FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       395 -----~~d~~l~~~~~~---~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                           .+..........   .....+....+.+++.+|++.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 000000000000   00001124467899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-38  Score=308.64  Aligned_cols=240  Identities=22%  Similarity=0.300  Sum_probs=187.9

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+++.. +++.||+|+++...   ......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999875 68899999997542   22345678899999998 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~  153 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TT  153 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cc
Confidence            99999987653 5899999999999999999999    77899999999999999999999999999875322111  12


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-----cHHHHHHhhcCchhHHhccccccccc
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-----SLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-----~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||+||+.||+..+..     ...++.....       ...... ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~-~p  225 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-------LEKQIR-IP  225 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-------HcCCCC-CC
Confidence            345789999999943    677999999999999999999999742211     1112221111       111110 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCC------HHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIH------TTNAA  439 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs------~~ev~  439 (457)
                            ......+.+++.+|++.+|.+||+      +.+++
T Consensus       226 ------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         226 ------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             ------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence                  012345789999999999999998      55664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-38  Score=296.72  Aligned_cols=244  Identities=30%  Similarity=0.473  Sum_probs=190.0

Q ss_pred             CccCCCCceEEEEEEeC-CCC--EEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGT--NVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. ++.  .+++|.++... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36999999999999875 343  46888887432 33455788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecc
Q 044428          254 GSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF  318 (457)
Q Consensus       254 g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  318 (457)
                      |+|.+++....               ..+++.++..++.|++.|++|||    ..+++||||||+||++++++.+||+||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEECCC
Confidence            99999997542               24788999999999999999999    678999999999999999999999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                      |++.....   .........+..|+|||.+    ++.++|||||||++|||++ |..||...........+..       
T Consensus       157 gl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-------  226 (270)
T cd05047         157 GLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-------  226 (270)
T ss_pred             CCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-------
Confidence            99863211   1111122346679999943    6779999999999999997 9999865332221111110       


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                           .....     .+..+...+.+++.+|++.+|.+||++.++++.|.++.
T Consensus       227 -----~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 -----GYRLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -----CCCCC-----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                 00000     01122446889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6e-38  Score=294.94  Aligned_cols=245  Identities=27%  Similarity=0.365  Sum_probs=199.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|+..+.||+|+||.||+|...+ ++.+++|.+.....  ...+.+|++++++++||||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888999999999999999864 88999999875533  568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++......+++.....++.+++.|+.|||    ..+++|+||+|+||++++++.+||+|||++........  
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999999999876667899999999999999999999    67799999999999999999999999999987643221  


Q ss_pred             eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      ......++..|+|||.    ..+.++||||||+++|||++|+.||...............        ..+       ..
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~-------~~  219 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--------PPP-------TL  219 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--------CCC-------CC
Confidence            1223457889999994    3677899999999999999999999753321111100000        000       00


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..+......+.+++.+|++.+|++||++.||++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111122456889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.1e-38  Score=305.96  Aligned_cols=236  Identities=24%  Similarity=0.309  Sum_probs=185.8

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +|..||+|+++...   ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999875 68899999997642   22344567788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA  153 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence            99999997653 4788999999999999999999    6789999999999999999999999999987532211  122


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+...         .+.+..       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~---------~~~~~~-------  217 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD---------TPHYPR-------  217 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------CCCCCC-------
Confidence            346789999999943    677999999999999999999999754322211111100         011100       


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTT-NAA  439 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~-ev~  439 (457)
                        .+...+.+++.+|++.||++||++. ++.
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 --WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              1134578999999999999999985 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.5e-38  Score=307.41  Aligned_cols=237  Identities=23%  Similarity=0.288  Sum_probs=188.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +|...+.||+|+||.||+|+.. +++.||+|++....   ......+..|..++..+ .|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777889999999999999875 67899999997543   22334567788888777 5899999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||+++++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            9999999999997654 4889999999999999999999    6789999999999999999999999999987543211


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                        .......||+.|+|||.+    ++.++|||||||++|||+||+.||.......+...+..           .... ..
T Consensus       156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-----------~~~~-~p  221 (323)
T cd05616         156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-----------HNVA-YP  221 (323)
T ss_pred             --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------CCCC-CC
Confidence              122345689999999943    67899999999999999999999976443222221111           1100 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                            ......+.+++.+|++.+|++|++.
T Consensus       222 ------~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 ------KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence                  0123457899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=315.99  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=190.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+++.. +|+.||||++....   ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888899999999999999864 78999999986532   233456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999999999997654 4788888899999999999999    7789999999999999999999999999986432110


Q ss_pred             Cc------------c---------------------------------eeccccccccccCCCCC----CCCccchhhhh
Q 044428          329 DS------------L---------------------------------IQTKTMATIGYMAPEGI----VSTKCDVYSYG  359 (457)
Q Consensus       329 ~~------------~---------------------------------~~~~~~gt~~y~aPE~~----~~~~~Dv~s~G  359 (457)
                      ..            .                                 ......||+.|+|||.+    ++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00            0                                 00124689999999944    67899999999


Q ss_pred             HHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCC---CCHH
Q 044428          360 ILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER---IHTT  436 (457)
Q Consensus       360 vvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~R---Ps~~  436 (457)
                      |++|||+||+.||...........+.. ..        ..+.-..     .......+.+++.+|+. +|.+|   +++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~-~~--------~~~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIIN-WR--------ETLYFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHc-cC--------CccCCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999975432211111100 00        0000000     00113457889999997 66665   5888


Q ss_pred             HHHHH
Q 044428          437 NAAAK  441 (457)
Q Consensus       437 ev~~~  441 (457)
                      |+++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            88764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.7e-38  Score=306.57  Aligned_cols=237  Identities=23%  Similarity=0.286  Sum_probs=188.5

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 57899999997542   23345677888999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++.....++.|++.||.|||    ..+++||||||+||++++++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TT  153 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cc
Confidence            99999987664 4899999999999999999999    77899999999999999999999999999875322111  12


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....|++.|+|||.+    ++.++|||||||++|||++|+.||...........+.           ......       
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-----------~~~~~~-------  215 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-----------EDEVRY-------  215 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-----------cCCCCC-------
Confidence            235689999999943    6789999999999999999999997543222111111           000000       


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHT-----TNAAA  440 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~-----~ev~~  440 (457)
                      +...+..+.+++.+|++.||.+||++     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            00124468899999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.8e-38  Score=294.99  Aligned_cols=248  Identities=23%  Similarity=0.431  Sum_probs=199.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|...+.||+|+||.||++...++..+|+|.+.... .....+.+|++++++++|+||+++.+++.. ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            5678889999999999999998888889999887542 234578899999999999999999999887 77899999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          253 NGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       253 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +++|.+++.... ..+++..+..++.+++.||.|||    ..+++|+||||+||+++.++.+||+|||.+........ .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999997643 45789999999999999999999    67799999999999999999999999999986543221 1


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......++..|+|||.+    .+.++|+|||||++||++| |+.||..........+.......        ..      
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~------  224 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------PR------  224 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------CC------
Confidence            12223456789999944    6778999999999999999 89999764433333322211100        00      


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                         ....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               01124568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.7e-38  Score=298.14  Aligned_cols=244  Identities=29%  Similarity=0.498  Sum_probs=192.6

Q ss_pred             CccCCCCceEEEEEEeCC-------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          179 NLLGIGSFGSVYKGTLSD-------GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +.||+|+||.||+|+..+       +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998642       3579999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-----cEEEeccc
Q 044428          251 MPNGSLEKWLYSH------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-----VAHVSDFG  319 (457)
Q Consensus       251 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-----~~kl~Dfg  319 (457)
                      +++++|.+++...      ...+++.+++.++.+++.|+.|||    ..+++|+||||+||+++.+.     .++++|||
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999999753      234788999999999999999999    67799999999999999877     89999999


Q ss_pred             cccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      +++...............++..|+|||    ...+.++|||||||++|||+| |+.||...........+...       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------  229 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-------  229 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-------
Confidence            998664332222222345678899999    346889999999999999998 99998754332222221110       


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                         ..+       ..+..++..+.+++.+|++.+|++||++.+|.+.|.
T Consensus       230 ---~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 ---GRL-------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---Ccc-------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               000       001123556889999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.2e-38  Score=299.76  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecC------
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL------  241 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  241 (457)
                      .+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678888899999999999999865 68899999987543 2345688899999998 699999999988653      


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      ...++||||+++|+|.+++.... ..+++..+..++.|++.|+.|||    ..+|+|+||+|+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            46889999999999999998743 46889999999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      ++.......  ......|+..|+|||.+         ++.++|||||||++|||++|+.||..............     
T Consensus       158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-----  230 (272)
T cd06637         158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-----  230 (272)
T ss_pred             ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-----
Confidence            986533211  12335688999999954         45689999999999999999999965432111111100     


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         ...+.+..        ..++..+.+++.+|+..+|.+|||+.|+++
T Consensus       231 ---~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 ---NPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---CCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence               00011100        112456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.3e-38  Score=332.12  Aligned_cols=256  Identities=22%  Similarity=0.300  Sum_probs=198.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....   ......|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888899999999999999875 68999999987542   223457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecc
Q 044428          249 EFMPNGSLEKWLYSH----------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF  318 (457)
Q Consensus       249 e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  318 (457)
                      ||+++|+|.+++...          ....++...++++.|++.||+|||    ..+|+||||||+||+++.++.+||+||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEEec
Confidence            999999999998642          123567788999999999999999    678999999999999999999999999


Q ss_pred             ccccccCCCCCc----------------ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC
Q 044428          319 GISKLLGEGDDS----------------LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM  378 (457)
Q Consensus       319 g~~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~  378 (457)
                      |+++........                .......||+.|+|||..    .+.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            999876211100                011124689999999943    678999999999999999999999763322


Q ss_pred             cHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhHH
Q 044428          379 SLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI-HTTNAAAKLRKIKV  447 (457)
Q Consensus       379 ~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-s~~ev~~~L~~i~~  447 (457)
                      .....  .       ...++.-.      ....+.+..+.+++.+|++.+|++|| ++.++.+.|+...+
T Consensus       238 ki~~~--~-------~i~~P~~~------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        238 KISYR--D-------VILSPIEV------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhh--h-------hccChhhc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11110  0       00000000      00112345688999999999999996 66777777777654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-39  Score=308.98  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=205.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe-eEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF-KALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  248 (457)
                      ++|..++.+|+|+||.++..+.+ ++..+++|.+...  .........+|+.++++++|||||.+.+.|..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46888899999999999999865 6789999988754  34455578899999999999999999999988887 99999


Q ss_pred             eccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      +|++||++.+.+.+.+ ..+++.....++.|++.|+.|||    ...|+|||||+.||+++.+..+||+|||+|+.+.+.
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999998776 66889999999999999999999    567999999999999999999999999999998765


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..  ......||+.|+.||.+    +..|+||||+||++|||++-+++|...+-.   ..+.+..+..    .++ +   
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~~----~~P-l---  226 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRGL----YSP-L---  226 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhcc----CCC-C---
Confidence            42  23457899999999944    889999999999999999999999765433   2222221111    111 1   


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                            +.....++..++..|++.+|+.||++.+++.+
T Consensus       227 ------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  227 ------PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ------CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                  11224568899999999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=295.51  Aligned_cols=247  Identities=20%  Similarity=0.321  Sum_probs=185.3

Q ss_pred             ccCCCCceEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          180 LLGIGSFGSVYKGTLSDG---TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .||+|+||.||+|...++   ..+++|.+.... ......|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975433   346677665433 2345679999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          256 LEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       256 L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      |.+++.+..   ...++.....++.|++.||+|||    ..+++||||||+|||++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999998643   23566777899999999999999    67799999999999999999999999999864322111112


Q ss_pred             eccccccccccCCCCC-----------CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          333 QTKTMATIGYMAPEGI-----------VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~-----------~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      .....++..|+|||..           .+.++|||||||++|||++ |..||......   ...............++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhhcccccCCCcc
Confidence            2335678899999954           3568999999999999997 56787653322   2222211111122223222


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      ...         ....+.+++..|| .+|++||++.+|++.|.
T Consensus       235 ~~~---------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 ELP---------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCC---------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            211         1335778888999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-37  Score=305.54  Aligned_cols=255  Identities=22%  Similarity=0.391  Sum_probs=199.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      .+|...+.||+|+||.||++...        ++..||+|.+.... ......+.+|++++.++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46788899999999999999742        22468999887543 33456789999999999 7999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                      ..++++||+++|+|.+++....               ..+++..++.++.|++.||.|||    ..+++||||||+||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nill  167 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNVLV  167 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEE
Confidence            9999999999999999997532               34788999999999999999999    6789999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHH
Q 044428          308 DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKH  382 (457)
Q Consensus       308 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~  382 (457)
                      ++++.+||+|||+++...............++..|+|||.+    ++.++||||||+++|||++ |..||.....   ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HH
Confidence            99999999999999876432222122223445789999944    6678999999999999998 8888865332   22


Q ss_pred             HHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       383 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      +.......         ....     .+..++..+.+++.+|++.+|++||++.|+++.|+++...
T Consensus       245 ~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         245 LFKLLKEG---------HRMD-----KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHHHHHcC---------CCCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            22111100         0000     0112245688999999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4e-38  Score=306.99  Aligned_cols=233  Identities=24%  Similarity=0.300  Sum_probs=182.8

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECE-VLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999875 78999999997542   122334455544 56788999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++.....++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT  153 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence            99999998654 4888899999999999999999    6789999999999999999999999999987542211  122


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||......   ......        ....... ..    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i--------~~~~~~~-~~----  217 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNI--------LNKPLRL-KP----  217 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHHHH--------HcCCCCC-CC----
Confidence            345689999999944    677899999999999999999999754321   111111        1111100 00    


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTT  436 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~  436 (457)
                        ..+..+.+++.+|++.+|++||++.
T Consensus       218 --~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 --NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              1134578999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-37  Score=295.06  Aligned_cols=244  Identities=25%  Similarity=0.335  Sum_probs=197.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ..|+..+.||.|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677789999999999999875 68899999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++|+|.+++...  .+++.+...++.+++.|++|||    ..+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            9999999999764  3788899999999999999999    67899999999999999999999999999977643221 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......++..|+|||..    .+.++|||||||++|||+||+.||.............            ....     
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------~~~~-----  218 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------------KNNP-----  218 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh------------cCCC-----
Confidence             12234678899999943    6779999999999999999999987543221111100            0000     


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ......++..+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            00112346678999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-38  Score=312.09  Aligned_cols=255  Identities=20%  Similarity=0.229  Sum_probs=191.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|...+.||+|+||.||++... +++.||+|....      ..+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999864 789999997532      34678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      . ++|.+++.... .+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....... .
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~  238 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N  238 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence            4 78988887654 4889999999999999999999    67899999999999999999999999999975432111 1


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC--------cHHHHHHhh------cCch--
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM--------SLKHWVNQS------LPHK--  391 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~--------~l~~~~~~~------~~~~--  391 (457)
                      ......||+.|+|||.+    ++.++|||||||++|||+||+.|+......        .+...+...      .+..  
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            12335799999999944    678999999999999999999886532111        011111100      0000  


Q ss_pred             --hHHhc---ccccc---ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 --LAEVV---DSNLV---RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 --~~~~~---d~~l~---~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        ..+..   .....   ..........+.+..+.+++.+|++.||++|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              01111   00000   000001111234567899999999999999999999985

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=315.75  Aligned_cols=246  Identities=25%  Similarity=0.427  Sum_probs=203.4

Q ss_pred             cCCccCCCCceEEEEEEeC--CC--CEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          177 ECNLLGIGSFGSVYKGTLS--DG--TNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ..++||+|.||.|++|.|.  +|  -.||||.++..... ...+|.+|+.+|.+|+|||+++++|...+ ....+|||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3458999999999999875  34  35899999876544 56789999999999999999999999887 6788999999


Q ss_pred             CCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYS-HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +.|+|.+.|++ .+..+-......++.|||.||.||.    .+++|||||..+|+||-..-.+||+|||+.+.++.+++.
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999998 4455677788899999999999999    778999999999999999999999999999999877666


Q ss_pred             ceecc-ccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          331 LIQTK-TMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       331 ~~~~~-~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ..... ..-.+.|+|||.+    ++.++|||+|||++|||+| |..||-...+..            +.+.+|.     .
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q------------IL~~iD~-----~  331 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ------------ILKNIDA-----G  331 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH------------HHHhccc-----c
Confidence            54433 4557789999944    7889999999999999999 778876543322            2233331     1


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                      .+...+..|++.++++++.||..+|++||++.++.+.+-.
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            2233455789999999999999999999999999865544

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=293.01  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=195.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|...+.||+|++|.||++... +++.||+|.+....     ......+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888899999999999999864 68999999986432     1234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+||+++++|.+++.... .+++.....++.+++.|+.|||    ..+++||||+|+||++++++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999998654 4788889999999999999999    67899999999999999999999999999986543


Q ss_pred             CCCcce-eccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLI-QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~-~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...... .....++..|+|||.+    .+.++||||||+++||+++|+.||..............   ..    ....+ 
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~----~~~~~-  228 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QP----TNPQL-  228 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc---cC----CCCCC-
Confidence            221111 1234578899999954    56789999999999999999999865332111111000   00    00000 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                              +..+...+.+++.+|+..+|++||++.|+++.
T Consensus       229 --------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         229 --------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                    11224468899999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-37  Score=293.58  Aligned_cols=234  Identities=24%  Similarity=0.399  Sum_probs=186.4

Q ss_pred             CccCCCCceEEEEEEeCCCC-----------EEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          179 NLLGIGSFGSVYKGTLSDGT-----------NVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      +.||+|+||.||+|...+..           .+++|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36999999999999976432           5788887655433 5778999999999999999999999988 778999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-------cEEEecccc
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-------VAHVSDFGI  320 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-------~~kl~Dfg~  320 (457)
                      |||+++|+|.+++......+++..+..++.|++.||+|||    ..+|+||||||+||+++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999999876656899999999999999999999    67899999999999999888       799999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                      +.....      .....++..|+|||.+      .+.++||||||+++|||++ |..|+..........+..        
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--------  220 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--------  220 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--------
Confidence            987543      1224467789999943      5678999999999999999 577776543221111111        


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                         .........        ...+.+++.+|+..+|.+||++.+|++.|+
T Consensus       221 ---~~~~~~~~~--------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ---DQHRLPMPD--------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---cCCCCCCCC--------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               000000000        145889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=306.45  Aligned_cols=251  Identities=22%  Similarity=0.277  Sum_probs=191.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888899999999999999875 68999999997532   223456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++......+++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999875556889999999999999999999    7789999999999999999999999999987654322


Q ss_pred             CcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      . .......||+.|+|||.+         ++.++|||||||++|||++|+.||.....   .+.........  ...  .
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---~~~~~~i~~~~--~~~--~  228 (331)
T cd05597         157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHK--EHF--Q  228 (331)
T ss_pred             C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---HHHHHHHHcCC--Ccc--c
Confidence            1 112234689999999944         46689999999999999999999965322   11111111000  000  0


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCM--ESPDERIHTTNAAAK  441 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~--~~P~~RPs~~ev~~~  441 (457)
                      +...      ....+..+.+++.+|+.  .++..||++.+++..
T Consensus       229 ~~~~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 FPPD------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCc------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0000      00123456777777664  444458898888754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=295.77  Aligned_cols=245  Identities=25%  Similarity=0.362  Sum_probs=206.4

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      -|+...+||+|+||+||+|.++ .|+.+|+|.+...  .+.+++.+|+.++++++.|++|+++|.|.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3566679999999999999875 7999999998754  356788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      -|+..+.+..++.++.+.++..++.+.++||+|||    ...-+|||||+.|||++.+|.+||+|||.+..+...  -..
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH----~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK  185 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH----DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK  185 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH----HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence            99999999998889999999999999999999999    555799999999999999999999999999876431  122


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchh
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS  408 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~  408 (457)
                      .....||+.|||||++    +..++||||+|++..||..|++||.+........             .-+  ......+.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------------MIP--T~PPPTF~  250 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------------MIP--TKPPPTFK  250 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------------ecc--CCCCCCCC
Confidence            3457899999999965    7889999999999999999999998754322111             111  12233344


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          409 AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       409 ~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .+++....+.+++.+|+-++|++|-|+.++++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            556667789999999999999999999988763

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.7e-38  Score=318.35  Aligned_cols=257  Identities=25%  Similarity=0.299  Sum_probs=187.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecC--------C
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--------D  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  242 (457)
                      .++|...+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++.+++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457899999999999999999874 68899999885432    2345799999999999999998876432        2


Q ss_pred             eeEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEecc
Q 044428          243 FKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDF  318 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Df  318 (457)
                      ..++||||++ ++|.+++..   ....+++.....++.|++.||+|||    ..+|+||||||+|||++.++ .+||+||
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            4678999997 577777653   3356889999999999999999999    67899999999999999664 7999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch--
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK--  391 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~--  391 (457)
                      |+++.+.....   .....||+.|+|||.+     ++.++|||||||++|||++|..||...........+.......  
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99987643322   1235689999999943     5778999999999999999999997643322222111111110  


Q ss_pred             -hHHhccccccc--------cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 -LAEVVDSNLVR--------REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 -~~~~~d~~l~~--------~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ......+....        ......-+...+.++.+++.+|++.+|.+|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence             00001110000        00000000112456889999999999999999999884

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=292.38  Aligned_cols=249  Identities=26%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|+..+.||.|+||.||+|... +++.+++|.+..........+.+|++++++++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888889999999999999874 67889999998665556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++......++......++.|++.|+.|||    ..+++|+||+|+||++++++.+||+|||.+........  
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  156 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--  156 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence            999999999876556899999999999999999999    67899999999999999999999999999886543211  


Q ss_pred             eeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          332 IQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ......++..|+|||..       .+.++||||||+++|||+||+.||..............       ..+.+..    
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~----  225 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-------SNFPPPK----  225 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------ccCCCcc----
Confidence            12235678899999943       55689999999999999999999975432111110000       0000000    


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        .......+..+.+++.+|++.+|.+||++.+|+.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0011123456899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-37  Score=295.58  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777789999999999999864 68999999987665455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++.... .+++.+...++.|++.|+.|||    ..+++|+||||+||+++.++.+||+|||++.......  .
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A  161 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence            9999999987654 4889999999999999999999    6789999999999999999999999999987653221  1


Q ss_pred             eeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          332 IQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ......|+..|+|||.+       ++.++|||||||++|||++|+.||.............   ..   ....+... . 
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~---~~---~~~~~~~~-~-  233 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT---KS---NFQPPKLK-D-  233 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh---cc---CCCCCccc-c-
Confidence            12335689999999954       4568999999999999999999986533211110000   00   00000000 0 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           ...++..+.+++.+|++.+|++||++.++++
T Consensus       234 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 -----KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 0012345789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=295.44  Aligned_cols=244  Identities=28%  Similarity=0.340  Sum_probs=197.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++.+++......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999875 68999999987553 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++...  .+++.....++.|++.|+.|||    ..+++|+||+|+||++++++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            9999999999876  5899999999999999999999    67899999999999999999999999999987754321 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......++..|+|||..    .+.++||||||+++|||+||+.||...........+...        ..+.+...   
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~---  221 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--------NPPSLEGN---  221 (274)
T ss_pred             -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc--------CCCCCccc---
Confidence             12235678899999943    678999999999999999999999754321111111111        01111100   


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           .++..+.+++.+|+..+|++||+++++++
T Consensus       222 -----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 -----KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 02445889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.6e-38  Score=299.92  Aligned_cols=257  Identities=23%  Similarity=0.308  Sum_probs=198.9

Q ss_pred             cCHHHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeee-
Q 044428          163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCS-  239 (457)
Q Consensus       163 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  239 (457)
                      +.+.++..+.++|+..+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445566778899999999999999999999874 68899999876432 2235678899999999 6999999999874 


Q ss_pred             ----cCCeeEEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          240 ----NLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       240 ----~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                          ..+..++||||+++++|.+++...   ...+++..+..++.|++.|+.|||    ..+++||||||+||++++++.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCC
Confidence                345789999999999999988632   245788899999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHH
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW  383 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~  383 (457)
                      +||+|||+++.+.....  ......|++.|+|||.+         ++.++|||||||++|||++|+.||.......  ..
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~  238 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL  238 (286)
T ss_pred             EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH
Confidence            99999999887643211  12234689999999954         4678999999999999999999987543211  11


Q ss_pred             HHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       384 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .. ..     ....+.+..       +..+...+.+++.+|++.+|++||++.|+++.
T Consensus       239 ~~-~~-----~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FK-IP-----RNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hh-cc-----ccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00 00     000000000       00113458899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-37  Score=293.08  Aligned_cols=245  Identities=20%  Similarity=0.286  Sum_probs=195.7

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ-LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      +|+..+.||+|+||.||++... +++.+|+|.++.. .......+.+|+.+++.++|+||+++.+++...+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677789999999999999875 7899999998643 2334567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++|+|.+++.... ..++......++.+++.||.|||    ..+++|+||||+||++++++.++++|||.+........ 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            9999999987543 45788999999999999999999    77899999999999999999999999999986643221 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......+++.|+|||..    .+.++||||||+++|+|++|+.||........   .........    . .+      
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~----~-~~------  220 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKVCQGSY----K-PL------  220 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHHhcCCC----C-CC------
Confidence             12235688899999943    67799999999999999999999975432111   111100000    0 00      


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                         +..+...+.+++.+||+.+|++||++.+++..
T Consensus       221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               01123457899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.7e-38  Score=313.07  Aligned_cols=198  Identities=23%  Similarity=0.365  Sum_probs=167.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5778899999999999999864 68899999997542   2334578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++.... .++......++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999997654 4788888889999999999999    67899999999999999999999999999753311000


Q ss_pred             ---------------------------------------------cceeccccccccccCCCCC----CCCccchhhhhH
Q 044428          330 ---------------------------------------------SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGI  360 (457)
Q Consensus       330 ---------------------------------------------~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gv  360 (457)
                                                                   ........||+.|+|||.+    ++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         0001124689999999954    677999999999


Q ss_pred             HHHHHhcCCCCCCCCC
Q 044428          361 LLLETFSRKKPTNDLG  376 (457)
Q Consensus       361 vl~el~tg~~p~~~~~  376 (457)
                      ++|||++|+.||....
T Consensus       237 il~elltG~~Pf~~~~  252 (382)
T cd05625         237 ILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHhCCCCCCCCC
Confidence            9999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=287.54  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=199.0

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +++|+..+.||+|.|+.||++.. .+|+.+|+|++...  .....+.+.+|+++.+.++||||+++...+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45677778999999999999975 47999999998754  2346778899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~~~  325 (457)
                      |+|.|++|..-+-.+ ...++...-..+.||++||.|.|    .++|||||+||+|+++-   ..--+||+|||+|..++
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999998766544 34677788889999999999999    78899999999999995   33468999999999886


Q ss_pred             CCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .+   .......|||+|||||.+    ++..+|||+.||+||-|+.|..||.+.+..++.+.+.+.-    .++     .
T Consensus       165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~----yd~-----~  232 (355)
T KOG0033|consen  165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA----YDY-----P  232 (355)
T ss_pred             Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc----cCC-----C
Confidence            32   234567899999999954    7889999999999999999999998755444333222110    011     0


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           ..++....++..+|+.+|+..||.+|.|+.|.+.
T Consensus       233 -----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 -----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                 1122233456789999999999999999998764

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-37  Score=299.86  Aligned_cols=246  Identities=23%  Similarity=0.305  Sum_probs=197.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ..+|...+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788899999999999999986 47999999999765555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++.+..  +++.++..++.+++.||.|||    ..+++||||||+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             cCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            99999999997643  788999999999999999999    67899999999999999999999999999886543221 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......+++.|+|||..    .+.++|||||||++|++++|+.||..........   ......     .+.+      
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~~~-----~~~~------  235 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNG-----TPEL------  235 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eeccCC-----CCCC------
Confidence             12235688899999943    5678999999999999999999996533211000   000000     0000      


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ..+......+.+++.+|++.+|++||++.++++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             001122445789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.5e-38  Score=314.96  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=189.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +|+..+.||+|+||.||+++.. +++.||||++....   ......+.+|++++++++||||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888899999999999999864 68999999986532   2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++.... .++......++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999997754 4788888889999999999999    67899999999999999999999999999753310000


Q ss_pred             -----------------------------------------cceeccccccccccCCCCC----CCCccchhhhhHHHHH
Q 044428          330 -----------------------------------------SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLE  364 (457)
Q Consensus       330 -----------------------------------------~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~e  364 (457)
                                                               ........||+.|+|||.+    ++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     0001124699999999944    6779999999999999


Q ss_pred             HhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 044428          365 TFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI---HTTNAAAK  441 (457)
Q Consensus       365 l~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP---s~~ev~~~  441 (457)
                      |++|+.||...........+.. ..        ..+....     .......+.+++.+|+ .+|++|+   ++.++++.
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~-~~--------~~~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVIN-WE--------TTLHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhc-cC--------ccccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999976432211111100 00        0000000     0011334667777765 5999999   78888753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7e-38  Score=305.59  Aligned_cols=238  Identities=23%  Similarity=0.272  Sum_probs=184.1

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHH-HHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSEC-EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999875 67889999987542   12223444444 456788999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+.......++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~  153 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT  153 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence            99999998654 3677788889999999999999    77899999999999999999999999999875432111  22


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||...........+.           .......      
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-----------~~~~~~~------  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-----------NKPLQLK------  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH-----------hCCcCCC------
Confidence            345699999999943    6779999999999999999999997543222211111           1111000      


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                       ......+.+++.+|++.+|.+||++.+.+..
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         217 -PNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence             0123457899999999999999998765443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-37  Score=315.34  Aligned_cols=257  Identities=19%  Similarity=0.196  Sum_probs=190.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ..|...+.||+|+||.||++... .++.||||...      ...+.+|++++++++|+|||++++++...+..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            36888899999999999999875 57889999643      234578999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                       .++|.+++......+++.+++.++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.........
T Consensus       243 -~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        243 -RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence             57999998776566999999999999999999999    6789999999999999999999999999998764332222


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCC----C----cHHHHHHhhc------Cch--
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGE----M----SLKHWVNQSL------PHK--  391 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~----~----~l~~~~~~~~------~~~--  391 (457)
                      ......||+.|+|||.+    ++.++|||||||++|||++|..|+-....    .    .+...+....      +..  
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            22345799999999944    67899999999999999998876533111    0    1111111100      000  


Q ss_pred             --hHHhcccc---ccccccchhHHH---HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 --LAEVVDSN---LVRREHSFSAKM---DCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 --~~~~~d~~---l~~~~~~~~~~~---~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        +.......   ..........+.   .....+.+++.+|++.||++|||+.|+++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence              00000000   000000000000   11235788999999999999999999986

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-37  Score=299.06  Aligned_cols=245  Identities=22%  Similarity=0.314  Sum_probs=197.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+|+..+.||.|++|.||+|.. .+|+.||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3578888999999999999985 578999999997655555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++...  .+++.++..++.+++.|+.|||    +.+++||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            999999999765  3899999999999999999999    77899999999999999999999999999886543322  


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      ......++..|+|||.+    .+.++|||||||++||+++|+.||...........+....        .+.+.      
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~~------  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--------TPELQ------  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------CcccC------
Confidence            12234688899999944    5678999999999999999999997643211111111000        00000      


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       .+..++..+.+++.+|+..+|++||++.+++.
T Consensus       237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             01122446889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-37  Score=308.02  Aligned_cols=260  Identities=23%  Similarity=0.262  Sum_probs=191.3

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-----  242 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  242 (457)
                      ..++|...+.||+|+||.||++... +|..||||++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999864 68999999987542  233456789999999999999999999886443     


Q ss_pred             -eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          243 -FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       243 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                       ..++||||+++ +|.+.+..   .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999964 67666643   2788888999999999999999    778999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchh-----
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL-----  392 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~-----  392 (457)
                      +.....   .......||+.|+|||.+    ++.++|||||||++|||++|+.||...+.......+........     
T Consensus       171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            764321   122345689999999954    67799999999999999999999976432221111111111100     


Q ss_pred             ------HHhccccccccccch-------------hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          393 ------AEVVDSNLVRREHSF-------------SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       393 ------~~~~d~~l~~~~~~~-------------~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                            ...............             .........+.+++.+|++.||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  000000000000000             0000113457899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-37  Score=302.68  Aligned_cols=268  Identities=21%  Similarity=0.272  Sum_probs=193.3

Q ss_pred             CCccCCC--CceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          178 CNLLGIG--SFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       178 ~~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      .++||+|  +|++||+++.. +|+.||+|++....  ......+.+|+++++.++||||+++++++...+..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4589999  78999999864 78999999997543  2334567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          253 NGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       253 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +|+|.+++.... ..+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.++++||+............
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999997543 34889999999999999999999    6789999999999999999999999998765432211110


Q ss_pred             -----eeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHH-HHHHhhcCchh-------
Q 044428          332 -----IQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK-HWVNQSLPHKL-------  392 (457)
Q Consensus       332 -----~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~-~~~~~~~~~~~-------  392 (457)
                           ......++..|+|||.+      ++.++|||||||++|||++|+.||......... .......+...       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 11123467789999944      567899999999999999999999753321111 11110000000       


Q ss_pred             HHh--------ccccccc----------c--ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHhHHHH
Q 044428          393 AEV--------VDSNLVR----------R--EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA--KLRKIKVQF  449 (457)
Q Consensus       393 ~~~--------~d~~l~~----------~--~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~--~L~~i~~~~  449 (457)
                      .+.        .+..+..          .  .............+.+++.+|++.||++|||+.|+++  .+.+++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~~  317 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA  317 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchhh
Confidence            000        0000000          0  0000001122456889999999999999999999986  344444333

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.3e-38  Score=297.61  Aligned_cols=243  Identities=26%  Similarity=0.336  Sum_probs=194.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3555668999999999999864 67899999987543 344567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++...  .+++..+..++.+++.|+.|||    ..+++|+||+|+||++++++.++|+|||++..+.....  
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            999999998764  4889999999999999999999    67899999999999999999999999999987643221  


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      ......++..|+|||..    ++.++||||||+++|||++|+.|+..........++...        ..+.+.      
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~------  222 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------SPPTLE------  222 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------CCCCCC------
Confidence            11224578899999943    567899999999999999999998754322221111110        001110      


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                         ..++..+.+++.+|++.+|++||++.++++.
T Consensus       223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 ---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               1224568899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6e-38  Score=295.82  Aligned_cols=235  Identities=24%  Similarity=0.338  Sum_probs=185.9

Q ss_pred             CccCCCCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          179 NLLGIGSFGSVYKGTLSD--------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +.||+|+||.||+|....        ...||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998642        234888888665545556788999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc--------EEEecccccc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV--------AHVSDFGISK  322 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~--------~kl~Dfg~~~  322 (457)
                      +++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999877666899999999999999999999    778999999999999987765        5999999887


Q ss_pred             ccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCC-CCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRK-KPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~-~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      .....      ....++..|+|||.+     ++.++||||||+++||+++|. .|+..........            +.
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~------------~~  218 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ------------FY  218 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH------------HH
Confidence            54321      224578899999944     466899999999999999985 5554332211111            00


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                      ..... ...      .....+.+++.+|++.+|++|||+.++++.|
T Consensus       219 ~~~~~-~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         219 EDRHQ-LPA------PKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             Hcccc-CCC------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            00000 000      0124588999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.8e-38  Score=306.17  Aligned_cols=238  Identities=25%  Similarity=0.312  Sum_probs=184.9

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECE-VLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +|+.+|+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999864 78999999997542   222344555554 46778999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|..++.... .+++.....++.||+.||+|||    ..+|+||||||+|||+++++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  153 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT  153 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence            99999887654 4889999999999999999999    77899999999999999999999999999875322111  22


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||.......   .....        ....+....     
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~--------~~~~~~~~~-----  217 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNI--------LHKPLVLRP-----  217 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHH--------HcCCccCCC-----
Confidence            345689999999943    6779999999999999999999997543211   11111        111110000     


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        .....+.+++.+|++.+|++||++.+.++.
T Consensus       218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         218 --GASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             --CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence              113457899999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.4e-37  Score=296.23  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=191.8

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      |+..+.||+|+||+||+|... +++.+|+|.+....   ......+.+|++++++++|+||+++.+++...+..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556678999999999999874 78999999986542   22234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++++|.+++.... ..+++.....++.|++.||.|||    ..+|+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999999887543 45899999999999999999999    67899999999999999999999999999876532211


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                         .....|+..|+|||.+    ++.++|+||||+++||+++|+.||...........+........     ...     
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-----~~~-----  224 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-----EVY-----  224 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-----ccc-----
Confidence               1235689999999944    67789999999999999999999975432111111111111000     000     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                          .......+.+++..|++.+|++||+     +.+++.
T Consensus       225 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 ----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                0112345789999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.4e-37  Score=294.11  Aligned_cols=246  Identities=25%  Similarity=0.326  Sum_probs=191.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577788999999999999986 478999999986542 33345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|..+.     .+++.....++.|++.||.|||    ..+++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9999997653     2678888999999999999999    7889999999999999999999999999998653321  


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH-hcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE-VVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~-~~d~~l~~~~~  405 (457)
                        .....++..|+|||.+    .+.++||||||+++|||++|+.||..........     ......+ ..+........
T Consensus       150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  222 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-----MPLQLLQCIVDEDPPVLPV  222 (279)
T ss_pred             --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-----chHHHHHHHhccCCCCCCC
Confidence              2335689999999954    6779999999999999999999996522111000     0000000 01110000000


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                           ......+.+++.+|++.+|++||++.|+++.
T Consensus       223 -----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         223 -----GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 0113457899999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1e-37  Score=303.83  Aligned_cols=233  Identities=23%  Similarity=0.291  Sum_probs=181.7

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECE-VLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 68899999987542   222334555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|..++.... .++......++.||+.||.|||    ..+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT  153 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence            99999887653 4778888899999999999999    6789999999999999999999999999987532211  122


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||...+.   .......        ....+.-.      
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i--------~~~~~~~~------  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNI--------LHKPLQLP------  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHH--------hcCCCCCC------
Confidence            345689999999944    67799999999999999999999975432   1111111        11111000      


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTT  436 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~  436 (457)
                       ......+.+++.+|++.+|.+||++.
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 -GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             01134578999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-37  Score=304.59  Aligned_cols=251  Identities=21%  Similarity=0.251  Sum_probs=192.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888899999999999999875 57889999986432   223345888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++......+++.....++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999876556899999999999999999999    6789999999999999999999999999987653322


Q ss_pred             CcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      . .......||+.|+|||.+         ++.++|||||||++|||++|+.||.....   ............ ..   .
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~-~~---~  228 (332)
T cd05623         157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHKE-RF---Q  228 (332)
T ss_pred             c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH---HHHHHHHhCCCc-cc---c
Confidence            1 122335799999999943         46789999999999999999999975432   111111111000 00   0


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCME--SPDERIHTTNAAAK  441 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~--~P~~RPs~~ev~~~  441 (457)
                      +..      ....+...+.+++.+|+..  ++..||++.|+++.
T Consensus       229 ~p~------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPA------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCC------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000      0012244577788887754  44447888888755

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.9e-37  Score=295.31  Aligned_cols=261  Identities=22%  Similarity=0.283  Sum_probs=196.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|++....  ....+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36788889999999999999876 68999999986542  2223567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++++|..++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999998888776543 4899999999999999999999    67899999999999999999999999999987644321


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---hhHHhcccc--
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---KLAEVVDSN--  399 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~~~~~~d~~--  399 (457)
                        ......++..|+|||.+     .+.++||||||+++|||++|+.||......+...........   ...+..+..  
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              12234578899999943     467899999999999999999999764432222211111111   001111100  


Q ss_pred             ---c--ccccc--ch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 ---L--VRREH--SF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 ---l--~~~~~--~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         +  .....  .. .........+.+++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               0  00000  00 000112456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=310.03  Aligned_cols=241  Identities=29%  Similarity=0.361  Sum_probs=199.9

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      -|...+.||.|+||.||.|+. .+...||||.+....++.   -.++.+|+..|++++|||++.+.|+|......+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            355567899999999999986 478899999998654333   4578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      || -|+-.+++.-.+.++...++..|..+.+.||.|||    +.+.||||||+.|||+++.|.+||+|||.|....+.. 
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-  180 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-  180 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence            99 68999999888788999999999999999999999    6779999999999999999999999999998876543 


Q ss_pred             cceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                           ...|||.|||||++       |+-|+||||+|+++.||..+++|+-...-.+....+.+.-        .|.+. 
T Consensus       181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe--------sPtLq-  246 (948)
T KOG0577|consen  181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------SPTLQ-  246 (948)
T ss_pred             -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC--------CCCCC-
Confidence                 36799999999954       7789999999999999999999975544332222222211        12221 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                             ..+....+.+++..|+++-|++|||..++++-
T Consensus       247 -------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 -------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                   11335568999999999999999999998753

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.6e-37  Score=290.79  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=194.8

Q ss_pred             cCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      +|...+.||+|+||.||+|...+|+.+|+|.+....      ......+.+|++++++++|+||+++++++...+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467778999999999999998889999999886432      22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      +||+++++|.+++.+.. .+++..+..++.|++.|++|||    ..+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999997654 4788899999999999999999    677999999999999999999999999998865321


Q ss_pred             CC----cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          328 DD----SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       328 ~~----~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ..    ........++..|+|||.+    .+.++||||||+++||+++|+.||...............  .    ...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~----~~~~~  229 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH--R----GLMPR  229 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc--c----CCCCC
Confidence            11    1112235688999999954    567899999999999999999999754321111110000  0    00011


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +..         .....+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~---------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 LPD---------SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC---------CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            110         12445789999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-37  Score=298.64  Aligned_cols=244  Identities=22%  Similarity=0.299  Sum_probs=193.7

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      |.....||+|+||.||++... ++..||||.+..........+.+|+..++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            333457999999999999864 6889999998765555566789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      ++|.+++...  .+++.....++.+++.||.|||    ..+++||||||+||++++++.++|+|||++........  ..
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  175 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR  175 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence            9999998654  3889999999999999999999    67899999999999999999999999999876532211  12


Q ss_pred             ccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....++..|+|||.    ..+.++||||||+++||+++|+.||...........+.        ....+......     
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~-----  242 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR--------DNLPPRVKDSH-----  242 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcCCCcccccc-----
Confidence            23568899999994    36789999999999999999999987533211111111        11111111100     


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        .....+.+++.+|+..+|++|||+.|+++.
T Consensus       243 --~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 --KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              113457889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4e-37  Score=289.45  Aligned_cols=245  Identities=30%  Similarity=0.529  Sum_probs=197.0

Q ss_pred             CcCCccCCCCceEEEEEEeCC-----CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          176 DECNLLGIGSFGSVYKGTLSD-----GTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ...+.||.|+||.||+++..+     +..||+|.+...... ....+..|++.+..++|+||+++++++...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999998753     488999999765433 56689999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |+++++|.+++...... +++..+..++.|++.|++|||    ..+++|+||+|+||++++++.++|+|||+++......
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999876543 899999999999999999999    6789999999999999999999999999998765432


Q ss_pred             CcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ... .....++..|+|||.    ..+.++||||+|++++||++ |+.||.......+...+....           ....
T Consensus       158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------~~~~  225 (258)
T smart00219      158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-----------RLPK  225 (258)
T ss_pred             ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------CCCC
Confidence            221 112347789999993    47789999999999999998 788886543322222221111           0000


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                            ...++..+.+++.+|+..+|++|||+.|+++.|
T Consensus       226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  011355689999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.1e-37  Score=295.04  Aligned_cols=261  Identities=21%  Similarity=0.289  Sum_probs=200.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|++|.||+|+.. +|+.||+|++....  ......+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999874 78999999987653  33356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      + +++|.+++......+++.++..++.|++.||.|||    ..+++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 99999999876667899999999999999999999    67899999999999999999999999999987644321 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhccc---
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVVDS---  398 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~d~---  398 (457)
                      .......++..|+|||.+     .+.++||||+|++++||+||+.||..........++.......    +.+..+.   
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence            112335688999999954     4678999999999999999988886543322222222211110    1110000   


Q ss_pred             c---cccccc-ch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          399 N---LVRREH-SF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       399 ~---l~~~~~-~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .   ...... .. ....+....+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   000000 00 000122467899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-37  Score=302.44  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=187.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +|+..+.||+|+||.||+|... +|+.||+|++....   ......+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999865 78999999997542   233456778888988886 577888999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.++..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            9999999999997654 4889999999999999999999    6789999999999999999999999999987542211


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                        .......||+.|+|||.+    ++.++|||||||++|||++|+.||...........+.           ..... ..
T Consensus       156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-----------~~~~~-~p  221 (323)
T cd05615         156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM-----------EHNVS-YP  221 (323)
T ss_pred             --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------hCCCC-CC
Confidence              112335689999999943    6789999999999999999999997643222211111           11100 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                            ......+.+++.+|++.+|.+|++.
T Consensus       222 ------~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         222 ------KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence                  0123457899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-37  Score=293.83  Aligned_cols=250  Identities=26%  Similarity=0.458  Sum_probs=193.7

Q ss_pred             CCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 044428          175 FDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD------  242 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  242 (457)
                      |...+.||+|+||.||+|.+.    +++.||||++....  ......+.+|+++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999863    46889999987542  334567889999999999999999999876532      


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEec
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                      ..++++||+++|+|.+++....     ..+++....+++.|++.|++|||    ..+|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEECc
Confidence            3478999999999998875321     34788899999999999999999    67899999999999999999999999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchh
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKL  392 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~  392 (457)
                      ||+++...............++..|++||..    .+.++||||||+++|||++ |+.||..........+.....    
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----  232 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN----  232 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC----
Confidence            9999876433222122233456789999943    5779999999999999999 888886544322222222110    


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                            .+..       ...++..+.+++.+|++.+|++||++.++.+.|+++
T Consensus       233 ------~~~~-------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 ------RLKQ-------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------cCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0000       012245689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=288.39  Aligned_cols=262  Identities=24%  Similarity=0.319  Sum_probs=201.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCc-cceeeeeeecCC------
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRN-LIKILSGCSNLD------  242 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  242 (457)
                      ..|...++||+|+||+||+|+.. +|+.||+|.++...+  +......+|+.++.+++|+| ||++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44566678999999999999864 789999999986643  33445689999999999999 999999998877      


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                      ..++||||+ .-+|..++....   ..++...+..++.|+..||+|||    +.+|+||||||.|||++++|.+||+|||
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeeeccc
Confidence            789999999 579999998765   34777788999999999999999    7889999999999999999999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----  390 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----  390 (457)
                      +|+...-...  ..+...+|..|.|||.+     +++..||||+||++.||++++.-|....+.+....+-..+..    
T Consensus       166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9997653222  24557789999999944     677899999999999999999999876554443333332221    


Q ss_pred             hhHHhc---cccc--cccccchhHHH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          391 KLAEVV---DSNL--VRREHSFSAKM---DCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       391 ~~~~~~---d~~l--~~~~~~~~~~~---~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .+..+.   +-..  ........-..   .-.....+++.+|++.+|.+|.|+..++..
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            122111   1110  00000000000   111357899999999999999999999875

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-37  Score=304.74  Aligned_cols=261  Identities=22%  Similarity=0.268  Sum_probs=193.1

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC----
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL----  241 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  241 (457)
                      ....++|...+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34567899999999999999999986 478899999987542  22345677899999999999999999887533    


Q ss_pred             --CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          242 --DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       242 --~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                        ...++++|++ +++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||++++++.+||+|||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEcCCc
Confidence              4578999988 78999888654  3899999999999999999999    6789999999999999999999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      +++.....     .....||+.|+|||.+     ++.++|||||||++|||++|+.||...........+.........+
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99865332     1235689999999943     5678999999999999999999997543222111111111000000


Q ss_pred             hc---c--------ccccccccc-hh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          395 VV---D--------SNLVRREHS-FS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       395 ~~---d--------~~l~~~~~~-~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ..   .        ..+...... .. ........+.+++.+|++.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00   0        000000000 00 000112346899999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-37  Score=295.28  Aligned_cols=248  Identities=24%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||.||++... +|..||+|.+.... ......+.+|++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36778889999999999999876 78999999887542 33346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      +++++|.+++...  ...+++..+..++.+++.||.|||+   ..+++|+||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999998764  2358999999999999999999994   2479999999999999999999999999987653221


Q ss_pred             CcceeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                          .....++..|+|||.+          ++.++|||||||++|||++|+.||............        ..+.+.
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~  225 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL--------SAIVDG  225 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH--------HHHhhc
Confidence                2234578899999954          367899999999999999999999653321111111        111111


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ....      .+.++...+.+++.+|++.+|++||++.+++..
T Consensus       226 ~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         226 DPPT------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCC------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1000      011235568899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-37  Score=304.07  Aligned_cols=250  Identities=20%  Similarity=0.263  Sum_probs=192.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+++.. +++.||+|++....   ......+.+|..++..++|+||+++.+++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999875 68899999987532   223445788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++......+++.....++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999875556889999999999999999999    7889999999999999999999999999998764322


Q ss_pred             CcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      . .......||+.|+|||.+         ++.++|||||||++|||++|+.||......   ..........      ..
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~------~~  226 (331)
T cd05624         157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHE------ER  226 (331)
T ss_pred             c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHHHcCC------Cc
Confidence            2 122335699999999933         567899999999999999999999753321   1111111000      00


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDE--RIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPs~~ev~~  440 (457)
                      +. ...   ...+.+..+.+++.+|+...+++  |+++.++.+
T Consensus       227 ~~-~p~---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 FQ-FPS---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cc-CCC---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            00 000   00112445788888888765544  467777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-37  Score=302.02  Aligned_cols=237  Identities=21%  Similarity=0.294  Sum_probs=185.6

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+++.. +++.||+|++....   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999875 67899999998643   23345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT  153 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence            99999887654 4899999999999999999999    67899999999999999999999999999875322111  12


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCC---CcHHHHHHhhcCchhHHhccccccccccc
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGE---MSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~---~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ....||+.|+|||.+    ++.++|||||||++|||++|+.||.....   .....+.....       ...... ..  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~~-~p--  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-------LEKPIR-IP--  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-------HhCCCC-CC--
Confidence            346789999999943    67799999999999999999999964221   11112221111       111000 00  


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTT  436 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~  436 (457)
                          ......+.+++.+|++.||++||++.
T Consensus       224 ----~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         224 ----RFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ----CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                01134578999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-37  Score=298.07  Aligned_cols=256  Identities=25%  Similarity=0.321  Sum_probs=199.1

Q ss_pred             cCHHHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 044428          163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSN  240 (457)
Q Consensus       163 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  240 (457)
                      ++..++..++++|...+.||+|+||.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344566677899999999999999999999874 78899999986542 2235677899999999 89999999998865


Q ss_pred             C-----CeeEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          241 L-----DFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       241 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      .     +..++||||+++|+|.++++.   ....+++..+..++.|++.||.|||    ..+++||||||+||++++++.
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCC
Confidence            3     358999999999999998864   2345889999999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHH
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW  383 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~  383 (457)
                      +||+|||++........  ......++..|+|||.+         .+.++|||||||++|||++|+.||...........
T Consensus       167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~  244 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK  244 (291)
T ss_pred             EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence            99999999887543221  12235688999999954         46789999999999999999999975432111110


Q ss_pred             HHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       384 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .....        .+.+.       ...+....+.+++.+|++.+|++||++.|+++
T Consensus       245 ~~~~~--------~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 IPRNP--------PPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HhcCC--------CCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00000        00000       01112345889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.4e-38  Score=294.51  Aligned_cols=248  Identities=31%  Similarity=0.427  Sum_probs=193.9

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhh--HHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERT--FVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      |+..+.||+|+||+||+++.. +++.+|+|++.......  .....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456679999999999999976 56789999998764332  223456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++... ..+++..+..++.|++.||.+||    +.+++|+||||+||++++++.++|+|||.+.....  ...
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE  153 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred             cccccccccccc-ccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccc--ccc
Confidence            999999999833 34899999999999999999999    67899999999999999999999999999986411  122


Q ss_pred             eeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......++..|+|||.     ..+.++||||+|+++++|++|..||......+..............    .....    
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~----  225 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP----SSSQQ----  225 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH----HHTTS----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc----ccccc----
Confidence            3345678999999994     3677999999999999999999999765211222221111111100    00000    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         .......+.+++.+|++.+|++||++.++++
T Consensus       226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0001256899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-37  Score=297.57  Aligned_cols=261  Identities=25%  Similarity=0.320  Sum_probs=196.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  .....+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36778899999999999999985 589999999865432  234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++++|.++..... .+++..+..++.|++.||.|||    ..+++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            999999988776543 3899999999999999999999    67899999999999999999999999999887543221


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHh---hcCchhHHhcccc--
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ---SLPHKLAEVVDSN--  399 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~---~~~~~~~~~~d~~--  399 (457)
                        ......++..|+|||..     .+.++||||||+++|||++|+.||......+...-+..   .+.+...+..+..  
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence              12234578899999943     46789999999999999999999865432211111111   0111111111100  


Q ss_pred             --------ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 --------LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 --------l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              ..............+..+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                    00000000001123556899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.5e-37  Score=294.28  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=192.5

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      |+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|+|++++.+.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566779999999999999875 78999999986542   12234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999986543 45889999999999999999999    77899999999999999999999999999876533221


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                         .....|+..|+|||.+    ++.++||||||+++|||++|+.||..........-..... ....    ....    
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~----~~~~----  225 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQ----EEYS----  225 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhh----hhcC----
Confidence               1234689999999943    6789999999999999999999997533211111111100 0000    0000    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                           ..+...+.+++.+|++.+|++|||     +.|+++
T Consensus       226 -----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 -----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 112345789999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-37  Score=295.88  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=193.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|++|.||+|+.. ++..||+|.+....  ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999875 78999999986542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ++ ++|.+++....  ..+++..+..++.|++.||.|||    ..+++||||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 68998887543  45899999999999999999999    6789999999999999999999999999998653321


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC---ch-h---HHh-
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP---HK-L---AEV-  395 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~---~~-~---~~~-  395 (457)
                        .......+++.|+|||.+     .+.++||||||++++||+||+.||..........-......   .. +   ... 
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              112234578899999943     46789999999999999999999975332111100000000   00 0   000 


Q ss_pred             -cccccccccc--chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 -VDSNLVRREH--SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 -~d~~l~~~~~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ..........  ..........++.+++.+|++.||++|||+.+|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000000000  00000112456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.6e-37  Score=295.91  Aligned_cols=260  Identities=25%  Similarity=0.308  Sum_probs=196.3

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER-----TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      +|+..+.||+|++|.||+|... +|+.||+|.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3667789999999999999875 6899999999754322     234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+ +|+|.+++......+++..+..++.|++.||.|||    ..+++|+||+|+||+++.++.++|+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 99999999876546899999999999999999999    678999999999999999999999999999876443


Q ss_pred             CCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHH---h
Q 044428          328 DDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAE---V  395 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~---~  395 (457)
                      ..  ......+++.|+|||.+     ++.++|||||||+++|+++|..||...................    ..+   .
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            21  12234567889999943     4678999999999999999988876544322211111111000    000   0


Q ss_pred             ccccccccccc---hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 VDSNLVRREHS---FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~d~~l~~~~~~---~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.........   ..........+.+++.+|++.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00000000000   0001122456889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-37  Score=295.34  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=188.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCccceeeeeeec-----CC
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNV---RHRNLIKILSGCSN-----LD  242 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  242 (457)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.++....  .....+.+|++++..+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777889999999999999875 789999999875422  2223456677777665   69999999998754     34


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            5789999997 58999887643 34899999999999999999999    678999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC--c--hhH
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--H--KLA  393 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~--~--~~~  393 (457)
                      +......   ......++..|+|||.+    ++.++|||||||++|||++|++||...........+.....  .  .+.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8764321   12335678999999944    67899999999999999999999975432221111111100  0  000


Q ss_pred             Hhc---cccccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          394 EVV---DSNLVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       394 ~~~---d~~l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...   ..........  .....+....+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000   0000000000  0001123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.2e-37  Score=291.03  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=194.4

Q ss_pred             cCCcCCccCCCCceEEEEEEeCC--CCEEEEEEeccc----------chhhHHHHHHHHHHHhh-cCCCccceeeeeeec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLSD--GTNVAIKIFNLQ----------LERTFVSFNSECEVLRN-VRHRNLIKILSGCSN  240 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  240 (457)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36777899999999999999764  788999987532          12234557788888875 799999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEec
Q 044428          241 LDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                      .+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+   ..+++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999998854   33458899999999999999999993   24699999999999999999999999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                      ||.+.......   ......++..|+|||..    ++.++||||||+++|||++|+.||...........+.        
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--------  226 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV--------  226 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh--------
Confidence            99998764332   22345688999999944    5678999999999999999999986533211111111        


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                         +.......     ....+..+.+++.+|++.+|++||++.|+.++++
T Consensus       227 ---~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 ---EAVYEPLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---hccCCcCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               11000000     0012456889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-37  Score=291.61  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=193.7

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc----------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL----------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD  242 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  242 (457)
                      +|...+.||+|+||.||+|... +|+.||+|.+....          ....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566789999999999999864 68999999886421          112346788999999999999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999999998764 5888999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ...............++..|+|||..      .+.++||||||+++||+++|..||......  ..... .........+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~-~~~~~~~~~~  233 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFK-LGNKRSAPPI  233 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHH-hhccccCCcC
Confidence            65332211122335688999999933      567899999999999999999998643221  11111 0000000000


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....         ..+++..+.+++.+|+..+|++||++.+|++
T Consensus       234 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         234 PPDV---------SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             Cccc---------cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0000         1123556889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-37  Score=290.49  Aligned_cols=244  Identities=26%  Similarity=0.391  Sum_probs=192.5

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch---------hhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---------RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      |.....||+|++|.||+|... +++.+|+|.+.....         .....+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            566789999999999999864 688999998864321         1235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++++|.+++.... .+++.....++.+++.|++|||    ..+++||||+|+||++++++.++|+|||.++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999997753 4788899999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCcc----eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          325 GEGDDSL----IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       325 ~~~~~~~----~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      .......    ......|+..|+|||.+    .+.++||||||+++|||++|+.||.........   ..     .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~-----~~~~~  228 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI---FK-----IGENA  228 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH---HH-----HhccC
Confidence            4211110    11124578899999943    567899999999999999999999753321110   00     00111


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.+.         ...+..+.+++.+|++.+|.+||++.|+++
T Consensus       229 ~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         229 SPEIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCcCC---------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            11111         122456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-37  Score=306.23  Aligned_cols=260  Identities=23%  Similarity=0.252  Sum_probs=191.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  241 (457)
                      ..++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 68899999987542  23345678899999999999999999987543      


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      ...++||||++ ++|.+.+..   .+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            35799999996 467777654   3788889999999999999999    788999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC--------
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--------  389 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~--------  389 (457)
                      +.....   .......||..|+|||.+    ++.++|||||||++|||++|+.||...+.......+.....        
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865332   122335689999999944    67799999999999999999999975432111111111000        


Q ss_pred             ---chhHHhcccccc-----------cccc--chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          390 ---HKLAEVVDSNLV-----------RREH--SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       390 ---~~~~~~~d~~l~-----------~~~~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                         ......++....           ....  ...........+.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               001111100000           0000  000001113457899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-37  Score=308.75  Aligned_cols=259  Identities=20%  Similarity=0.217  Sum_probs=193.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS---DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..+|...+.||+|+||.||++...   .+..||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357899999999999999999753   4678999988643     23467999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+. ++|.+++... ..+++..++.++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9995 7899988543 45899999999999999999999    6789999999999999999999999999998765433


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhh---c-------Cch---
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS---L-------PHK---  391 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~---~-------~~~---  391 (457)
                      .........||+.|+|||.+    ++.++|||||||++|||++|+.||...........+...   .       +..   
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            33233346799999999954    577999999999999999999999754322111111110   0       000   


Q ss_pred             -hHHhccccccccccchh-----HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          392 -LAEVVDSNLVRREHSFS-----AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       392 -~~~~~d~~l~~~~~~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                       +...+............     ........+.+++.+|+..+|++||++.|++..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             00000000000000000     000113457789999999999999999999864

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-37  Score=304.02  Aligned_cols=188  Identities=26%  Similarity=0.309  Sum_probs=160.9

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ...+|...+.||+|+||.||+|+.. ++..||+|+....      ....|+.++++++||||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999875 5788999975432      23568999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+ .++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            99 57899998876667999999999999999999999    6789999999999999999999999999987532211 


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCC
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPT  372 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~  372 (457)
                        ......||..|+|||.+    ++.++|||||||++|||+++..|+
T Consensus       212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              12235689999999944    678999999999999999865554

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.7e-37  Score=287.62  Aligned_cols=245  Identities=22%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||.|+||.||.++. .+++.+++|.+....  ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477888999999999999986 468899999986542  34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++... ...+++..+..++.|++.|+.|||    ..+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999999875 355899999999999999999999    67799999999999999999999999999987643221


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        ......+++.|+|||..    .+.++||||||+++|||++|+.||......   .......        .......  
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~--------~~~~~~~--  221 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIV--------QGNYTPV--  221 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH--------cCCCCCC--
Confidence              22335689999999944    567899999999999999999998653321   1111111        1111000  


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                          ...++..+.+++.+|++.+|.+||++.++++.
T Consensus       222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                01224568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7e-37  Score=296.14  Aligned_cols=242  Identities=29%  Similarity=0.351  Sum_probs=194.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..|...+.||+|+||.||+|+.. +|+.||+|.+....   ......+.+|+++++.++||||+++.++|...+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45788889999999999999875 68999999986432   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||++ |++.+++......+++..+..++.|++.||.|||    ..+++||||+|+||++++++.+||+|||++...... 
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9996 6888887765556899999999999999999999    678999999999999999999999999998765332 


Q ss_pred             CcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                           ....++..|+|||.+       ++.++||||||+++|||+||+.||...............   .     .+.+ 
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~-----~~~~-  234 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---D-----SPTL-  234 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---C-----CCCC-
Confidence                 224578899999954       566899999999999999999998654321111111100   0     0000 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                             ....+...+.+++.+||+.+|++||++.+++..
T Consensus       235 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         235 -------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                   011235568999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.8e-37  Score=292.96  Aligned_cols=250  Identities=23%  Similarity=0.412  Sum_probs=197.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|+....||+|+||.||+|+..      +...|++|.+...... ....+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888889999999999999864      3567999998765433 4567999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEec
Q 044428          246 LVLEFMPNGSLEKWLYSHN--------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||    ..+++||||||+||+++.++.++++|
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999997654        15899999999999999999999    67799999999999999999999999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchh
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKL  392 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~  392 (457)
                      ||+++....... .......++..|+|||.+    .+.++||||||+++||+++ |..||..............      
T Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~------  233 (275)
T cd05046         161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA------  233 (275)
T ss_pred             cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc------
Confidence            999875432211 112234567789999944    5678999999999999999 7888865332222221110      


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                           ..+....     ...++..+.+++.+|++.+|++||++.|+++.|.
T Consensus       234 -----~~~~~~~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -----GKLELPV-----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----CCcCCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 0000000     0122456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-37  Score=294.52  Aligned_cols=257  Identities=24%  Similarity=0.288  Sum_probs=198.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||+||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56777789999999999999865 68899999886543 33356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++...+ .+++.....++.+++.|+.|||+   ..+++||||+|+||++++++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            99999999987653 48899999999999999999994   2469999999999999999999999999987542211  


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                        .....|+..|+|||.+    .+.++|||||||++||++||+.||...........    ....+.+.+...+......
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  232 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD----DPMGILDLLQQIVQEPPPR  232 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh----hhhHHHHHHHHHhhccCCC
Confidence              1235689999999944    56799999999999999999999975332100000    0000111111111110000


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                      . ...+++..+.+++.+|++.+|++||++.|+++..
T Consensus       233 ~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 L-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             C-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0 0112456689999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=309.67  Aligned_cols=240  Identities=26%  Similarity=0.374  Sum_probs=197.7

Q ss_pred             ccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHHH
Q 044428          180 LLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK  258 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  258 (457)
                      +||+|.||+||-|+.. +...+|||.+........+....|+..-++++|.|||+++|.|.+.+..-+.||-+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999865 566799999987766666778999999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccccccCCCCCcceecc
Q 044428          259 WLYSHNYFL--DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTK  335 (457)
Q Consensus       259 ~l~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~  335 (457)
                      +|...=.++  ++...--+..||++||.|||    ...|||||||-+|||++ -.|.+||+|||-++.+..-.  .....
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET  735 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET  735 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence            998765455  66777788999999999999    66799999999999996 57899999999999875422  23455


Q ss_pred             ccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          336 TMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       336 ~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ..||..|||||.+      ++.++|||||||++.||.||++||...+......+             .-.+....+  ..
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-------------kVGmyKvHP--~i  800 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-------------KVGMYKVHP--PI  800 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-------------hhcceecCC--CC
Confidence            7899999999965      78899999999999999999999987654221111             111111111  12


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +++...+...++++|+.++|..||++.++++
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            3345667889999999999999999999874

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.4e-37  Score=288.48  Aligned_cols=242  Identities=29%  Similarity=0.499  Sum_probs=192.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|...+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4678889999999999999985 67889999986542  345788999999999999999999988654 4799999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          253 NGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       253 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +++|.+++.... ..+++..++.++.|++.|+.|||    ..+++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999998654 45789999999999999999999    6789999999999999999999999999987643211   


Q ss_pred             eeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                        .....+..|+|||.    .++.++||||||+++|||++ |+.||..............            .....   
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------~~~~~---  217 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------GYRME---  217 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC------------CCCCC---
Confidence              12334568999993    36778999999999999998 9999865432222111111            10000   


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                        ....++..+.+++.+|++.+|++||++.++++.|++
T Consensus       218 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 --PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              011234568899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.6e-37  Score=287.04  Aligned_cols=244  Identities=24%  Similarity=0.359  Sum_probs=193.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN-LDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  249 (457)
                      +|+..+.||+|++|.||+++.. +++.||+|.+....  ......+.+|++++++++|+|++++.+.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4777889999999999999865 67899999986542  2345568899999999999999999988764 446789999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |+++++|.+++.... ..+++.++..++.+++.|++|||    ..+++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999998643 45899999999999999999999    6789999999999999999999999999998764321


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .  ......+++.|+|||..    .+.++||||||++++|+++|+.||...+   .............     +..    
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~-----~~~----  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEGKL-----PPM----  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCC-----CCC----
Confidence            1  22335688999999944    5678999999999999999999987533   2222111110000     000    


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           +......+.+++.+|++.+|++||++.++++
T Consensus       223 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 -----PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 0112456889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-37  Score=308.13  Aligned_cols=199  Identities=25%  Similarity=0.403  Sum_probs=169.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.++..++||||+++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999875 68999999997532   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            9999999999997654 4888899999999999999999    7889999999999999999999999999987543211


Q ss_pred             Cc---------------------------------ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCC
Q 044428          329 DS---------------------------------LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKP  371 (457)
Q Consensus       329 ~~---------------------------------~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p  371 (457)
                      ..                                 .......||+.|+|||.+    ++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                                 001124689999999944    67899999999999999999999


Q ss_pred             CCCCC
Q 044428          372 TNDLG  376 (457)
Q Consensus       372 ~~~~~  376 (457)
                      |....
T Consensus       236 f~~~~  240 (360)
T cd05627         236 FCSET  240 (360)
T ss_pred             CCCCC
Confidence            97643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.2e-37  Score=290.82  Aligned_cols=247  Identities=25%  Similarity=0.305  Sum_probs=197.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|++|.||++... +++.+|+|++.... ......+.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35677789999999999999876 68999999987653 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL-APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++++|.+++......++......++.+++.|+.|||    . .+++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH----EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc----CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999999876556889999999999999999999    5 7899999999999999999999999999876532111


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCC--CcHHHHHHhhcCchhHHhcccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGE--MSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~--~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                          ....++..|+|||.    .++.++||||||+++||+++|+.||.....  ......+...        ...    .
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~----~  220 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--------VNE----P  220 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH--------hcC----C
Confidence                11568889999994    367789999999999999999999975421  1111111111        110    0


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..... .......+.+++.+|+..+|++||++.+++.
T Consensus       221 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 PPRLP-SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCCC-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            00000 0013456889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.3e-37  Score=304.80  Aligned_cols=260  Identities=22%  Similarity=0.236  Sum_probs=191.9

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  241 (457)
                      ..++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999864 68899999987542  23345678899999999999999999977543      


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      ...++||||++ ++|.+++..   .+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            35799999996 577777754   2788889999999999999999    778999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch---h--
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK---L--  392 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~---~--  392 (457)
                      +.....   .......+|..|+|||.+    ++.++|||||||++|||++|+.||...+.......+.......   .  
T Consensus       174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            865332   122345689999999943    6779999999999999999999997643222211111111100   0  


Q ss_pred             ------HHhcccccccccc-------------chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          393 ------AEVVDSNLVRREH-------------SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       393 ------~~~~d~~l~~~~~-------------~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                            .............             ...........+.+++.+|++.||.+|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  0000000000000             000000113457899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.5e-37  Score=291.09  Aligned_cols=257  Identities=23%  Similarity=0.249  Sum_probs=194.2

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecC--CeeEEEEe
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNL--DFKALVLE  249 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  249 (457)
                      |+..+.||+|+||.||+|+.. +++.||+|+++... ........+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456778999999999999864 78999999987542 222234557889999885 99999999999887  88999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++ |+|.+++......+++..+..++.|++.||.|||    ..+++||||+|+||+++. +.+||+|||+++.......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            996 6888888776566899999999999999999999    678999999999999999 9999999999987643221


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH---hcccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE---VVDSNLV  401 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~---~~d~~l~  401 (457)
                         .....++..|+|||..     .+.++|||||||++|||++|+.||...+..+...+..........+   .+...-.
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence               1224578899999943     5678999999999999999999997655444434433322211111   1100000


Q ss_pred             ccc-c-------chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RRE-H-------SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~-~-------~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ... .       ........+..+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000 0       00001133577999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=291.98  Aligned_cols=249  Identities=25%  Similarity=0.332  Sum_probs=196.3

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC-----
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD-----  242 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  242 (457)
                      .++++|+..+.||+|++|.||+|... +++.+++|++..... ....+.+|+++++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999975 678999999876543 345789999999999 6999999999986543     


Q ss_pred             -eeEEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecc
Q 044428          243 -FKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF  318 (457)
Q Consensus       243 -~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  318 (457)
                       ..++||||+++++|.+++...   ...+++..+..++.|++.||.|||    +.+++|+||+|+||++++++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEECCC
Confidence             589999999999999998753   256899999999999999999999    778999999999999999999999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      |++.......  .......++..|+|||.+         ++.++|||||||+++|+++|+.||..........   ... 
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~-  231 (275)
T cd06608         158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---KIP-  231 (275)
T ss_pred             ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH---Hhh-
Confidence            9987653321  112235688999999943         4568999999999999999999997533211111   100 


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ....+.+       .........+.+++.+|+..||++|||+.|+++
T Consensus       232 ----~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 ----RNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----ccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                0000011       111123456889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.7e-37  Score=294.30  Aligned_cols=261  Identities=21%  Similarity=0.326  Sum_probs=193.1

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++.+++...+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578889999999999999999864 689999999875432 22345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||++ ++|.+++......+++.....++.|++.||.|||    ..+++|+||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 7888877665555788888999999999999999    6789999999999999999999999999987643221


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhh-----cCch-------
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS-----LPHK-------  391 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~-----~~~~-------  391 (457)
                      .  ......+++.|+|||.+     .+.++|||||||++|||++|+.||......  ...+...     .+..       
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhh
Confidence            1  12234578899999954     456899999999999999999999753321  1111000     0000       


Q ss_pred             -----hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 -----LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 -----~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           ..+......................+.+++.+|++.||++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 0000000000000000000011345789999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.4e-37  Score=292.56  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=199.2

Q ss_pred             cCHHHHHHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 044428          163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSN  240 (457)
Q Consensus       163 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  240 (457)
                      .++.++..+.+.|+..+.||+|+||.||+|+. .+++.+|+|++.... .....+..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            46667777888999999999999999999987 468899999986543 2345688899999998 69999999998853


Q ss_pred             ------CCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcE
Q 044428          241 ------LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       241 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                            .+..+++|||+++|+|.+++.... ..+++..+..++.|++.|+.|||    ..+++|+||+|+||++++++.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCE
Confidence                  457899999999999999997643 45788888999999999999999    6789999999999999999999


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHH
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV  384 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~  384 (457)
                      +|+|||++........  ......|+..|+|||.+         ++.++|||||||++|||++|+.||........... 
T Consensus       161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-  237 (282)
T cd06636         161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-  237 (282)
T ss_pred             EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence            9999999876532111  12235688999999954         45589999999999999999999965321110000 


Q ss_pred             HhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          385 NQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       385 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             ......+.+.        ...++..+.+++.+||+.+|.+||++.|+++
T Consensus       238 -------~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 -------IPRNPPPKLK--------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -------HhhCCCCCCc--------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                   0000001110        1123456899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-36  Score=286.35  Aligned_cols=243  Identities=28%  Similarity=0.354  Sum_probs=194.7

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      +|...+.||+|++|.||+|... +++.|++|.+....     ......+.+|+++++.++|+||+++.+++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3666789999999999999876 78999999986543     23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      +||+++++|.+++.... .+++..+..++.+++.|+.|||    ..+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999998654 4789999999999999999999    678999999999999999999999999998875432


Q ss_pred             CCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .   ......++..|+|||..     .+.++|+||||+++||+++|+.||.......   ......     ..  .....
T Consensus       156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~-----~~--~~~~~  222 (258)
T cd06632         156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVFKIG-----RS--KELPP  222 (258)
T ss_pred             c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHHHHH-----hc--ccCCC
Confidence            2   12335688999999933     5678999999999999999999997643211   111100     00  00000


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .      +......+.+++.+|++.+|.+||++.+++.
T Consensus       223 ~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 I------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             c------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            0      0112345789999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=299.10  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=204.0

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh---hHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER---TFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  246 (457)
                      ...|+..+.||+|.||.||+++.+ +|+.+|+|.+.+....   ......+|+.+|+++. |||||.+.+.+......++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456777789999999999999976 5999999999866432   3467899999999998 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC----CCcEEEecccccc
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE----NMVAHVSDFGISK  322 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfg~~~  322 (457)
                      |||++.||.|++.+... . +++.....++.|++.|+.|||    ..+|+||||||+|+|+..    ++.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999887 3 899999999999999999999    788999999999999963    3579999999999


Q ss_pred             ccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ....   .......+||+.|+|||++    ++..+||||.||++|.|++|.+||..........           .+...
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----------~i~~~  253 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----------AILRG  253 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----------HHHcC
Confidence            8765   2234568999999999954    6889999999999999999999998754322221           11111


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .+   ......+......+-+++..|+..||..|+++.++++.
T Consensus       254 ~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            11   11112233345668899999999999999999999873

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-36  Score=286.52  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=199.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||.|+||.||+|... ++..+|+|++.... ......+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888899999999999999864 68899999987543 23556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      +++++|.+++....  ..+++.....++.|++.|+.|||    ..+++||||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999997642  45889999999999999999999    6789999999999999999999999999998765433


Q ss_pred             Ccc--eeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HHHHHHhhcCchhHHhccccc
Q 044428          329 DSL--IQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       329 ~~~--~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ...  ......++..|+|||.     ..+.++|||||||++|||++|+.||....... .......    .     .+.+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~----~-----~~~~  227 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN----D-----PPSL  227 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC----C-----CCCc
Confidence            221  1233468899999994     36778999999999999999999997543221 1111110    0     0001


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....    .....+..+.+++.+|++.+|++||++.++++
T Consensus       228 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCcc----ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000    00123456889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.6e-37  Score=294.87  Aligned_cols=241  Identities=23%  Similarity=0.309  Sum_probs=192.4

Q ss_pred             CCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          178 CNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ...||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||+++++++...+..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            447999999999999864 7899999998765444556788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccc
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT  336 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  336 (457)
                      .+++...  .+++..+..++.|++.||.|||    ..+++||||+|+||+++.++.+||+|||++........  .....
T Consensus       106 ~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~  177 (297)
T cd06659         106 TDIVSQT--RLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL  177 (297)
T ss_pred             HHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence            9988664  3889999999999999999999    67899999999999999999999999999876533211  12235


Q ss_pred             cccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHH
Q 044428          337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD  412 (457)
Q Consensus       337 ~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  412 (457)
                      .++..|+|||.+    .+.++|||||||++|||++|+.||...........+.....        .....       ...
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~-------~~~  242 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP--------PKLKN-------AHK  242 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--------CCccc-------cCC
Confidence            688999999943    57789999999999999999999975432221111111000        00000       001


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          413 CLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       413 ~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ....+.+++.+|++.+|++||++.++++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            13457899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=301.97  Aligned_cols=232  Identities=22%  Similarity=0.244  Sum_probs=179.9

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc---CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV---RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      ||+|+||.||+|+.. +|+.||||++....   ......+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 68999999986532   12233455677777665   699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++.... .+++.....++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~  153 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT  153 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence            99999987654 4889999999999999999999    67899999999999999999999999999875432221  12


Q ss_pred             ccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchh
Q 044428          334 TKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS  408 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~  408 (457)
                      ....||+.|+|||.+     ++.++|||||||++|||+||+.||.......+   .......      ...+...     
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~~i~~~------~~~~~~~-----  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YRNIAFG------KVRFPKN-----  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HHHHHcC------CCCCCCc-----
Confidence            345699999999943     57789999999999999999999975432111   1111000      0011000     


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 044428          409 AKMDCLLRIMNLALDCCMESPDERIHTT  436 (457)
Q Consensus       409 ~~~~~~~~l~~l~~~C~~~~P~~RPs~~  436 (457)
                         .....+.+++.+|++.+|++||++.
T Consensus       220 ---~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         220 ---VLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             ---cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence               1134578999999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.9e-36  Score=285.88  Aligned_cols=248  Identities=27%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|++|.||+|+.. +++.|++|++..... .....+.+|++.+.+++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36778899999999999999876 599999999876543 3456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL-APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++++|.+++... ..+++..+..++.|++.|+.|||    . .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999875 35899999999999999999999    6 8899999999999999999999999999987643322


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      .  .....++..|+|||..    .+.++||||||+++|||+||+.||.........+......        .......  
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~--  223 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--------DGPPPSL--  223 (264)
T ss_pred             c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--------cCCCCCC--
Confidence            1  1234578899999944    5678999999999999999999997654222222211111        1111000  


Q ss_pred             chhHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          406 SFSAKMD-CLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       406 ~~~~~~~-~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                          ... .+..+.+++.+|++.+|++||++.++++.
T Consensus       224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                011 34568999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.7e-37  Score=295.53  Aligned_cols=251  Identities=22%  Similarity=0.285  Sum_probs=194.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36788899999999999999875 67899999987543   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++.... .+++.....++.+++.|+.|||    ..+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999997654 4888899999999999999999    6789999999999999999999999999987421100


Q ss_pred             C-------------cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch
Q 044428          329 D-------------SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       329 ~-------------~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      .             ........++..|+|||.+    .+.++|+||||+++||+++|+.||.....   ..+........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~  232 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD  232 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Confidence            0             0011124578899999943    67899999999999999999999964322   11111111000


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                         ...+.   ..      ..++..+.+++.+|++.+|++||++.++.+.|+
T Consensus       233 ---~~~~~---~~------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         233 ---IEWPE---GD------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ---cCCCC---cc------ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence               00000   00      012456899999999999999999766665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.5e-37  Score=294.59  Aligned_cols=260  Identities=21%  Similarity=0.281  Sum_probs=193.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|+||.||+|+.. +|..||+|+++....  .....+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4677789999999999999875 789999999875422  2234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++ ++|.+++......+++.....++.||+.||.|||    ..+++||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            96 6888888765556899999999999999999999    67899999999999999999999999999986543221 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCc---h----hHHhcc
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPH---K----LAEVVD  397 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~---~----~~~~~d  397 (457)
                       ......++..|+|||.+     ++.++|||||||++|||+||+.|+...... .....+......   .    ..+..+
T Consensus       155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence             12234578899999943     577899999999999999999986442211 111111110000   0    001001


Q ss_pred             ccccccccch----hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHSF----SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~----~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..........    .........+.+++.+|++.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000000    000122456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-36  Score=286.18  Aligned_cols=244  Identities=22%  Similarity=0.322  Sum_probs=195.6

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|+||.+|+++.. +|+.||+|.+...  ......++.+|+.++++++||||+++.+++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4777889999999999999864 7899999998643  233455789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++++|.+++.... ..+++.+.++++.|++.|+.|||    ..+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999997643 35789999999999999999999    67899999999999999999999999999986543221


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        ......|++.|+|||.    ..+.++|||||||+++|+++|+.||.....   ...+......        .....  
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~~~~--------~~~~~--  221 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLVLKIIRG--------SYPPV--  221 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHHHHHhcC--------CCCCC--
Confidence              1123457889999994    356789999999999999999999865321   1211111110        00000  


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          +......+.+++.+|++.+|.+||++.+|++
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                1122456899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-36  Score=293.63  Aligned_cols=190  Identities=23%  Similarity=0.296  Sum_probs=155.1

Q ss_pred             CCccCCCCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCeeEEEEeccC
Q 044428          178 CNLLGIGSFGSVYKGTLS---DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFKALVLEFMP  252 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  252 (457)
                      ..+||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            358999999999999864   56789999986542  23457789999999999999999998854  456889999985


Q ss_pred             CCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee----cCCCcEEEecccc
Q 044428          253 NGSLEKWLYSHN--------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGI  320 (457)
Q Consensus       253 ~g~L~~~l~~~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfg~  320 (457)
                       ++|.+++....        ..+++.....++.|++.||.|||    ..+|+||||||+|||+    +.++.+||+|||+
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence             58888875321        24788889999999999999999    6789999999999999    4667999999999


Q ss_pred             ccccCCCCCc-ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          321 SKLLGEGDDS-LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       321 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                      ++........ .......||+.|+|||.+     ++.++||||+||++|||++|+.||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            9876432211 112346789999999943     56789999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=327.13  Aligned_cols=252  Identities=22%  Similarity=0.310  Sum_probs=194.7

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCe
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDF  243 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  243 (457)
                      ....++|...+.||+|+||.||+++.. ++..||+|++....  ......|..|+.++.+++|||||++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345578999999999999999999875 67889999987542  3345678899999999999999999998754  457


Q ss_pred             eEEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---CCCCeeeccCCCCCeeecC--------
Q 044428          244 KALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGH---ALAPIIHCDLKPSNILLDE--------  309 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~---~~~~ivH~dlk~~NIll~~--------  309 (457)
                      .++||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...   ...+|+||||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999999753   245899999999999999999999532   0146999999999999964        


Q ss_pred             ---------CCcEEEeccccccccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          310 ---------NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       310 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                               ...+||+|||++..+....   ......||+.|+|||.+      ++.++|||||||++|||+||+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     3358999999998764321   12335689999999954      56789999999999999999999975


Q ss_pred             CCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          375 LGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       375 ~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...  ....+.... .    .  +.+...        ..+..+.+++..||+.+|.+||++.|++.
T Consensus       246 ~~~--~~qli~~lk-~----~--p~lpi~--------~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        246 ANN--FSQLISELK-R----G--PDLPIK--------GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCc--HHHHHHHHh-c----C--CCCCcC--------CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            332  222211110 0    0  001000        11345889999999999999999999984

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=289.66  Aligned_cols=243  Identities=25%  Similarity=0.402  Sum_probs=195.0

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCeeEEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVR---HRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778999999999999986 478999999987543 334557889999999996   999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++...  .+++.....++.+++.|+.|||    ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999998764  4899999999999999999999    6789999999999999999999999999998765432


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .  ......|+..|+|||..     .+.++|||||||++|||++|+.||..............        ...+.+...
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  225 (277)
T cd06917         156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--------SKPPRLEDN  225 (277)
T ss_pred             c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc--------CCCCCCCcc
Confidence            1  12335688999999943     46789999999999999999999975432111111000        000111111


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              ..+..+.+++.+|++.+|++||++.|+++
T Consensus       226 --------~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         226 --------GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             --------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                    12456889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-36  Score=284.24  Aligned_cols=243  Identities=26%  Similarity=0.391  Sum_probs=194.8

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|++|.||++... +++.+|+|.+....  ......+.+|+++++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777889999999999999864 78899999987542  33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~~  328 (457)
                      +++++|.+++.... ..+++..+..++.+++.|+.|||    ..+++|+||+|+||+++++ +.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999998753 45889999999999999999999    6789999999999999854 568999999998764332


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .   .....++..|+|||..    .+.++||||||+++|||++|+.||...............   ..     ..+.   
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~---  222 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG---TF-----APIS---  222 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc---CC-----CCCC---
Confidence            1   1235688899999944    577899999999999999999998754322221111110   00     0000   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            ..++..+.+++.+|++.+|++|||+.|+++
T Consensus       223 ------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 ------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  012446889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-37  Score=305.85  Aligned_cols=237  Identities=24%  Similarity=0.417  Sum_probs=194.4

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEeccc----chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe--eEEEEecc
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ----LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF--KALVLEFM  251 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~~  251 (457)
                      .+||+|+|-+||||... +|..||--.++..    .....+.|..|+.+|+.|+||||++++.+|.+...  ..+|+|.|
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            48999999999999875 6777775544422    34455789999999999999999999999987654  77899999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ..|+|..|+.+.+. .+.....+|+.||++||.|||+.  .++|+|||||.+||+++ ..|.+||+|+|+|+.+..... 
T Consensus       126 TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-  201 (632)
T KOG0584|consen  126 TSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-  201 (632)
T ss_pred             cCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence            99999999998764 78889999999999999999975  57999999999999997 568999999999998754221 


Q ss_pred             ceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCC-CCCCcHHHHHHhhcCch-hHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQSLPHK-LAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~-~~~~~l~~~~~~~~~~~-~~~~~d~~l~~~~~  405 (457)
                         ....|||.|||||+.   |.+.+||||||+.++||+|+..||.. .+...+..-+....++. +..+-|+       
T Consensus       202 ---ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP-------  271 (632)
T KOG0584|consen  202 ---KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP-------  271 (632)
T ss_pred             ---ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH-------
Confidence               227899999999966   89999999999999999999999976 44444444444444433 3333332       


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                ++.+++.+|+.. .++|||+.|++.
T Consensus       272 ----------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  272 ----------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence                      378999999999 999999999974

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-36  Score=286.50  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=195.1

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      +|+..+.||+|++|.||+|.. .+++.||+|++....      ......+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467778999999999999986 578999999987432      1234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccccC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLG  325 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~  325 (457)
                      |+||+++++|.+++.... .+++.....++.|++.||.|||    ..+++|+||+|+||+++.++ .+||+|||.+..+.
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999997654 5789999999999999999999    67899999999999998775 69999999988764


Q ss_pred             CCCCc--ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          326 EGDDS--LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       326 ~~~~~--~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      .....  .......++..|+|||.    ..+.++||||+|++++|+++|+.||..................    ...+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~-  230 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----TTAP-  230 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc----CCCC-
Confidence            32111  11123467889999994    3577899999999999999999999754332222221111000    0000 


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              ..+......+.+++.+|++.+|++||++.++++
T Consensus       231 --------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 --------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    011122456889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.2e-37  Score=313.26  Aligned_cols=263  Identities=21%  Similarity=0.269  Sum_probs=189.4

Q ss_pred             HHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCC------Cccceeeeeee
Q 044428          167 DIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH------RNLIKILSGCS  239 (457)
Q Consensus       167 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  239 (457)
                      ++...+++|...+.||+|+||.||+|+.. +++.||||+++... .....+..|+.++..++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34455788999999999999999999864 68899999996432 223345667777777654      45888888886


Q ss_pred             cC-CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-------
Q 044428          240 NL-DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-------  311 (457)
Q Consensus       240 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-------  311 (457)
                      .. ...++|||++ +++|.+++.... .+++..+..++.||+.||+|||+.   .+|+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTE---LHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEecCCccccccc
Confidence            54 5788999988 788999887653 489999999999999999999931   4799999999999998765       


Q ss_pred             ---------cEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC
Q 044428          312 ---------VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM  378 (457)
Q Consensus       312 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~  378 (457)
                               .+||+|||.+.....     ......||+.|+|||.+    ++.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998764321     12346789999999954    677899999999999999999999865443


Q ss_pred             cHHHHHHhhcC---chh---------HHhcccccc--cccc----------chhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          379 SLKHWVNQSLP---HKL---------AEVVDSNLV--RREH----------SFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       379 ~l~~~~~~~~~---~~~---------~~~~d~~l~--~~~~----------~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      .....+.....   ..+         .++++....  ....          ...........+.+|+.+|++.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            33222222111   111         011110000  0000          00000001235789999999999999999


Q ss_pred             HHHHHH
Q 044428          435 TTNAAA  440 (457)
Q Consensus       435 ~~ev~~  440 (457)
                      +.|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999985

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-36  Score=291.71  Aligned_cols=247  Identities=23%  Similarity=0.314  Sum_probs=197.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||++.. .++..||+|.+..........+.+|+.++++++|||++++++++...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            36788889999999999999985 47889999998765444556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++.+..  +++..+..++.+++.|+.|||    ..+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        98 ~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999999997653  788999999999999999999    77899999999999999999999999999876543222 


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......+++.|+|||..    .+.++||||||+++||+++|+.||...........+..               .....
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~---------------~~~~~  234 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------------NGTPE  234 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---------------CCCCC
Confidence             12234688899999944    57789999999999999999999975332111000000               00000


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ..........+.+++.+||+.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111224458899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=291.84  Aligned_cols=261  Identities=21%  Similarity=0.326  Sum_probs=193.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999875 789999999875432 2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++ ++|.+++......+++.....++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++....... 
T Consensus        85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            97 5999999876666889999999999999999999    67899999999999999999999999999875432111 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCc---h-hHHhcc---
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPH---K-LAEVVD---  397 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~---~-~~~~~d---  397 (457)
                       ......++..|+|||..     .+.++||||||+++|||++|+.||...... ............   . ...+..   
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             11223468899999943     467899999999999999999999653311 111111111000   0 000000   


Q ss_pred             ---ccccc--cccchhH--HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 ---SNLVR--REHSFSA--KMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ---~~l~~--~~~~~~~--~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         .....  .......  .......+.+++.+|++.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               00000  0000000  0000145789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-36  Score=285.89  Aligned_cols=246  Identities=23%  Similarity=0.310  Sum_probs=187.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  244 (457)
                      .+|...+.||+|+||.||+|... ++..||+|.+....     ......+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888899999999999999864 68999999886432     2234568899999999999999999998865  3577


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++++||+++++|.+++.... .+++.....++.|++.||+|||    ..+++||||+|+||+++.++.+||+|||+++.+
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            89999999999999998654 3788999999999999999999    678999999999999999999999999998865


Q ss_pred             CCCCCc-ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          325 GEGDDS-LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       325 ~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ...... .......++..|+|||.+    .+.++|||||||++||+++|+.||......   ..+......    ...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~~----~~~~~  229 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIATQ----PTNPQ  229 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhcC----CCCCC
Confidence            321111 111224588999999944    567899999999999999999999753211   111110000    00111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +         +......+.+++ +|+..+|++||++.||++
T Consensus       230 ~---------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         230 L---------PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C---------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1         011123345555 799899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-36  Score=291.05  Aligned_cols=260  Identities=24%  Similarity=0.343  Sum_probs=193.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|++|.||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778889999999999999875 78999999987543  22335688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      ++ ++|.+++.... ..+++.....++.+++.||+|||    ..+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 68999887643 45899999999999999999999    67899999999999999999999999999886543221


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcH-HHHHHhhc-Cch-h----HHhcc
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL-KHWVNQSL-PHK-L----AEVVD  397 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l-~~~~~~~~-~~~-~----~~~~d  397 (457)
                        ......++..|+|||..     .+.++||||||+++|||+||+.||......+. .......- +.. .    .++.+
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence              12234568899999943     46789999999999999999999965432111 11111000 000 0    00000


Q ss_pred             --cccccc-ccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 --SNLVRR-EHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 --~~l~~~-~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        ...... ..... ........+.+++.+|++.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              000000 00000 00012345789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.5e-36  Score=281.45  Aligned_cols=245  Identities=28%  Similarity=0.389  Sum_probs=199.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      +|+..+.||+|++|.||++... ++..+++|++..........+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677789999999999999975 789999999987655556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +++|.+++......+++..+..++.+++.|+.|||    ..+++||||+|+||++++++.++|+|||.+........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            99999999887556899999999999999999999    67899999999999999999999999999987654321   


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchh
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS  408 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~  408 (457)
                      .....++..|+|||..    .+.++||||||++++|+++|+.||...+............   .     +.+.       
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-----~~~~-------  218 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG---P-----PGLR-------  218 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC---C-----CCcC-------
Confidence            2335688899999943    5789999999999999999999997643221111111100   0     0000       


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          409 AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       409 ~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .....+..+.+++.+|++.+|++|||+.|+++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00112346889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.2e-36  Score=287.07  Aligned_cols=243  Identities=26%  Similarity=0.351  Sum_probs=195.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      -|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667789999999999999864 78899999986443 334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++...  .+++.....++.+++.|+.|||    ..+++|+||+|+||+++.++.++|+|||++..+.....  
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            999999999764  3889999999999999999999    67899999999999999999999999999876543211  


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      ......++..|+|||..    .+.++|||||||++||+++|..||...........+....        .+.+       
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~-------  221 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--------PPTL-------  221 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--------CCCC-------
Confidence            11234578899999943    5678999999999999999999997543222111111100        0000       


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        ...++..+.+++.+|++.+|.+||++.++++.
T Consensus       222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              01224568899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.3e-36  Score=288.26  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=194.5

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      .|...+.||+|++|.||++.. .+++.+++|++..........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            344556999999999999986 4789999999876544455668899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +++|.+++...  .+++..+..++.+++.|+.|||    ..+++||||+|+||+++.++.++|+|||.+.......  ..
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~  171 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR  171 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence            99999999873  4889999999999999999999    6789999999999999999999999999887653221  11


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchh
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS  408 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~  408 (457)
                      .....|+..|+|||..    ++.++|||||||++|||++|+.||...........+...        ..+.+..      
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~------  237 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------LPPKLKN------  237 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--------CCCCCcc------
Confidence            2235688999999943    678899999999999999999998653321111111110        0011100      


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          409 AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       409 ~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ...++..+.+++.+|++.+|++||++.++++
T Consensus       238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             0012456899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.2e-36  Score=292.67  Aligned_cols=189  Identities=23%  Similarity=0.300  Sum_probs=154.4

Q ss_pred             CccCCCCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS---DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  253 (457)
                      .+||+|+||.||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            58999999999999865   45789999886542  23457889999999999999999998843  567899999986 


Q ss_pred             CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee----cCCCcEEEeccccc
Q 044428          254 GSLEKWLYSH--------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGIS  321 (457)
Q Consensus       254 g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfg~~  321 (457)
                      ++|.+++...        ...+++..+..++.|++.||.|||    +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5787777532        134788889999999999999999    6789999999999999    56779999999999


Q ss_pred             cccCCCCCc-ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          322 KLLGEGDDS-LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       322 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                      +........ .......+|+.|+|||.+     ++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876433221 112335689999999943     56789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-36  Score=288.04  Aligned_cols=249  Identities=25%  Similarity=0.286  Sum_probs=193.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  248 (457)
                      ++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778889999999999999974 689999999875432 3456789999999999999999999988653  4689999


Q ss_pred             eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||+++++|.+++..   ....++......++.|++.||.|||    ..+++|+||+|+||++++++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999988764   2345788899999999999999999    6789999999999999999999999999987653


Q ss_pred             CCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCC-----CcHHHHHHhhcCchhHHhc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGE-----MSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~-----~~l~~~~~~~~~~~~~~~~  396 (457)
                      ....    ....++..|+|||.    .++.++||||||+++|||++|+.||.....     .....+......       
T Consensus       157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  225 (287)
T cd06621         157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-------  225 (287)
T ss_pred             cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-------
Confidence            2211    23457889999994    357789999999999999999999976422     111222111100       


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       +.+......   ....+..+.+++.+|++.+|.+|||+.|+++
T Consensus       226 -~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 -PELKDEPGN---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -hhhccCCCC---CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             000000000   0012456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.7e-36  Score=283.39  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|...+.||+|+||.||+|... +++.||+|.+.....  .....+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4677789999999999999864 789999999876543  3567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++.... .+++..+..++.+++.|+.|||    ..+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999998754 4788899999999999999999    678999999999999999999999999999876443221


Q ss_pred             ce--eccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          331 LI--QTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       331 ~~--~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ..  .....++..|+|||.+       .+.++||||||++++|+++|+.||......  ........     ....+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~-----~~~~~~~~  228 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVG-----AGHKPPIP  228 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHh-----cCCCCCCC
Confidence            11  1124678899999943       466899999999999999999999654211  11111000     00011110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .       ...+...+.+++.+|++.+|++||++.|++.
T Consensus       229 ~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         229 D-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             c-------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0       1112445789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.4e-36  Score=291.37  Aligned_cols=265  Identities=24%  Similarity=0.300  Sum_probs=197.6

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD----  242 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  242 (457)
                      ...++|+..+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999975 68999999987543  223356778999999999999999999887654    


Q ss_pred             ------eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          243 ------FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       243 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                            ..++|+||+++ ++.+.+......+++.....++.|++.||+|||    ..+|+|+||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999975 787877766556899999999999999999999    6789999999999999999999999


Q ss_pred             ccccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch
Q 044428          317 DFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       317 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      |||++........ .......++..|+|||.+     .+.++|||||||++|||++|+.||...........+.......
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999987643322 111223467889999943     4678999999999999999999997644322222222211110


Q ss_pred             ----hHHhcccccc--------ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 ----LAEVVDSNLV--------RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ----~~~~~d~~l~--------~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ..++......        ............+..+.+++.+|++.+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                0111000000        000000001112556899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.9e-36  Score=284.46  Aligned_cols=246  Identities=23%  Similarity=0.272  Sum_probs=188.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--Cee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  244 (457)
                      .+|+..+.||+|+||.||+|... +|..||+|.+....     ......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999874 68999999886321     22345788899999999999999999988663  467


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++++|.+++.... .+++....+++.+++.||.|||    ..+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999997654 4788889999999999999999    678999999999999999999999999998865


Q ss_pred             CCCCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          325 GEGDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       325 ~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ....... ......++..|+|||.+    .+.++|||||||++|||++|+.||......  ... .......    ..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~-~~~~~~~----~~~~  229 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAI-FKIATQP----TNPV  229 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHH-HHHhcCC----CCCC
Confidence            3221111 11234588899999954    567899999999999999999998653211  111 1000000    0000


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .         +......+.+++.+|+. +|++||++.|+++
T Consensus       230 ~---------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         230 L---------PPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             C---------chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0         11223457788888984 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.9e-36  Score=289.66  Aligned_cols=257  Identities=22%  Similarity=0.289  Sum_probs=195.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER--TFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  247 (457)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++.....  ....+.+|++++.+++||||+++.+++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999976 6889999999754322  233567899999999999999999998777  899999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||++ ++|.+++......+++.....++.|++.||+|||    ..+++|+||||+||+++.++.+||+|||++......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99997 5999999876666899999999999999999999    678999999999999999999999999999876443


Q ss_pred             CCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHh---
Q 044428          328 DDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEV---  395 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~---  395 (457)
                      ..  ......+++.|+|||.+     .+.++|+||||+++|||++|+.||..........-+.......    +...   
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            21  12234578899999944     4678999999999999999999997643322111111111000    0000   


Q ss_pred             -----------ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 -----------VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 -----------~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                 ....+.......    .....+.+++.+|++.+|++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPAL----SLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhcccccc----CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                       000000000000    01445789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=289.73  Aligned_cols=262  Identities=25%  Similarity=0.295  Sum_probs=196.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||.||+|... +++.||+|+++...  ......+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36788889999999999999876 68899999987542  2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++++.+..+.... ..+++.....++.+++.|+.|||    ..+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99987776655443 44889999999999999999999    67899999999999999999999999999987654332


Q ss_pred             cceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc---CchhHHhc--ccc
Q 044428          330 SLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL---PHKLAEVV--DSN  399 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~---~~~~~~~~--d~~  399 (457)
                      . ......++..|+|||.     ..+.++||||||+++||+++|+.||......+.........   ........  ++.
T Consensus       156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            1 2233567889999994     35678999999999999999999997543322111111110   00000000  000


Q ss_pred             ccc-----cccchh----HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVR-----REHSFS----AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~-----~~~~~~----~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...     ......    .+..++..+.+++.+|+..+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000     000000    00112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.4e-36  Score=287.45  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..++.|+..+.||+|++|.||+|..+ ++..+++|++..... ....+.+|++.++.++|+|++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45567788889999999999999986 689999999976544 4567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++......+++..+..++.+++.||.|||    ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999999987546999999999999999999999    6889999999999999999999999999987654322


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .  ......++..|+|||.+    .+.++|||||||++|||++|+.||.............           ......  
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~~~--  235 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT-----------TKGIPP--  235 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------hcCCCC--
Confidence            1  11234578899999943    5779999999999999999999987543221111110           000000  


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        ......++..+.+++.+|++.+|.+||++.++++.
T Consensus       236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 --LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              00111234568899999999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=287.73  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeEEEEe
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKALVLE  249 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  249 (457)
                      |+..+.||+|++|.||+|+.. +|+.+|+|++....  ......+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456678999999999999876 58899999998653  33345688999999999999999999999887  89999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++ ++|.+++......+++..++.++.+++.||+|||    ..+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            997 5899998776556899999999999999999999    67799999999999999999999999999987644321


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhcc---
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVVD---  397 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~d---  397 (457)
                       .......++..|+|||.+     .+.++||||||+++|||+||+.||...........+.......    .....+   
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence             112334568889999943     5678999999999999999999997654322222221111100    000000   


Q ss_pred             -ccccccc---cch-hHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 -SNLVRRE---HSF-SAKMD-CLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 -~~l~~~~---~~~-~~~~~-~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       .......   ... ....+ ++..+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             0000000   000 00001 2567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=284.23  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=196.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +.|+..+.||.|.-|+||.+++. ++..+|+|++.+..   .......+.|-++|+.+.||.++.+++.++..+..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            35666779999999999999986 45899999998764   333456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC-
Q 044428          249 EFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE-  326 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~-  326 (457)
                      |||+||+|..+++++. ..++.....-++.+|..||+|||    ..|||.|||||+||||.++|++.|+||.++..... 
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999999875 66888888899999999999999    89999999999999999999999999998754311 


Q ss_pred             --------------------------------CCCc---------------------ceeccccccccccCCCCCC----
Q 044428          327 --------------------------------GDDS---------------------LIQTKTMATIGYMAPEGIV----  349 (457)
Q Consensus       327 --------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~----  349 (457)
                                                      ....                     ..+...+||-.|+|||.+-    
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0000                     0011245889999999884    


Q ss_pred             CCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCC
Q 044428          350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESP  429 (457)
Q Consensus       350 ~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P  429 (457)
                      +.++|+|+|||++|||+.|..||...+..           +.+..++-..+.     +....+.+..+.+|+.+.+.+||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~-----------~Tl~NIv~~~l~-----Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK-----------ETLRNIVGQPLK-----FPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch-----------hhHHHHhcCCCc-----CCCCCcchhHHHHHHHHHhccCh
Confidence            55899999999999999999999764421           112233322221     11111335668899999999999


Q ss_pred             CCCCC----HHHHH
Q 044428          430 DERIH----TTNAA  439 (457)
Q Consensus       430 ~~RPs----~~ev~  439 (457)
                      ++|..    +.||-
T Consensus       377 ~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIK  390 (459)
T ss_pred             hhhhccccchHHhh
Confidence            99998    66653

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.3e-36  Score=291.29  Aligned_cols=241  Identities=27%  Similarity=0.336  Sum_probs=192.6

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      |...+.||+|+||.||+|+.. +|..||+|.+....   ......+.+|++++++++|||++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            666779999999999999864 68999999986432   23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++ |+|.+.+......+++.++..++.+++.|+.|||    ..+++||||+|+||+++.++.+||+|||++......   
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            96 5888888766666899999999999999999999    678999999999999999999999999998754321   


Q ss_pred             ceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                         ....+++.|+|||.+       .+.++|||||||++|||++|+.||.............           .......
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~  244 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----------QNESPTL  244 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----------hccCCCC
Confidence               234688899999953       5678999999999999999999986532211111110           0000000


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                           ........+.+++.+|++.+|++||++.++++..
T Consensus       245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                 0112245688999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=297.17  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=194.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Cee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  244 (457)
                      +++|...+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468899999999999999999864 78999999986432 23345678899999999999999999876544     357


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++|+||++ ++|.+++...  .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999996 5888888654  3899999999999999999999    678999999999999999999999999999875


Q ss_pred             CCCCCcc-eeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHH
Q 044428          325 GEGDDSL-IQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAE  394 (457)
Q Consensus       325 ~~~~~~~-~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~  394 (457)
                      ....... ......|+..|+|||.+     .+.++|||||||++|||++|+.||...+.......+...+..    ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            4322111 11235688999999943     567899999999999999999999754322222222221111    1111


Q ss_pred             hcccccc-------cc-ccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          395 VVDSNLV-------RR-EHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       395 ~~d~~l~-------~~-~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      +.+....       .. ..... ........+.+++.+|++.+|++||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111100       00 00000 001124568899999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.8e-36  Score=282.49  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=195.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCeeEEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFKALVL  248 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  248 (457)
                      +|+..+.||.|+||.||++... +|+.+|+|++....  ......+..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677889999999999999864 78899999987532  3345568899999999999999999997754  45678999


Q ss_pred             eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          249 EFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGH-ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       249 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~-~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ||+++++|.+++...   ...+++...+.++.+++.||.|||..+ ...+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999764   356899999999999999999999331 1356999999999999999999999999999876


Q ss_pred             CCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      .....  ......++..|+|||.+    .+.++||||||+++++|++|+.||.......+...+....        .+.+
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~  230 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------FRRI  230 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------CCCC
Confidence            54322  12235689999999954    5678999999999999999999997644222222111110        0011


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                               +...+..+.+++.+|++.+|++||++.+|++
T Consensus       231 ---------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         231 ---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---------ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                     0122456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4e-36  Score=287.05  Aligned_cols=245  Identities=24%  Similarity=0.326  Sum_probs=188.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHH-HhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEV-LRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||.||+++.. +|+.||+|+++.... .....+..|+.. ++..+||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788889999999999999875 699999999876432 223455566665 566689999999999999999999999


Q ss_pred             ccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          250 FMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALA-PIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       250 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      |++ |+|.+++...   ...+++.....++.|++.||+|||    .. +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH----SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            996 7888887642   245899999999999999999999    44 79999999999999999999999999988653


Q ss_pred             CCCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      ...   ..+...++..|+|||.+        ++.++|+||||+++|||++|+.||..... .... .....     ....
T Consensus       156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~-~~~~~-----~~~~  225 (283)
T cd06617         156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PFQQ-LKQVV-----EEPS  225 (283)
T ss_pred             ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-CHHH-HHHHH-----hcCC
Confidence            211   12234678899999943        36789999999999999999999964321 1111 11000     0000


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +.+..        ...+..+.+++.+|+..+|++||++.++++
T Consensus       226 ~~~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 PQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11100        012456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=287.18  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=192.5

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      |+..+.||.|++|.||+|... +|..||+|++....  ......+.+|++++++++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999864 79999999987543  223356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      + ++|.+++.... ..+++..+..++.|++.||+|||    ..+++||||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            4 79999997654 45899999999999999999999    678999999999999999999999999999765332111


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HHHHHHhhc-Cch--------hHHh
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LKHWVNQSL-PHK--------LAEV  395 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~~~~~~~~-~~~--------~~~~  395 (457)
                        .....++..|+|||.+     .+.++||||||+++|||++|+.||....... +........ +..        ..+.
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence              1223568899999943     4678999999999999999999996533211 111111000 000        0000


Q ss_pred             ccccccccc-cc-hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 VDSNLVRRE-HS-FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~d~~l~~~~-~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .. ...... .. ..........+.+++.+|++.+|++||++.|+++
T Consensus       234 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KP-TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hh-hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00 000000 00 0000112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.2e-36  Score=286.38  Aligned_cols=260  Identities=21%  Similarity=0.291  Sum_probs=195.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      +|+..+.||.|++|.||+|+.. +|..||||++..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778889999999999999975 689999999876532 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          252 PNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       252 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      + ++|.+++....  ..+++..+..++.|++.||.|||    ..+++||||+|+||++++++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            7 58998887654  45899999999999999999999    67899999999999999999999999999976533211


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHHhccc-c
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAEVVDS-N  399 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~~~d~-~  399 (457)
                        ......++..|++||..     .+.++|||||||++||+++|+.||..................    .+..+.+. .
T Consensus       156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence              12234578899999943     467899999999999999999999764332211111111000    01111000 0


Q ss_pred             ccccccc------hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHS------FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~------~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +......      ......+...+.+++.+|++.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000      0001123456889999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.9e-36  Score=293.53  Aligned_cols=264  Identities=24%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCccceeeeeeecC--Cee
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL--DFK  244 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  244 (457)
                      ..++|+..+.||+|+||.||+|... +|+.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888899999999999999875 6889999988542  223344677899999999 999999999988643  468


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999996 6999998765  5889999999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCc---ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc------
Q 044428          325 GEGDDS---LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH------  390 (457)
Q Consensus       325 ~~~~~~---~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~------  390 (457)
                      ......   .......|+..|+|||.+     .+.++||||||+++|||+||+.||...........+......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            433221   122235688999999944     467899999999999999999999754322222111111110      


Q ss_pred             -----h-hHHhccccccccccchhH-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          391 -----K-LAEVVDSNLVRREHSFSA-KMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       391 -----~-~~~~~d~~l~~~~~~~~~-~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                           . ..++++............ ..+++..+.+++.+|++.+|++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 0 001111000000000000 01135668999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=314.55  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=204.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----C----CCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----D----GTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      ++....+.+|+|.||.|++|...    .    ...||||.++... ..+...+..|+++|..+ +|+||+.++|+|...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            33445559999999999999753    1    4579999998654 34567899999999999 6999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                      ..++|+||++.|+|.++|...+               ..+...+.+.++.|||.|++||+    +.++|||||-++|||+
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAARNVLI  451 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhhhEEe
Confidence            9999999999999999998776               34888999999999999999999    7789999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCcceecccc--ccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCC-CCc
Q 044428          308 DENMVAHVSDFGISKLLGEGDDSLIQTKTM--ATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMS  379 (457)
Q Consensus       308 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~-~~~  379 (457)
                      .++..+||+|||+++.....+.... ....  -...|||||.    .++.|+|||||||+||||+| |..||.... ..+
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            9999999999999996544333321 1122  3456999993    48899999999999999999 888986421 112


Q ss_pred             HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      +.+++                 +...+...+..|..++.+++..||+.+|++||++.++++.+....+
T Consensus       531 l~~~l-----------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  531 LLEFL-----------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHHHH-----------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            22221                 2222334455677889999999999999999999999999998644

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7e-36  Score=286.73  Aligned_cols=239  Identities=25%  Similarity=0.324  Sum_probs=192.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||++... +++.||+|++....   ......+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36778889999999999999875 68999999986532   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++.... .++...+..++.|++.||.|||    ..+++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999998764 5889999999999999999999    678999999999999999999999999999876432 


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          .....+++.|+|||..    .+.++||||||+++|||++|+.||...........           +...... ..
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------~~~~~~~-~~  218 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-----------ILEGKVR-FP  218 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------HhcCCcc-CC
Confidence                2235688999999944    46789999999999999999999975442111111           1111000 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAA  439 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~  439 (457)
                            ......+.+++.+|++.+|.+||     ++.|++
T Consensus       219 ------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         219 ------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                  01134578999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.4e-36  Score=282.91  Aligned_cols=243  Identities=25%  Similarity=0.337  Sum_probs=195.8

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +|...+.||.|+||.||+++.. ++..||+|++....   ......+.+|++++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4677789999999999999875 68999999997543   2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++++|.+++... ..+++.....++.+++.||.|||    ..+++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999876 45889999999999999999999    6789999999999999999999999999988764332 


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        ......++..|+|||..    .+.++|+||||+++|++++|+.||........... ......     ....      
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~-----~~~~------  220 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI-RAKQET-----ADVL------  220 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH-HHHhcc-----cccc------
Confidence              12335688899999943    57899999999999999999999986543211111 111110     0000      


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHT--TNAA  439 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~--~ev~  439 (457)
                         .+...+..+.+++.+|++.+|.+||++  .|+.
T Consensus       221 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 ---YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               011124568899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.1e-36  Score=290.32  Aligned_cols=262  Identities=26%  Similarity=0.307  Sum_probs=195.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER--TFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  246 (457)
                      .++|+..+.||+|+||.||+|... +|+.||+|.++.....  ....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467889999999999999999875 6899999998754321  223466899999999999999999998654  56899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||++ ++|.+++......+++.++..++.|++.|++|||    ..+++||||||+||++++++.+||+|||++.....
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999996 5899988876566899999999999999999999    67899999999999999999999999999987643


Q ss_pred             CCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc----c
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV----D  397 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~----d  397 (457)
                      ...  ......++..|+|||.+     .+.++||||+|+++|||++|+.||...........+............    +
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            321  12233457889999954     467899999999999999999999764433322222221111100000    0


Q ss_pred             cc------ccccccc-hh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SN------LVRREHS-FS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~------l~~~~~~-~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..      +...... .. ........+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00      0000000 00 00012455789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.7e-36  Score=288.80  Aligned_cols=264  Identities=21%  Similarity=0.314  Sum_probs=192.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD------  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  242 (457)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+....  ......+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357888999999999999999875 68999999886542  222335678999999999999999999886654      


Q ss_pred             --eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          243 --FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       243 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                        ..++||||++ ++|.+++......+++.+...++.|++.||.|||    ..+++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              4599999996 5888888776556899999999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCc--ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc---Cc
Q 044428          321 SKLLGEGDDS--LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL---PH  390 (457)
Q Consensus       321 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~---~~  390 (457)
                      +.........  .......++..|+|||..     .+.++||||||+++|||+||+.||...........+....   +.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9876432211  111234578899999943     4678999999999999999999997644322222222211   11


Q ss_pred             hh-H-----Hhccc-ccccccc-chhH---HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 KL-A-----EVVDS-NLVRREH-SFSA---KMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~~-~-----~~~d~-~l~~~~~-~~~~---~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .. .     +..+. .+..... ....   .......+.+++.+|++.+|++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00 0     00000 0000000 0000   0001234679999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.7e-35  Score=278.08  Aligned_cols=247  Identities=26%  Similarity=0.349  Sum_probs=199.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeEEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKALVL  248 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  248 (457)
                      +|...+.||+|++|.||+|... ++..|++|++.....  .....+.+|++++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999976 789999999876542  4466789999999999999999999999888  8999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++.... .+++..+..++.+++.|+.|||    ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999998765 6899999999999999999999    6789999999999999999999999999998765433


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .........++..|+|||..    .+.++||||||++++||++|+.||.....  .......        ......... 
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~--------~~~~~~~~~-  224 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYK--------IGSSGEPPE-  224 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHh--------ccccCCCcC-
Confidence            21112345688899999944    67799999999999999999999976541  1111111        100000000 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .+...+..+.+++.+|++.+|++||++.|++.
T Consensus       225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                01112456899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=283.85  Aligned_cols=259  Identities=25%  Similarity=0.305  Sum_probs=197.7

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      |+..+.||+|++|.||++... +|+.+++|.+.....  .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456678999999999999875 789999999875432  23457888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++ +|.+++......+++..+..++.+++.||.|||    ..+++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            74 898888876556899999999999999999999    6789999999999999999999999999998765432  1


Q ss_pred             eeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhcc-----
Q 044428          332 IQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVVD-----  397 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~d-----  397 (457)
                      ......++..|+|||.     ..+.++||||||+++|+++||+.||...+..+............    .....+     
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            1223457888999994     35778999999999999999999997644322222211111110    000000     


Q ss_pred             -cccccccc--chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 -SNLVRREH--SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 -~~l~~~~~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ........  ......+....+.+++.+|++.+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             00000000  00112235677999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=290.71  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=194.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|++|.||+|... ++..+|+|.+.....   .....+.+|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788889999999999999876 589999999976432   24456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      ||+++++|.+++.... ..+++..+..++.|++.||+|||    ..+++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999998643 45899999999999999999999    678999999999999999999999999998765322


Q ss_pred             CCcc---------------------------eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCC
Q 044428          328 DDSL---------------------------IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLG  376 (457)
Q Consensus       328 ~~~~---------------------------~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~  376 (457)
                      ....                           ......|+..|+|||..    .+.++||||||+++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1100                           01123578899999943    5779999999999999999999997543


Q ss_pred             CCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 044428          377 EMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH----TTNAAA  440 (457)
Q Consensus       377 ~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs----~~ev~~  440 (457)
                      ....  +         .++.+.......     ....+..+.+++.+|++.+|++||+    +.|++.
T Consensus       237 ~~~~--~---------~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET--F---------SNILKKEVTFPG-----SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH--H---------HHHhcCCccCCC-----ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2111  1         111111111000     0012456899999999999999999    555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.4e-36  Score=286.48  Aligned_cols=239  Identities=23%  Similarity=0.314  Sum_probs=191.7

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHH
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLE  257 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  257 (457)
                      .+||+|+||.||++... +|..||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            47999999999999874 78999999987555455567899999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecccc
Q 044428          258 KWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM  337 (457)
Q Consensus       258 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  337 (457)
                      +++...  .+++.....++.|++.|++|||    ..+++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         106 DIVTHT--RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence            988654  3789999999999999999999    67899999999999999999999999999876533211  122356


Q ss_pred             ccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHH
Q 044428          338 ATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDC  413 (457)
Q Consensus       338 gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  413 (457)
                      ++..|+|||..    .+.++|||||||++|||++|..||...........+....+.        .+..       ....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~-------~~~~  242 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--------KLKN-------LHKV  242 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc--------ccCC-------cccC
Confidence            88999999943    577899999999999999999998754322222222111111        1100       0012


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          414 LLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       414 ~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +..+.+++.+|++.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            345788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-36  Score=292.57  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=201.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ...|+..+.||.||.+.||++...+.+.+|+|.+...  ..+....|..|+..|.+++ |.+||++++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3568888999999999999999988889999877643  3455678999999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||- ..+|..+|.+.....+...+..+..|++.|+.+.|    ..||||.||||.|+|+-. |.+||.|||+|..+....
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH----HhceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            985 67999999987755553478889999999999999    788999999999999874 789999999999987766


Q ss_pred             CcceeccccccccccCCCCC---------------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          329 DSLIQTKTMATIGYMAPEGI---------------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~---------------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                      .+......+||+.||+||.+               ++.++||||+|||||+|+-|+.||.....    .|      .++.
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----~~------aKl~  583 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----QI------AKLH  583 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----HH------HHHH
Confidence            66666678999999999933               46789999999999999999999964210    11      1233


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.|+.-.-.+.....    ..++.+++..|+..||.+||+..++++
T Consensus       584 aI~~P~~~Iefp~~~~----~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  584 AITDPNHEIEFPDIPE----NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hhcCCCccccccCCCC----chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            4444432212221111    123899999999999999999999975

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=286.49  Aligned_cols=262  Identities=20%  Similarity=0.257  Sum_probs=191.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC---CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS---DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKA  245 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  245 (457)
                      +|+..+.||+|+||.||+|+..   +++.||+|.+....   ......+.+|+.++.+++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677789999999999999874   47899999998633   33345678899999999999999999999888  8899


Q ss_pred             EEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC----CCcEEEec
Q 044428          246 LVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE----NMVAHVSD  317 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~----~~~~kl~D  317 (457)
                      +||||++ ++|.+++....    ..++......++.|++.||.|||    ..+++||||||+||+++.    ++.+||+|
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            9999996 47777765332    25788899999999999999999    678999999999999999    99999999


Q ss_pred             cccccccCCCCCc-ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc----------HH
Q 044428          318 FGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS----------LK  381 (457)
Q Consensus       318 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~----------l~  381 (457)
                      ||+++........ .......+++.|+|||.+     ++.++||||||++++||++|+.||.......          +.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            9999876433221 112235678899999933     5678999999999999999999997533221          00


Q ss_pred             HHHHhhcCc------------hhHHhcccccccccc--chhHHH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          382 HWVNQSLPH------------KLAEVVDSNLVRREH--SFSAKM----DCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       382 ~~~~~~~~~------------~~~~~~d~~l~~~~~--~~~~~~----~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..+...-..            ......+........  ......    .....+.+++.+|++.+|++|||+.|+++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000            000000000000000  000000    12346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.6e-36  Score=292.80  Aligned_cols=264  Identities=23%  Similarity=0.302  Sum_probs=196.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN----LDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  244 (457)
                      .++|+..+.||+|+||.||+|... +|..||+|++....  ......+.+|+.++.+++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368888899999999999999864 69999999987542  2234567789999999999999999987753    3568


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+. |+|.+++.... .+++.....++.|++.||.|||    ..+++||||||+||++++++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999995 69999987654 4899999999999999999999    678999999999999999999999999999865


Q ss_pred             CCCCCc--ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch------
Q 044428          325 GEGDDS--LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK------  391 (457)
Q Consensus       325 ~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~------  391 (457)
                      ......  .......++..|+|||.+     .+.++|||||||++|||++|+.||...+.......+.......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            432211  112235688999999943     5678999999999999999999997654332222222111111      


Q ss_pred             ------hHHhccccccccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          392 ------LAEVVDSNLVRREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       392 ------~~~~~d~~l~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                            +.+.++..-........ .....+..+.+++.+|++.+|++||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  11111100000000000 011235678999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9e-36  Score=280.31  Aligned_cols=244  Identities=23%  Similarity=0.353  Sum_probs=194.2

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|+||.||+|... +|..+|+|.+....  ......+.+|+++++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677789999999999999875 68899999986542  23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~  328 (457)
                      +++++|.+++.... ..+++..+..++.+++.|+.|||    ..+++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999997654 35789999999999999999999    67799999999999999875 57999999998764322


Q ss_pred             CcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .  ......|++.|+|||.    ..+.++||||||++++|+++|+.||....   ...++........        ....
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~--------~~~~  223 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKICQGYF--------APIS  223 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhcccC--------CCCC
Confidence            1  1223458899999993    36789999999999999999999986432   2222222211111        0000


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .      ..+..+.+++.+|++.+|++|||+.|+++
T Consensus       224 ~------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 P------NFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             C------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0      11345889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=301.40  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=200.8

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      -|.++..||.|+||.||+|..+ .+-..|.|++.........+|.-||++|+.+.||+||++++.|...+.+++..|||+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3555667999999999999876 455568899988888888999999999999999999999999988899999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      ||-....+-.-+..+...++.-++++++.||.|||    +..|||||||+.|||++-+|.++|+|||.+......  ...
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk  186 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK  186 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence            99999999887788999999999999999999999    677999999999999999999999999988653211  111


Q ss_pred             eccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          333 QTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .....||+.|||||+.         |..++||||||++|.||..+.+|..........--+..               ..
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---------------Se  251 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---------------SE  251 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---------------cC
Confidence            2347799999999955         56689999999999999999999765443221111111               11


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+...++.-....+.++..+|+..||..||++.++++
T Consensus       252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1122223333567889999999999999999999875

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-35  Score=285.69  Aligned_cols=261  Identities=21%  Similarity=0.266  Sum_probs=190.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcC-CCccceeeeeeecCCe-----
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDF-----  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  243 (457)
                      ++|+..+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999875 789999999875432  23456888999999995 6999999998876655     


Q ss_pred             eEEEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEecc
Q 044428          244 KALVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDF  318 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Df  318 (457)
                      .++||||+++ +|.+++....    ..+++.....++.||+.||.|||    ..+++||||+|+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEeec
Confidence            8999999985 8988886532    35799999999999999999999    678999999999999998 899999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC--ch
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--HK  391 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~--~~  391 (457)
                      |+++.......  ......+++.|+|||.+     .+.++||||||+++|||++|..||..........-+.....  ..
T Consensus       156 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         156 GLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             ccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99886532211  11224568889999943     46789999999999999999999975432111110101000  00


Q ss_pred             --hHHhcccccc---cc-c-cc-hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 --LAEVVDSNLV---RR-E-HS-FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 --~~~~~d~~l~---~~-~-~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        ..........   .. . .. ..........+.+++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              0000000000   00 0 00 0001123556899999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=272.47  Aligned_cols=266  Identities=21%  Similarity=0.322  Sum_probs=206.7

Q ss_pred             CHHHHHHHhhcCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecC
Q 044428          164 SYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNL  241 (457)
Q Consensus       164 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  241 (457)
                      ++.|+-+.|++     .||+|+++.|..++ +.+|..+|||++.+..........+|++++.+.+ |+||++++.+|+++
T Consensus        74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            46787777776     99999999999986 5789999999999887677778899999999995 99999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC---cEEEecc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM---VAHVSDF  318 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~---~~kl~Df  318 (457)
                      ...|||||.|.||+|..+++++.. +++.+..++..+||.||.+||    .++|.|||+||+|||.....   -+||+||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeecc
Confidence            999999999999999999998764 788888999999999999999    78999999999999996443   4899999


Q ss_pred             ccccccCCCCC-----cceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHH
Q 044428          319 GISKLLGEGDD-----SLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV  384 (457)
Q Consensus       319 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~  384 (457)
                      .+..-......     +......+|+..|||||+.         +..++|.||+|||+|-|++|.+||....+.+ -.|-
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d-CGWd  302 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD-CGWD  302 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-CCcc
Confidence            88764322111     1122346788999999933         6789999999999999999999998754422 2232


Q ss_pred             HhhcCchhHHhccccccccccch--hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          385 NQSLPHKLAEVVDSNLVRREHSF--SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       385 ~~~~~~~~~~~~d~~l~~~~~~~--~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +...-+.-.+.+-..+.+....+  ..+.....+..+++...+..+|.+|.++.+++.
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            22211111122222222222222  234445566778888888899999999988875

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-35  Score=284.83  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=191.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|.+.....  .....+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999875 789999999865422  233568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEeccccccccCCC
Q 044428          250 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~  327 (457)
                      |++ ++|.+++.... ...++.....++.||+.||+|||    ..+++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            995 58888876543 33678888899999999999999    678999999999999985 567999999999765332


Q ss_pred             CCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc-----
Q 044428          328 DDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD-----  397 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d-----  397 (457)
                      .  .......+++.|+|||.+     ++.++|||||||++|||+||+.||......+...-..........+..+     
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            1  112234578899999943     5678999999999999999999997543221111111100000000000     


Q ss_pred             --cc--ccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 --SN--LVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 --~~--l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        ..  .......  ..........+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00  0000000  0000112345789999999999999999999986

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.8e-36  Score=280.94  Aligned_cols=241  Identities=24%  Similarity=0.329  Sum_probs=190.2

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ||+|+||.||+++.. +|+.+++|++.....   .....+.+|++++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 599999999875432   3456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC------c
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD------S  330 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~------~  330 (457)
                      .+++.+.. .+++..+..++.|++.||.|||    ..+++|+||+|+||++++++.++|+|||++........      .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99998765 5899999999999999999999    67899999999999999999999999999886533211      1


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      .......++..|+|||..    .+.++||||||++++|+++|+.||..............           .....    
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~~~----  220 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-----------GKIEW----  220 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------CCcCC----
Confidence            122335678899999943    56789999999999999999999975432211111110           00000    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                       ......+..+.+++.+|++.+|++||++.++.+.|
T Consensus       221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         221 -PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             -CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence             00000145688999999999999999996555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-35  Score=285.30  Aligned_cols=244  Identities=27%  Similarity=0.337  Sum_probs=192.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ---LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +.|+..+.||+|+||.||+|+.. ++..+|+|.+...   .......+.+|+++++.++|+|++++.+++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666779999999999999875 6788999998643   2233456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+. |++.+++......+++.++..++.+++.|+.|||    ..+++||||+|+||+++.++.++|+|||++...... 
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9996 6888888765556899999999999999999999    678999999999999999999999999998765432 


Q ss_pred             CcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                           ....++..|+|||.+       .+.++|||||||++|||++|+.||..............   .     ..+...
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~-----~~~~~~  235 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---N-----ESPALQ  235 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---c-----CCCCcC
Confidence                 234578899999943       56789999999999999999999865322111110000   0     000000


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                              .......+.+++.+||+.+|++||++.++++.-.
T Consensus       236 --------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             --------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                    0122455889999999999999999999986544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-35  Score=291.22  Aligned_cols=259  Identities=23%  Similarity=0.273  Sum_probs=192.3

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  241 (457)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|+.++.+++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999864 78999999986432  23345677899999999999999999987543      


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      ...++||||++ ++|.+.+...   ++......++.|++.||+|||    ..+++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999995 5888888653   788899999999999999999    678999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---hhHH
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---KLAE  394 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~~~~  394 (457)
                      +......   ......++..|+|||.+    ++.++|||||||++|+|++|+.||...+.......+...+..   ...+
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8764321   12234578899999943    678999999999999999999999754322211111111110   0001


Q ss_pred             hcc--------ccccccccch--------------hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VVD--------SNLVRREHSF--------------SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~d--------~~l~~~~~~~--------------~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .++        ..........              .........+.+++.+|++.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            100        0000000000              000122456789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=275.40  Aligned_cols=243  Identities=27%  Similarity=0.404  Sum_probs=196.8

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|++|.||+++.. +++.|++|.+.....  .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677789999999999999865 678999999976543  4556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++... ..+++..+..++.+++.|+.|||    ..+++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999999876 35899999999999999999999    678999999999999999999999999999876543321


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                        .....++..|+|||..    .+.++||||+|++++||++|+.||......  ....... ..     ..+.+      
T Consensus       156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~~-~~-----~~~~~------  219 (254)
T cd06627         156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRIV-QD-----DHPPL------  219 (254)
T ss_pred             --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHh-cc-----CCCCC------
Confidence              2235688899999933    567899999999999999999998754321  1111100 00     00000      


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         +...+..+.+++.+|+..+|++||++.+++.
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               0012446889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.7e-35  Score=275.72  Aligned_cols=244  Identities=26%  Similarity=0.377  Sum_probs=198.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|...+.||+|++|.||++... ++..+|+|++.....  .....+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677789999999999999875 689999999976532  4556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          251 MPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       251 ~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      +++++|.+++....   ..+++..+..++.+++.|+.|||    ..+++|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999998752   56899999999999999999999    678999999999999999999999999999876443


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .  .......|++.|+|||..    .+.++||||+|+++++|++|+.||...+...+   .........     +.+.  
T Consensus       157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~~-----~~~~--  224 (258)
T cd08215         157 V--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---ALKILKGQY-----PPIP--  224 (258)
T ss_pred             c--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---HHHHhcCCC-----CCCC--
Confidence            2  122335688899999933    67789999999999999999999875432211   111111000     0010  


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             ..+...+.+++.+|+..+|++||++.++++
T Consensus       225 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         225 -------SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   012456889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.1e-35  Score=283.86  Aligned_cols=240  Identities=28%  Similarity=0.327  Sum_probs=191.3

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      |...+.||+|+||.||+|+.. +|..|++|.+....   ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999864 68899999987532   23345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +. |++.+++......+++.++..++.|++.|+.|||    ..+++|+||+|+||++++++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            95 6888888766666899999999999999999999    67899999999999999999999999998864322    


Q ss_pred             ceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                        .....|+..|+|||.+       .+.++|||||||++|||++|..||................   .     +.... 
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---~-----~~~~~-  242 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---S-----PTLQS-  242 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---C-----CCCCc-
Confidence              1235688899999954       4568999999999999999999987643322222111100   0     00000 


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                             ......+.+++.+|++.+|.+||++.+++..
T Consensus       243 -------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 -------NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0113457899999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.6e-35  Score=276.93  Aligned_cols=242  Identities=29%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..+.||+|++|.||+++.. ++..+|+|.+....  ......+.+|++++++++|+||+++.+++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677889999999999999764 78899999987542  33455678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          251 MPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       251 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      +++++|.+++...   ...+++.....++.+++.||.|||    ..+++|+||+|+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999998762   245889999999999999999999    778999999999999999999999999999876543


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                          ......++..|+|||..    ++.++|+||||+++||+++|+.||...+...+...+....           .   
T Consensus       157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~---  218 (256)
T cd08530         157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-----------Y---  218 (256)
T ss_pred             ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------C---
Confidence                12235578899999943    5678999999999999999999997654322222111100           0   


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ..  ........+.+++.+|++.+|++||++.++++
T Consensus       219 -~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 -PP--IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -CC--CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             00  01123456899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-35  Score=285.38  Aligned_cols=249  Identities=22%  Similarity=0.262  Sum_probs=191.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC-CCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||.||+|+..+ ++.||||+++... ......+..|+.++.+.. ||||+++++++......++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999999864 8999999997543 233455677887777775 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++ +++.+++......+++..+..++.+++.|++|||.   ..+++||||+|+||++++++.+||+|||++..+.....
T Consensus        95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE---KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            985 57888777655578999999999999999999993   24799999999999999999999999999876543221


Q ss_pred             cceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                         .....++..|+|||.+        .+.++||||||+++|||++|+.||..... . .+...        .+.+....
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~-~~~~~--------~~~~~~~~  237 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-E-FEVLT--------KILQEEPP  237 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-H-HHHHH--------HHhcCCCC
Confidence               1234578899999954        45689999999999999999999964211 1 11111        11111100


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                      ....    ...++.++.+++.+|++.+|++||++.++++.-
T Consensus       238 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         238 SLPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            0000    001245689999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.9e-35  Score=279.96  Aligned_cols=238  Identities=22%  Similarity=0.292  Sum_probs=182.2

Q ss_pred             ccCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHh---hcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          180 LLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSECEVLR---NVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..++.   ..+||||+.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999874 689999998865421   11223344443333   3479999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++.... .+++.....++.|++.||.|||    ..+++||||||+||++++++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            999999987654 4899999999999999999999    6789999999999999999999999999987553221    


Q ss_pred             eccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....|+..|+|||..     ++.++|||||||+++||++|+.||.......... +.....     .....+       
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~-----~~~~~~-------  218 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL-----TVNVEL-------  218 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh-----cCCcCC-------
Confidence            1234689999999943     4678999999999999999999997543322211 111100     000011       


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAAK  441 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~~  441 (457)
                        +...+..+.+++.+|++.+|++||     ++.++++.
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              112245688999999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-35  Score=289.90  Aligned_cols=266  Identities=24%  Similarity=0.260  Sum_probs=196.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Ce
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  243 (457)
                      .++|...+.||+|+||.||+|+.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357888899999999999999864 7899999998753  223345677899999999999999999987644     35


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++|+||+. ++|.+++.... .+++.....++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999995 78999887653 5899999999999999999999    67899999999999999999999999999987


Q ss_pred             cCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHH
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAE  394 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~  394 (457)
                      .....  .......++..|+|||.     ..+.++|||||||++|||++|+.||...+..............    ....
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            64322  11223457889999993     3567999999999999999999999654321111111111100    0000


Q ss_pred             hccccc-------cc-cccc-hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHh
Q 044428          395 VVDSNL-------VR-REHS-FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK--LRKI  445 (457)
Q Consensus       395 ~~d~~l-------~~-~~~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~--L~~i  445 (457)
                      +.+...       .. .... .....++...+.+++.+|++.+|++|||+.++++.  +..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000       00 0000 00011345668999999999999999999999865  5444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.5e-35  Score=278.54  Aligned_cols=236  Identities=24%  Similarity=0.290  Sum_probs=184.4

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ||+|+||+||++... +|+.+|+|.+....   ......+..|++++++++||||+++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999764 78999999987532   22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecc
Q 044428          257 EKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK  335 (457)
Q Consensus       257 ~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  335 (457)
                      .+++.... ..+++..+..++.|++.|+.|||    ..+++||||+|+||++++++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            99997654 35899999999999999999999    6789999999999999999999999999988654311   1223


Q ss_pred             ccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHH
Q 044428          336 TMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM  411 (457)
Q Consensus       336 ~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  411 (457)
                      ..++..|+|||..    .+.++||||||++++||++|+.||...........+.......        ....      +.
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~------~~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM--------AVEY------PD  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc--------cccC------Cc
Confidence            4578899999943    5778999999999999999999997643211111111110000        0000      01


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHH
Q 044428          412 DCLLRIMNLALDCCMESPDERIHTTN  437 (457)
Q Consensus       412 ~~~~~l~~l~~~C~~~~P~~RPs~~e  437 (457)
                      .....+.+++.+|++.+|++||+..+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCc
Confidence            12445889999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.3e-35  Score=284.67  Aligned_cols=271  Identities=20%  Similarity=0.272  Sum_probs=196.4

Q ss_pred             ccCCC--CceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCC
Q 044428          180 LLGIG--SFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       180 ~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      .||+|  +||+||+++.. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|+||++++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            56766  99999999874 79999999987542  233467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc--
Q 044428          255 SLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL--  331 (457)
Q Consensus       255 ~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--  331 (457)
                      +|.+++.... ..+++.....++.|++.||+|||    ..+++||||||+||+++.++.++++||+.+..........  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999998643 34888899999999999999999    6789999999999999999999999998654432211110  


Q ss_pred             ---eeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcH-HHHHHhh---------cCchh
Q 044428          332 ---IQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL-KHWVNQS---------LPHKL  392 (457)
Q Consensus       332 ---~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l-~~~~~~~---------~~~~~  392 (457)
                         ......++..|+|||.+      ++.++|||||||++|||++|+.||........ .......         .+...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               00112345679999954      46789999999999999999999975332111 1110000         00000


Q ss_pred             HHh--------------c-cc----cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHHHhHHHHhh
Q 044428          393 AEV--------------V-DS----NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA--AKLRKIKVQFLD  451 (457)
Q Consensus       393 ~~~--------------~-d~----~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~--~~L~~i~~~~~~  451 (457)
                      ...              . ..    .+............+...+.+++.+|++.||++|||+.|++  ..++.+++....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~~  320 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQG  320 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhccc
Confidence            000              0 00    00000011112234567789999999999999999999997  456677766555


Q ss_pred             hhh
Q 044428          452 DVA  454 (457)
Q Consensus       452 ~~~  454 (457)
                      +++
T Consensus       321 ~~~  323 (328)
T cd08226         321 SIL  323 (328)
T ss_pred             chh
Confidence            544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=278.73  Aligned_cols=258  Identities=22%  Similarity=0.276  Sum_probs=192.9

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEecc
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      |...+.||+|++|+||+|+.. +++.|++|++..... .......+|+..+.+++ |+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456678999999999999985 578999999875432 22234567999999999 999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                       +|+|.+++.... ..+++..+..++.|++.+|.|||    ..+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             889999988764 46899999999999999999999    67899999999999999999999999999986543221 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----h------HHh
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----L------AEV  395 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~------~~~  395 (457)
                        .....++..|+|||.+     .+.++|+||||++++||++|+.||......+............    .      ...
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              1234578899999954     5678999999999999999999986543322221111111100    0      000


Q ss_pred             ccccccccccc-hh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 VDSNLVRREHS-FS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~d~~l~~~~~~-~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+..+...... .. ........+.+++.+|++.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000000 00 00011356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.2e-35  Score=284.47  Aligned_cols=255  Identities=22%  Similarity=0.204  Sum_probs=186.3

Q ss_pred             ccCCCCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHH
Q 044428          180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLE  257 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  257 (457)
                      .+|.|+++.||+++. +++.||||++...  .......+.+|+++++.++|+||+++++++...+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            445555666666655 7899999998754  2344567999999999999999999999999999999999999999999


Q ss_pred             HHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc-----c
Q 044428          258 KWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-----L  331 (457)
Q Consensus       258 ~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-----~  331 (457)
                      +++... ...+++.....++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||.+..+......     .
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            999864 345788899999999999999999    678999999999999999999999999988765322211     1


Q ss_pred             eeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HHHHHHhhcCchh-----HH-----
Q 044428          332 IQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LKHWVNQSLPHKL-----AE-----  394 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~~~~~~~~~~~~-----~~-----  394 (457)
                      ......++..|+|||.+      ++.++|||||||++|||++|+.||....... +.+......+..+     ..     
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            11234577889999943      5678999999999999999999997533211 1111110000000     00     


Q ss_pred             ------hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 ------VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ------~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            ..++... ..............+.+++.+||+.+|++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         244 SQSRSSNEHPNNR-DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             Ccccccccccchh-hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                  0000000 00000011122346889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.9e-35  Score=281.96  Aligned_cols=249  Identities=27%  Similarity=0.320  Sum_probs=188.3

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|...+.||+|+||.||++... +|+.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999875 68999999987543 234457889999999996 99999999999998999999999


Q ss_pred             cCCCCHHHH---HhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          251 MPNGSLEKW---LYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       251 ~~~g~L~~~---l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ++ +++.++   +... ...+++.....++.+++.||+|||+   ..+++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            86 455443   3322 2458899999999999999999994   24799999999999999999999999999986543


Q ss_pred             CCCcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ...   .....|++.|+|||.+       ++.++|||||||++|||++|+.||....  .....+.......     .+.
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~-----~~~  230 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGD-----PPI  230 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCC-----CCc
Confidence            211   1234578899999943       5668999999999999999999986532  1111111111100     011


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      +....     ...++..+.+++.+|++.+|++||++.+|++.
T Consensus       231 ~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 LSNSE-----EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcC-----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11100     01235568999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-35  Score=275.33  Aligned_cols=239  Identities=23%  Similarity=0.281  Sum_probs=183.0

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHH-hhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVL-RNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999874 68999999986542   12223344555444 445899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      ++|.+++.... .+++..+..++.|++.||.|||    ..+++||||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            99999997654 4788999999999999999999    67899999999999999999999999999876432      1


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....++..|+|||..    .+.++||||||+++||+++|..||..............           ......   ...
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~~~~---~~~  216 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-----------RRINWP---EEV  216 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----------cccCCC---Ccc
Confidence            234578899999943    57789999999999999999999975432211111100           000000   000


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                      ...++..+.+++.+|++.+|++||++.++.+.|
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            112355689999999999999999887665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-34  Score=274.12  Aligned_cols=232  Identities=28%  Similarity=0.335  Sum_probs=185.8

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ||.|++|.||+++.. +++.+|+|++....   ......+.+|+.+++.++||||+++++++.+....++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 58999999987543   23346789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccc
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT  336 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  336 (457)
                      .+++.+.. .+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            99998754 4788999999999999999999    6789999999999999999999999999998764432   11234


Q ss_pred             cccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHH
Q 044428          337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD  412 (457)
Q Consensus       337 ~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  412 (457)
                      .++..|+|||.+    .+.++|+||||+++||+++|..||...... .......        +.+.......     +..
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~--------~~~~~~~~~~-----~~~  218 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYND--------ILKGNGKLEF-----PNY  218 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHH--------HhccCCCCCC-----Ccc
Confidence            678899999944    567899999999999999999999764421 1111111        1110000000     111


Q ss_pred             HHHHHHHHHHhccCCCCCCCCC
Q 044428          413 CLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       413 ~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      +...+.+++.+|++.+|++||+
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcC
Confidence            2456899999999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=294.32  Aligned_cols=267  Identities=27%  Similarity=0.353  Sum_probs=200.7

Q ss_pred             CCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------CeeEE
Q 044428          175 FDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------DFKAL  246 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  246 (457)
                      |...+.||+|+||.||+|+. .+|+.||||.++... ....+...+|++++++++|+|||++++.=...      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            44556899999999999995 489999999998754 33456688999999999999999999875443      35679


Q ss_pred             EEeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec--CCC--cEEEecccc
Q 044428          247 VLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD--ENM--VAHVSDFGI  320 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~--~~~--~~kl~Dfg~  320 (457)
                      |||||++|||...|.+.+  .-|+..+.+.+..+++.||.|||    .++|+||||||.||++-  .+|  ..||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999998754  56999999999999999999999    67899999999999983  334  579999999


Q ss_pred             ccccCCCCCcceeccccccccccCCC-----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcC---ch
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPE-----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLP---HK  391 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~---~~  391 (457)
                      |+-+..+.   ......||..|++||     ..++..+|.|||||++||.+||..||....+. +..+.......   ..
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99886543   345688999999998     34778899999999999999999999875433 11111111111   11


Q ss_pred             hHHhcccccccc-------ccchhHHHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHhHHH
Q 044428          392 LAEVVDSNLVRR-------EHSFSAKMDCLLRIMNLALDCCMESPDERI--HTTNAAAKLRKIKVQ  448 (457)
Q Consensus       392 ~~~~~d~~l~~~-------~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP--s~~ev~~~L~~i~~~  448 (457)
                      +.-..++...+.       +............+..+...++..+|++|.  ...+..+.+..|...
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            222222222111       001111122344566777788888999999  777777777776543

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=275.43  Aligned_cols=258  Identities=23%  Similarity=0.304  Sum_probs=189.5

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCccceeeeeeecCCe-----
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNV---RHRNLIKILSGCSNLDF-----  243 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  243 (457)
                      |+..+.||+|+||.||+|+.+ +++.+|+|++.....  .....+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            556779999999999999986 589999999975432  2234566788777666   59999999999987776     


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      .+++|||++ ++|.+++.... ..+++..+..++.|++.||.|||    ..+++|+||+|+||++++++.+||+|||.+.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            999999996 58999887643 35899999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC-ch-hHHhc
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP-HK-LAEVV  396 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~-~~-~~~~~  396 (457)
                      .+.....   .....++..|+|||..    .+.++||||||+++|||++|+.||..........-+..... .. .....
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            7643221   1224578899999943    57799999999999999999999876433222111111110 00 00000


Q ss_pred             cc-----cccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DS-----NLVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~-----~l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..     ........  .....+....+.+++.+|++.+|.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00     00000000  0011123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.1e-35  Score=286.31  Aligned_cols=262  Identities=26%  Similarity=0.324  Sum_probs=195.3

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCe
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN-LDF  243 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  243 (457)
                      +...+++|+..+.||+|+||.||++... +|+.||+|++....  ......+.+|++++.+++||||+++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999865 79999999886432  2234567889999999999999999998865 567


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++|+||+ +++|.+++....  +++.....++.|++.||.|||    ..+++||||+|+||++++++.++|+|||.+..
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            88999998 578998887543  778888899999999999999    77899999999999999999999999999886


Q ss_pred             cCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC---------
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP---------  389 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~---------  389 (457)
                      .....     ....++..|+|||.+     ++.++||||||+++||++||+.||...........+.....         
T Consensus       158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            43211     224568889999943     56789999999999999999999975432221111111111         


Q ss_pred             ---chhHHhccccccccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          390 ---HKLAEVVDSNLVRREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       390 ---~~~~~~~d~~l~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                         ....+++............ ....+...+.+++.+|++.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               1111111100000000000 001234578999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-35  Score=287.66  Aligned_cols=262  Identities=22%  Similarity=0.293  Sum_probs=191.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------C
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------D  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  242 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378988999999999999999864 78999999987532  22334678999999999999999999988654      3


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++|+||+. .+|.++..   ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4689999996 47777653   23788999999999999999999    6789999999999999999999999999988


Q ss_pred             ccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---hhHH
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---KLAE  394 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~~~~  394 (457)
                      .....     .....++..|+|||.+     ++.++|||||||++|||++|+.||..........-+......   ...+
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            64321     1234578899999943     566899999999999999999999764322111111111100   0111


Q ss_pred             hccccc--------cc-cccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhH
Q 044428          395 VVDSNL--------VR-REHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK--LRKIK  446 (457)
Q Consensus       395 ~~d~~l--------~~-~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~--L~~i~  446 (457)
                      ..+...        .. ...... ........+.+++.+|++.+|++||++.+++..  ++.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            110000        00 000000 000123457899999999999999999999843  55544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.6e-35  Score=283.47  Aligned_cols=264  Identities=20%  Similarity=0.285  Sum_probs=192.0

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecC-------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNL-------  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  241 (457)
                      .++|+..+.||+|+||.||+|+.. +++.+|+|++.....  .....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468899999999999999999875 689999999865432  2234577899999999999999999877443       


Q ss_pred             -CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          242 -DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       242 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                       ...++|+||++ ++|.+.+......+++..+..++.|+++||.|||    ..+++|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             34699999996 5788877765556999999999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCcc---------eeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHh
Q 044428          321 SKLLGEGDDSL---------IQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ  386 (457)
Q Consensus       321 ~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~  386 (457)
                      ++.........         ..+...+++.|+|||.+     ++.++||||||+++|||++|+.||...........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            98654322111         11224568889999943     56789999999999999999999975433222111111


Q ss_pred             hcC---ch-------hHHhcccccc-ccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          387 SLP---HK-------LAEVVDSNLV-RREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       387 ~~~---~~-------~~~~~d~~l~-~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...   +.       +....+.... ....... ........+.+++.+|++.+|++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            100   00       0000000000 0000000 00112245789999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.7e-35  Score=280.03  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=194.3

Q ss_pred             cCCcCCccCCCCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCee
Q 044428          174 EFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  244 (457)
                      +|+..+.||+|++|.||+++.    .++..||||.++...    ......+.+|+.++.++ +||||+++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999999999975    367889999987432    22345688999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++|+|.+++.... .+++.....++.|++.||.|||    ..+++||||+|+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999999997653 4788899999999999999999    678999999999999999999999999998865


Q ss_pred             CCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ...... ......|+..|+|||..      .+.++||||||+++|||++|..||...+..........       .+...
T Consensus       156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~  227 (288)
T cd05583         156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-------RILKS  227 (288)
T ss_pred             cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-------HHHcc
Confidence            432211 12234588999999943      46789999999999999999999864332211111111       01100


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                      . ...      +......+.+++.+|++.+|++|||+.++.+.|..
T Consensus       228 ~-~~~------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 K-PPF------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             C-CCC------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0 000      01123457899999999999999999988777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.1e-35  Score=284.83  Aligned_cols=262  Identities=22%  Similarity=0.278  Sum_probs=192.3

Q ss_pred             hcCCc-CCccCCCCceEEEEEEeC-CCCEEEEEEecccchhh--------------HHHHHHHHHHHhhcCCCccceeee
Q 044428          173 NEFDE-CNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERT--------------FVSFNSECEVLRNVRHRNLIKILS  236 (457)
Q Consensus       173 ~~~~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  236 (457)
                      ++|.. .+.||+|+||.||+|... +++.||||.+.......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45543 367999999999999865 78999999986542111              124678999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                      ++...+..++||||++ |+|.+++.... .+++.....++.|++.||.|||    ..+++|+||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999996 69999987643 4888999999999999999999    6789999999999999999999999


Q ss_pred             ccccccccCCCCC------------cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc
Q 044428          317 DFGISKLLGEGDD------------SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS  379 (457)
Q Consensus       317 Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~  379 (457)
                      |||++........            ........++..|+|||.+     .+.++||||||+++|||++|+.||...+...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999986641110            0111224468889999954     4678999999999999999999997654333


Q ss_pred             HHHHHHhhcCch----hHHhccccc-----cccccch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          380 LKHWVNQSLPHK----LAEVVDSNL-----VRREHSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       380 l~~~~~~~~~~~----~~~~~d~~l-----~~~~~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....+.......    +.+..+-..     ....... .....+...+.+++.+|++.+|++||++.|++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            222222111110    000000000     0000000 000122456889999999999999999999985

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=279.12  Aligned_cols=253  Identities=21%  Similarity=0.243  Sum_probs=179.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC----CCEEEEEEecccchhh-----------HHHHHHHHHHHhhcCCCccceeeee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD----GTNVAIKIFNLQLERT-----------FVSFNSECEVLRNVRHRNLIKILSG  237 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~  237 (457)
                      ++|...+.||+|+||.||+|...+    +..+|+|+........           ......+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578889999999999999998754    4566777643322111           0112233445566789999999987


Q ss_pred             eecCC----eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcE
Q 044428          238 CSNLD----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       238 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                      +....    ..++++|++. .++.+.+.... ..++.....++.|++.||+|||    ..+|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCcE
Confidence            65443    4467888763 46666665432 3577888999999999999999    6789999999999999999999


Q ss_pred             EEeccccccccCCCCCcc-----eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCC-CcHHHH
Q 044428          314 HVSDFGISKLLGEGDDSL-----IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGE-MSLKHW  383 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~-~~l~~~  383 (457)
                      +|+|||+++.+.......     ......||+.|+|||.    .++.++|||||||++|||++|+.||..... ......
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            999999998764322111     1122469999999993    368899999999999999999999976522 221111


Q ss_pred             HHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       384 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                      ....+   +..+....+.        ...++..+.+++..|++.+|++||++.++.+.+
T Consensus       246 ~~~~~---~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDF---IKRLHEGKIK--------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHH---HHHhhhhhhc--------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11100   1111111110        112356789999999999999999999999876

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-35  Score=284.88  Aligned_cols=268  Identities=25%  Similarity=0.289  Sum_probs=200.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----eeE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-----FKA  245 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  245 (457)
                      +|...+.||+|++|.||+|+.. +|..||+|.+....  ......+.+|+.+++.++||||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677889999999999999975 58999999987643  334567889999999999999999999987765     789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||++ ++|.+++.... .+++..+..++.+++.||.|||    ..+++||||||+||+++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 58999987654 6899999999999999999999    6789999999999999999999999999998765


Q ss_pred             CCCCc-ceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch--------
Q 044428          326 EGDDS-LIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK--------  391 (457)
Q Consensus       326 ~~~~~-~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~--------  391 (457)
                      ..... .......++..|+|||.     ..+.++||||||+++|+|++|+.||...........+.......        
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            43210 11223457889999994     35678999999999999999999997654322222211111100        


Q ss_pred             ----hHHhccccccccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhHH
Q 044428          392 ----LAEVVDSNLVRREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK--LRKIKV  447 (457)
Q Consensus       392 ----~~~~~d~~l~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~--L~~i~~  447 (457)
                          ..+.+...-........ .....+..+.+++.+||+.+|++||++.++++.  ++.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                00111000000000000 001124568899999999999999999999874  555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=276.45  Aligned_cols=259  Identities=26%  Similarity=0.303  Sum_probs=195.8

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      |+..+.||+|++|.||+|+.. +++.+|+|++....  ......+..|+.+++.++|+|++++.+++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999876 59999999998653  333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      + ++|.+++......+++..+..++.+++.||.|||    ..+++||||+|+||++++++.+||+|||.++.......  
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            7 5999999876455899999999999999999999    67899999999999999999999999999987643221  


Q ss_pred             eeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhcc-----
Q 044428          332 IQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVVD-----  397 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~d-----  397 (457)
                      ......++..|+|||.     ..+.++||||||++++|+++|+.||...........+.......    +.+..+     
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            1223446778999994     46778999999999999999999997644322222221111100    111100     


Q ss_pred             ccccccccc-h-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHS-F-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~-~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ......... . .........+.+++.+|++.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000 0 000011456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-34  Score=285.55  Aligned_cols=266  Identities=22%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             CHHHHHHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 044428          164 SYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN  240 (457)
Q Consensus       164 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  240 (457)
                      ...++...+++|...+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|++++.+++||||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            4456777889999999999999999999985 478999999987542  2234567889999999999999999998754


Q ss_pred             C------CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEE
Q 044428          241 L------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH  314 (457)
Q Consensus       241 ~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~k  314 (457)
                      .      ...+++++++ +++|.+++....  +++..+..++.|++.||+|||    ..+++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEE
Confidence            3      3467888887 789999887653  899999999999999999999    67899999999999999999999


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc-
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL-  388 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~-  388 (457)
                      |+|||+++.....     .....++..|+|||..     .+.++|||||||++|||++|+.||...........+.... 
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999998864321     1234678899999933     5678999999999999999999996533221111111100 


Q ss_pred             --CchhHHhcccc--------cccc-ccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          389 --PHKLAEVVDSN--------LVRR-EHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       389 --~~~~~~~~d~~--------l~~~-~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        +..+...+...        +... ..... ........+.+++.+|++.+|.+||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence              00111000000        0000 00000 000123457899999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.5e-34  Score=277.33  Aligned_cols=246  Identities=25%  Similarity=0.315  Sum_probs=190.4

Q ss_pred             cCCcCCccCCCCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCee
Q 044428          174 EFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  244 (457)
                      +|+..+.||+|+||.||+++.    .+|..||+|++....    ......+.+|++++.++ +|+||+++.+++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999986    378999999987532    22345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++++|.+++.... .+++.....++.|++.||.|||    ..+++||||+|+||+++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999998654 4788888889999999999999    678999999999999999999999999999875


Q ss_pred             CCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCchhHHhcc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~~~~~~~d  397 (457)
                      ..... .......|+..|+|||..      .+.++||||||+++|||++|+.||...+.. ....+.......      .
T Consensus       156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------~  228 (290)
T cd05613         156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------E  228 (290)
T ss_pred             ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc------C
Confidence            43221 112235588999999954      356899999999999999999998643221 111211111000      0


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      +..         +..+...+.+++.+|++.+|++||     ++.++..
T Consensus       229 ~~~---------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 PPY---------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCC---------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            000         011244578999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-35  Score=289.73  Aligned_cols=198  Identities=29%  Similarity=0.357  Sum_probs=167.7

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-C-----CccceeeeeeecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-H-----RNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  246 (457)
                      +|+..+.||+|+||.|-+|.. .+++.||||+++.... -..+-..|+.+|..++ |     -|+|++++++...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788899999999999999975 4799999999986642 3345577999999996 4     489999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC--CcEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN--MVAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~~~~  323 (457)
                      |+|.+ .-+|.+++..++ ..++......|+.||+.||.+||    ..+|||+||||+||||.+-  ..+||+|||.++.
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99998 679999999876 55889999999999999999999    7889999999999999643  3799999999997


Q ss_pred             cCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHH
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKH  382 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~  382 (457)
                      ....-.     ...-+..|+|||++    ++++.||||||||+.||++|.+.|....+.+...
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~  398 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA  398 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence            543221     34567899999965    7889999999999999999988887655444333

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.7e-34  Score=271.44  Aligned_cols=244  Identities=20%  Similarity=0.252  Sum_probs=187.7

Q ss_pred             HHHHHHHhhcCCcCCcc--CCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 044428          165 YLDIQRATNEFDECNLL--GIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSN  240 (457)
Q Consensus       165 ~~~l~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  240 (457)
                      ..+.....++|+..+.+  |+|+||.||++... ++..+|+|.+.......     .|+.....+ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34555566777777776  99999999999864 78889999986542111     122222222 69999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccc
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFG  319 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg  319 (457)
                      .+..++||||+++++|.+++.... .+++.....++.|++.|+.|||    ..+++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999999998764 6899999999999999999999    67899999999999999998 99999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc--HHHHHHhhcCchhH
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLPHKLA  393 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~--l~~~~~~~~~~~~~  393 (457)
                      +++.....      ....++..|+|||.+    ++.++||||||+++|||++|+.||.......  ...+....      
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  223 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------  223 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh------
Confidence            98865322      124588999999943    5778999999999999999999997543222  12222111      


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH-TTNAAA  440 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-~~ev~~  440 (457)
                         .....       ........+.+++.+|++.+|.+||+ +.++++
T Consensus       224 ---~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 ---QKKLP-------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---cccCC-------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               00000       00022456889999999999999996 588763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=271.07  Aligned_cols=246  Identities=22%  Similarity=0.275  Sum_probs=189.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCccceeeeeeecC--Cee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ-----LERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  244 (457)
                      .+|...+.||+|+||.||+|... +|..||+|.+...     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888899999999999999864 6899999987532     123445788999999999999999999988664  467


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++|+||+++++|.+++.... .+++....+++.+++.|+.|||    ..+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999998654 3788899999999999999999    678999999999999999999999999999865


Q ss_pred             CCCCCc-ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          325 GEGDDS-LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       325 ~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ...... .......++..|+|||.+    .+.++|||||||+++|+++|+.||......  .. +.+......    .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~-~~~~~~~~~----~~~  229 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AA-IFKIATQPT----KPM  229 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HH-HHHHHcCCC----CCC
Confidence            321111 111234588999999954    567899999999999999999999753211  11 111100000    000


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +         +......+.+++.+|++ +|..||++.+++.
T Consensus       230 ~---------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         230 L---------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C---------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0         11124568899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-34  Score=276.60  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=195.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+.||+|++|.||+|... +|+.||+|++....   ......+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788889999999999999875 79999999987532   233467889999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++|+||+|+||+++.++.++++|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999998764 5899999999999999999999    678999999999999999999999999998876432


Q ss_pred             CCc------------------ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHH
Q 044428          328 DDS------------------LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN  385 (457)
Q Consensus       328 ~~~------------------~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~  385 (457)
                      ...                  .......++..|+|||..    .+.++||||||++++|+++|+.||..........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ---  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH---
Confidence            211                  111224578899999943    6778999999999999999999997644211111   


Q ss_pred             hhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 044428          386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHT----TNAAA  440 (457)
Q Consensus       386 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~----~ev~~  440 (457)
                              .+.+....  .     +...+..+.+++.+|++.+|.+||++    .++++
T Consensus       233 --------~~~~~~~~--~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 --------KILKLEYS--F-----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --------HHHhcCCC--C-----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                    11110000  0     00114458899999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-35  Score=299.56  Aligned_cols=265  Identities=20%  Similarity=0.221  Sum_probs=183.3

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC--CCCEEEEEE--------------ecc---cchhhHHHHHHHHHHHhhcCCCc
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS--DGTNVAIKI--------------FNL---QLERTFVSFNSECEVLRNVRHRN  230 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~--------------l~~---~~~~~~~~~~~E~~~l~~l~h~n  230 (457)
                      ...++|...+.||+|+||+||++..+  ++...+.|.              +..   ........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34578999999999999999998753  222222221              111   11123446889999999999999


Q ss_pred             cceeeeeeecCCeeEEEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       231 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      |+++++++...+..++|+|++ .++|.+++....    ..........++.|++.||.|||    ..+|+||||||+|||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NIL  299 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIF  299 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEE
Confidence            999999999999999999998 567888776432    12334566789999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCC-CCCCCCCcHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKP-TNDLGEMSLK  381 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p-~~~~~~~~l~  381 (457)
                      ++.++.+||+|||+++.+..... .......||..|+|||.+    ++.++|||||||++|||++|..+ +.........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987643221 122235789999999954    67789999999999999998754 4332222211


Q ss_pred             HHHHh---------hcCch---hHHhcccc-ccccccchh---HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          382 HWVNQ---------SLPHK---LAEVVDSN-LVRREHSFS---AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       382 ~~~~~---------~~~~~---~~~~~d~~-l~~~~~~~~---~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .....         .+++.   +.+.++.. +........   ........+.+++.+|++.||++|||+.|+++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11110         01110   11111110 000000000   00012335678899999999999999999986

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-35  Score=287.23  Aligned_cols=258  Identities=23%  Similarity=0.288  Sum_probs=193.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe----
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF----  243 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  243 (457)
                      ..++|...+.||+|++|.||+|+.. +++.||+|++....  ......+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578888999999999999999875 68899999986532  2234567789999999999999999988766554    


Q ss_pred             --eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          244 --KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       244 --~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                        .++|+||+ +++|.+++...  .+++..+..++.|++.||.|||    ..+++||||+|+||++++++.+||+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence              89999999 67999999764  4899999999999999999999    678999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---h--
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---K--  391 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~--  391 (457)
                      ......     .....++..|+|||.     ..+.++|||||||++||+++|+.||...........+......   .  
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            875432     123457888999993     3567999999999999999999999754322211111111110   0  


Q ss_pred             -------hHHhccccccccccchhH-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 -------LAEVVDSNLVRREHSFSA-KMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 -------~~~~~d~~l~~~~~~~~~-~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             ....+............. .......+.+++.+|++.+|++|||+.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                   011111000000000000 0112456899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.5e-35  Score=285.49  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=190.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecC----------
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL----------  241 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  241 (457)
                      .+|...+.||.|+||.||+|... +|..||+|.+..........+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888899999999999999874 6899999998766555566788999999999999999999766543          


Q ss_pred             ----CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEe
Q 044428          242 ----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVS  316 (457)
Q Consensus       242 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~  316 (457)
                          ...++||||++ ++|.+++...  .+++.....++.|++.||.|||    ..+++||||||+||+++ +++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                35789999996 6999888754  3889999999999999999999    67899999999999997 55689999


Q ss_pred             ccccccccCCCCCc-ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc
Q 044428          317 DFGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH  390 (457)
Q Consensus       317 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~  390 (457)
                      |||+++.+...... .......++..|+|||.+     .+.++|||||||++|||++|+.||..........-.....+.
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999865332111 111234578899999943     566899999999999999999999754322111111111100


Q ss_pred             h----hHHh---cccccc----ccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 K----LAEV---VDSNLV----RREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~----~~~~---~d~~l~----~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .    ..+.   ......    ....... ........+.+++.+|++.+|++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0    0000   000000    0000000 00112346789999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-34  Score=273.58  Aligned_cols=237  Identities=21%  Similarity=0.275  Sum_probs=182.1

Q ss_pred             ccCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHH---HHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          180 LLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSEC---EVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|.   ..++...||||+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 689999999865421   1112233343   34445579999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++.... .+++..+..++.|++.|+.|||    ..+++||||||+||+++.++.+||+|||++.......    
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            999999987653 5899999999999999999999    6789999999999999999999999999987653221    


Q ss_pred             eccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....|+..|+|||.+     ++.++|||||||++|||++|+.||...............      ......+.      
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~------  219 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------LTMAVELP------  219 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh------hccCCCCC------
Confidence            1234689999999943     567899999999999999999999764322211111100      00011111      


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                         ......+.+++.+|+..+|++||     ++.++++
T Consensus       220 ---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 ---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               01245688999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=272.21  Aligned_cols=263  Identities=20%  Similarity=0.346  Sum_probs=217.9

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeee
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGC  238 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~  238 (457)
                      .++.....++.....+-+|.||.||+|.+.      +.+.|-||.++... +-+...+..|--.+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            455555667888888999999999999653      44567788776543 33455688898899999999999999988


Q ss_pred             ec-CCeeEEEEeccCCCCHHHHHhh-----CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC
Q 044428          239 SN-LDFKALVLEFMPNGSLEKWLYS-----HN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN  310 (457)
Q Consensus       239 ~~-~~~~~lv~e~~~~g~L~~~l~~-----~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~  310 (457)
                      .+ .+..+.+|.++.-|+|..+|..     ..  ..+...+...++.|++.|++|||    ..++||.||.++|.++|+.
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhh
Confidence            55 4577889999999999999982     21  45677788899999999999999    7889999999999999999


Q ss_pred             CcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHH
Q 044428          311 MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVN  385 (457)
Q Consensus       311 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~  385 (457)
                      ..+||+|=.+++.+.+++.+....+......||+||.+    ++.++|||||||+||||+| |+.|+.+.++..+..++.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            99999999999998887776655566678899999944    8999999999999999999 999998877666665544


Q ss_pred             hhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       386 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ..                 .+..++.+|+.+++.++.-||...|++||+++|++.-|++.-.+.
T Consensus       513 dG-----------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  513 DG-----------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             cc-----------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            32                 233455678999999999999999999999999999999876554

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=263.13  Aligned_cols=244  Identities=24%  Similarity=0.276  Sum_probs=189.8

Q ss_pred             CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEecc
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+.+..||.|..|.|++++.. +|..+|||.+.+... ...+.+...++++..-. .|.||+.+|||.......+-||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344557999999999999875 689999999987643 34456777788777664 899999999999999999999998


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                       ...++.++.....++++.-.-++...+..||.||...   .+|+|||+||+|||+|+.|++|++|||++..+.+.   .
T Consensus       174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK---H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k  246 (391)
T KOG0983|consen  174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K  246 (391)
T ss_pred             -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh---cceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence             4567777777766778777778999999999999974   46999999999999999999999999999877432   2


Q ss_pred             eeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCC-CCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          332 IQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDL-GEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~-~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..+..+|-+.|||||.+       +.-++||||||+.++||.||+.||..- .+.+...-+....+        +.+...
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--------P~L~~~  318 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--------PLLPGH  318 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--------CCCCcc
Confidence            33456788999999955       455899999999999999999999752 22222221111111        122111


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .       .....+.++...|+++|+.+||...++++
T Consensus       319 ~-------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 M-------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             c-------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1       12345889999999999999999998875

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=283.95  Aligned_cols=259  Identities=24%  Similarity=0.301  Sum_probs=192.0

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD----  242 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  242 (457)
                      ...++|...+.||+|+||.||++.. .+|..||||++....  ......+.+|++++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3467899999999999999999985 478999999986432  223456789999999999999999999886543    


Q ss_pred             --eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          243 --FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       243 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                        ..++||||+ +++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence              458999999 78999888754  4889999999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc---Cchh
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL---PHKL  392 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~---~~~~  392 (457)
                      +......     .....+++.|+|||.+     .+.++|+||||+++|++++|+.||..........-.....   +...
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9865322     1234578899999943     5678999999999999999999997543211111000000   0000


Q ss_pred             HHhcccc--------ccccc-cch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          393 AEVVDSN--------LVRRE-HSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       393 ~~~~d~~--------l~~~~-~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.+...        +.... ... .....+...+.+++.+|++.+|++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000        00000 000 001123445889999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=315.65  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ..+-+|.....||.|.||.||.|.. ++|...|+|.++...  ......+.+|+.++..++|||+|+++|+=...+..++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3445677788999999999999974 689999999887543  3445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      .||||++|+|.+.+...+. .++.....+..|++.|+.|||    ..+||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1312 FMEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999999987642 455555568889999999999    77899999999999999999999999999998754


Q ss_pred             CCCc--ceeccccccccccCCCCCCCC-------ccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCchhHHhc
Q 044428          327 GDDS--LIQTKTMATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       327 ~~~~--~~~~~~~gt~~y~aPE~~~~~-------~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~~~~~~~  396 (457)
                      .-..  .......||+.|||||.+...       ++||||+|||++||+||++|+...+.. .+...+.....       
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~------- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK------- 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC-------
Confidence            3211  112346799999999987544       589999999999999999999765421 11111111110       


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       |.+         +.....+=.+++..|+..||++|.++.|+++
T Consensus      1460 -Pq~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 -PQI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             -CCC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence             111         1112344578999999999999999887654

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=276.22  Aligned_cols=243  Identities=21%  Similarity=0.324  Sum_probs=199.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +=|+..+.||+|.|..|-.|++- +|..||||++.+..-  -....+.+|++.|..++|||||+++.+...+..+|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            34666779999999999999753 899999999987542  234467899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      .-.+|+|++|+-++..-+.+....+++.||..|+.|+|    ..-+|||||||+||.+- .-|-+||+|||++-.+.++.
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH----qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH----QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh----hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            99999999999988877999999999999999999999    45599999999999874 67899999999998887665


Q ss_pred             CcceeccccccccccCCCCCC-----CCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~~-----~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .   .+..+|+..|-|||.+.     .++.||||+|||||-|++|+.||....+..-           +.-++|=..   
T Consensus       174 k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------LTmImDCKY---  236 (864)
T KOG4717|consen  174 K---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------LTMIMDCKY---  236 (864)
T ss_pred             h---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------hhhhhcccc---
Confidence            4   34578999999999663     3589999999999999999999987443211           122222111   


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .-+.-...++.+|+.+|+..||++|.+.++|+.
T Consensus       237 ----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 ----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                111223556789999999999999999999875

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.5e-34  Score=278.96  Aligned_cols=261  Identities=23%  Similarity=0.271  Sum_probs=187.8

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-C--CCEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCccceeeeeeec----CCe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-D--GTNVAIKIFNLQL--ERTFVSFNSECEVLRNV-RHRNLIKILSGCSN----LDF  243 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  243 (457)
                      +|+..+.||+|+||.||+++.. +  +..||+|++....  ......+.+|++++.++ .||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3667789999999999999875 3  7889999987432  22345678899999999 59999999986532    245


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++++||++ ++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||++++++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899985 78999987543 4889999999999999999999    67899999999999999999999999999987


Q ss_pred             cCCCCCc--ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---h-h
Q 044428          324 LGEGDDS--LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---K-L  392 (457)
Q Consensus       324 ~~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~-~  392 (457)
                      .......  .......|+..|+|||..     .+.++|||||||++||+++|+.||...+.......+...+..   . .
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6432211  111235689999999943     567899999999999999999999764322221111111100   0 0


Q ss_pred             HHhcccc-------c-cccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          393 AEVVDSN-------L-VRREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       393 ~~~~d~~-------l-~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..+..+.       . ........ ....+...+.+++.+|++.+|++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000       0 00000000 00012346889999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-34  Score=282.30  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=200.5

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ..+..|.....||+|.|+.|..|++. +|..||+|.+++..  ....+.+.+|+++|..++|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            44567888899999999999999875 79999999998654  2233458899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+.+|.+++++..+.. ........++.|+.+|++|+|    ...|||||||++||||+.++++||+|||++..+..
T Consensus       133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999998875 344777889999999999999    67799999999999999999999999999998754


Q ss_pred             CCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      +.   .....+|++.|.|||..     .++++|+||+||++|-|+.|..||+...-..+.           ..++...+.
T Consensus       208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~rvl~gk~r  273 (596)
T KOG0586|consen  208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PRVLRGKYR  273 (596)
T ss_pred             cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------chheeeeec
Confidence            32   34568899999999955     467899999999999999999999864321111           112222211


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      -...-       ...+.+++.+.+-.+|.+|+++.++.+-
T Consensus       274 Ip~~m-------s~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  274 IPFYM-------SCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             cccee-------echhHHHHHHhhccCccccCCHHHhhhh
Confidence            11111       2246788999999999999999998753

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.5e-34  Score=268.89  Aligned_cols=243  Identities=23%  Similarity=0.287  Sum_probs=187.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ-----LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      +|...+.||+|+||.||+++.. .+..+++|+++..     .......+..|+.++++++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4677789999999999999865 3455666665432     122334567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          248 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      |||+++++|.+++..   ....+++..++.++.|++.|+.|||    ..+++|+||+|+||++++ +.+||+|||+++..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeecccCceeec
Confidence            999999999998864   2346899999999999999999999    678999999999999975 56999999998876


Q ss_pred             CCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      .....  ......++..|+|||..    .+.++|+||||+++|+|++|..||.....   ..........     ..+..
T Consensus       156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~  225 (260)
T cd08222         156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEG-----PTPSL  225 (260)
T ss_pred             CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHcC-----CCCCC
Confidence            43222  12235578899999943    56789999999999999999999864321   1111111100     00000


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                               +..++..+.+++.+|++.+|++||++.|+++
T Consensus       226 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         226 ---------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                     1123456889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.2e-35  Score=303.14  Aligned_cols=252  Identities=27%  Similarity=0.361  Sum_probs=187.1

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----  241 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  241 (457)
                      .+-..+|++.+.||+||||.||+++.+ ||+.+|||++.... ......+.+|+..+++++|||||+++..|.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456789999999999999999999977 99999999998653 44556788999999999999999987543100     


Q ss_pred             --------------------------------------------------------------------------------
Q 044428          242 --------------------------------------------------------------------------------  241 (457)
Q Consensus       242 --------------------------------------------------------------------------------  241 (457)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 044428          242 ----------------------------------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH  287 (457)
Q Consensus       242 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH  287 (457)
                                                        ..+|+-||||+..+|.+++.++...-.....++++.+|+.||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1236788999888888888876532245677899999999999999


Q ss_pred             hcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC----------------CCCCcceeccccccccccCCCC----
Q 044428          288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG----------------EGDDSLIQTKTMATIGYMAPEG----  347 (457)
Q Consensus       288 ~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~----  347 (457)
                          ..+||||||||.||+++++..+||+|||+|+...                .+......+...||.-|+|||.    
T Consensus       715 ----~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  715 ----DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             ----hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence                7889999999999999999999999999998721                0111113345789999999993    


Q ss_pred             ---CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhc
Q 044428          348 ---IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDC  424 (457)
Q Consensus       348 ---~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C  424 (457)
                         .++.|+|+||+|||++||+.   ||...-  +-.. +-..++       +..+... ..+. ..+ ...=..++.++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~-iL~~LR-------~g~iP~~-~~f~-~~~-~~~e~slI~~L  854 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERAS-ILTNLR-------KGSIPEP-ADFF-DPE-HPEEASLIRWL  854 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchH--HHHH-HHHhcc-------cCCCCCC-cccc-ccc-chHHHHHHHHH
Confidence               37889999999999999997   554311  1011 111111       1111111 0000 001 22246889999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 044428          425 CMESPDERIHTTNAAA  440 (457)
Q Consensus       425 ~~~~P~~RPs~~ev~~  440 (457)
                      ++.||.+|||+.|++.
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999874

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=264.21  Aligned_cols=232  Identities=27%  Similarity=0.326  Sum_probs=187.2

Q ss_pred             cCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ||+|+||.||++... +++.+|+|++.....   .....+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999875 589999999876432   2455788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccc
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT  336 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  336 (457)
                      .+++.... .+++.....++.|++.|+.|||    ..+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            99998764 4899999999999999999999    6789999999999999999999999999998764321  112345


Q ss_pred             cccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHH
Q 044428          337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD  412 (457)
Q Consensus       337 ~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  412 (457)
                      .++..|+|||..    .+.++|+||||+++||+++|+.||...+.......+           ....+. .      +..
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-----------~~~~~~-~------~~~  215 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI-----------LKDPLR-F------PEF  215 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----------hcCCCC-C------CCC
Confidence            678899999944    567899999999999999999999754321111111           111110 0      001


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHH
Q 044428          413 CLLRIMNLALDCCMESPDERIHTTN  437 (457)
Q Consensus       413 ~~~~l~~l~~~C~~~~P~~RPs~~e  437 (457)
                      .+..+.+++.+|+..+|++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1445789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=259.52  Aligned_cols=246  Identities=23%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             HhhcCCcC-CccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeec----CCe
Q 044428          171 ATNEFDEC-NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSN----LDF  243 (457)
Q Consensus       171 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  243 (457)
                      .+++|... ++||-|-.|.|-.+..+ +|+.+|+|++....     ...+|++.--.. .|||||+++++|.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556544 58999999999999865 79999999986432     245677765555 69999999998765    457


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEEeccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFG  319 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg  319 (457)
                      +++|||.|+||.|++.+++++ ..+++.+.-.|+.||+.|+.|||    +..|.||||||+|+|..   .|-..||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEecccc
Confidence            789999999999999999876 56888999999999999999999    67799999999999996   45689999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHh
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV  395 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~  395 (457)
                      +|+.-.+   .......+.|+.|.|||++    +...+|+||+||++|-|++|.+||....+..+.        ++.   
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--------pgM---  275 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------PGM---  275 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--------hhH---
Confidence            9997533   2234457889999999966    566789999999999999999999875443221        111   


Q ss_pred             cccccc--ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 VDSNLV--RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~d~~l~--~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ..++.  ...+...++.+..+...+++...+..+|.+|.|+.+++.
T Consensus       276 -k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  276 -KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence             11111  122334566777888899999999999999999999874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=260.95  Aligned_cols=237  Identities=24%  Similarity=0.294  Sum_probs=191.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..++||+|.||.|-.++-+ +|+.+|+|++++..   ......-..|-++|+..+||.+..+...+...+.+++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            67888899999999999999854 79999999998763   333445678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||..||.|+-+|.+.+ .+++....-+-..|..||.|||    +.+||.||||.+|.|+|.||++||+|||+++.--.. 
T Consensus       248 eyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-  321 (516)
T ss_pred             EEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence            9999999999998765 3666666678889999999999    677999999999999999999999999999863222 


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                       .......+||+.|+|||++    ++...|.|.+|||+|||++|+.||...+...+-..+..      .++      ...
T Consensus       322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ed~------kFP  388 (516)
T KOG0690|consen  322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------EDL------KFP  388 (516)
T ss_pred             -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------hhc------cCC
Confidence             2234568999999999976    78899999999999999999999987654333322211      111      111


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      ...      ..+...|....+.+||.+|..
T Consensus       389 r~l------s~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  389 RTL------SPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ccC------CHHHHHHHHHHhhcChHhhcC
Confidence            111      233567778889999999973

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2e-33  Score=297.61  Aligned_cols=145  Identities=27%  Similarity=0.432  Sum_probs=130.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|... +++.||||+++...   ......+.+|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888899999999999999876 78999999987542   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ||+++++|.+++.... .+++...+.++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997654 4788889999999999999999    6789999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=297.52  Aligned_cols=203  Identities=23%  Similarity=0.374  Sum_probs=180.6

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL  241 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  241 (457)
                      .++....++|.+.++||+|+||.|..++++ +++.+|.|++++..   .....-|..|-++|..-..+-|+++.-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            455666789999999999999999999975 78999999998742   23445688999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      .++|+|||||+||+|-.++.... .++......++..|..||+-+|    ..|+|||||||+|||+|..|++||+|||.+
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999999887 6888888889999999999999    889999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCC---------CCCCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPE---------GIVSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE---------~~~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                      -.+... ....+...+|||-|++||         +.++..+|.||+||++|||+.|..||..
T Consensus       223 lkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  223 LKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             HhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            887643 344556689999999999         3478899999999999999999999964

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=269.97  Aligned_cols=243  Identities=27%  Similarity=0.354  Sum_probs=193.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +.|..-++||+|+||.||-++.+ +|+-+|.|.+.++.   .+...-...|-.++.+++.+.||.+-..|...+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56788889999999999999764 79999999887653   223344678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      ..|.||+|.-+|...+ ..+++....-++.+|+.||++||    ...||.||+||+|||||++|+++|+|.|+|..+..+
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            9999999999998765 45888899999999999999999    677999999999999999999999999999988665


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..   ....+||.||||||++    ++...|.||+||++|||+.|+.||....+..-.            +-+|.+....
T Consensus       341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------eEvdrr~~~~  405 (591)
T KOG0986|consen  341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------EEVDRRTLED  405 (591)
T ss_pred             Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH------------HHHHHHHhcc
Confidence            43   2345899999999944    788999999999999999999999764322111            1122222111


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTT  436 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~  436 (457)
                      ...++  ....++...+....++.||++|..-+
T Consensus       406 ~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 PEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hhhcc--cccCHHHHHHHHHHHccCHHHhccCC
Confidence            11111  12234466777788999999997544

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.1e-33  Score=253.58  Aligned_cols=198  Identities=25%  Similarity=0.350  Sum_probs=164.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC---C--CCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeec-CCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS---D--GTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSN-LDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  243 (457)
                      ...|+.+..||+|.||.||+|.-.   +  ...+|+|.++...+  +.....-+|+.+++.++|||++.+..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            357888999999999999999643   2  23689999986543  223456789999999999999999998876 778


Q ss_pred             eEEEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC----CcEEE
Q 044428          244 KALVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN----MVAHV  315 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~----~~~kl  315 (457)
                      .++++||.+ -+|.+.++-++    ..++.....+|+.||..|+.|||+++    |+||||||.|||+..+    |.+||
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW----vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW----VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh----eeeccCCcceEEEeccCCccCeeEe
Confidence            999999996 48888886443    56888889999999999999999554    9999999999999877    89999


Q ss_pred             eccccccccCCCCCcc-eeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          316 SDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                      +|||+++.+...-... ....++-|+.|.|||.+     +|.+.||||.|||+.||+|-.+-|..
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999999886543332 33447789999999954     78899999999999999998887765

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.1e-32  Score=252.97  Aligned_cols=233  Identities=29%  Similarity=0.377  Sum_probs=188.2

Q ss_pred             CceEEEEEEeC-CCCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHHHHHhh
Q 044428          185 SFGSVYKGTLS-DGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS  262 (457)
Q Consensus       185 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  262 (457)
                      +||.||+|+.. +|+.+|+|++....... ...+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 58999999998665444 67899999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccc
Q 044428          263 HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY  342 (457)
Q Consensus       263 ~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y  342 (457)
                      ... +++..+..++.+++.++.|||    ..+++|+||+|+||++++++.++|+|||.+.......   ......++..|
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            554 789999999999999999999    6789999999999999999999999999998765432   22345678899


Q ss_pred             cCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCC-CCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHH
Q 044428          343 MAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDL-GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRI  417 (457)
Q Consensus       343 ~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~-~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l  417 (457)
                      ++||.    ..+.++||||||++++|+++|..||... .......+....            ......   ....++..+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~------------~~~~~~---~~~~~~~~~  217 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP------------KPPFPP---PEWKISPEA  217 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc------------CCCCcc---ccccCCHHH
Confidence            99993    3678999999999999999999998752 221111111110            000000   000024568


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHH
Q 044428          418 MNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       418 ~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-32  Score=256.08  Aligned_cols=218  Identities=19%  Similarity=0.136  Sum_probs=171.7

Q ss_pred             CCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHHHHHhh
Q 044428          184 GSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS  262 (457)
Q Consensus       184 G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  262 (457)
                      |.+|.||+++.. +++.+|+|++....     .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999874 78999999987543     233455555666799999999999999999999999999999999976


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccc
Q 044428          263 HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY  342 (457)
Q Consensus       263 ~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y  342 (457)
                      .. .+++.....++.|++.||+|||    ..+++||||||+||+++.++.++++|||.+.......     ....++..|
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y  148 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY  148 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence            54 4899999999999999999999    7789999999999999999999999999887653321     223456789


Q ss_pred             cCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHH
Q 044428          343 MAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIM  418 (457)
Q Consensus       343 ~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~  418 (457)
                      +|||..    .+.++||||+|+++||+++|+.|+......             ........+.         ......+.
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~~~~~~~---------~~~~~~~~  206 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTHTTLNIP---------EWVSEEAR  206 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccccccCCc---------ccCCHHHH
Confidence            999954    567899999999999999999887532110             0000000000         01234578


Q ss_pred             HHHHhccCCCCCCCCCHHHH
Q 044428          419 NLALDCCMESPDERIHTTNA  438 (457)
Q Consensus       419 ~l~~~C~~~~P~~RPs~~ev  438 (457)
                      +++.+|++.||++||++.+.
T Consensus       207 ~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         207 SLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHHHHHccCCHHHhcCCCcc
Confidence            99999999999999997433

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-32  Score=284.75  Aligned_cols=257  Identities=22%  Similarity=0.238  Sum_probs=167.2

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-C----CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeee------ee
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-D----GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSG------CS  239 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  239 (457)
                      ..++|...+.||+|+||.||+|++. +    +..||||++......  ..+..|  .+.+..+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999975 4    789999987643211  111111  1222223333333221      24


Q ss_pred             cCCeeEEEEeccCCCCHHHHHhhCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 044428          240 NLDFKALVLEFMPNGSLEKWLYSHNYFL-------------------DILERLNIMIDVGLALEYLHYGHALAPIIHCDL  300 (457)
Q Consensus       240 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l-------------------~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dl  300 (457)
                      .....++||||+++++|.+++.......                   ....+..++.|++.||+|||    ..+|+||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDL  281 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDV  281 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcC
Confidence            5668899999999999999997653211                   12234578999999999999    678999999


Q ss_pred             CCCCeeecC-CCcEEEeccccccccCCCCCcceeccccccccccCCCCC--------------------------CCCcc
Q 044428          301 KPSNILLDE-NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--------------------------VSTKC  353 (457)
Q Consensus       301 k~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--------------------------~~~~~  353 (457)
                      ||+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+                          ++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999985 68999999999986643222 223346789999999933                          12356


Q ss_pred             chhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC--c---hhHHhcccccccc-ccchhHHHHHHHHHHHHHHhccCC
Q 044428          354 DVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--H---KLAEVVDSNLVRR-EHSFSAKMDCLLRIMNLALDCCME  427 (457)
Q Consensus       354 Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~--~---~~~~~~d~~l~~~-~~~~~~~~~~~~~l~~l~~~C~~~  427 (457)
                      |||||||++|||+++..|++.    .+..+......  .   .+...+.+..... ...+...........+++.+|++.
T Consensus       361 DVwSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            999999999999998776543    11111111000  0   0111111110000 000000000012345899999999


Q ss_pred             CCCCCCCHHHHHH
Q 044428          428 SPDERIHTTNAAA  440 (457)
Q Consensus       428 ~P~~RPs~~ev~~  440 (457)
                      ||++|||+.|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999986

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=255.73  Aligned_cols=245  Identities=26%  Similarity=0.313  Sum_probs=184.5

Q ss_pred             CCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCCC
Q 044428          178 CNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      ...||.|+||+|+|-.++ .|+..|||+++... +.+...+..|.+...+- +.||||+++|.+..++..++-||.| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            347999999999999875 79999999998664 35566788888765554 7999999999999999999999999 45


Q ss_pred             CHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          255 SLEKWL---YS-HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       255 ~L~~~l---~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ||..+-   +. ++..+++.-.-.|......||.||...   ..|+|||+||+|||++..|.+||||||++..+..   +
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~---lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S  221 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE---LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S  221 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH---hhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence            665433   22 224577777778888889999999864   4599999999999999999999999999987642   3


Q ss_pred             ceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ...+..+|-..|||||.+      +.-++||||+|++|+|+.||+-|+..-.  +.-+.+.+.+..      |+.+....
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv~g------dpp~l~~~  293 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVVIG------DPPILLFD  293 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHHcC------CCCeecCc
Confidence            334556788899999966      4558999999999999999999986422  111112211111      12111111


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .   ...+....+..++..|+.+|-..||...++.+
T Consensus       294 ~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  294 K---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             c---cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            0   11123556899999999999999999988764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=273.85  Aligned_cols=235  Identities=23%  Similarity=0.260  Sum_probs=189.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .+++|.....+|.|+|+.|-++.. .+++..+||++....    .+-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            366788888899999999999976 478899999997652    2335677676666 6999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee-cCCCcEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL-DENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |++.++-+.+.+.....  ....+..|+.+++.|+.|||    ..++|||||||+|||+ ++.++++|+|||.++.....
T Consensus       396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999988888877653  22677789999999999999    7889999999999999 69999999999999987543


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCchhHHhccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                           ....+-|..|.|||..    +++++|+||||++||||++|+.||...... .+...                +..
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~----------------i~~  528 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR----------------IQM  528 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh----------------hcC
Confidence                 2235678899999944    789999999999999999999999875432 11111                110


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...  +  ........+|+..|++.||.+||+|.++..
T Consensus       529 ~~~--s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 PKF--S--ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             Ccc--c--cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            000  0  122455789999999999999999999864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.7e-32  Score=273.39  Aligned_cols=260  Identities=21%  Similarity=0.235  Sum_probs=177.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-----------------CCCCEEEEEEecccchhhHHH--------------HHHH
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-----------------SDGTNVAIKIFNLQLERTFVS--------------FNSE  219 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E  219 (457)
                      ..++|+..++||+|+||.||+|..                 .+++.||||++.........+              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                 245789999987543322222              3457


Q ss_pred             HHHHhhcCCCcc-----ceeeeeeec--------CCeeEEEEeccCCCCHHHHHhhCC----------------------
Q 044428          220 CEVLRNVRHRNL-----IKILSGCSN--------LDFKALVLEFMPNGSLEKWLYSHN----------------------  264 (457)
Q Consensus       220 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  264 (457)
                      +..+.+++|.++     ++++++|..        .+..++||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777778876654     677787753        356899999999999999987431                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecccccccccc
Q 044428          265 -YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM  343 (457)
Q Consensus       265 -~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  343 (457)
                       ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.+...... ......+++.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence             12466778899999999999999    677999999999999999999999999999765432211 111234578999


Q ss_pred             CCCCCCC--------------------------CccchhhhhHHHHHHhcCCC-CCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          344 APEGIVS--------------------------TKCDVYSYGILLLETFSRKK-PTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       344 aPE~~~~--------------------------~~~Dv~s~Gvvl~el~tg~~-p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      |||.+..                          .+.||||+||+++||++|.. |+.......-.  ... ....... .
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~~~-~~~~~~~-~  453 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--LRQ-YDNDLNR-W  453 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--Hhh-ccchHHH-H
Confidence            9995421                          24699999999999999875 66432110000  000 0000000 0


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESP---DERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P---~~RPs~~ev~~  440 (457)
                      . ........++..........+++.+++..+|   .+|+|+.|+++
T Consensus       454 r-~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 R-MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             H-hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0 0000001111111224457889999998766   68999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-33  Score=256.88  Aligned_cols=258  Identities=23%  Similarity=0.266  Sum_probs=196.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-C-C----ccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-H-R----NLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~  244 (457)
                      +++|.....+|+|.||.|-.+... .+..||||+++.-. .-.++..-|++++.++. + |    -+|++.+++.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            688999999999999999999764 57899999987532 22345567999999993 2 2    377888999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC--------------
Q 044428          245 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE--------------  309 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~--------------  309 (457)
                      ++|+|.+ |-|++++|..++ .+.+...+..++.|+++++++||    ..+++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            9999998 669999999866 56888899999999999999999    788999999999999931              


Q ss_pred             ------CCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc
Q 044428          310 ------NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS  379 (457)
Q Consensus       310 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~  379 (457)
                            +..+|+.|||.|+.-....     +....|..|.|||.+    .+..+||||+||||.|+.||...|...+...
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  3458999999999754432     346789999999966    6889999999999999999999998766444


Q ss_pred             HHHHHHhhcCchhHHhcccc----------ccc--------------cccch----hHHHHHHHHHHHHHHhccCCCCCC
Q 044428          380 LKHWVNQSLPHKLAEVVDSN----------LVR--------------REHSF----SAKMDCLLRIMNLALDCCMESPDE  431 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d~~----------l~~--------------~~~~~----~~~~~~~~~l~~l~~~C~~~~P~~  431 (457)
                      ....+...+.+-...++.+.          +..              .....    ........++++|+.+++..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            33333333222111111111          000              00000    011234567999999999999999


Q ss_pred             CCCHHHHHH
Q 044428          432 RIHTTNAAA  440 (457)
Q Consensus       432 RPs~~ev~~  440 (457)
                      |+|+.|++.
T Consensus       397 RiTl~EAL~  405 (415)
T KOG0671|consen  397 RITLREALS  405 (415)
T ss_pred             cccHHHHhc
Confidence            999999874

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-32  Score=276.04  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=204.0

Q ss_pred             HHHHHHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeee---
Q 044428          165 YLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCS---  239 (457)
Q Consensus       165 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---  239 (457)
                      +..+...++-|+..+.||.|.+|.||+++. ++|+.+|+|++....+. .+++..|.+++... .|||++.++|++.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334445567788889999999999999985 57999999999876533 35567788899888 5999999999884   


Q ss_pred             --cCCeeEEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          240 --NLDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       240 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                        .++.++||||||.+||..+++..- +..+.|..+.-|+..++.|+.|||    ...++|||||-.|||++.++.+|++
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEEe
Confidence              457899999999999999999764 356899999999999999999999    5669999999999999999999999


Q ss_pred             ccccccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhh
Q 044428          317 DFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       317 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~  387 (457)
                      |||++..+...-.  ......||+.|||||++         ++.++|+||+|++..||.-|.+|+-+........     
T Consensus       166 DFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-----  238 (953)
T KOG0587|consen  166 DFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----  238 (953)
T ss_pred             eeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-----
Confidence            9999988754221  23346799999999966         4558999999999999999999987654322111     


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                ............+....+++.+++..|+.+|-++||++.++++
T Consensus       239 ----------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 ----------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                      1111122223334455778999999999999999999998874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=263.44  Aligned_cols=238  Identities=24%  Similarity=0.387  Sum_probs=189.4

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      +.||+|.||+||-|+++ +|+.||||++.+-.  .+......+|+.+|+++.||.||.+..-|+..+..+.|||.+.|.=
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            68999999999999875 89999999997643  3345678999999999999999999999999999999999996655


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC---CcEEEeccccccccCCCCCcce
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN---MVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      |+-.|.+...+++...-.-++.||+.||.|||    .++|+|+||||+|||+.+.   -.+||+|||+|++.++...   
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---  722 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---  722 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh---
Confidence            66666666677888888889999999999999    6779999999999999643   3799999999999876432   


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchh
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS  408 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~  408 (457)
                      .....||+.|+|||++    +...-|+||.||++|--++|.-||...+  ++.+.+..           ..++-.   ..
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQN-----------AaFMyP---p~  786 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQN-----------AAFMYP---PN  786 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhc-----------cccccC---CC
Confidence            3457899999999966    5667899999999999999999997643  22222211           111111   11


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 044428          409 AKMDCLLRIMNLALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       409 ~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~  439 (457)
                      .+.+......+++...++..=++|-+...-+
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            2344455677888888888888888876544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=223.36  Aligned_cols=260  Identities=22%  Similarity=0.271  Sum_probs=190.5

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +|+..++||+|.+|+|++|+. ++++.||+|+++.+.  ++......+|+-+++.++|.|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455567999999999999985 468899999987653  34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      | ..+|..+..+-+.-++.....+++.|+.+|+.+.|    +..+.|||+||.|.|++.+|+.|++|||+++.++-.-  
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            9 56888888877767898899999999999999999    6669999999999999999999999999999875422  


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcC---c-hhH---Hhcc
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLP---H-KLA---EVVD  397 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~---~-~~~---~~~d  397 (457)
                      ...+...-|..|.+|+++     +++..|+||.||++.|+.. |++.|...+-.+....+-..+.   + .+.   ..-|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            233446679999999955     6778999999999999998 5544543222121111111111   1 111   1111


Q ss_pred             ccccccccchhHHHHHHHH----HHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLR----IMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~----l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ......++....+.+....    =.++....+.-+|.+|.++++.++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1111111111111121111    245666777779999999988765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=254.10  Aligned_cols=237  Identities=23%  Similarity=0.297  Sum_probs=187.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .+|..+.+||+|+||.|..|.-+ +.+.+|||+++++.   ..+.+--..|-++|+.- +-|.++++..++..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888889999999999999765 56789999998763   22333345677777766 678999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+.||+|--++++-+. +.++...-+|..||-||-+||    +.+|+.||||..||++|.+|++||+|||+++.---+
T Consensus       429 MEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            999999999999887653 667778889999999999999    889999999999999999999999999999853222


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .  ......+||+.|+|||.+    ++..+|.|||||+||||+.|++||+..++..+-+-+.           +... ..
T Consensus       504 ~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-----------ehnv-sy  569 (683)
T KOG0696|consen  504 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-----------EHNV-SY  569 (683)
T ss_pred             C--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------HccC-cC
Confidence            2  233458899999999955    7889999999999999999999998866543322221           1111 11


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      ..      ....+...+....+.+.|.+|..
T Consensus       570 PK------slSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  570 PK------SLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cc------cccHHHHHHHHHHhhcCCccccC
Confidence            11      11345677788888899998864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=255.41  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=188.5

Q ss_pred             cCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccc--hhh-----HHHHHHHHHHHhhcCCCccceeeeeeec-CCee
Q 044428          174 EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERT-----FVSFNSECEVLRNVRHRNLIKILSGCSN-LDFK  244 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  244 (457)
                      +|-..++||+|+|+.||+|. +...+.||||+-....  ...     .+...+|.++-..+.||.||++++|+.- .+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            45556889999999999997 4578899999864332  111     2335689999999999999999999864 5677


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEEeccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGIS  321 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~  321 (457)
                      +-|.|||+|.+|.-+|..++ .+++.+...|+.||..||.||...  .++|||-||||.|||+.   .-|.+||+|||++
T Consensus       544 CTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            89999999999999998875 478889999999999999999854  57899999999999994   4578999999999


Q ss_pred             cccCCCCCcc-----eeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCC-CCcHHHHHHhh
Q 044428          322 KLLGEGDDSL-----IQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLG-EMSLKHWVNQS  387 (457)
Q Consensus       322 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~-~~~l~~~~~~~  387 (457)
                      +++.......     ..+...||..|++||.+        .+.|+||||.|||+|..+.|+.||.... ..++.+.    
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe----  696 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE----  696 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh----
Confidence            9986543332     23457899999999954        5679999999999999999999997521 1111111    


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~  439 (457)
                           ..++...-..    +........+...++.+|++.--++|....++.
T Consensus       697 -----NTIlkAtEVq----FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 -----NTILKATEVQ----FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -----hchhcceecc----CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                 0111111111    111112234567899999999888888766654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.2e-32  Score=240.34  Aligned_cols=263  Identities=21%  Similarity=0.330  Sum_probs=194.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--------
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--------  241 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  241 (457)
                      ..|+...+||+|.||.||+|+.+ +|+.||+|+.-...  ++-.....+|+.+|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555679999999999999875 67889998765432  22234568899999999999999999887432        


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      ...|+||++|+ -+|..+|......++..++.+++.++..||.|+|    ...|+|||+||.|+|++.++.+||+|||++
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            35799999995 5899999887767899999999999999999999    677999999999999999999999999999


Q ss_pred             cccCCCCCc--ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----
Q 044428          322 KLLGEGDDS--LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----  390 (457)
Q Consensus       322 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----  390 (457)
                      +.+......  ...++..-|..|++||.+     ++++.|||..|||+.||+||.+-+....+....+.+......    
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            876432221  123445679999999944     678899999999999999999888765444444444332211    


Q ss_pred             hhHHhccccccc-------cccchhHHHHHHH------HHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 KLAEVVDSNLVR-------REHSFSAKMDCLL------RIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~~~~~~d~~l~~-------~~~~~~~~~~~~~------~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.++..-.+..       .........+...      ..++++..++..||.+|+.+.+++.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            121111111100       0000111112222      4688999999999999999998874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=267.31  Aligned_cols=240  Identities=28%  Similarity=0.423  Sum_probs=181.9

Q ss_pred             CCcCCccCCCCceE-EEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccC
Q 044428          175 FDECNLLGIGSFGS-VYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       175 ~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      |...+++|.|+.|+ ||+|.. +|+.||||++-..   ...-.++|+..++.- +|||||++++.-.+.+..|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44456889999887 699998 5789999998643   233457899999888 6999999999989999999999999 


Q ss_pred             CCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---C--CcEEEecccccccc
Q 044428          253 NGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---N--MVAHVSDFGISKLL  324 (457)
Q Consensus       253 ~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~--~~~kl~Dfg~~~~~  324 (457)
                      ..+|.+++....   ..........+..|++.||+|||    +-+||||||||.|||++.   +  ..++|+|||+++.+
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            679999998741   11122445778899999999999    678999999999999975   3  57999999999998


Q ss_pred             CCCCCcce-eccccccccccCCCCC----CCCccchhhhhHHHHHHhcC-CCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          325 GEGDDSLI-QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       325 ~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg-~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ..+..+.. .....||-||+|||.+    -+..+||||+|||+|+.++| ..||.+.-.    .-++-....       .
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~----R~~NIl~~~-------~  730 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE----RQANILTGN-------Y  730 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH----hhhhhhcCc-------c
Confidence            76544432 3457899999999955    35578999999999999995 899976211    101100000       0


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+..    .....+|  +..+|+.+|+.++|..||++.+|+.
T Consensus       731 ~L~~----L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  731 TLVH----LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ceee----eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0100    0011122  5789999999999999999999963

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=255.18  Aligned_cols=237  Identities=25%  Similarity=0.370  Sum_probs=191.4

Q ss_pred             cCCcCCccCCCCceEEEEEEeCCCC-EEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          174 EFDECNLLGIGSFGSVYKGTLSDGT-NVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++..+..||-|+||.|=.++.+... .+|+|++++.-   .++.+....|-++|...+.|.||+++..|.+..+.|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4455667999999999999875433 48999987642   3445567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      -|-||.|...|..++. ++.....-++..+.+|++|||    ..+||.|||||+|.++|.+|.+||.|||+|+.+..+..
T Consensus       501 aClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            9999999999998765 566666678889999999999    78899999999999999999999999999999877655


Q ss_pred             cceeccccccccccCCCCCC----CCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~~----~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      +.   ..+||+.|.|||.+.    ...+|.||+|+++|||++|.+||+..+++.....+...        +|..-...  
T Consensus       576 Tw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG--------id~i~~Pr--  642 (732)
T KOG0614|consen  576 TW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG--------IDKIEFPR--  642 (732)
T ss_pred             ee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh--------hhhhhccc--
Confidence            43   478999999999775    45799999999999999999999876654333332221        12111101  


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                            -......+++.+.+..+|.+|..
T Consensus       643 ------~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  643 ------RITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------ccchhHHHHHHHHHhcCcHhhhc
Confidence                  11445678999999999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=236.71  Aligned_cols=241  Identities=22%  Similarity=0.306  Sum_probs=192.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...++||+|+|..|..+++. +.+.+|+|++++..   .......+.|-.+..+. +||.+|-+..++.....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57899999999999999999875 67899999998753   33455677888888877 699999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      .||+++|+|--+++++++ +++....-+...|..||.|||    ..||+.||||..|||+|..|++||+|+|+++.--..
T Consensus       330 ieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999999999888887654 888888889999999999999    889999999999999999999999999999864222


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCC----CCcHHHHHHhhcCchhHHhcccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLG----EMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~----~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      .  ...+..+||+.|+|||.+    ++...|.|++||+++||+.|+.||+-.+    +.+..+++-+..       +.+.
T Consensus       405 g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-------lekq  475 (593)
T KOG0695|consen  405 G--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-------LEKQ  475 (593)
T ss_pred             C--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-------hhhc
Confidence            2  234568999999999965    6778999999999999999999998632    233333333322       1222


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      +.-...       ...+...+...-+.+||.+|..
T Consensus       476 iriprs-------lsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  476 IRIPRS-------LSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ccccce-------eehhhHHHHHHhhcCCcHHhcC
Confidence            211111       1334567778889999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=222.84  Aligned_cols=197  Identities=27%  Similarity=0.353  Sum_probs=161.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLE-RTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ..++...+..||+|++|.|-+-++ .+|+..|||++..... +..+...+|+++..+. .+|.+|.++|........++.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            334455566899999999988876 4899999999986543 3445677888877665 799999999999999999999


Q ss_pred             EeccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          248 LEFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       248 ~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ||.| ..||..+-.   .++...++.-.-+|+..+..||.|||+   ...++|||+||+|||++.+|++|+||||++..+
T Consensus       124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            9999 567765543   234568888899999999999999996   456999999999999999999999999999887


Q ss_pred             CCCCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                      ..   +...+...|-..|||||.+        ++-|+||||+|+.+.||.+++.||+.
T Consensus       200 ~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  200 VD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             hh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            43   2223335677789999944        67799999999999999999999975

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.7e-29  Score=224.46  Aligned_cols=206  Identities=34%  Similarity=0.511  Sum_probs=178.6

Q ss_pred             cCCCCceEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHHH
Q 044428          181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK  258 (457)
Q Consensus       181 lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  258 (457)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999999866432 34678999999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEeccccccccCCCCCcceecccc
Q 044428          259 WLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSLIQTKTM  337 (457)
Q Consensus       259 ~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  337 (457)
                      ++......+++..+..++.+++.++.+||    ..+++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            99876445899999999999999999999    678999999999999999 89999999999987644321  122355


Q ss_pred             ccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHH
Q 044428          338 ATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD  412 (457)
Q Consensus       338 gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  412 (457)
                      +...|++||.     ..+.++|+|++|++++++                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            7888999994     455789999999999999                                               


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          413 CLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       413 ~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        ..+.+++..|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              237889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.4e-30  Score=250.92  Aligned_cols=207  Identities=23%  Similarity=0.397  Sum_probs=168.3

Q ss_pred             CHHHHHHHhh---cCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeee
Q 044428          164 SYLDIQRATN---EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILS  236 (457)
Q Consensus       164 ~~~~l~~~~~---~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~  236 (457)
                      .|..++++.-   -|..++.||-|+||+|.+++ .++...+|.|.+++..   ..+......|-++|+....+-||+|+-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            4444555543   36777899999999999996 4567789999987653   234455778999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                      .|.+.+.+|+||||++||++-.+|-+.+- +++.....++.+++.|+++.|    ..|+|||||||+|||+|.||++||+
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCceeee
Confidence            99999999999999999999999988764 455555567788999999999    7899999999999999999999999


Q ss_pred             cccccccc---------CCCCCcce-------------------------------eccccccccccCCCCC----CCCc
Q 044428          317 DFGISKLL---------GEGDDSLI-------------------------------QTKTMATIGYMAPEGI----VSTK  352 (457)
Q Consensus       317 Dfg~~~~~---------~~~~~~~~-------------------------------~~~~~gt~~y~aPE~~----~~~~  352 (457)
                      |||++.-+         ..++....                               .....||+.|+|||++    ++.-
T Consensus       772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~  851 (1034)
T KOG0608|consen  772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL  851 (1034)
T ss_pred             eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence            99998643         22211110                               0113599999999976    6778


Q ss_pred             cchhhhhHHHHHHhcCCCCCCCC
Q 044428          353 CDVYSYGILLLETFSRKKPTNDL  375 (457)
Q Consensus       353 ~Dv~s~Gvvl~el~tg~~p~~~~  375 (457)
                      +|.||.|||||||+.|+.||...
T Consensus       852 cdwws~gvil~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLAD  874 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCC
Confidence            99999999999999999999763

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=4.8e-29  Score=216.50  Aligned_cols=254  Identities=20%  Similarity=0.333  Sum_probs=188.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecC--CeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNL--DFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  247 (457)
                      .++|+..+++|+|.+++|+.|. ..+.+.++||+++.-.   .+.+.+|+.+|..++ ||||+++++...++  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678888999999999999997 4578899999997543   345789999999997 99999999988664  467899


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEeccccccccCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGE  326 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~  326 (457)
                      +||+.+.+...+-..    ++...+.-.+.+++.||.|+|    +.||.|||+||.|+++|. .-..+|.|+|+|.++.+
T Consensus       114 FE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999887766543    667788889999999999999    899999999999999995 45799999999999876


Q ss_pred             CCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHH---------------HHh
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW---------------VNQ  386 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~---------------~~~  386 (457)
                      +....   ....+..|--||.+     +...-|+|||||++.+|+..+.||-... .+..+.               +..
T Consensus       186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHHHHHH
Confidence            65432   34567778899955     5567899999999999999999985421 122221               111


Q ss_pred             ---hcCchhHHhccccccccccch--h-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          387 ---SLPHKLAEVVDSNLVRREHSF--S-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       387 ---~~~~~~~~~~d~~l~~~~~~~--~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         .+.+...+++.......-.++  + ...-...+..+++.+.+..|.++|||+.|.++
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence               111122222211110000000  0 00011345789999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=227.77  Aligned_cols=261  Identities=24%  Similarity=0.315  Sum_probs=189.9

Q ss_pred             CCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----CeeEE
Q 044428          175 FDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DFKAL  246 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  246 (457)
                      .+..+.||-|+||.||..+. ++|+.||+|.+..-.  --..+.+.+|+.++...+|.|++..++.....     ++.|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34557899999999999986 489999999886432  22345688999999999999999988866543     35678


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ++|.| ..+|...+-+.+ .++.....-+..||.+||.|||    +.+|.||||||.|.|++.+...||+|||+++.-..
T Consensus       135 ~TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            88888 567777766543 4777788889999999999999    78899999999999999999999999999997543


Q ss_pred             CCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchh---------
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL---------  392 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~---------  392 (457)
                      .+ ....+...-|-.|.|||.+     ++.+.||||.||++.|++.++-.|...+.....+.+...+....         
T Consensus       209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            32 2334446678899999954     67889999999999999999998877655544444444332211         


Q ss_pred             ---HHhccccccccc----cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          393 ---AEVVDSNLVRRE----HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       393 ---~~~~d~~l~~~~----~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                         ..++........    ...+.+...-.+...+...++..||..|.+..+.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence               111111111000    00000011122356677788999999999988876543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=8.8e-28  Score=220.74  Aligned_cols=195  Identities=28%  Similarity=0.435  Sum_probs=168.2

Q ss_pred             CCcCCccCCCCceEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      |...+.||+|++|.||++...+ +..+|+|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556789999999999999874 899999999876544 56788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +++|.+++......+++.....++.+++.++.+||    ..+++|+|++|+||+++.++.++|+|||.+........ ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~  155 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL  155 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence            99999999876533789999999999999999999    66899999999999999999999999999987654320 01


Q ss_pred             eccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          333 QTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                      .....++..|++||..     .+.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2234577889999954     45689999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=8.3e-29  Score=240.12  Aligned_cols=192  Identities=25%  Similarity=0.359  Sum_probs=164.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcC---CCccceeeeeeec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--------ERTFVSFNSECEVLRNVR---HRNLIKILSGCSN  240 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  240 (457)
                      .+|...+.+|+|+||.|+.|.++ +...|+||.+.+..        ++.....-.|+.+|+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888899999999999999876 56789999887542        122234567999999997   9999999999999


Q ss_pred             CCeeEEEEecc-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          241 LDFKALVLEFM-PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       241 ~~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                      ++.+||+||-. ++-+|++++..+. .+++.+..-|+.||+.|+++||    ..+|||||||-+||.++.+|-+||.|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEEeecc
Confidence            99999999976 4669999998775 3888999999999999999999    7889999999999999999999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCCC-----CCccchhhhhHHHHHHhcCCCCCC
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN  373 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~Dv~s~Gvvl~el~tg~~p~~  373 (457)
                      .+.....+..    ....||.+|.|||.+-     +...|||++|++||.++....||.
T Consensus       716 saa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9987644322    2467999999999664     456899999999999999998874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-29  Score=246.50  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=200.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|+....+|.|.+|.|||++. .++...|||+++..........++|+-+++..+||||+.++|.+...+...+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            35788889999999999999986 47999999999988777788889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +.+|+|++.-+-. ..+++.++.-..+...+|+.|||    +.+-+|||||-.||++++.+.+|++|||.+..+...  -
T Consensus        94 cgggslQdiy~~T-gplselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I  166 (829)
T ss_pred             cCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence            9999999876654 35888888889999999999999    778899999999999999999999999998765321  1


Q ss_pred             ceeccccccccccCCC-------CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          331 LIQTKTMATIGYMAPE-------GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE-------~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .......||+.|||||       +-+.+++|||+.|+...|+-.-++|.-+...+........       ..+++.-..+
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-------S~~qpp~lkD  239 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-------SGFQPPTLKD  239 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-------cCCCCCcccC
Confidence            1123467999999999       3378899999999999999998888654333322222222       1122221111


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..      .....+.++++.|+.++|++||+++..++
T Consensus       240 k~------kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 KT------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             Cc------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11      11345889999999999999999987764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-28  Score=215.38  Aligned_cols=247  Identities=20%  Similarity=0.287  Sum_probs=185.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeee-eeecCCeeEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILS-GCSNLDFKALV  247 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv  247 (457)
                      ..+.|.+.+.+|+|.||.+-.+.++ +.+.+++|-+.... ...++|.+|...--.+ .|.||+.-++ .|...+.+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3457888899999999999999986 67889999887653 3457899998876667 4899998876 46777888999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec--CCCcEEEeccccccccC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD--ENMVAHVSDFGISKLLG  325 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~  325 (457)
                      +||+|.|+|.+.+...+  +.+..-.+++.|+++|+.|+|    +..+||||||.+|||+-  +...+||||||..+..+
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999999988765  777788899999999999999    77799999999999993  34489999999988653


Q ss_pred             CCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCC--CCCcHHHHHHhhcCchhHH
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDL--GEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~--~~~~l~~~~~~~~~~~~~~  394 (457)
                      ..     ......+..|.+||..         ..+.+|||.||++++.++||+.|+...  ...+++.|..-.-+     
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r-----  244 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR-----  244 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc-----
Confidence            21     1223456779999832         456799999999999999999999853  33345554332111     


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                       ..+++......+      ...+.++..+-+..+|++|-...++.++
T Consensus       245 -k~~~~P~~F~~f------s~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  245 -KNPALPKKFNPF------SEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -cCccCchhhccc------CHHHHHHHHHhcCCcccccchhHHHHHH
Confidence             111222222222      2346778888889999998555554443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=7.5e-28  Score=218.85  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=186.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------Ce
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------DF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  243 (457)
                      .+|.....+|.|.- .|..+... .+++||+|.+....  ....+...+|...+..+.|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666778888887 66666543 68899999876542  23345678999999999999999999988643      36


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .|+||||| .++|.+.+.-.   ++......|..|++.|+.|||    +.+|+||||||+||++..+..+||.|||+|+.
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME---LDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccchhhcc
Confidence            78999999 67998888732   788888999999999999999    88999999999999999999999999999986


Q ss_pred             cCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHh--hcCc-------
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ--SLPH-------  390 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~--~~~~-------  390 (457)
                      -...   ...+....|..|.|||.+    +.+.+||||.||++.||++|+--|...+  .+.+|...  .+..       
T Consensus       168 e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d--~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  168 EDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD--HIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             cCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch--HHHHHHHHHHHhcCCCHHHHH
Confidence            4332   345667889999999955    5678999999999999999998886432  33344211  1110       


Q ss_pred             ----h---------------hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 ----K---------------LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ----~---------------~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .               ..+.+-..+..... .....+| ..+.+++.+|+-.+|++|-++.++++
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~-e~~~~~~-~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVL-EGSKLDC-SLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccc-cCCccch-HHHHHHHHHhhccChhhcccHHHHhc
Confidence                0               00011000000000 0001122 34689999999999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-27  Score=222.43  Aligned_cols=131  Identities=27%  Similarity=0.347  Sum_probs=111.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----C---Cccceeeeeee---
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-----H---RNLIKILSGCS---  239 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~---  239 (457)
                      .++|...++||-|.|++||++.. .+.+.||+|+.+... .-.+....||.+|++++     |   ..||+|+++|.   
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36888999999999999999986 478899999987543 22345678999999984     2   46999999885   


Q ss_pred             -cCCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          240 -NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       240 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                       ++.+++||+|++ |.+|..++.... .-++.....+|+.||+.||.|||..|   +|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence             467999999999 789999998765 44889999999999999999999877   59999999999999

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=7.2e-27  Score=220.01  Aligned_cols=197  Identities=30%  Similarity=0.403  Sum_probs=162.7

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      +....+.|..+++||+|.|++||++++.    ..+.||+|.+......  ..+..|++.|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4445577889999999999999999853    4678999998765433  3478999999999 5999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGIS  321 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~  321 (457)
                      ...+|+||++.....++...    ++..+...++..+..||.++|    ..|||||||||+|+|.+ ..+.-.|.|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccCCceEEechhH
Confidence            99999999999999988876    667888899999999999999    78999999999999997 4567899999998


Q ss_pred             cccCC-------------------CCC---------------c--------ceeccccccccccCCCCC-----CCCccc
Q 044428          322 KLLGE-------------------GDD---------------S--------LIQTKTMATIGYMAPEGI-----VSTKCD  354 (457)
Q Consensus       322 ~~~~~-------------------~~~---------------~--------~~~~~~~gt~~y~aPE~~-----~~~~~D  354 (457)
                      .....                   +..               .        .......||+||.|||++     .+++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            72100                   000               0        001124599999999955     577899


Q ss_pred             hhhhhHHHHHHhcCCCCCCC
Q 044428          355 VYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       355 v~s~Gvvl~el~tg~~p~~~  374 (457)
                      |||.|||++-+++++.||-.
T Consensus       261 iws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eeeccceeehhhcccccccc
Confidence            99999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=9.7e-27  Score=223.21  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=196.2

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC------CCccceeeeeeecCCe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIKILSGCSNLDF  243 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~  243 (457)
                      ...+|......|+|-|++|.+|... .|+.||||++.... -..+.=.+|+++|.+|+      --|+++++..|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            3467888889999999999999864 58899999998653 22344578999999995      3589999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEecccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGI  320 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~  320 (457)
                      +|||||-+ .-+|.+.|..-+  .-|.......++.|+.-||..|-    ..+|+|.||||.|||+++. ...||||||.
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeeccCcc
Confidence            99999988 579999998654  34777788899999999999998    6789999999999999865 4789999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHh---hcCch--
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ---SLPHK--  391 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~---~~~~~--  391 (457)
                      |......+-    +...-+..|.|||.+    +....|+||.||+||||.||+-.|.......+..+.-.   .++..  
T Consensus       584 A~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  584 ASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             ccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            987654332    334456789999955    56788999999999999999999987555444443211   11111  


Q ss_pred             -----hHHhccccc--------------------------------cccccchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          392 -----LAEVVDSNL--------------------------------VRREHSFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       392 -----~~~~~d~~l--------------------------------~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                           ..+-+|..+                                ........+.......+.+|...|+..||+.|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                 111111111                                1100011123345667899999999999999999


Q ss_pred             HHHHHH
Q 044428          435 TTNAAA  440 (457)
Q Consensus       435 ~~ev~~  440 (457)
                      ..++++
T Consensus       740 ~nqAL~  745 (752)
T KOG0670|consen  740 VNQALK  745 (752)
T ss_pred             HHHHhc
Confidence            998874

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.6e-26  Score=250.77  Aligned_cols=192  Identities=18%  Similarity=0.247  Sum_probs=134.7

Q ss_pred             hcCC-Cccceeeeee-------ecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 044428          225 NVRH-RNLIKILSGC-------SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII  296 (457)
Q Consensus       225 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~iv  296 (457)
                      .++| +||.++++++       ...+..+.++||+ +++|.+++......+++.+++.++.||++||.|||    ..+|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH----SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH----hCCee
Confidence            4455 5888888877       2234567788988 67999999876666899999999999999999999    78899


Q ss_pred             eccCCCCCeeecC-------------------CCcEEEeccccccccCCCCC--------------cceecccccccccc
Q 044428          297 HCDLKPSNILLDE-------------------NMVAHVSDFGISKLLGEGDD--------------SLIQTKTMATIGYM  343 (457)
Q Consensus       297 H~dlk~~NIll~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~  343 (457)
                      ||||||+|||++.                   ++.+|++|||+++.......              ........||+.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   44566667776654211000              00011245788999


Q ss_pred             CCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHH
Q 044428          344 APEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMN  419 (457)
Q Consensus       344 aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~  419 (457)
                      |||.+    ++.++|||||||+||||++|..|+..... .......        ....+..          ........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~~~--------~~~~~~~----------~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSLRH--------RVLPPQI----------LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHHHH--------hhcChhh----------hhcCHHHHH
Confidence            99954    68899999999999999999888643110 0000000        0111100          011223567


Q ss_pred             HHHhccCCCCCCCCCHHHHHH
Q 044428          420 LALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       420 l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ++.+|++++|.+||+|.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            888999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=2.2e-25  Score=197.56  Aligned_cols=165  Identities=24%  Similarity=0.236  Sum_probs=123.6

Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |+|.+++...+..+++.++..++.|++.||.|||    ..+      ||+||+++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH----RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence            7899999876667999999999999999999999    333      999999999999999  9998875432      


Q ss_pred             ccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc--HHHHHHhhcCchhHHhccccccccccch
Q 044428          334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~--l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                       ...||+.|+|||.+    ++.++|||||||++|||+||+.||.......  +..+.....         +.......  
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~~--  130 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP---------ADDPRDRS--  130 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---------cCCccccc--
Confidence             13588999999944    6789999999999999999999996532211  111111100         00000000  


Q ss_pred             hHHHHHH--HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          408 SAKMDCL--LRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       408 ~~~~~~~--~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                       ......  ..+.+++.+|++.+|++||++.|+++.+..+..+-
T Consensus       131 -~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      131 -NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             -cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence             011112  25899999999999999999999999998876553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-26  Score=204.00  Aligned_cols=243  Identities=23%  Similarity=0.367  Sum_probs=184.7

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      ..+|.+...|+.|+|+++ |..+++|++....  ....++|..|.-.++-..||||+.++|.|.......++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            347888999999999996 5567888886543  3334679999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceec
Q 044428          256 LEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT  334 (457)
Q Consensus       256 L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  334 (457)
                      |+..|++.. ...+..+..+++.++|+|++|||+-.  +-|.---|.+..|++|++.+++|+--. +++      +....
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad-~kf------sfqe~  344 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMAD-TKF------SFQEV  344 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheeccc-cee------eeecc
Confidence            999999875 44678899999999999999999643  223344689999999999999885211 111      11122


Q ss_pred             cccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          335 KTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       335 ~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....+.|++||.+       --..+|+|||++++||+.|+..||.+........-+       ..+.+...+..     
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------aleglrv~ipp-----  412 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------ALEGLRVHIPP-----  412 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------hhccccccCCC-----
Confidence            34567899999944       234789999999999999999999875433211100       01222222211     


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                          .....+.+++.-|+.+||.+||.+..|+-.|++++
T Consensus       413 ----gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 ----GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                11345788999999999999999999999998864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.2e-24  Score=211.44  Aligned_cols=163  Identities=23%  Similarity=0.222  Sum_probs=126.6

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC--CCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS--DGTNVAIKIFNLQ-----LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF  243 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  243 (457)
                      ..++|...+.||+|+||+||+|.+.  +++.||||++...     .......|.+|++++.+++|+|+++.+..+   +.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence            4567999999999999999999864  5788899987533     122345689999999999999998533222   45


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC-CCCCeeecCCCcEEEecccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL-KPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      .++||||+++++|... ...    .   ...++.+++.||.|||    ..+|+|||| ||+|||++.++.+||+|||+++
T Consensus        93 ~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             cEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            7999999999999732 111    1   1467889999999999    788999999 9999999999999999999999


Q ss_pred             ccCCCCCcce------eccccccccccCCCCC
Q 044428          323 LLGEGDDSLI------QTKTMATIGYMAPEGI  348 (457)
Q Consensus       323 ~~~~~~~~~~------~~~~~gt~~y~aPE~~  348 (457)
                      .+........      .....+++.|+|||.+
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            7754322111      1345678889999944

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=2.8e-21  Score=186.79  Aligned_cols=252  Identities=30%  Similarity=0.397  Sum_probs=192.2

Q ss_pred             CCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchh---hHHHHHHHHHHHhhcCCC-ccceeeeeeecCCeeEEEEec
Q 044428          175 FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER---TFVSFNSECEVLRNVRHR-NLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  250 (457)
                      |.....||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556678999999999999986  78999999765433   366799999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccccCCC
Q 044428          251 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEG  327 (457)
Q Consensus       251 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~  327 (457)
                      +.++++.+++....  ..+.......++.+++.++.|+|    ..+++|||+||+||+++... .++++|||.++.+...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            99999997777654  25888899999999999999999    67799999999999999988 7999999999866443


Q ss_pred             CCcc----eeccccccccccCCCC-------CCCCccchhhhhHHHHHHhcCCCCCCCCCC----CcHHHHHHhhcCchh
Q 044428          328 DDSL----IQTKTMATIGYMAPEG-------IVSTKCDVYSYGILLLETFSRKKPTNDLGE----MSLKHWVNQSLPHKL  392 (457)
Q Consensus       328 ~~~~----~~~~~~gt~~y~aPE~-------~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~----~~l~~~~~~~~~~~~  392 (457)
                      ....    ......|+..|+|||.       ..+...|+||+|++++++++|..|+.....    ......+......  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            3221    2345789999999993       355679999999999999999999765432    1112222111111  


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                        ...........     ......+.+++..|+..+|..|.++.+....
T Consensus       234 --~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              00000000000     1112457889999999999999999887764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-22  Score=200.80  Aligned_cols=214  Identities=25%  Similarity=0.341  Sum_probs=161.3

Q ss_pred             HhhcCCCccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 044428          223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP  302 (457)
Q Consensus       223 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~  302 (457)
                      |+.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+......++|.....++.+|+.||.|||+   ++-..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence            356889999999999999999999999999999999999877779999999999999999999994   23339999999


Q ss_pred             CCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC-----------CCCccchhhhhHHHHHHhcCCCC
Q 044428          303 SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----------VSTKCDVYSYGILLLETFSRKKP  371 (457)
Q Consensus       303 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----------~~~~~Dv~s~Gvvl~el~tg~~p  371 (457)
                      +|.++|..+.+||+|||+.................-..-|.|||.+           .+.++||||||++++|+++++.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998876431111111223345679999933           36679999999999999999999


Q ss_pred             CCCCCCCcH-HHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          372 TNDLGEMSL-KHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       372 ~~~~~~~~l-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      |+......- .+.+.. +.......+.|.+...       .+....+..++..||..+|++||++.+|-..++.+..
T Consensus       158 ~~~~~~~~~~~eii~~-~~~~~~~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILR-VKKGGSNPFRPSIELL-------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCChHHHHHH-HHhcCCCCcCcchhhh-------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            987322111 111111 1000111112221111       1334468999999999999999999999988877654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.2e-21  Score=187.48  Aligned_cols=257  Identities=20%  Similarity=0.184  Sum_probs=189.4

Q ss_pred             cCCcCCccCCCCceEEEEEEeCCC--CEEEEEEecccchhhHHHHHHHHHHHhhcCC----Cccceeeeee-ecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLSDG--TNVAIKIFNLQLERTFVSFNSECEVLRNVRH----RNLIKILSGC-SNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  246 (457)
                      +|...+.||+|+||.||.+.....  ..+|+|.-..........+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999987543  4789998765433222267788888888863    5888888888 57788999


Q ss_pred             EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-----CcEEEecccc
Q 044428          247 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-----MVAHVSDFGI  320 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfg~  320 (457)
                      ||+.. |.+|.++..... ..++....++|+.|+..+|.++|    ..|++||||||.|+.++..     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889999886554 67899999999999999999999    7889999999999999855     4699999999


Q ss_pred             cc--ccCCCCCc----c-e-eccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc
Q 044428          321 SK--LLGEGDDS----L-I-QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       321 ~~--~~~~~~~~----~-~-~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~  388 (457)
                      ++  .+......    . . .....||..|.++.    .-.+.+.|+||++.++.|++.|..|+..........-+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98  43221111    1 1 12356999999998    336789999999999999999999986533222111111110


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .   ...... .         ...++..+.++...+-..+..++|....+...+++....
T Consensus       254 ~---~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  254 R---KLLTDR-F---------GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             h---hhcccc-c---------cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            0   001110 0         001134566666677778999999999999998776554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=2.2e-21  Score=173.48  Aligned_cols=139  Identities=18%  Similarity=0.146  Sum_probs=107.5

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccchh--h-------H-----------------HHHHHHHHHHhhcCCCccc
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER--T-------F-----------------VSFNSECEVLRNVRHRNLI  232 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~niv  232 (457)
                      ..||+|+||.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            589999999999999888999999999754211  0       0                 1223599999999887764


Q ss_pred             eeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       233 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      ....+..  ...++||||++++++....... ..++......++.|++.+|.|+|+   ..+|+||||||+||+++ ++.
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCc
Confidence            4333222  2248999999988776553322 347888999999999999999942   56799999999999998 478


Q ss_pred             EEEecccccccc
Q 044428          313 AHVSDFGISKLL  324 (457)
Q Consensus       313 ~kl~Dfg~~~~~  324 (457)
                      ++|+|||++...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=3.8e-22  Score=206.81  Aligned_cols=246  Identities=21%  Similarity=0.234  Sum_probs=180.1

Q ss_pred             cCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc-hhhHHHHHHHHHH--HhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL-ERTFVSFNSECEV--LRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++...+.||.+.|=+|.+|+.++|. |+||++-+.. .-....|.++++-  ...++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999998887 9999997654 2334445444433  4555899999998887778888899999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc--CCC-
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL--GEG-  327 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~--~~~-  327 (457)
                      . .-+|+|.+..+. .+...+..=|+.|+..|+..+|    ..+|+|||||.+|||++....+.|+||..-+..  .+. 
T Consensus       103 v-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 V-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             H-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            8 458999998765 3666777779999999999999    788999999999999999999999999977653  221 


Q ss_pred             --CCcceeccccccccccCCCCC---------------CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcC
Q 044428          328 --DDSLIQTKTMATIGYMAPEGI---------------VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       328 --~~~~~~~~~~gt~~y~aPE~~---------------~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~  389 (457)
                        +....-.....-.+|+|||.+               .+++-||||.||++.||++ |++||.-      .+.......
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~~  250 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRSG  250 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhcc
Confidence              111222233445689999943               3567899999999999998 7888742      222211111


Q ss_pred             -chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          390 -HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       390 -~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                       ....+.+-..+.            -..+.+++..|++.||+.|.++.+.++.-+.
T Consensus       251 ~~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  251 NADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             CccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence             000111111110            1137889999999999999999999987543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.2e-21  Score=177.35  Aligned_cols=172  Identities=13%  Similarity=0.107  Sum_probs=131.3

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHH---------HHHHHHHHHhhcCCCccceeeeeeecC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV---------SFNSECEVLRNVRHRNLIKILSGCSNL  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~  241 (457)
                      ..++|...+++|.|+||.||.... ++..+|||++.........         .+.+|++.+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999766 5778999999754322221         267999999999999999998875532


Q ss_pred             --------CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcE
Q 044428          242 --------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       242 --------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                              ...++||||++|.+|.++..     ++.    ....+++.++..+|    ..+++|||++|+||++++++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeCCC-E
Confidence                    35789999999999988742     222    24568999999999    78899999999999999988 9


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCCCCCCCccchhhhhHHHHHHhc
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFS  367 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~Dv~s~Gvvl~el~t  367 (457)
                      +|+|||............         . ..-|.-+..++|+||||+.+.-+..
T Consensus       174 ~liDfg~~~~~~e~~a~d---------~-~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKD---------R-IDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEECCCcccccchhhHH---------H-HHHHhHhcccccccceeEeehHHHH
Confidence            999999887653211100         0 1112224468999999998877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=9.6e-22  Score=203.36  Aligned_cols=249  Identities=21%  Similarity=0.218  Sum_probs=180.9

Q ss_pred             cCCccCCCCceEEEEEEeC-CCCEEEEEEecc-----cchhh-HHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          177 ECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNL-----QLERT-FVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~-----~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ..+++|.|.+|.|+..... .....+.|....     ..... ...+..|.-+-..+.|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4568999999988777643 334344443321     11111 1225667777788899999998888877776666799


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++ +|+.++.+.. .+...++-.++.|+..|+.|+|    ..+|.|||+|++|+++..++.+||+|||.+....-...
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9999 9999998762 4788888999999999999999    78899999999999999999999999999987654443


Q ss_pred             c--ceeccccccccccCCCCCC-----CCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          330 S--LIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       330 ~--~~~~~~~gt~~y~aPE~~~-----~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .  .......|+..|+|||.+.     ....||||.|+++..|.+|+.||......+-.. ..        .........
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~--------~~~~~~~~~  546 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT--------NNYSDQRNI  546 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh--------hcccccccc
Confidence            3  4556688999999999653     335899999999999999999986522111000 00        000000000


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...........+.....++.++++.+|.+|-|+.+|++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            11111123344666788999999999999999999975

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.6e-20  Score=168.44  Aligned_cols=140  Identities=21%  Similarity=0.188  Sum_probs=110.3

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchh--------------------------hHHHHHHHHHHHhhcCCCcc
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER--------------------------TFVSFNSECEVLRNVRHRNL  231 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  231 (457)
                      ...||+|++|.||+|+..+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3589999999999999878999999998754210                          01124578999999999987


Q ss_pred             ceeeeeeecCCeeEEEEeccCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC
Q 044428          232 IKILSGCSNLDFKALVLEFMPNGSLEKW-LYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN  310 (457)
Q Consensus       232 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~  310 (457)
                      .....+...  ..++||||++++++... +..  ..++.....+++.+++.++.++|+   ..+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ---EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCChhhEEEE-C
Confidence            554443332  24899999998865443 433  237778889999999999999993   17899999999999999 8


Q ss_pred             CcEEEeccccccccC
Q 044428          311 MVAHVSDFGISKLLG  325 (457)
Q Consensus       311 ~~~kl~Dfg~~~~~~  325 (457)
                      +.++|+|||++..+.
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.2e-20  Score=163.24  Aligned_cols=182  Identities=16%  Similarity=0.114  Sum_probs=138.0

Q ss_pred             cCCccCCCCceEEEEEEeCCCCEEEEEEecccchhh----HHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEecc
Q 044428          177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERT----FVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ....|++|+||+||.+.- ++..++.+.+.......    ...+.+|+++|+++. |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456899999999997765 67888888776543211    124789999999995 5789999886    4469999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC-CCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL-KPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +|.+|.+.+...        ...++.+++.++.++|    ..+|+|||| ||+|||++.++.++|+|||++....+....
T Consensus        81 ~G~~L~~~~~~~--------~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         81 AGAAMYQRPPRG--------DLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cCccHHhhhhhh--------hHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999997654221        2357789999999999    788999999 799999999999999999999865433210


Q ss_pred             ----c-------eeccccccccccCCC--CCC---C-CccchhhhhHHHHHHhcCCCCCCCC
Q 044428          331 ----L-------IQTKTMATIGYMAPE--GIV---S-TKCDVYSYGILLLETFSRKKPTNDL  375 (457)
Q Consensus       331 ----~-------~~~~~~gt~~y~aPE--~~~---~-~~~Dv~s~Gvvl~el~tg~~p~~~~  375 (457)
                          .       .......++.|++|+  .+.   + .+.+.++-|.-+|.++||+.|....
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                0       011133677888887  222   2 3568999999999999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-19  Score=158.66  Aligned_cols=255  Identities=20%  Similarity=0.225  Sum_probs=181.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH-RNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .+.|..+++||.|+||.+|.|. ..+|..||+|+=......  ....-|..+.+.+++ ..|..+.-|..+.++..+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3678899999999999999997 568999999986654322  346678888888875 456666777888889999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC---CcEEEeccccccccCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN---MVAHVSDFGISKLLGE  326 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~~~~~~~  326 (457)
                      .. |.+|+++..--...++..+.+-++-|+..-++|+|    ..+++||||||+|.|.+-+   ..+.+.|||+++.+.+
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            98 88999998866566888999999999999999999    5669999999999999643   3688999999998744


Q ss_pred             CCCc-----ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          327 GDDS-----LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       327 ~~~~-----~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      ....     .......||.+|.+-...    .+.+.|+=|+|.+|...--|..||.......-.+-.....        .
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~--------E  238 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS--------E  238 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH--------H
Confidence            2221     122346799999876633    4668899999999999999999998743222211111111        1


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      ..+.-..  ..-....|.++.-.+.-|=..--++-|...=+.+..+
T Consensus       239 kK~s~~i--e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  239 KKMSTPI--EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             hhcCCCH--HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            1110000  0000112445666666776666677776655554444

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=4e-19  Score=160.44  Aligned_cols=136  Identities=18%  Similarity=0.205  Sum_probs=105.9

Q ss_pred             CcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-----CCCccceeeeeeecCC---eeE-E
Q 044428          176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-----RHRNLIKILSGCSNLD---FKA-L  246 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  246 (457)
                      .....||+|+||.||. .-.++. .+||++..........+.+|+.++..+     .||||++++|++.+..   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4456899999999996 223444 479988765444556789999999999     5799999999998864   333 7


Q ss_pred             EEec--cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCCeeeccCCCCCeeecC----CCcEEEeccc
Q 044428          247 VLEF--MPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL-EYLHYGHALAPIIHCDLKPSNILLDE----NMVAHVSDFG  319 (457)
Q Consensus       247 v~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfg  319 (457)
                      |+||  +++|+|.+++.+..  ++..  ..++.+++.++ +|||    ..+|+||||||+||+++.    ++.++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            8999  55899999997643  4544  35677888777 9999    678999999999999974    3489999954


Q ss_pred             cc
Q 044428          320 IS  321 (457)
Q Consensus       320 ~~  321 (457)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2.2e-19  Score=168.19  Aligned_cols=194  Identities=26%  Similarity=0.286  Sum_probs=138.1

Q ss_pred             CCCccceeeeeeec---------------------------CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 044428          227 RHRNLIKILSGCSN---------------------------LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV  279 (457)
Q Consensus       227 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i  279 (457)
                      +|||||++.++|.+                           ...+|+||.-+ ..+|.+++..+.  .+...+.-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence            69999999886632                           23568888877 469999998765  5556667789999


Q ss_pred             HHHHHHHHhcCCCCCeeeccCCCCCeee--cCCC--cEEEeccccccccCCCCC----cceeccccccccccCCCCC---
Q 044428          280 GLALEYLHYGHALAPIIHCDLKPSNILL--DENM--VAHVSDFGISKLLGEGDD----SLIQTKTMATIGYMAPEGI---  348 (457)
Q Consensus       280 a~~l~~LH~~~~~~~ivH~dlk~~NIll--~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~---  348 (457)
                      .+|+.|||    ..+|.|||+|++|||+  |+|.  ...|+|||.+-.-....-    ..-.....|...-||||..   
T Consensus       351 LEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  351 LEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999    7889999999999998  4444  578899998753211000    0011124567788999933   


Q ss_pred             -------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHH
Q 044428          349 -------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLA  421 (457)
Q Consensus       349 -------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~  421 (457)
                             --.|+|.|+.|.+.||+++...||...++..+...-.+       +---+.+         +..|+.-+.+++
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-------e~qLPal---------p~~vpp~~rqlV  490 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-------ESQLPAL---------PSRVPPVARQLV  490 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-------hhhCCCC---------cccCChHHHHHH
Confidence                   24589999999999999999999987665443322111       0001111         223455688999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHH
Q 044428          422 LDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       422 ~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      ...++.||.+|++..-....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999876665553

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.6e-20  Score=183.47  Aligned_cols=184  Identities=27%  Similarity=0.325  Sum_probs=153.3

Q ss_pred             ccCCCCceEEEEEE----eCCCCEEEEEEecccchh--hHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEeccC
Q 044428          180 LLGIGSFGSVYKGT----LSDGTNVAIKIFNLQLER--TFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      .+|+|.||.|+.++    ...|..+|.|++++....  .......|..++..++ ||.+|++...+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998764    235788999988765321  1224556788888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|.|...+..... .+..........++.+++++|    ..+++|||+|++||+++.+|++++.|||+++.......   
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            9999999987653 455556667788999999999    78899999999999999999999999999987643221   


Q ss_pred             eccccccccccCCCCC--CCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          333 QTKTMATIGYMAPEGI--VSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~--~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                         .+||..|||||.+  ....+|.||||++++||+||..||..
T Consensus       153 ---~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ---cccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence               2899999999966  46789999999999999999999865

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.6e-17  Score=152.41  Aligned_cols=196  Identities=21%  Similarity=0.283  Sum_probs=160.2

Q ss_pred             cCCcCCccCCCCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEecc
Q 044428          174 EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .|...++||+|+||..+.|+ +-++++||||.=...+  ...++..|.+..+.| ..+.|...+-|-..+.+..||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            67888999999999999997 4579999999754432  234566788888777 4788888888888888899999998


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-----CcEEEeccccccccCC
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-----MVAHVSDFGISKLLGE  326 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfg~~~~~~~  326 (457)
                       |-||+++..--++.++......+|.|+..-++|+|    ...+|.|||||+|.|++.-     ..+.+.|||+|+.+..
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence             88999988866667999999999999999999999    6669999999999999743     3689999999998754


Q ss_pred             CCCc-----ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCC
Q 044428          327 GDDS-----LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLG  376 (457)
Q Consensus       327 ~~~~-----~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~  376 (457)
                      ....     .......||.+||+-..-    -+.+.|+=|+|-|+...+-|..||....
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            3322     112346799999987633    4568899999999999999999998743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.7e-18  Score=156.73  Aligned_cols=134  Identities=22%  Similarity=0.304  Sum_probs=114.0

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE--------RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +.||+|++|.||+|.. +|..+++|+......        .....+.+|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899998654321        1123578899999999999998877777777888999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ++|++|.+++....    + .+..++.+++.++.++|    ..+++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999987543    2 78899999999999999    67899999999999999 78999999998875

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=9.6e-19  Score=163.24  Aligned_cols=225  Identities=20%  Similarity=0.281  Sum_probs=143.0

Q ss_pred             CcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCC-----------Ccccee-----e
Q 044428          176 DECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRH-----------RNLIKI-----L  235 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-----------~niv~l-----~  235 (457)
                      ...+.||.|+++.||.+++. +|+.+|||++....   ....+++.+|.-....+.+           .-++++     -
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34468999999999999986 69999999986543   3345567777655555322           112221     1


Q ss_pred             e---eeecC---C-----eeEEEEeccCCCCHHHHHhh---CC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 044428          236 S---GCSNL---D-----FKALVLEFMPNGSLEKWLYS---HN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHC  298 (457)
Q Consensus       236 ~---~~~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~  298 (457)
                      +   ++...   .     ..+++|+-+ .++|.+++..   ..   ..+....++.+..|+.+.+++||    ..|++|+
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlVHg  169 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH----SYGLVHG  169 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEEES
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh----hcceEec
Confidence            1   11111   1     235677777 6788887642   22   12445667888899999999999    7889999


Q ss_pred             cCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCC------------CCCCccchhhhhHHHHHHh
Q 044428          299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG------------IVSTKCDVYSYGILLLETF  366 (457)
Q Consensus       299 dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~------------~~~~~~Dv~s~Gvvl~el~  366 (457)
                      ||+|+|++++++|.++|+||+.....+..    ... ...+..|.+||.            .++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999887754321    111 334567888882            2577899999999999999


Q ss_pred             cCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044428          367 SRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER  432 (457)
Q Consensus       367 tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~R  432 (457)
                      +|+.||+.........|               .+. .      ..+.++.+..|+...++.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~~---------------~f~-~------C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---------------DFS-R------CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---------------GGT-T------SS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---------------cch-h------cCCcCHHHHHHHHHHccCCcccC
Confidence            99999986432111110               111 1      11447789999999999999988

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=7.1e-18  Score=175.01  Aligned_cols=139  Identities=22%  Similarity=0.235  Sum_probs=112.6

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEe-ccc-c------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-NLQ-L------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD  242 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l-~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  242 (457)
                      ....|...+.||+|+||.||+|.+.+.. +++|+. ... .      ......+.+|++++..++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3445567789999999999999875443 444432 211 1      112346889999999999999998888887777


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++||||+++++|.+++.         ....++.+++.+|.|||    ..+++||||||+||++ +++.++|+|||+++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            8899999999999999885         35678999999999999    7789999999999999 67899999999988


Q ss_pred             cc
Q 044428          323 LL  324 (457)
Q Consensus       323 ~~  324 (457)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            63

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=3.9e-18  Score=157.74  Aligned_cols=142  Identities=19%  Similarity=0.152  Sum_probs=109.9

Q ss_pred             cCCcCCccCCCCceEEEEEE--eCCCCEEEEEEecccchh------------------------hHHHHHHHHHHHhhcC
Q 044428          174 EFDECNLLGIGSFGSVYKGT--LSDGTNVAIKIFNLQLER------------------------TFVSFNSECEVLRNVR  227 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~  227 (457)
                      -|...+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46677899999999999998  568999999998743210                        1123568999999997


Q ss_pred             CCc--cceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-eeeccCCCCC
Q 044428          228 HRN--LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP-IIHCDLKPSN  304 (457)
Q Consensus       228 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~-ivH~dlk~~N  304 (457)
                      +..  +.+++++    ...++||||+++++|........ .........++.+++.++.+||    ..+ ++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCChhh
Confidence            533  3344432    23589999999988877653322 3455566789999999999999    778 9999999999


Q ss_pred             eeecCCCcEEEeccccccccC
Q 044428          305 ILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       305 Ill~~~~~~kl~Dfg~~~~~~  325 (457)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999988643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=8.1e-18  Score=152.03  Aligned_cols=143  Identities=20%  Similarity=0.191  Sum_probs=110.6

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccch----------------------hhHHHHHHHHHHHhh
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE----------------------RTFVSFNSECEVLRN  225 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~  225 (457)
                      +.+...-|...+.||+|+||.||++...+|+.||||++.....                      .....+..|...+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            3333334777789999999999999988899999998764320                      011235678888998


Q ss_pred             cCCCc--cceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 044428          226 VRHRN--LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPS  303 (457)
Q Consensus       226 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~  303 (457)
                      +.|++  +.+.++.    ...++||||+++++|.+....       .....++.+++.++.++|    ..+++||||+|+
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~  154 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY----KHGIIHGDLSEF  154 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH----HCCCCcCCCCcc
Confidence            88774  4444432    345899999999999775431       234578899999999999    678999999999


Q ss_pred             CeeecCCCcEEEeccccccccC
Q 044428          304 NILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       304 NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||++++++.++|+|||++....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.3e-17  Score=150.85  Aligned_cols=130  Identities=24%  Similarity=0.312  Sum_probs=107.3

Q ss_pred             ccCCCCceEEEEEEeCCCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .||+|+||.||+|.+ +|..|++|+.....        ......+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 57889999865321        111345778999999999887666555566666779999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ++++|.+++.....        .++.+++.+|.+||    ..+++|+|++|.||+++ ++.+++.|||+++.
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998865321        78999999999999    78899999999999999 88999999998875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=1.2e-17  Score=176.50  Aligned_cols=195  Identities=24%  Similarity=0.233  Sum_probs=149.7

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCee
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR---HRNLIKILSGCSNLDFK  244 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  244 (457)
                      .+...+.|.+.+.||+|+||+||+|...+|+.||+|+=+.....+   |.==.+++.+|+   -+-|..+...+.-.+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            334446778888999999999999999889999999876554332   111123334444   23344445555566778


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-------CCCcEEEec
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-------ENMVAHVSD  317 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-------~~~~~kl~D  317 (457)
                      ++|+||.+.|+|.+++... ...+|.-...++.++++.+++||    ..+|||+||||+|.||.       +...++|+|
T Consensus       770 ~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            8999999999999999954 45889999999999999999999    78899999999999994       344689999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCC
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKK  370 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~  370 (457)
                      ||.+..+.--.....-...++|-++-.+|+.    .+...|.|.++.+++-|+.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9998765332222233456788889999955    5778999999999999999874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=5.1e-16  Score=133.14  Aligned_cols=135  Identities=22%  Similarity=0.255  Sum_probs=114.5

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CccceeeeeeecCCeeEEEEeccCCCC
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH--RNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++.+++++....+..++++||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999999855 7899999865533  4568899999999976  589999998888888999999999887


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      +..+        +......++.+++.++.++|... ..+++|+|++|+||++++++.+++.|||.++..
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            7654        45677788999999999999543 357999999999999999999999999988753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=6.9e-16  Score=137.99  Aligned_cols=135  Identities=21%  Similarity=0.221  Sum_probs=96.2

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchh--hHHH----------------------HHHHHHHHhhcCCCc--c
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER--TFVS----------------------FNSECEVLRNVRHRN--L  231 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  231 (457)
                      .+.||+|+||.||+|...+|+.||||++......  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999888999999998753211  1111                      134555555554332  3


Q ss_pred             ceeeeeeecCCeeEEEEeccCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCCCCCeeecC
Q 044428          232 IKILSGCSNLDFKALVLEFMPNGSLEK-WLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL-APIIHCDLKPSNILLDE  309 (457)
Q Consensus       232 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~~ivH~dlk~~NIll~~  309 (457)
                      .+.+++    ...++||||++++++.. .+....  .. .....++.+++.++.++|    . .+++|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh----~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY----REAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh----hccCcCcCCCChhhEEEE-
Confidence            333332    23589999999854321 121111  11 456789999999999999    5 7899999999999999 


Q ss_pred             CCcEEEecccccccc
Q 044428          310 NMVAHVSDFGISKLL  324 (457)
Q Consensus       310 ~~~~kl~Dfg~~~~~  324 (457)
                      ++.++++|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=7.4e-17  Score=167.78  Aligned_cols=210  Identities=27%  Similarity=0.312  Sum_probs=139.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+|+.++.|..|++|.||..+++ ..+.+|.|+ +++.     .+.+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------------
Confidence            57899999999999999999876 467788853 2221     00100  22222333333                   


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC----
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG----  327 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~----  327 (457)
                        |+-...+...+. ++.        +.+.+++|||    ..+|+|||+||+|.++..-|++|++|||+++.....    
T Consensus       136 --gDc~tllk~~g~-lPv--------dmvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 --GDCATLLKNIGP-LPV--------DMVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             --chhhhhcccCCC-Ccc--------hhhHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence              555555544331 222        2278999999    789999999999999999999999999998753111    


Q ss_pred             --------CCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          328 --------DDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       328 --------~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                              +... .....+||+.|+|||++    |+.-+|+|++|+|+||.+-|..||.......+..   +.+.+.   
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg---~visd~---  274 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG---QVISDD---  274 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh---hhhhhh---
Confidence                    0011 12246899999999966    7789999999999999999999997654332222   111111   


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~  439 (457)
                           +...+.    ++..+.+..+++.+.++.+|.+|--....+
T Consensus       275 -----i~wpE~----dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  275 -----IEWPEE----DEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             -----cccccc----CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence                 111100    112245678899999999999998555433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=3.9e-17  Score=159.09  Aligned_cols=169  Identities=25%  Similarity=0.408  Sum_probs=122.5

Q ss_pred             eeEEEEeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      +.++.|+++...+|.+||....  ...++...+.++.|++.|++|       ++.+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-------ccchhhhccccccccccchhhhhhhhhh
Confidence            5789999999999999997543  557888899999999999998       3589999999999999999999999999


Q ss_pred             ccccCCCC----CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCch
Q 044428          321 SKLLGEGD----DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       321 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      ........    .....+...||..||+||.+    ++.|+||||+|++|+|++. =..++....              .
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------------t  468 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------------T  468 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH--------------h
Confidence            98765443    11233457799999999955    7899999999999999998 222221100              0


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNA  438 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev  438 (457)
                      ..++-|..+... .    ..+.+. =..+..+++...|.+||++.++
T Consensus       469 ~~d~r~g~ip~~-~----~~d~p~-e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  469 LTDIRDGIIPPE-F----LQDYPE-EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhhcCCCChH-H----hhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence            112211111100 0    011121 2578889999999999944433

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=3.3e-15  Score=138.46  Aligned_cols=135  Identities=19%  Similarity=0.195  Sum_probs=105.3

Q ss_pred             CccC-CCCceEEEEEEeCCCCEEEEEEecccc------h-------hhHHHHHHHHHHHhhcCCCcc--ceeeeeeecCC
Q 044428          179 NLLG-IGSFGSVYKGTLSDGTNVAIKIFNLQL------E-------RTFVSFNSECEVLRNVRHRNL--IKILSGCSNLD  242 (457)
Q Consensus       179 ~~lg-~G~~g~Vy~~~~~~g~~vavK~l~~~~------~-------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  242 (457)
                      ..|| .|+.|+||+++.. +..++||++....      .       .....+.+|++++.+++|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4787 8999999999885 6789999885421      0       122457889999999998875  66676644322


Q ss_pred             ----eeEEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEec
Q 044428          243 ----FKALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       243 ----~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                          ..++||||+++ .+|.+++....  ++..    .+.+++.++.+||    ..||+||||||.|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence                23599999997 69999886543  4432    3568999999999    78899999999999999999999999


Q ss_pred             ccccccc
Q 044428          318 FGISKLL  324 (457)
Q Consensus       318 fg~~~~~  324 (457)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988763

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=2.1e-14  Score=144.40  Aligned_cols=146  Identities=23%  Similarity=0.292  Sum_probs=103.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhh----------------------------------------
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERT----------------------------------------  212 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------  212 (457)
                      ..|+. +.||.|++|.||+|++.+|+.||||+.+......                                        
T Consensus       118 ~~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            34443 6899999999999999999999999986432110                                        


Q ss_pred             HHHHHHHHHHHhhcC----CCccceeeeee-ecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHH
Q 044428          213 FVSFNSECEVLRNVR----HRNLIKILSGC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL-ALEYL  286 (457)
Q Consensus       213 ~~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~-~l~~L  286 (457)
                      .-+|.+|.+.+.+++    |.+-+.+-..+ ......++||||++|++|.++........   .+.+++..++. .+..+
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence            012455665555552    33333333333 22445799999999999998775432112   24456666665 46778


Q ss_pred             HhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       287 H~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |    ..+++|+|++|.||++++++.+++.|||++..+.+
T Consensus       274 ~----~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 L----RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             H----hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8    67899999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.56  E-value=4e-15  Score=156.34  Aligned_cols=100  Identities=38%  Similarity=0.618  Sum_probs=87.6

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCC--Cccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEG--PFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~--~~~~   79 (457)
                      +|+.|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|...  .+.+
T Consensus       437 ~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~  516 (623)
T PLN03150        437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH  516 (623)
T ss_pred             HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcccc
Confidence            46788999999999999999999999999999999999999999999999999999999999999999999641  1234


Q ss_pred             ccccccccccccCCCCCcCCCCCc
Q 044428           80 FSTESFSWNYALCGPSRFQVPPCK  103 (457)
Q Consensus        80 ~~~~~~~~n~~lcg~~~~~~~~c~  103 (457)
                      ...+.+.+|+.+|+.+.  .++|.
T Consensus       517 ~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        517 RASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CceEEecCCccccCCCC--CCCCc
Confidence            55778999999998653  34674

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=7.9e-16  Score=159.56  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=182.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC--CCEEEEEEecccc--hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD--GTNVAIKIFNLQL--ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  247 (457)
                      ..|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            356666789999999998887543  4456677665442  222334455777766776 99999999999999999999


Q ss_pred             EeccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccccC
Q 044428          248 LEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLG  325 (457)
Q Consensus       248 ~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~  325 (457)
                      .+|..++++++-+ +......+....-.+..|+..++.|+|.   ..++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999988 4433235556667789999999999994   34699999999999999999 99999999999876


Q ss_pred             C-CCCcceeccccc-cccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCC--cHHHHHHhhcCchhHHhc
Q 044428          326 E-GDDSLIQTKTMA-TIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEM--SLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       326 ~-~~~~~~~~~~~g-t~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~--~l~~~~~~~~~~~~~~~~  396 (457)
                      . ...........| ++.|+|||..     ..+..|+||.|+++.-+++|..|++.....  ....|......      .
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------~  250 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR------F  250 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc------c
Confidence            6 333344455678 9999999954     356799999999999999999998763322  22222221100      0


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~  439 (457)
                        ..       ..+........++..+++..+|..|.+.+++.
T Consensus       251 --~~-------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  251 --TQ-------LPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             --cc-------CccccCChhhhhcccccccCCchhcccccccc
Confidence              00       00011123467788889989999999987764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=9e-14  Score=127.96  Aligned_cols=197  Identities=20%  Similarity=0.257  Sum_probs=133.7

Q ss_pred             HHHhhcCCCccceeeeeeecCC-----eeEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 044428          221 EVLRNVRHRNLIKILSGCSNLD-----FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHAL  292 (457)
Q Consensus       221 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~  292 (457)
                      .-+-++-|.|||++..|+.+..     ...++.|||+.|++.++|++..   ..+....-.+++.||..||.|||..  .
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~--~  196 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC--D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--C
Confidence            4455667999999999986543     5789999999999999998643   4466677788999999999999953  6


Q ss_pred             CCeeeccCCCCCeeecCCCcEEEeccccccccCC--CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHh
Q 044428          293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGE--GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETF  366 (457)
Q Consensus       293 ~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~  366 (457)
                      ++|+|+++..+-|++..++-+|++--.-...-..  ...........+-++|.|||    ...+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            8999999999999999999998853221111000  00001112245678999999    22456899999999999999


Q ss_pred             cCCCC-CCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          367 SRKKP-TNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       367 tg~~p-~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.-- .......         .   ..+.+...+.......         =...+..|++..|..||+|++++.
T Consensus       277 ilEiq~tnseS~~---------~---~ee~ia~~i~~len~l---------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKV---------E---VEENIANVIIGLENGL---------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCccee---------e---hhhhhhhheeeccCcc---------ccCcCcccccCCCCCCcchhhhhc
Confidence            87642 2211100         0   0111111111111111         135677899999999999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=3.8e-13  Score=133.84  Aligned_cols=245  Identities=22%  Similarity=0.228  Sum_probs=178.6

Q ss_pred             cCCcCCccCC--CCceEEEEEEe---CCCCEEEEEEecccch--hhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeE
Q 044428          174 EFDECNLLGI--GSFGSVYKGTL---SDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       174 ~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  245 (457)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|.-+....  .....=.+|......+ .|+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556678999  99999999987   3788899998443321  2222234566666666 4999999888999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEecccc
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGI  320 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~  320 (457)
                      +-+|++ +.+|.++.+.....++....+.+..+...    |+.++|    ...++|-|+||.||+...+ ...+++|||+
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheecccccceeecCCcce
Confidence            999998 58898888876666777777888888888    999999    7779999999999999999 8999999999


Q ss_pred             ccccCCCCCcceec---cccccccccCCC---CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          321 SKLLGEGDDSLIQT---KTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       321 ~~~~~~~~~~~~~~---~~~gt~~y~aPE---~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      ...+..+.......   ...|...|++||   .+++..+|+|++|.+.+|..++..+....-. +-+...++.+  .-.+
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~--ip~e  346 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGY--IPLE  346 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC-CCcccccccc--Cchh
Confidence            99887655332211   236788899999   5688899999999999999998776543200 0011111100  0011


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .++.              -..++......+++.+|..|++.+.+..
T Consensus       347 ~~~~--------------~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  347 FCEG--------------GSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhcC--------------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111              0223455888999999999999877653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=1.7e-12  Score=132.22  Aligned_cols=146  Identities=18%  Similarity=0.204  Sum_probs=95.3

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCC-CCEEEEEEecccchhh----------------------------------H--
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERT----------------------------------F--  213 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~--  213 (457)
                      ...+|+. +.||+|++|.||+|++++ |+.||||+.+......                                  .  
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 799999999999999987 9999999997542110                                  0  


Q ss_pred             ----HHHHHHHHHHhhcC----CCccceeeeeeec-CCeeEEEEeccCCCCHHHH--HhhCCCCCCHHHHHHHHHHHHH-
Q 044428          214 ----VSFNSECEVLRNVR----HRNLIKILSGCSN-LDFKALVLEFMPNGSLEKW--LYSHNYFLDILERLNIMIDVGL-  281 (457)
Q Consensus       214 ----~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~~l~~~~~~~i~~~ia~-  281 (457)
                          -+|.+|+..+.+++    +.+.+.+-..+.+ ....++||||++|+.+.+.  +...+  .+.   ..++...+. 
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~---~~la~~~v~~  271 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDM---KLLAERGVEV  271 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCH---HHHHHHHHHH
Confidence                12344444444442    3333333333322 4457899999999999874  32222  221   122222222 


Q ss_pred             HHHHHHhcCCCCCeeeccCCCCCeeecCCC----cEEEeccccccccCC
Q 044428          282 ALEYLHYGHALAPIIHCDLKPSNILLDENM----VAHVSDFGISKLLGE  326 (457)
Q Consensus       282 ~l~~LH~~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~~~~~~~  326 (457)
                      -+..++    ..+++|+|++|.||+++.++    .+++.|||++..+.+
T Consensus       272 ~~~Qif----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQVF----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHH----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            122333    46799999999999999888    999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.6e-12  Score=114.08  Aligned_cols=132  Identities=17%  Similarity=0.159  Sum_probs=96.7

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccce-eeeeeecCCeeEEEEeccCCCCH
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK-ILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ++.++.|.++.||+++.. +..+++|+...... ....+..|+.++..+.+.++++ ++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            357899999999999875 77899998765432 2335678999999987655543 44433  2345899999999887


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA-LAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .+.    .  .   ....++.++++++..||.... ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus        79 ~~~----~--~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D--F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c--c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            653    0  1   112456789999999994321 22369999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=1.1e-11  Score=124.71  Aligned_cols=165  Identities=17%  Similarity=0.191  Sum_probs=124.2

Q ss_pred             eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHH
Q 044428          194 LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL  273 (457)
Q Consensus       194 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~  273 (457)
                      ..++.+|.|...+...........+-++.++.+|||||++++..+...+..|+|+|-+  -.|..++.+..    .....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHH
Confidence            3478889998887665544455677889999999999999999999999999999987  35666666532    33444


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCCCCC--
Q 044428          274 NIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVST--  351 (457)
Q Consensus       274 ~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--  351 (457)
                      -.+.||+.||.+||+.|   +++|++|.-+.|+++..|+.||++|.++........  ......--..|..|+.+...  
T Consensus       108 ~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~~  182 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSEW  182 (690)
T ss_pred             HHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcccc
Confidence            56889999999999754   599999999999999999999999998765322111  00011122246666644333  


Q ss_pred             ccchhhhhHHHHHHhcCC
Q 044428          352 KCDVYSYGILLLETFSRK  369 (457)
Q Consensus       352 ~~Dv~s~Gvvl~el~tg~  369 (457)
                      ..|.|-||++++|++.|.
T Consensus       183 s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             chhhhhHHHHHHHHhCcc
Confidence            569999999999999993

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=6.3e-11  Score=108.64  Aligned_cols=143  Identities=21%  Similarity=0.199  Sum_probs=111.1

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCC--CccceeeeeeecCC---eeEEEEeccC
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRH--RNLIKILSGCSNLD---FKALVLEFMP  252 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  252 (457)
                      +.|+.|.++.||++...+|..+++|....... .....+..|.+++..+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            47899999999999987778999999765432 134568899999999975  34566777776543   5689999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH------------------------------------------  290 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------  290 (457)
                      +.++.+.+..  ..++..++..++.+++++|.+||...                                          
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988776542  23677778888889999998888421                                          


Q ss_pred             ----------CCCCeeeccCCCCCeeecC--CCcEEEeccccccc
Q 044428          291 ----------ALAPIIHCDLKPSNILLDE--NMVAHVSDFGISKL  323 (457)
Q Consensus       291 ----------~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~  323 (457)
                                ....++|+|+.+.||+++.  ++.+.|.||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      0245799999999999998  67789999998775

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.21  E-value=3.5e-10  Score=100.53  Aligned_cols=136  Identities=19%  Similarity=0.176  Sum_probs=97.4

Q ss_pred             CccCCCCceEEEEEEeCC-------CCEEEEEEecccc------------h----------hhHHHH----HHHHHHHhh
Q 044428          179 NLLGIGSFGSVYKGTLSD-------GTNVAIKIFNLQL------------E----------RTFVSF----NSECEVLRN  225 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~------------~----------~~~~~~----~~E~~~l~~  225 (457)
                      ..||.|.-+.||.|.-.+       +..+|||+.+...            +          .....+    .+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997543       4799999875310            0          011222    389999998


Q ss_pred             cCC--CccceeeeeeecCCeeEEEEeccCCCCHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCeeeccCC
Q 044428          226 VRH--RNLIKILSGCSNLDFKALVLEFMPNGSLE-KWLYSHNYFLDILERLNIMIDVGLALEYL-HYGHALAPIIHCDLK  301 (457)
Q Consensus       226 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~~ivH~dlk  301 (457)
                      +..  -++.+++++    ...++||||+.++.+. ..+...  .++..+...+..+++.+|..+ |    ..++||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H----~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK----ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH----hCCeecCCCC
Confidence            853  455556654    4578999999765442 223222  244455667788999999999 6    5689999999


Q ss_pred             CCCeeecCCCcEEEeccccccccC
Q 044428          302 PSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       302 ~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +.||+++ ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4679999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=4.3e-10  Score=96.68  Aligned_cols=131  Identities=23%  Similarity=0.277  Sum_probs=101.8

Q ss_pred             ccCCCCceEEEEEEeCCCCEEEEEEecccc------h--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQL------E--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~------~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+++|+-+.+|.+.+. |..+++|.=..+.      +  -......+|+.++++++---|.-..=+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            6789999999999774 4446666432221      1  11234678999999987666655555667778889999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      +|..|.+.+...        +..++..+..-+.-||    ..+|+|+||.++||++..+. +.+.|||++...
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999998765        3567778888899999    78899999999999998765 899999998853

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.12  E-value=1e-09  Score=93.91  Aligned_cols=142  Identities=23%  Similarity=0.256  Sum_probs=104.1

Q ss_pred             cCCccCCCCceEEEEEEeCCCCEEEEEE-ecccc-------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          177 ECNLLGIGSFGSVYKGTLSDGTNVAIKI-FNLQL-------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ....+-+|+-+.|+++.+. |+...||. +.+..       .-......+|++.+.+++--.|.-..-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4568889999999999984 66666663 33221       122345778999999987555554444566667778999


Q ss_pred             eccCC-CCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC---cEEEeccccccc
Q 044428          249 EFMPN-GSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM---VAHVSDFGISKL  323 (457)
Q Consensus       249 e~~~~-g~L~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~~~~  323 (457)
                      ||+++ .++.+++...-.. ........++..|.+.+.-||    ...|+|+||..+||++.+++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 4788888765322 222233678899999999999    67799999999999997655   468999999865

>PLN03150 hypothetical protein; Provisional

Probab=99.12  E-value=6.8e-11  Score=124.50  Aligned_cols=84  Identities=30%  Similarity=0.458  Sum_probs=77.6

Q ss_pred             cCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccccccccc
Q 044428            8 DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESFS   86 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~   86 (457)
                      .++.|+|++|.|+|.+|.++++|++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+|+|.+|. .+.+.++..+.++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            478899999999999999999999999999999999999999999999999999999999999986 4677888899998


Q ss_pred             ccccc
Q 044428           87 WNYAL   91 (457)
Q Consensus        87 ~n~~l   91 (457)
                      +|...
T Consensus       499 ~N~l~  503 (623)
T PLN03150        499 GNSLS  503 (623)
T ss_pred             CCccc
Confidence            88643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.12  E-value=9.6e-11  Score=130.89  Aligned_cols=91  Identities=42%  Similarity=0.611  Sum_probs=79.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~   80 (457)
                      .++++++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|.. ..+..+
T Consensus       494 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  573 (968)
T PLN00113        494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL  573 (968)
T ss_pred             hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCccc
Confidence            3567889999999999999999999999999999999999999999999999999999999999999988864 445677


Q ss_pred             cccccccccccC
Q 044428           81 STESFSWNYALC   92 (457)
Q Consensus        81 ~~~~~~~n~~lc   92 (457)
                      ..+.+++|+..+
T Consensus       574 ~~l~ls~N~l~~  585 (968)
T PLN00113        574 VQVNISHNHLHG  585 (968)
T ss_pred             CEEeccCCccee
Confidence            888888887554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=1.2e-10  Score=116.12  Aligned_cols=247  Identities=19%  Similarity=0.143  Sum_probs=172.0

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEe--CCCCEEEEEEecccchhhHHH--HHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTL--SDGTNVAIKIFNLQLERTFVS--FNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      ....+.+|..+..||.|.|+.|++...  .++..+++|.+.........+  -..|+-+...+ .|.+++.....+...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            344567899999999999999999864  378889999887654332222  23455555555 5999999888888888


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEeccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGIS  321 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~  321 (457)
                      ..++--||++++++.....-. ..++...++++..+++.++.++|    ++.++|+|+||+||++..+ +..+++|||.+
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccchhhhhccccccc
Confidence            888999999999887666322 23677788999999999999999    7889999999999999876 88999999998


Q ss_pred             cccCCCCCcceecccccccccc--CCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHh
Q 044428          322 KLLGEGDDSLIQTKTMATIGYM--APE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV  395 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~--aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~  395 (457)
                      ..+.-..     ......-++.  +|+    .....+.|+||||.-+.|.+++..--...     .+|..         +
T Consensus       415 t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----~~~~~---------i  475 (524)
T KOG0601|consen  415 TRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----VQSLT---------I  475 (524)
T ss_pred             cccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc-----cccee---------e
Confidence            7532111     1112233333  332    33567999999999999999987532211     11111         1


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ....+....       .....+..+...+..+++..||.+.+.....+..
T Consensus       476 ~~~~~p~~~-------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  476 RSGDTPNLP-------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ecccccCCC-------chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            000010000       0023466778888999999999998877655543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=1.8e-10  Score=120.89  Aligned_cols=246  Identities=19%  Similarity=0.257  Sum_probs=156.9

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ..+.|...+-+.+|.++.+..++-. .|...+.|+.....   ....+....+-.+.-..+||-++.....+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3456677778888999999887643 34344444433211   1122223333334334456777766655566778899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |++|..+++|...|+.... .+..........+..+.+|||    ...+.|+|++|.|++...++..+++|||.....+-
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~----s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH----SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc----cchhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999999987763 333233345556778899999    55589999999999999999999999984332110


Q ss_pred             ------C---------------CC--------cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCC
Q 044428          327 ------G---------------DD--------SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTN  373 (457)
Q Consensus       327 ------~---------------~~--------~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~  373 (457)
                            .               ..        ........+|+.|.+||..    -...+|.|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                  0               00        0011235689999999944    4567999999999999999999997


Q ss_pred             CCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 044428          374 DLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTT  436 (457)
Q Consensus       374 ~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~  436 (457)
                      ........           ..+....+...    ..+.+......+++..-+..+|.+|-.|.
T Consensus      1037 a~tpq~~f-----------~ni~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF-----------ENILNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh-----------hccccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence            64322111           11111111110    01112233456777777788888887765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.97  E-value=1.3e-08  Score=95.50  Aligned_cols=139  Identities=14%  Similarity=0.062  Sum_probs=100.1

Q ss_pred             ccCCCCceEEEEEEeCCCCEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCcc--ceeeeeeec-----C
Q 044428          180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER-----------TFVSFNSECEVLRNVRHRNL--IKILSGCSN-----L  241 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~  241 (457)
                      .+-+.....|.+..+ +|+.+.||+.......           ....+.+|...+.++...+|  .+++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444444455777766 5788999977433211           11147789998888853333  344555543     2


Q ss_pred             CeeEEEEeccCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-------CCc
Q 044428          242 DFKALVLEFMPNG-SLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-------NMV  312 (457)
Q Consensus       242 ~~~~lv~e~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-------~~~  312 (457)
                      ..-++|+|++++. +|.+++... ....+...+..++.+++..+.-||    ..||+|+|++++|||++.       ++.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEeccccCCCCCce
Confidence            3578999999886 899988642 223455677789999999999999    788999999999999975       568


Q ss_pred             EEEeccccccc
Q 044428          313 AHVSDFGISKL  323 (457)
Q Consensus       313 ~kl~Dfg~~~~  323 (457)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998764

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.95  E-value=2.9e-08  Score=97.47  Aligned_cols=168  Identities=20%  Similarity=0.202  Sum_probs=128.0

Q ss_pred             CceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeee----cCCeeEEEEeccCC-CCHHH
Q 044428          185 SFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS----NLDFKALVLEFMPN-GSLEK  258 (457)
Q Consensus       185 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~  258 (457)
                      -..+.||+... ||..+++|++.............-++.++++.|+|+|++..++.    .....++||+|+|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            45678999865 89999999995443222222344578899999999999988775    33467899999986 57776


Q ss_pred             HHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          259 WLYSH--------------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       259 ~l~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      +-...              +...++...+.++.|+..||.++|    +.|+.-+-|.+++|+++.+.+++|+..|....+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            54321              134677889999999999999999    677888999999999999999999999988776


Q ss_pred             CCCCCcceeccccccccccCCCCCCCCccchhhhhHHHHHHhcCCCC
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKP  371 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~Dv~s~Gvvl~el~tg~~p  371 (457)
                      .+....              | .-.-.+-|.=.||.+++.|.||..-
T Consensus       444 ~~d~~~--------------~-le~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDPTE--------------P-LESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCCCc--------------c-hhHHhhhhHHHHHHHHHHHhhcccc
Confidence            543311              0 0122467999999999999999643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.94  E-value=8.5e-08  Score=92.06  Aligned_cols=260  Identities=12%  Similarity=0.084  Sum_probs=156.6

Q ss_pred             cCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeee------eec-CCeeEEEE
Q 044428          177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSG------CSN-LDFKALVL  248 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~-~~~~~lv~  248 (457)
                      ....||+|+-+.+|..--  -...+.|+..........   +-+..|... .||-+-.-+.+      -.+ ....-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            446799999999996532  122456777654322111   123333333 45543321111      111 22255677


Q ss_pred             eccCCC-CHHHHHhh---C-C-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          249 EFMPNG-SLEKWLYS---H-N-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       249 e~~~~g-~L~~~l~~---~-~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..+++- ....+...   + . ...+|...++.+..+|.+.+.||    ..|.+-+|+.++|+|+++++.+.|.|-..-.
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH----~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH----EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH----hcCCcccccCccceeeecCceEEEEccccee
Confidence            776653 22222221   1 1 33689999999999999999999    6778889999999999999999998865433


Q ss_pred             ccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcC-CCCCCCC-----CCCcHHHHHHhh
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSR-KKPTNDL-----GEMSLKHWVNQS  387 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg-~~p~~~~-----~~~~l~~~~~~~  387 (457)
                      ....+   .......|...|.+||..         .+...|-|.+||++++++.| ++||+..     ....+..-+...
T Consensus       166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            32111   122235688899999933         35678999999999999886 9999862     111222111110


Q ss_pred             cCchhHHhccccc-cccccchhHHHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          388 LPHKLAEVVDSNL-VRREHSFSAKMDCLLRIMNLALDCCME--SPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       388 ~~~~~~~~~d~~l-~~~~~~~~~~~~~~~~l~~l~~~C~~~--~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      .   ....-|..- ...........-.+..+.-+..+|+..  ++.-|||++..+..|.+++++...
T Consensus       243 ~---f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         243 R---FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             e---eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            0   000001000 000011111222355677888899975  367899999999999999887653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.93  E-value=1.6e-10  Score=97.30  Aligned_cols=85  Identities=31%  Similarity=0.469  Sum_probs=78.9

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +-++++++.|.||+|+++ .+|+.+..|.+|+.|++++|+++ .+|.++.+++.|+.||++-|+++-.+-..|.|+.+..
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~lev  106 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEV  106 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhh
Confidence            456788899999999999 99999999999999999999999 9999999999999999999999988888888888888


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +++..|+
T Consensus       107 ldltynn  113 (264)
T KOG0617|consen  107 LDLTYNN  113 (264)
T ss_pred             hhccccc
Confidence            8888875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=9.1e-09  Score=91.12  Aligned_cols=125  Identities=24%  Similarity=0.257  Sum_probs=81.5

Q ss_pred             EEEEEEeCCCCEEEEEEecccc--------------h------------hhHHHHHHHHHHHhhcCCC--ccceeeeeee
Q 044428          188 SVYKGTLSDGTNVAIKIFNLQL--------------E------------RTFVSFNSECEVLRNVRHR--NLIKILSGCS  239 (457)
Q Consensus       188 ~Vy~~~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  239 (457)
                      .||.|...+|..+|||+.+...              .            .......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999875310              0            0123467899999999765  455555442 


Q ss_pred             cCCeeEEEEeccC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          240 NLDFKALVLEFMP--NGSLEKWLYSHNYFLDILERLNIMIDVGLALEY-LHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       240 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                         ...+||||++  +..+..+....   ++......++.++...+.. +|    ..+|+|+||.+.||+++++ .+.|.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecc-eEEEE
Confidence               3579999998  55554433322   1122345566777775555 46    6789999999999999988 99999


Q ss_pred             cccccccc
Q 044428          317 DFGISKLL  324 (457)
Q Consensus       317 Dfg~~~~~  324 (457)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.91  E-value=7.8e-10  Score=79.26  Aligned_cols=60  Identities=43%  Similarity=0.656  Sum_probs=54.0

Q ss_pred             ccCCeeeccCCcccccCC-cccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccC
Q 044428            7 KDLATLSLAANKFHGPIP-KSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL   67 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l   67 (457)
                      ++|+.|+|++|+|+ .+| ..|..+++|++|++++|+++..-|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57999999999999 566 6889999999999999999955556899999999999999986

...

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.89  E-value=2.7e-10  Score=95.88  Aligned_cols=87  Identities=25%  Similarity=0.365  Sum_probs=73.1

Q ss_pred             CCccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCC-CCCCCCC-cc
Q 044428            1 MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEG-EIPVEGP-FR   78 (457)
Q Consensus         1 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~-~~p~~~~-~~   78 (457)
                      |.|..|.+|+.|++++|++. .+|.++++|++|+.|+++-|+|. .+|.+|++++.|+.|||++|+++. .+|.... +.
T Consensus        50 pnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~  127 (264)
T KOG0617|consen   50 PNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMT  127 (264)
T ss_pred             CcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHH
Confidence            45778999999999999999 99999999999999999999999 999999999999999999999964 5564311 13


Q ss_pred             ccccccccccc
Q 044428           79 NFSTESFSWNY   89 (457)
Q Consensus        79 ~~~~~~~~~n~   89 (457)
                      .+.++.+++|-
T Consensus       128 tlralyl~dnd  138 (264)
T KOG0617|consen  128 TLRALYLGDND  138 (264)
T ss_pred             HHHHHHhcCCC
Confidence            45556666664

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.73  E-value=2.1e-09  Score=101.96  Aligned_cols=86  Identities=26%  Similarity=0.290  Sum_probs=79.8

Q ss_pred             CCccCCccCCeeeccCCcccccCCcccC-CCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccc
Q 044428            1 MTIGGLKDLATLSLAANKFHGPIPKSFG-SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRN   79 (457)
Q Consensus         1 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~   79 (457)
                      |+|++|+.|.+|++++|++. .+|.+.+ +|++|.+|||-.|++. +.|.++.-+.+|..||+|+|.+++.++..|.+ .
T Consensus       222 Pef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-h  298 (565)
T KOG0472|consen  222 PEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-H  298 (565)
T ss_pred             CCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-e
Confidence            57889999999999999998 8998876 8999999999999999 99999999999999999999999999998888 8


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+.|||
T Consensus       299 L~~L~leGNP  308 (565)
T KOG0472|consen  299 LKFLALEGNP  308 (565)
T ss_pred             eeehhhcCCc
Confidence            8888999986

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=4.7e-07  Score=80.80  Aligned_cols=138  Identities=18%  Similarity=0.086  Sum_probs=103.2

Q ss_pred             ccCCCCceEEEEEEeCCCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCC--ccceeeeeee-c----CCeeEE
Q 044428          180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQL------ERTFVSFNSECEVLRNVRHR--NLIKILSGCS-N----LDFKAL  246 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~----~~~~~l  246 (457)
                      --|+||-+.|++-.+. |..+-+|+-....      +-....|.+|...+.++...  .+.+.+ ++. .    ...-+|
T Consensus        25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            4577888999998775 4478899764211      22356799999999998532  244444 332 1    224679


Q ss_pred             EEeccCC-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc--EEEecccccc
Q 044428          247 VLEFMPN-GSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV--AHVSDFGISK  322 (457)
Q Consensus       247 v~e~~~~-g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~~~  322 (457)
                      |+|-+++ -+|.+++.... .+.+...+..++.+++..+.-||    ..++.|+|+.+.||+++.++.  +++.||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH----~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH----SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9997754 58999987643 34677788899999999999999    788999999999999986666  9999998776


Q ss_pred             c
Q 044428          323 L  323 (457)
Q Consensus       323 ~  323 (457)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.64  E-value=2.2e-08  Score=87.30  Aligned_cols=85  Identities=27%  Similarity=0.384  Sum_probs=38.0

Q ss_pred             cc-CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccch-hcCCCceEecccccCCCCC--CCCCCcc
Q 044428            3 IG-GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLE-ALLYLKQLNVSQNRLEGEI--PVEGPFR   78 (457)
Q Consensus         3 ~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~-~~~~L~~l~l~~n~l~~~~--p~~~~~~   78 (457)
                      ++ .|.+|+.|+||+|+|+ .++ .+..|++|++|+|++|+|+ .++..+. .+++|+.|+|++|++...-  -....++
T Consensus        37 L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~  113 (175)
T PF14580_consen   37 LGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLP  113 (175)
T ss_dssp             --TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-T
T ss_pred             hhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCC
Confidence            44 4778999999999998 675 5788999999999999999 7876664 6899999999999997532  2224567


Q ss_pred             cccccccccccc
Q 044428           79 NFSTESFSWNYA   90 (457)
Q Consensus        79 ~~~~~~~~~n~~   90 (457)
                      ++..+++.+||.
T Consensus       114 ~L~~L~L~~NPv  125 (175)
T PF14580_consen  114 KLRVLSLEGNPV  125 (175)
T ss_dssp             T--EEE-TT-GG
T ss_pred             CcceeeccCCcc
Confidence            777888888863

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.64  E-value=2.8e-07  Score=84.23  Aligned_cols=135  Identities=21%  Similarity=0.224  Sum_probs=93.9

Q ss_pred             CcCCccCCCCceEEEEEEeCCCCEEEEEEeccc----------c------------hhhHHHHHHHHHHHhhcCCC--cc
Q 044428          176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ----------L------------ERTFVSFNSECEVLRNVRHR--NL  231 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~----------~------------~~~~~~~~~E~~~l~~l~h~--ni  231 (457)
                      .....||.|.-+.||.|..++|..+|||.=+..          .            .-+.....+|.++|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            344689999999999999999999999943211          0            01234567899999998644  55


Q ss_pred             ceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC
Q 044428          232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM  311 (457)
Q Consensus       232 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~  311 (457)
                      .+.+++    +..++||||+++-.|...--      +....-.++..|..-+.-+-    ..|+||+|+++-||++++||
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~----~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAY----RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHH----HcCccccCCchheEEEecCC
Confidence            555554    56789999998866654331      12222233344444443333    35699999999999999999


Q ss_pred             cEEEecccccccc
Q 044428          312 VAHVSDFGISKLL  324 (457)
Q Consensus       312 ~~kl~Dfg~~~~~  324 (457)
                      .+.+.||--+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999766543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.64  E-value=3.3e-07  Score=83.08  Aligned_cols=106  Identities=24%  Similarity=0.235  Sum_probs=83.5

Q ss_pred             HHHHHHHHHHhhcCC--CccceeeeeeecC----CeeEEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 044428          214 VSFNSECEVLRNVRH--RNLIKILSGCSNL----DFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYL  286 (457)
Q Consensus       214 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~L  286 (457)
                      ....+|...+..+..  =.+.+.+++....    ...++|+|++++. +|.+++..... .+...+..++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            356788888877753  3345566666543    2458999999884 89999987433 55667788999999999999


Q ss_pred             HhcCCCCCeeeccCCCCCeeecCCC---cEEEecccccccc
Q 044428          287 HYGHALAPIIHCDLKPSNILLDENM---VAHVSDFGISKLL  324 (457)
Q Consensus       287 H~~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~~~~~  324 (457)
                      |    ..+|+|+|++++|||++.+.   .+.+.||+.++..
T Consensus       135 H----~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 H----DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H----HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9    78899999999999999887   8999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=2.5e-07  Score=94.12  Aligned_cols=148  Identities=20%  Similarity=0.241  Sum_probs=96.1

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhh-------------------------------------
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERT-------------------------------------  212 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------  212 (457)
                      ....+|+. +.|+.++-|.||+|++++|+.||||+.+......                                     
T Consensus       123 e~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~  201 (517)
T COG0661         123 ELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR  201 (517)
T ss_pred             HHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence            33345554 5899999999999999999999999886431100                                     


Q ss_pred             ---HHHHHHHHHHHhhcC-----CCccceeeeee-ecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHH-
Q 044428          213 ---FVSFNSECEVLRNVR-----HRNLIKILSGC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA-  282 (457)
Q Consensus       213 ---~~~~~~E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~-  282 (457)
                         .-++.+|..-+.+++     .+++ .+=..| .-.....|+|||++|..+.+...-.....+   +..++..++.+ 
T Consensus       202 l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f  277 (517)
T COG0661         202 LREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAF  277 (517)
T ss_pred             HHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHH
Confidence               112344444444442     2332 222223 335567899999999988887432222244   23334333333 


Q ss_pred             HHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       283 l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      +..+-    ..++.|.|..|.||+++.++.+.+-|||+...+.+
T Consensus       278 ~~q~~----~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 LRQLL----RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHH----hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            22222    34699999999999999999999999999887654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.58  E-value=9.9e-09  Score=102.36  Aligned_cols=86  Identities=35%  Similarity=0.354  Sum_probs=74.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccc-hhcCCCceEecccccCCCCCCCCCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSL-EALLYLKQLNVSQNRLEGEIPVEGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~-~~~~~L~~l~l~~n~l~~~~p~~~~~~~~   80 (457)
                      +|-.|..|+.||||+|+|+ .+|..+-+-+++-+|+||+|+|. +||..+ .++..|-.||||+|+|...+|....+.++
T Consensus        98 diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~L  175 (1255)
T KOG0444|consen   98 DIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSML  175 (1255)
T ss_pred             hhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhh
Confidence            4556788889999999998 89999888899999999999999 888865 57888999999999999999988777888


Q ss_pred             ccccccccc
Q 044428           81 STESFSWNY   89 (457)
Q Consensus        81 ~~~~~~~n~   89 (457)
                      .++.+++||
T Consensus       176 qtL~Ls~NP  184 (1255)
T KOG0444|consen  176 QTLKLSNNP  184 (1255)
T ss_pred             hhhhcCCCh
Confidence            888888887

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=4.6e-08  Score=99.41  Aligned_cols=148  Identities=14%  Similarity=0.196  Sum_probs=97.2

Q ss_pred             HHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce-------eccccccccccCCCCC
Q 044428          276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI-------QTKTMATIGYMAPEGI  348 (457)
Q Consensus       276 ~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~  348 (457)
                      +.+++.|+.|+|.   +.++||++|.|++|.++.++..||+.|+.+...........       ..-..-...|.|||.+
T Consensus       105 l~~v~dgl~flh~---sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  105 LGNVADGLAFLHR---SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhcccchhhhhcc---CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3455689999995   67899999999999999999999999998875543211111       1112345679999944


Q ss_pred             ----CCCccchhhhhHHHHHHhcCCCC-CCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHh
Q 044428          349 ----VSTKCDVYSYGILLLETFSRKKP-TNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALD  423 (457)
Q Consensus       349 ----~~~~~Dv~s~Gvvl~el~tg~~p-~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~  423 (457)
                          .+.++|+||+||++|.+..|..+ +...+...........        .+......      ..+.+.++.+=+.+
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~--------~~~~~~~~------s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL--------LNAGAFGY------SNNLPSELRESLKK  247 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc--------cccccccc------cccCcHHHHHHHHH
Confidence                56799999999999999954444 4332222111111110        01111111      12335667888888


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 044428          424 CCMESPDERIHTTNAAA  440 (457)
Q Consensus       424 C~~~~P~~RPs~~ev~~  440 (457)
                      .+..++.-||++.++..
T Consensus       248 ~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HhcCCcccCcchhhhhc
Confidence            99999999997766543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.55  E-value=2.4e-08  Score=94.80  Aligned_cols=87  Identities=29%  Similarity=0.466  Sum_probs=75.0

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccC----------------------CCCCcc-chhcCCCce
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS----------------------GEIPKS-LEALLYLKQ   59 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~----------------------g~~p~~-~~~~~~L~~   59 (457)
                      ++.+++|+.|+|+||-|. .+|.+++.+..|+.||+|+|+|-                      |.+|++ +.++.+|+.
T Consensus       431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~t  509 (565)
T KOG0472|consen  431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTT  509 (565)
T ss_pred             HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcce
Confidence            467888999999999998 89999999999999999888876                      244443 677888999


Q ss_pred             EecccccCCCCCCCCCCcccccccccccccc
Q 044428           60 LNVSQNRLEGEIPVEGPFRNFSTESFSWNYA   90 (457)
Q Consensus        60 l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~   90 (457)
                      |||.+|.+.-.+|..|.+.++..+.+.|||.
T Consensus       510 LDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  510 LDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             eccCCCchhhCChhhccccceeEEEecCCcc
Confidence            9999999999999999999999999999975

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.51  E-value=5.2e-08  Score=64.28  Aligned_cols=40  Identities=38%  Similarity=0.641  Sum_probs=28.3

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCC
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIP   48 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p   48 (457)
                      ++|++|+|++|+|+ .+|+.|++|++|+.|+|++|+|+ .+|
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            46777888888887 67777777888888888888777 443

...

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.47  E-value=2.8e-06  Score=78.08  Aligned_cols=139  Identities=14%  Similarity=0.115  Sum_probs=85.5

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--cceeeeeeecCCeeEEEEeccCCCC-
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN--LIKILSGCSNLDFKALVLEFMPNGS-  255 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  255 (457)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47899999999984   25567889876533  2344688999999886433  4566777777777889999998863 


Q ss_pred             HHHHH---------------------hhCC-CCCCHHHHHH-HHH----------HHH-HHHHHHHhcCCCCCeeeccCC
Q 044428          256 LEKWL---------------------YSHN-YFLDILERLN-IMI----------DVG-LALEYLHYGHALAPIIHCDLK  301 (457)
Q Consensus       256 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~ia-~~l~~LH~~~~~~~ivH~dlk  301 (457)
                      +...+                     |.-. ...+...+.. +..          .+. ....+|........++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            22111                     1110 0011111000 000          011 112222221223457999999


Q ss_pred             CCCeeecCCCcEEEeccccccc
Q 044428          302 PSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       302 ~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      |.||++++++ +.+.||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999997764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=3.6e-06  Score=85.47  Aligned_cols=146  Identities=19%  Similarity=0.254  Sum_probs=91.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchh-------------------------------------hHHH
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER-------------------------------------TFVS  215 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------------------------------------~~~~  215 (457)
                      .+|+. +.||.-+.|.||+|++++|+.||||+-+...+.                                     ..-+
T Consensus       162 ~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  162 SEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             HhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            34443 589999999999999999999999986532110                                     0113


Q ss_pred             HHHHHHHHhhc----CCCcc---ceeeeee-ecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 044428          216 FNSECEVLRNV----RHRNL---IKILSGC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH  287 (457)
Q Consensus       216 ~~~E~~~l~~l----~h~ni---v~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH  287 (457)
                      |.+|.+-..+.    +|-+.   |.+=..+ .-.....|+||||+|..+.+.-.-.+..++...   ++..+.++...+=
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qI  317 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQI  317 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHH
Confidence            44554433333    45551   1122222 234567899999999877654332222244443   3333333322211


Q ss_pred             hcCCCCCeeeccCCCCCeeecC----CCcEEEeccccccccC
Q 044428          288 YGHALAPIIHCDLKPSNILLDE----NMVAHVSDFGISKLLG  325 (457)
Q Consensus       288 ~~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfg~~~~~~  325 (457)
                        - ..|++|+|-.|.||+++.    ++.+.+-|||+...+.
T Consensus       318 --f-~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  318 --F-KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             --H-hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence              1 357999999999999984    6789999999988654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.29  E-value=2.1e-07  Score=88.37  Aligned_cols=91  Identities=24%  Similarity=0.237  Sum_probs=78.5

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      |+.|++|+.|+|++|++++.-+.+|..+..|+.|.|..|+|.-.--..|.++..|+.|+|.+|+++-.-|.. ..+..+.
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~  349 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS  349 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence            678999999999999999999999999999999999999999433446788999999999999999887743 2344677


Q ss_pred             ccccccccccCC
Q 044428           82 TESFSWNYALCG   93 (457)
Q Consensus        82 ~~~~~~n~~lcg   93 (457)
                      .+.+..||+.|.
T Consensus       350 ~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  350 TLNLLSNPFNCN  361 (498)
T ss_pred             eeehccCcccCc
Confidence            888999999885

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.29  E-value=9.7e-06  Score=73.58  Aligned_cols=155  Identities=20%  Similarity=0.196  Sum_probs=98.7

Q ss_pred             cccCHHHHHHHhhcCCcCC---ccCCCCceEEEEEEeCCCCEEEEEEecccchh------------------------hH
Q 044428          161 RRISYLDIQRATNEFDECN---LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLER------------------------TF  213 (457)
Q Consensus       161 ~~~~~~~l~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------------------~~  213 (457)
                      ...+...+...........   .|++|.-+.||+|.-.++..+|||+++.....                        ..
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3445555665555555444   45678888999999888999999998643100                        01


Q ss_pred             HHHHHHHHHHhhcC--CCccceeeeeeecCCeeEEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 044428          214 VSFNSECEVLRNVR--HRNLIKILSGCSNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH  290 (457)
Q Consensus       214 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~  290 (457)
                      ....+|..-|.++.  +-.+.+.+++.    ...|||||+... .-.-.|..-.  +...+...+..++.+.+.-|-.  
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~--~e~~e~~~~~~~~v~~~~~l~~--  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP--LELEEAEGLYEDVVEYMRRLYK--  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC--cCchhHHHHHHHHHHHHHHHHH--
Confidence            12345666666652  33333444432    346999999643 2122222222  2222455566777777777763  


Q ss_pred             CCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       291 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                       ..++||+||+.=|||+. ++.+.|+|||-|....
T Consensus       185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence             36799999999999999 8899999999887654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.28  E-value=9.5e-06  Score=74.68  Aligned_cols=142  Identities=22%  Similarity=0.252  Sum_probs=84.0

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC--ccceeeeeeec---CCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR--NLIKILSGCSN---LDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~  253 (457)
                      +.++.|..+.||+....+ +.+++|.....  .....+.+|..+++.+...  .+.+++.++..   ....+++|+|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            478899999999999877 68999997655  3445677888888888533  34566664432   3356899999999


Q ss_pred             CCHHH----------------HH---hhC--C-CCCCHHHH---------HHH------------HHHHHH-HHHHHHhc
Q 044428          254 GSLEK----------------WL---YSH--N-YFLDILER---------LNI------------MIDVGL-ALEYLHYG  289 (457)
Q Consensus       254 g~L~~----------------~l---~~~--~-~~l~~~~~---------~~i------------~~~ia~-~l~~LH~~  289 (457)
                      ..+..                .+   +..  . ....+...         ...            ...+.. .+..++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87777                11   111  0 11111110         000            111222 23333321


Q ss_pred             ---CCCCCeeeccCCCCCeeec-CCCcEEEeccccccc
Q 044428          290 ---HALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKL  323 (457)
Q Consensus       290 ---~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~  323 (457)
                         .....++|+|+.|+||+++ +++.+.|.||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               1146699999999999999 666668999987654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.24  E-value=1.6e-05  Score=74.01  Aligned_cols=140  Identities=16%  Similarity=0.088  Sum_probs=85.9

Q ss_pred             ccCCCCc-eEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEeccCCCCHH
Q 044428          180 LLGIGSF-GSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFMPNGSLE  257 (457)
Q Consensus       180 ~lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  257 (457)
                      .|..|.+ ..||+.... +..+.||+.....   .....+|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3455555 788999764 4788999876442   234677888888884 444556777776666789999999988776


Q ss_pred             HHH-------------------hhCC---CCCC--HHHHHHHHH--------------------HHHHHHHHHHh---cC
Q 044428          258 KWL-------------------YSHN---YFLD--ILERLNIMI--------------------DVGLALEYLHY---GH  290 (457)
Q Consensus       258 ~~l-------------------~~~~---~~l~--~~~~~~i~~--------------------~ia~~l~~LH~---~~  290 (457)
                      +..                   +...   ....  ...++....                    .+......|-.   ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   1110   0000  001110000                    01111222211   11


Q ss_pred             CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       291 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ....++|+|+.|.||+++++....|.||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            135589999999999999988889999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.23  E-value=6.6e-07  Score=59.00  Aligned_cols=39  Identities=38%  Similarity=0.591  Sum_probs=34.4

Q ss_pred             CCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCC
Q 044428           31 ISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE   70 (457)
Q Consensus        31 ~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~   70 (457)
                      ++|++|+|++|+|+ .+|+.+.+|++|+.|++++|+++..
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i   39 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDI   39 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCC
Confidence            57999999999999 8999999999999999999999843

...

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.23  E-value=1.3e-07  Score=94.50  Aligned_cols=87  Identities=24%  Similarity=0.356  Sum_probs=48.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccC----------------------CCCCccchhcCCCce
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS----------------------GEIPKSLEALLYLKQ   59 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~----------------------g~~p~~~~~~~~L~~   59 (457)
                      ++.+|.+|..+|||.|+|. .+|+.+-++.+|..|+||+|+|+                      ..+|..+..++.|+.
T Consensus       217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~k  295 (1255)
T KOG0444|consen  217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTK  295 (1255)
T ss_pred             chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHH
Confidence            3445666666666666666 66666666655555555555555                      045555555555555


Q ss_pred             EecccccC--CCCCCCCCCccccccccccccc
Q 044428           60 LNVSQNRL--EGEIPVEGPFRNFSTESFSWNY   89 (457)
Q Consensus        60 l~l~~n~l--~~~~p~~~~~~~~~~~~~~~n~   89 (457)
                      |.+.+|+|  .|.+...|.+.++.....++|.
T Consensus       296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~  327 (1255)
T KOG0444|consen  296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNK  327 (1255)
T ss_pred             HHhccCcccccCCccchhhhhhhHHHHhhccc
Confidence            55555544  2444445555555555555553

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.22  E-value=3.4e-05  Score=68.95  Aligned_cols=129  Identities=20%  Similarity=0.262  Sum_probs=91.5

Q ss_pred             cCCccCCCCceEEEEEEeCCCCEEEEEEecccc----------------hhhHHHHHHHHHHHhhcC------CCcccee
Q 044428          177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL----------------ERTFVSFNSECEVLRNVR------HRNLIKI  234 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l  234 (457)
                      ....||+|+.-.||.-  ++....+||++....                .....++.+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3458999999999854  455668899887554                223566778887777766      8899999


Q ss_pred             eeeeecCCeeEEEEeccCC------CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec
Q 044428          235 LSGCSNLDFKALVLEFMPN------GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD  308 (457)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~  308 (457)
                      +|+..+.....+|+|.+.+      -+|.+++....  ++. ...+.+.+.   ..||-    ...|+.+|++|+||++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~f---~~~l~----~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDEF---KRYLL----DHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHHH---HHHHH----HcCCeecCCCcccEEEE
Confidence            9999999999999998643      26888886654  444 333333333   44554    34499999999999996


Q ss_pred             CCC----cEEEec
Q 044428          309 ENM----VAHVSD  317 (457)
Q Consensus       309 ~~~----~~kl~D  317 (457)
                      ...    .+.|.|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            322    455555

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.22  E-value=1.7e-05  Score=71.15  Aligned_cols=138  Identities=15%  Similarity=0.143  Sum_probs=90.1

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHH---------HHHHHHHHHhhcC---CCccceeeeee
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV---------SFNSECEVLRNVR---HRNLIKILSGC  238 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~---h~niv~l~~~~  238 (457)
                      ..++|...+++-......|.+-.. +|..+++|..+.......+         ...+++..+.+++   -.....++...
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            446777777777777777777666 5788999988654322111         1234444444443   22333333222


Q ss_pred             e-----cCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcE
Q 044428          239 S-----NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       239 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                      .     -....+++|||++|..|.+...     ++.    .++..+..++.-+|    ..|+.|+|..|+|+++++++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH----~~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH----KHGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH----HcCCccCCCCcCcEEEECCc-E
Confidence            2     2234568999999988876542     221    24456778899999    78899999999999999655 8


Q ss_pred             EEeccccccc
Q 044428          314 HVSDFGISKL  323 (457)
Q Consensus       314 kl~Dfg~~~~  323 (457)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            8999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.18  E-value=1.3e-07  Score=76.94  Aligned_cols=82  Identities=29%  Similarity=0.410  Sum_probs=68.7

Q ss_pred             CccCCeeeccCCcccccCCcccCCC-CCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSL-ISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTES   84 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l-~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~   84 (457)
                      ...|+..+|++|.|. .+|+.|... +.++.|+|++|+|+ .+|..+..++.|+.+|+++|.|+-.+-...++.+|..+.
T Consensus        52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLD  129 (177)
T ss_pred             CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhc
Confidence            345677899999999 899888765 58999999999999 999999999999999999999998876666666666666


Q ss_pred             ccccc
Q 044428           85 FSWNY   89 (457)
Q Consensus        85 ~~~n~   89 (457)
                      ..+|.
T Consensus       130 s~~na  134 (177)
T KOG4579|consen  130 SPENA  134 (177)
T ss_pred             CCCCc
Confidence            65553

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.17  E-value=5.2e-07  Score=78.73  Aligned_cols=85  Identities=29%  Similarity=0.359  Sum_probs=27.6

Q ss_pred             CccCCccCCeeeccCCcccccCCcccC-CCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFG-SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~   79 (457)
                      .+.+..++++|+|++|+|+ .| +.++ .|.+|+.||||+|.|+ .++ .+..++.|+.|++++|+++..-+.. ..+++
T Consensus        14 ~~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~   89 (175)
T PF14580_consen   14 QYNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPN   89 (175)
T ss_dssp             ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT
T ss_pred             ccccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCc
Confidence            3456678999999999998 66 4677 5899999999999999 775 5888999999999999999764322 24678


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|..
T Consensus        90 L~~L~L~~N~I  100 (175)
T PF14580_consen   90 LQELYLSNNKI  100 (175)
T ss_dssp             --EEE-TTS--
T ss_pred             CCEEECcCCcC
Confidence            88888888853

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.13  E-value=2.9e-07  Score=96.02  Aligned_cols=86  Identities=34%  Similarity=0.439  Sum_probs=54.4

Q ss_pred             cCCccCCeeeccCCcccccCCc-ccCCCCCCCeEeCcCCccCCCCCc----------------------cchhcCCCceE
Q 044428            4 GGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPK----------------------SLEALLYLKQL   60 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~g~~p~----------------------~~~~~~~L~~l   60 (457)
                      -+..+|+.|+|++|+|. ++|+ .+.+|..|+.|+||+|+|+ .||.                      .+..+++|+.+
T Consensus       380 ~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~l  457 (1081)
T KOG0618|consen  380 VNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVL  457 (1081)
T ss_pred             ccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEE
Confidence            34555555566655555 5553 2455555555555555555 4554                      45556778888


Q ss_pred             ecccccCC-CCCCCCCCccccccccccccccc
Q 044428           61 NVSQNRLE-GEIPVEGPFRNFSTESFSWNYAL   91 (457)
Q Consensus        61 ~l~~n~l~-~~~p~~~~~~~~~~~~~~~n~~l   91 (457)
                      |||.|+|+ +.+|...+-+++..++++||.++
T Consensus       458 DlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  458 DLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             ecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99988886 44554444468889999999753

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.12  E-value=1e-05  Score=72.00  Aligned_cols=102  Identities=23%  Similarity=0.267  Sum_probs=82.0

Q ss_pred             HHHHHHHhhcCC-CccceeeeeeecCCeeEEEEeccCCCCHHHH---HhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 044428          217 NSECEVLRNVRH-RNLIKILSGCSNLDFKALVLEFMPNGSLEKW---LYSHNYFLDILERLNIMIDVGLALEYLHYGHAL  292 (457)
Q Consensus       217 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  292 (457)
                      ..|.-+++.+++ +++.+++|+|-.    ++|.||.+.+++...   +..- ...+|..|.+||.++++.+.+|+++.. 
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~-   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPL-   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCC-
Confidence            457788888876 699999999953    789999987766422   1111 236899999999999999999998763 


Q ss_pred             CCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          293 APIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       293 ~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ..+.-.|++++|+-+++++++|+.|...+...
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            34888999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.10  E-value=5.1e-07  Score=91.07  Aligned_cols=179  Identities=18%  Similarity=0.145  Sum_probs=126.7

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCeeEEEEeccCCC-C
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN-LIKILSGCSNLDFKALVLEFMPNG-S  255 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~  255 (457)
                      .+-.++|+++++||.+....+...++.+...     ....-++++|.+++||| .+..++-+..++...++++|+..+ +
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            3457889999999987543344445554422     34566899999999999 777777777788889999999877 3


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceecc
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK  335 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  335 (457)
                      -.......+..+...+...+...-+++++++|.    ..=+|+|    ||+..+ ...|..||+....+.+..   ....
T Consensus       322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~----~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t  389 (829)
T KOG0576|consen  322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHS----SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT  389 (829)
T ss_pred             ccccCChhhHhhhhhhhhhhhhhhccccccccc----ccccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence            322222222224444555566667788999993    3347888    777655 678999999998876543   2344


Q ss_pred             ccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCC
Q 044428          336 TMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTN  373 (457)
Q Consensus       336 ~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~  373 (457)
                      ..+++.|+|||..    +..+.|+|+.|+--.++.-|-+|-.
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            6789999999944    4567899999988778887777643

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=5e-05  Score=83.22  Aligned_cols=147  Identities=15%  Similarity=0.201  Sum_probs=91.7

Q ss_pred             CCccCCCCceEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcc--ceeeeeeecC---CeeEEE
Q 044428          178 CNLLGIGSFGSVYKGTLSDG---TNVAIKIFNLQL-ERTFVSFNSECEVLRNVR-HRNL--IKILSGCSNL---DFKALV  247 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  247 (457)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45789999999999887654   367778765432 122346889999999995 6665  6778887664   457899


Q ss_pred             EeccCCCCHHH--------------------H---HhhCC----------CCCCHHH--HHHH---------------HH
Q 044428          248 LEFMPNGSLEK--------------------W---LYSHN----------YFLDILE--RLNI---------------MI  277 (457)
Q Consensus       248 ~e~~~~g~L~~--------------------~---l~~~~----------~~l~~~~--~~~i---------------~~  277 (457)
                      |||+++..+.+                    .   ||.-.          .+..+..  .-.+               .-
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998764321                    1   11111          0001111  1000               01


Q ss_pred             HHHHHHHHHHhcCCC-------CCeeeccCCCCCeeecCC-C-cEEEecccccccc
Q 044428          278 DVGLALEYLHYGHAL-------APIIHCDLKPSNILLDEN-M-VAHVSDFGISKLL  324 (457)
Q Consensus       278 ~ia~~l~~LH~~~~~-------~~ivH~dlk~~NIll~~~-~-~~kl~Dfg~~~~~  324 (457)
                      .+...+.+|..+...       ..+||+|+++.||+++.+ . ..-|.||.++..-
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            233345667543321       359999999999999853 3 3578999988753

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.00  E-value=1.4e-06  Score=80.15  Aligned_cols=82  Identities=26%  Similarity=0.250  Sum_probs=68.3

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccc
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTES   84 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~   84 (457)
                      .-..|++||||+|.++ .|..+..-++.++.|+||+|.+. .+-. +..+++|+.||||+|.|+...-....+.|..++.
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLK  358 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeee
Confidence            3457899999999999 89999999999999999999998 6654 8889999999999999986554444566777777


Q ss_pred             ccccc
Q 044428           85 FSWNY   89 (457)
Q Consensus        85 ~~~n~   89 (457)
                      +++|.
T Consensus       359 La~N~  363 (490)
T KOG1259|consen  359 LAQNK  363 (490)
T ss_pred             hhhhh
Confidence            77774

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.98  E-value=9.9e-07  Score=87.82  Aligned_cols=66  Identities=32%  Similarity=0.432  Sum_probs=51.2

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCC
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~   69 (457)
                      +-+|++|+.|+||+|.|...-++++..+++|++|+||+|+|+ ++|+ +|..+..|+.|+|++|+++.
T Consensus       289 lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~  355 (873)
T KOG4194|consen  289 LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDH  355 (873)
T ss_pred             ccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHH
Confidence            456888888999999998778888888899999999999998 5554 56666666666666666653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.93  E-value=0.0001  Score=65.51  Aligned_cols=125  Identities=27%  Similarity=0.419  Sum_probs=90.4

Q ss_pred             hcCCcCCccCCCCc-eEEEEEEeCCCCEEEEEEecc---cc--------h----------hhHHHHHHHHHHHhhcC---
Q 044428          173 NEFDECNLLGIGSF-GSVYKGTLSDGTNVAIKIFNL---QL--------E----------RTFVSFNSECEVLRNVR---  227 (457)
Q Consensus       173 ~~~~~~~~lg~G~~-g~Vy~~~~~~g~~vavK~l~~---~~--------~----------~~~~~~~~E~~~l~~l~---  227 (457)
                      .+++.++.||.|.- |.||+++. +|+.+|+|++..   ..        .          .....|..|.+..++++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 99999999 577999999421   00        0          11235889999999885   


Q ss_pred             CCcc--ceeeeeeecC------------------CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 044428          228 HRNL--IKILSGCSNL------------------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH  287 (457)
Q Consensus       228 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH  287 (457)
                      +.++  |+.+||..-.                  ..+.+|.||++...          .+.    .+-+.+|.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHH
Confidence            4455  8888887321                  13468888886543          112    233456667778889


Q ss_pred             hcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       288 ~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                          ..+|+-+|+++.|..     .-||+|||.+
T Consensus       182 ----k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 ----KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ----HCCeeeccCcccccc-----CCEEEecccC
Confidence                788999999999986     3489999864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=97.92  E-value=5.1e-06  Score=59.28  Aligned_cols=58  Identities=40%  Similarity=0.478  Sum_probs=48.8

Q ss_pred             CCCCeEeCcCCccCCCCC-ccchhcCCCceEecccccCCCCCCCC-CCccccccccccccc
Q 044428           31 ISLESLDLSSNNLSGEIP-KSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFSTESFSWNY   89 (457)
Q Consensus        31 ~~l~~l~l~~n~l~g~~p-~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~   89 (457)
                      ++|++|+|++|+|+ .|| ..|..+++|+.|++++|+++...|.. ..++++..+.+++|.
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            57999999999999 666 47889999999999999999887743 556777888888874

...

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.91  E-value=0.0001  Score=68.24  Aligned_cols=73  Identities=8%  Similarity=0.086  Sum_probs=45.3

Q ss_pred             CccCCCCce-EEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC---ccceeeeeeecC---CeeEEEEecc
Q 044428          179 NLLGIGSFG-SVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR---NLIKILSGCSNL---DFKALVLEFM  251 (457)
Q Consensus       179 ~~lg~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  251 (457)
                      +.++.|+.. .||+.    +..+++|.....  .....+.+|.+.+..+...   .+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467767666 48875    235777875542  2234688899999888532   233344433332   2347899999


Q ss_pred             CCCCHH
Q 044428          252 PNGSLE  257 (457)
Q Consensus       252 ~~g~L~  257 (457)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.89  E-value=0.00015  Score=67.08  Aligned_cols=73  Identities=16%  Similarity=0.295  Sum_probs=48.8

Q ss_pred             CccCCCCceEEEEEEeCC--CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCeeEEEEeccCCCC
Q 044428          179 NLLGIGSFGSVYKGTLSD--GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL-IKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      +.|..|-...+|+....+  +..+++|+...... ...+..+|+.++..+....+ .++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467888889999998764  67899998764322 12234578888888854333 34444332    247999999876


Q ss_pred             H
Q 044428          256 L  256 (457)
Q Consensus       256 L  256 (457)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.87  E-value=9.2e-05  Score=69.54  Aligned_cols=138  Identities=14%  Similarity=0.120  Sum_probs=79.2

Q ss_pred             ccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccc-eeeeeeecCCeeEEEEeccCCCCHHH
Q 044428          180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI-KILSGCSNLDFKALVLEFMPNGSLEK  258 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~~  258 (457)
                      .+..|-...+|+... ++..+++|+.......-.....+|.++++.+....++ ++++...    ..+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456688889999884 5677889976543222112457788888888643333 3344332    368999999866532


Q ss_pred             H-----------------HhhCC---CCCCHHHHH-HHHHHH---------HHHHHHHHhc----CCCCCeeeccCCCCC
Q 044428          259 W-----------------LYSHN---YFLDILERL-NIMIDV---------GLALEYLHYG----HALAPIIHCDLKPSN  304 (457)
Q Consensus       259 ~-----------------l~~~~---~~l~~~~~~-~i~~~i---------a~~l~~LH~~----~~~~~ivH~dlk~~N  304 (457)
                      .                 +|...   ...+...++ ....++         ...+..+-..    .....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 12111   111221111 111111         1112222111    112358999999999


Q ss_pred             eeecCCCcEEEeccccccc
Q 044428          305 ILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       305 Ill~~~~~~kl~Dfg~~~~  323 (457)
                      |++++++ +.+.||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.84  E-value=0.00017  Score=62.18  Aligned_cols=129  Identities=20%  Similarity=0.199  Sum_probs=85.8

Q ss_pred             cCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      ..+.|++|.+|.||+|.+. |..+|+|+-+.++  ....+..|++++..++-.++.+=+-++.   ..++.|||+.|-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcch
Confidence            3458999999999999996 4589999866543  3567899999999988766654332222   23455999988888


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC-C-CCeeecCCCcEEEecccccccc
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLK-P-SNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk-~-~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      .++-...    +-.+.+    .+++.---|-    ..||-|+.|. | .||++.+ ..+.|.||..|+..
T Consensus       100 ~~~~~~~----~rk~l~----~vlE~a~~LD----~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112         100 GKLEIGG----DRKHLL----RVLEKAYKLD----RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhcc----cHHHHH----HHHHHHHHHH----HhccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            7765532    112222    2333311222    4568888886 3 4555554 48999999998843

>PRK10593 hypothetical protein; Provisional

Probab=97.83  E-value=0.00038  Score=66.83  Aligned_cols=78  Identities=12%  Similarity=0.018  Sum_probs=57.0

Q ss_pred             CcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC---Cccceeeeeeec---CCeeEEEEe
Q 044428          176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH---RNLIKILSGCSN---LDFKALVLE  249 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e  249 (457)
                      ...+.||.|..+.||+....+++ +.+|..+..  .....+..|.+.++.+.-   -.+.+++++|..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34467999999999999876664 677774331  123468899999988853   357778887754   356899999


Q ss_pred             ccCCCCH
Q 044428          250 FMPNGSL  256 (457)
Q Consensus       250 ~~~~g~L  256 (457)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998764

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.82  E-value=2.1e-06  Score=89.87  Aligned_cols=83  Identities=27%  Similarity=0.247  Sum_probs=64.6

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCCCCCCccccccc
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTE   83 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~   83 (457)
                      .++.|+.|+|.+|.|+-..=+-|-+..+|+.|+|++|+|. ++|+ .+.+++.|+.|+||+|+|+..+.....++.+.++
T Consensus       357 ~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL  435 (1081)
T KOG0618|consen  357 NHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTL  435 (1081)
T ss_pred             hhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHH
Confidence            3678999999999999766666888999999999999999 9998 4778999999999999999755333333333333


Q ss_pred             ccccc
Q 044428           84 SFSWN   88 (457)
Q Consensus        84 ~~~~n   88 (457)
                      ..-+|
T Consensus       436 ~ahsN  440 (1081)
T KOG0618|consen  436 RAHSN  440 (1081)
T ss_pred             hhcCC
Confidence            33333

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.81  E-value=4.4e-06  Score=83.37  Aligned_cols=89  Identities=29%  Similarity=0.450  Sum_probs=70.3

Q ss_pred             ccCCccCCeeeccCCcccccCCcc---cCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCCCC-CCc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKS---FGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPVE-GPF   77 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p~~-~~~   77 (457)
                      |.+|++|+.|||++|.|++.|-+.   |..|++|..|+|.+|+|. +||. .|..++.|++|||.+|.+....|.. .++
T Consensus       361 f~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m  439 (873)
T KOG4194|consen  361 FVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM  439 (873)
T ss_pred             HHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccc
Confidence            557889999999999999988764   667999999999999999 8886 7889999999999999998877743 222


Q ss_pred             ccccccccccccccCC
Q 044428           78 RNFSTESFSWNYALCG   93 (457)
Q Consensus        78 ~~~~~~~~~~n~~lcg   93 (457)
                       .+..+.+.....+|.
T Consensus       440 -~Lk~Lv~nSssflCD  454 (873)
T KOG4194|consen  440 -ELKELVMNSSSFLCD  454 (873)
T ss_pred             -hhhhhhhcccceEEe
Confidence             455555555555554

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.74  E-value=0.00075  Score=66.94  Aligned_cols=75  Identities=17%  Similarity=0.184  Sum_probs=52.3

Q ss_pred             CccCCCCceEEEEEEeCCC-CEEEEEEecccc-------hhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCeeEEE
Q 044428          179 NLLGIGSFGSVYKGTLSDG-TNVAIKIFNLQL-------ERTFVSFNSECEVLRNVR---HRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  247 (457)
                      +.||.|.+..||++...+| +.|+||.-....       .-....+..|.+.|..+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4789999999999998877 489999853211       113345667778777762   2456666666  34557899


Q ss_pred             EeccCCCC
Q 044428          248 LEFMPNGS  255 (457)
Q Consensus       248 ~e~~~~g~  255 (457)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.73  E-value=0.00023  Score=68.33  Aligned_cols=142  Identities=17%  Similarity=0.125  Sum_probs=85.2

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC--ccceeeeee------ecCCeeEEEEe
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR--NLIKILSGC------SNLDFKALVLE  249 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e  249 (457)
                      .+.+..|....+|+....+ ..+++|+...   ........|++++..+.+.  .+.+++...      ...+..+.|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4577888888999987654 4688898764   2234566678877777432  244444321      22345689999


Q ss_pred             ccCCCCHHH--------------HHhhC--C--------CCCCHHHHH----------HHHHHHHHHHHHHHhc---CCC
Q 044428          250 FMPNGSLEK--------------WLYSH--N--------YFLDILERL----------NIMIDVGLALEYLHYG---HAL  292 (457)
Q Consensus       250 ~~~~g~L~~--------------~l~~~--~--------~~l~~~~~~----------~i~~~ia~~l~~LH~~---~~~  292 (457)
                      |++|..+..              .+|..  .        ....|....          .....+..++.++...   ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998866421              01110  0        111222211          0111233344454421   113


Q ss_pred             CCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          293 APIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       293 ~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .+++|+|+.|.||+++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5699999999999999988789999997764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.70  E-value=1.9e-05  Score=84.29  Aligned_cols=76  Identities=22%  Similarity=0.180  Sum_probs=50.9

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFS   86 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~   86 (457)
                      ++|+.|+|++|+|+ .+|..+   ++|+.|+|++|+|+ .+|..+   .+|+.|++++|+|+..+.....+.++..+.++
T Consensus       382 ~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        382 SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLE  453 (788)
T ss_pred             cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCcccccChHHhhccCCCeEECC
Confidence            36777777777777 466543   56777888888887 577533   35677788888887543334556667777777


Q ss_pred             cccc
Q 044428           87 WNYA   90 (457)
Q Consensus        87 ~n~~   90 (457)
                      +|+.
T Consensus       454 ~N~L  457 (788)
T PRK15387        454 GNPL  457 (788)
T ss_pred             CCCC
Confidence            7753

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.63  E-value=4.2e-06  Score=68.35  Aligned_cols=81  Identities=25%  Similarity=0.333  Sum_probs=65.8

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESF   85 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~   85 (457)
                      .+.++.|||++|+|+ .+|.++..++.|+.|+++.|.|. ..|+.+..+.+|..|+..+|.+.- +|....++....+-.
T Consensus        76 f~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~e-id~dl~~s~~~al~~  152 (177)
T KOG4579|consen   76 FPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAE-IDVDLFYSSLPALIK  152 (177)
T ss_pred             cchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCcccc-CcHHHhccccHHHHH
Confidence            357789999999999 99999999999999999999999 999999999999999999998874 343333444444433


Q ss_pred             cccc
Q 044428           86 SWNY   89 (457)
Q Consensus        86 ~~n~   89 (457)
                      .+|.
T Consensus       153 lgne  156 (177)
T KOG4579|consen  153 LGNE  156 (177)
T ss_pred             hcCC
Confidence            3443

>PRK05231 homoserine kinase; Provisional

Probab=97.63  E-value=0.0025  Score=61.86  Aligned_cols=157  Identities=15%  Similarity=0.123  Sum_probs=84.2

Q ss_pred             cCHHHHHHHhhcCCc-----CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC--ccceee
Q 044428          163 ISYLDIQRATNEFDE-----CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR--NLIKIL  235 (457)
Q Consensus       163 ~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~  235 (457)
                      ++..++......|..     .+.++.|....+|+....+| .+++|++...   .......|+..+..+...  .+.+.+
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcce
Confidence            344555555455543     34566787789999987655 6889987621   122333455555555211  123333


Q ss_pred             ee------eecCCeeEEEEeccCCCCHH-----------HHH---hhCC----------CCCCH-HHHHHH---------
Q 044428          236 SG------CSNLDFKALVLEFMPNGSLE-----------KWL---YSHN----------YFLDI-LERLNI---------  275 (457)
Q Consensus       236 ~~------~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~~----------~~l~~-~~~~~i---------  275 (457)
                      ..      ....+..++++||++|..+.           +.+   |...          ..+.| .....-         
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            21      12245578999999886431           111   1110          01112 111110         


Q ss_pred             ---H-HHHHHHHHHHHhc---CCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          276 ---M-IDVGLALEYLHYG---HALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       276 ---~-~~ia~~l~~LH~~---~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                         . ..+...++.+...   .-..+++|+|+.+.||+++++...-|.||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               1 1111122222210   0145799999999999999776668999997764

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.61  E-value=5e-06  Score=82.72  Aligned_cols=68  Identities=29%  Similarity=0.453  Sum_probs=34.3

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV   73 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~   73 (457)
                      +++|..|+.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.++.|..|+.+.|.+...++.
T Consensus       117 i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsq  184 (722)
T KOG0532|consen  117 ICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQ  184 (722)
T ss_pred             hhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHH
Confidence            445555555555555555 4555544443 444555555555 4555555444455555555554444443

>PLN03210 Resistant to P

Probab=97.59  E-value=0.00012  Score=83.19  Aligned_cols=86  Identities=23%  Similarity=0.264  Sum_probs=60.5

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +..+++|+.|+|++|...+.+|. ++++++|+.|+|++|..-..+|..+.++++|+.|++++|.....+|....+.++..
T Consensus       630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~  708 (1153)
T PLN03210        630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYR  708 (1153)
T ss_pred             cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCE
Confidence            45677778888877655456764 77788888888877765557888888888888888887765556665445566666


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.++++.
T Consensus       709 L~Lsgc~  715 (1153)
T PLN03210        709 LNLSGCS  715 (1153)
T ss_pred             EeCCCCC
Confidence            6666653

syringae 6; Provisional

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	457
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-32
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-31
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-13
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-07
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-07
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-04
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		4e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 106/301 (35%), Positives = 155/301 (51%), Gaps = 27/301 (8%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ 208
           ++E+  + L   +R S  ++Q A++ F   N+LG G FG VYKG L+DGT VA+K   L+
Sbjct: 14  AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK--RLK 71
Query: 209 LERTF---VSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-- 263
            ER     + F +E E++    HRNL+++   C     + LV  +M NGS+   L     
Sbjct: 72  EERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 131
Query: 264 -NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK 322
               LD  +R  I +     L YLH  H    IIH D+K +NILLDE   A V DFG++K
Sbjct: 132 SQPPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190
Query: 323 LLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLE------TFSRKKPT 372
           L+ +  D  +      TIG++APE    G  S K DV+ YG++LLE       F   +  
Sbjct: 191 LM-DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 249
Query: 373 NDLGEMSLKHWVNQSLPH-KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE 431
           ND  ++ L  WV   L   KL  +VD +L       + K + + +++ +AL C   SP E
Sbjct: 250 ND-DDVMLLDWVKGLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPME 303
Query: 432 R 432
           R
Sbjct: 304 R 304

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 154/301 (51%), Gaps = 27/301 (8%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ 208
           ++E+  + L   +R S  ++Q A++ F   N+LG G FG VYKG L+DG  VA+K   L+
Sbjct: 6   AEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK--RLK 63
Query: 209 LERTF---VSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-- 263
            ERT    + F +E E++    HRNL+++   C     + LV  +M NGS+   L     
Sbjct: 64  EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 264 -NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK 322
               LD  +R  I +     L YLH  H    IIH D+K +NILLDE   A V DFG++K
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 323 LLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLE------TFSRKKPT 372
           L+ +  D  +       IG++APE    G  S K DV+ YG++LLE       F   +  
Sbjct: 183 LM-DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 373 NDLGEMSLKHWVNQSLPH-KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE 431
           ND  ++ L  WV   L   KL  +VD +L       + K + + +++ +AL C   SP E
Sbjct: 242 ND-DDVMLLDWVKGLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 432 R 432
           R
Sbjct: 296 R 296

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 154/300 (51%), Gaps = 21/300 (7%)
Query: 154 LLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF 213
           L+P  ++R +  +D++ ATN FD   L+G G FG VYKG L DG  VA+K    +  +  
Sbjct: 21  LVPFESYR-VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI 79
Query: 214 VSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN---YFLDIL 270
             F +E E L   RH +L+ ++  C   +   L+ ++M NG+L++ LY  +     +   
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
           +RL I I     L YLH       IIH D+K  NILLDEN V  ++DFGISK   E D +
Sbjct: 140 QRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 331 LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETF-SRKKPTNDLGE--MSLKHW 383
            +      T+GY+ PE    G ++ K DVYS+G++L E   +R      L    ++L  W
Sbjct: 196 HLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 384 VNQSLPH-KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL 442
             +S  + +L ++VD NL  +      + + L +  + A+ C   S ++R    +   KL
Sbjct: 256 AVESHNNGQLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 98/300 (32%), Positives = 153/300 (51%), Gaps = 21/300 (7%)
Query: 154 LLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF 213
           L+P  ++R +  +D++ ATN FD   L+G G FG VYKG L DG  VA+K    +  +  
Sbjct: 21  LVPFESYR-VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI 79
Query: 214 VSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN---YFLDIL 270
             F +E E L   RH +L+ ++  C   +   L+ ++M NG+L++ LY  +     +   
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
           +RL I I     L YLH       IIH D+K  NILLDEN V  ++DFGISK   E   +
Sbjct: 140 QRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQT 195
Query: 331 LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETF-SRKKPTNDLGE--MSLKHW 383
            +      T+GY+ PE    G ++ K DVYS+G++L E   +R      L    ++L  W
Sbjct: 196 HLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 384 VNQSLPH-KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL 442
             +S  + +L ++VD NL  +      + + L +  + A+ C   S ++R    +   KL
Sbjct: 256 AVESHNNGQLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 27/241 (11%)
Query: 142 QNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDE------CNLLGIGSFGSVYKGTLS 195
           +N+S + SD         +   S+ +++  TN FDE       N +G G FG VYKG ++
Sbjct: 1   ENKSLEVSD-------TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN 53
Query: 196 DGTNVAIK----IFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM 251
           + T VA+K    + ++  E     F+ E +V+   +H NL+++L   S+ D   LV  +M
Sbjct: 54  N-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLA--LEYLHYGHALAPIIHCDLKPSNILLDE 309
           PNGSL   L   +    +   +   I  G A  + +LH  H     IH D+K +NILLDE
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLDE 168
Query: 310 NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETF 366
              A +SDFG+++   +   +++ ++ + T  YMAPE   G ++ K D+YS+G++LLE  
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEII 228
Query: 367 S 367
           +
Sbjct: 229 T 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 127/241 (52%), Gaps = 27/241 (11%)
Query: 142 QNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDE------CNLLGIGSFGSVYKGTLS 195
           +N+S + SD         +   S+ +++  TN FDE       N +G G FG VYKG ++
Sbjct: 1   ENKSLEVSD-------TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN 53
Query: 196 DGTNVAIK----IFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM 251
           + T VA+K    + ++  E     F+ E +V+   +H NL+++L   S+ D   LV  +M
Sbjct: 54  N-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLA--LEYLHYGHALAPIIHCDLKPSNILLDE 309
           PNGSL   L   +    +   +   I  G A  + +LH  H     IH D+K +NILLDE
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLDE 168
Query: 310 NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETF 366
              A +SDFG+++   +   +++  + + T  YMAPE   G ++ K D+YS+G++LLE  
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEII 228
Query: 367 S 367
           +
Sbjct: 229 T 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 119/223 (53%), Gaps = 20/223 (8%)
Query: 160 WRRISYLDIQRATNEFDE------CNLLGIGSFGSVYKGTLSDGTNVAIK----IFNLQL 209
           +   S+ +++  TN FDE       N +G G FG VYKG +++ T VA+K    + ++  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E     F+ E +V+   +H NL+++L   S+ D   LV  +MPNGSL   L   +    +
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 270 LERLNIMIDVGLA--LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
              +   I  G A  + +LH  H     IH D+K +NILLDE   A +SDFG+++   + 
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 328 DDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFS 367
              ++  + + T  YMAPE   G ++ K D+YS+G++LLE  +
Sbjct: 181 AQXVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 113/223 (50%), Gaps = 20/223 (8%)
Query: 160 WRRISYLDIQRATNEFDE------CNLLGIGSFGSVYKGTLSDGTNVAIK----IFNLQL 209
           +   S+ +++  TN FDE       N  G G FG VYKG +++ T VA+K    + ++  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF--L 267
           E     F+ E +V    +H NL+++L   S+ D   LV  + PNGSL   L   +    L
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
               R  I       + +LH  H     IH D+K +NILLDE   A +SDFG+++   + 
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 328 DDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFS 367
              +  ++ + T  Y APE   G ++ K D+YS+G++LLE  +
Sbjct: 178 AQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIIT 220

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 131/263 (49%), Gaps = 27/263 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           +G GSFG+V++     G++VA+KI    +   ER    F  E  +++ +RH N++  +  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVLFMGA 102
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLNIMIDVGLALEYLHYGHALAPI 295
            +     ++V E++  GSL + L+       LD   RL++  DV   + YLH  +   PI
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP--PI 160
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VST 351
           +H DLK  N+L+D+     V DFG+S+L  +    L       T  +MAPE +     + 
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN---------QSLPHKLAEVVD---SN 399
           K DVYS+G++L E  + ++P  +L    +   V          ++L  ++A +++   +N
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN 278
Query: 400 LVRREHSFSAKMDCLLRIMNLAL 422
              +  SF+  MD L  ++  A+
Sbjct: 279 EPWKRPSFATIMDLLRPLIKSAV 301

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 41/289 (14%)
Query: 164 SYLDIQRATNEFDE-----C----NLLGIGSFGSVYKGTLS--DGTNVAIKIFNLQL--- 209
           +Y D  RA ++F +     C     ++G G FG V  G L      +VA+ I  L++   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E+    F  E  ++    H N++ +    +      +V+EFM NG+L+ +L  H+    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 270 LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
           ++ + ++  +   + YL    A    +H DL   NIL++ N+V  VSDFG+S+++ E D 
Sbjct: 145 IQLVGMLRGIAAGMRYL----ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDP 199
Query: 330 SLIQTKTMATIG--YMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
             + T T   I   + APE I     ++  DV+SYGI++ E  S        GE      
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-------YGERPYWDM 252
Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            NQ +   + E          +   A MDC   +  L LDC  +   ER
Sbjct: 253 SNQDVIKAIEE---------GYRLPAPMDCPAGLHQLMLDCWQKERAER 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 135/264 (51%), Gaps = 29/264 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           +G GSFG+V++     G++VA+KI    +   ER    F  E  +++ +RH N++  +  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVLFMGA 102
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLNIMIDVGLALEYLHYGHALAPI 295
            +     ++V E++  GSL + L+       LD   RL++  DV   + YLH  +   PI
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP--PI 160
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGI----VS 350
           +H +LK  N+L+D+     V DFG+S+L      + + +K+ A T  +MAPE +     +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS---TFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 351 TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN---------QSLPHKLAEVVD---S 398
            K DVYS+G++L E  + ++P  +L    +   V          ++L  ++A +++   +
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 399 NLVRREHSFSAKMDCLLRIMNLAL 422
           N   +  SF+  MD L  ++  A+
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKSAV 301

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 126/257 (49%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V+E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ + + +  Q      I + APE    G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 41/295 (13%)
Query: 163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIF-NLQLERTFVSFN 217
           +SY+ I+          ++G G FG V +G L       + VAIK       ER    F 
Sbjct: 15  VSYVKIE---------EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 65
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
           SE  ++    H N+I++    +N     ++ EFM NG+L+ +L  ++    +++ + ++ 
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            +   + YL    A    +H DL   NIL++ N+V  VSDFG+S+ L E      +T ++
Sbjct: 126 GIASGMRYL----AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 338 A---TIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH 390
                I + APE I     ++  D +SYGI++ E  S        GE       NQ +  
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS-------FGERPYWDMSNQDV-- 232
Query: 391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
                   N + +++      DC   +  L LDC  +  + R       + L K+
Sbjct: 233 -------INAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+KI  +       F +F +E  VLR  RH N++ +  G 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMGY 100
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
              D  A+V ++    SL K L+       + + ++I       ++YLH  +    IIH 
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN----IIHR 156
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           D+K +NI L E +   + DFG++ +      S    +   ++ +MAPE I        S 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 352 KCDVYSYGILLLETFSRKKP 371
           + DVYSYGI+L E  + + P
Sbjct: 217 QSDVYSYGIVLYELMTGELP 236

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 129
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ + + +  Q      I + APE    G  + K DV
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 188
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 189 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 232
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 233 SLHDLMCQCWRKEPEER 249

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 126/257 (49%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V+E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 34/260 (13%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+ GT +  T VAIK     N+  E    +F  E +V++ +RH  L+++ + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE----AFLQEAQVMKKLRHEKLVQLYAV 248
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            S      +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +
Sbjct: 249 VSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YV 303
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTK 352
           H DL+ +NIL+ EN+V  V+DFG+ +L+ E ++   +      I + APE    G  + K
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            DV+S+GILL E  ++       G +     VN+       EV+D   V R +      +
Sbjct: 363 SDVWSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPE 406
Query: 413 CLLRIMNLALDCCMESPDER 432
           C   + +L   C  + P+ER
Sbjct: 407 CPESLHDLMCQCWRKDPEER 426

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 388
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 448 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 491
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 492 SLHDLMCQCWRKEPEER 508

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 132
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 192 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 235
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 236 SLHDLMCQCWRKEPEER 252

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 31/278 (11%)
Query: 179 NLLGIGSFGSVYKGTLSDGTN-----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLI 232
            ++G G FG VYKG L   +      VAIK       E+  V F  E  ++    H N+I
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           ++    S      ++ E+M NG+L+K+L   +    +L+ + ++  +   ++YL    A 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL----AN 165
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPEGI--- 348
              +H DL   NIL++ N+V  VSDFG+S++L +  ++   T      I + APE I   
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 349 -VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             ++  DV+S+GI++ E  +        GE       N    H++ + ++          
Sbjct: 226 KFTSASDVWSFGIVMWEVMT-------YGERPYWELSN----HEVMKAINDGF-----RL 269
Query: 408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
              MDC   I  L + C  +    R    +  + L K+
Sbjct: 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 128
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 129 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 188 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 231
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 232 SLHDLMCQCWRKDPEER 248

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 130
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 131 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 190 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 233
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 234 SLHDLMCQCWRKDPEER 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 41/295 (13%)
Query: 163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIF-NLQLERTFVSFN 217
           +SY+ I+          ++G G FG V +G L       + VAIK       ER    F 
Sbjct: 13  VSYVKIE---------EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 63
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
           SE  ++    H N+I++    +N     ++ EFM NG+L+ +L  ++    +++ + ++ 
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            +   + YL    A    +H DL   NIL++ N+V  VSDFG+S+ L E       T ++
Sbjct: 124 GIASGMRYL----AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSL 179
Query: 338 A---TIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH 390
                I + APE I     ++  D +SYGI++ E  S        GE       NQ +  
Sbjct: 180 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS-------FGERPYWDMSNQDV-- 230
Query: 391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
                   N + +++      DC   +  L LDC  +  + R       + L K+
Sbjct: 231 -------INAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 305
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 365 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 408
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 409 SLHDLMCQCWRKEPEER 425

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 305
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 365 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 408
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 409 SLHDLMCQCWRKEPEER 425

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 121/265 (45%), Gaps = 32/265 (12%)
Query: 179 NLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIK 233
            ++G G  G V  G L         VAIK       ER    F SE  ++    H N+I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH-YGHAL 292
           +    +      +V E+M NGSL+ +L +H+    I++ + ++  VG  + YL   G+  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLL-GEGDDSLIQTKTMATIGYMAPEGIV-- 349
              +H DL   N+L+D N+V  VSDFG+S++L  + D +   T     I + APE I   
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             S+  DV+S+G+++ E  +        GE    +  N+       +V+ S  V   +  
Sbjct: 230 TFSSASDVWSFGVVMWEVLA-------YGERPYWNMTNR-------DVISS--VEEGYRL 273
Query: 408 SAKMDCLLRIMNLALDCCMESPDER 432
            A M C   +  L LDC  +   +R
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 121/265 (45%), Gaps = 32/265 (12%)
Query: 179 NLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIK 233
            ++G G  G V  G L         VAIK       ER    F SE  ++    H N+I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH-YGHAL 292
           +    +      +V E+M NGSL+ +L +H+    I++ + ++  VG  + YL   G+  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLL-GEGDDSLIQTKTMATIGYMAPEGIV-- 349
              +H DL   N+L+D N+V  VSDFG+S++L  + D +   T     I + APE I   
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             S+  DV+S+G+++ E  +        GE    +  N+       +V+ S  V   +  
Sbjct: 230 TFSSASDVWSFGVVMWEVLA-------YGERPYWNMTNR-------DVISS--VEEGYRL 273
Query: 408 SAKMDCLLRIMNLALDCCMESPDER 432
            A M C   +  L LDC  +   +R
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN----YVHRD 136
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 196 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 239
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 240 SLHDLMCQCWRKEPEER 256

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN----YVHRD 136
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 196 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 239
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 240 SLHDLMCQCWRKEPEER 256

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 37/287 (12%)
Query: 162 RISYLDIQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ER 211
           R S   +     E D  N+     +G G FG V  G L        +VAIK   +   E+
Sbjct: 17  RGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 76
Query: 212 TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE 271
               F  E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +++
Sbjct: 77  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 136
Query: 272 RLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
            + ++  +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  ++
Sbjct: 137 LVGMLRGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 191
Query: 331 LIQTK-TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN 385
              T+     I + +PE I     ++  DV+SYGI+L E  S        GE       N
Sbjct: 192 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSN 244
Query: 386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           Q +   + E          +     MDC   +  L LDC  +  + R
Sbjct: 245 QDVIKAVDE---------GYRLPPPMDCPAALYQLMLDCWQKDRNNR 282

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V+E+M  G L  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 30/263 (11%)
Query: 180 LLGIGSFGSVYKGTLSDGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI 234
           ++G+G FG V  G L         VAIK       ++    F SE  ++    H N+I +
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               +      ++ E+M NGSL+ +L  ++    +++ + ++  +G  ++YL    A   
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA--- 152
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPEGIV---- 349
            +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+     I + APE I     
Sbjct: 153 -VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           ++  DV+SYGI++ E  S        GE       NQ +   + E          +    
Sbjct: 212 TSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDVIKAIEE---------GYRLPP 255
Query: 410 KMDCLLRIMNLALDCCMESPDER 432
            MDC + +  L LDC  +   +R
Sbjct: 256 PMDCPIALHQLMLDCWQKERSDR 278

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 164 SYLDIQRATNEF----DECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL- 209
           +Y D  +  +EF    D  N+     +G G FG V  G L        +VAIK   +   
Sbjct: 25  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E+    F  E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +
Sbjct: 85  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 144
Query: 270 LERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
           ++ + ++  +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  
Sbjct: 145 IQLVGMLRGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 199
Query: 329 DSLIQTK-TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
           ++   T+     I + +PE I     ++  DV+SYGI+L E  S        GE      
Sbjct: 200 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEM 252
Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            NQ     + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 253 SNQD----VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 292

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 124/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L  +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 164 SYLDIQRATNEF----DECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL- 209
           +Y D  +  +EF    D  N+     +G G FG V  G L        +VAIK   +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E+    F  E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 270 LERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
           ++ + ++  +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 329 DSLIQTK-TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
           ++   T+     I + +PE I     ++  DV+SYGI+L E  S        GE      
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEM 254
Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            NQ     + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 255 SNQD----VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 164 SYLDIQRATNEF----DECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL- 209
           +Y D  +  +EF    D  N+     +G G FG V  G L        +VAIK   +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E+    F  E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 270 LERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
           ++ + ++  +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 329 DSLIQTK-TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
           ++   T+     I + +PE I     ++  DV+SYGI+L E  S        GE      
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEM 254
Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            NQ     + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 255 SNQD----VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 241 LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 305
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 365 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 408
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 409 SLHDLMCQCWRKEPEER 425

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 35/280 (12%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 94
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +++ + ++ 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-T 336
            +   ++YL    +    +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+  
Sbjct: 155 GIASGMKYL----SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
              I + +PE I     ++  DV+SYGI+L E  S        GE       NQ     +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQD----V 259
Query: 393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            + VD       +     MDC   +  L LDC  +  + R
Sbjct: 260 IKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 37/281 (13%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 94
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +++ + ++ 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 278 DVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK- 335
            +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+ 
Sbjct: 155 GIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               I + +PE I     ++  DV+SYGI+L E  S        GE       NQ     
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQD---- 258
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 259 VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 37/281 (13%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 94
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +++ + ++ 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 278 DVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK- 335
            +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+ 
Sbjct: 155 GIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               I + +PE I     ++  DV+SYGI+L E  S        GE       NQ     
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQD---- 258
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 259 VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 6   VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 65
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +++ + ++ 
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 125
Query: 278 DVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK- 335
            +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+ 
Sbjct: 126 GIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               I + +PE I     ++  DV+SYGI+L E  S        GE       NQ +   
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA 233
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + E          +     MDC   +  L LDC  +  + R
Sbjct: 234 VDE---------GYRLPPPMDCPAALYQLMLDCWQKDRNNR 265

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++EF+P GSL ++L  H   +D ++ L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 125 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 124/257 (48%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  G L  +L      +L + + +++   +   + Y+   +     +H D
Sbjct: 85  EPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +     VN+       EV+D   V R +      +C  
Sbjct: 199 WSFGILLTELTTK-------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECPE 242
Query: 416 RIMNLALDCCMESPDER 432
            + +L   C  + P+ER
Sbjct: 243 SLHDLMCQCWRKDPEER 259

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 123/280 (43%), Gaps = 35/280 (12%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 94
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E M NGSL+ +L  H+    +++ + ++ 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-T 336
            +   ++YL    A    +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+  
Sbjct: 155 GIASGMKYLSDMGA----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
              I + +PE I     ++  DV+SYGI+L E  S        GE       NQ     +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQD----V 259
Query: 393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            + VD       +     MDC   +  L LDC  +  + R
Sbjct: 260 IKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 37/281 (13%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 94
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +++ + ++ 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 278 DVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK- 335
            +   ++YL   G+     +H DL   NIL++ N+V  VSDFG++++L +  ++   T+ 
Sbjct: 155 GIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               I + +PE I     ++  DV+SYGI+L E  S        GE       NQ     
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQD---- 258
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 259 VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 30/263 (11%)
Query: 180 LLGIGSFGSVYKGTLSDGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI 234
           ++G+G FG V  G L         VAIK       ++    F SE  ++    H N+I +
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               +      ++ E+M NGSL+ +L  ++    +++ + ++  +G  ++YL    +   
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL----SDMS 136
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPEGIV---- 349
            +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+     I + APE I     
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           ++  DV+SYGI++ E  S        GE       NQ +   + E          +    
Sbjct: 197 TSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDVIKAIEE---------GYRLPP 240
Query: 410 KMDCLLRIMNLALDCCMESPDER 432
            MDC + +  L LDC  +   +R
Sbjct: 241 PMDCPIALHQLMLDCWQKERSDR 263

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 129/289 (44%), Gaps = 41/289 (14%)
Query: 164 SYLDIQRATNEF----DECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL- 209
           +Y D  +  +EF    D  N+     +G G FG V  G L        +VAIK   +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E+    F  E  ++    H N+I++    +      +V E M NGSL+ +L  H+    +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 270 LERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
           ++ + ++  +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 329 DSLIQTK-TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
           ++   T+     I + +PE I     ++  DV+SYGI+L E  S        GE      
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEM 254
Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            NQ     + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 255 SNQD----VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 30/263 (11%)
Query: 180 LLGIGSFGSVYKGTLSDGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI 234
           ++G+G FG V  G L         VAIK       ++    F SE  ++    H N+I +
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               +      ++ E+M NGSL+ +L  ++    +++ + ++  +G  ++YL    +   
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL----SDMS 130
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPEGIV---- 349
            +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+     I + APE I     
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           ++  DV+SYGI++ E  S        GE       NQ +   + E          +    
Sbjct: 191 TSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDVIKAIEE---------GYRLPP 234
Query: 410 KMDCLLRIMNLALDCCMESPDER 432
            MDC + +  L LDC  +   +R
Sbjct: 235 PMDCPIALHQLMLDCWQKERSDR 257

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 94
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E+M NGSL+ +L  H+    +++ + ++ 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 278 DVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK- 335
            +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+ ++L +  ++   T+ 
Sbjct: 155 GIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               I + +PE I     ++  DV+SYGI+L E  S        GE       NQ     
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQD---- 258
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + + VD       +     MDC   +  L LDC  +  + R
Sbjct: 259 VIKAVDEG-----YRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 123/261 (47%), Gaps = 28/261 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 76
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L++     ++ + ++I       ++YLH       IIH 
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHR 132
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E+    + DFG++ +      S    +   +I +MAPE I        S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM 411
           + DVY++GI+L E  + + P +++               ++ E+V    +  + S   + 
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINNRD-----------QIIEMVGRGSLSPDLS-KVRS 240
Query: 412 DCLLRIMNLALDCCMESPDER 432
           +C  R+  L  +C  +  DER
Sbjct: 241 NCPKRMKRLMAECLKKKRDER 261

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 37/281 (13%)
Query: 168 IQRATNEFDECNL-----LGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFN 217
           +     E D  N+     +G G FG V  G L        +VAIK   +   E+    F 
Sbjct: 6   VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL 65
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E  ++    H N+I++    +      +V E M NGSL+ +L  H+    +++ + ++ 
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 125
Query: 278 DVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK- 335
            +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  ++   T+ 
Sbjct: 126 GIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               I + +PE I     ++  DV+SYGI+L E  S        GE       NQ +   
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA 233
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + E          +     MDC   +  L LDC  +  + R
Sbjct: 234 VDE---------GYRLPPPMDCPAALYQLMLDCWQKDRNNR 265

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 36/268 (13%)
Query: 179 NLLGIGSFGSVYKGTLS-DGTN---VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIK 233
            ++G G FG V  G L   G     VAIK       E+    F SE  ++    H N+I 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +    +      ++ EFM NGSL+ +L  ++    +++ + ++  +   ++YL    A  
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----ADM 154
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG-----YMAPEGI 348
             +H DL   NIL++ N+V  VSDFG+S+ L   DD+   T T A  G     + APE I
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE 404
                ++  DV+SYGI++ E  S        GE       NQ +          N + ++
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMS-------YGERPYWDMTNQDV---------INAIEQD 256
Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDER 432
           +     MDC   +  L LDC  +  + R
Sbjct: 257 YRLPPPMDCPSALHQLMLDCWQKDRNHR 284

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 44/295 (14%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNL-------QLERTFVSFNSECEV 222
           A NE +    +G G FG V+KG L  D + VAIK   L       ++   F  F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           + N+ H N++K+     N     +V+EF+P G L   L    + +    +L +M+D+ L 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 283 LEYLHYGHALAPIIHCDLKPSNIL---LDEN--MVAHVSDFGISKLLGEGDDSLIQTKTM 337
           +EY+   +   PI+H DL+  NI    LDEN  + A V+DFG+S+        L     +
Sbjct: 135 IEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-----L 187
Query: 338 ATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               +MAPE I       + K D YS+ ++L    + + P ++               + 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---------------YS 232
Query: 392 LAEVVDSNLVRREH-SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
             ++   N++R E    +   DC  R+ N+   C    P +R H +    +L ++
Sbjct: 233 YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 121 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 176
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 177 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 125 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 126 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 181
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 182 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 122 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 129 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 184
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 185 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 128 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 183
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 184 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 16/224 (7%)
Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNS 218
           RR S  D +    +      +G GSFG+VYKG      +VA+K+ N+     +   +F +
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           E  VLR  RH N++ +  G S     A+V ++    SL   L+      ++++ ++I   
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               ++YLH       IIH DLK +NI L E++   + DFG++ +      S    +   
Sbjct: 141 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 196
Query: 339 TIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDL 375
           +I +MAPE I        S + DVY++GI+L E  + + P +++
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 127 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 182
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 183 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 164 SYLDIQRATNEFDE-----C----NLLGIGSFGSVYKGTLS-DGTN---VAIKIFNLQL- 209
           +Y D  +A +EF +     C     ++G G FG V  G L   G     VAIK   +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E+    F  E  ++    H N+I +    +      +V E+M NGSL+ +L  ++    +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 270 LERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
           ++ + ++  +   ++YL   G+     +H DL   NIL++ N+V  VSDFG+S++L +  
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 178
Query: 329 DSLIQTK-TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
           ++   T+     I + APE I     ++  DV+SYGI++ E  S        GE      
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS-------YGERPYWEM 231
Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            NQ +   + E          +   + MDC   +  L LDC  +  + R
Sbjct: 232 TNQDVIKAVEE---------GYRLPSPMDCPAALYQLMLDCWQKERNSR 271

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L +H   +D ++ L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 125 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 16/224 (7%)
Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNS 218
           RR S  D +    +      +G GSFG+VYKG      +VA+K+ N+     +   +F +
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 80
Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           E  VLR  RH N++ +  G S     A+V ++    SL   L+      ++++ ++I   
Sbjct: 81  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               ++YLH       IIH DLK +NI L E++   + DFG++ +      S    +   
Sbjct: 140 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 195
Query: 339 TIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDL 375
           +I +MAPE I        S + DVY++GI+L E  + + P +++
Sbjct: 196 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 122/261 (46%), Gaps = 28/261 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 88
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L++     ++ + ++I       ++YLH       IIH 
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHR 144
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E+    + DFG++        S    +   +I +MAPE I        S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM 411
           + DVY++GI+L E  + + P +++               ++ E+V    +  + S   + 
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRD-----------QIIEMVGRGSLSPDLS-KVRS 252
Query: 412 DCLLRIMNLALDCCMESPDER 432
           +C  R+  L  +C  +  DER
Sbjct: 253 NCPKRMKRLMAECLKKKRDER 273

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH DL   NIL++      + DFG++K+L +  +   ++   
Sbjct: 153 QICKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 208
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 131/295 (44%), Gaps = 44/295 (14%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNL-------QLERTFVSFNSECEV 222
           A NE +    +G G FG V+KG L  D + VAIK   L       ++   F  F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           + N+ H N++K+     N     +V+EF+P G L   L    + +    +L +M+D+ L 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 283 LEYLHYGHALAPIIHCDLKPSNIL---LDEN--MVAHVSDFGISKLLGEGDDSLIQTKTM 337
           +EY+   +   PI+H DL+  NI    LDEN  + A V+DFG S+        L     +
Sbjct: 135 IEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-----L 187
Query: 338 ATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               +MAPE I       + K D YS+ ++L    + + P ++               + 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---------------YS 232
Query: 392 LAEVVDSNLVRREH-SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
             ++   N++R E    +   DC  R+ N+   C    P +R H +    +L ++
Sbjct: 233 YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 122/261 (46%), Gaps = 28/261 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 88
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L++     ++ + ++I       ++YLH       IIH 
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHR 144
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E+    + DFG++        S    +   +I +MAPE I        S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM 411
           + DVY++GI+L E  + + P +++               ++ E+V    +  + S   + 
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRD-----------QIIEMVGRGSLSPDLS-KVRS 252
Query: 412 DCLLRIMNLALDCCMESPDER 432
           +C  R+  L  +C  +  DER
Sbjct: 253 NCPKRMKRLMAECLKKKRDER 273

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L+      ++++ ++I       ++YLH       IIH 
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 128
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E++   + DFG++ +      S    +   +I +MAPE I        S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 352 KCDVYSYGILLLETFSRKKPTNDL 375
           + DVY++GI+L E  + + P +++
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 74
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L+      ++++ ++I       ++YLH       IIH 
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 130
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E++   + DFG++ +      S    +   +I +MAPE I        S 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 352 KCDVYSYGILLLETFSRKKPTNDL 375
           + DVY++GI+L E  + + P +++
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L+      ++++ ++I       ++YLH       IIH 
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 133
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E++   + DFG++ +      S    +   +I +MAPE I        S 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 352 KCDVYSYGILLLETFSRKKPTNDL 375
           + DVY++GI+L E  + + P +++
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L+      ++++ ++I       ++YLH       IIH 
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 133
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E++   + DFG++ +      S    +   +I +MAPE I        S 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 352 KCDVYSYGILLLETFSRKKPTNDL 375
           + DVY++GI+L E  + + P +++
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 174 EFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVL 223
           +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E E+L
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 224 RNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           ++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATI 340
            +EYL         IH DL   NIL++      + DFG++K+L +  +   ++    + I
Sbjct: 124 GMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 179
Query: 341 GYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + APE +  +K     DV+S+G++L E F+
Sbjct: 180 FWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L+      ++++ ++I       ++YLH       IIH 
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 128
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E++   + DFG++ +      S    +   +I +MAPE I        S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 352 KCDVYSYGILLLETFSRKKPTNDL 375
           + DVY++GI+L E  + + P +++
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 174 EFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVL 223
           +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E E+L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 224 RNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           ++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATI 340
            +EYL         IH DL   NIL++      + DFG++K+L +  +   ++    + I
Sbjct: 126 GMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
Query: 341 GYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + APE +  +K     DV+S+G++L E F+
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 16/224 (7%)
Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNS 218
           RR S  D +    +      +G GSFG+VYKG      +VA+K+ N+     +   +F +
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 73
Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           E  VLR  RH N++ +  G S     A+V ++    SL   L+      ++++ ++I   
Sbjct: 74  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               ++YLH       IIH DLK +NI L E++   + DFG++        S    +   
Sbjct: 133 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 188
Query: 339 TIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDL 375
           +I +MAPE I        S + DVY++GI+L E  + + P +++
Sbjct: 189 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 16/224 (7%)
Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNS 218
           RR S  D +    +      +G GSFG+VYKG      +VA+K+ N+     +   +F +
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           E  VLR  RH N++ +  G S     A+V ++    SL   L+      ++++ ++I   
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               ++YLH       IIH DLK +NI L E++   + DFG++        S    +   
Sbjct: 141 TAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 196
Query: 339 TIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDL 375
           +I +MAPE I        S + DVY++GI+L E  + + P +++
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 174 EFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVL 223
           +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E E+L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 224 RNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           ++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATI 340
            +EYL         IH DL   NIL++      + DFG++K+L +  +   ++    + I
Sbjct: 126 GMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 341 GYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + APE +  +K     DV+S+G++L E F+
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 174 EFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVL 223
           +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E E+L
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 224 RNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           ++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATI 340
            +EYL         IH DL   NIL++      + DFG++K+L +  +   ++    + I
Sbjct: 144 GMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 341 GYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + APE +  +K     DV+S+G++L E F+
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 174 EFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVL 223
           +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E E+L
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 224 RNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           ++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATI 340
            +EYL         IH DL   NIL++      + DFG++K+L +  +   ++    + I
Sbjct: 144 GMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 341 GYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + APE +  +K     DV+S+G++L E F+
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 44/295 (14%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNL-------QLERTFVSFNSECEV 222
           A NE +    +G G FG V+KG L  D + VAIK   L       ++   F  F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           + N+ H N++K+     N     +V+EF+P G L   L    + +    +L +M+D+ L 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 283 LEYLHYGHALAPIIHCDLKPSNIL---LDEN--MVAHVSDFGISKLLGEGDDSLIQTKTM 337
           +EY+   +   PI+H DL+  NI    LDEN  + A V+DF +S+        L     +
Sbjct: 135 IEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-----L 187
Query: 338 ATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
               +MAPE I       + K D YS+ ++L    + + P ++               + 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---------------YS 232
Query: 392 LAEVVDSNLVRREH-SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
             ++   N++R E    +   DC  R+ N+   C    P +R H +    +L ++
Sbjct: 233 YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 170 RATNEFDECNL-----LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSE 219
           R   +F+E +L     LG G+FGSV       L D T   VA+K      E     F  E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            E+L++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            +   +EYL         IH +L   NIL++      + DFG++K+L +  +   ++   
Sbjct: 123 QICKGMEYL----GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 178
Query: 337 MATIGYMAPEGIVSTK----CDVYSYGILLLETFS 367
            + I + APE +  +K     DV+S+G++L E F+
Sbjct: 179 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N++ +  G 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           S     A+V ++    SL   L+      ++++ ++I       ++YLH       IIH 
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHR 128
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VST 351
           DLK +NI L E++   + DFG++        S    +   +I +MAPE I        S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 352 KCDVYSYGILLLETFSRKKPTNDL 375
           + DVY++GI+L E  + + P +++
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 47/282 (16%)
Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K      +     F+ E E+L N++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL------------ERLNIMIDVGLA 282
              C   D   +V E+M +G L K+L +H     ++            + L+I   +   
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           + YL   H     +H DL   N L+ EN++  + DFG+S+ +   D   +   TM  I +
Sbjct: 141 MVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 343 MAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
           M PE I+    +T+ DV+S G++L E F+  K          + W   S    +  +   
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------QPWYQLSNNEVIECITQG 246
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDER-----IHT 435
            +++R  +      C   +  L L C    P  R     IHT
Sbjct: 247 RVLQRPRT------CPQEVYELMLGCWQREPHMRKNIKGIHT 282

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 124/285 (43%), Gaps = 46/285 (16%)
Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIF----NLQLERTFVSFNSECEVLRNVRHRNLIKIL 235
           ++GIG FG VY+     G  VA+K      +  + +T  +   E ++   ++H N+I + 
Sbjct: 14  IIGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
             C       LV+EF   G L + L       DIL  +N  + +   + YLH   A+ PI
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLH-DEAIVPI 129
Query: 296 IHCDLKPSNILLDE--------NMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMA 344
           IH DLK SNIL+ +        N +  ++DFG+++          +T  M+  G   +MA
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-------EWHRTTKMSAAGAYAWMA 182
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
           PE I     S   DV+SYG+LL E  + + P   +  +++ + V     +KLA  + S  
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM---NKLALPIPST- 238
Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
                       C      L  DC    P  R   TN   +L  I
Sbjct: 239 ------------CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 119/268 (44%), Gaps = 36/268 (13%)
Query: 179 NLLGIGSFGSVYKGTLS-DGTN---VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIK 233
            ++G G FG V  G L   G     VAIK       E+    F SE  ++    H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +    +      ++ EFM NGSL+ +L  ++    +++ + ++  +   ++YL    A  
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----ADM 128
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG-----YMAPEGI 348
             +H  L   NIL++ N+V  VSDFG+S+ L   DD+   T T A  G     + APE I
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE 404
                ++  DV+SYGI++ E  S        GE       NQ +          N + ++
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS-------YGERPYWDMTNQDV---------INAIEQD 230
Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDER 432
           +     MDC   +  L LDC  +  + R
Sbjct: 231 YRLPPPMDCPSALHQLMLDCWQKDRNHR 258

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 45/278 (16%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K            F  E E+L N++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---------------ERLNIMIDV 279
              C + D   +V E+M +G L K+L +H     IL               + L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
              + YL   H     +H DL   N L+  N++  + DFG+S+ +   D   +   TM  
Sbjct: 143 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 340 IGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV 395
           I +M PE I+    +T+ DV+S+G++L E F+  K          + W   S    +  +
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK----------QPWFQLSNTEVIECI 248
Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
               ++ R         C   + ++ L C    P +R+
Sbjct: 249 TQGRVLERPRV------CPKEVYDVMLGCWQREPQQRL 280

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTF-VSFNSECEVLRNVRHRNLIKILSGC 238
           +G G+FG V+ G L +D T VA+K     L       F  E  +L+   H N+++++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           +      +V+E +  G    +L +    L +   L ++ D    +EYL         IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC----IHR 237
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCD 354
           DL   N L+ E  V  +SDFG+S+   +G  +         + + APE    G  S++ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 355 VYSYGILLLETFS 367
           V+S+GILL ETFS
Sbjct: 298 VWSFGILLWETFS 310

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                LV EFM +G L  +L +          L + +DV   + YL      A +IH DL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ASVIHRDL 129
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVY 356
              N L+ EN V  VSDFG+++ + + D     T T   + + +PE       S+K DV+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 357 SYGILLLETFSRKK 370
           S+G+L+ E FS  K
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTF-VSFNSECEVLRNVRHRNLIKILSGC 238
           +G G+FG V+ G L +D T VA+K     L       F  E  +L+   H N+++++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           +      +V+E +  G    +L +    L +   L ++ D    +EYL         IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC----IHR 237
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCD 354
           DL   N L+ E  V  +SDFG+S+   +G  +         + + APE    G  S++ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 355 VYSYGILLLETFS 367
           V+S+GILL ETFS
Sbjct: 298 VWSFGILLWETFS 310

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 121/257 (47%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ GT +  T VAIK        +  SF  E ++++ ++H  L+++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 241 LDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                +V E+M  GSL  +L       L +   +++   V   + Y+   +     IH D
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHRD 130
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+   ++  ++DFG+++L+ + + +  Q      I + APE    G  + K DV
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 189
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S+GILL E  ++       G +      N+       EV++   V R +      DC +
Sbjct: 190 WSFGILLTELVTK-------GRVPYPGMNNR-------EVLEQ--VERGYRMPCPQDCPI 233
Query: 416 RIMNLALDCCMESPDER 432
            +  L + C  + P+ER
Sbjct: 234 SLHELMIHCWKKDPEER 250

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                LV EFM +G L  +L +          L + +DV   + YL      A +IH DL
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 132
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVY 356
              N L+ EN V  VSDFG+++ + + D     T T   + + +PE       S+K DV+
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 357 SYGILLLETFSRKK 370
           S+G+L+ E FS  K
Sbjct: 192 SFGVLMWEVFSEGK 205

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                LV EFM +G L  +L +          L + +DV   + YL      A +IH DL
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 127
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVY 356
              N L+ EN V  VSDFG+++ + + D     T T   + + +PE       S+K DV+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 357 SYGILLLETFSRKK 370
           S+G+L+ E FS  K
Sbjct: 187 SFGVLMWEVFSEGK 200

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+ N+ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                ++ E+M NG L  +L    +     + L +  DV  A+EYL     L    H DL
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL----HRDL 146
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVY 356
              N L+++  V  VSDFG+S+ + + D+      +   + +  PE ++    S+K D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLD-DEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++G+L+ E +S       LG+M  + + N      +A+ +    + R H  S K      
Sbjct: 206 AFGVLMWEIYS-------LGKMPYERFTNSETAEHIAQGLR---LYRPHLASEK------ 249
Query: 417 IMNLALDCCMESPDER 432
           +  +   C  E  DER
Sbjct: 250 VYTIMYSCWHEKADER 265

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                LV EFM +G L  +L +          L + +DV   + YL      A +IH DL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 129
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVY 356
              N L+ EN V  VSDFG+++ + + D     T T   + + +PE       S+K DV+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 357 SYGILLLETFSRKK 370
           S+G+L+ E FS  K
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
            E +   ++G G+FG V K       +VAIK    + ER   +F  E   L  V H N++
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERK--AFIVELRQLSRVNHPNIV 65
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGLALEYLHYGH 290
           K+   C  L+   LV+E+   GSL   L+      +      ++  +     + YLH   
Sbjct: 66  KLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 291 ALAPIIHCDLKPSNILL-DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI- 348
             A +IH DLKP N+LL     V  + DFG +      D     T    +  +MAPE   
Sbjct: 124 PKA-LIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFE 177
Query: 349 ---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK-HWV--NQSLP---HKLAEVVDSN 399
               S KCDV+S+GI+L E  +R+KP +++G  + +  W   N + P     L + ++S 
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 237
Query: 400 LVR---REHSFSAKMDCLLRIMN 419
           + R   ++ S    M+ +++IM 
Sbjct: 238 MTRCWSKDPSQRPSMEEIVKIMT 260

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                LV EFM +G L  +L +          L + +DV   + YL      A +IH DL
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 149
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVY 356
              N L+ EN V  VSDFG+++ + + D     T T   + + +PE       S+K DV+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 357 SYGILLLETFSRKK 370
           S+G+L+ E FS  K
Sbjct: 209 SFGVLMWEVFSEGK 222

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           ++G G+FG V K       +VAIK    + ER   +F  E   L  V H N++K+   C 
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
            L+   LV+E+   GSL   L+      +      ++  +     + YLH     A +IH
Sbjct: 71  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIH 128
Query: 298 CDLKPSNILL-DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTK 352
            DLKP N+LL     V  + DFG +      D     T    +  +MAPE       S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLK 381
           CDV+S+GI+L E  +R+KP +++G  + +
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFR 212

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                LV EFM +G L  +L +          L + +DV   + YL      A +IH DL
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 130
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVY 356
              N L+ EN V  VSDFG+++ + + D     T T   + + +PE       S+K DV+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 357 SYGILLLETFSRKK 370
           S+G+L+ E FS  K
Sbjct: 190 SFGVLMWEVFSEGK 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+ N+ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                ++ E+M NG L  +L    +     + L +  DV  A+EYL         +H DL
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRDL 146
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVY 356
              N L+++  V  VSDFG+S+ + + D+      +   + +  PE ++    S+K D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++G+L+ E +S       LG+M  + + N      +A+ +    + R H  S K      
Sbjct: 206 AFGVLMWEIYS-------LGKMPYERFTNSETAEHIAQGLR---LYRPHLASEK------ 249
Query: 417 IMNLALDCCMESPDER 432
           +  +   C  E  DER
Sbjct: 250 VYTIMYSCWHEKADER 265

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+ N+ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                ++ E+M NG L  +L    +     + L +  DV  A+EYL     L    H DL
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL----HRDL 131
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVY 356
              N L+++  V  VSDFG+S+ + + D+      +   + +  PE ++    S+K D++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++G+L+ E +S       LG+M  + + N      +A+ +    + R H  S K      
Sbjct: 191 AFGVLMWEIYS-------LGKMPYERFTNSETAEHIAQGLR---LYRPHLASEK------ 234
Query: 417 IMNLALDCCMESPDER 432
           +  +   C  E  DER
Sbjct: 235 VYTIMYSCWHEKADER 250

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+ N+ H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                ++ E+M NG L  +L    +     + L +  DV  A+EYL     L    H DL
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL----HRDL 126
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVY 356
              N L+++  V  VSDFG+S+ + + D+      +   + +  PE ++    S+K D++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++G+L+ E +S       LG+M  + + N      +A+ +    + R H  S K      
Sbjct: 186 AFGVLMWEIYS-------LGKMPYERFTNSETAEHIAQGLR---LYRPHLASEK------ 229
Query: 417 IMNLALDCCMESPDER 432
           +  +   C  E  DER
Sbjct: 230 VYTIMYSCWHEKADER 245

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+ N+ H  L+++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                ++ E+M NG L  +L    +     + L +  DV  A+EYL     L    H DL
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL----HRDL 130
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVY 356
              N L+++  V  VSDFG+S+ + + D+      +   + +  PE ++    S+K D++
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++G+L+ E +S       LG+M  + + N      +A+ +    + R H  S K      
Sbjct: 190 AFGVLMWEIYS-------LGKMPYERFTNSETAEHIAQGLR---LYRPHLASEK------ 233
Query: 417 IMNLALDCCMESPDER 432
           +  +   C  E  DER
Sbjct: 234 VYTIMYSCWHEKADER 249

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 28/257 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+ N+ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                ++ E+M NG L  +L    +     + L +  DV  A+EYL     L    H DL
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL----HRDL 131
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPEGIV----STKCDV 355
              N L+++  V  VSDFG+S+ +   DD    ++ +   + +  PE ++    S+K D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +++G+L+ E +S       LG+M  + + N      +A+ +    + R H  S K     
Sbjct: 190 WAFGVLMWEIYS-------LGKMPYERFTNSETAEHIAQGLR---LYRPHLASEK----- 234
Query: 416 RIMNLALDCCMESPDER 432
            +  +   C  E  DER
Sbjct: 235 -VYTIMYSCWHEKADER 250

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 44/289 (15%)
Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K      E     F  E E+L  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------------ERLNIMIDVG 280
              C+      +V E+M +G L ++L SH     +L              + L +   V 
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             + YL   H     +H DL   N L+ + +V  + DFG+S+ +   D   +  +TM  I
Sbjct: 146 AGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
            +M PE I+    +T+ DV+S+G++L E F+  K          + W   S    +  + 
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK----------QPWYQLSNTEAIDCIT 251
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
               + R  +   ++  ++R       C    P +R    +  A+L+ +
Sbjct: 252 QGRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQAL 294

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 44/289 (15%)
Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K      E     F  E E+L  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------------ERLNIMIDVG 280
              C+      +V E+M +G L ++L SH     +L              + L +   V 
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             + YL   H     +H DL   N L+ + +V  + DFG+S+ +   D   +  +TM  I
Sbjct: 140 AGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
            +M PE I+    +T+ DV+S+G++L E F+  K          + W   S    +  + 
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK----------QPWYQLSNTEAIDCIT 245
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
               + R  +   ++  ++R       C    P +R    +  A+L+ +
Sbjct: 246 QGRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQAL 288

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VAIK+   +   +   F  E +V+ N+ H  L+++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                ++ E+M NG L  +L    +     + L +  DV  A+EYL     L    H DL
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL----HRDL 137
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVY 356
              N L+++  V  VSDFG+S+ + + D+      +   + +  PE ++    S+K D++
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++G+L+ E +S       LG+M  + + N      +A+ +    + R H  S K      
Sbjct: 197 AFGVLMWEIYS-------LGKMPYERFTNSETAEHIAQGLR---LYRPHLASEK------ 240
Query: 417 IMNLALDCCMESPDER 432
           +  +   C  E  DER
Sbjct: 241 VYTIMYSCWHEKADER 256

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 26/197 (13%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+++L     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 83
Query: 241 LDFKA---LVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGLALEYLHYGHALAP 294
           ++ K    +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL   +    
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN---- 137
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            +H DL   N+L+ E+ VA VSDFG++K     + S  Q      + + APE +     S
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 351 TKCDVYSYGILLLETFS 367
           TK DV+S+GILL E +S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 26/197 (13%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+++L     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 241 LDFKA---LVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGLALEYLHYGHALAP 294
           ++ K    +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL   +    
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN---- 122
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            +H DL   N+L+ E+ VA VSDFG++K     + S  Q      + + APE +     S
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 351 TKCDVYSYGILLLETFS 367
           TK DV+S+GILL E +S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 44/289 (15%)
Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG V+           D   VA+K      E     F  E E+L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--------------ERLNIMIDVG 280
              C+      +V E+M +G L ++L SH     +L              + L +   V 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             + YL   H     +H DL   N L+ + +V  + DFG+S+ +   D   +  +TM  I
Sbjct: 169 AGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
            +M PE I+    +T+ DV+S+G++L E F+  K          + W   S    +  + 
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK----------QPWYQLSNTEAIDCIT 274
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
               + R  +   ++  ++R       C    P +R    +  A+L+ +
Sbjct: 275 QGRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQAL 317

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 26/197 (13%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+++L     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 255
Query: 241 LDFKA---LVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGLALEYLHYGHALAP 294
           ++ K    +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL   +    
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN---- 309
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            +H DL   N+L+ E+ VA VSDFG++K     + S  Q      + + APE +     S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 351 TKCDVYSYGILLLETFS 367
           TK DV+S+GILL E +S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 77
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      +++EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 133
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 193 KSDVWAFGVLLWE 205

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 26/197 (13%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+++L     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 74
Query: 241 LDFKA---LVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGLALEYLHYGHALAP 294
           ++ K    +V E+M  GSL  +L S    +   D L  L   +DV  A+EYL   +    
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN---- 128
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            +H DL   N+L+ E+ VA VSDFG++K     + S  Q      + + APE +     S
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 351 TKCDVYSYGILLLETFS 367
           TK DV+S+GILL E +S
Sbjct: 184 TKSDVWSFGILLWEIYS 200

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G FG VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 74
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 130
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 190 KSDVWAFGVLLWE 202

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 81
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      +++EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 137
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 197 KSDVWAFGVLLWE 209

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRN--VRHRNLIKILSG 237
           L+G G +G+VYKG+L D   VA+K+F+    + F++   E  + R   + H N+ + + G
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNIYRVPLMEHDNIARFIVG 75
Query: 238 CSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY---- 288
              +         LV+E+ PNGSL K+L  H    D +    +   V   L YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 289 -GHALAPIIHCDLKPSNILLDENMVAHVSDFGIS------KLLGEGDDSLIQTKTMATIG 341
             H    I H DL   N+L+  +    +SDFG+S      +L+  G++       + TI 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 342 YMAP---EGIVS--------TKCDVYSYGILLLETFSR 368
           YMAP   EG V+         + D+Y+ G++  E F R
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 26/256 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V  G      +VA+K+   +   +   F  E + +  + H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
                +V E++ NG L  +L SH   L+  + L +  DV   + +L   H     IH DL
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE-SHQF---IHRDL 130
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVY 356
              N L+D ++   VSDFG+++ + + D  +    T   + + APE       S+K DV+
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           ++GIL+ E FS       LG+M    + N  +  K+++    + + R H  S   D + +
Sbjct: 190 AFGILMWEVFS-------LGKMPYDLYTNSEVVLKVSQ---GHRLYRPHLAS---DTIYQ 236
Query: 417 IMNLALDCCMESPDER 432
           IM     C  E P++R
Sbjct: 237 IM---YSCWHELPEKR 249

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 74
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      +++EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 130
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 190 KSDVWAFGVLLWE 202

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 81
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 137
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 197 KSDVWAFGVLLWE 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 76
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      +++EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 132
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 192 KSDVWAFGVLLWE 204

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 151
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 179 NLLGIGSFGSVYKGTL--SDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNVRHRNLI 232
            +LG G FGSV +G L   DGT++ + +  ++L    +R    F SE   +++  H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 233 KILSGCSNLDFKAL-----VLEFMPNGSLEKWL-YSH----NYFLDILERLNIMIDVGLA 282
           ++L  C  +  + +     +L FM  G L  +L YS        + +   L  M+D+ L 
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           +EYL   + L    H DL   N +L ++M   V+DFG+SK +  GD           + +
Sbjct: 160 MEYLSNRNFL----HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 343 MAPEG----IVSTKCDVYSYGILLLETFSR 368
           +A E     + ++K DV+++G+ + E  +R
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 76
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      +++EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 132
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 192 KSDVWAFGVLLWE 204

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 81
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 137
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 197 KSDVWAFGVLLWE 209

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 80
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 136
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 196 KSDVWAFGVLLWE 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 81
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 137
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 197 KSDVWAFGVLLWE 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 76
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 132
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 192 KSDVWAFGVLLWE 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 95
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      +V E+MP G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN----F 151
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN V  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 211 KSDVWAFGVLLWE 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 116/231 (50%), Gaps = 29/231 (12%)
Query: 181 LGIGSFGSVYKGTLSDGT----NVAIKIFNL---QLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G   +VY   L++ T     VAIK   +   + E T   F  E      + H+N++ 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           ++      D   LV+E++   +L +++ SH   L +   +N    +   L+ + + H + 
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQI---LDGIKHAHDMR 131
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPE---GIV 349
            I+H D+KP NIL+D N    + DFGI+K L E   SL QT   + T+ Y +PE   G  
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET--SLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 350 STKC-DVYSYGILLLETFSRKKPTNDLGE----MSLKHWVNQSLPHKLAEV 395
           + +C D+YS GI+L E    + P N  GE    +++KH +  S+P+   +V
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFN--GETAVSIAIKH-IQDSVPNVTTDV 236

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 76
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 132
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 192 KSDVWAFGVLLWE 204

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 40/263 (15%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+  T +  T VA+K     ++ +E    +F +E  V++ ++H  L+K L  
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----AFLAEANVMKTLQHDKLVK-LHA 77
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGLA-LEYLHYGHALA 293
               +   ++ EFM  GSL  +L S       L +L   +  I  G+A +E  +Y     
Sbjct: 78  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----- 132
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----V 349
             IH DL+ +NIL+  ++V  ++DFG+++++ E ++   +      I + APE I     
Sbjct: 133 --IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           + K DV+S+GILL+E  +        G +      N        EV+ +  + R +    
Sbjct: 190 TIKSDVWSFGILLMEIVT-------YGRIPYPGMSN-------PEVIRA--LERGYRMPR 233
Query: 410 KMDCLLRIMNLALDCCMESPDER 432
             +C   + N+ + C    P+ER
Sbjct: 234 PENCPEELYNIMMRCWKNRPEER 256

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 78
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 134
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 194 KSDVWAFGVLLWE 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 89
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 145
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 205 KSDVWAFGVLLWE 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 78
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 134
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 194 KSDVWAFGVLLWE 206

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 81
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 137
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 197 KSDVWAFGVLLWE 209

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 76
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 132
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 192 KSDVWAFGVLLWE 204

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 77
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 133
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 193 KSDVWAFGVLLWE 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 76
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 132
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 192 KSDVWAFGVLLWE 204

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 74
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 130
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 190 KSDVWAFGVLLWE 202

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 78
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 134
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 194 KSDVWAFGVLLWE 206

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 152
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 147
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 151
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 152
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 150
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 144
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 149
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 170
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 231 KFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   ++YL    A  
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASK 171
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 232 KFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 40/263 (15%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+  T +  T VA+K     ++ +E    +F +E  V++ ++H  L+K L  
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----AFLAEANVMKTLQHDKLVK-LHA 250
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGLA-LEYLHYGHALA 293
               +   ++ EFM  GSL  +L S       L +L   +  I  G+A +E  +Y     
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----- 305
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----V 349
             IH DL+ +NIL+  ++V  ++DFG+++++ E ++   +      I + APE I     
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           + K DV+S+GILL+E  +        G +      N        EV+ +  + R +    
Sbjct: 363 TIKSDVWSFGILLMEIVT-------YGRIPYPGMSN-------PEVIRA--LERGYRMPR 406
Query: 410 KMDCLLRIMNLALDCCMESPDER 432
             +C   + N+ + C    P+ER
Sbjct: 407 PENCPEELYNIMMRCWKNRPEER 429

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 131/316 (41%), Gaps = 63/316 (19%)
Query: 143 NRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DG--TN 199
           NR  K + +  + P++ W  I + D+            +G G+FG V K  +  DG   +
Sbjct: 4   NRKVKNNPDPTIYPVLDWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMD 51
Query: 200 VAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLIKILSGCSNLDFKALVLEFMPNGSLE 257
            AIK       +     F  E EVL  + H  N+I +L  C +  +  L +E+ P+G+L 
Sbjct: 52  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 111
Query: 258 KWLYSHNYF---------------LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP 302
            +L                     L   + L+   DV   ++YL    +    IH +L  
Sbjct: 112 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL----SQKQFIHRNLAA 167
Query: 303 SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPE----GIVSTKCDVY 356
            NIL+ EN VA ++DFG+S+    G +  ++ KTM    + +MA E     + +T  DV+
Sbjct: 168 RNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVW 222
Query: 357 SYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLR 416
           SYG+LL E  S       LG           L  KL +          +     ++C   
Sbjct: 223 SYGVLLWEIVS-------LGGTPYCGMTCAELYEKLPQ---------GYRLEKPLNCDDE 266
Query: 417 IMNLALDCCMESPDER 432
           + +L   C  E P ER
Sbjct: 267 VYDLMRQCWREKPYER 282

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   +++L    A  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASK 152
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   +++L    A  
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASK 157
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 218 KFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   +++L    A  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASK 150
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   +++L    A  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASK 152
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKI 234
           + LG+G+FG V  G     G  VA+KI N Q  R+         E + L+  RH ++IK+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               S      +V+E++  G L  ++   N  LD  E   +   +   ++Y H       
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---- 136
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----V 349
           ++H DLKP N+LLD +M A ++DFG+S ++ +G+       +  +  Y APE I      
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEVISGRLYA 193
Query: 350 STKCDVYSYGILLLETFSRKKPTND 374
             + D++S G++L        P +D
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   +++L    A  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASK 153
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   +++L    A  
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASK 211
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKI 234
           + LG+G+FG V  G     G  VA+KI N Q  R+         E + L+  RH ++IK+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               S      +V+E++  G L  ++  H   ++ +E   +   +  A++Y H       
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHR----HM 131
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----V 349
           ++H DLKP N+LLD +M A ++DFG+S ++ +G+   ++T +  +  Y APE I      
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRT-SCGSPNYAAPEVISGRLYA 188
Query: 350 STKCDVYSYGILLLETFSRKKPTND 374
             + D++S G++L        P +D
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 180 LLGIGSFGSVYKGTL--SDGTNV--AIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKI 234
           ++G G FG VY GTL  +DG  +  A+K  N   +   VS F +E  ++++  H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 235 LSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           L  C   +   LV L +M +G L  ++ +  +   + + +   + V   +++L    A  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASK 153
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N +LDE     V+DFG+++ + + +   +  KT A   + +MA E +   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 349 -VSTKCDVYSYGILLLETFSRKKP 371
             +TK DV+S+G+LL E  +R  P
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 27/267 (10%)
Query: 152 EDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNV----AIKIFN 206
           E L P  T    + L I + T E     +LG G+FG+VYKG  + +G  V    AIKI N
Sbjct: 18  EPLTPSGTAPNQAQLRILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN 76
Query: 207 LQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY 265
                +  V F  E  ++ ++ H +L+++L  C +   + LV + MP+G L ++++ H  
Sbjct: 77  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD 135
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
            +     LN  + +   + YL        ++H DL   N+L+       ++DFG+++LL 
Sbjct: 136 NIGSQLLLNWCVQIAKGMMYLEERR----LVHRDLAARNVLVKSPNHVKITDFGLARLL- 190
Query: 326 EGDDSLIQTK-TMATIGYMAPEGI----VSTKCDVYSYGILLLE--TFSRKK----PTND 374
           EGD+           I +MA E I     + + DV+SYG+ + E  TF  K     PT +
Sbjct: 191 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 250
Query: 375 LGEMSLKHWVNQSLPHKLAEVVDSNLV 401
           + ++  K    + LP      +D  +V
Sbjct: 251 IPDLLEK---GERLPQPPICTIDVYMV 274

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 322
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   ++ +  L +   +  A+EYL   +     
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 378
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH +L   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 438 KSDVWAFGVLLWE 450

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 174 EFDECN---LLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR 229
           E+DE     +LG G++G VY G  LS+   +AIK    +  R     + E  + ++++H+
Sbjct: 20  EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N+++ L   S   F  + +E +P GSL   L S    L   E+  I       LE L Y 
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYL 138
Query: 290 HALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+K  N+L++  + V  +SDFG SK L  G +   +T T  T+ YMAPE I
Sbjct: 139 HD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQYMAPEII 195
Query: 349 ------VSTKCDVYSYGILLLETFSRKKPTNDLGE 377
                      D++S G  ++E  + K P  +LGE
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVYKGTLSDGT-NVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G +G VY+G     +  VA+K      +++E     F  E  V++ ++H NL+++L 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 283
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPI 295
            C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   +     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 339
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH +L   N L+ EN +  V+DFG+S+L+  GD           I + APE +     S 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 352 KCDVYSYGILLLE 364
           K DV+++G+LL E
Sbjct: 399 KSDVWAFGVLLWE 411

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKI 234
           + LG+G+FG V  G     G  VA+KI N Q  R+         E + L+  RH ++IK+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
               S      +V+E++  G L  ++  H   ++ +E   +   +  A++Y H       
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHR----HM 131
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----V 349
           ++H DLKP N+LLD +M A ++DFG+S ++ +G+       +  +  Y APE I      
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRDSCGSPNYAAPEVISGRLYA 188
Query: 350 STKCDVYSYGILLLETFSRKKPTND 374
             + D++S G++L        P +D
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  ++ T VA+K        +  +F  E  +++ ++H  L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGLALEYLHYGHALAPIIHCD 299
            +   ++ E+M  GSL  +L S      +L +L +    +   + Y+   +     IH D
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 135
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDV 355
           L+ +N+L+ E+++  ++DFG+++++ E ++   +      I + APE I     + K DV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  K
Sbjct: 195 WSFGILLYEIVTYGK 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 174 EFDECN---LLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR 229
           E+DE     +LG G++G VY G  LS+   +AIK    +  R     + E  + ++++H+
Sbjct: 6   EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N+++ L   S   F  + +E +P GSL   L S    L   E+  I       LE L Y 
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYL 124
Query: 290 HALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+K  N+L++  + V  +SDFG SK L  G +   +T T  T+ YMAPE I
Sbjct: 125 HD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQYMAPEII 181
Query: 349 ------VSTKCDVYSYGILLLETFSRKKPTNDLGE 377
                      D++S G  ++E  + K P  +LGE
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 142
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 202 WSFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 140
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 143
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 203 WSFGILLTEIVTHGR 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  ++ T VA+K        +  +F  E  +++ ++H  L+++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGLALEYLHYGHALAPIIHCD 299
            +   ++ EFM  GSL  +L S      +L +L +    +   + Y+   +     IH D
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 134
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDV 355
           L+ +N+L+ E+++  ++DFG+++++ E ++   +      I + APE I     + K +V
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  K
Sbjct: 194 WSFGILLYEIVTYGK 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 129/312 (41%), Gaps = 63/312 (20%)
Query: 147 KKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DG--TNVAIK 203
           K + +  + P++ W  I + D+            +G G+FG V K  +  DG   + AIK
Sbjct: 11  KNNPDPTIYPVLDWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIK 58
Query: 204 IFNLQLERT-FVSFNSECEVLRNVRHR-NLIKILSGCSNLDFKALVLEFMPNGSLEKWLY 261
                  +     F  E EVL  + H  N+I +L  C +  +  L +E+ P+G+L  +L 
Sbjct: 59  RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
Query: 262 SHNYF---------------LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL 306
                               L   + L+   DV   ++YL    +    IH DL   NIL
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL----SQKQFIHRDLAARNIL 174
Query: 307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPE----GIVSTKCDVYSYGI 360
           + EN VA ++DFG+S+    G +  ++ KTM    + +MA E     + +T  DV+SYG+
Sbjct: 175 VGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229
Query: 361 LLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNL 420
           LL E  S       LG           L  KL +          +     ++C   + +L
Sbjct: 230 LLWEIVS-------LGGTPYCGMTCAELYEKLPQ---------GYRLEKPLNCDDEVYDL 273
Query: 421 ALDCCMESPDER 432
              C  E P ER
Sbjct: 274 MRQCWREKPYER 285

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 129/312 (41%), Gaps = 63/312 (20%)
Query: 147 KKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DG--TNVAIK 203
           K + +  + P++ W  I + D+            +G G+FG V K  +  DG   + AIK
Sbjct: 1   KNNPDPTIYPVLDWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIK 48
Query: 204 IFNLQLERT-FVSFNSECEVLRNVRHR-NLIKILSGCSNLDFKALVLEFMPNGSLEKWLY 261
                  +     F  E EVL  + H  N+I +L  C +  +  L +E+ P+G+L  +L 
Sbjct: 49  RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 108
Query: 262 SHNYF---------------LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL 306
                               L   + L+   DV   ++YL    +    IH DL   NIL
Sbjct: 109 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL----SQKQFIHRDLAARNIL 164
Query: 307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPE----GIVSTKCDVYSYGI 360
           + EN VA ++DFG+S+    G +  ++ KTM    + +MA E     + +T  DV+SYG+
Sbjct: 165 VGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 219
Query: 361 LLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNL 420
           LL E  S       LG           L  KL +          +     ++C   + +L
Sbjct: 220 LLWEIVS-------LGGTPYCGMTCAELYEKLPQ---------GYRLEKPLNCDDEVYDL 263
Query: 421 ALDCCMESPDER 432
              C  E P ER
Sbjct: 264 MRQCWREKPYER 275

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 136
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 196 WSFGILLTEIVTHGR 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 144
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 204 WSFGILLTEIVTHGR 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 135
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 195 WSFGILLTEIVTHGR 209

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 118/246 (47%), Gaps = 26/246 (10%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNV----AIKIFNLQL-ERTFVSFNSECEVLRNV 226
            E     +LG G+FG+VYKG  + +G  V    AIKI N     +  V F  E  ++ ++
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H +L+++L  C +   + LV + MP+G L ++++ H   +     LN  + +   + YL
Sbjct: 75  DHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAP 345
                   ++H DL   N+L+       ++DFG+++LL EGD+           I +MA 
Sbjct: 134 EERR----LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMAL 188
Query: 346 EGI----VSTKCDVYSYGILLLE--TFSRKK----PTNDLGEMSLKHWVNQSLPHKLAEV 395
           E I     + + DV+SYG+ + E  TF  K     PT ++ ++  K    + LP      
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK---GERLPQPPICT 245
Query: 396 VDSNLV 401
           +D  +V
Sbjct: 246 IDVYMV 251

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 140
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 139
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 199 WSFGILLTEIVTHGR 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 173 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 229 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 271
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 272 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 315

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 173 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 229 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 271
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 272 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 315

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 129
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 189 WSFGILLTEIVTHGR 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 142 YLNAKK----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 257
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+ KM    L I+NL  D
Sbjct: 258 V-TDLMRMCWQFNPKMRPTFLEIVNLLKD 285

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 159 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 215 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 257
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 258 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 301

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 145 YLNAKK----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+ KM    L I+NL  D
Sbjct: 261 V-TDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 181 LGIGSFGSV----YKGTLSDGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIK 233
           LG G FG V    Y  T +DGT   + +  L+ +   +    +  E ++LR + H ++IK
Sbjct: 39  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 234 ILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
               C +    +L  V+E++P GSL  +L  H+  L  L      I  G+A  YLH  H 
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMA--YLHAQH- 154
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGIVS 350
               IH DL   N+LLD + +  + DFG++K + EG +   ++    + + + APE +  
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 351 TK----CDVYSYGILLLETFS 367
            K     DV+S+G+ L E  +
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 150 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 206 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 248
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 249 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 292

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 159 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 215 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 257
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 258 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 301

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 185 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 241 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 283
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 284 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 327

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 165 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 221 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 263
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 264 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 307

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLE-----RTFVSFNSECEVLRNV 226
            E  +  +LG G FG+V+KG  + +G ++ I +    +E     ++F +       + ++
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H +++++L  C     + LV +++P GSL   +  H   L     LN  + +   + YL
Sbjct: 91  DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 149
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
              H +   +H +L   N+LL       V+DFG++ LL   D  L+ ++    I +MA E
Sbjct: 150 EE-HGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 347 GI----VSTKCDVYSYGILLLE--TFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
            I     + + DV+SYG+ + E  TF   +P   L               +LAEV D  L
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFG-AEPYAGL---------------RLAEVPD--L 247
Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTT 436
           + +    +    C + +  + + C M   DE I  T
Sbjct: 248 LEKGERLAQPQICTIDVYMVMVKCWMI--DENIRPT 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 176 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 232 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 274
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 275 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 318

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 175 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 231 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 273
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 274 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 317

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 158 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 214 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 256
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 257 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 300

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLE-----RTFVSFNSECEVLRNV 226
            E  +  +LG G FG+V+KG  + +G ++ I +    +E     ++F +       + ++
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H +++++L  C     + LV +++P GSL   +  H   L     LN  + +   + YL
Sbjct: 73  DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
              H +   +H +L   N+LL       V+DFG++ LL   D  L+ ++    I +MA E
Sbjct: 132 EE-HGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 347 GI----VSTKCDVYSYGILLLE--TFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
            I     + + DV+SYG+ + E  TF   +P   L               +LAEV D  L
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFG-AEPYAGL---------------RLAEVPD--L 229
Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTT 436
           + +    +    C + +  + + C M   DE I  T
Sbjct: 230 LEKGERLAQPQICTIDVYMVMVKCWMI--DENIRPT 263

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 129/314 (41%), Gaps = 59/314 (18%)
Query: 174 EFDECNL-----LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERT-FVSFNSECE 221
           EF   NL     LG G FG V K T       +  T VA+K+       +      SE  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWL--------------------- 260
           VL+ V H ++IK+   CS      L++E+   GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 261 --YSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF 318
             +     L + + ++    +   ++YL    A   ++H DL   NIL+ E     +SDF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 319 GISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTND 374
           G+S+ + E D  + +++    + +MA E     I +T+ DV+S+G+LL E  +       
Sbjct: 195 GLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 247
Query: 375 LGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH 434
           LG            P    E +  NL++  H      +C   +  L L C  + PD+R  
Sbjct: 248 LG--------GNPYPGIPPERL-FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 435 TTNAAAKLRKIKVQ 448
             + +  L K+ V+
Sbjct: 299 FADISKDLEKMMVK 312

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 199 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 255 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 297
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 298 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 341

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 129/314 (41%), Gaps = 59/314 (18%)
Query: 174 EFDECNL-----LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERT-FVSFNSECE 221
           EF   NL     LG G FG V K T       +  T VA+K+       +      SE  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWL--------------------- 260
           VL+ V H ++IK+   CS      L++E+   GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 261 --YSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF 318
             +     L + + ++    +   ++YL    A   ++H DL   NIL+ E     +SDF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL----AEMSLVHRDLAARNILVAEGRKMKISDF 194
Query: 319 GISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTND 374
           G+S+ + E D  + +++    + +MA E     I +T+ DV+S+G+LL E  +       
Sbjct: 195 GLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 247
Query: 375 LGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH 434
           LG            P    E +  NL++  H      +C   +  L L C  + PD+R  
Sbjct: 248 LG--------GNPYPGIPPERL-FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 435 TTNAAAKLRKIKVQ 448
             + +  L K+ V+
Sbjct: 299 FADISKDLEKMMVK 312

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + ++LE M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 159 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 215 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 257
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 258 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 301

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 129/314 (41%), Gaps = 59/314 (18%)
Query: 174 EFDECNL-----LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERT-FVSFNSECE 221
           EF   NL     LG G FG V K T       +  T VA+K+       +      SE  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWL--------------------- 260
           VL+ V H ++IK+   CS      L++E+   GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 261 --YSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF 318
             +     L + + ++    +   ++YL    A   ++H DL   NIL+ E     +SDF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 319 GISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTND 374
           G+S+ + E D  + +++    + +MA E     I +T+ DV+S+G+LL E  +       
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 247
Query: 375 LGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH 434
           LG            P    E +  NL++  H      +C   +  L L C  + PD+R  
Sbjct: 248 LG--------GNPYPGIPPERL-FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 435 TTNAAAKLRKIKVQ 448
             + +  L K+ V+
Sbjct: 299 FADISKDLEKMMVK 312

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 181 LGIGSFGSVYKGTL---SDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKILS 236
           LG G+FGSV +G         +VAIK+     E+        E +++  + +  +++++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            C   +   LV+E    G L K+L      + +     ++  V + ++YL   +     +
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FV 132
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI----VS 350
           H DL   N+LL     A +SDFG+SK LG  DDS    ++     + + APE I     S
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 351 TKCDVYSYGILLLETFSR-KKPTNDL 375
           ++ DV+SYG+ + E  S  +KP   +
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + +++E M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 158 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 214 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 256
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 257 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 300

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 181 LGIGSFGSVYKGTLSDGTN------VAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G+FG VY+G +S   N      VA+K    +  E+  + F  E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLH 287
            +        + +++E M  G L+ +L       S    L +L+ L++  D+    +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 288 YGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK------LLGEGDDSLIQTKTMA 338
             H     IH D+   N LL       VA + DFG+++         +G  +++  K M 
Sbjct: 173 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 339 TIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
              +M  EGI ++K D +S+G+LL E FS       LG M      NQ       EV++ 
Sbjct: 229 PEAFM--EGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-------EVLE- 271
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             V          +C   +  +   C    P++R    N A  L +I+
Sbjct: 272 -FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR---PNFAIILERIE 315

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 181 LGIGSFGSV----YKGTLSDGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIK 233
           LG G FG V    Y  T +DGT   + +  L+ +   +    +  E ++LR + H ++IK
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 234 ILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
               C +   K+L  V+E++P GSL  +L  H+  L  L      I  G+A  YLH  H 
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMA--YLHAQH- 137
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGIVS 350
               IH +L   N+LLD + +  + DFG++K + EG +   ++    + + + APE +  
Sbjct: 138 ---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 351 TK----CDVYSYGILLLETFS 367
            K     DV+S+G+ L E  +
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 50/263 (19%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G FG V+  T +  T VA+K     ++ +E    +F +E  V++ ++H  L+K L  
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----AFLAEANVMKTLQHDKLVK-LHA 244
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGLA-LEYLHYGHALA 293
               +   ++ EFM  GSL  +L S       L +L   +  I  G+A +E  +Y     
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----- 299
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----V 349
             IH DL+ +NIL+  ++V  ++DFG++++  +             I + APE I     
Sbjct: 300 --IHRDLRAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSF 346
Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           + K DV+S+GILL+E  +        G +      N        EV+ +  + R +    
Sbjct: 347 TIKSDVWSFGILLMEIVT-------YGRIPYPGMSN-------PEVIRA--LERGYRMPR 390
Query: 410 KMDCLLRIMNLALDCCMESPDER 432
             +C   + N+ + C    P+ER
Sbjct: 391 PENCPEELYNIMMRCWKNRPEER 413

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLRNVRH 228
           ++FD    LG G FG+VY         + A+K+ F  QLE+  V      E E+  ++RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++ +   +     L+LEF P G L K L  H  F D       M ++  AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHE 132
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 +IH D+KP N+L+       ++DFG S        SL +     T+ Y+ PE I
Sbjct: 133 ----RKVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMI 184
Query: 349 VST----KCDVYSYGILLLE 364
                  K D++  G+L  E
Sbjct: 185 EGKTHDEKVDLWCAGVLCYE 204

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 181 LGIGSFGSV----YKGTLSDGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIK 233
           LG G FG V    Y  T +DGT   + +  L+ +   +    +  E ++LR + H ++IK
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 234 ILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
               C +   K+L  V+E++P GSL  +L  H+  L  L      I  G+A  YLH  H 
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMA--YLHSQH- 137
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGIVS 350
               IH +L   N+LLD + +  + DFG++K + EG +   ++    + + + APE +  
Sbjct: 138 ---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 351 TK----CDVYSYGILLLETFS 367
            K     DV+S+G+ L E  +
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLRNVRH 228
           ++FD    LG G FG+VY         + A+K+ F  QLE+  V      E E+  ++RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++ +   +     L+LEF P G L K L  H  F D       M ++  AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHE 133
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 +IH D+KP N+L+       ++DFG S        SL +     T+ Y+ PE I
Sbjct: 134 ----RKVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMI 185
Query: 349 VST----KCDVYSYGILLLE 364
                  K D++  G+L  E
Sbjct: 186 EGKTHDEKVDLWCAGVLCYE 205

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 145 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+ KM    L I+NL  D
Sbjct: 261 V-TDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 144 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 259
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+ KM    L I+NL  D
Sbjct: 260 V-TDLMRMCWQFNPKMRPTFLEIVNLLKD 287

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 116/262 (44%), Gaps = 31/262 (11%)
Query: 181 LGIGSFGSV----YKGTLSDGTN--VAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIK 233
           LG G FG V    Y  T +DGT   VA+K           S +  E E+LR + H +++K
Sbjct: 17  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 234 ILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
               C +   K+  LV+E++P GSL  +L  H   L  L      I  G+A  YLH  H 
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMA--YLHAQH- 132
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGIVS 350
               IH  L   N+LLD + +  + DFG++K + EG +   ++    + + + APE +  
Sbjct: 133 ---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 351 TK----CDVYSYGILLLETF----SRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR 402
            K     DV+S+G+ L E      S + P     E+ + H   Q    +L E     L+ 
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTEL-IGHTQGQMTVLRLTE-----LLE 243
Query: 403 REHSFSAKMDCLLRIMNLALDC 424
           R         C   I +L  +C
Sbjct: 244 RGERLPRPDRCPCEIYHLMKNC 265

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +  ++L E T    N E      V+ +V
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 168 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMTFGSK 252

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 116/262 (44%), Gaps = 31/262 (11%)
Query: 181 LGIGSFGSV----YKGTLSDGTN--VAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIK 233
           LG G FG V    Y  T +DGT   VA+K           S +  E E+LR + H +++K
Sbjct: 16  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 234 ILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
               C +   K+  LV+E++P GSL  +L  H   L  L      I  G+A  YLH  H 
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMA--YLHAQH- 131
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKTMATIGYMAPEGIVS 350
               IH  L   N+LLD + +  + DFG++K + EG +   ++    + + + APE +  
Sbjct: 132 ---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 351 TK----CDVYSYGILLLETF----SRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR 402
            K     DV+S+G+ L E      S + P     E+ + H   Q    +L E     L+ 
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTEL-IGHTQGQMTVLRLTE-----LLE 242
Query: 403 REHSFSAKMDCLLRIMNLALDC 424
           R         C   I +L  +C
Sbjct: 243 RGERLPRPDRCPCEIYHLMKNC 264

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH +
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRN 130
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G  + K DV
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 190 WSFGILLTEIVTHGR 204

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 145 YLNAKK----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+  M    L I+NL  D
Sbjct: 261 V-TDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 181 LGIGSFGSVYKGTL---SDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKILS 236
           LG G+FGSV +G         +VAIK+     E+        E +++  + +  +++++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            C   +   LV+E    G L K+L      + +     ++  V + ++YL   +     +
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FV 458
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI----VS 350
           H +L   N+LL     A +SDFG+SK LG  DDS    ++     + + APE I     S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 351 TKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQS 387
           ++ DV+SYG+ + E  S  +KP   +    +  ++ Q 
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 135 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSK 219

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 138 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSK 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 134 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 135 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSK 219

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 136 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 137 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSK 221

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 145 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G  G V+ G  +  T VA+K    Q   +  +F +E  +++ ++H+ L+++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
                ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH D
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDV 355
           L+ +NIL+ + +   ++DFG+++L+ + + +  +      I + APE    G  + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP-IKWTAPEAINYGTFTIKSDV 193
Query: 356 YSYGILLLETFSRKK 370
           +S+GILL E  +  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQ--------LERTFVS 215
           LD++     +++ + LG G F +VYK      TN  VAIK   L         + RT + 
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKAR-DKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 216 FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
              E ++L+ + H N+I +L    +    +LV +FM    LE  +  ++  L        
Sbjct: 62  ---EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAY 117
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
           M+     LEYLH       I+H DLKP+N+LLDEN V  ++DFG++K  G  + +     
Sbjct: 118 MLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH-- 171
Query: 336 TMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSR 368
            + T  Y APE +   +      D+++ G +L E   R
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 148 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 149 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G+FGSV       L D T   + +  LQ         F  E ++L+ + H + I   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 73
Query: 236 SGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            G S    +    LV+E++P+G L  +L  H   LD    L     +   +EYL      
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC- 132
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEG---- 347
              +H DL   NIL++      ++DFG++KLL  + D  +++    + I + APE     
Sbjct: 133 ---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 348 IVSTKCDVYSYGILLLETFS 367
           I S + DV+S+G++L E F+
Sbjct: 190 IFSRQSDVWSFGVVLYELFT 209

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 24/248 (9%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 144 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 347 GIV----STKCDVYSYGILLLE--TFSRKK----PTNDLGEMSLKHWVNQSLPHKLAEVV 396
            I+    + + DV+SYG+ + E  TF  K     P +++  +  K    + LP      +
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTI 256
Query: 397 DSNLVRRE 404
           D  ++ R+
Sbjct: 257 DVYMIMRK 264

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 187 GSVYKGTLSDGTNVAIKIFNLQLERTFVS--FNSECEVLRNVRHRNLIKILSGCSN--LD 242
           G ++KG    G ++ +K+  ++   T  S  FN EC  LR   H N++ +L  C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 243 FKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLK 301
              L+  +MP GSL   L+   N+ +D  + +   +D+   + +LH    L P     L 
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP--RHALN 140
Query: 302 PSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTK-------CD 354
             ++++DE+M A +S       + +   S      M    ++APE +            D
Sbjct: 141 SRSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 355 VYSYGILLLETFSRKKPTNDLGEMSL 380
           ++S+ +LL E  +R+ P  DL  M +
Sbjct: 194 MWSFAVLLWELVTREVPFADLSNMEI 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 24/248 (9%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 137 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 347 GIV----STKCDVYSYGILLLE--TFSRKK----PTNDLGEMSLKHWVNQSLPHKLAEVV 396
            I+    + + DV+SYG+ + E  TF  K     P +++  +  K    + LP      +
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTI 249
Query: 397 DSNLVRRE 404
           D  ++ R+
Sbjct: 250 DVYMIMRK 257

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 24/248 (9%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 134 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 347 GIV----STKCDVYSYGILLLE--TFSRKK----PTNDLGEMSLKHWVNQSLPHKLAEVV 396
            I+    + + DV+SYG+ + E  TF  K     P +++  +  K    + LP      +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTI 246
Query: 397 DSNLVRRE 404
           D  ++ R+
Sbjct: 247 DVYMIMRK 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G + K L   + F D       + ++  AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALS 127
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 128 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 179
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 127/287 (44%), Gaps = 39/287 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVR 227
           ++ ++   +LG G    V+    L D  +VA+K+    L R    ++ F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 228 HRNLIKIL-SGCSNLDFKAL---VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  ++ +  +G +      L   V+E++   +L   +++    +     + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            + H       IIH D+KP+NI++       V DFGI++ + +  +S+ QT   + T  Y
Sbjct: 130 NFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSRKKP-TNDLGE-MSLKHWVNQSLPHKLAEVV 396
           ++PE      V  + DVYS G +L E  + + P T D  + ++ +H     +P       
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSA---- 241
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                 R    SA +D ++      L    ++P+ R  T   AA++R
Sbjct: 242 ------RHEGLSADLDAVV------LKALAKNPENRYQT---AAEMR 273

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNL-------QLERTFVSFNSECEVLR 224
            +F     LG GSFG V+   +  +G   A+K+          Q+E T    N E  +L 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT----NDERLMLS 61
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            V H  +I++     +     ++++++  G L   L     F + + +     +V LALE
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALE 120
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YLH       II+ DLKP NILLD+N    ++DFG +K + +     +      T  Y+A
Sbjct: 121 YLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIA 171
Query: 345 PEGIVSTK-----CDVYSYGILLLETFSRKKPTNDLGEM 378
           PE +VSTK      D +S+GIL+ E  +   P  D   M
Sbjct: 172 PE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 134 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 24/248 (9%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG +KLLG  +           I +MA E
Sbjct: 136 EDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 347 GIV----STKCDVYSYGILLLE--TFSRKK----PTNDLGEMSLKHWVNQSLPHKLAEVV 396
            I+    + + DV+SYG+ + E  TF  K     P +++  +  K    + LP      +
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTI 248
Query: 397 DSNLVRRE 404
           D  ++ R+
Sbjct: 249 DVYMIMRK 256

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 137 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSK 221

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 125/287 (43%), Gaps = 39/287 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVR 227
           ++ ++   +LG G    V+    L D  +VA+K+    L R    ++ F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 228 HRNLIKIL-SGCSNLDFKAL---VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  ++ +  +G +      L   V+E++   +L   +++    +     + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            + H       IIH D+KP+NIL+       V DFGI++ + +  +S+ QT   + T  Y
Sbjct: 130 NFSHQNG----IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL--KHWVNQSLPHKLAEVV 396
           ++PE      V  + DVYS G +L E  + + P      +S+  +H     +P       
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                 R    SA +D ++      L    ++P+ R  T   AA++R
Sbjct: 242 ------RHEGLSADLDAVV------LKALAKNPENRYQT---AAEMR 273

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 136 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         YS+N   +  E+L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 197 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 141 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 140 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMTFGSK 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 137 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSK 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 134 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 125/287 (43%), Gaps = 39/287 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVR 227
           ++ ++   +LG G    V+    L D  +VA+K+    L R    ++ F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 228 HRNLIKIL-SGCSNLDFKAL---VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  ++ +  +G +      L   V+E++   +L   +++    +     + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            + H       IIH D+KP+NI++       V DFGI++ + +  +S+ QT   + T  Y
Sbjct: 130 NFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL--KHWVNQSLPHKLAEVV 396
           ++PE      V  + DVYS G +L E  + + P      +S+  +H     +P       
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                 R    SA +D ++      L    ++P+ R  T   AA++R
Sbjct: 242 ------RHEGLSADLDAVV------LKALAKNPENRYQT---AAEMR 273

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 138 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWE 217

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG +KLLG  +           I +MA E
Sbjct: 136 EDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG +KLLG  +           I +MA E
Sbjct: 138 EDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSK 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 159 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELMTFGSK 243

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 128 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK 212

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 147 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWE 226

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLY-------------SHN--YFLDILERLNI 275
           +I +L  C+      +++E+   G+L ++L              SHN    L   + ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 131 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELMTFGSK 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         Y +N   +  E+L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 141 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G+FGSV       L D T   + +  LQ         F  E ++L+ + H + I   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 76
Query: 236 SGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            G S    +    LV+E++P+G L  +L  H   LD    L     +   +EYL      
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GS 132
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEG---- 347
              +H DL   NIL++      ++DFG++KLL  + D  +++    + I + APE     
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 348 IVSTKCDVYSYGILLLETFS 367
           I S + DV+S+G++L E F+
Sbjct: 193 IFSRQSDVWSFGVVLYELFT 212

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLI---KIL 235
           LG G FG V +    D G  VAIK    +L  +    +  E ++++ + H N++   ++ 
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 236 SGCSNL---DFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGH 290
            G   L   D   L +E+   G L K+L        + E     ++ D+  AL YLH   
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 142
Query: 291 ALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
               IIH DLKP NI+L    + ++  + D G +K L +G+   + T+ + T+ Y+APE 
Sbjct: 143 ----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 195
Query: 348 IVSTK----CDVYSYGILLLETFSRKKP 371
           +   K     D +S+G L  E  +  +P
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLI---KIL 235
           LG G FG V +    D G  VAIK    +L  +    +  E ++++ + H N++   ++ 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 236 SGCSNL---DFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGH 290
            G   L   D   L +E+   G L K+L        + E     ++ D+  AL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 291 ALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
               IIH DLKP NI+L    + ++  + D G +K L +G+   + T+ + T+ Y+APE 
Sbjct: 142 ----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 194
Query: 348 IVSTK----CDVYSYGILLLETFSRKKP 371
           +   K     D +S+G L  E  +  +P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T+   T+ Y+ 
Sbjct: 123 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 148
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 149 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 200
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 113/248 (45%), Gaps = 24/248 (9%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG +KLLG  +           I +MA E
Sbjct: 136 EDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 347 GIV----STKCDVYSYGILLLE--TFSRKK----PTNDLGEMSLKHWVNQSLPHKLAEVV 396
            I+    + + DV+SYG+ + E  TF  K     P +++  +  K    + LP      +
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTI 248
Query: 397 DSNLVRRE 404
           D  ++ R+
Sbjct: 249 DVYMIMRK 256

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 181 LGIGSFGSV---YKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G+FGSV       L D T   VA+K            F  E ++L+ + H + I   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 77
Query: 236 SGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            G S    +    LV+E++P+G L  +L  H   LD    L     +   +EYL      
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GS 133
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEG---- 347
              +H DL   NIL++      ++DFG++KLL  + D  +++    + I + APE     
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 348 IVSTKCDVYSYGILLLETFS 367
           I S + DV+S+G++L E F+
Sbjct: 194 IFSRQSDVWSFGVVLYELFT 213

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++  +    + DFG+++ + E        K +  + +MA
Sbjct: 145 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+ KM    L I+NL  D
Sbjct: 261 V-TDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G+FGSV       L D T   + +  LQ         F  E ++L+ + H + I   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 89
Query: 236 SGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            G S    +    LV+E++P+G L  +L  H   LD    L     +   +EYL      
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GS 145
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEG---- 347
              +H DL   NIL++      ++DFG++KLL  + D  +++    + I + APE     
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 348 IVSTKCDVYSYGILLLETFS 367
           I S + DV+S+G++L E F+
Sbjct: 206 IFSRQSDVWSFGVVLYELFT 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEV--LRNVRHRNLIKI 234
           LG GSFG V   Y  T   G  VA+KI N + L ++ +    E E+  LR +RH ++IK+
Sbjct: 22  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                + D   +V+E+  N  L  ++   +   +  E       +  A+EY H       
Sbjct: 80  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHR----HK 133
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----V 349
           I+H DLKP N+LLDE++   ++DFG+S ++ +G+   ++T +  +  Y APE I      
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKT-SCGSPNYAAPEVISGKLYA 190
Query: 350 STKCDVYSYGILLLETFSRKKPTND 374
             + DV+S G++L     R+ P +D
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q    +FD    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALS 126
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL  N    ++DFG S        S  +T    T+ Y+ 
Sbjct: 127 YCHSKR----VIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 178
Query: 345 PEGIVS----TKCDVYSYGILLLE 364
           PE I       K D++S G+L  E
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYE 202

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 128 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 179
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEV--LRNVRHRNLIKI 234
           LG GSFG V   Y  T   G  VA+KI N + L ++ +    E E+  LR +RH ++IK+
Sbjct: 12  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                + D   +V+E+  N  L  ++   +   +  E       +  A+EY H       
Sbjct: 70  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHR----HK 123
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----V 349
           I+H DLKP N+LLDE++   ++DFG+S ++ +G+   ++T +  +  Y APE I      
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKT-SCGSPNYAAPEVISGKLYA 180
Query: 350 STKCDVYSYGILLLETFSRKKPTND 374
             + DV+S G++L     R+ P +D
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G + K L   + F D       + ++  AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALS 127
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 128 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLXGTLDYLP 179
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVRHRNLIKI 234
           LG G FG V         D T   + + +L+ E           E E+LRN+ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 235 LSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
              C+        L++EF+P+GSL+++L  +   +++ ++L   + +   ++YL      
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL----GS 144
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLL-GEGDDSLIQTKTMATIGYMAPEGIVST 351
              +H DL   N+L++      + DFG++K +  + +   ++    + + + APE ++ +
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 352 K----CDVYSYGILLLETFS 367
           K     DV+S+G+ L E  +
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 19/228 (8%)
Query: 161 RRISYLDIQRATNE----FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVS 215
           R++  LD    T +    FD    LG GS+GSVYK    + G  VAIK   + +E     
Sbjct: 13  RQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQE 70
Query: 216 FNSECEVLRNVRHRNLIKIL-SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN 274
              E  +++     +++K   S   N D   +V+E+   GS+   +   N  L   E   
Sbjct: 71  IIKEISIMQQCDSPHVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKTLTEDEIAT 129
Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT 334
           I+      LEYLH+       IH D+K  NILL+    A ++DFG++  L   D    + 
Sbjct: 130 ILQSTLKGLEYLHFMRK----IHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRN 183
Query: 335 KTMATIGYMAPEGI--VSTKC--DVYSYGILLLETFSRKKPTNDLGEM 378
             + T  +MAPE I  +   C  D++S GI  +E    K P  D+  M
Sbjct: 184 XVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM 231

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILERLN------I 275
           +I +L  C+      +++E+   G+L ++L         Y +N   +  E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ +   D     T 
Sbjct: 156 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEV--LRNVRHRNLIKI 234
           LG GSFG V   Y  T   G  VA+KI N + L ++ +    E E+  LR +RH ++IK+
Sbjct: 21  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                + D   +V+E+  N  L  ++   +   +  E       +  A+EY H       
Sbjct: 79  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHR----HK 132
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----V 349
           I+H DLKP N+LLDE++   ++DFG+S ++ +G+   ++T +  +  Y APE I      
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKT-SCGSPNYAAPEVISGKLYA 189
Query: 350 STKCDVYSYGILLLETFSRKKPTND 374
             + DV+S G++L     R+ P +D
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +L  G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+++ MP G L  ++  H   +     LN  + +   + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 141 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 126 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 177
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQ-LERTFVSFNSECEV--LRNVRHRNLIKI 234
           LG GSFG V   Y  T   G  VA+KI N + L ++ +    E E+  LR +RH ++IK+
Sbjct: 16  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                + D   +V+E+  N  L  ++   +   +  E       +  A+EY H       
Sbjct: 74  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHR----HK 127
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----V 349
           I+H DLKP N+LLDE++   ++DFG+S ++ +G+   ++T +  +  Y APE I      
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKT-SCGSPNYAAPEVISGKLYA 184
Query: 350 STKCDVYSYGILLLETFSRKKPTND 374
             + DV+S G++L     R+ P +D
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 139
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 140 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 191
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 123 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 128 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 179
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVRHRNLIKI 234
           LG G FG V         D T   + + +L+ E           E E+LRN+ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 235 LSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
              C+        L++EF+P+GSL+++L  +   +++ ++L   + +   ++YL      
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL----GS 132
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLL-GEGDDSLIQTKTMATIGYMAPEGIVST 351
              +H DL   N+L++      + DFG++K +  + +   ++    + + + APE ++ +
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 352 K----CDVYSYGILLLETFS 367
           K     DV+S+G+ L E  +
Sbjct: 193 KFYIASDVWSFGVTLHELLT 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 123 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG +KLLG  +           I +MA E
Sbjct: 141 EDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 124 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLP 175
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 123 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKI----FNLQLERTFVSFNSECEVLRNVRHRNLIKIL 235
           +LG G FG   K T  +   V +      F+ + +RTF+    E +V+R + H N++K +
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPNVLKFI 73
Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
                      + E++  G+L   + S +      +R++   D+   + YLH  +    I
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN----I 129
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLL------GEGDDSLIQT---KTMATIG---YM 343
           IH DL   N L+ EN    V+DFG+++L+       EG  SL +    K    +G   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 344 APEGI----VSTKCDVYSYGILLLETFSR 368
           APE I       K DV+S+GI+L E   R
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 121
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 122 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 173
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +LG G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG +KLLG  +           I +MA E
Sbjct: 134 EDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 123 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 128 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLP 179
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 14/193 (7%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQ--LERTFV-SFNSECEVLRNVRH 228
           + F+    +G GSFG V     +D   + A+K  N Q  +ER  V +   E ++++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             L+ +     + +   +V++ +  G L   L  + +F +   +L I  ++ +AL+YL  
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CELVMALDYLQN 133
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEG 347
                 IIH D+KP NILLDE+   H++DF I+ +L        Q  TMA T  YMAPE 
Sbjct: 134 QR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEM 185
Query: 348 IVSTKCDVYSYGI 360
             S K   YS+ +
Sbjct: 186 FSSRKGAGYSFAV 198

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 126
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 127 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 178
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 209 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 124 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSC----HAPSSRRTTLSGTLDYLP 175
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 126 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 177
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 150 TYQLARGMEYL----ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H +L   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 145 YLN----AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+  M    L I+NL  D
Sbjct: 261 V-TDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 31/269 (11%)
Query: 181 LGIGSFGSVYKGTLSD------GTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY+G   D       T VA+K  N     R  + F +E  V++     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---------ILERLNIMIDVGLALE 284
           +L   S      +V+E M +G L+ +L S     +         + E + +  ++   + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H +L   N ++  +    + DFG+++ + E D      K +  + +MA
Sbjct: 146 YLN----AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 345 PE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLG-EMSLKHWVNQSL---PHKLAEV 395
           PE    G+ +T  D++S+G++L E  S  ++P   L  E  LK  ++      P    E 
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 261
Query: 396 VDSNLVRREHSFSAKM-DCLLRIMNLALD 423
           V ++L+R    F+  M    L I+NL  D
Sbjct: 262 V-TDLMRMCWQFNPNMRPTFLEIVNLLKD 289

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHA 291
           +         K +V E  P GSL   L  H  ++ L  L R  + +  G+   YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG--YLESKR- 135
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-- 348
               IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE +  
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 349 --VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S   D + +G+ L E F+  ++P   L    + H +++             L R E 
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------GERLPRPE- 242
Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 243 ------DCPQDIYNVMVQCWAHKPEDR 263

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E       SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWL-----------YSHNYF----LDILERLNI 275
           +I +L  C+      +++E+   G+L ++L           Y  N      +   + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 152 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHA 291
           +         K +V E  P GSL   L  H  ++ L  L R  + +  G+   YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG--YLESKR- 141
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD-SLIQTKTMATIGYMAPEGI-- 348
               IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE +  
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 349 --VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S   D + +G+ L E F+  ++P   L    + H +++             L R E 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------GERLPRPE- 248
Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 249 ------DCPQDIYNVMVQCWAHKPEDR 269

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++E+   G+L ++L +       Y  DI           + ++ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 155 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 153 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWE 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHA 291
           +         K +V E  P GSL   L  H  ++ L  L R  + +  G+   YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG--YLESKR- 131
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD-SLIQTKTMATIGYMAPEGI-- 348
               IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE +  
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 349 --VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S   D + +G+ L E F+  ++P   L    + H +++             L R E 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------GERLPRPE- 238
Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 239 ------DCPQDIYNVMVQCWAHKPEDR 259

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHA 291
           +         K +V E  P GSL   L  H  ++ L  L R  + +  G+   YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG--YLESKR- 141
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-- 348
               IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE +  
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 349 --VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S   D + +G+ L E F+  ++P   L    + H +++             L R E 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------GERLPRPE- 248
Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 249 ------DCPQDIYNVMVQCWAHKPEDR 269

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 144 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 200 PESLKDGVFTTYSDVWSFGVVLWE 223

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 143 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 198
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 199 PESLKDGVFTTYSDVWSFGVVLWE 222

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 153 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWE 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 147 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWE 226

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHA 291
           +         K +V E  P GSL   L  H  ++ L  L R  + +  G+   YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG--YLESKR- 135
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-- 348
               IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE +  
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 349 --VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S   D + +G+ L E F+  ++P   L    + H +++             L R E 
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------GERLPRPE- 242
Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 243 ------DCPQDIYNVMVQCWAHKPEDR 263

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 46/289 (15%)
Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIK 233
           LG   FG VYKG L           VAIK    + E      F  E  +   ++H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI---------------LERLNIMID 278
           +L   +     +++  +  +G L ++L   +   D+                + ++++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           +   +EYL   H    ++H DL   N+L+ + +   +SD G+ + +   D   +   ++ 
Sbjct: 154 IAAGMEYLSSHH----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
            I +MAPE I+    S   D++SYG++L E FS        G      + NQ       +
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------YGLQPYCGYSNQ-------D 255
Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
           VV+  ++R         DC   +  L ++C  E P  R    +  ++LR
Sbjct: 256 VVE--MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 146 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWE 225

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHA 291
           +         K +V E  P GSL   L  H  ++ L  L R  + +  G+   YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG--YLESKR- 131
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-- 348
               IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE +  
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 349 --VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S   D + +G+ L E F+  ++P   L    + H +++             L R E 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------GERLPRPE- 238
Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 239 ------DCPQDIYNVMVQCWAHKPEDR 259

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +L  G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 134 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 47/231 (20%)
Query: 177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKI 234
           EC  +G G +G V++G L  G +VA+KIF+ + E+   S+  E E+   V  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQ---SWFRETEIYNTVLLRHDNILGF 67
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNY----FLDILER--------LNIMIDVGLA 282
           ++  S++  +        N S + WL +H +      D L+R        L + +     
Sbjct: 68  IA--SDMTSR--------NSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACG 117
Query: 283 LEYLH---YGHALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI--QTKT 336
           L +LH   +G    P I H D K  N+L+  N+   ++D G++ +  +G D L       
Sbjct: 118 LAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR 177
Query: 337 MATIGYMAPEGI---VSTKC-------DVYSYGILLLETFSRKKPTNDLGE 377
           + T  YMAPE +   + T C       D++++G++L E  +R+   N + E
Sbjct: 178 VGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWE-IARRTIVNGIVE 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 54/286 (18%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERTF-VSFNSECEVLRNVRHRNLIK 233
           +G G+FG V++            T VA+K+   +        F  E  ++    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-----------------------LDIL 270
           +L  C+      L+ E+M  G L ++L S +                         L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
           E+L I   V   + YL    +    +H DL   N L+ ENMV  ++DFG+S+ +   D  
Sbjct: 175 EQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 331 LIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ 386
                    I +M PE I     +T+ DV++YG++L E FS            L+ +   
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS----------YGLQPYYGM 280
Query: 387 SLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           +    +  V D N++      +   +C L + NL   C  + P +R
Sbjct: 281 AHEEVIYYVRDGNIL------ACPENCPLELYNLMRLCWSKLPADR 320

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHA 291
           +         K +V E  P GSL   L  H  ++ L  L R  + +  G+   YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG--YLESKR- 131
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-- 348
               IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE +  
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 349 --VSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S   D + +G+ L E F+  ++P   L    + H +++             L R E 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------GERLPRPE- 238
Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 239 ------DCPQDIYNVMVQCWAHKPEDR 259

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 140 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWE 219

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 146 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWE 225

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 46/289 (15%)
Query: 181 LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIK 233
           LG   FG VYKG L           VAIK    + E      F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI---------------LERLNIMID 278
           +L   +     +++  +  +G L ++L   +   D+                + ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           +   +EYL   H    ++H DL   N+L+ + +   +SD G+ + +   D   +   ++ 
Sbjct: 137 IAAGMEYLSSHH----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
            I +MAPE I+    S   D++SYG++L E FS        G      + NQ       +
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------YGLQPYCGYSNQ-------D 238
Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
           VV+  ++R         DC   +  L ++C  E P  R    +  ++LR
Sbjct: 239 VVE--MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSE----CEVLRNV 226
            EF +  +L  G+FG+VYKG  + +G  V I +   +L E T    N E      V+ +V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG++KLLG  +           I +MA E
Sbjct: 141 EDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 119
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +T    T+ Y+ 
Sbjct: 120 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLP 171
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 173 NEFDECNLLGIGSFGSVY---KGTLSD-GTNVAIKIF---NLQLERTFVSFNSECEVLRN 225
           + F+   +LG GSFG V+   K T  D G   A+K+     L++ R  V    E ++L +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKV-RDRVRTKMERDILAD 86
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           V H  ++K+           L+L+F+  G L   L     F +   +   + ++ L L++
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALGLDH 145
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMA 344
           LH   +L  II+ DLKP NILLDE     ++DFG+SK   E  D   +  +   T+ YMA
Sbjct: 146 LH---SLG-IIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMA 198
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +     S   D +SYG+L+ E  +   P
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N ++ E+    + DFG+++ + E D      K +  + +M+
Sbjct: 175 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 231 PESLKDGVFTTYSDVWSFGVVLWE 254

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 126 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLP 177
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVS--FNSECEVLRNV 226
           ++  +++   L+G GS+G V K    D G  VAIK F    +   V      E ++L+ +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKW-LYSHNYFLDILERLNIMIDVGLALEY 285
           RH NL+ +L  C       LV EF+ +  L+   L+ +     ++++    I  G+   +
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
            H       IIH D+KP NIL+ ++ V  + DFG ++ L    +  +    +AT  Y AP
Sbjct: 142 SH------NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193
Query: 346 EGIV-----STKCDVYSYGILLLETF 366
           E +V         DV++ G L+ E F
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL--------QLERTFVSFNSECEVL 223
            ++D  +++G G    V +    + G   A+KI  +        QLE    +   E  +L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 224 RNVR-HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           R V  H ++I ++    +  F  LV + M  G L  +L +    L   E  +IM  +  A
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEA 212
Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           + +LH  +    I+H DLKP NILLD+NM   +SDFG S  L  G+      +   T GY
Sbjct: 213 VSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGY 265
Query: 343 MAPEGI----------VSTKCDVYSYGILLLETFSRKKP 371
           +APE +             + D+++ G++L    +   P
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 42/229 (18%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           R  ++F+E  +LG G+FG V K   + D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 229 -------------RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
                        RN +K ++         + +E+  NG+L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK------------- 322
              +  AL Y+H       IIH DLKP NI +DE+    + DFG++K             
Sbjct: 122 FRQILEALSYIHS----QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 323 --LLGEGDDSLIQTKTMATIGYMAPE-----GIVSTKCDVYSYGILLLE 364
             L G  D+    T  + T  Y+A E     G  + K D+YS GI+  E
Sbjct: 178 QNLPGSSDN---LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 123 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR 227
           +R   +F E  L+G G FG V+K     DG    IK      E+       E + L  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLD 62
Query: 228 HRNLIKILSGC-SNLDFKA----------------LVLEFMPNGSLEKWLYSH-NYFLDI 269
           H N++   +GC    D+                  + +EF   G+LE+W+       LD 
Sbjct: 63  HVNIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 270 LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG-ISKLLGEGD 328
           +  L +   +   ++Y+H       +I+ DLKPSNI L +     + DFG ++ L  +G 
Sbjct: 122 VLALELFEQITKGVDYIHS----KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 329 DSLIQTKTMATIGYMAPEGIVST----KCDVYSYGILLLE 364
               + ++  T+ YM+PE I S     + D+Y+ G++L E
Sbjct: 178 ----RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++ +   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 148
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 149 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLP 200
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYM 343
           Y H       +IH D+KP N+LL       ++DFG S        D+L       T+ Y+
Sbjct: 124 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC-----GTLDYL 174
Query: 344 APEGIVS----TKCDVYSYGILLLETFSRKKP 371
            PE I       K D++S G+L  E    K P
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 124
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 125 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLP 176
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 124
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       +++FG S        S  +T    T+ Y+ 
Sbjct: 125 YCHSKR----VIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLP 176
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q    +FD    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALS 126
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYM 343
           Y H       +IH D+KP N+LL  N    ++DFG S        D+L       T+ Y+
Sbjct: 127 YCHSKR----VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC-----GTLDYL 177
Query: 344 APEGIVS----TKCDVYSYGILLLE 364
            PE I       K D++S G+L  E
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYE 202

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 123 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 126 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLP 177
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVY----KGTLSDG--TNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG VY    KG + D   T VAIK  N     R  + F +E  V++     ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYS------HNYFL---DILERLNIMIDVGLALE 284
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YL+        +H DL   N  + E+    + DFG+++ + E D      K +  + +M+
Sbjct: 140 YLNANK----FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 345 PE----GIVSTKCDVYSYGILLLE 364
           PE    G+ +T  DV+S+G++L E
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWE 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       +++FG S        S  +T    T+ Y+ 
Sbjct: 126 YCHSKR----VIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLP 177
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 173 NEFDECNLLGIGSFGSVY---KGTLSDGTNV-AIKIF---NLQLERTFVSFNSECEVLRN 225
           ++F+   +LG GSFG V+   K + SD   + A+K+     L++ R  V    E ++L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVE 82
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           V H  ++K+           L+L+F+  G L   L     F +   +   + ++ LAL++
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDH 141
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMA 344
           LH   +L  II+ DLKP NILLDE     ++DFG+SK   E  D   +  +   T+ YMA
Sbjct: 142 LH---SLG-IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMA 194
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +     +   D +S+G+L+ E  +   P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 121/256 (47%), Gaps = 41/256 (16%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGT--NVAIKIFNLQLERTF-----------VSFNSE 219
           +E+     LG G+ G V K      T   VAIKI +   +R F           ++  +E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 65
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
            E+L+ + H  +IKI +     D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 123
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            LA++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   SL++T  
Sbjct: 124 LLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-L 176
Query: 337 MATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQS- 387
             T  Y+APE +VS          D +S G++L    S   P ++   ++SLK  +    
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 388 ---LPHKLAEVVDSNL 400
              +P   AEV +  L
Sbjct: 237 YNFIPEVWAEVSEKAL 252

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY     +   + A+K+ F  QLE+  V      E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 123 YCHS----KKVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLP 174
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 173 NEFDECNLLGIGSFGSVY---KGTLSDGTNV-AIKIF---NLQLERTFVSFNSECEVLRN 225
           ++F+   +LG GSFG V+   K + SD   + A+K+     L++ R  V    E ++L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVE 83
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           V H  ++K+           L+L+F+  G L   L     F +   +   + ++ LAL++
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDH 142
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMA 344
           LH   +L  II+ DLKP NILLDE     ++DFG+SK   E  D   +  +   T+ YMA
Sbjct: 143 LH---SLG-IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMA 195
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +     +   D +S+G+L+ E  +   P
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 121/256 (47%), Gaps = 41/256 (16%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGT--NVAIKIFNLQLERTF-----------VSFNSE 219
           +E+     LG G+ G V K      T   VAIKI +   +R F           ++  +E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 65
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
            E+L+ + H  +IKI +     D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 123
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            LA++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   SL++T  
Sbjct: 124 LLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-L 176
Query: 337 MATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQS- 387
             T  Y+APE +VS          D +S G++L    S   P ++   ++SLK  +    
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 388 ---LPHKLAEVVDSNL 400
              +P   AEV +  L
Sbjct: 237 YNFIPEVWAEVSEKAL 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVY--------KGTLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNV-RHRN 230
           LG G+FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------LERLNI 275
           +I +L  C+      +++ +   G+L ++L +       Y  DI           + ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ +   D     T 
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 336 TMATIGYMAPEG----IVSTKCDVYSYGILLLETFS 367
               + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKI-FNLQLERTFV--SFNSECEVLR 224
           Q A  +F+    LG G FG+VY         + A+K+ F  QLE+  V      E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           ++RH N++++     +     L+LE+ P G++ + L   + F D       + ++  AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       +IH D+KP N+LL       ++DFG S        S  +     T+ Y+ 
Sbjct: 126 YCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLP 177
Query: 345 PEGIVS----TKCDVYSYGILLLETFSRKKP 371
           PE I       K D++S G+L  E    K P
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 121/256 (47%), Gaps = 41/256 (16%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGT--NVAIKIFNLQLERTF-----------VSFNSE 219
           +E+     LG G+ G V K      T   VAIKI +   +R F           ++  +E
Sbjct: 9   DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 64
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
            E+L+ + H  +IKI +     D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 122
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            LA++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   SL++T  
Sbjct: 123 LLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-L 175
Query: 337 MATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQS- 387
             T  Y+APE +VS          D +S G++L    S   P ++   ++SLK  +    
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 235
Query: 388 ---LPHKLAEVVDSNL 400
              +P   AEV +  L
Sbjct: 236 YNFIPEVWAEVSEKAL 251

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 173 NEFDECNLLGIGSFGSVY---KGTLSDGTNV-AIKIF---NLQLERTFVSFNSECEVLRN 225
           ++F+   +LG GSFG V+   K + SD   + A+K+     L++ R  V    E ++L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVE 82
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           V H  ++K+           L+L+F+  G L   L     F +   +   + ++ LAL++
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDH 141
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMA 344
           LH   +L  II+ DLKP NILLDE     ++DFG+SK   E  D   +  +   T+ YMA
Sbjct: 142 LH---SLG-IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMA 194
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +     +   D +S+G+L+ E  +   P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 121/256 (47%), Gaps = 41/256 (16%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGT--NVAIKIFNLQLERTF-----------VSFNSE 219
           +E+     LG G+ G V K      T   VAIKI +   +R F           ++  +E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 65
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
            E+L+ + H  +IKI +     D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 123
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            LA++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   SL++T  
Sbjct: 124 LLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-L 176
Query: 337 MATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQS- 387
             T  Y+APE +VS          D +S G++L    S   P ++   ++SLK  +    
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 388 ---LPHKLAEVVDSNL 400
              +P   AEV +  L
Sbjct: 237 YNFIPEVWAEVSEKAL 252

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 174 EFDECNL-----LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV------SFNSECE 221
           EF   NL     LG G+FG V + T    G   A+    +++ ++        +  SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
           ++ ++ +H N++ +L  C++     ++ E+   G L  +L   +  L+      I     
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 281 LALEYLHYGHALAP---------IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
              + LH+   +A           IH D+   N+LL    VA + DFG+++ +    + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 332 IQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           ++      + +MAPE I     + + DV+SYGILL E FS
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 18/193 (9%)
Query: 181 LGIGSFGSVY-KGTLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G+FG V+     S G    IK  N    +       +E EVL+++ H N+IKI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER---LNIMIDVGLALEYLHYGHALAPI 295
            +     +V+E    G L + + S       L       +M  +  AL Y H  H    +
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH----V 145
Query: 296 IHCDLKPSNILLDE---NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---V 349
           +H DLKP NIL  +   +    + DFG+++L    + S   T    T  YMAPE     V
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFKRDV 202
Query: 350 STKCDVYSYGILL 362
           + KCD++S G+++
Sbjct: 203 TFKCDIWSAGVVM 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 50/233 (21%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR 227
           +R   +F E  L+G G FG V+K     DG    I+      E+       E + L  + 
Sbjct: 8   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLD 63
Query: 228 HRNLIKILSGC-SNLDFKA-----------------------------LVLEFMPNGSLE 257
           H N++   +GC    D+                               + +EF   G+LE
Sbjct: 64  HVNIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 258 KWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS 316
           +W+       LD +  L +   +   ++Y+H       +IH DLKPSNI L +     + 
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHS----KKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 317 DFG-ISKLLGEGDDSLIQTKTMATIGYMAPEGIVST----KCDVYSYGILLLE 364
           DFG ++ L  +G     +T++  T+ YM+PE I S     + D+Y+ G++L E
Sbjct: 179 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 120/256 (46%), Gaps = 41/256 (16%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGT--NVAIKIFNLQLERTF-----------VSFNSE 219
           +E+     LG G+ G V K      T   VAIKI +   +R F           ++  +E
Sbjct: 16  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETE 71
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
            E+L+ + H  +IKI +     D+  +VLE M  G L   +  +    +   +L     +
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 129
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            LA++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   SL++T  
Sbjct: 130 LLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-L 182
Query: 337 MATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKP-TNDLGEMSLKHWVNQS- 387
             T  Y+APE +VS          D +S G++L    S   P +    ++SLK  +    
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 242
Query: 388 ---LPHKLAEVVDSNL 400
              +P   AEV +  L
Sbjct: 243 YNFIPEVWAEVSEKAL 258

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 28/230 (12%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAI-KIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK    + + +A  K+ + + E     +  E ++L +  H N++K+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILER----LNIMIDVGLALEYLHYGHALAPI 295
             +   +++EF   G+++  +         LER      I +     L+ L+Y H    I
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLE-------LERPLTESQIQVVCKQTLDALNYLHD-NKI 156
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT--MATIGYMAPEGIV---- 349
           IH DLK  NIL   +    ++DFG+S      +   IQ +   + T  +MAPE ++    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA----KNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 350 -----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
                  K DV+S GI L+E    + P ++L  M +   + +S P  LA+
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 124/287 (43%), Gaps = 39/287 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVR 227
           ++ ++   +LG G    V+    L    +VA+K+    L R    ++ F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 228 HRNLIKI-LSGCSNLDFKAL---VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  ++ +  +G +      L   V+E++   +L   +++    +     + ++ D   AL
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            + H       IIH D+KP+NI++       V DFGI++ + +  +S+ QT   + T  Y
Sbjct: 130 NFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL--KHWVNQSLPHKLAEVV 396
           ++PE      V  + DVYS G +L E  + + P      +S+  +H     +P       
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                 R    SA +D ++      L    ++P+ R  T   AA++R
Sbjct: 242 ------RHEGLSADLDAVV------LKALAKNPENRYQT---AAEMR 273

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 124/287 (43%), Gaps = 39/287 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVR 227
           ++ ++   +LG G    V+    L    +VA+K+    L R    ++ F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 228 HRNLIKIL-SGCSNLDFKAL---VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  ++ +  +G +      L   V+E++   +L   +++    +     + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            + H       IIH D+KP+NI++       V DFGI++ + +  +S+ QT   + T  Y
Sbjct: 130 NFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL--KHWVNQSLPHKLAEVV 396
           ++PE      V  + DVYS G +L E  + + P      +S+  +H     +P       
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                 R    SA +D ++      L    ++P+ R  T   AA++R
Sbjct: 242 ------RHEGLSADLDAVV------LKALAKNPENRYQT---AAEMR 273

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 28/230 (12%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAI-KIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK    + + +A  K+ + + E     +  E ++L +  H N++K+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILER----LNIMIDVGLALEYLHYGHALAPI 295
             +   +++EF   G+++  +         LER      I +     L+ L+Y H    I
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLE-------LERPLTESQIQVVCKQTLDALNYLHD-NKI 156
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT--MATIGYMAPEGIV---- 349
           IH DLK  NIL   +    ++DFG+S      +   IQ +   + T  +MAPE ++    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA----KNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 350 -----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
                  K DV+S GI L+E    + P ++L  M +   + +S P  LA+
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 28/230 (12%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAI-KIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK    + + +A  K+ + + E     +  E ++L +  H N++K+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILER----LNIMIDVGLALEYLHYGHALAPI 295
             +   +++EF   G+++  +         LER      I +     L+ L+Y H    I
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLE-------LERPLTESQIQVVCKQTLDALNYLHD-NKI 156
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT--MATIGYMAPEGIV---- 349
           IH DLK  NIL   +    ++DFG+S      +   IQ +   + T  +MAPE ++    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 350 -----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
                  K DV+S GI L+E    + P ++L  M +   + +S P  LA+
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK    + G   A K+   + E     +  E E+L    H  ++K+L    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
           +     +++EF P G+++  +   +  L       I +     LE L++ H+   IIH D
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHS-KRIIHRD 142
Query: 300 LKPSNILLDENMVAHVSDFGIS----KLLGEGDDSLIQTKTMATIGYMAPEGIV------ 349
           LK  N+L+       ++DFG+S    K L +  DS I T       +MAPE ++      
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPY-----WMAPEVVMCETMKD 196
Query: 350 ---STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
                K D++S GI L+E    + P ++L  M +   + +S P  L
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL 242

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           LG G+FG VYK    + G   A K+   + E     +  E E+L    H  ++K+L    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
           +     +++EF P G+++  +   +  L       I +     LE L++ H+   IIH D
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHS-KRIIHRD 134
Query: 300 LKPSNILLDENMVAHVSDFGIS----KLLGEGDDSLIQTKTMATIGYMAPEGIV------ 349
           LK  N+L+       ++DFG+S    K L +  DS I T       +MAPE ++      
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPY-----WMAPEVVMCETMKD 188
Query: 350 ---STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
                K D++S GI L+E    + P ++L  M +   + +S P  L
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL 234

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 113/227 (49%), Gaps = 26/227 (11%)
Query: 171 ATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRH 228
           ++++F +   LG G++ +VYKG   + G  VA+K   L  E  T  +   E  +++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-------LDILERLNIMIDVGL 281
            N++++       +   LV EFM N  L+K++ S           L++++     +  GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           A  + H       I+H DLKP N+L+++     + DFG+++  G   ++   +  + T+ 
Sbjct: 122 A--FCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLW 173
Query: 342 YMAPEGIV-----STKCDVYSYGILLLETFSRK---KPTNDLGEMSL 380
           Y AP+ ++     ST  D++S G +L E  + K     TND  ++ L
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKI 234
           EC  +G G +G V++G+   G NVA+KIF+ + E+   S+  E E+   V  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGF 67
Query: 235 LSGCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH--- 287
           ++        +    L+  +   GSL  +L      LD +  L I++ +   L +LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 288 YGHALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI--QTKTMATIGYMA 344
           +G    P I H DLK  NIL+ +N    ++D G++ +  +  + L       + T  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 345 PEGIVST----------KCDVYSYGILLLETFSR 368
           PE +  T          + D++++G++L E   R
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 31/223 (13%)
Query: 177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKI 234
           EC  +G G +G V++G+   G NVA+KIF+ + E+   S+  E E+   V  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGF 67
Query: 235 LSGCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH--- 287
           ++        +    L+  +   GSL  +L      LD +  L I++ +   L +LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 288 YGHALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI--QTKTMATIGYMA 344
           +G    P I H DLK  NIL+ +N    ++D G++ +  +  + L       + T  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 345 PEGIVST----------KCDVYSYGILLLETFSRKKPTNDLGE 377
           PE +  T          + D++++G++L E  +R+  +N + E
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV-ARRMVSNGIVE 227

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI 234
           +  C ++G GSFG V++  L +   VAIK   LQ +R     N E +++R V+H N++ +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRF---KNRELQIMRIVKHPNVVDL 97
Query: 235 LSGC-SNLD-----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            +   SN D     F  LVLE++P  ++ +    +      +  L I + +   L  L Y
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 289 GHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
            H++  I H D+KP N+LLD  + V  + DFG +K+L  G+ ++     + +  Y APE 
Sbjct: 157 IHSIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---SXICSRYYRAPEL 212
Query: 348 IV-----STKCDVYSYGILLLE 364
           I      +T  D++S G ++ E
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAE 234

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 124/287 (43%), Gaps = 39/287 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVR 227
           ++ ++   +LG G    V+    L    +VA+K+    L R    ++ F  E +    + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 228 HRNLIKIL-SGCSNLDFKAL---VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  ++ +  +G +      L   V+E++   +L   +++    +     + ++ D   AL
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 146
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            + H       IIH D+KP+NI++       V DFGI++ + +  +S+ QT   + T  Y
Sbjct: 147 NFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL--KHWVNQSLPHKLAEVV 396
           ++PE      V  + DVYS G +L E  + + P      +S+  +H     +P       
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA---- 258
Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                 R    SA +D ++      L    ++P+ R  T   AA++R
Sbjct: 259 ------RHEGLSADLDAVV------LKALAKNPENRYQT---AAEMR 290

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 184 GSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLR--NVRHRNLIKILSG---C 238
           G FG V+K  L +   VA+KIF LQ ++   S+ SE E+     ++H NL++ ++     
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQ---SWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 239 SNLDFK-ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH------YGHA 291
           SNL+ +  L+  F   GSL  +L  +   +   E  ++   +   L YLH       G  
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 292 LAP-IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVS 350
             P I H D K  N+LL  ++ A ++DFG++     G         + T  YMAPE +  
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEG 199
Query: 351 T---------KCDVYSYGILLLETFSRKKPTN 373
                     + D+Y+ G++L E  SR K  +
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 24/225 (10%)
Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL---QLERTFVSFNSECEVLRNVRHRN 230
           F +   +G GSFG+VY    + +   VAIK  +    Q    +     E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 231 LIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
            I+   GC   +  A LV+E+   GS    L  H   L  +E   +       L YLH  
Sbjct: 116 TIQ-YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV 349
           +    +IH D+K  NILL E  +  + DFG + ++   +        + T  +MAPE I+
Sbjct: 174 N----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVIL 223
Query: 350 ST-------KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
           +        K DV+S GI  +E   RK P  ++  MS  + + Q+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKI 234
           EC  +G G +G V++G+   G NVA+KIF+ + E+   S+  E E+   V  RH N++  
Sbjct: 43  EC--VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGF 96
Query: 235 LSGCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH--- 287
           ++        +    L+  +   GSL  +L      LD +  L I++ +   L +LH   
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 154
Query: 288 YGHALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI--QTKTMATIGYMA 344
           +G    P I H DLK  NIL+ +N    ++D G++ +  +  + L       + T  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 345 PEGIVST----------KCDVYSYGILLLETFSR 368
           PE +  T          + D++++G++L E   R
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 159 TWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK-IFNLQLERTFVSF 216
           +W++ +  DI++   EF E   LG G+F  V      + G   A+K I    L+    S 
Sbjct: 12  SWKKQAE-DIKKIF-EFKET--LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSI 67
Query: 217 NSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILE 271
            +E  VLR ++H N++ +     + +   LV++ +  G L     EK  Y+      ++ 
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR 127
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGD 328
           ++         L+ ++Y H +  I+H DLKP N+L    DE     +SDFG+SK+ G+GD
Sbjct: 128 QV---------LDAVYYLHRMG-IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 329 DSLIQTKTMATIGYMAPEGIV----STKCDVYSYGIL 361
              + +    T GY+APE +     S   D +S G++
Sbjct: 178 ---VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 24/225 (10%)
Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL---QLERTFVSFNSECEVLRNVRHRN 230
           F +   +G GSFG+VY    + +   VAIK  +    Q    +     E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 231 LIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
            I+   GC   +  A LV+E+   GS    L  H   L  +E   +       L YLH  
Sbjct: 77  TIQ-YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV 349
           +    +IH D+K  NILL E  +  + DFG + ++   +        + T  +MAPE I+
Sbjct: 135 N----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVIL 184
Query: 350 ST-------KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
           +        K DV+S GI  +E   RK P  ++  MS  + + Q+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 97
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 98  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVL 153
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 154 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 201
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 249
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLR 271

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 24/198 (12%)
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
           +E E+L+ + H  +IKI +     D+  +VLE M  G L   +  +    +   +L    
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 246
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQT 334
            + LA++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   SL++T
Sbjct: 247 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 300
Query: 335 KTMATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQ 386
               T  Y+APE +VS          D +S G++L    S   P ++   ++SLK  +  
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359
Query: 387 S----LPHKLAEVVDSNL 400
                +P   AEV +  L
Sbjct: 360 GKYNFIPEVWAEVSEKAL 377

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 174 EFDECNL-----LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV------SFNSECE 221
           EF   NL     LG G+FG V + T    G   A+    +++ ++        +  SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
           ++ ++ +H N++ +L  C++     ++ E+   G L  +L   +  L+      I     
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 281 LALEYLHYGHALAP---------IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
              + LH+   +A           IH D+   N+LL    VA + DFG+++ +    + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 332 IQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           ++      + +MAPE I     + + DV+SYGILL E FS
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    +G GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E+MP G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    +G GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E+MP G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTL--SDGTNVAIKIFNLQLERTFVS----FNSEC 220
           D+     +F    +LG G FGSV +  L   DG+ V + +  L+ +    S    F  E 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 221 EVLRNVRHRNLIKILS------GCSNLDFKALVLEFMPNGSLEKWLYSHN-----YFLDI 269
             ++   H ++ K++           L    ++L FM +G L  +L +       + L +
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 270 LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
              +  M+D+   +EYL   +     IH DL   N +L E+M   V+DFG+S+ +  GD 
Sbjct: 137 QTLVRFMVDIACGMEYLSSRN----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 330 SLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKK 370
                 +   + ++A E +     +   DV+++G+ + E  +R +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 179 NLLGIGSFGSVYKGTLSDGTN----VAIKIFNLQLERTFV-SFNSECEVLRNVRHRN--- 230
            ++G G FG VY G   D        AIK  +   E   V +F  E  ++R + H N   
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           LI I+     L    ++L +M +G L +++ S      + + ++  + V   +EYL    
Sbjct: 87  LIGIMLPPEGL--PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---- 140
Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPEGI 348
           A    +H DL   N +LDE+    V+DFG+++ + + +   +Q    A   + + A E +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 349 ----VSTKCDVYSYGILLLETFSRKKPT-NDLGEMSLKHWVNQS 387
                +TK DV+S+G+LL E  +R  P    +    L H++ Q 
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 97
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 98  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 153
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 154 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWTLCG 201
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 249
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLR 271

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 24/198 (12%)
Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
           +E E+L+ + H  +IKI +     D+  +VLE M  G L   +  +    +   +L    
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 260
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQT 334
            + LA++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   SL++T
Sbjct: 261 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 314
Query: 335 KTMATIGYMAPEGIVST-------KCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQ 386
               T  Y+APE +VS          D +S G++L    S   P ++   ++SLK  +  
Sbjct: 315 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 373
Query: 387 S----LPHKLAEVVDSNL 400
                +P   AEV +  L
Sbjct: 374 GKYNFIPEVWAEVSEKAL 391

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 117/260 (45%), Gaps = 46/260 (17%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 82
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 83  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 138
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATI 340
             EYLH       +I+ DLKP N+L+D+     V+DFG +K +        +T T+  T 
Sbjct: 139 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTP 188
Query: 341 GYMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
            Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E +
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYEKI 236
Query: 397 DSNLVRREHSFSAKMDCLLR 416
            S  VR    FS+ +  LLR
Sbjct: 237 VSGKVRFPSHFSSDLKDLLR 256

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 97
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 98  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 153
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 154 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 201
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 249
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLR 271

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 86
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +L+ V    L+K+       SNL    +V+E++P G +   L     F +   R      
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQ 142
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T  
Sbjct: 143 IVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWX 190
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 238
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 239 IYEKIVSGKVRFPSHFSSDLKDLLR 263

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTL----NEKR 93
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +L+ V    L+K+     +     +V+E++P G +   L     F +   R      + L
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 42/229 (18%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           R  ++F+E  +LG G+FG V K   + D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 229 -------------RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
                        RN +K ++         + +E+  N +L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK------------- 322
              +  AL Y+H       IIH DLKP NI +DE+    + DFG++K             
Sbjct: 122 FRQILEALSYIHS----QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 323 --LLGEGDDSLIQTKTMATIGYMAPE-----GIVSTKCDVYSYGILLLE 364
             L G  D+    T  + T  Y+A E     G  + K D+YS GI+  E
Sbjct: 178 QNLPGSSDN---LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTL----NEKR 93
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +L+ V    L+K+     +     +V+E++P G +   L     F +   R      + L
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTL----NEKR 93
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +L+ V    L+K+     +     +V+E++P G +   L     F +   R      + L
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 150 DEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF---- 205
           DEED   + + R     +IQR   E   C  +G G FG V++G      N A+ +     
Sbjct: 372 DEEDTYTMPSTRD---YEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 206 -NLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN 264
            N   +     F  E   +R   H +++K++ G    +   +++E    G L  +L    
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRK 485
Query: 265 YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL 324
           + LD+   +     +  AL YL         +H D+   N+L+  N    + DFG+S+ +
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
Query: 325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLE 364
            E       +K    I +MAPE I     ++  DV+ +G+ + E
Sbjct: 542 -EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 3   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    Y LD+   +     +  
Sbjct: 61  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 120 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 174
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWE 201

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 9   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    Y LD+   +     +  
Sbjct: 67  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 126 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 180
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 181 WMAPESINFRRFTSASDVWMFGVCMWE 207

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 8   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    Y LD+   +     +  
Sbjct: 66  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 125 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 179
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWE 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    Y LD+   +     +  
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 123 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 177
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    Y LD+   +     +  
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 123 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 177
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 94
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +L+ V    L+K+       SNL    +V+E++P G +   L     F +   R      
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T  
Sbjct: 151 IVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWX 198
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 246
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 247 IYEKIVSGKVRFPSHFSSDLKDLLR 271

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 94
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +L+ V    L+K+       SNL    +V+E++P G +   L     F +   R      
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T  
Sbjct: 151 IVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWX 198
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 246
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 247 IYEKIVSGKVRFPSHFSSDLKDLLR 271

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLER---TFVSFNSECEVLRNVRHRNLIKILS 236
           LG GSFG V   T       VA+K  + QL +     +    E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
             +      +V+E+   G L  ++       +   R      +  A+EY H       I+
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCHRHK----IV 130
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VST 351
           H DLKP N+LLD+N+   ++DFG+S ++ +G+   ++T +  +  Y APE I        
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKT-SCGSPNYAAPEVINGKLYAGP 187
Query: 352 KCDVYSYGILLLETFSRKKPTND 374
           + DV+S GI+L      + P +D
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 94
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +L+ V    L+K+       SNL    +V+E++P G +   L     F +   R      
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T  
Sbjct: 151 IVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWX 198
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 246
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 247 IYEKIVSGKVRFPSHFSSDLKDLLR 271

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 34  EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    Y LD+   +     +  
Sbjct: 92  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 150
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 151 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 205
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWE 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 114
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +L+ V    L+K+       SNL    +V+E++P G +   L     F +   R      
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 170
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T  
Sbjct: 171 IVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWX 218
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 266
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 267 IYEKIVSGKVRFPSHFSSDLKDLLR 291

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 11  EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    Y LD+   +     +  
Sbjct: 69  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 128 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 182
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWE 209

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 111/259 (42%), Gaps = 45/259 (17%)
Query: 146 TKKSDEEDLLPLVTWRRISY---LDIQRATNEFDECNLLGIGSFGSVYKGTLS--DGTNV 200
           T  SD E     V +R   Y    +  R   EF +  +LG G+FG V   T      T V
Sbjct: 19  TGSSDNEYFY--VDFREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGV 74
Query: 201 AIKIFNLQLERTFVS-----FNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNG 254
           +I++    L+    S       SE +++  +  H N++ +L  C+      L+ E+   G
Sbjct: 75  SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 134
Query: 255 SLEKWL-------------YSHNYFLDILERLNIMI---------DVGLALEYLHYGHAL 292
            L  +L             Y +   L+  E LN++           V   +E+L +    
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---- 190
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP----EGI 348
              +H DL   N+L+    V  + DFG+++ +    + +++      + +MAP    EGI
Sbjct: 191 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250
Query: 349 VSTKCDVYSYGILLLETFS 367
            + K DV+SYGILL E FS
Sbjct: 251 YTIKSDVWSYGILLWEIFS 269

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 184 GSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV--LRNVRHRNLIKILSG---C 238
           G FG V+K  L +   VA+KIF +Q ++   S+ +E EV  L  ++H N+++ +      
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 239 SNLDFK-ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY-------GH 290
           +++D    L+  F   GSL  +L ++    + L  +   +  GLA  YLH        GH
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLA--YLHEDIPGLKDGH 148
Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVS 350
             A I H D+K  N+LL  N+ A ++DFG++     G  +      + T  YMAPE +  
Sbjct: 149 KPA-ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 351 T---------KCDVYSYGILLLETFSR 368
                     + D+Y+ G++L E  SR
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 9/182 (4%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLR 224
           ++   +F    +LG GSF +V     L+     AIKI    ++  E        E +V+ 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            + H   +K+     + +     L +  NG L K++     F +   R     ++  ALE
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 124
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YLH G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++
Sbjct: 125 YLH-GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 345 PE 346
           PE
Sbjct: 181 PE 182

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 86
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +L+ V    L+K+       SNL    +V+E++P G +   L     F +   R      
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 142
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T  
Sbjct: 143 IVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWX 190
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 238
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 239 IYEKIVSGKVRFPSHFSSDLKDLLR 263

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS-------------HNYFLDILERLNIMID 278
            +L  C+      +V+ EF   G+L  +L S             +  FL +   +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +     
Sbjct: 157 VAKGMEFL----ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFS 367
            + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 30/232 (12%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-L 207
           +D E++ P     +  YLD +  T E  E   LG G+FG+V KG       V       L
Sbjct: 353 ADPEEIRP-----KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKIL 404
Query: 208 QLERTFVSFN----SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH 263
           + E    +      +E  V++ + +  +++++  C    +  LV+E    G L K+L  +
Sbjct: 405 KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN 463
Query: 264 NYFLD--ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS 321
            +  D  I+E   ++  V + ++YL   +     +H DL   N+LL     A +SDFG+S
Sbjct: 464 RHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLS 516
Query: 322 KLLGEGDDSLIQTKTMAT--IGYMAPEGI----VSTKCDVYSYGILLLETFS 367
           K L   D++  + +T     + + APE I     S+K DV+S+G+L+ E FS
Sbjct: 517 KAL-RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLR 224
           ++   +F    +LG GSF +V     L+     AIKI    ++  E        E +V+ 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            + H   +K+     + +     L +  NG L K++     F +   R     ++  ALE
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 123
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YLH G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++
Sbjct: 124 YLH-GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 345 PEGIVSTKC----DVYSYGILLLE 364
           PE +         D+++ G ++ +
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQ 203

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG++K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 176 DECNL---LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRN 225
           D  NL   LG G+FG V +         +    VA+K+       +   +  SE ++L +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 226 VRHR-NLIKILSGCSNLDFKALVL-EFMPNGSLEKWLYS-----------HNYFLDILER 272
           + H  N++ +L  C+      +V+ EF   G+L  +L S           +  FL +   
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
           +     V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + 
Sbjct: 147 IXYSFQVAKGMEFL----ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 333 QTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           +      + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 9/182 (4%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLR 224
           ++   +F    +LG GSF +V     L+     AIKI    ++  E        E +V+ 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            + H   +K+     + +     L +  NG L K++     F +   R     ++  ALE
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 121
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YLH G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++
Sbjct: 122 YLH-GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 345 PE 346
           PE
Sbjct: 178 PE 179

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 30/232 (12%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-L 207
           +D E++ P     +  YLD +  T E  E   LG G+FG+V KG       V       L
Sbjct: 354 ADPEEIRP-----KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKIL 405
Query: 208 QLERTFVSFN----SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH 263
           + E    +      +E  V++ + +  +++++  C    +  LV+E    G L K+L  +
Sbjct: 406 KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN 464
Query: 264 NYFLD--ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS 321
            +  D  I+E   ++  V + ++YL   +     +H DL   N+LL     A +SDFG+S
Sbjct: 465 RHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLS 517
Query: 322 KLLGEGDDSLIQTKTMAT--IGYMAPEGI----VSTKCDVYSYGILLLETFS 367
           K L   D++  + +T     + + APE I     S+K DV+S+G+L+ E FS
Sbjct: 518 KAL-RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLR 224
           ++   +F    +LG GSF +V     L+     AIKI    ++  E        E +V+ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            + H   +K+     + +     L +  NG L K++     F +   R     ++  ALE
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 122
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YLH G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++
Sbjct: 123 YLH-GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 345 PEGIVSTKC----DVYSYGILLLE 364
           PE +         D+++ G ++ +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQ 202

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE +
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 349 ----VSTKCDVYSYGILLLE 364
                S   D+++ G ++ +
Sbjct: 207 TEKSASKSSDLWALGCIIYQ 226

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    +G GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 128 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 179
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    + LD+   +     +  
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I 
Sbjct: 123 ALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIK 177
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 31/237 (13%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-L 207
           +D E++ P     +  YLD +  T E  E   LG G+FG+V KG       V       L
Sbjct: 11  ADPEEIRP-----KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKIL 62
Query: 208 QLERTFVSFN----SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH 263
           + E    +      +E  V++ + +  +++++  C    +  LV+E    G L K+L  +
Sbjct: 63  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN 121
Query: 264 NYFLD--ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS 321
            +  D  I+E   ++  V + ++YL   +     +H DL   N+LL     A +SDFG+S
Sbjct: 122 RHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 322 KLLGEGDDSLIQTKTMAT--IGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
           K L   D++  + +T     + + APE I     S+K DV+S+G+L+ E FS  +KP
Sbjct: 175 KAL-RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 31/237 (13%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-L 207
           +D E++ P     +  YLD +  T E  E   LG G+FG+V KG       V       L
Sbjct: 11  ADPEEIRP-----KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKIL 62
Query: 208 QLERTFVSFN----SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH 263
           + E    +      +E  V++ + +  +++++  C    +  LV+E    G L K+L  +
Sbjct: 63  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN 121
Query: 264 NYFLD--ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS 321
            +  D  I+E   ++  V + ++YL   +     +H DL   N+LL     A +SDFG+S
Sbjct: 122 RHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 322 KLLGEGDDSLIQTKTMAT--IGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
           K L   D++  + +T     + + APE I     S+K DV+S+G+L+ E FS  +KP
Sbjct: 175 KAL-RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 31/237 (13%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-L 207
           +D E++ P     +  YLD +  T E  E   LG G+FG+V KG       V       L
Sbjct: 9   ADPEEIRP-----KEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKIL 60
Query: 208 QLERTFVSFN----SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH 263
           + E    +      +E  V++ + +  +++++  C    +  LV+E    G L K+L  +
Sbjct: 61  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN 119
Query: 264 NYFLD--ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS 321
            +  D  I+E   ++  V + ++YL   +     +H DL   N+LL     A +SDFG+S
Sbjct: 120 RHVKDKNIIE---LVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLS 172
Query: 322 KLLGEGDDSLIQTKTMAT--IGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
           K L   D++  + +T     + + APE I     S+K DV+S+G+L+ E FS  +KP
Sbjct: 173 KAL-RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG++K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 123 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 174
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 131 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 182
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGC 238
           +G G FG V++G    G  VA+KIF+ + ER   S+  E E+ + V  RH N++  ++  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA- 66
Query: 239 SNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY---GH 290
            N D        LV ++  +GSL  +L  +   ++ + +L +    GLA  +LH    G 
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA--HLHMEIVGT 124
Query: 291 ALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS--LIQTKTMATIGYMAPEG 347
              P I H DLK  NIL+ +N    ++D G++       D+  +     + T  YMAPE 
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 348 IVST----------KCDVYSYGILLLETFSR 368
           +  +          + D+Y+ G++  E   R
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 83
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 84  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 139
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+DE     V+DFG +K         ++ +T    G
Sbjct: 140 TFEYLHS----LDLIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTWXLCG 187
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 235
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 236 KIVSGKVRFPSHFSSDLKDLLR 257

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSF-NSECEVLRNVRHRNL 231
           F +   +G GSFG V+KG + + T   VAIKI +L+     +     E  VL       +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
            K            +++E++  GS    L +  +  D  +   ++ ++   L+YLH    
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLHSEKK 141
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPEGI-- 348
               IH D+K +N+LL E     ++DFG++   G+  D+ I+  T + T  +MAPE I  
Sbjct: 142 ----IHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIQQ 194
Query: 349 --VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
               +K D++S GI  +E    + P +D+  M +   + ++ P  L
Sbjct: 195 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL 240

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 125 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 176
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 131 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 182
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 180 LLGIGSFGSVYKGTLSD--GTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKI 234
           +LG G FG VY+G  ++  G  + + +   + + T      F SE  +++N+ H +++K+
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
           + G    +   +++E  P G L  +L  +   L +L  +   + +  A+ YL   +    
Sbjct: 91  I-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC--- 146
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            +H D+   NIL+       + DFG+S+ + E +D    + T   I +M+PE I     +
Sbjct: 147 -VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 351 TKCDVYSYGILLLETFSRKK 370
           T  DV+ + + + E  S  K
Sbjct: 205 TASDVWMFAVCMWEILSFGK 224

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGC 238
           +G G FG V++G    G  VA+KIF+ + ER   S+  E E+ + V  RH N++  ++  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA- 65
Query: 239 SNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY---GH 290
            N D        LV ++  +GSL  +L  +   ++ + +L +    GLA  +LH    G 
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA--HLHMEIVGT 123
Query: 291 ALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS--LIQTKTMATIGYMAPEG 347
              P I H DLK  NIL+ +N    ++D G++       D+  +     + T  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 348 IVST----------KCDVYSYGILLLETFSR 368
           +  +          + D+Y+ G++  E   R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 42/229 (18%)
Query: 174 EFDECNL-----LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV------SFNSECE 221
           EF   NL     LG G+FG V + T    G   A+    +++ ++        +  SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDILE 271
           ++ ++ +H N++ +L  C++     ++ E+   G L  +L         YS+N   +  E
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 272 RLNIMIDVGLALEYLHYGHALAP---------IIHCDLKPSNILLDENMVAHVSDFGISK 322
           +L+       + + LH+   +A           IH D+   N+LL    VA + DFG+++
Sbjct: 162 QLS-------SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 323 LLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
            +    + +++      + +MAPE I     + + DV+SYGILL E FS
Sbjct: 215 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 114/259 (44%), Gaps = 44/259 (16%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 117
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 118 AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 173
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K +     +L  T       
Sbjct: 174 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE----- 224
Query: 342 YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD 397
           Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E + 
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYEKIV 272
Query: 398 SNLVRREHSFSAKMDCLLR 416
           S  VR    FS+ +  LLR
Sbjct: 273 SGKVRFPSHFSSDLKDLLR 291

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 123 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 174
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 180 LLGIGSFGSVYKGTLSD--GTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKI 234
           +LG G FG VY+G  ++  G  + + +   + + T      F SE  +++N+ H +++K+
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
           + G    +   +++E  P G L  +L  +   L +L  +   + +  A+ YL   +    
Sbjct: 75  I-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC--- 130
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            +H D+   NIL+       + DFG+S+ + E +D    + T   I +M+PE I     +
Sbjct: 131 -VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 351 TKCDVYSYGILLLETFSRKK 370
           T  DV+ + + + E  S  K
Sbjct: 189 TASDVWMFAVCMWEILSFGK 208

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGC 238
           +G G FG V++G    G  VA+KIF+ + ER   S+  E E+ + V  RH N++  ++  
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA-A 104
Query: 239 SNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY---GH 290
            N D        LV ++  +GSL  +L  +   ++ + +L +    GLA  +LH    G 
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA--HLHMEIVGT 162
Query: 291 ALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS--LIQTKTMATIGYMAPEG 347
              P I H DLK  NIL+ +N    ++D G++       D+  +     + T  YMAPE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 348 IVST----------KCDVYSYGILLLETFSR 368
           +  +          + D+Y+ G++  E   R
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGC 238
           +G G FG V++G    G  VA+KIF+ + ER   S+  E E+ + V  RH N++  ++  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA- 68
Query: 239 SNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY---GH 290
            N D        LV ++  +GSL  +L  +   ++ + +L +    GLA  +LH    G 
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA--HLHMEIVGT 126
Query: 291 ALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS--LIQTKTMATIGYMAPEG 347
              P I H DLK  NIL+ +N    ++D G++       D+  +     + T  YMAPE 
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 348 IVST----------KCDVYSYGILLLETFSR 368
           +  +          + D+Y+ G++  E   R
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGC 238
           +G G FG V++G    G  VA+KIF+ + ER   S+  E E+ + V  RH N++  ++  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA- 71
Query: 239 SNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY---GH 290
            N D        LV ++  +GSL  +L  +   ++ + +L +    GLA  +LH    G 
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA--HLHMEIVGT 129
Query: 291 ALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS--LIQTKTMATIGYMAPEG 347
              P I H DLK  NIL+ +N    ++D G++       D+  +     + T  YMAPE 
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 348 IVST----------KCDVYSYGILLLETFSR 368
           +  +          + D+Y+ G++  E   R
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGC 238
           +G G FG V++G    G  VA+KIF+ + ER   S+  E E+ + V  RH N++  ++  
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA-A 91
Query: 239 SNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY---GH 290
            N D        LV ++  +GSL  +L  +   ++ + +L +    GLA  +LH    G 
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA--HLHMEIVGT 149
Query: 291 ALAPII-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS--LIQTKTMATIGYMAPEG 347
              P I H DLK  NIL+ +N    ++D G++       D+  +     + T  YMAPE 
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 348 IVST----------KCDVYSYGILLLETFSR 368
           +  +          + D+Y+ G++  E   R
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 180 LLGIGSFGSVYKGTLSD--GTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRNLIKI 234
           +LG G FG VY+G  ++  G  + + +   + + T      F SE  +++N+ H +++K+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
           + G    +   +++E  P G L  +L  +   L +L  +   + +  A+ YL   +    
Sbjct: 79  I-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC--- 134
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            +H D+   NIL+       + DFG+S+ + E +D    + T   I +M+PE I     +
Sbjct: 135 -VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 351 TKCDVYSYGILLLETFSRKK 370
           T  DV+ + + + E  S  K
Sbjct: 193 TASDVWMFAVCMWEILSFGK 212

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 176 DECNL---LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRN 225
           D  NL   LG G+FG V +         +    VA+K+       +   +  SE ++L +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 226 VRHR-NLIKILSGCSNLDFKALVL-EFMPNGSLEKWLYS-----------HNYFLDILER 272
           + H  N++ +L  C+      +V+ EF   G+L  +L S           +  FL +   
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
           +     V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + 
Sbjct: 147 ICYSFQVAKGMEFL----ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 333 QTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           +      + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS--------------HNYFLDILERLNIMI 277
            +L  C+      +V+ EF   G+L  +L S              +  FL +   +    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +    
Sbjct: 156 QVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 338 ATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
             + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 165 YLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-LQLERTFVSFN----SE 219
           YLD +  T E  E   LG G+FG+V KG       V       L+ E    +      +E
Sbjct: 12  YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMI 277
             V++ + +  +++++  C    +  LV+E    G L K+L  + +  D  I+E   ++ 
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVH 124
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            V + ++YL   +     +H DL   N+LL     A +SDFG+SK L   D++  + +T 
Sbjct: 125 QVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTH 179
Query: 338 AT--IGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
               + + APE I     S+K DV+S+G+L+ E FS  +KP
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 24/220 (10%)
Query: 165 YLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-LQLERTFVSFN----SE 219
           YLD +  T E  E   LG G+FG+V KG       V       L+ E    +      +E
Sbjct: 6   YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 62
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMI 277
             V++ + +  +++++  C    +  LV+E    G L K+L  + +  D  I+E   ++ 
Sbjct: 63  ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVH 118
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQTKT 336
            V + ++YL   +     +H DL   N+LL     A +SDFG+SK L   ++    QT  
Sbjct: 119 QVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 337 MATIGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
              + + APE I     S+K DV+S+G+L+ E FS  +KP
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLAG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 117
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 118 AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVL 173
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 174 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 221
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 269
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 270 KIVSGKVRFPSHFSSDLKDLLR 291

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGS-VYKGTLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF + V    L+     AIKI    ++  E        E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLXG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 147 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 146 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKI-FNLQLERTFVSFN----SECEVLRNV 226
            E  +  +LG G+FG+VYKG  + DG NV I +   +  E T    N     E  V+  V
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
               + ++L  C     + LV + MP G L   +  +   L   + LN  + +   + YL
Sbjct: 77  GSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL 135
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                   ++H DL   N+L+       ++DFG+++LL   +           I +MA E
Sbjct: 136 EDVR----LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 347 GIV----STKCDVYSYGILLLE--TFSRK 369
            I+    + + DV+SYG+ + E  TF  K
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAK 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 48/241 (19%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLE-------RTFVSFNSECE---- 221
           F + + +G GSFG VYKG + + T   VAIKI +L+         +  ++  S+C+    
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 222 ------VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
                  L++ +   +++ L G S LD        +  G LE+      Y   IL     
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDL-------LKPGPLEE-----TYIATILR---- 123
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
             ++   L+YLH        IH D+K +N+LL E     ++DFG++  L   D  + +  
Sbjct: 124 --EILKGLDYLHSERK----IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNX 175
Query: 336 TMATIGYMAPEGIVST----KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
            + T  +MAPE I  +    K D++S GI  +E    + P +DL  M +   + ++ P  
Sbjct: 176 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT 235
Query: 392 L 392
           L
Sbjct: 236 L 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 131
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 132 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 91
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 92  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVL 147
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 148 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 195
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 243
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 244 KIVSGKVRFPSHFSSDLKDLLR 265

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVL 223
           L  Q    ++ +   +G G++G VYK   S G  VA+K   L  E   +   +  E  +L
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLL 73
Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           + + H N++ ++    +     LV EFM    L+K L  +   L   +   I I +   L
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLL 129
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
             + + H    I+H DLKP N+L++ +    ++DFG+++  G    S   T  + T+ Y 
Sbjct: 130 RGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYR 186
Query: 344 APEGIV-----STKCDVYSYGILLLETFSRK 369
           AP+ ++     ST  D++S G +  E  + K
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 97
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 98  AVNFPFLTKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVL 153
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T    G
Sbjct: 154 TFEYLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 201
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 249
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLR 271

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVL 223
           L  Q    ++ +   +G G++G VYK   S G  VA+K   L  E   +   +  E  +L
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLL 73
Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           + + H N++ ++    +     LV EFM    L+K L  +   L   +   I I +   L
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLL 129
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
             + + H    I+H DLKP N+L++ +    ++DFG+++  G    S   T  + T+ Y 
Sbjct: 130 RGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYR 186
Query: 344 APEGIV-----STKCDVYSYGILLLETFSRK 369
           AP+ ++     ST  D++S G +  E  + K
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 150 DEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF---- 205
           DEED   + + R     +IQR   E   C  +G G FG V++G      N A+ +     
Sbjct: 372 DEEDTYTMPSTRD---YEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 206 -NLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN 264
            N   +     F  E   +R   H +++K++ G    +   +++E    G L  +L    
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRK 485
Query: 265 YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL 324
           + LD+   +     +  AL YL         +H D+   N+L+       + DFG+S+ +
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSATDCVKLGDFGLSRYM 541
Query: 325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLE 364
            E       +K    I +MAPE I     ++  DV+ +G+ + E
Sbjct: 542 -EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 94
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +L+ V    L+K+       SNL    +V+E+ P G +   L     F +   R      
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T  
Sbjct: 151 IVLTFEYLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWX 198
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 246
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 247 IYEKIVSGKVRFPSHFSSDLKDLLR 271

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 146 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 153 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 147 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/76 (44%), Positives = 46/76 (60%), Gaps = 4/76 (5%)
Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   NILL EN V  + DFG+++ + +  D + +  T   + +MAPE I     ST
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 352 KCDVYSYGILLLETFS 367
           K DV+SYG+LL E FS
Sbjct: 281 KSDVWSYGVLLWEIFS 296

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 165 YLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-LQLERTFVSFN----SE 219
           YLD +  T E  E   LG G+FG+V KG       V       L+ E    +      +E
Sbjct: 2   YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMI 277
             V++ + +  +++++  C    +  LV+E    G L K+L  + +  D  I+E   ++ 
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVH 114
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            V + ++YL   +     +H DL   N+LL     A +SDFG+SK L   D++  + +T 
Sbjct: 115 QVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTH 169
Query: 338 AT--IGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
               + + APE I     S+K DV+S+G+L+ E FS  +KP
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 155 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 18/228 (7%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL 207
           SDEE L  L +   +S  D ++    F++   +G G+ G+VY    ++ G  VAI+  NL
Sbjct: 1   SDEEILEKLRSI--VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL 55
Query: 208 QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 267
           Q +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +      +
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CM 113
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
           D  +   +  +   ALE+LH       +IH D+K  NILL  +    ++DFG    +   
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 328 DDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                +++ + T  +MAPE +       K D++S GI+ +E    + P
Sbjct: 170 QSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 165 YLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFN-LQLERTFVSFN----SE 219
           YLD +  T E  E   LG G+FG+V KG       V       L+ E    +      +E
Sbjct: 6   YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 62
Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMI 277
             V++ + +  +++++  C    +  LV+E    G L K+L  + +  D  I+E   ++ 
Sbjct: 63  ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVH 118
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            V + ++YL   +     +H DL   N+LL     A +SDFG+SK L   D++  + +T 
Sbjct: 119 QVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTH 173
Query: 338 AT--IGYMAPEGI----VSTKCDVYSYGILLLETFSR-KKP 371
               + + APE I     S+K DV+S+G+L+ E FS  +KP
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGLALEYL-HYG 289
            +L  C+      +V+ EF   G+L  +L S  N F+   E    +    L LE+L  Y 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 290 HALAP---------IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             +A           IH DL   NILL E  V  + DFG+++ + +  D + +      +
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFS 367
            +MAPE I     + + DV+S+G+LL E FS
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 97
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 98  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 153
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 154 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 201
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 249
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLR 271

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 110/232 (47%), Gaps = 26/232 (11%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL 207
           SDEE L  L +   +S  D ++    F++   +G G+ G+VY    ++ G  VAI+  NL
Sbjct: 1   SDEEILEKLRSI--VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL 55
Query: 208 QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 267
           Q +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +      +
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CM 113
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGE 326
           D  +   +  +   ALE+LH       +IH D+K  NILL  +    ++DFG  +++  E
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 327 GDDSLIQTKTMATIG---YMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                 Q+K    +G   +MAPE +       K D++S GI+ +E    + P
Sbjct: 170 ------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIF---NLQLERTFVSFNSECEVLRNVRH 228
            +F    +LG GSF +V     L+     AIKI    ++  E        E +V+  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              +K+     + +     L +  NG L K++     F +   R     ++  ALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 154
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           G     IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE
Sbjct: 155 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GL+  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 110/232 (47%), Gaps = 26/232 (11%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL 207
           SDEE L  L +   +S  D ++    F++   +G G+ G+VY    ++ G  VAI+  NL
Sbjct: 1   SDEEILEKLRSI--VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL 55
Query: 208 QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 267
           Q +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +      +
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CM 113
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGE 326
           D  +   +  +   ALE+LH       +IH D+K  NILL  +    ++DFG  +++  E
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 327 GDDSLIQTKTMATIG---YMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                 Q+K    +G   +MAPE +       K D++S GI+ +E    + P
Sbjct: 170 ------QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 97
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 98  AVNFPFLTKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 153
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T    G
Sbjct: 154 TFEYLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 201
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 249
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLR 271

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 97
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L K+       SNL    +V+E+ P G +   L     F +   R      + L
Sbjct: 98  AVNFPFLTKLEFSFKDNSNL---YMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVL 153
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+++D+     V+DFG +K         ++ +T    G
Sbjct: 154 TFEYLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 201
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 249
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLR 271

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 126
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+ E  +  + T++     YM+PE +
Sbjct: 127 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS-----YMSPERL 178
Query: 349 VST----KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE 404
             T    + D++S G+ L+E    + P   +    L  ++    P KL   V S      
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFS------ 232
Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDER 432
                     L   +    C +++P ER
Sbjct: 233 ----------LEFQDFVNKCLIKNPAER 250

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIK---IFNLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           +G G F  VY+   L DG  VA+K   IF+L   +       E ++L+ + H N+IK  +
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGLALEYLHYGHALA 293
                +   +VLE    G L + +        ++    +    + +  ALE++H      
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--- 156
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----V 349
            ++H D+KP+N+ +    V  + D G+ +       +      + T  YM+PE I     
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGY 213
Query: 350 STKCDVYSYGILLLETFSRKKP 371
           + K D++S G LL E  + + P
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP 235

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 155 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 110/232 (47%), Gaps = 26/232 (11%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL 207
           SDEE L  L +   +S  D ++    F++   +G G+ G+VY    ++ G  VAI+  NL
Sbjct: 2   SDEEILEKLRSI--VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL 56
Query: 208 QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 267
           Q +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +      +
Sbjct: 57  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CM 114
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGE 326
           D  +   +  +   ALE+LH       +IH D+K  NILL  +    ++DFG  +++  E
Sbjct: 115 DEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 170
Query: 327 GDDSLIQTKTMATIG---YMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                 Q+K    +G   +MAPE +       K D++S GI+ +E    + P
Sbjct: 171 ------QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 116/265 (43%), Gaps = 56/265 (21%)
Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECE 221
           ++F+    LG GSFG V    +K T   G + A+KI + Q       +E T     +E  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 94
Query: 222 VLRNVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           + + V    L+K+       SNL    +VLE+ P G +   L     F +   R      
Sbjct: 95  IQQAVNFPFLVKLEFSFKDNSNL---YMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           + L  EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T  
Sbjct: 151 IVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWX 198
Query: 339 TIG---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
             G   Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P +
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQ 246
Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR 416
           + E + S  VR    FS+ +  LLR
Sbjct: 247 IYEKIVSGKVRFPSHFSSDLKDLLR 271

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 59/274 (21%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLE-------RTFVSFNSECE---- 221
           F +   +G GSFG V+KG + + T   VAIKI +L+         +  ++  S+C+    
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 222 ------VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
                  L++ +   +++ L G S LD    +LE  P              LD  +   I
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALD----LLEPGP--------------LDETQIATI 109
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
           + ++   L+YLH        IH D+K +N+LL E+    ++DFG++   G+  D+ I+  
Sbjct: 110 LREILKGLDYLHSEKK----IHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRN 162
Query: 336 T-MATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP- 389
           T + T  +MAPE I      +K D++S GI  +E    + P ++L  M +   + ++ P 
Sbjct: 163 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP 222
Query: 390 -------HKLAEVVDSNLVRREHSFSAKMDCLLR 416
                    L E V++ L  +E SF      LL+
Sbjct: 223 TLEGNYSKPLKEFVEACL-NKEPSFRPTAKELLK 255

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 174 EFDECNL-----LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV------SFNSECE 221
           EF   NL     LG G+FG V + T    G   A+    +++ ++        +  SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLY---------SHNYFLDILE 271
           ++ ++ +H N++ +L  C++     ++ E+   G L  +L               L++ +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
            L+    V   + +L    A    IH D+   N+LL    VA + DFG+++ +    + +
Sbjct: 162 LLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 332 IQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           ++      + +MAPE I     + + DV+SYGILL E FS
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 174 EFDECNL-----LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV------SFNSECE 221
           EF   NL     LG G+FG V + T    G   A+    +++ ++        +  SE +
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLY---------SHNYFLDILE 271
           ++ ++ +H N++ +L  C++     ++ E+   G L  +L               L++ +
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
            L+    V   + +L    A    IH D+   N+LL    VA + DFG+++ +    + +
Sbjct: 154 LLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 332 IQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           ++      + +MAPE I     + + DV+SYGILL E FS
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++F+    LG GSFG V     +  G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 127 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 178
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 93/229 (40%), Gaps = 42/229 (18%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           R  ++F+E  +LG G+FG V K   + D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 229 -------------RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
                        RN +K  +         +  E+  N +L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK------------- 322
              +  AL Y+H       IIH +LKP NI +DE+    + DFG++K             
Sbjct: 122 FRQILEALSYIHS----QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 323 --LLGEGDDSLIQTKTMATIGYMAPE-----GIVSTKCDVYSYGILLLE 364
             L G  D+    T  + T  Y+A E     G  + K D YS GI+  E
Sbjct: 178 QNLPGSSDN---LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 146 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 127 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 178
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 126 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 177
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 172 TNEFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS---ECEVLRNV 226
           ++ +    +LG GSFG V   K  ++ G   A+K+ + +  +      S   E ++L+ +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N++K+     +  +  LV E    G L   + S   F ++ +   I+  V   + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 287 HYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           H       I+H DLKP N+LL+   ++    + DFG+S      + S      + T  Y+
Sbjct: 149 HKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 201
Query: 344 APE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
           APE   G    KCDV+S G++L    S   P N   E  +
Sbjct: 202 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 241

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 126 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 177
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 123 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 174
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 123 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 174
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 125 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 176
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 172 TNEFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS---ECEVLRNV 226
           ++ +    +LG GSFG V   K  ++ G   A+K+ + +  +      S   E ++L+ +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N++K+     +  +  LV E    G L   + S   F ++ +   I+  V   + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 287 HYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           H       I+H DLKP N+LL+   ++    + DFG+S      + S      + T  Y+
Sbjct: 166 HKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 218
Query: 344 APE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
           APE   G    KCDV+S G++L    S   P N   E  +
Sbjct: 219 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 258

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 146 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 126 ------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 177
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 172 TNEFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS---ECEVLRNV 226
           ++ +    +LG GSFG V   K  ++ G   A+K+ + +  +      S   E ++L+ +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N++K+     +  +  LV E    G L   + S   F ++ +   I+  V   + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 287 HYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           H       I+H DLKP N+LL+   ++    + DFG+S      + S      + T  Y+
Sbjct: 167 HKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 219
Query: 344 APE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
           APE   G    KCDV+S G++L    S   P N   E  +
Sbjct: 220 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 259

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 181 LGIGSFGSVYK-GTLSDGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           +G GS+G   K    SDG  +  K  +     E       SE  +LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 238 CSNLDFKAL--VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHY---- 288
             +     L  V+E+   G L   +        +LD    L +M  + LAL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
           GH    ++H DLKP+N+ LD      + DFG++++L   +D     + + T  YM+PE +
Sbjct: 134 GHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQM 188
Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS----LPHKLAEVVDSNL 400
                + K D++S G LL E  +   P     +  L   + +     +P++ ++ ++  +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 401 VR 402
            R
Sbjct: 249 TR 250

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 28/202 (13%)
Query: 181 LGIGSFGSVYKGTLSDG-TNVAIKIF-------------NLQLERTFVSFNSECEVLRNV 226
           LG G++G V      +G +  AIK+              N  +E+      +E  +L+++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N+IK+     +  +  LV EF   G L + + + + F D  +  NIM  +   + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSGICYL 162
Query: 287 HYGHALAPIIHCDLKPSNILLDEN---MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           H  +    I+H D+KP NILL+     +   + DFG+S    +  D  ++ + + T  Y+
Sbjct: 163 HKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDR-LGTAYYI 215
Query: 344 APEGI---VSTKCDVYSYGILL 362
           APE +    + KCDV+S G+++
Sbjct: 216 APEVLKKKYNEKCDVWSCGVIM 237

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 155 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 128 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 179
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 112/262 (42%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ E  +   P                 P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP------------FFADEPIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 27/258 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSF-NSECEVLRNVRHRNL 231
           F +   +G GSFG V+KG + + T   VAIKI +L+     +     E  VL       +
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
            K            +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKK 145
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPEGI-- 348
               IH D+K +N+LL E+    ++DFG++   G+  D+ I+  T + T  +MAPE I  
Sbjct: 146 ----IHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 349 --VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--------HKLAEVVDS 398
               +K D++S GI  +E    + P ++L  M +   + ++ P          L E V++
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 258
Query: 399 NLVRREHSFSAKMDCLLR 416
            L  +E SF      LL+
Sbjct: 259 CL-NKEPSFRPTAKELLK 275

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFN-LQLERTFVSFN----SECEVLRNVRHRNLIKIL 235
           LG G+FG+V KG       V       L+ E    +      +E  V++ + +  +++++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGLALEYLHYGHALA 293
             C    +  LV+E    G L K+L  + +  D  I+E   ++  V + ++YL   +   
Sbjct: 73  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQVSMGMKYLEESN--- 125
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT--IGYMAPEGI--- 348
             +H DL   N+LL     A +SDFG+SK L   D++  + +T     + + APE I   
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 349 -VSTKCDVYSYGILLLETFSR-KKP 371
             S+K DV+S+G+L+ E FS  +KP
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 125 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 176
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 125 ------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 176
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+APE I+S       D ++ G+L+ +  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ-LERTFVSFNS--------ECEVLRN 225
           F+   +LG G +G V++     G N   KIF ++ L++  +  N+        E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           V+H  ++ ++          L+LE++  G L   L     F++       + ++ +AL +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGH 136
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
           LH       II+ DLKP NI+L+      ++DFG+ K      D  +      TI YMAP
Sbjct: 137 LHQ----KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAP 190
Query: 346 EGIVST----KCDVYSYGILLLETFSRKKP 371
           E ++ +      D +S G L+ +  +   P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ-LERTFVSFNS--------ECEVLRN 225
           F+   +LG G +G V++     G N   KIF ++ L++  +  N+        E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           V+H  ++ ++          L+LE++  G L   L     F++       + ++ +AL +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGH 136
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
           LH       II+ DLKP NI+L+      ++DFG+ K      D  +      TI YMAP
Sbjct: 137 LHQ----KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAP 190
Query: 346 EGIVST----KCDVYSYGILLLETFSRKKP 371
           E ++ +      D +S G L+ +  +   P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 172 TNEFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS---ECEVLRNV 226
           ++ +    +LG GSFG V   K  ++ G   A+K+ + +  +      S   E ++L+ +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N++K+     +  +  LV E    G L   + S   F ++ +   I+  V   + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 287 HYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           H       I+H DLKP N+LL+   ++    + DFG+S      + S      + T  Y+
Sbjct: 143 HKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 195
Query: 344 APE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
           APE   G    KCDV+S G++L    S   P N   E  +
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+    L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 124 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+    L  E   V   +  E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y APE +
Sbjct: 123 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 174
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 181 LGIGSFGSVYKG------TLSDGTNVAIKIFNLQLERT-FVSFNSECEVLRNVRHR-NLI 232
           LG G+FG V +         +    VA+K+       +   +  SE ++L ++ H  N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 233 KILSGCSNLDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDILERLNIM 276
            +L  C+      +V+ EF   G+L  +L S               +  FL +   +   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V   +E+L    A    IH DL   NILL E  V  + DFG+++ + +  D + +   
Sbjct: 192 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
              + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 127 ------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 178
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIF-----NLQLERTFVSFNSECE 221
           +IQR   E   C  +G G FG V++G      N A+ +      N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            +R   H +++K++ G    +   +++E    G L  +L    + LD+   +     +  
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL YL         +H D+   N+L+       + DFG+S+ + E       +K    I 
Sbjct: 123 ALAYLESKR----FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 177
Query: 342 YMAPEGI----VSTKCDVYSYGILLLE 364
           +MAPE I     ++  DV+ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 31/214 (14%)
Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILS 236
            L+G G FG VY G       VAI++ +++   E    +F  E    R  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            C +    A++       +L   +      LD+ +   I  ++   + YLH       I+
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGIL 152
Query: 297 HCDLKPSNILLDENMVAHVSDFG---ISKLL--GEGDDSL-IQTKTMATIGYMAPEGI-- 348
           H DLK  N+  D   V  ++DFG   IS +L  G  +D L IQ   +    ++APE I  
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC---HLAPEIIRQ 208
Query: 349 -----------VSTKCDVYSYGILLLETFSRKKP 371
                       S   DV++ G +  E  +R+ P
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 22/236 (9%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRN 225
           L I+    +F+   +LG GSFG V+       TN    I  L+ +   +  + EC ++  
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEK 69
Query: 226 ------VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
                   H  L  +       +    V+E++  G L   + S + F D+        ++
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEI 128
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSLIQTKTM 337
            L L++LH       I++ DLK  NILLD++    ++DFG+ K  +LG+        +  
Sbjct: 129 ILGLQFLHS----KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNEFC 180
Query: 338 ATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP 389
            T  Y+APE ++  K     D +S+G+LL E    + P +   E  L H +    P
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 236

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 125 ------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 176
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 133/319 (41%), Gaps = 44/319 (13%)
Query: 155 LPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV 214
           LPL+  R I+         +      +G G +G V+ G    G  VA+K+F    E    
Sbjct: 27  LPLLVQRTIA--------KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---A 74
Query: 215 SFNSECEVLRNV--RHRNLIKILS----GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD 268
           S+  E E+ + V  RH N++  ++    G  +     L+ ++  NGSL  +L S    LD
Sbjct: 75  SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LD 132
Query: 269 ILERLNIMIDVGLALEYLHY----GHALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KL 323
               L +       L +LH           I H DLK  NIL+ +N    ++D G++ K 
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 324 LGEGDDSLIQTKT-MATIGYMAPEGIVST----------KCDVYSYGILLLETFSRKKPT 372
           + + ++  I   T + T  YM PE +  +            D+YS+G++L E   R    
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 373 NDLGEMSLK-HWVNQSLP--HKLAEVVDSNLVRREHSFSAKM---DCLLRIMNLALDCCM 426
             + E  L  H +  S P    + E+V    +R   SF  +    +CL ++  L  +C  
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR--PSFPNRWSSDECLRQMGKLMTECWA 310
Query: 427 ESPDERIHTTNAAAKLRKI 445
            +P  R+        L K+
Sbjct: 311 HNPASRLTALRVKKTLAKM 329

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 25/242 (10%)
Query: 181 LGIGSFGSVYK-GTLSDGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           +G GS+G   K    SDG  +  K  +     E       SE  +LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 238 CSNLDFKAL--VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHY---- 288
             +     L  V+E+   G L   +        +LD    L +M  + LAL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
           GH    ++H DLKP+N+ LD      + DFG++++L   D S  +T  + T  YM+PE +
Sbjct: 134 GHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKT-FVGTPYYMSPEQM 188
Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS----LPHKLAEVVDSNL 400
                + K D++S G LL E  +   P     +  L   + +     +P++ ++ ++  +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 401 VR 402
            R
Sbjct: 249 TR 250

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 115/257 (44%), Gaps = 25/257 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSF-NSECEVLRNVRHRNL 231
           F +   +G GSFG V+KG + + T   VAIKI +L+     +     E  VL       +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
            K            +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKK 140
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--- 348
               IH D+K +N+LL E+    ++DFG++  L   D  + +   + T  +MAPE I   
Sbjct: 141 ----IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 349 -VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--------HKLAEVVDSN 399
              +K D++S GI  +E    + P ++L  M +   + ++ P          L E V++ 
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
Query: 400 LVRREHSFSAKMDCLLR 416
           L  +E SF      LL+
Sbjct: 255 L-NKEPSFRPTAKELLK 270

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 115/257 (44%), Gaps = 25/257 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSF-NSECEVLRNVRHRNL 231
           F +   +G GSFG V+KG + + T   VAIKI +L+     +     E  VL       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
            K            +++E++  GS    L      LD  +   I+ ++   L+YLH    
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKK 125
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--- 348
               IH D+K +N+LL E+    ++DFG++  L   D  + +   + T  +MAPE I   
Sbjct: 126 ----IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 349 -VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--------HKLAEVVDSN 399
              +K D++S GI  +E    + P ++L  M +   + ++ P          L E V++ 
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 239
Query: 400 LVRREHSFSAKMDCLLR 416
           L  +E SF      LL+
Sbjct: 240 L-NKEPSFRPTAKELLK 255

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 25/242 (10%)
Query: 181 LGIGSFGSVYK-GTLSDGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           +G GS+G   K    SDG  +  K  +     E       SE  +LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 238 CSNLDFKAL--VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHY---- 288
             +     L  V+E+   G L   +        +LD    L +M  + LAL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
           GH    ++H DLKP+N+ LD      + DFG++++L    D+      + T  YM+PE +
Sbjct: 134 GHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQM 188
Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS----LPHKLAEVVDSNL 400
                + K D++S G LL E  +   P     +  L   + +     +P++ ++ ++  +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 401 VR 402
            R
Sbjct: 249 TR 250

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTN-VAIKI-FNLQLERTFV--SFNSECEVLRNVRH 228
           ++F+    LG G FG+VY          VA+K+ F  Q+E+  V      E E+  ++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++ +   +     L+LE+ P G L K L     F D      IM ++  AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTF-DEQRTATIMEELADALMYCHG 141
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEG 347
                 +IH D+KP N+LL       ++DFG S          ++ KTM  T+ Y+ PE 
Sbjct: 142 ----KKVIHRDIKPENLLLGLKGELKIADFGWSV-----HAPSLRRKTMCGTLDYLPPEM 192
Query: 348 IV----STKCDVYSYGILLLETFSRKKP 371
           I     + K D++  G+L  E      P
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 8/199 (4%)
Query: 187 GSVYKGTLSDGTNVAIKIFNLQLERTFVS--FNSECEVLRNVRHRNLIKILSGCSN--LD 242
           G ++KG    G ++ +K+  ++   T  S  FN EC  LR   H N++ +L  C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 243 FKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLK 301
              L+  + P GSL   L+   N+ +D  + +   +D      +LH    L P     L 
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIP--RHALN 140
Query: 302 PSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGIL 361
             ++ +DE+  A +S   +                        PE       D +S+ +L
Sbjct: 141 SRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSFAVL 200
Query: 362 LLETFSRKKPTNDLGEMSL 380
           L E  +R+ P  DL    +
Sbjct: 201 LWELVTREVPFADLSNXEI 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNV--AIKIFNLQLERTFVSFNSECEVL-RNVRH 228
           T+ ++    +G+GS+ SV K  +   TN+  A+KI    ++++      E E+L R  +H
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKI----IDKSKRDPTEEIEILLRYGQH 75
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N+I +     +  +  +V E M  G L   +    +F +  E   ++  +   +EYLH 
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH- 133
Query: 289 GHALAPIIHCDLKPSNIL-LDEN---MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
                 ++H DLKPSNIL +DE+       + DFG +K L   ++ L+ T    T  ++A
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCY-TANFVA 188
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +        CD++S G+LL    +   P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
              Y+AP  I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 169 QRATNEF---DECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERTFVSFNSECEVLR 224
           Q A N F    +  +LG G FG V+K    + G  +A KI   +  +      +E  V+ 
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            + H NLI++     + +   LV+E++  G L   +   +Y L  L+ +  M  +   + 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVS--DFGISKLLGEGDDSLIQTKTMATIGY 342
           ++H  +    I+H DLKP NIL        +   DFG+++     +   +      T  +
Sbjct: 202 HMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEF 254
Query: 343 MAPEGI----VSTKCDVYSYGIL 361
           +APE +    VS   D++S G++
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVI 277

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 50/261 (19%)
Query: 199 NVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLE 257
            VAIK  NL+  +T +     E + +    H N++   +     D   LV++ +  GS+ 
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV- 95
Query: 258 KWLYSHNYFLDILERL-----------------NIMIDVGLALEYLHYGHALAPIIHCDL 300
                    LDI++ +                  I+ +V   LEYLH        IH D+
Sbjct: 96  ---------LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ----IHRDV 142
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDD---SLIQTKTMATIGYMAPEGIVST-----K 352
           K  NILL E+    ++DFG+S  L  G D   + ++   + T  +MAPE +        K
Sbjct: 143 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK 202
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL-AEVVDSNLVRREHSFSAKM 411
            D++S+GI  +E  +   P +    M +     Q+ P  L   V D  ++++      KM
Sbjct: 203 ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM 262
Query: 412 DCLLRIMNLALDCCMESPDER 432
             L         C  + P++R
Sbjct: 263 ISL---------CLQKDPEKR 274

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 14/194 (7%)
Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           +D    LG G+FG V++    + G     K  N        +  +E  ++  + H  LI 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +     +     L+LEF+  G L   + + +Y +   E +N M      L+++H  H+  
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-EHS-- 169
Query: 294 PIIHCDLKPSNILLDENMVAHVS--DFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--- 348
            I+H D+KP NI+ +    + V   DFG++  L    D +++  T AT  + APE +   
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKV-TTATAEFAAPEIVDRE 225
Query: 349 -VSTKCDVYSYGIL 361
            V    D+++ G+L
Sbjct: 226 PVGFYTDMWAIGVL 239

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFN---LQLERTFVSFNSECEVL 223
           I     +F   NLLG GSF  VY+  ++  G  VAIK+ +   +          +E ++ 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
             ++H +++++ +   + ++  LVLE   NG + ++L +        E  + M  +   +
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
            YLH  H    I+H DL  SN+LL  NM   ++DFG++  L    +         T  Y+
Sbjct: 126 LYLH-SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYI 179
Query: 344 APEGIVST----KCDVYSYGILLLETFSRKKP 371
           +PE    +    + DV+S G +       + P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 20/220 (9%)
Query: 172 TNEFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS---ECEVLRNV 226
           ++ +    +LG GSFG V   K  ++ G   A+K+ + +  +      S   E ++L+ +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N+ K+     +  +  LV E    G L   + S   F ++ +   I+  V   + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 287 HYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           H       I+H DLKP N+LL+   ++    + DFG+S      + S      + T  Y+
Sbjct: 143 HKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYI 195
Query: 344 APE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
           APE   G    KCDV+S G++L    S   P N   E  +
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 50/261 (19%)
Query: 199 NVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLE 257
            VAIK  NL+  +T +     E + +    H N++   +     D   LV++ +  GS+ 
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV- 100
Query: 258 KWLYSHNYFLDILERL-----------------NIMIDVGLALEYLHYGHALAPIIHCDL 300
                    LDI++ +                  I+ +V   LEYLH        IH D+
Sbjct: 101 ---------LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ----IHRDV 147
Query: 301 KPSNILLDENMVAHVSDFGISKLLGEGDD---SLIQTKTMATIGYMAPEGIVST-----K 352
           K  NILL E+    ++DFG+S  L  G D   + ++   + T  +MAPE +        K
Sbjct: 148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK 207
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE-VVDSNLVRREHSFSAKM 411
            D++S+GI  +E  +   P +    M +     Q+ P  L   V D  ++++      KM
Sbjct: 208 ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM 267
Query: 412 DCLLRIMNLALDCCMESPDER 432
             L         C  + P++R
Sbjct: 268 ISL---------CLQKDPEKR 279

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 171 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 226
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAE 249

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 13/220 (5%)
Query: 181 LGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T    G  VA+K  +L+ ++      +E  ++R+  H N++ + S   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
             D   +V+EF+  G+L   + +H   ++  +   + + V  AL YLH       +IH D
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLHN----QGVIHRD 166
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDV 355
           +K  +ILL  +    +SDFG    + +  +   +   + T  +MAPE I      T+ D+
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKXLVGTPYWMAPEVISRLPYGTEVDI 224
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV 395
           +S GI+++E    + P  +   +     +  SLP ++ ++
Sbjct: 225 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDL 264

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN----VAIK-IFNLQLERTFVSFNSECEVLRNVRHR 229
           +D  ++LG G+F  V    L++       VAIK I    LE    S  +E  VL  ++H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 76
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N++ +     +     L+++ +  G L   +    ++ +  +   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLHD- 134
Query: 290 HALAPIIHCDLKPSNIL---LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                I+H DLKP N+L   LDE+    +SDFG+SK+   G  S++ T    T GY+APE
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST-ACGTPGYVAPE 188
Query: 347 GIV----STKCDVYSYGIL 361
            +     S   D +S G++
Sbjct: 189 VLAQKPYSKAVDCWSIGVI 207

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 26/232 (11%)
Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL 207
           SDEE L  L     +S  D ++    F++   +G G+ G+VY    ++ G  VAI+  NL
Sbjct: 2   SDEEILEKLRII--VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL 56
Query: 208 QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 267
           Q +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +      +
Sbjct: 57  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CM 114
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGE 326
           D  +   +  +   ALE+LH       +IH ++K  NILL  +    ++DFG  +++  E
Sbjct: 115 DEGQIAAVCRECLQALEFLHSNQ----VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE 170
Query: 327 GDDSLIQTKTMATIG---YMAPEGIV----STKCDVYSYGILLLETFSRKKP 371
                 Q+K    +G   +MAPE +       K D++S GI+ +E    + P
Sbjct: 171 ------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 46/226 (20%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIK----IFNL--QLERTFVSFNSECEVLRN 225
           +E++    +G G++G V        G  VAIK     F++    +RT      E ++L++
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKH 110
Query: 226 VRHRNLIKI----LSGCSNLDFKAL--VLEFMPNGSLEKWLYSHN--------YFLDILE 271
            +H N+I I           +FK++  VL+ M    L + ++S          YFL  L 
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL--GEGDD 329
           R          L+Y+H     A +IH DLKPSN+L++EN    + DFG+++ L     + 
Sbjct: 170 R---------GLKYMHS----AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 330 SLIQTKTMATIGYMAPEGIVS-----TKCDVYSYGILLLETFSRKK 370
               T+ +AT  Y APE ++S        D++S G +  E  +R++
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+ ++ +       L +++     +  GLA  + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 127 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 178
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 46/226 (20%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIK----IFNL--QLERTFVSFNSECEVLRN 225
           +E++    +G G++G V        G  VAIK     F++    +RT      E ++L++
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKH 109
Query: 226 VRHRNLIKI----LSGCSNLDFKAL--VLEFMPNGSLEKWLYSHN--------YFLDILE 271
            +H N+I I           +FK++  VL+ M    L + ++S          YFL  L 
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL--GEGDD 329
           R          L+Y+H     A +IH DLKPSN+L++EN    + DFG+++ L     + 
Sbjct: 169 R---------GLKYMHS----AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 330 SLIQTKTMATIGYMAPEGIVS-----TKCDVYSYGILLLETFSRKK 370
               T+ +AT  Y APE ++S        D++S G +  E  +R++
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 96
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 156 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 211
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAE 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 85
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 145 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 200
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAE 223

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 149 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 204
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAE 227

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 179 NLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILS 236
           ++LG G+   V     L      A+KI   Q          E E+L   + HRN+++++ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
                D   LV E M  GS+   ++   +F + LE   ++ DV  AL++LH       I 
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASVVVQDVASALDFLHN----KGIA 133
Query: 297 HCDLKPSNILLDE-NMVAHVS--DFGI-SKLLGEGDDSLIQTKTMAT----IGYMAPE-- 346
           H DLKP NIL +  N V+ V   DFG+ S +   GD S I T  + T      YMAPE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 347 -------GIVSTKCDVYSYGILLLETFSRKKP 371
                   I   +CD++S G++L    S   P
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 44/230 (19%)
Query: 170 RATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIK---IFNLQLERTFVSFNSECEVLRN 225
           R   +F+    LG G FG V++     D  N AIK   + N +L R  V    E + L  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM--REVKALAK 59
Query: 226 VRH------------RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER- 272
           + H            +N  + L   S   +  + ++     +L+ W+   N    I ER 
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERE 116
Query: 273 ----LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
               L+I + +  A+E+LH       ++H DLKPSNI    + V  V DFG+   + + +
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 329 DSLI----------QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLE 364
           +              T  + T  YM+PE I     S K D++S G++L E
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 171 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 226
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAE 249

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 149 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 204
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAE 227

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN----VAIK-IFNLQLERTFVSFNSECEVLRNVRHR 229
           +D  ++LG G+F  V    L++       VAIK I    LE    S  +E  VL  ++H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N++ +     +     L+++ +  G L   +    ++ +  +   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLHD- 134
Query: 290 HALAPIIHCDLKPSNIL---LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                I+H DLKP N+L   LDE+    +SDFG+SK+   G  S++ T    T GY+APE
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST-ACGTPGYVAPE 188
Query: 347 GIV----STKCDVYSYGIL 361
            +     S   D +S G++
Sbjct: 189 VLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN----VAIK-IFNLQLERTFVSFNSECEVLRNVRHR 229
           +D  ++LG G+F  V    L++       VAIK I    LE    S  +E  VL  ++H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N++ +     +     L+++ +  G L   +    ++ +  +   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLH-- 133
Query: 290 HALAPIIHCDLKPSNIL---LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                I+H DLKP N+L   LDE+    +SDFG+SK+   G  S++ T    T GY+APE
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST-ACGTPGYVAPE 188
Query: 347 GIV----STKCDVYSYGIL 361
            +     S   D +S G++
Sbjct: 189 VLAQKPYSKAVDCWSIGVI 207

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 IL-----SG-CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +      SG   ++ +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 137 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 192
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAE 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+ ++ +       L +++     +  GLA  + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 124 ------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 175
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 33/162 (20%)
Query: 218 SECEVLRNVRHRNLIKILSGCS--NLDFKALVLEFMPNGSLEKWL--------YSHNYFL 267
            E  +L+ + H N++K++      N D   +V E +  G + +           +  YF 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
           D+++           +EYLHY      IIH D+KPSN+L+ E+    ++DFG+S    +G
Sbjct: 145 DLIK----------GIEYLHY----QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KG 189
Query: 328 DDSLIQTKTMATIGYMAPEGIVSTK-------CDVYSYGILL 362
            D+L+ + T+ T  +MAPE +  T+        DV++ G+ L
Sbjct: 190 SDALL-SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 105
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 165 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 220
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAE 243

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 113
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 173 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 228
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAE 251

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 137 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 192
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAE 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 137 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 192
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAE 215

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 115
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 175 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 230
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAE 253

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 78
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 138 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 193
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAE 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 50/262 (19%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           ++FD    LG GSFG V      + G + A+KI + Q       +E T     +E  +L+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQ 96
Query: 225 NVRHRNLIKI---LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
            V    L+K+       SNL    +V+E++  G +   L     F +   R      + L
Sbjct: 97  AVNFPFLVKLEFSFKDNSNL---YMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVL 152
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
             EYLH       +I+ DLKP N+L+D+     V+DFG +K         ++ +T    G
Sbjct: 153 TFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 342 ---YMAPEGIVS----TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
               +APE I+S       D ++ G+L+ E  +   P           + +Q  P ++ E
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----------FFADQ--PIQIYE 248
Query: 395 VVDSNLVRREHSFSAKMDCLLR 416
            + S  VR    FS+ +  LLR
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLR 270

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 22/236 (9%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRN 225
           L I+    +F    +LG GSFG V+       TN    I  L+ +   +  + EC ++  
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 226 ------VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
                   H  L  +       +    V+E++  G L   + S + F D+        ++
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEI 127
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSLIQTKTM 337
            L L++LH       I++ DLK  NILLD++    ++DFG+ K  +LG+   +       
Sbjct: 128 ILGLQFLHS----KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF----C 179
Query: 338 ATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP 389
            T  Y+APE ++  K     D +S+G+LL E    + P +   E  L H +    P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 81
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 141 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 196
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAE 219

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 90
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 150 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 205
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAE 228

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+ ++ +       L +++     +  GLA  + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 127 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 178
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN----VAIK-IFNLQLERTFVSFNSECEVLRNVRHR 229
           +D  ++LG G+F  V    L++       VAIK I    LE    S  +E  VL  ++H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N++ +     +     L+++ +  G L   +    ++ +  +   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLHD- 134
Query: 290 HALAPIIHCDLKPSNIL---LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
                I+H DLKP N+L   LDE+    +SDFG+SK+   G  S++ T    T GY+APE
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST-ACGTPGYVAPE 188
Query: 347 GIV----STKCDVYSYGIL 361
            +     S   D +S G++
Sbjct: 189 VLAQKPYSKAVDCWSIGVI 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 156
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 216 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 271
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAE 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV EF+ +  L+ ++ +       L +++     +  GLA  + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 ++H DLKP N+L++      ++DFG+++  G    +      + T+ Y APE +
Sbjct: 126 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH--EVVTLWYRAPEIL 177
Query: 349 V-----STKCDVYSYGILLLETFSRK 369
           +     ST  D++S G +  E  +R+
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 137 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 192
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAE 215

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK---IFNLQLERTFVSFNSECEV---- 222
           AT+ ++    +G+G++G+VYK      G  VA+K   + N       +  ++  EV    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 223 -LRNVRHRNLIKILSGC----SNLDFK-ALVLEFMPNGSLEKWL-YSHNYFLDILERLNI 275
            L    H N+++++  C    ++ + K  LV E + +  L  +L  +    L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
           M      L++LH       I+H DLKP NIL+       ++DFG++++       +  T 
Sbjct: 126 MRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
            + T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   LQ +R     N E +++R + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 82
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 142 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 197
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAE 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHY 288
           +K+L      +   LV E + +  L+K++ +       L +++     +  GLA  + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT----MATIGYMA 344
                 ++H DLKP N+L++      ++DFG+++  G      +  +T    + T+ Y A
Sbjct: 127 ------VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYRA 174
Query: 345 PEGIV-----STKCDVYSYGILLLETFSRK 369
           PE ++     ST  D++S G +  E  +R+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVR 227
           AT+ ++    +G+G++G+VYK      G  VA+K   +    E   +S   E  +LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 228 ---HRNLIKILSGC----SNLDFK-ALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMID 278
              H N+++++  C    ++ + K  LV E + +  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               L++LH       I+H DLKP NIL+       ++DFG++++       +     + 
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALAPVVV 173
Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L  E   V   +  E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 232 IKILSGCSNLDFKALVLE--------FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           +K+L      +   LV E        FM   +L          L +++     +  GLA 
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALT------GIPLPLIKSYLFQLLQGLAF 117
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
            + H       ++H DLKP N+L++      ++DFG+++  G    +   T  + T+ Y 
Sbjct: 118 CHSHR------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 169
Query: 344 APEGIV-----STKCDVYSYGILLLETFSRK 369
           APE ++     ST  D++S G +  E  +R+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   +   + F   N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 137 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPE 192
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAE 215

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 37/275 (13%)
Query: 175 FDECNLLGIGSFGSVY---KGTLSD-GTNVAIKIFN----LQLERTFVSFNSECEVLRNV 226
           F+   +LG G++G V+   K +  D G   A+K+      +Q  +T     +E +VL ++
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 227 RHRNLIKILSGCSNLDFK-ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGLALE 284
           R    +  L      + K  L+L+++  G L   L     F +    + I + ++ LALE
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALE 173
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           +LH       II+ D+K  NILLD N    ++DFG+SK     D++        TI YMA
Sbjct: 174 HLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYMA 228
Query: 345 PEGIVS------TKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
           P+ +           D +S G+L+ E  +   P    GE + +  +++            
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR------------ 276
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
            +++ E  +  +M  L +  +L     M+ P +R+
Sbjct: 277 RILKSEPPYPQEMSALAK--DLIQRLLMKDPKKRL 309

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVR 227
           AT+ ++    +G+G++G+VYK      G  VA+K   +    E   +S   E  +LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 228 ---HRNLIKILSGC----SNLDFK-ALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMID 278
              H N+++++  C    ++ + K  LV E + +  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               L++LH       I+H DLKP NIL+       ++DFG++++       +     + 
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 33/230 (14%)
Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS- 218
           +RI Y      +++F   +LLG G++G V   T    G  VAIK      ++   +  + 
Sbjct: 3   KRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTL 57
Query: 219 -ECEVLRNVRHRNLIKILS-----GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER 272
            E ++L++ +H N+I I +        N +   ++ E M    L + + +     D ++ 
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQY 116
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE--GDDS 330
              +     A++ LH  +    +IH DLKPSN+L++ N    V DFG+++++ E   D+S
Sbjct: 117 F--IYQTLRAVKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 331 LI------QTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
                    T+ +AT  Y APE ++     S   DV+S G +L E F R+
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 185
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 186 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 237
Query: 349 VST----KCDVYSYGILLLETFSRKKP 371
             T    + D++S G+ L+E    + P
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           N+FD   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  ALEY
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 123
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMA 344
           LH       +++ D+K  N++LD++    ++DFG+ K   EG       KT   T  Y+A
Sbjct: 124 LHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLA 176
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   +   + F   N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 137 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 192
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAE 215

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNS 218
           +D +   N+FD   LLG G+FG V     K T   G   A+KI   ++   +       +
Sbjct: 3   MDPKVTMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVT 59
Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           E  VL+N RH  L  +       D    V+E+   G L   L     F +   R     +
Sbjct: 60  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAE 118
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTM 337
           +  ALEYLH       +++ D+K  N++LD++    ++DFG+ K   EG  D        
Sbjct: 119 IVSALEYLHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFC 171
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKP 371
            T  Y+APE +         D +  G+++ E    + P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 168 IQRATNEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVL 223
           +Q    ++D   ++G G+FG V    +K +        +  F +        F  E +++
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGL 281
                  ++++     +  +  +V+E+MP G L   +   NY  D+ E+       +V L
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVL 185
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATI 340
           AL+ +H       +IH D+KP N+LLD++    ++DFG    + E    ++   T + T 
Sbjct: 186 ALDAIHS----MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET--GMVHCDTAVGTP 239
Query: 341 GYMAPE--------GIVSTKCDVYSYGILLLETFSRKKP 371
            Y++PE        G    +CD +S G+ L E      P
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L D G  VAIK   +   + F   N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 234 I----LSGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +     S     D  +  LVL+++P  ++ +    ++     L  + + + +      L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 288 YGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           Y H+   I H D+KP N+LLD +  V  + DFG +K L  G+ ++     + +  Y APE
Sbjct: 137 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPE 192
Query: 347 GIV-----STKCDVYSYGILLLE 364
            I      ++  DV+S G +L E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAE 215

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 33/230 (14%)
Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS- 218
           +RI Y      +++F   +LLG G++G V   T    G  VAIK      ++   +  + 
Sbjct: 3   KRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTL 57
Query: 219 -ECEVLRNVRHRNLIKILS-----GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER 272
            E ++L++ +H N+I I +        N +   ++ E M    L + + +     D ++ 
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQY 116
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE--GDDS 330
              +     A++ LH  +    +IH DLKPSN+L++ N    V DFG+++++ E   D+S
Sbjct: 117 F--IYQTLRAVKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 331 LI------QTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
                    T+ +AT  Y APE ++     S   DV+S G +L E F R+
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           N+FD   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMA 344
           LH       +++ D+K  N++LD++    ++DFG+ K   EG       KT   T  Y+A
Sbjct: 121 LHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLA 173
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 19/191 (9%)
Query: 180 LLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           +LG G+F  V+  K  L+ G   A+K           S  +E  VL+ ++H N++ +   
Sbjct: 16  VLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
             +     LV++ +  G L   +     + +    L ++  V  A++YLH       I+H
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-VIQQVLSAVKYLHEN----GIVH 129
Query: 298 CDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----S 350
            DLKP N+L    +EN    ++DFG+SK+   G    I +    T GY+APE +     S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYS 185
Query: 351 TKCDVYSYGIL 361
              D +S G++
Sbjct: 186 KAVDCWSIGVI 196

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 150
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 151 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 202
Query: 349 VST----KCDVYSYGILLLETFSRKKP 371
             T    + D++S G+ L+E    + P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVR 227
           AT+ ++    +G+G++G+VYK      G  VA+K   +    E   +S   E  +LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 228 ---HRNLIKILSGC----SNLDFK-ALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMID 278
              H N+++++  C    ++ + K  LV E + +  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
               L++LH       I+H DLKP NIL+       ++DFG++++       +     + 
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           N+FD   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMA 344
           LH       +++ D+K  N++LD++    ++DFG+ K   EG       KT   T  Y+A
Sbjct: 121 LHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLA 173
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 160 WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS 218
           W+ +  L+I    N+F    ++G G FG VY    +D G   A+K     L++  +    
Sbjct: 177 WKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC----LDKKRIKMK- 230
Query: 219 ECEVLRNVRHRNLIKILSG-------CSNLDFK-----ALVLEFMPNGSLEKWLYSHNYF 266
           + E L  +  R ++ ++S        C +  F      + +L+ M  G L   L  H  F
Sbjct: 231 QGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 289
Query: 267 LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
            +   R     ++ L LE++H       +++ DLKP+NILLDE+    +SD G++    +
Sbjct: 290 SEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344
Query: 327 GDDSLIQTKTMATIGYMAPE----GIV-STKCDVYSYGILLLETFSRKKP 371
                    ++ T GYMAPE    G+   +  D +S G +L +      P
Sbjct: 345 KKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 160 WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS 218
           W+ +  L+I    N+F    ++G G FG VY    +D G   A+K     L++  +    
Sbjct: 176 WKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC----LDKKRIKMK- 229
Query: 219 ECEVLRNVRHRNLIKILSG-------CSNLDFK-----ALVLEFMPNGSLEKWLYSHNYF 266
           + E L  +  R ++ ++S        C +  F      + +L+ M  G L   L  H  F
Sbjct: 230 QGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 288
Query: 267 LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
            +   R     ++ L LE++H       +++ DLKP+NILLDE+    +SD G++    +
Sbjct: 289 SEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSK 343
Query: 327 GDDSLIQTKTMATIGYMAPE----GIV-STKCDVYSYGILLLETFSRKKP 371
                    ++ T GYMAPE    G+   +  D +S G +L +      P
Sbjct: 344 KKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 123
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 175
Query: 349 VST----KCDVYSYGILLLETFSRKKP 371
             T    + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVL-RNVRH 228
           T+ ++    +G+GS+ SV K  +   TN   A+KI    ++++      E E+L R  +H
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKI----IDKSKRDPTEEIEILLRYGQH 75
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N+I +     +  +  +V E    G L   +    +F +  E   ++  +   +EYLH 
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH- 133
Query: 289 GHALAPIIHCDLKPSNIL-LDEN---MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
                 ++H DLKPSNIL +DE+       + DFG +K L   ++ L+ T    T  ++A
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLXTPCY-TANFVA 188
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +        CD++S G+LL    +   P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 113/240 (47%), Gaps = 18/240 (7%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
             D   +V+EF+  G+L   + +H   ++  +   + + V  AL  LH       +IH D
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLHAQG----VIHRD 272
Query: 300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDV 355
           +K  +ILL  +    +SDFG    + +  +   +   + T  +MAPE I       + D+
Sbjct: 273 IKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYGPEVDI 330
Query: 356 YSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL 415
           +S GI+++E    + P  +   +     +  +LP +L      NL +   S    +D LL
Sbjct: 331 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----KNLHKVSPSLKGFLDRLL 385

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F+  + LG G+ G V K      G  +A K+ +L+++    +    E +VL       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GLA  YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 133
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YMAPE +
Sbjct: 134 HQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMAPERL 185
Query: 349 VST----KCDVYSYGILLLETFSRKKP 371
             T    + D++S G+ L+E    + P
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 160 WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS 218
           W+ +  L+I    N+F    ++G G FG VY    +D G   A+K     L++  +    
Sbjct: 177 WKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC----LDKKRIKMK- 230
Query: 219 ECEVLRNVRHRNLIKILSG-------CSNLDFK-----ALVLEFMPNGSLEKWLYSHNYF 266
           + E L  +  R ++ ++S        C +  F      + +L+ M  G L   L  H  F
Sbjct: 231 QGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 289
Query: 267 LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
            +   R     ++ L LE++H       +++ DLKP+NILLDE+    +SD G++    +
Sbjct: 290 SEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344
Query: 327 GDDSLIQTKTMATIGYMAPE----GIV-STKCDVYSYGILLLETFSRKKP 371
                    ++ T GYMAPE    G+   +  D +S G +L +      P
Sbjct: 345 KKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 160 WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNS 218
           W+ +  L+I    N+F    ++G G FG VY    +D G   A+K     L++  +    
Sbjct: 177 WKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC----LDKKRIKMK- 230
Query: 219 ECEVLRNVRHRNLIKILSG-------CSNLDFK-----ALVLEFMPNGSLEKWLYSHNYF 266
           + E L  +  R ++ ++S        C +  F      + +L+ M  G L   L  H  F
Sbjct: 231 QGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 289
Query: 267 LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
            +   R     ++ L LE++H       +++ DLKP+NILLDE+    +SD G++    +
Sbjct: 290 SEADMRF-YAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344
Query: 327 GDDSLIQTKTMATIGYMAPE----GIV-STKCDVYSYGILLLETFSRKKP 371
                    ++ T GYMAPE    G+   +  D +S G +L +      P
Sbjct: 345 KKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 24/243 (9%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGLA-LEYLHYGHALAPII 296
             D   +V+EF+  G+L   + +H        R+N   +  V LA L+ L   HA   +I
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLQALSVLHAQG-VI 147
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTK 352
           H D+K  +ILL  +    +SDFG    + +  +   +   + T  +MAPE I       +
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            D++S GI+++E    + P  +   +     +  +LP +L      NL +   S    +D
Sbjct: 206 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----KNLHKVSPSLKGFLD 260
Query: 413 CLL 415
            LL
Sbjct: 261 RLL 263

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 27/229 (11%)
Query: 178 CNLLGIGSFGSVYKGTLSD-GTNVAIKIFN-LQLERTFVSFNSECEVLRNVRHRNLIKIL 235
            ++LG G+  +V++G     G   AIK+FN +   R       E EVL+ + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 236 S--GCSNLDFKALVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           +    +    K L++EF P GSL   L   S+ Y L   E L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 292 LAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
              I+H ++KP NI+     D   V  ++DFG ++ L E D+  +      T  Y+ P  
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFV--SLYGTEEYLHP-- 184
Query: 348 IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK--HWVNQSLPHKLAE 394
                 D+Y   +L  +   +   T DL  + +   H    SLP +  E
Sbjct: 185 ------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 24/243 (9%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGLA-LEYLHYGHALAPII 296
             D   +V+EF+  G+L   + +H        R+N   +  V LA L+ L   HA   +I
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLQALSVLHAQG-VI 149
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTK 352
           H D+K  +ILL  +    +SDFG    + +  +   +   + T  +MAPE I       +
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            D++S GI+++E    + P  +   +     +  +LP +L      NL +   S    +D
Sbjct: 208 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----KNLHKVSPSLKGFLD 262
Query: 413 CLL 415
            LL
Sbjct: 263 RLL 265

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 179 NLLGIGSFGSVYKGTLSD-GTNVAIKIFN-LQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           ++LG G+  +V++G     G   AIK+FN +   R       E EVL+ + H+N++K+ +
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 237 --GCSNLDFKALVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
               +    K L++EF P GSL   L   S+ Y L   E L ++ DV   + +L      
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 293 APIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
             I+H ++KP NI+     D   V  ++DFG ++ L E D+  +      T  Y+ P   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVX--LYGTEEYLHP--- 184
Query: 349 VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK--HWVNQSLPHKLAE 394
                D+Y   +L  +   +   T DL  + +   H    SLP +  E
Sbjct: 185 -----DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 114/230 (49%), Gaps = 23/230 (10%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 142
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 143 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 194
Query: 349 VST----KCDVYSYGILLLETFSRKKPT-NDLGEMS----LKHWVNQSLP 389
             T    + D++S G+ L+E    + P  +  G M+    L + VN+  P
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPP 244

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 123
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 175
Query: 349 VST----KCDVYSYGILLLETFSRKKP 371
             T    + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 123
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 175
Query: 349 VST----KCDVYSYGILLLETFSRKKP 371
             T    + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVS----FNSECEVLRNVRHRNLIKI 234
           N +G GS+G V K  +  GT   I+    ++ + FV     F  E E+++++ H N+I++
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTR--IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                +     LV+E    G L + +     F +  +   IM DV  A+ Y H  +    
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCHKLN---- 126
Query: 295 IIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP---EGI 348
           + H DLKP N L      +    + DFG++     G   +++TK + T  Y++P   EG+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTK-VGTPYYVSPQVLEGL 183
Query: 349 VSTKCDVYSYGILL 362
              +CD +S G+++
Sbjct: 184 YGPECDEWSAGVMM 197

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 24/243 (9%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGLA-LEYLHYGHALAPII 296
             D   +V+EF+  G+L   + +H        R+N   +  V LA L+ L   HA   +I
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLQALSVLHAQG-VI 192
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTK 352
           H D+K  +ILL  +    +SDFG    + +  +   +   + T  +MAPE I       +
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            D++S GI+++E    + P  +   +     +  +LP +L      NL +   S    +D
Sbjct: 251 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----KNLHKVSPSLKGFLD 305
Query: 413 CLL 415
            LL
Sbjct: 306 RLL 308

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           N+FD   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTMATIGYMA 344
           LH       +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLA 173
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS----- 218
           L  Q  ++ +     LG G++G V   K  L+ G   AIKI    ++++ V+  S     
Sbjct: 14  LYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKI----IKKSSVTTTSNSGAL 68
Query: 219 --ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 276
             E  VL+ + H N++K+     +     LV+E    G L   +     F ++ +   IM
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-DAAVIM 127
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQ 333
             V     YLH  +    I+H DLKP N+LL+    + +  + DFG+S     G      
Sbjct: 128 KQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---M 180
Query: 334 TKTMATIGYMAPEGI---VSTKCDVYSYGILL 362
            + + T  Y+APE +      KCDV+S G++L
Sbjct: 181 KERLGTAYYIAPEVLRKKYDEKCDVWSCGVIL 212

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 64
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 109
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 110 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 168
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 101/233 (43%), Gaps = 43/233 (18%)
Query: 174 EFDECNL-----LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV------SFNSECE 221
           EF   NL     LG G+FG V + T    G   A+    +++ ++        +  SE +
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLY------------------- 261
           ++ ++ +H N++ +L  C++     ++ E+   G L  +L                    
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 262 ---SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF 318
                   L++ + L+    V   + +L    A    IH D+   N+LL    VA + DF
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 319 GISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           G+++ +    + +++      + +MAPE I     + + DV+SYGILL E FS
Sbjct: 203 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 24/243 (9%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGLA-LEYLHYGHALAPII 296
             D   +V+EF+  G+L   + +H        R+N   +  V LA L+ L   HA   +I
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLQALSVLHAQG-VI 138
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTK 352
           H D+K  +ILL  +    +SDFG    + +  +   +   + T  +MAPE I       +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            D++S GI+++E    + P  +   +     +  +LP +L      NL +   S    +D
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----KNLHKVSPSLKGFLD 251
Query: 413 CLL 415
            LL
Sbjct: 252 RLL 254

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           N+FD   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTMATIGYMA 344
           LH       +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLA 173
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSG 237
           ++LG G+ G++    + D  +VA+K     L   F   + E ++LR    H N+I+    
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRYFCT 86
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
             +  F+ + +E     +L++++   ++    LE + ++      L +LH  +    I+H
Sbjct: 87  EKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN----IVH 141
Query: 298 CDLKPSNILLD-----ENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIVST 351
            DLKP NIL+        + A +SDFG+ K L  G  S  +   +  T G++APE ++S 
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE-MLSE 200
Query: 352 KC--------DVYSYGILLLETFS 367
            C        D++S G +     S
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 179 NLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILS 236
           ++LG G+   V     L      A+KI   Q          E E+L   + HRN+++++ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
                D   LV E M  GS+   ++   +F + LE   ++ DV  AL++LH       I 
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASVVVQDVASALDFLHN----KGIA 133
Query: 297 HCDLKPSNILLDE-NMVAHVS--DFGI-SKLLGEGDDSLIQTKTMAT----IGYMAPE-- 346
           H DLKP NIL +  N V+ V   DF + S +   GD S I T  + T      YMAPE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 347 -------GIVSTKCDVYSYGILLLETFSRKKP 371
                   I   +CD++S G++L    S   P
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 123
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 175
Query: 349 ----VSTKCDVYSYGILLLETFSRKKP 371
                S + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGLALEYLHYG 289
           ++       +    ++ +E M  GSL++ L       + IL +++I +  GL   YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 123
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGYMAPEGI 348
           H    I+H D+KPSNIL++      + DFG+S +L+    +S + T++     YM+PE +
Sbjct: 124 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL 175
Query: 349 ----VSTKCDVYSYGILLLETFSRKKP 371
                S + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVS----FNSECEVLRNVRHRNLIKI 234
           N +G GS+G V K  +  GT   I+    ++ + FV     F  E E+++++ H N+I++
Sbjct: 32  NTIGRGSWGEV-KIAVQKGTR--IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 88
Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                +     LV+E    G L + +     F +  +   IM DV  A+ Y H  +    
Sbjct: 89  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCHKLN---- 143
Query: 295 IIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP---EGI 348
           + H DLKP N L      +    + DFG++     G   +++TK + T  Y++P   EG+
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTK-VGTPYYVSPQVLEGL 200
Query: 349 VSTKCDVYSYGILL 362
              +CD +S G+++
Sbjct: 201 YGPECDEWSAGVMM 214

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           N+FD   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTMATIGYMA 344
           LH       +++ D+K  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 121 LHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLA 173
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-- 226
           R T EF E   +G G FGSV+K     DG   AIK     L  +    N+  EV  +   
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 227 -RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGL 281
            +H ++++  S  +  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD-DSLIQTKTMATI 340
            L Y+H       ++H D+KPSNI +    + + +         EGD D     K M  I
Sbjct: 125 GLRYIHS----MSLVHMDIKPSNIFISRTSIPNAAS-------EEGDEDDWASNKVMFKI 173
Query: 341 G 341
           G
Sbjct: 174 G 174

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 181 LGIGSFGSVYKGTLSDGTNV--AIKIFNLQLERTFVSFNSECEVL-RNVRHRNLIKILSG 237
           +G+GS+ S  K  +   TN+  A+K+    ++++    + E E+L R  +H N+I +   
Sbjct: 35  IGVGSY-SECKRCVHKATNMEYAVKV----IDKSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
             +     LV E M  G L   +    +F +  E   ++  +G  +EYLH       ++H
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSE-REASFVLHTIGKTVEYLHS----QGVVH 144
Query: 298 CDLKPSNIL-LDEN---MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----V 349
            DLKPSNIL +DE+       + DFG +K L   ++ L+ T    T  ++APE +     
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMTPCY-TANFVAPEVLKRQGY 202
Query: 350 STKCDVYSYGILLLETFSRKKP 371
              CD++S GILL    +   P
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTP 224

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 90/191 (47%), Gaps = 14/191 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKILSGC 238
           +G G++G VYK   + G   A+K   L+ E   +   +  E  +L+ ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                  LV E + +  L+K L      L+ +   + ++ +   + Y H       ++H 
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR----VLHR 124
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-----STKC 353
           DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+ ++     ST  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 354 DVYSYGILLLE 364
           D++S G +  E
Sbjct: 183 DIWSVGCIFAE 193

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 90/191 (47%), Gaps = 14/191 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKILSGC 238
           +G G++G VYK   + G   A+K   L+ E   +   +  E  +L+ ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                  LV E + +  L+K L      L+ +   + ++ +   + Y H       ++H 
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR----VLHR 124
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-----STKC 353
           DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+ ++     ST  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 354 DVYSYGILLLE 364
           D++S G +  E
Sbjct: 183 DIWSVGCIFAE 193

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 90/191 (47%), Gaps = 14/191 (7%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKILSGC 238
           +G G++G VYK   + G   A+K   L+ E   +   +  E  +L+ ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                  LV E + +  L+K L      L+ +   + ++ +   + Y H       ++H 
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR----VLHR 124
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-----STKC 353
           DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+ ++     ST  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 354 DVYSYGILLLE 364
           D++S G +  E
Sbjct: 183 DIWSVGCIFAE 193

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 24/243 (9%)
Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V   T+ S G  VA+K  +L+ ++      +E  ++R+ +H N++++ +   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGLA-LEYLHYGHALAPII 296
             D   +V+EF+  G+L   + +H        R+N   +  V LA L+ L   HA   +I
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLQALSVLHAQG-VI 142
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTK 352
           H D+K  +ILL  +    +SDFG    + +  +   +   + T  +MAPE I       +
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            D++S GI+++E    + P  +   +     +  +LP +L      NL +   S    +D
Sbjct: 201 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----KNLHKVSPSLKGFLD 255
Query: 413 CLL 415
            LL
Sbjct: 256 RLL 258

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGT--LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRN 225
           RA  +++    +G G++G V+K     + G  VA+K   +Q   E   +S   E  VLR+
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 226 VR---HRNLIKILSGC--SNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERL-NIM 276
           +    H N++++   C  S  D +    LV E + +  L  +L          E + ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             +   L++LH       ++H DLKP NIL+  +    ++DFG++++       +  T  
Sbjct: 127 FQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSV 179
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           + T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-- 226
           R T EF E   +G G FGSV+K     DG   AIK     L  +    N+  EV  +   
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 227 -RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGL 281
            +H ++++  S  +  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD-DSLIQTKTMATI 340
            L Y+H       ++H D+KPSNI +    + + +         EGD D     K M  I
Sbjct: 125 GLRYIHS----MSLVHMDIKPSNIFISRTSIPNAAS-------EEGDEDDWASNKVMFKI 173
Query: 341 G 341
           G
Sbjct: 174 G 174

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 181 LGIGSFGSVYKGTLSDGTNV--AIKIFNLQLERTFVSFNSECEVL-RNVRHRNLIKILSG 237
           +G+GS+ S  K  +   TN+  A+K+    ++++    + E E+L R  +H N+I +   
Sbjct: 35  IGVGSY-SECKRCVHKATNMEYAVKV----IDKSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
             +     LV E M  G L   +    +F +  E   ++  +G  +EYLH       ++H
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSE-REASFVLHTIGKTVEYLHS----QGVVH 144
Query: 298 CDLKPSNIL-LDEN---MVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----V 349
            DLKPSNIL +DE+       + DFG +K L   ++ L+ T    T  ++APE +     
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMTPCY-TANFVAPEVLKRQGY 202
Query: 350 STKCDVYSYGILLLETFSRKKP 371
              CD++S GILL    +   P
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTP 224

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-- 226
           R T EF E   +G G FGSV+K     DG   AIK     L  +    N+  EV  +   
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 227 -RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGL 281
            +H ++++  S  +  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 126
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD-DSLIQTKTMATI 340
            L Y+H       ++H D+KPSNI +    + + +         EGD D     K M  I
Sbjct: 127 GLRYIHS----MSLVHMDIKPSNIFISRTSIPNAAS-------EEGDEDDWASNKVMFKI 175
Query: 341 G 341
           G
Sbjct: 176 G 176

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-- 226
           R T EF E   +G G FGSV+K     DG   AIK     L  +    N+  EV  +   
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 227 -RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNY----FLDILERLNIMIDVGL 281
            +H ++++  S  +  D   +  E+   GSL   + S NY    +    E  ++++ VG 
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 122
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD-DSLIQTKTMATI 340
            L Y+H       ++H D+KPSNI +    + + +         EGD D     K M  I
Sbjct: 123 GLRYIHS----MSLVHMDIKPSNIFISRTSIPNAAS-------EEGDEDDWASNKVMFKI 171
Query: 341 G 341
           G
Sbjct: 172 G 172

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           ++ +D    LG G+F  V +    + G   A KI N +    R F     E  + R ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER-----LNIMIDVGLAL 283
            N++++        F  LV + +  G L         F DI+ R      +    +   L
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 114
Query: 284 EYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           E + Y H+   I+H +LKP N+LL    +     ++DFG++    E +DS        T 
Sbjct: 115 ESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 170
Query: 341 GYMAPEGI----VSTKCDVYSYGILL 362
           GY++PE +     S   D+++ G++L
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           ++ +D    LG G+F  V +    + G   A KI N +    R F     E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER-----LNIMIDVGLAL 283
            N++++        F  LV + +  G L         F DI+ R      +    +   L
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115
Query: 284 EYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           E + Y H+   I+H +LKP N+LL    +     ++DFG++    E +DS        T 
Sbjct: 116 ESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 171
Query: 341 GYMAPEGI----VSTKCDVYSYGILL 362
           GY++PE +     S   D+++ G++L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           ++ +D    LG G+F  V +    + G   A KI N +    R F     E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER-----LNIMIDVGLAL 283
            N++++        F  LV + +  G L         F DI+ R      +    +   L
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115
Query: 284 EYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           E + Y H+   I+H +LKP N+LL    +     ++DFG++    E +DS        T 
Sbjct: 116 ESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 171
Query: 341 GYMAPEGI----VSTKCDVYSYGILL 362
           GY++PE +     S   D+++ G++L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 180 LLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERT--FVSFNSECEVLRNVRHRNLIKILS 236
           +LG GSFG V K          A+K+ N    +     +   E E+L+ + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
              +     +V E    G L   +     F +  +   I+  V   + Y+H  +    I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMHKHN----IV 143
Query: 297 HCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPE---G 347
           H DLKP NILL   +++    + DFG+S    +       TK    IG   Y+APE   G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN------TKMKDRIGTAYYIAPEVLRG 197
Query: 348 IVSTKCDVYSYGILLLETFSRKKP 371
               KCDV+S G++L    S   P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 157 LVTWRRISYLDIQRAT-NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFV 214
            + W+   +L+ Q  T N F +  +LG G FG V    + + G   A K    +  +   
Sbjct: 170 FLQWK---WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 215 SFN---SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE 271
                 +E ++L  V  R ++ +       D   LVL  M  G L+  +Y H       E
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPE 285
Query: 272 RLNIM--IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
              +    ++   LE LH       I++ DLKP NILLD++    +SD G++  + EG  
Sbjct: 286 ARAVFYAAEICCGLEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 339
Query: 330 SLIQTKTMATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKP 371
             I+ + + T+GYMAPE + + +     D ++ G LL E  + + P
Sbjct: 340 QTIKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 157 LVTWRRISYLDIQRAT-NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFV 214
            + W+   +L+ Q  T N F +  +LG G FG V    + + G   A K    +  +   
Sbjct: 170 FLQWK---WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 215 SFN---SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE 271
                 +E ++L  V  R ++ +       D   LVL  M  G L+  +Y H       E
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPE 285
Query: 272 RLNIM--IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
              +    ++   LE LH       I++ DLKP NILLD++    +SD G++  + EG  
Sbjct: 286 ARAVFYAAEICCGLEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 339
Query: 330 SLIQTKTMATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKP 371
             I+ + + T+GYMAPE + + +     D ++ G LL E  + + P
Sbjct: 340 QTIKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           ++ +D    LG G+F  V +    + G   A KI N +    R F     E  + R ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER-----LNIMIDVGLAL 283
            N++++        F  LV + +  G L         F DI+ R      +    +   L
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 138
Query: 284 EYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           E + Y H+   I+H +LKP N+LL    +     ++DFG++    E +DS        T 
Sbjct: 139 ESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 194
Query: 341 GYMAPEGI----VSTKCDVYSYGILL 362
           GY++PE +     S   D+++ G++L
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGT--LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRN 225
           RA  +++    +G G++G V+K     + G  VA+K   +Q   E   +S   E  VLR+
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 226 VR---HRNLIKILSGC--SNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERL-NIM 276
           +    H N++++   C  S  D +    LV E + +  L  +L          E + ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             +   L++LH       ++H DLKP NIL+  +    ++DFG++++       +  T  
Sbjct: 127 FQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSV 179
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           + T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGT--LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRN 225
           RA  +++    +G G++G V+K     + G  VA+K   +Q   E   +S   E  VLR+
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 226 VR---HRNLIKILSGC--SNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERL-NIM 276
           +    H N++++   C  S  D +    LV E + +  L  +L          E + ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             +   L++LH       ++H DLKP NIL+  +    ++DFG++++       +  T  
Sbjct: 127 FQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSV 179
Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           + T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 180 LLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERT--FVSFNSECEVLRNVRHRNLIKILS 236
           +LG GSFG V K          A+K+ N    +     +   E E+L+ + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
              +     +V E    G L   +     F +  +   I+  V   + Y+H  +    I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMHKHN----IV 143
Query: 297 HCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPE---G 347
           H DLKP NILL   +++    + DFG+S    +       TK    IG   Y+APE   G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN------TKMKDRIGTAYYIAPEVLRG 197
Query: 348 IVSTKCDVYSYGILLLETFSRKKP 371
               KCDV+S G++L    S   P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 109/230 (47%), Gaps = 33/230 (14%)
Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS- 218
           +RI Y      +++F   +LLG G++G V   T    G  VAIK      ++   +  + 
Sbjct: 3   KRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTL 57
Query: 219 -ECEVLRNVRHRNLIKILS-----GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER 272
            E ++L++ +H N+I I +        N +   ++ E M    L + + +     D ++ 
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQY 116
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE--GDDS 330
              +     A++ LH  +    +IH DLKPSN+L++ N    V DFG+++++ E   D+S
Sbjct: 117 F--IYQTLRAVKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 331 LIQTKT------MATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
               +       +AT  Y APE ++     S   DV+S G +L E F R+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 69/144 (47%), Gaps = 18/144 (12%)
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
           DIL +  I + +  ALE+LH   +   +IH D+KPSN+L++      + DFGIS  L   
Sbjct: 153 DILGK--IAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV-- 205
Query: 328 DDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGE-- 377
            DS+ +T       YMAPE I         S K D++S GI ++E    + P +  G   
Sbjct: 206 -DSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 264
Query: 378 MSLKHWVNQSLPHKLAEVVDSNLV 401
             LK  V +  P   A+   +  V
Sbjct: 265 QQLKQVVEEPSPQLPADKFSAEFV 288

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 180 LLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERT--FVSFNSECEVLRNVRHRNLIKILS 236
           +LG GSFG V K          A+K+ N    +     +   E E+L+ + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
              +     +V E    G L   +     F +  +   I+  V   + Y+H  +    I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMHKHN----IV 143
Query: 297 HCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPE---G 347
           H DLKP NILL   +++    + DFG+S    +       TK    IG   Y+APE   G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPEVLRG 197
Query: 348 IVSTKCDVYSYGILLLETFSRKKP 371
               KCDV+S G++L    S   P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 167 DIQRATNEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV 222
           D++    +++   ++G G+FG V    +K T        +  F +        F  E ++
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVG 280
           +       ++++     +  +  +V+E+MP G L   +   NY  D+ E+       +V 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEVV 178
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKT-MA 338
           LAL+ +H        IH D+KP N+LLD++    ++DFG   K+  EG   +++  T + 
Sbjct: 179 LALDAIHS----MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG---MVRCDTAVG 231
Query: 339 TIGYMAPE--------GIVSTKCDVYSYGILLLETFSRKKP 371
           T  Y++PE        G    +CD +S G+ L E      P
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIK 233
           +G G+F  V     +  G  VA+KI    +++T ++ +S  ++ R VR      H N++K
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKI----IDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 70
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +           LV+E+   G +  +L +H +  +   R      V  A++Y H      
Sbjct: 71  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS-AVQYCHQKF--- 126
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD--DSLIQTKTMATIGYMAPEGIVST 351
            I+H DLK  N+LLD +M   ++DFG S     G+  D+   +       Y APE     
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP-----YAAPELFQGK 180
Query: 352 K-----CDVYSYGILLLETFSRKKP 371
           K      DV+S G++L    S   P
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 172 TNEFDECNLLGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS-------ECEV 222
           ++ +     LG G++G V   K  L+ G   AIKI    ++++ V+  S       E  V
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKI----IKKSSVTTTSNSGALLDEVAV 57
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           L+ + H N++K+     +     LV+E    G L   +     F ++ +   IM  V   
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-DAAVIMKQVLSG 116
Query: 283 LEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
             YLH  +    I+H DLKP N+LL+    + +  + DFG+S     G       + + T
Sbjct: 117 TTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGT 169
Query: 340 IGYMAPEGI---VSTKCDVYSYGILL 362
             Y+APE +      KCDV+S G++L
Sbjct: 170 AYYIAPEVLRKKYDEKCDVWSCGVIL 195

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 175 FDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLI 232
           + +   +G G++G V         T VAIK  +    +T+      E ++L   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 233 KILSGCSNLDFKAL----VLEFMPNGSLEKWLYSHN-------YFLDILERLNIMIDVGL 281
            I         +A+    +++ +    L K L S         YFL  + R         
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILR--------- 155
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATI 340
            L+Y+H     A ++H DLKPSN+L++      + DFG++++   E D +   T+ +AT 
Sbjct: 156 GLKYIHS----ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 341 GYMAPEGIVSTK-----CDVYSYGILLLETFSRK 369
            Y APE ++++K      D++S G +L E  S +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 167 DIQRATNEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV 222
           D++    +++   ++G G+FG V    +K T        +  F +        F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVG 280
           +       ++++     +  +  +V+E+MP G L   +   NY  D+ E+       +V 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEVV 183
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKT-MA 338
           LAL+ +H        IH D+KP N+LLD++    ++DFG   K+  EG   +++  T + 
Sbjct: 184 LALDAIHS----MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG---MVRCDTAVG 236
Query: 339 TIGYMAPE--------GIVSTKCDVYSYGILLLETFSRKKP 371
           T  Y++PE        G    +CD +S G+ L E      P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 27/243 (11%)
Query: 150 DEEDLLPLVTWRRISYLDIQ-RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNL 207
           D +  L  + W+   +L+ Q    + F +  +LG G FG V+   + + G   A K  N 
Sbjct: 164 DSKYFLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK 220
Query: 208 QLERTFVSFNS---ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS-- 262
           +  +    +     E ++L  V  R ++ +           LV+  M  G +   +Y+  
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 263 -HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS 321
             N        +     +   LE+LH  +    II+ DLKP N+LLD++    +SD G++
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 322 KLLGEGDDSLIQTKT---MATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKPTND 374
             L  G     QTKT     T G+MAPE ++  +     D ++ G+ L E  + + P   
Sbjct: 337 VELKAG-----QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
Query: 375 LGE 377
            GE
Sbjct: 392 RGE 394

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 167 DIQRATNEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV 222
           D++    +++   ++G G+FG V    +K T        +  F +        F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVG 280
           +       ++++     +  +  +V+E+MP G L   +   NY  D+ E+       +V 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEVV 183
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS-KLLGEGDDSLIQTKT-MA 338
           LAL+ +H        IH D+KP N+LLD++    ++DFG   K+  EG   +++  T + 
Sbjct: 184 LALDAIHS----MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG---MVRCDTAVG 236
Query: 339 TIGYMAPE--------GIVSTKCDVYSYGILLLETFSRKKP 371
           T  Y++PE        G    +CD +S G+ L E      P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 109
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 110 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
           NEF+   LLG G+FG V      + G   A+KI   ++   +       +E  VL+N RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             L  +       D    V+E+   G L   L     F +   R     ++  AL+YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 265
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEG 347
             +   +++ DLK  N++LD++    ++DFG+ K   EG       KT   T  Y+APE 
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEV 320
Query: 348 I----VSTKCDVYSYGILLLETFSRKKP 371
           +         D +  G+++ E    + P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 173 NEFDECNLLGIGSFGSVY-KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
           NEF+   LLG G+FG V      + G   A+KI   ++   +       +E  VL+N RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             L  +       D    V+E+   G L   L     F +   R     ++  AL+YLH 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 268
Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEG 347
             +   +++ DLK  N++LD++    ++DFG+ K   EG       KT   T  Y+APE 
Sbjct: 269 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEV 323
Query: 348 I----VSTKCDVYSYGILLLETFSRKKP 371
           +         D +  G+++ E    + P
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVS-FNSECEVLRNVRHRNLIKILSG 237
           +G G+F  V     +  G  VA+KI +  QL  T +     E  +++ + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
                   LV+E+   G +  +L +H    +   R      V  A++Y H  +    I+H
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKY----IVH 137
Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGD--DSLIQTKTMATIGYMAPEGIVSTK--- 352
            DLK  N+LLD +M   ++DFG S     G+  D+   +       Y APE     K   
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPP-----YAAPELFQGKKYDG 192
Query: 353 --CDVYSYGILLLETFSRKKP 371
              DV+S G++L    S   P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 4   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 107
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 108 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 27/253 (10%)
Query: 137 VYVRCQNRSTKKSDEEDLLPLVTW-----RRISYLDIQRATNEFDECNLLGIGSFGSVYK 191
           +Y  C N   ++  E+++L  + W      ++  + + R   +F+   ++G G+FG V  
Sbjct: 37  LYDECNNSPLRR--EKNILEYLEWAKPFTSKVKQMRLHR--EDFEILKVIGRGAFGEVAV 92
Query: 192 GTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEVLRNVRHRNLIKILSGCSNLDFKALV 247
             L +   V A+KI N    L+R   + F  E +VL N   + +  +     + +   LV
Sbjct: 93  VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152
Query: 248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL 307
           +++   G L   L      L        + ++ +A++ +H  H     +H D+KP NIL+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH----YVHRDIKPDNILM 208
Query: 308 DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---------GIVSTKCDVYSY 358
           D N    ++DFG    L E D ++  +  + T  Y++PE         G    +CD +S 
Sbjct: 209 DMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 359 GILLLETFSRKKP 371
           G+ + E    + P
Sbjct: 268 GVCMYEMLYGETP 280

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVS-FNSECEVLRNVRHRNLIKILSG 237
           +G G+F  V     +  G  VAIKI +  QL  T +     E  +++ + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
                   L++E+   G +  +L +H    +   R      V  A++Y H       I+H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-AVQYCHQKR----IVH 137
Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPEGIVSTK-- 352
            DLK  N+LLD +M   ++DFG S      ++  +  K  A  G   Y APE     K  
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 353 ---CDVYSYGILLLETFSRKKP 371
               DV+S G++L    S   P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNS 218
           +D +   NEF+   LLG G+FG V     K T   G   A+KI   ++   +       +
Sbjct: 3   MDPRVTMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLT 59
Query: 219 ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           E  VL+N RH  L  +       D    V+E+   G L   L     F +   R     +
Sbjct: 60  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAE 118
Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTM 337
           +  AL+YLH   +   +++ DLK  N++LD++    ++DFG+ K   EG  D        
Sbjct: 119 IVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFC 172
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKP 371
            T  Y+APE +         D +  G+++ E    + P
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 109
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 110 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIK 233
           +G G+F  V     +  G  VA+KI    +++T ++ +S  ++ R VR      H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKI----IDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +           LV+E+   G +  +L +H    +   R      V  A++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKF--- 133
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPEGIVS 350
            I+H DLK  N+LLD +M   ++DFG S     G+      K  A  G   Y APE    
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN------KLDAFCGAPPYAAPELFQG 186
Query: 351 TK-----CDVYSYGILLLETFSRKKP 371
            K      DV+S G++L    S   P
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRN 230
           ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H N
Sbjct: 8   DWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALEYL 286
           ++K        + + L LE+   G L           D +E      D+G+    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQRFF 111
Query: 287 H-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K   T
Sbjct: 112 HQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 340 IGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
           + Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRN 230
           ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H N
Sbjct: 8   DWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALEYL 286
           ++K        + + L LE+   G L           D +E      D+G+    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQRFF 111
Query: 287 H-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K   T
Sbjct: 112 HQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 340 IGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
           + Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRN 230
           ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H N
Sbjct: 7   DWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALEYL 286
           ++K        + + L LE+   G L           D +E      D+G+    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQRFF 110
Query: 287 H-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K   T
Sbjct: 111 HQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 340 IGYMAPEGIV-----STKCDVYSYGILLLETFSRKKP 371
           + Y+APE +      +   DV+S GI+L    + + P
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRN 230
           ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H N
Sbjct: 8   DWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALEYL 286
           ++K        + + L LE+   G L           D +E      D+G+    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQRFF 111
Query: 287 H-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K   T
Sbjct: 112 HQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 340 IGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
           + Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGXXXXXXXXXXXXXXXXGEIPKSLEALLYLKQLNV 62
           IG +  L  L+L  N   G IP   G                G IP+++ AL  L ++++
Sbjct: 649 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 708
Query: 63  SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEEN 106
           S N L G IP  G F  F    F  N  LCG   + +P C   N
Sbjct: 709 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCG---YPLPRCDPSN 749

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGXXXXXXXXXXXXXXXXGEIPKSLEALLYLKQLNV 62
           IG +  L  L+L  N   G IP   G                G IP+++ AL  L ++++
Sbjct: 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711
Query: 63  SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEEN 106
           S N L G IP  G F  F    F  N  LCG   + +P C   N
Sbjct: 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCG---YPLPRCDPSN 752

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 154 LLPLVTWRRISYLDIQ-RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLER 211
            L  + W+   +L+ Q    + F +  +LG G FG V+   + + G   A K  N +  +
Sbjct: 168 FLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 212 TFVSFNS---ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS---HNY 265
               +     E ++L  V  R ++ +           LV+  M  G +   +Y+    N 
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
                  +     +   LE+LH  +    II+ DLKP N+LLD++    +SD G++  L 
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 326 EGDDSLIQTKT---MATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKPTNDLGE 377
            G     QTKT     T G+MAPE ++  +     D ++ G+ L E  + + P    GE
Sbjct: 341 AG-----QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRHRN 230
           ++D    LG G++G V +  ++  T  A+ +  + ++R      +   E  + + + H N
Sbjct: 8   DWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALEYL 286
           ++K        + + L LE+   G L           D +E      D+G+    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQRFF 111
Query: 287 H-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K   T
Sbjct: 112 HQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 340 IGYMAPEGIV-----STKCDVYSYGILLLETFSRKKP 371
           + Y+APE +      +   DV+S GI+L    + + P
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 154 LLPLVTWRRISYLDIQ-RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLER 211
            L  + W+   +L+ Q    + F +  +LG G FG V+   + + G   A K  N +  +
Sbjct: 168 FLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 212 TFVSFNS---ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS---HNY 265
               +     E ++L  V  R ++ +           LV+  M  G +   +Y+    N 
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
                  +     +   LE+LH  +    II+ DLKP N+LLD++    +SD G++  L 
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 326 EGDDSLIQTKT---MATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKPTNDLGE 377
            G     QTKT     T G+MAPE ++  +     D ++ G+ L E  + + P    GE
Sbjct: 341 AG-----QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 154 LLPLVTWRRISYLDIQ-RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLER 211
            L  + W+   +L+ Q    + F +  +LG G FG V+   + + G   A K  N +  +
Sbjct: 168 FLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 212 TFVSFNS---ECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS---HNY 265
               +     E ++L  V  R ++ +           LV+  M  G +   +Y+    N 
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
                  +     +   LE+LH  +    II+ DLKP N+LLD++    +SD G++  L 
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 326 EGDDSLIQTKT---MATIGYMAPEGIVSTK----CDVYSYGILLLETFSRKKPTNDLGE 377
            G     QTKT     T G+MAPE ++  +     D ++ G+ L E  + + P    GE
Sbjct: 341 AG-----QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/85 (41%), Positives = 46/85 (54%), Gaps = 11/85 (12%)
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI------ 348
           IIH D+KPSNILLD +    + DFGIS   G+  DS+ +T+      YMAPE I      
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 349 --VSTKCDVYSYGILLLETFSRKKP 371
                + DV+S GI L E  + + P
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIK 233
           +G G+F  V     +  G  VA+KI    +++T ++ +S  ++ R VR      H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKI----IDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +           LV+E+   G +  +L +H    +   R      V  A++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKF--- 133
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD--DSLIQTKTMATIGYMAPEGIVST 351
            I+H DLK  N+LLD +M   ++DFG S     G+  D+        +  Y APE     
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQGK 187
Query: 352 K-----CDVYSYGILLLETFSRKKP 371
           K      DV+S G++L    S   P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 56/114 (49%), Gaps = 17/114 (14%)
Query: 269 ILERL--NIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
           I ER+   + + +  AL YL   H    +IH D+KPSNILLDE     + DFGIS   G 
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS---GR 174
Query: 327 GDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKP 371
             D   + ++     YMAPE I            + DV+S GI L+E  + + P
Sbjct: 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 181 LGIGSFGSV-YKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS G V        G  VA+K+ +L+ ++      +E  ++R+ +H N++++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN---IMIDVGLALEYLHYGHALAP 294
             +   +++EF+  G+L           DI+   RLN   I       L+ L Y HA   
Sbjct: 113 VGEELWVLMEFLQGGALT----------DIVSQVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
           +IH D+K  +ILL  +    +SDFG    + +  D   +   + T  +MAPE I     +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 351 TKCDVYSYGILLLETFSRKKP 371
           T+ D++S GI+++E    + P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTD 181
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 182 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIK 233
           +G G+F  V     +  G  VA+KI    +++T ++ +S  ++ R VR      H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKI----IDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +           LV+E+   G +  +L +H    +   R      V  A++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKF--- 133
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD--DSLIQTKTMATIGYMAPEGIVST 351
            I+H DLK  N+LLD +M   ++DFG S     G+  D+        +  Y APE     
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQGK 187
Query: 352 K-----CDVYSYGILLLETFSRKKP 371
           K      DV+S G++L    S   P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 16/197 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
           + +D    LG G+FG V++ T  + G N A K      E    +   E + +  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 232 IKILSGCSNLDFKALVLEFMPNGSL-EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           + +     + +   ++ EFM  G L EK    HN   +  E +  M  V   L ++H  +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-EAVEYMRQVCKGLCHMHENN 169
Query: 291 ALAPIIHCDLKPSNILLDENMVAHVS--DFGISKLLGEGDDSLIQTKTMATIGYMAPE-- 346
                +H DLKP NI+        +   DFG++  L   D       T  T  + APE  
Sbjct: 170 ----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 222
Query: 347 --GIVSTKCDVYSYGIL 361
               V    D++S G+L
Sbjct: 223 EGKPVGYYTDMWSVGVL 239

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF-VSFNSECEVLRN--VRH 228
             ++D    LG G++G V +  ++  T  A+ +  + ++R      N + E+  N  + H
Sbjct: 6   VEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNH 64
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 109
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 110 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           F+   L+G G++G VYKG  +  G   AIK+ ++  +        E  +L+   H   I 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 234 ILSGC------SNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI---DVGLAL 283
              G         +D +  LV+EF   GS+   +   N   + L+   I     ++   L
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 142
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGY 342
            +LH       +IH D+K  N+LL EN    + DFG+S  L   D ++ +  T + T  +
Sbjct: 143 SHLHQ----HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYW 195
Query: 343 MAPEGIVST---------KCDVYSYGILLLETFSRKKPTNDLGEM 378
           MAPE I            K D++S GI  +E      P  D+  M
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTD 181
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 182 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 16/197 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
           + +D    LG G+FG V++ T  + G N A K      E    +   E + +  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 232 IKILSGCSNLDFKALVLEFMPNGSL-EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           + +     + +   ++ EFM  G L EK    HN   +  E +  M  V   L ++H  +
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-EAVEYMRQVCKGLCHMHENN 275
Query: 291 ALAPIIHCDLKPSNILLDENMVAHVS--DFGISKLLGEGDDSLIQTKTMATIGYMAPE-- 346
                +H DLKP NI+        +   DFG++  L   D       T  T  + APE  
Sbjct: 276 ----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 328
Query: 347 --GIVSTKCDVYSYGIL 361
               V    D++S G+L
Sbjct: 329 EGKPVGYYTDMWSVGVL 345

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           NEF+   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  AL+Y
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDY 124
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTMATIGYMA 344
           LH   +   +++ DLK  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 125 LH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLA 178
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           T+E+     LG G+F  V +   +  G   A KI N +    R       E  + R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++    S   F  LV + +  G L + + +  Y+ +     +    +   LE +++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILESVNH 118
Query: 289 GHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
            H L  I+H DLKP N+LL    +     ++DFG++ +  +GD          T GY++P
Sbjct: 119 CH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQ-AWFGFAGTPGYLSP 175
Query: 346 EGI----VSTKCDVYSYGILL 362
           E +         D+++ G++L
Sbjct: 176 EVLRKDPYGKPVDMWACGVIL 196

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEV 222
           ++Q    +F+   ++G G+FG V    + +   + A+KI N    L+R   + F  E +V
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG-- 280
           L N   + +  +     + +   LV+++   G L   L   + F D L        +G  
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEM 184
Query: 281 -LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMA 338
            LA++ +H  H     +H D+KP N+LLD N    ++DFG    L   DD  +Q+   + 
Sbjct: 185 VLAIDSIHQLH----YVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVG 238
Query: 339 TIGYMAPE---------GIVSTKCDVYSYGILLLETFSRKKP 371
           T  Y++PE         G    +CD +S G+ + E    + P
Sbjct: 239 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 83
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 84  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTD 187
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 188 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNL--QLERTFVS-FNSECEV 222
           ++Q    +F+   ++G G+FG V    + +   + A+KI N    L+R   + F  E +V
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG-- 280
           L N   + +  +     + +   LV+++   G L   L   + F D L        +G  
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEM 200
Query: 281 -LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMA 338
            LA++ +H  H     +H D+KP N+LLD N    ++DFG    L   DD  +Q+   + 
Sbjct: 201 VLAIDSIHQLH----YVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVG 254
Query: 339 TIGYMAPE---------GIVSTKCDVYSYGILLLETFSRKKP 371
           T  Y++PE         G    +CD +S G+ + E    + P
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
           NEF+   LLG G+FG V     K T   G   A+KI   ++   +       +E  VL+N
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            RH  L  +       D    V+E+   G L   L     F +   R     ++  AL+Y
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDY 123
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTMATIGYMA 344
           LH   +   +++ DLK  N++LD++    ++DFG+ K   EG  D         T  Y+A
Sbjct: 124 LH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLA 177
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKP 371
           PE +         D +  G+++ E    + P
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIVST-----KCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE +++        D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVS-FNSECEVLRNVRHRNLIKILSG 237
           +G G+F  V     +  G  VAIKI +  QL  T +     E  +++ + H N++K+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
                   L++E+   G +  +L +H    +   R      V  A++Y H       I+H
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-AVQYCHQKR----IVH 134
Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGD--DSLIQTKTMATIGYMAPEGIVSTK--- 352
            DLK  N+LLD +M   ++DFG S     G   D+   +       Y APE     K   
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPP-----YAAPELFQGKKYDG 189
Query: 353 --CDVYSYGILLLETFSRKKP 371
              DV+S G++L    S   P
Sbjct: 190 PEVDVWSLGVILYTLVSGSLP 210

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 46/221 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV     +  G  +A+K    +L R F S         E 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVK----KLSRPFQSIIHAKRTYREL 101
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 102 RLLKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQ 149
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 150 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 205
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLE 364
           D +  T  +AT  Y APE ++     +   D++S G ++ E
Sbjct: 206 DEM--TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAE 244

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVYKGTL-----SDGT-NVAIKIFNLQLERT-FVSFNSECEVLRNV-RHRNLI 232
           LG G+FG V + T      SD    VA+K+       T   +  SE +VL  +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIM--------------- 276
            +L  C+      ++ E+   G L  +L    + F+       IM               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 277 -IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   + +L    A    IH DL   NILL    +  + DFG+++ +    + +++  
Sbjct: 174 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
               + +MAPE I     + + DV+SYGI L E FS
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 183
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 184 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 25/167 (14%)
Query: 219 ECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM- 276
           E ++LR V  H N+I++        F  LV + M  G L  +L +    L   E   IM 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMR 131
Query: 277 --IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT 334
             ++V  AL  L+       I+H DLKP NILLD++M   ++DFG S  L  G+      
Sbjct: 132 ALLEVICALHKLN-------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 181
Query: 335 KTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKP 371
           +   T  Y+APE I             + D++S G+++    +   P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 20/178 (11%)
Query: 207 LQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF 266
           + ++  +  F +E +++ ++++   +      +N D   ++ E+M N S+ K+     YF
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF---DEYF 137
Query: 267 LDILERLNIMIDVGL-------ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG 319
             + +     I + +        L    Y H    I H D+KPSNIL+D+N    +SDFG
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG 197
Query: 320 ISKLLGEGDDSLIQTKTMATIGYMAPEGIVS------TKCDVYSYGILLLETFSRKKP 371
            S+ +    D  I+  +  T  +M PE   +       K D++S GI L   F    P
Sbjct: 198 ESEYMV---DKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 181
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 182 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 71
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 72  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 119
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 120 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 175
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 176 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIK 233
           +G G+F  V     +  G  VA++I    +++T ++ +S  ++ R VR      H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRI----IDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +           LV+E+   G +  +L +H    +   R      V  A++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKF--- 133
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTK- 352
            I+H DLK  N+LLD +M   ++DFG S     G+      +   +  Y APE     K 
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKY 189
Query: 353 ----CDVYSYGILLLETFSRKKP 371
                DV+S G++L    S   P
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 25/167 (14%)
Query: 219 ECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM- 276
           E ++LR V  H N+I++        F  LV + M  G L  +L +    L   E   IM 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMR 118
Query: 277 --IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT 334
             ++V  AL  L+       I+H DLKP NILLD++M   ++DFG S  L  G+      
Sbjct: 119 ALLEVICALHKLN-------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 168
Query: 335 KTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKP 371
           +   T  Y+APE I             + D++S G+++    +   P
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 178
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 179 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 69
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 70  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 173
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 174 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIK 233
           +G G+F  V     +  G  VA++I    +++T ++ +S  ++ R VR      H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRI----IDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +           LV+E+   G +  +L +H    +   R      V  A++Y H      
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKF--- 133
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD--DSLIQTKTMATIGYMAPEGIVST 351
            I+H DLK  N+LLD +M   ++DFG S     G+  D+        +  Y APE     
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQGK 187
Query: 352 K-----CDVYSYGILLLETFSRKKP 371
           K      DV+S G++L    S   P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVYKGTL-----SDGT-NVAIKIFNLQLERT-FVSFNSECEVLRNV-RHRNLI 232
           LG G+FG V + T      SD    VA+K+       T   +  SE +VL  +  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMI-------------- 277
            +L  C+      ++ E+   G L  +L    + F+       IM               
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 278 --DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   + +L    A    IH DL   NILL    +  + DFG+++ +    + +++  
Sbjct: 167 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
               + +MAPE I     + + DV+SYGI L E FS
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTD 178
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 179 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 172 TNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           T+E+     LG G+F  V +   +  G   A KI N +    R       E  + R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++    S   F  LV + +  G L + + +  Y+ +     +    +   LE +++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILESVNH 118
Query: 289 GHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
            H L  I+H DLKP N+LL    +     ++DFG++ +  +GD          T GY++P
Sbjct: 119 CH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQ-AWFGFAGTPGYLSP 175
Query: 346 EGI----VSTKCDVYSYGILL 362
           E +         D+++ G++L
Sbjct: 176 EVLRKDPYGKPVDMWACGVIL 196

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 78  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 181
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 182 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 178
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 179 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 69  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 172
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 173 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTD 182
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 183 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 83
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 84  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 187
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 188 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 69
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 70  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 173
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 174 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 91
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 92  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 195
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 196 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 69  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 172
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 173 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 75  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 178
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 179 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 182
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 183 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 46/211 (21%)
Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSECEVLRNVRHRNLIK 233
           +G G++GSV        G  VA+K    +L R F S         E  +L++++H N+I 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 95
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI--------LERLNIMIDVGL 281
           +L              F P  SLE+    +L +H    D+        L   ++   +  
Sbjct: 96  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 143
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     DD +  T  +AT  
Sbjct: 144 ILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRW 197
Query: 342 YMAPEGIV-----STKCDVYSYGILLLETFS 367
           Y APE ++     +   D++S G ++ E  +
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 95
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 96  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 199
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 200 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 84
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 85  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 188
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 189 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 84
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 85  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 188
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 189 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 182
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 183 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 70
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 71  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 118
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 119 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 174
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 175 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 181 LGIGSFG-SVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRNLIKILSG 237
           +G GSFG ++   +  DG    IK  N+    +     S  E  VL N++H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER-LNIMIDVGLALEYLHYGHALAPII 296
                   +V+++   G L K + +    L   ++ L+  + + LAL+++H       I+
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD----RKIL 147
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTK 352
           H D+K  NI L ++    + DFGI+++L    +  +    + T  Y++PE       + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNK 205
Query: 353 CDVYSYGILLLE 364
            D+++ G +L E
Sbjct: 206 SDIWALGCVLYE 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVYKGTL-----SDGT-NVAIKIFNLQLERT-FVSFNSECEVLRNV-RHRNLI 232
           LG G+FG V + T      SD    VA+K+       T   +  SE +VL  +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIM--------------- 276
            +L  C+      ++ E+   G L  +L    + F+       IM               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 277 -IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   + +L    A    IH DL   NILL    +  + DFG+++ +    + +++  
Sbjct: 174 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
               + +MAPE I     + + DV+SYGI L E FS
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 69  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCA 116
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 172
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 173 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 91
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 92  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 195
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 196 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 219 ECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM- 276
           E ++LR V  H N+I++        F  LV + M  G L  +L +    L   E   IM 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMR 131
Query: 277 --IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT 334
             ++V  AL  L+       I+H DLKP NILLD++M   ++DFG S  L  G+      
Sbjct: 132 ALLEVICALHKLN-------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 181
Query: 335 KTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKP 371
               T  Y+APE I             + D++S G+++    +   P
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 92
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 93  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 196
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 197 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVYKGTL-----SDGT-NVAIKIFNLQLERT-FVSFNSECEVLRNV-RHRNLI 232
           LG G+FG V + T      SD    VA+K+       T   +  SE +VL  +  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIM--------------- 276
            +L  C+      ++ E+   G L  +L    + F+       IM               
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 277 -IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   + +L    A    IH DL   NILL    +  + DFG+++ +    + +++  
Sbjct: 169 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
               + +MAPE I     + + DV+SYGI L E FS
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 92
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 93  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 196
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 197 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 181 LGIGSFGSVYKGTL-----SDGT-NVAIKIFNLQLERT-FVSFNSECEVLRNV-RHRNLI 232
           LG G+FG V + T      SD    VA+K+       T   +  SE +VL  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIM--------------- 276
            +L  C+      ++ E+   G L  +L    + F+       IM               
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 277 -IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              V   + +L    A    IH DL   NILL    +  + DFG+++ +    + +++  
Sbjct: 151 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 336 TMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
               + +MAPE I     + + DV+SYGI L E FS
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 79  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 182
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 183 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 48/218 (22%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVS--------FNSECEVLRN 225
           ++ C ++G G+F  V +    + G   A+KI ++     F S           E  +   
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVA---KFTSSPGLSTEDLKREASICHM 82
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSL---------EKWLYSH----NYFLDILER 272
           ++H +++++L   S+     +V EFM    L           ++YS     +Y   ILE 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDD 329
                    AL Y H  +    IIH D+KP N+LL   + +    + DFG++  LGE   
Sbjct: 142 ---------ALRYCHDNN----IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES-- 186
Query: 330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLL 363
            L+    + T  +MAPE +         DV+  G++L 
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTN-VAIKIFNLQLERTFVSFNSECEV--LRNVRHR 229
            ++++   +G G++G+V+K    +    VA+K   L  +   V  ++  E+  L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N++++     +     LV EF  +  L+K+  S N  LD     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE--- 346
           +    ++H DLKP N+L++ N    ++DFG+++  G        +  + T+ Y  P+   
Sbjct: 121 N----VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLF 174
Query: 347 --GIVSTKCDVYSYGILLLETFSRKKP 371
              + ST  D++S G +  E  +  +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTF---VSFNSECEVLRNVRH 228
             ++D    LG G+ G V +  ++  T  A+ +  + ++R      +   E  + + + H
Sbjct: 5   VEDWDLVQTLGEGAAGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----ALE 284
            N++K        + + L LE+   G L           D +E      D+G+    A  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL----------FDRIEP-----DIGMPEPDAQR 108
Query: 285 YLH-------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           + H       Y H +  I H D+KP N+LLDE     +SDFG++ +    +   +  K  
Sbjct: 109 FFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTN 373
            T+ Y+APE +      +   DV+S GI+L    + + P +
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 26/232 (11%)
Query: 156 PLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNL--QLERT 212
           P+V   R+  + +QR  ++F+   ++G G+F  V    +   G   A+KI N    L+R 
Sbjct: 48  PIVV--RLKEVRLQR--DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG 103
Query: 213 FVS-FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE 271
            VS F  E +VL N   R + ++     + ++  LV+E+   G L   L      +    
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM 163
Query: 272 RLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
               + ++ +A++ +H  G+     +H D+KP NILLD      ++DFG S L    D +
Sbjct: 164 ARFYLAEIVMAIDSVHRLGY-----VHRDIKPDNILLDRCGHIRLADFG-SCLKLRADGT 217
Query: 331 LIQTKTMATIGYMAPEGIVST-----------KCDVYSYGILLLETFSRKKP 371
           +     + T  Y++PE + +            +CD ++ G+   E F  + P
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
           FL +   +     V   +E+L    A    IH DL   NILL E  V  + DFG+++ + 
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 326 EGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           +  D + +      + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 54/217 (24%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSF------NSECEVLRNVRHRNL 231
           +G G++GSV   Y   L     VA+K    +L R F S         E  +L++++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGLALEY--- 285
           I +L              F P  S+E   +S  Y +  L   +  NI+    L+ E+   
Sbjct: 90  IGLLDV------------FTPATSIED--FSEVYLVTTLMGADLNNIVKSQALSDEHVQF 135
Query: 286 --------LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
                   L Y H+ A IIH DLKPSN+ ++E+    + DFG+++   + D+ +  T  +
Sbjct: 136 LVYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYV 189
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
           AT  Y APE ++     +   D++S G ++ E    K
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
           FL +   +     V   +E+L    A    IH DL   NILL E  V  + DFG+++ + 
Sbjct: 187 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 242
Query: 326 EGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           +  D + +      + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 243 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+ +     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
           FL +   +     V   +E+L    A    IH DL   NILL E  V  + DFG+++ + 
Sbjct: 194 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 249
Query: 326 EGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           +  D + +      + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 250 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG 325
           FL +   +     V   +E+L    A    IH DL   NILL E  V  + DFG+++ + 
Sbjct: 196 FLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 251
Query: 326 EGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
           +  D + +      + +MAPE I     + + DV+S+G+LL E FS
Sbjct: 252 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           T+E+     +G G+F  V +   L  G   A KI N +    R       E  + R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++    S   F  LV + +  G L + + +  Y+ +     +    +   LE + +
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILEAVLH 118
Query: 289 GHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
            H +  ++H DLKP N+LL    +     ++DFG++ +  +GD          T GY++P
Sbjct: 119 CHQMG-VVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQ-AWFGFAGTPGYLSP 175
Query: 346 EGI----VSTKCDVYSYGILL 362
           E +         D+++ G++L
Sbjct: 176 EVLRKEAYGKPVDIWACGVIL 196

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRN 230
           +   + +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N
Sbjct: 45  YTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN-----------IMIDV 279
           +I I     N   +A  +E M     + +L +H    D+ + L             +  +
Sbjct: 103 IIGI-----NDIIRAPTIEQMK----DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQI 153
Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMA 338
              L+Y+H     A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +A
Sbjct: 154 LRGLKYIHS----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 339 TIGYMAPEGIVSTK-----CDVYSYGILLLETFSRK 369
           T  Y APE ++++K      D++S G +L E  S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 184 GSFGSVYKGTLSDGTNVAIK-IFNLQLERTFVSFNSEC----EVLRNVR------HRNLI 232
           GS+G+V  G  S+G  VAIK +FN   +   V+  S+      VLR +R      H N++
Sbjct: 33  GSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92
Query: 233 KILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
            +     + +  A     LV E M    L + ++     +        M  + L L  LH
Sbjct: 93  GLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
                A ++H DL P NILL +N    + DF +++   E      +T  +    Y APE 
Sbjct: 152 E----AGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPEL 204
Query: 348 IVSTK-----CDVYSYGILLLETFSRK 369
           ++  K      D++S G ++ E F+RK
Sbjct: 205 VMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 171 ATNEFDECNLLGIGSFGSVYKG--TLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNV 226
           + + +     LG G++G VYK   T+++ T VAIK   L+ E   V   +  E  +L+ +
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGLALE 284
           +HRN+I++ S   +     L+ E+  N  L+K++  +    D+  R+  + +  +   + 
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVN 146
Query: 285 YLHYGHALAPIIHCDLKPSNILL-----DENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           + H    L    H DLKP N+LL      E  V  + DFG+++  G        T  + T
Sbjct: 147 FCHSRRCL----HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIIT 200
Query: 340 IGYMAPEGIV-----STKCDVYSYGILLLE 364
           + Y  PE ++     ST  D++S   +  E
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAE 230

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 184 GSFGSVYKGTLSDGTNVAIK-IFNLQLERTFVSFNSEC----EVLRNVR------HRNLI 232
           GS+G+V  G  S+G  VAIK +FN   +   V+  S+      VLR +R      H N++
Sbjct: 33  GSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92
Query: 233 KILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
            +     + +  A     LV E M    L + ++     +        M  + L L  LH
Sbjct: 93  GLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
                A ++H DL P NILL +N    + DF +++   E      +T  +    Y APE 
Sbjct: 152 E----AGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPEL 204
Query: 348 IVSTK-----CDVYSYGILLLETFSRK 369
           ++  K      D++S G ++ E F+RK
Sbjct: 205 VMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + D+G+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVS----FNSECEVLRNVRHRNLIKIL- 235
           +G GSF +VYKG L   T V +    LQ  +   S    F  E E L+ ++H N+++   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 236 SGCSNLDFK---ALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHA 291
           S  S +  K    LV E   +G+L+ +L       + +L      I  GL  ++LH    
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGL--QFLH--TR 148
Query: 292 LAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-- 348
             PIIH DLK  NI +        + D G++ L      +      + T  + APE    
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPEXYEE 204
Query: 349 -VSTKCDVYSYGILLLETFSRKKPTND 374
                 DVY++G   LE  + + P ++
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYPYSE 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFN------LQLERTFVSFNSEC 220
           I      +   + +G G++GSV        G  VA+K  +      +  +RT+     E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY----REL 84
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 85  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 188
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 189 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVS------FNSECEVLRNVR 227
           + +   +G G++G+V        G  VAIK    +L R F S         E  +L+++R
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 228 HRNLIKILSGCSN-------LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
           H N+I +L   +         DF  LV+ FM  G+    L  H    +  +R+  +  V 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDF-YLVMPFM--GTDLGKLMKHEKLGE--DRIQFL--VY 135
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             L+ L Y HA A IIH DLKP N+ ++E+    + DFG+++   + D  +     + T 
Sbjct: 136 QMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--XGXVVTR 189
Query: 341 GYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
            Y APE I+     +   D++S G ++ E  + K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFN---SECEVLRNVRH 228
            ++++   +G GS+G V+K    D G  VAIK F L+ E   V       E  +L+ ++H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGLALEYL 286
            NL+ +L          LV E+  +  L +      Y   + E L  +I      A+ + 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           H  +     IH D+KP NIL+ ++ V  + DFG ++LL    D       +AT  Y +PE
Sbjct: 119 HKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPE 172
Query: 347 GIV-----STKCDVYSYGILLLETFS 367
            +V         DV++ G +  E  S
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 92
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 93  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 196
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +     +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 197 DEM--XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++   +  
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
                T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++   +  
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
                T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 18/106 (16%)
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
           L+I I +  A+E+LH       ++H DLKPSNI    + V  V DFG+   + + ++   
Sbjct: 167 LHIFIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 333 QTKTMATIG----------YMAPEGI----VSTKCDVYSYGILLLE 364
               M              YM+PE I     S K D++S G++L E
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 30/201 (14%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           F+  + LG G+   VY+     GT    A+K+    +++  V   +E  VL  + H N+I
Sbjct: 55  FEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNII 111
Query: 233 KILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           K+          +LVLE +  G L     EK  YS     D ++++         LE + 
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI---------LEAVA 162
Query: 288 YGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H    I+H DLKP N+L      +    ++DFG+SK++   +  ++      T GY A
Sbjct: 163 YLHENG-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCA 218
Query: 345 PEGI----VSTKCDVYSYGIL 361
           PE +       + D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGII 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +     +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 80  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++   +  
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
                T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 54/217 (24%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSF------NSECEVLRNVRHRNL 231
           +G G++GSV   Y   L     VA+K    +L R F S         E  +L++++H N+
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGLALEY--- 285
           I +L              F P  S+E   +S  Y +  L   +  NI+    L+ E+   
Sbjct: 82  IGLLDV------------FTPATSIED--FSEVYLVTTLMGADLNNIVKCQALSDEHVQF 127
Query: 286 --------LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
                   L Y H+ A IIH DLKPSN+ ++E+    + DFG+++   + D+ +  T  +
Sbjct: 128 LVYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEM--TGYV 181
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
           AT  Y APE ++     +   D++S G ++ E    K
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 68
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 69  RLLKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 172
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +     +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 173 DEM--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +     +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 18/144 (12%)
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
           DIL +  I + +  ALE+LH   +   +IH D+KPSN+L++      + DFGIS  L   
Sbjct: 109 DILGK--IAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-- 161
Query: 328 DDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGE-- 377
            D + +        YMAPE I         S K D++S GI ++E    + P +  G   
Sbjct: 162 -DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220
Query: 378 MSLKHWVNQSLPHKLAEVVDSNLV 401
             LK  V +  P   A+   +  V
Sbjct: 221 QQLKQVVEEPSPQLPADKFSAEFV 244

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 181 LGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVS---FNSECEVLRNVRHRNLIK 233
           LG G F  V     KGT  +     IK   L   R  VS      E  +LR +RH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 234 ILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
           +     N     L+LE +  G L     EK   + +     L+++         L+ +HY
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI---------LDGVHY 123
Query: 289 GHALAPIIHCDLKPSNI-LLDENM---VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
            H+   I H DLKP NI LLD+N+      + DFGI+  +  G++         T  ++A
Sbjct: 124 LHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVA 179
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
           PE +    +  + D++S G++     S   P   LGE   +   N S
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPF--LGETKQETLTNIS 224

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 25/222 (11%)
Query: 181 LGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVS---FNSECEVLRNVRHRNLIK 233
           LG G F  V     KGT  +     IK   L   R  VS      E  +LR +RH N+I 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +     N     L+LE +  G L  +L       +  E    +  +   L+ +HY H+  
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQI---LDGVHYLHS-K 134
Query: 294 PIIHCDLKPSNI-LLDENM---VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI- 348
            I H DLKP NI LLD+N+      + DFGI+  +  G++         T  ++APE + 
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 191
Query: 349 ---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
              +  + D++S G++     S   P   LGE   +   N S
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPF--LGETKQETLTNIS 231

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 54/217 (24%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSF------NSECEVLRNVRHRNL 231
           +G G++GSV   Y   L     VA+K    +L R F S         E  +L++++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGLALEY--- 285
           I +L              F P  S+E   +S  Y +  L   +  NI+    L+ E+   
Sbjct: 90  IGLLDV------------FTPATSIED--FSEVYLVTTLMGADLNNIVKCQALSDEHVQF 135
Query: 286 --------LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
                   L Y H+ A IIH DLKPSN+ ++E+    + DFG+++   + D+ +  T  +
Sbjct: 136 LVYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYV 189
Query: 338 ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
           AT  Y APE ++     +   D++S G ++ E    K
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 43/205 (20%)
Query: 181 LGIGSFGSVY--KGTLSDGTNVAIKIFNLQLERTFVSFNS------ECEVLRNVRHRNLI 232
           LG G++G V   +  ++     AIKI    + +T VS +S      E  VL+ + H N++
Sbjct: 45  LGSGAYGEVLLCRDKVTH-VERAIKI----IRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGLALE 284
           K+     +     LV+E    G L         F +I+ R+         I+  V   + 
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGEL---------FDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 285 YLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           YLH  +    I+H DLKP N+LL   +++ +  + DFG+S +    ++     + + T  
Sbjct: 151 YLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAY 203
Query: 342 YMAPEGI---VSTKCDVYSYGILLL 363
           Y+APE +      KCDV+S G++L 
Sbjct: 204 YIAPEVLRKKYDEKCDVWSIGVILF 228

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 54/298 (18%)
Query: 167 DIQRATNEFDECN---------LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTF 213
           D  +A++  +EC          L  IGS GS  V++         AIK  NL+    +T 
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 98
Query: 214 VSFNSECEVLRNVRHRN--LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE 271
            S+ +E   L  ++  +  +I++        +  +V+E   N  L  WL      +D  E
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWE 156
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
           R +   ++   LE +H  H    I+H DLKP+N L+ + M+  + DFGI+  +     S+
Sbjct: 157 RKSYWKNM---LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSV 211
Query: 332 IQTKTMATIGYMAPEGIVSTKC---------------DVYSYGILLLETFSRKKPTNDLG 376
           ++   + T+ YM PE I                    DV+S G +L      K P     
Sbjct: 212 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----- 266
Query: 377 EMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
               +  +NQ    KL  ++D N    E  F    D   + +   L CC++  P +RI
Sbjct: 267 ---FQQIINQI--SKLHAIIDPN---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 95
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 96  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DFG+++     D
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 199
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +     +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 200 DEM--XGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 169 QRATNEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLER------TFVSFNSECE 221
           Q+  + +D    LG G F  V K    S G   A K    +  R      +      E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +LR V H N+I +     N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 282 ALEYLHYGHALAPIIHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGEGDDSLIQTKTM 337
            + YLH       I H DLKP NI LLD+N+ + H+   DFG++    E +D +      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGIL 361
            T  ++APE +    +  + D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRN 230
           +   + +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N
Sbjct: 25  YTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLN------IMIDVGLAL 283
           +I I     N   +A  +E M +  + + L   + Y L   + L+       +  +   L
Sbjct: 83  IIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGY 342
           +Y+H     A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y
Sbjct: 138 KYIHS----ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 343 MAPEGIVSTK-----CDVYSYGILLLETFSRK 369
            APE ++++K      D++S G +L E  S +
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHAL 292
              N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 142
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVST 351
           A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 352 K-----CDVYSYGILLLETFSRK 369
           K      D++S G +L E  S +
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 180 LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN--LIK 233
           L  IGS GS  V++         AIK  NL+    +T  S+ +E   L  ++  +  +I+
Sbjct: 14  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +        +  +V+E   N  L  WL      +D  ER +   ++   LE +H  H   
Sbjct: 74  LYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNM---LEAVHTIHQHG 128
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----- 348
            I+H DLKP+N L+ + M+  + DFGI+  +     S+++   + T+ YM PE I     
Sbjct: 129 -IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 349 ----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
                     +S K DV+S G +L      K P   +        +NQ    KL  ++D 
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------INQI--SKLHAIIDP 236
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
           N    E  F    D   + +   L CC++  P +RI
Sbjct: 237 N---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 266

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 169 QRATNEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLER------TFVSFNSECE 221
           Q+  + +D    LG G F  V K    S G   A K    +  R      +      E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +LR V H N+I +     N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 282 ALEYLHYGHALAPIIHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGEGDDSLIQTKTM 337
            + YLH       I H DLKP NI LLD+N+ + H+   DFG++    E +D +      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGIL 361
            T  ++APE +    +  + D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 56/299 (18%)
Query: 167 DIQRATNEFDECN---------LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTF 213
           D  +A++  +EC          L  IGS GS  V++         AIK  NL+    +T 
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 98
Query: 214 VSFNSECEVLRNVRHRN--LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE 271
            S+ +E   L  ++  +  +I++        +  +V+E   N  L  WL      +D  E
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWE 156
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
           R +   ++   LE +H  H    I+H DLKP+N L+ + M+  + DFGI+  +     S+
Sbjct: 157 RKSYWKNM---LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSV 211
Query: 332 IQTKTMATIGYMAPEGIVSTKC---------------DVYSYG-ILLLETFSRKKPTNDL 375
           ++   + T+ YM PE I                    DV+S G IL   T+         
Sbjct: 212 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY--------- 262
Query: 376 GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
           G+   +  +NQ    KL  ++D N    E  F    D   + +   L CC++  P +RI
Sbjct: 263 GKTPFQQIINQI--SKLHAIIDPN---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 180 LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN--LIK 233
           L  IGS GS  V++         AIK  NL+    +T  S+ +E   L  ++  +  +I+
Sbjct: 17  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 76
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +        +  +V+E   N  L  WL      +D  ER +   ++   LE +H  H   
Sbjct: 77  LYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNM---LEAVHTIHQHG 131
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----- 348
            I+H DLKP+N L+ + M+  + DFGI+  +     S+++   + T+ YM PE I     
Sbjct: 132 -IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 349 ----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
                     +S K DV+S G +L      K P         +  +NQ    KL  ++D 
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------FQQIINQI--SKLHAIIDP 239
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
           N    E  F    D   + +   L CC++  P +RI
Sbjct: 240 N---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 269

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 175 FDECNLLGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRN 230
           +   + +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N
Sbjct: 25  YTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLN------IMIDVGLAL 283
           +I I     N   +A  +E M +  + + L   + Y L   + L+       +  +   L
Sbjct: 83  IIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGY 342
           +Y+H     A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y
Sbjct: 138 KYIHS----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 343 MAPEGIVSTK-----CDVYSYGILLLETFSRK 369
            APE ++++K      D++S G +L E  S +
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHAL 292
              N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 142
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVST 351
           A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 352 K-----CDVYSYGILLLETFSRK 369
           K      D++S G +L E  S +
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 181 LGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVS---FNSECEVLRNVRHRNLIK 233
           LG G F  V     KGT  +     IK   L   R  VS      E  +LR +RH N+I 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 234 ILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
           +     N     L+LE +  G L     EK   + +     L+++         L+ +HY
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI---------LDGVHY 144
Query: 289 GHALAPIIHCDLKPSNI-LLDENM---VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
            H+   I H DLKP NI LLD+N+      + DFGI+  +  G++         T  ++A
Sbjct: 145 LHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVA 200
Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
           PE +    +  + D++S G++     S   P   LGE   +   N S
Sbjct: 201 PEIVNYEPLGLEADMWSIGVITYILLSGASPF--LGETKQETLTNIS 245

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 169 QRATNEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLER------TFVSFNSECE 221
           Q+  + +D    LG G F  V K    S G   A K    +  R      +      E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +LR V H N+I +     N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 282 ALEYLHYGHALAPIIHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGEGDDSLIQTKTM 337
            + YLH       I H DLKP NI LLD+N+ + H+   DFG++    E +D +      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGIL 361
            T  ++APE +    +  + D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 45/276 (16%)
Query: 180 LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN--LIK 233
           L  IGS GS  V++         AIK  NL+    +T  S+ +E   L  ++  +  +I+
Sbjct: 33  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +        +  +V+E   N  L  WL      +D  ER +   ++   LE +H  H   
Sbjct: 93  LYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNM---LEAVHTIHQHG 147
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKC 353
            I+H DLKP+N L+ + M+  + DFGI+  +     S+++   + T+ YM PE I     
Sbjct: 148 -IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 354 ---------------DVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
                          DV+S G +L      K P         +  +NQ    KL  ++D 
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------FQQIINQI--SKLHAIIDP 255
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
           N    E  F    D   + +   L CC++  P +RI
Sbjct: 256 N---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 285

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR------HRNLIK 233
           +G G+F  V     +  G  VA+KI    +++T ++ +S  ++ R VR      H N++K
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKI----IDKTQLNSSSLQKLFREVRIXKVLNHPNIVK 77
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +           LV E+   G +  +L +H    +   R      V  A++Y H      
Sbjct: 78  LFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS-AVQYCHQKF--- 133
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPEGIVS 350
            I+H DLK  N+LLD +    ++DFG S     G+      K  A  G   Y APE    
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN------KLDAFCGAPPYAAPELFQG 186
Query: 351 TK-----CDVYSYGILLLETFSRKKP 371
            K      DV+S G++L    S   P
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 169 QRATNEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLER------TFVSFNSECE 221
           Q+  + +D    LG G F  V K    S G   A K    +  R      +      E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +LR V H N+I +     N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 282 ALEYLHYGHALAPIIHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGEGDDSLIQTKTM 337
            + YLH       I H DLKP NI LLD+N+ + H+   DFG++    E +D +      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGIL 361
            T  ++APE +    +  + D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 24/196 (12%)
Query: 181 LGIGSFGSVYKGT--LSDGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G++ +VYKG   L+D   VA+K   L+ E     +   E  +L++++H N++ +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
                   LV E++ +  L+++L       +I+   N+ + +   L  L Y H    ++H
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR-QKVLH 123
Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT----MATIGYMAPEGIV---- 349
            DLKP N+L++E     ++DFG+++         I TKT    + T+ Y  P+ ++    
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKS------IPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 350 -STKCDVYSYGILLLE 364
            ST+ D++  G +  E
Sbjct: 178 YSTQIDMWGVGCIFYE 193

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLN------IMIDVGLALEYLHYGHA 291
            N   +A  +E M +  + + L   + Y L   + L+       +  +   L+Y+H    
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVS 350
            A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE +++
Sbjct: 147 -ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 351 TK-----CDVYSYGILLLETFSRK 369
           +K      D++S G +L E  S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 165 YLDIQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVL 223
           + D+ + T+E     LLG G++  V    +L +G   A+KI   Q   +      E E L
Sbjct: 10  FEDMYKLTSE-----LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETL 64
Query: 224 RNVR-HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
              + ++N+++++    +     LV E +  GS+   +    +F +  E   ++ DV  A
Sbjct: 65  YQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNE-REASRVVRDVAAA 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVS----DFGISKLLGEGDDSLIQTKTM 337
           L++LH       I H DLKP NIL +    V+ V     D G    L      +   +  
Sbjct: 124 LDFLH----TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 338 ATIG---YMAPEGI---------VSTKCDVYSYGILLLETFSRKKP 371
              G   YMAPE +            +CD++S G++L    S   P
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 13/188 (6%)
Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           LG G FG V++   +      +  F        V    E  +L   RHRN++ +     +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL 300
           ++   ++ EF+    + + + +  + L+  E ++ +  V  AL++LH  H +    H D+
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-SHNIG---HFDI 128
Query: 301 KPSNILLDENMVAHVS--DFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCD 354
           +P NI+      + +   +FG ++ L  GD+  +         Y APE     +VST  D
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATD 185
Query: 355 VYSYGILL 362
           ++S G L+
Sbjct: 186 MWSLGTLV 193

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 88
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHAL 292
              N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ 
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 144
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVST 351
           A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 352 K-----CDVYSYGILLLETFSRK 369
           K      D++S G +L E  S +
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 169 QRATNEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLER------TFVSFNSECE 221
           Q+  + +D    LG G F  V K    S G   A K    +  R      +      E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +LR V H N+I +     N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 282 ALEYLHYGHALAPIIHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGEGDDSLIQTKTM 337
            + YLH       I H DLKP NI LLD+N+ + H+   DFG++    E +D +      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGIL 361
            T  ++APE +    +  + D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 180 LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN--LIK 233
           L  IGS GS  V++         AIK  NL+    +T  S+ +E   L  ++  +  +I+
Sbjct: 13  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 72
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +        +  +V+E   N  L  WL      +D  ER +   ++   LE +H  H   
Sbjct: 73  LYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNM---LEAVHTIHQHG 127
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----- 348
            I+H DLKP+N L+ + M+  + DFGI+  +     S+++   + T+ YM PE I     
Sbjct: 128 -IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 349 ----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
                     +S K DV+S G +L      K P   +        +NQ    KL  ++D 
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------INQI--SKLHAIIDP 235
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
           N    E  F    D   + +   L CC++  P +RI
Sbjct: 236 N---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 265

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 39  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 94
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHAL 292
              N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ 
Sbjct: 95  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 150
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVST 351
           A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++
Sbjct: 151 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 352 K-----CDVYSYGILLLETFSRK 369
           K      D++S G +L E  S +
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHAL 292
              N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 142
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVST 351
           A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 352 K-----CDVYSYGILLLETFSRK 369
           K      D++S G +L E  S +
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 51  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 106
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLN------IMIDVGLALEYLHYG 289
              N   +A  +E M +  + + L   + Y L   + L+       +  +   L+Y+H  
Sbjct: 107 ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 162
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGI 348
              A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE +
Sbjct: 163 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 349 VSTK-----CDVYSYGILLLETFSRK 369
           +++K      D++S G +L E  S +
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 142
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS-AN 148
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 175 FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLI 232
           +   + +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLN------IMIDVGLALEY 285
            I     N   +A  +E M +  + + L   + Y L   + L+       +  +   L+Y
Sbjct: 89  GI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMA 344
           +H     A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y A
Sbjct: 144 IHS----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 345 PEGIVSTK-----CDVYSYGILLLETFSRK 369
           PE ++++K      D++S G +L E  S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    +  FG+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 149
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 93  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 150
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 211 YTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 84  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 141
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 202 YTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 148
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTN-VAIKIFNLQLERTFVSFNSECEV--LRNVRHR 229
            ++++   +G G++G+V+K    +    VA+K   L  +   V  ++  E+  L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N++++     +     LV EF  +  L+K+  S N  LD     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE--- 346
           +    ++H DLKP N+L++ N    +++FG+++  G        +  + T+ Y  P+   
Sbjct: 121 N----VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLF 174
Query: 347 --GIVSTKCDVYSYGILLLETFSRKKP 371
              + ST  D++S G +  E  +  +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 142
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR 223

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 169 QRATNEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERTFV------SFNSECE 221
           Q+  + +D    LG G F  V K    S G   A K    +  R             E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +LR V H N+I +     N     L+LE +  G L  +L +    L   E  + +  +  
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 282 ALEYLHYGHALAPIIHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGEGDDSLIQTKTM 337
            + YLH       I H DLKP NI LLD+N+ + H+   DFG++    E +D +      
Sbjct: 127 GVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 338 ATIGYMAPEGI----VSTKCDVYSYGIL 361
            T  ++APE +    +  + D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + D G+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI-- 88
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHAL 292
              N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ 
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 144
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVST 351
           A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 352 K-----CDVYSYGILLLETFSRK 369
           K      D++S G +L E  S +
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILS 236
           +G G++G V   +  D  N   VAIK  +    +T+      E ++L   RH N+I I  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI-- 88
Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLN------IMIDVGLALEYLHYG 289
              N   +A  +E M +  + + L   + Y L   + L+       +  +   L+Y+H  
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 144
Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGI 348
              A ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE +
Sbjct: 145 ---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 349 VSTK-----CDVYSYGILLLETFSRK 369
           +++K      D++S G +L E  S +
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 40/262 (15%)
Query: 140 RCQNRSTKKSDEEDLLPLVTWRRISYL---DIQRATNEFDECNLLGIGSFGSVYKGTLSD 196
           R +  S K  D E +L     + + Y    ++  AT++      LG GSFG V++  + D
Sbjct: 42  RSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHR--MED 95
Query: 197 ---GTNVAIKIFNLQLERTFVSFNSE----CEVLRNVRHRNLIKILSGCSNLDFKALVLE 249
              G   A+K   L++      F +E    C  L + R   ++ +        +  + +E
Sbjct: 96  KQTGFQCAVKKVRLEV------FRAEELMACAGLTSPR---IVPLYGAVREGPWVNIFME 146
Query: 250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE 309
            +  GSL + +         L     +  +G ALE L Y H+   I+H D+K  N+LL  
Sbjct: 147 LLEGGSLGQLVKEQG----CLPEDRALYYLGQALEGLEYLHSRR-ILHGDVKADNVLLSS 201
Query: 310 NMV-AHVSDFGISKLL---GEGDDSLIQTKTMATIGYMAPEGIVSTKC----DVYSYGIL 361
           +   A + DFG +  L   G G D L       T  +MAPE ++   C    DV+S   +
Sbjct: 202 DGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCM 261
Query: 362 LLETFSRKKPTNDL--GEMSLK 381
           +L   +   P      G + LK
Sbjct: 262 MLHMLNGCHPWTQFFRGPLCLK 283

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + D G+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 180 LLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIK 233
            LG G F   ++ + +D   V A KI    L     +R  +S   E  + R++ H++++ 
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVG 85
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                 + DF  +VLE     SL + L+     L   E    +  + L  +YLH      
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 141
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTM-ATIGYMAPEGIV-- 349
            +IH DLK  N+ L+E++   + DFG+ +K+  +G+    + KT+  T  Y+APE +   
Sbjct: 142 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKTLCGTPNYIAPEVLSKK 196
Query: 350 --STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVDS 398
             S + DV+S G ++      K P  T+ L E  L+   N+ S+P  +  V  S
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 250

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 180 LLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIK 233
            LG G F   ++ + +D   V A KI    L     +R  +S   E  + R++ H++++ 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVG 81
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                 + DF  +VLE     SL + L+     L   E    +  + L  +YLH      
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 137
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTM-ATIGYMAPEGIV-- 349
            +IH DLK  N+ L+E++   + DFG+ +K+  +G+    + KT+  T  Y+APE +   
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKTLCGTPNYIAPEVLSKK 192
Query: 350 --STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVDS 398
             S + DV+S G ++      K P  T+ L E  L+   N+ S+P  +  V  S
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + DF +++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G+++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G+++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 168 IQRATNEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSF------NSEC 220
           I      +   + +G G++GSV        G  VA+K    +L R F S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK----WLYSHNYFLDI------- 269
            +L++++H N+I +L              F P  SLE+    +L +H    D+       
Sbjct: 73  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
            L   ++   +   L  L Y H+ A IIH DLKPSN+ ++E+    + D G+++     D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTD 176
Query: 329 DSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
           D +  T  +AT  Y APE ++     +   D++S G ++ E  +
Sbjct: 177 DEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAI+  +    +T+      E ++L   RH N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 148
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +   T+ +AT  Y APE ++++K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 180 LLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIK 233
            LG G F   ++ + +D   V A KI    L     +R  +S   E  + R++ H++++ 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVG 81
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                 + DF  +VLE     SL + L+     L   E    +  + L  +YLH      
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 137
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTM-ATIGYMAPEGIV-- 349
            +IH DLK  N+ L+E++   + DFG+ +K+  +G+    + KT+  T  Y+APE +   
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKTLCGTPNYIAPEVLSKK 192
Query: 350 --STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVDS 398
             S + DV+S G ++      K P  T+ L E  L+   N+ S+P  +  V  S
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 246

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS------FNSECEVLRNVRHRNLIK 233
           +G G++GSV        G  VAIK    +L R F S         E  +L++++H N+I 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 105
Query: 234 IL------SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           +L      S   N     LV+ FM    L+K +    +  + ++ L   +  GL  +Y+H
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFM-QTDLQK-IMGMEFSEEKIQYLVYQMLKGL--KYIH 161
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
                A ++H DLKP N+ ++E+    + DFG+++     D  +  T  + T  Y APE 
Sbjct: 162 S----AGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGYVVTRWYRAPEV 212
Query: 348 IVS-----TKCDVYSYGILLLETFSRK 369
           I+S        D++S G ++ E  + K
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 181 LGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSG 237
           LG GSF S+ +  +   +N   A+KI + ++E    +   E   L+    H N++K+   
Sbjct: 19  LGEGSF-SICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLHEV 74
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
             +     LV+E +  G L + +    +F +  E   IM  +  A+ ++H       ++H
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMHD----VGVVH 129
Query: 298 CDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            DLKP N+L    ++N+   + DFG ++ L   D+  ++T    T+ Y APE +      
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFAR-LKPPDNQPLKTPCF-TLHYAAPELLNQNGYD 187
Query: 351 TKCDVYSYGILLLETFSRKKP 371
             CD++S G++L    S + P
Sbjct: 188 ESCDLWSLGVILYTMLSGQVP 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 43/211 (20%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS------FNSECEVLRNVRHRNLIK 233
           +G G++GSV        G  VAIK    +L R F S         E  +L++++H N+I 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 234 IL------SGCSNLDFKALVLEFMPNGSLEKWL---YSHNYFLDILERLNIMIDVGL-AL 283
           +L      S   N     LV+ FM    L+K +   +S        E++  ++   L  L
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSE-------EKIQYLVYQMLKGL 139
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           +Y+H     A ++H DLKP N+ ++E+    + DFG+++     D  +  T  + T  Y 
Sbjct: 140 KYIHS----AGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGYVVTRWYR 190
Query: 344 APEGIVS-----TKCDVYSYGILLLETFSRK 369
           APE I+S        D++S G ++ E  + K
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 79  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLXQVIQMELDHERMSYL 124
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 125 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVT 181
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIK-IFN-----LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG G++G V+K      G  VA+K IF+        +RTF       E+  +    NL+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +L   ++ D   LV ++M    L   + ++   L+ + +  ++  +   ++YLH G    
Sbjct: 77  VLRADNDRDV-YLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---- 128
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGE-------------------GDDSLIQT 334
            ++H D+KPSNILL+      V+DFG+S+                        DD  I T
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 335 KTMATIGYMAPEGIV-STK----CDVYSYGILLLETFSRK 369
             +AT  Y APE ++ STK     D++S G +L E    K
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 81/207 (39%), Gaps = 29/207 (14%)
Query: 173 NEFDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV----- 226
             F   + LG GS+G V+K  +  DG   A+K       R+   F    +  R +     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-------RSMSPFRGPKDRARKLAEVGS 109
Query: 227 -----RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
                +H   +++           L  E     SL++   +    L   +    + D  L
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           AL +LH       ++H D+KP+NI L       + DFG+   LG      +Q        
Sbjct: 169 ALAHLHS----QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPR 221
Query: 342 YMAPE---GIVSTKCDVYSYGILLLET 365
           YMAPE   G   T  DV+S G+ +LE 
Sbjct: 222 YMAPELLQGSYGTAADVFSLGLTILEV 248

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 56/299 (18%)
Query: 167 DIQRATNEFDECN---------LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTF 213
           D  +A++  +EC          L  IGS GS  V++         AIK  NL+    +T 
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 98
Query: 214 VSFNSECEVLRNVRHRN--LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILE 271
            S+ +E   L  ++  +  +I++        +  +V+E   N  L  WL      +D  E
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWE 156
Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
           R +   ++   LE +H  H    I+H DLKP+N L+ + M+  + DFGI+  +     S+
Sbjct: 157 RKSYWKNM---LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSV 211
Query: 332 IQTKTMATIGYMAPEGIVSTKC---------------DVYSYG-ILLLETFSRKKPTNDL 375
           ++   +  + YM PE I                    DV+S G IL   T+         
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY--------- 262
Query: 376 GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
           G+   +  +NQ    KL  ++D N    E  F    D   + +   L CC++  P +RI
Sbjct: 263 GKTPFQQIINQI--SKLHAIIDPN---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSDGTN-VAIKIFNLQL--ERTFVSFNSECEVLRNV 226
           R T+++     LG G+F  V +      T   A KI N +    R       E  + R +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           +H N++++    S   F  LV + +  G L + + +  Y+ +     +    +   LE +
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIHQILESV 143
Query: 287 HYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGIS-KLLGEGDDSLIQTKTMATIGY 342
           ++ H    I+H DLKP N+LL    +     ++DFG++ ++ GE            T GY
Sbjct: 144 NHIHQ-HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF---GFAGTPGY 199
Query: 343 MAPEGI----VSTKCDVYSYGILL 362
           ++PE +         D+++ G++L
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 115/276 (41%), Gaps = 45/276 (16%)
Query: 180 LLGIGSFGS--VYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN--LIK 233
           L  IGS GS  V++         AIK  NL+    +T  S+ +E   L  ++  +  +I+
Sbjct: 33  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +        +  +V+E   N  L  WL      +D  ER +   ++   LE +H  H   
Sbjct: 93  LYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNM---LEAVHTIHQHG 147
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKC 353
            I+H DLKP+N L+ + M+  + DFGI+  +      +++   + T+ YM PE I     
Sbjct: 148 -IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 354 ---------------DVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
                          DV+S G +L      K P   +        +NQ    KL  ++D 
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------INQI--SKLHAIIDP 255
Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCME-SPDERI 433
           N    E  F    D   + +   L CC++  P +RI
Sbjct: 256 N---HEIEFP---DIPEKDLQDVLKCCLKRDPKQRI 285

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 24/233 (10%)
Query: 180 LLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIK 233
            LG G F   ++ + +D   V A KI    L     +R  +S   E  + R++ H++++ 
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVG 103
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                 + DF  +VLE     SL + L+     L   E    +  + L  +YLH      
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 159
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTMATIGYMAPEGIV--- 349
            +IH DLK  N+ L+E++   + DFG+ +K+  +G+   +      T  Y+APE +    
Sbjct: 160 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKG 215
Query: 350 -STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVDS 398
            S + DV+S G ++      K P  T+ L E  L+   N+ S+P  +  V  S
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 268

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 148
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +    + +AT  Y APE ++++K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 181 LGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFN-SECEVLRNVRHRNLIKILSGC 238
           +G G++G V     + +   VAIK  +    +T+      E ++L   RH N+I I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYF----LDILERLNIMIDVGLALEYLHYGHALAP 294
            N   +A  +E M +  + + L   + +       L   +I   +   L  L Y H+ A 
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-AN 149
Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLG-EGDDSLIQTKTMATIGYMAPEGIVSTK- 352
           ++H DLKPSN+LL+      + DFG++++   + D +    + +AT  Y APE ++++K 
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 353 ----CDVYSYGILLLETFSRK 369
                D++S G +L E  S +
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR 230

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 26  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 80  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 182
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 183 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 24/233 (10%)
Query: 180 LLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIK 233
            LG G F   ++ + +D   V A KI    L     +R  +S   E  + R++ H++++ 
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVG 105
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                 + DF  +VLE     SL + L+     L   E    +  + L  +YLH      
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 161
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTMATIGYMAPEGIV--- 349
            +IH DLK  N+ L+E++   + DFG+ +K+  +G+   +      T  Y+APE +    
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKG 217
Query: 350 -STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVDS 398
            S + DV+S G ++      K P  T+ L E  L+   N+ S+P  +  V  S
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 270

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 26  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 80  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 182
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 183 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 31  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 85  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 130
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 131 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 187
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 188 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 87  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 189
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 79  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 181
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 87  ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 189
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 124 ISLLN------------VFTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 226
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 24/233 (10%)
Query: 180 LLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIK 233
            LG G F   ++ + +D   V A KI    L     +R  +S   E  + R++ H++++ 
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVG 79
Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
                 + DF  +VLE     SL + L+     L   E    +  + L  +YLH      
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 135
Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTMATIGYMAPEGIV--- 349
            +IH DLK  N+ L+E++   + DFG+ +K+  +G+   +      T  Y+APE +    
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKG 191
Query: 350 -STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVDS 398
            S + DV+S G ++      K P  T+ L E  L+   N+ S+P  +  V  S
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 244

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  +LE+  +   Y +  L   N+   + + L++    + 
Sbjct: 124 ISLLNV------------FTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 226
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPEVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRH 228
            +++++   +G G+FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 229 RNLIKILSGCSNLDFKA-----------LVLEFMPN---GSLEKWLYSHNYFLDILERLN 274
            N++ ++  C     KA           LV +F  +   G L   L    + L  ++R+ 
Sbjct: 77  ENVVNLIEICRT---KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVM 131
Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ- 333
            M+  GL   Y+H       I+H D+K +N+L+  + V  ++DFG+++      +S    
Sbjct: 132 QMLLNGLY--YIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 334 -TKTMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSR 368
               + T+ Y  PE ++  +      D++  G ++ E ++R
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 56/99 (56%), Gaps = 15/99 (15%)
Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEG 327
           E   IM D+G A+++LH  H +A   H D+KP N+L    +++ V  ++DFG +K   E 
Sbjct: 110 EAAEIMRDIGTAIQFLH-SHNIA---HRDVKPENLLYTSKEKDAVLKLTDFGFAK---ET 162
Query: 328 DDSLIQTKTMATIGYMAPEGIVSTK----CDVYSYGILL 362
             + +QT    T  Y+APE +   K    CD++S G+++
Sbjct: 163 TQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 64/144 (44%), Gaps = 18/144 (12%)
Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
           DIL +  I + +  ALE+LH   +   +IH D+KPSN+L++        DFGIS  L   
Sbjct: 136 DILGK--IAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLV-- 188
Query: 328 DDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGE-- 377
            D + +        Y APE I         S K D++S GI  +E    + P +  G   
Sbjct: 189 -DDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPF 247
Query: 378 MSLKHWVNQSLPHKLAEVVDSNLV 401
             LK  V +  P   A+   +  V
Sbjct: 248 QQLKQVVEEPSPQLPADKFSAEFV 271

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 56/99 (56%), Gaps = 15/99 (15%)
Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEG 327
           E   IM D+G A+++LH  H +A   H D+KP N+L    +++ V  ++DFG +K   E 
Sbjct: 129 EAAEIMRDIGTAIQFLH-SHNIA---HRDVKPENLLYTSKEKDAVLKLTDFGFAK---ET 181
Query: 328 DDSLIQTKTMATIGYMAPEGIVSTK----CDVYSYGILL 362
             + +QT    T  Y+APE +   K    CD++S G+++
Sbjct: 182 TQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 14/180 (7%)
Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVL-RNVR 227
           ++F    ++G GSFG V      ++    A+K+   +    ++      SE  VL +NV+
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H  L+ +       D    VL+++  G L   L     FL+   R     ++  AL YLH
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH 156
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
             +    I++ DLKP NILLD      ++DFG+ K   E  +    T T   T  Y+APE
Sbjct: 157 SLN----IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPE 209

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRH 228
            +++++   +G G+FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 229 RNLIKILSGCSNLDFKA-----------LVLEFMPN---GSLEKWLYSHNYFLDILERLN 274
            N++ ++  C     KA           LV +F  +   G L   L    + L  ++R+ 
Sbjct: 76  ENVVNLIEICRT---KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVM 130
Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ- 333
            M+  GL   Y+H       I+H D+K +N+L+  + V  ++DFG+++      +S    
Sbjct: 131 QMLLNGLY--YIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 334 -TKTMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSR 368
               + T+ Y  PE ++  +      D++  G ++ E ++R
Sbjct: 185 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 33/226 (14%)
Query: 172 TNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQ--LERTFVS------FNSECEV 222
           + ++   + LG G+FG V+     +    V +K    +  LE  ++          E  +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN------IM 276
           L  V H N+IK+L    N  F  LV+E   +G           F+D   RL+      I 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSG------LDLFAFIDRHPRLDEPLASYIF 136
Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             +  A+ YL     L  IIH D+K  NI++ E+    + DFG +  L  G   L  T  
Sbjct: 137 RQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYT-F 189
Query: 337 MATIGYMAPEGIVST-----KCDVYSYGILLLETFSRKKPTNDLGE 377
             TI Y APE ++       + +++S G+ L      + P  +L E
Sbjct: 190 CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 80  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 125
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 182
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 183 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 91  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 136
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 137 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 193
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 194 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRH 228
            +++++   +G G+FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 229 RNLIKILSGCSNLDFKA-----------LVLEFMPN---GSLEKWLYSHNYFLDILERLN 274
            N++ ++  C     KA           LV +F  +   G L   L    + L  ++R+ 
Sbjct: 77  ENVVNLIEICRT---KASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVM 131
Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ- 333
            M+  GL   Y+H       I+H D+K +N+L+  + V  ++DFG+++      +S    
Sbjct: 132 QMLLNGLY--YIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 334 -TKTMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSR 368
               + T+ Y  PE ++  +      D++  G ++ E ++R
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRH 228
            +++++   +G G+FG V+K      G  VA+K   ++ E+      +  E ++L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 229 RNLIKILSGCSNLDFKA-----------LVLEFMPN---GSLEKWLYSHNYFLDILERLN 274
            N++ ++  C     KA           LV +F  +   G L   L    + L  ++R+ 
Sbjct: 77  ENVVNLIEICRT---KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVM 131
Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ- 333
            M+  GL   Y+H       I+H D+K +N+L+  + V  ++DFG+++      +S    
Sbjct: 132 QMLLNGLY--YIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 334 -TKTMATIGYMAPEGIVSTK-----CDVYSYGILLLETFSR 368
               + T+ Y  PE ++  +      D++  G ++ E ++R
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 87  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 132
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 189
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGE 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S + T  + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S +    + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 19/202 (9%)
Query: 181 LGIGSFGSVYKGTLSD--------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           LG G+F  ++KG   +         T V +K+ +        SF     ++  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
                C   D   LV EF+  GSL+ +L  +   ++IL +L +   +  A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--- 132
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM--ATIGYMAPEGIVS 350
             +IH ++   NILL         +    KL   G    +  K +    I ++ PE I +
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 351 TK-----CDVYSYGILLLETFS 367
            K      D +S+G  L E  S
Sbjct: 192 PKNLNLATDKWSFGTTLWEICS 213

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 19/202 (9%)
Query: 181 LGIGSFGSVYKGTLSD--------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           LG G+F  ++KG   +         T V +K+ +        SF     ++  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
                C   D   LV EF+  GSL+ +L  +   ++IL +L +   +  A+ +L      
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEEN--- 132
Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM--ATIGYMAPEGIVS 350
             +IH ++   NILL         +    KL   G    +  K +    I ++ PE I +
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 351 TK-----CDVYSYGILLLETFS 367
            K      D +S+G  L E  S
Sbjct: 192 PKNLNLATDKWSFGTTLWEICS 213

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSD--GTNVAIKIFNLQLERTFVSFNSEC-----EVLRN 225
            +F+   +LG GSFG V    L+D  GT     I  L+ +      + EC      VL  
Sbjct: 19  TDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 226 VRHRNLIKILSGC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           +     +  L  C   +D    V+E++  G L   +     F +  + +    ++ + L 
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISIGLF 134
Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           +LH       II+ DLK  N++LD      ++DFG+ K      D +   +   T  Y+A
Sbjct: 135 FLHK----RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIA 188
Query: 345 PEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV---NQSLPHKLAE 394
           PE I         D ++YG+LL E  + + P +   E  L   +   N S P  L++
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSK 245

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 60/125 (48%), Gaps = 24/125 (19%)
Query: 253 NGSLEKWLYSHNYFLDILER----LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD 308
           NGS+  +  S    LD ++R     NIM  +  AL YLH       I H D+KP N L  
Sbjct: 151 NGSIHGFRES----LDFVQREKLISNIMRQIFSALHYLHN----QGICHRDIKPENFLFS 202
Query: 309 ENMVAHVS--DFGISK---LLGEGDDSLIQTKTMATIGYMAPEGIVST------KCDVYS 357
            N    +   DFG+SK    L  G+   + TK   T  ++APE + +T      KCD +S
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 358 YGILL 362
            G+LL
Sbjct: 262 AGVLL 266

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 110/247 (44%), Gaps = 23/247 (9%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRN 225
           R    +     LG G F   Y+ T  D   V A K+    +          ++E  + ++
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           + + +++       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTM-ATIGYM 343
           LH       +IH DLK  N+ L+++M   + DFG+ +K+  +G+    + KT+  T  Y+
Sbjct: 158 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE----RKKTLCGTPNYI 209
Query: 344 APEGIV----STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVV 396
           APE +     S + D++S G +L      K P  T+ L E  ++   N+ S+P  +  V 
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 397 DSNLVRR 403
            S L+RR
Sbjct: 270 -SALIRR 275

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 48/218 (22%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVS--------FNSECEVLRN 225
           ++ C ++G G F  V +    + G   A+KI ++     F S           E  +   
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA---KFTSSPGLSTEDLKREASICHM 84
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSL---------EKWLYSH----NYFLDILER 272
           ++H +++++L   S+     +V EFM    L           ++YS     +Y   ILE 
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 143
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDD 329
                    AL Y H  +    IIH D+KP  +LL   + +    +  FG++  LGE   
Sbjct: 144 ---------ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--S 188
Query: 330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLL 363
            L+    + T  +MAPE +         DV+  G++L 
Sbjct: 189 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 226

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 48/214 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 86  IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S +    + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVT 188
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLETFSRK 369
             Y APE I+        D++S G ++ E    K
Sbjct: 189 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 48/218 (22%)
Query: 175 FDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVS--------FNSECEVLRN 225
           ++ C ++G G F  V +    + G   A+KI ++     F S           E  +   
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA---KFTSSPGLSTEDLKREASICHM 82
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSL---------EKWLYSH----NYFLDILER 272
           ++H +++++L   S+     +V EFM    L           ++YS     +Y   ILE 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDD 329
                    AL Y H  +    IIH D+KP  +LL   + +    +  FG++  LGE   
Sbjct: 142 ---------ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--S 186
Query: 330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLL 363
            L+    + T  +MAPE +         DV+  G++L 
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 22/213 (10%)
Query: 171 ATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSEC-----EVLR 224
             + F+   +LG GSFG V    + + G   A+K+  L+ +      + EC      +L 
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILS 78
Query: 225 NVRHRNLIKILSGC-SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
             R+   +  L  C    D    V+EF+  G L   +     F +   R     ++  AL
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISAL 137
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGY 342
            +LH       II+ DLK  N+LLD      ++DFG+ K   EG  + + T T   T  Y
Sbjct: 138 MFLHD----KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDY 190
Query: 343 MAP----EGIVSTKCDVYSYGILLLETFSRKKP 371
           +AP    E +     D ++ G+LL E      P
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 48/209 (22%)
Query: 181 LGIGSFGSV---YKGTLSDGTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNL 231
           +G G+ G V   Y   L    NVAIK    +L R F +         E  +++ V H+N+
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +L+             F P  SLE+  +   Y +  L   N+   + + L++    + 
Sbjct: 88  IGLLN------------VFTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 133
Query: 292 L------------APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           L            A IIH DLKPSNI++  +    + DFG+++  G    S +    + T
Sbjct: 134 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVT 190
Query: 340 IGYMAPEGIVST----KCDVYSYGILLLE 364
             Y APE I+        D++S G ++ E
Sbjct: 191 RYYRAPEVILGMGYKENVDIWSVGCIMGE 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 43/190 (22%)
Query: 197 GTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNLIKILSGCSNLDFKALVLEF 250
           G NVA+K    +L R F +         E  +L+ V H+N+I +L+             F
Sbjct: 49  GINVAVK----KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------F 92
Query: 251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL------------APIIHC 298
            P  +LE+  +   Y +  L   N+   + + L++    + L            A IIH 
Sbjct: 93  TPQKTLEE--FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCD 354
           DLKPSNI++  +    + DFG+++       + + T  + T  Y APE I+    +   D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYAANVD 207
Query: 355 VYSYGILLLE 364
           ++S G ++ E
Sbjct: 208 IWSVGCIMGE 217

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 43/190 (22%)
Query: 197 GTNVAIKIFNLQLERTFVSFN------SECEVLRNVRHRNLIKILSGCSNLDFKALVLEF 250
           G NVA+K    +L R F +         E  +L+ V H+N+I +L+             F
Sbjct: 47  GINVAVK----KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------F 90
Query: 251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL------------APIIHC 298
            P  +LE+  +   Y +  L   N+   + + L++    + L            A IIH 
Sbjct: 91  TPQKTLEE--FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHR 148
Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVST----KCD 354
           DLKPSNI++  +    + DFG+++       + + T  + T  Y APE I+        D
Sbjct: 149 DLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMGYKENVD 205
Query: 355 VYSYGILLLE 364
           ++S G ++ E
Sbjct: 206 IWSVGCIMGE 215

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 21/246 (8%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRN 225
           R    +     LG G F   Y+ T  D   V A K+    +          ++E  + ++
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           + + +++       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTMATIGYMA 344
           LH       +IH DLK  N+ L+++M   + DFG+ +K+  +G+    +     T  Y+A
Sbjct: 158 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIA 210
Query: 345 PEGIV----STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVD 397
           PE +     S + D++S G +L      K P  T+ L E  ++   N+ S+P  +  V  
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA- 269
Query: 398 SNLVRR 403
           S L+RR
Sbjct: 270 SALIRR 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 21/246 (8%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRN 225
           R    +     LG G F   Y+ T  D   V A K+    +          ++E  + ++
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           + + +++       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTMATIGYMA 344
           LH       +IH DLK  N+ L+++M   + DFG+ +K+  +G+    +     T  Y+A
Sbjct: 158 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIA 210
Query: 345 PEGIV----STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVD 397
           PE +     S + D++S G +L      K P  T+ L E  ++   N+ S+P  +  V  
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA- 269
Query: 398 SNLVRR 403
           S L+RR
Sbjct: 270 SALIRR 275

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 21/246 (8%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRN 225
           R    +     LG G F   Y+ T  D   V A K+    +          ++E  + ++
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           + + +++       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI-SKLLGEGDDSLIQTKTMATIGYMA 344
           LH       +IH DLK  N+ L+++M   + DFG+ +K+  +G+    +     T  Y+A
Sbjct: 142 LHNNR----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIA 194
Query: 345 PEGIV----STKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQ-SLPHKLAEVVD 397
           PE +     S + D++S G +L      K P  T+ L E  ++   N+ S+P  +  V  
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA- 253
Query: 398 SNLVRR 403
           S L+RR
Sbjct: 254 SALIRR 259

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 21/254 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
            +FD   ++G GS+  V    L     + A+K+   +L   +       +E  V     +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 229 RNLIKILSGCSNLDFKAL-VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
              +  L  C   + +   V+E++  G L   +       +   R     ++ LAL YLH
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 127
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKTMATIGYMAPE 346
                  II+ DLK  N+LLD      ++D+G+ K  L  GD +   +    T  Y+APE
Sbjct: 128 E----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPE 180
Query: 347 GI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR 402
            +         D ++ G+L+ E  + + P + +G        +Q+    L +V+    +R
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQIR 237
Query: 403 REHSFSAKMDCLLR 416
              S S K   +L+
Sbjct: 238 IPRSLSVKAASVLK 251

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 21/254 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
            +FD   ++G GS+  V    L     + A+K+   +L   +       +E  V     +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 229 RNLIKILSGCSNLDFKAL-VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
              +  L  C   + +   V+E++  G L   +       +   R     ++ LAL YLH
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 123
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKTMATIGYMAPE 346
                  II+ DLK  N+LLD      ++D+G+ K  L  GD +   +    T  Y+APE
Sbjct: 124 E----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPE 176
Query: 347 GI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR 402
            +         D ++ G+L+ E  + + P + +G        +Q+    L +V+    +R
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQIR 233
Query: 403 REHSFSAKMDCLLR 416
              S S K   +L+
Sbjct: 234 IPRSLSVKAASVLK 247

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 33/207 (15%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLA 282
           H N+I +     N     L+LE +  G L     EK   +     + L+++         
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMA 338
           L  ++Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         
Sbjct: 124 LNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFG 179
Query: 339 TIGYMAPEGI----VSTKCDVYSYGIL 361
           T  ++APE +    +  + D++S G++
Sbjct: 180 TPAFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 21/254 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
            +FD   ++G GS+  V    L     + A+K+   +L   +       +E  V     +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 229 RNLIKILSGCSNLDFKAL-VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
              +  L  C   + +   V+E++  G L   +       +   R     ++ LAL YLH
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 138
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSLIQTKTMATIGYMAPE 346
                  II+ DLK  N+LLD      ++D+G+ K  L  GD +   +    T  Y+APE
Sbjct: 139 E----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPE 191
Query: 347 GI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR 402
            +         D ++ G+L+ E  + + P + +G        +Q+    L +V+    +R
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQIR 248
Query: 403 REHSFSAKMDCLLR 416
              S S K   +L+
Sbjct: 249 IPRSMSVKAASVLK 262

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G+F  V +   +  G   A KI N +    R       E  + R ++H N++++   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
            S      L+ + +  G L + + +  Y+ +     +    +   LE + + H +  ++H
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEA----DASHCIQQILEAVLHCHQMG-VVH 144
Query: 298 CDLKPSNILLDENM---VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VS 350
            DLKP N+LL   +      ++DFG++ +  EG+          T GY++PE +      
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYG 202
Query: 351 TKCDVYSYGILL 362
              D+++ G++L
Sbjct: 203 KPVDLWACGVIL 214

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 43/210 (20%)
Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV------LRNVRHRNLI 232
           +LLG GS+G V K  L   T     +  L+ ++     N E  V      LR +RH+N+I
Sbjct: 11  DLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 233 KILSGCSNLDFKAL--VLEFMPNGSLE----------KWLYSHNYFLDILERLNIMIDVG 280
           +++    N + + +  V+E+   G  E              +H YF  +++         
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID--------- 120
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE--GDDSLIQTKTMA 338
             LEYLH       I+H D+KP N+LL       +S  G+++ L     DD+     +  
Sbjct: 121 -GLEYLHS----QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQG 173
Query: 339 TIGYMAPE------GIVSTKCDVYSYGILL 362
           +  +  PE           K D++S G+ L
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 55/249 (22%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSDGT-NVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           +  + ++  +L+G GS+G VY     +   NVAIK    ++ R F        +LR +  
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIK----KVNRMFEDLIDCKRILREITI 80
Query: 229 RNLIK-----------ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
            N +K           I       D   +VLE + +  L+K L+    FL       I+ 
Sbjct: 81  LNRLKSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKK-LFKTPIFLTEQHVKTILY 138
Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ---- 333
           ++ L  +++H     + IIH DLKP+N LL+++    + DFG+++ +    D  I     
Sbjct: 139 NLLLGEKFIHE----SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 334 -------------------TKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
                              T  + T  Y APE I+     +   D++S G +  E  +  
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMM 254
Query: 370 K-----PTN 373
           K     PTN
Sbjct: 255 KSHINNPTN 263

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H N+I +     N     L+LE +  G L  +L +    L   E    +  +   L  ++
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQI---LNGVY 128
Query: 288 YGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         T  ++
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFV 184
Query: 344 APEGI----VSTKCDVYSYGIL 361
           APE +    +  + D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVA---IKIFNLQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A   IK    +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLA 282
           H N+I +     N     L+LE +  G L     EK   +     + L+++         
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMA 338
           L  ++Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         
Sbjct: 124 LNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFG 179
Query: 339 TIGYMAPEGI----VSTKCDVYSYGIL 361
           T  ++APE +    +  + D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H N+I +     N     L+LE +  G L  +L +    L   E    +  +   L  ++
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQI---LNGVY 127
Query: 288 YGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         T  ++
Sbjct: 128 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFV 183
Query: 344 APEGI----VSTKCDVYSYGIL 361
           APE +    +  + D++S G++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVI 205

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H N+I +     N     L+LE +  G L  +L +    L   E    +  +   L  ++
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQI---LNGVY 127
Query: 288 YGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         T  ++
Sbjct: 128 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFV 183
Query: 344 APEGI----VSTKCDVYSYGIL 361
           APE +    +  + D++S G++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVI 205

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 33/207 (15%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLA 282
           H N+I +     N     L+LE +  G L     EK   +     + L+++         
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMA 338
           L  ++Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         
Sbjct: 124 LNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFG 179
Query: 339 TIGYMAPEGI----VSTKCDVYSYGIL 361
           T  ++APE +    +  + D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 21/254 (8%)
Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNV-AIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
            +FD   ++G GS+  V    L     + A+++   +L   +       +E  V     +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 229 RNLIKILSGCSNLDFKAL-VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
              +  L  C   + +   V+E++  G L   +       +   R     ++ LAL YLH
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 170
Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
                  II+ DLK  N+LLD      ++D+G+ K   EG      T T   T  Y+APE
Sbjct: 171 E----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 223
Query: 347 GI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR 402
            +         D ++ G+L+ E  + + P + +G        +Q+    L +V+    +R
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQIR 280
Query: 403 REHSFSAKMDCLLR 416
              S S K   +L+
Sbjct: 281 IPRSLSVKAASVLK 294

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 33/207 (15%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLA 282
           H N+I +     N     L+LE +  G L     EK   +     + L+++         
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMA 338
           L  ++Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         
Sbjct: 124 LNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFG 179
Query: 339 TIGYMAPEGI----VSTKCDVYSYGIL 361
           T  ++APE +    +  + D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H N+I +     N     L+LE +  G L  +L +    L   E    +  +   L  ++
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQI---LNGVY 128
Query: 288 YGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         T  ++
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFV 184
Query: 344 APEGI----VSTKCDVYSYGIL 361
           APE +    +  + D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ-TKTMATIGYMAPEGI----VST 351
           H D+KP NIL+  +  A++ DFGI+      D+ L Q   T+ T+ Y APE       + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP 389
           + D+Y+   +L E  +   P            +NQ++P
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIP 252

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H N+I +     N     L+LE +  G L  +L +    L   E    +  +   L  ++
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQI---LNGVY 128
Query: 288 YGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         T  ++
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFV 184
Query: 344 APEGI----VSTKCDVYSYGILLLETFSRKKP 371
           APE +    +  + D++S G++     S   P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 28/49 (57%)
Query: 45  GEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCG 93
           G +P+ L  L +L  LNVS N L GEIP  G  + F   +++ N  LCG
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 33/207 (15%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLA 282
           H N+I +     N     L+LE +  G L     EK   +     + L+++         
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMA 338
           L  ++Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         
Sbjct: 124 LNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFG 179
Query: 339 TIGYMAPEGI----VSTKCDVYSYGIL 361
           T  ++APE +    +  + D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 25/224 (11%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEVL 223
           L I   ++ ++    +G G+FG V +      +N  VA+K    + E+   +   E    
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIE-RGEKIAANVKREIINH 69
Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           R++RH N+++           A+V+E+   G L + + +   F +   R          +
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QLI 125
Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAH--VSDFGISKLLGEGDDSLIQTKTMATIG 341
             + Y HA+  + H DLK  N LLD +      + DFG SK       S++ ++  +T+G
Sbjct: 126 SGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVG 178
Query: 342 ---YMAPEGIVSTK-----CDVYSYGILLLETFSRKKPTNDLGE 377
              Y+APE ++  +      DV+S G+ L        P  D  E
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLA 282
           H N+I +     N     L+LE +  G L     EK   +     + L+++         
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMA 338
           L  ++Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         
Sbjct: 124 LNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFG 179
Query: 339 TIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKP 371
           T  ++APE +    +  + D++S G++     S   P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 166 LDIQRATNEFDECNLLGIGSFG--SVYKGTLSDGTNVAIKIFNLQLER-TFVSFNSECEV 222
           + I   ++ +D    +G G+FG   + +  L+    VA+K     +ER   +  N + E+
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKY----IERGAAIDENVQREI 67
Query: 223 L--RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
           +  R++RH N+++           A+++E+   G L + + +   F +   R        
Sbjct: 68  INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---- 123
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAH--VSDFGISKLLGEGDDSLIQTKTMA 338
             L  + Y H++  I H DLK  N LLD +      + DFG SK       S++ ++  +
Sbjct: 124 QLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKS 176
Query: 339 TIG---YMAPEGIVSTK-----CDVYSYGILLLETFSRKKPTNDLGE 377
           T+G   Y+APE ++  +      DV+S G+ L        P  D  E
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILERLNIMIDVGLA 282
           H N+I +     N     L+LE +  G L     EK   +     + L+++         
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--------- 123
Query: 283 LEYLHYGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMA 338
           L  ++Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         
Sbjct: 124 LNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFG 179
Query: 339 TIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKP 371
           T  ++APE +    +  + D++S G++     S   P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV 226
           R T E+     LG G+F  V +   +  G   A  I N +    R       E  + R +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           +H N++++    S      L+ + +  G L + + +  Y+ +     +    +   LE +
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA----DASHCIQQILEAV 123
Query: 287 HYGHALAPIIHCDLKPSNILLDENM---VAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
            + H +  ++H +LKP N+LL   +      ++DFG++ +  EG+          T GY+
Sbjct: 124 LHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQ-AWFGFAGTPGYL 180
Query: 344 APEGI----VSTKCDVYSYGILL 362
           +PE +         D+++ G++L
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVIL 203

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 175 FDECNLLGIGSFGSVYK-GTLSDGTNVAIKIFN---LQLERTFVS---FNSECEVLRNVR 227
           +D    LG G F  V K    S G   A K       +  R  VS      E  +L+ ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H N+I +     N     L+LE +  G L  +L +    L   E    +  +   L  ++
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQI---LNGVY 128
Query: 288 YGHALAPIIHCDLKPSNI-LLDENMVA---HVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           Y H+L  I H DLKP NI LLD N+      + DFG++  +  G++         T  ++
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFV 184
Query: 344 APEGI----VSTKCDVYSYGILLLETFSRKKP 371
           APE +    +  + D++S G++     S   P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 47/223 (21%)
Query: 179 NLLGIGSFGSVYKGTLSDG-TNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK---- 233
           +L+G GS+G VY     +   NVAIK    ++ R F        +LR +   N +K    
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIK----KVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 234 -------ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
                  I       D   +VLE + +  L+K L+    FL       I+ ++ L   ++
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLE-IADSDLKK-LFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ------------- 333
           H     + IIH DLKP+N LL+++    V DFG+++ +    D+ I              
Sbjct: 146 HE----SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 334 -------TKTMATIGYMAPEGIV-----STKCDVYSYGILLLE 364
                  T  + T  Y APE I+     +   D++S G +  E
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 31/227 (13%)
Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLER-TFVSFNSECEV 222
           L I   ++ ++    +G G+FG V +       N  VA+K     +ER   +  N + E+
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFG-VARLMRDKQANELVAVKY----IERGEKIDENVKREI 66
Query: 223 L--RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
           +  R++RH N+++           A+V+E+   G L + + +   F +   R        
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---- 122
Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAH--VSDFGISKLLGEGDDSLIQTKTMA 338
             +  + Y HA+  + H DLK  N LLD +      ++DFG SK       S++ ++  +
Sbjct: 123 QLISGVSYAHAMQ-VAHRDLKLENTLLDGSPAPRLKIADFGYSKA------SVLHSQPKS 175
Query: 339 TIG---YMAPEGIVSTK-----CDVYSYGILLLETFSRKKPTNDLGE 377
            +G   Y+APE ++  +      DV+S G+ L        P  D  E
Sbjct: 176 AVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 169 QRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV- 226
           ++  + F    + G G+FG+V  G   S G +VAIK   +Q  R     N E ++++++ 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR---NRELQIMQDLA 74
Query: 227 --RHRNLIKILSGCSNLD-------FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
              H N++++ S    L        +  +V+E++P+ +L +     NY+   +    I+I
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC--CRNYYRRQVAPPPILI 131
Query: 278 DVGLALEYLHYGHALAP---IIHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSLIQ 333
            V L       G    P   + H D+KP N+L++E +    + DFG +K L   + ++  
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV-- 189
Query: 334 TKTMATIGYMAPEGIV-----STKCDVYSYGILLLE 364
              + +  Y APE I      +T  D++S G +  E
Sbjct: 190 -AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	457
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-84
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-79
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-71
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-47
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-20
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-19
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-08
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-05
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-04
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-04
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-04
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-06
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  260 bits (668), Expect = 2e-84
 Identities = 96/300 (32%), Positives = 147/300 (49%), Gaps = 20/300 (6%)

Query: 144 RSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIK 203
            S   +     L      R+  +D++ ATN FD   L+G G FG VYKG L DG  VA+K
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69

Query: 204 IFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLY-- 261
               +  +    F +E E L   RH +L+ ++  C   +   L+ ++M NG+L++ LY  
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 262 -SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI 320
                 +   +RL I I     L YLH       IIH D+K  NILLDEN V  ++DFGI
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGI 185

Query: 321 SKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTN--- 373
           SK   E D + + T    T+GY+ PE    G ++ K DVYS+G++L E    +       
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245

Query: 374 DLGEMSLKHWVNQSLPH-KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
               ++L  W  +S  + +L ++VD NL  +      + + L +  + A+ C   S ++R
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDR 300

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  247 bits (632), Expect = 7e-79
 Identities = 103/302 (34%), Positives = 154/302 (50%), Gaps = 30/302 (9%)

Query: 150 DEEDL-LPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ 208
            EED  + L   +R S  ++Q A++ F   N+LG G FG VYKG L+DGT VA+K    +
Sbjct: 6   AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----R 61

Query: 209 LERTFVS-----FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLY-- 261
           L+          F +E E++    HRNL+++   C     + LV  +M NGS+   L   
Sbjct: 62  LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121

Query: 262 -SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI 320
                 LD  +R  I +     L YLH  H    IIH D+K +NILLDE   A V DFG+
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 321 SKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTN--- 373
           +KL+    D+ + T    TIG++APE    G  S K DV+ YG++LLE  + ++  +   
Sbjct: 181 AKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239

Query: 374 DLGE--MSLKHWVNQSLPH-KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPD 430
              +  + L  WV   L   KL  +VD +L   + ++  +   + +++ +AL C   SP 
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDL---QGNYKDE--EVEQLIQVALLCTQSSPM 294

Query: 431 ER 432
           ER
Sbjct: 295 ER 296

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  227 bits (582), Expect = 1e-71
 Identities = 80/304 (26%), Positives = 140/304 (46%), Gaps = 35/304 (11%)

Query: 150 DEEDLLPLVTWRRISYLDIQRATNEFDE------CNLLGIGSFGSVYKGTLSDGTNVAIK 203
           ++   +    +   S+ +++  TN FDE       N +G G FG VYKG + + T VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 204 -------IFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL 256
                  I   +L++ F     E +V+   +H NL+++L   S+ D   LV  +MPNGSL
Sbjct: 61  KLAAMVDITTEELKQQFDQ---EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117

Query: 257 EKWLYSHNYF--LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH 314
              L   +    L    R  I       + +LH        IH D+K +NILLDE   A 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAK 173

Query: 315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKP 371
           +SDFG+++   +   +++ ++ + T  YMAPE   G ++ K D+YS+G++LLE  +    
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPA 233

Query: 372 TN-DLGEMSLKHWVNQSL--PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMES 428
            +       L     +       + + +D  +    +   +    +  + ++A  C  E 
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM----NDADST--SVEAMYSVASQCLHEK 287

Query: 429 PDER 432
            ++R
Sbjct: 288 KNKR 291

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  198 bits (506), Expect = 3e-60
 Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 32/296 (10%)

Query: 163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV 222
           +   ++   +       +   G FG V+K  L     VA+KIF +Q ++   S+ +E EV
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ---SWQNEYEV 69

Query: 223 --LRNVRHRNLIKILSGCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIM 276
             L  ++H N+++ +              L+  F   GSL  +L      +   E  +I 
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIA 127

Query: 277 IDVGLALEYLH------YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
             +   L YLH             I H D+K  N+LL  N+ A ++DFG++     G  +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 331 LIQTKTMATIGYMAPE---------GIVSTKCDVYSYGILLLETFSRKKPTNDLGE---M 378
                 + T  YMAPE              + D+Y+ G++L E  SR    +   +   +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 379 SLKHWVNQSLP-HKLAEVVDSNLVRREHSFS-AKMDCLLRIMNLALDCCMESPDER 432
             +  + Q      + EVV     R        K   +  +     +C     + R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  194 bits (495), Expect = 8e-59
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 29/268 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRN 230
            + +    +G GSFG+V++     G++VA+KI   Q         F  E  +++ +RH N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHY 288
           ++  +   +     ++V E++  GSL + L+       LD   RL++  DV   + YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
            +   PI+H +LK  N+L+D+     V DFG+S+L  +    L       T  +MAPE +
Sbjct: 156 RNP--PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVL 211

Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE 404
                + K DVYS+G++L E  + ++P  +L             P ++   V     R E
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLN------------PAQVVAAVGFKCKRLE 259

Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDER 432
                  +   ++  +   C    P +R
Sbjct: 260 IPR----NLNPQVAAIIEGCWTNEPWKR 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  191 bits (487), Expect = 1e-57
 Identities = 75/287 (26%), Positives = 115/287 (40%), Gaps = 39/287 (13%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
            E +   ++G G+FG V K       +VAIK    + ER   +F  E   L  V H N++
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIV 64

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGH 290
           K+   C N     LV+E+   GSL   L+      +      ++  +     + YLH   
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH-SM 121

Query: 291 ALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPE 346
               +IH DLKP N+LL     V  + DFG +          IQT      G   +MAPE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--------IQTHMTNNKGSAAWMAPE 173

Query: 347 GI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR 402
                  S KCDV+S+GI+L E  +R+KP +++G              ++   V +   R
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG----------GPAFRIMWAVHNGT-R 222

Query: 403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF 449
                    +    I +L   C  + P +R         +  +   F
Sbjct: 223 PPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (481), Expect = 6e-57
 Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 28/269 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN 230
            +      +G GSFG+VYKG      +VA+K+ N+     +   +F +E  VLR  RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++  +   +     A+V ++    SL   L++     ++ + ++I       ++YLH   
Sbjct: 82  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-- 348
               IIH DLK +NI L E+    + DFG++        S    +   +I +MAPE I  
Sbjct: 138 -AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 349 -----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR 403
                 S + DVY++GI+L E  + + P           + N +   ++ E+V       
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLP-----------YSNINNRDQIIEMVGRGS-LS 244

Query: 404 EHSFSAKMDCLLRIMNLALDCCMESPDER 432
                 + +C  R+  L  +C  +  DER
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  187 bits (478), Expect = 1e-56
 Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 22/224 (9%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN 230
            + +    L     G ++KG    G ++ +K+  ++    R    FN EC  LR   H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 231 LIKILSGCSN--LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLH 287
           ++ +L  C +       L+  +MP GSL   L+   N+ +D  + +   +D+   + +LH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE- 346
                  I    L   ++++DE+M A +S   +         S      M    ++APE 
Sbjct: 129 TLEP--LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179

Query: 347 ------GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV 384
                        D++S+ +LL E  +R+ P  DL  M +   V
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  185 bits (471), Expect = 2e-55
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 42/279 (15%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ-------LERTFVSFNSECEVLR 224
           NE +    +G G FG V+KG  + D + VAIK   L        +   F  F  E  ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           N+ H N++K+       +   +V+EF+P G L   L    + +    +L +M+D+ L +E
Sbjct: 79  NLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 285 YLHYGHALAPIIHCDLKPSNILLDE-----NMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           Y+   +   PI+H DL+  NI L        + A V+DFG+S+           +  +  
Sbjct: 137 YMQNQN--PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGN 189

Query: 340 IGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA 393
             +MAPE I       + K D YS+ ++L    + + P ++     +K          + 
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------IN 240

Query: 394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            + +  L R         DC  R+ N+   C    P +R
Sbjct: 241 MIREEGL-RPTIP----EDCPPRLRNVIELCWSGDPKKR 274

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (465), Expect = 8e-55
 Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 44/284 (15%)

Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ----LERTFVSFNSECE 221
           L+I     E     ++GIG FG VY+     G  VA+K         + +T  +   E +
Sbjct: 2   LEIDF--AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAK 58

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +   ++H N+I +   C       LV+EF   G L + L      +     +N  + +  
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIAR 116

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDE--------NMVAHVSDFGISKLLGEGDDSLIQ 333
            + YLH   A+ PIIH DLK SNIL+ +        N +  ++DFG+++          +
Sbjct: 117 GMNYLH-DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----K 171

Query: 334 TKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV-NQSL 388
                   +MAPE I     S   DV+SYG+LL E  + + P   +  +++ + V    L
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
              +                    C      L  DC    P  R
Sbjct: 232 ALPIPS-----------------TCPEPFAKLMEDCWNPDPHSR 258

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  183 bits (467), Expect = 1e-54
 Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 41/278 (14%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN 230
            + +   L+G G FG VY G    G  VAI++ +++   E    +F  E    R  RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++  +  C +    A++       +L   +      LD+ +   I  ++   + YLH   
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA---TIGYMAPEG 347
               I+H DLK  N+  D   V  ++DFG+  + G       + K       + ++APE 
Sbjct: 149 --KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 348 I-------------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
           I              S   DV++ G +  E  +R+ P           +  Q     +  
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-----------FKTQP-AEAIIW 253

Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            + + + +   S   ++     I ++ L C     +ER
Sbjct: 254 QMGTGM-KPNLS---QIGMGKEISDILLFCWAFEQEER 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  183 bits (466), Expect = 2e-54
 Identities = 66/277 (23%), Positives = 109/277 (39%), Gaps = 36/277 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
           ++     +LG G FG   K T    G  + +K      E T  +F  E +V+R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           +K +           + E++  G+L   + S +      +R++   D+   + YLH  + 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL---------IQTKTMATIG- 341
              IIH DL   N L+ EN    V+DFG+++L+ +               + K    +G 
Sbjct: 129 ---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 342 --YMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV 395
             +MAPE I       K DV+S+GI+L E   R     D    +                
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT----------MDFGLN 235

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           V   L  R        +C      + + CC   P++R
Sbjct: 236 VRGFL-DRY----CPPNCPPSFFPITVRCCDLDPEKR 267

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  180 bits (457), Expect = 6e-53
 Identities = 72/320 (22%), Positives = 125/320 (39%), Gaps = 43/320 (13%)

Query: 163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV 222
            +  +     +      L+G G +G+VYKG+L D   VA+K+F+    +   +F +E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 223 --LRNVRHRNLIKILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
             +  + H N+ + + G   +         LV+E+ PNGSL K+L  H    D +    +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116

Query: 276 MIDVGLALEYLH-----YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
              V   L YLH       H    I H DL   N+L+  +    +SDFG+S  L      
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 331 LIQTKTMA------TIGYMAPE-----------GIVSTKCDVYSYGILLLETFSRKK--- 370
               +  A      TI YMAPE                + D+Y+ G++  E F R     
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 371 PTNDLGEMSL-KHWVNQSLP--HKLAEVVDSNLVRRE--HSFSAKMDCLLRIMNLALDCC 425
           P   + E  +       + P    +  +V     R +   ++      +  +     DC 
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 426 MESPDERIHTTNAAAKLRKI 445
            +  + R+    A  ++ ++
Sbjct: 297 DQDAEARLTAQXAEERMAEL 316

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (444), Expect = 5e-51
 Identities = 68/318 (21%), Positives = 120/318 (37%), Gaps = 40/318 (12%)

Query: 155 LPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV 214
           LPL+  R      IQ       +   +G G +G V+ G    G  VA+K+F    E    
Sbjct: 27  LPLLVQR-TIAKQIQ-----MVKQ--IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA--- 74

Query: 215 SFNSECEV--LRNVRHRNLIKILSGCSNLDFK----ALVLEFMPNGSLEKWLYSHNYFLD 268
           S+  E E+     +RH N++  ++             L+ ++  NGSL  +L   +  LD
Sbjct: 75  SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLD 132

Query: 269 ILERLNIMIDVGLALEYLH----YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL 324
               L +       L +LH           I H DLK  NIL+ +N    ++D G++   
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 325 GEGDDSLIQTKTMA--TIGYMAPEGIVST----------KCDVYSYGILLLETFSRKKPT 372
               + +         T  YM PE +  +            D+YS+G++L E   R    
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 373 NDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH----SFSAKMDCLLRIMNLALDCCMES 428
             + E  L +           ++ +   +++      +  +  +CL ++  L  +C   +
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312

Query: 429 PDERIHTTNAAAKLRKIK 446
           P  R+        L K+ 
Sbjct: 313 PASRLTALRVKKTLAKMS 330

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  170 bits (434), Expect = 6e-50
 Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 34/294 (11%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEV--LRNVRHRNLIKILS 236
             +G G +G V++G+   G NVA+KIF+ + E+   S+  E E+     +RH N++  ++
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69

Query: 237 GCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH----Y 288
                   +    L+  +   GSL  +L      LD +  L I++ +   L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA--TIGYMAPE 346
                 I H DLK  NIL+ +N    ++D G++ +  +  + L         T  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 347 ----------GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
                          + D++++G++L E   R      + +     + +        E +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-PFYDVVPNDPSFEDM 246

Query: 397 DSNLVRREH-----SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
              +   +      +       L  +  L  +C  ++P  R+        L KI
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (422), Expect = 1e-47
 Identities = 66/320 (20%), Positives = 124/320 (38%), Gaps = 40/320 (12%)

Query: 155 LPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFV 214
           LPL+  R I+   I        E   +G G FG V++G    G  VA+KIF+ + ER   
Sbjct: 32  LPLLVQRTIA-RTIV-----LQES--IGKGRFGEVWRGKW-RGEEVAVKIFSSREER--- 79

Query: 215 SFNSECEV--LRNVRHRNLIKILSGCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLD 268
           S+  E E+     +RH N++  ++  +  +       LV ++  +GSL  +L  + Y + 
Sbjct: 80  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVT 137

Query: 269 ILERLNIMIDVGLALEYLH----YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL 324
           +   + + +     L +LH           I H DLK  NIL+ +N    ++D G++   
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

Query: 325 --GEGDDSLIQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPT 372
                   +     + T  YMAPE +             + D+Y+ G++  E   R    
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257

Query: 373 NDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH----SFSAKMDCLLRIMNLALDCCMES 428
               +  L ++        + E+      ++      +     + L  +  +  +C   +
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317

Query: 429 PDERIHTTNAAAKLRKIKVQ 448
              R+        L ++  Q
Sbjct: 318 GAARLTALRIKKTLSQLSQQ 337

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  144 bits (366), Expect = 3e-39
 Identities = 69/258 (26%), Positives = 109/258 (42%), Gaps = 26/258 (10%)

Query: 181 LGIGSFGSVYKGTL-SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G G+FG V+ G L +D T VA+K     L       F  E  +L+   H N+++++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
           +      +V+E +  G    +L +    L +   L ++ D    +EYL         IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC----CIHR 237

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCD 354
           DL   N L+ E  V  +SDFG+S+   +G  +         + + APE    G  S++ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297

Query: 355 VYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCL 414
           V+S+GILL ETFS       LG     +  NQ       +  +   V +         C 
Sbjct: 298 VWSFGILLWETFS-------LGASPYPNLSNQ-------QTREF--VEKGGRLPCPELCP 341

Query: 415 LRIMNLALDCCMESPDER 432
             +  L   C    P +R
Sbjct: 342 DAVFRLMEQCWAYEPGQR 359

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (355), Expect = 3e-38
 Identities = 58/265 (21%), Positives = 100/265 (37%), Gaps = 37/265 (13%)

Query: 181 LGIGSFGSVYKGTLSDG-----TNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG+VYKG            VAIK        +       E  V+ +V + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHA 291
           L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-- 349
               +H DL   N+L+       ++DFG++KLLG  +           I +MA E I+  
Sbjct: 139 ----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             + + DV+SYG+ + E  +        G                 E+    ++ +    
Sbjct: 195 IYTHQSDVWSYGVTVWELMT-------FGSKPYDGIPAS-------EISS--ILEKGERL 238

Query: 408 SAKMDCLLRIMNLALDCCMESPDER 432
                C + +  +   C M   D R
Sbjct: 239 PQPPICTIDVYMIMRKCWMIDADSR 263

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  139 bits (352), Expect = 5e-38
 Identities = 66/277 (23%), Positives = 124/277 (44%), Gaps = 24/277 (8%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVSFNSECEVL 223
           +F+E +L     LG G+FGSV          + G  VA+K      E     F  E E+L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 224 RNVRHRNLIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           ++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATI 340
            +EYL         IH DL   NIL++      + DFG++K+L +  +   ++    + I
Sbjct: 126 GMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181

Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP-HKLAEV 395
            + APE +     S   DV+S+G++L E F+  + +       ++   N       +  +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           ++  L++          C   I  +  +C   + ++R
Sbjct: 242 IE--LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  139 bits (353), Expect = 7e-38
 Identities = 66/277 (23%), Positives = 124/277 (44%), Gaps = 24/277 (8%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVSFNSECEVL 223
           +F+E +L     LG G+FGSV          + G  VA+K      E     F  E E+L
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96

Query: 224 RNVRHRNLIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           ++++H N++K    C +   +   L++E++P GSL  +L  H   +D ++ L     +  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATI 340
            +EYL         IH DL   NIL++      + DFG++K+L +  +   ++    + I
Sbjct: 157 GMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212

Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH-KLAEV 395
            + APE +     S   DV+S+G++L E F+  + +       ++   N       +  +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           ++  L++          C   I  +  +C   + ++R
Sbjct: 273 IE--LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (347), Expect = 1e-37
 Identities = 69/261 (26%), Positives = 107/261 (40%), Gaps = 36/261 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF--NLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +G G FG V+ G   +   VAIK        E  F+    E EV+  + H  L+++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHALAPI 295
                  LV EFM +G L  +L +          L + +DV   + YL            
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------- 125

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+ EN V  VSDFG+++ +   D     T T   + + +PE       S+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM 411
           K DV+S+G+L+ E FS        G++  ++  N        EVV+   +          
Sbjct: 185 KSDVWSFGVLMWEVFS-------EGKIPYENRSNS-------EVVE--DISTGFRLYKPR 228

Query: 412 DCLLRIMNLALDCCMESPDER 432
                +  +   C  E P++R
Sbjct: 229 LASTHVYQIMNHCWRERPEDR 249

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  137 bits (348), Expect = 2e-37
 Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 36/264 (13%)

Query: 181 LGIGSFGSVYKGTLSDG---TNVAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G+FGSV +G         +VAIK+      +        E +++  + +  +++++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHALA 293
            C       LV+E    G L K+L      + +     ++  V + ++YL   ++     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGIV--- 349
             +H DL   N+LL     A +SDFG+SK LG  D     ++     + + APE I    
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            S++ DV+SYG+ + E  S        G+   K            EV+    + +     
Sbjct: 190 FSSRSDVWSYGVTMWEALS-------YGQKPYKKMKGP-------EVMA--FIEQGKRME 233

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
              +C   +  L  DC +   ++R
Sbjct: 234 CPPECPPELYALMSDCWIYKWEDR 257

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (349), Expect = 2e-37
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 36/265 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTN----VAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKIL 235
           +G G  G V  G L         VAIK       ER    F SE  ++    H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHAL 292
              +      +V E+M NGSL+ +L +H+    I++ + ++  VG  + YL    Y    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGIV-- 349
              +H DL   N+L+D N+V  VSDFG+S++L +  D+    T     I + APE I   
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             S+  DV+S+G+++ E  +        GE    +  N+       +V+    V   +  
Sbjct: 230 TFSSASDVWSFGVVMWEVLA-------YGERPYWNMTNR-------DVIS--SVEEGYRL 273

Query: 408 SAKMDCLLRIMNLALDCCMESPDER 432
            A M C   +  L LDC  +   +R
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQR 298

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  138 bits (349), Expect = 3e-37
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 25/277 (9%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVSFNSECEVL 223
            F+E +L     LG G+FGSV          + G  VA+K            F  E ++L
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78

Query: 224 RNVRHRNLIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           + +    ++K          ++  LV+E++P+G L  +L  H   LD    L     +  
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATI 340
            +EYL         +H DL   NIL++      ++DFG++KLL    D  +++    + I
Sbjct: 139 GMEYLGSRR----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 341 GYMAPEGIV----STKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEV 395
            + APE +     S + DV+S+G++L E F+   K  +   E        + +P  L+ +
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP-ALSRL 253

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           ++  L+       A   C   +  L   C   SP +R
Sbjct: 254 LE--LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 288

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  138 bits (349), Expect = 5e-37
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 36/265 (13%)

Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKIL 235
           +G G FG V  G L        +VAIK   +   E+    F  E  ++    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHAL 292
              +      +V E+M NGSL+ +L  H+    +++ + ++  +   ++YL    Y    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGIV-- 349
              +H DL   NIL++ N+V  VSDFG+ ++L +  ++          I + +PE I   
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225

Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             ++  DV+SYGI+L E  S        GE       NQ       +V+ +  V   +  
Sbjct: 226 KFTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQ-------DVIKA--VDEGYRL 269

Query: 408 SAKMDCLLRIMNLALDCCMESPDER 432
              MDC   +  L LDC  +  + R
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNR 294

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  135 bits (343), Expect = 9e-37
 Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 40/282 (14%)

Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDG----TNVAIKIFNLQL-ERTFVSFNSEC 220
           +        F+E  ++G G FG VY GTL D      + A+K  N          F +E 
Sbjct: 20  IGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 77

Query: 221 EVLRNVRHRNLIKILSGCSNLDFKAL-VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
            ++++  H N++ +L  C   +   L VL +M +G L  ++ +  +   + + +   + V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 280 GLALEYL---HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
              ++YL    +       +H DL   N +LDE     V+DFG+++ + + +   +  KT
Sbjct: 138 AKGMKYLASKKF-------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190

Query: 337 MAT--IGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH 390
            A   + +MA E       +TK DV+S+G+LL E  +        G              
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-------RGAPPYPDVNTF---- 239

Query: 391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
              ++     + +         C   +  + L C     + R
Sbjct: 240 ---DIT--VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (342), Expect = 9e-37
 Identities = 62/267 (23%), Positives = 99/267 (37%), Gaps = 38/267 (14%)

Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIK 233
           LG GSFG V +G          +VA+K      L        F  E   + ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGH 290
           +         K +V E  P GSL   L  H     +       + V   + YL    +  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGIV 349
                IH DL   N+LL    +  + DFG+ + L + DD  ++Q        + APE + 
Sbjct: 143 -----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 350 ----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
               S   D + +G+ L E F+        G+                +++   + +   
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGS-------QILHK-IDKEGE 242

Query: 406 SFSAKMDCLLRIMNLALDCCMESPDER 432
                 DC   I N+ + C    P++R
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (347), Expect = 9e-37
 Identities = 65/360 (18%), Positives = 132/360 (36%), Gaps = 49/360 (13%)

Query: 99  VPPCKEENNKRSKKVALLVLNYILPPIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLV 158
           + P    ++   ++ A +    ++P     +  + +I        +     +        
Sbjct: 4   IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63

Query: 159 TWRRISYLD------IQRATNEFDECNL-----LGIGSFGSVYKGTLSDG----TNVAIK 203
               +S L+      +Q          +     +G G FG VY GTL D      + A+K
Sbjct: 64  VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 204 IFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL-VLEFMPNGSLEKWLY 261
             N          F +E  ++++  H N++ +L  C   +   L VL +M +G L  ++ 
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183

Query: 262 SHNYFLDILERLNIMIDVGLALEYL---HYGHALAPIIHCDLKPSNILLDENMVAHVSDF 318
           +  +   + + +   + V   +++L    +       +H DL   N +LDE     V+DF
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFLASKKF-------VHRDLAARNCMLDEKFTVKVADF 236

Query: 319 GISKLLGEGDDSLIQTKTMAT--IGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPT 372
           G+++ + + +   +  KT A   + +MA E       +TK DV+S+G+LL E  +     
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT----- 291

Query: 373 NDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
              G                 ++     + +         C   +  + L C     + R
Sbjct: 292 --RGAPPYPDVNTF-------DIT--VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  135 bits (341), Expect = 1e-36
 Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 36/261 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF--NLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G FG V  G      +VA+K+       E  F     E + +  + H  L+K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHALAPI 295
           S      +V E++ NG L  +L SH   L+  + L +  DV   + +L    +       
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------- 125

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           IH DL   N L+D ++   VSDFG+++ +   D  +    T   + + APE       S+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184

Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM 411
           K DV+++GIL+ E FS       LG+M    + N        EVV    V + H      
Sbjct: 185 KSDVWAFGILMWEVFS-------LGKMPYDLYTNS-------EVVL--KVSQGHRLYRPH 228

Query: 412 DCLLRIMNLALDCCMESPDER 432
                I  +   C  E P++R
Sbjct: 229 LASDTIYQIMYSCWHELPEKR 249

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (343), Expect = 1e-36
 Identities = 58/278 (20%), Positives = 113/278 (40%), Gaps = 24/278 (8%)

Query: 173 NEFDECNL-----LGIGSFGSVYKGTL-----SDGTNVAIKIF-NLQLERTFVSFNSECE 221
             F++  L     LG G FG V          + G  VA+K                E E
Sbjct: 16  THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75

Query: 222 VLRNVRHRNLIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
           +LRN+ H N++K    C+        L++EF+P+GSL+++L  +   +++ ++L   + +
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMA 338
              ++YL         +H DL   N+L++      + DFG++K +    +   ++    +
Sbjct: 136 CKGMDYLGSRQ----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191

Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
            + + APE ++        DV+S+G+ L E  +     +    + LK          +  
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251

Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           +V+   ++         +C   +  L   C    P  R
Sbjct: 252 LVN--TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (341), Expect = 1e-36
 Identities = 56/264 (21%), Positives = 98/264 (37%), Gaps = 37/264 (14%)

Query: 181 LGIGSFGSVYKGTLSDGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKIL 235
           +G G FG V++G      N    VAIK       +     F  E   +R   H +++K++
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHAL 292
              +      +++E    G L  +L    Y LD+   +     +  AL YL    +    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV--- 349
              +H D+   N+L+  N    + DFG+S+ + E       +K    I +MAPE I    
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            ++  DV+ +G+ + E           G    +   N        +V+    +       
Sbjct: 194 FTSASDVWMFGVCMWEILM-------HGVKPFQGVKNN-------DVIG--RIENGERLP 237

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
              +C   + +L   C    P  R
Sbjct: 238 MPPNCPPTLYSLMTKCWAYDPSRR 261

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  134 bits (340), Expect = 2e-36
 Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 36/261 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF--NLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G FG V  G      +VAIK+       E  F+    E +V+ N+ H  L+++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVC 88

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHALAPI 295
           +      ++ E+M NG L  +L    +     + L +  DV  A+EYL    +       
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------- 141

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----ST 351
           +H DL   N L+++  V  VSDFG+S+ +   D+      +   + +  PE ++    S+
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 352 KCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKM 411
           K D++++G+L+ E +S       LG+M  + + N        E  +   + +        
Sbjct: 201 KSDIWAFGVLMWEIYS-------LGKMPYERFTNS-------ETAE--HIAQGLRLYRPH 244

Query: 412 DCLLRIMNLALDCCMESPDER 432
               ++  +   C  E  DER
Sbjct: 245 LASEKVYTIMYSCWHEKADER 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (343), Expect = 2e-36
 Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 37/266 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTN-----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKI 234
           +G G FG VYKG L   +      VAIK       E+  V F  E  ++    H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHA 291
               S      ++ E+M NG+L+K+L   +    +L+ + ++  +   ++YL   +Y   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK-TMATIGYMAPEGIV- 349
               +H DL   NIL++ N+V  VSDFG+S++L +  ++   T      I + APE I  
Sbjct: 169 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 350 ---STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS 406
              ++  DV+S+GI++ E  +        GE       N        EV+    +     
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT-------YGERPYWELSNH-------EVMK--AINDGFR 268

Query: 407 FSAKMDCLLRIMNLALDCCMESPDER 432
               MDC   I  L + C  +    R
Sbjct: 269 LPTPMDCPSAIYQLMMQCWQQERARR 294

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  133 bits (338), Expect = 4e-36
 Identities = 62/265 (23%), Positives = 110/265 (41%), Gaps = 38/265 (14%)

Query: 181 LGIGSFGSVYKGTL---SDGTNVAIKIF--NLQLERTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G+FG+V KG          VA+KI               +E  V++ + +  +++++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHAL 292
             C    +  LV+E    G L K+L  + + +     + ++  V + ++YL   ++    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGIV-- 349
              +H DL   N+LL     A +SDFG+SK L   ++    QT     + + APE I   
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195

Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             S+K DV+S+G+L+ E FS        G+   +            EV    ++ +    
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS-------YGQKPYRGMKGS-------EVTA--MLEKGERM 239

Query: 408 SAKMDCLLRIMNLALDCCMESPDER 432
                C   + +L   C     + R
Sbjct: 240 GCPAGCPREMYDLMNLCWTYDVENR 264

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  136 bits (345), Expect = 7e-36
 Identities = 71/260 (27%), Positives = 124/260 (47%), Gaps = 28/260 (10%)

Query: 178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
              LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ + 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            S      +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +
Sbjct: 248 VSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YV 302

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STK 352
           H DL+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE  +    + K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            DV+S+GILL E  +        G +     VN+       EV+D   V R +      +
Sbjct: 362 SDVWSFGILLTELTT-------KGRVPYPGMVNR-------EVLD--QVERGYRMPCPPE 405

Query: 413 CLLRIMNLALDCCMESPDER 432
           C   + +L   C  + P+ER
Sbjct: 406 CPESLHDLMCQCWRKEPEER 425

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  133 bits (338), Expect = 7e-36
 Identities = 58/265 (21%), Positives = 101/265 (38%), Gaps = 37/265 (13%)

Query: 181 LGIGSFGSVYKGTLSDG-----TNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKI 234
           LG G+FG+VYKG            VAIK        +       E  V+ +V + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHA 291
           L  C     + L+ + MP G L  ++  H   +     LN  + +   + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-- 349
               +H DL   N+L+       ++DFG++KLLG  +           I +MA E I+  
Sbjct: 139 ----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 350 --STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             + + DV+SYG+ + E  +        G                 E+    ++ +    
Sbjct: 195 IYTHQSDVWSYGVTVWELMT-------FGSKPYDGIPAS-------EISS--ILEKGERL 238

Query: 408 SAKMDCLLRIMNLALDCCMESPDER 432
                C + +  + + C M   D R
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSR 263

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (338), Expect = 8e-36
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 42/277 (15%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG-----TNVAIKIFNLQL-ERTFVSFNSECEV 222
            F E  L     LG G FG+V+KG            V IK+   +   ++F +       
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           + ++ H +++++L  C     + LV +++P GSL   +  H   L     LN  + +   
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 283 LEYL---HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           + YL            +H +L   N+LL       V+DFG++ LL   D  L+ ++    
Sbjct: 128 MYYLEEHGM-------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 340 IGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV 395
           I +MA E I     + + DV+SYG+ + E  +        G                 EV
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT-------FGAEPYAGLRLA-------EV 226

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            D  L+ +    +    C + +  + + C M   + R
Sbjct: 227 PD--LLEKGERLAQPQICTIDVYMVMVKCWMIDENIR 261

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (350), Expect = 8e-36
 Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 36/264 (13%)

Query: 181 LGIGSFGSVYKGTLSDG---TNVAIKIF-NLQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG G+FGSV +G         +VAIK+      +        E +++  + +  +++++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHALA 293
            C       LV+E    G L K+L      + +     ++  V + ++YL   ++     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGIV--- 349
             +H +L   N+LL     A +SDFG+SK LG  D     ++     + + APE I    
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            S++ DV+SYG+ + E  S        G+   K            EV+    + +     
Sbjct: 516 FSSRSDVWSYGVTMWEALS-------YGQKPYKKMKGP-------EVMA--FIEQGKRME 559

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
              +C   +  L  DC +   ++R
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDR 583

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  137 bits (347), Expect = 1e-35
 Identities = 71/260 (27%), Positives = 124/260 (47%), Gaps = 28/260 (10%)

Query: 178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
              LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+++ + 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            S      +V E+M  GSL  +L      +L + + +++   +   + Y+   +     +
Sbjct: 331 VSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YV 385

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STK 352
           H DL+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE  +    + K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            DV+S+GILL E  +        G +     VN+       EV+D   V R +      +
Sbjct: 445 SDVWSFGILLTELTT-------KGRVPYPGMVNR-------EVLD--QVERGYRMPCPPE 488

Query: 413 CLLRIMNLALDCCMESPDER 432
           C   + +L   C  + P+ER
Sbjct: 489 CPESLHDLMCQCWRKEPEER 508

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (343), Expect = 2e-35
 Identities = 62/260 (23%), Positives = 119/260 (45%), Gaps = 28/260 (10%)

Query: 178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
              LG G FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K+ + 
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGLALEYLHYGHALAPII 296
            +  +   ++ EFM  GSL  +L S       + + ++    +   + ++   +     I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YI 306

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STK 352
           H DL+ +NIL+  ++V  ++DFG+++++ E ++   +      I + APE I     + K
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMD 412
            DV+S+GILL+E  +        G +      N        EV+    + R +      +
Sbjct: 366 SDVWSFGILLMEIVT-------YGRIPYPGMSNP-------EVIR--ALERGYRMPRPEN 409

Query: 413 CLLRIMNLALDCCMESPDER 432
           C   + N+ + C    P+ER
Sbjct: 410 CPEELYNIMMRCWKNRPEER 429

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  131 bits (332), Expect = 3e-35
 Identities = 56/280 (20%), Positives = 110/280 (39%), Gaps = 38/280 (13%)

Query: 168 IQRATNEFDECNLLGIGSFGSVYKGTLSDG----TNVAIKIFN-LQLERTFVSFNSECEV 222
           I           ++G G FG VY G   D        AIK  + +   +   +F  E  +
Sbjct: 16  IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75

Query: 223 LRNVRHRNLIKILSGCSNLD-FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +R + H N++ ++      +    ++L +M +G L +++ S      + + ++  + V  
Sbjct: 76  MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135

Query: 282 ALEYL---HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
            +EYL    +       +H DL   N +LDE+    V+DFG+++ + + +   +Q    A
Sbjct: 136 GMEYLAEQKF-------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 339 T--IGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
              + + A E       +TK DV+S+G+LL E  +        G    +H          
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT-------RGAPPYRHIDPF------ 235

Query: 393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
            ++   + + +         C   +  +   C    P  R
Sbjct: 236 -DLT--HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVR 272

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  131 bits (332), Expect = 5e-35
 Identities = 64/280 (22%), Positives = 114/280 (40%), Gaps = 32/280 (11%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVS---FNSEC 220
            F +  L     LG G FG V            G  VA+K   L+ +        +  E 
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEI 84

Query: 221 EVLRNVRHRNLIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           ++LR + H ++IK    C +    +  LV+E++P GSL  +L  H+  + + + L     
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQ 142

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LIQTKTM 337
           +   + YLH  H     IH DL   N+LLD + +  + DFG++K + EG +   ++    
Sbjct: 143 ICEGMAYLHAQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 338 ATIGYMAPEGIV----STKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKL 392
           + + + APE +         DV+S+G+ L E  +      +   +      + Q     +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TV 257

Query: 393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
             + +  L+ R         C   + +L  +C       R
Sbjct: 258 LRLTE--LLERGERLPRPDKCPAEVYHLMKNCWETEASFR 295

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 1e-34
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 36/226 (15%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           R  ++F+E  +LG G+FG V K     D    AIK      E    +  SE  +L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61

Query: 229 RNLIKI-------------LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
           + +++              ++         + +E+  NG+L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
              +  AL Y+H       IIH DLKP NI +DE+    + DFG++K +    D L    
Sbjct: 122 FRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 336 TMA------------TIGYMAPE-----GIVSTKCDVYSYGILLLE 364
                          T  Y+A E     G  + K D+YS GI+  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (326), Expect = 2e-34
 Identities = 58/264 (21%), Positives = 107/264 (40%), Gaps = 37/264 (14%)

Query: 181 LGIGSFGSVYKGTL----SDGTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLIKIL 235
           LG G FG VY+G       +  NVA+K             F SE  +++N+ H +++K++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHAL 292
                 +   +++E  P G L  +L  +   L +L  +   + +  A+ YL   +     
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV--- 349
              +H D+   NIL+       + DFG+S+ + E +D    + T   I +M+PE I    
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRR 190

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            +T  DV+ + + + E  S        G+       N+       +V+   ++ +     
Sbjct: 191 FTTASDVWMFAVCMWEILS-------FGKQPFFWLENK-------DVIG--VLEKGDRLP 234

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
               C   +  L   C    P +R
Sbjct: 235 KPDLCPPVLYTLMTRCWDYDPSDR 258

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (325), Expect = 2e-34
 Identities = 62/259 (23%), Positives = 120/259 (46%), Gaps = 32/259 (12%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIF--NLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G FG V+ G  +  T VA+K           F++   E  +++ ++H+ L+++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIH 297
           +  +   ++ E+M NGSL  +L + +   L I + L++   +   + ++   +     IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIH 132

Query: 298 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKC 353
            DL+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE I     + K 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191

Query: 354 DVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDC 413
           DV+S+GILL E  +        G +      N        EV+    + R +      +C
Sbjct: 192 DVWSFGILLTEIVT-------HGRIPYPGMTNP-------EVIQ--NLERGYRMVRPDNC 235

Query: 414 LLRIMNLALDCCMESPDER 432
              +  L   C  E P++R
Sbjct: 236 PEELYQLMRLCWKERPEDR 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  129 bits (327), Expect = 3e-34
 Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 45/284 (15%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG----TNVAIKIFNLQL--ERTFVSFNSECEV 222
             D   L     LG G FGSV +G L         VA+K   L    +R    F SE   
Sbjct: 30  VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89

Query: 223 LRNVRHRNLIKILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSH-----NYFLDILER 272
           +++  H N+I++L  C  +  +      ++L FM  G L  +L           + +   
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
           L  M+D+ L +EYL   +     +H DL   N +L ++M   V+DFG+SK +  GD    
Sbjct: 150 LKFMVDIALGMEYLSNRN----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205

Query: 333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL 388
                  + ++A E     + ++K DV+++G+ + E  +        G        N   
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT-------RGMTPYPGVQNH-- 256

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
                E+ D   +   H      DCL  +  +   C    P +R
Sbjct: 257 -----EMYD--YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  128 bits (324), Expect = 4e-34
 Identities = 66/263 (25%), Positives = 113/263 (42%), Gaps = 38/263 (14%)

Query: 181 LGIGSFGSVYKGTLSDG-TNVAIKIF--NLQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G +G VY+G        VA+K    +      F+    E  V++ ++H NL+++L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYL---HYGHALA 293
           C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   ++     
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----- 132

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV---- 349
             IH DL   N L+ EN +  V+DFG+S+L+  GD           I + APE +     
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           S K DV+++G+LL E  +        G                 +V +  L+ +++    
Sbjct: 190 SIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLS-------QVYE--LLEKDYRMER 233

Query: 410 KMDCLLRIMNLALDCCMESPDER 432
              C  ++  L   C   +P +R
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDR 256

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  132 bits (333), Expect = 6e-34
 Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 34/264 (12%)

Query: 178 CNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVS---FNSECEVLRNVRHRNLIK 233
            + LG G +G VY+G        VA+K     L+   +    F  E  V++ ++H NL++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHAL 292
           +L  C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL   +  
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 338

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV--- 349
              IH +L   N L+ EN +  V+DFG+S+L+  GD           I + APE +    
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 350 -STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            S K DV+++G+LL E  +        G                 +V +  L+ +++   
Sbjct: 396 FSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLS-------QVYE--LLEKDYRME 439

Query: 409 AKMDCLLRIMNLALDCCMESPDER 432
               C  ++  L   C   +P +R
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDR 463

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (335), Expect = 1e-33
 Identities = 58/308 (18%), Positives = 111/308 (36%), Gaps = 43/308 (13%)

Query: 142 QNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNL-----LGIGSFGSVYKGTLSD 196
           ++ +   S+ +D   ++     +Y        E     +     +G G FG V++G    
Sbjct: 355 RSHTVSVSETDDYAEIID-EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMS 413

Query: 197 GTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM 251
             N    VAIK       +     F  E   +R   H +++K++   +  +   +++E  
Sbjct: 414 PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELC 472

Query: 252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYGHALAPIIHCDLKPSNILLD 308
             G L  +L    + LD+   +     +  AL YL    +       +H D+   N+L+ 
Sbjct: 473 TLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF-------VHRDIAARNVLVS 525

Query: 309 ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLE 364
            N    + DFG+S+ + E       +K    I +MAPE       ++  DV+ +G+ + E
Sbjct: 526 SNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584

Query: 365 TFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDC 424
                      G    +   N        +V+    +          +C   + +L   C
Sbjct: 585 ILM-------HGVKPFQGVKNN-------DVI--GRIENGERLPMPPNCPPTLYSLMTKC 628

Query: 425 CMESPDER 432
               P  R
Sbjct: 629 WAYDPSRR 636

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (320), Expect = 1e-33
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 33/235 (14%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR 227
           +R   +F E  L+G G FG V+K     DG    IK      E+       E + L  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLD 62

Query: 228 HRNLIK--------------ILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHN-YFLDIL 270
           H N++                    S    K L   +EF   G+LE+W+       LD +
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
             L +   +   ++Y+H       +I+ DLKPSNI L +     + DFG+   L      
Sbjct: 123 LALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK- 177

Query: 331 LIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLK 381
             +T++  T+ YM+PE I       + D+Y+ G++L E         +  +    
Sbjct: 178 --RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (329), Expect = 1e-33
 Identities = 74/258 (28%), Positives = 114/258 (44%), Gaps = 34/258 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS- 239
           +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+++L     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                 +V E+M  GSL  +L S     L     L   +DV  A+EYL   +     +H 
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHR 313

Query: 299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCD 354
           DL   N+L+ E+ VA VSDFG++K     + S  Q      + + APE +     STK D
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368

Query: 355 VYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCL 414
           V+S+GILL E +S        G +       +       +VV    V + +   A   C 
Sbjct: 369 VWSFGILLWEIYS-------FGRVPYPRIPLK-------DVVP--RVEKGYKMDAPDGCP 412

Query: 415 LRIMNLALDCCMESPDER 432
             + ++  +C       R
Sbjct: 413 PAVYDVMKNCWHLDAATR 430

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  127 bits (320), Expect = 3e-33
 Identities = 59/285 (20%), Positives = 109/285 (38%), Gaps = 46/285 (16%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG----TNVAIKIF--NLQLERTFVSFNSECEV 222
              E        LG G FGSV +  L         VA+K+   ++        F  E   
Sbjct: 19  LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78

Query: 223 LRNVRHRNLIKILSGCSNLDFKA------LVLEFMPNGSLEKWLYSH-----NYFLDILE 271
           ++   H ++ K++        K       ++L FM +G L  +L +       + L +  
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
            +  M+D+   +EYL   +     IH DL   N +L E+M   V+DFG+S+ +  GD   
Sbjct: 139 LVRFMVDIACGMEYLSSRN----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194

Query: 332 IQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS 387
               +   + ++A E     + +   DV+++G+ + E  +        G+       N  
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-------RGQTPYAGIENA- 246

Query: 388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
                 E+   N +   +      +C+  + +L   C    P +R
Sbjct: 247 ------EIY--NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  126 bits (318), Expect = 4e-33
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 4/102 (3%)

Query: 1   MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
           +  G  K+   + LA N     +    G   +L  LDL +N + G +P+ L  L +L  L
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273

Query: 61  NVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPC 102
           NVS N L GEIP  G  + F   +++ N  LCG     +P C
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 88.7 bits (221), Expect = 9e-20
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 1/74 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQ-L 60
            +  +K L TL  + N   G +P S  SL +L  +    N +SG IP S  +   L   +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 61  NVSQNRLEGEIPVE 74
            +S+NRL G+IP  
Sbjct: 180 TISRNRLTGKIPPT 193

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 24/73 (32%), Positives = 33/73 (45%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            I  L  L  L +      G IP     + +L +LD S N LSG +P S+ +L  L  + 
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 62  VSQNRLEGEIPVE 74
              NR+ G IP  
Sbjct: 156 FDGNRISGAIPDS 168

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 83.7 bits (208), Expect = 4e-18
 Identities = 27/74 (36%), Positives = 43/74 (58%), Gaps = 2/74 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISL-ESLDLSSNNLSGEIPKSLEALLYLKQL 60
           +I  L +L  ++   N+  G IP S+GS   L  S+ +S N L+G+IP +  A L L  +
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF-ANLNLAFV 202

Query: 61  NVSQNRLEGEIPVE 74
           ++S+N LEG+  V 
Sbjct: 203 DLSRNMLEGDASVL 216

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 1/73 (1%)

Query: 3   IGGLKDLATLSLA-ANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           +  L  L  L +   N   GPIP +   L  L  L ++  N+SG IP  L  +  L  L+
Sbjct: 72  LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131

Query: 62  VSQNRLEGEIPVE 74
            S N L G +P  
Sbjct: 132 FSYNALSGTLPPS 144

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 54.8 bits (133), Expect = 2e-08
 Identities = 21/67 (31%), Positives = 27/67 (40%), Gaps = 3/67 (4%)

Query: 11 TLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGE--IPKSLEALLYLKQLNVS-QNRL 67
          T       + G +  +      + +LDLS  NL     IP SL  L YL  L +   N L
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

Query: 68 EGEIPVE 74
           G IP  
Sbjct: 90 VGPIPPA 96

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (315), Expect = 8e-33
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +LG G++G VY G  LS+   +AIK    +  R     + E  + ++++H+N+++ L   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGLALEYLHYGHALAPII 296
           S   F  + +E +P GSL   L S    L   E+        +   L+YLH       I+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IV 144

Query: 297 HCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGI------ 348
           H D+K  N+L++  + V  +SDFG SK L   +     T+T   T+ YMAPE I      
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEIIDKGPRG 201

Query: 349 VSTKCDVYSYGILLLETFSRKKPTNDLGE 377
                D++S G  ++E  + K P  +LGE
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGE 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  125 bits (317), Expect = 8e-33
 Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 49/288 (17%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFNLQLERTFVSFNSECEV 222
                ++     LG G+FG V+     +         VA+K      E     F  E E+
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF--------------LD 268
           L  ++H+++++    C+      +V E+M +G L ++L SH                 L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 269 ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
           + + L +   V   + YL   H     +H DL   N L+ + +V  + DFG+S+ +   D
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

Query: 329 DSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV 384
              +  +TM  I +M PE       +T+ DV+S+G++L E F+        G+       
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT-------YGKQPWYQLS 265

Query: 385 NQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           N        E +D   + +         C   +  +   C    P +R
Sbjct: 266 NT-------EAID--CITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (311), Expect = 2e-32
 Identities = 74/263 (28%), Positives = 114/263 (43%), Gaps = 40/263 (15%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
             +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+++L   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 239 S-NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYL---HYGHALA 293
                   +V E+M  GSL  +L S     L     L   +DV  A+EYL   ++     
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----- 138

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV---- 349
             +H DL   N+L+ E+ VA VSDFG++K     + S  Q      + + APE +     
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKF 191

Query: 350 STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA 409
           STK DV+S+GILL E +S        G +       +       +VV    V + +   A
Sbjct: 192 STKSDVWSFGILLWEIYS-------FGRVPYPRIPLK-------DVVP--RVEKGYKMDA 235

Query: 410 KMDCLLRIMNLALDCCMESPDER 432
              C   +  +  +C       R
Sbjct: 236 PDGCPPAVYEVMKNCWHLDAAMR 258

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (312), Expect = 2e-32
 Identities = 60/277 (21%), Positives = 98/277 (35%), Gaps = 57/277 (20%)

Query: 181 LGIGSFGSVYKGTL--------SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           LG G+F  ++KG             T V +K+ +        SF     ++  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL---HYG 289
                C   D   LV EF+  GSL+ +L  +   ++IL +L +   +  A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 290 HALAPIIHCDLKPSNILLD--------ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
                 IH ++   NILL               +SD GIS  +   D           I 
Sbjct: 135 ------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI------LQERIP 182

Query: 342 YMAPEGIV-----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
           ++ PE I      +   D +S+G  L E  S        G+  L    +Q         +
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS-------GGDKPLSALDSQ-------RKL 228

Query: 397 DSNLVRREHSFSAKMDC-LLRIMNLALDCCMESPDER 432
                   H   A     L  ++    +C    PD R
Sbjct: 229 Q--FYEDRHQLPAPKAAELANLI---NNCMDYEPDHR 260

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  124 bits (313), Expect = 3e-32
 Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 45/284 (15%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFNLQL-ERTFVSFNSECE 221
           E     +     LG GSFG VY+G           T VAIK  N     R  + F +E  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILER 272
           V++     +++++L   S      +++E M  G L+ +L S               + + 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
           + +  ++   + YL+        +H DL   N ++ E+    + DFG+++ + E D    
Sbjct: 141 IQMAGEIADGMAYLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL 388
             K +  + +M+PE    G+ +T  DV+S+G++L E  +       L E   +   N+  
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNE-- 247

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
                +V+    V          +C   +  L   C   +P  R
Sbjct: 248 -----QVLR--FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 284

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (313), Expect = 3e-32
 Identities = 48/249 (19%), Positives = 87/249 (34%), Gaps = 20/249 (8%)

Query: 140 RCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGT 198
           + Q    +  D E +L     + + Y + +   +       +G GSFG V++      G 
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84

Query: 199 NVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEK 258
             A+K   L++ R       E      +    ++ +        +  + +E +  GSL +
Sbjct: 85  QCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 259 WLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSD 317
            +       +       +      LEYLH       I+H D+K  N+LL  +   A + D
Sbjct: 140 LIKQMGCLPEDRAL-YYLGQALEGLEYLHTRR----ILHGDVKADNVLLSSDGSRAALCD 194

Query: 318 FGISKLLGEGDDSLIQTKTMATIG---YMAPEGI----VSTKCDVYSYGILLLETFSRKK 370
           FG +  L                G   +MAPE +       K D++S   ++L   +   
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

Query: 371 PTNDLGEMS 379
           P        
Sbjct: 255 PWTQYFRGP 263

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  122 bits (308), Expect = 7e-32
 Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 22/235 (9%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILS 236
            +G GSF +VYKG        VA          +     F  E E+L+ ++H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 237 GCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
              +         LV E M +G+L+ +L         + R +    +   L++LH     
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLHTRTP- 150

Query: 293 APIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGI-- 348
            PIIH DLK  NI +        + D G++ L           K +  T  +MAPE    
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE 204

Query: 349 -VSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLPHKLAEVVDSNL 400
                 DVY++G+ +LE  + + P ++    +   +   +   P    +V    +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  125 bits (315), Expect = 8e-32
 Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLI 232
            F   ++LG G+ G++    + D  +VA+K    +        + E ++LR    H N+I
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF---ADREVQLLRESDEHPNVI 81

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           +      +  F+ + +E     +L++++   ++    LE + ++      L +LH  +  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN-- 138

Query: 293 APIIHCDLKPSNILLDE-----NMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE 346
             I+H DLKP NIL+        + A +SDFG+ K L  G  S  +   +  T G++APE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 347 GI-------VSTKCDVYSYGILLLETFSRKKP 371
            +        +   D++S G +     S    
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (310), Expect = 8e-32
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 45/284 (15%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFN-LQLERTFVSFNSECE 221
           E    N+     LG G+FG VY+G +S          VA+K    +  E+  + F  E  
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNI 275
           ++    H+N+++ +        + +++E M  G L+ +L            L +L+ L++
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLI 332
             D+    +YL   H     IH D+   N LL       VA + DFG+++ +        
Sbjct: 146 ARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201

Query: 333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL 388
               M  + +M PE    GI ++K D +S+G+LL E FS       LG M      NQ  
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-- 252

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
                EV++   V          +C   +  +   C    P++R
Sbjct: 253 -----EVLE--FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (308), Expect = 9e-32
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 26/205 (12%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNL--IKI 234
             +G G    V++         AIK  NL+    +T  S+ +E   L  ++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H       
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI------ 348
           I+H DLKP+N L+ + M+  + DFGI+  +     S+++   + T+ YM PE I      
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 349 ---------VSTKCDVYSYGILLLE 364
                    +S K DV+S G +L  
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYY 231

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  121 bits (305), Expect = 2e-31
 Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 34/225 (15%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL-QLERTFVSFNSECEVLRNVR 227
           R   +F+    LG G FG V++     D  N AIK   L   E        E + L  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 228 HRNLIK----------ILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILER--L 273
           H  +++                +     L   ++     +L+ W+       +      L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 274 NIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD---- 329
           +I + +  A+E+LH       ++H DLKPSNI    + V  V DFG+   + + ++    
Sbjct: 122 HIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 330 ---SLIQTKTMATIG---YMAPEGIV----STKCDVYSYGILLLE 364
                   +    +G   YM+PE I     S K D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  126 bits (319), Expect = 2e-31
 Identities = 42/110 (38%), Positives = 52/110 (47%), Gaps = 3/110 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            IG +  L  L+L  N   G IP   G L  L  LDLSSN L G IP+++ AL  L +++
Sbjct: 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710

Query: 62  VSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSK 111
           +S N L G IP  G F  F    F  N  LCG     +P C   N     
Sbjct: 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY---PLPRCDPSNADGYA 757

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.4 bits (220), Expect = 7e-19
 Identities = 29/70 (41%), Positives = 39/70 (55%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +G L  L  L L  N   G IP+    + +LE+L L  N+L+GEIP  L     L  +++
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497

Query: 63  SQNRLEGEIP 72
           S NRL GEIP
Sbjct: 498 SNNRLTGEIP 507

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.0 bits (219), Expect = 1e-18
 Identities = 28/73 (38%), Positives = 37/73 (50%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +  +K L TL L  N   G IP    +  +L  + LS+N L+GEIPK +  L  L  L 
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520

Query: 62  VSQNRLEGEIPVE 74
           +S N   G IP E
Sbjct: 521 LSNNSFSGNIPAE 533

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 86.5 bits (215), Expect = 3e-18
 Identities = 31/67 (46%), Positives = 36/67 (53%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
              L  L L  N F G IP +  +   L SL LS N LSG IP SL +L  L+ L +  N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452

Query: 66  RLEGEIP 72
            LEGEIP
Sbjct: 453 MLEGEIP 459

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 85.3 bits (212), Expect = 7e-18
 Identities = 30/71 (42%), Positives = 38/71 (53%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           T+    +L +L L+ N   G IP S GSL  L  L L  N L GEIP+ L  +  L+ L 
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472

Query: 62  VSQNRLEGEIP 72
           +  N L GEIP
Sbjct: 473 LDFNDLTGEIP 483

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.4 bits (207), Expect = 3e-17
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 1/70 (1%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +    +L  L +++N F   IP   G   +L+ LD+S N LSG+  +++     LK LN+
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254

Query: 63  SQNRLEGEIP 72
           S N+  G IP
Sbjct: 255 SSNQFVGPIP 264

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 82.6 bits (205), Expect = 6e-17
 Identities = 33/72 (45%), Positives = 42/72 (58%), Gaps = 1/72 (1%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNV 62
           G    L  L L+ N F+G +P  FGS   LESL LSSNN SGE+P  +L  +  LK L++
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350

Query: 63  SQNRLEGEIPVE 74
           S N   GE+P  
Sbjct: 351 SFNEFSGELPES 362

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 82.3 bits (204), Expect = 6e-17
 Identities = 22/72 (30%), Positives = 37/72 (51%), Gaps = 2/72 (2%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +G    L  L ++ NK  G   ++  +   L+ L++SSN   G IP     L  L+ L++
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSL 276

Query: 63  SQNRLEGEIPVE 74
           ++N+  GEIP  
Sbjct: 277 AENKFTGEIPDF 288

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 82.3 bits (204), Expect = 8e-17
 Identities = 26/73 (35%), Positives = 37/73 (50%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +    +L  +SL+ N+  G IPK  G L +L  L LS+N+ SG IP  L     L  L+
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544

Query: 62  VSQNRLEGEIPVE 74
           ++ N   G IP  
Sbjct: 545 LNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 79.6 bits (197), Expect = 5e-16
 Identities = 29/70 (41%), Positives = 39/70 (55%), Gaps = 1/70 (1%)

Query: 6   LKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
           LK L  LSLA NKF G IP    G+  +L  LDLS N+  G +P    +   L+ L +S 
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327

Query: 65  NRLEGEIPVE 74
           N   GE+P++
Sbjct: 328 NNFSGELPMD 337

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 79.6 bits (197), Expect = 6e-16
 Identities = 29/76 (38%), Positives = 43/76 (56%), Gaps = 3/76 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSL-ISLESLDLSSNNLSGEIPKSL--EALLYLK 58
           T+  ++ L  L L+ N+F G +P+S  +L  SL +LDLSSNN SG I  +L       L+
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397

Query: 59  QLNVSQNRLEGEIPVE 74
           +L +  N   G+IP  
Sbjct: 398 ELYLQNNGFTGKIPPT 413

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 27/74 (36%), Positives = 39/74 (52%), Gaps = 2/74 (2%)

Query: 3   IGGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPKSLEALLY-LKQL 60
            G    L +L+L++N F G +P  +   +  L+ LDLS N  SGE+P+SL  L   L  L
Sbjct: 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373

Query: 61  NVSQNRLEGEIPVE 74
           ++S N   G I   
Sbjct: 374 DLSSNNFSGPILPN 387

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 25/73 (34%), Positives = 37/73 (50%), Gaps = 4/73 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            IG L++LA L L+ N F G IP   G   SL  LDL++N  +G IP ++          
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGK 564

Query: 62  VSQNRLEGEIPVE 74
           ++ N + G+  V 
Sbjct: 565 IAANFIAGKRYVY 577

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
            G  +L  L+++ NK  G +       ++LE LD+SSNN S  IP  L     L+ L++S
Sbjct: 175 DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDIS 231

Query: 64  QNRLEGEIPVE 74
            N+L G+    
Sbjct: 232 GNKLSGDFSRA 242

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 3/74 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALL-YLKQL 60
            I    +L  L++++N+F GPIP     L SL+ L L+ N  +GEIP  L      L  L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299

Query: 61  NVSQNRLEGEIPVE 74
           ++S N   G +P  
Sbjct: 300 DLSGNHFYGAVPPF 313

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 25/68 (36%), Positives = 36/68 (52%), Gaps = 2/68 (2%)

Query: 9   LATLSLAANKFHGPIPKSFG--SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNR 66
           L TL L++N F GPI  +       +L+ L L +N  +G+IP +L     L  L++S N 
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429

Query: 67  LEGEIPVE 74
           L G IP  
Sbjct: 430 LSGTIPSS 437

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 16/76 (21%), Positives = 28/76 (36%), Gaps = 2/76 (2%)

Query: 1   MTIGGLKDLATLSLAAN--KFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLK 58
           + I           A N  +F G   +    L +    +++S    G    + +    + 
Sbjct: 576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635

Query: 59  QLNVSQNRLEGEIPVE 74
            L++S N L G IP E
Sbjct: 636 FLDMSYNMLSGYIPKE 651

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 28/75 (37%), Positives = 39/75 (52%), Gaps = 3/75 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIP--KSLEALLYLKQ 59
           ++  L  L +L L+ +  +G +   F    SL SLDLS N+LSG +    SL +   LK 
Sbjct: 72  SLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF 130

Query: 60  LNVSQNRLEGEIPVE 74
           LNVS N L+    V 
Sbjct: 131 LNVSSNTLDFPGKVS 145

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 23/75 (30%), Positives = 33/75 (44%), Gaps = 3/75 (4%)

Query: 3   IGGLKDLATLSLAANKFHGPIP--KSFGSLISLESLDLSSNNLSGEIPKSLEALL-YLKQ 59
                 L +L L+ N   GP+    S GS   L+ L++SSN L      S    L  L+ 
Sbjct: 96  FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155

Query: 60  LNVSQNRLEGEIPVE 74
           L++S N + G   V 
Sbjct: 156 LDLSANSISGANVVG 170

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 24/75 (32%), Positives = 37/75 (49%), Gaps = 4/75 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEA---LLYLK 58
           +G    L  L++++N    P   S    L SLE LDLS+N++SG              LK
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181

Query: 59  QLNVSQNRLEGEIPV 73
            L +S N++ G++ V
Sbjct: 182 HLAISGNKISGDVDV 196

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 3/74 (4%)

Query: 8   DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
           DL++  L  N     +  S  SL  LESL LS+++++G +    +    L  L++S+N L
Sbjct: 56  DLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL 112

Query: 68  EGEIPVEGPFRNFS 81
            G +       + S
Sbjct: 113 SGPVTTLTSLGSCS 126

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 15/90 (16%), Positives = 35/90 (38%), Gaps = 7/90 (7%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +G  + L  L L  N F+G IP +        S  +++N ++G+    ++     K+ +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 62  VSQN--RLEGEIPVE-GPFRNFSTESFSWN 88
            + N    +G    +       +  + +  
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 56.8 bits (138), Expect = 9e-09
 Identities = 12/81 (14%), Positives = 22/81 (27%), Gaps = 3/81 (3%)

Query: 11  TLSLAANKFHGPIPKSFGSLISLESLDLSSN--NLSGEIPKSLEALLYLKQLNVSQNRLE 68
           +  +AAN   G       +    +    + N     G   + L  L      N++     
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621

Query: 69  GEIPVE-GPFRNFSTESFSWN 88
           G          +      S+N
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYN 642

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 3/61 (4%)

Query: 32  SLESLDLSSNNLS---GEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWN 88
            + S+DLSS  L+     +  SL +L  L+ L +S + + G +       + ++   S N
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110

Query: 89  Y 89
            
Sbjct: 111 S 111

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (310), Expect = 2e-31
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 26/212 (12%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNL--IKI 234
             +G G    V++         AIK  NL+    +T  S+ +E   L  ++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H       
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI------ 348
           I+H DLKP+N L+ + M+  + DFGI+  +     S+++   +  + YM PE I      
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 349 ---------VSTKCDVYSYGILLLETFSRKKP 371
                    +S K DV+S G +L      K P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  120 bits (304), Expect = 3e-31
 Identities = 67/292 (22%), Positives = 116/292 (39%), Gaps = 56/292 (19%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVSFNSECEV 222
                ++     LG G+FG V+           D   VA+K            F  E E+
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYFL 267
           L N++H +++K    C + D   +V E+M +G L K+L +H                  L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 268 DILERLNIMIDVGLALEYL---HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL 324
            + + L+I   +   + YL   H+       +H DL   N L+  N++  + DFG+S+ +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF-------VHRDLATRNCLVGANLLVKIGDFGMSRDV 183

Query: 325 GEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
              D   +   TM  I +M PE       +T+ DV+S+G++L E F+        G+   
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT-------YGKQPW 236

Query: 381 KHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
               N        EV++   + +         C   + ++ L C    P +R
Sbjct: 237 FQLSNT-------EVIE--CITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  121 bits (306), Expect = 3e-31
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 26/205 (12%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNL--IKI 234
             +G G    V++         AIK  NL+    +T  S+ +E   L  ++  +   I++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H       
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI------ 348
           I+H DLKP+N L+ + M+  + DFGI+  +     S+++   + T+ YM PE I      
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 349 ---------VSTKCDVYSYGILLLE 364
                    +S K DV+S G +L  
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYY 212

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  122 bits (308), Expect = 3e-31
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 45/284 (15%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFN-LQLERTFVSFNSECE 221
           E    N+     LG G+FG VY+G +S          VA+K    +  E+  + F  E  
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNI 275
           ++    H+N+++ +        + ++LE M  G L+ +L            L +L+ L++
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLI 332
             D+    +YL   H     IH D+   N LL       VA + DFG+++ +        
Sbjct: 187 ARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242

Query: 333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL 388
               M  + +M PE    GI ++K D +S+G+LL E FS       LG M      NQ  
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQ-- 293

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
                EV++   V          +C   +  +   C    P++R
Sbjct: 294 -----EVLE--FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  120 bits (302), Expect = 5e-31
 Identities = 64/293 (21%), Positives = 114/293 (38%), Gaps = 57/293 (19%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFNLQL-ERTFVSFNSECE 221
           E     +     LG   FG VYKG L           VAIK    +        F  E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------------NYF 266
           +   ++H N++ +L   +     +++  +  +G L ++L                     
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 267 LDILERLNIMIDVGLALEYL---HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL 323
           L+  + ++++  +   +EYL   H        +H DL   N+L+ + +   +SD G+ + 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHV-------VHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 324 LGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMS 379
           +   D   +   ++  I +MAPE I+    S   D++SYG++L E FS        G   
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------YGLQP 230

Query: 380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
              + NQ       +VV+  ++R         DC   +  L ++C  E P  R
Sbjct: 231 YCGYSNQ-------DVVE--MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 274

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  120 bits (303), Expect = 5e-31
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 23/213 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK---IFNLQLERTFVSFNSECEVLRNVRH 228
             F     +G G F  VY+   L DG  VA+K   IF+L   +       E ++L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 229 RNLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLAL 283
            N+IK  +  S ++   L  VLE    G L + +         +         + +  AL
Sbjct: 92  PNVIKYYA--SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGY 342
           E++H       ++H D+KP+N+ +    V  + D G+ +             ++  T  Y
Sbjct: 150 EHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYY 202

Query: 343 MAPEGI----VSTKCDVYSYGILLLETFSRKKP 371
           M+PE I     + K D++S G LL E  + + P
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  119 bits (301), Expect = 6e-31
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 17/213 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHR 229
            +++    +G GS+G   K    SDG  +  K  +     E       SE  +LR ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 230 NLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALE 284
           N+++      +     L  V+E+   G L   +        +LD    L +M  + LAL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 285 YLHYGHALA-PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGY 342
             H        ++H DLKP+N+ LD      + DFG++++L          KT   T  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTFVGTPYY 182

Query: 343 MAPEGIV----STKCDVYSYGILLLETFSRKKP 371
           M+PE +     + K D++S G LL E  +   P
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (302), Expect = 1e-30
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHR 229
            ++     +G GSFG         DG    IK  N+     +       E  VL N++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 230 NLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYL 286
           N+++     S  +  +L  V+++   G L K + +         + L+  + + LAL+++
Sbjct: 84  NIVQYRE--SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAP 345
           H       I+H D+K  NI L ++    + DFGI+++L    +     +    T  Y++P
Sbjct: 142 HDRK----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARACIGTPYYLSP 194

Query: 346 EGI----VSTKCDVYSYGILLLETFSRKKP 371
           E       + K D+++ G +L E  + K  
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA 224

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (296), Expect = 6e-30
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVSFNSECEVLRNVRHRNLIKILS- 236
           +LG G+  +V++G     G   AIK+FN +   R       E EVL+ + H+N++K+ + 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 237 -GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGHALA 293
              +    K L++EF P GSL   L   +    + E   L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132

Query: 294 PIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGI 348
            I+H ++KP NI+     D   V  ++DFG ++ L + +    Q  ++  T  Y+ P+  
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMY 187

Query: 349 VST------------KCDVYSYGILL 362
                            D++S G+  
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTF 213

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (295), Expect = 1e-29
 Identities = 71/301 (23%), Positives = 113/301 (37%), Gaps = 65/301 (21%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFN-LQLERTFVSFNSECE 221
           E+   N+     +G G+FG V++            T VA+K+            F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH------------------ 263
           ++    + N++K+L  C+      L+ E+M  G L ++L S                   
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 264 -----NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF 318
                   L   E+L I   V   + YL         +H DL   N L+ ENMV  ++DF
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADF 218

Query: 319 GISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTND 374
           G+S+ +   D           I +M PE       +T+ DV++YG++L E FS       
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------- 271

Query: 375 LGEMSLKHWVNQSLP---HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE 431
            G            P       EV+    VR  +  +   +C L + NL   C  + P +
Sbjct: 272 YGLQ----------PYYGMAHEEVIY--YVRDGNILACPENCPLELYNLMRLCWSKLPAD 319

Query: 432 R 432
           R
Sbjct: 320 R 320

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  115 bits (291), Expect = 2e-29
 Identities = 51/210 (24%), Positives = 78/210 (37%), Gaps = 17/210 (8%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV 226
                F   + LG GS+G V+K     DG   A+K         +      +E      V
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 227 -RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
            +H   +++           L  E     SL++   +    L   +    + D  LAL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMA 344
           LH       ++H D+KP+NI L       + DFG+   LG         +       YMA
Sbjct: 173 LHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMA 224

Query: 345 PE---GIVSTKCDVYSYGILLLETFSRKKP 371
           PE   G   T  DV+S G+ +LE     + 
Sbjct: 225 PELLQGSYGTAADVFSLGLTILEVACNMEL 254

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  117 bits (294), Expect = 3e-29
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVSFNSECEVLRNVRHRNLIKILS- 236
           +LG G+  +V++G     G   AIK+FN +   R       E EVL+ + H+N++K+ + 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 237 -GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGHALA 293
              +    K L++EF P GSL   L   +    + E   L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132

Query: 294 PIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPEGI 348
            I+H ++KP NI+     D   V  ++DFG ++ L + +    Q  ++  T  Y+ P+  
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMY 187

Query: 349 VST------------KCDVYSYGILL 362
                            D++S G+  
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTF 213

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  113 bits (286), Expect = 2e-28
 Identities = 70/278 (25%), Positives = 114/278 (41%), Gaps = 47/278 (16%)

Query: 179 NLLGIGSFGSVYKGTLSDG---TNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIK 233
           +++G G+FG V K  +       + AIK       +     F  E EVL  +  H N+I 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 278
           +L  C +  +  L +E+ P+G+L  +L                     L   + L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           V   ++YL         IH DL   NIL+ EN VA ++DFG+S+     +  + +T    
Sbjct: 151 VARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203

Query: 339 TIGYMAPEGIV----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
            + +MA E +     +T  DV+SYG+LL E  S       LG                 E
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------LGGTPYCGMTCA-------E 249

Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER 432
           + +   + + +     ++C   + +L   C  E P ER
Sbjct: 250 LYE--KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 285

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  112 bits (283), Expect = 3e-28
 Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 26/205 (12%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
            LG G F  V     L DG   A+K      ++       E ++ R   H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 239 SNLDFKA----LVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHA 291
                      L+L F   G+L   +        FL   + L +++ +   LE +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-------TIGYMA 344
                H DLKP+NILL +     + D G         +   Q  T+        TI Y A
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 345 PE-------GIVSTKCDVYSYGILL 362
           PE        ++  + DV+S G +L
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVL 236

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  116 bits (291), Expect = 5e-28
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 28/213 (13%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV 226
            +    ++    LG G FG V +      G  VAIK    +L  +    +  E ++++ +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 227 RHRNLIKIL------SGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMID 278
            H N++            +  D   L +E+   G L K+L        L       ++ D
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTK 335
           +  AL YLH       IIH DLKP NI+L    + ++  + D G +K L +G+       
Sbjct: 130 ISSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCT 181

Query: 336 TMA-TIGYMAPEGIVSTK-----CDVYSYGILL 362
               T+ Y+APE ++  K      D +S+G L 
Sbjct: 182 EFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLA 213

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  111 bits (281), Expect = 7e-28
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 37/227 (16%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECE 221
           EF    L     LG G+FG V +         +    VA+K+           +  SE +
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82

Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALV-LEFMPNGSLEKWLYSH---------------N 264
           +L ++  H N++ +L  C+      +V +EF   G+L  +L S                 
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 265 YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL 324
            FL +   +     V   +E+L    A    IH DL   NILL E  V  + DFG+++ +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198

Query: 325 GEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
            +  D + +      + +MAPE     + + + DV+S+G+LL E FS
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  111 bits (280), Expect = 9e-28
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 43/233 (18%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFNLQL-ERTFVSFNSECE 221
           EF   NL     LG G FG V K T          T VA+K+              SE  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH------------------ 263
           VL+ V H ++IK+   CS      L++E+   GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 264 -----NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF 318
                   L + + ++    +   ++YL        ++H DL   NIL+ E     +SDF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK----LVHRDLAARNILVAEGRKMKISDF 194

Query: 319 GISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
           G+S+ + E D  + +++    + +MA E     I +T+ DV+S+G+LL E  +
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  111 bits (281), Expect = 9e-28
 Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 38/228 (16%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSD--------GTNVAIKIFN-LQLERTFVSFNSE 219
           EF    L     LG G+FG V                  VA+K+      E+      SE
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90

Query: 220 CEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH--------------- 263
            E+++ + +H+N+I +L  C+      +++E+   G+L ++L +                
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 264 NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL 323
              +   + ++    +   +EYL         IH DL   N+L+ EN V  ++DFG+++ 
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARD 206

Query: 324 LGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
           +   D     T     + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  110 bits (277), Expect = 1e-27
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVS--FNSECEVLRNVRH 228
            +F+    LG G FG+VY          +A+K+    QLE+  V      E E+  ++RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++     +     L+LE+ P G++ + L   + F +       + ++  AL Y H 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHS 127

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEG 347
                 +IH D+KP N+LL       ++DFG S           +   +  T+ Y+ PE 
Sbjct: 128 KR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPE- 177

Query: 348 IVSTK-----CDVYSYGILLLE 364
           ++  +      D++S G+L  E
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYE 199

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  111 bits (279), Expect = 1e-27
 Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 38/228 (16%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSD------GTNVAIKIFNLQ-LERTFVSFNSECE 221
           EF    L     LG G+FG V + T            VA+K+           +  SE +
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH----------------- 263
           VL  +  H N++ +L  C+      ++ E+   G L  +L                    
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 264 NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL 323
              LD+ + L+    V   + +L   +     IH DL   NILL    +  + DFG+++ 
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 324 LGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
           +    + +++      + +MAPE     + + + DV+SYGI L E FS
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (282), Expect = 2e-27
 Identities = 57/236 (24%), Positives = 91/236 (38%), Gaps = 41/236 (17%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLR-NVR 227
           Q   N      +LG GS G+V       G  VA+K   +           E ++L  +  
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDD 67

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL------NIMIDVGL 281
           H N+I+     +   F  + LE   N +L+  + S N   + L+        +++  +  
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLD-------------ENMVAHVSDFGISKLLGEGD 328
            + +LH       IIH DLKP NIL+              EN+   +SDFG+ K L  G 
Sbjct: 127 GVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 329 DSLIQT-KTMA-TIGYMAPEGIV-----------STKCDVYSYGILLLETFSRKKP 371
            S        + T G+ APE +            +   D++S G +     S+ K 
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (278), Expect = 2e-27
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 34/224 (15%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSD------GTNVAIKIFNLQ-LERTFVSFNSECE 221
           EF   NL     LG G+FG V + T            VA+K+           +  SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101

Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-------------NYFL 267
           ++ ++ +H N++ +L  C++     ++ E+   G L  +L                N   
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
              + L+    V   + +L    A    IH D+   N+LL    VA + DFG+++ +   
Sbjct: 162 STRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

Query: 328 DDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
            + +++      + +MAPE     + + + DV+SYGILL E FS
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  111 bits (279), Expect = 4e-27
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 38/228 (16%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL--------SDGTNVAIKIFN-LQLERTFVSFNSE 219
           E     L     LG G+FG V             +  T VA+K+      E+      SE
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124

Query: 220 CEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH--------------- 263
            E+++ + +H+N+I +L  C+      +++E+   G+L ++L +                
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 264 NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL 323
              L   + ++    V   +EYL    A    IH DL   N+L+ E+ V  ++DFG+++ 
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240

Query: 324 LGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
           +   D     T     + +MAPE     I + + DV+S+G+LL E F+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (276), Expect = 7e-27
 Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 38/228 (16%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSD--------GTNVAIKIFN-LQLERTFVSFNSE 219
           EF    L     LG G FG V                  VA+K+      E+      SE
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136

Query: 220 CEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH--------------- 263
            E+++ + +H+N+I +L  C+      +++E+   G+L ++L +                
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 264 NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL 323
              +   + ++    +   +EYL    A    IH DL   N+L+ EN V  ++DFG+++ 
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252

Query: 324 LGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
           +   D     T     + +MAPE     + + + DV+S+G+L+ E F+
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (274), Expect = 1e-26
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 40/213 (18%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFN---LQLERTFVSFNS--------------ECEVL 223
           L  G F  +      D    A+K +    L+ +R F   N+              E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 224 RNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-------LDILERLNIM 276
            ++++   +      +N D   ++ E+M N S+ K+              + I     I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             V  +  Y+H       I H D+KPSNIL+D+N    +SDFG S+ +    D  I+  +
Sbjct: 158 KSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG-S 210

Query: 337 MATIGYMAPEGIVSTK-------CDVYSYGILL 362
             T  +M PE   S +        D++S GI L
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICL 242

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  111 bits (280), Expect = 1e-26
 Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 29/198 (14%)

Query: 180 LLGIGSFGSVYKG--TLSDGTNVAIKIFNLQLERTFVS-FNSECEVLRNVRHRNLIKIL- 235
            +  G  G +Y       +G  V +K      +    +   +E + L  V H ++++I  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 236 ------SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
                      + +  +V+E++   SL++        L + E +  ++++  AL YLH  
Sbjct: 147 FVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS- 200

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE--- 346
                +++ DLKP NI+L E  +  + D G    +       +      T G+ APE   
Sbjct: 201 ---IGLVYNDLKPENIMLTEEQLK-LIDLGAVSRI--NSFGYL----YGTPGFQAPEIVR 250

Query: 347 GIVSTKCDVYSYGILLLE 364
              +   D+Y+ G  L  
Sbjct: 251 TGPTVATDIYTVGRTLAA 268

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  107 bits (269), Expect = 2e-26
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 23/232 (9%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLER--TFVS-FNSECEVLRNVRHRNLIKIL 235
            LG G   +VY          VAIK   +        +  F  E      + H+N++ ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
                 D   LV+E++   +L +++ SH   L +   +N    +   +++ H       I
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR----I 132

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPE----GIVS 350
           +H D+KP NIL+D N    + DFGI+K L   + SL QT   + T+ Y +PE        
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 351 TKCDVYSYGILLLETFSRKKPTNDLGE----MSLKHWVNQSLPHKLAEVVDS 398
              D+YS GI+L E    + P N  GE    +++KH +  S+P+   +V   
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFN--GETAVSIAIKH-IQDSVPNVTTDVRKD 239

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (267), Expect = 3e-26
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 16/205 (7%)

Query: 167 DIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFVSFNSECEV 222
            I     +F   NLLG GSF  VY+   +  G  VAIK+ +   +          +E ++
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
              ++H +++++ +   + ++  LVLE   NG + ++L +        E  + M  +   
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIG 341
           + YLH       I+H DL  SN+LL  NM   ++DFG++  L    +      T+  T  
Sbjct: 125 MLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPN 177

Query: 342 YMAPEGIV----STKCDVYSYGILL 362
           Y++PE         + DV+S G + 
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMF 202

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  107 bits (269), Expect = 3e-26
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 18/198 (9%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLER--TFVS-FNSECEVLRNVRHRNLIKIL 235
           +LG G    V+    L D  +VA+K+    L R  +F   F  E +    + H  ++ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 236 -SGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
            +G +         +V+E++   +L   +++    +     + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNG- 136

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPE---- 346
              IIH D+KP+NI++       V DFGI++ + +  +S+ QT   + T  Y++PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 347 GIVSTKCDVYSYGILLLE 364
             V  + DVYS G +L E
Sbjct: 194 DSVDARSDVYSLGCVLYE 211

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (267), Expect = 3e-26
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 21/202 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKG-TLSDGTNVAIKIFN-LQLERTFVS--FNSECEVLRNVRH 228
           ++FD    LG G FG+VY      +   +A+K+    QLE+  V      E E+  ++RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++ +   +     L+LEF P G L K L  H  F +       M ++  AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHE 132

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEG 347
                 +IH D+KP N+L+       ++DFG S           + +TM  T+ Y+ PE 
Sbjct: 133 RK----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPE- 182

Query: 348 IVSTK-----CDVYSYGILLLE 364
           ++  K      D++  G+L  E
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYE 204

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  107 bits (270), Expect = 4e-26
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 51/237 (21%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTLSDG------TNVAIKIFNLQL-----ERTFVSFN 217
           EF   NL     LG G+FG V   T            VA+K     L          +  
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALM 96

Query: 218 SECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH------------- 263
           SE +++  +  H N++ +L  C+      L+ E+   G L  +L S              
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 264 ---------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH 314
                       L   + L     V   +E+L +       +H DL   N+L+    V  
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS----CVHRDLAARNVLVTHGKVVK 212

Query: 315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS 367
           + DFG+++ +    + +++      + +MAPE    GI + K DV+SYGILL E FS
Sbjct: 213 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (268), Expect = 4e-26
 Identities = 53/237 (22%), Positives = 90/237 (37%), Gaps = 28/237 (11%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLER--TFVS-FNSECEVLRNVRHRNLIKIL 235
           L+G G  G VY+         VA+K+ +  L     F +    E      ++  +++ I 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 236 -SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP 294
             G  +     + +  +    L   L      L     + I+  +G AL+  H       
Sbjct: 101 DFGEID-GQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---- 154

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPE----GIV 349
             H D+KP NIL+  +  A++ DFGI+      D+ L Q    + T+ YMAPE       
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 350 STKCDVYSYGILLLETFSRKKP-TNDLGEMSLKH---------WVNQSLPHKLAEVV 396
           + + D+Y+   +L E  +   P   D   +   H          V   +P     V+
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (266), Expect = 5e-26
 Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 17/192 (8%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIKIL 235
            LG G F   ++ +        A KI     L         + E  + R++ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
               + DF  +VLE     SL +         +   R   +  + L  +YLH       +
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 136

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIV----S 350
           IH DLK  N+ L+E++   + DFG++  +    +     K +  T  Y+APE +     S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHS 193

Query: 351 TKCDVYSYGILL 362
            + DV+S G ++
Sbjct: 194 FEVDVWSIGCIM 205

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (268), Expect = 6e-26
 Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 17/192 (8%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIKIL 235
            LG G F   ++ +        A KI     L         + E  + R++ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPI 295
               + DF  +VLE     SL +         +   R   +  + L  +YLH       +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 162

Query: 296 IHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIV----S 350
           IH DLK  N+ L+E++   + DFG++  +    +     K +  T  Y+APE +     S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHS 219

Query: 351 TKCDVYSYGILL 362
            + DV+S G ++
Sbjct: 220 FEVDVWSIGCIM 231

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  105 bits (265), Expect = 8e-26
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 44/214 (20%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           ++    LG G+FG VYK      G   A K+   + E     +  E E+L    H  ++K
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 234 ILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGLA 282
           +L G    D K  +++EF P G++            I+  L+          +   +  A
Sbjct: 81  LL-GAYYHDGKLWIMIEFCPGGAV----------DAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG- 341
           L +LH       IIH DLK  N+L+       ++DFG+S    +   +L +  +   IG 
Sbjct: 130 LNFLHSKR----IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSF--IGT 180

Query: 342 --YMAPEGIVS---------TKCDVYSYGILLLE 364
             +MAPE ++           K D++S GI L+E
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (266), Expect = 1e-25
 Identities = 40/224 (17%), Positives = 72/224 (32%), Gaps = 29/224 (12%)

Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTN------VAIKIFNLQLERTFVSFNSE 219
            + Q  +      +LLG G+F  VY+ T  D  +        +K+        F      
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL----EKWLYSHNYFLDILERLNI 275
            E L+       +K  S     +   LV E    G+L      +  +    +     ++ 
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH-----------VSDFGISKLL 324
            + +   +E +H       IIH D+KP N +L    +             + D G S  +
Sbjct: 178 AMRMLYMIEQVHDCE----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 325 GEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLE 364
                  I T    T G+   E +     + + D +     +  
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  105 bits (264), Expect = 4e-25
 Identities = 38/270 (14%), Positives = 88/270 (32%), Gaps = 54/270 (20%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLE---------------------------- 210
           +LG     +  + T    G +  + +                                  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 211 RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM-PNGSLE---KWLYSH--- 263
           +  + F    +++++ + + +I++     ++   +    +     +L+   + L SH   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 264 NYFLDILERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK 322
           +  L    RL + + V   L  LH YG     ++H  L+P +I+LD+     ++ F    
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 323 LLGEGDDSLIQTKTMATIGYMAPE---------GIVSTKCDVYSYGILLLETFSRKKPTN 373
             G    S    +  A     A            +++   D ++ G+ +   +    P  
Sbjct: 260 RDGASAVSP-IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 374 DLGEMSLKHWVNQSLPHKLAEVVDSNLVRR 403
           D   +    W+ +S  +    V    L+  
Sbjct: 319 DDAALGGSEWIFRSCKNIPQPVRA--LLEG 346

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (262), Expect = 4e-25
 Identities = 36/276 (13%), Positives = 88/276 (31%), Gaps = 65/276 (23%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERT-------------------------- 212
           +LG     +  + T    G +  + +                                  
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 213 --FVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM----PNGSLEKWLYSH--- 263
              + F    +++++ + + +I++     ++   +    +        +  + L SH   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 264 NYFLDILERLNIMIDVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK 322
           +  L    RL + + V   L  LH YG     ++H  L+P +I+LD+     ++ F    
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 323 LLGEGDDSLIQTKTMATIGYMAPE---------------GIVSTKCDVYSYGILLLETFS 367
             G       +  +  + G+  PE                +++   D ++ G+++   + 
Sbjct: 255 RDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 368 RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR 403
              P      +    W+ +S  +    V    L+  
Sbjct: 309 ADLPITKDAALGGSEWIFRSCKNIPQPVRA--LLEG 342

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (259), Expect = 7e-25
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 37/207 (17%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
            D    +G GS G V        G  VA+K+ +L+ ++      +E  ++R+ +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 234 ILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGLALE 284
           +      +  +  +++EF+  G+L           DI+   RLN      +   V  AL 
Sbjct: 107 MY-KSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALA 155

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG--- 341
           YLH       +IH D+K  +ILL  +    +SDFG    +      + + K++  +G   
Sbjct: 156 YLHAQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPY 206

Query: 342 YMAPEGIVS----TKCDVYSYGILLLE 364
           +MAPE I      T+ D++S GI+++E
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIE 233

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  103 bits (259), Expect = 8e-25
 Identities = 60/282 (21%), Positives = 102/282 (36%), Gaps = 50/282 (17%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSG 237
           +L  G F  VY+   +  G   A+K      E    +   E   ++ +  H N+++  S 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 238 CSNL-------DFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGLALEYLHY 288
            S           + L+L  +  G L ++L        L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA---------- 338
                PIIH DLK  N+LL       + DFG +  +    D     +  A          
Sbjct: 155 QKP--PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 339 TIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
           T  Y  PE I       +  K D+++ G +L     R+ P  D  ++ + +    S+P  
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-GKYSIP-- 269

Query: 392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
                         +       L+R M L ++     P+ER+
Sbjct: 270 -----------PHDTQYTVFHSLIRAM-LQVN-----PEERL 294

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  102 bits (257), Expect = 8e-25
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 33/205 (16%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           +     +G G+ G+VY    ++ G  VAI+  NLQ +       +E  V+R  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 234 ILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGLALE 284
            L     +  +  +V+E++  GSL           D++    ++      +  +   ALE
Sbjct: 82  YL-DSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQALE 130

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYM 343
           +LH       +IH D+K  NILL  +    ++DFG    +        +  TM  T  +M
Sbjct: 131 FLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWM 183

Query: 344 APEGIVS----TKCDVYSYGILLLE 364
           APE +       K D++S GI+ +E
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIE 208

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (256), Expect = 1e-24
 Identities = 44/234 (18%), Positives = 88/234 (37%), Gaps = 29/234 (12%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV 226
           R T EF E   +G G FGSV+K     DG   AIK     L       +   E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 227 -RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGLA 282
            +H ++++  S  +  D   +  E+   GSL   +  +   +      E  ++++ VG  
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ--------- 333
           L Y+H       ++H D+KPSNI +    + + +     +     +  + +         
Sbjct: 128 LRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 334 -TKTMATIG---YMAPEGIV-----STKCDVYSYGILLLETFSRKKPTNDLGEM 378
            +      G   ++A E +        K D+++  + ++     +    +  + 
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (258), Expect = 2e-24
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 28/205 (13%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSF-NSECEVLRNVRHRN 230
           ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 231 LIK-----ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGLALE 284
           ++         G  ++      +E M  GSL++ L         IL +  + I V   L 
Sbjct: 93  IVGFYGAFYSDGEISI-----CMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLT 145

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYM 343
           YL   H    I+H D+KPSNIL++      + DFG+S   G+  DS+    +   T  YM
Sbjct: 146 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSM--ANSFVGTRSYM 197

Query: 344 APEGIV----STKCDVYSYGILLLE 364
           +PE +     S + D++S G+ L+E
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVE 222

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (256), Expect = 5e-24
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 34/204 (16%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN--------LQLERTFVSFNSECEVLRNVRHRNL 231
           LG G+ G V           VAI+I +         +     ++  +E E+L+ + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGLALEYLHYG 289
           IKI +     D+  +VLE M  G L   +  +       E         + LA++YLH  
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHEN 258

Query: 290 HALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAP 345
                IIH DLKP N+LL   +E+ +  ++DFG SK+LGE        +T+  T  Y+AP
Sbjct: 259 G----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAP 310

Query: 346 EGIVST-------KCDVYSYGILL 362
           E +VS          D +S G++L
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (251), Expect = 6e-24
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 47/212 (22%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN---------LQLERTFVSFNSECEVLRNV-RHR 229
           LG G    V +          A+KI +          +++    +   E ++LR V  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGL 281
           N+I++        F  LV + M  G L         F  + E+          IM  +  
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGEL---------FDYLTEKVTLSEKETRKIMRALLE 135

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TI 340
            +  LH  +    I+H DLKP NILLD++M   ++DFG S  L  G+    + + +  T 
Sbjct: 136 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 187

Query: 341 GYMAPEGIV----------STKCDVYSYGILL 362
            Y+APE I             + D++S G+++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (251), Expect = 9e-24
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 32/212 (15%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSECEV-LRNVRHR 229
            +  +   +G G++GSV K      G  +A+K     + E+       + +V +R+    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 230 NLIK----ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLD---ILERL--NIMIDVG 280
            +++    +     +     + +E M + S +K  Y + Y +    I E +   I +   
Sbjct: 82  YIVQFYGALFRE-GDC---WICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATV 135

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
            AL +L        IIH D+KPSNILLD +    + DFGIS   G+  DS+ +T+     
Sbjct: 136 KALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCR 189

Query: 341 GYMAPEGIV--------STKCDVYSYGILLLE 364
            YMAPE I           + DV+S GI L E
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 1e-23
 Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 22/194 (11%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRHRNLIKILS 236
           LG GSFG V        G   A+K+ +   ++ +    S   E ++L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGLALEYLHYGHALAP 294
              +  +  LV E    G L   + S   F    E     I+  V   + Y+H       
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFS---EVDAARIIRQVLSGITYMHKNK---- 146

Query: 295 IIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GI 348
           I+H DLKP N+LL    ++    + DFG+S               + T  Y+APE   G 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGT 203

Query: 349 VSTKCDVYSYGILL 362
              KCDV+S G++L
Sbjct: 204 YDEKCDVWSTGVIL 217

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 39/204 (19%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           +LG G+F  V+       G   A+K           S  +E  VL+ ++H N++ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGLALEYLHYGH 290
            +     LV++ +  G L         F  ILER          ++  V  A++YLH   
Sbjct: 76  ESTTHYYLVMQLVSGGEL---------FDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 291 ALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE 346
               I+H DLKP N+L    +EN    ++DFG+SK+   G        T   T GY+APE
Sbjct: 127 ----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPE 177

Query: 347 GIV----STKCDVYSYG----ILL 362
            +     S   D +S G    ILL
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILL 201

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 48/211 (22%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN--------LQLERTFVSFNSECEVLRNVRHRNL 231
           LG G+ G V           VAIKI +         +     ++  +E E+L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 232 IKILSGCSNLDFKALVLEFMPNGSL-----EKWLYS----HNYFLDILERLNIMIDVGLA 282
           IKI +     D+  +VLE M  G L                 YF  +L           A
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----------A 126

Query: 283 LEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA- 338
           ++YLH       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE        +T+  
Sbjct: 127 VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCG 178

Query: 339 TIGYMAPEGIVST-------KCDVYSYGILL 362
           T  Y+APE +VS          D +S G++L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 21/199 (10%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           FD    LG GS+GSVYK      G  VAIK   ++ +        E  +++     +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ--EIIKEISIMQQCDSPHVVK 88

Query: 234 ILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
              G    +    +V+E+   GS+   +   N  L   E   I+      LEYLH+    
Sbjct: 89  YY-GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR-- 145

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPEGIV 349
              IH D+K  NILL+    A ++DFG++  L    D++ +  T+  IG   +MAPE I 
Sbjct: 146 --KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVIQ 198

Query: 350 ST----KCDVYSYGILLLE 364
                   D++S GI  +E
Sbjct: 199 EIGYNCVADIWSLGITAIE 217

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (249), Expect = 2e-23
 Identities = 23/234 (9%), Positives = 56/234 (23%), Gaps = 52/234 (22%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV---SFNSECEVLRNVRHRNLIKIL 235
            L +G    V+    +    + A+K+F +  E +       +        +   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 236 SGCSNLDFKA--------------------------LVLEFM-----PNGSLEKWLYSHN 264
                L                              L++           S   ++Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 265 YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL 324
               IL    +   +      L        ++H    P N+ +  +    + D      +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 325 GEGDDSLIQTKTMATIGYMAPE-------GIVSTKCDVYSYGILLLETFSRKKP 371
           G       +    +     AP           +   + +  G+ +   +    P
Sbjct: 245 GT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 38/208 (18%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRNLI 232
           F +   +G GSFG V+KG        VAIKI +L + E        E  VL       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 233 KILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGLAL 283
           K   G    D K  +++E++  GS           LD+LE   L+      I+ ++   L
Sbjct: 84  KYY-GSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGL 132

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG-- 341
           +YLH        IH D+K +N+LL E+    ++DFG++  L    D+ I+  T   +G  
Sbjct: 133 DYLHSEK----KIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTP 183

Query: 342 -YMAPEGIVS----TKCDVYSYGILLLE 364
            +MAPE I      +K D++S GI  +E
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIE 211

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 54/239 (22%)

Query: 160 WRRISYLDIQRATN---EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS 215
            R +  +D+    +    F+   L+G G++G VYKG  +  G   AIK+ ++        
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEE 66

Query: 216 FNSECEVLRNV-RHRNLIK-----ILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLD 268
              E  +L+    HRN+       I      +D +  LV+EF   GS+           D
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------TD 116

Query: 269 ILERLN-----------IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSD 317
           +++              I  ++   L +LH       +IH D+K  N+LL EN    + D
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVD 172

Query: 318 FGISKLLGEGDDSLIQTKTMATIG---YMAPEGIVS---------TKCDVYSYGILLLE 364
           FG+S  L   D ++ +  T   IG   +MAPE I            K D++S GI  +E
Sbjct: 173 FGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 25/211 (11%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL-QLERTFVSFNSECEVLRNVRHRN 230
           ++++   ++G G+   V           VAIK  NL + + +      E + +    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 231 LIKILSGCSNLDFKAL--VLEFMPNGSLE---KWLYSHNYFLD-ILERLNIMI---DVGL 281
           ++      S +    L  V++ +  GS+    K + +       +L+   I     +V  
Sbjct: 75  IVSYY--TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            LEYLH        IH D+K  NILL E+    ++DFG+S  L  G D          +G
Sbjct: 133 GLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 342 ---YMAPEGIVST-----KCDVYSYGILLLE 364
              +MAPE +        K D++S+GI  +E
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-ERTFVSFNSECEV-LRNVRHR 229
           ++ +    LG G++G V K   +  G  +A+K     +  +       + ++ +R V   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 230 NLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERL--NIMIDVGL 281
             +    G      ++    + +E M + SL+K  Y         I E +   I + +  
Sbjct: 67  FTVTFY-GALFREGDV---WICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           ALE+LH   +   +IH D+KPSN+L++      + DFGIS   G   D + +        
Sbjct: 121 ALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKP 174

Query: 342 YMAPEGIV--------STKCDVYSYGILLLE 364
           YMAPE I         S K D++S GI ++E
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIE 205

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (250), Expect = 6e-23
 Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 21/193 (10%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG G++G V            AIKI         +      E  VL+ + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGHALAPI 295
             +     LV+E    G L   +     F    E     I+  V   + YLH  +    I
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN---EVDAAVIIKQVLSGVTYLHKHN----I 157

Query: 296 IHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GIV 349
           +H DLKP N+LL   +++ +  + DFG+S +           + + T  Y+APE      
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKKY 214

Query: 350 STKCDVYSYGILL 362
             KCDV+S G++L
Sbjct: 215 DEKCDVWSIGVIL 227

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.8 bits (249), Expect = 8e-23
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 21/193 (10%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG GSFG V K          A+K+ N      +   +   E E+L+ + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGHALAPI 295
             +     +V E    G L   +     F    E     I+  V   + Y+H  +    I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN----I 142

Query: 296 IHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GIV 349
           +H DLKP NILL   +++    + DFG+S    +          + T  Y+APE   G  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGTY 199

Query: 350 STKCDVYSYGILL 362
             KCDV+S G++L
Sbjct: 200 DEKCDVWSAGVIL 212

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 98.2 bits (245), Expect = 9e-23
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 46/211 (21%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNL--------QLERTFVSFNSECEVLRNVR-HRN 230
           +G G    V +    + G   A+KI  +        QLE    +   E  +LR V  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--------NIMIDVGLA 282
           +I ++    +  F  LV + M  G L         F  + E++        +IM  +  A
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL---------FDYLTEKVALSEKETRSIMRSLLEA 212

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIG 341
           + +LH  +    I+H DLKP NILLD+NM   +SDFG S  L  G+    + + +  T G
Sbjct: 213 VSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPG 264

Query: 342 YMAPEGIV----------STKCDVYSYGILL 362
           Y+APE +             + D+++ G++L
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.4 bits (243), Expect = 9e-23
 Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 36/238 (15%)

Query: 143 NRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVA 201
             S K++             I     Q   N+ +    +G G+ G V+K      G  +A
Sbjct: 4   GSSGKQTGYLT---------IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIA 54

Query: 202 IKIFNLQL-ERTFVSFNSECEVL-RNVRHRNLIK----ILSGCSNLDFKALVLEFMPNGS 255
           +K       +        + +V+ ++     +++     ++  +++    + +E M    
Sbjct: 55  VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDV---FIAMELM-GTC 109

Query: 256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV 315
            EK        +       + + +  AL YL   H    +IH D+KPSNILLDE     +
Sbjct: 110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKL 166

Query: 316 SDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV---------STKCDVYSYGILLLE 364
            DFGIS   G   D   + ++     YMAPE I            + DV+S GI L+E
Sbjct: 167 CDFGIS---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 27/198 (13%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN--LQLERTFVSFNSECEVLRNVRHRNLIKILSG 237
           LG GSFG V K          A+K+ N      +   +   E E+L+ + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGHALAPI 295
             +     +V E    G L   +     F    E     I+  V   + Y+H  +    I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN----I 142

Query: 296 IHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE---GI 348
           +H DLKP NILL   +++    + DFG+S    +      + K    T  Y+APE   G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRGT 198

Query: 349 VSTKCDVYSYG----ILL 362
              KCDV+S G    ILL
Sbjct: 199 YDEKCDVWSAGVILYILL 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 31/209 (14%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFN-------LQLERTFVSFNSECE 221
            +F    +LG GSF +V       T       AIKI          ++         E +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYV----TRERD 82

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           V+  + H   +K+     + +     L +  NG L K++     F +   R     ++  
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVS 141

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATI 340
           ALEYLH       IIH DLKP NILL+E+M   ++DFG +K+L        +  +   T 
Sbjct: 142 ALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSFVGTA 196

Query: 341 GYMAPEGIVSTK-----CDVYSYGILLLE 364
            Y++PE +++ K      D+++ G ++ +
Sbjct: 197 QYVSPE-LLTEKSACKSSDLWALGCIIYQ 224

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 66/230 (28%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVSFNS------------------- 218
            +G GS+G V      +D T  A+K+ +  +L R                          
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 219 ------ECEVLRNVRHRNLIK---ILSGCSNLDFKALVLEFMPNGSL----------EKW 259
                 E  +L+ + H N++K   +L   +  D   +V E +  G +          E  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPLSED- 137

Query: 260 LYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG 319
             +  YF D++            +EYLHY      IIH D+KPSN+L+ E+    ++DFG
Sbjct: 138 -QARFYFQDLI----------KGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 320 ISKLLGEGDDSLIQTKTMATIGYMAPEGIVST-------KCDVYSYGILL 362
           +S    +G D+L+   T+ T  +MAPE +  T         DV++ G+ L
Sbjct: 183 VSNEF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 46/198 (23%), Positives = 78/198 (39%), Gaps = 33/198 (16%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GS+G V            A K            F  E E+++++ H N+I++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGLALEYLHYGHA 291
           +     LV+E    G L         F  ++ +          IM DV  A+ Y H  + 
Sbjct: 77  DNTDIYLVMELCTGGEL---------FERVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 126

Query: 292 LAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE- 346
              + H DLKP N L      +    + DFG++     G       +T   T  Y++P+ 
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSPQV 179

Query: 347 --GIVSTKCDVYSYGILL 362
             G+   +CD +S G+++
Sbjct: 180 LEGLYGPECDEWSAGVMM 197

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 32/206 (15%)

Query: 179 NLLGIGSFGSVYKGT-LSDGTNVAIKI-------------FNLQLERTFVSFNSECEVLR 224
             LG G++G V      +  +  AIK+              N  +E+      +E  +L+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGLA 282
           ++ H N+IK+     +  +  LV EF   G L + + + + F    E    NIM  +   
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECDAANIMKQILSG 158

Query: 283 LEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           + YLH  +    I+H D+KP NILL   +  +   + DFG+S    +          + T
Sbjct: 159 ICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGT 211

Query: 340 IGYMAPE---GIVSTKCDVYSYGILL 362
             Y+APE      + KCDV+S G+++
Sbjct: 212 AYYIAPEVLKKKYNEKCDVWSCGVIM 237

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 39/204 (19%), Positives = 71/204 (34%), Gaps = 31/204 (15%)

Query: 182 GIGSFGSVYKGT-LSDGTNVAIKIFNL--QLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           G     +V        G  V ++  NL             E  V +   H N++      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR--A 93

Query: 239 SNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGLALEYLHYGHALAP 294
           + +    L  V  FM  GS +  L   ++   + E     I+  V  AL+Y+H+      
Sbjct: 94  TFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHMG---- 148

Query: 295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY--------MAPE 346
            +H  +K S+IL+  +   ++S    +  +        + + +             ++PE
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSM---ISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 347 GIV------STKCDVYSYGILLLE 364
            +         K D+YS GI   E
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACE 229

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 40/214 (18%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
           ++ +D    LG G+F  V +    + G   A KI N +    R F     E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVG 280
            N++++        F  LV + +  G L         F DI+ R         + +  + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            ++ Y H       I+H +LKP N+LL    +     ++DFG++  + + +         
Sbjct: 116 ESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGF 167

Query: 338 A-TIGYMAPEGIV----STKCDVYSYG----ILL 362
           A T GY++PE +     S   D+++ G    ILL
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 46/223 (20%)

Query: 168 IQRATNEFDE----CNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSEC 220
           +  A+ +F +       LG G+F  V +    + G   A KI N +    R F     E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSL-----EKWLYS----HNYFLDILE 271
            + R ++H N++++        F  LV + +  G L      +  YS     +    ILE
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139

Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGD 328
                     ++ Y H       I+H +LKP N+LL    +     ++DFG++  + + +
Sbjct: 140 ----------SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185

Query: 329 DSLIQTKTMA-TIGYMAPEGIV----STKCDVYSYG----ILL 362
                    A T GY++PE +     S   D+++ G    ILL
Sbjct: 186 ----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 26/197 (13%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
           LG G+FG V+     S G    IK  N  + +       +E EVL+++ H N+IKI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 239 SNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDILER--LNIMIDVGLALEYLHYGHA 291
            +     +V+E    G L                   E     +M  +  AL Y H  H 
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH- 144

Query: 292 LAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE-- 346
              ++H DLKP NIL      +    + DFG+++L    +     T    T  YMAPE  
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVF 198

Query: 347 -GIVSTKCDVYSYGILL 362
              V+ KCD++S G+++
Sbjct: 199 KRDVTFKCDIWSAGVVM 215

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.6 bits (238), Expect = 7e-22
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 30/205 (14%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERT---FVSFNSECEVLRNVRHRN 230
           F +   +G GSFG+VY    + +   VAIK  +   +++   +     E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 231 LIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
            I+   GC   +  A LV+E+   GS    L  H   L  +E   +       L YLH  
Sbjct: 116 TIQYR-GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG---YMAPE 346
           +    +IH D+K  NILL E  +  + DFG + ++           +   +G   +MAPE
Sbjct: 174 N----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANSF--VGTPYWMAPE 220

Query: 347 GIVS-------TKCDVYSYGILLLE 364
            I++        K DV+S GI  +E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 95.1 bits (237), Expect = 8e-22
 Identities = 52/228 (22%), Positives = 88/228 (38%), Gaps = 48/228 (21%)

Query: 166 LDIQRATNEFDE----CNLLGIGSFGSVYKGT-LSDGTNVAIKI-----FNLQLERTFVS 215
           LD+      F++    C ++G G F  V +      G   A+KI     F      +   
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 216 FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN- 274
              E  +   ++H +++++L   S+     +V EFM    L           +I++R + 
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADA 123

Query: 275 -----------IMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGI 320
                       M  +  AL Y H  +    IIH D+KP  +LL   + +    +  FG+
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGV 179

Query: 321 SKLLGEGDDSLIQTKTMA-TIGYMAPEGIV-----STKCDVYSYGILL 362
           +  LGE             T  +MAPE +V         DV+  G++L
Sbjct: 180 AIQLGESGLVA---GGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVIL 223

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 49/208 (23%), Positives = 83/208 (39%), Gaps = 41/208 (19%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN----LQLERTFVSFNSECEVLRNVRHRNLIK- 233
           LLG GS+G V +          A+KI       ++     +   E ++LR +RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 234 --ILSGCSNLDFKALVLEFMPNGSLEKWLY----------SHNYFLDILERLNIMIDVGL 281
             +L          +V+E+   G  E              +H YF  +++          
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID---------- 120

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSLIQTKTMATI 340
            LEYLH       I+H D+KP N+LL       +S  G+++ L     D   +T +  + 
Sbjct: 121 GLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSP 175

Query: 341 GYMAPEGIVSTK------CDVYSYGILL 362
            +  PE             D++S G+ L
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.1 bits (239), Expect = 2e-21
 Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 18/234 (7%)

Query: 140 RCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDE----CNLLGIGSFGSVYKGT-L 194
           +        S   D      W++     ++   +   +       LG G+FG V++ T  
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 195 SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNG 254
           + G N A K      E    +   E + +  +RH  L+ +     + +   ++ EFM  G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 255 SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH 314
            L + +   +  +   E +  M  V   L ++H  +     +H DLKP NI+        
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNE 295

Query: 315 V--SDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILL 362
           +   DFG++  L           T  T  + APE      V    D++S G+L 
Sbjct: 296 LKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 16/197 (8%)

Query: 174 EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
              +  +LG G FG V+K    + G  +A KI   +  +      +E  V+  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           ++     + +   LV+E++  G L   +   +Y L  L+ +  M  +   + ++H  +  
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY-- 207

Query: 293 APIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI- 348
             I+H DLKP NIL    D   +  + DFG+++     +          T  ++APE + 
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVN 261

Query: 349 ---VSTKCDVYSYGILL 362
              VS   D++S G++ 
Sbjct: 262 YDFVSFPTDMWSVGVIA 278

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 42/211 (19%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSG 237
           +LG G+   V     L      A+KI   Q          E E+L   + HRN+++++  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 238 CSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGLALEYLHYG 289
               D   LV E M  GS+            I +R +        ++ DV  AL++LH  
Sbjct: 80  FEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELEASVVVQDVASALDFLHNK 130

Query: 290 HALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDD-SLIQTKTMATI----G 341
                I H DLKP NIL    ++     + DF +   +    D S I T  + T      
Sbjct: 131 G----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 342 YMAPEGIVST----------KCDVYSYGILL 362
           YMAPE +V            +CD++S G++L
Sbjct: 187 YMAPE-VVEAFSEEASIYDKRCDLWSLGVIL 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 51/226 (22%), Positives = 93/226 (41%), Gaps = 18/226 (7%)

Query: 148 KSDEEDLLPLVTWRRISYLDIQRATNEFDE----CNLLGIGSFGSVYKGT-LSDGTNVAI 202
           K ++ D      W++     ++       +       LG G+FG V++    + G     
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 203 KIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS 262
           K  N        +  +E  ++  + H  LI +     +     L+LEF+  G L   + +
Sbjct: 82  KFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 141

Query: 263 HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGI 320
            +Y +   E +N M      L+++H       I+H D+KP NI+ +    + V   DFG+
Sbjct: 142 EDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGL 197

Query: 321 SKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILL 362
           +  L   +   I   T AT  + APE +    V    D+++ G+L 
Sbjct: 198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 41/202 (20%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGC 238
           LG GSF    K          A+KI +   +R   +   E   L+    H N++K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGLALEYLHYGH 290
            +     LV+E +  G L         F  I ++ +        IM  +  A+ ++H   
Sbjct: 76  HDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126

Query: 291 ALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE 346
               ++H DLKP N+L    ++N+   + DFG ++L    +  L   KT   T+ Y APE
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL---KTPCFTLHYAAPE 179

Query: 347 GIV------STKCDVYSYGILL 362
             +         CD++S G++L
Sbjct: 180 --LLNQNGYDESCDLWSLGVIL 199

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.5 bits (233), Expect = 8e-21
 Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 43/216 (19%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTF--VSFNSECEVLRNVRH 228
           T E+     LG G+F  V +   +  G   A  I N +            E  + R ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVG 280
            N++++    S      L+ + +  G L         F DI+ R         + +  + 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQQIL 120

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            A+ + H       ++H +LKP N+LL    +     ++DFG++  +     +       
Sbjct: 121 EAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW---FGF 173

Query: 338 A-TIGYMAPEGIV------STKCDVYSYG----ILL 362
           A T GY++PE  V          D+++ G    ILL
Sbjct: 174 AGTPGYLSPE--VLRKDPYGKPVDLWACGVILYILL 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 43/215 (20%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFN-------LQLERTFVSFNSECE 221
           + F+    +G GSFG V       T       A+K  N        ++   F     E +
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVF----KELQ 67

Query: 222 VLRNVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
           +++ + H  L+  L        ++     V++ +  G L   L  + +F +   +L I  
Sbjct: 68  IMQGLEHPFLVN-LWYSFQDEEDMFM---VVDLLLGGDLRYHLQQNVHFKEETVKLFIC- 122

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
           ++ +AL+YL        IIH D+KP NILLDE+   H++DF I+ +L        Q  TM
Sbjct: 123 ELVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTM 174

Query: 338 A-TIGYMAPEGIVSTKCDVY-------SYGILLLE 364
           A T  YMAPE   S K   Y       S G+   E
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 40/204 (19%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
            LG G+   VY+          A+K+    +++  V   +E  VL  + H N+IK+    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKEIF 117

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGLALEYLHYGH 290
                 +LVLE +  G L         F  I+E+         + +  +  A+ YLH   
Sbjct: 118 ETPTEISLVLELVTGGEL---------FDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168

Query: 291 ALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE 346
               I+H DLKP N+L      +    ++DFG+SK++          KT+  T GY APE
Sbjct: 169 ----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPE 220

Query: 347 GIVST----KCDVYSYG----ILL 362
            +       + D++S G    ILL
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILL 244

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 51/206 (24%), Positives = 77/206 (37%), Gaps = 41/206 (19%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS------FNSECEVLRNVRHRNLIK 233
           LG G F  V K    S G   A K    +  R             E  +LR V H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 234 ILSGCSNLDFKALVLEFMPNGSL-----EKWLYS----HNYFLDILERLNIMIDVGLALE 284
           +     N     L+LE +  G L     +K   S     ++   IL+           + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD----------GVN 129

Query: 285 YLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           YLH       I H DLKP NI+L           + DFG++  + +G           T 
Sbjct: 130 YLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTP 182

Query: 341 GYMAPEGI----VSTKCDVYSYGILL 362
            ++APE +    +  + D++S G++ 
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVIT 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 39/201 (19%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVL-RNVRHRNLIKILSGC 238
           +G+GS+    +    +     A+KI +            E E+L R  +H N+I +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEIEILLRYGQHPNIITLKDVY 85

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGLALEYLHYGH 290
            +  +  +V E M  G L            IL +          ++  +   +EYLH   
Sbjct: 86  DDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136

Query: 291 ALAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAP 345
               ++H DLKPSNIL            + DFG +K L   +  L    T   T  ++AP
Sbjct: 137 ----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL---MTPCYTANFVAP 189

Query: 346 EGIVST----KCDVYSYGILL 362
           E +        CD++S G+LL
Sbjct: 190 EVLERQGYDAACDIWSLGVLL 210

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.1 bits (221), Expect = 9e-20
 Identities = 54/246 (21%), Positives = 87/246 (35%), Gaps = 59/246 (23%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-----FNSECEVLRN 225
             ++     +G GS+G V            AIKI N    R           +E  +++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSL----------------------------- 256
           + H N+ ++     +  +  LV+E    G L                             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 257 --------EKWLYSHNYFLDILERL--NIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL 306
                       +  +      E+L  NIM  +  AL YLH       I H D+KP N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFL 200

Query: 307 L--DENMVAHVSDFGISKLLGEGDDSLIQT-KTMA-TIGYMAPEGI------VSTKCDVY 356
              +++    + DFG+SK   + ++       T A T  ++APE +         KCD +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 357 SYGILL 362
           S G+LL
Sbjct: 261 SAGVLL 266

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 36/147 (24%), Positives = 60/147 (40%), Gaps = 20/147 (13%)

Query: 247 VLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSN 304
            ++     +L+ W+         +    L+I I +  A+E+LH       ++H DLKPSN
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG----LMHRDLKPSN 194

Query: 305 ILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA----------TIGYMAPEGIV----S 350
           I    + V  V DFG+   + + ++       M           T  YM+PE I     S
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254

Query: 351 TKCDVYSYGILLLETFSRKKPTNDLGE 377
            K D++S G++L E         +   
Sbjct: 255 HKVDIFSLGLILFELLYSFSTQMERVR 281

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 17/66 (25%), Positives = 27/66 (40%), Gaps = 2/66 (3%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL-QLERTFVSFNSECEVLRNVR 227
           R   +F+    +G G FG V++     D  N AIK   L   E        E + L  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 228 HRNLIK 233
           H  +++
Sbjct: 63  HPGIVR 68

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 49/205 (23%), Positives = 77/205 (37%), Gaps = 39/205 (19%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFV---SFNSECEVLRNVRHRNLIK 233
           LG G F  V K    S G   A K       +  R  V       E  +LR V H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGLALEY 285
           +     N     L+LE +  G L         F  + ++         + +  +   + Y
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 286 LHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
           LH       I H DLKP NI+L           + DFG++  + +G           T  
Sbjct: 131 LHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPE 183

Query: 342 YMAPEGI----VSTKCDVYSYGILL 362
           ++APE +    +  + D++S G++ 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 54/206 (26%), Positives = 78/206 (37%), Gaps = 41/206 (19%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFV---SFNSECEVLRNVRHRNLIK 233
           LG G F  V K      G   A K      L   R  V       E  +LR +RH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 234 ILSGCSNLDFKALVLEFMPNGSL-----EKWLYS----HNYFLDILERLNIMIDVGLALE 284
           +     N     L+LE +  G L     EK   +      +   IL+           + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD----------GVH 122

Query: 285 YLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           YLH       I H DLKP NI+L      N    + DFGI+  +  G+          T 
Sbjct: 123 YLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTP 175

Query: 341 GYMAPEGI----VSTKCDVYSYGILL 362
            ++APE +    +  + D++S G++ 
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVIT 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 17/202 (8%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ-LERTFVSFNSECEVLRNV 226
           +    ++     LG G FG V++    S       K   ++  ++  V    E  +L   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV--KKEISILNIA 58

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           RHRN++ +     +++   ++ EF+    + + + +  + L+  E ++ +  V  AL++L
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 287 HYGHALAPIIHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           H  +    I H D++P NI+     +    + +FG ++ L  GD             Y A
Sbjct: 119 HSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYA 171

Query: 345 PEGI----VSTKCDVYSYGILL 362
           PE      VST  D++S G L+
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 44/206 (21%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNL--------QLERTFVSFNSECEVLRNVRHRN 230
            LG G++G V           VA+KI ++         +++       E  + + + H N
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHEN 66

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGL 281
           ++K        + + L LE+   G L   +             +F  ++           
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------- 116

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            + YLH       I H D+KP N+LLDE     +SDFG++ +    +   +  K   T+ 
Sbjct: 117 GVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 342 YMAPEGIVS-----TKCDVYSYGILL 362
           Y+APE +          DV+S GI+L
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVL 198

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 23/197 (11%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN--------LQLERTFVSFNSECEVLRNVRHRNL 231
           LG G+FG V+          V +K              +        E  +L  V H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGLALEYLHYGH 290
           IK+L    N  F  LV+E   +G L+ + +   +  LD      I   +  A+ YL    
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-- 348
               IIH D+K  NI++ E+    + DFG +  L  G   L  T    TI Y APE +  
Sbjct: 151 ----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYT-FCGTIEYCAPEVLMG 203

Query: 349 ---VSTKCDVYSYGILL 362
                 + +++S G+ L
Sbjct: 204 NPYRGPELEMWSLGVTL 220

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNL-------QLERTFVSFNSECE 221
           ++FD    LG GSFG V     K +   G + A+KI +        Q+E T     +E  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHT----LNEKR 93

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +L+ V    L+K+     +     +V+E++  G +   L     F +   R      + L
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVL 152

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATI 340
             EYLH       +I+ DLKP N+L+D+     V+DFG +K +        +T T+  T 
Sbjct: 153 TFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTP 202

Query: 341 GYMAPEGIVSTK-----CDVYSYGILLLE 364
             +APE I+ +K      D ++ G+L+ E
Sbjct: 203 EALAPE-IILSKGYNKAVDWWALGVLIYE 230

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 50/206 (24%), Positives = 77/206 (37%), Gaps = 41/206 (19%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFV---SFNSECEVLRNVRHRNLIK 233
           LG G F  V K    S G   A K       +  R  V       E  +L+ ++H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 234 ILSGCSNLDFKALVLEFMPNGSL-----EKWLYS----HNYFLDILERLNIMIDVGLALE 284
           +     N     L+LE +  G L     EK   +      +   IL            + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN----------GVY 128

Query: 285 YLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           YLH       I H DLKP NI+L           + DFG++  +  G+          T 
Sbjct: 129 YLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 181

Query: 341 GYMAPEGI----VSTKCDVYSYGILL 362
            ++APE +    +  + D++S G++ 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVIT 207

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.0 bits (214), Expect = 7e-19
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 40/211 (18%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFN-------LQLERTFVSFNSECE 221
            +F     LG GSFG V+    +     G   A+K+          Q+E T    N E  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHT----NDERL 58

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           +L  V H  +I++     +     ++++++  G L   L     F + + +     +V L
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 117

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTM-A 338
           ALEYLH       II+ DLKP NILLD+N   H+  +DFG +K + +       T T+  
Sbjct: 118 ALEYLHSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCG 165

Query: 339 TIGYMAPEGIVSTK-----CDVYSYGILLLE 364
           T  Y+APE +VSTK      D +S+GIL+ E
Sbjct: 166 TPDYIAPE-VVSTKPYNKSIDWWSFGILIYE 195

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.8 bits (213), Expect = 8e-19
 Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 44/206 (21%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNL--------QLERTFVSFNSECEVLRNVRHRN 230
            LG G++G V           VA+KI ++         +++       E  + + + H N
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHEN 66

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGL 281
           ++K        + + L LE+   G L   +             +F  ++           
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------- 116

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIG 341
            + YLH       I H D+KP N+LLDE     +SDFG++ +    +   +  K   T+ 
Sbjct: 117 GVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 342 YMAPEGIVS-----TKCDVYSYGILL 362
           Y+APE +          DV+S GI+L
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVL 198

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 49/208 (23%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN----------LQLERTFVSFNSECEVLRNVRH 228
            LG+G+FG V  G     G  VA+KI N           +++R       E + L+  RH
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-------EIQNLKLFRH 70

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDV 279
            ++IK+    S      +V+E++  G L  ++  H           F  IL         
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-------- 122

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
             A++Y H       ++H DLKP N+LLD +M A ++DFG+S +    D   ++T +  +
Sbjct: 123 --AVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT-SCGS 173

Query: 340 IGYMAPEGI-----VSTKCDVYSYGILL 362
             Y APE I        + D++S G++L
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 51/209 (24%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN--LQLERTFVSFNSECEVL-RNVRHRNLIKIL 235
           +LG+G  G V +      G   A+K+     +  +       E +   +     +++ IL
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-------EVDHHWQASGGPHIVCIL 88

Query: 236 ----SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGL 281
               +         +++E M  G L         F  I ER +          IM D+G 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           A+++LH  +    I H D+KP N+L    +++ V  ++DFG +K   +        +T  
Sbjct: 140 AIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPC 190

Query: 339 -TIGYMAPEGIVSTK----CDVYSYGILL 362
            T  Y+APE +   K    CD++S G+++
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 49/203 (24%), Positives = 77/203 (37%), Gaps = 37/203 (18%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN--LQLERTFVSFNSECEVLRNVRHR-NLIKILS 236
           LG G F  V +    S G   A K      + +        E  VL   +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERL----------NIMIDVGLALEYL 286
              N     L+LE+   G +         F   L  L           ++  +   + YL
Sbjct: 97  VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 287 HYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           H  +    I+H DLKP NILL          + DFG+S+ +G         + M T  Y+
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYL 200

Query: 344 APEGI----VSTKCDVYSYGILL 362
           APE +    ++T  D+++ GI+ 
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 36/211 (17%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQLERTFVSFNSECE------- 221
           N F +  +LG G FG V     + T   G   A K     LE+  +              
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKK----LEKKRIKKRKGEAMALNEKQ 236

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVG 280
           +L  V  R ++ +       D   LVL  M  G L+  +Y          R      ++ 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTMA 338
             LE LH       I++ DLKP NILLD++   H+  SD G++  + EG       K   
Sbjct: 297 CGLEDLHRER----IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ----TIKGRV 346

Query: 339 -TIGYMAPEGIVSTKC----DVYSYGILLLE 364
            T+GYMAPE + + +     D ++ G LL E
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 38/257 (14%)

Query: 130 LLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRAT---NEFDECNLLGIGSF 186
           LL     +       + +K   +++   ++  + +   I+       +++   ++G G+F
Sbjct: 25  LLDGLDALVYDLDFPALRK--NKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAF 82

Query: 187 GSVY----KGTLSDGTNVAIKIFNLQ--LERTFVS-FNSECEVLRNVRHRNLIKILSGCS 239
           G V     K T       A+K+ +    ++R+  + F  E +++       ++++     
Sbjct: 83  GEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCD 299
           +  +  +V+E+MP G L   + +++   +   R     +V LAL+ +H        IH D
Sbjct: 140 DDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA-EVVLALDAIHSMG----FIHRD 193

Query: 300 LKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTM-ATIGYMAPEGIVSTK---- 352
           +KP N+LLD++   H+  +DFG    +    + +++  T   T  Y++PE ++ ++    
Sbjct: 194 VKPDNMLLDKS--GHLKLADFGTCMKM--NKEGMVRCDTAVGTPDYISPE-VLKSQGGDG 248

Query: 353 -----CDVYSYGILLLE 364
                CD +S G+ L E
Sbjct: 249 YYGRECDWWSVGVFLYE 265

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           ++    +  C ++G GSFG V++  L +   VAIK             N E +++R V+H
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK----NRELQIMRIVKH 91

Query: 229 RNLIKIL----SGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDV 279
            N++ +     S     D     LVLE++P  ++ +    +      +  L I   M  +
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDDSLIQTKTMA 338
             +L Y+H       I H D+KP N+LLD    V  + DFG +K+L  G+ +      + 
Sbjct: 151 LRSLAYIHS----IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYIC 203

Query: 339 TIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
           +  Y APE I      +T  D++S G ++ E    +
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 49/207 (23%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN------LQLERTFVSFNSECEVLRNVRHRNLI 232
            +G G+FG             VA+K           ++R       E    R++RH N++
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-------EIINHRSLRHPNIV 79

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGLAL 283
           +           A+++E+   G L + + +           +F  +L            +
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGV 129

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAH--VSDFGISKLLGEGDDSLIQTKTMATIG 341
            Y H       I H DLK  N LLD +      + DFG SK       S  ++ T+ T  
Sbjct: 130 SYCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKS-TVGTPA 182

Query: 342 YMAPEGIVSTK------CDVYSYGILL 362
           Y+APE ++  +       DV+S G+ L
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTL 208

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 85.7 bits (212), Expect = 5e-18
 Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 53/220 (24%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           N+F    ++G G FG VY      T   G   A+K     L++  +       +  N R 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKC----LDKKRIKMKQGETLALNER- 240

Query: 229 RNLIKILSGCSNLD----------FKA-----LVLEFMPNGSLEKWLYSHNYFLDILERL 273
                +LS  S  D          F        +L+ M  G L   L  H  F +   R 
Sbjct: 241 ----IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296

Query: 274 NIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSL 331
               ++ L LE++H       +++ DLKP+NILLDE+   HV  SD G++    +     
Sbjct: 297 YAA-EIILGLEHMHNRF----VVYRDLKPANILLDEH--GHVRISDLGLACDFSKK---- 345

Query: 332 IQTKTMA-TIGYMAPEGIVSTK------CDVYSYGILLLE 364
            +      T GYMAPE ++          D +S G +L +
Sbjct: 346 -KPHASVGTHGYMAPE-VLQKGVAYDSSADWFSLGCMLFK 383

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 42/203 (20%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN------LQLERTFVSFNSECEVLRNVRHRNLIK 233
           +G G+F  V     +  G  VAIKI +        L++ F     E  +++ + H N++K
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF----REVRIMKILNHPNIVK 78

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGLALE 284
           +           L++E+   G +  +L +H         + F  I+           A++
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS----------AVQ 128

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y H       I+H DLK  N+LLD +M   ++DFG S          +         Y A
Sbjct: 129 YCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDA-FCGAPPYAA 181

Query: 345 PEGI-----VSTKCDVYSYGILL 362
           PE          + DV+S G++L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVIL 204

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 55/211 (26%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN----------LQLERTFVSFNSECEVLRNVRH 228
            LG+G+FG V  G     G  VA+KI N           ++ R       E + L+  RH
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-------EIQNLKLFRH 75

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDV 279
            ++IK+    S      +V+E++  G L  ++  +           F  IL         
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-------- 127

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
              ++Y H       ++H DLKP N+LLD +M A ++DFG+S +    D   ++T    +
Sbjct: 128 --GVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT----S 175

Query: 340 IG---YMAPEGI-----VSTKCDVYSYGILL 362
            G   Y APE I        + D++S G++L
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 63/268 (23%), Positives = 112/268 (41%), Gaps = 57/268 (21%)

Query: 130 LLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRAT---NEFDECNLLGIGSF 186
           LL I I +Y  C N   ++  E+++L  + W +     +++      +F+   ++G G+F
Sbjct: 30  LLDILICLYDECNNSPLRR--EKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAF 87

Query: 187 GSVY----KGTLSDGTNVAIKIFNLQ--LERTFVS-FNSECEVLRNVRHRNLIKILSGCS 239
           G V     K         A+KI N    L+R   + F  E +VL N   + +  +     
Sbjct: 88  GEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144

Query: 240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID----------VGLALEYLHYG 289
           + +   LV+++   G L     +       L +    +           + +A++ +H  
Sbjct: 145 DDNNLYLVMDYYVGGDL----LTL------LSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194

Query: 290 HALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
           H     +H D+KP NIL+D N   H+  +DFG    L E  D  +Q+     T  Y++PE
Sbjct: 195 H----YVHRDIKPDNILMDMN--GHIRLADFGSCLKLME--DGTVQSSVAVGTPDYISPE 246

Query: 347 GIVSTK----------CDVYSYGILLLE 364
            I+             CD +S G+ + E
Sbjct: 247 -ILQAMEGGKGRYGPECDWWSLGVCMYE 273

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 14/208 (6%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNV 226
           Q    ++ +   +G G++G VYK   S G  VA+K   L  E   +   +  E  +L+ +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N++ ++    +     LV EFM    L+K L  +   L   +    +  +   + + 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           H       I+H DLKP N+L++ +    ++DFG+++  G    S   T  + T+ Y AP+
Sbjct: 136 HQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPD 189

Query: 347 GIV-----STKCDVYSYGILLLETFSRK 369
            ++     ST  D++S G +  E  + K
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 172 TNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN 230
              + +  ++G GSFG VY+  L D G  VAIK             N E +++R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK----NRELQIMRKLDHCN 108

Query: 231 LIKIL----SGCSNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGL 281
           ++++     S     D   L  VL+++P  ++ +    ++     L  + +   M  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           +L Y+H       I H D+KP N+LLD +  V  + DFG +K L  G+ +      + + 
Sbjct: 168 SLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSR 220

Query: 341 GYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
            Y APE I      ++  DV+S G +L E    +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 58/208 (27%), Positives = 82/208 (39%), Gaps = 43/208 (20%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN-LQLERTFVSFNS-----ECEVLRNVRHR--N 230
           LLG G FGSVY G  +SD   VAIK     ++       N      E  +L+ V      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 231 LIKILSGCSNLDFKALVLEF-MPNGSLEKWLYSH---------NYFLDILERLNIMIDVG 280
           +I++L      D   L+LE   P   L  ++            ++F  +LE         
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--------- 160

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
            A+ + H       ++H D+K  NIL+D N     + DFG   LL    D++       T
Sbjct: 161 -AVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGT 211

Query: 340 IGYMAPEGIVS-----TKCDVYSYGILL 362
             Y  PE I           V+S GILL
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 59/269 (21%), Positives = 111/269 (41%), Gaps = 42/269 (15%)

Query: 123 PPIISIMLLLIAIIV-YVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRAT---NEFDEC 178
           P  + +  LL  ++  +         +  ++ +   + W     + ++      ++F+  
Sbjct: 9   PGFLGLEPLLDLLLGVHQELGASELAQ--DKYVADFLQWAEPIVVRLKEVRLQRDDFEIL 66

Query: 179 NLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQ--LERTFVS-FNSECEVLRNVRHRNL 231
            ++G G+F  V     K T   G   A+KI N    L+R  VS F  E +VL N   R +
Sbjct: 67  KVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGLALEYLH-YG 289
            ++     + ++  LV+E+   G L   L      +   E     + ++ +A++ +H  G
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVHRLG 182

Query: 290 HALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTM-ATIGYMAPE 346
                 +H D+KP NILLD     H+  +DFG    L    D  +++     T  Y++PE
Sbjct: 183 -----YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRA--DGTVRSLVAVGTPDYLSPE 233

Query: 347 GIVSTK-----------CDVYSYGILLLE 364
            + +             CD ++ G+   E
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 29/210 (13%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIK-IFNLQLERTFVS-FNS---------ECEVLRNVRHR 229
           +  GS+G+V  G  S+G  VAIK +FN   +   V+  +          E  +L +  H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 230 NLIKIL---SGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
           N++ +                LV E M    L + ++     +        M  + L L 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
            LH     A ++H DL P NILL +N    + DF +++      +    T  +    Y A
Sbjct: 149 VLH----EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRA 201

Query: 345 PEGIVSTKC-----DVYSYGILLLETFSRK 369
           PE ++  K      D++S G ++ E F+RK
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 50/210 (23%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHR 229
            ++++   +G G++G+V+K         VA+K   L  +   V  ++  E  +L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 230 N---LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           N   L  +L     L    LV EF     L+K+  S N  LD     + +  +   L + 
Sbjct: 62  NIVRLHDVLHSDKKL---TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           H  +    ++H DLKP N+L++ N    +++FG+++  G        +  + T+ Y  P+
Sbjct: 118 HSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD 171

Query: 347 GIV-----STKCDVYSYGILLLETFSRKKP 371
            +      ST  D++S G +  E  +  +P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 56/211 (26%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN--LQLERTFVSFNSECEVLRNV-RHRNLIKILS 236
           LG+G  G V +          A+K+     +  R       E E+     +  ++++I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRASQCPHIVRIVD 122

Query: 237 GCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGLA 282
              NL        +V+E +  G L         F  I +R +          IM  +G A
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 173

Query: 283 LEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
           ++YLH  +    I H D+KP N+L      N +  ++DFG +K             ++ T
Sbjct: 174 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-------NSLTT 222

Query: 340 I----GYMAPEGIVSTK----CDVYSYGILL 362
                 Y+APE +   K    CD++S G+++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 37/213 (17%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIFNLQLERTFVSFNSECE------- 221
           + F +  +LG G FG V+    K T   G   A K     L +  +      +       
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKK----LNKKRLKKRKGYQGAMVEKK 237

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL--ERLNIMI-D 278
           +L  V  R ++ +           LV+  M  G +   +Y+ +         R       
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKT 336
           +   LE+LH  +    II+ DLKP N+LLD++   +V  SD G++  L  G      TK 
Sbjct: 298 IVSGLEHLHQRN----IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTK---TKG 348

Query: 337 MA-TIGYMAPEGIVSTK----CDVYSYGILLLE 364
            A T G+MAPE ++  +     D ++ G+ L E
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 55/210 (26%), Positives = 80/210 (38%), Gaps = 45/210 (21%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN------LQLERTFVSFNSECEVLRNVR----H 228
           LLG G FG+V+ G  L+D   VAIK+               V+   E  +L  V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 229 RNLIKILSGCSNLDFKALVLEF-MPNGSLEKWLYSH---------NYFLDILERLNIMID 278
             +I++L      +   LVLE  +P   L  ++             +F  ++        
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA------- 150

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
              A+++ H       ++H D+K  NIL+D     A + DFG   LL    D        
Sbjct: 151 ---AIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FD 199

Query: 338 ATIGYMAPEGIVS-----TKCDVYSYGILL 362
            T  Y  PE I           V+S GILL
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILL 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 45/221 (20%), Positives = 92/221 (41%), Gaps = 30/221 (13%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIK-IFNLQL--ERTFVSFNSECEVLR 224
           ++  + F    + G G+FG+V  G     G +VAIK +        R         + L 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL----QIMQDLA 74

Query: 225 NVRHRNLIKIL-----SGCSNLD--FKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-- 275
            + H N++++       G  +    +  +V+E++P+ +L +   ++         + I  
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV 133

Query: 276 -MIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQ 333
            +  +  ++  LH       + H D+KP N+L++  +    + DFG +K L   + +   
Sbjct: 134 FLFQLIRSIGCLHLPSV--NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--- 188

Query: 334 TKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
              + +  Y APE I      +T  D++S G +  E    +
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 30/208 (14%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIF-------NLQLERTFVSFNSECE 221
           NEF+   LLG G+FG V     K T   G   A+KI          ++  T     +E  
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTL----TENR 200

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           VL+N RH  L  +       D    V+E+   G L   L     F +   R     ++  
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVS 259

Query: 282 ALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM-ATI 340
           AL+YLH       +++ DLK  N++LD++    ++DFG+ K   +   +    KT   T 
Sbjct: 260 ALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTP 313

Query: 341 GYMAPEGIVSTK----CDVYSYGILLLE 364
            Y+APE +         D +  G+++ E
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYE 341

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.1 bits (196), Expect = 1e-16
 Identities = 47/204 (23%), Positives = 92/204 (45%), Gaps = 14/204 (6%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHRN 230
            ++     +G G++G VYK   + G   A+K   L+ E   +   +  E  +L+ ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++K+           LV E +    L+K L      L+ +   + ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV- 349
               ++H DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+ ++ 
Sbjct: 121 ----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMG 174

Query: 350 ----STKCDVYSYGILLLETFSRK 369
               ST  D++S G +  E  +  
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 50/208 (24%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFN----------LQLERTFVSFNSECEVLRNVRH 228
            LG GSFG V   T       VA+K  +          +++ER       E   L+ +RH
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-------EISYLKLLRH 68

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDV 279
            ++IK+    +      +V+E+   G L  ++             +F  I+         
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC-------- 119

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
             A+EY H       I+H DLKP N+LLD+N+   ++DFG+S +    D + ++T +  +
Sbjct: 120 --AIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKT-SCGS 170

Query: 340 IGYMAPEGI-----VSTKCDVYSYGILL 362
             Y APE I        + DV+S GI+L
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVL 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNV 226
           ++  +++   L+G GS+G V K      G  VAIK F    +   V   +  E ++L+ +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           RH NL+ +L  C       LV EF+ + ++   L      LD       +  +   + + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE 346
           H  +    IIH D+KP NIL+ ++ V  + DFG ++ L    +       +AT  Y APE
Sbjct: 141 HSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPE 194

Query: 347 GIV-----STKCDVYSYGILLLETFSRK 369
            +V         DV++ G L+ E F  +
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 24/218 (11%)

Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV-SFNS----E 219
           LD++     +++ + LG G F +VYK    +    VAIK   L          N     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 220 CEVLRNVRHRNLIK---ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 276
            ++L+ + H N+I         SN+   +LV +FM    LE  +  ++  L        M
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNI---SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
           +     LEYLH       I+H DLKP+N+LLDEN V  ++DFG++K  G  + +   T  
Sbjct: 119 LMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQ 172

Query: 337 MATIGYMAPE---GIV--STKCDVYSYGILLLETFSRK 369
           + T  Y APE   G        D+++ G +L E   R 
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 44/221 (19%)

Query: 172 TNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIK----IFNLQLE--RTFVSFNSECEVLR 224
              +     +G G+ G V     +    NVAIK     F  Q    R +     E  +++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMK 79

Query: 225 NVRHRNLIKIL----SGCSNLDFKA--LVLEFMPNGSLEKWLYS------HNYFLDILER 272
            V H+N+I +L       S  +F+   +V+E M   +L + +         +Y L  +  
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC 138

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
                     +++LH       IIH DLKPSNI++  +    + DFG+++  G       
Sbjct: 139 ---------GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-- 183

Query: 333 QTKTMATIGYMAPEGIVSTKC----DVYSYGILLLETFSRK 369
            T  + T  Y APE I+        D++S G ++ E     
Sbjct: 184 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 15/205 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNVRHR 229
            ++++   +G GS+G V+K      G  VAIK F    +   +   +  E  +L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           NL+ +L          LV E+  + ++   L  +   +      +I      A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV 349
           +     IH D+KP NIL+ ++ V  + DFG ++LL    D       +AT  Y +PE +V
Sbjct: 122 N----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLV 175

Query: 350 -----STKCDVYSYGILLLETFSRK 369
                    DV++ G +  E  S  
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGV 200

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)

Query: 173 NEFDECNLLGIGSFGSVY---KGTLSDGTNV-AIKIFN----LQLERTFVSFNSECEVLR 224
             F+   +LG G++G V+   K +  D   + A+K+      +Q  +T     +E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 225 NVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
           ++R    +  L       + L     +L+++  G L   L     F +   ++ +  ++ 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHL---ILDYINGGELFTHLSQRERFTEHEVQIYVG-EIV 169

Query: 281 LALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTM 337
           LALE+LH  G     II+ D+K  NILLD N   HV  +DFG+SK     +         
Sbjct: 170 LALEHLHKLG-----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER--AYDF 220

Query: 338 A-TIGYMAPEGIVSTK------CDVYSYGILLLE 364
             TI YMAP+ +           D +S G+L+ E
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 27/207 (13%)

Query: 173 NEFDECNLLGIGSFGSVY---KGTLSDGTNV-AIKIFN--LQLERTFVSFNSECEVLRNV 226
           ++F+   +LG GSFG V+   K + SD   + A+K+        R  V    E ++L  V
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H  ++K+           L+L+F+  G L   L     F +   +  +  ++ LAL++L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHL 142

Query: 287 H-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTM-ATIGY 342
           H  G     II+ DLKP NILLDE    H+  +DFG+SK   + +       +   T+ Y
Sbjct: 143 HSLG-----IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGTVEY 192

Query: 343 MAPEGIVSTK-----CDVYSYGILLLE 364
           MAPE +V+ +      D +S+G+L+ E
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFE 218

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 32/215 (14%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK----IFNLQLE--RTFVSFNSECEVLR 224
              +     +G G+ G V          NVAIK     F  Q    R +     E  +++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMK 116

Query: 225 NVRHRNLIKIL----SGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
            V H+N+I +L       +  +F+   LV+E M   +L + +      LD      ++  
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQ 172

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA 338
           +   +++LH       IIH DLKPSNI++  +    + DFG+++  G      + T  + 
Sbjct: 173 MLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVV 225

Query: 339 TIGYMAPEGIVSTKC----DVYSYGILLLETFSRK 369
           T  Y APE I+        D++S G ++ E    K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)

Query: 173 NEFDECNLLGIGSFGSVY---KGTLSDGTNV-AIKIFN----LQLERTFVSFNSECEVLR 224
             F+   +LG G +G V+   K T ++   + A+K+      ++  +      +E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            V+H  ++ ++          L+LE++  G L   L     F++      +  ++ +AL 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALG 135

Query: 285 YLH-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTMA-TI 340
           +LH  G     II+ DLKP NI+L+     HV  +DFG+ K           T T   TI
Sbjct: 136 HLHQKG-----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFCGTI 185

Query: 341 GYMAPEGIVSTK----CDVYSYGILLLE 364
            YMAPE ++ +      D +S G L+ +
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYD 213

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.9 bits (185), Expect = 6e-15
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 39/212 (18%)

Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIF-------NLQLERTFVSFNSECE 221
           N+FD   LLG G+FG V     K T   G   A+KI          ++  T     +E  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTV----TESR 57

Query: 222 VLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL 281
           VL+N RH  L  +       D    V+E+   G L   L     F +   R     ++  
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVS 116

Query: 282 ALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSLIQTKTM 337
           ALEYLH        +++ D+K  N++LD++   H+  +DFG+ K  + +G       KT 
Sbjct: 117 ALEYLHSRD-----VVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGA----TMKTF 165

Query: 338 -ATIGYMAPEGIVSTKC----DVYSYGILLLE 364
             T  Y+APE +         D +  G+++ E
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTF-VSFNSECEVLRNVRHRN 230
             + + + LG G++ +VYKG        VA+K   L+ E     +   E  +L++++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 231 ---LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
              L  I+    +L    LV E++    L+++L      +++      +  +   L Y H
Sbjct: 62  IVTLHDIIHTEKSL---TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM----ATIGYM 343
                  ++H DLKP N+L++E     ++DFG+++         I TKT      T+ Y 
Sbjct: 118 RQK----VLHRDLKPQNLLINERGELKLADFGLARAKS------IPTKTYDNEVVTLWYR 167

Query: 344 APEGIV-----STKCDVYSYGILLLETFSRK 369
            P+ ++     ST+ D++  G +  E  + +
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 8/122 (6%)

Query: 250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE 309
                  E     +  FL +   +     V   +E+L    A    IH DL   NILL E
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSE 228

Query: 310 NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLET 365
             V  + DFG+++ + +  D + +      + +MAPE I     + + DV+S+G+LL E 
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

Query: 366 FS 367
           FS
Sbjct: 289 FS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 35/163 (21%), Positives = 57/163 (34%), Gaps = 23/163 (14%)

Query: 174 EFDECNL-----LGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVS-FNSECE 221
           EF    L     LG G+FG V +         +    VA+K+       +      SE +
Sbjct: 18  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77

Query: 222 VLRNV-RHRNLIKILSGCSNLDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
           +L ++  H N++ +L  C+      +V +EF   G+L  +L S           N  +  
Sbjct: 78  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------NEFVPY 128

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK 322
                    G      I  DLK     +  +  +  S F   K
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 47/231 (20%), Positives = 92/231 (39%), Gaps = 51/231 (22%)

Query: 172 TNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIK--IFNLQLE--RTFVSFNSECEVLRNV 226
            + + +   LG G  G V+    +D    VAIK  +                E +++R +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRL 65

Query: 227 RHRNLIKIL------------SGCSNLDFKA--LVLEFMPNGSLEKWLYSHN-------Y 265
            H N++K+                S  +  +  +V E+M    L   L            
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARL 124

Query: 266 FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLL 324
           F+  L R          L+Y+H     A ++H DLKP+N+ ++ E++V  + DFG+++++
Sbjct: 125 FMYQLLR---------GLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 325 G-EGDDSLIQTKTMATIGYMAPEGIVSTKC-----DVYSYGILLLETFSRK 369
                     ++ + T  Y +P  ++S        D+++ G +  E  + K
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 42/222 (18%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK---IFNLQLE--RTFVSFNSECEVLRN 225
              +   + +G G++G V       +   VAIK    F  Q    RT      E ++L  
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLR 81

Query: 226 VRHRNLIKIL---SGCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILERL 273
            RH N+I I       +    K   +V + M    L K L +         YFL  + R 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR- 139

Query: 274 NIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL-GEGDDSLI 332
                    L+Y+H     A ++H DLKPSN+LL+      + DFG++++   + D +  
Sbjct: 140 --------GLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 333 QTKTMATIGYMAPEGIVSTKC-----DVYSYGILLLETFSRK 369
            T+ +AT  Y APE ++++K      D++S G +L E  S +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 51/230 (22%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK---IFNLQLE--RTFVSFNSECEVLRN 225
           +++F   +LLG G++G V   T    G  VAIK    F+  L   RT      E ++L++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKH 65

Query: 226 VRHRNLIKIL---SGCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFL-DILER 272
            +H N+I I       S  +F    ++ E M    L + + +         YF+   L  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLR- 123

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG----ISKLLGEGD 328
                    A++ LH     + +IH DLKPSN+L++ N    V DFG    I +   +  
Sbjct: 124 ---------AVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 329 DSLIQTKTM----ATIGYMAPEGIVSTKC-----DVYSYGILLLETFSRK 369
           +   Q   M    AT  Y APE ++++       DV+S G +L E F R+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 48/218 (22%), Positives = 99/218 (45%), Gaps = 23/218 (10%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNV 226
              +++++   +G G+FG V+K      G  VA+K   ++ E+      +  E ++L+ +
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73

Query: 227 RHRN---LIKILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +H N   LI+I    ++   +      LV +F  +  L   L +      + E   +M  
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ--TKT 336
           +   L Y+H       I+H D+K +N+L+  + V  ++DFG+++      +S     T  
Sbjct: 133 LLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 337 MATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
           + T+ Y  PE ++         D++  G ++ E ++R 
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 47/222 (21%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK----IFNLQLE--RTFVSFNSECEVLR 224
              +     +G G++GSV        G  VAIK     F  ++   R +     E  +L+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLK 78

Query: 225 NVRHRNLIKIL----SGCSNLDFKA--LVLEFMPNGSLEKWLYS------HNYFLDILER 272
           +++H N+I +L       S  +F    LV+ FM    L+K +          Y +  + +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK 137

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
                     L+Y+H     A ++H DLKP N+ ++E+    + DFG+++          
Sbjct: 138 ---------GLKYIHS----AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----- 179

Query: 333 QTKTMATIGYMAPEGIVS-----TKCDVYSYGILLLETFSRK 369
            T  + T  Y APE I+S        D++S G ++ E  + K
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 171 ATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS----ECEVLRN 225
           ++++F +   LG G++ +VYKG   + G  VA+K   L  E       S    E  +++ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKE 59

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-----LDILERLNIMIDVG 280
           ++H N++++       +   LV EFM N  L+K++ S         L++         + 
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTM--- 337
             L + H       I+H DLKP N+L+++     + DFG+++  G      I   T    
Sbjct: 119 QGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFG------IPVNTFSSE 168

Query: 338 -ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
             T+ Y AP+ ++     ST  D++S G +L E  + K
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 45/242 (18%), Positives = 89/242 (36%), Gaps = 52/242 (21%)

Query: 172 TNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN 230
           + ++     LG GSFG V +    + G   A+K             N E ++++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK----NRELDIMKVLDHVN 61

Query: 231 LIKILS---GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY-- 285
           +IK++       + + K        N    K    +N+   ++   +    + + +EY  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 286 --------------------------------LHYGHALAPIIHCDLKPSNILLD-ENMV 312
                                           + + H+   I H D+KP N+L++ ++  
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNT 180

Query: 313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-----STKCDVYSYGILLLETFS 367
             + DFG +K L   + S      + +  Y APE ++     +   D++S G +  E   
Sbjct: 181 LKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 368 RK 369
            K
Sbjct: 238 GK 239

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 48/214 (22%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIK-IFN-----LQLERTFVSFNSECEVLRNVRHRNLIK 233
           +G G++G+V        G  VAIK ++      L  +R +     E  +L+++RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENVIG 88

Query: 234 IL----SGCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVG 280
           +L       +  DF    LV+ FM    L K +           + +  + +        
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-------- 139

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
             L Y+H     A IIH DLKP N+ ++E+    + DFG+++     D  +  T  + T 
Sbjct: 140 -GLRYIHA----AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEM--TGYVVTR 189

Query: 341 GYMAPEGIVS-----TKCDVYSYGILLLETFSRK 369
            Y APE I++        D++S G ++ E  + K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 38/210 (18%)

Query: 175 FDECNLLGIGSFGSV----YKGTLSDGTNVAIKIFNLQLERTFVSFNSECE-------VL 223
           F+   +LG GSFG V     KGT       A+KI    L++  V  + + E       VL
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKI----LKKDVVIQDDDVECTMVEKRVL 395

Query: 224 RNVRHRNLIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
                   +  L  C     +   V+E++  G L   +     F +         ++ + 
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIG 454

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSLIQTKTMA- 338
           L +L        II+ DLK  N++LD     H+  +DFG+ K  + +G      TKT   
Sbjct: 455 LFFLQSKG----IIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV----TTKTFCG 504

Query: 339 TIGYMAPEGIVSTK----CDVYSYGILLLE 364
           T  Y+APE I         D +++G+LL E
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 42/193 (21%), Positives = 85/193 (44%), Gaps = 22/193 (11%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK-IFN-----LQLERTFVSFNSECEVLR 224
            + ++  +L+G GS+G V +     +   VAIK I       +  +R       E  +L 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILN 107

Query: 225 NVRHRNLIK---ILSGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
            + H +++K   I+       F    +VLE   +   +K   +  Y  ++  +  ++ ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
            + ++Y+H     A I+H DLKP+N L++++    V DFG+++ +   ++   Q      
Sbjct: 166 LVGVKYVHS----AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 340 IGYMAPEGIVSTK 352
              M       TK
Sbjct: 222 EDDMNLVTFPHTK 234

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 35/220 (15%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNS--ECEVLRNV 226
            + + +     LG G++G VYK         VAIK   L+ E   V   +  E  +L+ +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90

Query: 227 RHRN---LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           +HRN   L  ++     L    L+ E+  N  L+K++  +      + + + +  +   +
Sbjct: 91  QHRNIIELKSVIHHNHRL---HLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLINGV 145

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAH-----VSDFGISKLLGEGDDSLIQTKTM- 337
            + H        +H DLKP N+LL  +  +      + DFG+++  G      I  +   
Sbjct: 146 NFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG------IPIRQFT 195

Query: 338 ---ATIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
               T+ Y  PE ++     ST  D++S   +  E   + 
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 48/223 (21%)

Query: 172 TNEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLE------RTFVSFNSECEVLR 224
              +   + +G G++GSV     +  G  VA+K  +   +      RT+     E  +L+
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLK 83

Query: 225 NVRHRNLIKIL----SGCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILE 271
           +++H N+I +L       S  +F    LV   M    L   +           + +  + 
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQIL 142

Query: 272 RLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL 331
           R          L+Y+H     A IIH DLKPSN+ ++E+    + DFG+++   +     
Sbjct: 143 R---------GLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----- 184

Query: 332 IQTKTMATIGYMAPEGIVS-----TKCDVYSYGILLLETFSRK 369
             T  +AT  Y APE +++        D++S G ++ E  + +
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 19/71 (26%), Positives = 31/71 (43%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               L++L  L L+  +     P +F SL SL+ L++S NN         + L  L+ L+
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524

Query: 62  VSQNRLEGEIP 72
            S N +     
Sbjct: 525 YSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 24/81 (29%), Positives = 33/81 (40%), Gaps = 3/81 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPI-PKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
              GL  L  L +A N F     P  F  L +L  LDLS   L    P +  +L  L+ L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 61  NVSQNRLEGEIPVEGPFRNFS 81
           N+S N          P++  +
Sbjct: 500 NMSHNNFFSLDT--FPYKCLN 518

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 14/78 (17%), Positives = 28/78 (35%), Gaps = 2/78 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           +     +L  L L+  +       ++ SL  L +L L+ N +      +   L  L++L 
Sbjct: 47  SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106

Query: 62  VSQNRLEGEIPVEGPFRN 79
             +  L        P  +
Sbjct: 107 AVETNLASLEN--FPIGH 122

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 22/80 (27%), Positives = 33/80 (41%), Gaps = 1/80 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               L  L+TL L  N        +F  L SL+ L     NL+      +  L  LK+LN
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 62  VSQNRLEGEIPVEGPFRNFS 81
           V+ N ++    +   F N +
Sbjct: 131 VAHNLIQS-FKLPEYFSNLT 149

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 19/72 (26%), Positives = 29/72 (40%), Gaps = 1/72 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEI-PKSLEALLYLKQL 60
               L++L  L ++           F  L SLE L ++ N+      P     L  L  L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475

Query: 61  NVSQNRLEGEIP 72
           ++SQ +LE   P
Sbjct: 476 DLSQCQLEQLSP 487

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 18/74 (24%), Positives = 29/74 (39%), Gaps = 2/74 (2%)

Query: 8   DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
               L L+ N        SF S   L+ LDLS   +      + ++L +L  L ++ N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 68  EGEIPVEGPFRNFS 81
           +      G F   S
Sbjct: 89  QSLAL--GAFSGLS 100

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 7/90 (7%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEAL----LY 56
            IG LK L  L++A N      +P+ F +L +LE LDLSSN +       L  L    L 
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 57  LKQLNVSQNRLEGEIPVEGPFRNFSTESFS 86
              L++S N +    P  G F+       +
Sbjct: 179 NLSLDLSLNPMNFIQP--GAFKEIRLHKLT 206

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 1/72 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
              GL+ L  L    +        S F SL +L  LD+S  +           L  L+ L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 61  NVSQNRLEGEIP 72
            ++ N  +    
Sbjct: 451 KMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 18/72 (25%), Positives = 26/72 (36%), Gaps = 2/72 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQL 60
           +  G   L  L L+ N     +  +F  L  LE LD   +NL      S   +L  L  L
Sbjct: 368 SDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 61  NVSQNRLEGEIP 72
           ++S         
Sbjct: 427 DISHTHTRVAFN 438

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 20/82 (24%), Positives = 32/82 (39%), Gaps = 4/82 (4%)

Query: 2   TIGGLKDLATLSLAANK--FHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQ 59
           +   L  L  L L+ N   F G   +S     SL+ LDLS N +   +  +   L  L+ 
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEH 400

Query: 60  LNVSQNRLEGEIPVEGPFRNFS 81
           L+   + L+        F +  
Sbjct: 401 LDFQHSNLKQMSE-FSVFLSLR 421

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 17/88 (19%), Positives = 29/88 (32%), Gaps = 5/88 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLI-SLESLDLSSNNLSGEIPKS--LEALLYLK 58
               L  L  L  + N       +       SL  L+L+ N+ +        L+ +   +
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572

Query: 59  QLNVSQNRLEGEIPVEGPFRNFSTESFS 86
           QL V   R+E   P     +     S +
Sbjct: 573 QLLVEVERMECATP--SDKQGMPVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 18/106 (16%), Positives = 30/106 (28%), Gaps = 28/106 (26%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSL---------------------------ISLE 34
               L +L  L L++NK           L                           I L 
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203

Query: 35  SLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPVEGPFRN 79
            L L +N  S  + K  ++ L  L+   +       E  +E   ++
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 21/60 (35%), Positives = 25/60 (41%), Gaps = 2/60 (3%)

Query: 12  LSLAANKFHGPIPKSFGSLISLESLDLSSNNLS--GEIPKSLEALLYLKQLNVSQNRLEG 69
             L      G    S   L SLE LDLS N LS  G   +S      LK L++S N +  
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 13/90 (14%), Positives = 26/90 (28%), Gaps = 7/90 (7%)

Query: 2   TIGGLKDLATLSLAANK---FHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLK 58
            + GL +L            +   I   F  L ++ S  L S  +      S       +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQ 307

Query: 59  QLNVSQNRLEGEIPVEGPFRNFSTESFSWN 88
            L +   +           ++    +F+ N
Sbjct: 308 HLELVNCKFGQFPT--LKLKSLKRLTFTSN 335

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 10/70 (14%), Positives = 23/70 (32%), Gaps = 2/70 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               L ++++ SL +         S+      + L+L +          L++L  L   +
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS 334

Query: 62  VSQNRLEGEI 71
                   E+
Sbjct: 335 NKGGNAFSEV 344

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 33/244 (13%), Positives = 69/244 (28%), Gaps = 54/244 (22%)

Query: 180 LLGIGSFGSVYKGTLSD---GTNVAIKIFNLQL--ERTFVS-FNSECEVLRNVRHRNLIK 233
             G       ++    D      VA+   + Q       +    S    L  +    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 234 ILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA 293
           +L          +V E++  GSL++   +       +  +  M  +  A +  H     A
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RA 148

Query: 294 PIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKC 353
            +      PS +         VS  G   L              A    M      + + 
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPD---ANPQD 183

Query: 354 DVYSYGILLLETFSRKKPTNDLGEMS-----LKH---------WVNQSLPHKLAEVVDSN 399
           D+   G  L      + P  + G  S      +           +++ +P +++ V   +
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243

Query: 400 LVRR 403
           +   
Sbjct: 244 VQGD 247

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 25/217 (11%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGTLSDGTN--VAIKIFNLQLERTFVSFNSECEV----- 222
           RA  +++    +G G++G V+K          VA+K   +Q     +  ++  EV     
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 223 LRNVRHRN---LIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYSH-NYFLDILERLNIM 276
           L    H N   L  + +           LV E +    L  +L       +      ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             +   L++LH       ++H DLKP NIL+  +    ++DFG++++       +  T  
Sbjct: 127 FQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSV 179

Query: 337 MATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           + T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 44/215 (20%)

Query: 173 NEFDECNLLGIGSFGSV----YKGTLSDGTNVAIKIF-------NLQLERTFVSFNSECE 221
            +F    +LG GSFG V    +K T       AIK         +  +E T      E  
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECT----MVEKR 69

Query: 222 VL-RNVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 276
           VL     H  L   +        NL F   V+E++  G L   + S + F          
Sbjct: 70  VLSLAWEHPFLTH-MFCTFQTKENLFF---VMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQT 334
            ++ L L++LH       I++ DLK  NILLD++   H+  +DFG+ K    GD     T
Sbjct: 126 -EIILGLQFLHSKG----IVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---T 175

Query: 335 KTM-ATIGYMAPEGIVSTKC----DVYSYGILLLE 364
            T   T  Y+APE ++  K     D +S+G+LL E
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 27/219 (12%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLER-TFVSFNSEC--EV--- 222
            AT+ ++    +G+G++G+VYK      G  VA+K   +                EV   
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 223 --LRNVRHRNLIKILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHN-YFLDILERLN 274
             L    H N+++++  C+           LV E +    L  +L       L      +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT 334
           +M      L++LH       I+H DLKP NIL+       ++DFG++++       +  T
Sbjct: 125 LMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALT 177

Query: 335 KTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
             + T+ Y APE ++    +T  D++S G +  E F RK
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 61/214 (28%), Positives = 87/214 (40%), Gaps = 46/214 (21%)

Query: 175 FDECNLLGIGSFGSVY----KGTLSDGTNVAIKIF-------NLQLERTFVSFNSECEVL 223
           F    ++G GSFG V     K         A+K+          + +       SE  VL
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIM----SERNVL 92

Query: 224 -RNVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
            +NV+H  L+  L         L F   VL+++  G L   L     FL+   R     +
Sbjct: 93  LKNVKHPFLVG-LHFSFQTADKLYF---VLDYINGGELFYHLQRERCFLEPRARFYAA-E 147

Query: 279 VGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTK 335
           +  AL YLH        I++ DLKP NILLD     H+  +DFG+ K   E + +   T 
Sbjct: 148 IASALGYLHSLN-----IVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TS 197

Query: 336 TM-ATIGYMAPEGIVSTK----CDVYSYGILLLE 364
           T   T  Y+APE +         D +  G +L E
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 60/213 (28%), Positives = 87/213 (40%), Gaps = 44/213 (20%)

Query: 175 FDECNLLGIGSFGSVY----KGTLSDGTNVAIKIF-------NLQLERTFVSFNSECEVL 223
           F+   +LG GSFG V     K T   G   A+K+        +  +E T     +E  +L
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTM----TEKRIL 77

Query: 224 RNVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
              R+   +  L  C      L F   V+EF+  G L   +     F +   R     ++
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFF---VMEFVNGGDLMFHIQKSRRFDEARARF-YAAEI 133

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSLIQTKT 336
             AL +LH       II+ DLK  N+LLD     H   +DFG+ K  +  G      T T
Sbjct: 134 ISALMFLHDKG----IIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGV----TTAT 183

Query: 337 M-ATIGYMAPEGIVSTKC----DVYSYGILLLE 364
              T  Y+APE +         D ++ G+LL E
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 45/204 (22%), Positives = 79/204 (38%), Gaps = 63/204 (30%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFN--LQLERTFVSFNSECEVL-RNVRHRNLIKIL- 235
           LG+G  G V +          A+K+     +  R       E E+  R  +  ++++I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRASQCPHIVRIVD 78

Query: 236 ---SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGLA 282
              +  +      +V+E +  G L         F  I +R +          IM  +G A
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 283 LEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK-LLGEGDDSLIQTKTMA 338
           ++YLH  +    I H D+KP N+L      N +  ++DFG +K   GE            
Sbjct: 130 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE------------ 173

Query: 339 TIGYMAPEGIVSTKCDVYSYGILL 362
              Y          CD++S G+++
Sbjct: 174 --KY-------DKSCDMWSLGVIM 188

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 9e-13
 Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 46/216 (21%)

Query: 173 NEFDECNLLGIGSFGSVY----KGTLSDGTNVAIKIF-------NLQLERTFVSFNSECE 221
            +FD   ++G GS+  V     K T       A+K+        +  ++       +E  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQ----TEKH 61

Query: 222 VLRNVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
           V     +   +  L  C    S L F   V+E++  G L   +       +   R     
Sbjct: 62  VFEQASNHPFLVGLHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARFYSA- 117

Query: 278 DVGLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSLIQ 333
           ++ LAL YLH  G     II+ DLK  N+LLD     H+  +D+G+ K  L  GD     
Sbjct: 118 EISLALNYLHERG-----IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----T 166

Query: 334 TKTM-ATIGYMAPEGIVSTKC----DVYSYGILLLE 364
           T T   T  Y+APE +         D ++ G+L+ E
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.4 bits (168), Expect = 9e-13
 Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 46/214 (21%)

Query: 175 FDECNLLGIGSFGSV----YKGTLSDGTNVAIKIF-------NLQLERTFVSFNSECEVL 223
           F+   +LG GSFG V     KGT       A+KI        +  +E T      E  VL
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTM----VEKRVL 74

Query: 224 RNVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
                   +  L  C      L F   V+E++  G L   +     F +         ++
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYF---VMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EI 130

Query: 280 GLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSLIQTK 335
            + L +L   G     II+ DLK  N++LD     H+  +DFG+ K  + +G      TK
Sbjct: 131 AIGLFFLQSKG-----IIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV----TTK 179

Query: 336 TM-ATIGYMAPEGIVSTK----CDVYSYGILLLE 364
           T   T  Y+APE I         D +++G+LL E
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 46/214 (21%)

Query: 175 FDECNLLGIGSFGSVY----KGTLSDGTNVAIKIF-------NLQLERTFVSFNSECEVL 223
           FD   ++G GS+  V     K T       A+++        +  ++       +E  V 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQ----TEKHVF 106

Query: 224 RNVRHRNLIKILSGC----SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
               +   +  L  C    S L F   V+E++  G L   +       +   R     ++
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EI 162

Query: 280 GLALEYLH-YGHALAPIIHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSLIQTK 335
            LAL YLH  G     II+ DLK  N+LLD     H+  +D+G+ K  L  GD     T 
Sbjct: 163 SLALNYLHERG-----IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----TTS 211

Query: 336 TM-ATIGYMAPEGIVSTKC----DVYSYGILLLE 364
           T   T  Y+APE +         D ++ G+L+ E
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 20/70 (28%), Positives = 31/70 (44%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           + GL  L  L+L +N F     + F  L  L+ +DL  NNL+          + LK LN+
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL 591

Query: 63  SQNRLEGEIP 72
            +N +     
Sbjct: 592 QKNLITSVEK 601

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 17/80 (21%), Positives = 31/80 (38%), Gaps = 1/80 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLY-LKQL 60
               L +L  + L  N  +      F + +SL+SL+L  N ++    K        L +L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614

Query: 61  NVSQNRLEGEIPVEGPFRNF 80
           ++  N  +        F N+
Sbjct: 615 DMRFNPFDCTCESIAWFVNW 634

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 17/71 (23%), Positives = 25/71 (35%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               L  L  L+L  N+      K+F    +L  L L SN++             L  L+
Sbjct: 68  LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127

Query: 62  VSQNRLEGEIP 72
           +S N L     
Sbjct: 128 LSHNGLSSTKL 138

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 1/81 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
               L  L  L L  N+    +    +  L ++  + LS N        S   +  L++L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459

Query: 61  NVSQNRLEGEIPVEGPFRNFS 81
            + +  L+       PF+   
Sbjct: 460 MLRRVALKNVDSSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 2/80 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
                  L +L +  N      P+    L  L+ L+L  N LS    K+      L +L+
Sbjct: 44  NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103

Query: 62  VSQNRLEGEIPVEGPFRNFS 81
           +  N ++       PF    
Sbjct: 104 LMSNSIQKIKN--NPFVKQK 121

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 2/83 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           T     +L  L L +N         F    +L +LDLS N LS     +   L  L++L 
Sbjct: 92  TFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELL 151

Query: 62  VSQNRLEGEIPVEGPFRNFSTES 84
           +S N+++           F+  S
Sbjct: 152 LSNNKIQALKS--EELDIFANSS 172

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 19/76 (25%), Positives = 30/76 (39%), Gaps = 2/76 (2%)

Query: 6  LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
            ++  L+L  N+       +F     L SLD+  N +S   P+  + L  LK LN+  N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 66 RLEGEIPVEGPFRNFS 81
           L         F   +
Sbjct: 84 ELSQLSD--KTFAFCT 97

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 20/69 (28%), Positives = 29/69 (42%), Gaps = 2/69 (2%)

Query: 2   TIGGLKDLATLSLAANKFHG--PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQ 59
           +   +  L  L L           P  F  L +L  LDLS+NN++      LE L  L+ 
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508

Query: 60  LNVSQNRLE 68
           L++  N L 
Sbjct: 509 LDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 16/74 (21%), Positives = 31/74 (41%), Gaps = 3/74 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSL---EALLYLK 58
            I     L  L L++N+     P  F ++  L  L L++  L   + + L    A   ++
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225

Query: 59  QLNVSQNRLEGEIP 72
            L++S ++L     
Sbjct: 226 NLSLSNSQLSTTSN 239

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 1/69 (1%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVS 63
               L  L+L  NK       +F  L  LE LDL  N +  E+       L  + ++ +S
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438

Query: 64  QNRLEGEIP 72
            N+      
Sbjct: 439 YNKYLQLTR 447

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 26/92 (28%), Positives = 35/92 (38%), Gaps = 3/92 (3%)

Query: 2   TIGGLKD--LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQ 59
           T  GLK   L  L L+ N  +     SF  L  LE   L  NN+      SL  L  ++ 
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 60  LNVSQNRLEGEIPVEGPFRNFSTESFSWNYAL 91
           LN+ ++  +  I            SF W   L
Sbjct: 301 LNLKRSFTKQSIS-LASLPKIDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 18/79 (22%), Positives = 26/79 (32%), Gaps = 8/79 (10%)

Query: 2   TIGGLKDLATLSLAANK--------FHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEA 53
            + GL+ L  L L  N           G        L  L  L+L SN       +  + 
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 54  LLYLKQLNVSQNRLEGEIP 72
           L  LK +++  N L     
Sbjct: 559 LFELKIIDLGLNNLNTLPA 577

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 15/76 (19%), Positives = 27/76 (35%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
               S++          SF  L  LE L++  N++ G        L+ LK L++S +   
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

Query: 69  GEIPVEGPFRNFSTES 84
                   F + +   
Sbjct: 367 LRTLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 7/85 (8%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFG---SLISLESLDLSSNNLSGEIPKSLEALLY-- 56
               +  L  L L   +    + +      +  S+ +L LS++ LS     +   L +  
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249

Query: 57  LKQLNVSQNRLEGEIPVEGPFRNFS 81
           L  L++S N L         F    
Sbjct: 250 LTMLDLSYNNLNVVGN--DSFAWLP 272

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 62/230 (26%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK-IFN-----LQLERTFVSFNSECEVLR 224
            + +   +L+G GS+G VY     +   NVAIK +       +  +R       E  +L 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILN 80

Query: 225 NVRHRNLIKIL---SGCSNLDFKA--LVLEFMPNGSLEKWLYSHN--------YFL-DIL 270
            ++   +I++         L F    +VLE   +  L+K   +            L ++L
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL 139

Query: 271 ERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 330
                     L   ++H     + IIH DLKP+N LL+++    V DFG+++ +    D+
Sbjct: 140 ----------LGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 331 LIQTKTM--------------------ATIGYMAPEGIVSTKCDVYSYGI 360
            I                          T  Y APE I+    + Y+  I
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL--QENYTKSI 233

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 41/219 (18%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR--------HRN 230
            LG G F +V+    + + T+VA+KI     +    +   E ++L+ V            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 231 LIKILSGCSNLDFKA-------LVLEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVG 280
              IL    + + K        +V E +   +L   +  + +    L  +++  I   + 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAH------VSDFGISKLLGEGDDSLIQT 334
           L L+Y+H       IIH D+KP N+L++            ++D G +    E   + IQT
Sbjct: 142 LGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198

Query: 335 KTMATIGYMAPEGIV----STKCDVYSYGILLLETFSRK 369
           +      Y +PE ++        D++S   L+ E  +  
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 51/236 (21%), Positives = 99/236 (41%), Gaps = 48/236 (20%)

Query: 161 RRISYLDIQRATNEFDE------CNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL-QLERT 212
           R   Y D +    E+           LG G +  V++   +++   V +KI    + ++ 
Sbjct: 18  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 77

Query: 213 FVSFNSECEVLRNVR-HRNLIKIL----SGCSNLDFKALVLEFMPNGSLEKWLYSHN--- 264
                 E ++L N+R   N+I +        S     ALV E + N   ++   +     
Sbjct: 78  K----REIKILENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYD 131

Query: 265 --YFL-DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGI 320
             +++ +IL+          AL+Y H       I+H D+KP N+++D E+    + D+G+
Sbjct: 132 IRFYMYEILK----------ALDYCHS----MGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177

Query: 321 SKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKC-----DVYSYGILLLETFSRKKP 371
           ++    G +       +A+  +  PE +V  +      D++S G +L     RK+P
Sbjct: 178 AEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 15/73 (20%), Positives = 31/73 (42%), Gaps = 3/73 (4%)

Query: 3   IGGLKDLATLSLAANKF-HGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               + +  + +  N     P+  S   +  L  L+   N L G++P +  + + L  LN
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359

Query: 62  VSQNRLEGEIPVE 74
           ++ N++   IP  
Sbjct: 360 LAYNQITE-IPAN 371

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 19/84 (22%), Positives = 31/84 (36%), Gaps = 4/84 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSG----EIPKSLEALLYL 57
           ++     +  LSL      G +P + G L  LE L L S+          PK + A +  
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 58  KQLNVSQNRLEGEIPVEGPFRNFS 81
           +Q    +   +       P  +FS
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFS 159

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 23/81 (28%), Positives = 42/81 (51%), Gaps = 4/81 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLY-LKQL 60
           ++  +K L  L    N+  G +P +FGS I L SL+L+ N ++  IP +       ++ L
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENL 382

Query: 61  NVSQNRLEGEIPVEGPFRNFS 81
           + + N+L+  IP     ++ S
Sbjct: 383 SFAHNKLK-YIPNIFDAKSVS 402

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 12/87 (13%), Positives = 35/87 (40%), Gaps = 8/87 (9%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSG-------EIPKSLEAL 54
           T     ++++++L+ N+      + F +   L S++L  N L+        +  ++ +  
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487

Query: 55  LYLKQLNVSQNRLEGEIPVEGPFRNFS 81
             L  +++  N+L   +  +       
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 10/77 (12%), Positives = 22/77 (28%), Gaps = 9/77 (11%)

Query: 2   TIGGLKDLATLSL------AANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALL 55
                  L    +        N+     P+      SL  L + SN++   + + +    
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TP 587

Query: 56  YLKQLNVSQNRLEGEIP 72
            +  L++  N       
Sbjct: 588 NISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 13/99 (13%), Positives = 34/99 (34%), Gaps = 19/99 (19%)

Query: 2   TIGGLKDLATLSLAANKFHGP-------------------IPKSFGSLISLESLDLSSNN 42
            +  L  L    +  + F                          + +L  L  +++ +  
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260

Query: 43  LSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS 81
              ++P  L+AL  ++ +NV+ NR      ++  ++  +
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 9/82 (10%), Positives = 25/82 (30%), Gaps = 9/82 (10%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNL--------SGEIPKSLEA 53
               LKDL  + +        +P    +L  ++ ++++ N            +       
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV 303

Query: 54  LLYLKQLNVSQNRL-EGEIPVE 74
              ++ + +  N L    +   
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETS 325

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 12/74 (16%), Positives = 29/74 (39%), Gaps = 7/74 (9%)

Query: 3   IGGLKDLATLSLAANKFHG-------PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALL 55
              +  ++ +  + N+          P+  +    I++ S++LS+N +S    +      
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457

Query: 56  YLKQLNVSQNRLEG 69
            L  +N+  N L  
Sbjct: 458 PLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 14/79 (17%), Positives = 29/79 (36%), Gaps = 8/79 (10%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSG-------EIPKSLEA 53
             G  + +  LS A NK    P      S+  + ++D S N +          +  +   
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431

Query: 54  LLYLKQLNVSQNRLEGEIP 72
            + +  +N+S N++     
Sbjct: 432 GINVSSINLSNNQISKFPK 450

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 18/80 (22%), Positives = 26/80 (32%), Gaps = 8/80 (10%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIP------KSLEAL 54
                  L ++ L  NK           +L  L  +DLS N+ S   P       +L+  
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541

Query: 55  LYLKQLNVSQNRLEGEIPVE 74
               Q +   NR   E P  
Sbjct: 542 GIRNQRDAQGNRTLREWPEG 561

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 14/69 (20%), Positives = 27/69 (39%), Gaps = 1/69 (1%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
             DL    + ++     I KS    +    +   SNN++  + K++  L  L+Q  +  +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216

Query: 66  RLEGEIPVE 74
               E   E
Sbjct: 217 PFVAENICE 225

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 13/76 (17%), Positives = 25/76 (32%), Gaps = 6/76 (7%)

Query: 3   IGGLKDLATLSLAANKFHGP----IPKSFGSLISLESLDLSSNNLSGEIPKSL--EALLY 56
           IG L +L  L+L ++          PK   + +S E       +           E    
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160

Query: 57  LKQLNVSQNRLEGEIP 72
           L +  ++ +  +  I 
Sbjct: 161 LIKDCINSDPQQKSIK 176

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 12/66 (18%), Positives = 24/66 (36%)

Query: 11  TLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE 70
             +   + +      S  S   +  L L     SG +P ++  L  L+ L +  +  +  
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 71  IPVEGP 76
             + GP
Sbjct: 121 ERLFGP 126

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 7/67 (10%), Positives = 20/67 (29%), Gaps = 3/67 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            I     L  L + +N     + +      ++  LD+  N         +   +      
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617

Query: 62  VSQNRLE 68
           +  ++ +
Sbjct: 618 LFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 9/74 (12%), Positives = 16/74 (21%), Gaps = 3/74 (4%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFG--SLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
           I               +               L    ++S+     I KS    L   Q+
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188

Query: 61  NVSQNRLEGEIPVE 74
               N +   +   
Sbjct: 189 GQLSNNITF-VSKA 201

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 61/240 (25%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIK-IFN-----LQLERTFVSFNSECEVLR 224
             +++    LG G++G V+K      G  VA+K IF+        +RTF     E  +L 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILT 63

Query: 225 NVR-HRNLIKILSGCSNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFL-DILERL 273
            +  H N++ +L+     + +   LV ++M    L   + +         Y +  ++   
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLI--- 119

Query: 274 NIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ 333
                    ++YLH G     ++H D+KPSNILL+      V+DFG+S+           
Sbjct: 120 -------KVIKYLHSGG----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 334 TKTM-------------------ATIGYMAPEGIVSTKC-----DVYSYGILLLETFSRK 369
                                  AT  Y APE ++ +       D++S G +L E    K
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 24/80 (30%), Positives = 34/80 (42%), Gaps = 1/80 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
              GL  L+ L L  N      P SF  L SLE+L      L+      +  L+ LK+LN
Sbjct: 75  AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134

Query: 62  VSQNRLEGEIPVEGPFRNFS 81
           V+ N +     +   F N +
Sbjct: 135 VAHNFIHS-CKLPAYFSNLT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 14/66 (21%), Positives = 23/66 (34%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               L  L  L+++ N         +  L SL +LD S N +             L   N
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551

Query: 62  VSQNRL 67
           ++ N +
Sbjct: 552 LTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 22/72 (30%), Positives = 29/72 (40%), Gaps = 1/72 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
              GL  L TL +A N F      + F +  +L  LDLS   L        + L  L+ L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502

Query: 61  NVSQNRLEGEIP 72
           N+S N L     
Sbjct: 503 NMSHNNLLFLDS 514

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 18/71 (25%), Positives = 27/71 (38%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
                 +L  L L+  +        F +L  L+ L++S NNL          L  L  L+
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527

Query: 62  VSQNRLEGEIP 72
            S NR+E    
Sbjct: 528 CSFNRIETSKG 538

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 16/80 (20%), Positives = 28/80 (35%), Gaps = 2/80 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           +     +L  L L+  +      K++  L  L +L L+ N +    P S   L  L+ L 
Sbjct: 51  SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110

Query: 62  VSQNRLEGEIPVEGPFRNFS 81
             + +L        P     
Sbjct: 111 AVETKLASLES--FPIGQLI 128

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 17/81 (20%), Positives = 30/81 (37%), Gaps = 3/81 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLY-LKQL 60
               L+ L  L ++           F  L SL +L ++ N+       ++ A    L  L
Sbjct: 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478

Query: 61  NVSQNRLEGEIPVEGPFRNFS 81
           ++S+ +LE      G F    
Sbjct: 479 DLSKCQLEQISW--GVFDTLH 497

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 17/74 (22%), Positives = 25/74 (33%), Gaps = 1/74 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
              GL++L  L    +        S F SL  L  LD+S  N   +       L  L  L
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453

Query: 61  NVSQNRLEGEIPVE 74
            ++ N  +      
Sbjct: 454 KMAGNSFKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 7/88 (7%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQ- 59
            IG L  L  L++A N  H   +P  F +L +L  +DLS N +       L+ L    Q 
Sbjct: 123 PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182

Query: 60  ---LNVSQNRLEGEIPVEGPFRNFSTES 84
              L++S N ++        F+      
Sbjct: 183 NLSLDMSLNPIDFIQD--QAFQGIKLHE 208

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 17/74 (22%), Positives = 29/74 (39%), Gaps = 2/74 (2%)

Query: 8   DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
               + L+ N        SF +   L+ LDLS   +     K+   L +L  L ++ N +
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 68  EGEIPVEGPFRNFS 81
           +   P  G F   +
Sbjct: 93  QSFSP--GSFSGLT 104

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 2/69 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVS 63
           G   L  L L+ N     +  +F  L  L+ LD   + L      S   +L  L  L++S
Sbjct: 374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432

Query: 64  QNRLEGEIP 72
               + +  
Sbjct: 433 YTNTKIDFD 441

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 18/80 (22%), Positives = 29/80 (36%), Gaps = 4/80 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSF--GSLISLESLDLSSNNLSGEIPKSLEALLYLKQ 59
               L  L+ L L+ N        S+      SL  LDLS N     +  +   L  L+ 
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH 403

Query: 60  LNVSQNRLEGEIPVEGPFRN 79
           L+   + L+  +     F +
Sbjct: 404 LDFQHSTLKR-VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 22/67 (32%), Positives = 28/67 (41%), Gaps = 4/67 (5%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLE--ALLYLKQLN 61
             L  L +L+L  NK    I     +L SL  LDLS N LS     S        L+ L+
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 62  VSQNRLE 68
           +S N   
Sbjct: 383 LSFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 16/69 (23%), Positives = 23/69 (33%), Gaps = 2/69 (2%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRL 67
             +L ++ N     I       I L  L L  N  S  I K  L+ L  L    +     
Sbjct: 183 NLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241

Query: 68  EGEIPVEGP 76
           + E  +E  
Sbjct: 242 KDERNLEIF 250

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 9/43 (20%), Positives = 18/43 (41%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS 44
               L  L+TL  + N+             SL   +L++N+++
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 33/206 (16%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR------NLI 232
           ++G GSFG V K        +VA+K+     +R       E  +L ++R +      N+I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 233 KILSGCSNLDFKA---LVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGLALEYLH 287
            +L    N  F+    +  E + + +L + +  + +  F   L R      +   L+ LH
Sbjct: 163 HMLE---NFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALH 217

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAH--VSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
                  IIHCDLKP NILL +   +   V DFG S    +   + IQ++      Y AP
Sbjct: 218 KNR----IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAP 268

Query: 346 EGIV----STKCDVYSYGILLLETFS 367
           E I+        D++S G +L E  +
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 16/87 (18%), Positives = 29/87 (33%), Gaps = 10/87 (11%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSG---------EIPKSLE 52
           +   LKDL  + L        +P     L  L+SL+++ N              +    +
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545

Query: 53  ALLYLKQLNVSQNRLEGEIPVEGPFRN 79
               ++   +  N LE E P     + 
Sbjct: 546 TGPKIQIFYMGYNNLE-EFPASASLQK 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 17/100 (17%), Positives = 34/100 (34%), Gaps = 19/100 (19%)

Query: 3   IGGLKDLATLSLAANKFHGP-------------------IPKSFGSLISLESLDLSSNNL 43
           I  L  L  +  A + F                         S+ +L  L  ++L +   
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503

Query: 44  SGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTE 83
             ++P  L  L  L+ LN++ NR      ++  +   + +
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 13/95 (13%), Positives = 30/95 (31%), Gaps = 10/95 (10%)

Query: 2   TIGGLKDLATLSL------AANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALL 55
                  L    +        N+     P    +  SL  L + SN++  ++ + L    
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TP 827

Query: 56  YLKQLNVSQNRL-EGEIPVEGPFRNFSTESFSWNY 89
            L  L+++ N     ++    P+         ++ 
Sbjct: 828 QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 12/80 (15%), Positives = 28/80 (35%), Gaps = 8/80 (10%)

Query: 1   MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDL------SSNNLSGEIPKSLEAL 54
                L  L+ + ++ N F    P    +   L++  +        N +  + P  +   
Sbjct: 747 FRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805

Query: 55  LYLKQLNVSQNRLEGEIPVE 74
             L QL +  N +  ++  +
Sbjct: 806 PSLIQLQIGSNDIR-KVDEK 824

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 11/88 (12%), Positives = 33/88 (37%), Gaps = 8/88 (9%)

Query: 1   MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS-------GEIPKSLEA 53
           M      + +T++L+ N+      + F +   + ++ LS+N ++            + + 
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726

Query: 54  LLYLKQLNVSQNRLEGEIPVEGPFRNFS 81
              L  +++  N+L   +  +       
Sbjct: 727 TYLLTTIDLRFNKLT-SLSDDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 12/71 (16%), Positives = 25/71 (35%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +     +  LSLA     G +P + G L  L+ L   +++ +       +  L      
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377

Query: 62  VSQNRLEGEIP 72
             ++R+     
Sbjct: 378 ERKHRIRMHYK 388

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 14/74 (18%), Positives = 26/74 (35%), Gaps = 4/74 (5%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
                  +    +  N     P   S   ++ L  LD   N +   +  +    + L  L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL 600

Query: 61  NVSQNRLEGEIPVE 74
            +  N++E EIP +
Sbjct: 601 KLDYNQIE-EIPED 613

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 17/80 (21%), Positives = 25/80 (31%), Gaps = 8/80 (10%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
                  L T+ L  NK           +L  L ++D+S N  S   P        LK  
Sbjct: 723 NYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAF 781

Query: 61  NVSQ------NRLEGEIPVE 74
            +        NR+  + P  
Sbjct: 782 GIRHQRDAEGNRILRQWPTG 801

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 6/75 (8%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSL-----ISLESLDLSSNNLSGEIPKSLEALLYL 57
              +  + ++  + NK          S+     I+  ++ LS N +     +       +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699

Query: 58  KQLNVSQNRLEGEIP 72
             + +S N +   IP
Sbjct: 700 STIILSNNLMT-SIP 713

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 16/73 (21%), Positives = 24/73 (32%), Gaps = 3/73 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEA--LLYLKQ 59
             G    L  L L  N+              +E L  S N L   IP    A  +  +  
Sbjct: 590 AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648

Query: 60  LNVSQNRLEGEIP 72
           ++ S N++  E  
Sbjct: 649 VDFSYNKIGSEGR 661

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 13/74 (17%), Positives = 27/74 (36%), Gaps = 6/74 (8%)

Query: 5   GLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSG---EIPKSLEA--LLYLK 58
               +  L  + NK    P   +  S+  + S+D S N +      I  S++    +   
Sbjct: 617 FTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676

Query: 59  QLNVSQNRLEGEIP 72
            + +S N ++    
Sbjct: 677 TVTLSYNEIQKFPT 690

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 9/59 (15%), Positives = 20/59 (33%)

Query: 17  NKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEG 75
           + +         +   +  L L+     G +P ++  L  LK L+   +       + G
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 11/97 (11%), Positives = 27/97 (27%), Gaps = 25/97 (25%)

Query: 3   IGGLKDLATLSLAANKFHG------PIPKSFGSLISLESLDLSSNNLSG----------- 45
           +  +K  + +SL   +          I K+   L  L+ +  +++  +            
Sbjct: 414 MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473

Query: 46  --------EIPKSLEALLYLKQLNVSQNRLEGEIPVE 74
                       S   L  L  + +       ++P  
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 10/66 (15%), Positives = 23/66 (34%), Gaps = 1/66 (1%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLN 61
           IG L +L  LS   +             ++ +  +   + +     K  L+    L   +
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402

Query: 62  VSQNRL 67
           + Q+ +
Sbjct: 403 LLQDAI 408

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 38/216 (17%)

Query: 181 LGIGSFGSVYKGTLSDGTN---VAIKIFNLQLERTFVSFNSECEV--LRNVRHRNLIKIL 235
           +G G++G VYK    DG +    A+K    Q+E T +S ++  E+  LR ++H N+I + 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 84

Query: 236 SGCSNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGL----------AL 283
               +   +   L+ ++  +  L   +  H        +  + +  G+           +
Sbjct: 85  KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRA--SKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAH----VSDFGISKLLGEGDDSLIQ-TKTMA 338
            YLH       ++H DLKP+NIL+           ++D G ++L       L      + 
Sbjct: 142 HYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 339 TIGYMAPEGIV-----STKCDVYSYGILLLETFSRK 369
           T  Y APE ++     +   D+++ G +  E  + +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 36/160 (22%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G G+FG +  G  L     VAIK     LE       S    L         K L    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK-----LEPM----KSRAPQLH--LEYRFYKQLGSGD 65

Query: 240 NL----------DFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            +           + A+VLE +  G SLE      +    +   L I I +   +EY+H 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 289 GHALAPIIHCDLKPSNILL------DENMVAHVSDFGISK 322
            +    +I+ D+KP N L+       + ++ H+ DF ++K
Sbjct: 124 KN----LIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 34/158 (21%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GSFG +Y GT ++ G  VAIK+     E       ++   L       + K++ G  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL-----ECV----KTKHPQLH--IESKIYKMMQGGV 65

Query: 240 NL----------DFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            +          D+  +V+E +  G SLE      +    +   L +   +   +EY+H 
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 289 GHALAPIIHCDLKPSNILL----DENMVAHVSDFGISK 322
            +     IH D+KP N L+      N+V ++ DFG++K
Sbjct: 124 KN----FIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.4 bits (148), Expect = 1e-10
 Identities = 38/200 (19%), Positives = 59/200 (29%), Gaps = 55/200 (27%)

Query: 171 ATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKI--------FNLQLERTFVSFNSECEV 222
            T +   C  +G G FG V++    D T VAIKI         N   ++TF     E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 223 LRNV---------RHRNLIKILSGC------------------------------SNLDF 243
            + +         R    I + S                                   D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 244 KALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP 302
             +VLEF   G  LE+          +    +I+  +  +L             H DL  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASL---RFEHRDLHW 190

Query: 303 SNILLDENMVAHVSDFGISK 322
            N+LL +  +  +      K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 31/171 (18%), Positives = 66/171 (38%), Gaps = 38/171 (22%)

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFN-----------LQLERTFVSFNSECEVLRNVRH 228
            +G G FG +Y   ++   +V                 L  E  F    ++ E ++    
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 229 RNLIKIL----------SGCSNLDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNI-- 275
              +K L             +   ++ ++++    G  L+K   ++         L +  
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 276 -MIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK 322
            ++D+   LEY+H        +H D+K SN+LL   + + V ++ D+G++ 
Sbjct: 160 RILDI---LEYIHEHE----YVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 36/160 (22%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GSFG +++GT L +   VAIK         F    S+   LR        K+L+GC+
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK---------FEPRRSDAPQLR--DEYRTYKLLAGCT 66

Query: 240 NL----------DFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            +              LV++ +  G SLE  L        +         +   ++ +H 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 289 GHALAPIIHCDLKPSNILL------DENMVAHVSDFGISK 322
                 +++ D+KP N L+      + NM+ +V DFG+ K
Sbjct: 125 KS----LVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 14/80 (17%), Positives = 21/80 (26%), Gaps = 2/80 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           T      L TL L AN        +     +L+ L      +S      L     L+ L 
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135

Query: 62  VSQNRLEGEIPVEGPFRNFS 81
           +  N +              
Sbjct: 136 LGSNHISSIKL--PKGFPTE 153

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 19/78 (24%), Positives = 29/78 (37%), Gaps = 2/78 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           T   L +L  L L   + +     +F S   L++L L++N L      +L     LK L 
Sbjct: 52  TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111

Query: 62  VSQNRLEGEIPVEGPFRN 79
             Q  +        P  N
Sbjct: 112 FIQTGISSIDF--IPLHN 127

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 18/82 (21%), Positives = 36/82 (43%), Gaps = 3/82 (3%)

Query: 2   TIGGLKDLATLSLAANKFH--GPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQ 59
            +  L++L  L L+ +             +L  L+SL+LS N       ++ +    L+ 
Sbjct: 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404

Query: 60  LNVSQNRLEGEIPVEGPFRNFS 81
           L+++  RL+     + PF+N  
Sbjct: 405 LDLAFTRLKV-KDAQSPFQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 19/78 (24%), Positives = 26/78 (33%), Gaps = 2/78 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           T      L  L L A      +P     L +L+ L LS+N        S      L  L+
Sbjct: 273 TFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331

Query: 62  VSQNRLEGEIPVEGPFRN 79
           +  N    E+   G   N
Sbjct: 332 IKGNTKRLELG-TGCLEN 348

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 16/71 (22%), Positives = 23/71 (32%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            + G K L  L                +  +LESL L SN++S            LK L+
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159

Query: 62  VSQNRLEGEIP 72
              N +     
Sbjct: 160 FQNNAIHYLSK 170

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 21/74 (28%), Positives = 30/74 (40%), Gaps = 3/74 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPI---PKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLK 58
              GL  L  L+L  N F         S  +L  LE L LS  +LS     +  +L  + 
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503

Query: 59  QLNVSQNRLEGEIP 72
            +++S NRL     
Sbjct: 504 HVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 2/90 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEAL--LYLKQ 59
            +   K L +L L +N               L+ LD  +N +     + + +L       
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183

Query: 60  LNVSQNRLEGEIPVEGPFRNFSTESFSWNY 89
           LN++ N + G  P       F + +F    
Sbjct: 184 LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 1/71 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           ++  L  L  L L+          +F SL  +  +DLS N L+    ++L  L  +  LN
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLN 529

Query: 62  VSQNRLEGEIP 72
           ++ N +   +P
Sbjct: 530 LASNHISIILP 540

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 13/76 (17%), Positives = 23/76 (30%), Gaps = 2/76 (2%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
                 L  + N        +F  LI+L  LDL+   +      + ++   L  L ++ N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 66  RLEGEIPVEGPFRNFS 81
            L              
Sbjct: 92  PLIFMAE--TALSGPK 105

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 2/82 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
                  L  L LA  +      +S F +L  L+ L+LS + L     +  + L  L+ L
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454

Query: 61  NVSQNRLEGEIPVE-GPFRNFS 81
           N+  N        +    +   
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 20/73 (27%), Positives = 35/73 (47%), Gaps = 1/73 (1%)

Query: 1   MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQ 59
           + +  L  L +L+L+ N+      ++F     LE LDL+   L  +  +S  + L  LK 
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

Query: 60  LNVSQNRLEGEIP 72
           LN+S + L+    
Sbjct: 430 LNLSHSLLDISSE 442

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 5/83 (6%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQ-- 59
               L  L  L+L+ +       + F  L +L+ L+L  N+      +   +L  L +  
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479

Query: 60  -LNVSQNRLEGEIPVEGPFRNFS 81
            L +S   L         F +  
Sbjct: 480 ILVLSFCDLSSIDQ--HAFTSLK 500

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 18/74 (24%), Positives = 29/74 (39%), Gaps = 3/74 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPI-PKSFGSLISLESLDLSSNNL--SGEIPKSLEALLYLK 58
           +      L  LS+  N     +      +L +L  LDLS +++  S      L  L +L+
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379

Query: 59  QLNVSQNRLEGEIP 72
            LN+S N       
Sbjct: 380 SLNLSYNEPLSLKT 393

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 1/68 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               LK +  + L+ N+      ++   L  +  L+L+SN++S  +P  L  L   + +N
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTIN 553

Query: 62  VSQNRLEG 69
           + QN L+ 
Sbjct: 554 LRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 2/66 (3%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSL--ISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            ++ L   +          P  F  L  +S+ES++L  +        +      L++L++
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285

Query: 63  SQNRLE 68
           +   L 
Sbjct: 286 TATHLS 291

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 29/206 (14%)

Query: 179 NLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR------NL 231
           +L+G GSFG V K     +   VAIKI   + +        E  +L  +          +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 232 IKILSGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLH 287
           + +     +  F+    LV E + + +L   L + N+  + +         +  AL +L 
Sbjct: 119 VHLKR---HFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 288 YGHALAPIIHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
                  IIHCDLKP NILL   +     + DFG S  LG+     IQ++      Y +P
Sbjct: 175 TPEL--SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSP 227

Query: 346 EGIV----STKCDVYSYGILLLETFS 367
           E ++        D++S G +L+E  +
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHT 253

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 34/158 (21%)

Query: 181 LGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS 239
           +G GSFG +Y GT +     VAIK+     E       ++   L       + +IL G +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL-----ENV----KTKHPQLL--YESKIYRILQGGT 63

Query: 240 NL----------DFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            +          D+  LV++ +  G SLE      +  L +   L +   +   +E++H 
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121

Query: 289 GHALAPIIHCDLKPSNILL----DENMVAHVSDFGISK 322
                  +H D+KP N L+      N V ++ DFG++K
Sbjct: 122 KS----FLHRDIKPDNFLMGLGRRANQV-YIIDFGLAK 154

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 28/167 (16%), Positives = 58/167 (34%), Gaps = 32/167 (19%)

Query: 181 LGIGSFGSVYKGT---------LSDGTNVAIKI----FNLQLERTFVSFNSECEVLRNVR 227
               + G +Y+                  ++K+      L  E+ F    ++   +   +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 228 HRNLIKIL-------SGCSNLDFKALVLEFMPNG-SLEK-WLYSHNYFLDILERLNIMID 278
                 +L        G     ++ LVL  +  G SL+     S  + L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK 322
           +  ALE+LH        +H ++   NI +   D++ V  ++ +G + 
Sbjct: 168 LLDALEFLHENE----YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 41/171 (23%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIF--------NLQLERTFVSFNSECEVLRNVRHRN 230
            +G G FG +Y     +     A  +          L  E  F    ++ + ++    R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 231 LIKIL----------SGCSNLDFKALVLEFMPNG-SLEKWLYSHNYF-----LDILERLN 274
            +  L          +      ++ +V+E +  G  L+K    +  F     L +  R  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR-- 159

Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISK 322
            M+DV   LEY+H        +H D+K +N+LL   + + V +++D+G+S 
Sbjct: 160 -MLDV---LEYIHENE----YVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 3/73 (4%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           I  L++L +L +  +     +  +   L  LE LDL         P        LK+L +
Sbjct: 202 IANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260

Query: 63  S-QNRLEGEIPVE 74
              + L   +P++
Sbjct: 261 KDCSNLL-TLPLD 272

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 17/72 (23%), Positives = 32/72 (44%), Gaps = 2/72 (2%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
              L  L  +++ A      +P +      LE+L L+ N L   +P S+ +L  L++L++
Sbjct: 100 AFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157

Query: 63  SQNRLEGEIPVE 74
                  E+P  
Sbjct: 158 RACPELTELPEP 169

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 11/81 (13%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSL---------EA 53
           +     L TL+LA N     +P S  SL  L  L + +     E+P+ L         + 
Sbjct: 123 MQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

Query: 54  LLYLKQLNVSQNRLEGEIPVE 74
           L+ L+ L +    +   +P  
Sbjct: 182 LVNLQSLRLEWTGIR-SLPAS 201

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 16/73 (21%), Positives = 25/73 (34%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            I  L  L  L L         P  FG    L+ L L   +    +P  +  L  L++L+
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283

Query: 62  VSQNRLEGEIPVE 74
           +        +P  
Sbjct: 284 LRGCVNLSRLPSL 296

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.9 bits (120), Expect = 6e-07
 Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 3/69 (4%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
                 L L +       P     L  L+ + + +  L  E+P +++    L+ L +++N
Sbjct: 80  QPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN 137

Query: 66  RLEGEIPVE 74
            L   +P  
Sbjct: 138 PLR-ALPAS 145

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.9 bits (120), Expect = 7e-07
 Identities = 17/72 (23%), Positives = 33/72 (45%), Gaps = 2/72 (2%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
             GL +L +L L        +P S  +L +L+SL + ++ LS  +  ++  L  L++L++
Sbjct: 179 HQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236

Query: 63  SQNRLEGEIPVE 74
                    P  
Sbjct: 237 RGCTALRNYPPI 248

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 15/68 (22%), Positives = 21/68 (30%), Gaps = 2/68 (2%)

Query: 2   TIGGLKDLATLSLA-ANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
             GG   L  L L   +     +P     L  LE LDL        +P  +  L     +
Sbjct: 248 IFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306

Query: 61  NVSQNRLE 68
            V  +   
Sbjct: 307 LVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 20/76 (26%), Positives = 32/76 (42%), Gaps = 10/76 (13%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGS---------LISLESLDLSSNNLSGEIPKSLE 52
           +I  L  L  LS+ A      +P+   S         L++L+SL L    +   +P S+ 
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203

Query: 53  ALLYLKQLNVSQNRLE 68
            L  LK L +  + L 
Sbjct: 204 NLQNLKSLKIRNSPLS 219

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 55/228 (24%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNVRHR-----NLI 232
            +G G+FG V     + +    A+K+  N++  +   S   E ++L+ +++      N++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 233 KILSGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHY 288
           K         +     L+ E +   SL + +  +NY    I +     I++  AL YL  
Sbjct: 100 KYHG---KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVS-------------------------DFGISKL 323
                 + H DLKP NILLD+                                DFG +  
Sbjct: 156 MS----LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211

Query: 324 LGEGDDSLIQTKTMATIGYMAPEGIV----STKCDVYSYGILLLETFS 367
             +   S+I T+      Y APE I+        D++S+G +L E ++
Sbjct: 212 KSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 41/219 (18%)

Query: 180 LLGIGSFGSVYKG--TLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNVRHR------N 230
            LG G+FG V +        + VA+KI  N+   +   +   E  VL+ ++ +       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFL 83

Query: 231 LIKILSGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYL 286
            + +       +F     +  E +   +  ++L  +N+    +    ++   +  AL +L
Sbjct: 84  CVLMSD---WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI----------QTKT 336
           H       + H DLKP NIL   +    + +   S       ++ I            + 
Sbjct: 140 HENQ----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195

Query: 337 MATI----GYMAPEGIV----STKCDVYSYGILLLETFS 367
             TI     Y  PE I+    +  CDV+S G +L E + 
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)

Query: 180 LLGIGSFGSVYKG--TLSDGTNVAIKIF-NLQLERTFVSFNSECEVLRNVRHR------N 230
            LG G+FG V +     + G +VA+KI  N+  +R   +  SE +VL ++          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 231 LIKILSGCSNLDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYL 286
            +++L      +      +V E +   S   ++  + +    +     +   +  ++ +L
Sbjct: 79  CVQMLE---WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI----------QTKT 336
           H       + H DLKP NIL  ++      +  I +      +  I            + 
Sbjct: 135 HSNK----LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190

Query: 337 MATI----GYMAPEGIV----STKCDVYSYGILLLETFS 367
            +T+     Y APE I+    S  CDV+S G +L+E + 
Sbjct: 191 HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 22/80 (27%), Positives = 33/80 (41%), Gaps = 1/80 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               L  L+TL L  N        +F  L SL+ L     NL+      +  L  LK+LN
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 62  VSQNRLEGEIPVEGPFRNFS 81
           V+ N ++    +   F N +
Sbjct: 131 VAHNLIQ-SFKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 19/77 (24%), Positives = 32/77 (41%), Gaps = 4/77 (5%)

Query: 5   GLKDLATLSLAANKFH--GPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            L  L  L L+ N     G   +S     SL+ LDLS N +   +  +   L  L+ L+ 
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403

Query: 63  SQNRLEGEIPVEGPFRN 79
             + L+ ++     F +
Sbjct: 404 QHSNLK-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 14/76 (18%), Positives = 27/76 (35%), Gaps = 2/76 (2%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
               +L  L L+  +       ++ SL  L +L L+ N +      +   L  L++L   
Sbjct: 49  FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108

Query: 64  QNRLEGEIPVEGPFRN 79
           +  L        P  +
Sbjct: 109 ETNLASLEN--FPIGH 122

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 7/88 (7%)

Query: 2   TIGGLKDLATLSLAANKF-HGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLK-- 58
            IG LK L  L++A N      +P+ F +L +LE LDLSSN +       L  L  +   
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 59  --QLNVSQNRLEGEIPVEGPFRNFSTES 84
              L++S N +   I   G F+      
Sbjct: 179 NLSLDLSLNPMN-FIQ-PGAFKEIRLHK 204

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 25/81 (30%), Positives = 37/81 (45%), Gaps = 3/81 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
              GL  L  L +A N F        F  L +L  LDLS   L    P +  +L  L+ L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 61  NVSQNRLEGEIPVEGPFRNFS 81
           N++ N+L+  +P +G F   +
Sbjct: 500 NMASNQLK-SVP-DGIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVS 63
            L++L  L ++           F  L SLE L ++ N+            L  L  L++S
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 64  QNRLEGEIPVEGPFRN 79
           Q +LE ++     F +
Sbjct: 479 QCQLE-QLS-PTAFNS 492

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 18/79 (22%), Positives = 34/79 (43%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               L++L  L L+  +     P +F SL SL+ L+++SN L        + L  L+++ 
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524

Query: 62  VSQNRLEGEIPVEGPFRNF 80
           +  N  +   P       +
Sbjct: 525 LHTNPWDCSCPRIDYLSRW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 15/60 (25%), Positives = 25/60 (41%)

Query: 8  DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
              L L+ N        SF S   L+ LDLS   +      + ++L +L  L ++ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 17/81 (20%), Positives = 26/81 (32%), Gaps = 2/81 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
              GL+ L  L    +        S F SL +L  LD+S  +           L  L+ L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 61  NVSQNRLEGEIPVEGPFRNFS 81
            ++ N  +        F    
Sbjct: 451 KMAGNSFQENFL-PDIFTELR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 18/69 (26%), Positives = 26/69 (37%), Gaps = 2/69 (2%)

Query: 1   MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALL-YLKQ 59
            +  G   L  L L+ N     +  +F  L  LE LD   +NL      S+   L  L  
Sbjct: 367 QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425

Query: 60  LNVSQNRLE 68
           L++S     
Sbjct: 426 LDISHTHTR 434

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 51.9 bits (125), Expect = 6e-08
 Identities = 15/63 (23%), Positives = 25/63 (39%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           I GL +L  L +           +   L SL  LD+S +     I   +  L  +  +++
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 63  SQN 65
           S N
Sbjct: 144 SYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 19/73 (26%), Positives = 32/73 (43%), Gaps = 1/73 (1%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           + GL  L  L ++ +     I     +L  + S+DLS N    +I   L+ L  LK LN+
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166

Query: 63  SQNRLEGEIPVEG 75
             + +     +E 
Sbjct: 167 QFDGVHDYRGIED 179

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 13/70 (18%), Positives = 28/70 (40%), Gaps = 2/70 (2%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           I    ++  L++         P     L +LE L +   +++ +   +L  L  L  L++
Sbjct: 62  IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 63  SQNRLEGEIP 72
           S +  +  I 
Sbjct: 120 SHSAHDDSIL 129

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 53.3 bits (129), Expect = 7e-08
 Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 2/66 (3%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L +L L  N+      +  G L +L +L LS N+++   P  L +L  +   + 
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340

Query: 63  SQNRLE 68
           +   ++
Sbjct: 341 ANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 19/73 (26%), Positives = 32/73 (43%), Gaps = 2/73 (2%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L  L++ +N+          +L  L SL L++N L  E  + +  L  L  L +
Sbjct: 261 VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318

Query: 63  SQNRLEGEIPVEG 75
           SQN +    P+  
Sbjct: 319 SQNHITDIRPLAS 331

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 50.2 bits (121), Expect = 7e-07
 Identities = 15/73 (20%), Positives = 31/73 (42%), Gaps = 3/73 (4%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L +L  L L  +      P    +L  + SL+L +N+        L  +  L  L V
Sbjct: 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTV 162

Query: 63  SQNRLEGEIPVEG 75
           ++++++   P+  
Sbjct: 163 TESKVKDVTPIAN 175

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 19/73 (26%), Positives = 29/73 (39%), Gaps = 4/73 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           I  L DL +LSL  N+     P    SL SL       N ++   P  +  +  L  L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228

Query: 63  SQNRLEGEIPVEG 75
             N++    P+  
Sbjct: 229 GNNKITDLSPLAN 241

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 14/73 (19%), Positives = 31/73 (42%), Gaps = 3/73 (4%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  + +L+L AN           ++  L  L ++ + +    P  +  L  L  L++
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184

Query: 63  SQNRLEGEIPVEG 75
           + N++E   P+  
Sbjct: 185 NYNQIEDISPLAS 197

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.8 bits (112), Expect = 7e-06
 Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 4/70 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L  L +  NK       +  +L +L  L L+ +N+S   P  L  L  +  LN+
Sbjct: 84  LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139

Query: 63  SQNRLEGEIP 72
             N    ++ 
Sbjct: 140 GANHNLSDLS 149

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.8 bits (112), Expect = 8e-06
 Identities = 17/67 (25%), Positives = 31/67 (46%), Gaps = 4/67 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  +  L +L +  NK     P    +L  L  L++ +N +S     +++ L  LK LNV
Sbjct: 217 VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272

Query: 63  SQNRLEG 69
             N++  
Sbjct: 273 GSNQISD 279

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.1 bits (105), Expect = 6e-05
 Identities = 17/67 (25%), Positives = 30/67 (44%), Gaps = 4/67 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           T   L+ +  L +A  K      +    L +LE L+L+ N ++   P  L  L+ L  L 
Sbjct: 39  TQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94

Query: 62  VSQNRLE 68
           +  N++ 
Sbjct: 95  IGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 12/74 (16%), Positives = 27/74 (36%), Gaps = 4/74 (5%)

Query: 2  TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
              L +     L        +      L S+  L ++   ++    + +E L  L+ LN
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72

Query: 62 VSQNRLEGEIPVEG 75
          ++ N++    P+  
Sbjct: 73 LNGNQITDISPLSN 86

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 1/76 (1%)

Query: 5   GLKDLATLSLAANKFHGPI-PKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
            L+ L  L L +      I  ++F +L +L  LDL S+ +    P + + L +L +L + 
Sbjct: 46  FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105

Query: 64  QNRLEGEIPVEGPFRN 79
              L   +  +G FRN
Sbjct: 106 FCGLSDAVLKDGYFRN 121

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 16/64 (25%), Positives = 31/64 (48%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
           GL +L  L+L+ N        +F  L  +  +DL  N+++    ++ + L  L+ L++  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 65  NRLE 68
           N L 
Sbjct: 372 NALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 3/74 (4%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEAL--LYLK 58
               LK L  L L+ N+     +  SFG L SL+S+D SSN +       LE L    L 
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177

Query: 59  QLNVSQNRLEGEIP 72
             +++ N L   + 
Sbjct: 178 FFSLAANSLYSRVS 191

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 17/88 (19%), Positives = 31/88 (35%), Gaps = 11/88 (12%)

Query: 5  GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEI-PKSLEALLYLKQLNVS 63
           L     L L+ N        SF  L  L+ L+L S      I  ++   L  L+ L++ 
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 64 QNRLEGEIPVEGPFRNFSTESFSWNYAL 91
           +++               ++F   + L
Sbjct: 82 SSKI----------YFLHPDAFQGLFHL 99

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 19/66 (28%), Positives = 33/66 (50%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               LKDL  L+LA NK +    ++F  L +L+ L+LS N L      +   L  +  ++
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344

Query: 62  VSQNRL 67
           + +N +
Sbjct: 345 LQKNHI 350

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 19/72 (26%), Positives = 26/72 (36%), Gaps = 5/72 (6%)

Query: 1   MTIGGLKDLATLSLAANKFHGPI-----PKSFGSLISLESLDLSSNNLSGEIPKSLEALL 55
            T      L  L L  N              F  L  L+ L L+ N L+   P     L 
Sbjct: 445 QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504

Query: 56  YLKQLNVSQNRL 67
            L+ L+++ NRL
Sbjct: 505 ALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 19/67 (28%), Positives = 28/67 (41%), Gaps = 3/67 (4%)

Query: 5   GLKDLATLSLAANKFHGPI--PKSFGSLISLESLDLSSNNLSG-EIPKSLEALLYLKQLN 61
           GL  L  L L        +     F +L +L  LDLS N +    +  S   L  LK ++
Sbjct: 95  GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154

Query: 62  VSQNRLE 68
            S N++ 
Sbjct: 155 FSSNQIF 161

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 18/70 (25%), Positives = 26/70 (37%), Gaps = 6/70 (8%)

Query: 5   GLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEA-----LLYLK 58
            +  L  L L  N+F      ++     SLE L L  N L       L       L +L+
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483

Query: 59  QLNVSQNRLE 68
            L ++ N L 
Sbjct: 484 VLYLNHNYLN 493

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 4/91 (4%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
              GL  L  L L  N  +   P  F  L +L  L L+SN L+  +  +      L+ L+
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILD 532

Query: 62  VSQNRLEGEIPVEGPFRNFSTESFSWNYALC 92
           +S+N+L    P    F + S    + N  +C
Sbjct: 533 ISRNQL--LAPNPDVFVSLSVLDITHNKFIC 561

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 16/75 (21%), Positives = 27/75 (36%), Gaps = 2/75 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L  L  L L     +     SF  L  L+ L++S       +  +    L L  L+++ 
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233

Query: 65  NRLEGEIPVEGPFRN 79
             L   +P     R+
Sbjct: 234 CNLT-AVP-YLAVRH 246

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 22/75 (29%), Positives = 30/75 (40%), Gaps = 2/75 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L +L TL L +N+        F  L +L  LD+S N +   +    + L  LK L V  
Sbjct: 78  NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 65  NRLEGEIPVEGPFRN 79
           N L   I     F  
Sbjct: 138 NDLV-YIS-HRAFSG 150

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 19/67 (28%), Positives = 29/67 (43%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +  L  L  L+L+ N            L+ L+ + L    L+   P +   L YL+ LN
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302

Query: 62  VSQNRLE 68
           VS N+L 
Sbjct: 303 VSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 19/65 (29%), Positives = 28/65 (43%), Gaps = 2/65 (3%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVS 63
            L +L +L +  N       ++F  L SLE L L   NL+  IP  +L  L  L  L + 
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184

Query: 64  QNRLE 68
              + 
Sbjct: 185 HLNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 23/74 (31%), Positives = 32/74 (43%), Gaps = 2/74 (2%)

Query: 8   DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
           +   L L  N+        F S   LE L+L+ N +S   P +   L  L+ L +  NRL
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 68  EGEIPVEGPFRNFS 81
           +  IP  G F   S
Sbjct: 93  K-LIP-LGVFTGLS 104

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 18/82 (21%), Positives = 27/82 (32%), Gaps = 1/82 (1%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
           GL  L  L+L          ++   L  L  L L   N++     S + L  LK L +S 
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209

Query: 65  NRLEGEIPVEGPFRNFSTESFS 86
                 +         +  S S
Sbjct: 210 WPYLDTMT-PNCLYGLNLTSLS 230

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 17/73 (23%), Positives = 30/73 (41%), Gaps = 2/73 (2%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
           L +LS+           +   L+ L  L+LS N +S      L  LL L+++ +   +L 
Sbjct: 226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

Query: 69  GEIPVEGPFRNFS 81
             +     FR  +
Sbjct: 286 -VVE-PYAFRGLN 296

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 16/70 (22%), Positives = 26/70 (37%)

Query: 6  LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
                  +  +     +     S  +++ LDLS N LS      L     L+ LN+S N
Sbjct: 9  GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 66 RLEGEIPVEG 75
           L   + +E 
Sbjct: 69 VLYETLDLES 78

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 2/63 (3%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
              L TL L++NK    +   F S   +  + L +N L   I K+L     L+  ++  N
Sbjct: 190 FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247

Query: 66  RLE 68
              
Sbjct: 248 GFH 250

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 18/67 (26%), Positives = 29/67 (43%), Gaps = 2/67 (2%)

Query: 2  TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
                ++  L L+ N               LE L+LSSN L  E    LE+L  L+ L+
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLD 86

Query: 62 VSQNRLE 68
          ++ N ++
Sbjct: 87 LNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 2/77 (2%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLY-LKQLNV 62
              +    + LA NK         G    ++ LDL  N +       L A    L+ LN+
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 63  SQNRLEGEIPVEGPFRN 79
             N +  ++  +  F  
Sbjct: 177 QYNFIY-DVKGQVVFAK 192

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 12/66 (18%), Positives = 21/66 (31%), Gaps = 2/66 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS-GEIPKSLEALLYLKQL 60
                  +  +SL  NK    I K+     +LE  DL  N    G +         ++ +
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267

Query: 61  NVSQNR 66
                +
Sbjct: 268 AKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 8/78 (10%), Positives = 26/78 (33%), Gaps = 4/78 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +     + TL  A N     +          +++ L++N ++            ++ L+
Sbjct: 94  ELLVGPSIETLHAANNNISR-VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150

Query: 62  VSQNRLEGEIPVEGPFRN 79
           +  N ++  +       +
Sbjct: 151 LKLNEID-TVNFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 14/67 (20%), Positives = 27/67 (40%), Gaps = 8/67 (11%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +  L  L TL L  N       +      S+E+L  ++NN+S  +          K + 
Sbjct: 75  DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIY 126

Query: 62  VSQNRLE 68
           ++ N++ 
Sbjct: 127 LANNKIT 133

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 25/78 (32%), Positives = 36/78 (46%), Gaps = 1/78 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +    +L  L L +++ +     +F SL SLE LDLS N+LS         L  LK LN
Sbjct: 45  DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104

Query: 62  VSQNRLEGEIPVEGPFRN 79
           +  N  +  + V   F N
Sbjct: 105 LMGNPYQ-TLGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 5/91 (5%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQ 59
             G L  L  L+L  N +    +   F +L +L++L + +     EI +     L  L +
Sbjct: 93  WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152

Query: 60  LNVSQNRLEGEIPVE--GPFRNFSTESFSWN 88
           L +    L      +     R+    +   +
Sbjct: 153 LEIKALSLR-NYQSQSLKSIRDIHHLTLHLS 182

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 4/76 (5%)

Query: 3   IGGLKDLATLSLAANKFH--GPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
            G    L TL L+ N         +   +L +L SLD+S N     +P S +    ++ L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415

Query: 61  NVSQNRLEGEIPVEGP 76
           N+S   +   +    P
Sbjct: 416 NLSSTGIR-VVKTCIP 430

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 3/83 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS---LEALLYLK 58
               L+ +  +++  +K           L SLE LDLS N +  E  K+     A   L+
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364

Query: 59  QLNVSQNRLEGEIPVEGPFRNFS 81
            L +SQN L              
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 14/68 (20%), Positives = 29/68 (42%), Gaps = 1/68 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
               L +L TL +   +    I +  F  L SL  L++ + +L     +SL+++  +  L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 61  NVSQNRLE 68
            +  +   
Sbjct: 178 TLHLSESA 185

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 12/68 (17%), Positives = 23/68 (33%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
              GL  L  L + A        +S  S+  +  L L  +  +  +    + L  ++ L 
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202

Query: 62  VSQNRLEG 69
           +    L  
Sbjct: 203 LRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 15/72 (20%), Positives = 30/72 (41%), Gaps = 2/72 (2%)

Query: 8  DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
           + +L L+ NK          +  +L+ L L S+ ++     +  +L  L+ L++S N L
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 68 EGEIPVEGPFRN 79
             +     F  
Sbjct: 87 S-SLS-SSWFGP 96

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 19/92 (20%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS---GEIPKSLEALL------ 55
            LK+L +L ++ N FH P+P S      +  L+LSS  +      IP++LE L       
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL 443

Query: 56  --------YLKQLNVSQNRLEGEIPVEGPFRN 79
                    L++L +S+N+L+  +P    F  
Sbjct: 444 DSFSLFLPRLQELYISRNKLK-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 8/77 (10%), Positives = 26/77 (33%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
              +  L +        +   +  L  ++ + + ++ +        + L  L+ L++S+N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344

Query: 66  RLEGEIPVEGPFRNFST 82
            +  E       +    
Sbjct: 345 LMVEEYLKNSACKGAWP 361

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 2/63 (3%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
              L TL L++NK    +   F S   +  + L +N L   I K+L     L+  ++  N
Sbjct: 190 FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247

Query: 66  RLE 68
              
Sbjct: 248 GFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 15/62 (24%), Positives = 23/62 (37%)

Query: 6  LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
                  +  +     +     S  +++ LDLS N LS      L     L+ LN+S N
Sbjct: 9  GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 66 RL 67
           L
Sbjct: 69 VL 70

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 49.6 bits (119), Expect = 9e-07
 Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 2/64 (3%)

Query: 5  GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
             ++  L L+ N               LE L+LSSN L  E    LE+L  L+ L+++ 
Sbjct: 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNN 89

Query: 65 NRLE 68
          N ++
Sbjct: 90 NYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 14/73 (19%), Positives = 31/73 (42%), Gaps = 8/73 (10%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +     L  L+L++N  +  +     SL +L +LDL++N +       L     ++ L+
Sbjct: 53  DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLH 105

Query: 62  VSQNRLEGEIPVE 74
            + N +   +   
Sbjct: 106 AANNNIS-RVSCS 117

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 14/75 (18%), Positives = 27/75 (36%), Gaps = 2/75 (2%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSG-EIPKSLEALLYLKQLNVSQ 64
            +    + LA NK         G    ++ LDL  N +      +   +   L+ LN+  
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 65  NRLEGEIPVEGPFRN 79
           N +  ++  +  F  
Sbjct: 179 NFIY-DVKGQVVFAK 192

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 12/66 (18%), Positives = 21/66 (31%), Gaps = 2/66 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS-GEIPKSLEALLYLKQL 60
                  +  +SL  NK    I K+     +LE  DL  N    G +         ++ +
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267

Query: 61  NVSQNR 66
                +
Sbjct: 268 AKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 8/78 (10%), Positives = 26/78 (33%), Gaps = 4/78 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +     + TL  A N     +          +++ L++N ++            ++ L+
Sbjct: 94  ELLVGPSIETLHAANNNISR-VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150

Query: 62  VSQNRLEGEIPVEGPFRN 79
           +  N ++  +       +
Sbjct: 151 LKLNEID-TVNFAELAAS 167

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 14/67 (20%), Positives = 27/67 (40%), Gaps = 8/67 (11%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +  L  L TL L  N       +      S+E+L  ++NN+S  +          K + 
Sbjct: 75  DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIY 126

Query: 62  VSQNRLE 68
           ++ N++ 
Sbjct: 127 LANNKIT 133

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 7/46 (15%), Positives = 21/46 (45%)

Query: 23 IPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
          I +   +    +   ++ ++L   +    ++   +K+L++S N L 
Sbjct: 2  IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 19/91 (20%), Positives = 33/91 (36%), Gaps = 5/91 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               +  L  L L+ N     + ++      LE+L L  N++   +   L     LK L 
Sbjct: 290 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLT 345

Query: 62  VSQNRLEGEIPVEGPFRNFSTESFSWNYALC 92
           +S N  +    +   FRN +  +       C
Sbjct: 346 LSHNDWD-CNSLRALFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 1/67 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +     L  + L+ N+    +   F  +  LE L +S+N L   +    + +  LK L+
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301

Query: 62  VSQNRLE 68
           +S N L 
Sbjct: 302 LSHNHLL 308

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 14/76 (18%), Positives = 29/76 (38%), Gaps = 2/76 (2%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
              + +  L+L   +       +F    +++ L +  N +    P   + +  L  L + 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125

Query: 64  QNRLEGEIPVEGPFRN 79
           +N L   +P  G F N
Sbjct: 126 RNDLS-SLP-RGIFHN 139

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 2/84 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            +  L  L L  N         F +   L +L +S+NNL      + +A   L+ L +S 
Sbjct: 115 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 174

Query: 65  NRLEGEIPVEGPFRNFSTESFSWN 88
           NRL   +       +    + S+N
Sbjct: 175 NRLT-HVD-LSLIPSLFHANVSYN 196

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 21/65 (32%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
                L TLS++ N        +F +  SL++L LSSN L+  +   L  +  L   NVS
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 194

Query: 64  QNRLE 68
            N L 
Sbjct: 195 YNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 16/65 (24%), Positives = 24/65 (36%), Gaps = 2/65 (3%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
               +L  L L  N           +   L  +DLS N L   +      +  L++L +S
Sbjct: 223 PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280

Query: 64  QNRLE 68
            NRL 
Sbjct: 281 NNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 12/77 (15%), Positives = 28/77 (36%), Gaps = 9/77 (11%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  +  L   +++ N        +    I++E LD S N+++  +       + L  L +
Sbjct: 182 LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKL 233

Query: 63  SQNRLEGEIPVEGPFRN 79
             N L  +      +  
Sbjct: 234 QHNNLT-DTAWLLNYPG 249

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 20/73 (27%), Positives = 30/73 (41%), Gaps = 4/73 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           I  LK+L  L+L  N      P    SL  L+ L   +N +S     SL  L  +  L+ 
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSA 360

Query: 63  SQNRLEGEIPVEG 75
             N++    P+  
Sbjct: 361 GHNQISDLTPLAN 373

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 21/73 (28%), Positives = 30/73 (41%), Gaps = 4/73 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           + GL  L  L L AN+     P     L +L +L+L+ N L    P  +  L  L  L +
Sbjct: 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316

Query: 63  SQNRLEGEIPVEG 75
             N +    PV  
Sbjct: 317 YFNNISDISPVSS 329

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 17/73 (23%), Positives = 31/73 (42%), Gaps = 4/73 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L  + +  N+     P    +L +L  L L +N ++   P  L+ L  L +L +
Sbjct: 86  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141

Query: 63  SQNRLEGEIPVEG 75
           S N +     + G
Sbjct: 142 SSNTISDISALSG 154

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 23/73 (31%), Positives = 36/73 (49%), Gaps = 4/73 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +G L +L  LSL  N+       +  SL +L  LDL++N +S   P  L  L  L +L +
Sbjct: 217 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272

Query: 63  SQNRLEGEIPVEG 75
             N++    P+ G
Sbjct: 273 GANQISNISPLAG 285

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 4/74 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           T+  L +L  L LA N+     P     L  L  L L +N +S   P  L  L  L  L 
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293

Query: 62  VSQNRLEGEIPVEG 75
           +++N+LE   P+  
Sbjct: 294 LNENQLEDISPISN 307

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 19/67 (28%), Positives = 30/67 (44%), Gaps = 4/67 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           + GL  L  L L  N+     P    +L +L  L L  NN+S   P  + +L  L++L  
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338

Query: 63  SQNRLEG 69
             N++  
Sbjct: 339 YNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 14/70 (20%), Positives = 22/70 (31%), Gaps = 4/70 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L  L    NK          +L ++  L    N +S   P  L  L  + QL +
Sbjct: 327 VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382

Query: 63  SQNRLEGEIP 72
           +         
Sbjct: 383 NDQAWTNAPV 392

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 22/73 (30%), Positives = 33/73 (45%), Gaps = 5/73 (6%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           + GL  L  LS   N+     P    +L +LE LD+SSN +S      L  L  L+ L  
Sbjct: 152 LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIA 206

Query: 63  SQNRLEGEIPVEG 75
           + N++    P+  
Sbjct: 207 TNNQISDITPLGI 219

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 14/74 (18%), Positives = 28/74 (37%), Gaps = 4/74 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           +   L  + TL                 L +L  ++ S+N L+   P  L+ L  L  + 
Sbjct: 41  SQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 96

Query: 62  VSQNRLEGEIPVEG 75
           ++ N++    P+  
Sbjct: 97  MNNNQIADITPLAN 110

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 19/67 (28%), Positives = 33/67 (49%), Gaps = 4/67 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L  L +++NK           L +LESL  ++N +S   P  L  L  L +L++
Sbjct: 173 LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228

Query: 63  SQNRLEG 69
           + N+L+ 
Sbjct: 229 NGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 5/73 (6%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L +L  L+L  N+     P    +L +L  L+LSSN +S     +L  L  L+QL+ 
Sbjct: 108 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF 163

Query: 63  SQNRLEGEIPVEG 75
             N++    P+  
Sbjct: 164 G-NQVTDLKPLAN 175

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 5/68 (7%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +  L +L  L L++N            L SL+ L    N ++   P  L  L  L++L+
Sbjct: 129 PLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183

Query: 62  VSQNRLEG 69
           +S N++  
Sbjct: 184 ISSNKVSD 191

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 19/91 (20%), Positives = 33/91 (36%), Gaps = 5/91 (5%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               +  L  L L+ N     + ++      LE+L L  N++   +   L     LK L 
Sbjct: 296 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLT 351

Query: 62  VSQNRLEGEIPVEGPFRNFSTESFSWNYALC 92
           +S N  +    +   FRN +  +       C
Sbjct: 352 LSHNDWD-CNSLRALFRNVARPAVDDADQHC 381

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 1/67 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +     L  + L+ N+    +   F  +  LE L +S+N L   +    + +  LK L+
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307

Query: 62  VSQNRLE 68
           +S N L 
Sbjct: 308 LSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 14/76 (18%), Positives = 29/76 (38%), Gaps = 2/76 (2%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
              + +  L+L   +       +F    +++ L +  N +    P   + +  L  L + 
Sbjct: 72  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131

Query: 64  QNRLEGEIPVEGPFRN 79
           +N L   +P  G F N
Sbjct: 132 RNDLS-SLP-RGIFHN 145

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 4/85 (4%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVS 63
            +  L  L L  N         F +   L +L +S+NNL   I     +A   L+ L +S
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179

Query: 64  QNRLEGEIPVEGPFRNFSTESFSWN 88
            NRL   +       +    + S+N
Sbjct: 180 SNRLT-HVD-LSLIPSLFHANVSYN 202

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 21/65 (32%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
                L TLS++ N        +F +  SL++L LSSN L+  +   L  +  L   NVS
Sbjct: 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 200

Query: 64  QNRLE 68
            N L 
Sbjct: 201 YNLLS 205

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 4/75 (5%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
           GL +L  L+L        +P +   L+ LE L++S N+     P S   L  LK+L V  
Sbjct: 194 GLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 65  NRLEGEIPVEGPFRN 79
           +++   I     F  
Sbjct: 252 SQVS-LIE-RNAFDG 264

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 19/64 (29%), Positives = 31/64 (48%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L  L  L ++ N F    P SF  L SL+ L + ++ +S     + + L  L +LN++ 
Sbjct: 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275

Query: 65  NRLE 68
           N L 
Sbjct: 276 NNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 20/74 (27%), Positives = 27/74 (36%), Gaps = 2/74 (2%)

Query: 8   DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
           +   L+L  N        +F  L  LE L L  N++      +   L  L  L +  N L
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

Query: 68  EGEIPVEGPFRNFS 81
              IP  G F   S
Sbjct: 136 T-VIP-SGAFEYLS 147

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 5/76 (6%)

Query: 5   GLKDLATLSLA-ANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
            +  L  L L    K       +F  L +L+ L+L   N+  ++P +L  L+ L++L +S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226

Query: 64  QNRLEGEIPVEGPFRN 79
            N    EI   G F  
Sbjct: 227 GNHFP-EIR-PGSFHG 240

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 19/64 (29%), Positives = 29/64 (45%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
           +  GL  L  L +  ++       +F  L SL  L+L+ NNLS         L YL +L+
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELH 296

Query: 62  VSQN 65
           +  N
Sbjct: 297 LHHN 300

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 21/77 (27%), Positives = 35/77 (45%), Gaps = 4/77 (5%)

Query: 5   GLKDLATLSLAANK--FHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
            L  L  LSL++N   F G   +S     SL+ LDLS N +   +  +   L  L+ L+ 
Sbjct: 50  KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108

Query: 63  SQNRLEGEIPVEGPFRN 79
             + L+ ++     F +
Sbjct: 109 QHSNLK-QMSEFSVFLS 124

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 5/77 (6%)

Query: 5   GLKDLATLSLAANKF-HGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNV 62
           GL  L  L +A N F    +P  F  L +L  LDLS   L  ++   +  +L  L+ LN+
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206

Query: 63  SQNRLEGEIPVEGPFRN 79
           S N     +    P++ 
Sbjct: 207 SHNNFF-SLD-TFPYKC 221

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 20/78 (25%), Positives = 36/78 (46%), Gaps = 2/78 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L++L  L L+  +     P +F SL SL+ L++S NN         + L  L+ L+ S 
Sbjct: 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232

Query: 65  NRLEGEIPVEGPFRNFST 82
           N +      +   ++F +
Sbjct: 233 NHIM-TSK-KQELQHFPS 248

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 43.8 bits (104), Expect = 6e-05
 Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 2/65 (3%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSL-EALLYLKQLNVS 63
           G   L  L L+ N     +  +F  L  LE LD   +NL      S+  +L  L  L++S
Sbjct: 76  GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134

Query: 64  QNRLE 68
                
Sbjct: 135 HTHTR 139

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 21/62 (33%), Positives = 26/62 (41%), Gaps = 2/62 (3%)

Query: 8  DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLS--GEIPKSLEALLYLKQLNVSQN 65
              L L +NK        F  L  L  L LSSN LS  G   +S      LK L++S N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 66 RL 67
           +
Sbjct: 89 GV 90

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 17/78 (21%), Positives = 26/78 (33%), Gaps = 2/78 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
           GL+ L  L    +        S F SL +L  LD+S  +           L  L+ L ++
Sbjct: 99  GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158

Query: 64  QNRLEGEIPVEGPFRNFS 81
            N  +        F    
Sbjct: 159 GNSFQENFL-PDIFTELR 175

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 16/69 (23%), Positives = 23/69 (33%), Gaps = 4/69 (5%)

Query: 4   GGLKDLATLSLAANKFH---GPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLY-LKQ 59
                L  L+L         G       + + L+ LDLS N+L              L  
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 60  LNVSQNRLE 68
           LN+S   L+
Sbjct: 258 LNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 15/67 (22%), Positives = 22/67 (32%), Gaps = 4/67 (5%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS----LEALLYLKQLN 61
              L  LS+A         +      +L +LDLS N   GE              L+ L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 62  VSQNRLE 68
           +    +E
Sbjct: 208 LRNAGME 214

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 17/81 (20%), Positives = 27/81 (33%), Gaps = 7/81 (8%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKS----FGSLISLESLDLSSNN---LSGEIPKSLEAL 54
            +     L+TL L+ N   G              +L+ L L +      SG       A 
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227

Query: 55  LYLKQLNVSQNRLEGEIPVEG 75
           + L+ L++S N L        
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 21/68 (30%), Positives = 28/68 (41%), Gaps = 4/68 (5%)

Query: 3   IGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
                 L  L L+ N         S      L SL+LS   L  ++PK L A   L  L+
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLD 280

Query: 62  VSQNRLEG 69
           +S NRL+ 
Sbjct: 281 LSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 17/64 (26%), Positives = 25/64 (39%), Gaps = 5/64 (7%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
              L +L+L+       +PK   +   L  LDLS N L    P   E L  +  L++  N
Sbjct: 252 PSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGN 306

Query: 66  RLEG 69
               
Sbjct: 307 PFLD 310

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 36/218 (16%), Positives = 65/218 (29%), Gaps = 5/218 (2%)

Query: 4   GGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
               +L  L L+ N F   PI K FG++  L+ L LS+ +L       +  L   K L V
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 63  SQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYIL 122
                  +       ++F+TES    +       F +    +            VL    
Sbjct: 147 LGETYGEKED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205

Query: 123 PPIISIMLLLIAIIVYVRCQNRSTKKSDEEDL---LPLVTWRRISYLDIQRATNEFDECN 179
                 +L  +     +     +  ++        L LV    + Y  I     +     
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265

Query: 180 LLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFN 217
                S  S+   ++    +         +   F + N
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 23/77 (29%), Positives = 33/77 (42%), Gaps = 4/77 (5%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           I  L  L  L ++ N+        F     LE LDLS N L  +I       + LK L++
Sbjct: 41  ILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDL 97

Query: 63  SQNRLEGEIPVEGPFRN 79
           S N  +  +P+   F N
Sbjct: 98  SFNAFD-ALPICKEFGN 113

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 23/77 (29%), Positives = 41/77 (53%), Gaps = 5/77 (6%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
             K L +L++++N     I +       ++ LDL SN +   IPK +  L  L++LNV+ 
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453

Query: 65  NRLEGEIPVEGPFRNFS 81
           N+L+  +P +G F   +
Sbjct: 454 NQLK-SVP-DGIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 10/78 (12%), Positives = 26/78 (33%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
              ++   +   +            +     LD S+N L+  + ++   L  L+ L +  
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357

Query: 65  NRLEGEIPVEGPFRNFST 82
           N+L+    +        +
Sbjct: 358 NQLKELSKIAEMTTQMKS 375

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 3/65 (4%)

Query: 5   GLKDLATLSLAANKF-HGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
            +K L  L ++ N   +           SL SL++SSN L+  I + L     +K L++ 
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLH 429

Query: 64  QNRLE 68
            N+++
Sbjct: 430 SNKIK 434

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 89/260 (34%)

Query: 181 LGIGSFGSVYKG-TLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR--------HRNL 231
           LG G F +V+    +     VA+K+       T  + + E  +L++VR           +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103

Query: 232 IKILSGCSNLDFK---------ALVLEFMPNG-SLEKWLYSHNYFLDILERL-NIMIDVG 280
           +++L      DFK          +V E +  G  L KW+   NY    L  +  I+  V 
Sbjct: 104 VQLLD-----DFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILL--------------------------------- 307
             L+YLH       IIH D+KP NILL                                 
Sbjct: 157 QGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 308 ----------------DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-- 349
                            E +   ++D G +  + +     IQT+      Y + E ++  
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGS 268

Query: 350 --STKCDVYSYGILLLETFS 367
             +T  D++S   +  E  +
Sbjct: 269 GYNTPADIWSTACMAFELAT 288

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 21/75 (28%), Positives = 32/75 (42%), Gaps = 2/75 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L+ L  L L+ N        +F  L +L +L+L  N L+     +   L  LK+L +  
Sbjct: 86  HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN 145

Query: 65  NRLEGEIPVEGPFRN 79
           N +E  IP    F  
Sbjct: 146 NPIE-SIP-SYAFNR 158

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 16/67 (23%), Positives = 29/67 (43%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            +  L  L  L L+ N      P SF  L+ L+ L +  + +      + + L  L ++N
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261

Query: 62  VSQNRLE 68
           ++ N L 
Sbjct: 262 LAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 23/74 (31%), Positives = 30/74 (40%), Gaps = 2/74 (2%)

Query: 8   DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
           +   L+L  N+       SF  L  LE L LS N++      +   L  L  L +  NRL
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 68  EGEIPVEGPFRNFS 81
              IP  G F   S
Sbjct: 125 T-TIP-NGAFVYLS 136

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 18/64 (28%), Positives = 25/64 (39%), Gaps = 1/64 (1%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVS 63
            L  L  L L  N        +F  + SL  LDL        I + + E L  L+ LN++
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 64  QNRL 67
              L
Sbjct: 194 MCNL 197

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 15/61 (24%), Positives = 30/61 (49%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
           GL  L  L +  ++       +F +L SL  ++L+ NNL+         L +L+++++  
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288

Query: 65  N 65
           N
Sbjct: 289 N 289

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.5 bits (107), Expect = 3e-05
 Identities = 20/58 (34%), Positives = 26/58 (44%), Gaps = 3/58 (5%)

Query: 11  TLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
            L LA       +      L+ +  LDLS N L   +P +L AL  L+ L  S N LE
Sbjct: 445 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 18/66 (27%), Positives = 29/66 (43%), Gaps = 1/66 (1%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
            + GL +L  L++  +      P +F     L  L+LS N L   +       L L++L 
Sbjct: 51  DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109

Query: 62  VSQNRL 67
           +S N L
Sbjct: 110 LSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 3/88 (3%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
            + G ++L  L +   +    +       L  L +L +  + L    P +      L +L
Sbjct: 26  HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85

Query: 61  NVSQNRLEGEIPVEGPFRNFSTESFSWN 88
           N+S N LE  +      +  S +    +
Sbjct: 86  NLSFNALE-SLS-WKTVQGLSLQELVLS 111

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 19/75 (25%), Positives = 33/75 (44%), Gaps = 2/75 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L +L +L L+ N  +    ++F  + +L  LDLSSN+L          L  L+ L +  
Sbjct: 62  RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121

Query: 65  NRLEGEIPVEGPFRN 79
           N +   +     F +
Sbjct: 122 NHIV-VVD-RNAFED 134

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 20/68 (29%), Positives = 29/68 (42%), Gaps = 5/68 (7%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIP----KSLEALLYLKQL 60
            L+ L  L L  N        +F  +  L+ L LS N +S   P    K    L  L  L
Sbjct: 110 DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168

Query: 61  NVSQNRLE 68
           ++S N+L+
Sbjct: 169 DLSSNKLK 176

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 18/64 (28%), Positives = 27/64 (42%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L +L  L L  N+      ++F  L SL+ L L  N ++   P +   L  L  L +  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 65  NRLE 68
           N L 
Sbjct: 211 NNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 5/77 (6%)

Query: 5   GLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNV 62
           GL  L  L L+ N     +  + F  L  L +L L    L  E+       L  L+ L +
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 63  SQNRLEGEIPVEGPFRN 79
             N L+  +P +  FR+
Sbjct: 137 QDNALQ-ALP-DDTFRD 151

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 21/75 (28%), Positives = 31/75 (41%), Gaps = 2/75 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
           GL  L  L L  N        +F  L +L  L L  N +S    ++   L  L +L + Q
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 65  NRLEGEIPVEGPFRN 79
           NR+   +     FR+
Sbjct: 187 NRVA-HVH-PHAFRD 199

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 17/72 (23%), Positives = 27/72 (37%), Gaps = 1/72 (1%)

Query: 8   DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
               + L  N+       SF +  +L  L L SN L+     +   L  L+QL++S N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 68  EGEIPVEGPFRN 79
              +     F  
Sbjct: 93  LRSVD-PATFHG 103

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 2/73 (2%)

Query: 7   KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNR 66
            D A L L  NK        F +L +L +L L +N +S   P +   L+ L++L +S+N+
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111

Query: 67  LEGEIPVEGPFRN 79
           L+ E+P E   + 
Sbjct: 112 LK-ELP-EKMPKT 122

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 1/69 (1%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
           G    L  L L  NK       S   L +L  L LS N++S     SL    +L++L+++
Sbjct: 189 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248

Query: 64  QNRLEGEIP 72
            N+L  ++P
Sbjct: 249 NNKLV-KVP 256

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 14/79 (17%), Positives = 33/79 (41%), Gaps = 7/79 (8%)

Query: 5   GLKDLATLSLAANKFH-GPIPK-SFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           GL  +  + L  N      I   +F  +  L  + ++  N++  IP+ L     L +L++
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 199

Query: 63  SQNRLEGEIPVEGPFRNFS 81
             N++  ++      +  +
Sbjct: 200 DGNKIT-KVD-AASLKGLN 216

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 51/340 (15%), Positives = 113/340 (33%), Gaps = 38/340 (11%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L +L  L L+ N+        F     LE LD+S N L   I      +  L+ L++S 
Sbjct: 74  FLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSF 130

Query: 65  NRLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQ-VPPCKEENNKRSKKVALLVLNYILP 123
           N  +  +PV   F N +  +F    A    ++F+ +      +   S  +  LV  +I  
Sbjct: 131 NDFD-VLPVCKEFGNLTKLTFLGLSA----AKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185

Query: 124 PIISIMLLLIAIIVYVRCQNRSTKKSDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGI 183
                + +    ++++     S         +  +   ++S + +    N+ +   L+  
Sbjct: 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL----NDENCQRLM-- 239

Query: 184 GSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKI-LSGCSNLD 242
                    T          + N+ L+    ++    ++ +    R +  + +   +  +
Sbjct: 240 ---------TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290

Query: 243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIH--CDL 300
                       +L+  +  H      L     +  V   +       +  P IH  C  
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350

Query: 301 KPSNIL---LDENMVAHVSDFGISKLLGEGDDSLIQTKTM 337
            PS+       +N          +  + +G  +L + +T+
Sbjct: 351 SPSSFTFLNFTQN--------VFTDSVFQGCSTLKRLQTL 382

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 21/78 (26%), Positives = 41/78 (52%), Gaps = 5/78 (6%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
              + +  L+L++N   G + +       ++ LDL +N +   IPK +  L  L++LNV+
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481

Query: 64  QNRLEGEIPVEGPFRNFS 81
            N+L+  +P +G F   +
Sbjct: 482 SNQLK-SVP-DGVFDRLT 497

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 22/77 (28%), Positives = 33/77 (42%), Gaps = 3/77 (3%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNL-SGEIPK-SLEALLYLKQLNV 62
           GL  L  L L  N+F      +F  L +LE L L+  NL    +     + L  L+ L +
Sbjct: 77  GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136

Query: 63  SQNRLEGEIPVEGPFRN 79
             N ++ +I     F N
Sbjct: 137 RDNNIK-KIQPASFFLN 152

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 2/75 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
              DL  L+LA N+ +     +F  L  L  L+LS N L     +  E L  L+ L++S 
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356

Query: 65  NRLEGEIPVEGPFRN 79
           N +   +  +  F  
Sbjct: 357 NHIR-ALG-DQSFLG 369

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 4/78 (5%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVS 63
           GL  L  L+L+ N       + F +L  LE LDLS N++   +   S   L  LK+L + 
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALD 379

Query: 64  QNRLEGEIPVEGPFRNFS 81
            N+L+  +P +G F   +
Sbjct: 380 TNQLK-SVP-DGIFDRLT 395

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.8 bits (104), Expect = 9e-05
 Identities = 15/66 (22%), Positives = 25/66 (37%), Gaps = 6/66 (9%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L  +    N     + K     +SLES+   +N L       L+ L +L  +  
Sbjct: 191 LQNLPFLTAIYADNNS----LKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYA 244

Query: 63  SQNRLE 68
             N L+
Sbjct: 245 DNNLLK 250

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 9/83 (10%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
              L +L  + N     +P+   SL SL   + +   LS   P        L+ L VS N
Sbjct: 90  PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNN 141

Query: 66  RLEGEIPVEGPFRNFSTESFSWN 88
           +LE ++P               N
Sbjct: 142 QLE-KLPELQNSSFLKIIDVDNN 163

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 15/92 (16%), Positives = 29/92 (31%), Gaps = 20/92 (21%)

Query: 3   IGGLKDLATLSLAANKFHGPIPK---------------SFGSLISLESLDLSSNNLSGEI 47
              LK L   +          P                   +   L+ +D+ +N+L  ++
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KL 168

Query: 48  PKSLEALLYLKQLNVSQNRLEGEIPVEGPFRN 79
           P    +   L+ +    N+LE E+P       
Sbjct: 169 PDLPPS---LEFIAAGNNQLE-ELPELQNLPF 196

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 21/73 (28%), Positives = 30/73 (41%), Gaps = 2/73 (2%)

Query: 7   KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNR 66
            D   L L  N         F  L  L +L L +N +S    K+   L  L++L +S+N 
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113

Query: 67  LEGEIPVEGPFRN 79
           L  EIP      +
Sbjct: 114 LV-EIP-PNLPSS 124

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 15/72 (20%), Positives = 27/72 (37%), Gaps = 2/72 (2%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNL-SGEIPKSLEALLYLKQLNVSQ 64
              L  L +  N+        F  L ++  +++  N L +          L L  L +S+
Sbjct: 122 PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181

Query: 65  NRLEGEIPVEGP 76
            +L   IP + P
Sbjct: 182 AKLT-GIPKDLP 192

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 9/84 (10%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIP-------KSLEALLYL 57
            L  L  L L  NK    +P     L  L+ + L +NN++ ++               Y 
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296

Query: 58  KQLNVSQNRLEGEIPVEGPFRNFS 81
             +++  N +         FR  +
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVT 320

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 1/69 (1%)

Query: 4   GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
              + L  L L  NK      +       L  L L  N +      SL  L  L++L++ 
Sbjct: 190 DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLD 249

Query: 64  QNRLEGEIP 72
            N+L   +P
Sbjct: 250 NNKLS-RVP 257

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 20/127 (15%), Positives = 44/127 (34%), Gaps = 13/127 (10%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
             +L  L ++ N+    +P     L    SL +  N L+  +P+SL  L     +N+  N
Sbjct: 240 PSELKELMVSGNRLTS-LPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 66  RLEGEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEENNKRSKKVALLVLNYILPPI 125
            L      E   +     + +  Y+       +         + ++ + L   ++++P  
Sbjct: 295 PLS-----ERTLQALREITSAPGYSG---PIIRFDMAGASAPRETRALHLAAADWLVPAR 346

Query: 126 ISIMLLL 132
                  
Sbjct: 347 EGEPAPA 353

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 17/69 (24%), Positives = 29/69 (42%), Gaps = 9/69 (13%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
              L  LS++ N+    +P        L  L   +N L+  +P        L++L+VS N
Sbjct: 140 PPGLQELSVSDNQLAS-LPALPS---ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDN 191

Query: 66  RLEGEIPVE 74
           +L   +P  
Sbjct: 192 QLA-SLPTL 199

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 19/64 (29%), Positives = 32/64 (50%), Gaps = 2/64 (3%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVS 63
           GL+ L +L L  NK        F  L SL+ L L++N ++  +   + + L  L  L++ 
Sbjct: 78  GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 64  QNRL 67
            N+L
Sbjct: 137 DNKL 140

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 9/84 (10%)

Query: 2   TIGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIP----KSLEALLY 56
            IG LK L  L++A N      +P+ F +L +LE LDLSSN +   I     + L  +  
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPL 177

Query: 57  LK-QLNVSQNRLEGEIPVEGPFRN 79
           L   L++S N +   I   G F+ 
Sbjct: 178 LNLSLDLSLNPMN-FIQ-PGAFKE 199

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 22/81 (27%), Positives = 36/81 (44%), Gaps = 7/81 (8%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLE----SLDLSSNNLSGEIPKSLEALLYLKQL 60
            L +L  L L++NK           L  +     SLDLS N ++  I       + LK+L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205

Query: 61  NVSQNRLEGEIPVEGPFRNFS 81
            +  N+L+  +P +G F   +
Sbjct: 206 ALDTNQLK-SVP-DGIFDRLT 224

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 25/80 (31%), Positives = 34/80 (42%), Gaps = 11/80 (13%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEA-----LLYLKQ 59
            L  L+TL L  N        +F  L SL+ L     NL+     SLE      L  LK+
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-----SLENFPIGHLKTLKE 128

Query: 60  LNVSQNRLEGEIPVEGPFRN 79
           LNV+ N ++    +   F N
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSN 147

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 21/80 (26%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYL-------- 57
           +   + L L        +P +      +  L+++ N L   +P+   +L YL        
Sbjct: 58  INQFSELQLNRLNLSS-LPDNLPP--QITVLEITQNALI-SLPELPASLEYLDACDNRLS 113

Query: 58  ---------KQLNVSQNRLE 68
                    K L+V  N+L 
Sbjct: 114 TLPELPASLKHLDVDNNQLT 133

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 16/64 (25%), Positives = 31/64 (48%), Gaps = 2/64 (3%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVS 63
           G   +  + L +N+      K F  L SL++L L SN ++  +   S   L  ++ L++ 
Sbjct: 79  GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137

Query: 64  QNRL 67
            N++
Sbjct: 138 DNQI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 17/75 (22%), Positives = 28/75 (37%), Gaps = 2/75 (2%)

Query: 5   GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ 64
            L  L  ++ + NK       +F     +  + L+SN L     K  + L  LK L +  
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114

Query: 65  NRLEGEIPVEGPFRN 79
           NR+   +     F  
Sbjct: 115 NRIT-CVG-NDSFIG 127

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	457
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.6
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.36
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.32
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.29
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.27
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.26
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.23
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.21
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.19
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.19
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.08
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.08
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.03
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.02
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.01
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.01
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.01
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.01
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.0
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.0
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.99
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.99
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.98
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.98
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.98
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.98
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.97
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.97
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.95
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.94
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.93
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.9
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.89
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.89
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.88
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.88
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.87
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.87
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.87
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.85
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.85
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.84
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.83
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.83
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.82
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.82
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.82
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.81
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.81
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.81
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.8
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.79
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.79
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.79
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.79
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.79
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.78
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.78
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.77
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.77
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.77
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.76
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.76
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.75
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.75
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.75
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.72
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.72
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.71
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.71
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.7
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.69
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.69
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.68
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.67
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.67
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.66
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.66
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.64
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.63
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.63
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.63
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.63
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.63
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.62
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.62
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.62
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.62
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.61
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.6
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.6
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.6
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.6
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.56
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.56
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.56
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.55
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.48
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.48
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.46
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.43
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.4
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.4
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.39
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.37
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.3
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.3
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.29
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.28
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.21
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.2
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.19
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.07
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.99
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.97
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.54
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.52
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.44
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.43
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.32
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.29
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.27
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.21
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.15
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.13
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.02
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.99
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.98
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.98
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.77
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.73
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.67
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	96.47
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.44
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.34
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	96.29
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.08
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	95.84
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	95.5
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	94.53
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	94.02
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	93.71
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	93.53
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	93.26
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.06
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	91.35
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.84
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	89.9
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	89.88
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	89.59
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	89.34
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	89.02
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.61
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.46
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.99
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	82.66
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	82.31
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	80.47

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.3e-58  Score=438.77  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.......++|.+|++++++++|||||+++|+|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46777789999999999999864      478899999987766667889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEE
Q 044428          247 VLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH  314 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~k  314 (457)
                      |||||++|+|.++|+...            ..++|.+++.++.|||.||+|||    +++|+||||||+|||+++++++|
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcEE
Confidence            999999999999997642            46999999999999999999999    67799999999999999999999


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcC
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      |+|||+|+.....+.........||+.|||||    ..++.++|||||||++|||+| |+.||.......+...+.... 
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-  247 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-  247 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence            99999999775443333334467999999999    448999999999999999999 899997654333322222111 


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                                ..      ..+..|+.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus       248 ----------~~------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          248 ----------VL------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             ----------CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CC------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                      00      01123466789999999999999999999999999988764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-57  Score=440.88  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=204.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45666779999999999999864      478999999987766667789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          247 VLEFMPNGSLEKWLYSHN--------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      |||||++|+|.++++...              ..++|.++++|+.|||.||+|||    ..+|+||||||+|||++++++
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCCc
Confidence            999999999999997642              35899999999999999999999    677999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||+++.+...+.....+...||+.|||||.    .++.++|||||||++|||+| |+.||.......+...+...
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g  276 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG  276 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999997755444444455789999999993    47889999999999999999 89999765433322222211


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .        ..         ..+..|+..+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus       277 ~--------~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          277 R--------EL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             C--------CC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             C--------CC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1        00         01123466789999999999999999999999999998765

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-57  Score=433.98  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=202.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +++...+.||+|+||+||+|++++  .||||+++..  .....+.|.+|++++++++|||||+++|+|.+ +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            466777899999999999999753  5999998743  23456789999999999999999999999865 568999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      |++|+|.++|+..+..++|.+++.|+.|||.||+|||    +.+||||||||+|||+++++++||+|||+|+........
T Consensus       113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999887777999999999999999999999    678999999999999999999999999999977544333


Q ss_pred             ceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHH-HHHhhcCchhHHhccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKH-WVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~-~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .......||+.|||||.+       ++.++|||||||++|||+||+.||.......... .+....       ..+.+..
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~-------~~p~~~~  261 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY-------ASPDLSK  261 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC-------CCCCSTT
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC-------CCCCccc
Confidence            334557899999999943       6789999999999999999999997644322111 111111       1111111


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                            .+.+|+..+.+++.+||+.||++||||.||++.|+.++..
T Consensus       262 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          262 ------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             ------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             ------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence                  1123466789999999999999999999999999887644

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-57  Score=435.69  Aligned_cols=251  Identities=24%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             cCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++...+.||+|+||+||+|++.      +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3445678999999999999863      568899999976543 345689999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC
Q 044428          247 VLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM  311 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~  311 (457)
                      |||||++|+|.++|....               ..++|.++++|+.|||.||+|||    +.+||||||||+|||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECCCC
Confidence            999999999999997532               35899999999999999999999    67799999999999999999


Q ss_pred             cEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHh
Q 044428          312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQ  386 (457)
Q Consensus       312 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~  386 (457)
                      ++||+|||+++.+...+.....+...||+.|||||    ..++.++|||||||++|||+| |+.||.......+...+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999999775443333445578999999999    458999999999999999999 8999976543333322221


Q ss_pred             hcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          387 SLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       387 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ..           .      ...+.+|+..+.+++.+||+.||++||||.||++.|+.+
T Consensus       263 ~~-----------~------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          263 RQ-----------V------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TC-----------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CC-----------C------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            10           0      011224567799999999999999999999999999764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-55  Score=422.04  Aligned_cols=272  Identities=21%  Similarity=0.312  Sum_probs=200.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----eeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD----FKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  248 (457)
                      ++|...+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|...+    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3566678999999999999998 5899999999755322 223345666777899999999999997654    579999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH----ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      |||++|+|.++++...  ++|..+.+++.|++.||+|||+.+    ..++|+||||||+|||++.++++||+|||+++..
T Consensus        81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999998765  899999999999999999999542    1348999999999999999999999999999987


Q ss_pred             CCCCCcc--eeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCc--HHHHHHhhcC-
Q 044428          325 GEGDDSL--IQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLP-  389 (457)
Q Consensus       325 ~~~~~~~--~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~--l~~~~~~~~~-  389 (457)
                      .......  ......||+.|+|||.+          ++.++|||||||++|||+||+.|+.......  ...+...... 
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5443321  12346799999999954          3568999999999999999988875422111  0000000000 


Q ss_pred             chhH-HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          390 HKLA-EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       390 ~~~~-~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      +.+. .+.+..+...........+++..+.+++.+||+.||++||||.||++.|+++.++
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0011 1111111111111112235677899999999999999999999999999998764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-53  Score=411.97  Aligned_cols=245  Identities=22%  Similarity=0.319  Sum_probs=204.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      +.|+..+.||+|+||+||+|+.. +|+.||||++..........+.+|++++++++|||||++++++.+.+..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888889999999999999975 79999999998665555667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++|+|.+++....  +++.+...++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+|+.+.....  
T Consensus       154 ~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          154 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            9999999998754  899999999999999999999    67899999999999999999999999999998754322  


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....+||+.|||||.+    ++.++|||||||++|||++|+.||...........+....+        +.+.      
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--------~~~~------  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--------PRLK------  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC--------CCCS------
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--------CCCC------
Confidence            23457899999999943    78899999999999999999999976543332222222111        1111      


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       .+..+...+.+++.+||+.||++|||+.|+++
T Consensus       292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             01122456889999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.5e-53  Score=414.54  Aligned_cols=259  Identities=24%  Similarity=0.372  Sum_probs=210.5

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCC-CccceeeeeeecC
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRH-RNLIKILSGCSNL  241 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~  241 (457)
                      ...++|+..+.||+|+||+||+|++.      .++.||||++.... ....+.|.+|++++.+++| ||||+++|+|.+.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            34578888999999999999999864      24679999997654 3345679999999999976 8999999999764


Q ss_pred             -CeeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCe
Q 044428          242 -DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNI  305 (457)
Q Consensus       242 -~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NI  305 (457)
                       +..++|||||++|+|.++|+...               ..+++.+++.++.|||.||+|||    +.+||||||||+||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NI  216 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNI  216 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCccce
Confidence             57899999999999999997532               34899999999999999999999    67799999999999


Q ss_pred             eecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCC-c
Q 044428          306 LLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEM-S  379 (457)
Q Consensus       306 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~-~  379 (457)
                      |+++++++||+|||+|+.+.........+...||+.|||||    ..++.++|||||||++|||+| |+.||...... .
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999999876544444455678999999999    448999999999999999998 89999764322 1


Q ss_pred             HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      +...+....        ...         .+..++.++.+++.+||+.||++||||.||++.|+++.+.-
T Consensus       297 ~~~~i~~g~--------~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          297 FCRRLKEGT--------RMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHHHHTC--------CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHcCC--------CCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            212111111        011         11123556899999999999999999999999999987653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-53  Score=410.62  Aligned_cols=245  Identities=21%  Similarity=0.316  Sum_probs=195.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  ......+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57899999999999999999874 79999999997542  3445679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||++|+|.+++...+ ..+++.+...++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+|+.+... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            999999999998654 45789999999999999999999    678999999999999999999999999999976421 


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                       .......+||+.|||||.+    ++.++|||||||++|||+||+.||.......+...+..           .......
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-----------~~~~~~~  246 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-----------GSFPPVS  246 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-----------TCCCCCC
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-----------CCCCCCC
Confidence             1122346799999999943    67899999999999999999999976432222211111           1110000


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            ..++..+.+++.+||+.||++|||+.|+++
T Consensus       247 ------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          247 ------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  112446889999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.6e-53  Score=406.57  Aligned_cols=253  Identities=20%  Similarity=0.217  Sum_probs=203.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .+.|...++||+|+||.||+|+.. +|+.||||+++....     ..+|+.++++++|||||++++++.+.+..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356777789999999999999975 799999999975422     24799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++|+|.+++...+ .+++.....++.||+.||+|||    ..+|+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999998764 4899999999999999999999    78899999999999999987 699999999998754322


Q ss_pred             cc---eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          330 SL---IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       330 ~~---~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ..   .....+||+.|||||.+    ++.++|||||||++|||+||+.||.......+...+....+.         +..
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------~~~  277 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP---------IRE  277 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG---------GGG
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC---------chh
Confidence            11   12335799999999943    788999999999999999999999875444333322221100         000


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                            .+.+++..+.+++.+||+.||++|||+.|+++.|....++.
T Consensus       278 ------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          278 ------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence                  01123556889999999999999999999999988876653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-52  Score=397.49  Aligned_cols=243  Identities=23%  Similarity=0.351  Sum_probs=191.3

Q ss_pred             CcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCeeEEEE
Q 044428          176 DECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN----LDFKALVL  248 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  248 (457)
                      ...+.||+|+||+||+|+.. ++..||+|++....  ......|.+|++++++++|||||+++++|.+    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            34457999999999999875 68999999997542  3345679999999999999999999998864    35689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||++|+|.+++.+.. .+++.....++.||+.||+|||+..  ++|+||||||+|||++ .++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~--~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS--SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            9999999999998754 5899999999999999999999321  2399999999999997 4899999999999864321


Q ss_pred             CCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          .....+||+.|||||.+   ++.++|||||||++|||+||+.||.....  ...........     ..+...   
T Consensus       186 ----~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~-----~~~~~~---  251 (290)
T 3fpq_A          186 ----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSG-----VKPASF---  251 (290)
T ss_dssp             ----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTT-----CCCGGG---
T ss_pred             ----ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcC-----CCCCCC---
Confidence                22346899999999944   78899999999999999999999965332  12211111100     000000   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           +..++.++.+++.+||+.||++|||+.|+++
T Consensus       252 -----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          252 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0111345789999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-52  Score=401.04  Aligned_cols=244  Identities=23%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++.+..   ......+.+|++++++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999874 79999999997542   334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.+.+ .+++.....++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999998754 4899999999999999999999    6789999999999999999999999999999875544


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ........+||+.|||||.+    ++.++||||+||++|||+||+.||.......+...+...         +..+..  
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------~~~~p~--  255 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL---------EYDFPE--  255 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------CCCCCT--
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCCCCc--
Confidence            33334557899999999943    788999999999999999999999764432222211110         000100  


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~  439 (457)
                             ....++.+++.+|++.||++|||+.|+.
T Consensus       256 -------~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          256 -------KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                   1134578999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.9e-52  Score=412.54  Aligned_cols=245  Identities=22%  Similarity=0.320  Sum_probs=204.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++..........+.+|+.+|++++|||||++++++.+.+..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56889999999999999999975 79999999998665555667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++|+|.+++....  +++.+...++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+|+.+.....  
T Consensus       231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            9999999998754  899999999999999999999    67899999999999999999999999999998754322  


Q ss_pred             eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....+||+.|||||.+    ++.++|||||||++|||++|+.||...........+....+        +.+..     
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--------~~~~~-----  369 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--------PRLKN-----  369 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--------CCCSC-----
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--------CCCcc-----
Confidence            23457899999999943    78899999999999999999999976543333222222111        11111     


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        ...+...+.+++.+||+.||++|||+.|+++
T Consensus       370 --~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0112445889999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-51  Score=387.47  Aligned_cols=241  Identities=27%  Similarity=0.397  Sum_probs=185.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....   ......+.+|++++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999874 79999999997542   233457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+ +|+|.+++.+.. .+++.+...++.||+.||+|||    +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 689999998765 4999999999999999999999    6789999999999999999999999999998764322


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                         ......||+.|+|||.+     .+.++||||+||++|||+||+.||.......+...+....         ..+.  
T Consensus       167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~---------~~~p--  232 (275)
T 3hyh_A          167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV---------YTLP--  232 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------CCCC--
T ss_pred             ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------CCCC--
Confidence               22346899999999943     3578999999999999999999997643222211111100         0000  


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             ...+..+.+++.+|++.||++|||+.|+++
T Consensus       233 -------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          233 -------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   012345789999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-51  Score=392.27  Aligned_cols=238  Identities=26%  Similarity=0.326  Sum_probs=188.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|+..+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999862    57899999997542  2233468899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++.+.. .+++.+...++.|++.||+|||    +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999998764 4899999999999999999999    67899999999999999999999999999987543


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ...  .....+||+.|||||.+    ++.++||||+||++|||+||+.||...+...+...+...           ... 
T Consensus       179 ~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----------~~~-  244 (304)
T 3ubd_A          179 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-----------KLG-  244 (304)
T ss_dssp             --C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------CCC-
T ss_pred             CCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------CCC-
Confidence            221  23347899999999933    788999999999999999999999764432222221111           100 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                      ..      ..++..+.+++.+||+.||++|||+
T Consensus       245 ~p------~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          245 MP------QFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             CC------TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CC------CcCCHHHHHHHHHHcccCHHHCCCC
Confidence            00      1124458899999999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-49  Score=380.62  Aligned_cols=246  Identities=24%  Similarity=0.360  Sum_probs=183.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-------  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  242 (457)
                      .++|+..+.||+|+||+||+|+.. +|+.||||+++... +.....+.+|++++++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            357899999999999999999875 79999999997543 334467899999999999999999999886543       


Q ss_pred             -----eeEEEEeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEE
Q 044428          243 -----FKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV  315 (457)
Q Consensus       243 -----~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl  315 (457)
                           ..++||||+++|+|.+++....  ...++.....++.||+.||+|||    +.+|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEE
Confidence                 3689999999999999998764  23566778899999999999999    678999999999999999999999


Q ss_pred             eccccccccCCCCCcc----------eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHH
Q 044428          316 SDFGISKLLGEGDDSL----------IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK  381 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~  381 (457)
                      +|||+|+.+.......          ..+..+||+.|||||.    .++.++|||||||++|||++   ||....  +..
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~  234 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERV  234 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH
Confidence            9999999875432211          1223579999999993    37889999999999999997   775311  111


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..+        ..+.+...      .....+....+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~--------~~~~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTL--------TDVRNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH--------HHHHTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH--------HHHhcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111        11111100      0111222345678999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.7e-48  Score=381.71  Aligned_cols=262  Identities=24%  Similarity=0.307  Sum_probs=197.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec------CCe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN------LDF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  243 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++...  ......+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57899999999999999999874 79999999997543  2344578899999999999999999998753      367


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .|+|||||+ |+|.+++...+ .+++.....++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999995 78999998654 5999999999999999999999    67899999999999999999999999999987


Q ss_pred             cCCCCC--cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          324 LGEGDD--SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       324 ~~~~~~--~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      +.....  .......+||+.|+|||.+     ++.++||||+||++|||++|+.||......+....+.........+..
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            643221  1223457899999999943     578899999999999999999999765443333332221111000000


Q ss_pred             c-----------cccccc-ccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 D-----------SNLVRR-EHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d-----------~~l~~~-~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .           ..+... ..... ........+.+|+.+|++.||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0           000000 00000 00012345789999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-47  Score=369.57  Aligned_cols=277  Identities=35%  Similarity=0.568  Sum_probs=226.8

Q ss_pred             ccCHHHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 044428          162 RISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL  241 (457)
Q Consensus       162 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  241 (457)
                      ++++.++..++++|+..+.||+|+||.||+|+..+|+.||||++..........+.+|++++++++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            44555667788999999999999999999999888999999998876656677899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF  318 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  318 (457)
                      +..++||||+++|+|.+++....   ..+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEeec
Confidence            99999999999999999997654   35899999999999999999999    678999999999999999999999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCC---CCcHHHHHHhhcCch
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLG---EMSLKHWVNQSLPHK  391 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~---~~~l~~~~~~~~~~~  391 (457)
                      |+++...............||+.|+|||    ..++.++||||||+++|||+||+.||....   ......|........
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            9998764433333334456899999999    447889999999999999999999997632   223344433222211


Q ss_pred             -hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          392 -LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       392 -~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                       +.+.+++.+...     ...+++..+.+++.+|++.||++|||+.|+++.|+.+.+
T Consensus       264 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          264 QLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             CCCSSSSSSCTTC-----SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHhcChhhccc-----cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence             233333333221     123567789999999999999999999999999998865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.8e-47  Score=370.17  Aligned_cols=197  Identities=24%  Similarity=0.337  Sum_probs=166.6

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      +....++|+..+.||+|+||+||+|+.+    +++.||||++....  ....+.+|++++..+ +|||||++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3345678999999999999999999753    46789999986543  234678999999998 6999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEeccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGIS  321 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~  321 (457)
                      ..++||||+++|+|.+++..    +++.+...++.|++.||+|||    +.+|+||||||+|||++.+ +.+||+|||+|
T Consensus        94 ~~~lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999999953    889999999999999999999    6789999999999999877 79999999999


Q ss_pred             cccCCCCCc--------------------------ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCC
Q 044428          322 KLLGEGDDS--------------------------LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKK  370 (457)
Q Consensus       322 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~  370 (457)
                      +........                          ...+..+||+.|+|||.+     ++.++||||+||++|||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            865432110                          012235799999999933     6778999999999999999999


Q ss_pred             CCCC
Q 044428          371 PTND  374 (457)
Q Consensus       371 p~~~  374 (457)
                      ||..
T Consensus       246 Pf~~  249 (361)
T 4f9c_A          246 PFYK  249 (361)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            9964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.6e-46  Score=363.58  Aligned_cols=279  Identities=35%  Similarity=0.514  Sum_probs=232.1

Q ss_pred             cccccCHHHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeee
Q 044428          159 TWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSG  237 (457)
Q Consensus       159 ~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  237 (457)
                      ....+++.++....++|...+.||+|+||.||+|+..+|+.||||++..... .....+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            4567899999999999999999999999999999988899999999976532 223368999999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEE
Q 044428          238 CSNLDFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAH  314 (457)
Q Consensus       238 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~k  314 (457)
                      +...+..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||..+ .++|+||||||+||+++.++.+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEE
Confidence            999999999999999999999998654   34899999999999999999999543 34899999999999999999999


Q ss_pred             EeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCC-----CCCCcHHHHHH
Q 044428          315 VSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTND-----LGEMSLKHWVN  385 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~-----~~~~~l~~~~~  385 (457)
                      |+|||+++....... .......||+.|+|||.    .++.++||||||+++|||+||+.||..     ........|+.
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            999999987643322 23344669999999993    368899999999999999999999962     34556677776


Q ss_pred             hhcCch-hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 044428          386 QSLPHK-LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK  444 (457)
Q Consensus       386 ~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~  444 (457)
                      ...... .....+..+....     ..+++..+.+++.+|++.||++|||+.||++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNY-----KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSC-----CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhhchhhhhhcChhhcccc-----CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            655544 4444454443222     23457789999999999999999999999999975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.5e-46  Score=387.58  Aligned_cols=247  Identities=23%  Similarity=0.267  Sum_probs=204.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+|+++|+.++|||||++++++.+.+..++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            68999999999999999999875 79999999998765555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC--CcEEEeccccccccCCCCC
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN--MVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~~~~~~~~~~  329 (457)
                      ++|+|.+++......+++.+...++.||+.||+|||    ..+|+||||||+|||++.+  +.+||+|||+++.+.... 
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            999999999876666999999999999999999999    6789999999999999854  899999999999875432 


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        .....+||+.|+|||.+    ++.++||||+||++|||++|+.||...........+....         ..+..   
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~---------~~~~~---  377 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD---------WNMDD---  377 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC---------CCCCS---
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC---------CCCCc---
Confidence              23346799999999944    6779999999999999999999997654322222221110         00000   


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        .........+.+|+.+||+.||++|||+.|+++
T Consensus       378 --~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              001112345789999999999999999999976

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.2e-45  Score=351.89  Aligned_cols=278  Identities=29%  Similarity=0.476  Sum_probs=226.5

Q ss_pred             cccccCHHHHHHHhhcCCcC------CccCCCCceEEEEEEeCCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCC
Q 044428          159 TWRRISYLDIQRATNEFDEC------NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNVRH  228 (457)
Q Consensus       159 ~~~~~~~~~l~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h  228 (457)
                      ....+++.++..++++|...      +.||+|+||.||+|+. +++.||||++....    ......+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999999887      8899999999999997 68899999987532    2345678999999999999


Q ss_pred             CccceeeeeeecCCeeEEEEeccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       229 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      |||+++++++...+..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||    ..+++||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHEE
Confidence            99999999999999999999999999999999753  245899999999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LKH  382 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~~  382 (457)
                      ++.++.+||+|||+++...............||+.|+|||.+   ++.++||||||+++|||++|+.||....... +..
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            999999999999999876544333333446799999999933   6789999999999999999999998643322 222


Q ss_pred             HHHhh--cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          383 WVNQS--LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       383 ~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      +....  ....+.+.+++.+...      ...++..+.+++.+|++.+|.+||++.+|++.|+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMNDA------DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSCC------CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhhhhhhhhhhcccccccc------chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            22211  1122445555443221      23456779999999999999999999999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.7e-46  Score=361.34  Aligned_cols=269  Identities=23%  Similarity=0.318  Sum_probs=207.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----eeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD----FKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  247 (457)
                      .++|+..+.||+|+||.||+|+.. ++.||||++..... ....+.+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            367888899999999999999985 78999999975532 3345567999999999999999999998744    46999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC----------CeeeccCCCCCeeecCCCcEEEec
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA----------PIIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~----------~ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                      |||+++|+|.+++....  +++..+..++.|++.||.|||    ..          +|+||||||+|||++.++.+||+|
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH----~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH----EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT----CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999998765  899999999999999999999    55          899999999999999999999999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCCC---------CCccchhhhhHHHHHHhcCCCCCCCCCCCc---HHHHHH
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGIV---------STKCDVYSYGILLLETFSRKKPTNDLGEMS---LKHWVN  385 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~---l~~~~~  385 (457)
                      ||+++...............||+.|+|||.+.         +.++|||||||++|||+||+.||.......   ......
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            99998775543333334467999999999543         347899999999999999999997632211   111111


Q ss_pred             hhcCc-hhHHhc-cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          386 QSLPH-KLAEVV-DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       386 ~~~~~-~~~~~~-d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      ..... .+.+.+ ................++..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            10000 011111 1111111111112234567799999999999999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.4e-45  Score=350.13  Aligned_cols=261  Identities=24%  Similarity=0.367  Sum_probs=211.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+|+.. +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357888899999999999999975 6899999998766666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++|+|.+++......+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999987667999999999999999999999    678999999999999999999999999999876433221


Q ss_pred             c------------eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          331 L------------IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       331 ~------------~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      .            ......||+.|+|||.    .++.++||||||+++|||++|..|+........      ........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~------~~~~~~~~  238 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------DFGLNVRG  238 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT------TSSBCHHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH------HHhhhhhc
Confidence            1            0113579999999993    368899999999999999999999865321110      00001111


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      ..+....         ..++..+.+++.+|++.||++|||+.++++.|+++++....
T Consensus       239 ~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          239 FLDRYCP---------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             HHHHTCC---------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            1111111         12244588999999999999999999999999999887654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.9e-46  Score=382.77  Aligned_cols=243  Identities=20%  Similarity=0.282  Sum_probs=193.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHH---HHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSF---NSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++.+..   ......+   ..++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999875 79999999997542   1122223   33466777889999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||++||+|.++|.... .+++.....++.||+.||+|||    ..+||||||||+|||++.+|++||+|||+|+.+.
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999998764 4899999999999999999999    7889999999999999999999999999999765


Q ss_pred             CCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ...    ....+||+.|||||.+     ++.++||||+||++|||++|+.||......+........        .....
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--------~~~~~  411 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------LTMAV  411 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--------HHCCC
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--------cCCCC
Confidence            432    2346899999999943     678999999999999999999999764333322211111        01100


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAA  439 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~  439 (457)
                      . ...      .....+.+++.+|++.||.+|++     +.||.
T Consensus       412 ~-~p~------~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          412 E-LPD------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             C-CCT------TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             C-CCc------cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            0 000      11345789999999999999998     56664

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.1e-45  Score=359.77  Aligned_cols=259  Identities=23%  Similarity=0.415  Sum_probs=211.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe--------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL--------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  241 (457)
                      .++|...+.||+|+||.||+|+.        .++..||||+++... ......+.+|+++++++ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            36788889999999999999985        245679999997653 34456799999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||    ..+|+||||||+|||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL  235 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhEE
Confidence            99999999999999999998653               24789999999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLK  381 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~  381 (457)
                      ++.++.+||+|||+++...............+|+.|+|||.    .++.++|||||||++|||+| |+.||.......+.
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999999997654333323334567889999993    37889999999999999999 99999765443333


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      ..+......        ..         +..++..+.+++.+||+.+|++||++.|+++.|+++.....+
T Consensus       316 ~~~~~~~~~--------~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~  368 (370)
T 2psq_A          316 KLLKEGHRM--------DK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  368 (370)
T ss_dssp             HHHHTTCCC--------CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHhcCCCC--------CC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence            322221110        00         112355689999999999999999999999999999876544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-45  Score=365.65  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=209.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|...+.||+|+||.||+|++. +++.||||+++... ......|.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888899999999999999986 78999999987553 2334578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++......+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999876666899999999999999999999    67899999999999999999999999999986543211


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ........+++.|+|||.    .++.++|||||||++|||+| |+.||...........+.....          +    
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------~----  334 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR----------L----  334 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC----------C----
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------C----
Confidence            111122345788999993    36789999999999999999 9999976543222222221110          0    


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                         ..+..++..+.+++.+||+.||++|||+.++++.|++++++.
T Consensus       335 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          335 ---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence               001123556899999999999999999999999999998763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-45  Score=353.75  Aligned_cols=271  Identities=24%  Similarity=0.406  Sum_probs=206.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  244 (457)
                      .++|+..+.||+|+||.||+|++     .+++.||||++..........+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788889999999999999984     3688999999987766667789999999999999999999999855  3568


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999999887767999999999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCc-ceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-h-HHhcc
Q 044428          325 GEGDDS-LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-L-AEVVD  397 (457)
Q Consensus       325 ~~~~~~-~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-~-~~~~d  397 (457)
                      ...... .......++..|+|||    ..++.++||||||+++|||+||..|+..... ............. . .+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-EFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-HHHHHHCTTCCTHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH-HHHhhhcCccccchhHHHHHH
Confidence            543222 1223355788899999    4478899999999999999999999864211 1111111110000 0 01111


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      . +.. ......+..++..+.+++.+||+.||++|||+.|+++.|++++++.
T Consensus       244 ~-~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          244 L-LKN-NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             H-HHT-TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             H-Hhc-cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            0 000 0001112234567999999999999999999999999999998765

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=352.18  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=207.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+.||+|+||.||+|++.    .+..||||++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56778899999999999999974    34569999998653 34456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999877667999999999999999999999    678999999999999999999999999999987543


Q ss_pred             CCcc-eeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          328 DDSL-IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       328 ~~~~-~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .... ......+|+.|+|||.    .++.++||||||+++|||++ |+.||...........+.....        ..  
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--------~~--  274 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR--------LP--  274 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------CC--
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC--------CC--
Confidence            2221 2233556889999993    36889999999999999999 9999976543322222221110        00  


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                             .+..++..+.+++.+||+.||++||++.+|++.|+.+.+...
T Consensus       275 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          275 -------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                   011235568999999999999999999999999999876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.6e-45  Score=361.43  Aligned_cols=256  Identities=26%  Similarity=0.456  Sum_probs=197.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+.||+|+||.||+|+..    ++..||||+++... ......|.+|+.++++++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57888999999999999999864    57789999997653 34456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++......+++.+++.++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            9999999999999887767999999999999999999999    678999999999999999999999999999876543


Q ss_pred             CCcc-eeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          328 DDSL-IQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       328 ~~~~-~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .... ......+++.|+|||    ..++.++||||||+++|||++ |+.||...........+.            ....
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~------------~~~~  268 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD------------EGYR  268 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH------------TTEE
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------------cCCC
Confidence            2211 112234578899999    347889999999999999998 999997644322222111            1111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ..     .+.+++..+.+++.+||+.+|++||++.+|++.|+++.+..
T Consensus       269 ~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          269 LP-----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             CC-----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CC-----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            00     01123566899999999999999999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.9e-44  Score=347.69  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=210.0

Q ss_pred             cccCHHHHHHHhhc----------CCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC
Q 044428          161 RRISYLDIQRATNE----------FDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR  229 (457)
Q Consensus       161 ~~~~~~~l~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~  229 (457)
                      ..++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++..........+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            46788888888865          666679999999999999986 7999999999876555667789999999999999


Q ss_pred             ccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC
Q 044428          230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE  309 (457)
Q Consensus       230 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~  309 (457)
                      ||+++++++...+..++||||+++|+|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTL  176 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECC
Confidence            9999999999999999999999999999999765  4899999999999999999999    678999999999999999


Q ss_pred             CCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHH
Q 044428          310 NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN  385 (457)
Q Consensus       310 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~  385 (457)
                      ++.+||+|||+++.......  ......||+.|+|||.    .++.++||||||+++|||++|+.||...........+.
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~  254 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR  254 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            99999999999987643221  2234679999999993    36789999999999999999999997644322222221


Q ss_pred             hhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       386 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...        .+.+..       ...++..+.+++.+|++.||++|||+.|+++
T Consensus       255 ~~~--------~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          255 DSP--------PPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HSS--------CCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCC--------CCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111        111110       0112445889999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.3e-44  Score=345.50  Aligned_cols=246  Identities=22%  Similarity=0.303  Sum_probs=203.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999986 57899999999876655567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++|+|.+++....  +++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            99999999998764  899999999999999999999    67899999999999999999999999999987654322 


Q ss_pred             ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                       ......||+.|+|||.    .++.++|||||||++|||+||+.||...........+....        .+.+.     
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~~-----  237 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--------TPELQ-----  237 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------SCCCS-----
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------CCCCC-----
Confidence             2334679999999993    37889999999999999999999997643221111111100        00000     


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        .+..++..+.+++.+|++.||++|||+.|+++
T Consensus       238 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              01122456889999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-44  Score=340.55  Aligned_cols=253  Identities=27%  Similarity=0.392  Sum_probs=209.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|...+.||+|+||.||+|+..+++.||+|++..... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57888899999999999999998899999999976532 34578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++...... ...
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            99999999887777999999999999999999999    6779999999999999999999999999998764321 112


Q ss_pred             eccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....+|+.|+|||    ..++.++||||+|+++|||++ |+.||...........+.....        ...   .   
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------~~~---~---  229 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYK---P---  229 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------CCC---C---
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc--------CCC---C---
Confidence            23356788899999    447889999999999999999 9999976443222222211100        000   0   


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                         ..++..+.+++.+|++.+|++||++.|+++.|+++.+.
T Consensus       230 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          230 ---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence               01134588999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.8e-44  Score=345.91  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..++|+..+.||+|+||.||+|+. +|+.||||++....  ......+.+|++++++++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356788889999999999999987 58899999987543  334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          249 EFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAP--IIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ||+++|+|.+++....  ..+++..++.++.|++.||+|||    ..+  |+||||||+||+++.++.+||+|||+++..
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            9999999999998754  23899999999999999999999    666  999999999999999999999999999865


Q ss_pred             CCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ....  .......||+.|+|||.+    .+.++||||||+++|||+||+.||...........+.....       ...+
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------~~~~  260 (309)
T 3p86_A          190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------RLEI  260 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------CCCC
T ss_pred             cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------CCCC
Confidence            3321  122346799999999933    67899999999999999999999976543222221111000       0000


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                               +..++..+.+++.+||+.+|++|||+.++++.|+.+.+..
T Consensus       261 ---------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          261 ---------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                     0122456889999999999999999999999999886543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.7e-44  Score=339.36  Aligned_cols=254  Identities=26%  Similarity=0.372  Sum_probs=208.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|...+.||+|+||.||+|+..++..||||++..... ....+.+|++++.+++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467888899999999999999999888999999976532 3456899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++....... .
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V  160 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence            999999999877666999999999999999999999    67899999999999999999999999999987654322 2


Q ss_pred             eeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......+|+.|+|||.    .++.++||||||+++|||+| |+.||...........+.....           ....  
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~--  227 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-----------LYRP--  227 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-----------CCCC--
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-----------CCCC--
Confidence            2334567788999994    36889999999999999999 9999976443222211111100           0000  


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                          ..++..+.+++.+|++.+|++|||+.|+++.|+.++++
T Consensus       228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                01134588999999999999999999999999988765

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=351.95  Aligned_cols=264  Identities=26%  Similarity=0.418  Sum_probs=209.7

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL  241 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  241 (457)
                      ....++|...+.||+|+||.||+|+..      +++.||||+++... ......+.+|+.++++++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            334578999999999999999999874      34889999998653 33456799999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHC  298 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~  298 (457)
                      +..++||||+++|+|.+++....                       ..+++.+++.++.|++.||.|||    ..+|+||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~ivH~  198 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHR  198 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCS
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecC
Confidence            99999999999999999998642                       45899999999999999999999    6789999


Q ss_pred             cCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCC
Q 044428          299 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTN  373 (457)
Q Consensus       299 dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~  373 (457)
                      ||||+||+++.++.+||+|||+++...............+|+.|+|||    ..++.++||||||+++|||+| |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            999999999999999999999998764432222233466899999999    447889999999999999999 999997


Q ss_pred             CCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhhh
Q 044428          374 DLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDV  453 (457)
Q Consensus       374 ~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~~  453 (457)
                      ..........+..           ......      +..++..+.+++.+||+.+|++||++.++++.|+++.+++...+
T Consensus       279 ~~~~~~~~~~~~~-----------~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~~  341 (343)
T 1luf_A          279 GMAHEEVIYYVRD-----------GNILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTV  341 (343)
T ss_dssp             TSCHHHHHHHHHT-----------TCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC------
T ss_pred             CCChHHHHHHHhC-----------CCcCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhhc
Confidence            6443222222111           111000      01234568999999999999999999999999999988776543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.1e-44  Score=347.80  Aligned_cols=255  Identities=24%  Similarity=0.417  Sum_probs=201.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCE----EEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|+..+.||+|+||.||+|++. +|+.    ||+|.+.... ......+.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57888899999999999999864 4443    5888876433 344567999999999999999999999998765 789


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+||+++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999987777999999999999999999999    67899999999999999999999999999998765


Q ss_pred             CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........+|+.|+|||    ..++.++|||||||++|||+| |+.||.......+...+......           
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  238 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-----------  238 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-----------
Confidence            44433344466788999999    447889999999999999999 99999875544443333321110           


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                       ..     +..++..+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus       239 -~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          239 -PQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -CC-----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -CC-----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence             00     1112456889999999999999999999999999886543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.5e-44  Score=338.72  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|...+.||+|+||.||+|+..++..||+|++..... ....+.+|++++.+++||||+++++++...+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            467888899999999999999999888999999976532 3456899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  176 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  176 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence            999999999875556999999999999999999999    6789999999999999999999999999998764321 11


Q ss_pred             eeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......+|+.|+|||    ..++.++||||||+++|||+| |+.||...........+.....        ...    . 
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~----~-  243 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------LYR----P-  243 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--------CCC----C-
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--------CCC----C-
Confidence            223355788899999    347889999999999999998 9999976543222222221110        000    0 


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                          ..++..+.+++.+|++.+|++|||+.++++.|.++.++
T Consensus       244 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          244 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                01134588999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-43  Score=345.52  Aligned_cols=243  Identities=23%  Similarity=0.309  Sum_probs=200.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46789999999999999999997 589999999997543  334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++...+ .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999997654 4899999999999999999999    6789999999999999999999999999998765432


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .   .....||+.|+|||.+     .+.++||||+||++|||++|+.||.......+...+..           .... .
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-----------~~~~-~  233 (328)
T 3fe3_A          169 K---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR-----------GKYR-I  233 (328)
T ss_dssp             G---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------CCCC-C
T ss_pred             c---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------CCCC-C
Confidence            2   3446799999999943     35789999999999999999999976442222221111           0000 0


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..      .++..+.+++.+|++.||.+|||+.|+++
T Consensus       234 p~------~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          234 PF------YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CT------TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CC------CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00      11345789999999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.1e-44  Score=351.43  Aligned_cols=266  Identities=23%  Similarity=0.354  Sum_probs=212.2

Q ss_pred             cCHHHHHHHhhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcccee
Q 044428          163 ISYLDIQRATNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKI  234 (457)
Q Consensus       163 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  234 (457)
                      +...+.....++|...+.||+|+||.||+|++      .+++.||||+++... ......+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455556678999999999999999999974      256889999997643 33456799999999999 79999999


Q ss_pred             eeeeecCC-eeEEEEeccCCCCHHHHHhhCCC------------------------------------------------
Q 044428          235 LSGCSNLD-FKALVLEFMPNGSLEKWLYSHNY------------------------------------------------  265 (457)
Q Consensus       235 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  265 (457)
                      ++++...+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988755 48999999999999999986532                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          266 -----------------FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       266 -----------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                                       .+++..++.++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                             1889999999999999999999    6789999999999999999999999999998765444


Q ss_pred             CcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcH-HHHHHhhcCchhHHhccccccc
Q 044428          329 DSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSL-KHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l-~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .........||+.|+|||    ..++.++||||||+++|||+| |+.||........ ...+....        ..... 
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~-  318 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------RMRAP-  318 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--------CCCCC-
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--------CCCCC-
Confidence            433444567899999999    447889999999999999999 9999976432211 11111100        00000 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                              ..++..+.+++.+|++.||++|||+.|+++.|+++.+..
T Consensus       319 --------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          319 --------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                    112446889999999999999999999999999988754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=351.51  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=210.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  241 (457)
                      .++|...+.||+|+||.||+|+..        ++..||||++.... ......+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            367888899999999999999852        34679999997653 33456789999999999 999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||    ..+|+||||||+|||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcceEE
Confidence            99999999999999999998754               34899999999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLK  381 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~  381 (457)
                      ++.++.+||+|||+++...............+|+.|+|||.    .++.++|||||||++|||++ |+.||.......+.
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987755433333445668899999993    47889999999999999999 99999764432222


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ..+.....        ...         +..++..+.+++.+||+.+|++|||+.||++.|+++....
T Consensus       304 ~~~~~~~~--------~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          304 KLLKEGHR--------MDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHHTTCC--------CCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHcCCC--------CCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            22221110        000         0122456899999999999999999999999999987653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.2e-44  Score=352.37  Aligned_cols=266  Identities=14%  Similarity=0.136  Sum_probs=207.5

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCC------CCEEEEEEecccchhh-----------HHHHHHHHHHHhhcCCCccce
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSD------GTNVAIKIFNLQLERT-----------FVSFNSECEVLRNVRHRNLIK  233 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  233 (457)
                      ..++|...+.||+|+||.||+|++.+      ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34589999999999999999998764      4789999987543211           123445666777889999999


Q ss_pred             eeeeeecC----CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-
Q 044428          234 ILSGCSNL----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-  308 (457)
Q Consensus       234 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-  308 (457)
                      +++++...    ...++||||+ +++|.+++......+++..++.++.|++.||.|||    ..+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEec
Confidence            99998764    4589999999 99999999887667999999999999999999999    67899999999999999 


Q ss_pred             -CCCcEEEeccccccccCCCCCcc-----eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCC-CC
Q 044428          309 -ENMVAHVSDFGISKLLGEGDDSL-----IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDL-GE  377 (457)
Q Consensus       309 -~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~-~~  377 (457)
                       .++.+||+|||+++.+.......     ......||+.|+|||.+    ++.++|||||||++|||+||+.||... ..
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998764322111     11234599999999933    678999999999999999999999853 22


Q ss_pred             CcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          378 MSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       378 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ..............+.+++++.+...        .++..+.+++..|++.+|++||++.++++.|+++.++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAA--------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTT--------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccc--------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            22333333333333445554443211        12556899999999999999999999999999988764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-43  Score=341.55  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=210.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .++|...+.||+|+||.||+|+.      .++..||||++.... ......+.+|++++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788889999999999999986      245889999997643 34456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 044428          245 ALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLK  301 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk  301 (457)
                      ++||||+++|+|.+++....                       ..+++..++.++.|++.||.|||    ..+|+|||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dik  177 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHRDLA  177 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECCCCS
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCcccccc
Confidence            99999999999999998653                       23789999999999999999999    6789999999


Q ss_pred             CCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCC
Q 044428          302 PSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLG  376 (457)
Q Consensus       302 ~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~  376 (457)
                      |+||+++.++.+||+|||+++...............+++.|+|||.+    ++.++||||||+++|||+| |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999877554333333445678899999943    7889999999999999999 999997655


Q ss_pred             CCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          377 EMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       377 ~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      ...+...+.......        .         +..++..+.+++.+|++.||++||++.|+++.|+++.++
T Consensus       258 ~~~~~~~~~~~~~~~--------~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          258 PERLFNLLKTGHRME--------R---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGGHHHHHHTTCCCC--------C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhhcCCcCC--------C---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            444333332211100        0         012245689999999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=353.90  Aligned_cols=257  Identities=23%  Similarity=0.363  Sum_probs=207.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|...+.||+|+||.||+|++.      ++..||||++.... ......+.+|+.++++++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            57888899999999999999853      46789999997542 344557899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC---cEEEe
Q 044428          246 LVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM---VAHVS  316 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~---~~kl~  316 (457)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||+|||    ..+|+||||||+|||++.++   .+||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999998643      35899999999999999999999    67899999999999999544   59999


Q ss_pred             ccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCch
Q 044428          317 DFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       317 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      |||+++...............+|+.|+|||.    .++.++|||||||++|||+| |+.||.......+...+...... 
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~-  305 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-  305 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9999986533222222334567999999993    47889999999999999998 99999765433322222211100 


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                                ..      +..++..+.+++.+||+.+|++||++.+|++.|+.+.+...
T Consensus       306 ----------~~------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          306 ----------DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             ----------CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ----------CC------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                      00      11234568899999999999999999999999999877553

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.1e-43  Score=336.81  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=197.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCccceeeeeeec----CCeeE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRN--VRHRNLIKILSGCSN----LDFKA  245 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  245 (457)
                      .++|...+.||+|+||.||+|+. +|+.||||++....   ...+.+|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46889999999999999999998 68999999987542   3445667777766  799999999998654    35689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA----LAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      +||||+++|+|.+++...  .+++..++.++.|++.||+|||....    ..+|+||||||+|||++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  48999999999999999999993211    467999999999999999999999999999


Q ss_pred             cccCCCCCcc--eeccccccccccCCCCCC----------CCccchhhhhHHHHHHhcC----------CCCCCCCC--C
Q 044428          322 KLLGEGDDSL--IQTKTMATIGYMAPEGIV----------STKCDVYSYGILLLETFSR----------KKPTNDLG--E  377 (457)
Q Consensus       322 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~----------~~~~Dv~s~Gvvl~el~tg----------~~p~~~~~--~  377 (457)
                      +.........  ......||+.|+|||.+.          +.++|||||||++|||+||          +.||....  .
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8764433221  122357999999999442          2589999999999999999          77876522  1


Q ss_pred             CcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          378 MSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       378 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      .............    ...+.+.    .......++..+.+++.+||+.||++|||+.||++.|++|
T Consensus       241 ~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVD----QQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhcc----CCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            1111111111000    0011111    0111224567899999999999999999999999999876

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-43  Score=337.66  Aligned_cols=255  Identities=25%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            57888999999999999999864 78999999986432   334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++......
T Consensus        91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999999998764 4899999999999999999999    6789999999999999999999999999998764322


Q ss_pred             CcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      . .......||+.|+|||    ..++.++||||||+++|||+||+.||......................-.        
T Consensus       166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  236 (294)
T 4eqm_A          166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV--------  236 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS--------
T ss_pred             c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhc--------
Confidence            1 1223356999999999    33678999999999999999999999764321111100000000000000        


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERI-HTTNAAAKLRKIK  446 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-s~~ev~~~L~~i~  446 (457)
                           ..+++..+.+++.+|++.||++|| ++.++.+.|+.+.
T Consensus       237 -----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          237 -----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             -----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             -----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                 012245689999999999999999 8999998888754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-43  Score=339.83  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+..+.||+|+||.||+|+..+|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46788999999999999999999889999999997543  2234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |++ |+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            997 5899988877767999999999999999999999    67899999999999999999999999999987643222


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHHhcc---
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAEVVD---  397 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~~~d---  397 (457)
                        ......||+.|+|||.+     ++.++|||||||++|||++|+.||......+....+......    .+....+   
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence              22345789999999932     578899999999999999999999875554444333222111    0111100   


Q ss_pred             ---cccc--ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 ---SNLV--RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ---~~l~--~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         ....  ...........+..++.+++.+|++.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               0000  000000001112346789999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-43  Score=358.47  Aligned_cols=248  Identities=30%  Similarity=0.422  Sum_probs=204.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-eeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD-FKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+|++. |+.||||+++...  ....|.+|++++++++||||+++++++...+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888899999999999999985 7899999997653  4567999999999999999999999987665 78999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++..... .+++..++.++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999999987653 4789999999999999999999    678999999999999999999999999999864321  


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                         .....+++.|+|||.    .++.++|||||||++|||+| |+.||...........+......              
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------------  405 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------------  405 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC--------------
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence               122357889999993    47889999999999999999 99999875544443333221110              


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                         ..+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       406 ---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          406 ---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence               01113456789999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-43  Score=334.09  Aligned_cols=256  Identities=22%  Similarity=0.347  Sum_probs=197.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|+..+.||+|+||.||+|+..    .+..||+|++.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            467888899999999999999874    24579999987643 334567899999999999999999999985 467899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999887767999999999999999999999    67899999999999999999999999999987643


Q ss_pred             CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ... .......+++.|+|||    ..++.++||||||+++|||++ |..||...........+......        .+ 
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--------~~-  238 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--------PM-  238 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------CC-
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC--------CC-
Confidence            221 1223355788999999    347889999999999999997 99999875544433333221100        00 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                              +..++..+.+++.+|++.||++|||+.|+++.|+++.++..
T Consensus       239 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          239 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence                    01234568899999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3e-43  Score=339.65  Aligned_cols=259  Identities=23%  Similarity=0.354  Sum_probs=211.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccch-hhHHHHHHHHHHHhhc-CCCccceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQLE-RTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  243 (457)
                      .++|...+.||+|+||.||+|+.      .+++.||||++..... .....+.+|+.++.++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46788889999999999999985      3578899999976542 3456789999999999 99999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          244 KALVLEFMPNGSLEKWLYSHNY-----------------FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      .++||||+++|+|.+++.....                 .+++..++.++.|++.||.|||    ..+|+||||||+||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNIL  177 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEE
Confidence            9999999999999999987542                 4899999999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcH-
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSL-  380 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l-  380 (457)
                      ++.++.+||+|||+++...............+|+.|+|||    ..++.++||||||+++|||+| |+.||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            9999999999999998875544333334466788999999    447889999999999999999 9999976443221 


Q ss_pred             HHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          381 KHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       381 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      ...+...        .....         +..++..+.+++.+|++.||.+|||+.|+++.|+++.++...
T Consensus       258 ~~~~~~~--------~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          258 YKMIKEG--------FRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             HHHHHHT--------CCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             HHHhccC--------CCCCC---------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence            1111111        00000         011245689999999999999999999999999998876544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.4e-44  Score=363.04  Aligned_cols=254  Identities=23%  Similarity=0.424  Sum_probs=206.9

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ...++|...+.||+|+||.||+|++.++..||||+++... .....|.+|++++++++||||+++++++. .+..++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3456788889999999999999999889999999997643 34678999999999999999999999987 567899999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |+++|+|.+++.... ..+++..++.++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999998543 35889999999999999999999    6779999999999999999999999999998764321


Q ss_pred             CcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                       ........+++.|+|||    ..++.++|||||||++|||+| |+.||...........+....        .  +   
T Consensus       339 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~--~---  404 (454)
T 1qcf_A          339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------R--M---  404 (454)
T ss_dssp             -HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC--------C--C---
T ss_pred             -eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------C--C---
Confidence             11122345688999999    447889999999999999999 999997644322222221110        0  0   


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                          ..+..++..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus       405 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          405 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                0112345678999999999999999999999999988754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=344.95  Aligned_cols=263  Identities=23%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      ..++|...+.||+|+||.||+|+.      .++..||||++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            357888899999999999999986      246689999997543 23456789999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNY----------------------FLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL  300 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dl  300 (457)
                      ..++||||+++|+|.+++.....                      .+++..++.++.|++.||.|||    ..+|+||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Di  198 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDL  198 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTC
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCC
Confidence            99999999999999999986542                      3789999999999999999999    678999999


Q ss_pred             CCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCC
Q 044428          301 KPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDL  375 (457)
Q Consensus       301 k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~  375 (457)
                      ||+||+++.++.+||+|||+++...............+|+.|+|||    ..++.++||||||+++|||+| |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999999998765444333344566788999999    447889999999999999998 99999764


Q ss_pred             CCCc-HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhhhh
Q 044428          376 GEMS-LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDVA  454 (457)
Q Consensus       376 ~~~~-l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~~~  454 (457)
                      .... ....+....        ....         +..++..+.+++.+||+.||.+|||+.|+++.|+.+.....+++.
T Consensus       279 ~~~~~~~~~~~~~~--------~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~  341 (344)
T 1rjb_A          279 PVDANFYKLIQNGF--------KMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMY  341 (344)
T ss_dssp             CCSHHHHHHHHTTC--------CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--------
T ss_pred             CcHHHHHHHHhcCC--------CCCC---------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHHh
Confidence            4221 111111111        0000         011245689999999999999999999999999998777665543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-43  Score=332.03  Aligned_cols=253  Identities=27%  Similarity=0.387  Sum_probs=208.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|...+.||+|+||.||+|+..+++.||+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57888889999999999999998889999999976532 34678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++...... ...
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  161 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  161 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence            99999999887667899999999999999999999    6789999999999999999999999999998764321 112


Q ss_pred             eccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....+++.|+|||    ..++.++||||||+++|||++ |+.||...........+.....        ...   .   
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~--------~~~---~---  227 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYK---P---  227 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------CCC---C---
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc--------CCC---C---
Confidence            23355788999999    447889999999999999999 8999976443222222111110        000   0   


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                         ..++..+.+++.+|++.+|++||++.++++.|+++.+.
T Consensus       228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          228 ---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence               01234588999999999999999999999999998763

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-43  Score=343.06  Aligned_cols=256  Identities=23%  Similarity=0.395  Sum_probs=203.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCE----EEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|...+.||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46788889999999999999864 4554    7888775432 233456788999999999999999999986 456889


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999877666899999999999999999999    67899999999999999999999999999998765


Q ss_pred             CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........++..|+|||    ..++.++||||||+++|||+| |+.||...........+........         
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  238 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---------  238 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---------
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---------
Confidence            44443444567888999999    447889999999999999999 9999987554444333332111000         


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                              +..++..+.+++.+||+.+|++||++.++++.|+.+.....
T Consensus       239 --------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          239 --------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             --------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             --------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                    00123347889999999999999999999999998865443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=339.74  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=202.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467888999999999999999875 68899999987543 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC--CCcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~  328 (457)
                      +++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.  ++.+||+|||+++......
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            9999999999877667999999999999999999999    678999999999999987  7899999999998875432


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .   .....||+.|+|||.+    ++.++|||||||++|||++|+.||...........+....           ..   
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----------~~---  221 (321)
T 1tki_A          159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-----------YT---  221 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----------CC---
T ss_pred             c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC-----------CC---
Confidence            2   2345689999999944    5789999999999999999999997644322222111110           00   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .......+.+..+.+++.+|++.||++|||+.|+++
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000111123456889999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.7e-43  Score=340.83  Aligned_cols=257  Identities=23%  Similarity=0.437  Sum_probs=192.4

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCC-C---CEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSD-G---TNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      ..++|...+.||+|+||.||+|+... +   ..||||++...  .......+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34678999999999999999998753 3   27999999764  334567899999999999999999999999877655


Q ss_pred             ------EEEEeccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcE
Q 044428          245 ------ALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       245 ------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                            ++||||+++|+|.+++....     ..+++..+..++.|++.||.|||    ..+|+||||||+||++++++.+
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcCCCCE
Confidence                  99999999999999996432     25899999999999999999999    6789999999999999999999


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhc
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~  388 (457)
                      ||+|||+++...............+++.|+|||    ..++.++||||||+++|||++ |+.||...........+....
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999998765443333333456788999999    347889999999999999999 999998755444333222211


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .           ...      +..++..+.+++.+|++.||++|||+.++++.|+++.+.
T Consensus       257 ~-----------~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          257 R-----------LKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             C-----------CCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C-----------CCC------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            0           000      012245689999999999999999999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6e-43  Score=340.58  Aligned_cols=259  Identities=18%  Similarity=0.170  Sum_probs=208.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+|+. .+|+.||||++.....  ...+.+|+++++++ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            5788889999999999999986 5789999999875432  34588999999999 999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc-----EEEeccccccccC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV-----AHVSDFGISKLLG  325 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfg~~~~~~  325 (457)
                      + +++|.+++......+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.     +||+|||+++.+.
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            9 99999999976667999999999999999999999    678999999999999998887     9999999999764


Q ss_pred             CCCCcc-----eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          326 EGDDSL-----IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       326 ~~~~~~-----~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ......     ......||+.|+|||.+    ++.++|||||||++|||++|+.||.....................  .
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~--~  239 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA--T  239 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH--S
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc--C
Confidence            432211     12346799999999943    677999999999999999999999875544443332221100000  0


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ...        .....++ .+.+++..|++.+|.+||++.+|.+.|+++.++.
T Consensus       240 ~~~--------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          240 PIE--------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             CHH--------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CHH--------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            000        0000124 6899999999999999999999999999887764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.2e-43  Score=340.62  Aligned_cols=258  Identities=23%  Similarity=0.414  Sum_probs=209.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  241 (457)
                      .++|...+.||+|+||.||+|+..        ++..||||++.... ......+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468888899999999999999863        56789999997653 34456789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||    ..+|+||||||+||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccceEE
Confidence            99999999999999999998653               23889999999999999999999    678999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHH
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLK  381 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~  381 (457)
                      ++.++.+||+|||+++...............+++.|+|||.    .++.++||||||+++|||+| |+.||.......+.
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            99999999999999987754433333344567889999993    37889999999999999999 99999764432222


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      ..+.....        ...         +..++..+.+++.+|++.+|.+||++.|+++.|+++.....
T Consensus       270 ~~~~~~~~--------~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          270 KLLKEGHR--------MDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHTCC--------CCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCC--------CCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            22211110        000         01224568899999999999999999999999999977654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.3e-43  Score=334.57  Aligned_cols=248  Identities=29%  Similarity=0.465  Sum_probs=199.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh-------hHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER-------TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      ++|...+.||+|+||.||+|+.. +++.||+|++......       ....+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            57888899999999999999874 7899999998653221       1267899999999999999999999987665  


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCCeeecCCCc-----EEEec
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP--IIHCDLKPSNILLDENMV-----AHVSD  317 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~--ivH~dlk~~NIll~~~~~-----~kl~D  317 (457)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||    ..+  |+||||||+||+++.++.     +||+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            6999999999999999877777999999999999999999999    666  999999999999988776     99999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      ||+++....     ......||+.|+|||.+      ++.++||||||+++|||++|+.||........... .....  
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~--  244 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-NMIRE--  244 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-HHHHH--
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-HHHhc--
Confidence            999985432     23346799999999965      46689999999999999999999976543332111 10000  


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                        ....+.+         +..++..+.+++.+|++.||++|||+.|+++.|+++
T Consensus       245 --~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 --EGLRPTI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --SCCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --cCCCCCC---------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence              0000111         112345689999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-43  Score=357.48  Aligned_cols=258  Identities=20%  Similarity=0.260  Sum_probs=205.1

Q ss_pred             HHHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 044428          165 YLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSN  240 (457)
Q Consensus       165 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  240 (457)
                      +.++....++|+..++||+|+||+||+|+.. +++.||+|++....   ......+.+|+.++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455556789999999999999999999986 57899999997532   2223348899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      .+..++||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999886566999999999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      ++....... .......||+.|+|||.+         ++.++|||||||++|||++|+.||...........+   ....
T Consensus       222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~  297 (437)
T 4aw2_A          222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNHK  297 (437)
T ss_dssp             CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHH
T ss_pred             hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhcc
Confidence            987644322 223346799999999943         578999999999999999999999764322221111   1000


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE--RIHTTNAAA  440 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPs~~ev~~  440 (457)
                       ...   .+.....      .....+.+++.+|+..+|++  ||++.|+++
T Consensus       298 -~~~---~~p~~~~------~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          298 -ERF---QFPTQVT------DVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             -HHC---CCCSSCC------CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             -ccc---cCCcccc------cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence             000   0000000      11345789999999988888  999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-42  Score=332.80  Aligned_cols=262  Identities=16%  Similarity=0.133  Sum_probs=209.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....  ....+.+|+.++..+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35788899999999999999986 579999999986443  234678899999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc-----EEEecccccccc
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV-----AHVSDFGISKLL  324 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfg~~~~~  324 (457)
                      |+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.     +||+|||+++..
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 99999999987667999999999999999999999    788999999999999987776     999999999876


Q ss_pred             CCCCCc-----ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHh
Q 044428          325 GEGDDS-----LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV  395 (457)
Q Consensus       325 ~~~~~~-----~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~  395 (457)
                      ......     .......||+.|+|||.+    ++.++||||||+++|||++|+.||...................    
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  237 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK----  237 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc----
Confidence            543221     112346799999999933    6789999999999999999999998754333322221111000    


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      .....      ......++..+.+++.+|++.+|++||++.+|++.|+++.++..
T Consensus       238 ~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          238 QSTPL------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHSCH------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCccH------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            00000      00001235568999999999999999999999999999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.8e-43  Score=340.97  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=198.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999876 789999999875432 234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            999999999997654 4899999999999999999999    67899999999999999999999999999987643333


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcH--HHHHHhhcCchhHHhccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL--KHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l--~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ........||+.|+|||.+     .+.++|||||||++|||++|+.||........  ..+.....            ..
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------~~  228 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------YL  228 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT------------TS
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc------------cC
Confidence            3333456799999999943     36689999999999999999999976443221  11111100            00


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .     ....+...+.+++.+|++.||++|||+.|+++
T Consensus       229 ~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          229 N-----PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0     00112445789999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-42  Score=341.46  Aligned_cols=247  Identities=22%  Similarity=0.256  Sum_probs=200.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER------TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .+.|...+.||+|+||.||+|+.. +|+.||+|++......      ....+.+|+.++.+++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467888999999999999999875 6899999999764321      246789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC----cEEEecccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM----VAHVSDFGI  320 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~  320 (457)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||.|||    ..+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            99999999999999997654 5899999999999999999999    67899999999999998777    799999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ++......   ......||+.|+|||.    .++.++|||||||++|||++|..||...........+......      
T Consensus       166 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------  236 (361)
T 2yab_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD------  236 (361)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC------
T ss_pred             ceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Confidence            98765432   1234679999999993    3678999999999999999999999764432222111111000      


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              .........+..+.+++.+|+..||++|||+.|+++
T Consensus       237 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          237 --------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             --------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    000011122456889999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=342.37  Aligned_cols=268  Identities=25%  Similarity=0.423  Sum_probs=209.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--eeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD--FKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  245 (457)
                      ++|...+.||+|+||.||++++     .+|+.||||++..........+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5678889999999999999984     368999999998766666778999999999999999999999886644  789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999987767999999999999999999999    6789999999999999999999999999999875


Q ss_pred             CCCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc-----hhHHh
Q 044428          326 EGDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH-----KLAEV  395 (457)
Q Consensus       326 ~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~-----~~~~~  395 (457)
                      ...... ......++..|+|||.+    ++.++||||||+++|||+||..|+..... ............     .+.+.
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-EFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-HHHHHHCTTCCTHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-HHHHhhccccchhhhHHHHHHH
Confidence            433221 12235578889999943    67899999999999999999998753110 011111000000     01111


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      +.....     ...+..++..+.+++.+||+.+|++||++.|+++.|+++++++.
T Consensus       276 ~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          276 LKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hhcCCC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            111100     00112345678999999999999999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-43  Score=345.00  Aligned_cols=270  Identities=24%  Similarity=0.330  Sum_probs=207.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeee--cCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS--NLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  245 (457)
                      ++|+..+.||+|+||.||+|++     .+++.||||++..........+.+|++++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788889999999999999984     368899999998776666678999999999999999999999886  456789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++++|.+++......+++..++.++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999876556999999999999999999999    6789999999999999999999999999999875


Q ss_pred             CCCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchh---HHhcc
Q 044428          326 EGDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL---AEVVD  397 (457)
Q Consensus       326 ~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~---~~~~d  397 (457)
                      ...... ......+|+.|+|||.+    ++.++||||||+++|||++|+.||..........+.........   .+.+.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            433322 22335688899999943    67899999999999999999999864211100000000000011   11111


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      ......     .+..++..+.+++.+|++.||++|||+.|+++.|+.+......
T Consensus       259 ~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          259 EGQRLP-----APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             TTCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             cccCCC-----CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            111100     1123356789999999999999999999999999988665443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-42  Score=338.57  Aligned_cols=244  Identities=23%  Similarity=0.295  Sum_probs=199.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367888999999999999999875 79999999997642   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++.... .+++.....++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999999998654 4889999999999999999999    678999999999999999999999999999864322


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..  ......||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+..           ..+. .
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-----------~~~~-~  224 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------EEIR-F  224 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------CCCC-C
T ss_pred             CC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc-----------CCCC-C
Confidence            21  23346799999999954    67899999999999999999999976432222111111           1110 0


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      ..      .....+.+++.+|++.||++||     ++.|+++
T Consensus       225 p~------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 PR------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CT------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            00      1234588999999999999999     8888865

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.3e-43  Score=359.27  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=208.0

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+|++. ++..||||+++... .....|.+|+.++++++||||++++++|...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            467888899999999999999986 48899999997653 2456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            99999999998643 45899999999999999999999    6789999999999999999999999999999764322 


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ........+++.|+|||.    .++.++|||||||++|||+| |+.||...........+.....            .. 
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------~~-  439 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------ME-  439 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------CC-
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------CC-
Confidence            122233556789999994    37889999999999999999 9999976554333333222111            00 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                          .+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       440 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          440 ----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                1112356789999999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.9e-43  Score=336.33  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=192.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|...+.||+|+||.||+|+..  ..||||+++...  ......+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            457888899999999999999864  359999987543  34456799999999999999999999965 4556899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++++|.+++......+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999877777999999999999999999999    67899999999999999999999999999987644333


Q ss_pred             cceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HHHHHHhhcCchhHHhcccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ........||+.|+|||.+       ++.++||||||+++|||++|+.||....... ....+....       ..+.+.
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~  248 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-------LSPDLS  248 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS-------CCCCTT
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc-------cCcchh
Confidence            3333446799999999943       4668999999999999999999997643221 111111110       011110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      ..      ...++..+.+++.+|++.+|++|||+.++++.|+++.+
T Consensus       249 ~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 KV------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SS------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hc------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            00      11235668999999999999999999999999998753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=329.77  Aligned_cols=259  Identities=24%  Similarity=0.419  Sum_probs=209.6

Q ss_pred             hcCCcCC-ccCCCCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECN-LLGIGSFGSVYKGTLS---DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+ .||+|+||.||+|...   ++..||||++.... ......+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999863   67889999998653 34456799999999999999999999999 45668999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999877667999999999999999999999    678999999999999999999999999999887543


Q ss_pred             CCcc-eeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          328 DDSL-IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       328 ~~~~-~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .... ......+|+.|+|||.    .++.++||||||+++|||+| |+.||...........+.....        ... 
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~--------~~~-  234 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------MEC-  234 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------CCC-
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc--------CCC-
Confidence            3221 1223457899999993    36889999999999999999 9999976554333333222110        000 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhhh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDV  453 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~~  453 (457)
                              +..++..+.+++.+|++.+|++||++.++++.|+++........
T Consensus       235 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          235 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             --------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence                    01234568999999999999999999999999999987765543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=339.32  Aligned_cols=256  Identities=24%  Similarity=0.408  Sum_probs=200.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCE----EEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTN----VAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|+..+.||+|+||.||+|+.. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57888899999999999999864 4554    5777765432 334567899999999999999999999998765 789


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+||+++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999987777999999999999999999999    67899999999999999999999999999988754


Q ss_pred             CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........+|+.|+|||    ..++.++||||||+++|||++ |+.||.......+...+.......          
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------  239 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----------  239 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence            43333334456788999999    347889999999999999999 999998765544443333221100          


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                       .      +..++..+.+++.+||+.||++||++.|+++.|+++.+...
T Consensus       240 -~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          240 -Q------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             -C------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             -C------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence             0      01124468899999999999999999999999999876543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=335.80  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=200.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER------TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .+.|...+.||+|+||.||+|+.. +|+.||+|++......      ....+.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357888999999999999999975 6899999999754321      356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC----cEEEecccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM----VAHVSDFGI  320 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~  320 (457)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999997653 5899999999999999999999    67899999999999999887    899999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ++.......   .....||+.|+|||.    .++.++|||||||++|||++|+.||...........+.....       
T Consensus       165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------  234 (326)
T 2y0a_A          165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-------  234 (326)
T ss_dssp             CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-------
T ss_pred             CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-------
Confidence            987643321   234679999999993    367899999999999999999999975432222111111100       


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        ..     .......++..+.+++.+|++.||++|||+.|+++
T Consensus       235 --~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 --EF-----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --CC-----CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --Cc-----CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              00     00011122456889999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.4e-43  Score=337.60  Aligned_cols=264  Identities=21%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--Cee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-----SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  244 (457)
                      +.|+..+.||+|+||.||+|++     .+++.||||++.... ......+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578888999999999999984     368999999997543 33456789999999999999999999999876  668


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++|+|.+++......+++..++.++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            9999999999999999776666999999999999999999999    678999999999999999999999999999887


Q ss_pred             CCCCCc-ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC--ch--hHHh
Q 044428          325 GEGDDS-LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--HK--LAEV  395 (457)
Q Consensus       325 ~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~--~~--~~~~  395 (457)
                      ...... .......||..|+|||.+    ++.++||||||+++|||+||..|+...    ...+.....+  ..  ...+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP----MALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH----HHHHHHHHCSCCGGGHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch----hhHHhhccCCcccccCHHHH
Confidence            544322 223346688899999943    677899999999999999999986431    1111111000  00  1111


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      .........  ...+..++..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus       253 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEGKR--LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCC--CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            110000000  0011123556899999999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-42  Score=333.48  Aligned_cols=270  Identities=25%  Similarity=0.367  Sum_probs=201.1

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc--CCCccceeeeeeecC--
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV--RHRNLIKILSGCSNL--  241 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~--  241 (457)
                      ..-....++|...+.||+|+||.||+|+.. |+.||||++....   ...+.+|.+++...  +||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            333445678999999999999999999985 8999999986442   23445566665554  899999999998877  


Q ss_pred             --CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeeeccCCCCCeeecCCCcEEE
Q 044428          242 --DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH----ALAPIIHCDLKPSNILLDENMVAHV  315 (457)
Q Consensus       242 --~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~~~~ivH~dlk~~NIll~~~~~~kl  315 (457)
                        ...++||||+++|+|.+++....  +++..++.++.|++.||.|||...    ..++|+||||||+||+++.++.+||
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence              78899999999999999998764  899999999999999999999421    0128999999999999999999999


Q ss_pred             eccccccccCCCCCcc--eeccccccccccCCCCC----CCC------ccchhhhhHHHHHHhcC----------CCCCC
Q 044428          316 SDFGISKLLGEGDDSL--IQTKTMATIGYMAPEGI----VST------KCDVYSYGILLLETFSR----------KKPTN  373 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~----~~~------~~Dv~s~Gvvl~el~tg----------~~p~~  373 (457)
                      +|||+++.........  ......||+.|+|||.+    .+.      ++|||||||++|||+||          +.||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999998764332221  11245799999999944    223      38999999999999999          55654


Q ss_pred             CCC--CCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          374 DLG--EMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       374 ~~~--~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ...  ..........        +....+...........+++..+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus       264 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          264 DLVPSDPSYEDMREI--------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTSCSSCCHHHHHHH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhcCCCCchhhhHHH--------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            421  1111111111        0011111111111122366888999999999999999999999999999988754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-43  Score=332.09  Aligned_cols=247  Identities=23%  Similarity=0.394  Sum_probs=200.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL--DFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. |+.||||++....  ......+.+|+.++++++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888899999999999999985 8899999997643  33456799999999999999999999999877  7889999


Q ss_pred             eccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGLALEYLHYGHALAP--IIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||+++|+|.+++..... .+++..+..++.|++.||.|||    ..+  ++||||||+||+++.++.++|+|||++....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999987653 5899999999999999999999    566  9999999999999999999999999876532


Q ss_pred             CCCCcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      .       ....||+.|+|||.+       .+.++||||||+++|||++|+.||..............       ....+
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~  230 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-------EGLRP  230 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH-------SCCCC
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh-------cCCCC
Confidence            2       235689999999943       22379999999999999999999976442221111110       00011


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      .+.         ..++..+.+++.+|++.||++|||+.|+++.|+++.+
T Consensus       231 ~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 TIP---------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            110         1124568999999999999999999999999998864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=338.97  Aligned_cols=242  Identities=23%  Similarity=0.252  Sum_probs=191.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|+..++||+|+||+||+|+.. +|+.||||++....  ......+..|+..+.++ +||||++++++|.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            368999999999999999999986 79999999986532  23334556666666665 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+ +++|.+++......+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            9999 78999999887767999999999999999999999    677999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .   ......||++|+|||.+   ++.++|||||||++|||++|..|+....  .... +..           ...    
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~-~~~-----------~~~----  269 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE--GWQQ-LRQ-----------GYL----  269 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH--HHHH-HTT-----------TCC----
T ss_pred             C---CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHH-Hhc-----------cCC----
Confidence            2   22345699999999944   6789999999999999999977764311  1111 110           000    


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       .......++..+.+++.+|++.||++|||+.|+++
T Consensus       270 -~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 -PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             00011122456899999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.6e-43  Score=334.19  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=197.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+|+..+|+.||+|++.....  .....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888899999999999999998899999999875432  2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++ +|.+++......+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            974 999999876667899999999999999999999    67899999999999999999999999999987643211 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHHh-----c
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAEV-----V  396 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~~-----~  396 (457)
                       ......||+.|+|||.+     ++.++|||||||++|||++|+.||...........+......    .+...     .
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence             12335689999999932     678999999999999999999999765432222222111110    00000     0


Q ss_pred             cccccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ++........  ..........+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111000000  0000112456789999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.4e-42  Score=333.69  Aligned_cols=261  Identities=25%  Similarity=0.430  Sum_probs=197.5

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD  242 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  242 (457)
                      ....++|...+.||+|+||.||+|+..    ++..||||++....  ......+.+|+.++++++||||+++++++...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            334567888899999999999999763    34589999997542  334567899999999999999999999987755


Q ss_pred             -----eeEEEEeccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          243 -----FKALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       243 -----~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                           ..++||||+++|+|.+++...     ...+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEECTTSC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCc
Confidence                 349999999999999999532     255899999999999999999999    778999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||+++...............+++.|+|||.    .++.++||||||+++|||++ |..||...........+...
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            99999999987654333233334567889999993    36789999999999999999 88998765544433332221


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      ...        ..         +..++..+.+++.+|++.+|++||++.++++.|+++.++..
T Consensus       266 ~~~--------~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          266 HRL--------KQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             CCC--------CC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCC--------CC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            110        00         01224568999999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=343.17  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=193.4

Q ss_pred             cCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          177 ECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      ..+.||+|+||.||+|+.. +|+.||+|+++.........+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3567999999999999874 789999999987655566789999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee--cCCCcEEEeccccccccCCCCCccee
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      |.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||+  +.++.+||+|||+++.......   .
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~  245 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L  245 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence            99999877666999999999999999999999    6789999999999999  5678999999999998754322   2


Q ss_pred             ccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          334 TKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       334 ~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ....||+.|+|||    ..++.++|||||||++|||++|+.||...........+..           .......   ..
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-----------~~~~~~~---~~  311 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA-----------CRWDLED---EE  311 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----------TCCCSCS---GG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------ccCCCCh---hh
Confidence            3356999999999    3367799999999999999999999976442221111111           1000000   00


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .......+.+++.+|++.||++||++.|+++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1122456889999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-42  Score=337.03  Aligned_cols=264  Identities=23%  Similarity=0.408  Sum_probs=206.6

Q ss_pred             CCcCCccCCCCceEEEEEEeC-----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCeeEE
Q 044428          175 FDECNLLGIGSFGSVYKGTLS-----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFKAL  246 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  246 (457)
                      |...+.||+|+||.||++.+.     +|+.||||++.... ......+.+|++++++++||||+++++++..  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            378889999999999998653     68899999998654 3345678999999999999999999999987  467899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++....  +++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            999999999999998765  899999999999999999999    67899999999999999999999999999998755


Q ss_pred             CCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc------hhHHh
Q 044428          327 GDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH------KLAEV  395 (457)
Q Consensus       327 ~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~------~~~~~  395 (457)
                      ..... ......+|..|+|||.+    ++.++||||||+++|||+||+.||..... ....+  .....      ...+.
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~--~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT-KFLEL--IGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-HHHHH--HCSCCHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch-hhhhh--hcccccchhHHHHHHH
Confidence            43321 22345688899999943    67789999999999999999999864211 00000  00010      01111


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                      +.......     .+..++..+.+++.+||+.||++|||+.|+++.|+++.+++...
T Consensus       264 ~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          264 LERGERLP-----RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHTTCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HhcccCCC-----CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            11111111     11233567899999999999999999999999999999988643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.1e-42  Score=331.61  Aligned_cols=258  Identities=23%  Similarity=0.386  Sum_probs=204.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeee-cCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD----GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCS-NLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l  246 (457)
                      .+|...+.||+|+||.||+|+..+    ...||+|.+.... ......+.+|+.++++++||||+++++++. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            467778899999999999998642    2368999987543 334567899999999999999999999864 5568899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999877667899999999999999999999    67899999999999999999999999999987643


Q ss_pred             CCCc--ceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          327 GDDS--LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       327 ~~~~--~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ....  .......+|+.|+|||    ..++.++||||||+++|||++ |.+||...................        
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  252 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL--------  252 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC--------
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC--------
Confidence            2211  1223456788999999    347889999999999999999 566666555444433332211100        


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                         .      +..++..+.+++.+|++.+|++||++.|+++.|+++..++..
T Consensus       253 ---~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          253 ---Q------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             ---C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             ---C------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence               0      011244688999999999999999999999999999887654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=336.75  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=191.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--------------------------hhHHHHHHHHHHHh
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--------------------------RTFVSFNSECEVLR  224 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~  224 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.....                          .....+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357888999999999999999874 789999999865421                          11356889999999


Q ss_pred             hcCCCccceeeeeeec--CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 044428          225 NVRHRNLIKILSGCSN--LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP  302 (457)
Q Consensus       225 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~  302 (457)
                      +++||||+++++++..  .+..++||||+++++|.+++...  .+++..+..++.|++.||+|||    ..+|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCH
Confidence            9999999999999976  56889999999999998876543  4899999999999999999999    67899999999


Q ss_pred             CCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCCC-------CCccchhhhhHHHHHHhcCCCCCCCC
Q 044428          303 SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-------STKCDVYSYGILLLETFSRKKPTNDL  375 (457)
Q Consensus       303 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~Dv~s~Gvvl~el~tg~~p~~~~  375 (457)
                      +||+++.++.+||+|||+++.......  ......||+.|+|||.+.       +.++|||||||++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999987654322  234467999999999552       56789999999999999999999754


Q ss_pred             CCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          376 GEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       376 ~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....+...+...           ... ...    ...++..+.+++.+|++.||++||++.|+++
T Consensus       244 ~~~~~~~~~~~~-----------~~~-~~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIMCLHSKIKSQ-----------ALE-FPD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHHHHHHHHHHC-----------CCC-CCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHHHHHHHHhcc-----------cCC-CCC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            322111111110           000 000    0012446889999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=344.01  Aligned_cols=248  Identities=22%  Similarity=0.302  Sum_probs=202.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+|... +|+.||+|++..........+.+|++++.+++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467899999999999999999875 7899999999876555556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC--CCcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~  328 (457)
                      +++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.  ++.+||+|||+++......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999999999877667999999999999999999999    678999999999999974  5789999999999865432


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .   .....||+.|+|||.+    ++.++|||||||++|||++|+.||...........+....         ...... 
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------~~~~~~-  272 (387)
T 1kob_A          206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD---------WEFDED-  272 (387)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC---------CCCCSS-
T ss_pred             c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCCcc-
Confidence            2   2335799999999943    6778999999999999999999997644322222111100         000000 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ....++..+.+++.+|++.||++|||+.|+++
T Consensus       273 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          273 ----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                00112456889999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.8e-43  Score=331.26  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=189.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccch----hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE----RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+.. |+.||||++.....    .....+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888899999999999999985 88999999875432    23467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC--------CCcEEEecccc
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE--------NMVAHVSDFGI  320 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~--------~~~~kl~Dfg~  320 (457)
                      ||+++++|.+++...  .+++..+..++.|++.||.|||... ..+++||||||+||+++.        ++.+||+|||+
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~-~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEA-IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSS-SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-CCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999999754  4899999999999999999999533 223999999999999986        77899999999


Q ss_pred             ccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ++......    .....||+.|+|||    ..++.++||||||+++|||++|+.||.............           
T Consensus       163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------  227 (271)
T 3dtc_A          163 AREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-----------  227 (271)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-----------
T ss_pred             cccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-----------
Confidence            98754322    12356899999999    347889999999999999999999997643221111111           


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ........     +..++..+.+++.+|++.+|++|||+.|+++.|++|
T Consensus       228 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNKLALPI-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSCCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCCCCCCC-----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            00000000     112245689999999999999999999999999764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.2e-42  Score=327.53  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=204.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSD----GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|...+.||+|+||.||+|+..+    +..||+|++.... ......+.+|+.++++++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678888999999999999998642    3469999997653 33456799999999999999999999998754 5689


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++....
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999999999999877666899999999999999999999    67899999999999999999999999999987643


Q ss_pred             CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ... .......+++.|+|||    ..++.++||||||+++|||+| |+.||...........+.......          
T Consensus       166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~----------  234 (281)
T 3cc6_A          166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP----------  234 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC----------
T ss_pred             ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC----------
Confidence            221 1223356788999999    447889999999999999998 999997655444333322211100          


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                       .      +..++..+.+++.+|++.+|++||++.|+++.|+++.+.-
T Consensus       235 -~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          235 -K------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             -C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -C------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence             0      0112446889999999999999999999999999987653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-43  Score=345.37  Aligned_cols=258  Identities=23%  Similarity=0.405  Sum_probs=197.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeC--CC--CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCeeEEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS--DG--TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSN-LDFKALV  247 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  247 (457)
                      .|...+.||+|+||.||+|++.  ++  ..||||.++... ......|.+|+.++++++||||++++++|.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4556678999999999999863  22  468999987543 3445679999999999999999999998754 5678999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999877667899999999999999999999    678999999999999999999999999999876432


Q ss_pred             CCc--ceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          328 DDS--LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       328 ~~~--~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ...  .......+|+.|+|||    ..++.++||||||+++|||+| |..||...........+......          
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~----------  315 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----------  315 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC----------
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            211  1123356788999999    447889999999999999999 67788765555544433321110          


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                      . .      +..++..+.+++.+||+.+|++||++.|+++.|+++...+..+
T Consensus       316 ~-~------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          316 L-Q------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             C-C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             C-C------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            0 0      1123456899999999999999999999999999998776543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-43  Score=357.45  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=200.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ..++|...+.||+|+||.||+|++.++..||||+++... .....|.+|++++++++||||+++++++.. +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            346788889999999999999999888889999998653 234679999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||    ..+|+||||||+|||+++++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999997532 45899999999999999999999    67899999999999999999999999999987643221


Q ss_pred             cceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                       .......+++.|+|||    ..++.++|||||||++|||+| |+.||...........+.....          +    
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------~----  400 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------M----  400 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------C----
T ss_pred             -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------C----
Confidence             1223355788999999    447889999999999999999 9999975432222222111100          0    


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                         ..+..++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       401 ---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          401 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence               011134567899999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-42  Score=338.06  Aligned_cols=262  Identities=23%  Similarity=0.355  Sum_probs=210.3

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeCC-C-----CEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLSD-G-----TNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL  241 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  241 (457)
                      ...++|...+.||+|+||.||+|+... +     ..||+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345688889999999999999998642 2     479999997653 33456789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec
Q 044428          242 DFKALVLEFMPNGSLEKWLYSH-------------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD  308 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~  308 (457)
                      +..++||||+++|+|.+++...             ...+++..++.++.|++.||.|||    ..+|+||||||+||+++
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGCEEE
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceEEEC
Confidence            9999999999999999999753             234789999999999999999999    67899999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcH-HH
Q 044428          309 ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSL-KH  382 (457)
Q Consensus       309 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l-~~  382 (457)
                      .++.+||+|||+++...............+|+.|+|||    ..++.++||||||+++|||+| |..||........ ..
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            99999999999998765433333334456788999999    447889999999999999999 9999976432221 11


Q ss_pred             HHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       383 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                      .+....        ..    ..     +..++..+.+++.+|++.+|.+|||+.|+++.|+++.++..++
T Consensus       279 ~~~~~~--------~~----~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  331 (333)
T 2i1m_A          279 LVKDGY--------QM----AQ-----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE  331 (333)
T ss_dssp             HHHHTC--------CC----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCC--------CC----CC-----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence            111111        00    00     0012456889999999999999999999999999998876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=343.56  Aligned_cols=244  Identities=25%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+++.. +++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67888999999999999999875 68899999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            9999999999998754 4899999999999999999999    6789999999999999999999999999998764332


Q ss_pred             CcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                         ......||+.|+|||.+       ++.++|||||||++|||++|+.||................         ....
T Consensus       170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---------~~~~  237 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---------TTVV  237 (384)
T ss_dssp             ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---------HCCC
T ss_pred             ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---------hccc
Confidence               23446799999999955       5778999999999999999999997654443333222110         0000


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIH-TTNAA  439 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-~~ev~  439 (457)
                      ....      .+...+.+++.+|++.||++||+ +.++.
T Consensus       238 ~~p~------~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          238 TYPS------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             CCCT------TSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             CCCC------cCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            0110      12446889999999999999998 55554

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=333.42  Aligned_cols=266  Identities=23%  Similarity=0.295  Sum_probs=204.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--eeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD--FKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57888899999999999999976 58999999997543 334567889999999999999999999987655  779999


Q ss_pred             eccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee----cCCCcEEEecccccc
Q 044428          249 EFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISK  322 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfg~~~  322 (457)
                      ||+++|+|.+++....  ..+++..+..++.|++.||.|||    ..+|+||||||+||++    +.++.+||+|||+++
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            9999999999998654  33899999999999999999999    6789999999999999    788899999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCC------------CCCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHH---h
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEG------------IVSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVN---Q  386 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~------------~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~---~  386 (457)
                      .......   .....||+.|+|||.            .++.++|||||||++|||+||+.||...... .....+.   .
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            7654322   234569999999993            3577999999999999999999999753221 1111111   1


Q ss_pred             hcCch-hHHh---cccccc---ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          387 SLPHK-LAEV---VDSNLV---RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       387 ~~~~~-~~~~---~d~~l~---~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ..+.. +..+   ....+.   ...............+.+++.+|++.||++|||+.|+++...+.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11111 0000   000000   00000111234567789999999999999999999999887653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.4e-43  Score=341.93  Aligned_cols=266  Identities=23%  Similarity=0.384  Sum_probs=211.7

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeee
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGC  238 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~  238 (457)
                      .+.....++|...+.||+|+||.||+|+..      +++.||||++.... ......+.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344455678999999999999999999764      37889999997543 23445789999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC
Q 044428          239 SNLDFKALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE  309 (457)
Q Consensus       239 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~  309 (457)
                      ...+..++||||+++|+|.+++....         ..+++..++.++.|++.||.|||    ..+|+||||||+||+++.
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEEcC
Confidence            99999999999999999999997532         34689999999999999999999    678999999999999999


Q ss_pred             CCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHH
Q 044428          310 NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWV  384 (457)
Q Consensus       310 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~  384 (457)
                      ++.+||+|||+++...............+|+.|+|||    ..++.++||||||+++|||+| |+.||...........+
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            9999999999998764332222223355788999999    347889999999999999999 89998764432222221


Q ss_pred             HhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          385 NQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       385 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                      ..           .......      ..++..+.+++.+|++.+|++|||+.|+++.|+++.+.+..+
T Consensus       254 ~~-----------~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~  304 (322)
T 1p4o_A          254 ME-----------GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  304 (322)
T ss_dssp             HT-----------TCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             Hc-----------CCcCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence            11           1111111      122456889999999999999999999999998876554443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=346.88  Aligned_cols=250  Identities=20%  Similarity=0.285  Sum_probs=201.1

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ...++|+..+.||+|+||.||+|... +|+.+|+|++....  ......+.+|++++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999864 78999999987543  3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~  323 (457)
                      ||||+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+|||++   .++.+||+|||+++.
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999998764 4899999999999999999999    67899999999999998   467899999999987


Q ss_pred             cCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ......  ......||+.|+|||.    .++.++||||+||++|||++|+.||.......+...+......         
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------  231 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD---------  231 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---------
Confidence            644322  2234679999999993    3788999999999999999999999765433222222111100         


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...     .....++..+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 FPS-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCc-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000     001122456889999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.1e-42  Score=339.77  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=201.2

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ..++|...+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4578999999999999999999875 68999999997542  33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC---CcEEEecccccccc
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN---MVAHVSDFGISKLL  324 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~~~~~  324 (457)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.+   +.+||+|||+++..
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999998654 4899999999999999999999    6789999999999999865   45999999999876


Q ss_pred             CCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ....   ......||+.|+|||.    .++.++|||||||++|||++|+.||.......+...+......         .
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------~  249 (362)
T 2bdw_A          182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD---------Y  249 (362)
T ss_dssp             TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------C
T ss_pred             cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------C
Confidence            5322   1234679999999993    3778999999999999999999999765432222222111100         0


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                           .......++..+.+++.+|++.||++||++.|+++.
T Consensus       250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 000011224568899999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=341.45  Aligned_cols=239  Identities=23%  Similarity=0.282  Sum_probs=191.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++...   ......+.+|.+++..+ +||||+++++++...+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999875 68999999997642   33455678999999988 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999999998754 4899999999999999999999    67899999999999999999999999999986432


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ..  .......||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+.           .....-
T Consensus       177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-----------~~~~~~  243 (353)
T 3txo_A          177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-----------NDEVVY  243 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----------HCCCCC
T ss_pred             CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH-----------cCCCCC
Confidence            21  223346799999999944    7889999999999999999999997654322221111           111100


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                       ..      .....+.+++.+|++.||++||++
T Consensus       244 -p~------~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          244 -PT------WLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             -CT------TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             -CC------CCCHHHHHHHHHHhhhCHHHccCC
Confidence             00      113457899999999999999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=336.60  Aligned_cols=257  Identities=27%  Similarity=0.473  Sum_probs=199.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC-----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD-----GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ++|...+.||+|+||.||+|+...     +..||||++.... ......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            355667899999999999998642     2469999997653 3345578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999999999887667999999999999999999999    67899999999999999999999999999987644


Q ss_pred             CCCcc-eeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          327 GDDSL-IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       327 ~~~~~-~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ..... ......+|+.|+|||.    .++.++||||||+++|||++ |+.||...........+....        .  .
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~--------~--~  269 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF--------R--L  269 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------C--C
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC--------c--C
Confidence            32211 1223456889999993    36789999999999999999 999997644322222111110        0  0


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      .       .+..++..+.+++.+||+.+|++||++.++++.|+++.+...
T Consensus       270 ~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          270 P-------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             C-------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             C-------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            0       011234568999999999999999999999999999876543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=341.51  Aligned_cols=273  Identities=25%  Similarity=0.392  Sum_probs=196.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHH--HHHhhcCCCccceeeeeee-----cCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSEC--EVLRNVRHRNLIKILSGCS-----NLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~--~~l~~l~h~niv~l~~~~~-----~~~~~  244 (457)
                      .++|...+.||+|+||.||+|+. +++.||||++.....   ..+..|.  ..+..++||||+++++++.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36788889999999999999987 689999999975432   2334444  4455689999999997543     23467


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---------CeeeccCCCCCeeecCCCcEEE
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALA---------PIIHCDLKPSNILLDENMVAHV  315 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~---------~ivH~dlk~~NIll~~~~~~kl  315 (457)
                      ++||||+++|+|.+++....  .++..+..++.|++.||.|||    ..         +|+||||||+|||++.++.+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            89999999999999998765  589999999999999999999    55         8999999999999999999999


Q ss_pred             eccccccccCCCCC------cceeccccccccccCCCCCC-----------CCccchhhhhHHHHHHhcCCCCCCCCCCC
Q 044428          316 SDFGISKLLGEGDD------SLIQTKTMATIGYMAPEGIV-----------STKCDVYSYGILLLETFSRKKPTNDLGEM  378 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----------~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~  378 (457)
                      +|||+++.+.....      ........||+.|+|||.+.           +.++|||||||++|||++|..|+......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987643211      11222456999999999543           35799999999999999998776442111


Q ss_pred             c-----HHHHHHhhcCc-hhHHhcccccccc--ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          379 S-----LKHWVNQSLPH-KLAEVVDSNLVRR--EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       379 ~-----l~~~~~~~~~~-~~~~~~d~~l~~~--~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      .     ........... .....+.......  .........++..+.+++.+||+.||++|||+.|+++.|+++...|.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            0     00000000000 0011111000000  00011112356679999999999999999999999999999998887


Q ss_pred             hhhh
Q 044428          451 DDVA  454 (457)
Q Consensus       451 ~~~~  454 (457)
                      ++-.
T Consensus       322 ~~~~  325 (336)
T 3g2f_A          322 RNKS  325 (336)
T ss_dssp             C---
T ss_pred             hccc
Confidence            6543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-42  Score=334.37  Aligned_cols=266  Identities=23%  Similarity=0.359  Sum_probs=212.0

Q ss_pred             CHHHHHHHhhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceee
Q 044428          164 SYLDIQRATNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKIL  235 (457)
Q Consensus       164 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  235 (457)
                      .........++|...+.||+|+||.||+|+.      .+++.||||++.... ......+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344445568899999999999999999974      357899999997653 33456789999999999 799999999


Q ss_pred             eeeecCC-eeEEEEeccCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 044428          236 SGCSNLD-FKALVLEFMPNGSLEKWLYSHNY---------------FLDILERLNIMIDVGLALEYLHYGHALAPIIHCD  299 (457)
Q Consensus       236 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~d  299 (457)
                      +++...+ ..++||||+++|+|.+++.....               .+++..+..++.|++.||.|||    ..+|+|||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~d  173 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRD  173 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCSC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCccccc
Confidence            9987654 58999999999999999987542               2789999999999999999999    67899999


Q ss_pred             CCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCC
Q 044428          300 LKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTND  374 (457)
Q Consensus       300 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~  374 (457)
                      |||+||+++.++.+||+|||+++...............+|+.|+|||    ..++.++||||||+++|||+| |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999999999998765544333344566889999999    347889999999999999998 9999976


Q ss_pred             CCCCc-HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          375 LGEMS-LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       375 ~~~~~-l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      ..... ....+....        .....         ..++..+.+++.+|++.+|.+|||+.|+++.|+++.+...
T Consensus       254 ~~~~~~~~~~~~~~~--------~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          254 VKIDEEFCRRLKEGT--------RMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CCCSHHHHHHHHHTC--------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             cchhHHHHHHhccCc--------cCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            43221 111111110        00000         0124468899999999999999999999999999987653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=350.33  Aligned_cols=257  Identities=19%  Similarity=0.262  Sum_probs=203.1

Q ss_pred             HHHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 044428          165 YLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSN  240 (457)
Q Consensus       165 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  240 (457)
                      +.+.....++|+..+.||+|+||.||+++.. +|+.||||+++...   ......+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4445556789999999999999999999985 79999999997532   2234458899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      .+..++||||+++|+|.+++...+..+++..+..++.||+.||+|||    ..+|+||||||+|||++.++++||+|||+
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999999876556899999999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC-----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI-----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      ++....... .......||+.|+|||.+           ++.++|||||||++|||++|+.||...........+.   .
T Consensus       209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~---~  284 (412)
T 2vd5_A          209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV---H  284 (412)
T ss_dssp             CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---T
T ss_pred             heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH---h
Confidence            987654322 222346799999999943           5789999999999999999999997643222111111   0


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER---IHTTNAAA  440 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~R---Ps~~ev~~  440 (457)
                      .. .....+..         ....+..+.+++.+|+. +|++|   |++.|+.+
T Consensus       285 ~~-~~~~~p~~---------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YK-EHLSLPLV---------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH-HHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cc-cCcCCCcc---------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            00 00000000         01124568899999999 99998   58888753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4e-42  Score=332.97  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=186.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467889999999999999999875 689999999975532 234578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          250 FMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      |++ |+|.+++....     ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            997 69999987532     35889999999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---h-hHHh
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---K-LAEV  395 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~-~~~~  395 (457)
                      .....  ......||+.|+|||.     .++.++|||||||++|||++|+.||...........+......   . +..+
T Consensus       159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            43221  2234578999999993     3678999999999999999999999765433333222221110   0 0000


Q ss_pred             c-----ccccccccc-chh------HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 V-----DSNLVRREH-SFS------AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~-----d~~l~~~~~-~~~------~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .     .+.+..... ...      ........+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0     000000000 000      00012346899999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=334.42  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=195.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|+..+.||+|+||.||+|+.. ++.||||++...  .....|.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            56788889999999999999985 788999998643  345678999999999999999999998874  4799999999


Q ss_pred             CCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc-EEEeccccccccCCCCC
Q 044428          253 NGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV-AHVSDFGISKLLGEGDD  329 (457)
Q Consensus       253 ~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfg~~~~~~~~~~  329 (457)
                      +|+|.+++....  ..+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++. +||+|||++......  
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            999999998765  24788999999999999999999533 278999999999999998886 799999999865322  


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                         .....||+.|+|||.    .++.++||||||+++|||+||+.||........... ....     ....+...    
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~-----~~~~~~~~----  226 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WAVH-----NGTRPPLI----  226 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH-HHHH-----TTCCCCCB----
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH-HHHh-----cCCCCCcc----
Confidence               123468999999993    367899999999999999999999976443221111 1000     00000010    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                           ..++..+.+++.+|++.+|++|||+.++++.|+.+.+.+.
T Consensus       227 -----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          227 -----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             -----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence                 1124568899999999999999999999999999876654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.2e-42  Score=327.73  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=211.5

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ..++|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++++++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567888899999999999999976 58899999997543 345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          250 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      |+++++|.+++.... ..+++..+..++.+++.||.|||    ..+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999998743 45899999999999999999999    6679999999999999999999999999998765432


Q ss_pred             CcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                       ........+|+.|+|||    ..++.++||||||+++|||++ |..||...........+.......            
T Consensus       166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~------------  232 (288)
T 3kfa_A          166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME------------  232 (288)
T ss_dssp             -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC------------
T ss_pred             -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC------------
Confidence             22333456788999999    447889999999999999999 999997655444333332221110            


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      .     +..++..+.+++.+|++.||++|||+.++++.|+++.++.
T Consensus       233 ~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          233 R-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C-----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0     0122456899999999999999999999999999876654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.6e-43  Score=351.09  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=202.7

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL  241 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  241 (457)
                      .++....++|...+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            345556789999999999999999999975 68999999997532   22234588999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      +..++||||+++|+|.+++....  +++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999998754  889999999999999999999    678999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                      +...... ........||+.|+|||.+        ++.++|||||||++|||++|+.||...........+   .... .
T Consensus       216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~~~-~  290 (410)
T 3v8s_A          216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI---MNHK-N  290 (410)
T ss_dssp             EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHH-H
T ss_pred             EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH---Hhcc-c
Confidence            8764432 1223357899999999943        567999999999999999999999764322211111   1000 0


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDE--RIHTTNAAA  440 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPs~~ev~~  440 (457)
                      ..   .....       ......+.+++.+|++.+|++  ||++.||.+
T Consensus       291 ~~---~~p~~-------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 SL---TFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HC---CCCTT-------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cc---cCCCc-------ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            00   00000       011345889999999999998  999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-42  Score=337.83  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++....     ......+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357899999999999999999875 78999999986432     113567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc---EEEeccc
Q 044428          246 LVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV---AHVSDFG  319 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg  319 (457)
                      +||||+++|+|.+++...   ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.   +||+|||
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999888643   245899999999999999999999    678999999999999986654   9999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHh
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV  395 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~  395 (457)
                      +++......  .......||+.|+|||.+    ++.++|||||||++|||++|+.||.....    ....        .+
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~--------~i  244 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE--------GI  244 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH--------HH
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH--------HH
Confidence            998765432  123346799999999933    68899999999999999999999975321    1111        11


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ......   .........+..+.+++.+|++.||++|||+.|+++
T Consensus       245 ~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKYK---MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCCC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCC---CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110000   000011123456889999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.2e-42  Score=332.90  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=192.9

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD------  242 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  242 (457)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4568899999999999999999986 89999999997543 334567999999999999999999999885543      


Q ss_pred             ---------------------------------------------------eeEEEEeccCCCCHHHHHhhCC--CCCCH
Q 044428          243 ---------------------------------------------------FKALVLEFMPNGSLEKWLYSHN--YFLDI  269 (457)
Q Consensus       243 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~l~~  269 (457)
                                                                         ..++||||+++|+|.+++....  ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               3799999999999999998764  33567


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc----------ceecccccc
Q 044428          270 LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS----------LIQTKTMAT  339 (457)
Q Consensus       270 ~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt  339 (457)
                      ..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++........          .......||
T Consensus       164 ~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             HHHHHHHHHHHHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            778999999999999999    678999999999999999999999999999987543221          112335799


Q ss_pred             ccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHH
Q 044428          340 IGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLL  415 (457)
Q Consensus       340 ~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~  415 (457)
                      +.|+|||.    .++.++||||||+++|||++|..|+..     ......        .......      .........
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~--------~~~~~~~------~~~~~~~~~  300 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIIT--------DVRNLKF------PLLFTQKYP  300 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHH--------HHHTTCC------CHHHHHHCH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHH--------HhhccCC------CcccccCCh
Confidence            99999993    478899999999999999998776421     000000        1101000      011223345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          416 RIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       416 ~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.+++.+|++.||++|||+.|+++
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhh
Confidence            6789999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-42  Score=328.91  Aligned_cols=257  Identities=22%  Similarity=0.359  Sum_probs=203.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee-EEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DG---TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK-ALV  247 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  247 (457)
                      .|...+.||+|+||.||+|+.. ++   ..||+|++.... ......+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4555678999999999999853 22   379999987543 33456789999999999999999999999876655 999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+.+|+|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999886667899999999999999999999    678999999999999999999999999999865432


Q ss_pred             CCc--ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCC-CCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          328 DDS--LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKP-TNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       328 ~~~--~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p-~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ...  .......+++.|+|||.    .++.++||||||+++|||++|..| |...........+.......         
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---------  248 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---------  248 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---------
Confidence            211  12233567899999993    367899999999999999995555 44444433333333221110         


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                        .      +..++..+.+++.+|++.+|++|||+.++++.|+++.++...
T Consensus       249 --~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          249 --Q------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             --C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             --C------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence              0      011244688999999999999999999999999999887654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=360.88  Aligned_cols=250  Identities=24%  Similarity=0.433  Sum_probs=200.4

Q ss_pred             ccCCCCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          180 LLGIGSFGSVYKGTLS---DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .||+|+||.||+|.+.   ++..||||+++... ......|.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999864   56789999998653 3356789999999999999999999999976 56899999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc-eec
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-IQT  334 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  334 (457)
                      |.+++......+++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            99999877667999999999999999999999    6789999999999999999999999999998764432211 122


Q ss_pred             cccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhH
Q 044428          335 KTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSA  409 (457)
Q Consensus       335 ~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  409 (457)
                      ...+++.|+|||    ..++.++|||||||++|||+| |+.||...........+.....          +       ..
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----------~-------~~  560 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------M-------EC  560 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC----------C-------CC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------C-------CC
Confidence            344678999999    447889999999999999998 9999987554433333322110          0       00


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          410 KMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       410 ~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      +..++..+.+++.+||+.+|++||++.+|++.|+.+......
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            113456789999999999999999999999999988766543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9e-42  Score=330.37  Aligned_cols=241  Identities=26%  Similarity=0.343  Sum_probs=198.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367888999999999999999875 79999999997642   23455688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999998754 4889999999999999999999    788999999999999999999999999999875432


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                           .....||+.|+|||.+    ++.++|||||||++|||++|+.||..........           .+....+. .
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----------~i~~~~~~-~  222 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE-----------KILNAELR-F  222 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----------HHHHCCCC-C
T ss_pred             -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-----------HHHhCCCC-C
Confidence                 2346799999999933    6789999999999999999999997643221111           11111110 0


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      ..      .....+.+++.+|++.||++||     ++.|+.+
T Consensus       223 p~------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 PP------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CT------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            00      1134588999999999999999     8888763

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-42  Score=330.44  Aligned_cols=246  Identities=24%  Similarity=0.318  Sum_probs=199.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CC-------CEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DG-------TNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      ++|...+.||+|+||.||+|+.. ++       ..||+|++..........+.+|++++++++||||+++++++...+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            57888899999999999999864 23       57999999876666677899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc--------EEEe
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV--------AHVS  316 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~--------~kl~  316 (457)
                      ++||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.        +||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999987766999999999999999999999    678999999999999998887        9999


Q ss_pred             ccccccccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCC-CCCCCCCcHHHHHHhhcCc
Q 044428          317 DFGISKLLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKP-TNDLGEMSLKHWVNQSLPH  390 (457)
Q Consensus       317 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p-~~~~~~~~l~~~~~~~~~~  390 (457)
                      |||++......      ....+|+.|+|||.     .++.++||||||+++|||++|..| +..............    
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~----  233 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED----  233 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc----
Confidence            99998765321      22457889999993     367899999999999999996554 433221111111110    


Q ss_pred             hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       391 ~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                            ...+...         .+..+.+++.+|++.||++|||+.|+++.|+++..
T Consensus       234 ------~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          234 ------RHQLPAP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             ------TCCCCCC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ------cCCCCCC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                  0000000         12347899999999999999999999999988643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-41  Score=323.30  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=203.1

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ..++|...+.||+|+||.||+|... ++..||+|++..........+.+|++++++++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467899999999999999999875 577999999987655566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---cCCCcEEEeccccccccCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||++   +.++.+||+|||++.....
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999999987654 4899999999999999999999    6789999999999999   7889999999999987654


Q ss_pred             CCCcceeccccccccccCCC---CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE---~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..   ......||+.|+|||   ..++.++||||||+++|||++|+.||...........+......             
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  225 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT-------------  225 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred             cc---chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence            32   223457999999999   44788999999999999999999999764422221111111000             


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ........++..+.+++.+|++.||++|||+.|+++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 -FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000011123456889999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.8e-42  Score=326.63  Aligned_cols=256  Identities=22%  Similarity=0.394  Sum_probs=205.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|...+.||+|+||.||+|+..++..||||++.... .....+.+|++++++++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            36788889999999999999999888899999997543 235678999999999999999999999874 5689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++++|.+++.... ..+++..+..++.|++.||.|||    ..+++||||||+||++++++.+||+|||+++....... 
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            9999999997543 25899999999999999999999    67899999999999999999999999999987654321 


Q ss_pred             ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      .......++..|+|||.    .++.++||||||+++|||++ |+.||...........+....        ....     
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~-----  231 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------RMVR-----  231 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCC-----
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc--------CCCC-----
Confidence            12233557889999993    36889999999999999999 999997643322222211110        0000     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                          +..++..+.+++.+|++.+|++|||+.++++.|+++......
T Consensus       232 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             ----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence                012245689999999999999999999999999998776543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.7e-42  Score=334.51  Aligned_cols=257  Identities=23%  Similarity=0.381  Sum_probs=202.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .++|...+.||+|+||.||+|+.      .++..||||++.... ......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788899999999999999984      357789999997542 34456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEE
Q 044428          245 ALVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHV  315 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl  315 (457)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||    ..+|+||||||+||+++   .+..+||
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999998754      34889999999999999999999    67899999999999998   4556999


Q ss_pred             eccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCc
Q 044428          316 SDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPH  390 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~  390 (457)
                      +|||+++...............+++.|+|||    ..++.++||||||+++|||+| |+.||...........+......
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999998664433222233456789999999    447889999999999999998 99999764432222222211100


Q ss_pred             hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       391 ~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                              ..         +..++..+.+++.+||+.||.+||++.++++.|+.+.+..
T Consensus       265 --------~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          265 --------DP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             --------CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --------CC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                    00         0122456889999999999999999999999999887654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.8e-41  Score=330.05  Aligned_cols=273  Identities=22%  Similarity=0.351  Sum_probs=211.2

Q ss_pred             CHHHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCccceeeeeeecC
Q 044428          164 SYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRN--VRHRNLIKILSGCSNL  241 (457)
Q Consensus       164 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  241 (457)
                      +...-....++|...+.||+|+||.||+|+. +|+.||||++...   ....+.+|.+++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3344455678999999999999999999998 5899999999754   33567788888887  7899999999999877


Q ss_pred             C----eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeeeccCCCCCeeecCCCcE
Q 044428          242 D----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH----ALAPIIHCDLKPSNILLDENMVA  313 (457)
Q Consensus       242 ~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~~~~ivH~dlk~~NIll~~~~~~  313 (457)
                      .    ..++||||+++|+|.+++....  +++..++.++.|++.||.|||...    ...+|+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            6    7899999999999999998754  899999999999999999999321    13579999999999999999999


Q ss_pred             EEeccccccccCCCCCcc--eeccccccccccCCCCCCC----------CccchhhhhHHHHHHhcC----------CCC
Q 044428          314 HVSDFGISKLLGEGDDSL--IQTKTMATIGYMAPEGIVS----------TKCDVYSYGILLLETFSR----------KKP  371 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~----------~~~Dv~s~Gvvl~el~tg----------~~p  371 (457)
                      ||+|||+++.........  ......||+.|+|||.+..          .++||||||+++|||+||          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998765433221  1234579999999995432          579999999999999999          677


Q ss_pred             CCCCC--CCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          372 TNDLG--EMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       372 ~~~~~--~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      |....  ......+.......    ...+.+.    ......+++..+.+++.+||+.||++|||+.||++.|+++.++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQ----KLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTS----CCCCCCC----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccccCcCcccHHHHHHHHHHH----HhCCCCc----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            76532  11222222211111    0111111    11112355778999999999999999999999999999998764


Q ss_pred             h
Q 044428          450 L  450 (457)
Q Consensus       450 ~  450 (457)
                      .
T Consensus       339 ~  339 (342)
T 1b6c_B          339 G  339 (342)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-42  Score=340.67  Aligned_cols=269  Identities=21%  Similarity=0.235  Sum_probs=205.7

Q ss_pred             cccCHHHHHHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----CCcccee
Q 044428          161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-----HRNLIKI  234 (457)
Q Consensus       161 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l  234 (457)
                      ..+++.+.....++|...+.||+|+||.||+|+. .+++.||||++... ......+..|++++..++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3445555556678999999999999999999997 47899999999743 233456788999999986     9999999


Q ss_pred             eeeeecCCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC----
Q 044428          235 LSGCSNLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE----  309 (457)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~----  309 (457)
                      ++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||    ..+|+||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccEEEcccccc
Confidence            99999999999999999 999999998765 45899999999999999999999    678999999999999975    


Q ss_pred             ---------------------CCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHH
Q 044428          310 ---------------------NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLE  364 (457)
Q Consensus       310 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~e  364 (457)
                                           ++.+||+|||+++.....     .....||+.|+|||.    .++.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 889999999999875432     234678999999993    36889999999999999


Q ss_pred             HhcCCCCCCCCCCCcHHHHHHhhcCchh----HHhc--------cccc-----cccccchh-----------HHHHHHHH
Q 044428          365 TFSRKKPTNDLGEMSLKHWVNQSLPHKL----AEVV--------DSNL-----VRREHSFS-----------AKMDCLLR  416 (457)
Q Consensus       365 l~tg~~p~~~~~~~~l~~~~~~~~~~~~----~~~~--------d~~l-----~~~~~~~~-----------~~~~~~~~  416 (457)
                      |+||+.||...........+........    .+..        +...     ........           ........
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999986543333333322221110    0100        0000     00000000           00001145


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHH
Q 044428          417 IMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       417 l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +.+++.+|++.||++|||+.|+++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            789999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.9e-42  Score=340.57  Aligned_cols=247  Identities=21%  Similarity=0.283  Sum_probs=192.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|..++.++ +||||+++++++...+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467899999999999999999975 68899999997653   22334578899999887 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++.... .+++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999998754 4899999999999999999999    67899999999999999999999999999986332


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH-Hhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA-EVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~-~~~d~~l~  401 (457)
                      ..  .......||+.|+|||.+    ++.++|||||||++|||++|+.||...+.......   .....+. .+....+.
T Consensus       206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---~~~~~~~~~i~~~~~~  280 (396)
T 4dc2_A          206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---NTEDYLFQVILEKQIR  280 (396)
T ss_dssp             TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHCCCC
T ss_pred             CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---hhHHHHHHHHhccccC
Confidence            21  123457899999999943    67899999999999999999999965322111000   0000011 11111110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                       ...      .....+.+++.+|++.||++||++
T Consensus       281 -~p~------~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 -IPR------SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -CCT------TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -CCC------cCCHHHHHHHHHHhcCCHhHcCCC
Confidence             000      123457899999999999999996

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.4e-42  Score=326.98  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=196.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888899999999999999975 68999999997543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++ ++.+.+......+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence            9974 677777665566999999999999999999999    6789999999999999999999999999998764322 


Q ss_pred             cceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCC-CCcHHHHHHhhcCc----hhHHhcc--
Q 044428          330 SLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLG-EMSLKHWVNQSLPH----KLAEVVD--  397 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~-~~~l~~~~~~~~~~----~~~~~~d--  397 (457)
                       .......||+.|+|||.+     ++.++|||||||++|||++|..|+.... .......+......    .+.....  
T Consensus       156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence             123346789999999933     6889999999999999999988864322 11111111111110    0000000  


Q ss_pred             -ccccc----cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 -SNLVR----REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 -~~l~~----~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       .....    ..............+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence             00000    00000000122456789999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-42  Score=338.69  Aligned_cols=241  Identities=27%  Similarity=0.360  Sum_probs=195.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+. .+|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788899999999999999997 578999999997542   222356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+ +|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||+++++.+||+|||++.......
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            999 789999887654 4899999999999999999999    6679999999999999999999999999998764432


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .   .....||+.|+|||.+     .+.++|||||||++|||++|+.||.......+            ...+.......
T Consensus       163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------~~~i~~~~~~~  227 (336)
T 3h4j_B          163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------FKKVNSCVYVM  227 (336)
T ss_dssp             T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------------BCCCCSSCCCC
T ss_pred             c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------------HHHHHcCCCCC
Confidence            2   2346799999999955     26789999999999999999999975322110            00000000000


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .      ...+..+.+++.+|++.||.+|||+.|+++
T Consensus       228 p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          228 P------DFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             C------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             c------ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0      112345789999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.5e-42  Score=336.74  Aligned_cols=242  Identities=28%  Similarity=0.345  Sum_probs=196.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +.|...+.||+|+||.||+|+. .+|+.||||++....   ......+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999986 578999999997542   233457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||++ |+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9996 7898888766667999999999999999999999    678999999999999999999999999999875432 


Q ss_pred             CcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                           ....||+.|+|||.+       ++.++|||||||++|||++|+.||...........+..        ...+...
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~--------~~~~~~~  274 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NESPALQ  274 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------SCCCCCC
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------cCCCCCC
Confidence                 235699999999943       67799999999999999999999975432211111111        0011111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ..        .++..+.+++.+||+.+|++|||+.++++.
T Consensus       275 ~~--------~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          275 SG--------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC--------CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00        123457899999999999999999999853

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.9e-42  Score=326.54  Aligned_cols=264  Identities=19%  Similarity=0.230  Sum_probs=202.9

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeee-ecCCeeEEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC-SNLDFKALVL  248 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  248 (457)
                      ..++|...+.||+|+||.||+|+. .+++.||||++.....  ...+.+|+.++..++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 5789999998765432  23578899999999998888877765 6677889999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---cCCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||++   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 99999999876667999999999999999999999    6789999999999999   789999999999998765


Q ss_pred             CCCCcc-----eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          326 EGDDSL-----IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       326 ~~~~~~-----~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ......     ......||+.|+|||.    .++.++|||||||++|||++|+.||............        ..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~  231 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--------ERIS  231 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH--------HHHH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh--------hhhh
Confidence            433211     1234679999999993    3677999999999999999999999764322111111        1111


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      ........  ......++..+.+++.+|++.+|++||++.++++.|+++.++...
T Consensus       232 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          232 EKKMSTPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHHSCH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             cccccchh--hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            11000000  000011245689999999999999999999999999999887643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.3e-42  Score=336.98  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=197.9

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCe
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDF  243 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  243 (457)
                      ....++|...+.||+|+||.||+|+.. +|+.||+|+++...   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345578999999999999999999975 68999999997642   23455678899999887 99999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999998654 4899999999999999999999    67899999999999999999999999999986


Q ss_pred             cCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ......  ......||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+...         ...
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------~~~  236 (345)
T 1xjd_A          168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------NPF  236 (345)
T ss_dssp             CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------CCC
T ss_pred             cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC---------CCC
Confidence            432221  23446799999999943    678999999999999999999999764432222211110         000


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTT-NAA  439 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~-ev~  439 (457)
                      +..         .....+.+++.+|++.||++||++. |+.
T Consensus       237 ~p~---------~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 YPR---------WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCT---------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCc---------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            100         1134588999999999999999997 553

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-41  Score=324.12  Aligned_cols=262  Identities=19%  Similarity=0.238  Sum_probs=204.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeee-ecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC-SNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  249 (457)
                      .++|...+.||+|+||.||+|+. .+|+.||||++.....  ...+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46788999999999999999996 5899999999875432  24688999999999999887777665 56678899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---cCCCcEEEeccccccccCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+ +++|.+++......+++..+..++.|++.||+|||    ..+|+||||||+||++   ++++.+||+|||+++....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99 99999999866667999999999999999999999    6789999999999999   5889999999999987654


Q ss_pred             CCCcc-----eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          327 GDDSL-----IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       327 ~~~~~-----~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      .....     ......||+.|+|||.    .++.++|||||||++|||++|+.||...........        ...+..
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~~  232 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--------YERISE  232 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH--------HHHHHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh--------hhhhcc
Confidence            33211     1234679999999993    367899999999999999999999986332111000        001110


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      .......  ......++..+.+++.+|++.||++||++.++++.|+++.++..
T Consensus       233 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          233 KKMSTPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHSCH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cccCCch--HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            0000000  00001224568999999999999999999999999999887654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.1e-42  Score=340.56  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=194.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcC--CCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVR--HRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .+|...+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4588899999999999999998889999999987542  344567999999999997  599999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      | +.+++|.+++.... .+++..+..++.||+.||.|||    ..+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 56899999998765 5889999999999999999999    77899999999999995 5899999999998775433


Q ss_pred             CcceeccccccccccCCCC---------------CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          329 DSLIQTKTMATIGYMAPEG---------------IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~---------------~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                      .........||+.|+|||.               .++.++|||||||++|||++|+.||.....  ....        +.
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~--------~~  278 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISK--------LH  278 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHH--------HH
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHH--------HH
Confidence            3323345679999999994               367789999999999999999999975321  1111        11


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .++++.........     ....+.+++.+||+.||++||++.|+++.
T Consensus       279 ~~~~~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 AIIDPNHEIEFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHCTTSCCCCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCccccCCCCcc-----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            22222211111110     13457899999999999999999999853

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.9e-42  Score=339.62  Aligned_cols=265  Identities=18%  Similarity=0.229  Sum_probs=199.8

Q ss_pred             hhcCCcCCccCCC--CceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIG--SFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|+..+.||+|  +||.||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4678899999999  99999999986 79999999997653  3345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          247 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999998753 45899999999999999999999    6789999999999999999999999999987543


Q ss_pred             CCCCc-----ceeccccccccccCCCC------CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHH-HhhcCchh-
Q 044428          326 EGDDS-----LIQTKTMATIGYMAPEG------IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV-NQSLPHKL-  392 (457)
Q Consensus       326 ~~~~~-----~~~~~~~gt~~y~aPE~------~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~-~~~~~~~~-  392 (457)
                      .....     .......||+.|+|||.      .++.++|||||||++|||++|+.||............ ....+... 
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            21111     11223478999999993      3678999999999999999999999764433322111 10000000 


Q ss_pred             ----------------------HHhcccccc----ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          393 ----------------------AEVVDSNLV----RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       393 ----------------------~~~~d~~l~----~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                            .+.+.....    ...............+.+++.+|++.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                  000000000    000000011223456899999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-42  Score=334.42  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=193.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCC--CccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH--RNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|+..+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35688889999999999999999899999999987542  3345678999999999987  9999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      || +.+|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++ ++.+||+|||+++.....
T Consensus        88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99 46889999998764 4899999999999999999999    67899999999999997 678999999999877544


Q ss_pred             CCcceeccccccccccCCCCC---------------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchh
Q 044428          328 DDSLIQTKTMATIGYMAPEGI---------------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL  392 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~---------------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~  392 (457)
                      ..........||+.|+|||.+               ++.++|||||||++|||++|+.||.....  ....        .
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~--------~  230 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISK--------L  230 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHH--------H
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHH--------H
Confidence            333333456799999999943               56789999999999999999999975322  1111        1


Q ss_pred             HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       393 ~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ...+++........     .+...+.+++.+|++.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~-----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 HAIIDPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHCTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCcccCCcc-----cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            12222211111111     113457899999999999999999999854

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.6e-42  Score=327.16  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=203.0

Q ss_pred             hhcCCcCC-ccCCCCceEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          172 TNEFDECN-LLGIGSFGSVYKGTL---SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       172 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      .++|...+ .||+|+||.||+|.+   .+++.||||++....  ......+.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 899999999999964   257889999997653  22356799999999999999999999999 566789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++++|.+++.... .+++..++.++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++...
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            9999999999999998764 4899999999999999999999    6789999999999999999999999999998775


Q ss_pred             CCCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          326 EGDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       326 ~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ...... ......+++.|+|||.+    ++.++||||||+++|||+| |+.||...........+.....        ..
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~  240 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------MG  240 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CC
Confidence            433221 12234567899999943    5779999999999999999 9999976543332222221110        00


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      .         +..++..+.+++.+|++.||++||++.++++.|+++-..-..
T Consensus       241 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          241 C---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             C---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            0         012245689999999999999999999999999998665443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-41  Score=332.57  Aligned_cols=246  Identities=22%  Similarity=0.295  Sum_probs=193.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|..++.++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57888999999999999999975 68999999997643   23445688999999988 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999998654 4899999999999999999999    678999999999999999999999999999864322


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH-Hhccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA-EVVDSNLVR  402 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~-~~~d~~l~~  402 (457)
                      ..  ......||+.|+|||.+    ++.++|||||||++|||++|+.||...+..+....   .....+. .+...... 
T Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~i~~~~~~-  237 (345)
T 3a8x_A          164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---NTEDYLFQVILEKQIR-  237 (345)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHCCCC-
T ss_pred             CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc---ccHHHHHHHHHcCCCC-
Confidence            21  23446799999999943    67899999999999999999999975322111000   0000011 11111110 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                      ..      ......+.+++.+|++.||++||++
T Consensus       238 ~p------~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 IP------RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CC------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CC------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            00      0124458899999999999999996

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-41  Score=326.36  Aligned_cols=260  Identities=21%  Similarity=0.297  Sum_probs=195.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQ---LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35788899999999999999987 47999999998753   233456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          248 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      |||+++|+|.+++..   ....+++..++.++.+++.||.|||    ..+++||||||+||+++.++.+||+|||+++..
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999975   3355899999999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      .....  ......|++.|+|||.    .++.++||||||+++|||++|+.||..... ..........     ....+.+
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~-----~~~~~~~  258 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIE-----QCDYPPL  258 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHH-----TTCSCCC
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhh-----cccCCCC
Confidence            43221  1233568999999993    367799999999999999999999965321 1122111110     0000000


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                      ..        ..++..+.+++.+|++.||++||++.+|++.|++++.....
T Consensus       259 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          259 PS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             CT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             cc--------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            00        11244688999999999999999999999999999887643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=360.12  Aligned_cols=252  Identities=27%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ..++|...+.||+|+||.||+|++.++..||||+++... .....|.+|++++++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            346788888999999999999999888889999998653 234679999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++.... ..+++.+++.++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  417 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence            99999999997532 45899999999999999999999    6789999999999999999999999999998764311 


Q ss_pred             cceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ........++..|+|||    ..++.++|||||||++|||+| |+.||...........+.....          +    
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------~----  483 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------M----  483 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC----------C----
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------C----
Confidence            11122345788999999    447889999999999999999 9999975432222222211100          0    


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                         ..+..++..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       484 ---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               001134567899999999999999999999999998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.6e-42  Score=325.38  Aligned_cols=248  Identities=29%  Similarity=0.413  Sum_probs=196.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecC-CeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-DFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  250 (457)
                      .++|+..+.||+|+||.||+|+.. |+.||||++....  ....+.+|++++++++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            367888899999999999999884 8899999997543  456789999999999999999999987554 578999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++...... 
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            99999999998654 23788999999999999999999    6789999999999999999999999999988653321 


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          ....+++.|+|||.    .++.++||||||+++|||+| |+.||...........+.....        ...    
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~----  235 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDA----  235 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------CCC----
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------CCC----
Confidence                22457889999993    37889999999999999998 9999976544333322221110        000    


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                           +..++..+.+++.+|++.||++||++.|+++.|++++..
T Consensus       236 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          236 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                 112245688999999999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-41  Score=333.91  Aligned_cols=240  Identities=22%  Similarity=0.268  Sum_probs=197.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+++.. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999975 79999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999998754 4899999999999999999999    678999999999999999999999999999876432 


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          .....||+.|+|||.+    ++.++|||||||++|||++|+.||...........+.           ...+. ..
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-----------~~~~~-~p  258 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-----------SGKVR-FP  258 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----------HCCCC-CC
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH-----------cCCCC-CC
Confidence                2235799999999943    6789999999999999999999997643222111111           11110 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                            ..++..+.+++.+|++.||++||+     +.|+.+
T Consensus       259 ------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          259 ------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                  012445889999999999999998     777764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=334.54  Aligned_cols=247  Identities=23%  Similarity=0.301  Sum_probs=183.5

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ..++|...+.||+|+||.||+|+.. +++.||||++....  ....+.+|++++.+++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3467888999999999999999986 68899999997543  33568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCcEEEeccccccccCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGISKLLGE  326 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~~~~~~  326 (457)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.   ++.+||+|||+++....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            999999999998654 4899999999999999999999    678999999999999975   88999999999987643


Q ss_pred             CCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ..   ......||+.|+|||.    .++.++|||||||++|||++|+.||.......  .....        +.......
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~--------i~~~~~~~  270 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRR--------ILNCEYYF  270 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHH--------HHTTCCCC
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHH--------HHhCCCcc
Confidence            21   2234678999999993    36889999999999999999999997643221  11111        11100000


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..   ....+.+..+.+++.+|++.||++|||+.|+++
T Consensus       271 ~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 IS---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CT---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00   000122456889999999999999999999876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.7e-42  Score=330.05  Aligned_cols=260  Identities=22%  Similarity=0.276  Sum_probs=193.3

Q ss_pred             hcCCcC-CccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDEC-NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +.|... +.||+|+||.||+|+.. +++.||||++..........+.+|++++.++ +||||+++++++...+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467664 68999999999999864 7899999999866555567789999999985 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc---EEEeccccccccCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV---AHVSDFGISKLLGE  326 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg~~~~~~~  326 (457)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.   +||+|||+++....
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999998754 4899999999999999999999    678999999999999988776   99999999986532


Q ss_pred             CCCc-----ceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc--
Q 044428          327 GDDS-----LIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH--  390 (457)
Q Consensus       327 ~~~~-----~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~--  390 (457)
                      ....     .......||+.|+|||.+         ++.++|||||||++|||++|+.||......+. .|.......  
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~  245 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC-GWDRGEACPAC  245 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS-CC----CCHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc-cccccccchhH
Confidence            2111     111235699999999943         57899999999999999999999976432210 000000000  


Q ss_pred             --hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 --KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 --~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        .+.+.+......  .........+..+.+++.+|++.||++|||+.|+++
T Consensus       246 ~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 QNMLFESIQEGKYE--FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHCCCC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCcc--cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              000000000000  000011123456899999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.1e-41  Score=333.12  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=203.8

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhhc-CCCccceee
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--------RTFVSFNSECEVLRNV-RHRNLIKIL  235 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~  235 (457)
                      .......++|...+.||+|+||.||+|+.. +|+.||||++.....        .....+.+|++++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556678999999999999999999985 799999999865431        1245688999999999 799999999


Q ss_pred             eeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEE
Q 044428          236 SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV  315 (457)
Q Consensus       236 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl  315 (457)
                      +++......++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999998653 4899999999999999999999    678999999999999999999999


Q ss_pred             eccccccccCCCCCcceeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHH
Q 044428          316 SDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVN  385 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~  385 (457)
                      +|||++..+.....   .....||+.|+|||.+          ++.++|||||||++|||++|+.||...........+.
T Consensus       242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~  318 (365)
T 2y7j_A          242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM  318 (365)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99999987654322   2346799999999943          6779999999999999999999997643222222111


Q ss_pred             hhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          386 QSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       386 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .....              ........++..+.+++.+|++.||++|||+.|+++
T Consensus       319 ~~~~~--------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          319 EGQYQ--------------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HTCCC--------------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCC--------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11000              000011122456889999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-42  Score=334.72  Aligned_cols=255  Identities=24%  Similarity=0.293  Sum_probs=197.0

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL  241 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  241 (457)
                      +....++|...+.||+|+||.||+|+.. ++..||+|++....     ......+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4566789999999999999999999874 78899999987542     33456789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 044428          242 DFKALVLEFMPNGSLEKWLYSH---------------------------------------NYFLDILERLNIMIDVGLA  282 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~~  282 (457)
                      +..++||||+++|+|.+++...                                       ...+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998521                                       1123566778899999999


Q ss_pred             HHHHHhcCCCCCeeeccCCCCCeeecCCC--cEEEeccccccccCCCCCc--ceeccccccccccCCCC------CCCCc
Q 044428          283 LEYLHYGHALAPIIHCDLKPSNILLDENM--VAHVSDFGISKLLGEGDDS--LIQTKTMATIGYMAPEG------IVSTK  352 (457)
Q Consensus       283 l~~LH~~~~~~~ivH~dlk~~NIll~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~------~~~~~  352 (457)
                      |+|||    ..+|+||||||+||+++.++  .+||+|||+++.+......  .......||+.|+|||.      .++.+
T Consensus       181 l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          181 LHYLH----NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHH----HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHH----HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999    67899999999999998776  8999999999875432211  12334679999999993      35679


Q ss_pred             cchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044428          353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER  432 (457)
Q Consensus       353 ~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~R  432 (457)
                      +||||||+++|||++|+.||...........           +.........   .........+.+++.+|++.+|++|
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----------~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQ-----------VLNKKLCFEN---PNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------HHHCCCCTTS---GGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHH-----------HHhcccccCC---cccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999999976442221111           1111110000   0011124568899999999999999


Q ss_pred             CCHHHHHH
Q 044428          433 IHTTNAAA  440 (457)
Q Consensus       433 Ps~~ev~~  440 (457)
                      |++.|+++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999976

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3e-41  Score=327.33  Aligned_cols=247  Identities=22%  Similarity=0.277  Sum_probs=200.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER------TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||||++......      ....+.+|+.++.+++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467889999999999999999975 6899999999754321      356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC----cEEEecccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM----VAHVSDFGI  320 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~  320 (457)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            99999999999999998654 5889999999999999999999    67899999999999999888    799999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ++.......   .....||+.|+|||.    .++.++||||||+++|||++|+.||...........+......     .
T Consensus       166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----~  237 (321)
T 2a2a_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD-----F  237 (321)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-----C
T ss_pred             ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc-----c
Confidence            987654321   234569999999993    3678999999999999999999999764322222111111000     0


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ++         ......+..+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          238 DE---------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CH---------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Ch---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00         001122446889999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=339.83  Aligned_cols=259  Identities=12%  Similarity=0.103  Sum_probs=200.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccce----------
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD---------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK----------  233 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  233 (457)
                      ++|...+.||+|+||.||+|+...         ++.||||++...     ..+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578888999999999999998763         789999998744     35789999999999999998          


Q ss_pred             -----eeeeeec-CCeeEEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          234 -----ILSGCSN-LDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       234 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                           +++++.. ....++||||+ +++|.+++... ...+++..++.++.|++.||.|||    ..+|+||||||+||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEE
Confidence                 5566655 67889999999 99999999875 356999999999999999999999    678999999999999


Q ss_pred             ecCCC--cEEEeccccccccCCCCCcc-----eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCC
Q 044428          307 LDENM--VAHVSDFGISKLLGEGDDSL-----IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDL  375 (457)
Q Consensus       307 l~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~  375 (457)
                      ++.++  .+||+|||+++.+.......     ......||+.|+|||.    .++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998764322111     1133579999999993    3678999999999999999999999764


Q ss_pred             CCCc--HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          376 GEMS--LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       376 ~~~~--l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      ....  +...... ......+..+.....        ...+..+.+++.+|++.||++||++.++++.|+++.++..
T Consensus       272 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          272 LPNTEDIMKQKQK-FVDKPGPFVGPCGHW--------IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TTCHHHHHHHHHH-HHHSCCCEECTTSCE--------ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CcCHHHHHHHHHh-ccCChhhhhhhcccc--------CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            3111  1111110 000000011100000        0113568999999999999999999999999999987754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.2e-42  Score=332.61  Aligned_cols=255  Identities=21%  Similarity=0.370  Sum_probs=190.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe----
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF----  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  243 (457)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....   ......+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36788899999999999999996 578999999997643   2334578899999999999999999999876543    


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            499999999999999998654 4899999999999999999999    67899999999999999999999999999987


Q ss_pred             cCCCCCc-ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          324 LGEGDDS-LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       324 ~~~~~~~-~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ....... .......||+.|+|||.    .++.++||||||+++|||+||+.||...............           
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-----------  234 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-----------  234 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-----------
Confidence            6543222 12233568999999993    4678999999999999999999999764322111110000           


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHHh
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA-AKLRKI  445 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~-~~L~~i  445 (457)
                      ...   ........++..+.+++.+|++.||++||++.+++ ..+..+
T Consensus       235 ~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          235 DPI---PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCC---CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCC---CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            000   00000112245688999999999999999776655 444433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=338.75  Aligned_cols=260  Identities=16%  Similarity=0.137  Sum_probs=194.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCccceeeee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQLER-----------TFVSFNSECEVLRNVRHRNLIKILSG  237 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~  237 (457)
                      ++|...+.||+|+||.||+|+..    ++..+|||++......           ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888899999999999999975    5788999998754311           12346788899999999999999999


Q ss_pred             eec----CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC--
Q 044428          238 CSN----LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM--  311 (457)
Q Consensus       238 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~--  311 (457)
                      +..    ....++||||+ +++|.+++.... .+++..++.++.|++.||.|||    ..+|+||||||+|||++.++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSSTT
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCCCC
Confidence            887    77899999999 999999998765 6899999999999999999999    67899999999999999887  


Q ss_pred             cEEEeccccccccCCCCCc-----ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HH
Q 044428          312 VAHVSDFGISKLLGEGDDS-----LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LK  381 (457)
Q Consensus       312 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~  381 (457)
                      .+||+|||+++.+......     .......||+.|+|||.    .++.++|||||||++|||+||+.||....... ..
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432111     11134579999999993    36889999999999999999999996422111 11


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                      ..........+.+.+......        ..++..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPS--------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCT--------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHhhcccccHHHHhhccc--------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111111111111111100000        022456899999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-41  Score=330.78  Aligned_cols=244  Identities=21%  Similarity=0.295  Sum_probs=187.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  243 (457)
                      .++|+..+.||+|+||.||+++.    .+|+.||+|+++...    ......+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36788999999999999999987    478999999997542    2234567889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999998654 4888999999999999999999    67899999999999999999999999999986


Q ss_pred             cCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      .....  .......||+.|+|||.+    ++.++||||||+++|||++|+.||...........+.           ...
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-----------~~~  237 (327)
T 3a62_A          171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL-----------KCK  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----------HTC
T ss_pred             cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----------hCC
Confidence            43221  122346799999999943    6789999999999999999999997643222111111           111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      .. ...      .....+.+++.+|++.||++||     ++.|+++
T Consensus       238 ~~-~p~------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 LN-LPP------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CC-CCT------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CC-CCC------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            10 000      1234588999999999999999     6667654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-41  Score=324.32  Aligned_cols=246  Identities=25%  Similarity=0.328  Sum_probs=194.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+++.. ++..||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            57888899999999999999874 68999999987654 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---cCCCcEEEecccccccc
Q 044428          251 MPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLL  324 (457)
Q Consensus       251 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~~  324 (457)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||    ..+|+||||||+||++   +.++.+||+|||+++..
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999998643   255899999999999999999999    6789999999999999   45688999999999876


Q ss_pred             CCCCCcceeccccccccccCCC---CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE---~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ....   ......||+.|+|||   ..++.++||||||+++|||++|+.||...............         .+...
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~---------~~~~~  245 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK---------EPNYA  245 (285)
T ss_dssp             ------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------CCCCC
T ss_pred             CCcc---cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC---------Ccccc
Confidence            4322   123467899999999   33678999999999999999999999764422222111111         01110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....      ..+..+.+++.+|++.||++|||+.|+++
T Consensus       246 ~~~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 VECR------PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C--C------CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccC------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000      01345789999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-41  Score=344.61  Aligned_cols=242  Identities=25%  Similarity=0.393  Sum_probs=200.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888899999999999999975 79999999997543   223457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999998654 4899999999999999999999    7889999999999999999999999999998765432


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                         ......||+.|+|||.+     .+.++|||||||++|||++|+.||.......+...+..           .... .
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-----------~~~~-~  235 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD-----------GIFY-T  235 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT-----------TCCC-C
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----------CCcC-C
Confidence               22346799999999943     36789999999999999999999986543222221111           1110 0


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..      .....+.+++.+|++.||++|||+.|+++
T Consensus       236 p~------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          236 PQ------YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CT------TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Cc------cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            00      11345789999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-41  Score=339.25  Aligned_cols=264  Identities=25%  Similarity=0.323  Sum_probs=189.1

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC-CCccceeeeeeecCC--e
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLD--F  243 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  243 (457)
                      ...++|...+.||+|+||.||+|... +|+.||||++...  .......+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999874 7899999998643  2334566889999999997 999999999987543  7


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||++ |+|.+++...  .+++..+..++.|++.||+|||    +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999997 6999999875  4899999999999999999999    67899999999999999999999999999987


Q ss_pred             cCCCCC-------------------cceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCc
Q 044428          324 LGEGDD-------------------SLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMS  379 (457)
Q Consensus       324 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~  379 (457)
                      ......                   ....+...||+.|+|||.     .++.++|||||||++|||++|+.||...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            533111                   112234679999999993     36788999999999999999999997654332


Q ss_pred             HHHHHHhhcCchhHHhc---ccc--------c--------cccccchhH----------HHHHHHHHHHHHHhccCCCCC
Q 044428          380 LKHWVNQSLPHKLAEVV---DSN--------L--------VRREHSFSA----------KMDCLLRIMNLALDCCMESPD  430 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~---d~~--------l--------~~~~~~~~~----------~~~~~~~l~~l~~~C~~~~P~  430 (457)
                      ....+.........+.+   ...        +        ......+..          ...+...+.+++.+|++.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            22222111110000000   000        0        000000000          002245688999999999999


Q ss_pred             CCCCHHHHHH
Q 044428          431 ERIHTTNAAA  440 (457)
Q Consensus       431 ~RPs~~ev~~  440 (457)
                      +|||+.|+++
T Consensus       319 ~R~t~~e~l~  328 (388)
T 3oz6_A          319 KRISANDALK  328 (388)
T ss_dssp             GSCCHHHHTT
T ss_pred             cCCCHHHHhC
Confidence            9999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=326.64  Aligned_cols=262  Identities=25%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccch-----hhHHHHHHHHHHHhhcC---CCccceeeeeeecC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLE-----RTFVSFNSECEVLRNVR---HRNLIKILSGCSNL  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  241 (457)
                      ..++|+..+.||+|+||.||+|+. .+|+.||||++.....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999996 4789999999875321     12345677887777764   99999999998765


Q ss_pred             C-----eeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEE
Q 044428          242 D-----FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHV  315 (457)
Q Consensus       242 ~-----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl  315 (457)
                      .     ..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEE
Confidence            4     5799999996 69999998765 34899999999999999999999    677999999999999999999999


Q ss_pred             eccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch
Q 044428          316 SDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       316 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      +|||+++......   ......||+.|+|||.    .++.++|||||||++|||++|+.||...........+.......
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998764322   2234678999999993    37889999999999999999999997654333322222111100


Q ss_pred             ----hHHhc---cccccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 ----LAEVV---DSNLVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ----~~~~~---d~~l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          +....   ...+......  .....+....+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                00000   0000000000  0001123456889999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=334.37  Aligned_cols=250  Identities=17%  Similarity=0.111  Sum_probs=200.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEE------eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCccceeeeeeecC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGT------LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR---HRNLIKILSGCSNL  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  241 (457)
                      ..++|...+.||+|+||.||+|.      ..+++.||||++....   ..++..|++++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34678888999999999999994      4478999999997543   345677788777776   99999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC--------
Q 044428          242 DFKALVLEFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE--------  309 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~--------  309 (457)
                      +..++||||+++|+|.+++..    ....+++..+..++.|++.||+|||    ..+|+||||||+|||++.        
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC---
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCcccc
Confidence            999999999999999999975    3356999999999999999999999    778999999999999998        


Q ss_pred             ---CCcEEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHH
Q 044428          310 ---NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKH  382 (457)
Q Consensus       310 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~  382 (457)
                         ++.+||+|||+++.+.............||+.|+|||.+    ++.++|||||||++|||+||+.||.......   
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence               899999999999865433333344557899999999933    6889999999999999999999986422110   


Q ss_pred             HHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHHhHHHH
Q 044428          383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDER-IHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       383 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~R-Ps~~ev~~~L~~i~~~~  449 (457)
                                 ......+... ..       ...+.+++..|++.+|.+| |++.++.+.|+++.++.
T Consensus       293 -----------~~~~~~~~~~-~~-------~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 -----------CKPEGLFRRL-PH-------LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             -----------EEECSCCTTC-SS-------HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -----------eeechhcccc-Cc-------HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                       0001111111 11       3346788999999999998 57888888888876654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=335.77  Aligned_cols=261  Identities=20%  Similarity=0.287  Sum_probs=194.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER-TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999975 7899999999754322 222456799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++ |+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  154 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence            97 6999999887777999999999999999999999    6789999999999999999999999999998654322  


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhcccc--
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVVDSN--  399 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~d~~--  399 (457)
                      .......||+.|+|||.+     ++.++|||||||++|||++|+.||...........+.......    +.......  
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            122345689999999932     5788999999999999999999998755433333333221111    11111000  


Q ss_pred             ----ccc--cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 ----LVR--REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 ----l~~--~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ...  ..............+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                000  00000011122446789999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=322.58  Aligned_cols=245  Identities=23%  Similarity=0.348  Sum_probs=184.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35788899999999999999987 479999999997543   22346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999987667999999999999999999999    678999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..  ......||+.|+|||.+    .+.++||||||+++|||++|+.||.........           ..+....... 
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~~-  231 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------NKVVLADYEM-  231 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCCCC-
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------HHHhhcccCC-
Confidence            21  12235689999999954    577999999999999999999999764322111           1111111000 


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .      ...+..+.+++.+|++.||++||++.++++
T Consensus       232 ~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 P------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0      012345889999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-41  Score=335.18  Aligned_cols=248  Identities=21%  Similarity=0.249  Sum_probs=188.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+++.. +++.||||++..... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467889999999999999999976 789999999975432 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc--EEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV--AHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~~~~~~~~~  328 (457)
                      +++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.  +||+|||+++......
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999999997654 4899999999999999999999    678999999999999987765  9999999998543221


Q ss_pred             CcceeccccccccccCCCCC----C-CCccchhhhhHHHHHHhcCCCCCCCCCC-CcHHHHHHhhcCchhHHhccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----V-STKCDVYSYGILLLETFSRKKPTNDLGE-MSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~-~~~~Dv~s~Gvvl~el~tg~~p~~~~~~-~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                         ......||+.|+|||.+    + +.++|||||||++|||++|+.||..... ......+...        .......
T Consensus       173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~  241 (361)
T 3uc3_A          173 ---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI--------LSVKYSI  241 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH--------HTTCCCC
T ss_pred             ---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH--------hcCCCCC
Confidence               12345699999999943    3 3348999999999999999999976432 2222222211        1111100


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ..     ...+...+.+++.+|++.+|++|||+.|+++.
T Consensus       242 ~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          242 PD-----DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CT-----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CC-----cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            00     00113457899999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=328.86  Aligned_cols=255  Identities=22%  Similarity=0.240  Sum_probs=200.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeee----cCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS----NLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l  246 (457)
                      .++|...+.||+|+||.||+++. .+|+.||||++..........+.+|+++++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            35788899999999999999997 579999999997665566778999999999999999999999986    3457899


Q ss_pred             EEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ||||+++|+|.+++..   ....+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999976   3456899999999999999999999    67899999999999999999999999999876


Q ss_pred             cCCCCCcc-------eeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCC--CCCcHHHHHHhh
Q 044428          324 LGEGDDSL-------IQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDL--GEMSLKHWVNQS  387 (457)
Q Consensus       324 ~~~~~~~~-------~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~--~~~~l~~~~~~~  387 (457)
                      ........       ......||+.|+|||.+       ++.++||||||+++|||++|+.||...  ..........  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--  261 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--  261 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--
Confidence            53211100       01124579999999955       477999999999999999999998531  1111111111  


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                                .......     ...++..+.+++.+|++.||.+||++.++++.|+.+..
T Consensus       262 ----------~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          262 ----------NQLSIPQ-----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ----------CC--CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ----------ccCCCCc-----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                      1000000     01124568999999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=327.66  Aligned_cols=261  Identities=22%  Similarity=0.260  Sum_probs=196.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++.....  .....+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888899999999999999975 689999999865432  234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            999999999887654 4899999999999999999999    67899999999999999999999999999987643222


Q ss_pred             cceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch---hHHhccc---
Q 044428          330 SLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK---LAEVVDS---  398 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~---~~~~~d~---  398 (457)
                        ......||+.|+|||.     .++.++||||||+++|||++|+.||......+....+.......   .......   
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence              2234578999999993     36789999999999999999999997654333332222221111   0000000   


Q ss_pred             ----cccccc---cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          399 ----NLVRRE---HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       399 ----~l~~~~---~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .+....   ........++..+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                000000   000000123456889999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-41  Score=321.40  Aligned_cols=244  Identities=23%  Similarity=0.304  Sum_probs=196.2

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      +.++|...+.||+|+||.||+|+.. ++..||||++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3468889999999999999999875 67899999986542   2234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999998654 4899999999999999999999    78899999999999999999999999999865432


Q ss_pred             CCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .    ......|++.|+|||.    ..+.++||||||+++|||++|+.||...........+...         ..... 
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~-  227 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFTFP-  227 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------CCCCC-
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC---------CCCCC-
Confidence            2    1234578999999993    3678999999999999999999999754322221111110         00000 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                              ..++..+.+++.+|++.+|++||++.|+++.
T Consensus       228 --------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          228 --------DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    0123457899999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4e-41  Score=320.27  Aligned_cols=247  Identities=21%  Similarity=0.333  Sum_probs=199.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .++|...+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468889999999999999999875 68999999997543  334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc---EEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV---AHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg~~~~~~  325 (457)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999999887654 4899999999999999999999    678999999999999986655   9999999998764


Q ss_pred             CCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...   ......||+.|+|||.    .++.++||||||+++|||++|+.||...........+.......         .
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~  227 (284)
T 3kk8_A          160 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY---------P  227 (284)
T ss_dssp             SSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------C
T ss_pred             cCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC---------C
Confidence            322   2234679999999993    36789999999999999999999997644322222221111000         0


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           ......++..+.+++.+|++.||++|||+.|+++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          228 -----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 0000112446889999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.1e-42  Score=346.75  Aligned_cols=244  Identities=23%  Similarity=0.274  Sum_probs=190.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999874 78999999997542   23345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL-APIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||    . .+|+||||||+|||++.++.+||+|||+++....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh----hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999999997654 4899999999999999999999    4 6799999999999999999999999999986432


Q ss_pred             CCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ..  .......||+.|+|||.    .++.++|||||||++|||++|+.||.......+...+..           .... 
T Consensus       302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-----------~~~~-  367 (446)
T 4ejn_A          302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------EEIR-  367 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------CCCC-
T ss_pred             CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh-----------CCCC-
Confidence            22  22344779999999993    378899999999999999999999976443222221111           1000 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      ...      ..+..+.+++.+|++.||++||     ++.|+++
T Consensus       368 ~p~------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FPR------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCT------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCc------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            000      1234588999999999999999     9999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-41  Score=356.30  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=196.5

Q ss_pred             CccCCCCceEEEEEEeC---CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS---DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||.||+|.+.   +++.||||+++....  .....+.+|++++.+++|||||+++++|.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999653   567899999976532  335689999999999999999999999965 457899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc-ce
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-LI  332 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~  332 (457)
                      |+|.+++.... .+++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999998654 4899999999999999999999    678999999999999999999999999999987543322 12


Q ss_pred             eccccccccccCCCC----CCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....+|+.|+|||.    .++.++|||||||++|||+| |+.||...........+......            .    
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------~----  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------G----  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------C----
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------C----
Confidence            233557889999993    47889999999999999999 99999765433322222211100            0    


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                       .+..++..+.+++.+||+.||++||++.+|++.|+++-...
T Consensus       593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence             01123567899999999999999999999999999876554

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-41  Score=332.78  Aligned_cols=239  Identities=22%  Similarity=0.280  Sum_probs=194.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||+|+++...   ......+..|..++..+ +||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999986 58899999997642   23455688899999988 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999998654 4899999999999999999999    67899999999999999999999999999986432


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ..  .......||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...+.           ..... 
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-----------~~~~~-  239 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-----------EHNVA-  239 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----------HCCCC-
T ss_pred             CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------hCCCC-
Confidence            21  123346799999999933    6789999999999999999999997643222211111           11110 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                      ...      .....+.+++.+|++.||++||++
T Consensus       240 ~p~------~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          240 YPK------SMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             CCT------TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             CCC------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            000      124468899999999999999964

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6e-42  Score=328.94  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=195.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+|++++..++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467888999999999999999986 6899999999876656677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++......  .
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            9999999999876666999999999999999999999    678999999999999999999999999987643211  0


Q ss_pred             ceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          331 LIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .......||+.|+|||.+         ++.++||||||+++|||++|+.||................        .+.. 
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~-  242 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--------PPTL-  242 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCCC-
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--------Cccc-
Confidence            112235689999999943         5779999999999999999999997644221111111100        0000 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            ..+..++..+.+++.+|++.||++|||+.|+++
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  001122456889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=331.92  Aligned_cols=253  Identities=23%  Similarity=0.266  Sum_probs=186.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeee--------cC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCS--------NL  241 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  241 (457)
                      ..+|...+.||+|+||.||+|+.. +|+.||||++..........+.+|+.++.+++ ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357888899999999999999974 78999999997666556678899999999996 999999999883        34


Q ss_pred             CeeEEEEeccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCCeeecCCCcEEEec
Q 044428          242 DFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGLALEYLHYGHALAP--IIHCDLKPSNILLDENMVAHVSD  317 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~--ivH~dlk~~NIll~~~~~~kl~D  317 (457)
                      ...++||||++ |+|.+++..  ....+++..++.++.|++.||.|||    ..+  |+||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCCEEEec
Confidence            56899999995 899998875  3346999999999999999999999    566  99999999999999999999999


Q ss_pred             cccccccCCCCCcc----------eeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcH
Q 044428          318 FGISKLLGEGDDSL----------IQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL  380 (457)
Q Consensus       318 fg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l  380 (457)
                      ||+++.........          ......||+.|+|||.+       ++.++||||||+++|||++|+.||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            99998765432211          11134589999999965       46689999999999999999999965332111


Q ss_pred             HHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          381 KHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       381 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                         .....        ......         .+...+.+++.+|++.||++||++.|+++.|+++.+..
T Consensus       262 ---~~~~~--------~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          262 ---VNGKY--------SIPPHD---------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             -------C--------CCCTTC---------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ---hcCcc--------cCCccc---------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence               11000        000000         01234778999999999999999999999999987754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-41  Score=328.62  Aligned_cols=241  Identities=22%  Similarity=0.306  Sum_probs=176.8

Q ss_pred             CCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEeccCCCC
Q 044428          178 CNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      .+.||+|+||.||+|+.. +|+.||||++...   ....+.+|+.++..++ ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            368999999999999975 6899999999754   3456788999999997 9999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC---cEEEeccccccccCCCCCcce
Q 044428          256 LEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM---VAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       256 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      |.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++   .+||+|||+++.......  .
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~  165 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P  165 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence            999998764 5899999999999999999999    67899999999999997665   899999999987643222  2


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC----cHHHHHHhhcCchhHHhccccccccc
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM----SLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~----~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .....||+.|+|||.+    ++.++|||||||++|||++|+.||......    ........        +.....   .
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------i~~~~~---~  234 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK--------IKKGDF---S  234 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH--------HTTTCC---C
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH--------HHcCCC---C
Confidence            2345689999999954    677899999999999999999999763321    11111111        111110   0


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~  439 (457)
                      ........++..+.+++.+|++.||++|||+.|++
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            01111223456789999999999999999999886

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-41  Score=326.76  Aligned_cols=257  Identities=20%  Similarity=0.258  Sum_probs=197.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|...+.||+|+||.||+|+.. +++.||+|++.....   .....+.+|+.++.+++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999975 789999999976532   2346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999998654 4899999999999999999999    678999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .. .......|++.|+|||.+    ++.++||||||+++|||++|+.||.......+...+....+.       +  .  
T Consensus       188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------~--~--  255 (309)
T 2h34_A          188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPR-------P--S--  255 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCC-------G--G--
T ss_pred             cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCC-------c--c--
Confidence            21 122345689999999954    577999999999999999999999753321111111111100       0  0  


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERI-HTTNAAAKLRKIKVQF  449 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-s~~ev~~~L~~i~~~~  449 (457)
                          .....++..+.+++.+|++.||++|| ++.++++.|+++.+..
T Consensus       256 ----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          256 ----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                00112244688999999999999999 9999999998865443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-42  Score=340.97  Aligned_cols=269  Identities=23%  Similarity=0.290  Sum_probs=206.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--eeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD--FKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            57888899999999999999976 58999999997543 234567889999999999999999999987655  779999


Q ss_pred             eccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee----cCCCcEEEecccccc
Q 044428          249 EFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL----DENMVAHVSDFGISK  322 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfg~~~  322 (457)
                      ||+++|+|.+++....  ..+++..++.++.|++.||+|||    ..+|+||||||+||++    +.++.+||+|||+++
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            9999999999998654  33899999999999999999999    6789999999999999    788889999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCCC------------CCCccchhhhhHHHHHHhcCCCCCCCCCC-CcHHHHHHh---
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI------------VSTKCDVYSYGILLLETFSRKKPTNDLGE-MSLKHWVNQ---  386 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~------------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~-~~l~~~~~~---  386 (457)
                      ......   ......||+.|+|||.+            ++.++|||||||++|||++|+.||..... ......+..   
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            764322   22346799999999943            45689999999999999999999975322 111111111   


Q ss_pred             hcCch-hHHh---cccccc---ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          387 SLPHK-LAEV---VDSNLV---RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       387 ~~~~~-~~~~---~d~~l~---~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      ..+.. +..+   ....+.   ...............+.+++.+|++.||++||++.|+++.++++.++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11111 1000   000000   00000111234567789999999999999999999999999887543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-41  Score=319.35  Aligned_cols=248  Identities=22%  Similarity=0.331  Sum_probs=201.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3468899999999999999999975 78999999997543 334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999997653 4899999999999999999999    6789999999999999999999999999998764332


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc--HHHHHHhhcCchhHHhcccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~--l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .........|++.|+|||.+     .+.++||||||+++|||++|+.||.......  ...|.....           ..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~  228 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----------YL  228 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-----------TS
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-----------cc
Confidence            22223446789999999954     2567999999999999999999997644322  112211100           00


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .      .....+..+.+++.+|++.||++|||+.|+++
T Consensus       229 ~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 N------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0      00112445789999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6e-41  Score=318.92  Aligned_cols=254  Identities=21%  Similarity=0.287  Sum_probs=200.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHhhcCCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE------RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  244 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++.....      .....+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357888999999999999999986 789999999875421      1356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC----cEEEecccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM----VAHVSDFGI  320 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~  320 (457)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++    .+||+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999997653 4899999999999999999999    67899999999999998877    899999999


Q ss_pred             ccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      +........   .....|++.|+|||    ..++.++||||||+++|||++|+.||...........+......      
T Consensus       159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  229 (283)
T 3bhy_A          159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD------  229 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------
T ss_pred             ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC------
Confidence            987643221   23356899999999    33678999999999999999999999764322211111111000      


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHhHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA--KLRKIKV  447 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~--~L~~i~~  447 (457)
                              ........++..+.+++.+|++.||++||++.|+++  .++.++.
T Consensus       230 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          230 --------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             --------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             --------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence                    000011122456889999999999999999999986  4454443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.8e-42  Score=327.15  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=193.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC--CCC--EEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS--DGT--NVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|+..+.||+|+||.||+|++.  +++  .||||+++...   ......+.+|++++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57888899999999999999853  333  68999987542   334567899999999999999999999998765 88


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +|+||+++|+|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++...
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            999999999999999876566899999999999999999999    6789999999999999999999999999998875


Q ss_pred             CCCCcc-eeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          326 EGDDSL-IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       326 ~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ...... ......+|+.|+|||.+    ++.++||||||+++|||++ |+.||...........+....         ..
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------~~  243 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG---------ER  243 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC---------CC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC---------CC
Confidence            433322 22335678899999943    6779999999999999999 999997644322222111100         00


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      ..       ....++..+.+++.+|++.+|++||++.++++.|+++.+.
T Consensus       244 ~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          244 LP-------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CC-------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            00       0112345689999999999999999999999999987654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=330.82  Aligned_cols=240  Identities=25%  Similarity=0.350  Sum_probs=197.8

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLE--------RTFVSFNSECEVLRNVRHRNLIKILSGCSN  240 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  240 (457)
                      ...++|...+.||+|+||.||+|+. .+++.||||++.....        .....+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3457899999999999999999986 4789999999975421        133457789999999999999999999999


Q ss_pred             CCeeEEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          241 LDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       241 ~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                      .+..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            99999999999777 9999998764 4899999999999999999999    6789999999999999999999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      +++.......   .....||+.|+|||.+     .+.++||||||+++|||++|+.||.....                 
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------  235 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------  235 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence            9987654322   2335699999999943     36789999999999999999999964211                 


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ..........       .++..+.+++.+|++.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 TVEAAIHPPY-------LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             GTTTCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHhhccCCCc-------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111111000       113458899999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-41  Score=328.97  Aligned_cols=253  Identities=29%  Similarity=0.455  Sum_probs=199.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCE--EEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTN--VAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+.||+|+||.||+|+.. +|..  ||+|.+.... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888899999999999999864 5654  4999887532 33455789999999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          248 LEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      |||+++|+|.+++....               ..+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGC
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccceEEEcCCCe
Confidence            99999999999998653               36899999999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||+++.....   .......+++.|+|||.+    ++.++||||||+++|||+| |+.||...........+...
T Consensus       181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            999999999753211   112234578899999943    6889999999999999998 99999764322211111110


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                              ....   .      +..++..+.+++.+|++.+|++||++.|+++.|.++.++.
T Consensus       258 --------~~~~---~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          258 --------YRLE---K------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             --------CCCC---C------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             --------CCCC---C------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence                    0000   0      0122456889999999999999999999999999987654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-41  Score=327.15  Aligned_cols=257  Identities=25%  Similarity=0.348  Sum_probs=184.6

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3568999999999999999999864 78999999987543 334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          249 EFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       249 e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      ||+++++|.+++..       ....+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            99999999999974       2345899999999999999999999    678999999999999999999999999999


Q ss_pred             cccCCCCCc---ceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          322 KLLGEGDDS---LIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       322 ~~~~~~~~~---~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                      .........   .......||+.|+|||.     .++.++||||||+++|||++|+.||.....................
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            876433211   11233568999999993     3688999999999999999999999875544333222221111111


Q ss_pred             -HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          394 -EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       394 -~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ...++....         .++..+.+++.+|++.||++||++.|+++
T Consensus       249 ~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          249 TGVQDKEMLK---------KYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             C-----CCCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccchhhh---------hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             111111111         11345889999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.4e-41  Score=338.00  Aligned_cols=248  Identities=27%  Similarity=0.367  Sum_probs=190.2

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--------ERTFVSFNSECEVLRNVRHRNLIKILSGCSN  240 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  240 (457)
                      ...++|...+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45678999999999999999999875 68999999987542        1122358899999999999999999999754


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC---CcEEEec
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN---MVAHVSD  317 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~---~~~kl~D  317 (457)
                       +..++||||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||++.+   +.+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEEee
Confidence             45799999999999999987654 4899999999999999999999    6779999999999999654   4599999


Q ss_pred             cccccccCCCCCcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCC-CCcHHHHHHhhcC
Q 044428          318 FGISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLG-EMSLKHWVNQSLP  389 (457)
Q Consensus       318 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~-~~~l~~~~~~~~~  389 (457)
                      ||+++......   ......||+.|+|||.+       ++.++|||||||++|||+||+.||.... ...+...+.....
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            99998764322   22346799999999965       3458999999999999999999997643 2233332222111


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....              .....++..+.+++.+|++.||++||++.|+++
T Consensus       363 ~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          363 NFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCCH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCc--------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1000              011123456889999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.4e-42  Score=341.55  Aligned_cols=247  Identities=14%  Similarity=0.185  Sum_probs=189.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHH---HHHhhcCCCccceee-------ee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQ---LERTFVSFNSEC---EVLRNVRHRNLIKIL-------SG  237 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  237 (457)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...   .......+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45788889999999999999996 57999999999743   234456789999   555566899999998       44


Q ss_pred             eecCC-----------------eeEEEEeccCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 044428          238 CSNLD-----------------FKALVLEFMPNGSLEKWLYSHNY------FLDILERLNIMIDVGLALEYLHYGHALAP  294 (457)
Q Consensus       238 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~ia~~l~~LH~~~~~~~  294 (457)
                      +...+                 ..++||||+ +|+|.+++.....      .+++..++.++.|++.||+|||    ..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYG  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH----HTT
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH----hCC
Confidence            44432                 378999999 6899999986432      2336888899999999999999    678


Q ss_pred             eeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----C-----------CCCCccchhhhh
Q 044428          295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----G-----------IVSTKCDVYSYG  359 (457)
Q Consensus       295 ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~-----------~~~~~~Dv~s~G  359 (457)
                      |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||    .           .++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999986432     2234567 9999999    3           578899999999


Q ss_pred             HHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 044428          360 ILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       360 vvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~  439 (457)
                      |++|||++|+.||........           ...+..     ...      .++..+.+++.+||+.||++||++.|++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~-----------~~~~~~-----~~~------~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGG-----------SEWIFR-----SCK------NIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHHSSCCC------CC-----------SGGGGS-----SCC------CCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccc-----------hhhhhh-----hcc------CCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            999999999999965332110           011111     001      1244688999999999999999999999


Q ss_pred             H--HHHHhHHHHhh
Q 044428          440 A--KLRKIKVQFLD  451 (457)
Q Consensus       440 ~--~L~~i~~~~~~  451 (457)
                      +  .+.++++....
T Consensus       359 ~hp~f~~~~~~~~~  372 (377)
T 3byv_A          359 ETPEYEQLRTELSA  372 (377)
T ss_dssp             TSHHHHHHHHHHHH
T ss_pred             hChHHHHHHHHHHH
Confidence            6  56666665443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.9e-41  Score=321.03  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=200.3

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec--------
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN--------  240 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  240 (457)
                      ...++|+..+.||+|+||.||+|+.. +|+.||+|++....    ..+.+|++++++++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34568999999999999999999986 79999999997543    346789999999999999999998754        


Q ss_pred             --------CCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC
Q 044428          241 --------LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM  311 (457)
Q Consensus       241 --------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~  311 (457)
                              ....++||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||++++++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEcCCC
Confidence                    445899999999999999997643 46899999999999999999999    67899999999999999999


Q ss_pred             cEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhh
Q 044428          312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       312 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~  387 (457)
                      .+||+|||+++.......   .....|++.|+|||.    .++.++||||||+++|||++|..|+...     ..+..  
T Consensus       160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~--  229 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFT--  229 (284)
T ss_dssp             EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHH--
T ss_pred             CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHH--
Confidence            999999999987654321   234568999999993    3688999999999999999999886321     11111  


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                            ...+..+..         ..+..+.+++.+|++.||++||++.|+++.|+.+++.....
T Consensus       230 ------~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          230 ------DLRDGIISD---------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             ------HHHTTCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             ------Hhhcccccc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence                  111111110         11345789999999999999999999999999987765543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-40  Score=316.42  Aligned_cols=243  Identities=22%  Similarity=0.325  Sum_probs=192.7

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN----LDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  246 (457)
                      .|...+.||+|+||.||+|... ++..||+|++....  ......+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3566678999999999999874 68899999987543  3445678999999999999999999998765    456899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCCeeec-CCCcEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAP--IIHCDLKPSNILLD-ENMVAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~  323 (457)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+  ++||||||+||+++ +++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999998753 4889999999999999999999    556  99999999999997 889999999999976


Q ss_pred             cCCCCCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      .....    .....||+.|+|||.+   ++.++||||||+++|||++|+.||.....  ............     .+..
T Consensus       182 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~-----~~~~  250 (290)
T 1t4h_A          182 KRASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV-----KPAS  250 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTC-----CCGG
T ss_pred             ccccc----cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccC-----Cccc
Confidence            53321    2335689999999943   68899999999999999999999975332  222211111100     0000


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .        ....+..+.+++.+|++.||++|||+.|+++
T Consensus       251 ~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 F--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             G--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0        0011345889999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-40  Score=338.22  Aligned_cols=260  Identities=20%  Similarity=0.249  Sum_probs=205.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC-ccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR-NLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|...+.||+|+||.||+|+. .+++.||||++.....  ...+.+|++++..++|+ ++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36899999999999999999986 5799999998765432  23578899999999875 55555666677888999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---cCCCcEEEeccccccccCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+ +++|.+++......+++..++.++.||+.||.|||    ..+|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 99999999876667999999999999999999999    6789999999999999   6889999999999998654


Q ss_pred             CCCcc-----eeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          327 GDDSL-----IQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       327 ~~~~~-----~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      .....     ......||+.|+|||.+    ++.++|||||||++|||++|+.||...........+...........+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            33211     12246799999999943    6789999999999999999999998755433333222211111100000


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                                .....++.++.+++..||+.+|++||++.+|++.|+++..+
T Consensus       239 ----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          239 ----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             ----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence                      00112355789999999999999999999999999998664

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.5e-41  Score=321.66  Aligned_cols=244  Identities=25%  Similarity=0.352  Sum_probs=200.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +.|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888899999999999999864 78999999997543 34457799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++++|.+++...  .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++.......  
T Consensus       102 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          102 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            9999999999764  4899999999999999999999    6789999999999999999999999999998764322  


Q ss_pred             ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          331 LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      .......|++.|+|||.    .++.++||||||+++|||++|+.||...........+....        .+.+..    
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~----  241 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--------PPTLEG----  241 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCCCCS----
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--------CCCCcc----
Confidence            12234678999999993    36789999999999999999999997644322222211111        111111    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                           .++..+.+++.+|++.+|++|||+.|+++.
T Consensus       242 -----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 -----NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                 113458899999999999999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.4e-41  Score=342.55  Aligned_cols=248  Identities=24%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3468999999999999999999975 78999999996542  23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEEecccccccc
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLL  324 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~~  324 (457)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999999987654 4899999999999999999999    67899999999999995   5668999999999876


Q ss_pred             CCCCCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ....   ......||+.|+|||.+   ++.++||||+||++|||++|+.||...........+....           ..
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----------~~  240 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK-----------YA  240 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------CC
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------CC
Confidence            4332   22346799999999944   6789999999999999999999997654322222221110           00


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         .....+..++..+.+++.+|++.+|++|||+.|+++
T Consensus       241 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ---SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               000111122456889999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-41  Score=329.64  Aligned_cols=261  Identities=25%  Similarity=0.322  Sum_probs=196.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57888899999999999999975 58999999986543  2234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus       105 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          105 FVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             CCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999999988876543 4899999999999999999999    67899999999999999999999999999987643221


Q ss_pred             cceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---hhHHhc-----
Q 044428          330 SLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---KLAEVV-----  396 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~~~~~~-----  396 (457)
                        ......||+.|+|||.     .++.++||||||+++|||++|+.||...........+......   ...+.+     
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence              2234568999999993     3678999999999999999999999765432222221111110   000100     


Q ss_pred             -----cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 -----DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 -----d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           .+.+............++..+.+++.+|++.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 01111110000111123567899999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-41  Score=334.19  Aligned_cols=245  Identities=23%  Similarity=0.285  Sum_probs=188.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHH-HhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEV-LRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....   ......+.+|..+ ++.++||||+++++++...+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357889999999999999999975 68899999997653   2233456677776 567899999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++.... .+++.....++.||+.||+|||    ..+|+||||||+|||++.++++||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999998754 4788899999999999999999    67899999999999999999999999999986433


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ...  ......||+.|+|||.+    ++.++|||||||++|||++|+.||.......+...           +....+. 
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-----------i~~~~~~-  257 (373)
T 2r5t_A          192 HNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN-----------ILNKPLQ-  257 (373)
T ss_dssp             CCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH-----------HHHSCCC-
T ss_pred             CCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----------HHhcccC-
Confidence            221  23446799999999943    67899999999999999999999975432211111           1111110 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ...      .....+.+++.+|++.||++||++.+.++.
T Consensus       258 ~~~------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          258 LKP------NITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             CCS------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             CCC------CCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence            000      113457899999999999999998654433

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7e-41  Score=322.07  Aligned_cols=246  Identities=24%  Similarity=0.332  Sum_probs=196.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||.||+++.. +|+.||+|++..........+.+|+.++.+++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467888999999999999999975 7899999999865444456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---cCCCcEEEeccccccccCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      +++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||++   +.++.+||+|||+++.....
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            99999999997654 4889999999999999999999    6789999999999999   78899999999998764322


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                          ......||+.|+|||.+    ++.++||||||+++|||++|+.||.......+...+......         ... 
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------~~~-  228 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE---------FES-  228 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------CCT-
T ss_pred             ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------CCc-
Confidence                12235689999999955    567899999999999999999999764432222221111100         000 


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ......+..+.+++.+|++.||++||++.|+++
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 ----PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                000122456889999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-41  Score=331.91  Aligned_cols=265  Identities=26%  Similarity=0.336  Sum_probs=195.3

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER-----TFVSFNSECEVLRNVRHRNLIKILSGCSNLD  242 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  242 (457)
                      ....++|...+.||+|+||.||+|+.. +|+.||||++......     ....+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            445678999999999999999999975 6899999999753211     1346789999999999999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++||||+++ +|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999975 899999877667889999999999999999999    6779999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhH
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLA  393 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~  393 (457)
                      .......  ......||+.|+|||.+     ++.++|||||||++|||++|..||...........+......    .+.
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            7643221  23346789999999943     567899999999999999999998764432222221111100    000


Q ss_pred             Hhc---cccccccccc---hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          394 EVV---DSNLVRREHS---FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       394 ~~~---d~~l~~~~~~---~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +..   +.........   ......+...+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000   0000000000   0000122456899999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.5e-41  Score=337.71  Aligned_cols=243  Identities=21%  Similarity=0.302  Sum_probs=185.0

Q ss_pred             hcCCcC-CccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhh-cCCCccceeeeeeec----CCeeE
Q 044428          173 NEFDEC-NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRN-VRHRNLIKILSGCSN----LDFKA  245 (457)
Q Consensus       173 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~  245 (457)
                      ++|... +.||+|+||.||+++.. +|+.||||++...     ..+.+|++++.+ .+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456655 68999999999999875 7899999998632     346778888754 489999999998865    56789


Q ss_pred             EEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCcEEEeccccc
Q 044428          246 LVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGIS  321 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~  321 (457)
                      +||||+++|+|.+++.... ..+++..+..++.||+.||.|||    ..+|+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999998754 45899999999999999999999    678999999999999997   789999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc----HHHHHHhhcCchhH
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS----LKHWVNQSLPHKLA  393 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~----l~~~~~~~~~~~~~  393 (457)
                      +......   ......||+.|+|||.+    ++.++|||||||++|||++|+.||.......    ....+...      
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~------  282 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG------  282 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT------
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC------
Confidence            8754322   22346789999999954    6789999999999999999999997643321    11111110      


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                           .....   ......+...+.+++.+|++.||++|||+.|+++.
T Consensus       283 -----~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 -----QYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -----CCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----cccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 00000   00011234568899999999999999999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=320.74  Aligned_cols=246  Identities=27%  Similarity=0.363  Sum_probs=194.4

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      +|.....||+|+||.||+|+. .+++.||||.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455566999999999999986 4788999999987655556779999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEeccccccccCCCCC
Q 044428          253 NGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       253 ~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|.+++....  ..+++..+..++.|++.||.|||    ..+++||||||+||+++. ++.+||+|||+++.......
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            999999998753  34678889999999999999999    678999999999999987 89999999999987643221


Q ss_pred             cceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                        ......|++.|+|||.+      ++.++||||||+++|||++|+.||..........+....      ....+.+.  
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~--  248 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM------FKVHPEIP--  248 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH------HCCCCCCC--
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc------cccccccc--
Confidence              22345789999999943      678999999999999999999999653322111110000      00011111  


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             ..++..+.+++.+|++.||++||++.|+++
T Consensus       249 -------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 -------ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   112456889999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.4e-41  Score=329.71  Aligned_cols=248  Identities=22%  Similarity=0.328  Sum_probs=195.8

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ..++|+..+.||+|+||.||+++.. +|+.||||++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4568999999999999999999875 689999999975432    245688888888 7999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC----CcEEEecccccccc
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN----MVAHVSDFGISKLL  324 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~~~~~  324 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    ..+|+||||||+|||+.++    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999999998664 4899999999999999999999    6789999999999998433    35999999999876


Q ss_pred             CCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      .....  ......||+.|+|||.+    ++.++|||||||++|||++|+.||...................      ..+
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~------~~~  242 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK------FSL  242 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC------CCC
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC------ccc
Confidence            44322  22346789999999954    6779999999999999999999997643333322222111000      000


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...     .+......+.+++.+|++.||++||++.|+++
T Consensus       243 ~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 SGG-----YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CST-----TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             Ccc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000     00112456889999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1e-40  Score=328.93  Aligned_cols=269  Identities=21%  Similarity=0.239  Sum_probs=198.6

Q ss_pred             CHHHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccch-----------hhHHHHHHHHHHHhhcCCCccc
Q 044428          164 SYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE-----------RTFVSFNSECEVLRNVRHRNLI  232 (457)
Q Consensus       164 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~niv  232 (457)
                      ...++....++|...+.||+|+||.||+|...+|+.||||++.....           .....+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35677888899999999999999999999988899999999865321           1236789999999999999999


Q ss_pred             eeeeeeec-----CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          233 KILSGCSN-----LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       233 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                      ++++++..     ....++||||++ |+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEE
Confidence            99999843     346899999997 7999999877667999999999999999999999    6789999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHH
Q 044428          308 DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKH  382 (457)
Q Consensus       308 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~  382 (457)
                      +.++.+||+|||+++......   ......||+.|+|||.     .++.++|||||||++|||++|+.||..........
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999998643322   2234678999999993     36788999999999999999999997644322222


Q ss_pred             HHHhhcCc-hh-----------HHhccccccccccc--hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          383 WVNQSLPH-KL-----------AEVVDSNLVRREHS--FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       383 ~~~~~~~~-~~-----------~~~~d~~l~~~~~~--~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+...... ..           .+.+...+......  ......+...+.+++.+|++.||++|||+.|+++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            22111111 01           11111111110000  0001122456889999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-41  Score=344.70  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=202.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467889999999999999999975 78999999986542   33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---cCCCcEEEecccccccc
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLL  324 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~~  324 (457)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999998654 4899999999999999999999    6789999999999999   56789999999999876


Q ss_pred             CCCCCcceeccccccccccCCC---CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE---~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .....   .....||+.|+|||   ..++.++||||+||++|||++|+.||...........+....           ..
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----------~~  245 (484)
T 3nyv_A          180 EASKK---MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK-----------YT  245 (484)
T ss_dssp             CCCCS---HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------CC
T ss_pred             ccccc---cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----------CC
Confidence            54322   23457999999999   447889999999999999999999997654333222222110           00


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         .....+..++..+.+++.+|++.+|++|||+.|+++
T Consensus       246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               000111123456889999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=319.55  Aligned_cols=247  Identities=21%  Similarity=0.270  Sum_probs=195.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCccceeeeee--ecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL----ERTFVSFNSECEVLRNVRHRNLIKILSGC--SNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~  244 (457)
                      .++|...+.||+|+||.||++... +++.||+|++....    ......+.+|++++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999974 78999999997543    23456789999999999999999999998  445688


Q ss_pred             EEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ++||||++++ |.+++... ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999876 77777654 356899999999999999999999    67899999999999999999999999999987


Q ss_pred             cCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      ..............||+.|+|||..      .+.++||||||+++|||++|+.||...........+....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~---------  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS---------  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC---------
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC---------
Confidence            6543333333456799999999943      2568999999999999999999997643221111111100         


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      ..+.         .+++..+.+++.+|++.||++|||+.|+++.
T Consensus       230 ~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 YAIP---------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CCCC---------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CCCC---------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000         1124568899999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.6e-41  Score=327.79  Aligned_cols=264  Identities=21%  Similarity=0.317  Sum_probs=199.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec--------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN--------  240 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  240 (457)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36889999999999999999997 478999999986543  2234567899999999999999999999876        


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      .+..++||||++ |+|.+.+......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            346899999997 5888888776666999999999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCc--ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---
Q 044428          321 SKLLGEGDDS--LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---  390 (457)
Q Consensus       321 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---  390 (457)
                      ++........  .......||+.|+|||.+     ++.++|||||||++|||+||+.||...........+......   
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9876432221  122346789999999933     578999999999999999999999875443333333222111   


Q ss_pred             h-hHHhccccc------c-ccccchhHH---HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 K-LAEVVDSNL------V-RREHSFSAK---MDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~-~~~~~d~~l------~-~~~~~~~~~---~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      . ....-....      . .........   ......+.+++.+|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1 111100000      0 000000000   011345789999999999999999999976

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-40  Score=337.98  Aligned_cols=258  Identities=22%  Similarity=0.228  Sum_probs=190.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecC------C
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------D  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  242 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467899999999999999999865 6899999999754  233456788999999999999999999998654      4


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++||||+++ +|.+.+..   .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            67999999965 57666654   3889999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-------
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-------  391 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-------  391 (457)
                      ......   ..+...||+.|+|||.    .++.++||||+||++|||++|+.||...+..+....+.......       
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          213 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            764321   2344679999999994    36789999999999999999999997654322222221111110       


Q ss_pred             ----hHHhccccccccc-------------cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 ----LAEVVDSNLVRRE-------------HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ----~~~~~d~~l~~~~-------------~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ....+........             ............+.+++.+|++.||++|||+.|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                0111110000000             000111222556899999999999999999999976

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-41  Score=330.17  Aligned_cols=257  Identities=23%  Similarity=0.298  Sum_probs=191.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD------  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  242 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            357888899999999999999874 79999999986532  333567889999999999999999999987653      


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++||||+ +++|.+++....  +++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~--l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 899999998753  899999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch---hHH
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK---LAE  394 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~---~~~  394 (457)
                      .....     .....+|+.|+|||.     .++.++||||+||+++||++|+.||...+..+....+.......   ...
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            75432     234678999999993     47889999999999999999999997654332222221111110   000


Q ss_pred             hcc--------cccccc-ccch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VVD--------SNLVRR-EHSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~d--------~~l~~~-~~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.        ..+... .... .....+...+.+++.+|++.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            000        000000 0000 000122456889999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.5e-40  Score=342.26  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=198.5

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch-------------hhHHHHHHHHHHHhhcCCCccceeee
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-------------RTFVSFNSECEVLRNVRHRNLIKILS  236 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  236 (457)
                      ..++|...+.||+|+||.||+|+.. +++.||||++.....             .....+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3568999999999999999999975 688999999875421             23457889999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC---cE
Q 044428          237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM---VA  313 (457)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~---~~  313 (457)
                      ++.+....++||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999997654 4899999999999999999999    67899999999999998776   69


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCC---CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH  390 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE---~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~  390 (457)
                      ||+|||+++......   ......||+.|+|||   ..++.++||||+||++|||++|+.||.......+...+....  
T Consensus       189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--  263 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK--  263 (504)
T ss_dssp             EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--
T ss_pred             EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--
Confidence            999999998765432   223467999999999   347889999999999999999999997654322222221110  


Q ss_pred             hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                               .   ......+...+..+.+++.+|++.||.+|||+.|+++
T Consensus       264 ---------~---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          264 ---------Y---YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ---------C---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------C---CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                     0   0001111223456899999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-40  Score=338.53  Aligned_cols=190  Identities=26%  Similarity=0.395  Sum_probs=150.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec-----CCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN-----LDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~  244 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++..     ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999865 78999999986532  3345678999999999999999999999843     3578


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+ +|+|.+++.... .+++..+..++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+++..
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            9999998 579999997654 5899999999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCc-------------------------ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcC
Q 044428          325 GEGDDS-------------------------LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSR  368 (457)
Q Consensus       325 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg  368 (457)
                      ......                         ...+...||+.|+|||.+     ++.++|||||||++|||+||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            432111                         112345789999999943     67899999999999999993

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.8e-41  Score=343.05  Aligned_cols=247  Identities=23%  Similarity=0.312  Sum_probs=195.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .++|...+.||+|+||.||+|+.. ++..||+|++....  ......+.+|+.+++.++||||+++++++......++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457889999999999999999975 78999999997543  233567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~~~~~  325 (457)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999887653 4899999999999999999999    678999999999999975   4569999999998765


Q ss_pred             CCCCcceeccccccccccCCC---CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE---~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ...   ......||+.|+|||   ..++.++||||+||++|||++|+.||.......+...+......         .  
T Consensus       191 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------~--  256 (494)
T 3lij_A          191 NQK---KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT---------F--  256 (494)
T ss_dssp             TTB---CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------C--
T ss_pred             CCc---cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------C--
Confidence            332   223467999999999   34788999999999999999999999765432222222111000         0  


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         .......++..+.+++.+|++.+|++|||+.|+++
T Consensus       257 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          257 ---DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ---CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence               00011122456889999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.5e-41  Score=326.64  Aligned_cols=263  Identities=22%  Similarity=0.280  Sum_probs=190.4

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ...++|...+.||+|+||.||+|+.. +|+.||||++.....  .....+.+|++++++++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999999864 789999999975432  224567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee-----cCCCcEEEeccccc
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL-----DENMVAHVSDFGIS  321 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll-----~~~~~~kl~Dfg~~  321 (457)
                      ||||++ |+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||+     +.++.+||+|||++
T Consensus       111 v~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999997 59999998765 4899999999999999999999    6789999999999999     45566999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC--ch--h
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP--HK--L  392 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~--~~--~  392 (457)
                      +.......  ......||+.|+|||.+     ++.++|||||||++|||++|+.||...........+.....  ..  .
T Consensus       185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            87643221  22345689999999932     67899999999999999999999976443222221111100  00  0


Q ss_pred             HHhc-----cccc---cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          393 AEVV-----DSNL---VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       393 ~~~~-----d~~l---~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....     ....   ............+...+.+++.+|++.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000     0000   0000000000112456889999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-40  Score=315.86  Aligned_cols=242  Identities=25%  Similarity=0.402  Sum_probs=190.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888899999999999999986 79999999997543   223457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++.......
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999998654 4899999999999999999999    6679999999999999999999999999998764322


Q ss_pred             CcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                         ......|++.|+|||.+     .+.++||||||+++|||++|+.||...........+...            ....
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------~~~~  230 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------------VFYI  230 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------CCCC
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------------cccC
Confidence               12335689999999954     246899999999999999999999764322221111110            0000


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .      ..+...+.+++.+|++.||++|||+.|+++
T Consensus       231 ~------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          231 P------EYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c------hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0      011345889999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-40  Score=315.97  Aligned_cols=241  Identities=24%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888899999999999999875 67899999986542   223457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||++.......
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            9999999999998754 4899999999999999999999    7889999999999999999999999999987654321


Q ss_pred             CcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          .....|++.|+|||.    .++.++||||||+++|||++|+.||...........           +...... ..
T Consensus       169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----------~~~~~~~-~~  232 (284)
T 2vgo_A          169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-----------IVNVDLK-FP  232 (284)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------HHTTCCC-CC
T ss_pred             ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-----------HhccccC-CC
Confidence                234578999999993    367899999999999999999999976432211111           1111110 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .      ..+..+.+++.+|++.+|++||++.|+++
T Consensus       233 ~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          233 P------FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             T------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            0      11345789999999999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-40  Score=318.70  Aligned_cols=245  Identities=20%  Similarity=0.250  Sum_probs=198.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|...+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357888899999999999999976 68899999987542   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999987654 4899999999999999999999    678999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..  ......||+.|+|||.+    .+.++||||||+++|||++|+.||...........+.           ..... .
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~~-~  234 (294)
T 2rku_A          169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----------KNEYS-I  234 (294)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----------TTCCC-C
T ss_pred             cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----------hccCC-C
Confidence            21  12346789999999933    6779999999999999999999997643211111111           10000 0


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                      .      ......+.+++.+|++.||++|||+.|+++.
T Consensus       235 ~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          235 P------KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             C------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             c------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0      0113457899999999999999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.1e-41  Score=345.37  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=199.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++.+++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467888899999999999999875 79999999997542   23345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          248 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      |||+++|+|.+++.... ..+++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999998654 34899999999999999999999    67899999999999999999999999999987654


Q ss_pred             CCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ...   .....||+.|+|||.+    ++.++|||||||++|||++|+.||...........+.        ..+......
T Consensus       339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--------~~i~~~~~~  407 (576)
T 2acx_A          339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------RLVKEVPEE  407 (576)
T ss_dssp             TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--------HHHHHCCCC
T ss_pred             Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--------HHhhccccc
Confidence            322   2345799999999943    6789999999999999999999998643221111111        100000000


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                      ...      .....+.+++.+|++.||++||     ++.||++
T Consensus       408 ~p~------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 YSE------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCT------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CCc------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            000      1134588999999999999999     6788764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=329.62  Aligned_cols=256  Identities=23%  Similarity=0.349  Sum_probs=197.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|...+.||+|+||.||+|+..+  .+|+|++....  ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4678889999999999999999753  59999987542  2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++ ++.+||+|||+++.......
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            99999999999887767899999999999999999999    67899999999999998 67999999999876532111


Q ss_pred             ---cceeccccccccccCCCCC-------------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhH
Q 044428          330 ---SLIQTKTMATIGYMAPEGI-------------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA  393 (457)
Q Consensus       330 ---~~~~~~~~gt~~y~aPE~~-------------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~  393 (457)
                         ........|++.|+|||.+             ++.++||||||+++|||++|+.||...........+...      
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------  258 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG------  258 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT------
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC------
Confidence               1122235689999999943             467899999999999999999999764322221111111      


Q ss_pred             HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       394 ~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                        ..+.....        .++..+.+++.+|++.+|++|||+.++++.|+++.++..
T Consensus       259 --~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          259 --MKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             --CCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             --CCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence              11111110        113358899999999999999999999999999887653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-41  Score=320.81  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeee--cCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCS--NLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  246 (457)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++....  ......+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467888999999999999999875 78999999997543  334567899999999999999999999874  4678999


Q ss_pred             EEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          247 VLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGH-ALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~-~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ||||+++|+|.+++....   ..+++..++.++.|++.||.|||... ...+++||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997532   44899999999999999999999432 01229999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      .......  ......|++.|+|||.    .++.++||||||+++|||++|+.||.......+...+.....        +
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--------~  234 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--------R  234 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------C
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--------c
Confidence            7643221  1223568999999993    367899999999999999999999976543222222211110        0


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL  442 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L  442 (457)
                      .+.         ..++..+.+++.+|++.+|++||++.|+++.+
T Consensus       235 ~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          235 RIP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cCC---------cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            110         01245688999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=321.40  Aligned_cols=247  Identities=26%  Similarity=0.327  Sum_probs=195.4

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ..++|+..+.||+|+||.||+|... +|+.||||++....  ....+.+|+.++.+++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567899999999999999999875 68999999997543  34578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++......+++..+..++.+++.||.|||    ..+++|+||||+||+++.++.+||+|||++........
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999999999865556899999999999999999999    67899999999999999999999999999987643211


Q ss_pred             cceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        ......|++.|+|||.    .++.++||||||+++|||++|+.||................        .+...    
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~----  246 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--------PPTFR----  246 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCCCS----
T ss_pred             --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--------CcccC----
Confidence              2234578999999993    36789999999999999999999997643221111111110        00000    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         .+..++..+.+++.+|++.||++|||+.++++
T Consensus       247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               01112456889999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.2e-41  Score=332.39  Aligned_cols=259  Identities=23%  Similarity=0.318  Sum_probs=198.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||.||+|+.. +|..||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57888899999999999999975 78999999997653 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++|+|.+++.... .+++..+..++.+++.||.|||+.   .+|+||||||+||+++.++.+||+|||+++.....   
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHh---CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            99999999998754 488999999999999999999942   26999999999999999999999999999765321   


Q ss_pred             ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC-----------------
Q 044428          331 LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP-----------------  389 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~-----------------  389 (457)
                       ......||+.|+|||.+    ++.++||||||+++|||++|+.||.......+.........                 
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             12335789999999933    67799999999999999999999976432222111100000                 


Q ss_pred             ----------chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          390 ----------HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       390 ----------~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                ....+..+.......... ....++..+.+++.+|++.||++|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCC-CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCC-CcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      001111111111100000 00112446889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-40  Score=324.66  Aligned_cols=244  Identities=20%  Similarity=0.255  Sum_probs=198.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      .++|...+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            367888899999999999999975 68899999987542   23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999987653 4899999999999999999999    678999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      ..  ......||+.|+|||.    .++.++||||||+++|||++|+.||...........+...         ...+.. 
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~-  262 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------EYSIPK-  262 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------CCCCCT-
T ss_pred             cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------CCCCCc-
Confidence            21  1234678999999993    3678999999999999999999999754321111111100         000000 


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              .+...+.+++.+|++.||++||++.|+++
T Consensus       263 --------~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          263 --------HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    11345789999999999999999999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.2e-41  Score=329.09  Aligned_cols=258  Identities=23%  Similarity=0.281  Sum_probs=200.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhh-----------------HHHHHHHHHHHhhcCCCcccee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERT-----------------FVSFNSECEVLRNVRHRNLIKI  234 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  234 (457)
                      .++|...+.||+|+||.||+|+. +|+.||||++.......                 ...+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36888999999999999999999 89999999997543211                 1679999999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCCCCCee
Q 044428          235 LSGCSNLDFKALVLEFMPNGSLEKW------LYSH-NYFLDILERLNIMIDVGLALEYLHYGHAL-APIIHCDLKPSNIL  306 (457)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~~ivH~dlk~~NIl  306 (457)
                      ++++...+..++||||+++|+|.++      +... ...+++..+..++.|++.||.|||    . .+++||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH----NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTSCEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh----ccCCEeecCCChHhEE
Confidence            9999999999999999999999998      6553 356899999999999999999999    5 78999999999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCCCC-----C-ccchhhhhHHHHHHhcCCCCCCCCCC-Cc
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVS-----T-KCDVYSYGILLLETFSRKKPTNDLGE-MS  379 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~-~~Dv~s~Gvvl~el~tg~~p~~~~~~-~~  379 (457)
                      ++.++.+||+|||.+......    ......|++.|+|||.+..     . ++||||||+++|||++|+.||..... ..
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999876432    2344679999999995532     3 89999999999999999999986543 22


Q ss_pred             HHHHHHhhcCchh---HHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          380 LKHWVNQSLPHKL---AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       380 l~~~~~~~~~~~~---~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....+........   .....+.. ... .......++..+.+++.+|++.||++||++.|+++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLT-NKK-STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTC-C---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhcccc-ccc-cccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2222221110000   00000000 000 00001123456899999999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-40  Score=317.92  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=200.1

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---------hhhHHHHHHHHHHHhhcC-CCccceeeeeee
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---------ERTFVSFNSECEVLRNVR-HRNLIKILSGCS  239 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  239 (457)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++....         ......+.+|++++.+++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578899999999999999999975 68999999986532         123456889999999996 999999999999


Q ss_pred             cCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          240 NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       240 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                      ..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999998653 4899999999999999999999    6789999999999999999999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP  389 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~  389 (457)
                      ++........   .....|++.|+|||.+          ++.++||||||+++|||++|+.||...........+.... 
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-  245 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-  245 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC-
Confidence            9987654322   2345689999999943          5779999999999999999999997643222221111110 


Q ss_pred             chhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          390 HKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       390 ~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                ....   ......++..+.+++.+|++.||++|||+.|+++
T Consensus       246 ----------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 ----------YQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ----------CCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----------cccC---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                      0000   0001123456899999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-40  Score=350.83  Aligned_cols=255  Identities=22%  Similarity=0.348  Sum_probs=202.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .++|...+.||+|+||.||+|++.    .+..||||.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            466778889999999999999874    24679999987543 334567999999999999999999999985 456899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+++|+|.+++......+++..++.++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999999999999887667999999999999999999999    67899999999999999999999999999987643


Q ss_pred             CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ... .......+|+.|+|||    ..++.++|||||||++|||++ |..||...........+.....        ..+ 
T Consensus       544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~--------~~~-  613 (656)
T 2j0j_A          544 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------LPM-  613 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC--------CCC-
T ss_pred             Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--------CCC-
Confidence            322 1223355788999999    347889999999999999997 9999976543322222221110        000 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                              +..++..+.+++.+||+.||++||++.++++.|+++.++.
T Consensus       614 --------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          614 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                    1123456899999999999999999999999999987653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.1e-40  Score=315.44  Aligned_cols=240  Identities=21%  Similarity=0.293  Sum_probs=194.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  246 (457)
                      ..++|...+.||+|+||.||+|+.. +++.||||++....  ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999986 79999999997542  33456788999999999 99999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC--------------
Q 044428          247 VLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE--------------  309 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~--------------  309 (457)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC---------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999998642   45899999999999999999999    678999999999999984              


Q ss_pred             -----CCcEEEeccccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc
Q 044428          310 -----NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS  379 (457)
Q Consensus       310 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~  379 (457)
                           ...+||+|||.+.......      ...||+.|+|||.+     .+.++||||||+++|||++|..|+....   
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---  235 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---  235 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence                 4479999999998764322      24589999999943     3468999999999999999998764321   


Q ss_pred             HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....+.           .........      .++..+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~-----------~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 QWHEIR-----------QGRLPRIPQ------VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHHHH-----------TTCCCCCSS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHH-----------cCCCCCCCc------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            111111           111100000      12346889999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-40  Score=328.40  Aligned_cols=262  Identities=23%  Similarity=0.274  Sum_probs=200.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Cee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  244 (457)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457899999999999999999875 78899999997543 33346789999999999999999999998654     468


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||++ |+|.+++....  +++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999996 69999998754  899999999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCcc-eeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          325 GEGDDSL-IQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       325 ~~~~~~~-~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ....... ......||+.|+|||.+     ++.++|||||||++|||++|+.||......+....+.........+.+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            4322111 12345799999999932     68899999999999999999999987654444433322221111100000


Q ss_pred             -----------cccc-cccch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          399 -----------NLVR-REHSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       399 -----------~l~~-~~~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                 .+.. ..... .....+...+.+++.+|++.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       0000 00000 000112456889999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-41  Score=331.33  Aligned_cols=250  Identities=25%  Similarity=0.314  Sum_probs=198.5

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL----ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      .++|...+.||+|+||.||+++.    .+|+.||||+++...    ......+.+|++++.++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36789999999999999999987    378999999987542    23345677899999999 6999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999998654 4899999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCchhHHh
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPHKLAEV  395 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~~~~~~  395 (457)
                      ....... .......||+.|+|||.+      ++.++|||||||++|||++|+.||...... .........        
T Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------  278 (355)
T 1vzo_A          208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--------  278 (355)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred             ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--------
Confidence            7533221 122345799999999943      467899999999999999999999754322 222211111        


Q ss_pred             ccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 044428          396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAAKL  442 (457)
Q Consensus       396 ~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~~L  442 (457)
                      .... ...      +.+++..+.+++.+|++.||++||     ++.|+++..
T Consensus       279 ~~~~-~~~------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 LKSE-PPY------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHCC-CCC------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             hccC-CCC------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            0000 000      011244578999999999999999     899987643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=321.93  Aligned_cols=261  Identities=20%  Similarity=0.293  Sum_probs=191.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeee------------
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS------------  239 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------------  239 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++..........+.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57888899999999999999986 58999999998766666678999999999999999999998873            


Q ss_pred             --cCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEe
Q 044428          240 --NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVS  316 (457)
Q Consensus       240 --~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~  316 (457)
                        .....++||||++ |+|.+++...  .+++..+..++.|++.||+|||    ..+|+||||||+||+++ +++.+||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence              4467899999997 6999999764  4889999999999999999999    67899999999999997 57799999


Q ss_pred             ccccccccCCCCCc-ceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc
Q 044428          317 DFGISKLLGEGDDS-LIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH  390 (457)
Q Consensus       317 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~  390 (457)
                      |||+++........ .......+|..|+|||.     .++.++||||||+++|||++|+.||...........+....+.
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999876432111 11233567899999993     3677899999999999999999999865433222222222111


Q ss_pred             h----hHHhc-------cccccccccch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 K----LAEVV-------DSNLVRREHSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~----~~~~~-------d~~l~~~~~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .    ..+..       ........... .....++..+.+++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0    00100       00000000000 000123556899999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-40  Score=323.68  Aligned_cols=258  Identities=19%  Similarity=0.257  Sum_probs=201.2

Q ss_pred             ccCHHHHHHHhhcCCcC-CccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcC-CCccceeee
Q 044428          162 RISYLDIQRATNEFDEC-NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVR-HRNLIKILS  236 (457)
Q Consensus       162 ~~~~~~l~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~  236 (457)
                      ++.+.......+.|... +.||+|+||.||+|+.. +|+.||+|++....  ......+.+|+.++..++ ||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34445556667778877 78999999999999875 68999999997643  233567899999999995 699999999


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCc
Q 044428          237 GCSNLDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMV  312 (457)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~  312 (457)
                      ++...+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||    ..+|+||||||+||+++.   ++.
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCc
Confidence            999999999999999999999998654 356899999999999999999999    678999999999999987   789


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~  388 (457)
                      +||+|||+++.......   .....||+.|+|||.    .++.++||||||+++|||++|+.||...........+....
T Consensus       173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  249 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN  249 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             EEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence            99999999987643221   233579999999993    36789999999999999999999997644322211111110


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..         ...     .....++..+.+++.+|++.||++|||+.|+++
T Consensus       250 ~~---------~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 VD---------YSE-----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             CC---------CCT-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc---------cCc-----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            00         000     001122456889999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-40  Score=333.47  Aligned_cols=196  Identities=27%  Similarity=0.358  Sum_probs=163.3

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Ce
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  243 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            368889999999999999999875 68899999997542  33456789999999999999999999998765     57


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||++ |+|.+++.... .+++..+..++.||+.||.|||    +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999996 69999998653 4899999999999999999999    67899999999999999999999999999997


Q ss_pred             cCCCCCc--------------------ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCC
Q 044428          324 LGEGDDS--------------------LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTN  373 (457)
Q Consensus       324 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~  373 (457)
                      .......                    ...+...||+.|+|||.+     ++.++||||+||++|||++|..||.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            6443211                    112456799999999943     6789999999999999998655543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.9e-40  Score=324.72  Aligned_cols=257  Identities=22%  Similarity=0.235  Sum_probs=187.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------e
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD------F  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  243 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            57888999999999999999865 78999999997542  334567889999999999999999999987654      7


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||++ |+|.+++..   .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             eEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            899999996 578888863   3889999999999999999999    67899999999999999999999999999987


Q ss_pred             cCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch--------
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK--------  391 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~--------  391 (457)
                      .....   ......||+.|+|||.+    ++.++|||||||++|||++|+.||...........+.......        
T Consensus       177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            54321   22346789999999933    6789999999999999999999997644322222111111110        


Q ss_pred             ---hHHhcccc--ccc-----------cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 ---LAEVVDSN--LVR-----------REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ---~~~~~d~~--l~~-----------~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         ....+...  ...           ..............+.+++.+|++.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence               00000000  000           00001112233567899999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.7e-40  Score=319.71  Aligned_cols=247  Identities=28%  Similarity=0.371  Sum_probs=194.1

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  241 (457)
                      ..++|...+.||+|+||.||+|+.. +++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4568999999999999999999875 68899999986532        11234588999999999999999999998766


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc---EEEecc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV---AHVSDF  318 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~---~kl~Df  318 (457)
                      + .++||||+++|+|.+++.... .+++.....++.|++.||.|||    ..+|+||||||+||+++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 899999999999999997654 5899999999999999999999    678999999999999987654   999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCC-CcHHHHHHhhcCc
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGE-MSLKHWVNQSLPH  390 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~-~~l~~~~~~~~~~  390 (457)
                      |+++......   ......||+.|+|||.+       ++.++||||||+++|||++|+.||..... ..+...+......
T Consensus       162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (322)
T 2ycf_A          162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  238 (322)
T ss_dssp             TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred             ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence            9998764321   12235689999999943       57799999999999999999999976432 2333322221111


Q ss_pred             hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...+              ...+++..+.+++.+|++.||++||++.|+++
T Consensus       239 ~~~~--------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          239 FIPE--------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCHH--------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCch--------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0000              01122456889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.6e-40  Score=317.69  Aligned_cols=254  Identities=20%  Similarity=0.287  Sum_probs=193.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeec--CCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSN--LDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+. .+++.||||++....   ...+.+|+.++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6788899999999999999986 578999999987433   456889999999997 9999999999987  66789999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~  327 (457)
                      ||+++++|.+++..    +++..+..++.|++.||+|||    ..+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999999864    788999999999999999999    67899999999999999776 8999999999876543


Q ss_pred             CCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcC-chhHHhccc--
Q 044428          328 DDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLP-HKLAEVVDS--  398 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~-~~~~~~~d~--  398 (457)
                      ..   .....|+..|+|||.     .++.++|||||||++|||++|+.||...... .....+..... ....+.++.  
T Consensus       185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            22   234578999999993     3678999999999999999999999543211 11111111100 001111110  


Q ss_pred             -------------ccccc---ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          399 -------------NLVRR---EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       399 -------------~l~~~---~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                   .....   .............+.+++.+|++.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                         00000   0000001113456899999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.2e-41  Score=318.67  Aligned_cols=246  Identities=23%  Similarity=0.286  Sum_probs=182.8

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++.....  .....+.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999997 4789999999976432  22333455556688889999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          249 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALA-PIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       249 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ||++ |+|.+++..   ....+++..+..++.|++.||.|||    .. +++||||||+||+++.++.+||+|||+++..
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9997 588887764   3456999999999999999999999    44 7999999999999999999999999999876


Q ss_pred             CCCCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ....   ......||+.|+|||.+        ++.++||||||+++|||+||+.||..... .... ..        ...
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~-~~--------~~~  227 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-PFQQ-LK--------QVV  227 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-HHHH-HH--------HHH
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-hHHH-HH--------HHh
Confidence            4322   12335689999999953        56789999999999999999999975321 1111 11        111


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ........     ...++..+.+++.+|++.||++|||+.|+++
T Consensus       228 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          228 EEPSPQLP-----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HSCCCCCC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCCCcc-----cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11110000     0112446889999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-40  Score=329.69  Aligned_cols=267  Identities=20%  Similarity=0.251  Sum_probs=195.3

Q ss_pred             HHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec-------
Q 044428          169 QRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN-------  240 (457)
Q Consensus       169 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  240 (457)
                      ....++|...+.||+|+||.||+|+. .+|+.||||++.....    ...+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999986 5799999999865432    23479999999999999999998843       


Q ss_pred             -------------------------------CCeeEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHH
Q 044428          241 -------------------------------LDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYL  286 (457)
Q Consensus       241 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~L  286 (457)
                                                     ....++||||++ |+|.+.+..   ....+++..+..++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 688877763   335689999999999999999999


Q ss_pred             HhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccccccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhH
Q 044428          287 HYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGI  360 (457)
Q Consensus       287 H~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gv  360 (457)
                      |    ..+|+||||||+||+++ .++.+||+|||+++.+.....   .....||+.|+|||.     .++.++||||+||
T Consensus       158 H----~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          158 H----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             H----TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             H----HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            9    78899999999999998 689999999999987644322   234568999999993     2678999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-hHHhc--cc--------cccccccchhHHHHHHHHHHHHHHhccCCCC
Q 044428          361 LLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-LAEVV--DS--------NLVRREHSFSAKMDCLLRIMNLALDCCMESP  429 (457)
Q Consensus       361 vl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-~~~~~--d~--------~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P  429 (457)
                      ++|||++|+.||......+....+....... ..++.  ++        .+.........+..++..+.+++.+|++.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999998654333222222111111 11000  00        0000000000011124568999999999999


Q ss_pred             CCCCCHHHHHH--HHHHhHH
Q 044428          430 DERIHTTNAAA--KLRKIKV  447 (457)
Q Consensus       430 ~~RPs~~ev~~--~L~~i~~  447 (457)
                      ++|||+.|+++  .+.+++.
T Consensus       311 ~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GGSCCHHHHHTSGGGHHHHH
T ss_pred             hhCCCHHHHhcCHHHHHHHh
Confidence            99999999984  3444444

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.2e-40  Score=337.40  Aligned_cols=242  Identities=23%  Similarity=0.331  Sum_probs=196.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++...+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888899999999999999985 79999999997543   233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          249 EFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      ||+++|+|.+++....   ..+++.....++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999997643   45899999999999999999999    6789999999999999999999999999998765


Q ss_pred             CCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCC-cHHHHHHhhcCchhHHhccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEM-SLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~-~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ....  ......||+.|+|||.+    ++.++|||||||++|||+||+.||...... ........        +.....
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~--------i~~~~~  410 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--------VLEQAV  410 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH--------HHHCCC
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH--------Hhhccc
Confidence            4322  12335799999999943    678999999999999999999999764321 11111111        111111


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                      . ..      ...+..+.+++.+|++.||++||++
T Consensus       411 ~-~p------~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 T-YP------DKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             C-CC------TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             C-CC------cccCHHHHHHHHHhccCCHhHCCCC
Confidence            0 00      1124468899999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=325.47  Aligned_cols=256  Identities=25%  Similarity=0.337  Sum_probs=197.2

Q ss_pred             ccCHHHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeee
Q 044428          162 RISYLDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCS  239 (457)
Q Consensus       162 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  239 (457)
                      .+++.++....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|+.++.++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3444455566788999999999999999999974 78999999987543 2346788999999999 7999999999987


Q ss_pred             c------CCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          240 N------LDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       240 ~------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      .      .+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCCC
Confidence            6      468899999999999999998753 45889999999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHH
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW  383 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~  383 (457)
                      +||+|||++........  ......||+.|+|||.+         ++.++||||||+++|||++|+.||...........
T Consensus       168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  245 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            99999999987643211  12335689999999943         57789999999999999999999976442221111


Q ss_pred             HHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       384 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +...        ..+.+...        .++..+.+++.+|++.||++||++.++++
T Consensus       246 ~~~~--------~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 IPRN--------PAPRLKSK--------KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHS--------CCCCCSCS--------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhcC--------ccccCCcc--------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1110        00111111        11346889999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-41  Score=332.91  Aligned_cols=262  Identities=10%  Similarity=0.091  Sum_probs=183.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc--CCCccceee-------eeee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE---RTFVSFNSECEVLRNV--RHRNLIKIL-------SGCS  239 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~  239 (457)
                      .+|...+.||+|+||.||+|+.. +|+.||||++.....   .....+.+|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45788899999999999999975 789999999987532   3345677885555444  699988755       3332


Q ss_pred             cC-----------------CeeEEEEeccCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCCee
Q 044428          240 NL-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDILER------LNIMIDVGLALEYLHYGHALAPII  296 (457)
Q Consensus       240 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~~iv  296 (457)
                      ..                 ...++||||++ |+|.+++......+++..+      +.++.|++.||+|||    ..+|+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGLV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCCc
Confidence            22                 34799999998 9999999875444566666      788899999999999    67899


Q ss_pred             eccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCC
Q 044428          297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKK  370 (457)
Q Consensus       297 H~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~  370 (457)
                      ||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||.+      ++.++|||||||++|||+||+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999876321     1135577999999933      5779999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHhHHH
Q 044428          371 PTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA--KLRKIKVQ  448 (457)
Q Consensus       371 p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~--~L~~i~~~  448 (457)
                      ||..........|...    ...........     ......++..+.+++.+||+.||++|||+.|+++  .+.++...
T Consensus       292 Pf~~~~~~~~~~~~~~----~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRP----SLRVPGTDSLA-----FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             STTBCCTTCTTCCCBC----CTTSCCCCSCC-----CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             CCCCcCcccccchhhh----hhhhccccccc-----hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            9976432110000000    00000000000     0001123456899999999999999999999984  56666666


Q ss_pred             Hhhhh
Q 044428          449 FLDDV  453 (457)
Q Consensus       449 ~~~~~  453 (457)
                      .....
T Consensus       363 ~~~~~  367 (371)
T 3q60_A          363 ISSSL  367 (371)
T ss_dssp             HHHHH
T ss_pred             Hhhhh
Confidence            55443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.2e-40  Score=315.69  Aligned_cols=249  Identities=25%  Similarity=0.307  Sum_probs=189.0

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec---------
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN---------  240 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  240 (457)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++... ......+.+|+.++++++||||+++++++..         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4578999999999999999999974 7999999999654 3345678999999999999999999998754         


Q ss_pred             ----CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          241 ----LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       241 ----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                          ....++||||+++|+|.+++......+++..++.++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEEe
Confidence                45789999999999999999977666888999999999999999999    6789999999999999999999999


Q ss_pred             ccccccccCCCCC------------cceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCc
Q 044428          317 DFGISKLLGEGDD------------SLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMS  379 (457)
Q Consensus       317 Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~  379 (457)
                      |||+++.......            ........||+.|+|||.     .++.++||||||+++|||++   ||....  +
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence            9999987643211            111233568999999993     36789999999999999998   553211  1


Q ss_pred             HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .........     . ....+....     ...++..+.+++.+|++.||++|||+.++++
T Consensus       234 ~~~~~~~~~-----~-~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RVNILKKLR-----S-VSIEFPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHH-----S-TTCCCCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcc-----c-cccccCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            111111100     0 000010000     1122455789999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.5e-40  Score=331.58  Aligned_cols=195  Identities=25%  Similarity=0.304  Sum_probs=167.4

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc------CCCccceeeeeeecCCee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNV------RHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  244 (457)
                      ..+|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+|++++..+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            357888999999999999999875 68999999997542 3345677888888877      577999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc--EEEeccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV--AHVSDFGIS  321 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~~  321 (457)
                      ++||||++ ++|.+++.... ..+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999995 79999998765 45899999999999999999999    667999999999999999887  999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCC
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGE  377 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~  377 (457)
                      +.....     .....||+.|+|||.    .++.++|||||||++|||+||+.||.....
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            765332     223578999999994    378899999999999999999999976543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-40  Score=329.04  Aligned_cols=257  Identities=23%  Similarity=0.300  Sum_probs=179.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC------C
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------D  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  242 (457)
                      .++|...+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36888999999999999999986 478999999997542  33456788999999999999999999998654      5


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++|+||+ +++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 78999998764  4899999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      .....     .....||+.|+|||.     .++.++|||||||++|||++|+.||...+..+....+.........+.+.
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            75322     234578999999993     36789999999999999999999997654333222222211111000000


Q ss_pred             -----------ccccc-cccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 -----------SNLVR-REHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 -----------~~l~~-~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                 ..+.. ...... ....+...+.+++.+|++.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                       00000 000000 00112345889999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.1e-40  Score=347.65  Aligned_cols=240  Identities=22%  Similarity=0.278  Sum_probs=195.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeE
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  245 (457)
                      ..++|+..+.||+|+||.||+|+.. +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999875 68899999997542   33455678899999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++|+|.+++.... .+++..+..++.||+.||+|||    ..+|+||||||+|||++.++++||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999999998754 4899999999999999999999    6789999999999999999999999999998643


Q ss_pred             CCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ....  ......||+.|+|||.+    ++.++|||||||++|||++|+.||...+...+...+           ....+.
T Consensus       494 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i-----------~~~~~~  560 (674)
T 3pfq_A          494 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI-----------MEHNVA  560 (674)
T ss_dssp             CTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----------HSSCCC
T ss_pred             cCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH-----------HhCCCC
Confidence            2221  23457799999999933    688999999999999999999999764432222111           111110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHT  435 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~  435 (457)
                       ...      .....+.+++.+|++.||++||++
T Consensus       561 -~p~------~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          561 -YPK------SMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             -CCT------TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             -CCc------cCCHHHHHHHHHHccCCHHHCCCC
Confidence             000      124468899999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.9e-40  Score=318.46  Aligned_cols=258  Identities=22%  Similarity=0.277  Sum_probs=198.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe--CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc------cceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL--SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN------LIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  243 (457)
                      .++|+..+.||+|+||.||+|..  .+|+.||||++.... .....+.+|++++..++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35788899999999999999986  368899999997542 34567889999999887654      9999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-------------
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-------------  309 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-------------  309 (457)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+|||    ..+|+||||||+||+++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 899999998765 45889999999999999999999    678999999999999987             


Q ss_pred             ------CCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCc
Q 044428          310 ------NMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMS  379 (457)
Q Consensus       310 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~  379 (457)
                            ++.+||+|||+++.....     .....||+.|+|||.    .++.++||||||+++|||++|+.||.......
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  678999999999875432     233578999999993    36889999999999999999999998654333


Q ss_pred             HHHHHHhhcCchhHHhcc----cc------cccc----------------ccchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044428          380 LKHWVNQSLPHKLAEVVD----SN------LVRR----------------EHSFSAKMDCLLRIMNLALDCCMESPDERI  433 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d----~~------l~~~----------------~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP  433 (457)
                      ....+.........+...    ..      ....                .........+...+.+++.+|++.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            322222221110000000    00      0000                000000113466789999999999999999


Q ss_pred             CHHHHHH
Q 044428          434 HTTNAAA  440 (457)
Q Consensus       434 s~~ev~~  440 (457)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.1e-40  Score=316.36  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=194.0

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcC--CCccceeeeeeecCCe
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVR--HRNLIKILSGCSNLDF  243 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  243 (457)
                      +....++|...+.||+|+||.||+++..+++.||||++....  ......+.+|++++.+++  ||||+++++++...+.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            334456789999999999999999999889999999997542  334567899999999997  5999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||| +.+++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||++++ +.+||+|||+++.
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence            999999 56899999998764 5899999999999999999999    678999999999999964 8999999999987


Q ss_pred             cCCCCCcceeccccccccccCCCC---------------CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEG---------------IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~---------------~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~  388 (457)
                      ..............||+.|+|||.               .++.++||||||+++|||++|+.||......  ....    
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~----  249 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKL----  249 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH----
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHH----
Confidence            654333222334678999999994               3566899999999999999999999753221  1111    


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK  441 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~  441 (457)
                          ...+++........     .++..+.+++.+|++.||++||++.|+++.
T Consensus       250 ----~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          250 ----HAIIDPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ----HHHHCTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHhcccccCCcc-----cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                11222211111110     113458899999999999999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-39  Score=311.28  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=200.2

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      ...++|...+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999975 78999999987543  2345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCcEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~~~  323 (457)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.   ++.+||+|||++..
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999999887654 4899999999999999999999    678999999999999975   44799999999987


Q ss_pred             cCCCCCcceeccccccccccCCC---CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPE---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE---~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ......   .....+++.|+|||   ..++.++||||||+++|||++|+.||...........+....           .
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~  239 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK-----------Y  239 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------C
T ss_pred             ecCCCc---cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------C
Confidence            643321   22345899999999   347889999999999999999999997644322222111110           0


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..   .......++..+.+++.+|++.+|++|||+.|+++
T Consensus       240 ~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          240 AF---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CC---CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC---CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00   00011122456889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9e-40  Score=325.74  Aligned_cols=258  Identities=22%  Similarity=0.279  Sum_probs=193.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC--------CCccceeeeeee---
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR--------HRNLIKILSGCS---  239 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  239 (457)
                      .++|...+.||+|+||.||+|+.. +++.||||++... ......+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            367999999999999999999864 7889999999754 234567889999999986        788999999887   


Q ss_pred             -cCCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCCeeecCCC-----
Q 044428          240 -NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALA-PIIHCDLKPSNILLDENM-----  311 (457)
Q Consensus       240 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-~ivH~dlk~~NIll~~~~-----  311 (457)
                       .....++||||+ +++|.+++.... ..+++..+..++.|++.||.|||    .. +|+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccchhhhh
Confidence             566899999999 566666665443 56899999999999999999999    55 799999999999999775     


Q ss_pred             --------------------------------------------cEEEeccccccccCCCCCcceeccccccccccCCCC
Q 044428          312 --------------------------------------------VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG  347 (457)
Q Consensus       312 --------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  347 (457)
                                                                  .+||+|||+++.....     .....||+.|+|||.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876432     233578999999993


Q ss_pred             C----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcH------HHHHHhhcCc---hh-------HHhcccc--c---cc
Q 044428          348 I----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL------KHWVNQSLPH---KL-------AEVVDSN--L---VR  402 (457)
Q Consensus       348 ~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l------~~~~~~~~~~---~~-------~~~~d~~--l---~~  402 (457)
                      +    ++.++|||||||++|||+||+.||........      ...+......   ..       .+.+...  +   ..
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            3    78899999999999999999999976433221      1111111100   00       0000000  0   00


Q ss_pred             c-c--------cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 R-E--------HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~-~--------~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      . .        .......+....+.+++.+|++.||++|||+.|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0 0        000012345677999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.7e-40  Score=322.32  Aligned_cols=261  Identities=25%  Similarity=0.263  Sum_probs=195.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Cee
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DFK  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  244 (457)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888999999999999999975 78999999997543 33455788999999999999999999987654     678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999996 6999999875  3899999999999999999999    678999999999999999999999999999876


Q ss_pred             CCCCCcc--------eeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc-
Q 044428          325 GEGDDSL--------IQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH-  390 (457)
Q Consensus       325 ~~~~~~~--------~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~-  390 (457)
                      .......        ......||+.|+|||.     .++.++|||||||++|||++|+.||...........+...... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            4322111        1123568999999993     3677899999999999999999999765422222111111000 


Q ss_pred             ------------hhHHhccccccccc-cc-hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 ------------KLAEVVDSNLVRRE-HS-FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ------------~~~~~~d~~l~~~~-~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                  ...+.+.. +.... .. ......++..+.+++.+|++.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKS-LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHT-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhccccccccchhhHHhhc-ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                        00011000 00000 00 0001123456889999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.8e-40  Score=317.29  Aligned_cols=263  Identities=24%  Similarity=0.326  Sum_probs=196.8

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEe--CCCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCccceeeeeee---
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTL--SDGTNVAIKIFNLQLE--RTFVSFNSECEVLRNV---RHRNLIKILSGCS---  239 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  239 (457)
                      .+.++|...+.||+|+||.||+|+.  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457899999999999999999997  4688999999875432  2233567788877776   8999999999987   


Q ss_pred             --cCCeeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          240 --NLDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       240 --~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                        .....++||||++ |+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEe
Confidence              5667899999997 69999998754 44899999999999999999999    6789999999999999999999999


Q ss_pred             ccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-
Q 044428          317 DFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-  391 (457)
Q Consensus       317 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-  391 (457)
                      |||+++.....   .......||+.|+|||.    .++.++||||||+++|||++|+.||...........+....... 
T Consensus       163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999865321   12234678999999993    36889999999999999999999997654333222222111100 


Q ss_pred             ---hHHhcc-c--cccc--cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 ---LAEVVD-S--NLVR--REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ---~~~~~d-~--~l~~--~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         +..... +  ....  ..........++..+.+++.+|++.||++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               000000 0  0000  00000000122456889999999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-39  Score=324.99  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=189.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------eeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD------FKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  246 (457)
                      .+|...+.||+|+||.||+|+..++..||+|++.....    ...+|+++++.++||||+++++++....      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46888899999999999999997777799998864322    2246999999999999999999985433      3789


Q ss_pred             EEeccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~  323 (457)
                      ||||++++.+.....  .....+++..+..++.|++.||+|||    ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            999998654443332  22356899999999999999999999    67899999999999999 899999999999987


Q ss_pred             cCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-h--HHh
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-L--AEV  395 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-~--~~~  395 (457)
                      ......   .....||+.|+|||.+     ++.++|||||||++|||++|+.||......+....+....... .  ...
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            644322   2345789999999932     6789999999999999999999997654332222221111110 0  011


Q ss_pred             ccccccccc------cchh--HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 VDSNLVRRE------HSFS--AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~d~~l~~~~------~~~~--~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .++......      ....  .....+..+.+++.+|++.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            111110000      0000  00112456899999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-39  Score=322.18  Aligned_cols=256  Identities=21%  Similarity=0.264  Sum_probs=191.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCee----
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFK----  244 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  244 (457)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357888899999999999999875 78999999997643  33356788999999999999999999999877654    


Q ss_pred             --EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          245 --ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       245 --~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                        ++||||++ ++|.+++..   .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999996 788888753   3899999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHh--
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV--  395 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~--  395 (457)
                      .....     .....||+.|+|||.     .++.++|||||||++|||++|+.||...........+.........+.  
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            65332     234578999999993     367899999999999999999999976443222222211111000000  


Q ss_pred             -cc--------cccccc-ccch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 -VD--------SNLVRR-EHSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 -~d--------~~l~~~-~~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       +.        ..+... .... .....+...+.+++.+|++.||++|||+.|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             00        000000 0000 000122456899999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-39  Score=328.02  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=187.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecC------CeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNL------DFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  245 (457)
                      .+|...+.||+|+||.||+|+.. +|+.||||++....    ..+.+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            36888899999999999999985 69999999986542    2234799999999999999999988432      2467


Q ss_pred             EEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-CcEEEeccccc
Q 044428          246 LVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGIS  321 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~  321 (457)
                      +||||+++ +|.+.+..   ....+++..+..++.|++.||.|||    ..+|+||||||+|||++.+ +.+||+|||++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            99999975 66665542   3456899999999999999999999    7889999999999999955 67899999999


Q ss_pred             cccCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc-h---h
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH-K---L  392 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~-~---~  392 (457)
                      +.+.....   .....||+.|+|||.     .++.++|||||||++|||++|+.||......+....+...+.. .   +
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            97644322   233578999999993     3678999999999999999999999764432222111111111 0   1


Q ss_pred             HHhccccccccccc------hh--HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          393 AEVVDSNLVRREHS------FS--AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       393 ~~~~d~~l~~~~~~------~~--~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+. ++........      ..  .....+..+.+|+.+|++.||++||++.|+++
T Consensus       282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            111 1111000000      00  00112456899999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.7e-39  Score=318.89  Aligned_cols=200  Identities=26%  Similarity=0.319  Sum_probs=168.2

Q ss_pred             HHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CC-----ccceeeeeeecCC
Q 044428          170 RATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HR-----NLIKILSGCSNLD  242 (457)
Q Consensus       170 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  242 (457)
                      ...++|...+.||+|+||.||+|+.. +++.||||+++... .....+..|+.++..++ |+     +|+++.+++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999875 68899999997542 33456778888888885 44     4999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec--CCCcEEEeccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD--ENMVAHVSDFG  319 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfg  319 (457)
                      ..++||||++ |+|.+++.... ..+++..+..++.|++.||.|||..  ..+|+||||||+|||++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999995 69999998764 4589999999999999999999942  36799999999999994  57889999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCC
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEM  378 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~  378 (457)
                      +++.....     .....||+.|+|||.    .++.++|||||||++|||+||+.||......
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99876432     234678999999993    3688999999999999999999999865433

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-39  Score=314.79  Aligned_cols=248  Identities=24%  Similarity=0.297  Sum_probs=176.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHH-HHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECE-VLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|...+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888899999999999999985 78999999997653 233345556665 6777899999999999999999999999


Q ss_pred             ccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          250 FMPNGSLEKWLYS----HNYFLDILERLNIMIDVGLALEYLHYGHALA-PIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       250 ~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      |++ |+|.+++..    ....+++..+..++.+++.||.|||    .. +|+||||||+||+++.++.+||+|||+++..
T Consensus       102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK----ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH----HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh----ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            997 488887763    2356899999999999999999999    45 7999999999999999999999999999876


Q ss_pred             CCCCCcceeccccccccccCCCCC--------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI--------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ....   ......||+.|+|||.+        ++.++||||||+++|||++|+.||......  ...........     
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~-----  246 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGD-----  246 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSC-----
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCC-----
Confidence            4322   12234689999999965        577999999999999999999999753211  11111111000     


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .+.+....     ...++..+.+++.+|++.||++||++.|+++
T Consensus       247 ~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 PPQLSNSE-----EREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCS-----SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcc-----cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00111000     0112456899999999999999999999976

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.6e-39  Score=317.46  Aligned_cols=268  Identities=20%  Similarity=0.245  Sum_probs=187.5

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe-
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF-  243 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  243 (457)
                      .......++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455677889999999999999999999975 78999999986542 223456778888999999999999999865433 


Q ss_pred             ------eEEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcE
Q 044428          244 ------KALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVA  313 (457)
Q Consensus       244 ------~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~  313 (457)
                            .++||||+++ +|.+.+..   ....+++..+..++.|++.||.|||..  ..+|+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcE
Confidence                  7899999976 55544432   335588999999999999999999932  467999999999999996 8999


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~  388 (457)
                      ||+|||+++.......   .....||+.|+|||.+     ++.++|||||||++|||++|+.||...........+....
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            9999999987654322   2345689999999933     6889999999999999999999998754333222222211


Q ss_pred             Cch---hHHhcccccccc-----c-cch-----hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          389 PHK---LAEVVDSNLVRR-----E-HSF-----SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       389 ~~~---~~~~~d~~l~~~-----~-~~~-----~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ...   ....+++.....     . ...     .....+...+.+++.+|++.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111   111111100000     0 000     000013557899999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.6e-39  Score=315.61  Aligned_cols=258  Identities=22%  Similarity=0.273  Sum_probs=195.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CC-CEEEEEEecccchhhHHHHHHHHHHHhhcCCCc------cceeeeeeecCCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DG-TNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN------LIKILSGCSNLDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  243 (457)
                      .++|...+.||+|+||.||+|... ++ +.||+|+++... .....+.+|++++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368889999999999999999874 34 789999997542 34467888999999997766      8999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee---------------
Q 044428          244 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL---------------  307 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll---------------  307 (457)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+|||    ..+|+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecccccccccccccc
Confidence            99999999 677777776554 56899999999999999999999    7789999999999999               


Q ss_pred             ----cCCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCc
Q 044428          308 ----DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMS  379 (457)
Q Consensus       308 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~  379 (457)
                          +.++.+||+|||+++.....     .....||+.|+|||.    .++.++|||||||++|||++|+.||.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                67889999999999875332     233578999999994    36889999999999999999999998654333


Q ss_pred             HHHHHHhhcCchhHHhcc----c------ccccc----------------ccchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044428          380 LKHWVNQSLPHKLAEVVD----S------NLVRR----------------EHSFSAKMDCLLRIMNLALDCCMESPDERI  433 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d----~------~l~~~----------------~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP  433 (457)
                      ....+.........+...    .      .....                .........+...+.+++.+|++.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            322222221111000000    0      00000                000000112355789999999999999999


Q ss_pred             CHHHHHH
Q 044428          434 HTTNAAA  440 (457)
Q Consensus       434 s~~ev~~  440 (457)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=323.45  Aligned_cols=196  Identities=22%  Similarity=0.292  Sum_probs=150.4

Q ss_pred             hcCCc-CCccCCCCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeee--cCCeeEE
Q 044428          173 NEFDE-CNLLGIGSFGSVYKGTLS---DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCS--NLDFKAL  246 (457)
Q Consensus       173 ~~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  246 (457)
                      +.|.. .++||+|+||.||+|+..   +++.||||++....  ....+.+|+.++++++||||+++++++.  .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44555 458999999999999975   57899999997543  2346789999999999999999999994  4678999


Q ss_pred             EEeccCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee----cCCCcEE
Q 044428          247 VLEFMPNGSLEKWLYSHN--------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL----DENMVAH  314 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll----~~~~~~k  314 (457)
                      ||||++ |+|.+++....        ..+++..+..++.|++.||.|||    ..+|+||||||+|||+    +.++.+|
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            999996 68888776321        24899999999999999999999    6779999999999999    7789999


Q ss_pred             EeccccccccCCCCCc-ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCC
Q 044428          315 VSDFGISKLLGEGDDS-LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDL  375 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~  375 (457)
                      |+|||+++........ .......||+.|+|||.+     ++.++|||||||++|||++|+.||...
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999999876432211 122346789999999933     677899999999999999999999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=317.81  Aligned_cols=255  Identities=21%  Similarity=0.269  Sum_probs=190.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe------
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF------  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  243 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888899999999999999875 78999999997543  2335678899999999999999999999877654      


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||++ |+|.+++..   .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            499999997 688887753   3899999999999999999999    67899999999999999999999999999986


Q ss_pred             cCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---hhHHh
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---KLAEV  395 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~~~~~  395 (457)
                      ....     .....+|+.|+|||.     .++.++||||||+++|||++|+.||......+....+......   ...+.
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5322     233568999999993     3678999999999999999999999764432222221111110   00000


Q ss_pred             cc--------cccccc-ccch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 VD--------SNLVRR-EHSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 ~d--------~~l~~~-~~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +.        ..+... .... .....++..+.+++.+|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00        000000 0000 000122456899999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=314.52  Aligned_cols=248  Identities=23%  Similarity=0.261  Sum_probs=178.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE--RTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.....  .....+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888899999999999999985 789999999975432  22233445556788889999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+ ++.+..+.......+++..+..++.+++.||.|||+.   .+++||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh---CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5666666665455689999999999999999999931   279999999999999999999999999998654322


Q ss_pred             CcceeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                         ......||+.|+|||.+         ++.++||||||+++|||++|+.||.....  .........     ....+.
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~-----~~~~~~  249 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVL-----QEEPPL  249 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHH-----HSCCCC
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHh-----ccCCCC
Confidence               12335689999999954         46789999999999999999999975321  111111110     000000


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +...       ..++..+.+++.+|++.||.+||++.|+++
T Consensus       250 ~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 LPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCSS-------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCcc-------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1000       012446889999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.8e-39  Score=314.58  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=168.9

Q ss_pred             hhcCCcCC-ccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCeeE
Q 044428          172 TNEFDECN-LLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN----LDFKA  245 (457)
Q Consensus       172 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  245 (457)
                      .++|...+ .||+|+||.||+|+.. +|+.||||++....    ....+....+..++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46788754 6999999999999986 79999999986532    112223344566799999999999876    45689


Q ss_pred             EEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCcEEEeccccc
Q 044428          246 LVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGIS  321 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~  321 (457)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999998764 46899999999999999999999    678999999999999976   456999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      +.....    ......||+.|+|||.+    ++.++||||||+++|||++|+.||...................  ..  
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~--  250 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG--QY--  250 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc--cc--
Confidence            865432    12345689999999965    4568999999999999999999997643322111111000000  00  


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ...     ......++..+.+++.+|++.||++|||+.|+++
T Consensus       251 -~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          251 -GFP-----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -CCC-----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -ccC-----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             000     0001122456889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3e-39  Score=326.17  Aligned_cols=245  Identities=23%  Similarity=0.296  Sum_probs=180.6

Q ss_pred             CCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEeccCC
Q 044428          175 FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      |...+.||+|+||+||.+...+|+.||||++....   ...+.+|+.++.++ +||||+++++++.+.+..++||||++ 
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            34457899999999987766789999999987542   34578899999887 89999999999999999999999995 


Q ss_pred             CCHHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCC-------------CcEE
Q 044428          254 GSLEKWLYSHNYF------LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDEN-------------MVAH  314 (457)
Q Consensus       254 g~L~~~l~~~~~~------l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~-------------~~~k  314 (457)
                      |+|.+++......      .++..++.++.||+.||+|||    ..+|+||||||+|||++.+             +.+|
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            7999999875421      123345789999999999999    6789999999999999754             4899


Q ss_pred             EeccccccccCCCCCcc--eeccccccccccCCCCC-----------CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcH
Q 044428          315 VSDFGISKLLGEGDDSL--IQTKTMATIGYMAPEGI-----------VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSL  380 (457)
Q Consensus       315 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~-----------~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l  380 (457)
                      |+|||+++.........  ......||+.|+|||.+           ++.++|||||||++|||+| |+.||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999999875433221  12345799999999933           5778999999999999999 999996532211 


Q ss_pred             HHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          381 KHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       381 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..........       +.+     .......++..+.+++.+|++.||++|||+.||++
T Consensus       248 ~~i~~~~~~~-------~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 SNIIRGIFSL-------DEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHTCCCC-------CCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCCc-------ccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1111111000       000     00011234567899999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-39  Score=313.03  Aligned_cols=237  Identities=25%  Similarity=0.278  Sum_probs=193.3

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchh------hHHHHHHHHHHHhhcC--CCccceeeeeeecC
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLER------TFVSFNSECEVLRNVR--HRNLIKILSGCSNL  241 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  241 (457)
                      ..++|...+.||+|+||.||+|+. .+++.||||++......      ....+.+|+.++.+++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            446788999999999999999986 47899999999754321      2245678999999996  59999999999999


Q ss_pred             CeeEEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccc
Q 044428          242 DFKALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFG  319 (457)
Q Consensus       242 ~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg  319 (457)
                      +..++|+||+.+ ++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++ +++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            999999999976 89999998754 4899999999999999999999    67899999999999999 78999999999


Q ss_pred             cccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          320 ISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      +++......    .....||+.|+|||.+     .+.++||||||+++|||++|+.||....     ....         
T Consensus       196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~---------  257 (320)
T 3a99_A          196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR---------  257 (320)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH---------
T ss_pred             ccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhc---------
Confidence            998764322    2345689999999933     3678899999999999999999996421     1111         


Q ss_pred             hccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         ...... .      .++..+.+++.+||+.||++|||+.|+++
T Consensus       258 ---~~~~~~-~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 ---GQVFFR-Q------RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---CCCCCS-S------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cccccc-c------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000000 0      11345889999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=310.97  Aligned_cols=241  Identities=26%  Similarity=0.302  Sum_probs=186.1

Q ss_pred             HHHHHhhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccch------hhHHHHHHHHHHHhhc----CCCccceee
Q 044428          167 DIQRATNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLE------RTFVSFNSECEVLRNV----RHRNLIKIL  235 (457)
Q Consensus       167 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~  235 (457)
                      +.....++|...+.||+|+||.||+|+. .+++.||||++.....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445567899999999999999999986 4789999999975432      1233466799999998    899999999


Q ss_pred             eeeecCCeeEEEEec-cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcE
Q 044428          236 SGCSNLDFKALVLEF-MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVA  313 (457)
Q Consensus       236 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~  313 (457)
                      +++...+..++|+|| +++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++ .++.+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChhhEEEeCCCCeE
Confidence            999999999999999 78999999998754 4899999999999999999999    56799999999999999 89999


Q ss_pred             EEeccccccccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc
Q 044428          314 HVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL  388 (457)
Q Consensus       314 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~  388 (457)
                      ||+|||+++......    .....|+..|+|||.+     .+.++||||||+++|||++|+.||....     ...    
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~----  246 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL----  246 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH----
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh----
Confidence            999999998764322    2345689999999933     3458999999999999999999996421     111    


Q ss_pred             CchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       389 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              ...... .      ..+...+.+++.+|++.+|++||++.|+++
T Consensus       247 --------~~~~~~-~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 --------EAELHF-P------AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --------HTCCCC-C------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------hhccCC-c------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    111100 0      012345789999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=323.86  Aligned_cols=245  Identities=22%  Similarity=0.310  Sum_probs=183.5

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .+|...+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            46788889999999997655556899999999865322   2356899999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-----CCcEEEeccccccccCC
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-----NMVAHVSDFGISKLLGE  326 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfg~~~~~~~  326 (457)
                      + |+|.+++........+.....++.||+.||.|||    ..+|+||||||+|||++.     ...+||+|||+++....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            5 6999999877655555667889999999999999    678999999999999943     34688999999987754


Q ss_pred             CCCc-ceeccccccccccCCCCCC-------CCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          327 GDDS-LIQTKTMATIGYMAPEGIV-------STKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       327 ~~~~-~~~~~~~gt~~y~aPE~~~-------~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      .... .......||+.|+|||.+.       +.++|||||||++|||+| |..||......... ..   ......+...
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~~~~~~  251 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACSLDCLH  251 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCCCTTSC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCCccccC
Confidence            3222 1233467999999999653       458999999999999999 99998643221111 10   0000000000


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           .      .......+.+++.+|++.||++|||+.||++
T Consensus       252 -----~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          252 -----P------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -----T------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----c------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                 0      0122445789999999999999999999983

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.8e-39  Score=315.79  Aligned_cols=257  Identities=21%  Similarity=0.276  Sum_probs=190.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCccceeeeeeec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-----------HRNLIKILSGCSN  240 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  240 (457)
                      ++|...+.||+|+||.||+|+. .+++.||||++.... .....+.+|+.++.+++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5788899999999999999987 478999999997542 23456788999998886           8999999999876


Q ss_pred             CC----eeEEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCCeeec------
Q 044428          241 LD----FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALA-PIIHCDLKPSNILLD------  308 (457)
Q Consensus       241 ~~----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-~ivH~dlk~~NIll~------  308 (457)
                      .+    ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||    .. +|+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCCCc
Confidence            54    789999999 899999998743 45899999999999999999999    55 799999999999994      


Q ss_pred             CCCcEEEeccccccccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHH---
Q 044428          309 ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK---  381 (457)
Q Consensus       309 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~---  381 (457)
                      .++.+||+|||+++.....     .....||+.|+|||.    .++.++|||||||++|||+||+.||.........   
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999876432     233578999999993    3788999999999999999999999764322110   


Q ss_pred             HHH---Hhhc---Cchh-------HHhcccc-cccc-----c--------cchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044428          382 HWV---NQSL---PHKL-------AEVVDSN-LVRR-----E--------HSFSAKMDCLLRIMNLALDCCMESPDERIH  434 (457)
Q Consensus       382 ~~~---~~~~---~~~~-------~~~~d~~-l~~~-----~--------~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs  434 (457)
                      ..+   ....   +...       ...+... ....     .        .....+..+...+.+++.+|++.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            000   0000   0000       0000000 0000     0        000012345678999999999999999999


Q ss_pred             HHHHHH
Q 044428          435 TTNAAA  440 (457)
Q Consensus       435 ~~ev~~  440 (457)
                      +.|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-38  Score=303.96  Aligned_cols=232  Identities=13%  Similarity=0.061  Sum_probs=183.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+..+.+++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57888899999999999999985 58999999997653   233467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++++|.+++...   ....+..+++.|++.||+|||    ..+|+||||||+|||++.++.+||+++|         
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999999653   355678899999999999999    6789999999999999999999998554         


Q ss_pred             CcceeccccccccccCCCCCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccc-h
Q 044428          329 DSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS-F  407 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~-~  407 (457)
                                   |++|   ++.++|||||||++|||+||+.||.............            ..+...... .
T Consensus       175 -------------~~~~---~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------~~~~~~~~~~~  226 (286)
T 3uqc_A          175 -------------TMPD---ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------RDTAGQPIEPA  226 (286)
T ss_dssp             -------------CCTT---CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------BCTTSCBCCHH
T ss_pred             -------------ccCC---CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------HHhccCCCChh
Confidence                         2333   5779999999999999999999998643221000000            000000000 0


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      ....+++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus       227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0011235568999999999999999 9999999999986543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.4e-38  Score=329.89  Aligned_cols=258  Identities=24%  Similarity=0.309  Sum_probs=191.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeec------CCe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSN------LDF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  243 (457)
                      .++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999874 68999999987643 3445678999999999999999999998765      677


Q ss_pred             eEEEEeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc---EEEecc
Q 044428          244 KALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV---AHVSDF  318 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~---~kl~Df  318 (457)
                      .++||||+++|+|.+++....  ..+++..+..++.+++.||.|||    ..+|+||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            899999999999999998754  35888899999999999999999    678999999999999996664   999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      |+++.......   .....||+.|+|||.+    ++.++||||||+++|||++|+.||....  ....|...........
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~--~~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW--QPVQWHGKVREKSNEH  243 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC--HHHHSSTTCC------
T ss_pred             ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc--chhhhhhhhhcccchh
Confidence            99987654322   2346799999999954    6789999999999999999999996532  2222222111111111


Q ss_pred             -hcccccccc-------ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 044428          395 -VVDSNLVRR-------EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNA  438 (457)
Q Consensus       395 -~~d~~l~~~-------~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev  438 (457)
                       .......+.       ..........+..+.+++.+|++.||++|||+.|+
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence             001000000       00000111235678999999999999999999883

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.1e-38  Score=333.92  Aligned_cols=238  Identities=21%  Similarity=0.245  Sum_probs=191.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC--CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCe-----e
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS--DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDF-----K  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  244 (457)
                      ++|...+.||+|+||.||+|+..  +|+.||||++.... ......+.+|++++.+++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999975  68999999986543 3345578999999999999999999999987655     6


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ++||||+++++|.+++..   .+++.+++.++.||+.||.|||    ..+|+||||||+|||++.+ .+||+|||+++..
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            999999999999998765   4899999999999999999999    6789999999999999986 8999999999876


Q ss_pred             CCCCCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          325 GEGDDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       325 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...      ....||++|+|||.+   .+.++|||||||++|||++|..|+......            .+        .
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~~--------~  285 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD------------GL--------P  285 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS------------SC--------C
T ss_pred             ccC------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc------------cc--------c
Confidence            432      335699999999933   578999999999999999999887642100            00        0


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHHhHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIH-TTNAAAKLRKIKVQ  448 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-~~ev~~~L~~i~~~  448 (457)
                      .    ..........+.+++.+|++.||++||+ +.++...|..+..+
T Consensus       286 ~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence            0    0011122456889999999999999994 66677777766544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-37  Score=298.56  Aligned_cols=229  Identities=20%  Similarity=0.310  Sum_probs=177.4

Q ss_pred             hcCCcC-CccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHH-hhcCCCccceeeeeeec----CCeeE
Q 044428          173 NEFDEC-NLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVL-RNVRHRNLIKILSGCSN----LDFKA  245 (457)
Q Consensus       173 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  245 (457)
                      ++|... +.||+|+||.||+|.. .+++.||+|++...     ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            566666 6799999999999987 47899999998642     3467888888 55689999999999876    67889


Q ss_pred             EEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCcEEEeccccc
Q 044428          246 LVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGIS  321 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~  321 (457)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            9999999999999998764 46899999999999999999999    678999999999999998   789999999998


Q ss_pred             cccCCCCCcceeccccccccccCCCCCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .....                    ..++.++|||||||++|||+||+.||.........    ......   +....  
T Consensus       168 ~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----~~~~~~---~~~~~--  218 (299)
T 3m2w_A          168 KETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTR---IRMGQ--  218 (299)
T ss_dssp             EECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------CCSCCS---SCTTC--
T ss_pred             ccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----HHHHHH---Hhhcc--
Confidence            76432                    12466899999999999999999999754321110    000000   00000  


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ..........++..+.+++.+|++.||++|||+.|+++
T Consensus       219 -~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 -YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00001111233567899999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-38  Score=318.62  Aligned_cols=245  Identities=15%  Similarity=0.180  Sum_probs=179.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCC-Cccceeeee---------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLE---RTFVSFNSECEVLRNVRH-RNLIKILSG---------  237 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~---------  237 (457)
                      +..|...+.||+|+||.||+|++ .+|+.||||++.....   ...+.+.+|+.++..++| +|......+         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34566778999999999999995 4799999999874332   235678999999999987 322211111         


Q ss_pred             ------------eec-----CCeeEEEEeccCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 044428          238 ------------CSN-----LDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGLALEYLHYGHALAP  294 (457)
Q Consensus       238 ------------~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~  294 (457)
                                  +..     ....+++|+++ +++|.+++.      .....+++..++.++.|++.||+|||    ..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~  231 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYG  231 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTT
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCC
Confidence                        111     12356677765 789999884      22345788899999999999999999    678


Q ss_pred             eeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCC--------------CCCccchhhhhH
Q 044428          295 IIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI--------------VSTKCDVYSYGI  360 (457)
Q Consensus       295 ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--------------~~~~~Dv~s~Gv  360 (457)
                      |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||.+              ++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998865321     334567 999999965              456999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          361 LLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       361 vl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ++|||+||+.||.......               ..+..+....       .++..+.+++.+||+.||++||++.|+++
T Consensus       306 il~elltg~~Pf~~~~~~~---------------~~~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALG---------------GSEWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGS---------------CSGGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCCCCCCCcchhh---------------hHHHHHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999997532111               1111111111       11356899999999999999999988865


Q ss_pred             H--HHHhHHHH
Q 044428          441 K--LRKIKVQF  449 (457)
Q Consensus       441 ~--L~~i~~~~  449 (457)
                      .  ++++++..
T Consensus       364 ~~~~~~~~~~~  374 (413)
T 3dzo_A          364 TPEYEQLRTEL  374 (413)
T ss_dssp             SHHHHHHHHHH
T ss_pred             CHHHHHHHHHH
Confidence            3  44444433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.8e-36  Score=293.24  Aligned_cols=240  Identities=19%  Similarity=0.225  Sum_probs=178.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcC---------C------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--------ERTFVSFNSECEVLRNVR---------H------  228 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h------  228 (457)
                      .++|...+.||+|+||.||+|+. +|+.||||++....        ......+.+|+.+++.++         |      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788899999999999999998 68999999997642        223467889999998886         5      


Q ss_pred             -----------Cccceeeeeeec-------------CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 044428          229 -----------RNLIKILSGCSN-------------LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE  284 (457)
Q Consensus       229 -----------~niv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~  284 (457)
                                 |||+++++++..             .+..++||||+++|++.+.+..  ..+++..+..++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence                       555555554443             6789999999999977776654  34899999999999999999


Q ss_pred             HHHhcCCCCCeeeccCCCCCeeecCCC--------------------cEEEeccccccccCCCCCcceeccccccccccC
Q 044428          285 YLHYGHALAPIIHCDLKPSNILLDENM--------------------VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA  344 (457)
Q Consensus       285 ~LH~~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  344 (457)
                      |||+   ..+|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+|
T Consensus       176 ~lH~---~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a  245 (336)
T 2vuw_A          176 VAEA---SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD  245 (336)
T ss_dssp             HHHH---HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred             HHHH---hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence            9992   24599999999999999887                    9999999999976432       2469999999


Q ss_pred             CCCC---CCCccchhhhhHH-HHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHH
Q 044428          345 PEGI---VSTKCDVYSYGIL-LLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNL  420 (457)
Q Consensus       345 PE~~---~~~~~Dv~s~Gvv-l~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l  420 (457)
                      ||.+   .+.++||||+|++ .+++++|..||..      ..|.....    ..+.................+...+.++
T Consensus       246 PE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLT----DKMLKQMTFKTKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             SGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHH----HHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred             hhhhcCCCccceehhhhhCCCCcccccccCCCcc------hhhhhHHH----HhhhhhhccCcccchhhhhhcCHHHHHH
Confidence            9954   4668999998777 7789999998732      12211110    0111110111111122334567789999


Q ss_pred             HHhccCCCCCCCCCHHHHH
Q 044428          421 ALDCCMESPDERIHTTNAA  439 (457)
Q Consensus       421 ~~~C~~~~P~~RPs~~ev~  439 (457)
                      +.+|++.|     |+.|++
T Consensus       316 i~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHGGGSS-----SHHHHH
T ss_pred             HHHHhccC-----CHHHHH
Confidence            99999966     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.6e-30  Score=268.29  Aligned_cols=182  Identities=18%  Similarity=0.093  Sum_probs=129.8

Q ss_pred             ccCCCCceEEEEEE-eCCCCEEEEEEecccc----------hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL----------ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       180 ~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ..+.|++|.+..++ .--|+.+|+|++....          +...++|.+|+++|+++ .|+||+++++++.+.+..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34556666655543 2358889999996531          23346799999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||++|++|.+++...+ .++..   +|+.||+.||+|+|    ..+||||||||+|||+++++.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999998765 35543   58999999999999    788999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCC
Q 044428          328 DDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKP  371 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p  371 (457)
                      ..  ......||++|+|||.+   ...++|+||+|++++++.++..|
T Consensus       393 ~~--~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS--WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C--CSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             Cc--cccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            21  23346799999999955   55689999999999888776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.9e-27  Score=245.47  Aligned_cols=182  Identities=19%  Similarity=0.189  Sum_probs=142.6

Q ss_pred             CcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          176 DECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ...+.||+|+||.||+|+. .++.+++|+.....        ....+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4456899999999999954 57889999864321        11234589999999999999999777777777888999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++++|.+++..         +..++.|++.||.|||    ..+|+||||||+|||++.  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999976         4579999999999999    678999999999999998  9999999999987542


Q ss_pred             CCcc-----eeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCC
Q 044428          328 DDSL-----IQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTN  373 (457)
Q Consensus       328 ~~~~-----~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~  373 (457)
                      ....     ......||+.|+|||.+      ++..+|+||..+-.++-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2111     11346799999999954      5667899999999999888887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.2e-23  Score=199.49  Aligned_cols=140  Identities=15%  Similarity=0.146  Sum_probs=113.1

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccch------------------hhHHHHHHHHHHHhhcCCC
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE------------------RTFVSFNSECEVLRNVRHR  229 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~  229 (457)
                      +......|...+.||+|+||.||+|...+|+.||||+++....                  .....+.+|++++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3444445666689999999999999998899999999964321                  13456899999999999  


Q ss_pred             ccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC
Q 044428          230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE  309 (457)
Q Consensus       230 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~  309 (457)
                      | +++.+++.. +..++||||+++|+|.+ +..       .....++.|++.||.|||    ..+|+||||||+|||++ 
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-
Confidence            5 666665543 55699999999999998 422       123469999999999999    67899999999999999 


Q ss_pred             CCcEEEecccccccc
Q 044428          310 NMVAHVSDFGISKLL  324 (457)
Q Consensus       310 ~~~~kl~Dfg~~~~~  324 (457)
                      ++.+||+|||+++..
T Consensus       228 ~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          228 EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             TTEEEECCCTTCEET
T ss_pred             CCcEEEEECCCCeEC
Confidence            999999999998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=8.7e-20  Score=170.64  Aligned_cols=137  Identities=21%  Similarity=0.260  Sum_probs=105.6

Q ss_pred             CCcCCccCCCCceEEEEEEe-CCCCE--EEEEEecccch------------------------hhHHHHHHHHHHHhhcC
Q 044428          175 FDECNLLGIGSFGSVYKGTL-SDGTN--VAIKIFNLQLE------------------------RTFVSFNSECEVLRNVR  227 (457)
Q Consensus       175 ~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l~  227 (457)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++....                        .....+.+|+..+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45667999999999999998 68889  99998754311                        01236789999999998


Q ss_pred             CCcc--ceeeeeeecCCeeEEEEeccCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 044428          228 HRNL--IKILSGCSNLDFKALVLEFMPN-G----SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDL  300 (457)
Q Consensus       228 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dl  300 (457)
                      |+++  ..++++    +..++||||+.+ |    +|.++...    .++.....++.|++.||.|||.   ..+|+||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ---EAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH---TSCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH---HCCEEeCCC
Confidence            8864  333332    356899999942 4    77776543    2234567899999999999994   246999999


Q ss_pred             CCCCeeecCCCcEEEecccccccc
Q 044428          301 KPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       301 k~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ||+|||+++  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999865

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=1e-17  Score=163.30  Aligned_cols=147  Identities=13%  Similarity=0.121  Sum_probs=100.1

Q ss_pred             HHHHHhhc---CCcCCccCCCCceEEEEEEeCCCCEEEEEEecccch--------------hhHHHHHHHHHHHhhcCCC
Q 044428          167 DIQRATNE---FDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLE--------------RTFVSFNSECEVLRNVRHR  229 (457)
Q Consensus       167 ~l~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~  229 (457)
                      .+....++   |+..+.||+|++|.||+|...+|+.||||+++....              ........+.++.+...|+
T Consensus        86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            44444444   888899999999999999999999999998753210              0111222222222223344


Q ss_pred             ccceeeeeee------cCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 044428          230 NLIKILSGCS------NLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPS  303 (457)
Q Consensus       230 niv~l~~~~~------~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~  303 (457)
                      |+.++.....      .....++||||+++++|.++....       ....++.|++.+|.|||    ..+||||||||.
T Consensus       166 nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~lH----~~gIVHrDLKp~  234 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRLA----KHGLIHGDFNEF  234 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHHH----HTTEECSCCSTT
T ss_pred             HHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHHH----HCCCcCCCCCHH
Confidence            4433322111      112237999999998887654321       23467899999999999    678999999999


Q ss_pred             CeeecCCC----------cEEEecccccccc
Q 044428          304 NILLDENM----------VAHVSDFGISKLL  324 (457)
Q Consensus       304 NIll~~~~----------~~kl~Dfg~~~~~  324 (457)
                      |||+++++          .+.|+||+-+...
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99998776          4899999977653

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.60  E-value=5e-16  Score=167.38  Aligned_cols=102  Identities=41%  Similarity=0.698  Sum_probs=93.8

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      +|++|++|+.|+|++|+|+|.||.+|++|++|+.|||++|+|+|.||..+.++++|+.|||++|+|+|.+|..++|.++.
T Consensus       651 ~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~  730 (768)
T 3rgz_A          651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP  730 (768)
T ss_dssp             GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSC
T ss_pred             HHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCC
Confidence            57889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCcCCCCCcccc
Q 044428           82 TESFSWNYALCGPSRFQVPPCKEEN  106 (457)
Q Consensus        82 ~~~~~~n~~lcg~~~~~~~~c~~~~  106 (457)
                      ..++.+|+++||++.   ++|....
T Consensus       731 ~~~~~gN~~Lcg~~l---~~C~~~~  752 (768)
T 3rgz_A          731 PAKFLNNPGLCGYPL---PRCDPSN  752 (768)
T ss_dssp             GGGGCSCTEEESTTS---CCCCSCC
T ss_pred             HHHhcCCchhcCCCC---cCCCCCc
Confidence            999999999999863   3786543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=1.9e-12  Score=120.77  Aligned_cols=149  Identities=15%  Similarity=0.080  Sum_probs=115.9

Q ss_pred             HHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEE
Q 044428          168 IQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       168 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  246 (457)
                      +......|.....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3445567877778888899999999864 6889999987543233346889999999984 6778889999988889999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH------------------------------------  290 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------  290 (457)
                      ||||++|.+|.+.+..      ......++.+++.++..||.-.                                    
T Consensus        88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999999876421      1223468889999999999610                                    


Q ss_pred             -------------------CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          291 -------------------ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       291 -------------------~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                                         ....++|+|++|.||+++++..+.|.||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               014589999999999998766677999997653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.36  E-value=4.8e-13  Score=128.36  Aligned_cols=93  Identities=35%  Similarity=0.573  Sum_probs=86.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .++++++|+.|+|++|++++.+|. +..+++|++|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..+.++++.
T Consensus       216 ~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~  294 (313)
T 1ogq_A          216 LFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD  294 (313)
T ss_dssp             GCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSC
T ss_pred             HHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccC
Confidence            467889999999999999977766 8899999999999999999999999999999999999999999999988899999


Q ss_pred             ccccccccccCCCC
Q 044428           82 TESFSWNYALCGPS   95 (457)
Q Consensus        82 ~~~~~~n~~lcg~~   95 (457)
                      .+.+.+|+.+||.+
T Consensus       295 ~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          295 VSAYANNKCLCGSP  308 (313)
T ss_dssp             GGGTCSSSEEESTT
T ss_pred             hHHhcCCCCccCCC
Confidence            99999999999975

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.32  E-value=2e-12  Score=114.89  Aligned_cols=91  Identities=24%  Similarity=0.349  Sum_probs=75.3

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..+++|+.|+|++|++++.+|. ...+.++.
T Consensus        50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  129 (192)
T 1w8a_A           50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT  129 (192)
T ss_dssp             GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred             cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCC
Confidence            67788889999999999887788888899999999999999877777788888899999999999888764 35567788


Q ss_pred             ccccccccccCC
Q 044428           82 TESFSWNYALCG   93 (457)
Q Consensus        82 ~~~~~~n~~lcg   93 (457)
                      .+.+++|+..|.
T Consensus       130 ~L~L~~N~l~c~  141 (192)
T 1w8a_A          130 SLNLASNPFNCN  141 (192)
T ss_dssp             EEECTTCCBCCS
T ss_pred             EEEeCCCCccCc
Confidence            888888887653

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.29  E-value=4.4e-12  Score=112.70  Aligned_cols=92  Identities=22%  Similarity=0.265  Sum_probs=67.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      .++++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++.++. ...+.++
T Consensus        49 ~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  128 (193)
T 2wfh_A           49 ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSAL  128 (193)
T ss_dssp             GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTC
T ss_pred             HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccc
Confidence            356677788888888888765556777788888888888888865556777778888888888888766653 3456677


Q ss_pred             cccccccccccCC
Q 044428           81 STESFSWNYALCG   93 (457)
Q Consensus        81 ~~~~~~~n~~lcg   93 (457)
                      ..+.+++|++.|.
T Consensus       129 ~~L~L~~N~~~C~  141 (193)
T 2wfh_A          129 SHLAIGANPLYCD  141 (193)
T ss_dssp             CEEECCSSCEECS
T ss_pred             cEEEeCCCCeecC
Confidence            7777888877663

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.27  E-value=9e-12  Score=108.73  Aligned_cols=87  Identities=25%  Similarity=0.305  Sum_probs=77.4

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCCC-CCCcccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTES   84 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~   84 (457)
                      ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++ +|. .+.++++|+.|+|++|+|++.++. ...+.++..+.
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~  111 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY  111 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence            689999999999998888999999999999999999995 555 568999999999999999988875 56678899999


Q ss_pred             cccccccCCC
Q 044428           85 FSWNYALCGP   94 (457)
Q Consensus        85 ~~~n~~lcg~   94 (457)
                      +++|+..|.+
T Consensus       112 L~~N~~~c~~  121 (174)
T 2r9u_A          112 LYNNPWDCEC  121 (174)
T ss_dssp             CCSSCBCTTB
T ss_pred             eCCCCccccc
Confidence            9999987754

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.27  E-value=9.5e-12  Score=108.16  Aligned_cols=88  Identities=23%  Similarity=0.206  Sum_probs=78.1

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESF   85 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~   85 (457)
                      ++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..+++|+.|+|++|+|++.+|. ...+.++..+.+
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            6899999999999987789999999999999999999955555678999999999999999998885 567788999999


Q ss_pred             ccccccCCC
Q 044428           86 SWNYALCGP   94 (457)
Q Consensus        86 ~~n~~lcg~   94 (457)
                      ++|+..|..
T Consensus       110 ~~N~~~c~c  118 (170)
T 3g39_A          110 LNNPWDCAC  118 (170)
T ss_dssp             CSSCBCTTB
T ss_pred             CCCCCCCCc
Confidence            999987754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=8.7e-12  Score=115.83  Aligned_cols=138  Identities=15%  Similarity=0.064  Sum_probs=100.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--cceeeeeeecCCeeEEEEecc
Q 044428          174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN--LIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++......+.|..+.||++...+|..+++|+....   ....+.+|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34433333456669999998877888999997643   2345788999999986544  455888888777889999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH-----------------------------------------  290 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------------------  290 (457)
                      +|.+|.  ...    .+   ...++.+++..+..||...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    11   2356778888888888421                                         


Q ss_pred             -------------CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          291 -------------ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       291 -------------~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                                   ....++|+|++|.||+++++..+.|.||+.+..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                         012399999999999998876777999998764

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.27  E-value=8.7e-12  Score=113.19  Aligned_cols=86  Identities=21%  Similarity=0.143  Sum_probs=46.4

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|. ...+.++.
T Consensus        53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (220)
T 2v70_A           53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR  132 (220)
T ss_dssp             GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred             hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence            44555666666666666544444555566666666666666544444455555555555555555555442 23334444


Q ss_pred             ccccccc
Q 044428           82 TESFSWN   88 (457)
Q Consensus        82 ~~~~~~n   88 (457)
                      .+.+++|
T Consensus       133 ~L~L~~N  139 (220)
T 2v70_A          133 LLSLYDN  139 (220)
T ss_dssp             EEECTTS
T ss_pred             EEECCCC
Confidence            5555554

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.26  E-value=4.5e-12  Score=136.50  Aligned_cols=89  Identities=31%  Similarity=0.456  Sum_probs=82.6

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~   80 (457)
                      .++++++|+.|+|++|+|+|.+|.+|++|++|+.|+|++|+|+|.||..++++++|+.|||++|+++|.+|.. ..+..+
T Consensus       627 ~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L  706 (768)
T 3rgz_A          627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML  706 (768)
T ss_dssp             SCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC
T ss_pred             hhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence            4678899999999999999999999999999999999999999999999999999999999999999999964 566788


Q ss_pred             cccccccccc
Q 044428           81 STESFSWNYA   90 (457)
Q Consensus        81 ~~~~~~~n~~   90 (457)
                      ..+.+++|+-
T Consensus       707 ~~L~ls~N~l  716 (768)
T 3rgz_A          707 TEIDLSNNNL  716 (768)
T ss_dssp             SEEECCSSEE
T ss_pred             CEEECcCCcc
Confidence            8899999853

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.23  E-value=1.3e-11  Score=120.03  Aligned_cols=91  Identities=20%  Similarity=0.163  Sum_probs=80.2

Q ss_pred             ccCCccCCeeeccC-CcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            3 IGGLKDLATLSLAA-NKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      |+.+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.++++|+.|+|++|+|++.+|.......+.
T Consensus        27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~  106 (347)
T 2ifg_A           27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQ  106 (347)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCC
T ss_pred             CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCce
Confidence            67888999999996 99997777889999999999999999998888899999999999999999999887654433488


Q ss_pred             ccccccccccCC
Q 044428           82 TESFSWNYALCG   93 (457)
Q Consensus        82 ~~~~~~n~~lcg   93 (457)
                      .+.+.+|+..|.
T Consensus       107 ~l~l~~N~~~c~  118 (347)
T 2ifg_A          107 ELVLSGNPLHCS  118 (347)
T ss_dssp             EEECCSSCCCCC
T ss_pred             EEEeeCCCccCC
Confidence            889999988774

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.22  E-value=2.6e-11  Score=110.08  Aligned_cols=87  Identities=29%  Similarity=0.347  Sum_probs=59.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCcc-chhcCCCceEecccccCCCCCCC-CCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVSQNRLEGEIPV-EGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~   79 (457)
                      .++++++|+.|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. +..+++|+.|+|++|++++..|. ...+.+
T Consensus        51 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  129 (220)
T 2v9t_B           51 AFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN  129 (220)
T ss_dssp             SSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             HhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCC
Confidence            4566777777777777777666777777777777777777777 45543 56677777777777777776553 234455


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+++|.
T Consensus       130 L~~L~L~~N~  139 (220)
T 2v9t_B          130 LNLLSLYDNK  139 (220)
T ss_dssp             CCEEECCSSC
T ss_pred             CCEEECCCCc
Confidence            6666666664

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.21  E-value=5.4e-12  Score=128.57  Aligned_cols=30  Identities=17%  Similarity=0.157  Sum_probs=26.0

Q ss_pred             HHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 044428          213 FVSFNSECEVLRNVRHRNLIKILSGCSNLD  242 (457)
Q Consensus       213 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  242 (457)
                      ..+|.+|++.+++++|+|+|+++|||....
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            567999999999999999999999998753

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.19  E-value=4.7e-11  Score=109.04  Aligned_cols=88  Identities=25%  Similarity=0.331  Sum_probs=43.4

Q ss_pred             cCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccccc
Q 044428            4 GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFST   82 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~   82 (457)
                      +++++|+.|+|++|+|++..|..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+. ...+.++..
T Consensus        85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  163 (229)
T 3e6j_A           85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH  163 (229)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence            44455555555555555333333445555555555555555 5555555555555555555555544432 233444555


Q ss_pred             cccccccccC
Q 044428           83 ESFSWNYALC   92 (457)
Q Consensus        83 ~~~~~n~~lc   92 (457)
                      +.+.+|+..|
T Consensus       164 L~l~~N~~~c  173 (229)
T 3e6j_A          164 AYLFGNPWDC  173 (229)
T ss_dssp             EECTTSCBCT
T ss_pred             EEeeCCCccC
Confidence            5555555444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.19  E-value=5.5e-11  Score=103.89  Aligned_cols=88  Identities=23%  Similarity=0.185  Sum_probs=42.3

Q ss_pred             cCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccccc
Q 044428            4 GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFST   82 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~   82 (457)
                      +++++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++.++.. ..+.++..
T Consensus        49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  128 (177)
T 2o6r_A           49 DKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQK  128 (177)
T ss_dssp             TTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             cCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCE
Confidence            44555555555555555333333455555555555555555333333445555555555555555444332 23444455


Q ss_pred             ccccccccc
Q 044428           83 ESFSWNYAL   91 (457)
Q Consensus        83 ~~~~~n~~l   91 (457)
                      +.+++|+..
T Consensus       129 L~l~~N~~~  137 (177)
T 2o6r_A          129 IWLHTNPWD  137 (177)
T ss_dssp             EECCSSCBC
T ss_pred             EEecCCCee
Confidence            555555443

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.11  E-value=9.1e-11  Score=122.97  Aligned_cols=92  Identities=25%  Similarity=0.291  Sum_probs=82.2

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCc-cc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPF-RN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~-~~   79 (457)
                      .++.+++|+.|+|++|+|++..|..|++|++|++|+|++|+|++..|..+..+++|+.|+|++|+|++.+|.. ..+ .+
T Consensus       489 ~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~  568 (635)
T 4g8a_A          489 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS  568 (635)
T ss_dssp             CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTT
T ss_pred             hhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCc
Confidence            4678999999999999999888999999999999999999999777788999999999999999999998864 333 56


Q ss_pred             ccccccccccccCC
Q 044428           80 FSTESFSWNYALCG   93 (457)
Q Consensus        80 ~~~~~~~~n~~lcg   93 (457)
                      +..+.+++|++.|.
T Consensus       569 L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          569 LAFLNLTQNDFACT  582 (635)
T ss_dssp             CCEEECTTCCBCCS
T ss_pred             CCEEEeeCCCCccc
Confidence            88899999999884

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.11  E-value=1.8e-10  Score=106.55  Aligned_cols=87  Identities=29%  Similarity=0.308  Sum_probs=55.5

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++.+|. ...+.++.
T Consensus        79 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  158 (251)
T 3m19_A           79 FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQ  158 (251)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCC
Confidence            55667777777777777754445566777777777777777743333456667777777777777666552 34455666


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       159 ~L~L~~N~  166 (251)
T 3m19_A          159 TLSLSTNQ  166 (251)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCc
Confidence            66666664

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.11  E-value=2.3e-10  Score=102.60  Aligned_cols=87  Identities=25%  Similarity=0.263  Sum_probs=57.1

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++.++. ...+.++.
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  127 (208)
T 2o6s_A           48 FDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK  127 (208)
T ss_dssp             TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCC
Confidence            45677777777777777744344567777777777777777744344466777777777777777766554 24455666


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       128 ~L~l~~N~  135 (208)
T 2o6s_A          128 DLRLYQNQ  135 (208)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCc
Confidence            66666664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.08  E-value=5.6e-11  Score=105.41  Aligned_cols=72  Identities=29%  Similarity=0.385  Sum_probs=67.6

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV   73 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~   73 (457)
                      .++++++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++.+|..+..+++|+.|+|++|++++..+.
T Consensus        73 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             HcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            578899999999999999988888899999999999999999999999999999999999999999988763

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.08  E-value=3.1e-10  Score=106.38  Aligned_cols=87  Identities=22%  Similarity=0.249  Sum_probs=50.9

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|++++|++++.+|.. ..+.++.
T Consensus       105 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  184 (272)
T 3rfs_A          105 FDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLK  184 (272)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCC
Confidence            455666666666666666544445666666666666666666444444556666666666666666555432 3445555


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       185 ~L~L~~N~  192 (272)
T 3rfs_A          185 DLRLYQNQ  192 (272)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCc
Confidence            55555553

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.08  E-value=2e-10  Score=104.08  Aligned_cols=92  Identities=23%  Similarity=0.259  Sum_probs=73.9

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      .++++++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|. ...+.++
T Consensus        76 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  155 (220)
T 2v70_A           76 AFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSL  155 (220)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTC
T ss_pred             HhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCC
Confidence            467888888888888888866666788888888888888888877788888888888888888888888664 3456677


Q ss_pred             cccccccccccCC
Q 044428           81 STESFSWNYALCG   93 (457)
Q Consensus        81 ~~~~~~~n~~lcg   93 (457)
                      ..+.+++|++.|.
T Consensus       156 ~~L~L~~N~l~c~  168 (220)
T 2v70_A          156 STLNLLANPFNCN  168 (220)
T ss_dssp             CEEECCSCCEECS
T ss_pred             CEEEecCcCCcCC
Confidence            7888888887664

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.08  E-value=2.4e-10  Score=111.63  Aligned_cols=142  Identities=15%  Similarity=0.178  Sum_probs=105.9

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEec--ccc-hhhHHHHHHHHHHHhhcC--CCccceeeeeeecC---CeeEEEEe
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFN--LQL-ERTFVSFNSECEVLRNVR--HRNLIKILSGCSNL---DFKALVLE  249 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  249 (457)
                      .+.++.|.++.||+....+ ..+++|+..  ... ......+.+|..+++.+.  +..+.++++++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4578999999999998754 678889876  332 123456888999999997  45678888888776   45899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH---------------------------------------  290 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------  290 (457)
                      |++|..+.+...   ..++..++..++.+++.+|..||...                                       
T Consensus       122 ~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999987754211   22677888899999999999999621                                       


Q ss_pred             ---------------CCCCeeeccCCCCCeeecCCCc--EEEeccccccc
Q 044428          291 ---------------ALAPIIHCDLKPSNILLDENMV--AHVSDFGISKL  323 (457)
Q Consensus       291 ---------------~~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~~~~  323 (457)
                                     ....++|+|+++.||++++++.  +.|.||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                           0256999999999999997753  68999998875

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.07  E-value=5.6e-11  Score=113.90  Aligned_cols=89  Identities=30%  Similarity=0.453  Sum_probs=75.1

Q ss_pred             CccCCccCCeeecc-CCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccc
Q 044428            2 TIGGLKDLATLSLA-ANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~-~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~   79 (457)
                      +++++++|+.|+|+ +|+++|.+|..|+++++|++|+|++|+++|.+|..+.++++|+.|+|++|++++.+|. ...+++
T Consensus        71 ~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  150 (313)
T 1ogq_A           71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN  150 (313)
T ss_dssp             GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTT
T ss_pred             hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCC
Confidence            46788899999999 4899989999999999999999999999988999899999999999999999887774 355677


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|..
T Consensus       151 L~~L~L~~N~l  161 (313)
T 1ogq_A          151 LVGITFDGNRI  161 (313)
T ss_dssp             CCEEECCSSCC
T ss_pred             CCeEECcCCcc
Confidence            88888888753

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.06  E-value=3.3e-10  Score=102.72  Aligned_cols=89  Identities=29%  Similarity=0.410  Sum_probs=46.9

Q ss_pred             ccCCccCCeeeccCCcccccCCc-ccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      |+++++|+.|+|++|+|+ .+|. .|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..+. ...+.++
T Consensus        76 ~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  154 (220)
T 2v9t_B           76 FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI  154 (220)
T ss_dssp             TTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             hhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCC
Confidence            445555555555555555 3333 245555555555555555544455555555555555555555555443 2334445


Q ss_pred             cccccccccccC
Q 044428           81 STESFSWNYALC   92 (457)
Q Consensus        81 ~~~~~~~n~~lc   92 (457)
                      ..+.+++|++.|
T Consensus       155 ~~L~L~~N~~~c  166 (220)
T 2v9t_B          155 QTMHLAQNPFIC  166 (220)
T ss_dssp             CEEECCSSCEEC
T ss_pred             CEEEeCCCCcCC
Confidence            555555555544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.04  E-value=2.1e-10  Score=118.82  Aligned_cols=86  Identities=22%  Similarity=0.269  Sum_probs=64.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCC-C-CCCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEI-P-VEGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~-p-~~~~~~~   79 (457)
                      .+++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ | ..+.+++
T Consensus       458 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~  534 (567)
T 1dce_A          458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR  534 (567)
T ss_dssp             CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred             CccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCC
Confidence            3667777888888888887 778778888888888888888874 66 7777788888888888887774 3 4456667


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|+.
T Consensus       535 L~~L~L~~N~l  545 (567)
T 1dce_A          535 LVLLNLQGNSL  545 (567)
T ss_dssp             CCEEECTTSGG
T ss_pred             CCEEEecCCcC
Confidence            77777777753

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.04  E-value=1.3e-10  Score=100.51  Aligned_cols=86  Identities=22%  Similarity=0.194  Sum_probs=72.9

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCC--CCCCCcccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEI--PVEGPFRNF   80 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~--p~~~~~~~~   80 (457)
                      ++.+++|+.|+|++|+|++.  ..++.+++|++|+|++|++++.+|..+..+++|+.|+|++|++++..  +....++++
T Consensus        45 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L  122 (168)
T 2ell_A           45 TAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECL  122 (168)
T ss_dssp             CGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCC
T ss_pred             HHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCC
Confidence            47789999999999999854  78899999999999999999778888888999999999999998864  455667788


Q ss_pred             cccccccccc
Q 044428           81 STESFSWNYA   90 (457)
Q Consensus        81 ~~~~~~~n~~   90 (457)
                      ..+.+++|+.
T Consensus       123 ~~L~l~~N~l  132 (168)
T 2ell_A          123 KSLDLFNCEV  132 (168)
T ss_dssp             CEEECCSSGG
T ss_pred             CEEEeeCCcC
Confidence            8888888854

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.04  E-value=1.8e-10  Score=97.44  Aligned_cols=82  Identities=26%  Similarity=0.276  Sum_probs=56.0

Q ss_pred             CccCCeeeccCCccc-ccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccccc
Q 044428            6 LKDLATLSLAANKFH-GPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFSTE   83 (457)
Q Consensus         6 l~~L~~l~l~~N~l~-g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~   83 (457)
                      .++|+.|+|++|+++ |.+|..++.+++|+.|+|++|++++.  ..+..+++|+.|++++|++++.+|.. ..++++..+
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            466777777777777 67777777777777777777777743  56667777777777777777755543 235566666


Q ss_pred             cccccc
Q 044428           84 SFSWNY   89 (457)
Q Consensus        84 ~~~~n~   89 (457)
                      .+++|.
T Consensus        94 ~ls~N~   99 (149)
T 2je0_A           94 NLSGNK   99 (149)
T ss_dssp             ECTTSC
T ss_pred             ECCCCc
Confidence            666664

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.03  E-value=5.5e-10  Score=105.73  Aligned_cols=88  Identities=22%  Similarity=0.155  Sum_probs=62.5

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++..|..+..+++|+.|+|++|+|++.++.. ..+.++.
T Consensus        96 ~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~  175 (290)
T 1p9a_G           96 GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD  175 (290)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCC
T ss_pred             hccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCC
Confidence            566778888888888888555567888888888888888888444445677788888888888887666543 3455666


Q ss_pred             ccccccccc
Q 044428           82 TESFSWNYA   90 (457)
Q Consensus        82 ~~~~~~n~~   90 (457)
                      .+.+++|..
T Consensus       176 ~L~L~~N~l  184 (290)
T 1p9a_G          176 TLLLQENSL  184 (290)
T ss_dssp             EEECCSSCC
T ss_pred             EEECCCCcC
Confidence            666666643

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.02  E-value=2e-10  Score=124.87  Aligned_cols=87  Identities=30%  Similarity=0.392  Sum_probs=74.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +++|++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..+.  ++|+.|+|++|+|++.+|..  |.++..
T Consensus       476 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~  551 (844)
T 3j0a_A          476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSV  551 (844)
T ss_dssp             SSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCE
T ss_pred             hcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCE
Confidence            66789999999999999988888899999999999999999954444444  78999999999999998854  668889


Q ss_pred             cccccccccCC
Q 044428           83 ESFSWNYALCG   93 (457)
Q Consensus        83 ~~~~~n~~lcg   93 (457)
                      +.+++|++.|.
T Consensus       552 l~l~~Np~~C~  562 (844)
T 3j0a_A          552 LDITHNKFICE  562 (844)
T ss_dssp             EEEEEECCCCS
T ss_pred             EEecCCCcccc
Confidence            99999999984

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.01  E-value=7e-11  Score=100.06  Aligned_cols=87  Identities=21%  Similarity=0.191  Sum_probs=76.2

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCC--CCCCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEI--PVEGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~--p~~~~~~~   79 (457)
                      .++.+++|+.|+|++|++++.  ..++++++|++|+|++|++++.+|..+..+++|+.|++++|++++..  +....+++
T Consensus        37 ~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~  114 (149)
T 2je0_A           37 LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN  114 (149)
T ss_dssp             CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTT
T ss_pred             HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCC
Confidence            357899999999999999965  88999999999999999999879998889999999999999999853  45566778


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|..
T Consensus       115 L~~L~l~~N~l  125 (149)
T 2je0_A          115 LKSLDLFNCEV  125 (149)
T ss_dssp             CCEEECTTCGG
T ss_pred             CCEEeCcCCcc
Confidence            88899998853

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.01  E-value=3.7e-10  Score=97.61  Aligned_cols=84  Identities=26%  Similarity=0.296  Sum_probs=73.8

Q ss_pred             CCccCCeeeccCCccc-ccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCC-Ccccccc
Q 044428            5 GLKDLATLSLAANKFH-GPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEG-PFRNFST   82 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~-g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~-~~~~~~~   82 (457)
                      ..++|+.|+|++|+++ |.+|..+..+++|+.|+|++|++++ + ..+..+++|+.|+|++|++++.+|... .++++..
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            4578999999999998 8999999999999999999999995 4 788999999999999999999777543 3778888


Q ss_pred             cccccccc
Q 044428           83 ESFSWNYA   90 (457)
Q Consensus        83 ~~~~~n~~   90 (457)
                      +.+++|..
T Consensus       100 L~Ls~N~l  107 (168)
T 2ell_A          100 LNLSGNKL  107 (168)
T ss_dssp             EECBSSSC
T ss_pred             EeccCCcc
Confidence            89988853

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.01  E-value=2.2e-10  Score=101.95  Aligned_cols=87  Identities=18%  Similarity=0.255  Sum_probs=53.2

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      ++++++|+.|+|++|++++..|..|+.+++|++|+|++|++++..|..+..+++|+.|++++|++.+.+|....++++..
T Consensus        84 l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~  163 (197)
T 4ezg_A           84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKS  163 (197)
T ss_dssp             GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCE
T ss_pred             hhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCE
Confidence            45566666666666666665666666666666666666666665666666666666666666663333344444555566


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       164 L~l~~n~  170 (197)
T 4ezg_A          164 LNIQFDG  170 (197)
T ss_dssp             EECTTBC
T ss_pred             EECCCCC
Confidence            6665553

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.01  E-value=6.7e-10  Score=101.31  Aligned_cols=82  Identities=26%  Similarity=0.308  Sum_probs=44.4

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCC-ccchhcCCCceEecccccCCCCCCCC-CCcccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIP-KSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFSTES   84 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p-~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~   84 (457)
                      ++|+.|+|++|+|++..|..|+++++|++|+|++|+|+ .+| ..+..+++|+.|+|++|+|++.++.. ..+.++..+.
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~  118 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF  118 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence            44556666666666555555555666666666666665 333 33455556666666666665554432 3344555555


Q ss_pred             ccccc
Q 044428           85 FSWNY   89 (457)
Q Consensus        85 ~~~n~   89 (457)
                      +++|.
T Consensus       119 Ls~N~  123 (229)
T 3e6j_A          119 MCCNK  123 (229)
T ss_dssp             CCSSC
T ss_pred             ccCCc
Confidence            55543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.00  E-value=7.6e-10  Score=102.34  Aligned_cols=86  Identities=22%  Similarity=0.257  Sum_probs=41.0

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++.++.. ..+.++.
T Consensus        55 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  134 (251)
T 3m19_A           55 FRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLK  134 (251)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCccc
Confidence            344455555555555555444444455555555555555555333334444555555555555555444432 2334444


Q ss_pred             ccccccc
Q 044428           82 TESFSWN   88 (457)
Q Consensus        82 ~~~~~~n   88 (457)
                      .+.+++|
T Consensus       135 ~L~Ls~N  141 (251)
T 3m19_A          135 ELRLNTN  141 (251)
T ss_dssp             EEECCSS
T ss_pred             EEECcCC
Confidence            4444444

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.00  E-value=5.1e-10  Score=112.70  Aligned_cols=90  Identities=27%  Similarity=0.239  Sum_probs=44.9

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..++++.
T Consensus       319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  398 (455)
T 3v47_A          319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ  398 (455)
T ss_dssp             TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCccc
Confidence            344455555555555554444444555555555555555555444455555555555555555555444322 3344455


Q ss_pred             ccccccccccC
Q 044428           82 TESFSWNYALC   92 (457)
Q Consensus        82 ~~~~~~n~~lc   92 (457)
                      .+.+++|+..|
T Consensus       399 ~L~l~~N~l~~  409 (455)
T 3v47_A          399 KIWLHTNPWDC  409 (455)
T ss_dssp             EEECCSSCBCC
T ss_pred             EEEccCCCccc
Confidence            55555555444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.00  E-value=4.8e-10  Score=108.13  Aligned_cols=88  Identities=17%  Similarity=0.194  Sum_probs=76.6

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      .++++++|+.|+|++|+++ .+|+.++++++|++|+|++|++.|.+|..+..+++|+.|+|++|++.+.+|. ...+.++
T Consensus       201 ~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L  279 (328)
T 4fcg_A          201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL  279 (328)
T ss_dssp             GGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTC
T ss_pred             hhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCC
Confidence            4678899999999999999 5888899999999999999999999999999999999999999999998885 3566778


Q ss_pred             cccccccccc
Q 044428           81 STESFSWNYA   90 (457)
Q Consensus        81 ~~~~~~~n~~   90 (457)
                      ..+.+++|+.
T Consensus       280 ~~L~L~~n~~  289 (328)
T 4fcg_A          280 EKLDLRGCVN  289 (328)
T ss_dssp             CEEECTTCTT
T ss_pred             CEEeCCCCCc
Confidence            8888888764

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.00  E-value=9.5e-10  Score=102.85  Aligned_cols=86  Identities=27%  Similarity=0.298  Sum_probs=46.4

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..|+++++|++|+|++|+|++..+..+..+++|+.|+|++|++++..+. ...+.++.
T Consensus       105 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  184 (270)
T 2o6q_A          105 FDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELK  184 (270)
T ss_dssp             TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             cccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcC
Confidence            34556666666666666644444556666666666666666632223355555666666666665555442 22334444


Q ss_pred             ccccccc
Q 044428           82 TESFSWN   88 (457)
Q Consensus        82 ~~~~~~n   88 (457)
                      .+.+++|
T Consensus       185 ~L~L~~N  191 (270)
T 2o6q_A          185 TLKLDNN  191 (270)
T ss_dssp             EEECCSS
T ss_pred             EEECCCC
Confidence            4555544

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.99  E-value=5.2e-10  Score=112.38  Aligned_cols=92  Identities=21%  Similarity=0.255  Sum_probs=69.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~   80 (457)
                      .++.+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|+|++.++.. ..+.++
T Consensus       202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  281 (440)
T 3zyj_A          202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL  281 (440)
T ss_dssp             CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred             ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence            3556677777777777777766777888888888888888888766777788888888888888888766643 456677


Q ss_pred             cccccccccccCC
Q 044428           81 STESFSWNYALCG   93 (457)
Q Consensus        81 ~~~~~~~n~~lcg   93 (457)
                      ..+.+++|++.|.
T Consensus       282 ~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          282 ERIHLHHNPWNCN  294 (440)
T ss_dssp             CEEECCSSCEECS
T ss_pred             CEEEcCCCCccCC
Confidence            7888888888774

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.99  E-value=7.1e-10  Score=98.32  Aligned_cols=84  Identities=27%  Similarity=0.310  Sum_probs=75.3

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESF   85 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~   85 (457)
                      ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|. ...+.++..+.+
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            57999999999999 8999999999999999999999977677899999999999999999998874 456778888999


Q ss_pred             cccccc
Q 044428           86 SWNYAL   91 (457)
Q Consensus        86 ~~n~~l   91 (457)
                      ++|...
T Consensus       110 ~~N~l~  115 (193)
T 2wfh_A          110 HGNDIS  115 (193)
T ss_dssp             CSSCCC
T ss_pred             CCCCCC
Confidence            998643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.98  E-value=2.4e-10  Score=108.91  Aligned_cols=186  Identities=16%  Similarity=0.162  Sum_probs=121.5

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCc--cceeeeeeecCC---eeEEEEecc
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRN--LIKILSGCSNLD---FKALVLEFM  251 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  251 (457)
                      .+.++.|.+..||+..    ..+++|+....  .....+.+|.++++.+. +..  +.+++......+   ..++||+|+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568899999999864    46899986533  33456889999998884 332  334444443333   357899999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH-----------------------------------------  290 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------------------  290 (457)
                      +|.+|.+....   .++..++..++.+++..+..||...                                         
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888754332   2667778888888888888888511                                         


Q ss_pred             -------------CCCCeeeccCCCCCeeecC--CCcEEEeccccccccCCCCCcceeccc---ccc-------ccc--c
Q 044428          291 -------------ALAPIIHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGDDSLIQTKT---MAT-------IGY--M  343 (457)
Q Consensus       291 -------------~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~---~gt-------~~y--~  343 (457)
                                   ....++|+|++|.||++++  +..+.|.||+.+....+..+.......   .+.       ..|  .
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         1235899999999999998  556889999988764321110000000   000       011  1


Q ss_pred             C-CCCC--CCCccchhhhhHHHHHHhcCCCCC
Q 044428          344 A-PEGI--VSTKCDVYSYGILLLETFSRKKPT  372 (457)
Q Consensus       344 a-PE~~--~~~~~Dv~s~Gvvl~el~tg~~p~  372 (457)
                      . |+..  .....+.|++|.++|++.+|..+|
T Consensus       256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1 1100  111358999999999999998765

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.98  E-value=5.9e-10  Score=112.37  Aligned_cols=93  Identities=25%  Similarity=0.264  Sum_probs=70.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~   80 (457)
                      .++.+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.++.. ..+.++
T Consensus       213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  292 (452)
T 3zyi_A          213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL  292 (452)
T ss_dssp             CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTC
T ss_pred             cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCC
Confidence            3556677777777777777767777888888888888888888777777888888888888888888766543 456677


Q ss_pred             cccccccccccCCC
Q 044428           81 STESFSWNYALCGP   94 (457)
Q Consensus        81 ~~~~~~~n~~lcg~   94 (457)
                      ..+.+++|++.|..
T Consensus       293 ~~L~L~~Np~~CdC  306 (452)
T 3zyi_A          293 VELHLHHNPWNCDC  306 (452)
T ss_dssp             CEEECCSSCEECST
T ss_pred             CEEEccCCCcCCCC
Confidence            78888888877753

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.98  E-value=4.7e-10  Score=105.73  Aligned_cols=86  Identities=26%  Similarity=0.241  Sum_probs=46.2

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..+..|+++++|++|+|++|++++..+..+..+++|+.|++++|++++..|. ...++++.
T Consensus       125 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  204 (285)
T 1ozn_A          125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM  204 (285)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             hhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCccccc
Confidence            44556666666666666643334456666666666666666632223455556666666666666555442 23334445


Q ss_pred             ccccccc
Q 044428           82 TESFSWN   88 (457)
Q Consensus        82 ~~~~~~n   88 (457)
                      .+.+++|
T Consensus       205 ~L~l~~n  211 (285)
T 1ozn_A          205 TLYLFAN  211 (285)
T ss_dssp             EEECCSS
T ss_pred             EeeCCCC
Confidence            5555554

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.98  E-value=5.4e-10  Score=107.74  Aligned_cols=86  Identities=21%  Similarity=0.238  Sum_probs=77.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|+|+ .+|.+++++++|++|+|++|+++ .+|..+..+++|+.|+|++|++.+.+|. .+.+.++.
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~  256 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK  256 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred             hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence            456999999999999999 99999999999999999999999 6888999999999999999999999886 35677888


Q ss_pred             ccccccccc
Q 044428           82 TESFSWNYA   90 (457)
Q Consensus        82 ~~~~~~n~~   90 (457)
                      .+.+++|..
T Consensus       257 ~L~L~~n~~  265 (328)
T 4fcg_A          257 RLILKDCSN  265 (328)
T ss_dssp             EEECTTCTT
T ss_pred             EEECCCCCc
Confidence            888988754

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.97  E-value=5.9e-10  Score=118.89  Aligned_cols=85  Identities=26%  Similarity=0.235  Sum_probs=54.0

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +.+|++|+.|+|++|+|+ .||.+|++|++|++|+|++|+|+ .||..++++++|+.|+|++|.|+..++..+.+.++..
T Consensus       243 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~  320 (727)
T 4b8c_D          243 IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQF  320 (727)
T ss_dssp             GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCC
T ss_pred             hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccE
Confidence            345666666666666666 66666666666666666666666 6666666666666666666666644334455556666


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       321 L~L~~N~  327 (727)
T 4b8c_D          321 LGVEGNP  327 (727)
T ss_dssp             EECTTSC
T ss_pred             EeCCCCc
Confidence            6666664

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.97  E-value=1.5e-09  Score=97.25  Aligned_cols=84  Identities=23%  Similarity=0.195  Sum_probs=54.8

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFSTES   84 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~   84 (457)
                      .++|+.|+|++|++++..+..|+++++|++|+|++|++++..+..+..+++|+.|+|++|++++.++.. ..+.++..+.
T Consensus        27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  106 (208)
T 2o6s_A           27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA  106 (208)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence            346777777777777444445677777777777777777433334566777777777777777665542 4556666666


Q ss_pred             ccccc
Q 044428           85 FSWNY   89 (457)
Q Consensus        85 ~~~n~   89 (457)
                      +++|.
T Consensus       107 L~~N~  111 (208)
T 2o6s_A          107 LNTNQ  111 (208)
T ss_dssp             CCSSC
T ss_pred             cCCCc
Confidence            66664

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.95  E-value=1.2e-09  Score=94.74  Aligned_cols=72  Identities=21%  Similarity=0.236  Sum_probs=63.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV   73 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~   73 (457)
                      .++++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|+++...+.
T Consensus        49 ~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           49 VFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             hhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            478899999999999999965556689999999999999999955555699999999999999999988763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.95  E-value=6.8e-10  Score=116.07  Aligned_cols=70  Identities=31%  Similarity=0.324  Sum_probs=34.1

Q ss_pred             ccCCccCCeeeccCCccccc-CCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCC
Q 044428            3 IGGLKDLATLSLAANKFHGP-IPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP   72 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~-~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p   72 (457)
                      ++++++|+.|+|++|++++. +|..|+.+++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|
T Consensus       444 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  514 (606)
T 3vq2_A          444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS  514 (606)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEG
T ss_pred             hcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCH
Confidence            34445555555555555442 44444555555555555555554444444444555555555555544433

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.94  E-value=1.5e-09  Score=103.38  Aligned_cols=88  Identities=28%  Similarity=0.360  Sum_probs=61.6

Q ss_pred             ccCCccCCeeeccCCcccc-cCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            3 IGGLKDLATLSLAANKFHG-PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g-~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      ++++++|+.|+|++|++++ .+|..++.+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+. ...+.++
T Consensus       146 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  225 (306)
T 2z66_A          146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL  225 (306)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTC
T ss_pred             cccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccC
Confidence            5667777777777777775 4677777777777777777777766667777777777777777777766552 3445566


Q ss_pred             cccccccccc
Q 044428           81 STESFSWNYA   90 (457)
Q Consensus        81 ~~~~~~~n~~   90 (457)
                      ..+.+++|..
T Consensus       226 ~~L~L~~N~l  235 (306)
T 2z66_A          226 QVLDYSLNHI  235 (306)
T ss_dssp             CEEECTTSCC
T ss_pred             CEeECCCCCC
Confidence            6667766643

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.93  E-value=1.1e-09  Score=97.45  Aligned_cols=86  Identities=22%  Similarity=0.242  Sum_probs=75.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .+++|++|+.|+|++|++++..|..++.+++|++|+|++|++.+.+| .+..+++|+.|++++|++++.. ....++++.
T Consensus       107 ~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~  184 (197)
T 4ezg_A          107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLN  184 (197)
T ss_dssp             CCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCC
T ss_pred             hhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCC
Confidence            57889999999999999998899999999999999999999333787 7999999999999999999854 556678888


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|+
T Consensus       185 ~L~l~~N~  192 (197)
T 4ezg_A          185 QLYAFSQT  192 (197)
T ss_dssp             EEEECBC-
T ss_pred             EEEeeCcc
Confidence            89998885

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.93  E-value=2.2e-09  Score=100.49  Aligned_cols=88  Identities=24%  Similarity=0.295  Sum_probs=67.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~   80 (457)
                      .++++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|++++|++++.+|.. ..+.++
T Consensus        80 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  159 (272)
T 3rfs_A           80 ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNL  159 (272)
T ss_dssp             GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccC
Confidence            4667888888888888888666666788888888888888888655556788888888888888888777653 456777


Q ss_pred             ccccccccc
Q 044428           81 STESFSWNY   89 (457)
Q Consensus        81 ~~~~~~~n~   89 (457)
                      ..+.+++|.
T Consensus       160 ~~L~l~~n~  168 (272)
T 3rfs_A          160 TELDLSYNQ  168 (272)
T ss_dssp             CEEECCSSC
T ss_pred             CEEECCCCC
Confidence            777777774

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.90  E-value=1.7e-09  Score=94.26  Aligned_cols=79  Identities=19%  Similarity=0.249  Sum_probs=41.9

Q ss_pred             cCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccc-hhcCCCceEecccccCCCCCC--CCCCcccccccc
Q 044428            8 DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSL-EALLYLKQLNVSQNRLEGEIP--VEGPFRNFSTES   84 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~-~~~~~L~~l~l~~n~l~~~~p--~~~~~~~~~~~~   84 (457)
                      +|+.|+|++|+|++ + +.|+.+++|++|+|++|+|+ .+|+.+ ..+++|+.|++++|+++...+  ....++++..+.
T Consensus        43 ~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCc-c-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEE
Confidence            55566666666653 2 45555666666666666665 344333 555666666666666543322  223344455555


Q ss_pred             ccccc
Q 044428           85 FSWNY   89 (457)
Q Consensus        85 ~~~n~   89 (457)
                      +++|+
T Consensus       120 l~~N~  124 (176)
T 1a9n_A          120 ILRNP  124 (176)
T ss_dssp             CCSSG
T ss_pred             ecCCC
Confidence            55554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.89  E-value=2.1e-09  Score=111.37  Aligned_cols=91  Identities=27%  Similarity=0.346  Sum_probs=61.4

Q ss_pred             ccCCccCCeeeccCCccc-ccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            3 IGGLKDLATLSLAANKFH-GPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~-g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      ++++++|+.|+|++|+++ |.+|..++.+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|. ...++++
T Consensus       441 ~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  520 (570)
T 2z63_A          441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL  520 (570)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             hhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCC
Confidence            455666777777777766 56677777777777777777777766666777777777777777777766654 2445666


Q ss_pred             cccccccccccCC
Q 044428           81 STESFSWNYALCG   93 (457)
Q Consensus        81 ~~~~~~~n~~lcg   93 (457)
                      ..+.+++|+..|.
T Consensus       521 ~~L~l~~N~~~~~  533 (570)
T 2z63_A          521 QKIWLHTNPWDCS  533 (570)
T ss_dssp             CEEECCSSCBCCC
T ss_pred             cEEEecCCcccCC
Confidence            6677777766554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.89  E-value=2.6e-09  Score=92.98  Aligned_cols=71  Identities=27%  Similarity=0.386  Sum_probs=61.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCCC
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPV   73 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p~   73 (457)
                      .++++++|+.|+|++|+|++..|..|+++++|++|+|++|+|+ .+|. .+..+++|+.|+|++|++....+.
T Consensus        52 ~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           52 VFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             HhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccc-eeCHHHhccccCCCEEEeCCCCccccccc
Confidence            4788999999999999999644445799999999999999999 5555 599999999999999999987653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.88  E-value=4e-09  Score=91.87  Aligned_cols=85  Identities=20%  Similarity=0.202  Sum_probs=72.9

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFSTES   84 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~   84 (457)
                      .++|+.|+|++|++++..|..|+++++|++|+|++|+|++..|..+..+++|+.|++++|++++.++.. ..+.++..+.
T Consensus        27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  106 (177)
T 2o6r_A           27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA  106 (177)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence            468999999999999655567899999999999999999555556789999999999999999888753 5678888999


Q ss_pred             cccccc
Q 044428           85 FSWNYA   90 (457)
Q Consensus        85 ~~~n~~   90 (457)
                      +++|..
T Consensus       107 l~~N~l  112 (177)
T 2o6r_A          107 LDTNQL  112 (177)
T ss_dssp             CCSSCC
T ss_pred             CcCCcc
Confidence            998854

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.88  E-value=4.2e-09  Score=99.61  Aligned_cols=86  Identities=29%  Similarity=0.286  Sum_probs=70.9

Q ss_pred             cCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccccc
Q 044428            4 GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFST   82 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~   82 (457)
                      +.+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..+..+++|+.|+|++|++++.++.. ..+.++..
T Consensus        74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence            56888999999999998 88888889999999999999999555567888999999999999998876643 45667788


Q ss_pred             cccccccc
Q 044428           83 ESFSWNYA   90 (457)
Q Consensus        83 ~~~~~n~~   90 (457)
                      +.+++|..
T Consensus       153 L~L~~N~l  160 (290)
T 1p9a_G          153 LSLANNNL  160 (290)
T ss_dssp             EECTTSCC
T ss_pred             EECCCCcC
Confidence            88888753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.87  E-value=2.3e-09  Score=104.77  Aligned_cols=86  Identities=23%  Similarity=0.131  Sum_probs=66.8

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccccc
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTE   83 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~   83 (457)
                      ++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|. ...+.++..+
T Consensus        62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  141 (361)
T 2xot_A           62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL  141 (361)
T ss_dssp             CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence            788888888888888866667788888888888888888855555678888888888888888877653 3456677777


Q ss_pred             ccccccc
Q 044428           84 SFSWNYA   90 (457)
Q Consensus        84 ~~~~n~~   90 (457)
                      .+++|..
T Consensus       142 ~L~~N~l  148 (361)
T 2xot_A          142 YLSQNQI  148 (361)
T ss_dssp             ECCSSCC
T ss_pred             ECCCCcC
Confidence            7777753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.87  E-value=2.4e-09  Score=112.18  Aligned_cols=88  Identities=17%  Similarity=0.203  Sum_probs=66.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      +|++|++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|.++++|+.|+|++|++++.++. .+.+.++
T Consensus        71 ~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L  150 (635)
T 4g8a_A           71 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL  150 (635)
T ss_dssp             TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTC
T ss_pred             HHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCccc
Confidence            467788888888888888855556788888888888888888843334677888888888888888877663 4566677


Q ss_pred             ccccccccc
Q 044428           81 STESFSWNY   89 (457)
Q Consensus        81 ~~~~~~~n~   89 (457)
                      ..+.+++|.
T Consensus       151 ~~L~Ls~N~  159 (635)
T 4g8a_A          151 KELNVAHNL  159 (635)
T ss_dssp             CEEECCSSC
T ss_pred             CeeccccCc
Confidence            777777775

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.87  E-value=9.2e-10  Score=95.98  Aligned_cols=85  Identities=22%  Similarity=0.183  Sum_probs=71.0

Q ss_pred             CccCCccCCeeeccCCcccccCCcc-cCCCCCCCeEeCcCCccCCCCCc--cchhcCCCceEecccccCCCCCCC----C
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSGEIPK--SLEALLYLKQLNVSQNRLEGEIPV----E   74 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~l~l~~n~l~g~~p~--~~~~~~~L~~l~l~~n~l~~~~p~----~   74 (457)
                      .++++++|+.|+|++|+|+ .+|+. ++.+++|++|+|++|+|+ .+|.  .+..+++|+.|++++|+++...+.    .
T Consensus        59 ~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~  136 (176)
T 1a9n_A           59 GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI  136 (176)
T ss_dssp             CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHH
T ss_pred             ccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHH
Confidence            5788999999999999999 56655 499999999999999997 8887  899999999999999999865442    3


Q ss_pred             CCcccccccccccc
Q 044428           75 GPFRNFSTESFSWN   88 (457)
Q Consensus        75 ~~~~~~~~~~~~~n   88 (457)
                      ..++++..+.++.|
T Consensus       137 ~~l~~L~~Ld~~~n  150 (176)
T 1a9n_A          137 YKVPQVRVLDFQKV  150 (176)
T ss_dssp             HHCTTCSEETTEEC
T ss_pred             HHCCccceeCCCcC
Confidence            45566666666665

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.85  E-value=2.2e-09  Score=111.03  Aligned_cols=71  Identities=24%  Similarity=0.279  Sum_probs=66.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCC-CccchhcCCCceEecccccCCCCCCCC
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEI-PKSLEALLYLKQLNVSQNRLEGEIPVE   74 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~-p~~~~~~~~L~~l~l~~n~l~~~~p~~   74 (457)
                      ++++|++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++.+ |..+..+++|+.|+|++|+|++.+|..
T Consensus       481 ~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          481 ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             hhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            57889999999999999996 88 8999999999999999999776 999999999999999999999998854

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.85  E-value=2.5e-09  Score=102.06  Aligned_cols=83  Identities=23%  Similarity=0.165  Sum_probs=46.0

Q ss_pred             cCCccCCeeeccCCcccccCCc----ccCCCCCCCeEeCcCCccCCCCCccchhc---CCCceEecccccCCCCCCCCCC
Q 044428            4 GGLKDLATLSLAANKFHGPIPK----SFGSLISLESLDLSSNNLSGEIPKSLEAL---LYLKQLNVSQNRLEGEIPVEGP   76 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~~l~l~~n~l~g~~p~~~~~~---~~L~~l~l~~n~l~~~~p~~~~   76 (457)
                      +++++|+.|+|++|+|+ .+|.    .++++++|++|+|++|+|++.+|..+..+   ++|+.|+|++|+|+.. |... 
T Consensus       194 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~l-p~~~-  270 (310)
T 4glp_A          194 HKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQV-PKGL-  270 (310)
T ss_dssp             TSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSC-CSCC-
T ss_pred             hcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCch-hhhh-
Confidence            45666666666666665 3332    13555666666666666665556555554   4666666666666633 3221 


Q ss_pred             ccccccccccccc
Q 044428           77 FRNFSTESFSWNY   89 (457)
Q Consensus        77 ~~~~~~~~~~~n~   89 (457)
                      ++++..+.+++|.
T Consensus       271 ~~~L~~L~Ls~N~  283 (310)
T 4glp_A          271 PAKLRVLDLSSNR  283 (310)
T ss_dssp             CSCCSCEECCSCC
T ss_pred             cCCCCEEECCCCc
Confidence            2455555565553

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.84  E-value=1.4e-09  Score=113.61  Aligned_cols=89  Identities=24%  Similarity=0.240  Sum_probs=56.1

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..+.+++.| .|++++|++++.+|.. ..+.++.
T Consensus       472 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~  550 (606)
T 3t6q_A          472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQR  550 (606)
T ss_dssp             GGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSS
T ss_pred             hccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCC
Confidence            4455666666666666665556666666666666666666666666666666666 6666666666665542 3345566


Q ss_pred             ccccccccccC
Q 044428           82 TESFSWNYALC   92 (457)
Q Consensus        82 ~~~~~~n~~lc   92 (457)
                      .+.+++|+..|
T Consensus       551 ~L~l~~N~~~c  561 (606)
T 3t6q_A          551 TINLRQNPLDC  561 (606)
T ss_dssp             EEECTTCCEEC
T ss_pred             EEeCCCCCccc
Confidence            66677776655

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.83  E-value=4.1e-09  Score=100.29  Aligned_cols=89  Identities=24%  Similarity=0.288  Sum_probs=68.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCC-CCCccchhcCCCceEecccccCCCCCCC-CCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSG-EIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g-~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~   79 (457)
                      .++++++|+.|+|++|++++..|..|+++++|++|+|++|++++ .+|..+..+++|+.|++++|++++..|. ...+++
T Consensus       121 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  200 (306)
T 2z66_A          121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS  200 (306)
T ss_dssp             TTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             hhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCC
Confidence            35677888888888888887777778888888888888888876 5777888888888888888888877653 345567


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|..
T Consensus       201 L~~L~L~~N~l  211 (306)
T 2z66_A          201 LQVLNMSHNNF  211 (306)
T ss_dssp             CCEEECTTSCC
T ss_pred             CCEEECCCCcc
Confidence            77777777753

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.83  E-value=3.7e-09  Score=101.04  Aligned_cols=84  Identities=24%  Similarity=0.197  Sum_probs=76.1

Q ss_pred             CCccCCeeeccCCcccccCCccc--CCCCCCCeEeCcCCccCCCCCccchhc-----CCCceEecccccCCCCCC-CCCC
Q 044428            5 GLKDLATLSLAANKFHGPIPKSF--GSLISLESLDLSSNNLSGEIPKSLEAL-----LYLKQLNVSQNRLEGEIP-VEGP   76 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~--~~l~~l~~l~l~~n~l~g~~p~~~~~~-----~~L~~l~l~~n~l~~~~p-~~~~   76 (457)
                      ++++|+.|+|++|+++|.+|..+  +.+++|++|+|++|++++. |..+..+     ++|+.|+|++|++++.+| ..+.
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            68999999999999999999987  9999999999999999966 9989888     899999999999999886 3467


Q ss_pred             ccccccccccccc
Q 044428           77 FRNFSTESFSWNY   89 (457)
Q Consensus        77 ~~~~~~~~~~~n~   89 (457)
                      +.++..+.+++|.
T Consensus       172 l~~L~~L~Ls~N~  184 (312)
T 1wwl_A          172 FPALSTLDLSDNP  184 (312)
T ss_dssp             CSSCCEEECCSCT
T ss_pred             CCCCCEEECCCCC
Confidence            7888899999885

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.82  E-value=1.5e-09  Score=114.20  Aligned_cols=88  Identities=18%  Similarity=0.321  Sum_probs=78.1

Q ss_pred             Ccc--CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCc-cCC-CCCccchhc------CCCceEecccccCCCCC
Q 044428            2 TIG--GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNN-LSG-EIPKSLEAL------LYLKQLNVSQNRLEGEI   71 (457)
Q Consensus         2 ~~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~-l~g-~~p~~~~~~------~~L~~l~l~~n~l~~~~   71 (457)
                      +++  +|++|+.|+|++|+++|.+|.+|+++++|++|+|++|+ ++| .+|..++++      ++|+.|++++|+++ .+
T Consensus       242 ~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~i  320 (636)
T 4eco_A          242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TF  320 (636)
T ss_dssp             CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SC
T ss_pred             hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-cc
Confidence            456  89999999999999999999999999999999999998 999 899999887      89999999999999 55


Q ss_pred             CC---CCCcccccccccccccc
Q 044428           72 PV---EGPFRNFSTESFSWNYA   90 (457)
Q Consensus        72 p~---~~~~~~~~~~~~~~n~~   90 (457)
                      |.   .+.+.++..+.+++|..
T Consensus       321 p~~~~l~~l~~L~~L~L~~N~l  342 (636)
T 4eco_A          321 PVETSLQKMKKLGMLECLYNQL  342 (636)
T ss_dssp             CCHHHHTTCTTCCEEECCSCCC
T ss_pred             CchhhhccCCCCCEEeCcCCcC
Confidence            54   57778888888888754

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.82  E-value=5.4e-09  Score=109.97  Aligned_cols=84  Identities=24%  Similarity=0.226  Sum_probs=51.4

Q ss_pred             CCccCCeeeccCCcccccCCcccC--CCCCCCeEeCcCCccCCCCCccchhcCCCceEec------ccccCCCCCCC-CC
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFG--SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV------SQNRLEGEIPV-EG   75 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~--~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l------~~n~l~~~~p~-~~   75 (457)
                      +|++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+.++++|+.|+|      ++|++.+.+|. ..
T Consensus       486 ~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~  563 (636)
T 4eco_A          486 NTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT  563 (636)
T ss_dssp             TGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGG
T ss_pred             ccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHh
Confidence            3446666666666666 5666665  66666666666666664 6666666666666666      34555665553 23


Q ss_pred             Ccccccccccccccc
Q 044428           76 PFRNFSTESFSWNYA   90 (457)
Q Consensus        76 ~~~~~~~~~~~~n~~   90 (457)
                      .++++..+.+++|..
T Consensus       564 ~l~~L~~L~Ls~N~l  578 (636)
T 4eco_A          564 LCPSLTQLQIGSNDI  578 (636)
T ss_dssp             GCSSCCEEECCSSCC
T ss_pred             cCCCCCEEECCCCcC
Confidence            445556666666543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.82  E-value=3.9e-09  Score=107.04  Aligned_cols=91  Identities=25%  Similarity=0.254  Sum_probs=76.7

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+.. ..+.++.
T Consensus       244 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  323 (477)
T 2id5_A          244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE  323 (477)
T ss_dssp             HTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCC
T ss_pred             hcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccC
Confidence            567888999999999998777778889999999999999999888888999999999999999998877643 4567788


Q ss_pred             ccccccccccCC
Q 044428           82 TESFSWNYALCG   93 (457)
Q Consensus        82 ~~~~~~n~~lcg   93 (457)
                      .+.+++|+..|.
T Consensus       324 ~L~l~~N~l~c~  335 (477)
T 2id5_A          324 TLILDSNPLACD  335 (477)
T ss_dssp             EEECCSSCEECS
T ss_pred             EEEccCCCccCc
Confidence            889999988764

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.81  E-value=6.6e-09  Score=97.33  Aligned_cols=86  Identities=17%  Similarity=0.195  Sum_probs=37.9

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCC-CCCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP-VEGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p-~~~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|+.|++++|++++..+ ....+.++.
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  127 (276)
T 2z62_A           48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK  127 (276)
T ss_dssp             TTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCC
T ss_pred             hccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCC
Confidence            3344444444444444443333344444444444444444443333444444444444444444444333 123333444


Q ss_pred             ccccccc
Q 044428           82 TESFSWN   88 (457)
Q Consensus        82 ~~~~~~n   88 (457)
                      .+.+++|
T Consensus       128 ~L~l~~n  134 (276)
T 2z62_A          128 ELNVAHN  134 (276)
T ss_dssp             EEECCSS
T ss_pred             EEECcCC
Confidence            4444444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.81  E-value=1.1e-08  Score=95.68  Aligned_cols=87  Identities=24%  Similarity=0.271  Sum_probs=67.5

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++.++. ...+.++.
T Consensus        81 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  160 (270)
T 2o6q_A           81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK  160 (270)
T ss_dssp             TSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccc
Confidence            46788888888888888854455678888888888888888866666778888888888888888877664 35566777


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       161 ~L~L~~n~  168 (270)
T 2o6q_A          161 ELRLYNNQ  168 (270)
T ss_dssp             EEECCSSC
T ss_pred             eeEecCCc
Confidence            77777774

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.81  E-value=3.1e-09  Score=106.97  Aligned_cols=88  Identities=23%  Similarity=0.238  Sum_probs=55.4

Q ss_pred             CccCCccCCeeeccCCcccccCC-cccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC---CCCc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIP-KSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV---EGPF   77 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~---~~~~   77 (457)
                      .+++|++|+.|+|++|.+++.+| ..|+++++|++|+|++|++++..|..+.++++|+.|+|++|++++.+|.   ...+
T Consensus        49 ~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l  128 (455)
T 3v47_A           49 SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL  128 (455)
T ss_dssp             TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTC
T ss_pred             HhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCc
Confidence            35666677777777777665554 4566677777777777777665666666666777777777766664433   2334


Q ss_pred             cccccccccccc
Q 044428           78 RNFSTESFSWNY   89 (457)
Q Consensus        78 ~~~~~~~~~~n~   89 (457)
                      .++..+.+++|.
T Consensus       129 ~~L~~L~L~~n~  140 (455)
T 3v47_A          129 TSLEMLVLRDNN  140 (455)
T ss_dssp             TTCCEEECCSSB
T ss_pred             ccCCEEECCCCc
Confidence            555555666554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.80  E-value=2.4e-09  Score=115.80  Aligned_cols=89  Identities=19%  Similarity=0.234  Sum_probs=72.1

Q ss_pred             CccCCccCCeeeccCCcccc-----------------cCCcccC--CCCCCCeEeCcCCccCCCCCccchhcCCCceEec
Q 044428            2 TIGGLKDLATLSLAANKFHG-----------------PIPKSFG--SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV   62 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g-----------------~~p~~~~--~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l   62 (457)
                      +|++|++|+.|+|++|+|+|                 .+|++++  +|++|++|+|++|++.|.+|..+.++++|+.|+|
T Consensus       443 ~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~L  522 (876)
T 4ecn_A          443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI  522 (876)
T ss_dssp             GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEEC
T ss_pred             HHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEEC
Confidence            47788999999999999998                 4899888  9999999999999999999999999999999999


Q ss_pred             cccc-CCC-CCCCC-C-------Ccccccccccccccc
Q 044428           63 SQNR-LEG-EIPVE-G-------PFRNFSTESFSWNYA   90 (457)
Q Consensus        63 ~~n~-l~~-~~p~~-~-------~~~~~~~~~~~~n~~   90 (457)
                      ++|+ ++| .+|.. +       .++++..+.+++|..
T Consensus       523 s~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             cCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            9998 888 66631 2       223667777777653

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.80  E-value=1.1e-08  Score=96.22  Aligned_cols=89  Identities=24%  Similarity=0.207  Sum_probs=73.2

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCc-cCCCCCccchhcCCCceEecccccCCCCCCCC-CCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNN-LSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~-l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~   79 (457)
                      .++++++|+.|+|++|++++..|..|+++++|++|+|++|+ +++..|..+..+++|+.|++++|++++..|.. ..+.+
T Consensus        51 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  130 (285)
T 1ozn_A           51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA  130 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred             HcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcC
Confidence            46788999999999999997778889999999999999997 77555778888999999999999998876643 45677


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|..
T Consensus       131 L~~L~l~~n~l  141 (285)
T 1ozn_A          131 LQYLYLQDNAL  141 (285)
T ss_dssp             CCEEECCSSCC
T ss_pred             CCEEECCCCcc
Confidence            78888887753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.79  E-value=6e-09  Score=101.76  Aligned_cols=82  Identities=22%  Similarity=0.122  Sum_probs=57.4

Q ss_pred             cCCeeeccCCcccccCCcccC-CCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccccccc
Q 044428            8 DLATLSLAANKFHGPIPKSFG-SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESF   85 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~   85 (457)
                      .|+.|+|++|+|++..+..|. ++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+. ...+.++..+.+
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            467777777777755555565 777777777777777755555677777777777777777766553 345566677777


Q ss_pred             cccc
Q 044428           86 SWNY   89 (457)
Q Consensus        86 ~~n~   89 (457)
                      ++|.
T Consensus       120 ~~N~  123 (361)
T 2xot_A          120 YNNH  123 (361)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7764

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.79  E-value=9e-09  Score=106.64  Aligned_cols=90  Identities=27%  Similarity=0.268  Sum_probs=49.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcc-cCCCCCCCeEeCcCCccCC---------------------CCCccchhcCCCceE
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKS-FGSLISLESLDLSSNNLSG---------------------EIPKSLEALLYLKQL   60 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~l~l~~n~l~g---------------------~~p~~~~~~~~L~~l   60 (457)
                      ++++++|+.|+|++|++++.+|.. +..+++|+.|+|++|+++|                     .||..+..+++|+.|
T Consensus       399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L  478 (562)
T 3a79_B          399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQEL  478 (562)
T ss_dssp             TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEE
T ss_pred             hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEE
Confidence            566777777777777777656653 5555555555555555544                     455544455555555


Q ss_pred             ecccccCCCCCCC-CCCcccccccccccccccC
Q 044428           61 NVSQNRLEGEIPV-EGPFRNFSTESFSWNYALC   92 (457)
Q Consensus        61 ~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~lc   92 (457)
                      +|++|+++..++. ...++++..+.+++|++.|
T Consensus       479 ~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c  511 (562)
T 3a79_B          479 NVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  511 (562)
T ss_dssp             ECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred             ECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCC
Confidence            5555555543332 3334445555555555444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.79  E-value=4.7e-09  Score=100.34  Aligned_cols=84  Identities=25%  Similarity=0.274  Sum_probs=49.4

Q ss_pred             cCCccCCeeeccCCcccc--cCCc-ccCCCCCCCeEeCcCCccCCCCC-ccchhcCCCceEecccccCCCCCCCCCCccc
Q 044428            4 GGLKDLATLSLAANKFHG--PIPK-SFGSLISLESLDLSSNNLSGEIP-KSLEALLYLKQLNVSQNRLEGEIPVEGPFRN   79 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g--~~p~-~~~~l~~l~~l~l~~n~l~g~~p-~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~   79 (457)
                      +++++|+.|+|++|+|++  .+|. .+.++++|++|+|++|++++.+| ..+..+++|+.|+|++|+++ .+|.... .+
T Consensus       198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~  275 (312)
T 1wwl_A          198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AK  275 (312)
T ss_dssp             TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SE
T ss_pred             ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CC
Confidence            566677777777777762  2332 23456677777777777766554 34445666777777777766 3343222 45


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+++|.
T Consensus       276 L~~L~Ls~N~  285 (312)
T 1wwl_A          276 LSVLDLSYNR  285 (312)
T ss_dssp             EEEEECCSSC
T ss_pred             ceEEECCCCC
Confidence            6666666664

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.79  E-value=3.4e-09  Score=107.78  Aligned_cols=86  Identities=22%  Similarity=0.099  Sum_probs=63.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccC-CCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFG-SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~   80 (457)
                      .++++++|+.|+|++|+|+|.+|..+. ++++|+.|+|++|+|++. |. +..+++|+.|+|++|+|++.+|....++++
T Consensus       139 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L  216 (487)
T 3oja_A          139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGV  216 (487)
T ss_dssp             CGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTC
T ss_pred             hhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCc
Confidence            456788888888888888887887775 678888888888887744 32 334777777777777777776666666667


Q ss_pred             ccccccccc
Q 044428           81 STESFSWNY   89 (457)
Q Consensus        81 ~~~~~~~n~   89 (457)
                      ..+.+++|.
T Consensus       217 ~~L~Ls~N~  225 (487)
T 3oja_A          217 TWISLRNNK  225 (487)
T ss_dssp             SEEECTTSC
T ss_pred             cEEEecCCc
Confidence            777777764

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.79  E-value=9.4e-09  Score=98.92  Aligned_cols=83  Identities=24%  Similarity=0.180  Sum_probs=42.8

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFS   86 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~   86 (457)
                      ++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|+++..++....++++..+.++
T Consensus       192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~  271 (330)
T 1xku_A          192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH  271 (330)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECC
T ss_pred             ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECC
Confidence            44555555555555444555555555555555555555444445555555555555555555333333344444555555


Q ss_pred             ccc
Q 044428           87 WNY   89 (457)
Q Consensus        87 ~n~   89 (457)
                      +|.
T Consensus       272 ~N~  274 (330)
T 1xku_A          272 NNN  274 (330)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.78  E-value=8e-09  Score=100.43  Aligned_cols=81  Identities=21%  Similarity=0.226  Sum_probs=36.9

Q ss_pred             cCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccccccccc
Q 044428            8 DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESFS   86 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~   86 (457)
                      +|+.|+|++|++++..+..|+++++|++|+|++|++++..|..+.++++|+.|++++|++++..+. ...+.++..+.++
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  132 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL  132 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence            444555555555432223444455555555555555433344444444555555555554443332 2333444444444


Q ss_pred             cc
Q 044428           87 WN   88 (457)
Q Consensus        87 ~n   88 (457)
                      +|
T Consensus       133 ~n  134 (353)
T 2z80_A          133 GN  134 (353)
T ss_dssp             TC
T ss_pred             CC
Confidence            44

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.77  E-value=1.1e-08  Score=98.45  Aligned_cols=67  Identities=25%  Similarity=0.299  Sum_probs=33.8

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCC
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE   70 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~   70 (457)
                      ++++++|+.|+|++|++++..|..++.+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++.
T Consensus       213 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~  279 (332)
T 2ft3_A          213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV  279 (332)
T ss_dssp             STTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred             hcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCcc
Confidence            344455555555555555433444555555555555555555 4555555555555555555555443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.77  E-value=9e-09  Score=109.74  Aligned_cols=88  Identities=23%  Similarity=0.182  Sum_probs=77.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .+..+++|+.|+|++|+|+ .+|..+.+|++|++|+|++|+|+ .||..+.++++|+.|+|++|+|+..++..+.+.++.
T Consensus       219 ~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~  296 (727)
T 4b8c_D          219 SKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLK  296 (727)
T ss_dssp             ---CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCS
T ss_pred             hhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCC
Confidence            3677899999999999999 89999999999999999999999 999999999999999999999995544557778899


Q ss_pred             cccccccccc
Q 044428           82 TESFSWNYAL   91 (457)
Q Consensus        82 ~~~~~~n~~l   91 (457)
                      .+.+++|...
T Consensus       297 ~L~L~~N~l~  306 (727)
T 4b8c_D          297 YFYFFDNMVT  306 (727)
T ss_dssp             EEECCSSCCC
T ss_pred             EEECCCCCCC
Confidence            9999998643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.77  E-value=2.4e-09  Score=115.79  Aligned_cols=86  Identities=22%  Similarity=0.275  Sum_probs=77.0

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCc-cCC-CCCccchhcC-------CCceEecccccCCCCCCC--
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNN-LSG-EIPKSLEALL-------YLKQLNVSQNRLEGEIPV--   73 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~-l~g-~~p~~~~~~~-------~L~~l~l~~n~l~~~~p~--   73 (457)
                      +|++|+.|+|++|+++|.+|..|++|++|+.|+|++|+ |+| .+|..+++++       +|+.|+|++|+++ .+|.  
T Consensus       489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~  567 (876)
T 4ecn_A          489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA  567 (876)
T ss_dssp             GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred             cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence            89999999999999999999999999999999999998 999 8999888876       9999999999999 6665  


Q ss_pred             -CCCccccccccccccccc
Q 044428           74 -EGPFRNFSTESFSWNYAL   91 (457)
Q Consensus        74 -~~~~~~~~~~~~~~n~~l   91 (457)
                       .+.+.++..+.+++|...
T Consensus       568 ~l~~L~~L~~L~Ls~N~l~  586 (876)
T 4ecn_A          568 SLQKMVKLGLLDCVHNKVR  586 (876)
T ss_dssp             HHTTCTTCCEEECTTSCCC
T ss_pred             hhhcCCCCCEEECCCCCcc
Confidence             577788888888888643

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.77  E-value=1.1e-08  Score=95.73  Aligned_cols=88  Identities=27%  Similarity=0.288  Sum_probs=76.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCC-CC-CCCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE-IP-VEGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~-~p-~~~~~~~   79 (457)
                      .++++++|+.|+|++|++++..|..|+++++|++|++++|++++..+..+..+++|+.|++++|++++. +| ....+.+
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~  150 (276)
T 2z62_A           71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN  150 (276)
T ss_dssp             TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTT
T ss_pred             HccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCC
Confidence            478899999999999999987778999999999999999999966666899999999999999999873 35 3456678


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+++|.
T Consensus       151 L~~L~Ls~N~  160 (276)
T 2z62_A          151 LEHLDLSSNK  160 (276)
T ss_dssp             CCEEECCSSC
T ss_pred             CCEEECCCCC
Confidence            8888888874

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.76  E-value=1.3e-08  Score=104.19  Aligned_cols=89  Identities=25%  Similarity=0.249  Sum_probs=48.1

Q ss_pred             ccCCccCCeeeccCCcccccCCcc-cCCCC----------------------CCCeEeCcCCccCCCCCccchhcCCCce
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKS-FGSLI----------------------SLESLDLSSNNLSGEIPKSLEALLYLKQ   59 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~----------------------~l~~l~l~~n~l~g~~p~~~~~~~~L~~   59 (457)
                      ++++++|+.|+|++|++++.+|.. +..++                      +|+.|+|++|+|+ .+|..+..+++|+.
T Consensus       370 ~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~  448 (520)
T 2z7x_B          370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQE  448 (520)
T ss_dssp             HTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCE
T ss_pred             HhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCE
Confidence            445666666666666666545543 44444                      4555555555555 55555555555666


Q ss_pred             EecccccCCCCCCC-CCCcccccccccccccccC
Q 044428           60 LNVSQNRLEGEIPV-EGPFRNFSTESFSWNYALC   92 (457)
Q Consensus        60 l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~lc   92 (457)
                      |+|++|+++..++. ...+.++..+.+++|+..|
T Consensus       449 L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             EECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence            66666666543332 3334455555555655544

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.76  E-value=1.2e-08  Score=106.51  Aligned_cols=88  Identities=19%  Similarity=0.252  Sum_probs=62.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCC-CCCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP-VEGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p-~~~~~~~~   80 (457)
                      +++++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|++|+|++|++++..| ..+.+.++
T Consensus        51 ~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  130 (606)
T 3vq2_A           51 SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL  130 (606)
T ss_dssp             TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTC
T ss_pred             hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCC
Confidence            46677777777777777776666777777777777777777776667777777777777777777776653 23455566


Q ss_pred             ccccccccc
Q 044428           81 STESFSWNY   89 (457)
Q Consensus        81 ~~~~~~~n~   89 (457)
                      ..+.+++|.
T Consensus       131 ~~L~L~~n~  139 (606)
T 3vq2_A          131 KKLNVAHNF  139 (606)
T ss_dssp             CEEECCSSC
T ss_pred             CEEeCCCCc
Confidence            666666664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.75  E-value=7.8e-09  Score=106.60  Aligned_cols=88  Identities=27%  Similarity=0.217  Sum_probs=62.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCC--CCCCCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE--IPVEGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~--~p~~~~~~~   79 (457)
                      +++++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|+.|++++|++++.  ++..+.+.+
T Consensus        45 ~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~  124 (549)
T 2z81_A           45 DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN  124 (549)
T ss_dssp             TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTT
T ss_pred             hhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCC
Confidence            466777777777777777766667777777788888888877755555577777778888887777752  234455666


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+++|.
T Consensus       125 L~~L~L~~n~  134 (549)
T 2z81_A          125 LQTLRIGNVE  134 (549)
T ss_dssp             CCEEEEEESS
T ss_pred             ccEEECCCCc
Confidence            6667776664

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.75  E-value=9.6e-09  Score=111.69  Aligned_cols=87  Identities=26%  Similarity=0.317  Sum_probs=59.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCcc--chhcCCCceEecccccCCCCCCC--CCCc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS--LEALLYLKQLNVSQNRLEGEIPV--EGPF   77 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~--~~~~~~L~~l~l~~n~l~~~~p~--~~~~   77 (457)
                      +|++|++|+.|+|++|+|++..|..|++|++|++|+|++|++++.+|..  +.++++|+.|+|++|++++..|.  .+.+
T Consensus        68 ~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L  147 (844)
T 3j0a_A           68 AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL  147 (844)
T ss_dssp             TTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTC
T ss_pred             HhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhC
Confidence            3566777777777777777666777777777777777777777666654  67777777777777777665442  3455


Q ss_pred             ccccccccccc
Q 044428           78 RNFSTESFSWN   88 (457)
Q Consensus        78 ~~~~~~~~~~n   88 (457)
                      +++..+.+++|
T Consensus       148 ~~L~~L~Ls~N  158 (844)
T 3j0a_A          148 NSLKSIDFSSN  158 (844)
T ss_dssp             SSCCEEEEESS
T ss_pred             CCCCEEECCCC
Confidence            55666666555

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.75  E-value=1.5e-08  Score=105.83  Aligned_cols=86  Identities=16%  Similarity=0.120  Sum_probs=55.4

Q ss_pred             cCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccccc
Q 044428            4 GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFST   82 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~   82 (457)
                      +++++|+.|+|++|+|++..|..|+++++|++|+|++|.|++..|..++++++|+.|+|++|.+++.++.. +.+.++..
T Consensus        72 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~  151 (597)
T 3oja_B           72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT  151 (597)
T ss_dssp             HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCE
Confidence            44666777777777776555556666777777777777776555555666667777777777666655543 45556666


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       152 L~Ls~N~  158 (597)
T 3oja_B          152 LSMSNNN  158 (597)
T ss_dssp             EECCSSC
T ss_pred             EEeeCCc
Confidence            6666654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.72  E-value=1.6e-08  Score=101.85  Aligned_cols=83  Identities=19%  Similarity=0.114  Sum_probs=54.3

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESF   85 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~   85 (457)
                      ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+.++++|+.|+|++|++++.++. ...+.++..+.+
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            3566777777777766666677777777777777777755556666677777777777777665553 334556666666


Q ss_pred             cccc
Q 044428           86 SWNY   89 (457)
Q Consensus        86 ~~n~   89 (457)
                      ++|.
T Consensus       155 ~~N~  158 (452)
T 3zyi_A          155 RNNP  158 (452)
T ss_dssp             CSCC
T ss_pred             CCCC
Confidence            6664

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.72  E-value=2.3e-08  Score=98.47  Aligned_cols=87  Identities=16%  Similarity=0.130  Sum_probs=59.4

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|+.|+|++|+++..++.. ..+.++.
T Consensus        65 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~  144 (390)
T 3o6n_A           65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT  144 (390)
T ss_dssp             HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCc
Confidence            345677777777777777555557777777777777777777655666777777777777777777555442 4556666


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       145 ~L~L~~n~  152 (390)
T 3o6n_A          145 TLSMSNNN  152 (390)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCc
Confidence            67776664

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.71  E-value=1.3e-08  Score=106.23  Aligned_cols=87  Identities=22%  Similarity=0.205  Sum_probs=74.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCcc-chhcCCCceEecccccCCCCCCC-CCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVSQNRLEGEIPV-EGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~   79 (457)
                      .|+++++|+.|+|++|.|++..|..|+++++|++|+|++|+|+ .+|.. +.++++|+.|+|++|.+++.+|. ...+.+
T Consensus        94 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  172 (597)
T 3oja_B           94 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS  172 (597)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT
T ss_pred             HhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCc
Confidence            5788999999999999999877778899999999999999999 56655 68899999999999999988874 466778


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+++|.
T Consensus       173 L~~L~L~~N~  182 (597)
T 3oja_B          173 LQNLQLSSNR  182 (597)
T ss_dssp             CCEEECTTSC
T ss_pred             CcEEECcCCC
Confidence            8888888875

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.71  E-value=1.5e-08  Score=105.82  Aligned_cols=89  Identities=20%  Similarity=0.098  Sum_probs=66.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      +|+++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|+.|++++|++++..|. ...+.++
T Consensus        52 ~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L  131 (606)
T 3t6q_A           52 TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL  131 (606)
T ss_dssp             TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTC
T ss_pred             HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcc
Confidence            467778888888888888877777788888888888888888877777788888888888888888775332 3455666


Q ss_pred             cccccccccc
Q 044428           81 STESFSWNYA   90 (457)
Q Consensus        81 ~~~~~~~n~~   90 (457)
                      ..+.+++|..
T Consensus       132 ~~L~L~~n~l  141 (606)
T 3t6q_A          132 ESLYLGSNHI  141 (606)
T ss_dssp             CEEECCSSCC
T ss_pred             cEEECCCCcc
Confidence            6777776643

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.70  E-value=1.5e-08  Score=98.12  Aligned_cols=69  Identities=26%  Similarity=0.293  Sum_probs=60.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCC
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEI   71 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~   71 (457)
                      .|++|++|+.|+|++|+|+|..|..|++|++|+.|+|++|+|+ .+|..+.....|+.|+|++|.|...-
T Consensus        51 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           51 DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC  119 (347)
T ss_dssp             GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             HhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence            4789999999999999999988889999999999999999999 56665544444999999999998653

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.69  E-value=2.5e-08  Score=96.07  Aligned_cols=81  Identities=25%  Similarity=0.196  Sum_probs=53.9

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFS   86 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~   86 (457)
                      ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|+.|++++|+++..++..  +.++..+.++
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~--~~~L~~L~l~  131 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNL--PSSLVELRIH  131 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSC--CTTCCEEECC
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCccc--cccCCEEECC
Confidence            46777777777777555566777777777777777777655667777777777777777776433322  2556666666


Q ss_pred             ccc
Q 044428           87 WNY   89 (457)
Q Consensus        87 ~n~   89 (457)
                      +|.
T Consensus       132 ~n~  134 (332)
T 2ft3_A          132 DNR  134 (332)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            654

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.69  E-value=1.1e-08  Score=93.54  Aligned_cols=67  Identities=19%  Similarity=0.291  Sum_probs=32.2

Q ss_pred             ccCCccCCeeeccCCc-ccccCCcccCCCCCCCeEeCcC-CccCCCCCccchhcCCCceEecccccCCC
Q 044428            3 IGGLKDLATLSLAANK-FHGPIPKSFGSLISLESLDLSS-NNLSGEIPKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~-l~g~~p~~~~~l~~l~~l~l~~-n~l~g~~p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      ++++++|+.|+|++|+ +++..|..|+++++|++|+|++ |++++..|..+.++++|+.|++++|++++
T Consensus        51 ~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~  119 (239)
T 2xwt_C           51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM  119 (239)
T ss_dssp             TTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS
T ss_pred             ccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc
Confidence            4445555555555554 4422223455555555555554 55552222344455555555555555554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.68  E-value=2.2e-08  Score=101.41  Aligned_cols=86  Identities=26%  Similarity=0.335  Sum_probs=51.5

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCCC-CCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPV-EGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~   79 (457)
                      .|+++++|+.|+|++|++++..|..|+++++|++|+|++|+++ .+|. .+.++++|+.|+|++|++++.+|. ...+.+
T Consensus        51 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~  129 (477)
T 2id5_A           51 EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN  129 (477)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEECCCCccccCChhHcccccc
Confidence            3555666666666666666555666666666666666666666 3333 456666666666666666655542 233445


Q ss_pred             ccccccccc
Q 044428           80 FSTESFSWN   88 (457)
Q Consensus        80 ~~~~~~~~n   88 (457)
                      +..+.+++|
T Consensus       130 L~~L~l~~n  138 (477)
T 2id5_A          130 LKSLEVGDN  138 (477)
T ss_dssp             CCEEEECCT
T ss_pred             CCEEECCCC
Confidence            555555555

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.68  E-value=1.4e-08  Score=107.55  Aligned_cols=92  Identities=30%  Similarity=0.436  Sum_probs=67.6

Q ss_pred             ccCCccCCeeeccCCcccccCCc-ccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-C-Cccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-G-PFRN   79 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~-~~~~   79 (457)
                      ++++++|+.|+|++|+|+ .+|. .|+++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++.+|.. . .+++
T Consensus       532 ~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  610 (680)
T 1ziw_A          532 LKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN  610 (680)
T ss_dssp             TTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTT
T ss_pred             hcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccc
Confidence            566777777788888777 5664 4778888888888888888433334567788888888888888776643 2 4567


Q ss_pred             ccccccccccccCCCC
Q 044428           80 FSTESFSWNYALCGPS   95 (457)
Q Consensus        80 ~~~~~~~~n~~lcg~~   95 (457)
                      +..+.+++|++.|...
T Consensus       611 L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          611 LTELDMRFNPFDCTCE  626 (680)
T ss_dssp             CSEEECTTCCCCBCCC
T ss_pred             cCEEEccCCCcccCCc
Confidence            8888899999888643

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.67  E-value=1.8e-08  Score=96.45  Aligned_cols=85  Identities=22%  Similarity=0.130  Sum_probs=45.8

Q ss_pred             ccCCccCCeeeccCCcccccCCcccC-CCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFG-SLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..|..+. .+++|++|+|++|+++ .+|. ...+++|+.|+|++|++++.+|....+.++.
T Consensus       140 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~  217 (317)
T 3o53_A          140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVT  217 (317)
T ss_dssp             TGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCS
T ss_pred             hhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccc-ccccccCCEEECCCCcCCcchhhhcccCccc
Confidence            44556666666666666655555442 4556666666666655 3332 2235555555555555555544444444555


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       218 ~L~L~~N~  225 (317)
T 3o53_A          218 WISLRNNK  225 (317)
T ss_dssp             EEECTTSC
T ss_pred             EEECcCCc
Confidence            55555553

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.67  E-value=5.2e-10  Score=99.55  Aligned_cols=83  Identities=23%  Similarity=0.213  Sum_probs=51.5

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      ++++++|+.|+|++|+|++ +| .++++++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++. |....+.++..
T Consensus        44 ~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~  119 (198)
T 1ds9_A           44 LSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRV  119 (198)
T ss_dssp             HHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCH-HHHHHHHHSSE
T ss_pred             HhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcC-CccccCCCCCE
Confidence            4456666666666666664 66 6666666666666666666 6666666666666666666666653 33334445555


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       120 L~l~~N~  126 (198)
T 1ds9_A          120 LYMSNNK  126 (198)
T ss_dssp             EEESEEE
T ss_pred             EECCCCc
Confidence            5665553

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.66  E-value=2.8e-08  Score=99.62  Aligned_cols=81  Identities=23%  Similarity=0.147  Sum_probs=38.4

Q ss_pred             cCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCcccccccccc
Q 044428            8 DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESFS   86 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~   86 (457)
                      +|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..+. ...+.++..+.++
T Consensus        65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  144 (440)
T 3zyj_A           65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR  144 (440)
T ss_dssp             TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred             CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence            344555555555544444455555555555555555533334444555555555555555544332 2333444444444


Q ss_pred             cc
Q 044428           87 WN   88 (457)
Q Consensus        87 ~n   88 (457)
                      +|
T Consensus       145 ~N  146 (440)
T 3zyj_A          145 NN  146 (440)
T ss_dssp             SC
T ss_pred             CC
Confidence            44

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.66  E-value=2.7e-08  Score=98.03  Aligned_cols=87  Identities=22%  Similarity=0.205  Sum_probs=60.4

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCcc-chhcCCCceEecccccCCCCCCC-CCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVSQNRLEGEIPV-EGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~   79 (457)
                      .++++++|+.|+|++|++++..|..|+++++|++|+|++|+++ .+|.. +.++++|+.|++++|++++..|. ...+++
T Consensus        88 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  166 (390)
T 3o6n_A           88 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS  166 (390)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTT
T ss_pred             hccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCC
Confidence            4566777777777777777655666777777777777777777 56654 46777777777777777766654 345566


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+++|.
T Consensus       167 L~~L~l~~n~  176 (390)
T 3o6n_A          167 LQNLQLSSNR  176 (390)
T ss_dssp             CCEEECCSSC
T ss_pred             CCEEECCCCc
Confidence            6666666664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.64  E-value=4e-08  Score=94.47  Aligned_cols=84  Identities=23%  Similarity=0.269  Sum_probs=49.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCC-CCCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP-VEGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p-~~~~~~~~~   81 (457)
                      ++++++|+.|+|++|+++ .+|..+.  ++|++|+|++|++++..|..+..+++|+.|+|++|++++..+ ....+.++.
T Consensus       167 ~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  243 (330)
T 1xku_A          167 FQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR  243 (330)
T ss_dssp             GGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCC
T ss_pred             ccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCC
Confidence            445566666666666666 4555543  566666666666665555666666666666666666665554 223445555


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       244 ~L~L~~N~  251 (330)
T 1xku_A          244 ELHLNNNK  251 (330)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCc
Confidence            55666554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.63  E-value=2.6e-08  Score=94.13  Aligned_cols=83  Identities=29%  Similarity=0.382  Sum_probs=62.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .++++++|+.|+|++|++++ + +.++.+++|+.|+|++|++++ + ..+..+++|+.|++++|++++..| ...++++.
T Consensus       107 ~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~  181 (291)
T 1h6t_A          107 SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQ  181 (291)
T ss_dssp             GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCC
T ss_pred             hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEccCCccccchh-hcCCCccC
Confidence            36677888888888888874 4 467788888888888888884 4 567788888888888888887766 55666777


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       182 ~L~L~~N~  189 (291)
T 1h6t_A          182 NLYLSKNH  189 (291)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCc
Confidence            77777774

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.63  E-value=2.2e-08  Score=103.69  Aligned_cols=81  Identities=26%  Similarity=0.231  Sum_probs=43.7

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFS   86 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~   86 (457)
                      ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|+.|+|++|+++. +|.. .+.++..+.++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-~l~~L~~L~Ls  129 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC-PMASLRHLDLS  129 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC-CCTTCSEEECC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc-ccccCCEEECC
Confidence            345555555555554444455555555555555555554445555555555555555555553 3322 44555555555


Q ss_pred             ccc
Q 044428           87 WNY   89 (457)
Q Consensus        87 ~n~   89 (457)
                      +|.
T Consensus       130 ~N~  132 (562)
T 3a79_B          130 FND  132 (562)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            553

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.63  E-value=2.1e-08  Score=97.11  Aligned_cols=83  Identities=29%  Similarity=0.363  Sum_probs=48.7

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      ++.+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++ + +.+..+++|+.|++++|++++..|. ...++++.
T Consensus       239 ~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence            4556666666666666663 3 346666666666666666663 3 3455666666666666666655443 23345555


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|+
T Consensus       315 ~L~L~~n~  322 (347)
T 4fmz_A          315 TLFLSQNH  322 (347)
T ss_dssp             EEECCSSS
T ss_pred             EEEccCCc
Confidence            66666654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.63  E-value=4.5e-08  Score=91.10  Aligned_cols=81  Identities=21%  Similarity=0.281  Sum_probs=57.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +..+++|+.|+|++|+++ .+| .++.+++|+.|+|++|+|+ .+|. +..+++|+.|+|++|++++..+...  .++..
T Consensus        37 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~  110 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPS--ACLSR  110 (263)
T ss_dssp             HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCSCCTTCCC--SSCCE
T ss_pred             hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCccCCcCcccc--CcccE
Confidence            445677888888888887 666 6777888888888888887 4554 7777888888888888877543322  56666


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       111 L~L~~N~  117 (263)
T 1xeu_A          111 LFLDNNE  117 (263)
T ss_dssp             EECCSSC
T ss_pred             EEccCCc
Confidence            6676664

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.62  E-value=2.7e-08  Score=101.92  Aligned_cols=86  Identities=22%  Similarity=0.252  Sum_probs=75.4

Q ss_pred             cCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCC--CCCccchhcCCCceEecccccCCCCCCC--CCCccc
Q 044428            4 GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSG--EIPKSLEALLYLKQLNVSQNRLEGEIPV--EGPFRN   79 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g--~~p~~~~~~~~L~~l~l~~n~l~~~~p~--~~~~~~   79 (457)
                      +.+++|+.|+|++|++++.+|..++++++|+.|+|++|++++  .+|..+..+++|+.|++++|++++.+|.  ...+.+
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            678999999999999999999999999999999999999996  6778899999999999999999996664  345567


Q ss_pred             cccccccccc
Q 044428           80 FSTESFSWNY   89 (457)
Q Consensus        80 ~~~~~~~~n~   89 (457)
                      +..+.+++|.
T Consensus       401 L~~L~Ls~N~  410 (520)
T 2z7x_B          401 LLSLNMSSNI  410 (520)
T ss_dssp             CCEEECCSSC
T ss_pred             CCEEECcCCC
Confidence            7888888874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.62  E-value=4.4e-08  Score=101.31  Aligned_cols=88  Identities=17%  Similarity=0.196  Sum_probs=62.9

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCC-CCCCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP-VEGPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p-~~~~~~~~   80 (457)
                      +++++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|++++|++++..+ ..+.+.++
T Consensus        47 ~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L  126 (570)
T 2z63_A           47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL  126 (570)
T ss_dssp             TTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTC
T ss_pred             HhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccc
Confidence            46677778888888887776556677777888888888887775555677777777777777777776654 24555666


Q ss_pred             ccccccccc
Q 044428           81 STESFSWNY   89 (457)
Q Consensus        81 ~~~~~~~n~   89 (457)
                      ..+.+++|.
T Consensus       127 ~~L~L~~n~  135 (570)
T 2z63_A          127 KELNVAHNL  135 (570)
T ss_dssp             CEEECCSSC
T ss_pred             cEEecCCCc
Confidence            677776664

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.62  E-value=5.3e-08  Score=92.01  Aligned_cols=83  Identities=29%  Similarity=0.356  Sum_probs=71.1

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      ++++++|+.|+|++|++++ +|. ++++++|++|+|++|++++ + +.+..+++|+.|++++|++++. +....+.++..
T Consensus        86 l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~  160 (291)
T 1h6t_A           86 LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDT  160 (291)
T ss_dssp             GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSE
T ss_pred             cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCE
Confidence            6788999999999999984 554 9999999999999999994 5 5688999999999999999987 65667788888


Q ss_pred             cccccccc
Q 044428           83 ESFSWNYA   90 (457)
Q Consensus        83 ~~~~~n~~   90 (457)
                      +.+++|..
T Consensus       161 L~L~~N~l  168 (291)
T 1h6t_A          161 LSLEDNQI  168 (291)
T ss_dssp             EECCSSCC
T ss_pred             EEccCCcc
Confidence            88888853

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.62  E-value=3.8e-08  Score=102.52  Aligned_cols=83  Identities=29%  Similarity=0.382  Sum_probs=55.8

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .++.|++|+.|+|++|+|++ + +.+++|++|+.|+|++|+|++ + ..+..+++|+.|+|++|+|++.+| ...+.++.
T Consensus       104 ~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~  178 (605)
T 1m9s_A          104 SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQ  178 (605)
T ss_dssp             TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCC
T ss_pred             hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCCchh-hccCCCCC
Confidence            45667777777777777774 3 346777777777777777774 3 556677777777777777776666 45556666


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       179 ~L~Ls~N~  186 (605)
T 1m9s_A          179 NLYLSKNH  186 (605)
T ss_dssp             EEECCSSC
T ss_pred             EEECcCCC
Confidence            66666653

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.61  E-value=2.7e-08  Score=102.53  Aligned_cols=84  Identities=20%  Similarity=0.167  Sum_probs=77.4

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTESF   85 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~   85 (457)
                      ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|+.|+|++|++++.+|. .+.+.++..+.+
T Consensus        26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  105 (549)
T 2z81_A           26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL  105 (549)
T ss_dssp             TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred             CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence            5899999999999988889999999999999999999988888999999999999999999999886 677888999999


Q ss_pred             ccccc
Q 044428           86 SWNYA   90 (457)
Q Consensus        86 ~~n~~   90 (457)
                      ++|..
T Consensus       106 s~n~l  110 (549)
T 2z81_A          106 MGNPY  110 (549)
T ss_dssp             TTCCC
T ss_pred             CCCcc
Confidence            98864

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.60  E-value=4.5e-08  Score=93.32  Aligned_cols=82  Identities=23%  Similarity=0.375  Sum_probs=53.5

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      ++++++|+.|+|++|++++ +|. ++++++|+.|+|++|+++ .+|. +..+++|+.|++++|++++..+ ...+.++..
T Consensus       125 l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~  199 (308)
T 1h6u_A          125 LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIE  199 (308)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCE
T ss_pred             hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCC-CChh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCE
Confidence            5667777777777777773 443 667777777777777777 3444 6667777777777777766554 344555666


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       200 L~L~~N~  206 (308)
T 1h6u_A          200 VHLKNNQ  206 (308)
T ss_dssp             EECTTSC
T ss_pred             EEccCCc
Confidence            6666654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.60  E-value=5.8e-08  Score=92.52  Aligned_cols=82  Identities=22%  Similarity=0.369  Sum_probs=62.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      ++++++|+.|+|++|++++ +| .++++++|++|+|++|+++ .+|. +..+++|+.|++++|++++..+ ...+.++..
T Consensus        81 ~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~  155 (308)
T 1h6u_A           81 LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQY  155 (308)
T ss_dssp             GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCE
T ss_pred             HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCC-Cchh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccE
Confidence            5678888888888888884 44 6888888888888888888 4554 7788888888888888887655 455667777


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       156 L~l~~n~  162 (308)
T 1h6u_A          156 LSIGNAQ  162 (308)
T ss_dssp             EECCSSC
T ss_pred             EEccCCc
Confidence            7777764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.60  E-value=3.3e-08  Score=94.30  Aligned_cols=84  Identities=20%  Similarity=0.115  Sum_probs=71.5

Q ss_pred             CccCCeeeccCCcccccCCccc--CCCCCCCeEeCcCCccCCCCC----ccchhcCCCceEecccccCCCCCCC-CCCcc
Q 044428            6 LKDLATLSLAANKFHGPIPKSF--GSLISLESLDLSSNNLSGEIP----KSLEALLYLKQLNVSQNRLEGEIPV-EGPFR   78 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~--~~l~~l~~l~l~~n~l~g~~p----~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~   78 (457)
                      +++|++|+|++|+++|.+|..+  +++++|++|+|++|++++.+|    ..+..+++|+.|+|++|++++.+|. ...+.
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            4679999999999999999988  899999999999999998776    3445688999999999999888764 35677


Q ss_pred             ccccccccccc
Q 044428           79 NFSTESFSWNY   89 (457)
Q Consensus        79 ~~~~~~~~~n~   89 (457)
                      ++..+.+++|.
T Consensus       170 ~L~~L~Ls~N~  180 (310)
T 4glp_A          170 ALTSLDLSDNP  180 (310)
T ss_dssp             TCCEEECCSCT
T ss_pred             CCCEEECCCCC
Confidence            88888999885

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.60  E-value=4.1e-08  Score=91.39  Aligned_cols=82  Identities=21%  Similarity=0.247  Sum_probs=66.9

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .++.+++|+.|+|++|+|++ +|+ ++++++|+.|+|++|+++ .+|....  ++|+.|+|++|++++. |....+.++.
T Consensus        58 ~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L~~N~l~~~-~~l~~l~~L~  131 (263)
T 1xeu_A           58 GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFLDNNELRDT-DSLIHLKNLE  131 (263)
T ss_dssp             TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEECCSSCCSBS-GGGTTCTTCC
T ss_pred             HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEccCCccCCC-hhhcCccccc
Confidence            46778899999999999994 555 899999999999999999 5665433  8899999999999875 4566677888


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       132 ~L~Ls~N~  139 (263)
T 1xeu_A          132 ILSIRNNK  139 (263)
T ss_dssp             EEECTTSC
T ss_pred             EEECCCCc
Confidence            88888875

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.58  E-value=3.5e-08  Score=90.30  Aligned_cols=87  Identities=15%  Similarity=0.101  Sum_probs=72.6

Q ss_pred             CccCCccCCeeeccC-CcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCc---eEecccc-cCCCCCCC-CC
Q 044428            2 TIGGLKDLATLSLAA-NKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLK---QLNVSQN-RLEGEIPV-EG   75 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~---~l~l~~n-~l~~~~p~-~~   75 (457)
                      .++++++|+.|+|++ |+|++..|..|.++++|++|+|++|++++ +|. +..+++|+   .|++++| ++++..+. ..
T Consensus        75 ~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~  152 (239)
T 2xwt_C           75 SFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ  152 (239)
T ss_dssp             TEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT
T ss_pred             HcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCccccc
Confidence            467899999999998 99996555789999999999999999994 887 88888888   9999999 88877664 34


Q ss_pred             Cccccc-ccccccccc
Q 044428           76 PFRNFS-TESFSWNYA   90 (457)
Q Consensus        76 ~~~~~~-~~~~~~n~~   90 (457)
                      .+.++. .+.+++|..
T Consensus       153 ~l~~L~~~L~l~~n~l  168 (239)
T 2xwt_C          153 GLCNETLTLKLYNNGF  168 (239)
T ss_dssp             TTBSSEEEEECCSCCC
T ss_pred             chhcceeEEEcCCCCC
Confidence            566777 888887743

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.56  E-value=6.1e-07  Score=85.35  Aligned_cols=136  Identities=14%  Similarity=0.056  Sum_probs=94.4

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC---ccceeeeeee-cCCeeEEEEeccCCC
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR---NLIKILSGCS-NLDFKALVLEFMPNG  254 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g  254 (457)
                      +.++.|....||+.    |..+++|+...  ......+.+|.+++..+.+.   .+.+.+.++. ..+..++||||++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            46788888899988    56788998532  23345788999999999753   2455666663 445678999999998


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 044428          255 SLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH--------------------------------------------  290 (457)
Q Consensus       255 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------  290 (457)
                      ++.+....   .++..++..++.+++..|..||.-.                                            
T Consensus        99 ~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           99 ILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             ECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             ECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            88763221   1344455555556666665555311                                            


Q ss_pred             ------------CCCCeeeccCCCCCeeecC---CCc-EEEeccccccc
Q 044428          291 ------------ALAPIIHCDLKPSNILLDE---NMV-AHVSDFGISKL  323 (457)
Q Consensus       291 ------------~~~~ivH~dlk~~NIll~~---~~~-~kl~Dfg~~~~  323 (457)
                                  ....++|+|+++.||+++.   ++. ..|.||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                        1345799999999999987   455 58999998764

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.56  E-value=8.4e-08  Score=99.90  Aligned_cols=82  Identities=30%  Similarity=0.369  Sum_probs=59.1

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +++|++|+.|+|++|+|++ +| .+++|++|+.|+|++|+|++ + +.+..+++|+.|+|++|++++. +....+.++..
T Consensus        83 l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~  157 (605)
T 1m9s_A           83 LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDT  157 (605)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSE
T ss_pred             hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCE
Confidence            5667778888888888773 44 67777888888888888774 4 3577777788888888877776 55556667777


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       158 L~Ls~N~  164 (605)
T 1m9s_A          158 LSLEDNQ  164 (605)
T ss_dssp             EECCSSC
T ss_pred             EECcCCc
Confidence            7777764

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.56  E-value=4.8e-08  Score=94.90  Aligned_cols=87  Identities=28%  Similarity=0.221  Sum_probs=76.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCcc-chhcCCCceEecccccCCCCCC--CCCCcc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVSQNRLEGEIP--VEGPFR   78 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~L~~l~l~~n~l~~~~p--~~~~~~   78 (457)
                      .++++++|+.|+|++|++++..|..|+++++|++|+|++|+++ .+|.. +.++++|+.|++++|++++..+  ....++
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~  149 (353)
T 2z80_A           71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT  149 (353)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCT
T ss_pred             HhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCC
Confidence            5788999999999999999877888999999999999999999 56665 8899999999999999997655  345677


Q ss_pred             ccccccccccc
Q 044428           79 NFSTESFSWNY   89 (457)
Q Consensus        79 ~~~~~~~~~n~   89 (457)
                      ++..+.+++|.
T Consensus       150 ~L~~L~l~~n~  160 (353)
T 2z80_A          150 KLQILRVGNMD  160 (353)
T ss_dssp             TCCEEEEEESS
T ss_pred             CCcEEECCCCc
Confidence            88888888874

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=6.7e-07  Score=83.20  Aligned_cols=136  Identities=18%  Similarity=0.101  Sum_probs=98.1

Q ss_pred             ccCCCCce-EEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          180 LLGIGSFG-SVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       180 ~lg~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      .+..|..| .||+.... ++..++||+-...   ....+.+|...|+.+. +-.+.++++++...+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556665 68988765 5678999986533   3456788999998884 33466788888888999999999999888


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH----------------------------------------------  290 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------------  290 (457)
                      .+......     .....+..+++..|..||.-.                                              
T Consensus       108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            77654321     123345666677777776211                                              


Q ss_pred             --------CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          291 --------ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       291 --------~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                              ....++|+|+.+.||++++++.+-|.||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    112379999999999999887778999998764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.55  E-value=3.4e-08  Score=91.51  Aligned_cols=65  Identities=25%  Similarity=0.366  Sum_probs=35.2

Q ss_pred             CccCCeeeccCCcccc--cCCcccCCCCCCCeEeCcCCccCCCCCccchhcC--CCceEecccccCCCCCC
Q 044428            6 LKDLATLSLAANKFHG--PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALL--YLKQLNVSQNRLEGEIP   72 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g--~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~--~L~~l~l~~n~l~~~~p   72 (457)
                      +++|+.|+|++|+|++  .+|..++.+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|.+.+.+|
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence            4555666666666655  4445555556666666666665532  2333333  55556666665555444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.53  E-value=7.6e-08  Score=101.93  Aligned_cols=85  Identities=21%  Similarity=0.222  Sum_probs=46.0

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCCC-CCCcccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPV-EGPFRNF   80 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~   80 (457)
                      ++++++|+.|+|++|++++..|..|+++++|++|+|++|+++ .+|. .+.++++|++|+|++|++++.+|. .+.+.++
T Consensus        45 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  123 (680)
T 1ziw_A           45 FTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL  123 (680)
T ss_dssp             GGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTC
T ss_pred             HhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCC
Confidence            455555666666666665555555555556666666665555 3443 455555555555555555554432 2334444


Q ss_pred             cccccccc
Q 044428           81 STESFSWN   88 (457)
Q Consensus        81 ~~~~~~~n   88 (457)
                      ..+.+++|
T Consensus       124 ~~L~Ls~n  131 (680)
T 1ziw_A          124 ITLDLSHN  131 (680)
T ss_dssp             CEEECCSS
T ss_pred             CEEECCCC
Confidence            55555444

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.48  E-value=1.5e-07  Score=95.02  Aligned_cols=64  Identities=28%  Similarity=0.392  Sum_probs=30.7

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCC
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE   70 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~   70 (457)
                      ++.+++|+.|+|++|++++. |+ ++.+++|+.|+|++|++++..|  +..+++|+.|++++|++++.
T Consensus       283 ~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          283 LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            34455555555555555532 22 4455555555555555553333  34444444444444444443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.48  E-value=4.6e-08  Score=93.61  Aligned_cols=83  Identities=22%  Similarity=0.092  Sum_probs=50.5

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccch-hcCCCceEecccccCCCCCCCCCCcccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLE-ALLYLKQLNVSQNRLEGEIPVEGPFRNFSTES   84 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~-~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~   84 (457)
                      +++|+.|+|++|++++..|..++.+++|++|+|++|++++..|..+. .+++|+.|+|++|++++.. ....+.++..+.
T Consensus       119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~  197 (317)
T 3o53_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLD  197 (317)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEE
T ss_pred             cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEE
Confidence            45666666666666655555666666666666666666655555553 5666666666666666552 223355566666


Q ss_pred             ccccc
Q 044428           85 FSWNY   89 (457)
Q Consensus        85 ~~~n~   89 (457)
                      +++|.
T Consensus       198 Ls~N~  202 (317)
T 3o53_A          198 LSSNK  202 (317)
T ss_dssp             CCSSC
T ss_pred             CCCCc
Confidence            66653

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.46  E-value=2.6e-07  Score=93.08  Aligned_cols=60  Identities=23%  Similarity=0.305  Sum_probs=26.6

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCC
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      ++++|+.|+|++|+|+| +| +++.+++|++|+|++|+|++ +|  ++.+++|+.|++++|++++
T Consensus        40 ~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~   99 (457)
T 3bz5_A           40 QLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN   99 (457)
T ss_dssp             HHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred             HcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce
Confidence            34444444444444442 23 34444444444444444442 22  4444444444444444444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.43  E-value=1.2e-08  Score=90.61  Aligned_cols=84  Identities=23%  Similarity=0.314  Sum_probs=72.0

Q ss_pred             cCCccCCeeeccCCcccccCCc------ccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCc
Q 044428            4 GGLKDLATLSLAANKFHGPIPK------SFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPF   77 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~------~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~   77 (457)
                      .....++.++|+.|.|+|.+|.      .|+++++|++|+|++|++++ +| .+..+++|+.|++++|+++..++....+
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~   92 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVA   92 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcC
Confidence            4567889999999999999998      89999999999999999995 88 9999999999999999999544333344


Q ss_pred             cccccccccccc
Q 044428           78 RNFSTESFSWNY   89 (457)
Q Consensus        78 ~~~~~~~~~~n~   89 (457)
                      +++..+.+++|.
T Consensus        93 ~~L~~L~L~~N~  104 (198)
T 1ds9_A           93 DTLEELWISYNQ  104 (198)
T ss_dssp             HHCSEEEEEEEE
T ss_pred             CcCCEEECcCCc
Confidence            678888888874

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.43  E-value=2.9e-07  Score=88.89  Aligned_cols=83  Identities=22%  Similarity=0.374  Sum_probs=56.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .++.+++|+.|+|++|+++ .+|. +.++++|++|+|++|+++ .+| .+..+++|+.|++++|++++..+ ...+.++.
T Consensus        61 ~~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l~~n~i~~~~~-~~~l~~L~  135 (347)
T 4fmz_A           61 GIEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYLNEDNISDISP-LANLTKMY  135 (347)
T ss_dssp             TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECTTSCCCCCGG-GTTCTTCC
T ss_pred             hhhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEECcCCcccCchh-hccCCcee
Confidence            3556777777777777777 4555 777777777777777777 444 46777777777777777776544 44556666


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       136 ~L~l~~n~  143 (347)
T 4fmz_A          136 SLNLGANH  143 (347)
T ss_dssp             EEECTTCT
T ss_pred             EEECCCCC
Confidence            66666664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.40  E-value=3.4e-07  Score=92.25  Aligned_cols=64  Identities=28%  Similarity=0.264  Sum_probs=56.0

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCC
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP   72 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p   72 (457)
                      ++.+++|+.|+|++|+|++ +  .++++++|+.|+|++|+|+| +|  +..+++|+.|++++|++++.++
T Consensus       187 l~~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~  250 (457)
T 3bz5_A          187 VSQNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV  250 (457)
T ss_dssp             CTTCTTCCEEECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred             cccCCCCCEEECcCCcCCe-e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence            6778899999999999996 4  48899999999999999996 77  8889999999999999998754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.40  E-value=4e-07  Score=93.91  Aligned_cols=55  Identities=27%  Similarity=0.459  Sum_probs=23.5

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCC
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      ++|+.|+|++|+|++ ||. +++  +|++|+|++|+|++ +|.   .+++|+.|+|++|+|++
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~  154 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM  154 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred             CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc
Confidence            344444444444443 444 332  44444444444442 443   23444444444444444

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.39  E-value=3.2e-07  Score=92.64  Aligned_cols=83  Identities=20%  Similarity=0.300  Sum_probs=64.9

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .+..+++|+.|+|++|++++ +|+ ++++++|++|+|++|++++ +|+ +.++++|+.|++++|++++..+ ...++++.
T Consensus        63 ~~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~  137 (466)
T 1o6v_A           63 GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGLTLFNNQITDIDP-LKNLTNLN  137 (466)
T ss_dssp             TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCS
T ss_pred             chhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCcccc-Chh-hcCCCCCCEEECCCCCCCCChH-HcCCCCCC
Confidence            45678888888898888884 555 8888888888888888884 444 8888888888888888887755 55667777


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       138 ~L~l~~n~  145 (466)
T 1o6v_A          138 RLELSSNT  145 (466)
T ss_dssp             EEEEEEEE
T ss_pred             EEECCCCc
Confidence            77777764

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.37  E-value=3.4e-07  Score=94.40  Aligned_cols=75  Identities=27%  Similarity=0.202  Sum_probs=50.2

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccc----
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNF----   80 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~----   80 (457)
                      .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|. +.  ++|+.|+|++|+|+.. |....  ++    
T Consensus       138 ~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~l-p~~~~--~L~~~~  206 (571)
T 3cvr_A          138 LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESL-PAVPV--RNHHSE  206 (571)
T ss_dssp             CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSC-CCCC---------
T ss_pred             cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCch-hhHHH--hhhccc
Confidence            35677888888888874 776   46778888888888874 777 54  7788888888877743 33222  45    


Q ss_pred             ---cccccccccc
Q 044428           81 ---STESFSWNYA   90 (457)
Q Consensus        81 ---~~~~~~~n~~   90 (457)
                         ..+.+++|..
T Consensus       207 ~~L~~L~Ls~N~l  219 (571)
T 3cvr_A          207 ETEIFFRCRENRI  219 (571)
T ss_dssp             -CCEEEECCSSCC
T ss_pred             ccceEEecCCCcc
Confidence               6666666654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=6.3e-07  Score=87.04  Aligned_cols=79  Identities=8%  Similarity=-0.042  Sum_probs=55.5

Q ss_pred             Ccc-CCCCceEEEEEEeC-------CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcC-C--CccceeeeeeecC---
Q 044428          179 NLL-GIGSFGSVYKGTLS-------DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVR-H--RNLIKILSGCSNL---  241 (457)
Q Consensus       179 ~~l-g~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  241 (457)
                      +.| +.|....+|+....       +++.+++|+.....   ......+.+|..+++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            467 88999999998764       26789999865432   101245778888888884 2  3466777777655   


Q ss_pred             CeeEEEEeccCCCCHH
Q 044428          242 DFKALVLEFMPNGSLE  257 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~  257 (457)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987654

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.30  E-value=4.6e-08  Score=96.26  Aligned_cols=86  Identities=17%  Similarity=0.232  Sum_probs=53.8

Q ss_pred             cCCccCCeeeccCCccc--c---cCCcccCCCCCCCeEeCcCCccC----CCCCccchhcCCCceEecccccCCCC----
Q 044428            4 GGLKDLATLSLAANKFH--G---PIPKSFGSLISLESLDLSSNNLS----GEIPKSLEALLYLKQLNVSQNRLEGE----   70 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~--g---~~p~~~~~l~~l~~l~l~~n~l~----g~~p~~~~~~~~L~~l~l~~n~l~~~----   70 (457)
                      +.+++|+.|+|++|+|+  |   .+|..+.++++|+.|+|++|+++    +.+|..+..+++|+.|+|++|++++.    
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  263 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  263 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence            45667777777777776  3   34446667777777777777774    46666667777777777777776654    


Q ss_pred             CCCC---CCccccccccccccc
Q 044428           71 IPVE---GPFRNFSTESFSWNY   89 (457)
Q Consensus        71 ~p~~---~~~~~~~~~~~~~n~   89 (457)
                      +|..   +.++++..+.+++|.
T Consensus       264 l~~~l~~~~~~~L~~L~L~~n~  285 (386)
T 2ca6_A          264 VVDAFSKLENIGLQTLRLQYNE  285 (386)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSC
T ss_pred             HHHHHhhccCCCeEEEECcCCc
Confidence            2221   224556666666654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.30  E-value=1.3e-06  Score=87.89  Aligned_cols=75  Identities=20%  Similarity=0.264  Sum_probs=45.7

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFS   86 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~   86 (457)
                      ++|+.|+|++|++++ +| +|+++++|++|++++|++++ +|..+   .+|+.|++++|++++ +|..+.+.++..+.++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~  203 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYAD  203 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECC
Confidence            467777777777774 66 47777777777777777773 66543   356666666666665 3344444444444444


Q ss_pred             cc
Q 044428           87 WN   88 (457)
Q Consensus        87 ~n   88 (457)
                      +|
T Consensus       204 ~N  205 (454)
T 1jl5_A          204 NN  205 (454)
T ss_dssp             SS
T ss_pred             CC
Confidence            44

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.29  E-value=1.4e-06  Score=87.70  Aligned_cols=74  Identities=24%  Similarity=0.293  Sum_probs=50.7

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFS   86 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~   86 (457)
                      ++|+.|+|++|++++ +|..   .++|++|+|++|++++ +| .+.++++|+.|++++|++++. |..  ..++..+.++
T Consensus       111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~--~~~L~~L~L~  181 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKL-PDL--PPSLEFIAAG  181 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCC-CCC--CTTCCEEECC
T ss_pred             CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCccc-CCC--cccccEEECc
Confidence            455555555555552 3322   1578888888888884 88 588888888888888888873 432  2467777777


Q ss_pred             ccc
Q 044428           87 WNY   89 (457)
Q Consensus        87 ~n~   89 (457)
                      +|.
T Consensus       182 ~n~  184 (454)
T 1jl5_A          182 NNQ  184 (454)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            774

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.28  E-value=6.1e-08  Score=93.27  Aligned_cols=81  Identities=16%  Similarity=0.147  Sum_probs=47.2

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCC-CCccchhcCCCceEecccccCCCCCCC-CCCcccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGE-IPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFSTES   84 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~-~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~   84 (457)
                      ++|+.|+|++|.+++..|. +.++++|++|+|++|++++. +|..+..+++|+.|++++|++++..|. ...++++..+.
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            5566666666666654443 44566666666666666654 666666666666666666666544332 23345555555


Q ss_pred             cccc
Q 044428           85 FSWN   88 (457)
Q Consensus        85 ~~~n   88 (457)
                      +++|
T Consensus       149 L~~~  152 (336)
T 2ast_B          149 LSGC  152 (336)
T ss_dssp             CTTC
T ss_pred             CCCC
Confidence            5555

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.21  E-value=1.6e-07  Score=87.02  Aligned_cols=84  Identities=23%  Similarity=0.221  Sum_probs=63.0

Q ss_pred             CCccCCe--eeccCCcc---cccCCcccCCCCCCCeEeCcCCccCC--CCCccchhcCCCceEecccccCCCCCCCCCCc
Q 044428            5 GLKDLAT--LSLAANKF---HGPIPKSFGSLISLESLDLSSNNLSG--EIPKSLEALLYLKQLNVSQNRLEGEIPVEGPF   77 (457)
Q Consensus         5 ~l~~L~~--l~l~~N~l---~g~~p~~~~~l~~l~~l~l~~n~l~g--~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~   77 (457)
                      ..+.|..  ++++.|+.   .+.++....++++|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++. .....+
T Consensus       139 ~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l  217 (267)
T 3rw6_A          139 SDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKI  217 (267)
T ss_dssp             GCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGG
T ss_pred             CCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhc
Confidence            3344444  67788844   33333333678999999999999998  7778889999999999999999986 223334


Q ss_pred             c--ccccccccccc
Q 044428           78 R--NFSTESFSWNY   89 (457)
Q Consensus        78 ~--~~~~~~~~~n~   89 (457)
                      .  ++..+.+++|+
T Consensus       218 ~~l~L~~L~L~~Np  231 (267)
T 3rw6_A          218 KGLKLEELWLDGNS  231 (267)
T ss_dssp             TTSCCSEEECTTST
T ss_pred             ccCCcceEEccCCc
Confidence            4  77888899986

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.20  E-value=1.8e-06  Score=90.01  Aligned_cols=52  Identities=31%  Similarity=0.210  Sum_probs=26.4

Q ss_pred             CCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccccccccccc
Q 044428           31 ISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNY   89 (457)
Q Consensus        31 ~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~   89 (457)
                      ++|+.|+|++|+|+ .+|   ..+++|+.|+|++|+|+..++   .+.++..+.+++|.
T Consensus       221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~  272 (622)
T 3g06_A          221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQ  272 (622)
T ss_dssp             TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSC
T ss_pred             CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCC
Confidence            44555566666555 355   233455555555555553322   23445555555553

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.19  E-value=1.4e-07  Score=92.72  Aligned_cols=83  Identities=18%  Similarity=0.288  Sum_probs=54.8

Q ss_pred             ccCCeeeccCCccc-ccCC---cccCCCCCCCeEeCcCCccC--C---CCCccchhcCCCceEecccccCC----CCCCC
Q 044428            7 KDLATLSLAANKFH-GPIP---KSFGSLISLESLDLSSNNLS--G---EIPKSLEALLYLKQLNVSQNRLE----GEIPV   73 (457)
Q Consensus         7 ~~L~~l~l~~N~l~-g~~p---~~~~~l~~l~~l~l~~n~l~--g---~~p~~~~~~~~L~~l~l~~n~l~----~~~p~   73 (457)
                      ++|+.|+|++|+|+ +.+|   ..+.++++|++|+|++|+++  |   .+|..+..+++|+.|+|++|.++    +.+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            67777777777776 4555   45667777777777777777  3   34446777777777777777775    33332


Q ss_pred             -CCCccccccccccccc
Q 044428           74 -EGPFRNFSTESFSWNY   89 (457)
Q Consensus        74 -~~~~~~~~~~~~~~n~   89 (457)
                       ...++++..+.+++|.
T Consensus       239 ~l~~~~~L~~L~L~~n~  255 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCL  255 (386)
T ss_dssp             HGGGCTTCCEEECTTCC
T ss_pred             HHccCCCcCEEECCCCC
Confidence             2344566666676664

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.17  E-value=1.2e-07  Score=91.12  Aligned_cols=86  Identities=16%  Similarity=0.154  Sum_probs=72.4

Q ss_pred             ccCCccCCeeeccCCccccc-CCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccc-cCCCC-CCC-CCCcc
Q 044428            3 IGGLKDLATLSLAANKFHGP-IPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN-RLEGE-IPV-EGPFR   78 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~-~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n-~l~~~-~p~-~~~~~   78 (457)
                      +.++++|+.|+|++|++++. +|..+.++++|++|+|++|++++.+|..+..+++|+.|+|++| .+++. +|. ...++
T Consensus        89 ~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~  168 (336)
T 2ast_B           89 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS  168 (336)
T ss_dssp             CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred             hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCC
Confidence            56789999999999999876 8888999999999999999999889999999999999999999 67752 333 34466


Q ss_pred             cccccccccc
Q 044428           79 NFSTESFSWN   88 (457)
Q Consensus        79 ~~~~~~~~~n   88 (457)
                      ++..+.+++|
T Consensus       169 ~L~~L~l~~~  178 (336)
T 2ast_B          169 RLDELNLSWC  178 (336)
T ss_dssp             TCCEEECCCC
T ss_pred             CCCEEcCCCC
Confidence            7888888877

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.13  E-value=1.5e-06  Score=90.57  Aligned_cols=77  Identities=22%  Similarity=0.171  Sum_probs=56.6

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESF   85 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~   85 (457)
                      +++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+..++....++++..+.+
T Consensus       220 ~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          220 PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNL  291 (622)
T ss_dssp             CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEEC
T ss_pred             CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEe
Confidence            3678888888888884 77   45677888888888888 6776   567788888888888855444455667777777


Q ss_pred             ccccc
Q 044428           86 SWNYA   90 (457)
Q Consensus        86 ~~n~~   90 (457)
                      ++|+.
T Consensus       292 ~~N~l  296 (622)
T 3g06_A          292 EGNPL  296 (622)
T ss_dssp             CSCCC
T ss_pred             cCCCC
Confidence            77753

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.08  E-value=3e-06  Score=82.04  Aligned_cols=83  Identities=20%  Similarity=0.170  Sum_probs=64.2

Q ss_pred             ccCCeeeccCCcccccCCc-ccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCc-eEecccccCCCCCCCC-CCcccccc
Q 044428            7 KDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPK-SLEALLYLK-QLNVSQNRLEGEIPVE-GPFRNFST   82 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~-~l~l~~n~l~~~~p~~-~~~~~~~~   82 (457)
                      ++|+.|+|++|+|+ .||+ .|.+|++|++|+|++|++.+.+|. .|.++++|. .+.+++|+++...|.. ..+.++..
T Consensus        30 ~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~  108 (350)
T 4ay9_X           30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY  108 (350)
T ss_dssp             TTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCE
T ss_pred             CCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccc
Confidence            47899999999998 6764 689999999999999998777876 567787765 4667778888877653 45667777


Q ss_pred             cccccccc
Q 044428           83 ESFSWNYA   90 (457)
Q Consensus        83 ~~~~~n~~   90 (457)
                      +.+++|..
T Consensus       109 L~l~~n~l  116 (350)
T 4ay9_X          109 LLISNTGI  116 (350)
T ss_dssp             EEEEEECC
T ss_pred             cccccccc
Confidence            77777753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=2.6e-05  Score=74.79  Aligned_cols=140  Identities=14%  Similarity=0.089  Sum_probs=79.3

Q ss_pred             CccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----CCccceee-e--eeecCCeeEEEEec
Q 044428          179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-----HRNLIKIL-S--GCSNLDFKALVLEF  250 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~  250 (457)
                      +.|+.|..+.||+....+| .+++|+.....    ..+..|..++..+.     .|.++... |  +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3566677899999987655 48999987532    22334555555442     23333311 1  11245678899999


Q ss_pred             cCCCCHH--------------HHHhhC--CC-----------CCCHHHHH------------------------------
Q 044428          251 MPNGSLE--------------KWLYSH--NY-----------FLDILERL------------------------------  273 (457)
Q Consensus       251 ~~~g~L~--------------~~l~~~--~~-----------~l~~~~~~------------------------------  273 (457)
                      ++|..+.              ..+|..  ..           ...|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              112211  00           11232211                              


Q ss_pred             -HHHHHHHHHHHHHHh--------c-CCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          274 -NIMIDVGLALEYLHY--------G-HALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       274 -~i~~~ia~~l~~LH~--------~-~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                       .+...+..++.+|+.        . .....++|+|+++.||+++.++.+.|.||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             011123345666653        1 0146799999999999998888999999997653

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.08  E-value=8.7e-07  Score=86.31  Aligned_cols=84  Identities=23%  Similarity=0.269  Sum_probs=64.8

Q ss_pred             CccCCeeeccCCcccccCC----cccCCCC-CCCeEeCcCCccCCCCCccchhc-----CCCceEecccccCCCCCCC--
Q 044428            6 LKDLATLSLAANKFHGPIP----KSFGSLI-SLESLDLSSNNLSGEIPKSLEAL-----LYLKQLNVSQNRLEGEIPV--   73 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p----~~~~~l~-~l~~l~l~~n~l~g~~p~~~~~~-----~~L~~l~l~~n~l~~~~p~--   73 (457)
                      .++|+.|+|++|+|++.-+    ..|.+++ +|++|+|++|++++..+..+..+     ++|+.|+|++|++++..+.  
T Consensus        21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l  100 (362)
T 3goz_A           21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL  100 (362)
T ss_dssp             CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred             CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence            4558999999999985555    6777888 89999999999997777777776     8899999999998876653  


Q ss_pred             ---CCCc-cccccccccccc
Q 044428           74 ---EGPF-RNFSTESFSWNY   89 (457)
Q Consensus        74 ---~~~~-~~~~~~~~~~n~   89 (457)
                         ...+ .++..+.+++|.
T Consensus       101 ~~~l~~~~~~L~~L~Ls~N~  120 (362)
T 3goz_A          101 VKTLAAIPFTITVLDLGWND  120 (362)
T ss_dssp             HHHHHTSCTTCCEEECCSSC
T ss_pred             HHHHHhCCCCccEEECcCCc
Confidence               1222 567777777775

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.07  E-value=1.7e-05  Score=74.50  Aligned_cols=79  Identities=16%  Similarity=0.112  Sum_probs=56.9

Q ss_pred             cCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC---ccceeeeeeecCCeeEEEEec
Q 044428          174 EFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR---NLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~  250 (457)
                      +....+.+|.|..+.||+.++.||+.|+||+...........|.+|...|+.+.-.   .+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            34455678999999999999999999999987654433344678899999888422   233444432    34789999


Q ss_pred             cCCCCH
Q 044428          251 MPNGSL  256 (457)
Q Consensus       251 ~~~g~L  256 (457)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.06  E-value=2e-05  Score=77.65  Aligned_cols=75  Identities=16%  Similarity=0.182  Sum_probs=49.0

Q ss_pred             CCccCCCCceEEEEEEeC-CCCEEEEEEecccch-------hhHHHHHHHHHHHhhcCC--Cccc-eeeeeeecCCeeEE
Q 044428          178 CNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE-------RTFVSFNSECEVLRNVRH--RNLI-KILSGCSNLDFKAL  246 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l  246 (457)
                      .+.+|.|.++.||+++.. +++.++||.......       .....+..|.+++..+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999764 568899998653211       122346778888888742  4444 44443  3445689


Q ss_pred             EEeccCCC
Q 044428          247 VLEFMPNG  254 (457)
Q Consensus       247 v~e~~~~g  254 (457)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.05  E-value=2.5e-06  Score=82.60  Aligned_cols=58  Identities=21%  Similarity=0.240  Sum_probs=28.5

Q ss_pred             eeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCC
Q 044428           11 TLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIP   72 (457)
Q Consensus        11 ~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p   72 (457)
                      .++-++|+|+ .||..+  .+++++|+|++|+|+ .||. .|.++++|+.|+|++|++.+.+|
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~   71 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIE   71 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence            4444555555 455444  234555555555555 4443 34555555555555555544443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.99  E-value=8.2e-07  Score=86.49  Aligned_cols=87  Identities=17%  Similarity=0.181  Sum_probs=69.3

Q ss_pred             ccCCc-cCCeeeccCCcccccCCcccCCC-----CCCCeEeCcCCccCCCCCccchhc-----CCCceEecccccCCCCC
Q 044428            3 IGGLK-DLATLSLAANKFHGPIPKSFGSL-----ISLESLDLSSNNLSGEIPKSLEAL-----LYLKQLNVSQNRLEGEI   71 (457)
Q Consensus         3 ~~~l~-~L~~l~l~~N~l~g~~p~~~~~l-----~~l~~l~l~~n~l~g~~p~~~~~~-----~~L~~l~l~~n~l~~~~   71 (457)
                      +.+++ +|+.|+|++|+|++..+..++.+     ++|++|+|++|++++..|..+...     ++|+.|+|++|++++..
T Consensus        46 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  125 (362)
T 3goz_A           46 FANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS  125 (362)
T ss_dssp             HHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred             HHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence            45677 89999999999998878888776     999999999999998777766554     89999999999998765


Q ss_pred             CCC-----CC-ccccccccccccc
Q 044428           72 PVE-----GP-FRNFSTESFSWNY   89 (457)
Q Consensus        72 p~~-----~~-~~~~~~~~~~~n~   89 (457)
                      +..     .. ..++..+.+++|.
T Consensus       126 ~~~l~~~l~~~~~~L~~L~Ls~N~  149 (362)
T 3goz_A          126 SSEFKQAFSNLPASITSLNLRGND  149 (362)
T ss_dssp             HHHHHHHHTTSCTTCCEEECTTSC
T ss_pred             HHHHHHHHHhCCCceeEEEccCCc
Confidence            521     11 1367778888774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.97  E-value=5.8e-05  Score=71.63  Aligned_cols=137  Identities=14%  Similarity=0.066  Sum_probs=91.6

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCeeEEEEeccCCC
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR---HRNLIKILSGCSNLDFKALVLEFMPNG  254 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  254 (457)
                      .+.|+.|....+|+... +++.++||+....   ....+.+|.+.|+.+.   ...+.++++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            35789999999999986 4678889987543   3456888999888884   356778888888788899999999987


Q ss_pred             CHH--------H---HHhhCCC---------------------CCCHHHH-----HHHHHH--------------HHHH-
Q 044428          255 SLE--------K---WLYSHNY---------------------FLDILER-----LNIMID--------------VGLA-  282 (457)
Q Consensus       255 ~L~--------~---~l~~~~~---------------------~l~~~~~-----~~i~~~--------------ia~~-  282 (457)
                      .+.        +   .||....                     .-+|..-     +.-..+              +... 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            642        1   2232210                     1245432     111111              1111 


Q ss_pred             HHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccc
Q 044428          283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFG  319 (457)
Q Consensus       283 l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  319 (457)
                      ...|......+.++|+|+.+.|++++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            12332222256799999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=0.00017  Score=71.54  Aligned_cols=75  Identities=17%  Similarity=0.137  Sum_probs=45.3

Q ss_pred             CCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCCC-------CCccchhhhhHHHHH
Q 044428          292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV-------STKCDVYSYGILLLE  364 (457)
Q Consensus       292 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~Dv~s~Gvvl~e  364 (457)
                      ...++|+|+++.||+++.++ +++.||+.+..-.+..+-.. ....-...|.+|+...       ....++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            46799999999999999876 99999998876322111000 0000012345544221       112445677778887


Q ss_pred             HhcC
Q 044428          365 TFSR  368 (457)
Q Consensus       365 l~tg  368 (457)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.54  E-value=5.6e-06  Score=83.07  Aligned_cols=86  Identities=24%  Similarity=0.180  Sum_probs=56.2

Q ss_pred             cCCccCCeeeccCCcccccCCcccCC-----CCCCCeEeCcCCccCCC----CCccchhcCCCceEecccccCCCCCCCC
Q 044428            4 GGLKDLATLSLAANKFHGPIPKSFGS-----LISLESLDLSSNNLSGE----IPKSLEALLYLKQLNVSQNRLEGEIPVE   74 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~~~~~-----l~~l~~l~l~~n~l~g~----~p~~~~~~~~L~~l~l~~n~l~~~~p~~   74 (457)
                      .++++|+.|+|++|++++.-+..+..     .++|+.|+|++|++++.    +|..+..+++|+.|++++|++++..+..
T Consensus       281 ~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~  360 (461)
T 1z7x_W          281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE  360 (461)
T ss_dssp             HHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred             hhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHH
Confidence            45778888888888887544443332     26788888888888765    5666677788888888888776543211


Q ss_pred             ------CCccccccccccccc
Q 044428           75 ------GPFRNFSTESFSWNY   89 (457)
Q Consensus        75 ------~~~~~~~~~~~~~n~   89 (457)
                            ....++..+.+++|.
T Consensus       361 l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          361 LCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             HHHHHTSTTCCCCEEECTTSC
T ss_pred             HHHHHcCCCCceEEEECCCCC
Confidence                  013456666676663

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.52  E-value=9.2e-06  Score=81.47  Aligned_cols=84  Identities=15%  Similarity=0.086  Sum_probs=66.1

Q ss_pred             CccCCeeeccCCccccc----CCcccCCCCCCCeEeCcCCccCCCCCccchh-----cCCCceEecccccCCC----CCC
Q 044428            6 LKDLATLSLAANKFHGP----IPKSFGSLISLESLDLSSNNLSGEIPKSLEA-----LLYLKQLNVSQNRLEG----EIP   72 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~-----~~~L~~l~l~~n~l~~----~~p   72 (457)
                      .++|+.|+|++|++++.    +|..+.++++|++|+|++|++++..+..+..     .++|+.|++++|++++    .+|
T Consensus       312 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~  391 (461)
T 1z7x_W          312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA  391 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             CccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHH
Confidence            46899999999999865    6777888899999999999998766666654     6789999999999985    444


Q ss_pred             C-CCCccccccccccccc
Q 044428           73 V-EGPFRNFSTESFSWNY   89 (457)
Q Consensus        73 ~-~~~~~~~~~~~~~~n~   89 (457)
                      . ...++++..+.+++|.
T Consensus       392 ~~l~~~~~L~~L~l~~N~  409 (461)
T 1z7x_W          392 ATLLANHSLRELDLSNNC  409 (461)
T ss_dssp             HHHHHCCCCCEEECCSSS
T ss_pred             HHHHhCCCccEEECCCCC
Confidence            2 2345677888888875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.51  E-value=0.00059  Score=64.75  Aligned_cols=159  Identities=12%  Similarity=0.092  Sum_probs=89.9

Q ss_pred             ccCHHHHHHHhhcCCc-----CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--ccee
Q 044428          162 RISYLDIQRATNEFDE-----CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN--LIKI  234 (457)
Q Consensus       162 ~~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  234 (457)
                      .++..++......|..     .+.|+.|....+|+....+| .+++|+.....  ....+..|..++..+....  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3556667666666654     23567788899999987666 58899887531  1234556777777764212  2333


Q ss_pred             eee------eecCCeeEEEEeccCCCCHHH--------------HHhhC--C--CC-------CCHHHHHH---------
Q 044428          235 LSG------CSNLDFKALVLEFMPNGSLEK--------------WLYSH--N--YF-------LDILERLN---------  274 (457)
Q Consensus       235 ~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~--~~-------l~~~~~~~---------  274 (457)
                      +..      ....+..+++++|++|..+..              .+|..  .  ..       ..|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      122356789999998864311              12211  0  00       11322111         


Q ss_pred             ---HHHHHHHHHHHHHhcC---CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          275 ---IMIDVGLALEYLHYGH---ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       275 ---i~~~ia~~l~~LH~~~---~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                         +...+...+++++...   ....++|+|+.+.||+++++..+.|.||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               0112344555555321   135699999999999999876668999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.001  Score=63.52  Aligned_cols=141  Identities=12%  Similarity=0.024  Sum_probs=73.7

Q ss_pred             CccCCCCceE-EEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CccceeeeeeecCCeeEEEEeccCCCC
Q 044428          179 NLLGIGSFGS-VYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH--RNLIKILSGCSNLDFKALVLEFMPNGS  255 (457)
Q Consensus       179 ~~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  255 (457)
                      +.|+.|.... +|+....+|+.+++|.......   ..+..|+.++..+..  -.+.+++.+....+  +++||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3565565554 6677654467788876543221   234556777666632  23455666543333  78999998777


Q ss_pred             HHHHHhhCC-------------------------CCCCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 044428          256 LEKWLYSHN-------------------------YFLDILERL-------N-------------IMIDVGLALEYLHY--  288 (457)
Q Consensus       256 L~~~l~~~~-------------------------~~l~~~~~~-------~-------------i~~~ia~~l~~LH~--  288 (457)
                      +.+++....                         ...+.....       .             ....+...+..+..  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            765443211                         001111000       0             00011122222211  


Q ss_pred             cCCCCCeeeccCCCCCeeecCC----CcEEEecccccccc
Q 044428          289 GHALAPIIHCDLKPSNILLDEN----MVAHVSDFGISKLL  324 (457)
Q Consensus       289 ~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~~~~~  324 (457)
                      ......++|||+.+.||+++.+    ..+.|.||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1114579999999999999875    68899999988753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.47  E-value=0.00047  Score=64.90  Aligned_cols=137  Identities=15%  Similarity=0.149  Sum_probs=75.6

Q ss_pred             CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCeeEEEEecc-CCCC
Q 044428          178 CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL-IKILSGCSNLDFKALVLEFM-PNGS  255 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  255 (457)
                      .+.|+.|....+|+.     ..+++|+....... .....+|..+++.+....+ .+++++.  .+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            568889999999999     55889987653221 1234568887777743233 3455443  33457899999 5544


Q ss_pred             HHH------------------HHhhCCCC----CCHHHHHH-HHH--------------HHHHHH----HHHHhcCCCCC
Q 044428          256 LEK------------------WLYSHNYF----LDILERLN-IMI--------------DVGLAL----EYLHYGHALAP  294 (457)
Q Consensus       256 L~~------------------~l~~~~~~----l~~~~~~~-i~~--------------~ia~~l----~~LH~~~~~~~  294 (457)
                      +..                  .+|.....    .+...++. +..              .+...+    ..+........
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            421                  11111100    11111110 000              011111    11111122345


Q ss_pred             eeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          295 IIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       295 ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ++|+|+.+.||+ .+++.+.+.||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667789999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.44  E-value=0.0015  Score=62.17  Aligned_cols=159  Identities=13%  Similarity=0.054  Sum_probs=90.5

Q ss_pred             cccCHHHHHHHhhcCCc-----CCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC--ccce
Q 044428          161 RRISYLDIQRATNEFDE-----CNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHR--NLIK  233 (457)
Q Consensus       161 ~~~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~  233 (457)
                      ..++..++......|..     ...++ |....||+....+|+.+++|+..... .....+..|..++..+...  .+.+
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            34555666666555532     23466 88889999887778789999986331 1234566788887777422  2344


Q ss_pred             eeee-----eecCCeeEEEEeccCCCCHH-----H------H---Hhh----CC----CCCCHHHH----HHH-------
Q 044428          234 ILSG-----CSNLDFKALVLEFMPNGSLE-----K------W---LYS----HN----YFLDILER----LNI-------  275 (457)
Q Consensus       234 l~~~-----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~----~~----~~l~~~~~----~~i-------  275 (457)
                      ++..     ....+..+++|+|++|..+.     .      .   +|.    ..    ...++...    ..+       
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4433     12234567899999875431     1      1   111    00    11222111    001       


Q ss_pred             --------HHHHHHHHHHHHhcC---CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          276 --------MIDVGLALEYLHYGH---ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       276 --------~~~ia~~l~~LH~~~---~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                              ...+...+..+....   ....++|+|+++.||+++ + .+.+.||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    111112233332211   135689999999999999 4 899999987764

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.43  E-value=2.2e-05  Score=76.57  Aligned_cols=85  Identities=18%  Similarity=0.204  Sum_probs=64.0

Q ss_pred             CCccCCeeeccCCcccc----cCCcccCCCCCCCeEeCcCCccCC----CCCccchhcCCCceEecccccCCCCCCC---
Q 044428            5 GLKDLATLSLAANKFHG----PIPKSFGSLISLESLDLSSNNLSG----EIPKSLEALLYLKQLNVSQNRLEGEIPV---   73 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g----~~p~~~~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~L~~l~l~~n~l~~~~p~---   73 (457)
                      ..++|+.|+|++|+|+.    .++..+..+++|++|+|++|+|++    .++..+...++|+.|+|++|.++..-..   
T Consensus       153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~  232 (372)
T 3un9_A          153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA  232 (372)
T ss_dssp             TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred             cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence            46789999999999974    356666788999999999999884    2356677788999999999998753210   


Q ss_pred             --CCCccccccccccccc
Q 044428           74 --EGPFRNFSTESFSWNY   89 (457)
Q Consensus        74 --~~~~~~~~~~~~~~n~   89 (457)
                        ....+++..+.+++|.
T Consensus       233 ~~L~~~~~L~~L~Ls~N~  250 (372)
T 3un9_A          233 RAAREHPSLELLHLYFNE  250 (372)
T ss_dssp             HHHHHCSSCCEEECTTSS
T ss_pred             HHHHhCCCCCEEeccCCC
Confidence              1123567788888885

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.32  E-value=0.0004  Score=68.98  Aligned_cols=71  Identities=17%  Similarity=0.236  Sum_probs=48.7

Q ss_pred             CccCCCCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCeeEEEEe
Q 044428          179 NLLGIGSFGSVYKGTLSD--------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL-IKILSGCSNLDFKALVLE  249 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  249 (457)
                      +.|+.|....+|+....+        +..+++|+....  .....+.+|..++..+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            468889899999998753        578999988432  111345578888888853333 556666543    38999


Q ss_pred             ccCCCC
Q 044428          250 FMPNGS  255 (457)
Q Consensus       250 ~~~~g~  255 (457)
                      |++|.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            998633

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.29  E-value=4.5e-05  Score=79.02  Aligned_cols=85  Identities=11%  Similarity=-0.009  Sum_probs=47.8

Q ss_pred             CCccCCeeeccC--CcccccCCcccCC-CCCCCeEeCcCCccCC-CCCccchhcCCCceEecccccCCCC-CCC-CCCcc
Q 044428            5 GLKDLATLSLAA--NKFHGPIPKSFGS-LISLESLDLSSNNLSG-EIPKSLEALLYLKQLNVSQNRLEGE-IPV-EGPFR   78 (457)
Q Consensus         5 ~l~~L~~l~l~~--N~l~g~~p~~~~~-l~~l~~l~l~~n~l~g-~~p~~~~~~~~L~~l~l~~n~l~~~-~p~-~~~~~   78 (457)
                      ++++|+.|+|+.  |.+++..+..++. +++|++|+|++|++++ .+|..+..+++|+.|+|++|++++. ++. ...++
T Consensus       434 ~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~  513 (592)
T 3ogk_B          434 GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLP  513 (592)
T ss_dssp             HCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCS
T ss_pred             hCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcC
Confidence            466677777653  3355555544443 6667777777776665 3444445566677777777766432 111 12344


Q ss_pred             ccccccccccc
Q 044428           79 NFSTESFSWNY   89 (457)
Q Consensus        79 ~~~~~~~~~n~   89 (457)
                      ++..+.+++|.
T Consensus       514 ~L~~L~ls~n~  524 (592)
T 3ogk_B          514 SLRYLWVQGYR  524 (592)
T ss_dssp             SCCEEEEESCB
T ss_pred             ccCeeECcCCc
Confidence            55666666654

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.27  E-value=0.00049  Score=56.17  Aligned_cols=56  Identities=23%  Similarity=0.411  Sum_probs=44.9

Q ss_pred             CeeeccCCccc-ccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCC
Q 044428           10 ATLSLAANKFH-GPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLE   68 (457)
Q Consensus        10 ~~l~l~~N~l~-g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~   68 (457)
                      ..++.+++.|+ ..+|..+.  ++|+.|+|++|+|+ .||. .|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            47889999997 56887643  57999999999999 6766 4677889999999888765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.21  E-value=0.002  Score=62.73  Aligned_cols=140  Identities=13%  Similarity=0.122  Sum_probs=82.1

Q ss_pred             CccCCCCceEEEEEEeC--------CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEe
Q 044428          179 NLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +.+..|-...+|+....        +++.+++|+..... .....+.+|..+++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            46777888999999875        35789999864322 23455678999998884 3333556666654    29999


Q ss_pred             ccCCCCHHH-----------------HHhhCC----CCCC--HHHHHHHHHHHH-------------------HHHHH--
Q 044428          250 FMPNGSLEK-----------------WLYSHN----YFLD--ILERLNIMIDVG-------------------LALEY--  285 (457)
Q Consensus       250 ~~~~g~L~~-----------------~l~~~~----~~l~--~~~~~~i~~~ia-------------------~~l~~--  285 (457)
                      |++|.+|..                 -+|...    ....  |.+..++..++.                   ..+.+  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998755421                 112221    1122  233333333221                   12233  


Q ss_pred             --HHhcCCCCCeeeccCCCCCeeecCC----CcEEEeccccccc
Q 044428          286 --LHYGHALAPIIHCDLKPSNILLDEN----MVAHVSDFGISKL  323 (457)
Q Consensus       286 --LH~~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~~~~  323 (457)
                        |........++|+|+.+.||+++.+    +.+.+.||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              3222224569999999999999876    7899999998764

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.15  E-value=6.9e-05  Score=73.08  Aligned_cols=84  Identities=18%  Similarity=0.167  Sum_probs=61.5

Q ss_pred             CccCCeeeccCCcccccCCccc-----CCCCCCCeEeCcCCccCC----CCCccchhcCCCceEecccccCCCCC----C
Q 044428            6 LKDLATLSLAANKFHGPIPKSF-----GSLISLESLDLSSNNLSG----EIPKSLEALLYLKQLNVSQNRLEGEI----P   72 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~-----~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~L~~l~l~~n~l~~~~----p   72 (457)
                      +++|+.|+|++|+|+..-...+     ...++|++|+|++|+|+.    .++..+..+++|+.|+|++|+++..-    +
T Consensus       125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~  204 (372)
T 3un9_A          125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA  204 (372)
T ss_dssp             HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred             HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence            5689999999999975433333     346889999999999974    35556677899999999999987421    1


Q ss_pred             -CCCCccccccccccccc
Q 044428           73 -VEGPFRNFSTESFSWNY   89 (457)
Q Consensus        73 -~~~~~~~~~~~~~~~n~   89 (457)
                       ......++..+.+++|.
T Consensus       205 ~~L~~~~~L~~L~Ls~N~  222 (372)
T 3un9_A          205 AQLDRNRQLQELNVAYNG  222 (372)
T ss_dssp             HHGGGCSCCCEEECCSSC
T ss_pred             HHHhcCCCcCeEECCCCC
Confidence             11223467788888874

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.13  E-value=3.1e-05  Score=80.23  Aligned_cols=81  Identities=12%  Similarity=0.077  Sum_probs=56.0

Q ss_pred             CCccCCeeeccCCccccc----CCcccCCCCCCCeEeCcCCccC----CCCCccchhcCCCceEecccccCCCCCCCCCC
Q 044428            5 GLKDLATLSLAANKFHGP----IPKSFGSLISLESLDLSSNNLS----GEIPKSLEALLYLKQLNVSQNRLEGEIPVEGP   76 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~n~l~----g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~   76 (457)
                      +|++|+.|+|++|.+++.    ++..+.++++|++|+|++|+++    +.++..+.++++|+.|++++|.+.+.......
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~  241 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKA  241 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhh
Confidence            578888888988888765    4445567888888888888887    34555566788888888888887764332223


Q ss_pred             ccccccccc
Q 044428           77 FRNFSTESF   85 (457)
Q Consensus        77 ~~~~~~~~~   85 (457)
                      ++++..+.+
T Consensus       242 ~~~L~~L~l  250 (592)
T 3ogk_B          242 AANLEEFCG  250 (592)
T ss_dssp             CTTCCEEEE
T ss_pred             hhHHHhhcc
Confidence            334444443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.04  E-value=9.2e-05  Score=71.82  Aligned_cols=85  Identities=16%  Similarity=0.245  Sum_probs=58.5

Q ss_pred             CCccCCeeeccC--Cccccc-----CCccc--CCCCCCCeEeCcCCccCCCCCccch---hcCCCceEecccccCCCC--
Q 044428            5 GLKDLATLSLAA--NKFHGP-----IPKSF--GSLISLESLDLSSNNLSGEIPKSLE---ALLYLKQLNVSQNRLEGE--   70 (457)
Q Consensus         5 ~l~~L~~l~l~~--N~l~g~-----~p~~~--~~l~~l~~l~l~~n~l~g~~p~~~~---~~~~L~~l~l~~n~l~~~--   70 (457)
                      .+++|+.|+|+.  |...|.     +-..+  +.+++|++|+|++|.+++..+..+.   .+++|+.|+|+.|.+++.  
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~  296 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA  296 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence            689999999863  333222     11122  3589999999999999865555554   478999999999999763  


Q ss_pred             --CCCC-CCccccccccccccc
Q 044428           71 --IPVE-GPFRNFSTESFSWNY   89 (457)
Q Consensus        71 --~p~~-~~~~~~~~~~~~~n~   89 (457)
                        ++.. ..++++..+.++.|.
T Consensus       297 ~~L~~~L~~l~~L~~L~L~~n~  318 (362)
T 2ra8_A          297 RLLLDHVDKIKHLKFINMKYNY  318 (362)
T ss_dssp             HHHHTTHHHHTTCSEEECCSBB
T ss_pred             HHHHhhcccCCcceEEECCCCc
Confidence              2221 245677777777663

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.02  E-value=0.00088  Score=65.01  Aligned_cols=72  Identities=15%  Similarity=0.245  Sum_probs=44.2

Q ss_pred             CccCCCCceEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCeeEEEE
Q 044428          179 NLLGIGSFGSVYKGTLSD---------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN-LIKILSGCSNLDFKALVL  248 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  248 (457)
                      ..++.|....+|+....+         ++.+++|+...... ...+...|.+++..+.... ..++++...    ..+||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            367788889999998754         26889998764322 1123467888888875333 335665432    36899


Q ss_pred             eccCCCC
Q 044428          249 EFMPNGS  255 (457)
Q Consensus       249 e~~~~g~  255 (457)
                      ||++|..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.99  E-value=0.00016  Score=63.01  Aligned_cols=67  Identities=18%  Similarity=0.234  Sum_probs=53.0

Q ss_pred             ccCCccCCeeeccCC-ccccc----CCcccCCCCCCCeEeCcCCccCC----CCCccchhcCCCceEecccccCCC
Q 044428            3 IGGLKDLATLSLAAN-KFHGP----IPKSFGSLISLESLDLSSNNLSG----EIPKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N-~l~g~----~p~~~~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      +...++|+.|+|++| .|+..    +...+...++|++|+|++|+|+.    .+...+...++|+.|+|++|.++.
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            456789999999999 88632    45567778999999999999974    244456666899999999999874

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.98  E-value=0.00014  Score=63.31  Aligned_cols=67  Identities=19%  Similarity=0.304  Sum_probs=54.3

Q ss_pred             ccCCccCCeeeccCCccccc----CCcccCCCCCCCeEeCcCCccCCC----CCccchhcCCCceEec--ccccCCC
Q 044428            3 IGGLKDLATLSLAANKFHGP----IPKSFGSLISLESLDLSSNNLSGE----IPKSLEALLYLKQLNV--SQNRLEG   69 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~L~~l~l--~~n~l~~   69 (457)
                      +...++|++|+|++|+|+..    +...+...++|++|+|++|+|+..    +...+...++|+.|+|  ++|.++.
T Consensus        61 L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A           61 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            45578999999999999632    445566678999999999999853    5667777889999999  8898874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.98  E-value=0.0016  Score=65.14  Aligned_cols=73  Identities=15%  Similarity=0.186  Sum_probs=47.9

Q ss_pred             CccCCCCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCeeEEEEeccCCCCH
Q 044428          179 NLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL-IKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      +.|+.|-...+|+....+ +..+++|+...... ...+..+|..++..+...++ .++++++.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            468889999999998865 57888998754321 11223578999998865555 45666663  2  259999987443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.77  E-value=7.7e-05  Score=77.23  Aligned_cols=41  Identities=17%  Similarity=0.129  Sum_probs=20.1

Q ss_pred             cCCCCCCCeEeCcCCccCCCCCccchh-cCCCceEecccccCC
Q 044428           27 FGSLISLESLDLSSNNLSGEIPKSLEA-LLYLKQLNVSQNRLE   68 (457)
Q Consensus        27 ~~~l~~l~~l~l~~n~l~g~~p~~~~~-~~~L~~l~l~~n~l~   68 (457)
                      +.++++|+.|+|++ ++++..+..+.. +++|+.|+|++|.++
T Consensus       428 ~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~  469 (594)
T 2p1m_B          428 VEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDS  469 (594)
T ss_dssp             HHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSS
T ss_pred             HhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCc
Confidence            34455555555544 444433334443 455555555555543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.73  E-value=0.012  Score=51.82  Aligned_cols=100  Identities=12%  Similarity=-0.033  Sum_probs=66.9

Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCccee
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQ  333 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  333 (457)
                      -+|.+.|...+.++++.+.+.++.|.+.+|.-+-... .+  ..+=+.|..|++..+|.+...+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-QP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence            4899999998889999999999999999987762111 11  1223456899999999888764 1110           


Q ss_pred             ccccccccccCCCCCC---CCccchhhhhHHHHHHhcCCCC
Q 044428          334 TKTMATIGYMAPEGIV---STKCDVYSYGILLLETFSRKKP  371 (457)
Q Consensus       334 ~~~~gt~~y~aPE~~~---~~~~Dv~s~Gvvl~el~tg~~p  371 (457)
                         .....+.|||...   +++.=|||+|+++|.-+--..|
T Consensus        98 ---~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence               1122456888543   6788899999999998874444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.67  E-value=0.0095  Score=56.98  Aligned_cols=32  Identities=19%  Similarity=0.305  Sum_probs=28.1

Q ss_pred             CCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       292 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35699999999999999888899999987764

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=96.47  E-value=0.0026  Score=60.58  Aligned_cols=79  Identities=16%  Similarity=0.140  Sum_probs=60.8

Q ss_pred             CccCCeeeccCCcccccCCc-ccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCc-eEecccccCCCCCCC-CCCccccc
Q 044428            6 LKDLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPK-SLEALLYLK-QLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~-~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      |++|+.|+|++|+++ .||+ .|.+|++|+.|+|++| ++ .|+. .|.++.+|+ .+++++ +++...+. ...+.++.
T Consensus       225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~  300 (329)
T 3sb4_A          225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLR  300 (329)
T ss_dssp             CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEE
T ss_pred             cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCC
Confidence            789999999999999 6774 6999999999999998 87 6665 688999999 999988 56544332 22334566


Q ss_pred             ccccccc
Q 044428           82 TESFSWN   88 (457)
Q Consensus        82 ~~~~~~n   88 (457)
                      .+.+.+|
T Consensus       301 ~l~l~~n  307 (329)
T 3sb4_A          301 YVLATGD  307 (329)
T ss_dssp             EEEECSS
T ss_pred             EEEeCCC
Confidence            6666554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.34  E-value=0.00044  Score=71.43  Aligned_cols=84  Identities=14%  Similarity=0.119  Sum_probs=58.4

Q ss_pred             CCccCCeeeccCCcccccCCcccC-CCCCCCeEeCcCC-ccCCC-CCccchhcCCCceEecccccCCCCCCCC-----CC
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFG-SLISLESLDLSSN-NLSGE-IPKSLEALLYLKQLNVSQNRLEGEIPVE-----GP   76 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~n-~l~g~-~p~~~~~~~~L~~l~l~~n~l~~~~p~~-----~~   76 (457)
                      .+++|+.|+|++|.+++..+..+. ++++|++|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..     ..
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            467888888888888877777775 6888888888888 55532 4555557888888888888876643221     13


Q ss_pred             cccccccccccc
Q 044428           77 FRNFSTESFSWN   88 (457)
Q Consensus        77 ~~~~~~~~~~~n   88 (457)
                      ++++..+.+++|
T Consensus       183 ~~~L~~L~l~~~  194 (594)
T 2p1m_B          183 YTSLVSLNISCL  194 (594)
T ss_dssp             CCCCCEEECTTC
T ss_pred             CCcCcEEEeccc
Confidence            446666666655

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=96.29  E-value=0.0042  Score=59.09  Aligned_cols=64  Identities=17%  Similarity=0.251  Sum_probs=37.3

Q ss_pred             ccCCccCCeeeccCCcccccCC-cccCCCCCCC-eEeCcCCccCCCCC-ccchhcCCCceEecccccCCCC
Q 044428            3 IGGLKDLATLSLAANKFHGPIP-KSFGSLISLE-SLDLSSNNLSGEIP-KSLEALLYLKQLNVSQNRLEGE   70 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~-~l~l~~n~l~g~~p-~~~~~~~~L~~l~l~~n~l~~~   70 (457)
                      |.+|++|+.|+|.+| ++ .|+ ..|.+|++|+ .|+|++ +++ .|+ ..|.+|++|+.+++++|++...
T Consensus       246 F~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~I  312 (329)
T 3sb4_A          246 FAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITTL  312 (329)
T ss_dssp             TTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred             hhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCcc
Confidence            455666666666665 55 344 3466666666 666666 555 343 4566666666666666665544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.08  E-value=0.0066  Score=59.90  Aligned_cols=73  Identities=15%  Similarity=0.281  Sum_probs=48.6

Q ss_pred             CccCCCCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCeeEEEEe
Q 044428          179 NLLGIGSFGSVYKGTLSD--------GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRN-LIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  249 (457)
                      +.+..|-...+|+....+        +..+++|+..... ....+..+|..+++.+.-.. ..++++.+.    .++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            467778899999998763        5789999875432 22223467888888874323 344555432    378999


Q ss_pred             ccCCCCH
Q 044428          250 FMPNGSL  256 (457)
Q Consensus       250 ~~~~g~L  256 (457)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=95.84  E-value=0.0067  Score=49.28  Aligned_cols=36  Identities=25%  Similarity=0.414  Sum_probs=32.2

Q ss_pred             cCCeeeccCCcccccCCc-ccCCCCCCCeEeCcCCccC
Q 044428            8 DLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLS   44 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~   44 (457)
                      +|+.|+|++|+|+ .||. .|..+++|+.|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            7999999999999 6764 5788999999999999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=95.50  E-value=0.0024  Score=61.82  Aligned_cols=84  Identities=14%  Similarity=0.145  Sum_probs=57.4

Q ss_pred             CccCCeeeccCCcccccCCcccC--CCCCCCeEeCcC--CccCCC-----CCccc--hhcCCCceEecccccCCCCCC--
Q 044428            6 LKDLATLSLAANKFHGPIPKSFG--SLISLESLDLSS--NNLSGE-----IPKSL--EALLYLKQLNVSQNRLEGEIP--   72 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~--~l~~l~~l~l~~--n~l~g~-----~p~~~--~~~~~L~~l~l~~n~l~~~~p--   72 (457)
                      +++|+.|+|..|.++...-..++  ++++|+.|+|+.  |...|.     +-..+  ..+++|+.|+|++|.+.+..+  
T Consensus       192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~  271 (362)
T 2ra8_A          192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM  271 (362)
T ss_dssp             CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred             CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence            78999999999888754434444  799999999863  332222     11122  347899999999999875332  


Q ss_pred             --CCCCccccccccccccc
Q 044428           73 --VEGPFRNFSTESFSWNY   89 (457)
Q Consensus        73 --~~~~~~~~~~~~~~~n~   89 (457)
                        ..+.++++..+.++.|.
T Consensus       272 la~a~~~~~L~~LdLs~n~  290 (362)
T 2ra8_A          272 FLESDILPQLETMDISAGV  290 (362)
T ss_dssp             HHHCSSGGGCSEEECCSSC
T ss_pred             HHhCccCCCCCEEECCCCC
Confidence              11346778888887764

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=94.53  E-value=0.043  Score=53.72  Aligned_cols=62  Identities=15%  Similarity=0.180  Sum_probs=39.4

Q ss_pred             CccCCccCCeeeccCCccc----ccCC-cccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccc
Q 044428            2 TIGGLKDLATLSLAANKFH----GPIP-KSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQN   65 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~----g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n   65 (457)
                      +|.+|++|+.++|.+|.+.    ..|+ ..|..|++|+.++|+ |+++ .|+. .|.+|.+|+.+.|.+|
T Consensus       266 aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~  333 (401)
T 4fdw_A          266 AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN  333 (401)
T ss_dssp             TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT
T ss_pred             HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc
Confidence            3556777777777776664    1133 456777777777777 4466 5544 5666777777777554

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=94.02  E-value=0.007  Score=51.80  Aligned_cols=81  Identities=12%  Similarity=0.087  Sum_probs=54.2

Q ss_pred             cCCeeeccCCcccccCCcccCCCCCCCeEeCcCCc-cCCCCCccchhc----CCCceEeccccc-CCCC-CCCCCCcccc
Q 044428            8 DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNN-LSGEIPKSLEAL----LYLKQLNVSQNR-LEGE-IPVEGPFRNF   80 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~-l~g~~p~~~~~~----~~L~~l~l~~n~-l~~~-~p~~~~~~~~   80 (457)
                      +|+.||||++.++-.=-..+..|++|++|+|+++. ++..=-..++.+    ++|+.|+|+++. ++.. +.....++++
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            58999999999874333457889999999999985 774332334443    479999999984 6521 1111235566


Q ss_pred             cccccccc
Q 044428           81 STESFSWN   88 (457)
Q Consensus        81 ~~~~~~~n   88 (457)
                      ..+.+++-
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            66666553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=93.71  E-value=0.014  Score=50.00  Aligned_cols=47  Identities=13%  Similarity=0.263  Sum_probs=33.4

Q ss_pred             cCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEeccccc-CC
Q 044428           22 PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNR-LE   68 (457)
Q Consensus        22 ~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~-l~   68 (457)
                      .+|...-.-.+|+.||||++.++..=-..+..+++|+.|+|+++. ++
T Consensus        52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It   99 (176)
T 3e4g_A           52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE   99 (176)
T ss_dssp             GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred             cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence            345544333578999999988875434456788899999999885 54

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=93.53  E-value=0.023  Score=49.58  Aligned_cols=65  Identities=18%  Similarity=0.222  Sum_probs=48.8

Q ss_pred             CCccCCeeeccCC-cccc----cCCcccCCCCCCCeEeCcCCccCC----CCCccchhcCCCceEecccccCCC
Q 044428            5 GLKDLATLSLAAN-KFHG----PIPKSFGSLISLESLDLSSNNLSG----EIPKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         5 ~l~~L~~l~l~~N-~l~g----~~p~~~~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      +-+.|+.|+|++| +|.-    .|-..+..-+.|+.|+|++|+|..    .|-..+..-+.|+.|+|++|+|..
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            4468999999986 7742    133456667899999999999983    233345556899999999999974

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=93.26  E-value=0.081  Score=51.70  Aligned_cols=59  Identities=12%  Similarity=0.190  Sum_probs=39.5

Q ss_pred             ccCCccCCeeeccCCcccccCC-cccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIP-KSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN   65 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n   65 (457)
                      +.++ +|+.+.|.+ .++ .|+ ..|.+|++|+.++|++|+++ .||.....+.+|+.+.|.+|
T Consensus       154 F~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~  213 (401)
T 4fdw_A          154 FFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT  213 (401)
T ss_dssp             TTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT
T ss_pred             cCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc
Confidence            3443 577777765 565 344 56777778888888777777 67765555677777777644

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.06  E-value=0.054  Score=52.95  Aligned_cols=30  Identities=33%  Similarity=0.389  Sum_probs=25.2

Q ss_pred             CeeeccCCCCCeee------cCCCcEEEeccccccc
Q 044428          294 PIIHCDLKPSNILL------DENMVAHVSDFGISKL  323 (457)
Q Consensus       294 ~ivH~dlk~~NIll------~~~~~~kl~Dfg~~~~  323 (457)
                      .++|+|+.+.||++      +++..+.+.||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998764

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=91.35  E-value=0.24  Score=31.20  Aligned_cols=27  Identities=15%  Similarity=0.325  Sum_probs=11.8

Q ss_pred             hhhhHHHHHHHHHHHHHHhhhhhcCCC
Q 044428          120 YILPPIISIMLLLIAIIVYVRCQNRST  146 (457)
Q Consensus       120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (457)
                      .++++++++++++++.++|+|++++++
T Consensus        15 gVVgGv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           15 GVIGGLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             eehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            334444444444444444444444433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.84  E-value=0.22  Score=31.48  Aligned_cols=20  Identities=10%  Similarity=0.426  Sum_probs=7.6

Q ss_pred             hHHHHHHHHHHHHHHhhhhh
Q 044428          123 PPIISIMLLLIAIIVYVRCQ  142 (457)
Q Consensus       123 ~~~~~~~~~~~~~~~~~~~~  142 (457)
                      +++++++++++++++|++++
T Consensus        19 gGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           19 GALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHhhhh
Confidence            33333333333333344433

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=89.90  E-value=0.3  Score=47.37  Aligned_cols=59  Identities=27%  Similarity=0.319  Sum_probs=44.5

Q ss_pred             ccCCccCCeeeccCCcccccCC-cccCCCCCCCeEeCcCCccCCCCC-ccchhcCCCceEecccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIP-KSFGSLISLESLDLSSNNLSGEIP-KSLEALLYLKQLNVSQN   65 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p-~~~~~~~~L~~l~l~~n   65 (457)
                      +.++.+|+.+.+.+| ++ .|+ ..|.++++|+.++|.++ ++ .|+ ..|.+|.+|+.+++..|
T Consensus       293 F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          293 FYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             TTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred             ccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence            557888888888765 65 455 56888899999998754 66 665 46788889999888766

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=89.88  E-value=0.53  Score=29.60  Aligned_cols=21  Identities=10%  Similarity=0.335  Sum_probs=9.2

Q ss_pred             HHHHHHHHHHHHHhhhhhcCC
Q 044428          125 IISIMLLLIAIIVYVRCQNRS  145 (457)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~~~  145 (457)
                      ++.++++.+.+++|+++++.+
T Consensus        21 vll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           21 ILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHHHHHhheehhhhh
Confidence            333333444444455544443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=89.59  E-value=0.29  Score=47.00  Aligned_cols=60  Identities=12%  Similarity=0.208  Sum_probs=43.8

Q ss_pred             ccCCccCCeeeccCCcccccCC-cccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIP-KSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQN   65 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n   65 (457)
                      +.++.+|+.+.+..+ ++ .++ ..|..+++|+.+.+.+|.++ .|+. .|.++.+|+.+.|..+
T Consensus       259 F~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~  320 (379)
T 4h09_A          259 LQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA  320 (379)
T ss_dssp             TTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT
T ss_pred             cceeehhcccccccc-ce-eccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcCcc
Confidence            456777888877654 55 455 45778888888888888887 6654 6778888888888654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=89.34  E-value=0.065  Score=46.65  Aligned_cols=61  Identities=20%  Similarity=0.227  Sum_probs=44.4

Q ss_pred             CCccCCeeeccCCccccc----CCcccCCCCCCCeEeCcCCccCCC----CCccchhcCCCceEecccc
Q 044428            5 GLKDLATLSLAANKFHGP----IPKSFGSLISLESLDLSSNNLSGE----IPKSLEALLYLKQLNVSQN   65 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~L~~l~l~~n   65 (457)
                      .-+.|+.|+|++|+|.-.    |-..+..-+.|++|+|++|+|+..    |-..+..-..|+.|+|++|
T Consensus        68 ~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           68 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            346899999999999721    233444568899999999999842    2223444567999999876

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=89.02  E-value=0.51  Score=45.63  Aligned_cols=82  Identities=16%  Similarity=0.319  Sum_probs=53.5

Q ss_pred             CccCCccCCeeeccCCcccccCC-cccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCCC--CCCc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIP-KSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIPV--EGPF   77 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p~--~~~~   77 (457)
                      .+.++++|+.+.+. +.++ .|+ ..|.+|++|+.++|..| ++ .|.. .|.+|.+|+.+.+..+ ++. +..  ....
T Consensus       283 aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~~-I~~~aF~~C  356 (394)
T 4gt6_A          283 AFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VTK-IPESAFSNC  356 (394)
T ss_dssp             TTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CCB-CCGGGGTTC
T ss_pred             ccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cCE-EhHhHhhCC
Confidence            35678888888886 4566 565 46888899999998765 66 5544 6788888998888654 332 221  1223


Q ss_pred             cccccccccccc
Q 044428           78 RNFSTESFSWNY   89 (457)
Q Consensus        78 ~~~~~~~~~~n~   89 (457)
                      .++..+.+.++.
T Consensus       357 ~~L~~i~~~~~~  368 (394)
T 4gt6_A          357 TALNNIEYSGSR  368 (394)
T ss_dssp             TTCCEEEESSCH
T ss_pred             CCCCEEEECCce
Confidence            445555665553

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.61  E-value=1.3  Score=38.76  Aligned_cols=117  Identities=13%  Similarity=0.100  Sum_probs=78.6

Q ss_pred             CCCccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCee
Q 044428          227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNIL  306 (457)
Q Consensus       227 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIl  306 (457)
                      .||+.++. ..-...+...+.|+.-+.+.=+..+.    ..+...+++++..|+....+++    .  -+|--+.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~----~--r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNR----T--RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGG----S--SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhc----C--ceEEEEecceEE
Confidence            57777765 44555666666666543222222232    2678899999999998876665    2  378899999999


Q ss_pred             ecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCCCCCccchhhhhHHHHHHhcCCCCCCC
Q 044428          307 LDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTND  374 (457)
Q Consensus       307 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~Dv~s~Gvvl~el~tg~~p~~~  374 (457)
                      ++.++.+++.-.|+...+.+..                    .++..=.-.+=+++..+++++..|+.
T Consensus       112 f~~~~~p~i~~RGik~~l~P~~--------------------~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVDPLP--------------------VSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             ECTTSCEEESCCEETTTBSCCC--------------------CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EcCCCCEEEEEccCccCCCCCC--------------------CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999888755442211                    11222234567788999999888754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.46  E-value=2.4  Score=37.19  Aligned_cols=115  Identities=10%  Similarity=0.035  Sum_probs=77.1

Q ss_pred             CCCccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCCeeeccCCCCCe
Q 044428          227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE-YLHYGHALAPIIHCDLKPSNI  305 (457)
Q Consensus       227 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~~ivH~dlk~~NI  305 (457)
                      .||+.  -...-.+.+...+.|+.-+++.=+..+..    .+...+++++.+++.... +++      .-+|--+.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~~------~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHSA------RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCCS------SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhhh------CceeEEEeCceE
Confidence            57776  33334666777777776545433444432    678899999999887766 454      247888999999


Q ss_pred             eecCCCcEEEeccccccccCCCCCcceeccccccccccCCCCCCCCccchhhhhHHHHHHhcCCCCCC
Q 044428          306 LLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIVSTKCDVYSYGILLLETFSRKKPTN  373 (457)
Q Consensus       306 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~Dv~s~Gvvl~el~tg~~p~~  373 (457)
                      +++.++.+++.-.|+-..+                   +|.. .++.-=.-.+=+++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~~l-------------------pP~e-~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESL-------------------PPDE-WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTTB-------------------SSCS-CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCcccC-------------------CCCC-CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999988875543                   2321 1111123356678888888877664

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.99  E-value=0.12  Score=51.45  Aligned_cols=59  Identities=12%  Similarity=0.045  Sum_probs=16.6

Q ss_pred             CCccCCCCceEEEEEEeCC-CCEEEE------EEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeee
Q 044428          178 CNLLGIGSFGSVYKGTLSD-GTNVAI------KIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCS  239 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~~-g~~vav------K~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  239 (457)
                      .+.+|   ||.||+|.+.. ..+|||      |..+...  ......|.+|..++...+|||+++..++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            34566   99999999864 467888      6655322  223456888999999999999999887653

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=82.66  E-value=2.1  Score=41.22  Aligned_cols=61  Identities=15%  Similarity=0.324  Sum_probs=46.7

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQN   65 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n   65 (457)
                      ++.++..|+.+.+.++..+ .-...|.++++|+.+.++ +.++ .|+. .|.++.+|+.+++..|
T Consensus       260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~  321 (394)
T 4gt6_A          260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG  321 (394)
T ss_dssp             TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT
T ss_pred             eeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc
Confidence            4667889999988776554 333568889999999996 5566 6665 6778999999999764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=82.31  E-value=1.4  Score=42.15  Aligned_cols=63  Identities=16%  Similarity=0.279  Sum_probs=45.7

Q ss_pred             ccCCccCCeeeccCCcccccCC-cccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCC
Q 044428            3 IGGLKDLATLSLAANKFHGPIP-KSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~   69 (457)
                      +.++..|+.+.+..+ ++ .|+ ..|.++.+|+.+.+..+ ++ .++. .+..+.+|+.+.+.+|.++.
T Consensus       236 f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~  300 (379)
T 4h09_A          236 FYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIET  300 (379)
T ss_dssp             TTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCE
T ss_pred             ccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccccccccccce
Confidence            456788888888765 55 444 56778888999888654 55 4554 57788899999988877653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=80.47  E-value=1.6  Score=42.05  Aligned_cols=58  Identities=16%  Similarity=0.128  Sum_probs=38.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQN   65 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n   65 (457)
                      +.++..|+.+.+..+.+.   ...|..+.+|+.+.+.+| ++ .|+. .|.++.+|+.+++.++
T Consensus       272 F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~  330 (394)
T 4fs7_A          272 FYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL  330 (394)
T ss_dssp             TTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred             cccccccceeccCceeec---cccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc
Confidence            455667777766665432   245777888888888755 55 5544 5777888888888644

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	457
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-51
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-48
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-43
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-41
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-34
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-30
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-60
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN 230
            +      +G GSFG+VYKG       VA+K+ N+     +   +F +E  VLR  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++  + G S     A+V ++    SL   L+      ++++ ++I       ++YLH   
Sbjct: 66  ILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---- 346
               IIH DLK +NI L E++   + DFG++ +      S    +   +I +MAPE    
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 347 ---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLPHKLAEVVDSNLV 401
                 S + DVY++GI+L E  + + P +++      +       L   L++V      
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS---- 236

Query: 402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
                     +C   +  L  +C  +  DER       A +  + 
Sbjct: 237 ----------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 3e-51
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 32/283 (11%)

Query: 181 LGIGSFGSVYKGTL---SDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHRNLIKILS 236
           LG G+FGSV +G         +VAIK+     E+        E +++  + +  +++++ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 237 GCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPII 296
            C       LV+E    G L K+L      + +     ++  V + ++YL         +
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFV 131

Query: 297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE----GIVST 351
           H DL   N+LL     A +SDFG+SK LG  D            + + APE       S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 352 KCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAK 410
           + DV+SYG+ + E  S  +KP   +    +  ++ Q    +                   
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------- 235

Query: 411 MDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDV 453
            +C   +  L  DC +   ++R        ++R         V
Sbjct: 236 -ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (438), Expect = 4e-51
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 41/303 (13%)

Query: 164 SYLDIQRATNEFDEC---------NLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL- 209
           ++ D   A  EF +           ++G G FG V  G L         VAIK       
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 210 ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDI 269
           E+    F SE  ++    H N+I +    +      ++ EFM NGSL+ +L  ++    +
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127

Query: 270 LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 329
           ++ + ++  +   ++YL   +     +H DL   NIL++ N+V  VSDFG+S+ L +   
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 330 SLIQTKT---MATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKH 382
               T        I + APE       ++  DV+SYGI++ E  S  +      +M+ + 
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW--DMTNQD 241

Query: 383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKL 442
            +N               + +++     MDC   +  L LDC  +  + R         L
Sbjct: 242 VINA--------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 443 RKI 445
            K+
Sbjct: 288 DKM 290

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 6e-50
 Identities = 61/272 (22%), Positives = 109/272 (40%), Gaps = 16/272 (5%)

Query: 168 IQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVS-FNSECEVLRN 225
           ++   ++F++ + LG G+ G V+K +    G  +A K+ +L+++    +    E +VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
                ++       +    ++ +E M  GSL++ L      +       + I V   L Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
           L   H    I+H D+KPSNIL++      + DFG+S  L +     +    + T  YM+P
Sbjct: 120 LREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172

Query: 346 E----GIVSTKCDVYSYGILLLETFSRKKP--TNDLGEMSLKHWVNQSLPHKLAEVVDSN 399
           E       S + D++S G+ L+E    + P    D  E+ L                   
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDE 431
             R   S+       + I  L      E P +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 1e-49
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 28/278 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
           +E      +G G FG V+ G   +   VAIK            F  E EV+  + H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           ++   C       LV EFM +G L  +L +          L + +DV   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GI 348
             +IH DL   N L+ EN V  VSDFG+++ + + D     T T   + + +PE      
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 349 VSTKCDVYSYGILLLETFSRKK-PTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
            S+K DV+S+G+L+ E FS  K P  +     +   ++         +  +++       
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY------ 232

Query: 408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
                       +   C  E P++R   +    +L +I
Sbjct: 233 -----------QIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-49
 Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 28/292 (9%)

Query: 181 LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN 240
           +G G FG V++G    G  VA+KIF+ + ER++    +E      +RH N++  ++  + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 241 LDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH----YGHAL 292
            +       LV ++  +GSL  +L  + Y + +   + + +     L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT--MATIGYMAPE---- 346
             I H DLK  NIL+ +N    ++D G++       D++       + T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 347 ------GIVSTKCDVYSYGILLLETFSRKKPTNDLGE----MSLKHWVNQSLPHKLAEVV 396
                      + D+Y+ G++  E   R        +           + S+      V 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ 448
           +  L     +     + L  +  +  +C   +   R+        L ++  Q
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 3e-48
 Identities = 60/277 (21%), Positives = 103/277 (37%), Gaps = 33/277 (11%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV 226
           RA + ++    +G GS+G   K    SDG  +  K  +     E       SE  +LR +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 227 RHRNLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGL 281
           +H N+++      +     L  V+E+   G L   +        +LD    L +M  + L
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 282 ALEYLHY-GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
           AL+  H        ++H DLKP+N+ LD      + DFG++++L    D+      + T 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTP 178

Query: 341 GYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
            YM+PE       + K D++S G LL E  +   P     +  L   + +    ++    
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
              L                   +           R 
Sbjct: 239 SDELN-----------------EIITRMLNLKDYHRP 258

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-48
 Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 26/277 (9%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
            +      LG G FG V  G      +VAIK+       +   F  E +V+ N+ H  L+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
           ++   C+      ++ E+M NG L  +L    +     + L +  DV  A+EYL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---- 118

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GI 348
              +H DL   N L+++  V  VSDFG+S+ + + D+      +   + +  PE      
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 349 VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFS 408
            S+K D++++G+L+ E +S  K            +   +       +     + R H  S
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMP----------YERFTNSETAEHIAQGLRLYRPHLAS 227

Query: 409 AKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
            K+        +   C  E  DER       + +  +
Sbjct: 228 EKV------YTIMYSCWHEKADERPTFKILLSNILDV 258

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-48
 Identities = 60/278 (21%), Positives = 119/278 (42%), Gaps = 28/278 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
                   LG G FG V+ G  +  T VA+K        +  +F +E  +++ ++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGHA 291
           ++       +   ++ E+M NGSL  +L + +   L I + L++   +   + ++   + 
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----G 347
               IH DL+ +NIL+ + +   ++DFG+++L+ E ++   +      I + APE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 348 IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             + K DV+S+GILL E  +  +       M+    +                + R +  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPEVIQN--------------LERGYRM 229

Query: 408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
               +C   +  L   C  E P++R       + L   
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 8e-48
 Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 34/280 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
            E      +G G FG V  G    G  VA+K   ++ + T  +F +E  V+  +RH NL+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 233 KILSGCSNLDFK-ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGLALEYLHYGH 290
           ++L           +V E+M  GSL  +L S     L     L   +DV  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-- 121

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---- 346
                +H DL   N+L+ E+ VA VSDFG++K          Q      + + APE    
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE 174

Query: 347 GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS 406
              STK DV+S+GILL E +S  +       + LK  V +              V + + 
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPR--------------VEKGYK 218

Query: 407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             A   C   +  +  +C       R        +L  IK
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-47
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 28/278 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLI 232
                   LG G FG V+ GT +  T VAIK        +  +F  E +V++ +RH  L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDIL-ERLNIMIDVGLALEYLHYGHA 291
           ++ +  S  +   +V E+M  GSL  +L         L + +++   +   + Y+   + 
Sbjct: 76  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----G 347
               +H DL+ +NIL+ EN+V  V+DFG+++L+ E ++   +      I + APE    G
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 348 IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF 407
             + K DV+S+GILL E  ++ +       M  +  ++Q              V R +  
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQ--------------VERGYRM 233

Query: 408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
               +C   + +L   C  + P+ER       A L   
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 3e-47
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 31/284 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTN-----VAIKIFNLQL-ERTFVSFNSECEVLRNV 226
           +      ++G G FG VYKG L   +      VAIK       E+  V F  E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 227 RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
            H N+I++    S      ++ E+M NG+L+K+L   +    +L+ + ++  +   ++YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAP 345
                    +H DL   NIL++ N+V  VSDFG+S++L +  ++   T      I + AP
Sbjct: 127 AN----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 346 E----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV 401
           E       ++  DV+S+GI++ E  +  +               +   H++ + ++    
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER-----------PYWELSNHEVMKAINDGF- 230

Query: 402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
                    MDC   I  L + C  +    R    +  + L K+
Sbjct: 231 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 19/243 (7%)

Query: 165 YLDIQRATN---EFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSEC 220
           Y  + R  N    ++    LG G+FG VYK          A K+ + + E     +  E 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 221 EVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 280
           ++L +  H N++K+L      +   +++EF   G+++  +      L   +   +     
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 281 LALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATI 340
            AL YLH       IIH DLK  NIL   +    ++DFG+S               + T 
Sbjct: 121 DALNYLHDNK----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTP 174

Query: 341 GYMAPE---------GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
            +MAPE              K DV+S GI L+E    + P ++L  M +   + +S P  
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 392 LAE 394
           LA+
Sbjct: 235 LAQ 237

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 2e-46
 Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 58/319 (18%)

Query: 162 RISYLDIQRATNEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFVS 215
           ++  L+  R  N  +    +G G+FG V++            T VA+K+   +      +
Sbjct: 4   KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 216 -FNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-------- 266
            F  E  ++    + N++K+L  C+      L+ E+M  G L ++L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 267 ---------------LDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM 311
                          L   E+L I   V   + YL         +H DL   N L+ ENM
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENM 177

Query: 312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS 367
           V  ++DFG+S+ +   D           I +M PE I     +T+ DV++YG++L E FS
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 368 RKK-PTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCM 426
               P   +    + ++V         E                 +C L + NL   C  
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNILACPE-----------------NCPLELYNLMRLCWS 280

Query: 427 ESPDERIHTTNAAAKLRKI 445
           + P +R    +    L+++
Sbjct: 281 KLPADRPSFCSIHRILQRM 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 65/305 (21%), Positives = 128/305 (41%), Gaps = 34/305 (11%)

Query: 161 RRISYLDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTN----VAIKIFNLQLERTFVS- 215
           + + ++ I  ++       ++G G FG VY GTL D        A+K  N   +   VS 
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74

Query: 216 FNSECEVLRNVRHRNLIKILSGCSNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLN 274
           F +E  ++++  H N++ +L  C   +    +VL +M +G L  ++ +  +   + + + 
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134

Query: 275 IMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQT 334
             + V   +++L         +H DL   N +LDE     V+DFG+++ + + +   +  
Sbjct: 135 FGLQVAKGMKFLAS----KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 335 KT--MATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKK-PTNDLGEMSLKHWVNQS 387
           KT     + +MA E       +TK DV+S+G+LL E  +R   P  D+    +  ++ Q 
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250

Query: 388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV 447
                 E                  C   +  + L C     + R   +   +++  I  
Sbjct: 251 RRLLQPE-----------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

Query: 448 QFLDD 452
            F+ +
Sbjct: 294 TFIGE 298

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (404), Expect = 6e-46
 Identities = 67/270 (24%), Positives = 101/270 (37%), Gaps = 38/270 (14%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL---QLERTFVSFNSECEVLRNVRHRN 230
           F +   +G GSFG+VY    + +   VAIK  +    Q    +     E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
            I+            LV+E+    + +     H   L  +E   +       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS-- 133

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI-- 348
               +IH D+K  NILL E  +  + DFG + ++            + T  +MAPE I  
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILA 185

Query: 349 -----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR 403
                   K DV+S GI  +E   RK P  ++  MS  + + Q+    L     S   R 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR- 244

Query: 404 EHSFSAKMDCLLRIMNLALDCCMESPDERI 433
                          N    C  + P +R 
Sbjct: 245 ---------------NFVDSCLQKIPQDRP 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 34/280 (12%)

Query: 177 ECNLLGIGSFGSVYKGTLSD---GTNVAIKIFNLQLERTFV--SFNSECEVLRNVRHRNL 231
           E   LG G+FG+V KG          VA+KI   +     +     +E  V++ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           ++++ G    +   LV+E    G L K+L  + + +     + ++  V + ++YL   + 
Sbjct: 71  VRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMAPE---- 346
               +H DL   N+LL     A +SDFG+SK L   ++           + + APE    
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 347 GIVSTKCDVYSYGILLLETFSRKK-PTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              S+K DV+S+G+L+ E FS  + P   +    +   + +                   
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA----------- 233

Query: 406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
                  C   + +L   C     + R        +LR  
Sbjct: 234 ------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (395), Expect = 5e-45
 Identities = 66/291 (22%), Positives = 113/291 (38%), Gaps = 30/291 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
            +    + LG G +G VY+G        VA+K            F  E  V++ ++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGLALEYLHYGH 290
           +++L  C+      ++ EFM  G+L  +L   N   +  +  L +   +  A+EYL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 133

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP----E 346
                IH DL   N L+ EN +  V+DFG+S+L+  GD           I + AP     
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 347 GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS 406
              S K DV+++G+LL E  +                       ++ E+++ +       
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS-----------PYPGIDLSQVYELLEKDY-----R 234

Query: 407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI--KVQFLDDVAK 455
                 C  ++  L   C   +P +R            +  +    D+V K
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-43
 Identities = 57/270 (21%), Positives = 101/270 (37%), Gaps = 31/270 (11%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHRN 230
            ++D    LG G++G V           VA+KI +++       +   E  + + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++K        + + L LE+   G L   +          +       +   + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG 123

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---- 346
               I H D+KP N+LLDE     +SDFG++ +    +   +  K   T+ Y+APE    
Sbjct: 124 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 347 -GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLPHKLAEVVDSNLVRR 403
               +   DV+S GI+L    + + P +   +       W  +       + +DS  +  
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-- 237

Query: 404 EHSFSAKMDCLLRIMNLALDCCMESPDERI 433
                           L     +E+P  RI
Sbjct: 238 ---------------ALLHKILVENPSARI 252

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-43
 Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 39/273 (14%)

Query: 174 EFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN 230
           +FD    +G GSF +VYKG  ++    VA      +   +     F  E E+L+ ++H N
Sbjct: 12  KFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 231 LIKIL----SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           +++      S         LV E M +G+L+ +L      + I    +    +   L++L
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFL 128

Query: 287 HYGHALAPIIHCDLKPSNILL-DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
           H      PIIH DLK  NI +        + D G++ L             + T  +MAP
Sbjct: 129 HTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

Query: 346 E---GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMS--LKHWVNQSLPHKLAEVVDSNL 400
           E          DVY++G+ +LE  + + P ++    +   +   +   P    +V    +
Sbjct: 183 EMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
                              +   C  ++ DER 
Sbjct: 243 K-----------------EIIEGCIRQNKDERY 258

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-43
 Identities = 57/295 (19%), Positives = 106/295 (35%), Gaps = 53/295 (17%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTN------VAIKIFNLQLERTFV-SFNSECEVLRN 225
              +   +LG G+FG V   T    +       VA+K+   + + +   +  SE +++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 226 V-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHN-------------------- 264
           +  H N++ +L  C+      L+ E+   G L  +L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 265 --YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK 322
               L   + L     V   +E+L +       +H DL   N+L+    V  + DFG+++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF----KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 323 LLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEM 378
            +    + +++      + +MAPE    GI + K DV+SYGILL E FS           
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------- 265

Query: 379 SLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
               +    +     +++ +                  I  +   C      +R 
Sbjct: 266 ---PYPGIPVDANFYKLIQNGF-----KMDQPFYATEEIYIIMQSCWAFDSRKRP 312

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 4e-43
 Identities = 62/287 (21%), Positives = 99/287 (34%), Gaps = 34/287 (11%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRN 225
            +      LG GSFG V +G          +VA+K     +         F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           + HRNLI++         K +V E  P GSL   L  H     +       + V   + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGYMA 344
           L         IH DL   N+LL    +  + DFG+ + L + DD  +  +       + A
Sbjct: 127 LES----KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 345 P----EGIVSTKCDVYSYGILLLETFSRKK-PTNDLGEMSLKHWVNQSLPHKLAEVVDSN 399
           P        S   D + +G+ L E F+  + P   L    + H +               
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI--------------- 227

Query: 400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
             +         DC   I N+ + C    P++R         L + +
Sbjct: 228 -DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-43
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 33/290 (11%)

Query: 149 SDEEDLLPLVTWRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL 207
           SDEE L  L +   +S  D ++   ++     +G G+ G+VY    ++ G  VAI+  NL
Sbjct: 1   SDEEILEKLRS--IVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL 55

Query: 208 QLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFL 267
           Q +       +E  V+R  ++ N++  L      D   +V+E++  GSL   +       
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115

Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
              +   +  +   ALE+LH       +IH D+K  NILL  +    ++DFG    +   
Sbjct: 116 G--QIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 328 DDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
                 +  + T  +MAPE +       K D++S GI+ +E    + P  +   +   + 
Sbjct: 170 QSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227

Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
           +  +   +L         +     SA     L    L +D      ++R 
Sbjct: 228 IATNGTPEL---------QNPEKLSAIFRDFLNRC-LDMD-----VEKRG 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 9e-43
 Identities = 62/291 (21%), Positives = 118/291 (40%), Gaps = 32/291 (10%)

Query: 166 LDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-----ERTFVSFNSE 219
           L I + T EF +  +LG G+FG+VYKG  + +G  V I +   +L      +       E
Sbjct: 3   LRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 279
             V+ +V + ++ ++L  C     + L+ + MP G L  ++  H   +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 280 GLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMAT 339
              + YL        ++H DL   N+L+       ++DFG++KLLG  +           
Sbjct: 121 AKGMNYLED----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 340 IGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV 395
           I +MA E     I + + DV+SYG+ + E  +                 +     +++ +
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-----------PYDGIPASEISSI 225

Query: 396 VDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK 446
           ++      +        C + +  + + C M   D R        +  K+ 
Sbjct: 226 LEKGERLPQPP-----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-42
 Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 31/293 (10%)

Query: 169 QRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVLR 224
           ++   +F    +LG GSF +V     L+     AIKI   +    E        E +V+ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 225 NVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            + H   +K+     + +     L +  NG L K++     F D         ++  ALE
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALE 122

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           YLH       IIH DLKP NILL+E+M   ++DFG +K+L            + T  Y++
Sbjct: 123 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 345 PEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
           PE +         D+++ G ++ +  +   P     E  +                   +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ----------------KI 222

Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDDV 453
           ++ E+ F  K     R  +L     +    +R+               F + V
Sbjct: 223 IKLEYDFPEKFFPKAR--DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-41
 Identities = 58/302 (19%), Positives = 106/302 (35%), Gaps = 48/302 (15%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQLERTFV-SFNSECEVLRN 225
           N       LG G+FG V + T            VA+K+       T   +  SE +VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 226 V-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH-----------------NYFL 267
           +  H N++ +L  C+      ++ E+   G L  +L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
           D+ + L+    V   + +L   +     IH DL   NILL    +  + DFG+++ +   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 328 DDSLIQTKTMATIGYMAP----EGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
            + +++      + +MAP      + + + DV+SYGI L E FS               +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----------PY 248

Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
               +  K  +++            +       + ++   C    P +R         + 
Sbjct: 249 PGMPVDSKFYKMIKEGF-----RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 444 KI 445
           K 
Sbjct: 304 KQ 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-41
 Identities = 70/297 (23%), Positives = 117/297 (39%), Gaps = 47/297 (15%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDG---TNVAIKIFNLQLERTFV-SFNSECEVLRNV-R 227
           N+    +++G G+FG V K  +       + AIK       +     F  E EVL  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILER 272
           H N+I +L  C +  +  L +E+ P+G+L  +L                     L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 273 LNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI 332
           L+   DV   ++YL         IH DL   NIL+ EN VA ++DFG+S+     +  + 
Sbjct: 130 LHFAADVARGMDYLSQ----KQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVK 182

Query: 333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL 388
           +T     + +MA E     + +T  DV+SYG+LL E  S          M+      +  
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEK-- 238

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
                       + + +     ++C   + +L   C  E P ER         L ++
Sbjct: 239 ------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  148 bits (375), Expect = 2e-41
 Identities = 57/268 (21%), Positives = 97/268 (36%), Gaps = 28/268 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
           + +D    LG G+FG V++ T  + G N A K      E    +   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           + +     + +   ++ EFM  G L + +   +  +   E +  M  V   L ++H  + 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144

Query: 292 LAPIIHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI- 348
               +H DLKP NI+     +    + DFG++  L           T  T  + APE   
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 198

Query: 349 ---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              V    D++S G+L     S   P     +      V     +               
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS-------- 250

Query: 406 SFSAKMDCLLRIMNLALDCCMESPDERI 433
             S      +R + L  D     P+ R+
Sbjct: 251 GISEDGKDFIRKL-LLAD-----PNTRM 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 3e-41
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 17/225 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFN---LQLERTFVSFNSECEVLRNVRH 228
            +F+    LG G FG+VY          +A+K+     L+          E E+  ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
            N++++     +     L+LE+ P G++ + L   + F D       + ++  AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHS 124

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE-- 346
                 +IH D+KP N+LL       ++DFG S        + +      T+ Y+ PE  
Sbjct: 125 KR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMI 176

Query: 347 --GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP 389
              +   K D++S G+L  E    K P            +++   
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 8e-41
 Identities = 60/288 (20%), Positives = 102/288 (35%), Gaps = 35/288 (12%)

Query: 168 IQRATNEFDECNLLGIGSFGSVYKGTLSDGTN----VAIKIFNLQLERTFVS-FNSECEV 222
           IQR     +    +G G FG V++G      N    VAIK        +    F  E   
Sbjct: 4   IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 223 LRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLA 282
           +R   H +++K++   +  +   +++E    G L  +L    Y LD+   +     +  A
Sbjct: 62  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 283 LEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           L YL         +H D+   N+L+  N    + DFG+S+ + E       +K    I +
Sbjct: 121 LAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175

Query: 343 MAPE----GIVSTKCDVYSYGILLLETFSRKK-PTNDLGEMSLKHWVNQSLPHKLAEVVD 397
           MAPE       ++  DV+ +G+ + E       P   +    +   +       +     
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235

Query: 398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
             L                  +L   C    P  R   T   A+L  I
Sbjct: 236 PTLY-----------------SLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  144 bits (365), Expect = 6e-40
 Identities = 57/268 (21%), Positives = 105/268 (39%), Gaps = 28/268 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL 231
           + +D    LG G+FG V++    + G     K  N        +  +E  ++  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           I +     +     L+LEF+  G L   + + +Y +   E +N M      L+++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 147

Query: 292 LAPIIHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI- 348
              I+H D+KP NI+ +    + V   DFG++  L   +   I   T AT  + APE + 
Sbjct: 148 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVD 201

Query: 349 ---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
              V    D+++ G+L     S   P     ++     V +       +           
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS-------- 253

Query: 406 SFSAKMDCLLRIMNLALDCCMESPDERI 433
           S S +    ++ + L  +     P +R+
Sbjct: 254 SVSPEAKDFIKNL-LQKE-----PRKRL 275

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 1e-39
 Identities = 60/302 (19%), Positives = 119/302 (39%), Gaps = 40/302 (13%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNL-QLERTFVSFNSECEVLRN 225
            +      LG GSFG VY+G           T VAIK  N     R  + F +E  V++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------LDILERLNIM 276
               +++++L   S      +++E M  G L+ +L S               + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
            ++   + YL+        +H DL   N ++ E+    + DFG+++ + E D      K 
Sbjct: 140 GEIADGMAYLNA----NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 337 MATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKL 392
           +  + +M+PE    G+ +T  DV+S+G++L E  +  +            +   S    L
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----------YQGLSNEQVL 245

Query: 393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD 452
             V++  L+ +  +    +        L   C   +P  R       + +++       +
Sbjct: 246 RFVMEGGLLDKPDNCPDML------FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

Query: 453 VA 454
           V+
Sbjct: 300 VS 301

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  138 bits (349), Expect = 2e-38
 Identities = 59/288 (20%), Positives = 118/288 (40%), Gaps = 33/288 (11%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVR 227
           ++ ++   +LG G    V+    L    +VA+K+    L      ++ F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 228 HRNLIKILSGCSNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           H  ++ +               +V+E++   +L   +++    +     + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMA-TIGY 342
            + H       IIH D+KP+NI++       V DFGI++ + +  +S+ QT  +  T  Y
Sbjct: 125 NFSHQ----NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 343 MAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS 398
           ++PE      V  + DVYS G +L E  + + P      +S+ +   +  P   +     
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA---- 236

Query: 399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNA-AAKLRKI 445
               R    SA +D ++           ++P+ R  T     A L ++
Sbjct: 237 ----RHEGLSADLDAVVL------KALAKNPENRYQTAAEMRADLVRV 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (346), Expect = 3e-37
 Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 36/281 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSD-GTNVAIKIFNL------QLERTFVSFNSECEVLRN 225
           N+F    ++G G FG VY    +D G   A+K  +       Q E   ++      ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
                ++ +       D  + +L+ M  G L   L  H  F +  +      ++ L LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAP 345
           +H       +++ DLKP+NILLDE+    +SD G++    +         ++ T GYMAP
Sbjct: 123 MHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAP 174

Query: 346 EGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL 400
           E +       +  D +S G +L +      P                  H++  +  +  
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------HEIDRMTLTMA 225

Query: 401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK 441
           V    SFS ++  LL  + L  D      + R+      A+
Sbjct: 226 VELPDSFSPELRSLLEGL-LQRD-----VNRRLGCLGRGAQ 260

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-36
 Identities = 63/302 (20%), Positives = 117/302 (38%), Gaps = 49/302 (16%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL--------SDGTNVAIKIFNLQL-ERTFVSFNSECEVL 223
           +       LG G+FG V             +  T VA+K+      E+      SE E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 224 RNV-RHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYF---------------L 267
           + + +H+N+I +L  C+      +++E+   G+L ++L +                   L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 268 DILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG 327
              + ++    V   +EYL         IH DL   N+L+ E+ V  ++DFG+++ +   
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS----KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 328 DDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW 383
           D     T     + +MAPE     I + + DV+S+G+LL E F+          + ++  
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--GVPVEEL 246

Query: 384 VNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR 443
                           L++  H      +C   +  +  DC    P +R         L 
Sbjct: 247 F--------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 444 KI 445
           +I
Sbjct: 293 RI 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 5e-36
 Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 15/212 (7%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
            LG G FG V++    S       K   ++     V    E  +L   RHRN++ +    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
            +++   ++ EF+    + + + +  + L+  E ++ +  V  AL++LH       I H 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS----HNIGHF 126

Query: 299 DLKPSNILLDENMVAHV--SDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTK 352
           D++P NI+      + +   +FG ++ L  GD+            Y APE     +VST 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTA 183

Query: 353 CDVYSYGILLLETFSRKKPTNDLGEMSLKHWV 384
            D++S G L+    S   P        +   +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  132 bits (334), Expect = 7e-36
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 18/216 (8%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
            +F     LG GSFG V+      +G   A+K+   ++    +     N E  +L  V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             +I++     +     ++++++  G L       +             +V LALEYLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 II+ DLKP NILLD+N    ++DFG +K + +   +L       T  Y+APE +
Sbjct: 123 ----KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVV 173

Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSL 380
                +   D +S+GIL+ E  +   P  D   M  
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 16/227 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFN---LQLERTFVSFNSECEVL-RNVR 227
            +F    +LG GSFG V+           AIK      + ++        E  VL     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLH 287
           H  L  +       +    V+E++  G L   + S + F D+        ++ L L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEG 347
                  I++ DLK  NILLD++    ++DFG+ K    GD          T  Y+APE 
Sbjct: 121 SKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEI 174

Query: 348 I----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH 390
           +     +   D +S+G+LL E    + P +   E  L H +    P 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 43/280 (15%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNL---------QLERTFVSFNSECEVLR 224
           ++   +LG G    V +          A+KI ++         +++    +   E ++LR
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 225 NVR-HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
            V  H N+I++        F  LV + M  G L  +L      L   E   IM  +   +
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 123

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
             LH  +    I+H DLKP NILLD++M   ++DFG S  L  G+      +   T  Y+
Sbjct: 124 CALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYL 176

Query: 344 APE----------GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLA 393
           APE               + D++S G+++    +   P     +M +   +        +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236

Query: 394 EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
              D         +S  +  L+    L +      P +R 
Sbjct: 237 PEWD--------DYSDTVKDLVSRF-LVVQ-----PQKRY 262

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 6e-35
 Identities = 60/301 (19%), Positives = 106/301 (35%), Gaps = 47/301 (15%)

Query: 173 NEFDECNLLGIGSFGSVYKGT------LSDGTNVAIKIFNL-QLERTFVSFNSECEVLRN 225
           +       LG G+FG V +         +    VA+K+           +  SE ++L +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 226 VRHRNLIKILSGCSNLDFKAL--VLEFMPNGSLEKWLYSHNY---------------FLD 268
           + H   +  L G        L  ++EF   G+L  +L S                  FL 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 269 ILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 328
           +   +     V   +E+L         IH DL   NILL E  V  + DFG+++ + +  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS----RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 329 DSLIQTKTMATIGYMAP----EGIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV 384
           D + +      + +MAP    + + + + DV+S+G+LL E FS          + +    
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--GVKIDEEF 246

Query: 385 NQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRK 444
            +              ++      A       +    LDC    P +R   +     L  
Sbjct: 247 CR-------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

Query: 445 I 445
           +
Sbjct: 294 L 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 7e-35
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 36/283 (12%)

Query: 160 WRRISYLDIQRATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQ-LERTFVSFN 217
           W++    DI+   + +D  ++LG G+F  V           VAIK    + LE    S  
Sbjct: 1   WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55

Query: 218 SECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 277
           +E  VL  ++H N++ +     +     L+++ +  G L   +     F    +   ++ 
Sbjct: 56  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114

Query: 278 DVGLALEYLHYGHALAPIIHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSLIQT 334
            V  A++YLH       I+H DLKP N+L    DE+    +SDFG+SK+   G    + +
Sbjct: 115 QVLDAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLS 167

Query: 335 KTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH 390
               T GY+APE +     S   D +S G++         P  D  +  L   + ++   
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227

Query: 391 KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
             +   D          S      +R + +  D     P++R 
Sbjct: 228 FDSPYWD--------DISDSAKDFIRHL-MEKD-----PEKRF 256

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 5e-34
 Identities = 53/285 (18%), Positives = 108/285 (37%), Gaps = 27/285 (9%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFV-SFNSECEVLRNVRHR 229
              +   + +G G++G V       +   VAIK  +    +T+      E ++L   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGLALEYLH 287
           N+I I         + +   ++    +   LY       L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 288 YGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-MATIGYMAPE 346
             +    ++H DLKPSN+LL+      + DFG++++     D        +AT  Y APE
Sbjct: 127 SAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 347 GIV-----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV 401
            ++     +   D++S G +L E  S +        +   + +   L     E ++  + 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 402 RREHSFSAKMDCLLRI-------------MNLALDCCMESPDERI 433
            +  ++   +    ++             ++L       +P +RI
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-33
 Identities = 63/291 (21%), Positives = 115/291 (39%), Gaps = 32/291 (10%)

Query: 168 IQRATNEFDECNLLGIGSFGSVYKGT--LSDGTNVAIKIFNLQL--ERTFVSFNSECEVL 223
           + RA  +++    +G G++G V+K     + G  VA+K   +Q   E   +S   E  VL
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 224 R---NVRHRNLIKILSGCSNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNI 275
           R      H N++++   C+           LV E +               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 276 MIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTK 335
           M  +   L++LH       ++H DLKP NIL+  +    ++DFG++++          T 
Sbjct: 122 MFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTS 174

Query: 336 TMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
            + T+ Y APE +     +T  D++S G +  E F RK       ++     +   +   
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 392 LAEVVDSNLVRREHSFSAKMDCLLR-----IMNLALD----CCMESPDERI 433
             E    ++     +F +K    +      I  L  D    C   +P +RI
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 34/279 (12%)

Query: 179 NLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL-----ERTFVSFNSECEVLRNVRHRNLI 232
           + LG G F +VYK    +    VAIK   L       +    +   E ++L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 233 KILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHAL 292
            +L    +    +LV +FM        +  ++  L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 293 APIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGIV--- 349
             I+H DLKP+N+LLDEN V  ++DFG++K  G  + +   T  + T  Y APE +    
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 176

Query: 350 --STKCDVYSYGILLLETFSRKKP-------------TNDLGEMSLKHWVNQSLPHKLAE 394
                 D+++ G +L E   R                   LG  + + W +         
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 395 VVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
                 +   H FSA  D LL   +L     + +P  RI
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLL---DLIQGLFLFNPCARI 272

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (311), Expect = 5e-33
 Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 29/281 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRN 230
            ++     +G G++G VYK   + G   A+K   L+   E    +   E  +L+ ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 231 LIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH 290
           ++K+           LV E + +  L+K L      L+ +   + ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 291 ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE---- 346
               ++H DLKP N+L++      ++DFG+++  G           + T+ Y AP+    
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMG 174

Query: 347 -GIVSTKCDVYSYGILLLETFSRKKP-------------TNDLGEMSLKHWVNQSLPHKL 392
               ST  D++S G +  E  +                    LG  + K+W N +   K 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 393 AEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
                        SF   +D      +L        P++RI
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGI--DLLSKMLKLDPNQRI 273

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (306), Expect = 3e-32
 Identities = 49/289 (16%), Positives = 100/289 (34%), Gaps = 29/289 (10%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH 228
           R  N +     +G GSFG +Y GT ++ G  VAIK+  ++ +      + E ++ + ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQG 61

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
              I  +  C       +++  +   SLE      +    +   L +   +   +EY+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 289 GHALAPIIHCDLKPSNIL---LDENMVAHVSDFGISKLLGEGDDSLIQ-----TKTMATI 340
            +     IH D+KP N L     +  + ++ DFG++K   +                 T 
Sbjct: 122 KN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 341 GYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV 396
            Y +         S + D+ S G +L+       P   L   + +    +    K++  +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI 445
           +                          C     D++   +      R +
Sbjct: 238 E----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-32
 Identities = 54/242 (22%), Positives = 98/242 (40%), Gaps = 14/242 (5%)

Query: 175 FDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNL 231
           F +   +G G++G VYK      G  VA+K   L    E    +   E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 232 IKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHA 291
           +K+L      +   LV EF+     +    S    + +    + +  +   L + H    
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 292 LAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----- 346
              ++H DLKP N+L++      ++DFG+++  G        T  + T+ Y APE     
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGC 177

Query: 347 GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS 406
              ST  D++S G +  E  +R+       E+     + ++L      V        ++ 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 407 FS 408
            S
Sbjct: 238 PS 239

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 6e-32
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)

Query: 175 FDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIK 233
           + +  ++G GSFG VY+  L   G  VAIK             N E +++R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77

Query: 234 ILSGC------SNLDFKALVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGLALEY 285
           +           +  +  LVL+++P        +       L ++     M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 286 LHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           +H       I H D+KP N+LLD +  V  + DFG +K L  G+        + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRA 190

Query: 345 PEGI-----VSTKCDVYSYGILLLETFSRKKP 371
           PE I      ++  DV+S G +L E    +  
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 7e-32
 Identities = 57/246 (23%), Positives = 84/246 (34%), Gaps = 24/246 (9%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL------ERTFVSFNSECEVLRN 225
           +++    LLG G FGSVY G  +SD   VAIK                     E  +L+ 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 226 VR--HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           V      +I++L      D   L+LE            +    L      +    V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
            + H       ++H D+K  NIL+D N     + DFG   LL +       T    T  Y
Sbjct: 124 RHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 175

Query: 343 MAPE-----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWV-NQSLPHKLAEVV 396
             PE             V+S GILL +      P     E+        Q +  +   ++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 235

Query: 397 DSNLVR 402
              L  
Sbjct: 236 RWCLAL 241

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (303), Expect = 8e-32
 Identities = 42/290 (14%), Positives = 84/290 (28%), Gaps = 33/290 (11%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
            +G GSFG +++GT L +   VAIK    + +        E    + +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHC 298
                  +++  +   SLE  L        +         +   ++ +H       +++ 
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYR 125

Query: 299 DLKPSNILLDENMVAH-----VSDFGISKLLGEGDDSLIQTKTMA-----TIGYMAPEGI 348
           D+KP N L+      +     V DFG+ K   +                 T  YM+    
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE 404
                S + D+ + G + +       P   L   + K    +    K +  +        
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC---- 241

Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI--KVQFLDD 452
                                  + D             K+  ++   +D
Sbjct: 242 ------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 2e-31
 Identities = 55/268 (20%), Positives = 102/268 (38%), Gaps = 36/268 (13%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVL-RNVRHRNLIKILSG 237
           +LG+G  G V +          A+K+      +       E E+  R  +  ++++I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 238 CSNLDFKA----LVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHAL 292
             NL        +V+E +  G L   +    +      E   IM  +G A++YLH  +  
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131

Query: 293 APIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI- 348
             I H D+KP N+L      N +  ++DFG +K     +     T    T  Y+APE + 
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLG 186

Query: 349 ---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH 405
                  CD++S G+++        P      +++   +   +  ++ +    N    E 
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--RMGQYEFPNPEWSEV 244

Query: 406 SFSAKMDCLLRIMNLALDCCMESPDERI 433
           S   K         L  +     P +R+
Sbjct: 245 SEEVK--------MLIRNLLKTEPTQRM 264

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 53/296 (17%), Positives = 119/296 (40%), Gaps = 37/296 (12%)

Query: 170 RATNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNV 226
              +++++   +G G+FG V+K      G  VA+K   ++   E   ++   E ++L+ +
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 227 RHRNLIKILSGCSNLDFKA--------LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 278
           +H N++ ++  C               LV +F  +            F  + E   +M  
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQM 125

Query: 279 VGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT-- 336
           +   L Y+H       I+H D+K +N+L+  + V  ++DFG+++      +S     T  
Sbjct: 126 LLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 337 MATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKP---TNDLGEMSLKHWVNQSL 388
           + T+ Y  PE +          D++  G ++ E ++R        +  +++L   +  S+
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 389 PHKLAEVVDSNLVRREHSFSAKMDCLLR-----------IMNLALDCCMESPDERI 433
             ++   VD+  +  +          ++            ++L     +  P +RI
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 7e-31
 Identities = 60/277 (21%), Positives = 101/277 (36%), Gaps = 36/277 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
           ++FD    LG GSFG V        G + A+KI + Q     +      +E  +L+ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             L+K+     +     +V+E++  G +   L     F            + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHS 159

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 +I+ DLKP N+L+D+     V+DFG +K +     +L       T   +APE I
Sbjct: 160 LD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEII 210

Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE 404
                +   D ++ G+L+ E  +   P      + +   +                 R  
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------RFP 258

Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK 441
             FS+ +  LLR      +       +R         
Sbjct: 259 SHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVN 289

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-30
 Identities = 64/277 (23%), Positives = 110/277 (39%), Gaps = 33/277 (11%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRH 228
           N+FD   LLG G+FG V      + G   A+KI   ++   +       +E  VL+N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 229 RNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
             L  +       D    V+E+   G L   L     F +         ++  ALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHS 123

Query: 289 GHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPEGI 348
                 +++ D+K  N++LD++    ++DFG+ K       ++       T  Y+APE +
Sbjct: 124 ----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVL 177

Query: 349 ----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE 404
                    D +  G+++ E    + P  +                +L E++    +R  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------HERLFELILMEEIRFP 225

Query: 405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK 441
            + S +   LL  + L  D     P +R+    + AK
Sbjct: 226 RTLSPEAKSLLAGL-LKKD-----PKQRLGGGPSDAK 256

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 42/207 (20%), Positives = 91/207 (43%), Gaps = 15/207 (7%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHR 229
            ++++   +G G++G+V+K         VA+K   L    E    S   E  +L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 230 NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYG 289
           N++++     +     LV EF      + +   +          + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHSR 120

Query: 290 HALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE--- 346
           +    ++H DLKP N+L++ N    +++FG+++  G        +  + T+ Y  P+   
Sbjct: 121 N----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLF 174

Query: 347 --GIVSTKCDVYSYGILLLETFSRKKP 371
              + ST  D++S G +  E  +  +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-29
 Identities = 59/276 (21%), Positives = 99/276 (35%), Gaps = 37/276 (13%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL------ERTFVSFNSECEVLRN 225
           + +D    LG G F  V K    S G   A K    +         +      E  +L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 226 VRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEY 285
           ++H N+I +     N     L+LE +  G L  +L       +  E    +  +   + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128

Query: 286 LHYGHALAPIIHCDLKPSNILLDENMVA----HVSDFGISKLLGEGDDSLIQTKTMATIG 341
           LH       I H DLKP NI+L +  V      + DFG++  +  G++         T  
Sbjct: 129 LHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181

Query: 342 YMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD 397
           ++APE      +  + D++S G++     S   P     +      V+        E   
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241

Query: 398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI 433
                   + SA     +R + L  D     P +R+
Sbjct: 242 --------NTSALAKDFIRRL-LVKD-----PKKRM 263

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (274), Expect = 2e-27
 Identities = 45/209 (21%), Positives = 92/209 (44%), Gaps = 24/209 (11%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRN 230
           +++     LG G +  V++   +++   V +KI     ++       E ++L N+R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 231 LIKILSGCSNLDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHY 288
           +I +     +   +  ALV E + N   ++   +    L   +    M ++  AL+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 147

Query: 289 GHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE- 346
                 I+H D+KP N+++D E+    + D+G+++    G +       +A+  +  PE 
Sbjct: 148 MG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPEL 200

Query: 347 ----GIVSTKCDVYSYGILLLETFSRKKP 371
                +     D++S G +L     RK+P
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 7e-27
 Identities = 65/284 (22%), Positives = 115/284 (40%), Gaps = 35/284 (12%)

Query: 173 NEFDECNLLGIGSFGSVYKGTL----SDGTNVAIKIFN----LQLERTFVSFNSECEVLR 224
             F+   +LG G++G V+          G   A+K+      +Q  +T     +E +VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 225 NVRHR-NLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           ++R    L+ +           L+L+++  G L   L     F +      + I VG  +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
             L + H L  II+ D+K  NILLD N    ++DFG+SK     +          TI YM
Sbjct: 140 LALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYM 197

Query: 344 APEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD 397
           AP+ +           D +S G+L+ E  +   P    GE + +  +++           
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR----------- 246

Query: 398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAK 441
             +++ E  +  +M  L +  +L     M+ P +R+      A 
Sbjct: 247 -RILKSEPPYPQEMSALAK--DLIQRLLMKDPKKRLGCGPRDAD 287

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 8e-26
 Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 37/295 (12%)

Query: 167 DIQRATNEFDE----CNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSE 219
           ++ +   E          +G G++G+V        G  VAIK        E        E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 220 CEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIM 276
             +L+++RH N+I +L   +  +      +F                +  L       ++
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 127

Query: 277 IDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKT 336
             +   L Y+H       IIH DLKP N+ ++E+    + DFG+++           T  
Sbjct: 128 YQMLKGLRYIHAAG----IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGY 178

Query: 337 MATIGYMAPEGIV-----STKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK 391
           + T  Y APE I+     +   D++S G ++ E  + K        +     + +     
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238

Query: 392 LAEVVDSNLVRREHSFSAKM---------DCLLRIMNLALD----CCMESPDERI 433
            AE V         ++   +           L     LA++      +   ++R+
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 54/282 (19%), Positives = 110/282 (39%), Gaps = 25/282 (8%)

Query: 172 TNEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRH 228
              +   + +G G++GSV        G  VA+K  +              E  +L++++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 229 RNLIKIL----SGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALE 284
            N+I +L       S  +F  + L     G+    +       D      ++  +   L+
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLK 135

Query: 285 YLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMA 344
           Y+H       IIH DLKPSN+ ++E+    + DFG+++   +     + T+       M 
Sbjct: 136 YIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML 191

Query: 345 PEGIVSTKCDVYSYGILLLETFSRKKP---TNDLGEMSLKHWVNQSLPHKLAEVVDSNLV 401
                +   D++S G ++ E  + +     T+ + ++ L   +  +   +L + + S   
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 402 RREHSFSAKM------DCLLRIMNLALD----CCMESPDERI 433
           R       +M      +  +    LA+D      +   D+RI
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.4 bits (236), Expect = 3e-22
 Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 24/235 (10%)

Query: 173 NEFDECNLLGIGSFGSVYKGT-LSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHR 229
             +     +G G+ G V          NVAIK  +     +        E  +++ V H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 230 NLIKILSGCSNLDFK------ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           N+I +L+  +            LV+E M     +          D      ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132

Query: 284 EYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYM 343
           ++LH       IIH DLKPSNI++  +    + DFG+++  G      + T  + T  Y 
Sbjct: 133 KHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185

Query: 344 APEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE 394
           APE I         D++S G ++ E    K        +   + V + L     E
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 93.6 bits (231), Expect = 1e-21
 Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 25/213 (11%)

Query: 180 LLGIGSFGSVYKGT-LSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGC 238
            LG G F +V+    + + T+VA+KI       T  +   E ++L+ V   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 239 SNLDFK---------------ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLAL 283
           +N   K                +V E +    L       +  + ++    I   + L L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 284 EYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGY 342
           +Y+H       IIH D+KP N+L++  +   ++    I+ L          T ++ T  Y
Sbjct: 139 DYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 343 MAPE----GIVSTKCDVYSYGILLLETFSRKKP 371
            +PE           D++S   L+ E  +    
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.2 bits (184), Expect = 2e-16
 Identities = 23/160 (14%), Positives = 50/160 (31%), Gaps = 23/160 (14%)

Query: 179 NLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL----------ERTFVSFNSECEVLRNVRH 228
            L+G G   +V+           +K   +            +   + F+           
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 229 RNLIKILSGC--SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYL 286
           R L K+          ++   +       +E       Y + +     ++  +   +   
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAV------LMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 287 HYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE 326
           ++      I+H DL   N+L+ E  +  + DF  S  +GE
Sbjct: 120 YHRG----IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGE 154

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 68.2 bits (165), Expect = 3e-13
 Identities = 26/66 (39%), Positives = 36/66 (54%), Gaps = 3/66 (4%)

Query: 37  DLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNYALCGPSR 96
           DL +N + G +P+ L  L +L  LNVS N L GEIP  G  + F   +++ N  LCG   
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-- 307

Query: 97  FQVPPC 102
             +P C
Sbjct: 308 -PLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 43.6 bits (101), Expect = 3e-05
 Identities = 12/47 (25%), Positives = 21/47 (44%), Gaps = 1/47 (2%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIP 48
            +  LK L +L+++ N   G IP   G+L   +    ++N      P
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 2e-08
 Identities = 19/70 (27%), Positives = 30/70 (42%), Gaps = 4/70 (5%)

Query: 6   LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN 65
           LK+L  L+L  N      P    SL  L+ L  ++N +S     SL  L  +  L+   N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 66  RLEGEIPVEG 75
           ++    P+  
Sbjct: 362 QISDLTPLAN 371

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 5e-08
 Identities = 16/63 (25%), Positives = 24/63 (38%), Gaps = 4/63 (6%)

Query: 3   IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNV 62
           +  L  L  L  A NK       S  +L ++  L    N +S   P  L  L  + QL +
Sbjct: 325 VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380

Query: 63  SQN 65
           +  
Sbjct: 381 NDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 22/98 (22%), Positives = 36/98 (36%), Gaps = 5/98 (5%)

Query: 9   LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE 68
           L  LSL  N+       +  SL +L  LDL++N +S   P  L  L  L +L +  N++ 
Sbjct: 221 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276

Query: 69  GEIPVEGPFRNFSTESFSWNYALCGPSRFQVPPCKEEN 106
              P+ G     +    + N          +       
Sbjct: 277 NISPLAG-LTALTNLELNENQLEDISPISNLKNLTYLT 313

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.6 bits (109), Expect = 3e-06
 Identities = 20/63 (31%), Positives = 33/63 (52%)

Query: 7  KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNR 66
           D A L L  NK        F +L +L +L L +N +S   P +   L+ L++L +S+N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 67 LEG 69
          L+ 
Sbjct: 91 LKE 93

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 21/70 (30%), Positives = 29/70 (41%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLN 61
               LK+L TL L  NK     P +F  L+ LE L LS N L     K  + L  L+   
Sbjct: 50  DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE 109

Query: 62  VSQNRLEGEI 71
               ++   +
Sbjct: 110 NEITKVRKSV 119

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 3e-05
 Identities = 17/73 (23%), Positives = 25/73 (34%), Gaps = 9/73 (12%)

Query: 9   LATLSLAANKFHG----PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALL-----YLKQ 59
           L  L LA           +  +  +  SL  LDLS+N L       L   +      L+Q
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 60  LNVSQNRLEGEIP 72
           L +       E+ 
Sbjct: 431 LVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 1e-04
 Identities = 12/70 (17%), Positives = 23/70 (32%), Gaps = 5/70 (7%)

Query: 8  DLATLSLAANKF-HGPIPKSFGSLISLESLDLSSNNLSGE----IPKSLEALLYLKQLNV 62
          D+ +L +   +       +    L   + + L    L+      I  +L     L +LN+
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 63 SQNRLEGEIP 72
            N L     
Sbjct: 63 RSNELGDVGV 72

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 3e-04
 Identities = 11/71 (15%), Positives = 21/71 (29%), Gaps = 4/71 (5%)

Query: 3  IGGLKDLATLSLAANKFHG----PIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLK 58
          +  L+    + L            I  +     +L  L+L SN L       +   L   
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82

Query: 59 QLNVSQNRLEG 69
             + +  L+ 
Sbjct: 83 SCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.001
 Identities = 15/62 (24%), Positives = 20/62 (32%), Gaps = 5/62 (8%)

Query: 2   TIGGLKDLATLSLAANKFHGPIPKSFGSLI-----SLESLDLSSNNLSGEIPKSLEALLY 56
           T+     L  L L+ N             +      LE L L     S E+   L+AL  
Sbjct: 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451

Query: 57  LK 58
            K
Sbjct: 452 DK 453

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 2e-04
 Identities = 22/72 (30%), Positives = 32/72 (44%), Gaps = 9/72 (12%)

Query: 1   MTIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQL 60
                   L  L+++ NK    +P     L   E L  S N+L+ E+P+  + L   KQL
Sbjct: 278 SLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQNL---KQL 329

Query: 61  NVSQNRLEGEIP 72
           +V  N L  E P
Sbjct: 330 HVEYNPLR-EFP 340

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 6e-04
 Identities = 9/49 (18%), Positives = 15/49 (30%), Gaps = 1/49 (2%)

Query: 19  FHGPIP-KSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNR 66
               +P   F        LD+S   +       LE L  L+  +    +
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 8e-04
 Identities = 14/59 (23%), Positives = 25/59 (42%), Gaps = 5/59 (8%)

Query: 26  SFGSLISLESLDLSSNNLSGEIPKSLEALLY-----LKQLNVSQNRLEGEIPVEGPFRN 79
           S    I L++L L  N +  +  ++L+ ++      L  L ++ NR   E  V    R 
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIRE 326

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 12/51 (23%), Positives = 17/51 (33%), Gaps = 1/51 (1%)

Query: 17  NKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRL 67
           N            L +L++L L  N+L   IPK       L    +  N  
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 12/65 (18%), Positives = 26/65 (40%), Gaps = 2/65 (3%)

Query: 9  LATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGE-IPKSLEALLYLKQLNVSQNRL 67
          +       +    P+ + F S   ++ +DLS++ +    +   L     L+ L++   RL
Sbjct: 25 VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83

Query: 68 EGEIP 72
             I 
Sbjct: 84 SDPIV 88

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.002
 Identities = 12/47 (25%), Positives = 19/47 (40%), Gaps = 4/47 (8%)

Query: 17  NKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVS 63
           NK     P    SL +L  + L +N +S   P  L     L  + ++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	457
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.45
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.22
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.18
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.08
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.03
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.01
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.93
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.89
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.87
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.86
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.78
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.76
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.75
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.69
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.63
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.57
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.49
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.47
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.44
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.44
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.42
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.41
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.36
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.36
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.25
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.24
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.2
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.06
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.91
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.56
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.47
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.47
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.25
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.01
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.86
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.85
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.82
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.6
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	96.2
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	96.18
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	95.45
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	95.27
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.45
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	88.62

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=412.39  Aligned_cols=257  Identities=26%  Similarity=0.452  Sum_probs=203.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQ--LERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|...+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            367888999999999999999874  36999999754  24456789999999999999999999998865 56899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++...+..+++..++.++.||+.||+|||    +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999999887777999999999999999999999    67899999999999999999999999999988754443


Q ss_pred             cceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHH-HHHHhhcCchhHHhcccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLK-HWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~-~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ........||+.|+|||.+       ++.++|||||||++|||+||+.||......... ..+....       ..+.+.
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-------~~p~~~  232 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-------LSPDLS  232 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS-------CCCCGG
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC-------CCCcch
Confidence            3344557899999999943       577899999999999999999999764432211 1111111       111111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .      ...+++..+.+++.+||+.||++||||.||++.|+.+++.
T Consensus       233 ~------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         233 K------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             G------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             h------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1      1113456789999999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-54  Score=412.40  Aligned_cols=266  Identities=27%  Similarity=0.461  Sum_probs=204.3

Q ss_pred             ccCHHHHHHHhhcC---------CcCCccCCCCceEEEEEEeC-CC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcC
Q 044428          162 RISYLDIQRATNEF---------DECNLLGIGSFGSVYKGTLS-DG---TNVAIKIFNLQL-ERTFVSFNSECEVLRNVR  227 (457)
Q Consensus       162 ~~~~~~l~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~  227 (457)
                      .++|+|+.+++.+|         +..+.||+|+||+||+|++. +|   ..||||.+.... ....+.|.+|++++++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            45666666666555         34578999999999999875 33   368999887543 445567999999999999


Q ss_pred             CCccceeeeeeecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          228 HRNLIKILSGCSNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       228 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                      |||||+++|+|...+..++||||+++|+|.+++......+++.++++++.|||.||+|||    +.+|+||||||+|||+
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILV  161 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEE
Confidence            999999999999999999999999999999999887777999999999999999999999    6789999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCcce---eccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCc
Q 044428          308 DENMVAHVSDFGISKLLGEGDDSLI---QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMS  379 (457)
Q Consensus       308 ~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~  379 (457)
                      +.++++||+|||+++.+........   .....||+.|+|||    ..++.++|||||||++|||+| |+.||.......
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999998754322211   12245799999999    447889999999999999998 899997654333


Q ss_pred             HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          380 LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       380 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      +...+.....                 ...+.+++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       242 ~~~~i~~~~~-----------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 VINAIEQDYR-----------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHcCCC-----------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            3332222110                 001123456789999999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=403.22  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4677888999999999999999889999999997643 334679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++......+++..+++++.|||.||+|||    ..+|+||||||+|||+++++.+||+|||+++........ .
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S  158 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence            99999999887777999999999999999999999    677999999999999999999999999999876543222 2


Q ss_pred             eccccccccccCCC----CCCCCccchhhhhHHHHHHhcC-CCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSR-KKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg-~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....||+.|+|||    ..++.++|||||||++|||+|+ ++|+.......+...+.....        ...       
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------~~~-------  223 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYK-------  223 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------CCC-------
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC--------CCC-------
Confidence            23467899999999    3478899999999999999995 555543332222222221110        000       


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                        +..++.++.+++.+||+.||++||||+||++.|++|++.
T Consensus       224 --p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         224 --PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence              112345689999999999999999999999999999763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=389.79  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=209.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|+..+.||+|+||+||+|++++++.||||+++.... ...+|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57889999999999999999999899999999986533 35679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcce
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLI  332 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  332 (457)
                      +|+|.+++......+++..+.+++.|+++||.|||    ..+|+||||||+||++++++.+||+|||+++........ .
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~  157 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S  157 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence            99999998887777999999999999999999999    678999999999999999999999999999876543322 2


Q ss_pred             eccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....||+.|+|||    ..++.++|||||||++|||+| |+.||.......+...+.....          +.      
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~----------~~------  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LY------  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC----------CC------
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC----------CC------
Confidence            33467899999999    347889999999999999998 8999976543332222221110          00      


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                       .+..++..+.+++.+||+.||++|||+.++++.|.+|
T Consensus       222 -~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             0112345689999999999999999999999998654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=394.66  Aligned_cols=257  Identities=23%  Similarity=0.429  Sum_probs=207.9

Q ss_pred             hcCCcCCc-cCCCCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNL-LGIGSFGSVYKGTLS---DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+. ||+|+||+||+|.++   ++..||||+++... ....+.|.+|++++++++|||||+++|+|.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34555554 999999999999864   45679999997654 3445789999999999999999999999865 467899


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++...+..+++..+..++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999999877667999999999999999999999    678999999999999999999999999999987654


Q ss_pred             CCcc-eeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          328 DDSL-IQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       328 ~~~~-~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      .... ......||+.|+|||    ..++.++|||||||++|||+| |+.||.......+...+.....        +.  
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~--------~~--  232 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------ME--  232 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------CC--
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CC--
Confidence            3322 223466899999999    347889999999999999998 8999986554333333222111        00  


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLD  451 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~  451 (457)
                             .+..++.++.+++.+||+.+|++||||.+|.+.|+.+-.....
T Consensus       233 -------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         233 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             -------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             -------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence                   1123456789999999999999999999999999887655443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=395.04  Aligned_cols=251  Identities=23%  Similarity=0.409  Sum_probs=202.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      .++|+..+.||+|+||.||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35788888999999999999999988999999997543 334679999999999999999999998865 5678999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++|+|.+++.... ..+++..+++++.||+.||.|||    ..+|+||||||+|||+++++.+||+|||+++.+.... .
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~  164 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence            9999999886543 35899999999999999999999    6779999999999999999999999999999875432 2


Q ss_pred             ceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCC-CCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~-~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      .......||+.|+|||    ..++.++|||||||++|||+||..|+.. .........+....        .+..     
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~--------~~~~-----  231 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------RMVR-----  231 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCC-----
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------CCCC-----
Confidence            2334567899999999    4478899999999999999996665433 22222222221111        0000     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                          +..++..+.+++.+||+.||++||||.||++.|+++-
T Consensus       232 ----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence                1123556899999999999999999999999998764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=394.36  Aligned_cols=248  Identities=22%  Similarity=0.293  Sum_probs=199.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57889999999999999999975 79999999997543 23345689999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +++|+|.+++.... .+++..+..++.|++.||+|||    +.+|+||||||+|||+++++.+||+|||+|+........
T Consensus        85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999997654 5899999999999999999999    678999999999999999999999999999987544433


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      ...+...||+.|+|||.+     .+.++||||+||++|||+||+.||...............          ......  
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~----------~~~~~~--  227 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----------KKTYLN--  227 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT----------TCTTST--
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------CCCCCC--
Confidence            334557899999999933     356899999999999999999999764432221111110          000000  


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                         ........+.+++.+|++.||++|||+.|+++
T Consensus       228 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               00112345789999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=392.46  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=202.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999986 479999999998765555677999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++|+|.+++....  +++.+...++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus       100 ~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1         100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             TTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            9999999987754  899999999999999999999    67899999999999999999999999999998754322  


Q ss_pred             eeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          332 IQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      ......||+.|+|||.    .++.++|||||||++|||+||+.||...........+....        .+.+       
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------~~~~-------  236 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--------TPEL-------  236 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------SCCC-------
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------CCCC-------
Confidence            2345679999999993    36889999999999999999999997644222111111110        0001       


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..+..++..+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001122456889999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=395.18  Aligned_cols=256  Identities=26%  Similarity=0.454  Sum_probs=199.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCC-----CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDG-----TNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      +.|+..++||+|+||+||+|++++.     ..||||++.... ......|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577788999999999999987532     479999997543 3345579999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ||||+.+|++.+++......+++.++++++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999999887777999999999999999999999    67899999999999999999999999999998754


Q ss_pred             CCCc-ceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCC-CCCCcHHHHHHhhcCchhHHhccccc
Q 044428          327 GDDS-LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       327 ~~~~-~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~-~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      .... .......||+.|+|||    ..++.++|||||||++|||+||..|+.. .....+...+....        .+  
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~--------~~--  232 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF--------RL--  232 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------CC--
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC--------CC--
Confidence            3222 2233456899999999    4478899999999999999997666543 22211221111111        00  


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                             ..+.+++..+.+++.+||+.||++||||.||++.|+++.+..
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         233 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                   011234567899999999999999999999999999987653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=399.53  Aligned_cols=247  Identities=25%  Similarity=0.327  Sum_probs=205.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45788899999999999999975 78999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      ++|+|.+++.+....+++.++..++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~  165 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ  165 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence            999999998876667999999999999999999999    678999999999999999999999999999765321  11


Q ss_pred             eeccccccccccCCCCC---------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          332 IQTKTMATIGYMAPEGI---------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~---------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ......||+.|+|||.+         ++.++|||||||++|||+||+.||...........+....+.        .   
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~--------~---  234 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP--------T---  234 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC--------C---
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--------C---
Confidence            22346799999999943         577899999999999999999999875544333222211110        0   


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ...+..++..+.+++.+||+.||++|||+.|+++
T Consensus       235 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 ----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0111123456889999999999999999999976

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-52  Score=397.93  Aligned_cols=253  Identities=24%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++++|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            457888899999999999999975 68899999997553 3456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          251 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       251 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      +++|+|.+++... ...+++..++.++.||+.||+|||    ..+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-  169 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  169 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence            9999999999764 356899999999999999999999    6789999999999999999999999999999765432 


Q ss_pred             cceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCC-CCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          330 SLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDL-GEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~-~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      ........|++.|+|||    ..++.++|||||||++|||++|..|+... ....+...+..            ......
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~------------~~~~~~  237 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------DYRMER  237 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT------------TCCCCC
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc------------CCCCCC
Confidence            22334466899999999    44788999999999999999977776432 21111111111            111110


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                           +..++..+.+++.+||+.||++||||.||++.|+.+.+
T Consensus       238 -----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         238 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 11235568999999999999999999999999988743

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=386.58  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=196.5

Q ss_pred             CccCCCCceEEEEEEeC---CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccCC
Q 044428          179 NLLGIGSFGSVYKGTLS---DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMPN  253 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  253 (457)
                      +.||+|+||+||+|.++   .++.||||+++...  ....+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999864   35689999997543  2335679999999999999999999999865 457899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc-e
Q 044428          254 GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL-I  332 (457)
Q Consensus       254 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~  332 (457)
                      |+|.+++.... .+++..++.++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+++.+....... .
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999998764 4899999999999999999999    6779999999999999999999999999999875443332 2


Q ss_pred             eccccccccccCCCCC----CCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccccch
Q 044428          333 QTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSF  407 (457)
Q Consensus       333 ~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~  407 (457)
                      .....||+.|+|||.+    ++.++|||||||++|||+| |+.||.......+...+....+                 .
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-----------------~  229 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-----------------M  229 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------C
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-----------------C
Confidence            2346789999999943    7889999999999999998 8999976543332222221110                 0


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          408 SAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       408 ~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      ..+..++..+.+++.+||+.||++|||+.+|.++|+.+-.
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            0112345678999999999999999999999999887643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=383.30  Aligned_cols=241  Identities=22%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57888999999999999999985 78999999987542   233567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            9999999999998654 4899999999999999999999    6789999999999999999999999999998754322


Q ss_pred             CcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          .....||+.|+|||.    .++.++|||||||++|||+||+.||.......+...+...   .      ..+.   
T Consensus       161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---~------~~~p---  224 (263)
T d2j4za1         161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---E------FTFP---  224 (263)
T ss_dssp             ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---C------CCCC---
T ss_pred             ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC---C------CCCC---
Confidence                234679999999993    3688999999999999999999999764322222211110   0      0000   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                            ..++..+.+++.+|++.||++|||+.|+++
T Consensus       225 ------~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 ------DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                  012446889999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-51  Score=394.10  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=210.3

Q ss_pred             HHHHHhhcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCccceeeeeee
Q 044428          167 DIQRATNEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNVRHRNLIKILSGCS  239 (457)
Q Consensus       167 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  239 (457)
                      +++...++|+..+.||+|+||+||+|++.      +++.||||+++.... .....|.+|++++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999863      457899999976543 34567999999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 044428          240 NLDFKALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGLALEYLHYGHALAPII  296 (457)
Q Consensus       240 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~iv  296 (457)
                      ..+..++||||+++|+|.+++....                       ..+++..++.++.|++.||+|||    ..+|+
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~iv  162 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFV  162 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeE
Confidence            9999999999999999999997532                       24789999999999999999999    67899


Q ss_pred             eccCCCCCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCC-CC
Q 044428          297 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRK-KP  371 (457)
Q Consensus       297 H~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~-~p  371 (457)
                      ||||||+|||++.++++||+|||+++.+.........+...|++.|+|||    ..++.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998775544444444577899999999    44889999999999999999986 56


Q ss_pred             CCCCCCCcHHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          372 TNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       372 ~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      |...........+...           .....      +..++..+.+++.+||+.+|++||||.||+++|++|++
T Consensus       243 ~~~~~~~e~~~~v~~~-----------~~~~~------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDG-----------NILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTTSCHHHHHHHHHTT-----------CCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCHHHHHHHHHcC-----------CCCCC------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            7654433332222211           11100      11235568999999999999999999999999998863

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=396.75  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=202.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC-C-----CEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD-G-----TNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  244 (457)
                      ++|+..+.||+|+||+||+|++.. +     ..||||.+.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578888999999999999998642 2     369999986543 33456789999999998 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 044428          245 ALVLEFMPNGSLEKWLYSHN----------------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKP  302 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~  302 (457)
                      ++||||+++|+|.+++....                      ..+++..++.++.||+.||+|||    +.+|+||||||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDlKp  192 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAA  192 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCch
Confidence            99999999999999997653                      24889999999999999999999    67899999999


Q ss_pred             CCeeecCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCC
Q 044428          303 SNILLDENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGE  377 (457)
Q Consensus       303 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~  377 (457)
                      +|||++.++.+||+|||+|+...............||+.|+|||    ..++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998875544444445567899999999    447899999999999999998 8999976443


Q ss_pred             Cc-HHHHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 044428          378 MS-LKHWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLR  443 (457)
Q Consensus       378 ~~-l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~  443 (457)
                      .. +...+....            .     ...+..++..+.+++.+||+.||++||||.||++.|.
T Consensus       273 ~~~~~~~~~~~~------------~-----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFYKLIQNGF------------K-----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHHHHHHTTC------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCC------------C-----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            22 222222111            0     0011123567899999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=385.77  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=188.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN--LDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  247 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  +...+.+.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999874 78999999987643  3345678999999999999999999998864  4568999


Q ss_pred             EeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          248 LEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGLALEYLHYGH-ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~-~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998642   356999999999999999999999642 124599999999999999999999999999998


Q ss_pred             cCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      +....  .......||+.|+|||.+    ++.++|||||||++|||+||+.||.......+...+..           ..
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-----------~~  230 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-----------GK  230 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-----------TC
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-----------CC
Confidence            75422  223346799999999943    78899999999999999999999976543322222111           11


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .....      ..++.++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~------~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         231 FRRIP------YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCC------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11000      112446889999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=387.85  Aligned_cols=256  Identities=24%  Similarity=0.408  Sum_probs=204.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT----NVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  246 (457)
                      .+|+..+.||+|+||+||+|++. +|+    .||+|.++... ....+.|.+|++++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999874 444    58999886543 34567899999999999999999999999875 5678


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      ++||+.+|+|.+++......+++..+++++.|||.||+|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            88999999999999988778999999999999999999999    67899999999999999999999999999998765


Q ss_pred             CCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                      ...........||+.|+|||    ..++.++|||||||++|||+| |+.||.......+...+......           
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-----------  232 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-----------  232 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            54444444567899999999    447899999999999999999 78898765544443333321110           


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                            ..+..++..+.+++.+||+.||++|||+.||++.|..+.+.+.
T Consensus       233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~  275 (317)
T d1xkka_         233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  275 (317)
T ss_dssp             ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred             ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence                  0111235568999999999999999999999999998876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=387.59  Aligned_cols=272  Identities=22%  Similarity=0.321  Sum_probs=200.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----eeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD----FKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  248 (457)
                      ++|...+.||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++++|...+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4566677899999999999997 5889999999754322 122334555667789999999999997654    678999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCeeeccCCCCCeeecCCCcEEEecccccccc
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH----ALAPIIHCDLKPSNILLDENMVAHVSDFGISKLL  324 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~  324 (457)
                      ||+++|+|.+++++..  ++|..+++++.|+|.||+|||+..    ..++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999999998764  899999999999999999999531    1368999999999999999999999999999987


Q ss_pred             CCCCCcc--eeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHH--HHhhcC-
Q 044428          325 GEGDDSL--IQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHW--VNQSLP-  389 (457)
Q Consensus       325 ~~~~~~~--~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~--~~~~~~-  389 (457)
                      .......  ......||+.|+|||.+          ++.++|||||||++|||+||..|+...........  ...... 
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            5443322  22346799999999943          35589999999999999999988754221110000  000000 


Q ss_pred             chhH-HhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          390 HKLA-EVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       390 ~~~~-~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      ..+. .+.+..+...........+++..+.+++.+||+.||++||||.||++.|+++.++
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0011 1122222111111222334567799999999999999999999999999998865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=377.74  Aligned_cols=243  Identities=23%  Similarity=0.351  Sum_probs=190.6

Q ss_pred             CcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCeeEEEE
Q 044428          176 DECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN----LDFKALVL  248 (457)
Q Consensus       176 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  248 (457)
                      +..+.||+|+||+||+|+.. +++.||+|.+....  ....+.|.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            34457999999999999875 68899999987543  3345679999999999999999999999864    35679999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec-CCCcEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD-ENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~  327 (457)
                      ||+++|+|.+++.+.. .+++..+..++.||+.||+|||+..  .+|+||||||+|||++ +++.+||+|||+++.....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~--~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS--SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCC--CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            9999999999998754 4899999999999999999999321  2399999999999996 5889999999999865322


Q ss_pred             CCcceeccccccccccCCCCC---CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPEGI---VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~---~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          ......||+.|+|||.+   ++.++|||||||++|||+||+.||.....  ...........     ..+...   
T Consensus       169 ----~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~-----~~~~~~---  234 (270)
T d1t4ha_         169 ----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSG-----VKPASF---  234 (270)
T ss_dssp             ----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTT-----CCCGGG---
T ss_pred             ----ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcC-----CCCccc---
Confidence                12346799999999944   78899999999999999999999975332  11111111100     000000   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                           +..+..++.+++.+|++.||++|||+.|+++
T Consensus       235 -----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 0112345789999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-51  Score=384.71  Aligned_cols=245  Identities=23%  Similarity=0.319  Sum_probs=198.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57899999999999999999974 79999999997542   334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++...+ .+++.....++.|++.||+|||    ..+|+||||||+|||+++++.+||+|||+++.+....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999988664 4899999999999999999999    6789999999999999999999999999999875443


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .........||+.|+|||.+    ++.++||||+||++|||+||+.||.......+...+..   ..      ..+..  
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---~~------~~~p~--  231 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK---LE------YDFPE--  231 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---TC------CCCCT--
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc---CC------CCCCc--
Confidence            33334456799999999933    78899999999999999999999976432222111111   00      00100  


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             .....+.+++.+|++.||++|||+.|+.+
T Consensus       232 -------~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         232 -------KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -------TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -------cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                   12345789999999999999999999754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-51  Score=379.32  Aligned_cols=247  Identities=30%  Similarity=0.415  Sum_probs=197.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN-LDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  251 (457)
                      ++|+..+.||+|+||.||+|+++ |+.||||+++...  ..+.|.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46777889999999999999984 7899999997543  44679999999999999999999999865 45689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          252 PNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       252 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      ++|+|.+++.... ..++|..+++++.||+.||.|||    +.+|+||||||+||+++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            9999999997653 35899999999999999999999    678999999999999999999999999999875432   


Q ss_pred             ceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                        .....++..|+|||    ..++.++|||||||++|||+| |+.||......++..++.......        +     
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~--------~-----  221 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD--------A-----  221 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC--------C-----
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--------C-----
Confidence              22356889999999    458899999999999999998 688887665555555543322111        1     


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                          +..++.++.+++.+||+.||++||||.|++++|++|+..
T Consensus       222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                112245688999999999999999999999999998753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-50  Score=385.91  Aligned_cols=241  Identities=26%  Similarity=0.315  Sum_probs=196.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      +.|+..+.||+|+||+||+|+.. +|+.||||++....   ......+.+|++++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999864 78999999997543   233457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|..++... ..+++.++..++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999998776654 35899999999999999999999    678999999999999999999999999999875432 


Q ss_pred             CcceeccccccccccCCCCC-------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI-------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLV  401 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~-------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~  401 (457)
                           ....||+.|+|||.+       ++.++|||||||++|||++|+.||...........+..        ...+.+.
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~--------~~~~~~~  235 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NESPALQ  235 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------SCCCCCS
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------CCCCCCC
Confidence                 235799999999943       67799999999999999999999975432211111111        0011111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          402 RREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       402 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .        ..++..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 S--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1        112446889999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=377.77  Aligned_cols=253  Identities=22%  Similarity=0.357  Sum_probs=198.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSD----GTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|+..+.||+|+||.||+|++..    +..||||.++... ......|.+|++++++++|||||++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578888999999999999998742    4568999986543 334567999999999999999999999986 4678999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++......+++..++.++.||+.||.|||    +.+|+||||||+||++++++.+||+|||+++.+...
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998887777999999999999999999999    678999999999999999999999999999876433


Q ss_pred             CCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      .. ...+...||+.|+|||    ..++.++|||||||++|||+| |..||.......+...+.......           
T Consensus       162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~-----------  229 (273)
T d1mp8a_         162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-----------  229 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------
T ss_pred             cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence            22 2234467899999999    447889999999999999998 899998766554444333221110           


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                            .+..++..+.+++.+||+.||++|||+.||++.|++|.++
T Consensus       230 ------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                  0112356789999999999999999999999999998766

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=389.49  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=199.7

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .++|+..+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.++++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999974 78999999997653 3335678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+++|+|.+++.+.. .+++..+..++.|++.||.|||+.   .+|+||||||+|||+++++.+||+|||+|+.....  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHh---CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999998654 489999999999999999999942   36999999999999999999999999999976321  


Q ss_pred             cceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---------------
Q 044428          330 SLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---------------  390 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---------------  390 (457)
                        ......||+.|+|||    ..++.++||||+||++|||++|+.||..................               
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              123468999999999    34889999999999999999999999764332211110000000               


Q ss_pred             ------------hhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 ------------KLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ------------~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                                  ...+..+........... ......++.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                        000000000000000000 0001345789999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=381.33  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=197.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEeccC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFMP  252 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  252 (457)
                      ++|+..+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5788899999999999999999888899999997543 335679999999999999999999999854 56789999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          253 NGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       253 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +|+|..++.... ..++|.+++.++.||+.||+|||    ..+|+||||||+|||+++++++||+|||+++....... .
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            999999987643 45899999999999999999999    67799999999999999999999999999987654322 2


Q ss_pred             eeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCC-CCCCcHHHHHHhhcCchhHHhccccccccccc
Q 044428          332 IQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTND-LGEMSLKHWVNQSLPHKLAEVVDSNLVRREHS  406 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~-~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~  406 (457)
                      ......||+.|+|||    ..++.++|||||||++|||+||..|+.. .........+.....        ..       
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------~~-------  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MP-------  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CC-------
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--------CC-------
Confidence            234467899999999    4578999999999999999997666543 222222222221110        00       


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhH
Q 044428          407 FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIK  446 (457)
Q Consensus       407 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~  446 (457)
                        .+.+++.++.+++.+||+.||++||+|.+|+++|+++.
T Consensus       235 --~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             --CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence              11133557899999999999999999999999887643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=381.83  Aligned_cols=253  Identities=24%  Similarity=0.411  Sum_probs=203.7

Q ss_pred             CccCCCCceEEEEEEeCCC----CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCeeEEEEeccC
Q 044428          179 NLLGIGSFGSVYKGTLSDG----TNVAIKIFNLQ-LERTFVSFNSECEVLRNVRHRNLIKILSGCSN-LDFKALVLEFMP  252 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  252 (457)
                      ++||+|+||+||+|++.++    ..||||+++.. .......|.+|++++++++||||++++|+|.. +...++||||++
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~  112 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  112 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence            5899999999999987532    36899999753 34456789999999999999999999999875 568899999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc--
Q 044428          253 NGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS--  330 (457)
Q Consensus       253 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--  330 (457)
                      +|+|.+++.......++..+++++.|++.||.|||    ..+|+||||||+|||+++++.+||+|||+++........  
T Consensus       113 ~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             cCchhhhhccccccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999988777889999999999999999999    678999999999999999999999999999987543322  


Q ss_pred             ceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCC-CCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          331 LIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDL-GEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~-~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                      .......||+.|+|||    ..++.++||||||+++|||+||+.||... ...+...++.....          ..    
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----------~~----  254 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------LL----  254 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----------CC----
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------CC----
Confidence            1223467899999999    45889999999999999999988887542 22222222221110          00    


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFLDD  452 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~~~  452 (457)
                         .+..++..+.+++.+||+.||++||+|.||++.|+++.+.+..+
T Consensus       255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence               01123556899999999999999999999999999998876554

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=378.86  Aligned_cols=252  Identities=25%  Similarity=0.410  Sum_probs=194.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC--CC--CEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS--DG--TNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||++....   ....+.|.+|++++++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888899999999999999863  23  368999987542   3345679999999999999999999999976 4678


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++|++.+++..+...+++..++.++.|+|.||.|||    .++|+||||||+||+++.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999999999999998877667999999999999999999999    6789999999999999999999999999999875


Q ss_pred             CCCCcc-eeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHHHHHhhcCchhHHhcccc
Q 044428          326 EGDDSL-IQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSN  399 (457)
Q Consensus       326 ~~~~~~-~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~  399 (457)
                      ...... ......|+..|+|||    ..++.++|||||||++|||+| |+.||..........++...           .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-----------~  231 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----------G  231 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----------C
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC-----------C
Confidence            543332 223456788999999    347889999999999999998 89999765443333332211           0


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 044428          400 LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKI  445 (457)
Q Consensus       400 l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i  445 (457)
                      ..     ...+..++..+.+++.+||+.||++||||.||.+.|.+.
T Consensus       232 ~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ER-----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            00     001112345689999999999999999999999888764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-49  Score=386.11  Aligned_cols=247  Identities=23%  Similarity=0.270  Sum_probs=203.3

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999874 79999999998766556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec--CCCcEEEeccccccccCCCCC
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD--ENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      ++|+|.+++......+++..+..++.||+.||+|||    ..+|+||||||+|||++  .++.+||+|||+++.+.....
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999776667999999999999999999999    67899999999999996  467899999999998754322


Q ss_pred             cceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccccc
Q 044428          330 SLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRREH  405 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~  405 (457)
                         .....||+.|+|||.+    ++.++||||+||++|||+||+.||...........+....         ..+..   
T Consensus       182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------~~~~~---  246 (350)
T d1koaa2         182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD---------WNMDD---  246 (350)
T ss_dssp             ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------CCSCC---
T ss_pred             ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCCc---
Confidence               2346799999999933    6789999999999999999999997543222221111100         00000   


Q ss_pred             chhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          406 SFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       406 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        .....++..+.+++.+|++.||++|||+.|+++
T Consensus       247 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         247 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             --GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              001112445789999999999999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-49  Score=380.77  Aligned_cols=247  Identities=24%  Similarity=0.307  Sum_probs=185.6

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      .+.|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++|||||++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356888999999999999999975 78999999997653 2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEEeccccccccCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~~~~  326 (457)
                      |+++|+|.+++...+ .+++.....++.|++.||+|||    ..+|+||||||+||++.   +++.+||+|||+++....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999998654 5899999999999999999999    67899999999999994   578999999999987643


Q ss_pred             CCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccc
Q 044428          327 GDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVR  402 (457)
Q Consensus       327 ~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~  402 (457)
                      ..   ......||+.|+|||.    .++.++|||||||++|||+||+.||.......+...+......         .. 
T Consensus       163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---------~~-  229 (307)
T d1a06a_         163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE---------FD-  229 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC---------CC-
T ss_pred             CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC---------CC-
Confidence            32   2234679999999993    3788999999999999999999999764433222222211000         00 


Q ss_pred             cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          403 REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       403 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .....+.+..+.+++.+|++.||++|||+.|+++
T Consensus       230 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 ----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                0001122456889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.1e-49  Score=385.47  Aligned_cols=248  Identities=22%  Similarity=0.302  Sum_probs=205.0

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++.........+.+|++++++++|||||++++++.+.+..++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999874 7999999999876555566789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec--CCCcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD--ENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      +++|+|.+++......+++.+...++.||+.||+|||    ..+|+||||||+|||++  .++.+||+|||+++.+....
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999999998877767999999999999999999999    67899999999999998  67899999999999875432


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .   .....||+.|+|||.+    ++.++||||+||++|||+||+.||...........+.....         ..... 
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------~~~~~-  250 (352)
T d1koba_         184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---------EFDED-  250 (352)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC---------CCCSS-
T ss_pred             c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------CCCcc-
Confidence            2   3346799999999943    78899999999999999999999976443322222211100         00000 


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          .....+..+.+++.+|++.||.+|||+.|+++
T Consensus       251 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 ----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00112446889999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-49  Score=372.91  Aligned_cols=246  Identities=21%  Similarity=0.270  Sum_probs=200.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL------ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....      ....+.+.+|++++++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999974 79999999987542      123567999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC----cEEEeccccc
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM----VAHVSDFGIS  321 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~~  321 (457)
                      +||||+++|+|.+++...+ .+++.....++.|++.||+|||    ..+|+||||||+|||++.++    .+||+|||++
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999998754 4899999999999999999999    67899999999999998776    5999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      +.......   .....||+.|+|||.    .++.++|||||||++|||+||+.||...........+......       
T Consensus       165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-------  234 (293)
T d1jksa_         165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-------  234 (293)
T ss_dssp             EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC-------
T ss_pred             hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------
Confidence            88754322   234678999999993    4788999999999999999999999764432222211111000       


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             ........++..+.+++.+||+.||++|||+.|+++
T Consensus       235 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 -------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   000111123456889999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=375.37  Aligned_cols=255  Identities=24%  Similarity=0.381  Sum_probs=195.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecC-Ce
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNL-DF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  243 (457)
                      ++|+..+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            67888999999999999999853      35689999997543 33456788888888887 689999999987654 56


Q ss_pred             eEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec
Q 044428          244 KALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD  308 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~  308 (457)
                      .++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||    +.+|+||||||+|||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCccceeEC
Confidence            899999999999999997542               34889999999999999999999    67899999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCC-CCCCCCCCCc-HHH
Q 044428          309 ENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRK-KPTNDLGEMS-LKH  382 (457)
Q Consensus       309 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~-~p~~~~~~~~-l~~  382 (457)
                      +++++||+|||+|+...........+...||+.|+|||    ..++.++|||||||++|||+||. .||....... +..
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999999765544443444578999999999    44789999999999999999975 5776533221 111


Q ss_pred             HHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       383 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      .+....        .+..         +..++..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       249 ~~~~~~--------~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         249 RLKEGT--------RMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHTC--------CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCC--------CCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            111111        1111         112345689999999999999999999999999998753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=374.91  Aligned_cols=254  Identities=24%  Similarity=0.407  Sum_probs=203.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC--------CCCEEEEEEecccch-hhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS--------DGTNVAIKIFNLQLE-RTFVSFNSECEVLRNV-RHRNLIKILSGCSNLD  242 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  242 (457)
                      ++|...+.||+|+||.||+|+..        ++..||||+++.... .....+.+|...+.++ +|||||+++++|.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            57888899999999999999853        235799999976543 4456789999999888 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          243 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                      ..++||||+++|+|.+++....               ..+++.++++++.|++.||+|||    ..+|+||||||+|||+
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeecccceee
Confidence            9999999999999999997553               34899999999999999999999    6789999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhc-CCCCCCCCCCCcHHH
Q 044428          308 DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFS-RKKPTNDLGEMSLKH  382 (457)
Q Consensus       308 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~t-g~~p~~~~~~~~l~~  382 (457)
                      +.++.+||+|||+++...............+|+.|+|||    ..++.++|||||||++|||+| |..||.......+..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            999999999999999875544433445577999999999    558999999999999999998 688886544322222


Q ss_pred             HHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          383 WVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       383 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                      .+.....        +..         +..++..+.+++.+||+.||++|||+.||++.|++|..
T Consensus       249 ~i~~~~~--------~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         249 LLKEGHR--------MDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHTTCC--------CCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC--------CCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            2221110        000         11224568999999999999999999999999998854

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=374.16  Aligned_cols=255  Identities=23%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCee
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL------SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFK  244 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  244 (457)
                      ++|+..+.||+|+||.||+|++      .+++.||||+++... ......|.+|+.+++++ +|||||+++++|.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5788889999999999999985      356789999997644 33455799999999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeee
Q 044428          245 ALVLEFMPNGSLEKWLYSHN-----------------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILL  307 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll  307 (457)
                      ++||||+++|+|.+++....                 ..+++..+..++.||+.||+|||    ..+++||||||+||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH----~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILL  178 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccccccccc
Confidence            99999999999999997643                 25889999999999999999999    6779999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcC-CCCCCCCCCCc-HH
Q 044428          308 DENMVAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSR-KKPTNDLGEMS-LK  381 (457)
Q Consensus       308 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg-~~p~~~~~~~~-l~  381 (457)
                      +.++.+|++|||+++...............||+.|+|||    ..++.++|||||||++|||+|+ .+|+....... +.
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999999876555544555678999999999    5578999999999999999995 45454433221 22


Q ss_pred             HHHHhhcCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHH
Q 044428          382 HWVNQSLPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQ  448 (457)
Q Consensus       382 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~  448 (457)
                      ..+....+.            ...     ..++..+.+++.+||+.||++||||.||+++|+++..+
T Consensus       259 ~~i~~~~~~------------~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         259 KMIKEGFRM------------LSP-----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHTCCC------------CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCC------------CCc-----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            222221111            110     11245689999999999999999999999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=378.34  Aligned_cols=256  Identities=23%  Similarity=0.393  Sum_probs=206.9

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS------DGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|...+.||+|+||+||+|.+.      +++.||||+++... ......|.+|++++++++|||||+++|+|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            67788889999999999999863      35789999997543 344557999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEe
Q 044428          246 LVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVS  316 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~  316 (457)
                      +||||+++|+|.+++....         ..+++..+.+++.|+|.||.|||    ..+|+||||||+|||+++++++||+
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999987532         34789999999999999999999    6779999999999999999999999


Q ss_pred             ccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCC-CCCCCCCCCcHHHHHHhhcCch
Q 044428          317 DFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRK-KPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       317 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~-~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      |||+++.+.............||+.|+|||    ..++.++||||||+++|||+||. .||.....   .+....     
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~-----  247 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRF-----  247 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHH-----
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHHHHH-----
Confidence            999999775544333344467899999999    44788999999999999999985 66654332   222211     


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                         +.+......      +..++..+.+++.+||+.+|++||||.+|++.|++..+..
T Consensus       248 ---i~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         248 ---VMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             ---HHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             ---HHhCCCCCC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence               111111111      1123556999999999999999999999999998875544

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=374.79  Aligned_cols=254  Identities=29%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGT--NVAIKIFNLQ-LERTFVSFNSECEVLRNV-RHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|+..+.||+|+||+||+|++. +|.  .||||+++.. .....+.|.+|+++++++ +|||||+++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57778889999999999999875 444  4788887643 334556799999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCc
Q 044428          248 LEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMV  312 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~  312 (457)
                      |||+++|+|.++++..               ...+++..+..++.|||.||.|||    +.+|+||||||+|||++.++.
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCCc
Confidence            9999999999999754               256899999999999999999999    678999999999999999999


Q ss_pred             EEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCC-CCCCCCCCcHHHHHHhh
Q 044428          313 AHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKK-PTNDLGEMSLKHWVNQS  387 (457)
Q Consensus       313 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~-p~~~~~~~~l~~~~~~~  387 (457)
                      +||+|||+++......   ......||..|+|||    ..++.++|||||||++|||++|.. ||.......+...+...
T Consensus       166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            9999999998653221   123356899999999    347889999999999999999765 56543322222221111


Q ss_pred             cCchhHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHHh
Q 044428          388 LPHKLAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQFL  450 (457)
Q Consensus       388 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~~  450 (457)
                      .        .+.         .+..++..+.+++.+||+.||++||||.||++.|+++.++..
T Consensus       243 ~--------~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         243 Y--------RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             C--------CCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             C--------CCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            0        000         111235568999999999999999999999999999886543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-48  Score=365.91  Aligned_cols=246  Identities=26%  Similarity=0.347  Sum_probs=200.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---------hhhHHHHHHHHHHHhhcC-CCccceeeeeeecC
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---------ERTFVSFNSECEVLRNVR-HRNLIKILSGCSNL  241 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  241 (457)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...         ......+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6788999999999999999987 479999999987542         112346889999999997 99999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccc
Q 044428          242 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGIS  321 (457)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~  321 (457)
                      +..++||||+++|+|.+++..+. .+++.+...++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999998654 5899999999999999999999    678999999999999999999999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC----------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI----------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK  391 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~  391 (457)
                      +.......   .....||+.|+|||.+          ++.++||||+||++|||+||+.||...........+...    
T Consensus       158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~----  230 (277)
T d1phka_         158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG----  230 (277)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred             eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC----
Confidence            98754322   2446799999999933          577899999999999999999999865432222111111    


Q ss_pred             hHHhccccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          392 LAEVVDSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       392 ~~~~~d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                             ...   ........++.++.+++.+|++.||++|||+.||++
T Consensus       231 -------~~~---~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         231 -------NYQ---FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -------CCC---CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -------CCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   000   000011123456889999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=373.33  Aligned_cols=243  Identities=23%  Similarity=0.290  Sum_probs=200.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++++..   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999997 479999999997542   334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||    +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999999998765 4788899999999999999999    6789999999999999999999999999998764322


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .  .....+||+.|+|||.+    ++.++||||+||++|||++|+.||...+...+........         ..+.   
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~---------~~~p---  225 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRFP---  225 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CCCC---
T ss_pred             c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC---------CCCC---
Confidence            2  23446799999999954    7889999999999999999999997654322222111100         0010   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                            ..+...+.+++.+|++.||++||+     +.|+++
T Consensus       226 ------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 ------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                  012345789999999999999995     677764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.2e-48  Score=369.54  Aligned_cols=240  Identities=26%  Similarity=0.331  Sum_probs=198.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++...   ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57889999999999999999974 79999999997542   234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+++|+|..++.... .+++.....++.||+.||+|||    +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999998765 4788888899999999999999    788999999999999999999999999999986432 


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          .....||+.|+|||.+    ++.++||||+||++|||+||+.||...........+.           ..... ..
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-----------~~~~~-~p  221 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-----------NAELR-FP  221 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----------HCCCC-CC
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH-----------cCCCC-CC
Confidence                2346799999999933    7889999999999999999999997644222211111           11110 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                            ...+..+.+++.+|++.||.+||     |+.|+++
T Consensus       222 ------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 ------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                  01234578999999999999996     8888865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.9e-48  Score=364.82  Aligned_cols=256  Identities=20%  Similarity=0.376  Sum_probs=196.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----e
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD----F  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  243 (457)
                      .++|+..+.||+|+||.||+|+. .+|+.||||+++...   ......|.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36788999999999999999986 479999999997543   233457899999999999999999999887543    4


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||+++|+|.+++...+ .+++.+...++.||+.||+|||    ..+|+||||||+|||++.++..+++|||.++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceeehhhhhhh
Confidence            789999999999999987764 4899999999999999999999    67899999999999999999999999999886


Q ss_pred             cCCCCCc-ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          324 LGEGDDS-LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       324 ~~~~~~~-~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ....... .......||+.|+|||.    .++.++|||||||++|||+||+.||........   ........   ...+
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~~~~~~---~~~~  234 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---AYQHVRED---PIPP  234 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHCC---CCCG
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH---HHHHHhcC---CCCC
Confidence            5433222 22334679999999993    367899999999999999999999976432221   11111000   0000


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERI-HTTNAAAKLRKIK  446 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-s~~ev~~~L~~i~  446 (457)
                      ..        ...+++..+.+++.+|++.||++|| |++++.+.|.+++
T Consensus       235 ~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 SA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            00        0012245688999999999999999 8999999888764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=367.49  Aligned_cols=247  Identities=21%  Similarity=0.305  Sum_probs=201.2

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      .++|...+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++++.++|||||++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467889999999999999999875 788999999976543 334688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC--CCcEEEeccccccccCCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~  328 (457)
                      +++|+|.+++......+++.+...++.||+.||+|||    ..+|+||||||+|||++.  ...+||+|||+++......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999999999877667999999999999999999999    678999999999999984  4589999999998764432


Q ss_pred             CcceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                      .   .....+|+.|+|||.    .++.++||||+||++|||++|+.||...........+...           ...   
T Consensus       159 ~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~-----------~~~---  221 (321)
T d1tkia_         159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-----------EYT---  221 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----------CCC---
T ss_pred             c---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------CCC---
Confidence            2   234678999999993    3688999999999999999999999765432222211110           000   


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ........++..+.+++.+|++.||++|||+.|+++
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000011122456889999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-47  Score=374.34  Aligned_cols=244  Identities=20%  Similarity=0.286  Sum_probs=195.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHH---HHHHHhhcCCCccceeeeeeecCCeeE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNS---ECEVLRNVRHRNLIKILSGCSNLDFKA  245 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~  245 (457)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ......+.+   |+++++.++|||||++++++...+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57889999999999999999975 79999999986432   112223334   467777788999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccC
Q 044428          246 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLG  325 (457)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~  325 (457)
                      +||||+++|+|.+++.... .+++.....++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999998764 4789999999999999999999    6789999999999999999999999999999765


Q ss_pred             CCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccc
Q 044428          326 EGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNL  400 (457)
Q Consensus       326 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l  400 (457)
                      ...    .....||+.|+|||.+     ++.++|||||||++|||+||+.||...................        .
T Consensus       159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~--------~  226 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------V  226 (364)
T ss_dssp             SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC--------C
T ss_pred             CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--------C
Confidence            432    2346799999999933     6789999999999999999999998755444333222211110        0


Q ss_pred             cccccchhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          401 VRREHSFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       401 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                       ....      .++..+.+++.+|++.||++|||     +.|+++
T Consensus       227 -~~~~------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 -ELPD------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -CCCS------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CCCC------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             0000      12345889999999999999999     577753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-47  Score=369.72  Aligned_cols=240  Identities=22%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  248 (457)
                      ++|+.++.||+|+||.||+|+.. +|+.||||++....   ......+.+|+++++.++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999875 79999999997542   234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGD  328 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~  328 (457)
                      ||+.+|+|.+++...+ .+++.....++.||+.||.|||    ..+|+||||||+|||++.++.+||+|||+++.+... 
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999998764 4899999999999999999999    678999999999999999999999999999986432 


Q ss_pred             CcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccccccccc
Q 044428          329 DSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRRE  404 (457)
Q Consensus       329 ~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~  404 (457)
                          .....||+.|+|||.+    ++.++|||||||++|||+||+.||.......+...+...           ... ..
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-----------~~~-~p  258 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-----------KVR-FP  258 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------CCC-CC
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-----------CCC-CC
Confidence                2246799999999943    688999999999999999999999754322222211111           100 00


Q ss_pred             cchhHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 044428          405 HSFSAKMDCLLRIMNLALDCCMESPDERI-----HTTNAAA  440 (457)
Q Consensus       405 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----s~~ev~~  440 (457)
                            ..++..+.+++.+|++.||.+|+     |+.|+++
T Consensus       259 ------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 ------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                  01244588999999999999994     8888875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-47  Score=366.46  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=193.5

Q ss_pred             hhcCCcCC-ccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCccceeeeeeec----CCee
Q 044428          172 TNEFDECN-LLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNV-RHRNLIKILSGCSN----LDFK  244 (457)
Q Consensus       172 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  244 (457)
                      .++|.... .||+|+||.||+|+. .+|+.||||+++..     ..+.+|++++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35787764 599999999999987 57999999998643     3467899987665 89999999998865    4678


Q ss_pred             EEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC---CCcEEEecccc
Q 044428          245 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE---NMVAHVSDFGI  320 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~  320 (457)
                      ++|||||++|+|.+++.... ..+++.+...++.|++.||+|||    ..+|+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH----HcCCccccccccccccccccccccccccccce
Confidence            99999999999999998653 56899999999999999999999    678999999999999985   56799999999


Q ss_pred             ccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          321 SKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       321 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      ++.......   .....||+.|+|||.+    ++.++|||||||++|||+||+.||...........+.......     
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~-----  232 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-----  232 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC-----
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC-----
Confidence            997654322   2346799999999965    6789999999999999999999997644333222211111000     


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                        .   ..........++.++.+++.+|++.||++|||+.|+++
T Consensus       233 --~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 --Q---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --S---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --C---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              0   00011122344567899999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=363.47  Aligned_cols=262  Identities=23%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...  +.....+.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788999999999999999997 579999999996543  2235678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      |+.++.+..........+++..+..++.|++.||+|||    ..+||||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99655444443444566999999999999999999999    67799999999999999999999999999987654322


Q ss_pred             cceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhc--Cch--hHHhcc-cc
Q 044428          330 SLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSL--PHK--LAEVVD-SN  399 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~--~~~--~~~~~d-~~  399 (457)
                        ......||+.|+|||.     ..+.++||||+||++|||++|+.||......+...-+....  +..  ...+.. +.
T Consensus       158 --~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         158 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             --CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence              2334679999999993     35789999999999999999999997644322211111110  010  001000 00


Q ss_pred             cccc-----ccc-hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRR-----EHS-FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~-----~~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....     ... ..........+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0000     000 0000112346789999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=365.29  Aligned_cols=256  Identities=25%  Similarity=0.298  Sum_probs=191.0

Q ss_pred             CCccCCCCceEEEEEEeC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEecc
Q 044428          178 CNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLER-----TFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEFM  251 (457)
Q Consensus       178 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  251 (457)
                      +++||+|+||+||+|+.. +|+.||||+++.....     ....+.+|++++++++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999974 7999999999754321     1346889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCcc
Q 044428          252 PNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSL  331 (457)
Q Consensus       252 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  331 (457)
                      +++++..+... ...+++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 ~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          83 ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             SEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             cchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            88877666543 445888899999999999999999    67899999999999999999999999999987644322  


Q ss_pred             eeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHHhccc---c
Q 044428          332 IQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAEVVDS---N  399 (457)
Q Consensus       332 ~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~~~d~---~  399 (457)
                      ......||+.|+|||.+     ++.++|||||||++|||+||+.||......+....+.......    +.+....   .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            22346799999999943     5789999999999999999999997655433332222211100    0000000   0


Q ss_pred             ccccccch---hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          400 LVRREHSF---SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       400 l~~~~~~~---~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ........   .........+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000000   000012345889999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=365.17  Aligned_cols=242  Identities=24%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHh-hcCCCccceeeeeeecCCeeEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL---ERTFVSFNSECEVLR-NVRHRNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  247 (457)
                      ++|...+.||+|+||+||+|+.. +|+.||||+++...   ......+..|..++. .++|||||++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888999999999999999875 79999999997542   333456677777765 68999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCC
Q 044428          248 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~  327 (457)
                      |||+++|+|.+++.... .+++.+...++.||+.||+|||    +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999998654 4889999999999999999999    678999999999999999999999999999876432


Q ss_pred             CCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcccccccc
Q 044428          328 DDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDSNLVRR  403 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~  403 (457)
                      .  ...+...||+.|+|||    ..++.++|||||||++|||+||+.||.......+...+...         .+.+.  
T Consensus       157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------~~~~p--  223 (320)
T d1xjda_         157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------NPFYP--  223 (320)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------CCCCC--
T ss_pred             c--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCCCC--
Confidence            2  2234467999999999    34788999999999999999999999764432222211111         01010  


Q ss_pred             ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 044428          404 EHSFSAKMDCLLRIMNLALDCCMESPDERIHTT-NAA  439 (457)
Q Consensus       404 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~-ev~  439 (457)
                             ..++..+.+++.+|++.||++||++. |+.
T Consensus       224 -------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         224 -------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             -------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------ccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                   01244588999999999999999995 664

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-46  Score=357.21  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=196.2

Q ss_pred             hcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||+||+|+.++|+.||||+++...  +.....+.+|+.++++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788899999999999999999999999999997543  22356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCCc
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS  330 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~  330 (457)
                      +.++.+..+.... ..+++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+|++|||.+........ 
T Consensus        82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            9877666665544 56999999999999999999999    67799999999999999999999999999988654322 


Q ss_pred             ceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc----hhHHhc-----
Q 044428          331 LIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH----KLAEVV-----  396 (457)
Q Consensus       331 ~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~----~~~~~~-----  396 (457)
                       ......+++.|+|||.+     ++.++||||+||++|||++|+.||......+....+......    ...+..     
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence             22345689999999933     578999999999999999999999765432222211111110    000000     


Q ss_pred             cccccc-cccc-hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVR-REHS-FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~-~~~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      +..... .... ..........+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000 0000 0000112345789999999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=352.18  Aligned_cols=235  Identities=25%  Similarity=0.280  Sum_probs=190.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHhhcC--CCccceeeeeeecCCe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLE------RTFVSFNSECEVLRNVR--HRNLIKILSGCSNLDF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  243 (457)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++.....      .....+.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57888899999999999999874 799999999875421      12234678999999996  8999999999999999


Q ss_pred             eEEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-CCcEEEeccccc
Q 044428          244 KALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-NMVAHVSDFGIS  321 (457)
Q Consensus       244 ~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~  321 (457)
                      .++||||+.+ +++.+++.... .+++..+..++.|++.||+|||    +.+|+||||||+|||++. ++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 68888887654 4899999999999999999999    678999999999999985 479999999999


Q ss_pred             cccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          322 KLLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      +.....    ..+...||+.|+|||.+     .+.++||||+||++|||+||+.||....     .            +.
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~------------i~  217 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E------------II  217 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------------HH
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H------------Hh
Confidence            875432    22346799999999933     3567999999999999999999996421     0            00


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..... ...      .++.++.+++.+|++.||++|||+.|+++
T Consensus       218 ~~~~~-~~~------~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQVF-FRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCCCC-CSS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcccC-CCC------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            00000 000      11345789999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=355.36  Aligned_cols=263  Identities=23%  Similarity=0.297  Sum_probs=194.7

Q ss_pred             HhhcCCcCCccCCCCceEEEEEEeC-C-CCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCccceeeeeeec---
Q 044428          171 ATNEFDECNLLGIGSFGSVYKGTLS-D-GTNVAIKIFNLQLE--RTFVSFNSECEVLRNV---RHRNLIKILSGCSN---  240 (457)
Q Consensus       171 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  240 (457)
                      +.++|+.++.||+|+||+||+|+.. + ++.||||+++....  .....+.+|+.+++.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3478999999999999999999873 4 67799999975432  2234567788877766   79999999998853   


Q ss_pred             --CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecc
Q 044428          241 --LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF  318 (457)
Q Consensus       241 --~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  318 (457)
                        ....+++|||++++++..........+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeecch
Confidence              34789999999988877666666667899999999999999999999    678999999999999999999999999


Q ss_pred             ccccccCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHH
Q 044428          319 GISKLLGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAE  394 (457)
Q Consensus       319 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~  394 (457)
                      |+++....   ........||+.|+|||.+    ++.++||||+||++|||+||+.||......+....+.........+
T Consensus       161 g~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            99886432   2233457899999999943    7889999999999999999999997654333222221111100000


Q ss_pred             hccc-------ccccc-ccc-hhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VVDS-------NLVRR-EHS-FSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~d~-------~l~~~-~~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ....       ..... ... ..........+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000       00000 000 0000112345789999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=352.59  Aligned_cols=262  Identities=22%  Similarity=0.255  Sum_probs=192.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----eeEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL-ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD----FKAL  246 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  246 (457)
                      .+|+..+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+++|++++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4688899999999999999986 489999999997543 334567899999999999999999999986543    2345


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCC
Q 044428          247 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGE  326 (457)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~  326 (457)
                      +++|+.+|+|.+++....  +++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        88 l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            556677999999998764  899999999999999999999    67899999999999999999999999999987644


Q ss_pred             CCCcc-eeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch-h-------
Q 044428          327 GDDSL-IQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK-L-------  392 (457)
Q Consensus       327 ~~~~~-~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~-~-------  392 (457)
                      ..... ......||+.|+|||.+     ++.++||||+||++|||++|+.||......+............ .       
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            32221 22346799999999944     5678999999999999999999997654322222211111110 0       


Q ss_pred             ----HHhccccccccccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          393 ----AEVVDSNLVRREHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       393 ----~~~~d~~l~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                          ................ .......++.+++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000000000000000 00011235789999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-44  Score=345.62  Aligned_cols=264  Identities=20%  Similarity=0.296  Sum_probs=192.0

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec--------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN--------  240 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  240 (457)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++....  +.....+.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999997 489999999986542  3345678899999999999999999998754        


Q ss_pred             CCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccc
Q 044428          241 LDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGI  320 (457)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  320 (457)
                      .+..++||||++++++...... ...++......++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEeeecce
Confidence            3467999999987766655443 345888899999999999999999    67899999999999999999999999999


Q ss_pred             ccccCCCCCcc--eeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---
Q 044428          321 SKLLGEGDDSL--IQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---  390 (457)
Q Consensus       321 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---  390 (457)
                      ++.........  ......||+.|+|||.+     ++.++||||+||++|||++|+.||...........+......   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            98765332221  12235799999999932     678999999999999999999999765433332222221111   


Q ss_pred             hh-HHhccccc-------cccccchh---HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          391 KL-AEVVDSNL-------VRREHSFS---AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       391 ~~-~~~~d~~l-------~~~~~~~~---~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .. ........       ........   ........+.+++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00 00000000       00000000   01111335678999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-44  Score=341.49  Aligned_cols=258  Identities=19%  Similarity=0.225  Sum_probs=196.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceee-eeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKIL-SGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-~~~~~~~~~~lv~e~  250 (457)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++.....  ...+..|+++++.++|+|++..+ ++....+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            4688999999999999999987 4789999999875432  34578899999999888766655 455777888999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeec---CCCcEEEeccccccccCCC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLD---ENMVAHVSDFGISKLLGEG  327 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~~~~~  327 (457)
                      + +++|.+.+......+++..+..++.|++.||+|||    ..+|+||||||+|||++   .+..+||+|||+|+.+...
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9 66777777766667999999999999999999999    67899999999999875   4567999999999987543


Q ss_pred             CCc-----ceeccccccccccCCCC----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhccc
Q 044428          328 DDS-----LIQTKTMATIGYMAPEG----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVDS  398 (457)
Q Consensus       328 ~~~-----~~~~~~~gt~~y~aPE~----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d~  398 (457)
                      ...     .......||+.|+|||.    .++.++|||||||++|||+||+.||...........+.......       
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-------  232 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------  232 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-------
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-------
Confidence            322     12234679999999993    37889999999999999999999997644332222211110000       


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHH
Q 044428          399 NLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKV  447 (457)
Q Consensus       399 ~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~  447 (457)
                       +...  .......++.++.+++..|++.+|++||++.++.+.|+.+..
T Consensus       233 -~~~~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         233 -MSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             -HHSC--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             -CCCC--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence             0000  000011235668999999999999999999999999888644

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=349.30  Aligned_cols=257  Identities=24%  Similarity=0.303  Sum_probs=190.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLD------  242 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  242 (457)
                      .++|+.++.||+|+||+||+|... +|+.||||+++...  ......+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357889999999999999999874 79999999997542  334567889999999999999999999987654      


Q ss_pred             eeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecccccc
Q 044428          243 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISK  322 (457)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~  322 (457)
                      ..++||||+ +++|..+.....  +++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhccccccccccccccee
Confidence            579999999 678888877654  899999999999999999999    6789999999999999999999999999998


Q ss_pred             ccCCCCCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCc---hhHH
Q 044428          323 LLGEGDDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPH---KLAE  394 (457)
Q Consensus       323 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~---~~~~  394 (457)
                      .....     .+...||+.|+|||.+     .+.++||||+||++|||++|+.||..................   ...+
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            76432     2346799999999933     578999999999999999999999765432222111111100   0000


Q ss_pred             h--------ccccccccc-cch-hHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 V--------VDSNLVRRE-HSF-SAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~--------~d~~l~~~~-~~~-~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      .        ....+.... ... .........+.+++.+|++.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0        000000000 000 000112345789999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=351.30  Aligned_cols=256  Identities=23%  Similarity=0.292  Sum_probs=188.3

Q ss_pred             cCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCccceeeeeeec------CCeeEE
Q 044428          174 EFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNLIKILSGCSN------LDFKAL  246 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l  246 (457)
                      +|...++||+|+||+||+|+.. +|+.||||++.....    .+.+|++++++++||||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777889999999999999975 799999999975432    23479999999999999999998853      235789


Q ss_pred             EEeccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccc
Q 044428          247 VLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKL  323 (457)
Q Consensus       247 v~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~  323 (457)
                      ||||++++.+..+..  .....+++.++..++.||+.||+|||    +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999998665444432  23456999999999999999999999    78899999999999999775 899999999987


Q ss_pred             cCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCch----hHH
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHK----LAE  394 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~----~~~  394 (457)
                      ......   .....||+.|+|||.     .++.++||||+||++|||++|+.||......+...-+.......    +.+
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            654322   234679999999993     36889999999999999999999997644322211111111110    111


Q ss_pred             hc----cccccc---cccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VV----DSNLVR---REHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~----d~~l~~---~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..    +.....   ..............+.+|+.+|++.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10    000000   00000000012345789999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-43  Score=336.25  Aligned_cols=260  Identities=16%  Similarity=0.141  Sum_probs=205.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CccceeeeeeecCCeeEEEEec
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH-RNLIKILSGCSNLDFKALVLEF  250 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  250 (457)
                      ++|...+.||+|+||+||+|+.. +|+.||||++....  ....+.+|++.+..++| +|++.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57888999999999999999975 78999999986543  22457789999999975 8999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecC-----CCcEEEeccccccccC
Q 044428          251 MPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDE-----NMVAHVSDFGISKLLG  325 (457)
Q Consensus       251 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfg~~~~~~  325 (457)
                      + +++|.+++......+++.....++.|++.||+|||    +.+|+||||||+|||++.     ++.+||+|||+++.+.
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9 78999999887777999999999999999999999    788999999999999974     5789999999999865


Q ss_pred             CCCCc-----ceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhc
Q 044428          326 EGDDS-----LIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVV  396 (457)
Q Consensus       326 ~~~~~-----~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~  396 (457)
                      .....     .......||+.|+|||.+    ++.++|||||||++|||+||+.||.................... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STP  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSC
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCC
Confidence            43221     122346799999999933    78899999999999999999999986544333322211100000 000


Q ss_pred             cccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhHHHH
Q 044428          397 DSNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAAKLRKIKVQF  449 (457)
Q Consensus       397 d~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~~L~~i~~~~  449 (457)
                      -+.+         ...++.++.+++..|++.+|++||+++.+.+.|+++.++.
T Consensus       237 ~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         237 LREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0000         0123556899999999999999999999999998877654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=336.24  Aligned_cols=259  Identities=20%  Similarity=0.263  Sum_probs=197.6

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCeeEEEEe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      ++|+.++.||+|+||+||+|+. .+|+.||||+++...  ......+.+|+.+++.++||||+++++++...+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4788999999999999999997 478999999996543  3346788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccccCCCCC
Q 044428          250 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD  329 (457)
Q Consensus       250 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~  329 (457)
                      ++.+++|..++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999999988877554 5789999999999999999999    67899999999999999999999999999998654322


Q ss_pred             cceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHh---hcCc----hh---HH
Q 044428          330 SLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQ---SLPH----KL---AE  394 (457)
Q Consensus       330 ~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~---~~~~----~~---~~  394 (457)
                        ......+++.|+|||.     ..+.++||||+||++|||++|+.||....  +..+....   ....    ..   ..
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhhh
Confidence              2233557788999983     25789999999999999999999975432  22222111   1000    00   00


Q ss_pred             hcccc----ccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          395 VVDSN----LVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       395 ~~d~~----l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                      ..+..    .................+.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000    00000000001112345789999999999999999999865

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=344.16  Aligned_cols=248  Identities=25%  Similarity=0.324  Sum_probs=196.7

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC----CCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCC-CccceeeeeeecCCe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS----DGTNVAIKIFNLQL----ERTFVSFNSECEVLRNVRH-RNLIKILSGCSNLDF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  243 (457)
                      ++|+..+.||+|+||+||+|+..    +|+.||||+++...    ......+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999852    58899999987542    2334568899999999977 899999999999999


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||+.+|+|.+++..... ++......++.|++.||+|+|    ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999987653 677888899999999999999    67799999999999999999999999999987


Q ss_pred             cCCCCCcceeccccccccccCCCCC------CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHhcc
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI------VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEVVD  397 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~~d  397 (457)
                      +...... ......|++.|+|||.+      ++.++|||||||+||||+||+.||...........+...       ...
T Consensus       179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-------~~~  250 (322)
T d1vzoa_         179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-------ILK  250 (322)
T ss_dssp             CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-------HHH
T ss_pred             hcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-------ccc
Confidence            6432222 23346799999999933      577899999999999999999999765433322221111       000


Q ss_pred             ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 044428          398 SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIH-----TTNAAA  440 (457)
Q Consensus       398 ~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----~~ev~~  440 (457)
                      .... .      +.++...+.+++.+|+++||++|||     ++|+++
T Consensus       251 ~~~~-~------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 SEPP-Y------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCC-C------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCC-C------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            0000 0      0122456899999999999999995     677764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.5e-43  Score=336.60  Aligned_cols=254  Identities=19%  Similarity=0.280  Sum_probs=191.1

Q ss_pred             hcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeec--CCeeEEEE
Q 044428          173 NEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSN--LDFKALVL  248 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  248 (457)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...   ...+.+|++++.+++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999997 479999999987542   456889999999995 9999999999864  45689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC-cEEEeccccccccCCC
Q 044428          249 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM-VAHVSDFGISKLLGEG  327 (457)
Q Consensus       249 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~  327 (457)
                      ||+++++|..+..    .+++..+..++.||+.||+|||    +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999977642    4899999999999999999999    67899999999999998654 6999999999876543


Q ss_pred             CCcceeccccccccccCCCCC-----CCCccchhhhhHHHHHHhcCCCCCCCCCCCc-HHHHHHhhcC------------
Q 044428          328 DDSLIQTKTMATIGYMAPEGI-----VSTKCDVYSYGILLLETFSRKKPTNDLGEMS-LKHWVNQSLP------------  389 (457)
Q Consensus       328 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~-l~~~~~~~~~------------  389 (457)
                      ..   .....+|+.|+|||.+     ++.++||||+||+++|+++|+.||....... ....+.....            
T Consensus       184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            22   2446789999999932     5788999999999999999999997643211 1111111000            


Q ss_pred             -c---hhHHhcccccccc---ccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          390 -H---KLAEVVDSNLVRR---EHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       390 -~---~~~~~~d~~l~~~---~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       .   ...+.........   ............++.+|+.+|++.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0   0001100000000   0000011122345789999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=342.54  Aligned_cols=258  Identities=21%  Similarity=0.279  Sum_probs=192.1

Q ss_pred             hhcCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Ce
Q 044428          172 TNEFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSNL-----DF  243 (457)
Q Consensus       172 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  243 (457)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++...  ......+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999986 479999999997543  23445788999999999999999999988533     34


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .+++++|+.+|+|.+++..+.  +++..+..++.||+.||+|||    ..+|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~--l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccccc--ccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCccccccccccccccccchhcc
Confidence            466778888999999997654  899999999999999999999    67899999999999999999999999999976


Q ss_pred             cCCCCCcceeccccccccccCCCC-----CCCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcCchhHHh---
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEG-----IVSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLPHKLAEV---  395 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~~~~~~~---  395 (457)
                      ...     ......||+.|+|||.     ..+.++||||+||++|||++|+.||...+.......+.........+.   
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            432     2234678999999993     257899999999999999999999976543333222221111100000   


Q ss_pred             --------ccccccc-cccchh-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          396 --------VDSNLVR-REHSFS-AKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       396 --------~d~~l~~-~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                              ....+.. ...... ........+.+++.+|++.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                    0000000 000000 00112345789999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-42  Score=335.28  Aligned_cols=255  Identities=24%  Similarity=0.267  Sum_probs=184.4

Q ss_pred             hcCCcCCccCCCCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCccceeeeeeec------CCe
Q 044428          173 NEFDECNLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL--ERTFVSFNSECEVLRNVRHRNLIKILSGCSN------LDF  243 (457)
Q Consensus       173 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  243 (457)
                      ++|+..++||+|+||+||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57899999999999999999975 79999999997543  3344568899999999999999999999853      468


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          244 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      .++||||+.++ +.+.+..   .+++.....++.|++.||+|||    ..+|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeeechhhhhc
Confidence            89999999655 4444432   3889999999999999999999    67899999999999999999999999999887


Q ss_pred             cCCCCCcceeccccccccccCCCCC----CCCccchhhhhHHHHHHhcCCCCCCCCCCCcHHHHHHhhcC----------
Q 044428          324 LGEGDDSLIQTKTMATIGYMAPEGI----VSTKCDVYSYGILLLETFSRKKPTNDLGEMSLKHWVNQSLP----------  389 (457)
Q Consensus       324 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~l~~~~~~~~~----------  389 (457)
                      .....   ......+|+.|+|||.+    ++.++||||+||+++||++|+.||...+......-+.....          
T Consensus       169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            54322   23446789999999943    67899999999999999999999975432221111111000          


Q ss_pred             -chhHHhcc---------------ccccccccchhHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 044428          390 -HKLAEVVD---------------SNLVRREHSFSAKMDCLLRIMNLALDCCMESPDERIHTTNAAA  440 (457)
Q Consensus       390 -~~~~~~~d---------------~~l~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~ev~~  440 (457)
                       ....+...               ......  ...........+.+++.+|+..||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPA--DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCC--SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccc--cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             00111111               111100  01122344667899999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-37  Score=299.14  Aligned_cols=258  Identities=20%  Similarity=0.244  Sum_probs=180.3

Q ss_pred             cCCcCCccCCCCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCccceeeeeeec-
Q 044428          174 EFDECNLLGIGSFGSVYKGTL-SDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-----------HRNLIKILSGCSN-  240 (457)
Q Consensus       174 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~-  240 (457)
                      +|+..+.||+|+||+||+|+. .+|+.||||+++... .....+.+|+.+++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            588899999999999999997 479999999997653 23356788888888775           5789999988754 


Q ss_pred             -CCeeEEEEeccCCCCHHH-HHh-hCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCC------
Q 044428          241 -LDFKALVLEFMPNGSLEK-WLY-SHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENM------  311 (457)
Q Consensus       241 -~~~~~lv~e~~~~g~L~~-~l~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~------  311 (457)
                       ....+++++++..+.... ... .....+++..+..++.||+.||+|||+   ..+|+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCcccccc
Confidence             345666776665544332 222 333568889999999999999999994   26799999999999998655      


Q ss_pred             cEEEeccccccccCCCCCcceeccccccccccCCC----CCCCCccchhhhhHHHHHHhcCCCCCCCCCCCc---HHHH-
Q 044428          312 VAHVSDFGISKLLGEGDDSLIQTKTMATIGYMAPE----GIVSTKCDVYSYGILLLETFSRKKPTNDLGEMS---LKHW-  383 (457)
Q Consensus       312 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE----~~~~~~~Dv~s~Gvvl~el~tg~~p~~~~~~~~---l~~~-  383 (457)
                      .++++|||.+......     .....||+.|+|||    .-++.++||||+||+++||++|+.||.......   .... 
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            3999999999865322     23467999999999    336889999999999999999999997633211   1111 


Q ss_pred             ---HHh--hcCchh-------HHhcccc-----cccccc---------chhHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 044428          384 ---VNQ--SLPHKL-------AEVVDSN-----LVRREH---------SFSAKMDCLLRIMNLALDCCMESPDERIHTTN  437 (457)
Q Consensus       384 ---~~~--~~~~~~-------~~~~d~~-----l~~~~~---------~~~~~~~~~~~l~~l~~~C~~~~P~~RPs~~e  437 (457)
                         +..  ..+...       ...++..     +.....         ...........+.+++.+|+..||++|||+.|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence               100  000000       1111100     000000         00011244667899999999999999999999


Q ss_pred             HHH
Q 044428          438 AAA  440 (457)
Q Consensus       438 v~~  440 (457)
                      +++
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1e-23  Score=186.16  Aligned_cols=132  Identities=17%  Similarity=0.197  Sum_probs=104.4

Q ss_pred             cCCccCCCCceEEEEEEeCCCCEEEEEEecccc------------------hhhHHHHHHHHHHHhhcCCCccceeeeee
Q 044428          177 ECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQL------------------ERTFVSFNSECEVLRNVRHRNLIKILSGC  238 (457)
Q Consensus       177 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~~  238 (457)
                      ..++||+|+||+||+|+..+|+.||||+++...                  ........+|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            346899999999999999899999999875321                  01123456788899999999999887653


Q ss_pred             ecCCeeEEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEecc
Q 044428          239 SNLDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDF  318 (457)
Q Consensus       239 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  318 (457)
                      .    .+++|||++++.+.+        ++......++.|++.++.|||    ..+|+||||||+|||++++ .++|+||
T Consensus        84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             C----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            2    379999998766543        333345678999999999999    6789999999999999965 5899999


Q ss_pred             ccccccC
Q 044428          319 GISKLLG  325 (457)
Q Consensus       319 g~~~~~~  325 (457)
                      |.|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9998754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.45  E-value=3e-14  Score=134.47  Aligned_cols=97  Identities=35%  Similarity=0.611  Sum_probs=89.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .++.+++|+.|++++|.++|.+| +++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..+.+.++.
T Consensus       216 ~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~  294 (313)
T d1ogqa_         216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD  294 (313)
T ss_dssp             GCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSC
T ss_pred             ccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCC
Confidence            35678999999999999998765 68999999999999999999999999999999999999999999999988899999


Q ss_pred             ccccccccccCCCCCcCCCCC
Q 044428           82 TESFSWNYALCGPSRFQVPPC  102 (457)
Q Consensus        82 ~~~~~~n~~lcg~~~~~~~~c  102 (457)
                      .+.+.+|+.+||.+   .|+|
T Consensus       295 ~l~l~~N~~l~g~p---lp~c  312 (313)
T d1ogqa_         295 VSAYANNKCLCGSP---LPAC  312 (313)
T ss_dssp             GGGTCSSSEEESTT---SSCC
T ss_pred             HHHhCCCccccCCC---CCCC
Confidence            99999999999975   4566

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.22  E-value=8.4e-12  Score=100.38  Aligned_cols=86  Identities=22%  Similarity=0.282  Sum_probs=70.3

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCC--CCCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP--VEGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p--~~~~~~~   79 (457)
                      .+++|++|++|+|++|+|+ .+|++++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|+++...+  ....+++
T Consensus        15 ~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~   91 (124)
T d1dcea3          15 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR   91 (124)
T ss_dssp             CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred             ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCC
Confidence            4677889999999999998 78888999999999999999998 666 48889999999999999986543  2345567


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|+.
T Consensus        92 L~~L~l~~N~i  102 (124)
T d1dcea3          92 LVLLNLQGNSL  102 (124)
T ss_dssp             CCEEECTTSGG
T ss_pred             CCEEECCCCcC
Confidence            77888888863

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.18  E-value=1.4e-11  Score=107.23  Aligned_cols=91  Identities=24%  Similarity=0.364  Sum_probs=60.2

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.. ..+.++.
T Consensus        50 f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~  129 (192)
T d1w8aa_          50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT  129 (192)
T ss_dssp             GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred             cCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccc
Confidence            456677777777777777666666777777777777777777444445667777777777777777666542 3455666


Q ss_pred             ccccccccccCC
Q 044428           82 TESFSWNYALCG   93 (457)
Q Consensus        82 ~~~~~~n~~lcg   93 (457)
                      .+.+++|++.|.
T Consensus       130 ~l~L~~N~~~~~  141 (192)
T d1w8aa_         130 SLNLASNPFNCN  141 (192)
T ss_dssp             EEECTTCCBCCS
T ss_pred             cccccccccccc
Confidence            667777766543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=1.2e-10  Score=97.41  Aligned_cols=91  Identities=20%  Similarity=0.199  Sum_probs=76.0

Q ss_pred             CccCCccCCeeeccCC-cccccCC-cccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccc
Q 044428            2 TIGGLKDLATLSLAAN-KFHGPIP-KSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N-~l~g~~p-~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~   79 (457)
                      .+.++++|++|+|++| .|+ .|| ..|.++++|+.|+|++|+|+..-|..|..+++|+.|+|++|+|+...+......+
T Consensus        26 ~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~  104 (156)
T d2ifga3          26 HLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS  104 (156)
T ss_dssp             TSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC
T ss_pred             cccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcccc
Confidence            3567889999999766 588 565 6799999999999999999955567799999999999999999977775544456


Q ss_pred             ccccccccccccCC
Q 044428           80 FSTESFSWNYALCG   93 (457)
Q Consensus        80 ~~~~~~~~n~~lcg   93 (457)
                      +..+.+++|++.|.
T Consensus       105 l~~L~L~~Np~~C~  118 (156)
T d2ifga3         105 LQELVLSGNPLHCS  118 (156)
T ss_dssp             CCEEECCSSCCCCC
T ss_pred             ccccccCCCcccCC
Confidence            88899999998764

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.03  E-value=1.9e-10  Score=92.20  Aligned_cols=77  Identities=27%  Similarity=0.308  Sum_probs=69.4

Q ss_pred             CeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccccccccccc
Q 044428           10 ATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFSWNY   89 (457)
Q Consensus        10 ~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~   89 (457)
                      +.|+|++|+|+ .+| .++++++|++|+|++|+|+ .+|+.+..+++|+.|++++|++++. |....++++..+.+++|.
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCc
Confidence            57999999999 777 4999999999999999999 8999999999999999999999975 556778889999999986


Q ss_pred             c
Q 044428           90 A   90 (457)
Q Consensus        90 ~   90 (457)
                      .
T Consensus        77 i   77 (124)
T d1dcea3          77 L   77 (124)
T ss_dssp             C
T ss_pred             c
Confidence            4

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.01  E-value=5.3e-11  Score=111.65  Aligned_cols=84  Identities=30%  Similarity=0.460  Sum_probs=64.4

Q ss_pred             cCCeeeccCCcccc--cCCcccCCCCCCCeEeCcC-CccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccccc
Q 044428            8 DLATLSLAANKFHG--PIPKSFGSLISLESLDLSS-NNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFSTE   83 (457)
Q Consensus         8 ~L~~l~l~~N~l~g--~~p~~~~~l~~l~~l~l~~-n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~   83 (457)
                      +++.|+|++|.++|  .||++|++|++|++|+|++ |+++|.||++++++++|++|+|++|++.+.+|.. ..+..+..+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            57788888888887  4788888888888888876 7888888888888888888888888888877642 334455666


Q ss_pred             cccccccc
Q 044428           84 SFSWNYAL   91 (457)
Q Consensus        84 ~~~~n~~l   91 (457)
                      .++.|...
T Consensus       131 ~l~~N~~~  138 (313)
T d1ogqa_         131 DFSYNALS  138 (313)
T ss_dssp             ECCSSEEE
T ss_pred             cccccccc
Confidence            66666543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.93  E-value=1.2e-09  Score=99.70  Aligned_cols=91  Identities=25%  Similarity=0.188  Sum_probs=74.6

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +..+.+|+.|++++|.+++..|..+..+++|+.|++++|+|++..|..+..+++|+.|+|++|+|+..++....+.++..
T Consensus       120 ~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~  199 (266)
T d1p9ag_         120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPF  199 (266)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSE
T ss_pred             cccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCE
Confidence            45567778888888888854456678899999999999999976667789999999999999999955555566778899


Q ss_pred             cccccccccCC
Q 044428           83 ESFSWNYALCG   93 (457)
Q Consensus        83 ~~~~~n~~lcg   93 (457)
                      +.+++||+.|.
T Consensus       200 L~L~~Np~~Cd  210 (266)
T d1p9ag_         200 AFLHGNPWLCN  210 (266)
T ss_dssp             EECCSCCBCCS
T ss_pred             EEecCCCCCCC
Confidence            99999999885

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=3.4e-10  Score=95.28  Aligned_cols=86  Identities=19%  Similarity=0.143  Sum_probs=69.6

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCcccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNF   80 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~   80 (457)
                      ++.++.+|++|+|++|+|+ .||..+..+++|+.|+|++|+|+ .++ .+..+++|+.|++++|+++...+.. ..++++
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            4567788899999999998 78877788999999999999998 775 5788899999999999998776643 346677


Q ss_pred             cccccccccc
Q 044428           81 STESFSWNYA   90 (457)
Q Consensus        81 ~~~~~~~n~~   90 (457)
                      ..+.+++|..
T Consensus        90 ~~L~L~~N~i   99 (162)
T d1a9na_          90 TELILTNNSL   99 (162)
T ss_dssp             CEEECCSCCC
T ss_pred             ccceeccccc
Confidence            8888888753

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.87  E-value=9.8e-10  Score=101.31  Aligned_cols=91  Identities=24%  Similarity=0.278  Sum_probs=69.3

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCC-CCCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPV-EGPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~-~~~~~~~~   81 (457)
                      +..+++|+.|+|++|+|++..|..|..+++|+.|++++|++++..|..|..+++|+.|++++|++++.+|. ...+.++.
T Consensus       149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~  228 (284)
T d1ozna_         149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ  228 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred             hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence            55677788888888888866667777888888888888888877777888888888888888888877663 24566777


Q ss_pred             ccccccccccCC
Q 044428           82 TESFSWNYALCG   93 (457)
Q Consensus        82 ~~~~~~n~~lcg   93 (457)
                      .+.+++|+..|.
T Consensus       229 ~L~l~~N~l~C~  240 (284)
T d1ozna_         229 YLRLNDNPWVCD  240 (284)
T ss_dssp             EEECCSSCEECS
T ss_pred             EEEecCCCCCCC
Confidence            888888887663

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.86  E-value=6.1e-10  Score=96.53  Aligned_cols=92  Identities=27%  Similarity=0.329  Sum_probs=71.0

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+....+.......+.
T Consensus        73 ~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~  152 (192)
T d1w8aa_          73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLR  152 (192)
T ss_dssp             TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHH
T ss_pred             ccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhh
Confidence            46789999999999999996666789999999999999999996666678999999999999999987654321111233


Q ss_pred             ccccccccccCC
Q 044428           82 TESFSWNYALCG   93 (457)
Q Consensus        82 ~~~~~~n~~lcg   93 (457)
                      ...+..|...|.
T Consensus       153 ~~~l~~~~~~c~  164 (192)
T d1w8aa_         153 KKSLNGGAARCG  164 (192)
T ss_dssp             HHCCSGGGCBBC
T ss_pred             hhcccCCCeEeC
Confidence            334444544454

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.78  E-value=2.8e-09  Score=89.55  Aligned_cols=84  Identities=18%  Similarity=0.216  Sum_probs=69.9

Q ss_pred             cCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCcc-chhcCCCceEecccccCCCCC--CCCCCcccc
Q 044428            4 GGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKS-LEALLYLKQLNVSQNRLEGEI--PVEGPFRNF   80 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~L~~l~l~~n~l~~~~--p~~~~~~~~   80 (457)
                      ..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++ .+|.. +..+++|+.|++++|+++...  .....++++
T Consensus        38 ~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L  114 (162)
T d1a9na_          38 ATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL  114 (162)
T ss_dssp             GGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTC
T ss_pred             cccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccceecccccccccccccccccccc
Confidence            56889999999999999 775 5899999999999999999 67765 467999999999999998643  233456778


Q ss_pred             cccccccccc
Q 044428           81 STESFSWNYA   90 (457)
Q Consensus        81 ~~~~~~~n~~   90 (457)
                      ..+.+.+|+.
T Consensus       115 ~~L~l~~N~i  124 (162)
T d1a9na_         115 TYLCILRNPV  124 (162)
T ss_dssp             CEEECCSSGG
T ss_pred             chhhcCCCcc
Confidence            8888888853

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.76  E-value=4.4e-09  Score=87.65  Aligned_cols=66  Identities=27%  Similarity=0.321  Sum_probs=60.0

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCC
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE   68 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~   68 (457)
                      +|.+|++|+.|+|++|+|++.-|..|..+++|++|+|++|+|+ .+|.......+|+.|+|++|.+.
T Consensus        51 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          51 DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             hhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            5788999999999999999655778999999999999999999 89888777678999999999986

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.75  E-value=7.3e-09  Score=96.22  Aligned_cols=91  Identities=22%  Similarity=0.258  Sum_probs=69.1

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-------
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-------   74 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-------   74 (457)
                      .+.+++.++.|++++|++++..|..+.++++|++|+|++|+|+ .||..+.++++|+.|+|++|+|+...+..       
T Consensus       190 ~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~  268 (305)
T d1xkua_         190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN  268 (305)
T ss_dssp             GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCC
T ss_pred             Hhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchh
Confidence            3567788888888888888766778888888888888888888 78888888888888888888888643211       


Q ss_pred             CCcccccccccccccccCC
Q 044428           75 GPFRNFSTESFSWNYALCG   93 (457)
Q Consensus        75 ~~~~~~~~~~~~~n~~lcg   93 (457)
                      ....++..+.+.+|++.+.
T Consensus       269 ~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         269 TKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             TTSCCCSEEECCSSSSCGG
T ss_pred             cccCCCCEEECCCCcCccC
Confidence            1234566677888876543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.69  E-value=9.3e-08  Score=86.39  Aligned_cols=151  Identities=15%  Similarity=0.097  Sum_probs=104.9

Q ss_pred             HHHHHHhhcCCcCCccCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCee
Q 044428          166 LDIQRATNEFDECNLLGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFK  244 (457)
Q Consensus       166 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  244 (457)
                      .++.+..+.|...+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+....+..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35666667777655544455578999875 56667889887655445556788988888774 43456778888888889


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 044428          245 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGLALEYLHYGH----------------------------------  290 (457)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------  290 (457)
                      ++||+++++.++.+......      ....++.+++..+..||...                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988866543221      12334555666666666211                                  


Q ss_pred             ---------------------CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          291 ---------------------ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       291 ---------------------~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                                           ....++|+|+.|.||+++++...-|.||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 112379999999999999877777999997764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=1.2e-08  Score=92.86  Aligned_cols=81  Identities=21%  Similarity=0.226  Sum_probs=59.0

Q ss_pred             ccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccccc
Q 044428            7 KDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESFS   86 (457)
Q Consensus         7 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~   86 (457)
                      ++|+.|+|++|+|++.-|..|.++++|++|+|++|+|+ .+|. ++.+++|+.|+|++|++++..+....+.++..+.++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccccccccccccccccccccc
Confidence            35788888888887444456788888888888888887 6664 466778888888888887776666666667777776


Q ss_pred             ccc
Q 044428           87 WNY   89 (457)
Q Consensus        87 ~n~   89 (457)
                      +|.
T Consensus       109 ~~~  111 (266)
T d1p9ag_         109 FNR  111 (266)
T ss_dssp             SSC
T ss_pred             ccc
Confidence            664

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.57  E-value=2.4e-08  Score=95.33  Aligned_cols=81  Identities=25%  Similarity=0.359  Sum_probs=65.1

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +..+++|+.|+|++|++++ ++ .+..+++|++|+|++|+|+ .+| .+.++++|+.|++++|++++.+| ...++++..
T Consensus       303 ~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~  377 (384)
T d2omza2         303 ISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQ  377 (384)
T ss_dssp             GGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSE
T ss_pred             cchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCE
Confidence            4567888899999999985 44 3788899999999999998 565 68889999999999999988776 456677777


Q ss_pred             cccccc
Q 044428           83 ESFSWN   88 (457)
Q Consensus        83 ~~~~~n   88 (457)
                      +.+++|
T Consensus       378 L~L~~N  383 (384)
T d2omza2         378 LGLNDQ  383 (384)
T ss_dssp             EECCCE
T ss_pred             eeCCCC
Confidence            777776

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.49  E-value=1.7e-09  Score=94.04  Aligned_cols=83  Identities=23%  Similarity=0.215  Sum_probs=67.4

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +++|++|+.|+|++|+|+ .++ .|..|++|+.|+|++|+|+ .+|.....+++|+.|++++|+++.. +....+.++..
T Consensus        44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~  119 (198)
T d1m9la_          44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRV  119 (198)
T ss_dssp             HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSE
T ss_pred             HhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccc
Confidence            567889999999999998 776 5889999999999999998 8887666677899999999998864 33445567777


Q ss_pred             ccccccc
Q 044428           83 ESFSWNY   89 (457)
Q Consensus        83 ~~~~~n~   89 (457)
                      +.+++|.
T Consensus       120 L~L~~N~  126 (198)
T d1m9la_         120 LYMSNNK  126 (198)
T ss_dssp             EEESEEE
T ss_pred             cccccch
Confidence            7777774

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.47  E-value=1.9e-09  Score=93.73  Aligned_cols=86  Identities=22%  Similarity=0.258  Sum_probs=72.9

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCC--CCCCCccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEI--PVEGPFRN   79 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~--p~~~~~~~   79 (457)
                      .+++|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ .++ .+..+++|+.|++++|+++...  .....+++
T Consensus        65 ~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~  141 (198)
T d1m9la_          65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDK  141 (198)
T ss_dssp             CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred             cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhccccccccccCCCc
Confidence            4667899999999999998 88887777889999999999999 664 5889999999999999998653  23456778


Q ss_pred             ccccccccccc
Q 044428           80 FSTESFSWNYA   90 (457)
Q Consensus        80 ~~~~~~~~n~~   90 (457)
                      +..+.+++|+.
T Consensus       142 L~~L~L~~N~l  152 (198)
T d1m9la_         142 LEDLLLAGNPL  152 (198)
T ss_dssp             CSEEEECSSHH
T ss_pred             cceeecCCCcc
Confidence            88999999863

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.44  E-value=9.1e-08  Score=84.64  Aligned_cols=79  Identities=22%  Similarity=0.381  Sum_probs=61.8

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFST   82 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~   82 (457)
                      +.++++|+.|++++|++++ ++ .++++++|+.|+|++|+++ .+|. +.++++|+.|+|++|++++..| ...++++..
T Consensus       147 ~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~  221 (227)
T d1h6ua2         147 LAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFI  221 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCE
T ss_pred             hcccccccccccccccccc-ch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCE
Confidence            5667889999999999873 33 3888999999999999998 5654 8889999999999999987654 445566666


Q ss_pred             cccc
Q 044428           83 ESFS   86 (457)
Q Consensus        83 ~~~~   86 (457)
                      +.++
T Consensus       222 L~ls  225 (227)
T d1h6ua2         222 VTLT  225 (227)
T ss_dssp             EEEE
T ss_pred             EEee
Confidence            5554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.44  E-value=1.4e-07  Score=86.35  Aligned_cols=86  Identities=23%  Similarity=0.220  Sum_probs=46.4

Q ss_pred             ccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCC-CCccccc
Q 044428            3 IGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVE-GPFRNFS   81 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~-~~~~~~~   81 (457)
                      ++++++|++|+|++|.+.+..+..++.+++|+.+++++|+|++..|..+..+++|+.|++++|++++..|.. ..+.++.
T Consensus       101 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~  180 (284)
T d1ozna_         101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD  180 (284)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             hcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccc
Confidence            455666666666666665444455555666666666666666333344555556666666666665544422 2233444


Q ss_pred             ccccccc
Q 044428           82 TESFSWN   88 (457)
Q Consensus        82 ~~~~~~n   88 (457)
                      .+.+++|
T Consensus       181 ~l~l~~N  187 (284)
T d1ozna_         181 RLLLHQN  187 (284)
T ss_dssp             EEECCSS
T ss_pred             hhhhhhc
Confidence            4444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.42  E-value=1.8e-07  Score=80.84  Aligned_cols=78  Identities=22%  Similarity=0.294  Sum_probs=38.8

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESF   85 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~   85 (457)
                      +.+|+.|++++|.++ .++ .+..+++|++|+|++|++++ +|+ +.++++|+.|++++|.+....+ ...+..+..+.+
T Consensus        39 l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~l  113 (199)
T d2omxa2          39 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTL  113 (199)
T ss_dssp             HTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEC
T ss_pred             hcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccccccc-cccccccccccc
Confidence            445555555555555 342 35555555555555555552 332 5555555555555555544322 233344444444


Q ss_pred             ccc
Q 044428           86 SWN   88 (457)
Q Consensus        86 ~~n   88 (457)
                      +++
T Consensus       114 ~~~  116 (199)
T d2omxa2         114 FNN  116 (199)
T ss_dssp             CSS
T ss_pred             ccc
Confidence            443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.41  E-value=1.8e-07  Score=86.47  Aligned_cols=86  Identities=23%  Similarity=0.145  Sum_probs=75.2

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccc
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTES   84 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~   84 (457)
                      -+++|+.|++++|..++..|..|.+++.++.|++++|++++..|..+..+++|+.|+|++|+|+..++....++++..+.
T Consensus       169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~  248 (305)
T d1xkua_         169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY  248 (305)
T ss_dssp             CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEE
T ss_pred             cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEE
Confidence            36788999999999998889999999999999999999997777888999999999999999997755566788899999


Q ss_pred             cccccc
Q 044428           85 FSWNYA   90 (457)
Q Consensus        85 ~~~n~~   90 (457)
                      +++|..
T Consensus       249 Ls~N~i  254 (305)
T d1xkua_         249 LHNNNI  254 (305)
T ss_dssp             CCSSCC
T ss_pred             CCCCcc
Confidence            998853

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.36  E-value=2.2e-07  Score=80.35  Aligned_cols=83  Identities=31%  Similarity=0.439  Sum_probs=67.5

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .++++++|+.|++++|.+.. + +.+..+++|+.|++++|++. .+| .+..+++|+.|++++|++++..| ...++++.
T Consensus       101 ~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~  175 (199)
T d2omxa2         101 PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLE  175 (199)
T ss_dssp             GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCC
T ss_pred             cccccccccccccccccccc-c-cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCcc-ccCCCCCC
Confidence            46788899999999998874 3 34788999999999999988 555 58888999999999999987644 56778888


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       176 ~L~ls~N~  183 (199)
T d2omxa2         176 RLDISSNK  183 (199)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCC
Confidence            88888885

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.36  E-value=2.5e-07  Score=80.78  Aligned_cols=79  Identities=18%  Similarity=0.246  Sum_probs=57.4

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccccccc
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTESF   85 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~   85 (457)
                      |.+|+.|++++|.++ .++ .+..+++|++|+|++|+++ .+| .+..+++|+.|++++|++++. |....++++..+.+
T Consensus        45 L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~-~l~-~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~l  119 (210)
T d1h6ta2          45 LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSL  119 (210)
T ss_dssp             HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEEC
T ss_pred             hcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCcccc-Ccc-ccccCcccccccccccccccc-cccccccccccccc
Confidence            567888888888887 444 3777888888888888888 455 367788888888888888764 44555666777777


Q ss_pred             cccc
Q 044428           86 SWNY   89 (457)
Q Consensus        86 ~~n~   89 (457)
                      .+|.
T Consensus       120 ~~~~  123 (210)
T d1h6ta2         120 EHNG  123 (210)
T ss_dssp             TTSC
T ss_pred             cccc
Confidence            6664

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.25  E-value=3.4e-07  Score=80.81  Aligned_cols=59  Identities=25%  Similarity=0.360  Sum_probs=52.8

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEeccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQ   64 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~   64 (457)
                      .+++|++|+.|+|++|+++ .+|+ ++++++|++|+|++|+|+ .+|+ +.++++|+.|++++
T Consensus       168 ~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         168 PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTN  226 (227)
T ss_dssp             GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEEE
T ss_pred             hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEeeC
Confidence            4688999999999999999 5654 899999999999999999 6764 89999999999985

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.24  E-value=5.3e-07  Score=85.71  Aligned_cols=80  Identities=21%  Similarity=0.296  Sum_probs=64.8

Q ss_pred             CCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCcccccccc
Q 044428            5 GLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFSTES   84 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~   84 (457)
                      .+.+|++|+|++|.++ .+ +.+..|++|++|+|++|+|+ .+|+ +.++++|+.|++++|++.+..| .+.++++..+.
T Consensus        42 ~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~  116 (384)
T d2omza2          42 DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLT  116 (384)
T ss_dssp             HHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred             HhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccccc-ccccccccccc
Confidence            4678999999999998 56 46888999999999999999 5664 8889999999999999987654 55667777777


Q ss_pred             ccccc
Q 044428           85 FSWNY   89 (457)
Q Consensus        85 ~~~n~   89 (457)
                      ..+|.
T Consensus       117 ~~~~~  121 (384)
T d2omza2         117 LFNNQ  121 (384)
T ss_dssp             CCSSC
T ss_pred             ccccc
Confidence            76654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.20  E-value=7.4e-07  Score=77.62  Aligned_cols=83  Identities=28%  Similarity=0.352  Sum_probs=64.0

Q ss_pred             CccCCccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCCCCCCCCccccc
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIPVEGPFRNFS   81 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p~~~~~~~~~   81 (457)
                      .+.++++|+.|++++|.++ .+ +.+..+++|+.+++++|.+++  +..+..+++|+.+++++|++++..| ...++++.
T Consensus       107 ~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~  181 (210)
T d1h6ta2         107 SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQ  181 (210)
T ss_dssp             GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCC
T ss_pred             ccccccccccccccccccc-cc-ccccccccccccccccccccc--ccccccccccccccccccccccccc-ccCCCCCC
Confidence            4677888999999999887 44 357888888888888888873  3356778888888888888887544 55667788


Q ss_pred             cccccccc
Q 044428           82 TESFSWNY   89 (457)
Q Consensus        82 ~~~~~~n~   89 (457)
                      .+.+++|.
T Consensus       182 ~L~Ls~N~  189 (210)
T d1h6ta2         182 NLYLSKNH  189 (210)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCC
Confidence            88888774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=4.8e-06  Score=74.32  Aligned_cols=132  Identities=16%  Similarity=0.090  Sum_probs=85.4

Q ss_pred             ccCCCCc-eEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CccceeeeeeecCCeeEEEEeccCCCCH
Q 044428          180 LLGIGSF-GSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH--RNLIKILSGCSNLDFKALVLEFMPNGSL  256 (457)
Q Consensus       180 ~lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  256 (457)
                      .+..|.. +.||+....++..+++|......   ...+..|...++.+..  -.+.++++++.+.+..++||+|++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 67999998888889999865432   2346778888877743  3356678888888889999999987654


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 044428          257 EKWLYSHNYFLDILERLNIMIDVGLALEYLH-------------------------------------------------  287 (457)
Q Consensus       257 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH-------------------------------------------------  287 (457)
                      .+..      ..   ....+.+++..|.-||                                                 
T Consensus        94 ~~~~------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3210      00   0011112222222222                                                 


Q ss_pred             --hcC---CCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          288 --YGH---ALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       288 --~~~---~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                        ...   ....++|+|+.|.||+++++..+-|.||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence              111   122379999999999999887778999997654

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.06  E-value=5.4e-07  Score=75.10  Aligned_cols=42  Identities=33%  Similarity=0.362  Sum_probs=21.3

Q ss_pred             cCCCCCCCeEeCcCCccCCCC---CccchhcCCCceEecccccCCC
Q 044428           27 FGSLISLESLDLSSNNLSGEI---PKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus        27 ~~~l~~l~~l~l~~n~l~g~~---p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      +.++++|++|+||+|+|+ .+   +..+..+++|+.|+|++|.++.
T Consensus        61 ~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~  105 (162)
T d1koha1          61 EENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKS  105 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred             HHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCcccc
Confidence            344555555555555555 22   2234445555555555555554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.97  E-value=5.5e-06  Score=77.22  Aligned_cols=57  Identities=35%  Similarity=0.362  Sum_probs=43.1

Q ss_pred             CccCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCCCC
Q 044428            6 LKDLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLEGE   70 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~   70 (457)
                      +++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|+|++|+++..
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~l  339 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREF  339 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCC
Confidence            467888888888888 77764   467778888888888 77764   35678888888888743

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.91  E-value=8.7e-06  Score=75.79  Aligned_cols=53  Identities=34%  Similarity=0.404  Sum_probs=33.9

Q ss_pred             cCCeeeccCCcccccCCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccccCC
Q 044428            8 DLATLSLAANKFHGPIPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQNRLE   68 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n~l~   68 (457)
                      +|+.|+|++|.|+ .+|+.   +++|++|+|++|+|+ .+|..+.   +|+.|++++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~---~L~~L~l~~n~l~   91 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLK   91 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCT---TCCEEECCSSCCS
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchh---hhhhhhhhhcccc
Confidence            5677777777777 67754   456777777777777 7776543   4455555555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.78  E-value=9.6e-07  Score=73.53  Aligned_cols=67  Identities=22%  Similarity=0.269  Sum_probs=54.9

Q ss_pred             cCCccCCeeeccCCcccccC---CcccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEecccccCCCCCC
Q 044428            4 GGLKDLATLSLAANKFHGPI---PKSFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQNRLEGEIP   72 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~~---p~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~n~l~~~~p   72 (457)
                      ..+++|++|+|++|+|+ .+   +..+..+++|+.|+|++|+++ .+++ .......|+.|++++|.+.....
T Consensus        62 ~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          62 ENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             HHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             HhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence            35889999999999998 44   345778999999999999999 7776 33344578999999999987655

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.56  E-value=2.5e-05  Score=68.91  Aligned_cols=80  Identities=21%  Similarity=0.262  Sum_probs=45.6

Q ss_pred             cCCeeeccCCcccccCCc-ccCCCCCCCeEeCcCCccCCCCCc-cchhcCCCceEeccc-ccCCCCCCCC-CCccccccc
Q 044428            8 DLATLSLAANKFHGPIPK-SFGSLISLESLDLSSNNLSGEIPK-SLEALLYLKQLNVSQ-NRLEGEIPVE-GPFRNFSTE   83 (457)
Q Consensus         8 ~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~L~~l~l~~-n~l~~~~p~~-~~~~~~~~~   83 (457)
                      ++++|+|++|+|+ .+|. .|.++++|++|+|++|.+...+|. .+..++.++.+.+.. |++....+.. ..++++..+
T Consensus        30 ~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l  108 (242)
T d1xwdc1          30 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  108 (242)
T ss_dssp             CCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred             CCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence            5666777777776 4443 466677777777777766654543 455666666666543 4554444331 233455555


Q ss_pred             ccccc
Q 044428           84 SFSWN   88 (457)
Q Consensus        84 ~~~~n   88 (457)
                      .+.+|
T Consensus       109 ~l~~~  113 (242)
T d1xwdc1         109 LISNT  113 (242)
T ss_dssp             EEESC
T ss_pred             ccchh
Confidence            55554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.47  E-value=0.00027  Score=66.95  Aligned_cols=75  Identities=15%  Similarity=0.102  Sum_probs=47.0

Q ss_pred             CccCCCCceEEEEEEeC-CCCEEEEEEecccc-------hhhHHHHHHHHHHHhhcC-C--CccceeeeeeecCCeeEEE
Q 044428          179 NLLGIGSFGSVYKGTLS-DGTNVAIKIFNLQL-------ERTFVSFNSECEVLRNVR-H--RNLIKILSGCSNLDFKALV  247 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  247 (457)
                      +.||.|....||+.+.. +++.++||.-....       .........|.+.++.+. +  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999875 46789999653211       112223456888777662 2  234445544  44566899


Q ss_pred             EeccCCCC
Q 044428          248 LEFMPNGS  255 (457)
Q Consensus       248 ~e~~~~g~  255 (457)
                      |||+++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.47  E-value=4.4e-05  Score=67.19  Aligned_cols=71  Identities=23%  Similarity=0.323  Sum_probs=61.0

Q ss_pred             CccCCccCCeeeccCCcccccCCc-ccCCCCCCCeEeCc-CCccCCCCCccchhcCCCceEecccccCCCCCC
Q 044428            2 TIGGLKDLATLSLAANKFHGPIPK-SFGSLISLESLDLS-SNNLSGEIPKSLEALLYLKQLNVSQNRLEGEIP   72 (457)
Q Consensus         2 ~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~-~n~l~g~~p~~~~~~~~L~~l~l~~n~l~~~~p   72 (457)
                      .|.+|++|++|+|++|.+...+|. .|.++++++.|+++ .|++....|..+.++++|+.+++++|.+....+
T Consensus        48 ~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~  120 (242)
T d1xwdc1          48 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD  120 (242)
T ss_dssp             TTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred             Hhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccc
Confidence            478899999999999999877764 68899999999976 578887777789999999999999999986543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.25  E-value=0.00091  Score=61.46  Aligned_cols=135  Identities=11%  Similarity=0.088  Sum_probs=77.4

Q ss_pred             ceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcc--ceeee-----eeecCCeeEEEEeccCCCCHH-
Q 044428          186 FGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRHRNL--IKILS-----GCSNLDFKALVLEFMPNGSLE-  257 (457)
Q Consensus       186 ~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~-  257 (457)
                      --.||+++.++|+.+++|+.+... .+..++..|...+..+....+  +..+.     .....+..+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            357999999999999999986542 244567788888887742222  11111     223456778899999764221 


Q ss_pred             ----H------H---Hhh----C----CCCCCHH-------------------HHHHHHHHHHHHHHHHHh---cCCCCC
Q 044428          258 ----K------W---LYS----H----NYFLDIL-------------------ERLNIMIDVGLALEYLHY---GHALAP  294 (457)
Q Consensus       258 ----~------~---l~~----~----~~~l~~~-------------------~~~~i~~~ia~~l~~LH~---~~~~~~  294 (457)
                          .      .   ++.    .    ....++.                   .+..+...+...++.+..   .....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                0      1   110    0    0111211                   111122222223333322   112456


Q ss_pred             eeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          295 IIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       295 ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                      ++|+|+.+.|||++++  ..+.||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899997764

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.01  E-value=0.00026  Score=63.91  Aligned_cols=36  Identities=31%  Similarity=0.375  Sum_probs=17.5

Q ss_pred             CCCCCCeEeCcCC-ccCCCCCccchhcCCCceEeccc
Q 044428           29 SLISLESLDLSSN-NLSGEIPKSLEALLYLKQLNVSQ   64 (457)
Q Consensus        29 ~l~~l~~l~l~~n-~l~g~~p~~~~~~~~L~~l~l~~   64 (457)
                      ++++|++|+|++| .+++..+..+.++++|+.|+|++
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~  209 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR  209 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCC
Confidence            3445555555443 34444444445555555555554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.86  E-value=0.0042  Score=56.40  Aligned_cols=159  Identities=11%  Similarity=0.010  Sum_probs=86.8

Q ss_pred             ccCHHHHHHHhhcCCcCCc-----cCCCCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-----Ccc
Q 044428          162 RISYLDIQRATNEFDECNL-----LGIGSFGSVYKGTLSDGTNVAIKIFNLQLERTFVSFNSECEVLRNVRH-----RNL  231 (457)
Q Consensus       162 ~~~~~~l~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-----~ni  231 (457)
                      .++..++.....+|...+.     |..|---+.|+.+..+|+ +++|+.....  ...+...|++++..+..     |..
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            3567788888888877544     345666788999887665 8999986432  22344556777776632     222


Q ss_pred             ceee-e--eeecCCeeEEEEeccCCCCHH--------------HHHhh----CC-----CCCCH----------------
Q 044428          232 IKIL-S--GCSNLDFKALVLEFMPNGSLE--------------KWLYS----HN-----YFLDI----------------  269 (457)
Q Consensus       232 v~l~-~--~~~~~~~~~lv~e~~~~g~L~--------------~~l~~----~~-----~~l~~----------------  269 (457)
                      +... |  +.........++.+..+....              ..++.    ..     ....+                
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            2211 1  112234556677776653221              01110    00     00000                


Q ss_pred             -HHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCCeeecCCCcEEEeccccccc
Q 044428          270 -LERLNIMIDVGLALEYLHYGHALAPIIHCDLKPSNILLDENMVAHVSDFGISKL  323 (457)
Q Consensus       270 -~~~~~i~~~ia~~l~~LH~~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~  323 (457)
                       ......+......+...+...-..++||+|+.+.||+++.+...-|.||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence             011122222333333333222256799999999999999988888999997753

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.85  E-value=0.00011  Score=70.58  Aligned_cols=14  Identities=36%  Similarity=0.366  Sum_probs=6.9

Q ss_pred             CCCCeEeCcCCccC
Q 044428           31 ISLESLDLSSNNLS   44 (457)
Q Consensus        31 ~~l~~l~l~~n~l~   44 (457)
                      ++|++|+|++|+++
T Consensus       340 ~~L~~L~Ls~N~i~  353 (460)
T d1z7xw1         340 RFLLELQISNNRLE  353 (460)
T ss_dssp             SSCCEEECCSSBCH
T ss_pred             cchhhhheeeeccc
Confidence            34555555555544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.82  E-value=0.00014  Score=65.81  Aligned_cols=65  Identities=18%  Similarity=0.151  Sum_probs=53.2

Q ss_pred             cCCccCCeeeccCCccccc-CCcccCCCCCCCeEeCcCCccCCCCCccchhcCCCceEecccc-cCC
Q 044428            4 GGLKDLATLSLAANKFHGP-IPKSFGSLISLESLDLSSNNLSGEIPKSLEALLYLKQLNVSQN-RLE   68 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~-~p~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~L~~l~l~~n-~l~   68 (457)
                      ....+|+.|+|+++.++.. ++.-+.++++|++|+|+++++++..+..++.+++|+.|+++++ .++
T Consensus        43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it  109 (284)
T d2astb2          43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS  109 (284)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred             ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence            3467889999999988754 4455788999999999999998888888888999999999884 454

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.76  E-value=0.0015  Score=61.73  Aligned_cols=72  Identities=15%  Similarity=0.158  Sum_probs=49.1

Q ss_pred             CccCCCCceEEEEEEeCCC--------CEEEEEEecccchhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCeeEEEEe
Q 044428          179 NLLGIGSFGSVYKGTLSDG--------TNVAIKIFNLQLERTFVSFNSECEVLRNVR-HRNLIKILSGCSNLDFKALVLE  249 (457)
Q Consensus       179 ~~lg~G~~g~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  249 (457)
                      +.|+.|-.-.+|+....++        ..|.+++... . .......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4688899999999987543        4577777652 2 22345668888888884 4333467777653    68999


Q ss_pred             ccCCCCH
Q 044428          250 FMPNGSL  256 (457)
Q Consensus       250 ~~~~g~L  256 (457)
                      |+++.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.60  E-value=0.00022  Score=68.26  Aligned_cols=85  Identities=18%  Similarity=0.210  Sum_probs=50.6

Q ss_pred             CCccCCeeeccCCccc----ccCCcccCCCCCCCeEeCcCCccCCC----CCccch-hcCCCceEecccccCCCC----C
Q 044428            5 GLKDLATLSLAANKFH----GPIPKSFGSLISLESLDLSSNNLSGE----IPKSLE-ALLYLKQLNVSQNRLEGE----I   71 (457)
Q Consensus         5 ~l~~L~~l~l~~N~l~----g~~p~~~~~l~~l~~l~l~~n~l~g~----~p~~~~-~~~~L~~l~l~~n~l~~~----~   71 (457)
                      .|++|+.|+|++|.|+    ..|+..+..+++|++|||++|+|+..    +...+. ...+|+.|+|++|+++..    +
T Consensus        25 ~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l  104 (460)
T d1z7xw1          25 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL  104 (460)
T ss_dssp             HHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             hCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccc
Confidence            4667778888888776    13445566777888888888877521    111221 123678888888877643    1


Q ss_pred             C-CCCCccccccccccccc
Q 044428           72 P-VEGPFRNFSTESFSWNY   89 (457)
Q Consensus        72 p-~~~~~~~~~~~~~~~n~   89 (457)
                      + ......++..+.+++|.
T Consensus       105 ~~~l~~~~~L~~L~L~~N~  123 (460)
T d1z7xw1         105 SSTLRTLPTLQELHLSDNL  123 (460)
T ss_dssp             HHHTTSCTTCCEEECCSSB
T ss_pred             cchhhcccccccccccccc
Confidence            1 12234556666666664

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=96.20  E-value=0.00041  Score=64.25  Aligned_cols=62  Identities=21%  Similarity=0.287  Sum_probs=28.4

Q ss_pred             CccCCeeeccCCcccc----cCCcccCCCCCCCeEeCcCCccCCC-----CCccchhcCCCceEecccccC
Q 044428            6 LKDLATLSLAANKFHG----PIPKSFGSLISLESLDLSSNNLSGE-----IPKSLEALLYLKQLNVSQNRL   67 (457)
Q Consensus         6 l~~L~~l~l~~N~l~g----~~p~~~~~l~~l~~l~l~~n~l~g~-----~p~~~~~~~~L~~l~l~~n~l   67 (457)
                      .+.|+.|++++|+++-    .+...+..+++|+.|+|++|+++..     +...+..+++|+.|+|++|.+
T Consensus       157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i  227 (344)
T d2ca6a1         157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF  227 (344)
T ss_dssp             CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred             Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccc
Confidence            3445555555555431    1222233445555555555554421     222344445555555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=96.18  E-value=0.00048  Score=63.82  Aligned_cols=86  Identities=16%  Similarity=0.184  Sum_probs=61.6

Q ss_pred             cCCccCCeeeccCCccccc-----CCcccCCCCCCCeEeCcCCccCCC----CCccchhcCCCceEecccccCCCCCCC-
Q 044428            4 GGLKDLATLSLAANKFHGP-----IPKSFGSLISLESLDLSSNNLSGE----IPKSLEALLYLKQLNVSQNRLEGEIPV-   73 (457)
Q Consensus         4 ~~l~~L~~l~l~~N~l~g~-----~p~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~L~~l~l~~n~l~~~~p~-   73 (457)
                      ..++.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..++.|+.|+|++|.+++.-.. 
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~  262 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  262 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence            4567899999999998631     345577889999999999998632    455677888999999999988753110 


Q ss_pred             ------CCCccccccccccccc
Q 044428           74 ------EGPFRNFSTESFSWNY   89 (457)
Q Consensus        74 ------~~~~~~~~~~~~~~n~   89 (457)
                            ......+..+.+++|.
T Consensus       263 l~~~l~~~~~~~L~~L~ls~N~  284 (344)
T d2ca6a1         263 VVDAFSKLENIGLQTLRLQYNE  284 (344)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSC
T ss_pred             HHHHhhhccCCCCCEEECCCCc
Confidence                  0123456677777774

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=95.45  E-value=0.0028  Score=51.97  Aligned_cols=65  Identities=18%  Similarity=0.222  Sum_probs=48.8

Q ss_pred             CCccCCeeeccCC-ccccc----CCcccCCCCCCCeEeCcCCccCCC----CCccchhcCCCceEecccccCCC
Q 044428            5 GLKDLATLSLAAN-KFHGP----IPKSFGSLISLESLDLSSNNLSGE----IPKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         5 ~l~~L~~l~l~~N-~l~g~----~p~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      +.++|++|+|+++ .++-.    +-..+...++|++|+|++|.++..    +-..+...+.|+.|+|++|.++.
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence            5689999999974 46422    233567788999999999998742    22345566899999999999874

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=95.27  E-value=0.002  Score=52.85  Aligned_cols=67  Identities=19%  Similarity=0.193  Sum_probs=50.1

Q ss_pred             ccCCccCCeeeccCCccccc----CCcccCCCCCCCeEeCcCCccCCCC----CccchhcCCCceEecccccCCC
Q 044428            3 IGGLKDLATLSLAANKFHGP----IPKSFGSLISLESLDLSSNNLSGEI----PKSLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~n~l~g~~----p~~~~~~~~L~~l~l~~n~l~~   69 (457)
                      +...++|+.|+|++|.++-.    +-..+...+.|++|+|++|.++..=    -..+...++|+.|++++|.+..
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~  114 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSV  114 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCC
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCC
Confidence            45678899999999999732    2234556789999999999998432    2235556789999999997653

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.45  E-value=0.017  Score=46.73  Aligned_cols=66  Identities=18%  Similarity=0.226  Sum_probs=48.5

Q ss_pred             cCCccCCeeeccC-Cccccc----CCcccCCCCCCCeEeCcCCccCCCCCc----cchhcCCCceEecccccCCC
Q 044428            4 GGLKDLATLSLAA-NKFHGP----IPKSFGSLISLESLDLSSNNLSGEIPK----SLEALLYLKQLNVSQNRLEG   69 (457)
Q Consensus         4 ~~l~~L~~l~l~~-N~l~g~----~p~~~~~l~~l~~l~l~~n~l~g~~p~----~~~~~~~L~~l~l~~n~l~~   69 (457)
                      .+.++|+.|+|++ |.++..    +=..+...++|++|+|++|.++..--.    .+...++|+.+++++|.++.
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            4578999999997 556422    223456789999999999998743222    34556899999999998863

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=88.62  E-value=0.037  Score=44.66  Aligned_cols=66  Identities=20%  Similarity=0.307  Sum_probs=47.7

Q ss_pred             ccCCccCCeeeccCCccccc----CCcccCCCCCCCeEeCcCCccCCC----CCccchhcCCCceEec--ccccCC
Q 044428            3 IGGLKDLATLSLAANKFHGP----IPKSFGSLISLESLDLSSNNLSGE----IPKSLEALLYLKQLNV--SQNRLE   68 (457)
Q Consensus         3 ~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~L~~l~l--~~n~l~   68 (457)
                      +...++|+.|+|++|.++..    +-..+...++|+.|++++|.++..    +-..+...++|+.++|  ++|.+.
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence            45788999999999998643    223455678999999999998743    2245566788987555  556554